data_6rh5_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6rh5 _Structure_validation_residue.Date_analyzed 2019-08-30 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.3 m . . . . . 0 CA--C 1.529 0.156 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.2 p -68.45 144.81 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 121.557 -0.714 . . . . 0.0 112.544 178.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.5 mt -129.5 -39.81 1.46 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.685 1.594 . . . . 0.0 112.508 -172.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 45.2 t -152.7 134.74 14.85 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.693 1.197 . . . . 0.0 110.384 173.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 94.6 t -130.28 127.24 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.363 1.065 . . . . 0.0 109.68 171.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -131.62 142.07 43.98 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 124.496 1.118 . . . . 0.0 112.206 173.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.6 -15.46 19.45 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.851 3.034 . . . . 0.0 114.972 -175.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -135.48 108.28 7.54 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.072 0.949 . . . . 0.0 111.653 -170.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 p -145.49 144.62 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 125.522 1.529 . . . . 0.0 110.213 171.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.1 m -126.04 129.15 48.58 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.12 0.968 . . . . 0.0 111.371 -171.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.5 t -96.05 136.82 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.738 1.615 . . . . 0.0 112.294 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -129.86 127.92 41.21 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.39 1.476 . . . . 0.0 109.407 170.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -70.1 123.76 22.4 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.359 0.664 . . . . 0.0 109.491 165.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.6 pt . . . . . 0 N--CA 1.477 0.88 0 C-N-CA 124.785 1.234 . . . . 0.0 113.57 -168.055 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 17.7 m-30 . . . . . 0 CA--C 1.534 0.34 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.86 19.84 10.92 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -174.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 56.81 -48.33 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.932 2.493 . . . . 0.0 115.455 -170.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.9 m -67.58 -15.07 63.46 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.294 1.838 . . . . 0.0 114.85 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.82 -15.99 56.35 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.701 0.8 . . . . 0.0 112.502 172.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 17.9 m0 -86.22 169.52 12.96 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.382 1.473 . . . . 0.0 111.178 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -78.88 57.25 2.09 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.189 1.796 . . . . 0.0 114.211 -177.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.7 mt -61.75 -20.35 63.44 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -95.49 -12.97 24.96 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.509 1.124 . . . . 0.0 112.592 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -152.09 69.72 7.62 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 125.61 1.564 . . . . 0.0 112.265 -165.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -54.37 147.22 47.59 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.471 2.781 . . . . 0.0 113.358 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -72.51 -29.3 63.49 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.195 0.598 . . . . 0.0 111.427 168.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.2 t90 -156.95 154.58 29.92 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.37 1.468 . . . . 0.0 111.058 173.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.2 p -133.93 148.82 51.25 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.239 1.015 . . . . 0.0 111.81 168.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.37 -142.88 5.69 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 123.067 0.365 . . . . 0.0 113.48 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.7 mtm105 -110.51 148.19 32.61 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.305 1.842 . . . . 0.0 112.103 -173.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.0 tp -92.91 137.85 32.0 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.22 1.808 . . . . 0.0 110.277 172.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.6 ttt85 -143.98 88.71 1.98 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.043 1.337 . . . . 0.0 110.869 169.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 25.2 mt -75.78 127.63 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 170.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.1 p -138.62 170.39 16.08 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.664 1.986 . . . . 0.0 110.071 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.9 t -157.85 159.46 36.68 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.804 -1.185 . . . . 0.0 112.198 175.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -146.86 120.76 9.32 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.775 0.798 . . . . 0.0 111.843 159.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.43 -119.65 11.79 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 125.753 1.644 . . . . 0.0 110.139 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -95.55 13.49 25.97 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.6 1.56 . . . . 0.0 113.708 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.0 m -127.58 110.78 13.05 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.934 0.894 . . . . 0.0 111.063 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.85 159.46 19.07 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.405 0.682 . . . . 0.0 111.364 171.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -139.76 105.98 5.25 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.302 1.841 . . . . 0.0 109.252 -174.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.7 mp -82.61 97.55 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 168.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.4 mttp -94.31 139.29 31.27 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.38 0.672 . . . . 0.0 111.448 174.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.5 mp -112.34 135.51 52.94 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.445 1.898 . . . . 0.0 109.775 172.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -136.15 153.67 51.2 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.941 0.896 . . . . 0.0 113.018 -172.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -74.12 143.94 45.12 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.931 0.872 . . . . 0.0 111.969 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 pttt -84.87 -6.46 59.35 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.371 1.868 . . . . 0.0 115.124 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 92.0 t -122.4 -44.58 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 125.234 1.414 . . . . 0.0 111.396 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.7 m -91.72 -23.5 19.76 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -175.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.33 7.04 86.91 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 123.776 0.703 . . . . 0.0 113.586 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -82.81 155.55 24.13 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.327 1.451 . . . . 0.0 112.326 -175.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.7 tp -72.31 125.98 28.69 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.372 0.669 . . . . 0.0 110.684 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -84.51 -53.9 5.11 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.944 0.898 . . . . 0.0 110.915 169.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.34 161.3 37.6 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.067 1.347 . . . . 0.0 111.357 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -142.67 139.89 31.37 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.391 0.676 . . . . 0.0 112.382 171.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.98 110.54 41.57 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 124.854 1.261 . . . . 0.0 111.135 176.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -80.52 140.45 13.39 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.894 3.063 . . . . 0.0 111.565 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.1 t -134.83 131.26 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.805 1.642 . . . . 0.0 109.817 -172.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -97.47 -19.8 18.18 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -163.53 150.46 12.31 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.97 2.108 . . . . 0.0 110.085 175.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -125.57 130.67 24.01 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.558 1.143 . . . . 0.0 112.452 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -60.46 151.29 50.81 Favored 'Cis proline' 0 CA--C 1.54 0.781 0 CA-C-N 119.919 1.007 . . . . 0.0 113.313 -12.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.35 -171.35 29.49 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.909 1.242 . . . . 0.0 113.485 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.6 tp -59.29 -31.51 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.54 4.27 53.9 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -172.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.7 t -148.98 130.35 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.162 0.985 . . . . 0.0 111.233 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -140.39 162.4 35.41 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.325 1.85 . . . . 0.0 112.545 -176.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 38.8 p -117.33 158.03 25.09 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 127.1 2.16 . . . . 0.0 111.587 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.0 m -85.21 173.46 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.556 1.142 . . . . 0.0 111.385 168.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 72.5 p -94.49 -32.5 13.47 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.238 1.415 . . . . 0.0 113.17 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -94.59 -40.91 9.59 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -163.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.5 t -141.02 130.35 23.68 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -175.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.1 m -73.01 16.38 0.16 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -171.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.457 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.28 33.5 ptt180 -111.44 18.5 19.1 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 178.631 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -139.32 135.55 33.9 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.078 0.951 . . . . 0.0 110.842 -172.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -133.77 163.81 28.63 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.907 1.283 . . . . 0.0 111.016 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.7 t -120.6 142.59 35.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 124.583 1.153 . . . . 0.0 108.744 167.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.89 148.0 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 118.721 0.692 . . . . 0.0 112.425 173.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -89.88 81.77 6.28 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.675 0.79 . . . . 0.0 111.369 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -67.09 142.52 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 122.577 0.351 . . . . 0.0 111.372 177.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 . . . . . 0 N--CA 1.469 0.487 0 C-N-CA 125.733 1.613 . . . . 0.0 111.68 -171.382 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.2 p . . . . . 0 C--O 1.234 0.288 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.76 145.76 31.83 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.282 1.433 . . . . 0.0 110.869 169.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -90.66 118.36 30.04 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.131 0.573 . . . . 0.0 109.485 168.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.4 pt -117.27 141.54 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.306 1.042 . . . . 0.0 110.753 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.9 143.41 17.07 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 174.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.0 pt -128.87 140.86 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 125.341 1.456 . . . . 0.0 111.679 173.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -119.66 143.91 17.24 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.042 1.306 . . . . 0.0 113.338 175.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -106.88 167.86 9.59 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.352 1.861 . . . . 0.0 111.032 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.8 t -71.78 -36.09 70.23 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.738 -0.601 . . . . 0.0 112.304 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -153.07 153.32 32.61 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.204 -0.935 . . . . 0.0 112.299 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -58.07 -36.69 73.16 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.652 1.181 . . . . 0.0 112.096 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.95 -13.42 64.11 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 123.916 0.77 . . . . 0.0 114.408 177.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -102.44 -34.07 9.29 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 118.431 1.115 . . . . 0.0 112.376 170.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.457 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -64.07 -29.97 71.07 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.088 -1.008 . . . . 0.0 113.253 170.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -54.95 -33.35 62.21 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.603 -0.686 . . . . 0.0 112.289 168.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -69.25 -33.75 73.74 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.087 -1.008 . . . . 0.0 112.028 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -60.56 -50.32 74.03 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.143 0.977 . . . . 0.0 111.475 171.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.49 -26.27 45.91 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -177.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.5 t -77.39 -43.25 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 119.301 0.955 . . . . 0.0 111.246 175.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 96.7 p -64.85 -31.03 72.07 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.36 0.982 . . . . 0.0 113.103 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.7 mt -69.03 -54.89 12.75 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.063 0.945 . . . . 0.0 112.061 170.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -67.22 -29.71 69.44 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.055 -1.028 . . . . 0.0 112.978 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -82.84 -2.7 55.39 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.566 1.147 . . . . 0.0 112.672 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 63.9 t60 -88.39 -42.6 12.07 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.391 -0.818 . . . . 0.0 111.812 157.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -84.44 -7.24 59.35 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -172.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.481 1.092 0 CA-C-N 120.971 1.714 . . . . 0.0 115.366 -173.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.8 m . . . . . 0 N--CA 1.467 0.387 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.0 t -63.75 142.49 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 124.005 0.922 . . . . 0.0 111.761 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.7 mt -128.31 -43.56 1.45 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.309 1.443 . . . . 0.0 112.592 -176.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 34.2 t -148.39 135.16 19.91 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.379 1.072 . . . . 0.0 111.037 175.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.1 t -128.55 128.03 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.734 1.214 . . . . 0.0 109.539 172.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -124.9 135.28 26.53 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 125.577 1.551 . . . . 0.0 109.774 172.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -73.54 -29.57 10.8 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.918 2.412 . . . . 0.0 115.179 -168.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -138.16 114.92 10.64 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.263 1.03 . . . . 0.0 111.86 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.2 p -143.43 149.01 18.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 127.788 2.435 . . . . 0.0 109.004 176.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.2 m -123.3 132.02 53.86 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.257 0.623 . . . . 0.0 112.17 -167.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.7 t -96.24 138.21 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.837 1.655 . . . . 0.0 111.904 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -130.19 136.77 49.61 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.139 -1.392 . . . . 0.0 110.31 171.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -56.6 137.43 53.78 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.296 151.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.3 pt . . . . . 0 N--CA 1.473 0.71 0 C-N-CA 125.182 1.393 . . . . 0.0 111.258 178.099 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 18.8 m-30 . . . . . 0 C--O 1.22 -0.463 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.66 16.35 9.53 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -172.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.65 -46.5 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 128.152 2.581 . . . . 0.0 115.547 -171.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 94.5 p -68.41 -18.59 64.48 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.536 1.935 . . . . 0.0 115.082 -176.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -85.94 -1.95 57.81 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.22 1.008 . . . . 0.0 113.402 171.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.9 m0 -90.72 174.12 7.66 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.925 1.29 . . . . 0.0 110.952 174.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -76.67 47.98 0.53 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.855 1.662 . . . . 0.0 114.646 -176.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.2 mt -56.4 -33.55 65.87 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 -169.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -91.5 -2.51 57.18 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -145.74 71.99 13.86 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 125.868 1.667 . . . . 0.0 111.994 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -52.5 138.11 57.38 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.513 2.142 . . . . 0.0 112.088 174.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -73.09 -25.24 60.81 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.11 0.564 . . . . 0.0 111.194 172.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 50.4 t90 -155.84 154.08 30.74 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.69 1.596 . . . . 0.0 110.801 170.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.8 p -134.28 151.29 51.19 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.663 0.785 . . . . 0.0 112.001 165.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 173.04 -149.66 11.52 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 123.155 0.407 . . . . 0.0 113.484 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.0 mtt180 -94.35 141.15 28.91 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.227 1.811 . . . . 0.0 111.609 -174.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 24.9 tp -79.22 138.04 37.65 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 157.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.7 ttt-85 -144.82 87.47 1.85 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.234 1.016 . . . . 0.0 110.905 167.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.5 mt -72.44 127.07 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 172.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.5 p -134.19 165.02 26.07 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.697 1.999 . . . . 0.0 109.933 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.4 m -147.57 161.56 40.87 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.807 1.243 . . . . 0.0 112.212 175.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -150.6 118.09 6.09 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.307 0.643 . . . . 0.0 111.482 157.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 65.14 -132.23 36.22 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.034 1.302 . . . . 0.0 110.635 -175.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -85.92 22.65 1.64 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.902 1.681 . . . . 0.0 113.922 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.1 m -131.71 126.66 35.08 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.768 1.227 . . . . 0.0 110.282 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.63 160.04 14.59 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.659 1.184 . . . . 0.0 110.94 168.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -142.07 105.43 4.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.372 1.869 . . . . 0.0 108.986 -173.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.3 mp -81.03 95.99 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 169.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -92.04 137.95 31.94 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.274 0.63 . . . . 0.0 110.813 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.8 mp -112.43 128.88 56.44 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.814 1.646 . . . . 0.0 109.723 174.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -135.66 148.83 49.1 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.157 0.983 . . . . 0.0 111.639 -169.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -69.31 139.86 54.32 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 120.432 -1.417 . . . . 0.0 111.72 -176.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.5 pttt -79.74 -4.56 52.47 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -177.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.8 t -123.06 -43.59 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 125.297 1.439 . . . . 0.0 111.363 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.4 m -94.42 -21.97 18.59 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.41 15.37 77.2 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.143 0.878 . . . . 0.0 113.788 -176.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -88.5 148.44 24.15 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.212 1.405 . . . . 0.0 112.056 -176.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.6 tp -71.59 126.78 30.57 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.445 -0.784 . . . . 0.0 111.272 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -84.83 -58.9 2.52 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.055 0.942 . . . . 0.0 110.552 168.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.84 165.8 35.41 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.109 1.363 . . . . 0.0 111.369 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -142.46 143.0 32.41 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.333 0.653 . . . . 0.0 112.47 171.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.37 105.85 41.19 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 124.871 1.268 . . . . 0.0 110.99 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -77.22 145.06 23.92 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.792 2.995 . . . . 0.0 111.948 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.2 t -138.03 127.36 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 126.245 1.818 . . . . 0.0 109.58 -172.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -91.32 -22.77 20.37 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.66 147.83 13.93 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.412 1.885 . . . . 0.0 110.437 170.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -116.33 129.97 24.83 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.589 1.156 . . . . 0.0 110.956 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.83 149.09 79.9 Favored 'Cis proline' 0 CA--C 1.543 0.946 0 CA-C-N 119.824 0.973 . . . . 0.0 112.733 -6.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.68 -164.38 13.14 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.6 1.571 . . . . 0.0 112.548 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 19.3 tt -72.42 -35.58 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 121.654 -0.909 . . . . 0.0 112.979 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.67 6.26 21.55 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -167.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.0 t -151.37 129.18 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.508 1.523 . . . . 0.0 109.984 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -141.77 162.22 36.01 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.217 1.807 . . . . 0.0 112.86 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.5 p -109.75 160.35 16.4 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.792 2.037 . . . . 0.0 111.431 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.4 m -85.95 175.45 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 124.477 1.111 . . . . 0.0 111.398 168.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 71.8 p -91.18 -36.84 13.72 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.954 1.702 . . . . 0.0 112.098 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -89.33 -43.59 10.82 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -166.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.6 t -142.45 122.45 13.65 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -171.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.58 -9.06 23.38 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -169.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.438 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.305 49.0 ptt85 -84.73 19.33 2.07 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 178.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -139.13 139.94 37.78 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.479 1.512 . . . . 0.0 111.977 -176.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -140.66 162.21 35.94 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.437 1.495 . . . . 0.0 111.683 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 78.6 t -116.14 142.27 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.372 1.069 . . . . 0.0 109.294 166.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.67 147.3 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 118.98 0.809 . . . . 0.0 112.399 173.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -88.91 82.5 6.71 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.833 0.853 . . . . 0.0 111.187 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.5 pt -63.36 144.71 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 120.819 0.342 . . . . 0.0 111.696 174.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 . . . . . 0 N--CA 1.466 0.338 0 C-N-CA 125.661 1.584 . . . . 0.0 110.868 -178.606 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.1 p . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.15 145.16 29.45 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.941 1.296 . . . . 0.0 111.389 171.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -90.66 114.53 26.85 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.794 0.837 . . . . 0.0 109.322 170.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.4 pt -115.01 148.73 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.875 1.27 . . . . 0.0 111.228 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.04 143.91 16.91 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 174.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.7 pt -128.24 144.01 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 125.386 1.474 . . . . 0.0 111.34 169.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.16 139.6 11.08 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.888 1.233 . . . . 0.0 112.967 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -101.17 157.18 16.96 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.814 1.646 . . . . 0.0 111.466 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.1 t -73.52 -20.27 60.7 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.911 0.884 . . . . 0.0 112.822 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -152.24 148.79 27.98 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.526 1.13 . . . . 0.0 111.935 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 47.4 ttt-85 -63.04 -31.53 72.68 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.642 1.177 . . . . 0.0 113.503 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.52 -31.76 79.67 Favored Glycine 0 CA--C 1.536 1.365 0 CA-C-N 119.039 0.836 . . . . 0.0 113.572 176.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -78.39 -35.44 47.19 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.771 -0.841 . . . . 0.0 111.407 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.438 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -65.97 -37.13 85.17 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.926 0.891 . . . . 0.0 113.209 168.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.21 -40.44 97.48 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.508 -0.745 . . . . 0.0 111.25 171.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -62.33 -36.76 83.2 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.592 1.087 . . . . 0.0 112.55 172.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -57.42 -56.33 23.3 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.392 0.996 . . . . 0.0 112.017 171.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -75.7 -24.68 56.26 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -176.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.5 -38.68 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 121.058 -1.027 . . . . 0.0 110.773 173.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 41.2 t -57.67 -38.55 75.3 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.406 0.683 . . . . 0.0 112.529 176.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.9 -52.32 20.81 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.456 0.702 . . . . 0.0 112.36 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -67.57 -28.48 67.81 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.045 -1.034 . . . . 0.0 113.064 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -83.91 0.1 49.15 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.581 1.152 . . . . 0.0 112.724 175.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -89.51 -39.97 12.97 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.253 -0.904 . . . . 0.0 112.284 161.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -91.99 -1.92 57.0 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -172.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.481 1.125 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.7 m . . . . . 0 N--CA 1.468 0.454 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.0 t -65.43 145.83 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.473 1.109 . . . . 0.0 111.409 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.6 mt -129.86 -39.73 1.4 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.124 1.769 . . . . 0.0 112.309 -172.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 37.6 t -152.15 137.38 17.47 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.687 1.195 . . . . 0.0 110.646 174.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 88.5 t -129.77 126.87 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.764 1.226 . . . . 0.0 109.275 171.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -126.78 136.08 28.24 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 125.677 1.591 . . . . 0.0 110.233 174.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -78.9 -15.8 13.05 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.158 2.572 . . . . 0.0 115.037 -173.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -130.89 107.32 9.03 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.379 1.072 . . . . 0.0 110.904 -176.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -140.16 141.5 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 125.475 1.51 . . . . 0.0 109.988 170.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.5 m -124.35 125.84 44.99 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.301 1.04 . . . . 0.0 111.12 -171.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.7 t -92.4 136.72 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.064 1.346 . . . . 0.0 111.79 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -126.46 128.6 47.21 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.942 1.297 . . . . 0.0 109.284 169.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -65.33 133.68 51.93 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 160.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.6 pt . . . . . 0 N--CA 1.474 0.752 0 C-N-CA 124.445 1.098 . . . . 0.0 112.483 -172.501 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 . . . . . 0 CA--C 1.54 0.588 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.14 20.83 13.56 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.27 -48.94 0.05 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 127.175 2.19 . . . . 0.0 114.672 -163.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.2 m -64.46 -9.17 16.76 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.362 1.865 . . . . 0.0 114.739 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.5 -11.41 59.9 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.645 1.178 . . . . 0.0 112.876 172.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -104.18 175.92 5.33 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.248 1.819 . . . . 0.0 112.499 -171.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -76.92 47.33 0.51 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.715 2.006 . . . . 0.0 114.455 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.6 mt -55.0 -34.3 63.32 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -169.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -95.45 -0.36 52.45 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.134 0.973 . . . . 0.0 113.29 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.37 61.61 10.26 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 126.23 1.812 . . . . 0.0 111.719 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -55.44 136.67 74.84 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.593 2.195 . . . . 0.0 112.034 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -69.64 -26.04 64.22 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.561 1.144 . . . . 0.0 111.666 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.4 t90 -154.86 152.8 30.22 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.683 1.593 . . . . 0.0 110.747 170.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.7 p -134.42 148.79 50.7 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.874 0.87 . . . . 0.0 111.927 169.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.59 -145.34 6.5 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 113.931 0.333 . . . . 0.0 113.931 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -108.82 148.82 29.99 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.29 1.836 . . . . 0.0 111.721 -176.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 61.0 tp -92.92 142.22 27.55 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.099 1.76 . . . . 0.0 110.832 173.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -144.03 94.29 2.56 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.269 1.827 . . . . 0.0 109.494 173.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.9 mt -84.23 134.43 26.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 170.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.24 166.69 26.27 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.037 1.735 . . . . 0.0 110.338 -166.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 99.0 p -156.52 160.5 39.56 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 120.845 -1.159 . . . . 0.0 112.3 175.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -151.04 120.46 6.88 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.472 0.709 . . . . 0.0 112.23 156.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 65.22 -132.12 35.98 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 125.088 1.327 . . . . 0.0 110.502 -176.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -87.19 26.6 1.17 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.637 1.575 . . . . 0.0 113.328 178.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.0 m -132.97 129.65 38.51 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.85 1.26 . . . . 0.0 110.172 173.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.76 160.8 14.15 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.648 1.179 . . . . 0.0 110.577 167.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -140.64 109.61 6.08 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.811 1.644 . . . . 0.0 108.952 -173.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.0 mp -88.08 105.58 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 168.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -107.66 142.38 37.71 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.592 1.157 . . . . 0.0 111.179 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.4 mp -115.23 131.58 56.88 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.429 1.891 . . . . 0.0 109.656 177.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -133.58 148.35 51.59 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.828 0.851 . . . . 0.0 112.614 -174.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -67.47 135.64 53.38 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.065 0.946 . . . . 0.0 111.573 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -75.15 -6.96 52.38 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 -175.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 86.3 t -119.22 -43.72 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.158 1.383 . . . . 0.0 111.389 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.5 m -93.44 -20.15 20.58 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -175.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.8 15.7 76.0 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.279 0.942 . . . . 0.0 113.588 -177.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -90.53 149.92 21.98 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.144 1.378 . . . . 0.0 112.355 -174.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 31.3 tp -70.91 123.89 23.07 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.727 0.811 . . . . 0.0 111.566 -176.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -86.46 -55.24 3.98 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.47 1.108 . . . . 0.0 111.123 170.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.79 162.57 39.73 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.507 1.123 . . . . 0.0 112.146 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -142.71 135.21 27.75 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.052 1.341 . . . . 0.0 111.891 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.0 100.59 42.82 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.534 1.534 . . . . 0.0 111.136 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -68.45 142.07 53.01 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.995 3.13 . . . . 0.0 112.529 170.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.1 t -134.52 130.58 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.868 1.667 . . . . 0.0 109.894 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -86.1 -26.37 25.29 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -164.63 153.89 13.26 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.551 1.54 . . . . 0.0 111.239 169.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -118.02 133.0 23.44 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.883 1.273 . . . . 0.0 111.461 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.37 147.83 75.91 Favored 'Cis proline' 0 CA--C 1.541 0.875 0 CA-C-N 119.899 0.999 . . . . 0.0 112.22 -8.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.9 -175.82 36.69 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.491 1.043 . . . . 0.0 114.058 -177.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.2 tp -53.71 -34.65 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -169.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.04 4.92 52.03 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -172.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.6 t -148.6 127.31 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 CA-C-N 119.409 1.004 . . . . 0.0 111.739 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -140.61 168.93 18.64 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.648 1.979 . . . . 0.0 113.116 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 34.0 p -123.09 158.89 29.66 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.586 1.954 . . . . 0.0 111.59 -171.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.8 m -85.81 173.22 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 O-C-N 121.573 -0.704 . . . . 0.0 112.121 169.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 70.8 p -87.34 -35.93 18.12 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.851 1.26 . . . . 0.0 112.586 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -94.11 -42.4 9.01 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -162.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.4 t -143.33 130.24 20.52 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.3 m -69.3 4.53 1.66 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -172.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.438 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.281 30.2 ptt180 -96.59 17.05 17.15 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 176.1 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -140.15 132.12 27.76 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.181 0.992 . . . . 0.0 110.784 -174.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -137.05 162.53 33.08 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.325 1.45 . . . . 0.0 110.495 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.6 t -121.59 139.3 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.425 1.09 . . . . 0.0 108.717 171.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.29 147.44 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 118.81 0.732 . . . . 0.0 112.536 176.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -90.15 85.92 6.4 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.461 0.705 . . . . 0.0 111.099 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -69.38 139.95 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 122.635 0.374 . . . . 0.0 111.161 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 . . . . . 0 N--CA 1.469 0.521 0 C-N-CA 126.172 1.789 . . . . 0.0 111.429 -170.403 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 80.7 p . . . . . 0 C--O 1.235 0.303 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.73 147.58 32.08 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.604 1.561 . . . . 0.0 110.992 169.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -90.71 120.62 31.92 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.098 0.559 . . . . 0.0 109.584 167.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.9 pt -117.79 143.03 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.553 1.141 . . . . 0.0 110.871 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.38 143.15 17.14 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 174.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.9 pt -127.35 139.0 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 124.987 1.315 . . . . 0.0 111.644 171.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.37 143.7 16.72 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.83 1.681 . . . . 0.0 112.251 174.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -106.37 167.67 9.67 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.64 1.576 . . . . 0.0 111.534 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.3 t -68.91 -36.21 77.74 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.143 0.577 . . . . 0.0 112.172 175.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -156.66 154.3 29.89 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.086 -1.009 . . . . 0.0 112.048 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 72.2 mtm-85 -55.74 -39.34 71.0 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.554 1.142 . . . . 0.0 112.382 173.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.78 -6.53 30.68 Favored Glycine 0 CA--C 1.542 1.731 0 C-N-CA 124.407 1.004 . . . . 0.0 115.133 178.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -111.22 -33.86 6.33 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.243 1.417 . . . . 0.0 111.728 168.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.438 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -69.72 -24.96 63.63 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 175.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -61.21 -30.4 70.4 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.729 -1.232 . . . . 0.0 112.297 169.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -69.92 -27.93 65.18 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.495 1.043 . . . . 0.0 112.635 176.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -61.81 -44.87 95.99 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.408 -0.807 . . . . 0.0 111.26 169.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -76.95 -35.26 57.4 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.376 1.07 . . . . 0.0 113.147 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 66.6 t -78.73 -38.86 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.366 -0.834 . . . . 0.0 111.87 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 88.5 p -66.86 -31.65 72.4 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.984 -1.073 . . . . 0.0 113.312 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 73.2 mt -68.85 -51.6 38.73 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.943 0.897 . . . . 0.0 111.859 172.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -68.09 -27.8 66.8 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.111 -0.993 . . . . 0.0 112.756 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -82.44 -3.02 54.97 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.399 1.08 . . . . 0.0 112.795 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -89.63 -40.7 12.41 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 121.315 -0.866 . . . . 0.0 111.963 160.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -90.55 -0.29 57.62 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 -173.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.483 1.213 0 CA-C-N 120.909 1.686 . . . . 0.0 115.288 -177.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.9 m . . . . . 0 N--CA 1.469 0.495 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.0 t -59.08 143.45 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 125.307 1.443 . . . . 0.0 112.877 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.1 mt -129.26 -39.37 1.53 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.544 1.938 . . . . 0.0 111.99 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 47.5 t -149.7 142.69 24.87 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.627 1.571 . . . . 0.0 109.611 174.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.6 t -137.97 126.9 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.702 1.201 . . . . 0.0 108.149 170.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -138.11 130.4 16.21 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 123.751 0.82 . . . . 0.0 111.912 -176.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -75.14 -17.08 19.53 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.188 2.592 . . . . 0.0 115.413 -167.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -130.61 109.72 10.87 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.249 1.019 . . . . 0.0 110.958 -176.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -142.26 145.95 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.589 1.556 . . . . 0.0 109.876 168.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.9 m -126.83 132.66 50.93 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.278 1.031 . . . . 0.0 110.85 -174.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.3 t -100.52 135.09 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.078 1.351 . . . . 0.0 111.527 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.4 119.71 22.03 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.884 1.274 . . . . 0.0 108.837 168.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -64.11 131.52 47.76 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.57 -0.706 . . . . 0.0 109.491 166.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.4 pt . . . . . 0 CA--C 1.545 0.776 0 C-N-CA 124.696 1.199 . . . . 0.0 112.806 -167.509 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 . . . . . 0 CA--C 1.536 0.43 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.8 19.36 19.21 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.74 -50.08 0.05 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 127.169 2.188 . . . . 0.0 114.206 -165.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.5 m -65.39 -11.31 41.13 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.174 1.79 . . . . 0.0 114.788 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.71 -14.86 59.49 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.339 1.056 . . . . 0.0 112.494 171.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 16.0 m0 -96.73 171.06 8.76 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.866 1.666 . . . . 0.0 111.693 -174.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -80.56 56.35 2.58 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.2 1.4 . . . . 0.0 113.081 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.0 mt -57.69 -24.88 59.05 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -169.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -106.96 0.58 23.85 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.347 1.059 . . . . 0.0 112.593 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -132.27 77.56 70.39 Favored Pre-proline 0 C--O 1.239 0.521 0 C-N-CA 125.809 1.644 . . . . 0.0 111.378 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -69.18 144.95 58.92 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 CA-C-N 118.94 0.657 . . . . 0.0 112.784 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -70.63 -28.92 65.19 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.705 0.802 . . . . 0.0 111.172 168.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 52.6 t90 -160.42 154.21 22.66 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.606 1.962 . . . . 0.0 110.579 175.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.4 p -133.13 149.16 52.12 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.286 1.035 . . . . 0.0 111.534 167.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.26 -143.43 5.97 Favored Glycine 0 CA--C 1.524 0.635 0 O-C-N 122.15 -0.343 . . . . 0.0 113.407 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -107.28 142.41 37.08 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.679 1.592 . . . . 0.0 111.657 -176.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.3 tp -81.79 137.92 35.23 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.131 1.372 . . . . 0.0 109.426 165.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.6 ttt-85 -145.74 89.28 1.89 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 122.217 1.008 . . . . 0.0 110.938 168.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.5 mt -74.91 127.03 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 172.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.0 p -131.73 173.92 10.66 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 127.083 2.153 . . . . 0.0 109.62 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -160.19 160.72 33.14 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.479 -1.388 . . . . 0.0 110.16 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -148.9 127.2 12.17 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 122.044 0.926 . . . . 0.0 111.769 153.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.02 -114.76 5.73 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 126.078 1.799 . . . . 0.0 110.061 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -104.24 15.38 28.46 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.615 1.566 . . . . 0.0 113.277 176.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.3 m -124.4 109.19 13.0 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.892 0.877 . . . . 0.0 110.649 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.26 159.52 20.06 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.371 0.668 . . . . 0.0 110.99 171.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -141.39 100.79 3.86 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.926 1.69 . . . . 0.0 109.533 -171.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mp -79.92 94.47 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 170.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -91.15 137.82 32.07 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.21 0.604 . . . . 0.0 111.088 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.2 mp -110.62 129.64 55.76 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 126.011 1.724 . . . . 0.0 109.329 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -133.04 145.82 51.15 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.958 0.903 . . . . 0.0 112.241 -169.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -68.43 135.7 52.13 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.12 -0.987 . . . . 0.0 111.655 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.9 pttt -75.11 -7.46 53.82 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -175.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.3 t -119.47 -43.17 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.188 1.395 . . . . 0.0 111.48 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.0 m -95.42 -19.84 19.57 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -174.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.86 14.42 75.74 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.461 1.029 . . . . 0.0 113.713 -176.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -88.07 151.53 22.68 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.224 1.41 . . . . 0.0 112.097 -175.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.3 tp -72.41 126.6 30.24 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.568 -0.707 . . . . 0.0 111.468 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -85.66 -56.69 3.38 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.377 1.071 . . . . 0.0 110.929 169.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.4 162.46 40.03 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.326 1.45 . . . . 0.0 110.918 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -143.36 139.06 29.87 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 172.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.53 106.77 53.89 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.845 1.258 . . . . 0.0 111.037 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.64 139.79 14.43 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.941 3.094 . . . . 0.0 111.325 175.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 t -134.45 121.95 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.611 1.565 . . . . 0.0 109.88 -171.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -89.04 -17.34 29.55 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.86 141.87 8.74 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.834 2.053 . . . . 0.0 110.167 174.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -126.51 127.48 24.54 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 124.352 1.061 . . . . 0.0 111.095 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -61.29 147.07 48.47 Favored 'Cis proline' 0 CA--C 1.539 0.767 0 CA-C-N 120.162 1.094 . . . . 0.0 114.104 -4.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.81 -163.76 29.59 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.99 1.281 . . . . 0.0 113.873 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.8 tp -64.67 -38.58 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 -167.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.77 6.21 48.38 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -168.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.8 t -151.09 124.52 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.75 1.22 . . . . 0.0 110.474 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -140.13 162.79 34.4 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.792 1.637 . . . . 0.0 113.459 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.2 p -109.18 162.46 14.26 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.87 1.668 . . . . 0.0 111.462 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.9 m -84.18 176.87 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.032 0.933 . . . . 0.0 111.299 169.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 57.8 p -90.82 -37.92 13.3 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.512 1.525 . . . . 0.0 111.798 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -96.0 -41.12 8.92 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 -165.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.5 t -139.74 116.54 10.89 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -171.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.69 -3.54 6.83 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -168.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.445 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.306 49.2 ptt85 -86.93 20.74 2.51 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 176.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -140.67 139.57 34.81 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.448 1.499 . . . . 0.0 111.36 -176.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -138.68 161.86 36.09 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.216 1.406 . . . . 0.0 111.615 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.6 t -117.93 137.46 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.04 0.936 . . . . 0.0 108.924 165.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.17 147.96 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 118.737 0.699 . . . . 0.0 112.157 174.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -91.33 84.39 5.6 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.623 0.769 . . . . 0.0 110.936 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -68.93 138.86 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.849 0.357 . . . . 0.0 110.965 176.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 . . . . . 0 N--CA 1.469 0.503 0 C-N-CA 125.445 1.498 . . . . 0.0 111.42 -169.896 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 95.6 p . . . . . 0 C--O 1.236 0.383 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.31 142.43 29.43 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.284 1.434 . . . . 0.0 110.963 168.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -91.74 118.85 31.05 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.44 0.696 . . . . 0.0 109.861 170.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.7 pt -118.0 141.77 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.732 1.213 . . . . 0.0 110.889 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -90.11 142.37 16.43 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 175.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.7 pt -129.42 145.98 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.907 1.283 . . . . 0.0 112.167 170.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.75 148.45 16.77 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.025 1.298 . . . . 0.0 113.698 176.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -114.57 156.65 24.27 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.15 1.78 . . . . 0.0 111.531 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.6 t -74.27 -23.77 59.17 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.054 0.941 . . . . 0.0 112.936 -178.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -151.91 147.66 26.85 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.414 1.086 . . . . 0.0 111.981 -176.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 -62.97 -33.59 75.71 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.241 1.016 . . . . 0.0 113.21 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.45 -28.46 73.63 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 119.086 0.857 . . . . 0.0 113.525 175.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -85.51 -30.11 23.71 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.116 0.966 . . . . 0.0 112.581 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.445 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -66.9 -35.96 81.19 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.588 -0.695 . . . . 0.0 112.625 163.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -62.29 -35.89 80.42 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.402 -0.811 . . . . 0.0 111.661 169.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -62.92 -36.65 84.1 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 119.846 1.203 . . . . 0.0 112.5 173.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -60.48 -51.51 69.15 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.035 0.934 . . . . 0.0 112.386 169.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.84 -26.18 40.51 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -175.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.3 t -77.27 -42.38 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 O-C-N 121.127 -0.983 . . . . 0.0 110.938 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 91.6 p -63.66 -31.36 72.51 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.895 0.77 . . . . 0.0 112.882 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.1 mt -68.51 -56.86 6.92 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.105 0.962 . . . . 0.0 111.993 169.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -68.16 -25.45 65.27 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.918 -1.113 . . . . 0.0 113.5 -173.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -79.46 -4.31 50.62 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.255 1.022 . . . . 0.0 112.518 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -90.17 -28.32 18.99 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.29 -0.881 . . . . 0.0 112.587 161.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -101.07 -1.16 34.86 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.875 1.805 . . . . 0.0 115.875 -175.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.482 1.163 0 CA-C-N 120.959 1.709 . . . . 0.0 115.164 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.7 m . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.2 t -70.13 147.36 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.898 1.279 . . . . 0.0 112.062 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.0 mt -132.33 -39.54 1.03 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.963 1.705 . . . . 0.0 110.995 -173.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.7 t -151.1 146.91 26.48 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.987 1.315 . . . . 0.0 110.86 175.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 72.4 t -139.99 123.34 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.239 1.416 . . . . 0.0 109.31 171.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -118.42 141.05 29.03 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 125.017 1.327 . . . . 0.0 111.141 175.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.72 -19.32 21.35 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 123.661 2.907 . . . . 0.0 114.515 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -133.29 110.83 10.35 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.191 0.905 . . . . 0.0 111.388 -172.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.2 p -142.55 143.03 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.917 1.287 . . . . 0.0 110.755 169.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.2 m -127.86 130.32 48.39 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.69 1.196 . . . . 0.0 110.993 -174.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.2 t -97.34 136.98 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.929 1.291 . . . . 0.0 111.948 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.17 126.75 36.44 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.823 1.249 . . . . 0.0 109.381 168.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -63.12 131.62 49.12 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 161.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.6 pt . . . . . 0 N--CA 1.475 0.807 0 C-N-CA 123.904 0.882 . . . . 0.0 112.676 -168.352 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 . . . . . 0 CA--C 1.533 0.322 0 CA-C-O 119.991 -0.052 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.83 18.48 6.71 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -171.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.56 -51.11 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 128.149 2.58 . . . . 0.0 115.697 -174.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.5 m -65.07 -13.0 56.88 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.337 1.855 . . . . 0.0 114.367 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -89.41 -4.9 57.83 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.704 1.202 . . . . 0.0 112.552 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 22.4 m0 -92.75 172.11 8.56 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.867 1.667 . . . . 0.0 110.74 174.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -80.57 55.06 2.22 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.163 1.385 . . . . 0.0 114.074 -177.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.2 mt -60.34 -17.81 45.63 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -174.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -102.14 -8.13 21.64 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.82 1.248 . . . . 0.0 113.126 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -148.74 80.05 8.37 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.563 1.145 . . . . 0.0 112.102 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.72 146.8 53.13 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.498 2.798 . . . . 0.0 112.886 174.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -71.45 -29.64 65.09 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.497 0.719 . . . . 0.0 111.393 167.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 51.4 t90 -158.54 154.43 26.66 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.028 1.731 . . . . 0.0 110.937 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.3 p -134.88 148.01 50.0 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.57 1.148 . . . . 0.0 111.594 169.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.48 -141.16 4.88 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 113.916 0.326 . . . . 0.0 113.916 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -110.79 140.53 45.13 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.802 2.041 . . . . 0.0 110.318 -170.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.6 tp -93.55 137.66 32.6 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.328 1.051 . . . . 0.0 109.997 173.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 28.0 ttp-105 -127.98 136.1 50.83 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.236 1.014 . . . . 0.0 110.271 156.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.1 mt -111.35 135.28 51.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 125.227 1.411 . . . . 0.0 107.25 164.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.74 166.77 28.4 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.847 1.659 . . . . 0.0 110.23 -164.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.3 t -157.45 160.35 38.24 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.056 -1.028 . . . . 0.0 111.951 172.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -144.68 119.95 10.2 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.513 0.725 . . . . 0.0 111.609 157.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.61 -115.11 6.72 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 125.802 1.668 . . . . 0.0 110.494 -177.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -104.5 17.02 24.93 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.17 1.788 . . . . 0.0 113.225 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.4 m -124.84 108.5 12.0 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.065 0.946 . . . . 0.0 110.396 177.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.64 159.47 25.34 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.734 0.413 . . . . 0.0 110.98 169.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -139.23 117.25 11.72 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.795 1.638 . . . . 0.0 109.214 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.1 mp -92.21 109.22 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 165.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -112.65 130.79 55.92 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.216 1.006 . . . . 0.0 111.876 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.9 mp -104.2 127.06 51.78 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.763 1.625 . . . . 0.0 110.053 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -132.98 150.28 52.17 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -170.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -65.61 141.7 58.32 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 122.252 1.025 . . . . 0.0 112.744 -173.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.0 pttt -74.81 -10.36 59.43 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -175.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 64.0 t -121.12 -38.32 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.868 1.267 . . . . 0.0 111.963 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.3 m -118.93 -8.64 10.23 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -172.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.84 14.49 80.01 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 123.992 0.806 . . . . 0.0 114.44 177.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -63.29 136.83 57.93 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.91 1.684 . . . . 0.0 111.277 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 38.1 tp -71.12 112.75 7.51 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.767 -0.583 . . . . 0.0 111.011 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -78.27 -53.52 7.23 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.932 0.893 . . . . 0.0 110.674 172.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.81 161.54 38.39 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.487 1.115 . . . . 0.0 112.052 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -141.86 134.47 28.34 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.03 1.332 . . . . 0.0 111.357 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.78 96.67 50.28 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 124.997 1.319 . . . . 0.0 111.573 176.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -59.56 138.51 84.09 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 124.213 3.275 . . . . 0.0 112.824 164.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.0 t -135.55 131.8 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.082 1.753 . . . . 0.0 109.598 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -91.15 -24.14 20.04 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -165.47 155.5 13.02 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.772 1.629 . . . . 0.0 111.18 169.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -126.19 127.22 24.71 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.87 1.268 . . . . 0.0 111.171 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.18 147.93 78.61 Favored 'Cis proline' 0 CA--C 1.542 0.888 0 CA-C-N 119.98 1.028 . . . . 0.0 113.185 -2.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -161.54 -164.71 16.98 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.901 1.715 . . . . 0.0 112.556 -178.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.9 tt -73.36 -38.62 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -175.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.5 7.51 16.81 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -167.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.2 t -149.94 130.55 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.78 1.632 . . . . 0.0 109.703 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.16 164.08 33.36 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.081 1.752 . . . . 0.0 112.731 -171.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 73.1 p -121.49 161.67 21.86 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.861 1.664 . . . . 0.0 111.956 -174.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.8 m -91.39 169.91 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.102 1.361 . . . . 0.0 110.906 168.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 79.6 p -95.03 -31.09 13.76 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.894 1.277 . . . . 0.0 113.506 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -95.3 -39.55 9.99 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -163.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.0 t -138.95 123.24 18.16 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -174.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.1 m -79.34 31.12 0.22 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 -168.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.411 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.257 18.4 ptt180 -120.68 18.06 11.95 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.293 1.437 . . . . 0.0 114.693 174.341 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -138.34 137.84 37.75 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.219 1.008 . . . . 0.0 111.202 -170.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -136.66 160.35 39.08 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.967 1.307 . . . . 0.0 111.325 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 80.7 t -112.75 143.8 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.498 1.119 . . . . 0.0 108.88 165.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.8 148.49 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 118.981 0.81 . . . . 0.0 112.104 171.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -89.28 89.28 7.84 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.668 0.787 . . . . 0.0 110.426 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -71.27 142.0 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 O-C-N 122.161 -0.337 . . . . 0.0 110.802 175.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 . . . . . 0 N--CA 1.47 0.557 0 C-N-CA 125.594 1.558 . . . . 0.0 111.83 -172.478 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 86.3 p . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.93 148.38 31.71 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.455 1.502 . . . . 0.0 111.348 172.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -93.08 116.74 29.33 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.53 0.732 . . . . 0.0 109.733 170.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.7 pt -116.94 146.01 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.715 1.206 . . . . 0.0 111.149 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.8 142.68 16.17 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 174.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.6 pt -127.54 139.81 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 125.319 1.448 . . . . 0.0 111.866 171.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -117.38 142.71 17.51 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 125.45 1.5 . . . . 0.0 112.474 174.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -100.37 162.74 12.75 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.209 1.404 . . . . 0.0 111.842 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.3 t -68.76 -28.02 66.42 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.643 0.777 . . . . 0.0 112.388 176.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -158.71 155.85 28.8 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.601 1.16 . . . . 0.0 111.406 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.3 ttp85 -54.28 -40.98 68.36 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.397 1.079 . . . . 0.0 112.513 173.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.69 -29.85 73.21 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 123.995 0.807 . . . . 0.0 114.304 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -82.2 -36.82 26.89 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.298 1.049 . . . . 0.0 111.748 176.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.411 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -63.61 -31.59 72.8 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.523 -0.735 . . . . 0.0 112.764 168.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -72.54 0.9 9.2 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.795 1.405 . . . . 0.0 114.795 170.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -96.87 -32.77 11.91 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.431 -0.793 . . . . 0.0 112.322 162.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -58.4 -53.03 62.93 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.638 1.175 . . . . 0.0 112.518 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -66.41 -34.47 78.02 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.669 1.187 . . . . 0.0 113.366 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 52.6 t -75.48 -40.04 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.44 1.096 . . . . 0.0 111.005 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.3 m -66.69 -28.55 68.54 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.34 0.656 . . . . 0.0 112.735 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.7 mt -75.74 -53.1 9.05 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.828 0.851 . . . . 0.0 111.981 171.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -66.62 -27.39 67.66 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.224 -0.922 . . . . 0.0 113.161 -175.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -84.29 -3.12 58.04 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.303 1.041 . . . . 0.0 112.752 175.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 52.5 t60 -88.85 -38.8 14.31 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 120.901 -1.125 . . . . 0.0 111.911 158.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -91.92 1.83 56.93 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 -171.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -177.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.2 m . . . . . 0 N--CA 1.473 0.7 0 CA-C-O 120.607 0.241 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.48 145.07 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.914 1.286 . . . . 0.0 112.221 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 71.8 mt -128.58 -41.38 1.52 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.077 1.751 . . . . 0.0 112.529 -175.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.6 t -151.37 135.71 16.86 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.86 1.264 . . . . 0.0 110.346 175.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 78.6 t -128.16 127.87 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.6 1.16 . . . . 0.0 109.624 171.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -126.95 131.66 23.97 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 124.797 1.239 . . . . 0.0 110.945 172.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -66.71 -24.91 46.99 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.098 2.532 . . . . 0.0 115.349 -176.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -133.81 120.95 21.12 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.108 0.963 . . . . 0.0 112.336 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -150.97 147.24 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.732 2.013 . . . . 0.0 109.369 174.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.8 m -125.95 130.94 52.24 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.852 0.861 . . . . 0.0 111.84 -171.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.3 t -96.65 137.38 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.773 1.629 . . . . 0.0 112.153 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -131.39 126.05 34.17 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.876 1.271 . . . . 0.0 109.472 168.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -67.11 118.08 10.04 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.595 0.758 . . . . 0.0 109.478 166.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.9 pt . . . . . 0 CA--C 1.545 0.788 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -166.854 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 . . . . . 0 CA--C 1.535 0.38 0 CA-C-O 120.845 0.355 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.4 16.35 3.18 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -171.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.75 -49.04 0.06 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 127.805 2.442 . . . . 0.0 115.673 -176.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.9 m -68.5 -15.58 63.59 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.028 1.731 . . . . 0.0 114.18 -177.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.45 -11.75 59.64 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.8 0.84 . . . . 0.0 112.995 171.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 18.0 m0 -88.61 171.17 10.23 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.136 1.374 . . . . 0.0 110.851 178.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -81.42 55.52 2.63 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.21 1.404 . . . . 0.0 114.095 -174.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.5 mt -61.14 -14.6 25.97 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -171.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -108.83 -3.46 17.66 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.609 1.163 . . . . 0.0 113.033 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -148.71 71.33 10.54 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 125.151 1.38 . . . . 0.0 112.105 177.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -56.46 144.39 84.03 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.131 2.554 . . . . 0.0 112.307 173.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -70.22 -29.85 66.79 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.378 1.071 . . . . 0.0 111.689 175.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 38.8 t90 -156.84 152.48 26.9 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.554 1.542 . . . . 0.0 110.559 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.2 p -134.03 150.77 51.23 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.691 0.796 . . . . 0.0 111.869 168.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.28 -143.62 6.31 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 123.129 0.395 . . . . 0.0 113.542 -176.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 36.7 mtm105 -105.74 149.37 26.49 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.597 1.959 . . . . 0.0 112.135 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.5 tp -90.37 138.68 31.35 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.707 1.203 . . . . 0.0 109.755 162.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.8 ttp85 -144.1 91.44 2.21 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.17 0.988 . . . . 0.0 110.731 162.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.2 mt -72.06 131.93 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 170.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.41 174.91 10.01 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 127.364 2.265 . . . . 0.0 110.564 -177.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.6 p -158.32 153.31 25.26 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 120.721 -1.237 . . . . 0.0 111.562 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -158.76 128.61 5.77 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.242 1.017 . . . . 0.0 112.085 159.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.59 53.65 37.08 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.452 1.025 . . . . 0.0 114.902 163.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt 61.99 24.25 14.41 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 126.292 1.837 . . . . 0.0 113.909 -175.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.5 m -123.7 132.26 53.79 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.659 1.584 . . . . 0.0 108.726 165.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.17 157.55 16.5 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.219 1.008 . . . . 0.0 110.162 166.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -136.54 107.62 6.75 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.501 1.521 . . . . 0.0 109.22 -175.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.5 mp -81.18 96.38 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 168.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -95.93 136.83 35.85 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.268 0.556 . . . . 0.0 111.516 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.6 mp -110.36 133.46 53.24 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 126.238 1.815 . . . . 0.0 109.4 174.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -139.6 154.05 47.5 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.854 0.862 . . . . 0.0 111.946 -169.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -74.88 148.77 39.87 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 120.974 -1.079 . . . . 0.0 112.311 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.1 pttt -89.08 -1.35 58.06 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.9 1.68 . . . . 0.0 114.986 -178.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 80.3 t -127.83 -41.8 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.152 1.381 . . . . 0.0 111.951 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.1 p -96.15 -27.42 15.05 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.53 1.059 . . . . 0.0 113.289 175.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.58 8.59 87.15 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-O 119.346 -0.697 . . . . 0.0 113.8 -170.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -68.75 151.34 46.78 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.622 1.211 . . . . 0.0 111.886 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.4 tp -72.66 125.96 28.74 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.638 -0.664 . . . . 0.0 110.683 176.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -86.37 -55.02 4.1 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.133 0.973 . . . . 0.0 111.063 171.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.8 159.56 36.87 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.66 1.184 . . . . 0.0 111.651 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -140.3 133.97 30.31 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.47 0.708 . . . . 0.0 112.576 175.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.74 103.24 53.91 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 125.108 1.363 . . . . 0.0 111.257 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -74.65 141.72 28.11 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.566 2.844 . . . . 0.0 111.728 173.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.5 t -134.94 125.38 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.68 1.992 . . . . 0.0 109.07 -174.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -90.04 -23.51 21.43 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -161.86 150.03 15.02 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.67 1.988 . . . . 0.0 110.151 171.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -122.85 127.56 25.69 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 124.537 1.135 . . . . 0.0 110.973 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -62.18 147.72 55.53 Favored 'Cis proline' 0 CA--C 1.541 0.869 0 CA-C-N 119.991 1.033 . . . . 0.0 114.392 -5.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.37 -166.68 18.81 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.919 1.723 . . . . 0.0 112.392 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.0 tt -69.52 -37.39 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 121.607 -0.937 . . . . 0.0 112.873 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.83 6.66 23.71 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -165.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.6 t -150.4 130.71 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.481 1.512 . . . . 0.0 110.063 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -140.32 161.34 37.92 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.282 1.833 . . . . 0.0 112.316 177.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.2 p -107.96 160.98 15.35 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.6 1.96 . . . . 0.0 111.735 177.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.1 m -87.01 173.33 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.212 1.005 . . . . 0.0 110.879 163.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 73.9 p -104.56 -23.3 13.14 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.485 1.514 . . . . 0.0 113.921 -176.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -99.87 -39.29 8.26 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -171.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.9 t -134.03 117.27 16.48 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -173.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.0 m -72.48 24.82 0.05 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 115.956 1.835 . . . . 0.0 115.956 -169.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.4 ptt85 -131.42 27.08 4.77 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.507 1.923 . . . . 0.0 113.995 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -140.09 141.28 36.18 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.671 1.589 . . . . 0.0 111.441 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -140.14 162.11 36.03 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.03 1.332 . . . . 0.0 111.54 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.9 t -116.96 142.85 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.596 1.158 . . . . 0.0 108.997 167.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.21 148.09 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 173.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -87.94 84.68 6.96 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.976 0.911 . . . . 0.0 110.717 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -68.3 141.03 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 120.816 0.341 . . . . 0.0 110.582 173.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 . . . . . 0 N--CA 1.467 0.413 0 C-N-CA 125.302 1.441 . . . . 0.0 111.78 -169.744 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 82.3 p . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.54 147.67 41.53 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.539 1.536 . . . . 0.0 110.612 164.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -92.83 116.75 29.32 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 167.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.1 pt -117.62 144.11 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.474 1.109 . . . . 0.0 110.937 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.73 142.08 15.92 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 175.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.4 pt -127.15 140.14 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 125.478 1.511 . . . . 0.0 111.661 172.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -119.94 141.35 15.35 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.798 1.189 . . . . 0.0 113.511 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -109.06 153.85 23.06 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.488 1.915 . . . . 0.0 110.792 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.3 t -73.0 -23.16 60.6 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.616 0.766 . . . . 0.0 112.784 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -155.54 151.06 27.17 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.446 1.098 . . . . 0.0 111.62 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.33 -33.05 70.65 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.904 0.882 . . . . 0.0 112.732 177.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.0 -19.25 63.32 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-N 118.979 0.808 . . . . 0.0 114.59 177.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -94.83 -37.31 11.28 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.689 1.244 . . . . 0.0 111.694 176.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.42 -29.14 68.8 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.135 0.974 . . . . 0.0 112.929 166.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . 0.262 19.8 m-85 -92.51 19.39 7.33 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.571 1.548 . . . . 0.0 114.112 170.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -99.71 -38.7 8.59 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.551 -0.718 . . . . 0.0 111.295 142.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -54.3 -57.72 10.14 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.58 1.082 . . . . 0.0 112.927 178.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -80.42 -22.74 40.91 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.256 -0.902 . . . . 0.0 113.345 -174.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 93.7 t -81.48 -39.2 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.412 0.685 . . . . 0.0 110.803 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 95.1 p -65.46 -31.42 72.49 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.566 -0.709 . . . . 0.0 112.848 173.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 72.0 mt -69.54 -52.65 24.4 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.189 0.995 . . . . 0.0 111.951 172.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -67.67 -29.03 68.22 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 120.971 -1.081 . . . . 0.0 112.823 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -82.77 -3.0 56.0 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.507 1.123 . . . . 0.0 112.916 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -90.15 -29.25 18.4 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.165 -0.96 . . . . 0.0 112.547 166.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -101.75 -4.15 26.91 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -176.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -176.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -72.34 149.67 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.825 1.25 . . . . 0.0 113.855 -171.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.5 mt -134.07 -38.6 0.87 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.05 1.74 . . . . 0.0 112.425 -171.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 39.0 t -152.59 139.52 19.08 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.89 1.276 . . . . 0.0 110.588 172.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 79.1 t -131.71 127.55 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.697 1.199 . . . . 0.0 109.28 171.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -129.21 135.24 27.29 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 125.207 1.403 . . . . 0.0 110.524 173.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.66 -18.46 13.52 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.987 2.458 . . . . 0.0 114.975 -172.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -129.65 109.42 10.97 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.5 1.12 . . . . 0.0 111.146 -175.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.7 p -143.05 141.37 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.721 1.609 . . . . 0.0 110.028 171.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.3 m -123.33 125.36 44.87 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.265 1.026 . . . . 0.0 111.371 -171.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.6 t -92.16 137.82 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.142 1.377 . . . . 0.0 112.201 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -127.31 123.3 36.05 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.277 1.431 . . . . 0.0 108.621 168.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -68.96 109.3 3.88 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 164.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.4 pt . . . . . 0 N--CA 1.473 0.716 0 C-N-CA 124.425 1.09 . . . . 0.0 113.819 -166.388 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 . . . . . 0 N--CA 1.451 -0.398 0 CA-C-O 120.997 0.427 . . . . 0.0 109.966 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.31 131.09 53.54 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 163.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.18 -33.73 63.24 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.454 1.102 . . . . 0.0 113.215 -172.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.7 p -65.44 -13.26 58.35 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 175.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.29 -10.25 58.63 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.054 0.942 . . . . 0.0 112.704 170.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 22.8 m0 -94.68 171.71 8.62 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.629 1.572 . . . . 0.0 111.835 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -79.22 47.52 0.8 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.16 1.784 . . . . 0.0 114.177 -176.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.7 mt -54.72 -34.86 63.02 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -167.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -93.77 -2.41 53.72 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.95 0.9 . . . . 0.0 113.321 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -145.89 66.85 12.0 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 125.992 1.717 . . . . 0.0 111.747 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -55.91 144.02 79.69 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.282 2.654 . . . . 0.0 112.84 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -73.86 -27.81 61.26 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.45 1.1 . . . . 0.0 111.73 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 40.7 t90 -153.17 152.48 31.3 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.656 1.582 . . . . 0.0 110.663 170.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.5 p -134.56 143.17 47.24 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.964 0.906 . . . . 0.0 111.864 171.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.15 -144.63 5.4 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 114.556 0.582 . . . . 0.0 114.556 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -107.9 144.3 35.34 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.507 1.923 . . . . 0.0 111.035 -172.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 42.9 tp -91.56 138.44 31.57 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.652 1.581 . . . . 0.0 110.119 170.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -144.26 99.53 3.39 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.685 1.194 . . . . 0.0 110.57 170.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.4 mt -86.31 132.96 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.604 1.162 . . . . 0.0 108.624 174.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.12 171.28 14.3 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.167 1.787 . . . . 0.0 111.279 -170.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.8 t -156.21 149.06 24.03 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.796 -1.19 . . . . 0.0 112.555 173.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -150.86 132.76 15.1 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.724 152.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.47 58.45 5.45 Favored Glycine 0 N--CA 1.474 1.192 0 C-N-CA 124.752 1.168 . . . . 0.0 114.466 166.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 56.52 27.3 12.07 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 126.203 1.801 . . . . 0.0 113.174 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.7 m -137.93 121.83 17.72 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.655 1.582 . . . . 0.0 108.536 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -90.33 158.57 17.08 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.842 0.857 . . . . 0.0 110.513 171.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -139.34 99.52 3.76 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.318 1.847 . . . . 0.0 108.628 -173.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.3 mp -79.65 103.66 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 168.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 50.6 mttt -105.12 141.18 37.13 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.939 0.876 . . . . 0.0 111.732 174.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.8 mp -108.9 133.01 53.49 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 126.301 1.84 . . . . 0.0 109.785 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -132.2 147.19 52.41 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.942 0.897 . . . . 0.0 112.499 -168.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -66.33 140.81 58.12 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.882 0.873 . . . . 0.0 112.717 -175.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.274 0.0 OUTLIER -77.59 -5.22 49.48 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 -174.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.6 t -112.46 -48.59 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.93 1.292 . . . . 0.0 111.107 170.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.8 m -99.54 -16.75 18.18 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -167.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.87 12.43 74.8 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.658 1.123 . . . . 0.0 113.994 -176.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -82.78 152.09 25.84 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.078 1.351 . . . . 0.0 112.322 -174.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.7 122.16 19.31 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.959 0.903 . . . . 0.0 112.074 -169.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -86.1 -54.91 4.19 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.217 1.007 . . . . 0.0 111.098 168.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.58 161.61 38.73 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.895 1.278 . . . . 0.0 111.771 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -141.22 134.88 30.1 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.722 1.209 . . . . 0.0 112.065 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.86 100.68 48.5 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.955 1.302 . . . . 0.0 111.405 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -65.1 139.07 59.36 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 124.292 3.328 . . . . 0.0 112.422 167.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.4 t -135.8 129.68 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.73 1.612 . . . . 0.0 109.659 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -89.71 -23.52 21.8 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.75 150.05 13.38 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.15 1.78 . . . . 0.0 110.391 172.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -126.12 132.19 24.23 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.526 1.13 . . . . 0.0 112.131 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -63.57 144.66 53.94 Favored 'Cis proline' 0 CA--C 1.54 0.814 0 CA-C-N 119.71 0.932 . . . . 0.0 113.772 -6.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -169.59 -173.26 36.97 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.606 1.098 . . . . 0.0 114.116 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.6 tp -54.86 -36.72 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -166.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.55 8.35 39.25 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -171.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.4 t -148.33 129.12 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.307 1.043 . . . . 0.0 111.221 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -138.11 162.52 33.97 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.282 1.833 . . . . 0.0 112.218 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 65.8 p -112.49 161.28 16.91 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.628 1.971 . . . . 0.0 111.388 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.4 m -89.57 173.1 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.841 0.857 . . . . 0.0 111.453 166.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 46.5 p -99.05 -24.9 14.73 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 174.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -81.21 -42.69 20.38 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -171.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.2 t -156.76 134.44 10.86 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.0 m -72.99 22.15 0.07 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -174.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.468 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.26 5.1 ptm180 -108.73 19.67 19.4 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.011 1.724 . . . . 0.0 114.043 173.268 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -142.53 135.5 28.38 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.029 1.331 . . . . 0.0 110.412 -174.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -135.95 164.49 27.85 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.975 1.31 . . . . 0.0 111.103 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.2 t -117.72 142.96 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.705 1.202 . . . . 0.0 108.418 166.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.89 147.13 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 118.664 0.665 . . . . 0.0 112.14 172.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -87.75 86.67 7.2 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.507 0.723 . . . . 0.0 110.449 176.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -69.04 140.32 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.575 0.226 . . . . 0.0 110.8 175.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 . . . . . 0 N--CA 1.47 0.534 0 C-N-CA 125.762 1.625 . . . . 0.0 111.792 -170.247 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 76.8 p . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.11 147.46 30.6 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.465 1.506 . . . . 0.0 111.234 171.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -90.92 117.99 29.96 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.396 0.678 . . . . 0.0 109.472 168.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.4 pt -116.93 143.19 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.567 1.147 . . . . 0.0 111.027 177.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.25 144.06 17.72 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 174.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.0 pt -128.9 139.61 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 C-N-CA 125.59 1.556 . . . . 0.0 111.641 171.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.68 142.14 15.53 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 125.663 1.601 . . . . 0.0 112.725 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -105.25 163.63 12.45 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.419 1.488 . . . . 0.0 111.298 -177.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.7 t -76.32 -24.65 54.31 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 177.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -156.19 151.14 26.25 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.402 1.081 . . . . 0.0 111.636 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -62.62 -32.69 73.75 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.087 0.955 . . . . 0.0 113.151 178.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.24 -30.09 76.92 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 118.942 0.792 . . . . 0.0 113.646 175.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -82.84 -36.49 25.42 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.119 0.96 . . . . 0.0 111.918 175.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.468 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -64.2 -31.77 73.09 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 169.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -61.25 -33.75 74.04 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.098 -1.001 . . . . 0.0 112.508 171.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -70.36 -32.72 70.54 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.835 1.198 . . . . 0.0 112.846 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -57.64 -43.85 85.18 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.029 0.831 . . . . 0.0 111.329 170.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -81.28 -35.59 30.91 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.532 1.133 . . . . 0.0 113.496 -175.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.5 t -76.78 -40.5 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 O-C-N 121.245 -0.909 . . . . 0.0 111.519 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 85.4 p -63.67 -27.41 69.2 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 83.8 mt -75.38 -55.51 5.62 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.018 0.927 . . . . 0.0 111.534 171.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -66.83 -30.71 70.97 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.09 -1.006 . . . . 0.0 113.484 -172.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -90.91 4.38 52.04 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.8 1.64 . . . . 0.0 112.716 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -97.67 -33.12 11.43 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.304 -0.872 . . . . 0.0 112.276 163.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -89.96 -2.37 58.14 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.321 0 CA-C-N 121.18 1.809 . . . . 0.0 115.09 -174.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.6 m . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.6 t -69.99 143.05 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 O-C-N 121.305 -0.872 . . . . 0.0 111.673 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.5 mt -126.88 -41.75 1.8 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.572 1.549 . . . . 0.0 112.293 -174.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.4 t -153.92 135.39 14.24 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.229 1.012 . . . . 0.0 111.245 173.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.1 t -128.31 127.33 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.677 1.191 . . . . 0.0 109.014 171.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -131.07 137.43 30.7 Favored Pre-proline 0 N--CA 1.475 0.81 0 C-N-CA 125.408 1.483 . . . . 0.0 110.65 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.53 -18.57 22.59 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.217 2.611 . . . . 0.0 113.689 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -109.08 122.64 47.7 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.025 1.33 . . . . 0.0 112.152 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.0 p -154.72 143.25 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.803 1.241 . . . . 0.0 109.585 157.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.7 p -127.32 144.14 51.1 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.071 1.348 . . . . 0.0 110.586 177.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.4 t -113.41 130.22 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.931 1.292 . . . . 0.0 111.113 -177.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.67 118.17 14.81 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.418 1.487 . . . . 0.0 108.976 173.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 -69.45 132.45 46.35 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.893 0.877 . . . . 0.0 109.943 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.3 pt . . . . . 0 CA--C 1.545 0.78 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -160.152 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 . . . . . 0 CA--C 1.532 0.284 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.77 15.96 8.07 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 -174.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 55.84 -48.15 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.825 2.85 . . . . 0.0 116.156 -173.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 90.7 p -64.53 -17.77 64.21 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.095 1.758 . . . . 0.0 114.466 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -85.84 -4.79 59.25 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.445 1.498 . . . . 0.0 112.633 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.8 m0 -93.44 168.52 11.0 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.085 1.754 . . . . 0.0 110.635 175.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -78.13 49.7 0.84 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.659 1.584 . . . . 0.0 114.041 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 45.7 mt -56.46 -36.07 68.64 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -172.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -92.8 -2.68 55.73 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.237 1.015 . . . . 0.0 113.232 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -141.6 70.32 25.7 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 125.521 1.528 . . . . 0.0 111.726 177.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.85 147.37 73.42 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.144 2.563 . . . . 0.0 113.16 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -74.03 -27.94 61.18 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.158 0.983 . . . . 0.0 111.535 169.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 57.7 t90 -158.15 155.01 28.35 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.399 1.88 . . . . 0.0 110.884 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.1 p -136.72 149.9 48.13 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.666 1.186 . . . . 0.0 112.024 169.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.69 -142.49 4.6 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 123.319 0.485 . . . . 0.0 113.825 -177.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -118.91 148.74 42.6 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.849 2.06 . . . . 0.0 111.558 -175.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.1 tp -89.15 140.42 29.48 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.54 1.536 . . . . 0.0 110.626 174.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -141.01 93.36 2.58 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.519 1.127 . . . . 0.0 110.567 162.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.1 mt -76.65 127.24 37.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 166.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.1 p -138.31 171.71 13.98 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 126.919 2.088 . . . . 0.0 110.153 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.8 p -152.81 166.09 33.34 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 125.014 1.326 . . . . 0.0 112.185 174.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -148.68 121.25 8.56 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.243 0.544 . . . . 0.0 111.326 154.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.33 -118.43 9.32 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 125.232 1.396 . . . . 0.0 110.211 -176.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -101.48 20.16 16.55 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.331 1.852 . . . . 0.0 113.714 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.4 m -127.47 128.15 45.25 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.704 1.202 . . . . 0.0 109.957 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.65 160.8 14.03 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.552 1.141 . . . . 0.0 111.157 170.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -141.21 107.13 5.15 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.733 2.013 . . . . 0.0 108.802 -174.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -83.99 94.56 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 168.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -88.58 136.67 32.88 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.86 0.864 . . . . 0.0 110.805 174.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.3 mp -111.98 131.2 55.55 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.143 1.777 . . . . 0.0 110.111 174.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -132.67 147.56 52.33 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.858 0.863 . . . . 0.0 113.177 -170.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -67.8 135.39 52.54 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.367 1.067 . . . . 0.0 111.329 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.7 pttt -76.05 -5.2 45.35 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -175.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 85.6 t -120.26 -43.17 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 125.03 1.332 . . . . 0.0 111.47 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.5 m -93.82 -19.71 20.76 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.32 13.5 76.97 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.487 1.041 . . . . 0.0 113.693 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -90.58 152.16 21.01 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.241 1.416 . . . . 0.0 112.295 -173.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.5 tp -72.47 128.34 35.29 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.491 -0.756 . . . . 0.0 111.666 -175.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -85.35 -58.25 2.75 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.55 1.14 . . . . 0.0 110.778 169.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.68 165.44 36.25 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.042 1.737 . . . . 0.0 110.12 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -146.35 146.22 30.59 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 169.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.34 107.2 49.74 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.333 1.453 . . . . 0.0 111.665 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -67.92 144.47 64.66 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.838 3.026 . . . . 0.0 111.988 169.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.2 t -139.23 126.52 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.46 1.504 . . . . 0.0 109.414 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -95.45 -19.96 19.45 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -160.56 145.49 14.43 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.733 2.013 . . . . 0.0 110.081 171.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -126.22 127.67 24.6 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 124.697 1.199 . . . . 0.0 110.488 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -64.47 146.96 67.06 Favored 'Cis proline' 0 CA--C 1.542 0.899 0 CA-C-N 120.073 1.062 . . . . 0.0 113.434 -2.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.65 -156.94 8.74 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.721 1.629 . . . . 0.0 112.642 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.6 tt -79.33 -41.89 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -176.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.59 8.0 15.57 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -165.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 23.5 t -153.02 130.45 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 126.363 1.865 . . . . 0.0 109.122 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.17 158.72 44.24 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.871 1.268 . . . . 0.0 113.067 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.0 p -104.73 161.6 14.02 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.506 1.522 . . . . 0.0 112.182 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.3 m -90.72 173.27 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.81 1.244 . . . . 0.0 110.806 167.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.6 p -96.79 -29.4 13.78 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.31 1.444 . . . . 0.0 113.384 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -91.32 -43.1 9.99 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -169.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.7 t -143.32 124.48 14.52 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -176.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -67.29 -7.89 27.87 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.297 1.592 . . . . 0.0 115.297 -169.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.429 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.32 44.9 ptt85 -84.91 21.3 1.62 Allowed 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -179.338 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -142.86 140.02 31.09 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.814 1.646 . . . . 0.0 111.868 -174.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -142.62 149.36 38.86 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.435 1.494 . . . . 0.0 112.512 -176.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.9 t -92.4 142.35 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 161.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.26 149.65 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 119.348 0.977 . . . . 0.0 111.949 164.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.486 ' HE ' ' NE2' ' A' ' 97' ' ' GLN . 41.1 ttp180 -93.04 95.72 9.63 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.706 0.803 . . . . 0.0 110.259 174.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -76.91 150.98 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.301 0.64 . . . . 0.0 111.705 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.486 ' NE2' ' HE ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.594 0 C-N-CA 125.901 1.68 . . . . 0.0 110.395 174.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 84.7 p . . . . . 0 N--CA 1.465 0.32 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.59 142.45 27.98 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.671 1.188 . . . . 0.0 111.276 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -87.66 117.54 26.55 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.378 0.671 . . . . 0.0 109.537 168.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.9 pt -118.56 147.61 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.888 1.275 . . . . 0.0 110.761 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.7 136.32 12.9 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.5 pt -127.66 159.77 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 125.008 1.323 . . . . 0.0 112.067 171.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -154.38 168.82 32.68 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-O 122.039 0.799 . . . . 0.0 114.513 173.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -121.77 157.41 31.08 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 126.08 1.752 . . . . 0.0 111.797 -171.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.7 t -70.01 -19.34 63.33 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.055 0.942 . . . . 0.0 112.592 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -154.79 150.76 27.88 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.197 0.999 . . . . 0.0 111.921 -176.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 35.6 ttt-85 -61.32 -31.62 71.48 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.694 1.198 . . . . 0.0 113.276 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.27 -29.33 75.02 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-N 119.102 0.865 . . . . 0.0 113.976 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -82.53 -34.67 27.8 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.455 -1.026 . . . . 0.0 111.642 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.429 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -67.67 -30.51 70.06 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.26 1.024 . . . . 0.0 113.388 167.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -61.5 -47.48 85.42 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.446 -0.784 . . . . 0.0 110.797 168.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -62.31 -36.92 83.64 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.386 0.993 . . . . 0.0 112.876 175.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -55.55 -55.76 28.13 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.224 0.92 . . . . 0.0 112.263 173.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -81.34 -27.3 35.01 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.114 1.154 . . . . 0.0 114.114 -174.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 73.0 t -76.3 -38.8 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 O-C-N 121.45 -0.781 . . . . 0.0 111.181 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 93.5 p -65.05 -30.98 71.98 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.152 0.887 . . . . 0.0 112.988 175.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.5 mt -68.43 -54.99 13.45 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.265 1.026 . . . . 0.0 111.761 171.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -67.27 -26.74 66.71 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 120.988 -1.07 . . . . 0.0 113.007 -176.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -81.78 -3.87 54.95 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.874 1.27 . . . . 0.0 112.713 174.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -91.53 -25.13 19.39 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.681 -1.262 . . . . 0.0 112.446 163.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -100.29 -6.76 25.42 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 116.007 1.855 . . . . 0.0 116.007 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -174.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.535 0.383 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.3 t -70.96 141.1 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 O-C-N 121.138 -0.976 . . . . 0.0 112.971 -168.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.3 mt -122.7 -41.77 2.35 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.874 1.67 . . . . 0.0 112.495 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 33.6 t -152.42 132.31 13.32 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.545 1.138 . . . . 0.0 110.596 175.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 72.6 t -127.94 127.07 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.546 1.138 . . . . 0.0 109.744 172.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -133.17 143.03 46.64 Favored Pre-proline 0 N--CA 1.474 0.737 0 C-N-CA 124.853 1.261 . . . . 0.0 111.683 173.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.02 -17.42 22.25 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.51 2.807 . . . . 0.0 115.098 -174.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -134.25 110.81 9.77 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.118 0.967 . . . . 0.0 112.21 -169.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -149.36 146.37 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 126.324 1.85 . . . . 0.0 109.739 171.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.3 m -125.27 131.59 53.06 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.058 0.943 . . . . 0.0 111.573 -171.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.1 t -98.9 139.97 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 126.028 1.731 . . . . 0.0 112.054 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -127.59 132.38 49.83 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.71 1.604 . . . . 0.0 108.968 169.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 48.0 mtm180 -70.05 139.29 52.61 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 155.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.8 pt . . . . . 0 N--CA 1.479 1.006 0 C-N-CA 125.16 1.384 . . . . 0.0 112.95 -163.59 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.27 22.9 4.81 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.284 1.434 . . . . 0.0 113.021 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 56.64 -46.94 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 128.471 2.709 . . . . 0.0 115.304 -170.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.4 m -64.82 -13.43 55.82 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.552 1.941 . . . . 0.0 114.276 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -78.57 -4.6 49.56 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.405 1.482 . . . . 0.0 113.588 170.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 10.6 m0 -107.0 167.83 9.62 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.655 1.582 . . . . 0.0 111.425 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -78.01 53.67 1.21 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.02 1.728 . . . . 0.0 113.589 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.9 mt -55.56 -32.6 63.14 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -170.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -87.63 -6.82 58.1 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.068 0.947 . . . . 0.0 113.085 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -140.19 59.29 12.35 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 126.886 2.075 . . . . 0.0 111.183 -160.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -65.04 139.61 62.03 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 CA-C-N 119.593 0.89 . . . . 0.0 112.424 -171.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -74.46 -26.64 60.17 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.207 1.003 . . . . 0.0 111.717 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 39.4 t90 -153.6 153.57 32.59 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.887 1.675 . . . . 0.0 110.71 169.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 56.0 p -135.88 148.38 48.58 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.486 1.114 . . . . 0.0 112.091 171.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 173.09 -144.13 7.64 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 123.017 0.341 . . . . 0.0 113.852 177.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.4 mtm180 -98.14 145.48 26.53 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.94 1.696 . . . . 0.0 112.069 -174.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.4 tp -85.61 136.47 33.37 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.584 1.553 . . . . 0.0 109.778 163.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 39.3 ttt-85 -145.68 87.08 1.76 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.626 1.17 . . . . 0.0 110.862 167.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.1 mt -71.28 125.59 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 171.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.7 p -128.23 163.91 23.7 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.376 1.87 . . . . 0.0 110.131 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.3 t -163.78 148.73 10.67 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.678 -1.264 . . . . 0.0 110.754 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.515 ' HE3' ' CE1' ' A' ' 57' ' ' TYR . 57.9 mttt -125.21 -126.37 0.24 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.967 1.307 . . . . 0.0 110.037 -172.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.48 94.11 1.69 Allowed Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.293 1.425 . . . . 0.0 112.309 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 54.58 28.54 10.0 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 126.653 1.981 . . . . 0.0 113.635 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.0 m -148.16 118.21 7.23 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.634 1.573 . . . . 0.0 109.35 -174.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -96.0 163.89 12.94 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.057 1.343 . . . . 0.0 111.63 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.515 ' CE1' ' HE3' ' A' ' 52' ' ' LYS . 82.2 m-85 -147.67 107.38 3.96 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.205 1.802 . . . . 0.0 109.298 -174.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.3 mp -80.46 96.11 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 170.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -92.41 138.21 31.71 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.173 0.589 . . . . 0.0 111.475 173.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.1 mp -115.62 134.48 55.01 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.365 1.866 . . . . 0.0 109.911 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -136.09 148.47 48.29 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.962 0.905 . . . . 0.0 112.07 -168.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -71.01 141.05 50.98 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 122.766 1.269 . . . . 0.0 111.643 177.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.54 ' H ' ' CD ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -85.25 1.53 47.84 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 127.007 2.123 . . . . 0.0 116.139 -175.124 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.1 t -116.97 -45.67 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 125.336 1.454 . . . . 0.0 111.014 171.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.2 m -96.71 -20.12 18.47 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -173.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.79 9.69 83.14 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.431 1.015 . . . . 0.0 113.823 -176.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -83.34 149.07 26.96 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.999 1.319 . . . . 0.0 112.186 -174.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.4 tp -70.89 125.45 26.88 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.59 0.756 . . . . 0.0 111.24 -177.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -83.5 -57.82 3.08 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.725 0.81 . . . . 0.0 110.475 167.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.59 163.02 40.69 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.486 1.114 . . . . 0.0 112.071 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -136.39 137.69 40.79 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.469 1.507 . . . . 0.0 110.606 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.81 92.1 49.31 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.291 1.036 . . . . 0.0 111.535 176.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -56.6 139.56 88.16 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 124.649 3.566 . . . . 0.0 113.457 168.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.3 t -138.94 123.99 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 126.58 1.952 . . . . 0.0 109.618 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -88.59 -21.41 24.05 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 121.01 -1.056 . . . . 0.0 113.425 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -160.29 144.94 14.53 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.169 1.788 . . . . 0.0 110.252 170.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -118.34 129.08 25.6 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.493 1.117 . . . . 0.0 110.75 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -66.39 148.23 76.77 Favored 'Cis proline' 0 CA--C 1.542 0.887 0 CA-C-N 119.976 1.027 . . . . 0.0 113.094 -4.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.81 -163.4 15.39 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.529 1.537 . . . . 0.0 113.054 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.4 tt -69.9 -37.42 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 O-C-N 121.797 -0.826 . . . . 0.0 113.191 -175.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.54 7.14 27.35 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -165.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 23.8 t -150.55 125.13 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.478 1.511 . . . . 0.0 109.606 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -139.16 159.83 41.23 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.114 1.766 . . . . 0.0 112.17 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.0 p -114.35 156.06 25.13 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.085 1.754 . . . . 0.0 111.725 -176.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.5 m -85.91 172.09 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.089 0.956 . . . . 0.0 111.114 170.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 70.5 p -96.7 -28.09 14.47 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 178.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -88.62 -43.37 11.41 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.232 0.826 . . . . 0.0 113.232 -168.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.5 t -146.17 125.73 13.28 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.34 1.77 3.56 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -170.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.456 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.286 31.5 ptt180 -86.59 16.59 4.52 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 177.162 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -139.5 137.6 35.65 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.997 1.319 . . . . 0.0 111.102 -173.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -139.07 155.02 48.24 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.979 1.312 . . . . 0.0 111.567 -178.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.76 141.77 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.497 0.719 . . . . 0.0 109.38 164.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.44 146.85 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 118.811 0.732 . . . . 0.0 112.354 171.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -87.54 89.87 8.16 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.906 0.883 . . . . 0.0 110.071 176.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.1 pt -68.34 144.14 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 O-C-N 122.126 -0.359 . . . . 0.0 111.127 173.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 . . . . . 0 N--CA 1.471 0.577 0 C-N-CA 124.713 1.205 . . . . 0.0 111.613 -175.884 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.0 p . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.73 146.39 33.12 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.271 1.429 . . . . 0.0 111.334 168.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -92.55 117.37 29.88 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.704 0.802 . . . . 0.0 109.672 171.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 32.9 pt -118.76 145.56 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.939 1.296 . . . . 0.0 111.419 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -90.95 141.83 15.88 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 176.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.3 pt -127.95 140.56 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 125.385 1.474 . . . . 0.0 111.646 171.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.08 143.78 15.84 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.835 1.207 . . . . 0.0 113.324 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -105.77 163.74 12.47 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.878 1.671 . . . . 0.0 111.061 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.1 t -74.08 -30.57 62.42 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.241 0.616 . . . . 0.0 112.407 176.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -151.1 150.21 30.41 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.133 0.973 . . . . 0.0 112.107 -174.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 54.7 ttt-85 -61.06 -33.68 73.7 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.43 1.092 . . . . 0.0 113.154 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.04 -27.17 73.77 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 123.901 0.763 . . . . 0.0 113.849 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -83.43 -36.27 24.35 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.088 0.944 . . . . 0.0 111.422 175.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -65.12 -33.08 75.17 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 169.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -61.0 -33.79 73.8 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.42 -0.8 . . . . 0.0 112.674 172.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -64.86 -37.87 89.08 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.808 1.185 . . . . 0.0 111.943 173.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -58.27 -50.38 73.79 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.738 0.815 . . . . 0.0 111.837 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.96 -24.27 38.2 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -176.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.7 t -80.67 -41.79 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 119.368 0.986 . . . . 0.0 111.427 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 93.2 p -63.47 -32.96 74.55 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.4 1.0 . . . . 0.0 112.87 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 61.6 mt -64.54 -58.46 6.33 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.22 1.008 . . . . 0.0 111.798 170.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -66.82 -29.8 69.83 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.247 -0.908 . . . . 0.0 113.121 -174.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -80.68 -3.55 51.08 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.42 1.088 . . . . 0.0 112.579 177.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -95.13 -19.39 20.14 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 163.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -101.41 -9.21 21.31 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.315 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 -174.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.4 m . . . . . 0 N--CA 1.464 0.248 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.6 t -65.06 142.05 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 123.766 0.826 . . . . 0.0 111.288 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.5 mt -128.18 -40.17 1.67 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.633 1.573 . . . . 0.0 112.338 -175.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 37.0 t -152.99 135.99 15.52 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.464 1.106 . . . . 0.0 111.036 173.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.4 t -129.0 126.89 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.492 1.117 . . . . 0.0 109.253 171.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -128.12 134.65 26.47 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 125.352 1.461 . . . . 0.0 110.287 175.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -78.64 -13.28 14.79 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.21 2.607 . . . . 0.0 115.268 -171.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -135.18 108.19 7.63 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.806 0.843 . . . . 0.0 111.339 -174.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.52 143.34 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.084 1.354 . . . . 0.0 110.568 173.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.5 m -123.65 131.93 53.73 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.426 1.09 . . . . 0.0 111.254 -173.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 76.6 t -97.44 134.32 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.509 1.524 . . . . 0.0 111.68 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.17 132.83 53.66 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.198 1.399 . . . . 0.0 108.685 168.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -71.4 131.72 43.78 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 162.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.1 pt . . . . . 0 N--CA 1.476 0.849 0 C-N-CA 124.043 0.937 . . . . 0.0 113.327 -164.955 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 . . . . . 0 CA--C 1.54 0.566 0 CA-C-O 119.661 -0.209 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.43 18.89 7.5 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -175.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.92 -51.4 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.968 2.507 . . . . 0.0 115.481 -173.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.0 m -65.43 -13.26 58.31 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.253 1.821 . . . . 0.0 114.257 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -79.89 -12.01 59.77 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.323 1.049 . . . . 0.0 112.645 172.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -95.35 165.33 12.43 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.801 1.641 . . . . 0.0 111.12 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.1 mttt -78.07 57.68 1.84 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.622 1.569 . . . . 0.0 113.261 175.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.1 mt -55.47 -31.75 62.23 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -173.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -89.68 -5.67 56.85 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.838 0.855 . . . . 0.0 113.042 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -138.62 68.92 45.24 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 125.479 1.512 . . . . 0.0 111.685 -161.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -68.0 145.66 68.43 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 CA-C-N 119.535 0.869 . . . . 0.0 113.097 -170.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -71.33 -31.15 67.05 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.255 0.622 . . . . 0.0 111.001 166.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 54.9 t90 -157.36 154.8 29.51 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.757 1.623 . . . . 0.0 111.149 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.2 p -132.94 148.31 52.28 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.745 1.218 . . . . 0.0 111.522 170.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.484 ' HA2' ' HE3' ' A' ' 63' ' ' LYS . . . -178.54 -146.1 6.37 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 114.332 0.493 . . . . 0.0 114.332 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -110.84 145.08 38.85 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.426 1.89 . . . . 0.0 110.952 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.6 tp -85.49 138.73 32.03 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.594 1.558 . . . . 0.0 109.939 170.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.1 ttt85 -142.81 87.95 2.02 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.676 1.19 . . . . 0.0 110.649 170.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.1 mt -75.37 124.82 34.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 170.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.4 p -134.78 169.37 17.45 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 127.065 2.146 . . . . 0.0 109.712 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.3 t -157.17 160.14 38.45 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.732 -1.23 . . . . 0.0 112.176 176.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -147.85 118.66 7.58 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.658 0.742 . . . . 0.0 111.879 160.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.24 -119.96 11.23 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 125.899 1.714 . . . . 0.0 110.506 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -92.03 10.62 28.33 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.853 1.661 . . . . 0.0 113.824 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.1 m -129.31 112.75 14.19 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.592 0.757 . . . . 0.0 111.231 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.13 161.27 16.59 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.55 0.74 . . . . 0.0 111.493 172.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -141.45 106.01 4.87 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.443 1.897 . . . . 0.0 109.31 -173.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -82.77 95.68 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 168.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -91.1 138.28 31.72 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.74 0.816 . . . . 0.0 110.86 175.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mp -112.75 130.48 56.05 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.075 1.75 . . . . 0.0 109.927 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -133.99 148.78 51.16 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.005 0.922 . . . . 0.0 112.427 -172.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -66.53 147.56 53.11 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.05 -1.031 . . . . 0.0 111.824 177.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.484 ' HE3' ' HA2' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -83.93 -0.3 50.86 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -174.168 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.5 t -120.05 -45.26 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.856 1.262 . . . . 0.0 111.508 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.7 p -94.04 -23.54 17.97 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.55 11.85 80.29 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 123.814 0.721 . . . . 0.0 113.478 -169.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -70.57 142.8 51.71 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.888 1.344 . . . . 0.0 111.621 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.4 tp -71.03 125.21 26.25 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.154 0.582 . . . . 0.0 111.208 -176.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -85.23 -56.35 3.58 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.443 1.097 . . . . 0.0 110.923 170.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.0 164.41 36.8 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.563 1.545 . . . . 0.0 110.547 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -144.98 143.32 30.46 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 169.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -114.56 111.97 46.07 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 125.086 1.355 . . . . 0.0 111.177 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.57 144.07 13.91 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.406 2.737 . . . . 0.0 111.36 175.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.8 t -135.65 128.91 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.488 1.515 . . . . 0.0 109.496 -173.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -94.65 -21.5 18.75 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.74 147.59 11.88 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.636 1.974 . . . . 0.0 110.05 170.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -116.07 128.61 25.85 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 124.803 1.241 . . . . 0.0 110.859 176.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -67.56 149.72 82.88 Favored 'Cis proline' 0 CA--C 1.544 0.978 0 CA-C-N 119.788 0.96 . . . . 0.0 112.804 -5.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.54 -167.31 17.62 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.658 1.599 . . . . 0.0 112.728 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.6 tt -67.52 -36.7 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 O-C-N 121.56 -0.965 . . . . 0.0 112.907 -177.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.32 4.23 32.11 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 -167.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.2 t -151.49 127.61 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.145 1.378 . . . . 0.0 110.448 -177.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -142.63 158.25 43.85 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.983 1.713 . . . . 0.0 112.872 -177.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.5 p -101.72 163.27 12.34 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.237 1.815 . . . . 0.0 111.749 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.5 m -89.54 169.64 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.178 0.991 . . . . 0.0 110.084 162.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 81.3 p -95.09 -30.72 13.92 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.864 1.266 . . . . 0.0 113.53 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -94.73 -39.1 10.48 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -164.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.6 t -137.09 118.84 15.06 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -175.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.3 m -74.92 21.02 0.12 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -164.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.9 ptt-85 -120.44 20.94 11.79 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.532 1.933 . . . . 0.0 114.095 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -138.56 140.9 39.23 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.308 1.443 . . . . 0.0 110.883 -173.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -140.8 156.84 46.06 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.842 1.257 . . . . 0.0 111.42 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 83.2 t -107.97 142.42 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.991 0.917 . . . . 0.0 109.5 165.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.75 148.19 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 118.492 0.587 . . . . 0.0 111.889 169.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.0 ttp85 -92.19 91.81 7.93 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.337 0.655 . . . . 0.0 110.581 176.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.5 pp -75.26 152.96 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.64 0.776 . . . . 0.0 112.05 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.507 0 C-N-CA 125.958 1.703 . . . . 0.0 110.9 173.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.6 p . . . . . 0 N--CA 1.466 0.36 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.03 143.4 28.35 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.824 1.25 . . . . 0.0 111.646 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -84.36 118.07 24.0 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.681 0.792 . . . . 0.0 109.536 168.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 30.3 pt -118.34 144.73 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.828 1.251 . . . . 0.0 110.996 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -92.08 139.0 14.5 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.1 pt -124.23 142.21 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 125.039 1.336 . . . . 0.0 111.867 171.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -124.05 143.16 14.68 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 124.777 1.179 . . . . 0.0 113.69 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -106.0 159.79 15.78 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.976 1.711 . . . . 0.0 110.833 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.5 t -72.87 -23.83 60.78 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.699 0.799 . . . . 0.0 112.739 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -158.75 153.74 25.13 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.915 1.286 . . . . 0.0 110.82 -175.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -58.78 -34.44 71.45 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.575 0.75 . . . . 0.0 112.715 176.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.46 -31.65 78.28 Favored Glycine 0 CA--C 1.536 1.368 0 CA-C-N 119.491 1.041 . . . . 0.0 114.348 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -85.85 -36.02 20.26 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.237 1.018 . . . . 0.0 112.114 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.92 -31.96 71.46 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.681 -0.637 . . . . 0.0 112.472 167.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . 0.28 8.2 m-85 -78.88 11.19 2.78 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 173.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -105.24 -31.46 9.09 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.765 0.826 . . . . 0.0 112.813 157.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -55.38 -47.09 76.34 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.263 1.025 . . . . 0.0 112.227 175.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -78.23 -32.71 49.95 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.8 t -76.87 -41.62 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.316 1.046 . . . . 0.0 110.906 -177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 81.8 p -64.35 -30.32 71.37 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 81.5 mt -71.67 -54.91 8.82 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.115 0.966 . . . . 0.0 111.92 171.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -66.85 -28.64 68.5 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.048 -1.033 . . . . 0.0 113.194 -175.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -84.76 -3.63 58.69 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.282 1.033 . . . . 0.0 112.664 175.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 53.1 t60 -89.06 -39.49 13.62 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 120.838 -1.164 . . . . 0.0 111.765 158.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -89.84 -1.63 58.03 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -172.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.031 0 CA-C-N 120.705 1.593 . . . . 0.0 114.638 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 p -66.85 145.45 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.386 0.674 . . . . 0.0 112.54 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 50.0 mt -126.82 -44.02 1.67 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.747 1.619 . . . . 0.0 112.209 -176.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.3 t -152.36 134.84 15.24 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.637 1.175 . . . . 0.0 110.482 175.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 86.3 t -127.21 127.06 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.333 1.053 . . . . 0.0 109.325 170.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -127.64 132.91 24.57 Favored Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 125.081 1.352 . . . . 0.0 110.228 174.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.13 -15.75 16.08 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.137 2.558 . . . . 0.0 114.874 -172.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -133.81 106.9 7.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.353 1.061 . . . . 0.0 110.987 -175.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.2 p -142.77 146.18 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 125.342 1.457 . . . . 0.0 110.224 173.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.5 m -127.83 132.13 49.47 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.057 0.943 . . . . 0.0 111.597 -171.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.2 t -98.8 130.24 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.399 1.479 . . . . 0.0 111.803 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -131.31 131.49 43.83 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.236 1.414 . . . . 0.0 109.637 170.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.8 mmt-85 -59.89 140.36 56.71 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.482 165.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.9 pt . . . . . 0 N--CA 1.475 0.817 0 C-N-CA 125.499 1.519 . . . . 0.0 112.834 -174.749 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 . . . . . 0 CA--C 1.532 0.274 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.13 19.67 6.43 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -172.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.49 -50.07 0.05 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.789 2.435 . . . . 0.0 115.39 -174.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.9 m -68.54 -16.62 63.94 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.843 1.657 . . . . 0.0 114.75 -175.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.52 -7.35 59.55 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 172.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.0 m0 -85.58 168.02 14.85 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.857 1.263 . . . . 0.0 110.639 175.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.8 mttt -77.72 52.23 0.99 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.129 1.372 . . . . 0.0 113.964 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.8 mt -57.52 -28.46 63.49 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -175.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -90.28 -6.15 55.48 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -149.91 83.56 6.18 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.502 1.121 . . . . 0.0 112.332 177.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -56.52 147.08 71.55 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.248 2.632 . . . . 0.0 112.95 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -70.1 -33.96 72.51 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.399 0.68 . . . . 0.0 111.14 165.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.5 t90 -156.61 152.68 27.49 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.812 1.645 . . . . 0.0 110.801 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.3 p -132.55 149.88 52.25 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.122 0.969 . . . . 0.0 111.554 167.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.99 -141.44 5.13 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 123.07 0.367 . . . . 0.0 113.282 -178.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.2 mtm105 -109.8 144.92 37.55 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.065 1.746 . . . . 0.0 111.88 -175.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.8 tp -85.36 137.59 32.84 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.711 1.204 . . . . 0.0 109.129 163.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.8 ttt-85 -143.97 89.37 2.03 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.263 1.025 . . . . 0.0 110.56 164.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.1 mt -71.53 130.05 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 170.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 p -132.83 173.76 11.04 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.933 2.093 . . . . 0.0 110.282 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 92.9 p -161.89 166.73 25.82 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 120.687 -1.258 . . . . 0.0 111.712 178.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.2 mmtt -152.92 -117.74 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.658 1.583 . . . . 0.0 110.451 153.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.47 92.05 0.41 Allowed Glycine 0 N--CA 1.471 1.024 0 C-N-CA 125.636 1.588 . . . . 0.0 113.802 -160.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.7 mttt 50.99 27.91 3.52 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.429 1.891 . . . . 0.0 112.915 -175.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.1 m -143.42 127.82 17.85 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.24 1.416 . . . . 0.0 109.269 -173.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.76 161.57 13.51 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.637 1.175 . . . . 0.0 110.562 169.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -141.25 102.34 4.21 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.163 1.785 . . . . 0.0 108.905 -173.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.1 mp -78.57 98.09 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 170.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -97.61 138.02 35.65 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.395 0.617 . . . . 0.0 111.575 173.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mp -109.11 132.93 53.64 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.197 1.799 . . . . 0.0 109.568 174.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -137.88 151.92 48.52 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.891 0.876 . . . . 0.0 112.569 -168.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -74.12 143.99 45.1 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.123 -0.986 . . . . 0.0 112.092 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -84.07 -6.55 59.43 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.376 1.871 . . . . 0.0 115.128 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 92.5 t -123.37 -44.32 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 125.315 1.446 . . . . 0.0 111.423 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.8 m -93.64 -22.88 18.5 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -174.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.0 6.88 86.43 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 123.956 0.789 . . . . 0.0 113.805 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -82.37 155.68 24.6 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.364 1.466 . . . . 0.0 112.441 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.3 tp -74.5 129.01 36.97 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.492 0.717 . . . . 0.0 111.223 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -88.04 -55.19 3.86 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.234 1.014 . . . . 0.0 111.16 169.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.39 161.25 40.13 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.918 1.287 . . . . 0.0 111.323 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -144.22 140.74 29.46 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.759 0.824 . . . . 0.0 112.565 176.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.79 102.5 22.37 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 125.936 1.694 . . . . 0.0 111.157 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -69.33 147.15 64.98 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.927 3.085 . . . . 0.0 112.438 170.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.9 t -138.15 125.07 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.796 1.638 . . . . 0.0 109.152 -176.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -92.02 -22.48 19.94 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -159.88 147.45 16.73 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.562 1.945 . . . . 0.0 109.642 168.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -124.14 127.62 25.29 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 124.684 1.194 . . . . 0.0 110.964 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.43 147.4 50.06 Favored 'Cis proline' 0 CA--C 1.541 0.87 0 CA-C-N 120.079 1.064 . . . . 0.0 114.534 -4.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.33 -166.58 19.44 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.488 1.518 . . . . 0.0 113.429 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.4 tp -70.65 -31.24 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -174.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.85 3.54 50.84 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -171.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.9 t -150.34 133.54 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.902 1.281 . . . . 0.0 110.844 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -141.35 161.61 37.49 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.319 1.448 . . . . 0.0 112.83 175.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 73.0 p -107.21 161.23 14.96 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 127.055 2.142 . . . . 0.0 111.093 177.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.8 m -88.27 172.83 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 123.897 0.879 . . . . 0.0 111.232 166.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 60.0 p -96.22 -30.29 13.55 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.39 1.476 . . . . 0.0 113.368 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -96.28 -40.59 9.08 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -165.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.5 t -137.74 117.96 13.59 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -173.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.3 p -75.08 29.25 0.09 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -172.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.96 24.82 7.48 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 127.108 2.163 . . . . 0.0 113.937 174.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -140.96 139.88 34.31 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.902 1.281 . . . . 0.0 111.261 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -137.74 159.87 40.8 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.813 1.245 . . . . 0.0 110.738 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.8 t -112.18 144.66 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 124.288 1.035 . . . . 0.0 108.772 165.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.94 148.07 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 118.095 0.407 . . . . 0.0 111.755 168.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -89.86 99.98 12.88 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.31 0.644 . . . . 0.0 109.542 172.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -84.7 155.21 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.536 1.135 . . . . 0.0 111.335 176.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 . . . . . 0 N--CA 1.469 0.507 0 C-N-CA 124.969 1.308 . . . . 0.0 111.592 178.244 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 84.1 p . . . . . 0 N--CA 1.473 0.719 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.48 144.77 28.82 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.89 1.276 . . . . 0.0 111.267 172.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -87.88 119.89 28.67 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 165.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 31.3 pt -120.69 142.81 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.628 1.171 . . . . 0.0 111.218 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.69 137.31 13.51 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 176.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.3 pt -124.6 139.05 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 125.226 1.41 . . . . 0.0 111.713 175.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.1 140.28 14.45 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.719 1.152 . . . . 0.0 113.082 177.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -101.84 159.47 15.31 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.025 1.73 . . . . 0.0 111.37 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.5 t -70.58 -27.38 64.07 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.32 0.648 . . . . 0.0 112.646 178.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -158.05 155.96 30.23 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.382 1.073 . . . . 0.0 111.997 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -56.58 -38.41 71.94 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.662 1.185 . . . . 0.0 112.482 174.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.05 -10.43 46.72 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.541 1.067 . . . . 0.0 115.022 176.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -104.75 -35.97 7.58 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.746 1.273 . . . . 0.0 111.754 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.7 -28.27 68.52 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.65 0.78 . . . . 0.0 112.835 164.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -70.74 -6.51 38.01 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 169.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -93.76 -35.25 12.87 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.939 1.245 . . . . 0.0 112.26 163.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -55.2 -55.76 27.64 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.304 0.957 . . . . 0.0 112.267 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -78.81 -27.66 44.42 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 -173.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.6 t -79.74 -39.58 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 121.749 -0.595 . . . . 0.0 111.043 -178.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 88.5 p -65.7 -33.31 75.59 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.544 -0.722 . . . . 0.0 112.524 174.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 40.6 mt -66.62 -55.73 13.96 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.035 0.934 . . . . 0.0 112.154 172.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -64.85 -27.26 68.75 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.136 0.88 . . . . 0.0 112.874 -176.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -79.0 -7.8 58.38 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.345 1.058 . . . . 0.0 112.873 176.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -84.89 -15.61 44.0 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.087 -1.008 . . . . 0.0 112.815 165.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -115.17 -7.92 12.41 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -173.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.466 0.352 0 CA-C-O 120.53 0.205 . . . . 0.0 111.299 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.5 t -73.52 143.72 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.741 1.216 . . . . 0.0 111.583 -169.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.9 mt -128.86 -38.67 1.65 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.73 1.612 . . . . 0.0 112.625 -174.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 34.8 t -154.22 136.76 15.09 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.618 1.167 . . . . 0.0 110.726 173.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 88.7 t -130.14 127.27 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.639 1.176 . . . . 0.0 109.383 171.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -129.05 140.17 37.84 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 125.791 1.636 . . . . 0.0 110.794 176.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -77.35 -27.26 6.64 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.464 2.776 . . . . 0.0 115.84 -168.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -140.05 115.87 10.24 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.087 0.946 . . . . 0.0 111.843 -175.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.9 145.4 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 126.84 2.056 . . . . 0.0 109.726 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.2 m -124.71 130.05 51.68 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.767 0.827 . . . . 0.0 112.133 -167.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 77.8 t -94.6 137.44 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.212 1.405 . . . . 0.0 112.051 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.56 128.72 37.84 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.624 1.17 . . . . 0.0 110.133 169.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.41 135.95 57.34 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.306 1.042 . . . . 0.0 111.035 161.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.8 pt . . . . . 0 N--CA 1.475 0.8 0 C-N-CA 126.248 1.819 . . . . 0.0 112.294 -177.623 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.62 18.45 6.83 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -170.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.73 -50.67 0.05 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.879 2.472 . . . . 0.0 115.464 -175.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.6 m -66.77 -14.6 62.79 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.069 1.748 . . . . 0.0 114.19 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -76.36 -21.51 56.01 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.723 1.209 . . . . 0.0 112.56 172.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 17.3 m0 -84.52 172.09 11.96 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.667 1.587 . . . . 0.0 111.524 -177.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -80.16 54.55 1.98 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.365 1.466 . . . . 0.0 113.978 -177.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.7 mt -60.71 -17.27 47.23 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -174.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -102.08 -8.04 21.77 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.813 1.245 . . . . 0.0 113.104 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -149.0 72.52 10.29 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.896 1.278 . . . . 0.0 111.867 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -57.47 145.58 87.77 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.043 2.495 . . . . 0.0 112.374 174.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -70.07 -29.14 66.07 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.513 1.125 . . . . 0.0 111.749 175.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 42.1 t90 -159.44 152.99 22.63 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.035 1.734 . . . . 0.0 110.476 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.2 p -133.7 152.31 51.85 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.575 -0.703 . . . . 0.0 112.381 166.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.08 -146.72 7.35 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 116.174 -0.466 . . . . 0.0 114.085 -176.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 42.7 mtm105 -104.84 148.27 26.83 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.047 2.139 . . . . 0.0 111.734 -175.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.3 tp -89.51 139.43 30.54 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.257 1.423 . . . . 0.0 110.247 167.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 -141.53 97.15 3.1 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.65 1.58 . . . . 0.0 109.682 167.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.3 mt -83.31 130.67 35.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 169.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.81 162.82 34.47 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.51 2.324 . . . . 0.0 109.508 -168.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.5 t -163.48 153.73 15.66 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.431 -1.418 . . . . 0.0 110.508 175.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -128.58 -41.79 1.5 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 116.786 2.143 . . . . 0.0 116.786 -176.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.92 82.53 0.1 OUTLIER Glycine 0 N--CA 1.472 1.072 0 CA-C-N 118.652 0.66 . . . . 0.0 112.075 -175.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt 54.71 25.24 6.29 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.006 1.722 . . . . 0.0 112.749 -171.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.7 m -141.43 118.27 11.11 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.197 1.399 . . . . 0.0 107.649 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.51 160.06 14.69 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.241 1.016 . . . . 0.0 110.799 174.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -138.44 113.81 9.55 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 126.346 1.858 . . . . 0.0 108.956 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.5 mp -86.12 102.17 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 166.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -100.67 140.01 35.55 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.349 1.059 . . . . 0.0 111.409 176.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.8 mp -113.32 130.6 56.22 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.444 1.898 . . . . 0.0 109.605 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -135.85 153.26 51.54 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.079 0.952 . . . . 0.0 112.259 -174.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -73.12 142.91 47.49 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.85 -1.156 . . . . 0.0 111.9 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.3 pttt -84.63 -4.64 59.1 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.973 1.709 . . . . 0.0 115.048 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 64.8 t -124.79 -43.81 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 125.468 1.507 . . . . 0.0 111.361 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.7 m -91.54 -24.2 19.69 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.5 5.77 87.99 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 123.992 0.806 . . . . 0.0 113.831 -177.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -82.78 151.17 26.24 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.343 1.457 . . . . 0.0 112.566 -173.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.1 tp -73.36 126.12 29.41 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.612 0.765 . . . . 0.0 110.886 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -87.65 -54.8 4.07 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.462 1.105 . . . . 0.0 111.226 171.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.29 163.64 38.51 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.575 1.15 . . . . 0.0 112.01 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -142.23 134.41 27.59 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.707 1.203 . . . . 0.0 111.653 177.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.15 97.08 50.5 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.11 1.364 . . . . 0.0 111.669 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -58.89 139.7 91.97 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 124.568 3.512 . . . . 0.0 113.315 166.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.3 t -139.13 128.87 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.571 1.949 . . . . 0.0 109.52 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -90.77 -24.12 20.44 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.34 149.97 15.94 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.034 1.734 . . . . 0.0 110.772 173.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -118.83 130.43 24.82 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.589 1.156 . . . . 0.0 111.469 175.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -63.34 148.33 64.16 Favored 'Cis proline' 0 CA--C 1.542 0.879 0 CA-C-N 119.761 0.951 . . . . 0.0 113.583 -7.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -152.39 -163.91 11.96 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.578 1.561 . . . . 0.0 112.461 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.9 tt -78.13 -36.47 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 O-C-N 121.82 -0.812 . . . . 0.0 112.938 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.94 8.71 9.76 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -169.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.0 t -149.8 133.69 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 126.33 1.852 . . . . 0.0 109.446 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -146.43 159.17 43.74 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.464 1.506 . . . . 0.0 112.489 -177.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.8 p -109.7 155.66 21.25 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 126.638 1.975 . . . . 0.0 111.696 176.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.1 m -80.51 173.46 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 124.01 0.924 . . . . 0.0 110.982 165.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.6 p -95.68 -30.21 13.88 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.409 1.484 . . . . 0.0 113.357 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -91.1 -50.24 5.96 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.927 0.891 . . . . 0.0 113.266 -167.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.7 m -133.78 117.39 16.84 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -167.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.0 m -73.23 28.36 0.06 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -171.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.418 ' HA ' ' CB ' ' A' ' 116' ' ' ALA . 6.1 ptm180 -125.23 23.62 7.61 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.859 2.064 . . . . 0.0 113.577 175.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -141.07 137.43 32.87 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.279 1.432 . . . . 0.0 110.99 -178.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -137.35 165.24 26.67 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.855 1.262 . . . . 0.0 111.128 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.3 t -120.28 143.29 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 124.658 1.183 . . . . 0.0 108.539 168.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.72 149.05 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 118.639 0.654 . . . . 0.0 111.744 172.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -92.49 90.23 7.08 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.051 0.54 . . . . 0.0 110.858 177.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -70.57 141.32 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 122.894 0.478 . . . . 0.0 110.995 177.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 . . . . . 0 N--CA 1.47 0.564 0 C-N-CA 126.09 1.756 . . . . 0.0 111.491 -172.83 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 93.6 p . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.14 146.46 30.87 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.527 1.531 . . . . 0.0 111.29 171.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -87.11 124.56 33.38 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.737 -0.602 . . . . 0.0 109.425 166.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.8 pt -122.5 143.57 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.522 1.129 . . . . 0.0 111.092 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -90.18 144.28 17.46 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 173.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.8 pt -129.67 140.43 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 125.53 1.532 . . . . 0.0 111.991 173.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.23 137.7 11.59 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 125.64 1.591 . . . . 0.0 113.151 178.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -102.09 162.92 12.54 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.252 1.821 . . . . 0.0 111.29 -178.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.4 t -74.14 -27.73 60.99 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.722 0.809 . . . . 0.0 113.006 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -157.11 153.27 27.52 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.276 1.03 . . . . 0.0 112.229 -177.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -60.01 -34.4 73.28 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.601 1.16 . . . . 0.0 113.151 176.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.1 -31.54 81.12 Favored Glycine 0 CA--C 1.536 1.39 0 CA-C-N 119.131 0.878 . . . . 0.0 113.382 176.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -83.69 -34.69 24.9 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.804 0.842 . . . . 0.0 112.093 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.418 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -65.46 -33.51 76.12 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 170.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -61.77 -32.19 72.45 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.043 -1.036 . . . . 0.0 112.582 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -66.34 -30.15 70.49 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.049 -1.032 . . . . 0.0 112.738 173.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -63.09 -49.35 74.83 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.372 0.987 . . . . 0.0 111.943 173.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.8 -25.11 33.03 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -177.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.8 t -78.37 -41.59 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 119.197 0.908 . . . . 0.0 111.39 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 93.7 p -64.58 -29.49 70.51 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.251 0.932 . . . . 0.0 113.302 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 78.0 mt -70.96 -54.28 11.9 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.004 0.922 . . . . 0.0 111.712 171.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -68.51 -32.74 72.91 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.01 -1.056 . . . . 0.0 113.225 -174.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -83.81 -1.34 54.12 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.088 0.955 . . . . 0.0 112.364 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -96.44 -33.24 11.95 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 120.931 -1.106 . . . . 0.0 112.545 164.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -93.05 -3.28 54.57 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.301 0 CA-C-N 121.595 1.998 . . . . 0.0 114.936 -175.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 82.6 p . . . . . 0 N--CA 1.469 0.509 0 CA-C-O 121.083 0.468 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 82.5 t -70.62 141.01 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.916 0.886 . . . . 0.0 111.053 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.6 mt -127.49 -40.54 1.77 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.697 1.599 . . . . 0.0 112.646 -171.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 51.1 t -146.87 137.28 23.65 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.505 1.522 . . . . 0.0 109.247 172.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 76.8 t -126.6 130.48 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.355 1.062 . . . . 0.0 108.936 168.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -133.57 127.84 19.79 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 124.562 1.145 . . . . 0.0 111.076 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.19 -13.24 12.65 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.986 2.457 . . . . 0.0 114.947 -171.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -134.11 104.52 6.25 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.223 1.009 . . . . 0.0 110.717 -176.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.5 p -143.18 144.42 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.508 1.123 . . . . 0.0 110.726 174.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.8 m -124.88 131.21 53.46 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.55 1.14 . . . . 0.0 110.629 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.0 t -96.61 134.33 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.946 1.298 . . . . 0.0 111.127 177.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.38 120.63 25.87 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.06 1.344 . . . . 0.0 108.932 169.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -63.24 130.79 46.06 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.425 -0.797 . . . . 0.0 109.145 163.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.2 pt . . . . . 0 CA--C 1.544 0.745 0 C-N-CA 124.845 1.258 . . . . 0.0 112.834 -166.703 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 . . . . . 0 C--O 1.223 -0.329 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.92 18.64 7.86 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -171.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.16 -49.89 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 128.141 2.576 . . . . 0.0 115.607 -173.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.5 m -67.61 -15.2 63.53 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.012 1.725 . . . . 0.0 114.603 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.95 -10.8 58.62 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 171.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.0 m0 -85.55 170.45 12.59 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.813 1.245 . . . . 0.0 110.841 176.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.9 mtmm -80.24 52.94 1.66 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.408 1.483 . . . . 0.0 113.606 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.6 mt -57.89 -23.76 54.69 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -173.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -96.28 -6.51 37.71 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.547 1.139 . . . . 0.0 112.446 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -151.99 72.37 7.88 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 125.111 1.364 . . . . 0.0 111.817 -169.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -57.97 149.59 69.62 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.725 2.95 . . . . 0.0 113.605 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -73.32 -31.11 63.81 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.76 0.824 . . . . 0.0 111.401 167.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 33.5 t90 -158.13 153.02 25.15 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.48 1.912 . . . . 0.0 110.391 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.2 p -134.18 146.74 50.45 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.719 1.208 . . . . 0.0 111.486 171.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.41 -138.5 4.28 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 114.088 0.395 . . . . 0.0 114.088 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -115.89 144.72 43.64 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.816 1.646 . . . . 0.0 111.578 -172.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.2 tp -92.49 137.72 32.12 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.354 1.462 . . . . 0.0 109.821 172.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 53.9 ttp85 -138.68 102.21 4.53 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.96 0.904 . . . . 0.0 110.026 162.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 25.8 mt -79.16 132.67 31.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 169.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.74 171.69 14.13 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 126.229 1.812 . . . . 0.0 110.708 -175.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.0 t -161.41 159.53 28.31 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.369 1.068 . . . . 0.0 110.869 172.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -147.55 -85.03 0.1 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 158.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.56 68.39 3.36 Favored Glycine 0 N--CA 1.474 1.226 0 C-N-CA 124.629 1.109 . . . . 0.0 113.959 -166.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.7 mttt 51.67 30.13 6.39 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.815 1.646 . . . . 0.0 112.49 -172.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.8 m -146.92 120.8 9.3 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.383 1.873 . . . . 0.0 108.237 -173.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.84 156.7 19.77 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.318 1.047 . . . . 0.0 110.939 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -135.15 100.41 4.54 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.336 1.855 . . . . 0.0 108.713 -173.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.6 mp -79.74 104.84 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 171.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.4 mttt -105.4 135.26 47.11 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.526 0.73 . . . . 0.0 111.775 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -101.08 133.17 46.01 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 125.237 1.415 . . . . 0.0 110.189 169.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -138.32 148.34 44.5 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.038 0.935 . . . . 0.0 112.233 -171.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -68.51 149.67 48.97 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.217 1.008 . . . . 0.0 113.688 -171.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.89 -3.84 43.73 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.9 t -123.41 -48.25 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.636 1.174 . . . . 0.0 111.705 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.6 p -95.35 -24.6 16.66 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -176.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.05 13.98 76.16 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 123.609 0.623 . . . . 0.0 113.522 -167.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -69.13 149.28 48.82 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 118.727 1.263 . . . . 0.0 111.533 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.4 tp -71.2 124.11 23.75 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.444 0.698 . . . . 0.0 111.441 -175.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -84.26 -53.86 5.2 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.971 0.908 . . . . 0.0 110.924 168.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -159.39 157.67 30.74 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.925 1.29 . . . . 0.0 111.516 -177.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -138.99 138.77 37.56 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.59 0.756 . . . . 0.0 112.81 174.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.65 111.09 36.4 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.059 1.343 . . . . 0.0 111.685 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -82.81 123.73 3.76 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.981 3.121 . . . . 0.0 111.91 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.6 t -114.41 119.73 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 126.862 2.065 . . . . 0.0 109.324 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -81.97 -20.56 38.28 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 -176.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.08 162.54 15.44 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.245 1.818 . . . . 0.0 109.308 171.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -120.45 129.81 25.15 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -173.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -64.95 151.94 76.03 Favored 'Cis proline' 0 CA--C 1.542 0.912 0 CA-C-N 119.193 0.748 . . . . 0.0 112.895 -11.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -147.37 175.48 26.71 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.165 0.888 . . . . 0.0 114.15 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.5 tp -52.97 -30.11 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 124.695 1.198 . . . . 0.0 114.066 -176.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.68 9.82 28.28 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.6 p -155.45 138.36 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.197 0.999 . . . . 0.0 113.561 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -152.24 161.12 43.09 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.664 1.586 . . . . 0.0 113.069 -172.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 62.9 p -112.88 161.01 17.46 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 127.307 2.243 . . . . 0.0 111.202 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.0 m -88.5 175.8 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.319 1.047 . . . . 0.0 111.314 167.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.7 p -95.79 -31.59 13.11 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.673 1.589 . . . . 0.0 113.357 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -93.98 -42.37 9.08 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -165.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.4 t -142.49 121.39 12.77 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -177.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.15 0.73 5.69 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -169.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.472 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.303 28.4 ptt180 -87.12 16.21 5.34 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 176.509 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -137.24 136.8 38.43 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.168 1.387 . . . . 0.0 110.908 -174.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -137.54 160.3 39.54 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.138 1.375 . . . . 0.0 111.263 -177.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.1 t -116.2 143.05 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.258 1.023 . . . . 0.0 108.915 166.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.67 149.66 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 123.441 0.697 . . . . 0.0 111.395 170.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -93.25 87.44 5.65 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.776 0.831 . . . . 0.0 110.357 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -70.24 138.35 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 120.958 0.409 . . . . 0.0 110.695 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 . . . . . 0 N--CA 1.468 0.442 0 C-N-CA 125.484 1.514 . . . . 0.0 111.212 -167.77 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 95.6 p . . . . . 0 CA--C 1.534 0.362 0 N-CA-C 114.646 1.351 . . . . 0.0 114.646 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.14 140.72 28.18 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.208 1.403 . . . . 0.0 110.927 168.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -88.39 119.69 29.06 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.175 0.59 . . . . 0.0 109.896 170.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.8 pt -118.54 142.0 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.543 1.137 . . . . 0.0 110.756 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -90.99 144.27 17.12 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 173.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.2 pt -128.38 141.81 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 125.052 1.341 . . . . 0.0 111.631 169.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -121.4 142.67 15.52 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.142 1.353 . . . . 0.0 113.169 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -107.19 164.97 11.72 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.718 1.607 . . . . 0.0 111.551 -177.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.6 t -74.39 -31.91 62.52 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.486 0.714 . . . . 0.0 112.521 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -151.71 146.36 25.71 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.245 -0.909 . . . . 0.0 112.071 -172.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -61.71 -33.78 74.62 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.329 1.051 . . . . 0.0 113.195 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.7 -25.54 75.03 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-N 118.935 0.789 . . . . 0.0 113.838 176.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -92.96 -26.38 17.59 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.193 0.997 . . . . 0.0 112.821 176.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.472 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -66.11 -34.53 78.27 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.422 -0.799 . . . . 0.0 112.598 161.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -59.82 -31.32 69.62 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.049 -1.032 . . . . 0.0 112.197 168.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -67.28 -25.19 65.93 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 119.553 1.07 . . . . 0.0 112.968 174.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -69.74 -51.87 30.42 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.205 1.002 . . . . 0.0 111.878 168.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.08 -25.3 40.08 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -174.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 65.0 t -77.97 -42.41 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 121.134 -0.979 . . . . 0.0 111.05 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 88.7 p -66.37 -30.66 71.09 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.1 mt -69.93 -55.95 8.33 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.828 0.851 . . . . 0.0 111.536 171.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -63.68 -33.7 76.22 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.117 0.871 . . . . 0.0 113.256 -174.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -83.53 -0.89 52.26 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.468 1.107 . . . . 0.0 112.762 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -94.11 -13.41 26.81 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.263 -0.898 . . . . 0.0 113.31 164.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -108.17 -4.86 17.26 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.331 0 CA-C-N 121.079 1.763 . . . . 0.0 115.677 -176.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.0 m . . . . . 0 N--CA 1.468 0.451 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.36 146.99 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.779 0.831 . . . . 0.0 113.015 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.6 mt -130.82 -42.56 1.12 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.65 1.58 . . . . 0.0 112.409 -173.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 27.1 t -151.64 134.67 15.8 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.336 1.054 . . . . 0.0 110.933 177.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 96.9 t -129.31 127.85 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.516 1.126 . . . . 0.0 109.474 172.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -127.36 130.55 23.7 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 125.176 1.391 . . . . 0.0 110.085 173.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.7 -13.96 15.99 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 122.959 2.439 . . . . 0.0 115.144 -171.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -134.37 108.59 8.26 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.029 0.932 . . . . 0.0 111.425 -176.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.69 146.16 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.975 1.71 . . . . 0.0 109.926 174.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.0 m -127.6 131.02 49.99 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.908 0.883 . . . . 0.0 111.695 -170.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 68.2 t -97.77 131.66 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.361 1.464 . . . . 0.0 111.749 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.17 120.89 25.26 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.071 1.348 . . . . 0.0 108.611 167.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.0 mtt-85 -71.69 130.08 40.27 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.094 0.557 . . . . 0.0 109.939 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.4 pt . . . . . 0 N--CA 1.474 0.726 0 C-N-CA 124.095 0.958 . . . . 0.0 113.435 -163.482 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 . . . . . 0 CA--C 1.534 0.327 0 CA-C-O 120.444 0.164 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.21 18.58 4.92 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -173.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 59.98 -48.47 0.09 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 128.4 2.68 . . . . 0.0 115.253 -174.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.5 p -65.5 -18.32 65.23 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.838 2.055 . . . . 0.0 114.688 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.74 -15.32 59.21 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.963 0.905 . . . . 0.0 112.988 173.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -90.56 165.29 13.85 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.853 1.261 . . . . 0.0 110.341 176.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.3 mtmt -87.0 64.17 8.33 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.793 0.837 . . . . 0.0 112.435 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.0 mt -56.52 -27.63 57.89 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.752 1.621 . . . . 0.0 115.032 -172.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -86.04 -8.09 58.16 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.107 0.963 . . . . 0.0 113.137 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -135.04 58.82 29.96 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 125.27 1.428 . . . . 0.0 111.814 -161.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -65.82 139.45 57.3 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 CA-C-N 119.719 0.935 . . . . 0.0 112.421 -172.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -69.44 -27.88 65.64 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.747 0.819 . . . . 0.0 111.222 174.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 50.2 t90 -158.09 151.34 23.15 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.89 1.676 . . . . 0.0 110.713 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.3 p -132.97 150.68 52.14 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.791 0.836 . . . . 0.0 111.835 167.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.1 -142.91 5.53 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 116.259 -0.428 . . . . 0.0 113.524 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.5 mtm180 -109.64 146.4 34.84 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.528 1.931 . . . . 0.0 111.812 -176.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.2 tp -84.99 139.49 31.75 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.483 1.513 . . . . 0.0 109.746 163.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -143.93 92.41 2.33 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.091 1.356 . . . . 0.0 110.714 167.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.3 mt -76.95 126.27 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 171.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.2 p -138.22 165.53 26.46 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.771 2.028 . . . . 0.0 110.111 -178.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.0 m -148.15 160.12 43.24 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.562 1.145 . . . . 0.0 112.426 175.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -148.8 125.0 10.79 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.281 0.562 . . . . 0.0 112.35 155.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.55 -124.24 8.66 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 125.377 1.465 . . . . 0.0 110.025 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -99.86 17.86 19.77 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.714 1.605 . . . . 0.0 113.317 176.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.3 m -124.45 125.8 44.85 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.63 1.172 . . . . 0.0 110.172 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.68 160.11 14.5 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.549 1.14 . . . . 0.0 111.205 171.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -141.78 103.16 4.3 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.849 2.06 . . . . 0.0 109.071 -171.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.3 mp -81.45 94.16 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 169.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -90.15 141.7 28.43 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.613 0.765 . . . . 0.0 111.27 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.4 mp -113.2 133.04 55.26 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.618 1.967 . . . . 0.0 109.918 173.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -131.45 147.86 52.59 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.105 0.962 . . . . 0.0 113.003 -172.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -68.68 133.77 48.91 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.066 -1.021 . . . . 0.0 110.93 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.5 pttt -77.48 -4.24 44.49 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -176.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 64.1 t -120.62 -42.44 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 125.205 1.402 . . . . 0.0 111.537 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.9 m -93.44 -20.57 20.18 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.09 11.46 79.09 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.551 1.072 . . . . 0.0 113.831 -176.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -87.19 152.44 22.32 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.325 1.45 . . . . 0.0 112.254 -173.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.5 tp -71.9 127.19 31.79 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.601 -0.687 . . . . 0.0 111.389 -178.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -87.27 -55.87 3.62 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.361 1.065 . . . . 0.0 111.047 169.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.95 163.54 39.02 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.438 1.495 . . . . 0.0 110.603 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -145.99 141.43 27.68 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 172.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.08 104.16 52.56 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 125.323 1.449 . . . . 0.0 111.606 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -64.6 142.59 78.16 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.037 3.158 . . . . 0.0 112.54 169.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.6 t -138.37 132.29 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.972 1.709 . . . . 0.0 108.793 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -103.42 -18.22 14.91 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.98 147.24 14.8 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.909 2.083 . . . . 0.0 109.766 173.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -134.3 124.62 17.36 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.484 1.113 . . . . 0.0 111.551 -177.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -59.25 147.89 38.86 Favored 'Cis proline' 0 CA--C 1.54 0.81 0 CA-C-N 120.123 1.08 . . . . 0.0 114.533 -4.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -161.7 -160.0 10.57 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 126.166 1.841 . . . . 0.0 112.025 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.6 tt -76.12 -40.0 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 118.185 0.993 . . . . 0.0 113.158 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.77 7.24 18.42 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -166.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.3 t -150.73 130.08 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.575 1.55 . . . . 0.0 109.947 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -141.84 158.01 44.31 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.041 1.736 . . . . 0.0 112.487 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.4 p -108.28 160.81 15.55 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.745 2.018 . . . . 0.0 111.153 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.9 m -88.87 169.35 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 124.062 0.945 . . . . 0.0 110.862 165.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.5 p -94.1 -29.5 15.13 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.869 1.267 . . . . 0.0 113.556 178.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -92.71 -41.25 10.26 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -166.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.2 t -142.27 112.76 7.21 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -177.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.6 p -72.94 30.32 0.06 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -174.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.421 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.254 1.0 OUTLIER -115.86 23.12 12.51 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.854 2.061 . . . . 0.0 113.519 166.785 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -140.44 138.59 34.82 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.69 1.596 . . . . 0.0 110.622 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -137.34 163.59 30.64 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.902 1.281 . . . . 0.0 111.562 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 37.2 t -117.57 144.83 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.862 1.265 . . . . 0.0 109.13 166.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.69 148.76 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 123.07 0.548 . . . . 0.0 111.538 170.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.471 ' HE ' ' NE2' ' A' ' 97' ' ' GLN . 42.0 ttp180 -91.05 98.82 12.0 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.397 0.679 . . . . 0.0 109.858 173.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -79.61 150.17 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.793 0.837 . . . . 0.0 111.628 176.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.471 ' NE2' ' HE ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.638 0 C-N-CA 125.848 1.659 . . . . 0.0 110.835 177.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 CA--C 1.534 0.354 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.25 144.23 29.72 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.999 1.319 . . . . 0.0 111.334 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -89.87 120.25 30.94 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.509 0.724 . . . . 0.0 109.607 169.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.5 pt -120.31 144.05 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.77 1.228 . . . . 0.0 111.053 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.44 142.71 16.17 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 124.151 0.881 . . . . 0.0 111.312 174.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.7 pt -129.33 143.09 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 125.506 1.522 . . . . 0.0 112.121 174.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.19 144.2 17.09 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.797 1.189 . . . . 0.0 113.491 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -107.08 158.7 16.86 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.084 1.754 . . . . 0.0 111.213 -178.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.8 t -72.21 -26.73 62.16 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.596 0.758 . . . . 0.0 112.796 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -157.23 151.64 25.17 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.441 1.096 . . . . 0.0 111.804 -176.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 43.2 ttm105 -61.32 -32.58 72.45 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.226 1.01 . . . . 0.0 113.197 177.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.94 -31.72 81.75 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 119.382 0.992 . . . . 0.0 113.464 176.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -85.89 -30.67 22.69 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 117.963 0.882 . . . . 0.0 112.395 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.421 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -65.92 -37.39 85.93 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 168.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -61.28 -36.46 80.12 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.105 -0.997 . . . . 0.0 110.91 170.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -71.17 -13.28 61.88 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 113.547 0.944 . . . . 0.0 113.547 175.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -77.97 -50.73 11.58 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.55 1.14 . . . . 0.0 111.568 165.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.11 -27.14 39.23 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -174.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 71.8 t -77.86 -43.02 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.129 -0.982 . . . . 0.0 111.159 177.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 92.1 p -65.58 -33.9 76.99 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.606 -0.684 . . . . 0.0 112.687 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 35.1 tp -72.58 -47.04 51.25 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.913 1.285 . . . . 0.0 111.591 176.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -69.75 -29.82 67.26 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.162 -0.961 . . . . 0.0 113.239 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -78.96 -4.02 47.85 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.215 1.006 . . . . 0.0 112.333 177.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -89.5 -21.89 22.72 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.299 -0.876 . . . . 0.0 113.143 162.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -99.28 -13.23 19.76 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -177.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 -172.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.3 m . . . . . 0 N--CA 1.473 0.695 0 N-CA-C 110.65 -0.13 . . . . 0.0 110.65 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.9 p -69.24 148.82 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.492 1.117 . . . . 0.0 112.908 -177.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.2 mt -135.58 -38.84 0.73 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.916 1.686 . . . . 0.0 112.305 -171.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.0 t -147.02 140.52 25.58 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.415 1.486 . . . . 0.0 109.753 174.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.4 t -131.85 132.07 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.374 1.07 . . . . 0.0 108.637 167.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.61 131.72 18.39 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 124.694 1.197 . . . . 0.0 111.341 177.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -81.04 -15.63 10.32 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.843 2.362 . . . . 0.0 115.302 -170.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -130.5 106.79 8.76 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.38 1.072 . . . . 0.0 110.82 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.8 p -143.81 142.38 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.032 1.333 . . . . 0.0 110.359 173.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.8 m -125.72 132.04 52.43 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.721 1.208 . . . . 0.0 111.137 -173.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 79.4 t -97.43 130.68 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.497 1.119 . . . . 0.0 111.225 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -131.78 117.02 18.01 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.99 1.316 . . . . 0.0 108.295 168.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.3 mtt-85 -71.63 128.85 37.14 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.87 -0.519 . . . . 0.0 109.73 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 39.3 pt . . . . . 0 CA--C 1.543 0.674 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -163.161 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 . . . . . 0 CA--C 1.533 0.324 0 N-CA-C 110.606 -0.146 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.67 21.36 7.73 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -173.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 56.9 -49.91 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.29 2.636 . . . . 0.0 115.399 -171.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.7 m -64.71 -14.64 59.36 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.26 1.824 . . . . 0.0 114.558 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -84.18 -7.84 59.24 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.774 1.23 . . . . 0.0 113.039 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.2 m0 -93.7 169.4 10.35 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.73 1.612 . . . . 0.0 111.151 176.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -76.56 51.89 0.76 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.194 1.798 . . . . 0.0 114.185 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.5 mt -55.58 -28.54 55.64 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.205 1.402 . . . . 0.0 114.487 -177.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -88.37 -7.42 56.68 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.428 0.691 . . . . 0.0 112.547 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -152.38 66.52 6.47 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.965 1.306 . . . . 0.0 111.887 -168.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -58.27 145.29 93.86 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.397 2.731 . . . . 0.0 112.856 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -72.56 -28.8 63.04 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.544 1.138 . . . . 0.0 111.657 174.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 42.1 t90 -158.11 152.14 24.08 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.431 1.892 . . . . 0.0 110.234 177.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.8 p -134.11 150.63 51.16 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.882 0.873 . . . . 0.0 111.862 169.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.38 -139.15 4.19 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 123.233 0.444 . . . . 0.0 113.325 -177.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.1 mtm105 -115.82 150.36 37.08 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.709 2.004 . . . . 0.0 112.001 -173.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.5 tp -94.61 138.33 32.61 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.227 1.811 . . . . 0.0 110.207 171.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.5 ttm-85 -135.74 111.1 9.08 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.825 1.25 . . . . 0.0 109.808 160.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 24.9 mt -91.32 131.3 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 168.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.25 170.36 16.1 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 127.396 2.279 . . . . 0.0 110.13 -173.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.6 t -158.54 149.47 20.47 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 120.409 -1.432 . . . . 0.0 111.792 176.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -151.42 129.14 11.55 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.631 0.772 . . . . 0.0 112.663 158.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.88 45.88 55.41 Favored Glycine 0 N--CA 1.473 1.162 0 C-N-CA 124.432 1.015 . . . . 0.0 114.956 164.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt 62.99 26.24 15.42 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.294 1.838 . . . . 0.0 113.269 -174.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.4 m -131.03 114.11 14.79 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.112 1.365 . . . . 0.0 108.72 168.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -83.99 159.23 21.27 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.507 0.723 . . . . 0.0 110.464 172.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -136.08 115.7 12.89 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 125.956 1.702 . . . . 0.0 108.693 -175.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.7 mp -92.29 99.48 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 168.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -99.83 139.7 35.12 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.876 0.846 . . . . 0.0 112.207 175.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.8 mp -110.68 132.94 53.76 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.091 1.756 . . . . 0.0 109.92 176.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -134.77 151.02 50.64 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.017 0.927 . . . . 0.0 113.04 -171.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -73.14 144.11 47.04 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.924 0.869 . . . . 0.0 112.112 -178.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.1 pttt -84.22 -6.56 59.41 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.209 1.804 . . . . 0.0 115.144 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 95.7 t -122.73 -44.17 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.206 1.402 . . . . 0.0 111.447 178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.0 m -94.08 -21.8 18.9 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -175.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.01 5.92 85.4 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.182 0.896 . . . . 0.0 113.861 -177.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -82.02 153.88 25.96 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.276 1.431 . . . . 0.0 112.752 -173.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.5 tp -73.52 126.08 29.41 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.993 0.917 . . . . 0.0 111.107 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -86.18 -55.78 3.76 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.437 1.095 . . . . 0.0 111.121 170.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.85 164.01 38.55 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.755 1.222 . . . . 0.0 111.838 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -140.83 136.4 32.36 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.831 1.252 . . . . 0.0 111.816 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.4 107.69 36.58 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 124.778 1.231 . . . . 0.0 111.633 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -76.42 136.55 17.72 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.563 2.842 . . . . 0.0 111.925 173.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.1 t -127.71 119.53 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 127.093 2.157 . . . . 0.0 108.761 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -88.27 -17.69 30.18 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.48 151.33 16.9 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.18 1.792 . . . . 0.0 109.939 172.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -116.28 130.91 24.1 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 123.597 0.759 . . . . 0.0 113.014 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.63 151.37 74.54 Favored 'Cis proline' 0 CA--C 1.542 0.886 0 CA-C-N 119.247 0.767 . . . . 0.0 112.694 -13.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -132.16 -163.1 10.61 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.099 1.333 . . . . 0.0 113.361 176.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.6 tt -79.77 -34.6 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.538 0.735 . . . . 0.0 112.263 171.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.04 11.72 3.88 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.484 1.114 . . . . 0.0 113.63 -172.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.7 p -156.4 141.85 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 126.369 1.868 . . . . 0.0 110.815 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -159.3 161.26 35.85 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.489 1.116 . . . . 0.0 113.552 -175.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.2 p -110.76 159.54 17.54 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 127.114 2.165 . . . . 0.0 111.719 174.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.9 m -85.02 176.52 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.659 1.183 . . . . 0.0 111.255 166.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 73.4 p -92.28 -33.71 14.53 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.761 1.224 . . . . 0.0 113.47 177.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -92.45 -41.31 10.37 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -162.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.2 t -141.41 132.92 26.9 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -176.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.8 m -64.45 -12.14 40.57 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -172.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.431 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.289 31.3 ptt180 -89.0 14.56 10.3 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -174.743 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -135.72 136.48 40.86 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.472 1.109 . . . . 0.0 111.87 -173.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -138.04 161.07 37.68 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.113 1.365 . . . . 0.0 111.655 -178.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.2 t -114.67 143.2 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.499 1.12 . . . . 0.0 108.951 166.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.29 150.37 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 118.468 0.576 . . . . 0.0 111.625 169.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -93.06 89.72 6.61 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.012 0.925 . . . . 0.0 110.398 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -71.09 137.78 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 120.712 0.291 . . . . 0.0 110.956 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 . . . . . 0 N--CA 1.47 0.528 0 C-N-CA 126.066 1.746 . . . . 0.0 110.924 -168.283 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 89.6 p . . . . . 0 CA--C 1.535 0.379 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.11 140.97 25.83 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.338 1.455 . . . . 0.0 111.005 168.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -90.01 119.61 30.51 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.294 0.638 . . . . 0.0 109.837 171.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.4 pt -117.8 145.41 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.594 1.158 . . . . 0.0 110.955 177.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.68 140.02 14.82 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 173.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.6 pt -125.12 141.75 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 124.879 1.272 . . . . 0.0 111.665 173.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -125.13 141.88 13.4 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.265 1.412 . . . . 0.0 112.572 174.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -101.96 170.97 7.79 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.165 1.786 . . . . 0.0 111.417 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.7 t -70.04 -37.56 75.59 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.349 0.66 . . . . 0.0 112.277 175.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -152.99 154.35 34.78 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.073 -1.017 . . . . 0.0 112.765 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -58.14 -38.87 77.38 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.349 1.46 . . . . 0.0 112.131 176.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.05 -14.05 73.26 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.014 0.816 . . . . 0.0 114.06 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -97.26 -36.94 10.26 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 118.191 0.995 . . . . 0.0 111.69 172.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.431 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -64.91 -30.73 71.74 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.293 1.037 . . . . 0.0 113.668 170.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.13 -29.05 60.17 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.439 1.018 . . . . 0.0 112.974 175.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -69.66 -27.19 64.83 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.316 -0.865 . . . . 0.0 112.954 176.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -62.77 -52.59 62.59 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.429 1.092 . . . . 0.0 111.356 173.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -80.61 -24.33 39.15 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -175.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.7 t -78.87 -42.56 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 119.062 0.846 . . . . 0.0 111.542 174.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 93.8 p -65.62 -31.3 72.26 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.434 1.015 . . . . 0.0 113.337 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.5 mt -69.38 -54.13 15.99 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.77 0.828 . . . . 0.0 111.435 172.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -65.61 -31.37 72.36 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.408 -0.808 . . . . 0.0 112.763 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -81.11 -4.37 55.08 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.339 1.056 . . . . 0.0 112.727 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -95.84 -15.86 22.21 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 164.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -106.52 -6.18 18.28 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.301 0 CA-C-N 121.397 1.908 . . . . 0.0 115.577 -175.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.471 0.596 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.6 t -64.39 145.13 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 125.753 1.621 . . . . 0.0 112.386 -177.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.4 mt -130.79 -41.24 1.17 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.814 1.646 . . . . 0.0 112.223 -173.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 36.8 t -148.65 137.68 21.62 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.75 1.22 . . . . 0.0 110.717 174.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 81.8 t -130.21 127.79 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.912 1.285 . . . . 0.0 109.511 172.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -125.96 132.4 24.3 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 125.362 1.465 . . . . 0.0 110.096 173.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.52 -10.88 14.5 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.36 2.706 . . . . 0.0 115.495 -170.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -136.74 111.79 8.97 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.92 0.867 . . . . 0.0 112.192 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -143.9 144.02 23.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 125.437 1.495 . . . . 0.0 110.144 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.9 m -125.86 128.18 47.22 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.227 1.011 . . . . 0.0 111.492 -170.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.8 t -92.87 136.21 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.374 1.47 . . . . 0.0 112.006 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -129.85 128.36 42.11 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.962 1.305 . . . . 0.0 109.281 169.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 17.7 mmm-85 -76.02 112.55 12.57 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.003 0.921 . . . . 0.0 108.867 172.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.5 pt . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -162.541 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 . . . . . 0 CA--C 1.532 0.285 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.78 19.39 6.11 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -172.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 56.68 -47.07 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 128.127 2.571 . . . . 0.0 115.893 -173.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.4 m -64.71 -18.41 64.98 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.062 1.745 . . . . 0.0 114.576 -177.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -85.3 -5.82 59.29 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 173.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.0 m0 -89.09 172.01 9.41 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.039 1.336 . . . . 0.0 110.743 174.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -79.72 52.86 1.51 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.187 1.395 . . . . 0.0 114.279 -176.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 mt -59.83 -18.56 44.85 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 -172.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -105.43 -6.08 19.8 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.771 1.229 . . . . 0.0 113.168 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -148.97 67.74 9.32 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.863 1.265 . . . . 0.0 112.055 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -54.66 145.52 59.26 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.554 2.836 . . . . 0.0 113.02 177.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -70.7 -29.34 65.61 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.424 1.089 . . . . 0.0 111.661 175.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 40.8 t90 -156.96 154.12 29.16 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.615 1.566 . . . . 0.0 110.946 173.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.3 p -135.69 150.42 49.57 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.238 1.015 . . . . 0.0 112.331 171.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.18 -142.1 5.14 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.239 0.447 . . . . 0.0 114.006 -176.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.5 mtm180 -111.23 152.0 27.63 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 127.066 2.146 . . . . 0.0 111.919 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.4 tp -90.31 139.6 30.5 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.075 1.75 . . . . 0.0 110.184 165.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -140.07 98.83 3.53 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.053 1.341 . . . . 0.0 110.249 163.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.2 mt -80.03 130.4 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 170.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.4 p -137.5 159.35 42.2 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.592 1.957 . . . . 0.0 110.06 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.2 t -156.26 133.89 10.95 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.474 -1.391 . . . . 0.0 113.411 173.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -146.15 128.58 15.94 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.159 1.784 . . . . 0.0 110.587 177.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.75 36.88 52.45 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.438 1.018 . . . . 0.0 114.963 169.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? 61.95 27.92 16.96 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.467 1.907 . . . . 0.0 113.477 -170.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.0 m -132.23 117.82 18.71 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.195 1.398 . . . . 0.0 109.132 172.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.32 157.5 19.89 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.746 0.818 . . . . 0.0 110.856 172.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -138.3 116.67 11.95 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.6 1.56 . . . . 0.0 108.928 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mp -86.1 93.45 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 168.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -88.02 139.43 30.52 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.502 0.721 . . . . 0.0 111.265 174.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.0 mp -113.69 132.87 55.64 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.442 1.897 . . . . 0.0 110.63 176.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -129.06 147.88 50.96 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -171.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.94 128.21 34.83 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 121.18 -0.95 . . . . 0.0 109.539 171.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -75.44 -9.01 58.19 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -172.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.5 t -112.28 -36.95 2.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 124.239 1.016 . . . . 0.0 110.807 -171.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.1 m -110.47 -15.44 13.91 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.66 19.77 79.77 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 118.882 0.764 . . . . 0.0 113.708 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -63.51 158.94 19.68 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.647 1.179 . . . . 0.0 111.442 173.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.8 tp -95.11 119.59 33.88 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.832 0.853 . . . . 0.0 109.279 167.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -84.31 -55.44 4.17 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.611 0.764 . . . . 0.0 111.28 175.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.4 165.91 35.16 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.724 1.21 . . . . 0.0 111.533 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -144.63 135.32 24.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.737 1.215 . . . . 0.0 111.036 175.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.71 97.17 48.34 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.169 0.988 . . . . 0.0 111.943 175.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.78 137.26 80.25 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 124.367 3.378 . . . . 0.0 113.121 165.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.8 t -139.14 129.03 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 126.414 1.886 . . . . 0.0 109.739 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -90.19 -23.07 21.39 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.44 152.19 16.09 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.82 1.648 . . . . 0.0 111.078 174.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -130.85 135.51 27.46 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 124.876 1.27 . . . . 0.0 112.003 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -61.7 145.0 45.39 Favored 'Cis proline' 0 CA--C 1.539 0.747 0 CA-C-N 119.889 0.996 . . . . 0.0 113.19 -9.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -157.29 -155.71 7.6 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.736 1.16 . . . . 0.0 114.0 -174.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.59 -38.94 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.464 1.106 . . . . 0.0 113.692 -174.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.37 9.29 15.91 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -173.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.6 t -149.33 133.18 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.819 1.648 . . . . 0.0 109.922 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.55 163.99 34.0 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.248 1.819 . . . . 0.0 112.555 -174.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 62.2 p -116.84 162.27 17.98 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.166 1.787 . . . . 0.0 111.822 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.7 m -89.75 175.46 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.296 1.038 . . . . 0.0 111.057 165.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 71.5 p -95.96 -30.9 13.35 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.218 1.407 . . . . 0.0 113.441 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -90.18 -43.78 10.2 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -167.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.3 t -143.37 127.67 17.73 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -176.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.43 -3.28 7.97 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -173.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.469 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.278 23.4 ptt180 -84.7 14.89 4.23 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 177.761 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -139.25 134.06 32.14 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.744 1.218 . . . . 0.0 111.119 -174.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -136.11 161.46 35.64 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.257 1.423 . . . . 0.0 111.168 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 75.9 t -116.21 143.89 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.577 1.151 . . . . 0.0 108.937 167.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.86 148.51 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 119.123 0.874 . . . . 0.0 112.261 173.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -87.65 88.76 7.76 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.414 0.686 . . . . 0.0 110.259 173.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.25 141.6 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 O-C-N 121.99 -0.444 . . . . 0.0 110.841 174.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 . . . . . 0 N--CA 1.47 0.569 0 C-N-CA 125.425 1.49 . . . . 0.0 111.597 -175.58 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.0 p . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -148.08 150.51 34.02 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.32 1.448 . . . . 0.0 111.523 172.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -92.94 118.7 31.44 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.251 0.62 . . . . 0.0 109.787 168.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.8 pt -120.11 145.84 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.668 1.187 . . . . 0.0 111.063 178.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.44 144.32 17.11 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 173.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.1 pt -128.1 140.62 48.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.719 1.608 . . . . 0.0 111.452 172.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.83 143.06 14.69 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.857 1.694 . . . . 0.0 112.787 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -104.98 161.75 13.94 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.11 1.364 . . . . 0.0 112.466 -174.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.7 t -69.86 -28.1 65.39 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.245 1.018 . . . . 0.0 112.699 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -156.85 151.02 25.06 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.27 1.028 . . . . 0.0 111.828 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -62.43 -34.66 77.21 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.281 1.032 . . . . 0.0 113.118 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.35 -26.16 74.82 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 123.864 0.745 . . . . 0.0 113.733 175.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -84.91 -32.73 22.98 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.039 0.936 . . . . 0.0 111.632 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.469 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -67.61 -32.11 72.61 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 168.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.04 -31.54 67.13 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.377 -0.827 . . . . 0.0 112.569 173.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -68.3 -27.39 66.26 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.315 -0.865 . . . . 0.0 112.992 174.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -63.87 -55.17 24.78 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.816 1.189 . . . . 0.0 111.739 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -75.13 -24.87 58.08 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.5 t -75.94 -40.81 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 121.414 -0.804 . . . . 0.0 111.093 173.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.5 t -59.04 -39.67 82.72 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.061 0.846 . . . . 0.0 112.662 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.6 mt -67.94 -54.43 18.72 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.408 0.683 . . . . 0.0 111.92 175.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -67.15 -32.21 73.16 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.3 -0.875 . . . . 0.0 113.02 -174.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -84.82 -0.63 54.56 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.379 1.072 . . . . 0.0 112.708 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -92.81 -37.97 12.02 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.438 -0.789 . . . . 0.0 112.287 159.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -85.39 -7.15 59.1 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -175.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -172.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.245 0 N-CA-C 110.596 -0.15 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.4 t -75.31 145.67 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.031 0.932 . . . . 0.0 111.231 -169.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.8 mt -131.45 -39.79 1.13 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.624 1.569 . . . . 0.0 111.856 -171.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.5 t -148.57 141.72 24.99 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.058 1.343 . . . . 0.0 110.393 176.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.7 t -136.37 127.32 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.984 1.314 . . . . 0.0 108.882 169.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -131.8 138.53 32.74 Favored Pre-proline 0 N--CA 1.48 1.062 0 C-N-CA 125.135 1.374 . . . . 0.0 111.072 177.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -81.23 -17.1 9.31 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 123.242 2.628 . . . . 0.0 115.67 -170.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -132.81 107.55 8.42 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.988 0.915 . . . . 0.0 111.345 -173.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.4 p -143.75 142.95 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.488 1.515 . . . . 0.0 110.331 173.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.8 m -126.32 128.0 46.42 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.456 1.102 . . . . 0.0 111.518 -171.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.2 t -93.99 137.13 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.128 1.371 . . . . 0.0 112.091 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -129.88 125.22 35.09 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.037 1.335 . . . . 0.0 108.98 168.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.9 mmt85 -70.58 109.18 4.71 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.524 -0.735 . . . . 0.0 109.617 169.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.1 pt . . . . . 0 CA--C 1.544 0.738 0 C-N-CA 125.019 1.328 . . . . 0.0 113.292 -171.383 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 . . . . . 0 CA--C 1.533 0.289 0 CA-C-O 120.366 0.126 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.66 18.97 5.69 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -172.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.53 -50.01 0.05 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.968 2.507 . . . . 0.0 115.411 -174.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.2 m -65.97 -14.9 62.42 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.247 1.819 . . . . 0.0 114.359 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.25 -15.54 58.67 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.84 0.856 . . . . 0.0 112.813 172.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -89.66 172.51 8.89 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.442 1.497 . . . . 0.0 111.424 -178.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -81.11 54.86 2.34 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.438 1.495 . . . . 0.0 114.059 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.9 mt -60.3 -17.41 42.51 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -172.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -105.96 -3.89 21.21 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.558 1.143 . . . . 0.0 113.078 177.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -147.81 72.03 11.45 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.068 1.347 . . . . 0.0 111.949 176.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -56.77 143.92 88.86 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 123.147 2.564 . . . . 0.0 112.43 173.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -71.04 -29.09 64.9 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.682 1.193 . . . . 0.0 111.766 175.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 37.9 t90 -156.95 153.17 27.66 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.675 1.59 . . . . 0.0 110.52 174.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.7 p -134.57 150.14 50.69 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.673 0.789 . . . . 0.0 112.043 169.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.18 -141.07 4.92 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 123.336 0.493 . . . . 0.0 113.422 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.7 mtm105 -113.51 149.92 33.67 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.712 2.005 . . . . 0.0 112.168 -173.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.5 tp -90.28 141.57 28.59 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.751 1.62 . . . . 0.0 110.629 169.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.6 ttm-85 -132.66 130.94 40.79 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.214 1.406 . . . . 0.0 109.719 156.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.4 mt -107.9 132.56 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 164.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.14 156.06 44.71 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 127.523 2.329 . . . . 0.0 108.72 -166.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.6 t -163.9 152.24 13.23 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.107 -1.621 . . . . 0.0 110.819 178.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -127.39 -46.6 1.47 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 -174.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.1 86.04 0.1 OUTLIER Glycine 0 N--CA 1.472 1.065 0 C-N-CA 123.606 0.622 . . . . 0.0 111.722 -175.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 94.1 mttt 55.53 23.47 6.0 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.141 1.776 . . . . 0.0 112.826 -171.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.9 m -141.74 121.04 13.09 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.836 1.254 . . . . 0.0 108.237 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.87 160.13 14.54 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.628 1.171 . . . . 0.0 111.053 174.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -139.2 113.19 8.64 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 127.076 2.15 . . . . 0.0 108.839 -176.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.3 mp -88.62 109.04 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 167.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -108.44 134.75 50.8 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.748 1.219 . . . . 0.0 111.588 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.6 mp -105.31 132.4 51.56 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 125.435 1.494 . . . . 0.0 110.089 176.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -134.9 151.6 51.02 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.946 0.899 . . . . 0.0 112.98 -170.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -74.12 143.91 45.14 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.282 -0.886 . . . . 0.0 112.071 -178.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.4 pttt -84.41 -6.61 59.4 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.296 1.838 . . . . 0.0 115.067 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.1 t -122.7 -44.18 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.341 1.456 . . . . 0.0 111.543 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.6 m -93.93 -22.37 18.63 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -174.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.3 6.08 86.05 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.14 0.876 . . . . 0.0 113.803 -177.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -81.8 154.59 25.86 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.31 1.444 . . . . 0.0 112.623 -174.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.5 tp -75.05 125.46 28.96 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.94 0.896 . . . . 0.0 111.147 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -85.23 -54.19 4.76 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.286 1.035 . . . . 0.0 111.156 170.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.52 162.89 38.86 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.595 1.158 . . . . 0.0 112.098 -178.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -140.68 133.86 29.53 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.831 1.252 . . . . 0.0 111.905 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.17 104.29 43.78 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.362 1.465 . . . . 0.0 111.159 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.96 144.52 30.49 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.833 3.022 . . . . 0.0 112.141 173.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.8 t -139.78 125.41 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 126.327 1.851 . . . . 0.0 109.554 -172.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -91.01 -23.4 20.39 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.13 149.15 15.65 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.268 1.827 . . . . 0.0 110.344 172.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -118.0 129.69 25.2 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.639 1.176 . . . . 0.0 111.153 175.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.85 149.41 80.32 Favored 'Cis proline' 0 CA--C 1.542 0.891 0 CA-C-N 119.715 0.934 . . . . 0.0 112.737 -6.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -151.57 -162.42 10.75 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.827 1.679 . . . . 0.0 112.293 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 19.6 tt -76.43 -35.15 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 121.688 -0.889 . . . . 0.0 112.837 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.47 7.23 17.58 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -168.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.1 t -150.97 130.51 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.856 1.662 . . . . 0.0 109.736 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -141.09 158.95 43.22 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.641 1.977 . . . . 0.0 112.317 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 47.4 p -107.05 160.89 15.21 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.751 2.02 . . . . 0.0 111.356 175.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 m -86.81 172.28 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.149 0.98 . . . . 0.0 110.949 163.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 58.8 p -95.07 -30.0 14.3 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.011 1.325 . . . . 0.0 113.608 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -90.11 -50.25 6.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.889 0.876 . . . . 0.0 113.229 -167.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.9 m -136.35 116.91 13.84 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.352 0.661 . . . . 0.0 112.724 -169.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.26 -8.68 18.9 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -168.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.453 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.322 43.2 ptt85 -84.12 21.31 1.39 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 178.875 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -140.3 137.45 34.18 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.896 1.278 . . . . 0.0 111.496 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -138.88 163.35 32.53 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.176 1.39 . . . . 0.0 111.032 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 55.9 t -118.21 142.44 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 124.546 1.139 . . . . 0.0 108.914 167.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.73 148.62 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 118.527 0.603 . . . . 0.0 111.975 173.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -90.66 87.54 6.75 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.57 0.748 . . . . 0.0 111.007 178.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -70.83 139.48 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 122.574 0.35 . . . . 0.0 111.044 176.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 . . . . . 0 N--CA 1.471 0.612 0 C-N-CA 126.251 1.82 . . . . 0.0 111.044 -169.192 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 56.8 p . . . . . 0 N--CA 1.466 0.362 0 N-CA-C 115.046 1.498 . . . . 0.0 115.046 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.46 145.05 31.67 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.668 1.587 . . . . 0.0 110.495 165.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -91.1 119.85 31.58 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 167.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.8 pt -118.28 144.56 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.447 1.099 . . . . 0.0 110.93 178.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.63 142.95 16.3 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 174.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.9 pt -128.46 139.29 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 125.456 1.502 . . . . 0.0 111.725 173.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -118.85 139.78 14.68 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.93 1.729 . . . . 0.0 112.518 176.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -102.47 155.79 18.03 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.524 1.53 . . . . 0.0 112.222 -176.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.1 t -71.3 -23.56 61.98 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.351 1.061 . . . . 0.0 112.839 177.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -154.18 147.04 24.38 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.157 0.983 . . . . 0.0 112.212 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -64.42 -35.11 79.84 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.428 1.091 . . . . 0.0 113.273 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.36 -30.42 76.6 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-N 118.851 0.75 . . . . 0.0 113.165 176.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -82.5 -31.76 29.11 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.877 -0.778 . . . . 0.0 112.248 177.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.453 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -64.93 -38.58 91.43 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 166.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -61.35 -38.27 86.34 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.132 -0.98 . . . . 0.0 111.279 168.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -67.43 -36.31 80.98 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 119.093 0.861 . . . . 0.0 112.856 177.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -54.65 -51.39 65.6 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.74 1.216 . . . . 0.0 111.735 167.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -68.52 -42.55 78.37 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.611 0.764 . . . . 0.0 112.496 -177.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.8 t -65.84 -37.76 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 O-C-N 121.615 -0.678 . . . . 0.0 110.884 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 55.7 m -65.9 -14.42 61.49 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 176.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.6 mt -91.75 -54.13 4.0 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.008 0.923 . . . . 0.0 111.342 168.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -69.33 -32.92 72.33 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.952 -1.093 . . . . 0.0 113.669 -172.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -87.27 7.0 30.51 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.397 1.079 . . . . 0.0 112.423 174.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -102.77 -34.0 9.18 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.049 0.94 . . . . 0.0 112.631 165.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -89.5 -4.11 58.07 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.282 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -175.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.8 m . . . . . 0 CA--C 1.539 0.558 0 CA-C-O 120.944 0.402 . . . . 0.0 111.295 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.97 144.05 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.761 1.224 . . . . 0.0 111.964 -174.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 78.8 mt -126.05 -43.94 1.79 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.786 1.634 . . . . 0.0 112.308 -175.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 46.5 t -153.77 136.03 14.88 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.519 1.128 . . . . 0.0 110.939 175.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.9 t -127.28 125.83 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.588 1.155 . . . . 0.0 109.47 172.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -129.08 133.61 25.39 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 125.367 1.467 . . . . 0.0 110.579 176.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.83 -12.02 15.01 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.22 2.613 . . . . 0.0 115.331 -172.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -129.74 106.38 8.67 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.273 1.029 . . . . 0.0 110.854 -177.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.1 p -141.66 142.01 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.782 1.233 . . . . 0.0 110.52 170.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.4 m -124.37 130.32 52.28 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.443 1.097 . . . . 0.0 110.751 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 77.1 t -94.18 136.47 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.749 1.22 . . . . 0.0 111.355 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.09 125.75 33.97 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.48 1.112 . . . . 0.0 109.436 168.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.7 mtt85 -62.39 131.3 48.8 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.347 0.659 . . . . 0.0 109.371 163.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.6 pt . . . . . 0 N--CA 1.474 0.761 0 C-N-CA 124.239 1.016 . . . . 0.0 112.533 -171.131 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.7 m-30 . . . . . 0 C--O 1.224 -0.285 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.54 18.25 8.12 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -172.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.31 -49.35 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 128.094 2.557 . . . . 0.0 115.565 -173.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.5 m -66.65 -15.93 63.83 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.887 1.675 . . . . 0.0 114.646 -176.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.01 -7.91 59.28 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 171.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.7 m0 -88.1 171.61 10.13 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.006 1.322 . . . . 0.0 110.769 176.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -79.6 54.34 1.76 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.214 1.406 . . . . 0.0 114.068 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.5 mt -60.75 -16.59 41.75 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -173.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -105.3 -4.59 21.41 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.565 1.146 . . . . 0.0 112.958 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -148.42 81.34 8.01 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 124.539 1.136 . . . . 0.0 112.015 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.3 145.35 67.19 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.395 2.73 . . . . 0.0 112.89 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -71.86 -29.62 64.57 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.822 0.849 . . . . 0.0 111.267 168.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 41.1 t90 -159.6 155.05 25.57 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.996 1.718 . . . . 0.0 110.929 175.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.3 p -133.76 142.54 47.96 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.717 1.207 . . . . 0.0 111.961 171.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.31 -148.39 6.54 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 123.419 0.533 . . . . 0.0 114.195 -177.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -110.76 144.64 39.43 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.737 1.615 . . . . 0.0 110.849 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.1 tp -82.53 136.43 34.86 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.13 1.372 . . . . 0.0 109.369 168.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.6 ttt-85 -142.09 88.07 2.08 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.579 1.152 . . . . 0.0 109.952 166.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.7 mt -70.22 122.11 21.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 169.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.01 -179.88 4.29 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 127.82 2.448 . . . . 0.0 109.542 177.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.423 ' HB2' ' CE1' ' A' ' 126' ' ' HIS . 80.3 p -161.27 171.2 18.79 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.858 2.063 . . . . 0.0 108.491 177.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -140.0 -107.64 0.16 Allowed 'General case' 0 CA--C 1.54 0.59 0 O-C-N 122.004 -0.435 . . . . 0.0 109.929 166.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.62 106.13 3.21 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.051 1.31 . . . . 0.0 112.603 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 51.48 28.69 4.7 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 126.768 2.027 . . . . 0.0 113.917 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.8 m -148.1 131.07 16.21 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.17 1.788 . . . . 0.0 108.582 -172.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.69 159.5 15.12 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.084 1.353 . . . . 0.0 110.917 171.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -138.33 111.83 8.15 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.532 1.533 . . . . 0.0 109.785 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.2 mp -81.97 98.39 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 170.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -100.15 139.87 35.2 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.621 0.724 . . . . 0.0 111.831 175.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mp -113.82 127.96 56.22 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 126.487 1.915 . . . . 0.0 109.771 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -134.06 146.68 50.55 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.96 0.904 . . . . 0.0 112.114 -170.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -66.47 143.41 57.11 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 120.918 -1.114 . . . . 0.0 112.442 -177.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.545 ' H ' ' HD3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -81.81 -3.63 54.43 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 -173.753 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.0 t -115.91 -42.46 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.95 1.3 . . . . 0.0 111.403 173.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.3 m -116.13 -6.26 11.9 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -169.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.26 16.83 78.65 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 123.864 0.745 . . . . 0.0 114.171 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -66.73 126.75 29.98 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.531 1.533 . . . . 0.0 111.199 -175.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 57.4 tp -68.16 110.07 3.83 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.538 0.608 . . . . 0.0 110.424 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -79.29 -52.05 8.63 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.536 1.135 . . . . 0.0 111.042 176.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.27 162.06 37.77 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.437 1.095 . . . . 0.0 112.025 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -142.71 133.72 25.74 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.035 1.334 . . . . 0.0 111.551 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.24 101.93 48.99 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 124.742 1.217 . . . . 0.0 111.633 176.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -66.29 141.05 60.91 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 124.25 3.3 . . . . 0.0 112.788 171.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 t -137.14 123.79 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.763 1.625 . . . . 0.0 109.652 -177.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -89.05 -21.75 23.29 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -159.91 145.13 15.25 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.439 1.895 . . . . 0.0 110.291 169.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -116.97 130.12 24.83 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 124.664 1.186 . . . . 0.0 110.98 176.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.82 148.56 78.85 Favored 'Cis proline' 0 CA--C 1.542 0.915 0 CA-C-N 119.86 0.986 . . . . 0.0 112.968 -5.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.28 -168.2 24.88 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.95 1.262 . . . . 0.0 113.916 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.8 tp -63.69 -32.83 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -172.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.26 5.47 49.04 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -170.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.4 t -149.57 131.3 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.458 1.103 . . . . 0.0 110.892 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -140.64 158.85 43.37 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.711 1.604 . . . . 0.0 112.94 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 75.1 p -105.13 158.87 16.28 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.666 1.986 . . . . 0.0 110.941 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.4 m -84.12 176.03 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.762 0.825 . . . . 0.0 110.9 165.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 59.1 p -94.89 -31.98 13.44 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.598 1.559 . . . . 0.0 113.011 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -92.65 -43.77 8.92 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -167.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.7 t -142.81 120.16 11.61 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -173.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.25 -2.87 9.08 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -169.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . 0.265 0.9 OUTLIER -87.47 22.3 2.24 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.677 1.591 . . . . 0.0 114.217 174.242 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -140.92 135.33 31.15 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.052 1.341 . . . . 0.0 111.254 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -135.76 161.3 35.96 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.206 1.402 . . . . 0.0 111.376 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 89.8 t -115.89 141.8 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.628 1.171 . . . . 0.0 108.675 166.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.52 147.56 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 118.754 0.707 . . . . 0.0 112.392 173.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -89.79 84.74 6.28 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.627 0.771 . . . . 0.0 111.074 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -68.92 139.51 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 122.627 0.371 . . . . 0.0 111.062 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 . . . . . 0 N--CA 1.468 0.441 0 C-N-CA 125.947 1.699 . . . . 0.0 111.604 -170.396 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.9 p . . . . . 0 CA--C 1.533 0.301 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.61 148.28 32.95 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.579 1.552 . . . . 0.0 111.106 169.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -93.41 118.54 31.43 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.466 0.707 . . . . 0.0 109.682 168.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 27.7 pt -118.06 144.2 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.493 1.117 . . . . 0.0 111.15 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -90.5 144.49 17.45 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.059 0.838 . . . . 0.0 111.013 174.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.8 pt -129.96 140.61 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 125.43 1.492 . . . . 0.0 111.667 172.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.26 142.95 16.37 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.66 1.6 . . . . 0.0 113.077 176.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -106.76 161.07 14.99 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.85 1.66 . . . . 0.0 111.855 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.9 t -73.09 -28.02 62.05 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.64 0.776 . . . . 0.0 112.857 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -155.88 151.86 27.61 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.312 1.045 . . . . 0.0 112.083 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 63.7 ttt-85 -62.8 -33.07 74.44 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.501 1.12 . . . . 0.0 113.397 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.64 -28.62 73.03 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-N 118.798 0.726 . . . . 0.0 113.525 175.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -83.71 -34.15 24.97 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.963 0.905 . . . . 0.0 111.812 175.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.51 -31.77 73.01 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 168.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.39 -35.64 74.32 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.349 -0.844 . . . . 0.0 112.611 173.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -67.0 -29.46 69.3 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.228 -0.92 . . . . 0.0 112.934 176.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -60.82 -50.24 74.24 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.304 0.956 . . . . 0.0 111.693 172.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -82.19 -25.1 34.56 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.8 t -77.38 -42.25 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.194 -0.941 . . . . 0.0 111.285 175.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 92.5 p -65.52 -31.57 72.7 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.354 0.979 . . . . 0.0 113.111 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 61.0 mt -68.51 -52.5 31.46 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.961 0.905 . . . . 0.0 112.006 172.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -67.47 -29.38 68.82 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.957 -1.089 . . . . 0.0 112.793 -177.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -81.31 -1.53 45.6 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.055 1.342 . . . . 0.0 112.571 174.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.423 ' CE1' ' HB2' ' A' ' 51' ' ' SER . 29.6 t-80 -91.29 -23.31 20.18 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 120.701 -1.249 . . . . 0.0 113.005 165.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -104.16 -4.37 23.22 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -176.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.203 0 CA-C-N 120.444 1.474 . . . . 0.0 114.52 -177.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.8 m . . . . . 0 CA--C 1.536 0.438 0 CA-C-O 120.995 0.426 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.44 142.17 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 125.367 1.467 . . . . 0.0 111.273 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.3 mt -127.41 -44.21 1.57 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.183 1.393 . . . . 0.0 111.813 -172.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 27.6 t -151.9 137.12 17.48 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.599 1.16 . . . . 0.0 111.013 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.7 t -130.84 121.82 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.774 1.23 . . . . 0.0 109.962 174.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -117.57 137.92 24.66 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 125.27 1.428 . . . . 0.0 110.192 172.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.93 -20.51 25.64 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.478 2.786 . . . . 0.0 114.418 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -135.9 113.27 10.68 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.953 0.901 . . . . 0.0 111.668 -169.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.0 p -149.56 146.38 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.737 1.615 . . . . 0.0 110.248 175.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.6 m -125.18 128.37 48.25 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.024 0.93 . . . . 0.0 111.381 -172.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.1 t -94.84 139.12 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.457 1.503 . . . . 0.0 112.067 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -127.63 123.82 36.53 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.109 1.364 . . . . 0.0 109.772 171.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -69.54 101.9 1.71 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.39 0.676 . . . . 0.0 109.198 166.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.2 pt . . . . . 0 CA--C 1.546 0.813 0 C-N-CA 124.109 0.963 . . . . 0.0 113.11 -172.164 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.7 20.6 15.14 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.52 -1.362 . . . . 0.0 114.347 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.15 -47.99 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.761 2.424 . . . . 0.0 115.092 -168.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.4 m -64.92 -16.09 62.86 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.496 1.918 . . . . 0.0 115.016 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -81.08 -10.01 59.74 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.715 0.806 . . . . 0.0 112.846 173.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 14.2 m0 -92.96 173.23 7.85 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.488 1.515 . . . . 0.0 111.147 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -79.5 53.39 1.55 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.33 1.452 . . . . 0.0 114.182 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.5 mt -61.3 -16.49 46.2 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.389 1.625 . . . . 0.0 115.389 -172.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -108.22 -3.58 18.35 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.45 1.1 . . . . 0.0 112.714 177.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -149.39 67.29 8.83 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.362 1.465 . . . . 0.0 111.48 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -53.26 141.03 60.98 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.163 2.575 . . . . 0.0 111.926 176.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -72.83 -27.51 61.99 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.453 0.701 . . . . 0.0 111.717 -177.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -151.92 152.66 32.83 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.214 1.805 . . . . 0.0 110.152 169.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.5 p -135.14 148.52 49.77 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.925 0.89 . . . . 0.0 111.646 169.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.64 -141.32 5.17 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 114.097 0.399 . . . . 0.0 114.097 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -107.06 145.64 32.13 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.01 2.124 . . . . 0.0 111.106 -174.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.8 tp -93.13 136.48 33.35 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.993 1.317 . . . . 0.0 109.458 169.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.3 ttp85 -137.76 103.51 5.03 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.594 0.758 . . . . 0.0 110.223 160.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.0 mt -77.7 118.76 25.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 166.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.55 178.12 4.58 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 127.93 2.492 . . . . 0.0 110.272 176.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 t -160.12 172.45 17.45 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 126.804 2.042 . . . . 0.0 107.763 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -143.66 -107.29 0.12 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.336 1.055 . . . . 0.0 109.01 167.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.19 97.5 2.0 Allowed Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.135 1.35 . . . . 0.0 112.564 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 52.86 28.5 6.55 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 126.603 1.961 . . . . 0.0 113.811 178.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.1 m -147.2 116.36 6.93 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 126.177 1.791 . . . . 0.0 108.396 -173.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.94 159.22 18.43 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.098 0.959 . . . . 0.0 110.823 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -136.12 117.08 14.24 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.206 1.402 . . . . 0.0 109.911 177.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.4 mp -87.15 100.48 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 168.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -98.64 137.0 37.92 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.793 0.806 . . . . 0.0 111.813 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -102.38 131.95 48.69 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.499 1.519 . . . . 0.0 109.636 168.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -136.44 152.27 50.4 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.784 0.834 . . . . 0.0 111.781 -173.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -73.03 142.01 47.66 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.865 -1.147 . . . . 0.0 112.667 -170.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -78.36 -6.13 54.24 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.194 1.797 . . . . 0.0 115.703 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 99.4 t -121.85 -44.63 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.101 1.36 . . . . 0.0 111.257 177.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.7 m -98.67 -19.99 17.21 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -174.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.77 10.3 80.02 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.513 1.054 . . . . 0.0 114.033 -176.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -82.71 154.24 24.93 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.243 1.417 . . . . 0.0 112.466 -175.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.2 tp -72.53 125.12 26.66 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.68 0.792 . . . . 0.0 111.918 -174.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -87.37 -55.22 3.9 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.118 0.967 . . . . 0.0 111.035 168.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.63 160.87 39.81 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.622 1.169 . . . . 0.0 112.027 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -141.47 131.12 24.06 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.797 1.239 . . . . 0.0 111.93 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.2 102.88 53.6 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 124.464 1.106 . . . . 0.0 111.534 175.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.77 139.93 25.53 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.963 3.109 . . . . 0.0 111.958 175.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.5 t -134.42 123.49 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 126.193 1.797 . . . . 0.0 109.548 -174.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -87.53 -23.02 24.52 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 121.366 -0.834 . . . . 0.0 113.158 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.12 144.3 15.96 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.409 1.883 . . . . 0.0 110.199 169.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -115.11 130.13 24.49 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.547 1.139 . . . . 0.0 110.918 176.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.94 148.05 78.12 Favored 'Cis proline' 0 CA--C 1.541 0.873 0 CA-C-N 119.827 0.974 . . . . 0.0 113.032 -5.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.85 -170.72 30.19 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.937 1.256 . . . . 0.0 113.822 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.3 tp -60.44 -31.05 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -170.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.4 4.33 53.65 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -171.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.5 t -149.33 130.37 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 119.456 1.025 . . . . 0.0 111.631 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -142.42 165.87 26.23 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.563 1.945 . . . . 0.0 112.364 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 56.1 p -116.9 160.17 21.29 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 127.087 2.155 . . . . 0.0 111.63 -176.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.7 m -84.16 172.58 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.034 0.934 . . . . 0.0 111.565 168.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.6 p -91.61 -33.59 15.05 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.313 1.445 . . . . 0.0 112.768 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -97.51 -40.66 8.55 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -162.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.5 t -139.2 122.59 17.16 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -175.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 p -74.5 30.19 0.08 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 -172.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.426 ' HA ' ' CB ' ' A' ' 116' ' ' ALA . 53.9 ptt85 -123.65 23.58 8.76 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.14 1.776 . . . . 0.0 114.298 171.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -140.52 138.76 34.81 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.905 1.282 . . . . 0.0 111.227 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -137.0 164.54 28.11 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.597 1.559 . . . . 0.0 111.108 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.2 t -122.1 139.67 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.737 1.215 . . . . 0.0 108.589 167.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.87 148.05 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 118.731 0.696 . . . . 0.0 112.415 176.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -89.34 85.68 6.64 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.475 0.71 . . . . 0.0 110.805 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.08 137.22 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 122.105 -0.372 . . . . 0.0 110.773 175.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 . . . . . 0 N--CA 1.468 0.473 0 C-N-CA 125.474 1.51 . . . . 0.0 111.738 -169.123 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 86.2 p . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.57 146.63 29.48 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.664 1.586 . . . . 0.0 111.057 168.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -92.12 121.4 33.63 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.058 0.543 . . . . 0.0 109.853 168.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.1 pt -120.92 144.57 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.675 1.19 . . . . 0.0 110.929 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -88.32 145.88 19.27 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 173.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.6 pt -128.05 141.63 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 125.274 1.43 . . . . 0.0 111.634 167.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.15 143.28 15.53 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.601 1.572 . . . . 0.0 112.931 175.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -108.65 157.41 18.54 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.51 1.924 . . . . 0.0 110.903 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.6 t -69.26 -27.7 65.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.918 0.887 . . . . 0.0 112.644 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -155.52 153.09 29.68 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.204 1.001 . . . . 0.0 112.029 -178.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.54 -35.03 75.02 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.589 1.156 . . . . 0.0 112.122 175.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.95 -14.73 68.42 Favored Glycine 0 CA--C 1.54 1.604 0 CA-C-O 119.384 -0.676 . . . . 0.0 114.364 176.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -97.1 -30.9 12.77 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.819 1.248 . . . . 0.0 111.886 171.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.426 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -72.98 -30.84 64.13 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 173.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -59.44 -32.1 69.91 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.35 -0.844 . . . . 0.0 112.064 172.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -64.77 -32.43 74.11 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.531 -0.731 . . . . 0.0 112.384 174.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -63.11 -56.35 17.58 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.213 1.005 . . . . 0.0 111.691 178.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -73.97 -24.48 59.63 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -177.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 68.4 t -78.29 -42.3 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 121.254 -0.904 . . . . 0.0 111.306 174.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.9 m -66.36 -30.78 71.25 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.137 0.88 . . . . 0.0 112.539 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.0 mt -67.37 -57.3 6.86 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.457 0.703 . . . . 0.0 111.867 170.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -64.74 -31.94 73.39 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.457 -0.777 . . . . 0.0 112.973 -173.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -80.73 -0.28 37.75 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.368 1.067 . . . . 0.0 112.666 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -101.78 -3.99 27.14 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 164.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -111.45 -10.8 14.16 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 175.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -176.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.824 0.345 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.8 t -70.54 144.42 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.705 0.802 . . . . 0.0 111.126 -171.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 44.9 mt -127.07 -42.83 1.7 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.715 1.606 . . . . 0.0 111.949 -174.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 32.7 t -149.26 139.22 22.02 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.59 1.156 . . . . 0.0 109.808 177.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.5 t -133.99 127.15 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.641 1.176 . . . . 0.0 109.116 170.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -131.0 134.37 25.88 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 125.004 1.322 . . . . 0.0 110.23 175.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.28 -18.51 16.02 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.878 2.385 . . . . 0.0 114.854 -172.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -132.69 111.79 11.46 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.452 1.101 . . . . 0.0 111.434 -173.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.0 p -146.61 144.63 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.847 1.659 . . . . 0.0 109.882 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.6 m -123.73 131.8 53.68 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.986 0.915 . . . . 0.0 111.549 -173.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 76.0 t -96.97 131.6 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.492 1.517 . . . . 0.0 111.594 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -128.82 126.9 40.85 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.936 1.295 . . . . 0.0 109.15 169.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -65.83 129.9 41.41 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.479 0.712 . . . . 0.0 109.546 170.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.6 pt . . . . . 0 N--CA 1.476 0.875 0 C-N-CA 124.333 1.053 . . . . 0.0 112.851 -171.095 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 . . . . . 0 C--O 1.221 -0.413 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.37 19.92 7.44 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -171.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.42 -48.29 0.05 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 127.76 2.424 . . . . 0.0 115.299 -172.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.6 m -66.44 -16.63 64.25 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.239 1.816 . . . . 0.0 114.813 -177.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -85.5 -2.53 58.23 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 172.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 24.7 m0 -92.3 169.16 10.8 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.059 1.344 . . . . 0.0 110.833 173.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.5 mttt -78.33 52.44 1.13 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.341 1.456 . . . . 0.0 114.136 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.9 mt -57.53 -28.43 63.49 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -175.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -91.36 -6.07 53.56 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -149.76 74.36 9.45 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 124.873 1.269 . . . . 0.0 111.917 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -56.69 143.39 89.79 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.913 2.408 . . . . 0.0 112.565 174.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -72.0 -28.43 63.4 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.739 1.216 . . . . 0.0 111.624 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 49.4 t90 -155.73 151.97 27.98 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.985 1.714 . . . . 0.0 110.523 174.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.6 p -134.9 149.63 50.31 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.006 0.922 . . . . 0.0 111.723 170.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.74 -142.24 6.01 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 114.135 0.414 . . . . 0.0 114.135 -178.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 47.0 mtt180 -105.16 144.46 31.91 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 127.233 2.213 . . . . 0.0 111.751 -173.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.5 tp -90.29 137.15 32.58 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.434 1.494 . . . . 0.0 110.324 166.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.0 ttm-85 -130.27 132.23 45.83 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.659 1.184 . . . . 0.0 109.56 156.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.7 mt -109.59 131.57 60.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 163.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.72 151.06 42.61 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 127.879 2.471 . . . . 0.0 108.23 -168.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 92.3 p -161.04 155.08 22.64 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 120.142 -1.598 . . . . 0.0 111.908 -169.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -132.56 -105.1 0.25 Allowed 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.066 -1.022 . . . . 0.0 112.378 -173.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.32 -125.53 0.28 Allowed Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.26 0.933 . . . . 0.0 111.252 168.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -77.13 34.11 0.15 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.962 1.305 . . . . 0.0 112.52 173.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.8 m -143.45 133.59 24.36 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.935 0.894 . . . . 0.0 110.671 -174.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -115.09 162.86 16.44 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.15 1.38 . . . . 0.0 111.052 169.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -144.13 107.95 4.69 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.612 1.965 . . . . 0.0 108.88 -170.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mp -86.34 108.29 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 169.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -109.01 128.96 55.41 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.732 1.213 . . . . 0.0 111.309 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.0 mp -101.62 131.11 48.02 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.871 1.268 . . . . 0.0 110.168 177.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -133.16 149.66 52.05 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.063 0.945 . . . . 0.0 112.602 -169.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -69.58 141.14 53.82 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.033 -1.042 . . . . 0.0 111.977 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.0 pttt -79.85 -4.7 53.32 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 -177.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 95.8 t -121.98 -43.84 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.171 1.389 . . . . 0.0 111.355 178.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.9 m -97.47 -20.27 17.87 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.19 11.32 79.31 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.443 1.021 . . . . 0.0 114.032 -176.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -83.59 151.19 25.48 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.192 1.397 . . . . 0.0 112.24 -175.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.3 tp -72.96 127.26 32.02 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.437 0.695 . . . . 0.0 111.66 -175.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -86.76 -55.41 3.87 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.704 1.202 . . . . 0.0 111.171 169.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.11 159.69 38.11 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.117 1.367 . . . . 0.0 111.307 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -139.35 137.57 35.86 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 174.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.32 106.5 48.82 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.601 1.56 . . . . 0.0 110.621 177.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.57 142.13 18.1 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.718 2.946 . . . . 0.0 111.107 173.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.9 t -135.58 129.91 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 126.352 1.861 . . . . 0.0 109.476 -170.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -97.68 -20.1 17.83 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.227 1.011 . . . . 0.0 113.061 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.91 147.39 11.49 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.449 2.3 . . . . 0.0 110.33 -177.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -135.12 125.11 16.83 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 124.064 0.946 . . . . 0.0 111.529 174.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -65.31 150.13 75.93 Favored 'Cis proline' 0 CA--C 1.541 0.849 0 CA-C-N 119.894 0.998 . . . . 0.0 113.122 -2.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -170.06 -158.86 14.62 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.037 1.304 . . . . 0.0 113.697 -175.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.4 tp -75.53 -39.79 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -172.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.54 5.6 41.94 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -168.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.4 t -150.8 130.91 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.684 1.593 . . . . 0.0 109.397 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.3 163.2 34.39 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.814 1.646 . . . . 0.0 112.735 -174.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 66.3 p -116.43 162.9 16.85 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.904 1.682 . . . . 0.0 111.659 -177.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.5 m -91.08 177.39 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 124.479 1.112 . . . . 0.0 110.726 166.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.8 p -98.81 -32.4 11.38 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.051 1.74 . . . . 0.0 113.045 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -88.68 -43.36 11.37 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -167.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.2 t -143.9 124.44 14.01 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -176.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.05 -1.4 7.48 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 -170.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.467 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.295 27.9 ptt180 -85.63 15.37 4.71 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 177.469 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -137.02 133.97 36.07 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.874 1.269 . . . . 0.0 110.855 -173.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -133.74 160.46 37.52 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.087 1.355 . . . . 0.0 111.512 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 78.8 t -112.25 143.92 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.328 1.051 . . . . 0.0 108.985 164.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.0 149.49 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 119.025 0.829 . . . . 0.0 112.049 169.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -91.72 82.88 5.24 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.783 0.833 . . . . 0.0 111.177 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -66.93 139.99 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 120.91 0.386 . . . . 0.0 111.065 176.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 . . . . . 0 N--CA 1.469 0.487 0 C-N-CA 125.778 1.631 . . . . 0.0 111.474 -169.314 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.1 p . . . . . 0 C--O 1.234 0.288 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.25 146.26 32.54 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.491 1.516 . . . . 0.0 110.832 167.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -90.95 120.31 31.85 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.074 0.55 . . . . 0.0 109.65 167.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.6 pt -117.9 143.22 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.404 1.082 . . . . 0.0 110.832 176.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -92.24 140.69 15.26 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 175.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.0 pt -126.64 141.35 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 125.285 1.434 . . . . 0.0 111.708 173.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.1 142.14 14.3 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.038 1.304 . . . . 0.0 113.144 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -104.37 162.42 13.24 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.626 1.57 . . . . 0.0 111.531 -177.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.1 t -72.64 -29.18 63.24 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.578 0.751 . . . . 0.0 112.486 176.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -153.04 147.63 26.11 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.184 0.994 . . . . 0.0 112.069 -174.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.6 ttt-85 -62.33 -32.82 73.64 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.348 1.059 . . . . 0.0 113.234 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.96 -28.32 73.45 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-N 119.025 0.829 . . . . 0.0 113.714 176.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -84.71 -32.51 23.49 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.015 0.907 . . . . 0.0 111.953 176.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.467 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -66.9 -34.37 77.62 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 166.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -60.57 -35.96 77.33 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.251 -0.906 . . . . 0.0 111.677 168.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -62.47 -37.59 86.53 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 119.247 0.93 . . . . 0.0 111.88 175.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -58.73 -56.54 20.87 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.448 1.099 . . . . 0.0 112.017 171.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.03 -26.13 53.35 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -174.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.2 t -77.24 -43.31 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 121.193 -0.942 . . . . 0.0 110.98 176.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.3 t -69.91 -29.77 67.03 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.137 0.88 . . . . 0.0 112.469 -178.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.6 mt -64.44 -55.06 23.35 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.445 -0.784 . . . . 0.0 112.124 167.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -68.27 -29.48 68.28 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.108 -0.995 . . . . 0.0 113.069 -173.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -82.62 -3.64 56.51 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.852 0.861 . . . . 0.0 112.799 176.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -93.45 -34.08 13.56 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.39 -0.819 . . . . 0.0 112.47 161.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -90.64 -6.39 54.63 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 -177.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.484 1.228 0 CA-C-N 121.259 1.845 . . . . 0.0 115.773 -173.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.8 m . . . . . 0 CA--C 1.53 0.206 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.5 p -70.62 145.33 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 178.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.6 mt -129.86 -39.68 1.4 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.829 1.652 . . . . 0.0 111.957 -172.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.427 ' SG ' ' HE2' ' A' ' 14' ' ' LYS . 12.5 t -152.8 133.25 13.7 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.096 0.958 . . . . 0.0 111.26 175.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 92.9 t -130.5 127.14 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.538 1.135 . . . . 0.0 108.963 170.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.427 ' HE2' ' SG ' ' A' ' 12' ' ' CYS . 68.1 mttm -133.55 144.08 50.62 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 124.968 1.307 . . . . 0.0 112.3 -179.522 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -77.7 -11.44 16.91 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 124.098 3.199 . . . . 0.0 114.636 -178.289 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -117.99 110.15 17.34 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.148 1.379 . . . . 0.0 111.673 -174.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 p -156.82 142.05 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.527 1.131 . . . . 0.0 110.424 163.296 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.6 m -123.43 144.23 49.64 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.408 1.483 . . . . 0.0 110.238 178.517 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 76.7 t -113.7 129.36 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.821 1.248 . . . . 0.0 111.047 177.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.17 116.41 11.85 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.89 1.676 . . . . 0.0 109.196 173.796 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.9 mtt-85 -71.37 134.54 46.77 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.138 0.975 . . . . 0.0 110.509 -176.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.7 pt . . . . . 0 CA--C 1.546 0.801 0 C-N-CA 124.266 1.026 . . . . 0.0 113.177 -165.003 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 . . . . . 0 N--CA 1.466 0.361 0 CA-C-O 119.446 -0.311 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.401 ' HE ' ' CG ' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -118.61 26.13 9.78 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 178.113 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 60.46 -42.13 0.1 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.686 2.394 . . . . 0.0 115.272 -170.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 89.6 p -66.47 -15.92 63.72 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.384 1.874 . . . . 0.0 114.398 -179.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.401 ' CG ' ' HE ' ' A' ' 32' ' ' ARG . 31.9 m-20 -63.33 -26.21 68.66 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 167.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 9.6 m0 -94.13 164.89 12.88 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.964 1.306 . . . . 0.0 111.256 -168.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -76.92 55.21 1.08 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.643 1.577 . . . . 0.0 114.172 179.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.6 mt -59.49 -25.69 64.66 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.66 1.184 . . . . 0.0 113.745 -179.278 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -94.87 -7.63 39.58 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.608 0.763 . . . . 0.0 113.004 -179.053 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -149.88 78.97 7.96 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.644 1.178 . . . . 0.0 111.959 175.549 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.88 147.61 50.68 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.519 2.813 . . . . 0.0 113.114 176.229 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -71.22 -28.92 64.54 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.881 0.872 . . . . 0.0 111.302 169.003 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 66.9 t90 -156.56 153.53 28.81 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.243 1.817 . . . . 0.0 110.891 177.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.7 p -135.67 149.4 49.27 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.576 1.151 . . . . 0.0 111.331 169.374 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.62 -140.44 4.29 Favored Glycine 0 CA--C 1.525 0.717 0 O-C-N 122.135 -0.353 . . . . 0.0 113.462 -178.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.9 mtm105 -119.56 147.76 44.1 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.222 1.809 . . . . 0.0 111.715 -173.189 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 40.4 tp -85.13 142.04 29.79 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.674 1.59 . . . . 0.0 110.616 176.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.8 ttm-85 -142.2 95.55 2.82 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.376 1.07 . . . . 0.0 111.073 165.427 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.7 mt -83.06 128.53 38.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 169.271 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.8 p -140.57 171.97 13.37 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.71 2.004 . . . . 0.0 110.472 -176.011 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.7 t -155.34 153.43 30.48 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.681 1.192 . . . . 0.0 112.076 175.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -155.96 123.76 5.62 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.166 0.986 . . . . 0.0 111.012 163.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.52 46.31 48.71 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.151 0.882 . . . . 0.0 114.845 167.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt 63.32 28.2 15.58 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 126.408 1.883 . . . . 0.0 113.679 -176.061 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.1 m -135.42 120.55 18.84 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.658 1.583 . . . . 0.0 108.774 170.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.3 159.25 18.85 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.891 0.876 . . . . 0.0 111.034 174.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -137.63 114.05 10.23 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.592 1.557 . . . . 0.0 109.29 178.514 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.4 mp -85.93 92.88 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 167.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -84.98 146.1 27.38 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.208 1.003 . . . . 0.0 110.266 172.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -110.44 137.54 48.02 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.564 1.546 . . . . 0.0 111.2 172.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -123.71 147.7 47.22 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.34 1.056 . . . . 0.0 113.286 -178.103 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.73 144.15 52.86 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 122.148 0.975 . . . . 0.0 112.065 169.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.4 pttt -81.49 -6.38 58.9 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -177.021 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 90.7 t -122.62 -39.52 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.657 1.183 . . . . 0.0 111.983 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.4 m -116.0 -10.38 11.6 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -172.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.65 19.74 79.3 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 123.613 0.625 . . . . 0.0 114.331 177.399 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -65.79 139.13 58.31 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.385 1.474 . . . . 0.0 111.24 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.9 tp -72.23 112.31 8.2 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.103 0.561 . . . . 0.0 109.882 172.492 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -78.52 -56.58 4.32 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.241 0.616 . . . . 0.0 111.3 177.071 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.0 165.24 35.61 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.225 1.81 . . . . 0.0 109.795 179.266 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -146.25 142.87 28.78 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 170.488 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.22 105.71 50.31 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.355 1.462 . . . . 0.0 111.808 -178.544 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -67.54 142.89 60.71 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 124.129 3.22 . . . . 0.0 112.39 170.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.5 t -139.2 117.33 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.294 1.437 . . . . 0.0 109.688 -177.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -81.45 -25.96 35.68 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 121.45 -0.781 . . . . 0.0 112.96 -177.396 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.19 145.35 16.52 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.336 1.854 . . . . 0.0 110.077 169.435 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -118.75 127.94 26.25 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.569 1.148 . . . . 0.0 110.588 175.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.54 147.5 75.76 Favored 'Cis proline' 0 CA--C 1.542 0.905 0 CA-C-N 119.997 1.035 . . . . 0.0 113.434 -2.684 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.91 -158.2 9.05 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.686 1.612 . . . . 0.0 112.948 -179.169 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.2 tt -76.29 -40.41 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 O-C-N 121.853 -0.793 . . . . 0.0 113.093 -178.245 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.44 7.72 18.77 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -166.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.9 t -152.83 125.99 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 126.421 1.889 . . . . 0.0 108.571 177.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -145.95 154.06 41.5 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.607 1.163 . . . . 0.0 112.224 -173.834 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.7 p -103.2 154.78 18.96 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.524 1.53 . . . . 0.0 112.453 179.693 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.9 m -76.42 175.28 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.8 1.24 . . . . 0.0 111.065 165.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 68.7 p -92.21 -30.12 16.08 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.909 1.283 . . . . 0.0 113.152 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -100.94 -39.34 7.8 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -163.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.4 t -141.42 125.76 17.58 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -176.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.88 -12.73 26.93 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -172.318 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.444 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.272 27.7 ptt180 -82.61 11.78 5.4 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -176.892 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -136.98 140.82 42.45 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.082 1.353 . . . . 0.0 112.03 -174.078 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -140.95 158.82 43.41 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.231 1.412 . . . . 0.0 111.656 -178.262 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.3 t -108.39 140.26 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.379 1.072 . . . . 0.0 108.56 162.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.95 148.31 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 119.159 0.891 . . . . 0.0 112.229 170.184 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -93.25 91.65 7.35 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.743 0.817 . . . . 0.0 110.834 178.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -75.02 152.28 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.245 0.618 . . . . 0.0 111.894 176.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.46 0 C-N-CA 125.591 1.556 . . . . 0.0 110.102 171.249 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 90.5 p . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.81 146.69 31.26 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.894 1.278 . . . . 0.0 111.443 174.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -90.38 117.12 28.85 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.552 0.741 . . . . 0.0 109.438 167.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.8 pt -116.77 144.63 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.804 1.242 . . . . 0.0 110.821 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -92.36 139.15 14.54 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 176.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 31.7 pt -130.67 160.61 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.175 1.39 . . . . 0.0 112.152 171.386 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -155.2 174.45 33.36 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-O 121.865 0.703 . . . . 0.0 114.794 167.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -124.2 149.26 46.57 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 126.721 2.008 . . . . 0.0 110.642 -173.255 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.0 t -74.68 -11.97 60.31 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 178.379 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -119.12 -24.16 6.57 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -155.282 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 61.09 -41.29 0.12 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 127.152 2.181 . . . . 0.0 115.036 -166.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.17 -27.89 72.14 Favored Glycine 0 CA--C 1.537 1.456 0 CA-C-N 119.675 1.125 . . . . 0.0 113.632 171.038 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -79.69 -34.72 39.96 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.122 0.961 . . . . 0.0 112.095 173.317 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.444 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -63.96 -36.77 85.05 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.563 -0.711 . . . . 0.0 112.636 167.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -70.27 9.91 0.52 Allowed 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 167.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -122.4 -32.57 3.6 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.219 1.408 . . . . 0.0 112.114 170.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -50.15 -48.89 53.58 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.223 1.409 . . . . 0.0 111.974 164.148 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -77.07 -29.83 55.22 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -178.672 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.2 t -77.96 -42.75 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 121.041 -1.037 . . . . 0.0 111.004 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 77.8 p -64.08 -26.66 68.65 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 176.309 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.9 mt -71.62 -59.51 2.72 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.22 1.008 . . . . 0.0 112.004 168.092 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -65.3 -30.34 71.18 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -172.412 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -79.04 -1.18 34.44 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.484 1.114 . . . . 0.0 112.608 177.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -100.06 -3.98 30.83 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 164.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -113.87 -10.24 12.98 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 176.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.28 0 CA-C-N 120.431 1.469 . . . . 0.0 114.855 -176.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.234 0.274 0 N-CA-C 111.405 0.15 . . . . 0.0 111.405 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.0 p -72.3 146.26 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 123.481 0.712 . . . . 0.0 111.184 -178.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.7 mt -129.5 -37.47 1.6 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.361 1.465 . . . . 0.0 112.521 -170.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 36.8 t -149.31 139.42 22.14 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.954 1.301 . . . . 0.0 109.865 173.312 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.2 t -134.84 127.71 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.826 1.25 . . . . 0.0 108.864 168.636 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -130.96 136.98 29.75 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 125.048 1.339 . . . . 0.0 110.868 176.162 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.11 -14.32 16.82 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.349 2.699 . . . . 0.0 114.968 -174.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -134.58 108.69 8.21 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.135 0.974 . . . . 0.0 111.295 -173.149 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.37 144.35 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.189 1.396 . . . . 0.0 110.191 171.659 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.1 m -123.19 137.5 54.88 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.441 1.096 . . . . 0.0 111.267 -176.574 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.2 t -101.79 133.05 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.324 1.449 . . . . 0.0 111.444 178.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.22 121.51 22.6 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.973 1.309 . . . . 0.0 109.109 170.597 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -66.51 130.82 44.49 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.069 0.548 . . . . 0.0 109.98 174.123 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.0 pt . . . . . 0 CA--C 1.545 0.765 0 C-N-CA 124.134 0.974 . . . . 0.0 113.205 -168.206 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 . . . . . 0 C--O 1.224 -0.258 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.54 18.53 7.46 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -172.412 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.3 -49.66 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 128.192 2.597 . . . . 0.0 115.597 -173.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.2 m -65.21 -17.8 64.79 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.99 1.716 . . . . 0.0 114.611 -176.295 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.89 -8.64 59.14 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 172.695 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -88.99 168.9 11.99 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.78 1.232 . . . . 0.0 110.732 174.639 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -81.26 55.36 2.53 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.686 1.195 . . . . 0.0 113.436 179.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.3 mt -54.84 -31.53 59.55 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -172.432 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -90.34 -8.78 49.9 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.32 1.048 . . . . 0.0 113.054 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -137.16 71.17 55.06 Favored Pre-proline 0 N--CA 1.471 0.62 0 C-N-CA 125.624 1.57 . . . . 0.0 111.358 -164.239 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -69.0 148.14 69.35 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 CA-C-N 119.315 0.791 . . . . 0.0 113.051 -171.753 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -72.35 -29.59 63.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.323 0.649 . . . . 0.0 111.239 167.486 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 56.0 t90 -159.56 154.21 24.32 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.533 1.933 . . . . 0.0 110.612 176.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.6 p -133.29 149.27 51.94 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.32 1.048 . . . . 0.0 111.749 167.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.84 -139.91 4.45 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 123.058 0.361 . . . . 0.0 113.261 -179.392 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.7 mtm105 -113.78 143.91 43.85 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.087 1.755 . . . . 0.0 111.736 -173.025 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.6 tp -83.37 140.34 32.47 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.62 1.168 . . . . 0.0 110.142 168.13 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -133.39 138.24 46.19 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.508 1.523 . . . . 0.0 108.816 156.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.1 mt -120.4 133.41 67.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 166.078 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.44 162.82 34.41 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 127.1 2.16 . . . . 0.0 109.309 -167.515 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 84.1 p -160.21 132.46 6.27 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 120.018 -1.676 . . . . 0.0 113.954 -169.452 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.64 137.18 7.64 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 125.51 1.524 . . . . 0.0 114.653 172.027 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 65.5 48.96 63.25 Favored Glycine 0 N--CA 1.475 1.259 0 C-N-CA 125.74 1.638 . . . . 0.0 114.123 171.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 56.1 30.57 16.58 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.99 1.716 . . . . 0.0 112.986 -174.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.5 m -134.05 132.92 40.6 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.775 2.03 . . . . 0.0 108.257 178.489 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.63 158.35 16.16 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.091 0.956 . . . . 0.0 110.434 171.418 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -142.12 91.89 2.38 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.666 1.586 . . . . 0.0 108.833 -164.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.8 mp -78.52 110.84 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 171.558 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -112.9 127.91 56.32 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.927 0.891 . . . . 0.0 110.868 177.201 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mp -96.94 130.29 44.28 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.583 1.153 . . . . 0.0 110.019 177.754 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -129.96 149.56 51.63 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.873 0.869 . . . . 0.0 112.845 -171.358 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -73.58 144.79 45.87 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.983 0.897 . . . . 0.0 112.186 -178.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.0 pttt -84.44 -6.73 59.41 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.238 1.815 . . . . 0.0 115.158 -178.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 96.0 t -122.7 -43.99 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.241 1.416 . . . . 0.0 111.586 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.2 m -95.34 -21.39 18.42 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -174.508 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.13 6.94 84.0 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.218 0.913 . . . . 0.0 113.902 -176.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.43 155.89 24.42 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.421 1.489 . . . . 0.0 112.626 -174.425 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.8 tp -74.57 128.06 34.62 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.632 0.773 . . . . 0.0 111.149 178.282 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -85.93 -56.41 3.49 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.327 1.051 . . . . 0.0 111.133 169.041 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.88 160.71 39.4 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.162 1.385 . . . . 0.0 111.204 -178.602 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? -140.18 136.02 33.02 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 176.17 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.73 100.56 51.02 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 126.136 1.774 . . . . 0.0 110.691 179.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -74.83 141.44 27.17 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.35 2.7 . . . . 0.0 111.33 169.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.5 t -134.65 125.93 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 126.921 2.088 . . . . 0.0 108.987 -172.108 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -90.97 -22.24 20.92 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.295 0.952 . . . . 0.0 113.53 -177.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -161.54 150.5 16.0 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.322 1.849 . . . . 0.0 110.438 173.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -130.16 131.77 23.65 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.347 1.059 . . . . 0.0 111.443 175.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.73 145.42 46.72 Favored 'Cis proline' 0 CA--C 1.539 0.736 0 CA-C-N 119.922 1.008 . . . . 0.0 113.739 -7.042 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -161.77 -156.26 8.29 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 125.669 1.605 . . . . 0.0 112.357 -177.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 19.9 tt -81.42 -39.94 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -176.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.68 6.35 15.53 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -167.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.1 t -152.22 128.51 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 126.364 1.866 . . . . 0.0 109.238 178.568 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -140.02 158.46 44.03 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.438 1.495 . . . . 0.0 113.11 176.155 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 67.5 p -100.56 159.04 15.48 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.294 1.838 . . . . 0.0 111.638 175.191 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.9 m -83.91 174.22 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.738 0.815 . . . . 0.0 110.862 164.575 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 59.9 p -96.02 -30.71 13.42 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.35 1.46 . . . . 0.0 113.224 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -96.04 -40.72 9.11 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -165.513 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.1 t -137.38 120.59 16.8 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -174.19 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.8 m -73.91 24.44 0.08 Allowed 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 -168.001 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -128.61 23.82 5.82 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 127.136 2.175 . . . . 0.0 113.529 -178.169 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -141.55 139.52 33.21 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.644 1.577 . . . . 0.0 111.391 -178.454 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -140.18 161.29 37.99 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.807 1.243 . . . . 0.0 111.89 -177.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 78.1 t -113.04 142.34 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.473 1.109 . . . . 0.0 108.725 166.021 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.43 149.46 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 118.509 0.595 . . . . 0.0 112.085 170.51 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -89.47 87.4 7.06 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.814 0.846 . . . . 0.0 110.508 177.019 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.8 141.05 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 O-C-N 122.102 -0.374 . . . . 0.0 110.469 172.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 . . . . . 0 N--CA 1.467 0.402 0 C-N-CA 125.377 1.471 . . . . 0.0 111.418 -170.262 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 84.1 p . . . . . 0 N--CA 1.47 0.547 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.87 145.92 31.81 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.644 1.577 . . . . 0.0 110.952 170.048 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -93.57 116.56 29.08 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.63 0.772 . . . . 0.0 109.726 171.284 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.3 pt -115.69 144.04 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.539 1.136 . . . . 0.0 110.953 179.339 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.46 142.47 16.11 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 174.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.4 pt -128.85 147.78 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 125.331 1.452 . . . . 0.0 111.925 172.217 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.15 146.94 17.89 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.454 1.026 . . . . 0.0 114.022 177.178 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -109.72 161.1 15.73 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.536 1.934 . . . . 0.0 111.104 178.405 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.9 t -74.41 -24.13 59.06 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.721 0.808 . . . . 0.0 112.802 179.091 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -157.47 156.35 31.96 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.814 1.246 . . . . 0.0 111.504 -177.133 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -57.84 -33.25 68.44 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 118.642 -0.694 . . . . 0.0 112.465 175.228 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -59.65 -30.98 69.91 Favored Glycine 0 CA--C 1.536 1.401 0 CA-C-N 119.491 1.041 . . . . 0.0 114.237 -179.279 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -86.85 -36.89 18.21 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.381 1.09 . . . . 0.0 112.241 176.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.46 -30.26 70.48 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 168.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . 0.259 18.3 m-85 -91.0 17.92 7.35 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.006 1.722 . . . . 0.0 114.096 170.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -99.41 -40.66 7.77 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.635 -0.666 . . . . 0.0 111.099 143.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -53.78 -56.7 15.13 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.566 1.076 . . . . 0.0 113.047 178.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -80.45 -24.47 39.54 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -175.396 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 85.2 t -81.76 -39.2 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 123.144 0.577 . . . . 0.0 110.941 -177.136 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 89.4 p -64.41 -31.64 72.94 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 175.115 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 67.5 mt -68.14 -56.8 7.47 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.28 1.032 . . . . 0.0 111.704 171.143 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -67.23 -32.63 73.8 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.319 -0.863 . . . . 0.0 113.004 -173.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -84.69 -3.16 58.41 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.785 0.834 . . . . 0.0 112.762 177.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -93.97 -31.9 14.08 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.41 -0.806 . . . . 0.0 112.375 163.3 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -90.4 -9.81 46.2 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -178.539 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -171.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.4 p -72.57 144.56 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.707 0.803 . . . . 0.0 112.579 -174.512 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.6 mt -128.26 -43.97 1.44 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.239 1.416 . . . . 0.0 112.248 -173.539 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 24.4 t -149.6 135.06 18.38 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.376 1.07 . . . . 0.0 110.604 175.494 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 96.5 t -127.91 127.96 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.551 1.14 . . . . 0.0 109.304 171.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -128.35 133.27 24.97 Favored Pre-proline 0 N--CA 1.476 0.87 0 C-N-CA 125.259 1.424 . . . . 0.0 110.122 174.207 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.22 -15.48 14.36 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.116 2.544 . . . . 0.0 115.037 -171.305 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -133.48 108.58 8.73 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.138 0.975 . . . . 0.0 110.879 -174.444 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.3 p -144.94 144.48 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.161 1.384 . . . . 0.0 110.289 174.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.0 m -125.9 130.64 51.71 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.188 0.995 . . . . 0.0 111.081 -172.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.5 t -96.39 134.82 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.286 1.435 . . . . 0.0 111.345 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.98 124.76 26.86 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.952 1.301 . . . . 0.0 108.918 170.959 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.4 mmm-85 -63.14 136.77 57.96 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.634 -0.666 . . . . 0.0 110.451 167.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.5 pt . . . . . 0 CA--C 1.544 0.727 0 C-N-CA 124.981 1.312 . . . . 0.0 112.349 -174.841 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 . . . . . 0 CA--C 1.538 0.51 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.13 22.6 12.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.911 -1.118 . . . . 0.0 113.821 178.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.87 -48.78 0.06 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.369 2.268 . . . . 0.0 114.969 -167.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.6 m -66.86 -13.79 62.01 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.943 1.697 . . . . 0.0 114.903 -176.207 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.38 -12.98 60.37 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.129 0.972 . . . . 0.0 112.876 171.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 13.7 m0 -95.76 171.77 8.45 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.483 1.513 . . . . 0.0 111.958 -174.345 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -75.69 49.39 0.51 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.146 1.779 . . . . 0.0 113.844 177.19 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.5 mt -56.06 -33.61 65.15 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -171.025 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -94.44 -3.89 49.29 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.457 1.103 . . . . 0.0 113.209 177.492 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -128.04 59.91 43.05 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 127.054 2.141 . . . . 0.0 111.843 -173.715 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.0 133.34 33.07 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 CA-C-N 120.537 1.227 . . . . 0.0 112.423 -173.468 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -70.34 -24.49 62.99 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.853 1.261 . . . . 0.0 111.243 178.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 33.9 t90 -159.74 154.47 24.37 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.862 2.065 . . . . 0.0 110.451 170.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.9 p -133.76 150.17 51.46 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.075 0.95 . . . . 0.0 112.112 167.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.16 -140.15 4.74 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.099 0.38 . . . . 0.0 113.581 -178.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.0 mtm105 -111.5 147.7 34.78 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.538 1.935 . . . . 0.0 111.971 -175.355 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.9 tp -89.19 138.43 31.43 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.632 1.573 . . . . 0.0 109.672 166.441 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 36.8 ttt-85 -144.5 93.04 2.37 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.475 1.11 . . . . 0.0 110.697 165.44 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.1 mt -73.08 128.29 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 171.69 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.2 p -132.86 167.32 20.41 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.741 2.016 . . . . 0.0 110.552 -179.18 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.3 t -160.54 146.77 15.24 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.603 -1.311 . . . . 0.0 112.153 177.076 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.5 mmtt -153.3 131.76 12.13 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.358 1.463 . . . . 0.0 111.428 161.154 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.98 45.99 47.48 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.859 1.219 . . . . 0.0 115.026 163.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt 63.68 21.39 12.68 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.432 1.893 . . . . 0.0 113.696 -173.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.2 m -127.7 112.7 15.11 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.072 1.349 . . . . 0.0 109.143 170.411 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.97 161.49 18.98 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.63 0.772 . . . . 0.0 110.573 170.024 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -141.11 108.75 5.61 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.941 1.696 . . . . 0.0 108.695 -175.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.5 mp -81.39 95.14 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 168.36 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -95.04 137.29 34.29 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.445 0.641 . . . . 0.0 111.605 175.586 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.3 mp -110.94 134.36 52.64 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.447 1.899 . . . . 0.0 109.491 176.402 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -139.21 152.13 47.1 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.544 0.738 . . . . 0.0 112.734 -168.374 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -73.6 143.26 46.44 Favored 'General case' 0 C--O 1.238 0.492 0 O-C-N 121.304 -0.872 . . . . 0.0 111.907 -176.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.4 pttt -84.01 -6.18 59.36 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.377 1.871 . . . . 0.0 115.05 -178.761 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 91.8 t -123.5 -44.42 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.357 1.463 . . . . 0.0 111.416 178.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.9 m -92.77 -23.11 18.99 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -174.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.84 6.06 86.94 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 123.872 0.748 . . . . 0.0 113.778 -177.421 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -82.05 154.48 25.6 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.361 1.464 . . . . 0.0 112.616 -174.625 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.1 tp -73.37 125.54 28.1 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.818 0.847 . . . . 0.0 110.981 178.136 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -84.56 -56.94 3.35 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.131 0.972 . . . . 0.0 110.806 169.683 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.32 163.3 39.67 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.744 1.218 . . . . 0.0 111.774 -179.273 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -139.63 135.79 33.65 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.583 1.153 . . . . 0.0 111.5 177.405 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.53 102.81 49.67 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.547 1.139 . . . . 0.0 111.076 174.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -70.06 137.89 35.63 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.828 3.019 . . . . 0.0 112.09 173.213 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.8 t -131.98 131.93 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.212 1.805 . . . . 0.0 109.251 -179.193 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -101.11 -16.29 17.11 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.435 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -161.71 152.13 17.42 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.926 1.69 . . . . 0.0 110.411 175.151 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -124.7 134.88 25.99 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -173.095 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -66.9 149.31 80.4 Favored 'Cis proline' 0 CA--C 1.542 0.909 0 CA-C-N 119.41 0.825 . . . . 0.0 111.221 -13.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -148.09 -172.78 18.41 Favored Glycine 0 N--CA 1.474 1.217 0 N-CA-C 115.1 0.8 . . . . 0.0 115.1 -174.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.3 tp -58.79 -29.03 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -174.521 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.53 7.97 43.77 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.584 1.154 . . . . 0.0 113.763 -172.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.1 p -158.94 128.58 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.004 0.922 . . . . 0.0 113.266 179.008 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -148.57 165.51 31.04 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.185 1.794 . . . . 0.0 113.455 -168.147 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 50.0 p -121.77 155.91 34.28 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.625 1.97 . . . . 0.0 111.592 -172.692 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.0 m -84.45 172.89 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.761 0.824 . . . . 0.0 111.901 172.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 68.7 p -89.03 -34.17 16.9 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.028 1.331 . . . . 0.0 112.539 177.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -92.92 -43.41 8.97 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -164.307 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.4 t -145.81 121.56 10.54 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -174.2 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.37 -2.3 5.99 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -169.707 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.408 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.264 1.2 ptm180 -88.19 22.16 2.54 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.922 1.689 . . . . 0.0 114.528 174.2 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -140.47 134.71 31.11 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.893 1.277 . . . . 0.0 110.813 178.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -134.26 161.55 34.64 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.418 1.487 . . . . 0.0 111.763 -179.672 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.5 t -117.5 142.35 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.522 1.129 . . . . 0.0 109.116 166.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.38 150.77 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 123.381 0.673 . . . . 0.0 111.721 171.014 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -95.06 89.69 5.66 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.125 0.97 . . . . 0.0 109.988 177.78 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -71.05 137.0 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 120.724 0.297 . . . . 0.0 110.757 177.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 . . . . . 0 N--CA 1.467 0.406 0 C-N-CA 125.725 1.61 . . . . 0.0 111.521 -167.198 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 CA--C 1.535 0.383 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.75 141.02 26.3 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.303 1.441 . . . . 0.0 111.195 167.565 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -87.42 125.13 34.09 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 121.842 -0.536 . . . . 0.0 110.352 169.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 14.9 pt -122.27 142.92 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.117 1.367 . . . . 0.0 110.469 175.131 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.99 143.68 16.68 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 172.542 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.9 pt -129.17 141.59 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.971 1.308 . . . . 0.0 111.951 172.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -119.21 145.31 18.07 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.936 1.255 . . . . 0.0 113.157 175.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -108.21 161.51 14.92 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.016 1.726 . . . . 0.0 111.689 -176.334 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.9 t -72.57 -29.41 63.51 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.744 0.818 . . . . 0.0 112.91 -179.391 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -155.6 153.37 30.0 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.523 1.129 . . . . 0.0 111.753 -178.469 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 57.4 ttt-85 -61.29 -34.29 74.97 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.185 0.994 . . . . 0.0 113.176 178.065 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.43 -29.67 74.38 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 118.898 0.772 . . . . 0.0 113.515 175.481 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -82.43 -33.51 28.55 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 117.893 0.847 . . . . 0.0 111.825 175.349 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.408 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -67.09 -33.4 75.39 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.7 0.8 . . . . 0.0 112.962 170.146 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -60.84 -34.06 74.0 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.51 -0.744 . . . . 0.0 112.347 172.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -64.87 -32.63 74.43 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.543 1.065 . . . . 0.0 112.606 174.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -60.97 -55.66 30.24 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.241 0.928 . . . . 0.0 111.604 173.011 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.05 -26.73 56.85 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -175.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.9 t -74.62 -43.29 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 119.288 0.949 . . . . 0.0 110.953 175.271 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 41.9 m -66.41 -27.18 67.64 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.96 0.8 . . . . 0.0 112.843 -179.187 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 75.4 mt -73.71 -57.52 3.93 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.638 0.775 . . . . 0.0 111.483 169.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -64.27 -32.35 73.91 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -173.595 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -80.58 -5.42 56.78 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.039 0.936 . . . . 0.0 112.575 178.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -94.77 -15.05 24.14 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 165.403 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -108.81 -7.01 15.6 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-N 121.218 1.826 . . . . 0.0 115.786 -175.653 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.9 t -73.55 147.25 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.103 1.361 . . . . 0.0 111.622 -174.54 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.84 -40.88 1.05 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.516 1.527 . . . . 0.0 111.843 -172.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 22.5 t -147.41 142.5 27.1 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.899 1.28 . . . . 0.0 110.669 173.58 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 76.1 t -136.05 129.03 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 125.076 1.35 . . . . 0.0 109.087 170.082 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -130.92 137.65 31.24 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 125.44 1.496 . . . . 0.0 110.381 173.27 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.59 -17.86 15.87 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.028 2.485 . . . . 0.0 114.797 -174.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -133.77 111.11 10.27 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.236 1.015 . . . . 0.0 111.794 -171.009 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.0 p -148.42 144.3 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.038 1.735 . . . . 0.0 110.017 172.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.4 m -123.09 136.63 54.88 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.45 1.1 . . . . 0.0 111.29 -174.053 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.2 t -101.29 133.42 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.063 1.345 . . . . 0.0 111.532 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -134.18 119.6 19.02 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.055 1.342 . . . . 0.0 108.864 171.044 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -66.36 129.86 41.26 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.975 0.51 . . . . 0.0 109.808 174.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.4 pt . . . . . 0 CA--C 1.544 0.746 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -166.575 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 . . . . . 0 CA--C 1.534 0.355 0 CA-C-O 120.505 0.193 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.42 17.13 3.68 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -171.377 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.06 -52.23 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 128.16 2.584 . . . . 0.0 115.616 -175.487 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.6 m -66.66 -13.94 61.85 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.872 1.669 . . . . 0.0 114.187 -176.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -84.6 -8.44 58.89 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.943 1.297 . . . . 0.0 112.633 173.479 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.2 m0 -92.93 169.36 10.5 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.753 1.621 . . . . 0.0 111.234 177.214 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -79.62 51.33 1.25 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.197 1.799 . . . . 0.0 112.574 178.305 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.2 mt -54.62 -32.44 58.92 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.389 1.476 . . . . 0.0 114.36 -173.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -87.92 -9.5 53.44 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.796 0.838 . . . . 0.0 112.485 -177.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -139.13 68.66 41.23 Favored Pre-proline 0 N--CA 1.47 0.545 0 C-N-CA 125.396 1.478 . . . . 0.0 111.231 -160.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -68.7 147.23 69.17 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 CA-C-N 119.519 0.864 . . . . 0.0 113.215 -169.1 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -72.52 -30.12 64.19 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.493 0.717 . . . . 0.0 111.286 168.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.6 t90 -159.24 155.14 26.47 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.472 1.909 . . . . 0.0 110.517 176.789 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.8 p -134.7 146.99 49.98 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.81 1.244 . . . . 0.0 111.945 171.233 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.14 -140.8 5.45 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 114.574 0.59 . . . . 0.0 114.574 176.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -107.14 141.54 38.25 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 126.677 1.991 . . . . 0.0 111.249 -169.253 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.5 tp -84.67 139.39 32.06 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.037 1.335 . . . . 0.0 110.127 168.237 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.6 ttm-85 -131.82 132.05 43.4 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.408 1.083 . . . . 0.0 109.554 154.546 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.4 mt -109.34 132.8 56.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 163.282 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.84 164.19 31.24 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 126.379 1.871 . . . . 0.0 109.866 -168.322 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.2 t -156.96 155.99 32.24 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 120.772 -1.205 . . . . 0.0 111.805 177.241 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -159.97 133.3 6.92 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.388 1.475 . . . . 0.0 110.045 152.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.97 49.94 20.28 Favored Glycine 0 N--CA 1.475 1.258 0 C-N-CA 124.7 1.143 . . . . 0.0 114.82 166.666 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt 59.93 23.1 12.16 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 126.406 1.882 . . . . 0.0 113.697 -175.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.8 m -126.93 126.48 43.31 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.824 1.65 . . . . 0.0 108.308 172.285 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.68 161.11 13.81 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.125 0.97 . . . . 0.0 110.873 170.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -139.65 110.68 6.89 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 126.438 1.895 . . . . 0.0 108.356 -175.057 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.5 mp -86.33 106.92 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 166.098 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.7 mttt -107.43 131.3 54.43 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.64 1.176 . . . . 0.0 111.358 177.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.0 mp -103.32 130.01 50.49 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.053 1.341 . . . . 0.0 110.481 178.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -131.75 147.2 52.48 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.912 0.885 . . . . 0.0 113.289 -167.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -64.42 142.92 58.25 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.815 -1.178 . . . . 0.0 113.063 -177.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.26 -2.7 36.07 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 -178.299 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.5 t -116.78 -48.77 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.481 1.112 . . . . 0.0 111.269 170.836 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.7 m -114.22 -4.67 13.04 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.6 1.334 . . . . 0.0 114.6 -168.045 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.21 15.73 78.73 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 123.85 0.738 . . . . 0.0 114.143 177.257 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -63.97 133.35 53.03 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.839 1.656 . . . . 0.0 111.383 -177.032 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.1 tp -68.67 115.11 7.66 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 122.881 0.472 . . . . 0.0 111.056 -179.391 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -80.8 -53.3 6.61 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.714 1.206 . . . . 0.0 111.131 173.569 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.24 159.13 35.69 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.052 1.341 . . . . 0.0 111.287 -178.187 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -138.31 136.63 36.61 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.5 0.72 . . . . 0.0 112.502 173.182 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.96 107.93 47.23 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 125.339 1.456 . . . . 0.0 110.752 176.517 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -79.66 141.07 15.24 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.721 2.947 . . . . 0.0 111.314 175.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.8 t -134.14 129.52 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 126.145 1.778 . . . . 0.0 109.237 -172.3 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -96.52 -21.14 17.88 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 178.836 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.33 149.12 13.42 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.704 2.001 . . . . 0.0 110.301 175.981 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -129.24 129.76 23.33 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 124.334 1.054 . . . . 0.0 111.963 177.224 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -65.58 149.02 75.63 Favored 'Cis proline' 0 CA--C 1.541 0.854 0 CA-C-N 119.807 0.967 . . . . 0.0 113.191 -5.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -169.1 -162.28 21.03 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.639 1.59 . . . . 0.0 113.473 -177.282 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.9 tp -68.43 -35.42 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -170.249 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.04 4.1 53.81 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -168.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.4 t -151.35 129.64 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.806 1.242 . . . . 0.0 110.229 -179.38 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -138.84 158.4 44.3 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.535 1.534 . . . . 0.0 112.91 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 57.0 p -104.79 156.77 17.7 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.35 1.86 . . . . 0.0 111.225 175.785 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.7 m -82.89 178.37 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.82 0.848 . . . . 0.0 110.759 166.058 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 73.3 p -107.99 -22.27 12.48 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.775 1.63 . . . . 0.0 114.005 -177.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -90.68 -45.04 9.11 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -175.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t -145.32 125.7 13.96 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -179.416 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.8 m -69.57 11.83 0.23 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 -173.012 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.45 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.27 28.9 ptt180 -96.51 12.58 30.99 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.27 1.428 . . . . 0.0 114.43 174.016 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -136.75 139.66 42.02 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.428 1.491 . . . . 0.0 111.382 -173.338 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -140.13 162.89 34.15 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.062 1.345 . . . . 0.0 111.602 -177.26 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.4 t -117.17 141.77 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.526 1.131 . . . . 0.0 108.446 166.053 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.32 148.36 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 118.805 0.729 . . . . 0.0 112.281 171.246 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -91.04 81.76 5.61 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.906 0.883 . . . . 0.0 111.162 179.417 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -67.26 141.55 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.966 0.412 . . . . 0.0 111.148 176.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 . . . . . 0 N--CA 1.468 0.465 0 C-N-CA 125.646 1.578 . . . . 0.0 111.736 -169.058 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.9 p . . . . . 0 CA--C 1.534 0.33 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.35 146.22 32.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.436 1.494 . . . . 0.0 110.803 168.301 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -91.44 117.13 29.42 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.361 0.664 . . . . 0.0 109.535 168.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.6 pt -115.2 142.19 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.442 1.097 . . . . 0.0 110.795 177.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.7 141.27 16.01 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 175.293 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.5 pt -127.32 148.72 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 125.19 1.396 . . . . 0.0 111.602 170.432 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -134.61 147.24 19.05 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 124.093 0.854 . . . . 0.0 113.423 175.46 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -105.12 157.06 17.52 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.449 1.5 . . . . 0.0 111.279 176.1 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.4 t -73.8 -17.4 61.09 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.554 0.742 . . . . 0.0 112.78 178.211 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -154.28 145.92 23.27 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.675 1.19 . . . . 0.0 110.868 -178.188 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -64.27 -28.07 69.48 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.84 0.856 . . . . 0.0 113.193 -179.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.82 -30.75 78.07 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 124.164 0.888 . . . . 0.0 114.257 173.299 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -81.79 -34.89 30.08 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.603 1.201 . . . . 0.0 111.763 176.486 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.45 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -66.68 -30.18 70.37 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.162 0.985 . . . . 0.0 113.446 168.919 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.01 -49.54 76.51 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.363 0.665 . . . . 0.0 111.048 166.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -64.37 -28.96 70.05 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 118.837 0.744 . . . . 0.0 113.007 176.782 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -62.43 -61.25 2.57 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.651 1.114 . . . . 0.0 111.535 170.397 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -76.78 -27.29 55.22 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -171.589 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 65.5 t -71.76 -37.97 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 O-C-N 121.404 -0.81 . . . . 0.0 110.924 176.582 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 51.1 m -67.11 -16.29 64.24 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 176.466 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.5 mt -84.75 -56.73 3.43 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.164 0.985 . . . . 0.0 111.3 168.192 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -66.89 -34.33 77.54 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -172.184 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -85.77 -0.45 55.28 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.688 0.795 . . . . 0.0 112.44 177.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -99.4 -29.06 12.98 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.064 -1.023 . . . . 0.0 112.524 165.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -96.83 -5.95 37.12 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -179.601 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.248 0 CA-C-N 121.302 1.865 . . . . 0.0 114.887 -173.529 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.2 m . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.7 t -73.6 143.44 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.066 0.946 . . . . 0.0 110.764 177.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.2 mt -131.09 -36.8 1.3 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.089 1.355 . . . . 0.0 111.817 -169.576 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 47.9 t -153.17 142.67 21.76 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.3 1.44 . . . . 0.0 110.182 171.266 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 89.4 t -134.55 127.31 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.49 1.116 . . . . 0.0 109.315 169.223 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -121.54 133.35 24.21 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 124.932 1.293 . . . . 0.0 111.027 174.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -69.06 -29.96 26.34 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.47 2.113 . . . . 0.0 115.911 -171.508 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -137.14 122.48 19.4 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.792 0.805 . . . . 0.0 112.744 -175.218 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 p -149.24 149.07 15.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 127.571 2.348 . . . . 0.0 109.243 177.115 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.7 m -124.75 130.96 53.41 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.652 0.781 . . . . 0.0 112.358 -169.238 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 78.6 t -96.58 136.42 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.733 1.613 . . . . 0.0 112.473 -178.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -129.2 126.44 39.17 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.148 1.379 . . . . 0.0 109.357 169.892 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -66.88 131.29 45.6 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 167.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.7 pt . . . . . 0 N--CA 1.476 0.829 0 C-N-CA 124.699 1.2 . . . . 0.0 112.36 -175.088 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 . . . . . 0 C--O 1.223 -0.318 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.67 18.27 10.34 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -174.5 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 60.35 -46.47 0.1 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.583 2.353 . . . . 0.0 115.064 -171.573 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 92.1 p -65.66 -16.91 64.19 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.56 1.944 . . . . 0.0 114.694 179.309 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -73.32 -18.79 61.16 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.766 1.226 . . . . 0.0 112.86 171.417 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 16.6 m0 -90.52 173.09 8.26 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.454 1.501 . . . . 0.0 111.881 -176.171 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -79.23 53.65 1.52 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.653 1.581 . . . . 0.0 114.36 -176.252 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.1 mt -60.01 -17.87 41.84 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -171.304 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -106.78 -3.16 20.74 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.497 1.119 . . . . 0.0 113.067 177.209 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -149.09 69.33 9.79 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 125.207 1.403 . . . . 0.0 112.122 177.798 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -55.31 145.69 65.46 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.134 2.556 . . . . 0.0 112.44 174.571 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.28 -30.68 68.83 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.711 0.804 . . . . 0.0 111.394 173.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 46.8 t90 -156.62 152.67 27.48 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.225 1.41 . . . . 0.0 111.056 176.076 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.9 p -133.57 152.2 51.86 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.495 -0.753 . . . . 0.0 112.13 166.274 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 176.55 -149.58 9.83 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.139 -0.482 . . . . 0.0 113.558 -175.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 17.5 mtm180 -97.05 148.27 23.18 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.432 1.893 . . . . 0.0 111.677 -175.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.0 tp -91.75 134.5 34.68 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.664 1.185 . . . . 0.0 109.596 163.332 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -127.83 119.53 25.87 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.891 1.276 . . . . 0.0 108.882 160.677 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.5 mt -101.93 130.86 50.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 166.471 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.92 166.48 26.62 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 126.254 1.822 . . . . 0.0 110.028 -166.906 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.9 t -157.21 160.12 38.38 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 121.273 -0.892 . . . . 0.0 112.168 173.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -144.42 122.04 11.82 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.652 0.739 . . . . 0.0 111.809 154.594 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.2 -117.98 9.68 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 125.863 1.697 . . . . 0.0 110.523 -177.551 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -100.2 14.01 32.28 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.917 1.687 . . . . 0.0 113.378 179.11 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.0 m -123.57 108.74 12.95 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.904 0.882 . . . . 0.0 110.285 177.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -83.16 158.94 22.16 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.158 0.504 . . . . 0.0 110.762 169.418 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -138.74 112.89 8.64 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.358 1.863 . . . . 0.0 108.729 -175.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.2 mp -91.98 105.54 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 165.458 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -104.09 135.06 46.28 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.115 1.366 . . . . 0.0 110.798 178.112 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.1 mp -107.06 128.79 54.69 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.616 1.566 . . . . 0.0 109.664 176.438 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -132.69 146.55 51.95 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.943 0.897 . . . . 0.0 112.004 -170.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -69.23 133.13 47.54 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.75 -1.219 . . . . 0.0 111.128 -179.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.5 pttt -77.19 -2.5 34.82 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -176.759 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.07 -42.41 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.42 1.488 . . . . 0.0 111.466 178.64 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.4 m -93.6 -21.07 19.63 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -178.764 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.66 10.07 82.83 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.645 1.117 . . . . 0.0 113.99 -177.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -86.75 149.11 25.1 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.287 1.435 . . . . 0.0 112.512 -172.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.3 tp -72.57 123.92 24.18 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.603 -0.686 . . . . 0.0 111.404 -178.029 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -87.49 -54.47 4.26 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.864 1.265 . . . . 0.0 111.245 171.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.9 163.2 40.64 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.684 1.194 . . . . 0.0 111.691 -177.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -145.84 131.46 18.86 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.505 1.122 . . . . 0.0 111.531 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.33 104.79 49.65 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 125.472 1.509 . . . . 0.0 110.855 178.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -77.22 144.32 23.26 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.053 2.502 . . . . 0.0 111.264 173.149 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.3 t -135.94 131.42 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.727 1.611 . . . . 0.0 109.014 -174.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -96.07 -22.68 17.19 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -179.54 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -163.29 150.67 12.89 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.786 2.034 . . . . 0.0 110.202 173.451 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -122.69 128.42 25.41 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.865 1.266 . . . . 0.0 111.204 177.635 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -63.14 149.49 65.88 Favored 'Cis proline' 0 CA--C 1.541 0.83 0 CA-C-N 119.849 0.982 . . . . 0.0 113.793 -6.344 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.01 -165.99 14.77 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.715 1.626 . . . . 0.0 112.532 178.347 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.7 tt -73.06 -36.86 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 O-C-N 121.698 -0.883 . . . . 0.0 112.867 -179.215 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.63 6.27 18.34 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -167.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.2 t -150.36 132.74 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.639 1.576 . . . . 0.0 110.26 -178.801 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -146.62 161.46 40.5 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.355 1.862 . . . . 0.0 112.331 -175.616 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 20.0 p -111.15 162.97 14.38 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 126.834 2.054 . . . . 0.0 111.719 177.447 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.0 m -87.7 174.8 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.64 1.176 . . . . 0.0 110.543 164.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 73.2 p -96.09 -36.38 11.01 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.147 1.379 . . . . 0.0 112.629 179.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -103.51 -28.33 11.83 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 -161.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.6 t -132.87 127.0 33.47 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.489 1.04 . . . . 0.0 113.51 -177.608 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.6 p -75.79 22.08 0.15 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.914 2.086 . . . . 0.0 116.164 -166.049 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -138.81 26.77 2.48 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 126.245 1.818 . . . . 0.0 114.632 -173.225 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -141.7 141.93 33.32 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.871 1.268 . . . . 0.0 111.735 -175.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -140.09 163.5 32.55 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.053 1.341 . . . . 0.0 111.085 -179.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.2 t -116.47 144.54 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.938 1.295 . . . . 0.0 108.843 166.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.8 149.42 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 118.565 0.621 . . . . 0.0 111.811 171.159 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.453 ' HE ' ' NE2' ' A' ' 97' ' ' GLN . 38.6 ttp180 -91.87 103.14 15.72 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.158 0.583 . . . . 0.0 109.954 173.285 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -84.96 148.29 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.441 1.096 . . . . 0.0 111.434 177.057 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.453 ' NE2' ' HE ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.804 0 C-N-CA 125.863 1.665 . . . . 0.0 111.447 -179.756 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 82.8 p . . . . . 0 N--CA 1.465 0.316 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.62 145.48 30.97 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.983 1.313 . . . . 0.0 110.999 170.38 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -90.13 121.72 32.44 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 166.056 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.8 pt -121.66 144.12 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.823 1.249 . . . . 0.0 110.965 178.698 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -90.7 142.81 16.41 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 173.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.1 pt -126.86 140.58 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 125.404 1.482 . . . . 0.0 111.651 172.104 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.48 138.95 11.83 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.185 1.374 . . . . 0.0 112.93 177.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -100.64 158.21 16.11 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.768 1.627 . . . . 0.0 111.488 -177.505 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.9 t -73.81 -21.56 60.11 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.732 0.813 . . . . 0.0 112.834 178.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -157.89 151.3 23.47 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.473 1.109 . . . . 0.0 111.577 -178.543 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -55.23 -41.64 72.36 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.716 1.207 . . . . 0.0 112.762 174.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.83 -29.08 71.29 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.163 0.887 . . . . 0.0 114.149 -179.275 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -83.72 -36.43 23.68 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.242 1.021 . . . . 0.0 112.103 176.225 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.0 -31.81 73.03 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.562 -0.711 . . . . 0.0 112.524 168.057 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -75.91 5.95 5.79 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 171.214 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -99.38 -32.51 11.12 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.419 -0.801 . . . . 0.0 112.715 157.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -55.88 -50.96 69.2 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.822 1.192 . . . . 0.0 112.458 178.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 48.0 p-10 -70.87 -34.28 71.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.262 1.025 . . . . 0.0 113.617 -179.44 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.1 t -73.91 -39.65 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.383 1.073 . . . . 0.0 110.742 178.825 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 27.6 t -57.28 -38.06 73.34 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.855 1.262 . . . . 0.0 112.63 176.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.7 mt -76.45 -52.53 9.66 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.875 0.87 . . . . 0.0 112.333 176.394 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -65.88 -30.79 71.45 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.409 -0.807 . . . . 0.0 112.999 -175.203 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -88.24 6.3 37.54 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.379 1.072 . . . . 0.0 112.942 176.684 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -94.14 -43.65 8.37 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.498 -0.751 . . . . 0.0 111.97 154.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -85.82 1.1 51.07 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -171.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 -178.754 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.74 147.23 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.343 1.057 . . . . 0.0 113.152 175.76 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.1 mt -123.57 -38.72 2.5 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.727 2.011 . . . . 0.0 110.32 179.804 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.1 t -155.36 147.28 23.39 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.344 1.458 . . . . 0.0 110.686 170.102 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.0 t -136.9 125.28 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.342 1.457 . . . . 0.0 108.906 174.121 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -127.82 143.12 46.49 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 124.63 1.172 . . . . 0.0 112.482 178.392 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.19 -19.34 15.53 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.836 3.024 . . . . 0.0 115.623 -172.834 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -132.25 112.07 11.93 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.9 0.88 . . . . 0.0 111.713 -172.008 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.8 p -145.07 143.58 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.785 1.634 . . . . 0.0 110.074 169.722 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.3 m -126.61 127.78 45.76 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.204 1.001 . . . . 0.0 111.172 -172.843 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 78.7 t -94.91 138.39 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.383 1.473 . . . . 0.0 112.194 -177.652 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -129.2 126.71 39.78 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.026 1.33 . . . . 0.0 109.356 168.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -69.55 119.25 13.51 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 165.454 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.5 pt . . . . . 0 N--CA 1.477 0.894 0 C-N-CA 124.247 1.019 . . . . 0.0 113.304 -167.922 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 . . . . . 0 C--O 1.223 -0.321 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.38 18.12 6.44 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -171.162 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.07 -47.05 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 127.842 2.457 . . . . 0.0 115.591 -171.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.5 m -66.29 -17.08 64.54 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.359 1.864 . . . . 0.0 114.739 -178.623 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -87.04 -2.01 58.31 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.075 0.95 . . . . 0.0 113.261 172.22 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 22.2 m0 -93.0 169.29 10.54 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.319 1.447 . . . . 0.0 110.615 172.866 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.6 mmtm -77.22 53.63 1.02 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.762 1.625 . . . . 0.0 114.445 -178.086 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.8 mt -58.52 -20.94 50.32 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 -175.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -100.79 -4.0 28.87 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 178.753 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -153.19 81.72 5.02 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.914 1.286 . . . . 0.0 111.784 175.041 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.37 145.8 34.85 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.308 2.672 . . . . 0.0 112.936 175.331 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -68.62 -31.54 70.78 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.092 0.557 . . . . 0.0 111.077 169.523 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 42.3 t90 -157.06 156.15 32.36 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.703 1.601 . . . . 0.0 111.057 174.297 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.8 p -135.08 149.46 50.07 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.277 1.031 . . . . 0.0 112.276 169.157 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.42 -143.94 6.17 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 123.289 0.471 . . . . 0.0 113.631 179.586 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.3 mtm105 -107.94 150.68 26.78 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.61 1.964 . . . . 0.0 112.093 -175.604 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.7 tp -94.71 138.18 32.86 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.485 1.914 . . . . 0.0 110.513 173.211 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -134.77 106.39 6.89 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.494 1.518 . . . . 0.0 109.684 165.26 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.3 mt -87.18 130.64 36.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 166.16 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.88 164.93 29.13 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.817 1.647 . . . . 0.0 110.739 -169.366 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.4 t -159.0 157.02 30.45 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.572 1.149 . . . . 0.0 111.009 171.54 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.4 mmtt -147.62 128.6 14.5 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.027 0.931 . . . . 0.0 110.782 152.728 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.43 -125.49 7.36 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 125.841 1.686 . . . . 0.0 110.054 -177.332 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -104.44 22.62 14.59 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.638 1.575 . . . . 0.0 112.78 177.389 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.6 m -127.47 123.17 35.37 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.995 1.318 . . . . 0.0 109.678 178.633 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.29 162.1 13.82 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.164 0.986 . . . . 0.0 110.791 169.487 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -140.93 112.74 7.65 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.041 1.736 . . . . 0.0 108.758 -176.326 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -89.88 105.41 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 167.28 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -108.84 141.93 40.16 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.893 1.277 . . . . 0.0 111.286 179.138 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.3 mp -111.69 131.1 55.52 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 126.047 1.739 . . . . 0.0 110.347 178.877 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -126.04 154.16 43.4 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.347 1.059 . . . . 0.0 113.441 -171.685 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -72.7 141.98 48.21 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 122.093 0.949 . . . . 0.0 111.611 174.254 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -83.99 -2.83 57.35 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 -176.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.7 t -126.43 -39.77 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.572 1.149 . . . . 0.0 111.871 -179.212 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.6 m -110.8 -15.57 13.78 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -172.14 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.97 21.83 79.56 Favored Glycine 0 CA--C 1.535 1.307 0 O-C-N 121.823 -0.548 . . . . 0.0 113.966 -179.702 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -63.63 160.75 16.17 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.683 1.193 . . . . 0.0 111.43 171.556 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.3 tp -93.92 120.54 34.31 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.048 0.939 . . . . 0.0 109.653 169.049 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -83.46 -54.3 5.07 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.479 0.712 . . . . 0.0 111.255 173.257 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.13 163.86 37.19 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.565 1.146 . . . . 0.0 111.973 -178.463 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -144.72 134.8 24.0 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.882 1.273 . . . . 0.0 111.841 179.477 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.74 100.88 43.32 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.482 1.513 . . . . 0.0 111.189 178.834 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -68.96 142.1 50.49 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 124.123 3.216 . . . . 0.0 112.559 172.203 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.0 t -136.31 130.89 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 126.003 1.721 . . . . 0.0 109.697 -176.528 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -92.65 -23.24 19.05 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.76 149.69 13.07 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.438 1.895 . . . . 0.0 110.234 172.118 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -115.37 131.01 23.82 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 124.526 1.13 . . . . 0.0 111.346 175.374 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.26 149.19 81.33 Favored 'Cis proline' 0 CA--C 1.542 0.92 0 CA-C-N 119.929 1.01 . . . . 0.0 112.574 -6.567 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.15 -176.88 36.41 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.561 1.077 . . . . 0.0 114.155 -179.022 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.9 tp -56.89 -32.38 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 125.184 1.394 . . . . 0.0 114.55 -171.459 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.85 4.82 52.03 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -171.485 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.6 t -148.2 128.83 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.334 1.054 . . . . 0.0 110.898 179.829 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.75 164.33 30.4 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.682 1.993 . . . . 0.0 112.43 -171.574 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 72.8 p -123.26 160.81 25.83 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.957 1.703 . . . . 0.0 111.697 -173.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.5 m -90.21 175.3 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 124.512 1.125 . . . . 0.0 111.202 169.374 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.6 p -94.99 -34.94 12.17 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.464 1.506 . . . . 0.0 112.867 178.567 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -89.5 -42.25 11.57 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -165.349 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.2 t -142.27 125.19 16.12 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -177.217 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.9 m -70.51 9.19 0.67 Allowed 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -173.261 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.45 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.315 44.8 ptt85 -97.14 19.71 12.53 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.179 1.392 . . . . 0.0 114.75 173.795 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -140.14 136.33 33.41 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.774 1.23 . . . . 0.0 110.993 -175.585 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -135.55 162.45 32.66 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.971 1.308 . . . . 0.0 111.01 -179.752 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.1 t -117.15 142.02 32.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 124.504 1.122 . . . . 0.0 108.71 166.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.15 147.56 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 118.962 0.801 . . . . 0.0 111.875 173.344 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -88.61 88.01 7.46 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.187 0.595 . . . . 0.0 110.661 177.33 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -71.55 137.74 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 120.797 0.332 . . . . 0.0 110.789 176.897 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 . . . . . 0 N--CA 1.468 0.449 0 C-N-CA 126.047 1.739 . . . . 0.0 111.233 -169.185 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 94.2 p . . . . . 0 CA--C 1.535 0.37 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.03 146.18 30.86 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.8 1.64 . . . . 0.0 110.848 167.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -94.04 119.39 32.84 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.278 0.631 . . . . 0.0 109.926 170.28 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.6 pt -117.63 143.14 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.449 1.099 . . . . 0.0 111.062 176.606 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.04 144.22 17.9 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 174.013 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.8 pt -129.42 140.86 48.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 125.563 1.545 . . . . 0.0 111.674 171.348 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -116.47 144.62 18.49 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.258 1.408 . . . . 0.0 112.884 174.256 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -106.46 153.61 22.03 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 126.013 1.725 . . . . 0.0 111.215 178.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.1 t -74.36 -18.07 60.73 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.017 0.927 . . . . 0.0 113.115 -178.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -154.56 145.32 22.44 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.61 1.164 . . . . 0.0 111.116 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -66.29 -30.91 71.43 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 179.787 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.76 -33.02 86.13 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-N 119.083 0.856 . . . . 0.0 113.328 173.381 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -80.69 -30.78 36.37 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.619 -0.93 . . . . 0.0 112.381 175.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.45 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -67.43 -37.26 82.75 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 167.697 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -61.23 -41.34 96.71 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.637 -0.664 . . . . 0.0 110.964 168.195 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.66 -34.18 77.28 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 121.452 -0.78 . . . . 0.0 112.709 175.652 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -59.78 -55.53 33.09 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.298 1.039 . . . . 0.0 112.194 168.496 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.65 -24.98 62.8 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -177.921 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.1 t -73.15 -41.65 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 121.422 -0.799 . . . . 0.0 110.942 172.059 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.0 m -64.71 -16.25 62.63 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 177.369 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.4 mt -88.51 -55.42 3.73 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.604 1.162 . . . . 0.0 112.427 167.793 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -69.05 -33.71 74.01 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.829 -1.17 . . . . 0.0 113.595 -173.032 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -86.9 5.62 36.03 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.665 1.186 . . . . 0.0 112.189 176.147 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -97.22 -42.59 7.74 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.664 0.786 . . . . 0.0 112.048 160.22 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -84.9 -2.98 58.5 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -174.897 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 -177.569 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.0 m . . . . . 0 N--CA 1.468 0.457 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.8 p -66.33 147.81 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.193 0.997 . . . . 0.0 112.077 175.843 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.6 mt -132.9 -37.9 1.0 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.673 1.589 . . . . 0.0 112.493 -171.853 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 35.0 t -153.34 137.52 16.5 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.691 1.196 . . . . 0.0 110.585 173.706 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 87.9 t -130.97 126.49 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.654 1.181 . . . . 0.0 109.226 171.708 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -129.2 136.41 29.11 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 125.443 1.497 . . . . 0.0 110.76 176.652 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -81.42 -13.69 10.85 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.267 2.645 . . . . 0.0 115.405 -171.819 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -131.08 105.52 7.77 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.249 1.02 . . . . 0.0 110.945 -175.781 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.0 p -141.77 140.14 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.972 1.309 . . . . 0.0 110.367 172.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.6 m -125.73 126.91 45.37 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.587 1.155 . . . . 0.0 110.979 -171.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 79.1 t -92.85 137.74 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.356 1.462 . . . . 0.0 111.92 -178.848 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -130.83 132.64 45.33 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.945 1.298 . . . . 0.0 109.885 169.5 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -60.22 131.96 52.44 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.256 0.622 . . . . 0.0 109.732 157.398 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.9 pt . . . . . 0 N--CA 1.477 0.892 0 C-N-CA 124.666 1.187 . . . . 0.0 112.431 -173.833 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 . . . . . 0 CA--C 1.532 0.286 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.88 19.42 5.55 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -170.372 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.95 -46.15 0.06 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 128.453 2.701 . . . . 0.0 115.655 -174.632 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 90.9 p -64.04 -18.49 64.38 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.854 2.062 . . . . 0.0 114.61 179.626 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.52 -9.12 59.77 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.077 0.951 . . . . 0.0 113.144 174.054 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 16.7 m0 -92.88 170.58 9.57 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.22 1.408 . . . . 0.0 110.881 177.226 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.1 mtmm -80.28 54.53 2.01 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.041 1.337 . . . . 0.0 113.749 -177.844 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.0 mt -54.66 -29.3 52.11 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 -171.208 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -90.62 -10.67 42.41 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.033 0.933 . . . . 0.0 112.714 179.178 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -139.52 60.42 16.49 Favored Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 126.303 1.841 . . . . 0.0 110.842 -161.487 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -64.66 140.11 66.67 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 120.648 0.899 . . . . 0.0 111.966 -173.225 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -70.52 -26.91 63.79 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.79 0.836 . . . . 0.0 111.445 176.774 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 42.6 t90 -156.96 154.21 29.31 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.552 1.541 . . . . 0.0 111.023 170.08 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.4 p -134.15 144.95 48.84 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.312 1.045 . . . . 0.0 112.083 171.478 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.89 -143.69 5.17 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 123.497 0.57 . . . . 0.0 113.812 -178.087 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 34.8 mtm105 -117.92 148.59 42.01 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.818 2.047 . . . . 0.0 111.193 -172.576 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.7 tp -92.68 141.84 28.03 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.175 1.79 . . . . 0.0 111.029 176.208 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -142.47 99.08 3.42 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.926 1.69 . . . . 0.0 109.716 169.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.1 mt -85.98 133.8 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 169.693 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.04 168.15 22.28 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.093 1.757 . . . . 0.0 110.495 -168.286 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.2 t -157.17 150.75 24.23 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.741 -1.225 . . . . 0.0 112.087 173.658 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -149.86 134.19 17.33 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.53 151.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.34 50.28 33.69 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.513 1.054 . . . . 0.0 114.814 164.6 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt 60.06 26.88 16.26 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.075 1.75 . . . . 0.0 113.347 -175.765 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.5 m -130.67 124.06 30.76 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 126.028 1.731 . . . . 0.0 108.035 170.142 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -92.94 159.83 15.16 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.647 0.779 . . . . 0.0 110.585 170.183 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -139.04 106.39 5.53 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.149 1.78 . . . . 0.0 108.518 -172.669 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.3 mp -87.37 104.29 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 168.646 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -104.9 138.79 40.6 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.937 1.295 . . . . 0.0 111.121 177.508 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.9 mp -110.23 131.24 55.23 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.814 1.646 . . . . 0.0 109.933 176.596 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -130.38 149.85 51.87 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.558 1.143 . . . . 0.0 112.1 -173.713 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -75.28 152.46 38.24 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.007 -1.058 . . . . 0.0 112.455 177.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.499 ' H ' ' HD3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -93.79 -0.61 55.78 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.131 1.773 . . . . 0.0 115.486 -176.829 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.8 t -118.73 -45.8 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.207 1.403 . . . . 0.0 111.378 173.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.3 m -97.24 -21.22 17.4 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -173.714 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.72 6.81 85.51 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.085 0.85 . . . . 0.0 113.886 -177.466 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -79.3 151.25 31.19 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.045 1.338 . . . . 0.0 112.462 -174.513 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.6 tp -72.52 126.82 30.78 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.769 0.828 . . . . 0.0 110.924 178.361 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -86.66 -55.32 3.92 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.425 1.09 . . . . 0.0 111.265 170.688 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.39 160.67 39.85 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.852 1.261 . . . . 0.0 111.58 -178.349 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -141.65 136.22 30.73 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.75 0.82 . . . . 0.0 112.721 177.091 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.99 98.08 47.7 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 125.96 1.704 . . . . 0.0 111.482 -179.068 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -62.52 140.29 80.91 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 124.33 3.353 . . . . 0.0 113.042 166.002 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.1 t -136.43 126.47 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 126.453 1.901 . . . . 0.0 109.223 -178.493 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -86.69 -25.82 24.6 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 121.27 -0.894 . . . . 0.0 113.289 -178.054 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.31 151.15 15.14 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.102 1.761 . . . . 0.0 110.808 173.594 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -122.57 129.82 24.9 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.653 1.181 . . . . 0.0 111.174 176.486 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -62.65 148.2 59.79 Favored 'Cis proline' 0 CA--C 1.539 0.746 0 CA-C-N 119.982 1.029 . . . . 0.0 113.754 -6.14 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.29 -164.38 15.26 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.48 1.514 . . . . 0.0 112.702 179.772 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.0 tt -75.21 -38.32 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -177.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.06 6.51 16.04 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -167.424 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 25.1 t -149.03 132.09 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 125.992 1.717 . . . . 0.0 109.522 178.13 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.24 161.43 38.92 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.006 1.722 . . . . 0.0 111.94 -177.199 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.9 p -110.16 165.67 11.57 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.427 1.491 . . . . 0.0 111.373 177.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.7 m -87.05 179.51 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.469 0.707 . . . . 0.0 110.473 160.116 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 71.0 p -101.23 -30.01 11.77 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.614 1.566 . . . . 0.0 113.543 177.884 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -90.24 -42.77 10.81 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -167.604 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.2 t -143.31 125.12 15.08 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -176.26 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.04 -3.85 14.71 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -170.471 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.414 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.286 0.9 OUTLIER -86.68 22.86 1.81 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.56 1.544 . . . . 0.0 114.615 174.434 . . . . . . . . 4 4 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -142.24 133.25 25.91 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.633 1.173 . . . . 0.0 111.703 -179.575 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -136.07 162.94 31.51 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.373 1.469 . . . . 0.0 111.587 179.347 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 55.2 t -117.14 142.91 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.877 1.271 . . . . 0.0 109.044 168.597 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.62 148.72 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 118.835 0.743 . . . . 0.0 112.47 173.48 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -86.11 85.33 7.36 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.096 0.959 . . . . 0.0 110.406 175.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -68.82 140.31 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 121.945 -0.472 . . . . 0.0 110.428 172.311 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 . . . . . 0 N--CA 1.468 0.435 0 C-N-CA 125.704 1.602 . . . . 0.0 111.087 -171.038 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 38.3 p . . . . . 0 N--CA 1.467 0.416 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -137.3 150.03 47.49 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.646 1.578 . . . . 0.0 110.635 162.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -95.32 113.06 24.69 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.497 0.719 . . . . 0.0 109.346 170.177 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 32.2 pt -112.41 146.36 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.62 1.168 . . . . 0.0 111.109 -179.617 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -92.33 142.99 16.26 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 174.271 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 34.3 pt -128.45 139.76 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 125.171 1.388 . . . . 0.0 111.56 172.552 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -118.45 143.96 17.8 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.69 1.614 . . . . 0.0 112.567 174.197 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -105.31 161.39 14.33 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.806 1.642 . . . . 0.0 111.812 -176.373 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.3 t -72.7 -27.63 62.19 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.62 0.768 . . . . 0.0 113.055 178.132 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -156.05 150.75 26.03 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.165 0.986 . . . . 0.0 112.152 -178.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 47.3 ttt-85 -62.27 -34.84 77.31 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.555 1.142 . . . . 0.0 113.107 178.446 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.16 -26.72 73.99 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 118.814 0.734 . . . . 0.0 113.698 176.084 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -85.56 -32.84 21.91 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.048 0.939 . . . . 0.0 111.821 173.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.414 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -67.76 -32.18 72.59 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 170.914 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -57.68 -36.57 72.1 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.547 -0.721 . . . . 0.0 112.074 172.356 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -66.18 -29.27 69.51 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.207 -0.933 . . . . 0.0 112.999 176.431 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -62.38 -47.99 81.72 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.473 1.033 . . . . 0.0 112.032 174.029 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -83.33 -25.22 31.68 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.345 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.0 t -78.45 -42.09 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 121.36 -0.838 . . . . 0.0 111.486 177.07 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 92.4 p -65.07 -28.56 69.55 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 179.666 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.3 mt -72.23 -54.41 9.68 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.98 0.912 . . . . 0.0 111.658 170.742 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -68.42 -33.96 75.14 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.028 -1.045 . . . . 0.0 113.102 -173.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -86.44 7.33 26.31 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.309 1.044 . . . . 0.0 112.538 175.986 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -102.72 -35.73 8.56 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.056 0.943 . . . . 0.0 112.42 161.885 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -88.6 -3.35 58.82 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -179.508 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.263 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -175.278 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 86.4 t -68.79 143.06 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.651 1.18 . . . . 0.0 111.854 -176.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.6 mt -125.19 -40.98 2.09 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.908 1.683 . . . . 0.0 112.168 -176.278 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 49.9 t -153.2 135.01 14.58 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.563 1.145 . . . . 0.0 110.664 172.091 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 74.1 t -127.88 127.59 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.677 1.191 . . . . 0.0 109.261 170.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -127.87 134.8 26.6 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 124.861 1.264 . . . . 0.0 111.035 174.602 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -63.17 -26.14 72.69 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.084 2.522 . . . . 0.0 114.328 178.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -111.82 129.18 56.23 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.349 1.46 . . . . 0.0 113.228 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.4 p -157.64 142.3 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 126.327 1.851 . . . . 0.0 108.886 158.789 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.7 m -124.4 134.83 52.99 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.361 1.065 . . . . 0.0 110.493 -178.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 86.2 t -103.18 134.87 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.819 1.248 . . . . 0.0 111.751 -177.773 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.75 118.92 11.99 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.997 1.319 . . . . 0.0 109.096 172.859 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -63.4 130.46 44.56 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.983 0.913 . . . . 0.0 110.618 176.46 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.6 pt . . . . . 0 N--CA 1.474 0.748 0 C-N-CA 124.645 1.178 . . . . 0.0 112.669 -173.758 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.18 21.19 11.85 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -176.104 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.18 -50.26 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.856 2.462 . . . . 0.0 114.879 -168.421 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.3 m -63.63 -13.89 46.64 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.61 1.964 . . . . 0.0 114.692 -178.474 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.53 -24.0 58.9 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.697 1.199 . . . . 0.0 112.506 172.77 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 12.5 m0 -88.25 168.47 12.69 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.068 1.747 . . . . 0.0 111.499 -174.753 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.3 mtpp -77.45 53.82 1.09 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.836 1.654 . . . . 0.0 113.402 176.861 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.5 mt -55.76 -38.23 69.56 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.84 1.256 . . . . 0.0 114.017 -173.375 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -87.12 -3.84 59.1 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.518 1.127 . . . . 0.0 113.029 179.444 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -136.74 63.64 47.07 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 126.339 1.856 . . . . 0.0 111.561 -166.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -68.9 148.15 69.97 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 CA-C-N 119.916 1.006 . . . . 0.0 113.103 -169.689 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -69.49 -31.12 69.19 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.901 0.88 . . . . 0.0 111.355 168.626 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 39.6 t90 -161.25 155.68 23.04 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.667 1.987 . . . . 0.0 110.414 177.432 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 55.5 p -135.28 147.81 49.33 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.835 1.254 . . . . 0.0 112.002 171.361 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.11 -142.36 5.27 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.177 0.418 . . . . 0.0 114.064 179.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.3 mtm180 -106.91 145.27 32.4 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.434 1.894 . . . . 0.0 111.619 -174.596 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.7 tp -82.46 138.49 34.36 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.714 0.806 . . . . 0.0 109.544 163.428 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.6 ttt-85 -145.75 90.76 2.02 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 122.159 0.981 . . . . 0.0 111.333 163.307 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.0 mt -73.6 128.3 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 170.444 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.2 p -134.79 175.96 9.09 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.958 2.103 . . . . 0.0 110.642 -177.248 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.7 t -156.53 148.94 23.42 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.687 -1.258 . . . . 0.0 111.118 173.78 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -150.77 132.11 14.6 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.358 0.663 . . . . 0.0 112.76 154.168 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.12 51.13 19.48 Favored Glycine 0 N--CA 1.474 1.213 0 C-N-CA 124.561 1.076 . . . . 0.0 114.298 169.092 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 59.3 23.47 11.9 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 126.412 1.885 . . . . 0.0 113.326 -175.619 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.5 m -130.79 111.65 12.33 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 125.2 1.4 . . . . 0.0 108.733 176.494 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.93 159.36 24.96 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.073 0.463 . . . . 0.0 110.371 172.389 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -137.98 107.24 6.08 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.787 1.635 . . . . 0.0 108.577 -176.187 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.5 mp -78.36 96.63 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 106.463 -1.681 . . . . 0.0 106.463 167.177 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -95.67 137.99 33.96 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.168 0.587 . . . . 0.0 111.479 174.601 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.6 mp -110.43 129.77 55.7 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.066 1.746 . . . . 0.0 110.183 177.024 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -132.9 149.77 52.22 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -166.384 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -65.98 142.5 57.82 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.986 -1.071 . . . . 0.0 112.788 179.02 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.34 -3.78 35.48 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 116.955 2.206 . . . . 0.0 116.955 -177.959 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.1 t -117.59 -45.04 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.506 1.122 . . . . 0.0 111.822 174.289 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.7 m -117.2 -4.82 11.38 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -169.759 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.5 15.15 79.19 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 123.871 0.748 . . . . 0.0 114.245 176.638 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -61.33 131.72 51.23 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.906 1.683 . . . . 0.0 111.308 -177.267 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 39.0 tp -69.78 115.92 9.57 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 122.782 0.433 . . . . 0.0 111.146 -178.104 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -81.36 -53.87 5.95 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.439 1.095 . . . . 0.0 111.085 173.088 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.55 160.93 38.68 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.064 1.346 . . . . 0.0 111.206 -178.971 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -141.87 137.14 31.19 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.758 0.823 . . . . 0.0 112.572 174.776 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.65 103.72 50.35 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.136 1.374 . . . . 0.0 111.182 177.6 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -67.9 140.97 52.08 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 124.17 3.247 . . . . 0.0 112.65 172.015 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.2 t -135.3 126.63 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.788 1.635 . . . . 0.0 109.464 -177.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -90.24 -24.32 20.99 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 179.704 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -161.59 150.0 15.5 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.696 1.999 . . . . 0.0 110.401 172.44 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -121.63 132.38 24.24 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.74 1.216 . . . . 0.0 111.57 176.403 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -62.15 147.21 54.06 Favored 'Cis proline' 0 CA--C 1.541 0.854 0 CA-C-N 119.874 0.991 . . . . 0.0 113.583 -7.153 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.63 -172.49 32.17 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.632 1.11 . . . . 0.0 113.954 -178.722 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.2 tp -61.87 -34.92 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -171.619 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.05 4.62 49.68 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -169.062 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.8 t -149.04 126.48 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.414 1.086 . . . . 0.0 110.539 -178.645 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -139.43 158.57 43.91 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.799 2.04 . . . . 0.0 111.775 -172.698 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.1 p -113.52 163.52 14.82 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.579 1.952 . . . . 0.0 111.381 -179.051 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.2 m -88.8 178.67 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.255 1.422 . . . . 0.0 109.769 165.496 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.2 t -105.16 -23.81 12.85 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.707 1.203 . . . . 0.0 113.604 179.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -88.65 -51.17 5.82 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -174.673 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.3 t -139.37 129.79 25.61 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -174.56 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.66 -2.86 12.89 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -171.562 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.474 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.299 31.4 ptt180 -84.78 15.65 3.77 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 178.061 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -140.36 136.77 33.49 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.203 1.401 . . . . 0.0 110.768 -172.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -138.48 165.43 26.86 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.271 1.429 . . . . 0.0 111.281 -178.634 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.5 t -118.49 141.53 37.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 124.7 1.2 . . . . 0.0 108.745 165.547 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.8 148.11 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 119.036 0.835 . . . . 0.0 112.516 171.711 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -89.17 82.41 6.59 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.794 0.838 . . . . 0.0 111.1 177.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -67.72 141.96 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 121.01 0.433 . . . . 0.0 111.04 176.04 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 . . . . . 0 N--CA 1.468 0.454 0 C-N-CA 125.831 1.653 . . . . 0.0 111.307 -170.296 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 65.0 p . . . . . 0 CA--C 1.533 0.314 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.95 147.54 32.81 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.367 1.467 . . . . 0.0 110.873 168.249 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -92.15 115.4 28.05 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.421 0.689 . . . . 0.0 109.316 169.355 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 28.8 pt -112.7 141.73 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.379 1.072 . . . . 0.0 110.747 179.419 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.15 139.73 15.38 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 175.954 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.2 pt -129.49 155.37 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 125.259 1.424 . . . . 0.0 111.952 172.351 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -148.48 166.29 29.13 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 114.421 0.528 . . . . 0.0 114.421 168.57 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -116.73 162.76 17.18 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.995 1.718 . . . . 0.0 111.388 -175.378 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.3 t -70.54 -22.9 62.56 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.462 0.705 . . . . 0.0 112.455 175.635 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -152.76 147.24 25.84 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.798 0.839 . . . . 0.0 112.537 -174.267 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 47.1 ttt-85 -62.61 -32.61 73.65 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.694 1.198 . . . . 0.0 113.152 179.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.26 -27.21 73.84 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-N 118.908 0.776 . . . . 0.0 113.851 176.649 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -84.33 -36.2 22.71 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 118.074 0.937 . . . . 0.0 111.658 175.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.474 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -65.17 -32.34 73.98 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 168.564 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -59.32 -37.48 77.89 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.264 -0.898 . . . . 0.0 111.98 173.279 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -67.19 -31.42 71.81 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.194 -0.941 . . . . 0.0 112.847 176.013 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -58.6 -50.91 72.09 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.295 0.952 . . . . 0.0 111.545 171.667 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.2 -24.28 30.15 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -176.302 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.3 t -78.46 -40.37 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 O-C-N 121.068 -1.02 . . . . 0.0 110.954 176.641 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 95.0 p -63.75 -28.86 70.17 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 177.411 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 78.5 mt -72.14 -52.97 14.18 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.182 0.993 . . . . 0.0 111.923 172.307 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -68.58 -31.17 70.18 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.993 -1.067 . . . . 0.0 113.22 -176.112 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -87.88 2.14 52.24 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.641 1.176 . . . . 0.0 112.492 174.383 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -92.03 -40.02 11.32 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 120.74 -1.225 . . . . 0.0 111.992 163.975 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -89.31 -1.73 58.18 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 -174.518 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.104 0 CA-C-N 120.25 1.386 . . . . 0.0 114.524 -175.07 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.4 m . . . . . 0 N--CA 1.468 0.432 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.9 t -63.57 141.68 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 124.496 1.118 . . . . 0.0 111.717 178.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.4 mt -126.94 -39.9 1.92 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.992 1.717 . . . . 0.0 112.54 -177.369 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.0 t -152.27 133.06 14.06 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.412 1.085 . . . . 0.0 110.821 174.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 81.1 t -128.67 128.13 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.394 1.078 . . . . 0.0 109.319 171.822 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -130.49 134.79 26.46 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 125.293 1.437 . . . . 0.0 110.337 176.429 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -77.35 -13.96 16.58 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.285 2.657 . . . . 0.0 114.76 -174.347 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -134.37 106.57 7.15 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.404 1.082 . . . . 0.0 111.236 -174.125 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -143.69 144.64 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.144 1.378 . . . . 0.0 110.205 171.078 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.0 m -118.0 140.66 49.42 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.354 1.062 . . . . 0.0 111.388 -176.485 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 66.1 t -105.76 138.28 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.726 1.61 . . . . 0.0 111.792 175.741 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -125.1 127.99 47.76 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.47 1.508 . . . . 0.0 108.995 170.67 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -76.58 111.62 12.25 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 165.111 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.7 pt . . . . . 0 N--CA 1.475 0.808 0 C-N-CA 124.492 1.117 . . . . 0.0 113.286 -164.185 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 . . . . . 0 CA--C 1.533 0.32 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.405 ' HE ' ' CG ' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -122.66 25.03 8.93 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.046 0.938 . . . . 0.0 113.385 178.796 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 60.42 -44.81 0.1 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.569 2.347 . . . . 0.0 114.936 -172.269 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.6 m -63.92 -13.14 43.27 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.738 2.015 . . . . 0.0 114.26 177.122 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.405 ' CG ' ' HE ' ' A' ' 32' ' ' ARG . 43.5 m-20 -59.03 -30.6 68.15 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.834 0.853 . . . . 0.0 112.839 164.95 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 9.2 m0 -99.24 171.23 8.13 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.035 1.334 . . . . 0.0 112.592 -164.447 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -78.86 49.34 0.9 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.377 1.871 . . . . 0.0 113.87 -178.531 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.8 mt -54.86 -35.07 63.63 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -166.635 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -94.79 -1.87 52.02 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.203 1.001 . . . . 0.0 113.644 179.552 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -145.46 73.76 14.04 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 125.573 1.549 . . . . 0.0 112.019 179.658 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.85 148.16 38.63 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.515 2.81 . . . . 0.0 113.736 178.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -71.93 -31.54 66.45 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.247 0.619 . . . . 0.0 111.295 168.269 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 48.7 t90 -154.3 154.37 33.26 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.846 1.659 . . . . 0.0 110.869 174.793 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.4 p -133.36 148.37 51.85 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.109 0.964 . . . . 0.0 111.674 169.004 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.51 -141.76 4.69 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 116.366 -0.379 . . . . 0.0 113.433 -178.804 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.7 mtm105 -114.32 144.97 42.4 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.152 1.781 . . . . 0.0 111.92 -172.901 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.1 tp -85.34 139.98 31.14 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.26 1.424 . . . . 0.0 109.822 168.386 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.1 ttt85 -145.5 86.64 1.75 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.699 1.199 . . . . 0.0 110.866 168.245 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.0 mt -74.33 127.74 36.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 170.649 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 p -136.51 171.68 14.14 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.854 2.062 . . . . 0.0 110.188 -178.663 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.7 t -156.7 148.89 23.12 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 120.632 -1.292 . . . . 0.0 111.674 177.866 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -153.59 128.26 9.39 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.723 0.809 . . . . 0.0 112.193 161.418 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.35 54.12 18.0 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.316 0.96 . . . . 0.0 114.231 166.344 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 93.8 mttt 60.02 25.75 15.01 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 126.249 1.82 . . . . 0.0 113.31 -176.059 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.8 m -136.22 114.45 11.57 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.25 1.42 . . . . 0.0 109.429 177.875 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.7 159.78 19.06 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.559 0.743 . . . . 0.0 110.775 173.872 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -139.89 105.31 5.07 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.099 1.76 . . . . 0.0 108.725 -175.727 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.4 mp -79.99 91.99 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 167.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -86.01 138.18 32.16 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.221 0.608 . . . . 0.0 110.421 173.167 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.4 mp -112.17 133.33 54.37 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.125 1.77 . . . . 0.0 109.645 173.103 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -135.14 153.47 51.98 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -172.269 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -73.92 144.61 45.26 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.946 0.879 . . . . 0.0 111.94 179.614 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.4 pttt -85.36 -6.18 59.25 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.368 1.867 . . . . 0.0 115.125 -178.635 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 92.6 t -122.47 -44.61 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.234 1.414 . . . . 0.0 111.437 178.648 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.2 m -92.32 -23.06 19.38 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -175.296 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.96 7.16 86.48 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 123.973 0.797 . . . . 0.0 113.702 -177.452 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -82.7 154.51 24.8 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.288 1.435 . . . . 0.0 112.473 -175.082 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.5 tp -73.45 127.18 31.99 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.371 0.668 . . . . 0.0 110.827 177.337 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -84.47 -54.99 4.38 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.427 1.091 . . . . 0.0 110.922 170.098 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -159.5 165.85 32.12 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.689 1.596 . . . . 0.0 110.562 179.755 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -144.99 142.49 29.84 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 168.706 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.78 111.53 48.5 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.071 1.348 . . . . 0.0 111.378 177.729 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -82.85 140.29 10.18 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.57 2.847 . . . . 0.0 111.502 176.961 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.26 128.61 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.396 1.478 . . . . 0.0 109.857 -174.449 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -90.64 -24.26 20.55 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 178.274 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -164.31 149.37 10.15 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.144 1.778 . . . . 0.0 110.411 171.569 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.408 ' CD2' ' HA ' ' A' ' 78' ' ' PRO . 82.5 t80 -125.75 130.28 24.09 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.819 1.248 . . . . 0.0 111.53 -177.554 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.408 ' HA ' ' CD2' ' A' ' 77' ' ' TYR . 73.5 Cg_endo -66.51 143.89 65.54 Favored 'Cis proline' 0 CA--C 1.54 0.801 0 CA-C-N 120.267 1.131 . . . . 0.0 113.353 -2.077 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.02 -168.34 29.06 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.12 1.343 . . . . 0.0 113.637 -176.607 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.3 tp -59.08 -39.64 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -169.659 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -89.31 3.84 50.78 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -167.395 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.6 t -151.54 124.18 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.392 1.077 . . . . 0.0 110.82 -176.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -141.39 167.07 23.04 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.626 1.97 . . . . 0.0 112.863 -176.264 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 73.1 p -121.25 158.62 27.72 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.503 1.521 . . . . 0.0 112.061 -169.807 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.3 m -84.62 168.12 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.839 0.856 . . . . 0.0 110.676 166.584 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 72.3 p -96.74 -24.94 15.71 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.956 1.302 . . . . 0.0 113.642 179.532 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -98.69 -38.97 8.89 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -166.21 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.6 t -138.87 124.12 19.17 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -173.905 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.2 m -74.54 26.1 0.08 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 -168.226 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.456 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.265 34.3 ptt180 -125.29 18.69 8.26 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.631 1.572 . . . . 0.0 114.923 179.851 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -140.28 142.6 35.7 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.404 1.082 . . . . 0.0 112.167 -171.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -141.7 158.2 44.11 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.189 1.396 . . . . 0.0 111.933 -176.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.2 t -110.68 137.93 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.939 0.895 . . . . 0.0 108.812 163.555 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.88 146.73 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 119.263 0.938 . . . . 0.0 112.018 172.472 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -91.16 92.54 8.72 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.379 0.672 . . . . 0.0 110.124 175.737 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -74.49 152.72 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.07 0.548 . . . . 0.0 111.229 176.09 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.459 0 C-N-CA 125.488 1.515 . . . . 0.0 111.171 173.865 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 95.3 p . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.96 146.1 28.84 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.989 1.315 . . . . 0.0 111.226 172.124 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -87.9 121.11 29.92 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 166.147 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.8 pt -119.32 144.93 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.82 1.248 . . . . 0.0 110.58 176.295 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.04 141.33 16.24 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 174.355 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.6 pt -126.33 144.49 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 124.548 1.139 . . . . 0.0 112.503 168.961 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -125.67 138.27 10.77 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 124.857 1.218 . . . . 0.0 113.244 177.923 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -102.91 163.6 12.12 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.849 1.66 . . . . 0.0 109.998 166.541 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.9 t -92.91 -20.65 20.43 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 175.559 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -109.15 -18.75 13.56 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -149.47 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 60.49 -48.72 0.1 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.914 2.086 . . . . 0.0 114.134 -161.236 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.44 -31.2 66.12 Favored Glycine 0 CA--C 1.539 1.564 0 CA-C-N 119.578 1.081 . . . . 0.0 114.176 174.575 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -81.0 -32.01 34.41 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.35 -1.088 . . . . 0.0 112.466 175.648 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -68.57 -32.69 72.78 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 168.112 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -60.67 -47.49 86.04 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.588 0.755 . . . . 0.0 110.204 166.767 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -60.3 -42.2 95.01 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 118.703 0.683 . . . . 0.0 112.356 177.19 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -53.09 -54.81 30.1 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.811 1.244 . . . . 0.0 112.566 174.125 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -82.4 -26.04 33.17 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -174.71 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.3 t -75.92 -40.97 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 121.6 -0.687 . . . . 0.0 110.898 177.823 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 91.4 p -64.05 -29.81 70.92 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 175.217 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.5 mt -68.81 -59.09 3.33 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.087 0.955 . . . . 0.0 111.779 170.168 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -64.94 -30.98 72.0 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -172.791 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -83.25 -4.15 58.14 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.648 1.179 . . . . 0.0 112.721 178.218 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -95.32 -11.71 27.36 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.94 -1.1 . . . . 0.0 113.39 165.639 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -110.42 -6.02 15.05 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 179.376 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.176 0 CA-C-N 121.182 1.81 . . . . 0.0 113.896 -176.521 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.449 -0.498 0 CA-C-O 121.909 0.862 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.9 t -57.83 139.41 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 125.401 1.48 . . . . 0.0 112.088 -174.062 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.3 mt -125.5 -40.36 2.1 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.682 1.593 . . . . 0.0 112.14 -176.353 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 33.0 t -154.41 136.06 14.36 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.495 1.118 . . . . 0.0 110.678 176.926 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.3 t -130.68 125.79 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.421 1.088 . . . . 0.0 109.239 172.42 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -131.61 142.98 47.28 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 124.68 1.192 . . . . 0.0 112.021 176.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.01 -19.08 20.82 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.535 2.824 . . . . 0.0 115.048 -174.951 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -135.15 112.52 10.56 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.777 0.831 . . . . 0.0 112.279 -167.509 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.3 p -149.64 143.27 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.209 1.803 . . . . 0.0 109.902 171.191 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.9 m -120.71 129.23 53.57 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.351 1.06 . . . . 0.0 111.19 -174.272 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.1 t -93.0 140.47 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.331 1.452 . . . . 0.0 111.929 178.57 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -121.62 129.09 52.58 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.659 1.184 . . . . 0.0 109.628 168.655 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 -78.8 73.9 5.33 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.46 1.504 . . . . 0.0 109.841 172.143 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.7 pt . . . . . 0 CA--C 1.545 0.77 0 C-N-CA 125.629 1.572 . . . . 0.0 114.468 -164.516 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 . . . . . 0 CA--C 1.535 0.372 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.24 17.88 5.46 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -171.77 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.89 -45.84 0.06 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 127.75 2.42 . . . . 0.0 115.679 -175.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.2 m -69.41 -14.46 62.91 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.689 1.596 . . . . 0.0 113.908 -177.318 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.88 -13.31 60.54 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 169.786 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -95.88 171.65 8.51 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.462 1.505 . . . . 0.0 111.613 -174.59 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -79.57 53.81 1.65 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.383 1.473 . . . . 0.0 113.941 -178.463 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 69.3 mt -61.35 -14.85 30.57 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -172.842 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -107.02 -4.51 18.9 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.455 1.102 . . . . 0.0 112.782 177.03 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -150.26 77.18 8.31 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 125.083 1.353 . . . . 0.0 111.653 176.258 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -50.11 141.99 28.95 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.171 2.581 . . . . 0.0 112.462 175.245 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -72.09 -27.72 62.83 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.071 0.548 . . . . 0.0 111.577 175.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 33.4 t90 -154.26 156.54 37.21 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.937 1.695 . . . . 0.0 110.738 168.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.9 p -133.97 146.18 50.21 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.623 1.169 . . . . 0.0 111.978 170.327 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 176.77 -142.65 5.97 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 114.536 0.574 . . . . 0.0 114.536 177.213 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -106.22 143.83 33.79 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 126.603 1.961 . . . . 0.0 111.547 -169.822 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.0 tp -88.4 138.18 31.66 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.468 1.507 . . . . 0.0 110.154 170.21 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -143.93 96.77 2.95 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.396 1.078 . . . . 0.0 110.788 168.461 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.0 mt -82.06 129.03 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 172.364 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.46 160.57 38.05 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 127.38 2.272 . . . . 0.0 109.738 -177.703 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.618 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 8.7 t -161.37 160.8 29.99 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 120.811 -1.181 . . . . 0.0 111.079 177.517 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -129.22 -106.01 0.29 Allowed 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.142 -0.974 . . . . 0.0 111.499 -174.526 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.59 -116.68 0.21 Allowed Glycine 0 N--CA 1.472 1.072 0 C-N-CA 124.489 1.042 . . . . 0.0 111.134 169.42 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -86.12 25.16 1.2 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.693 1.197 . . . . 0.0 113.118 174.366 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.5 m -137.55 123.0 19.58 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.8 0.84 . . . . 0.0 110.589 -178.312 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.26 164.16 12.25 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.232 1.413 . . . . 0.0 111.706 172.5 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -145.89 103.59 3.77 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.744 1.618 . . . . 0.0 110.054 -172.574 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.7 mp -82.06 101.52 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 169.071 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -102.78 140.8 36.58 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.863 0.84 . . . . 0.0 111.519 176.413 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.3 mp -112.12 132.93 54.58 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.434 1.894 . . . . 0.0 110.045 179.508 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -133.79 151.2 51.5 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.897 0.879 . . . . 0.0 112.518 -168.31 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -69.82 144.0 52.74 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 120.812 -1.18 . . . . 0.0 113.175 -175.409 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.67 -3.79 36.6 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 116.666 2.099 . . . . 0.0 116.666 -179.365 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.1 t -118.8 -50.44 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.749 1.22 . . . . 0.0 110.892 172.622 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.0 m -96.9 -18.15 19.68 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -170.245 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.22 12.6 76.29 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.317 0.96 . . . . 0.0 113.759 -175.672 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -79.97 150.83 30.34 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.079 1.352 . . . . 0.0 112.005 -176.603 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 32.5 tp -71.34 122.16 19.81 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.85 0.86 . . . . 0.0 111.797 -171.663 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -84.64 -56.25 3.7 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.272 1.029 . . . . 0.0 110.877 169.547 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.81 163.24 40.08 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.973 1.309 . . . . 0.0 111.537 -179.042 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -143.85 132.82 22.78 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.603 1.161 . . . . 0.0 111.561 -179.351 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.56 97.78 49.41 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 124.721 1.208 . . . . 0.0 111.236 176.009 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -58.03 136.29 74.04 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 124.085 3.19 . . . . 0.0 112.288 163.065 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.7 t -132.24 123.54 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 126.528 1.931 . . . . 0.0 108.885 -178.42 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -91.56 -19.32 22.88 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 121.413 -0.804 . . . . 0.0 112.781 -177.405 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -163.64 143.21 8.3 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.831 2.452 . . . . 0.0 109.425 -178.584 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -135.92 121.93 13.9 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-O 118.375 -0.822 . . . . 0.0 111.301 175.291 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -61.92 149.45 57.75 Favored 'Cis proline' 0 CA--C 1.539 0.758 0 CA-C-N 119.956 1.02 . . . . 0.0 114.504 -1.648 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -170.96 -158.29 14.58 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 126.016 1.769 . . . . 0.0 112.442 -177.109 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.3 tt -79.17 -39.03 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -176.556 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.35 4.49 17.72 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -168.145 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.9 t -152.02 129.01 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 126.028 1.731 . . . . 0.0 109.744 179.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -141.05 160.26 40.47 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.05 1.74 . . . . 0.0 112.24 176.656 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.6 p -101.23 159.39 15.29 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.988 1.715 . . . . 0.0 111.589 175.324 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.4 m -81.28 169.34 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 O-C-N 121.587 -0.696 . . . . 0.0 110.523 162.418 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.5 p -98.31 -24.69 15.12 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.168 1.387 . . . . 0.0 113.587 -178.278 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -100.84 -40.41 7.32 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -167.136 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.5 t -134.41 116.15 14.84 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -175.038 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.6 m -73.59 24.93 0.07 Allowed 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 116.159 1.911 . . . . 0.0 116.159 -165.386 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.4 ' HA ' ' CB ' ' A' ' 116' ' ' ALA . 4.9 ptm180 -127.3 23.43 6.42 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 127.309 2.244 . . . . 0.0 113.875 -178.915 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -140.82 143.94 35.09 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.756 1.623 . . . . 0.0 111.955 -177.124 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -142.04 161.24 38.49 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.251 1.42 . . . . 0.0 111.496 -178.299 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 89.0 t -114.73 139.67 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.403 1.081 . . . . 0.0 109.112 166.455 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.64 147.83 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 118.667 0.667 . . . . 0.0 112.085 173.808 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -89.51 89.33 7.8 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.838 0.855 . . . . 0.0 110.745 178.322 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.1 pp -71.32 140.38 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 122.542 0.337 . . . . 0.0 111.172 175.616 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 . . . . . 0 N--CA 1.472 0.629 0 C-N-CA 125.999 1.72 . . . . 0.0 111.718 -172.769 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.9 p . . . . . 0 CA--C 1.534 0.342 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.91 149.1 34.7 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.661 1.584 . . . . 0.0 110.964 170.021 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -94.05 117.36 30.0 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.465 0.706 . . . . 0.0 109.308 169.122 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 17.8 pt -116.61 147.41 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.595 1.158 . . . . 0.0 111.046 177.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -87.73 146.15 19.8 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 172.394 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.2 pt -129.02 145.51 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 125.388 1.475 . . . . 0.0 111.488 167.167 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.61 146.53 16.96 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 125.097 1.332 . . . . 0.0 113.518 177.163 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -108.47 164.48 12.3 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.286 1.834 . . . . 0.0 111.77 178.605 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.6 t -73.88 -25.49 60.06 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.056 0.942 . . . . 0.0 112.906 177.049 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -156.41 154.68 30.86 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.759 1.224 . . . . 0.0 111.924 -176.229 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -57.45 -35.62 70.37 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.253 1.021 . . . . 0.0 112.82 175.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.25 -35.97 92.36 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 119.48 1.036 . . . . 0.0 113.406 -179.802 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -80.19 -35.48 36.28 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 117.988 0.894 . . . . 0.0 112.265 177.256 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.4 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -62.88 -39.45 94.51 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 169.237 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -68.67 -33.54 74.15 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.065 -1.022 . . . . 0.0 111.877 174.403 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -68.2 -36.87 80.24 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 119.365 0.984 . . . . 0.0 112.417 173.731 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -57.91 -45.59 86.26 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.134 1.374 . . . . 0.0 111.65 168.649 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -74.95 -38.16 61.79 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.713 1.205 . . . . 0.0 113.252 -176.399 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.9 t -77.73 -39.75 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 O-C-N 121.213 -0.93 . . . . 0.0 111.599 -179.088 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 78.7 p -64.79 -30.78 71.8 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.236 -0.915 . . . . 0.0 113.125 177.248 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 44.4 tp -73.12 -49.17 29.85 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.805 1.242 . . . . 0.0 111.689 175.331 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -70.52 -23.53 62.66 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.248 -0.907 . . . . 0.0 113.434 -178.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -79.42 -1.04 35.41 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.378 1.071 . . . . 0.0 112.418 175.572 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.618 ' CD2' ' HG ' ' A' ' 51' ' ' SER . 45.2 t60 -87.94 -35.3 17.74 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.325 -0.859 . . . . 0.0 112.708 157.504 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -89.29 -5.55 57.48 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 -172.819 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 115.81 1.782 . . . . 0.0 115.81 -175.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.612 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 56.9 m -129.51 112.46 17.89 Favored Pre-proline 0 N--CA 1.477 0.882 0 C-N-CA 124.857 1.263 . . . . 0.0 111.099 -174.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -81.1 2.16 8.78 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 123.946 3.097 . . . . 0.0 113.796 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -68.32 -4.12 13.29 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.337 1.855 . . . . 0.0 114.893 -168.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 61.8 p -68.34 -15.74 63.67 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.203 1.401 . . . . 0.0 113.836 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.3 mtm -129.88 151.29 50.6 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.599 1.56 . . . . 0.0 111.746 174.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.44 -42.99 0.1 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.846 1.258 . . . . 0.0 112.532 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 63.4 m -107.83 101.18 10.48 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.269 1.428 . . . . 0.0 108.351 171.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -129.42 19.53 5.77 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.051 1.341 . . . . 0.0 114.109 -168.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.95 48.1 0.69 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.961 1.704 . . . . 0.0 112.548 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -97.29 52.91 1.14 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.221 1.808 . . . . 0.0 110.334 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -150.03 142.03 23.92 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.566 1.546 . . . . 0.0 109.543 -174.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -176.41 128.55 0.2 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.69 1.596 . . . . 0.0 108.606 167.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.3 m -89.62 110.9 21.73 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 165.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.2 p -68.45 144.81 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 121.557 -0.714 . . . . 0.0 112.544 178.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.5 mt -129.5 -39.81 1.46 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.685 1.594 . . . . 0.0 112.508 -172.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 45.2 t -152.7 134.74 14.85 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.693 1.197 . . . . 0.0 110.384 173.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 94.6 t -130.28 127.24 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.363 1.065 . . . . 0.0 109.68 171.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -131.62 142.07 43.98 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 124.496 1.118 . . . . 0.0 112.206 173.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.6 -15.46 19.45 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.851 3.034 . . . . 0.0 114.972 -175.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -135.48 108.28 7.54 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.072 0.949 . . . . 0.0 111.653 -170.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 p -145.49 144.62 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 125.522 1.529 . . . . 0.0 110.213 171.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.1 m -126.04 129.15 48.58 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.12 0.968 . . . . 0.0 111.371 -171.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.5 t -96.05 136.82 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.738 1.615 . . . . 0.0 112.294 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -129.86 127.92 41.21 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.39 1.476 . . . . 0.0 109.407 170.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -70.1 123.76 22.4 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.359 0.664 . . . . 0.0 109.491 165.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.6 pt -99.12 157.3 34.31 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 124.785 1.234 . . . . 0.0 113.57 -168.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -66.6 156.74 64.2 Favored 'Trans proline' 0 CA--C 1.548 1.215 0 C-N-CA 122.795 2.33 . . . . 0.0 111.425 160.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.58 147.4 70.26 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.221 2.614 . . . . 0.0 112.61 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -68.46 139.52 55.72 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.698 1.199 . . . . 0.0 112.067 -176.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -159.84 137.75 10.05 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.67 1.188 . . . . 0.0 110.196 162.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.9 m -63.83 -17.45 63.14 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.519 1.527 . . . . 0.0 114.614 -175.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -73.78 -10.61 59.85 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.414 1.086 . . . . 0.0 113.287 171.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.3 ptt-85 -128.36 -45.78 1.35 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.789 1.635 . . . . 0.0 113.653 174.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.68 159.59 2.33 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.656 1.122 . . . . 0.0 112.262 -169.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 17.7 m-30 -72.06 119.14 15.82 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 156.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.86 19.84 10.92 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -174.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 56.81 -48.33 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.932 2.493 . . . . 0.0 115.455 -170.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.9 m -67.58 -15.07 63.46 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.294 1.838 . . . . 0.0 114.85 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.82 -15.99 56.35 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.701 0.8 . . . . 0.0 112.502 172.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 17.9 m0 -86.22 169.52 12.96 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.382 1.473 . . . . 0.0 111.178 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -78.88 57.25 2.09 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.189 1.796 . . . . 0.0 114.211 -177.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.7 mt -61.75 -20.35 63.44 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -95.49 -12.97 24.96 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.509 1.124 . . . . 0.0 112.592 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -152.09 69.72 7.62 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 125.61 1.564 . . . . 0.0 112.265 -165.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -54.37 147.22 47.59 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.471 2.781 . . . . 0.0 113.358 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -72.51 -29.3 63.49 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.195 0.598 . . . . 0.0 111.427 168.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.2 t90 -156.95 154.58 29.92 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.37 1.468 . . . . 0.0 111.058 173.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.2 p -133.93 148.82 51.25 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.239 1.015 . . . . 0.0 111.81 168.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.37 -142.88 5.69 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 123.067 0.365 . . . . 0.0 113.48 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.7 mtm105 -110.51 148.19 32.61 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.305 1.842 . . . . 0.0 112.103 -173.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.0 tp -92.91 137.85 32.0 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.22 1.808 . . . . 0.0 110.277 172.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.6 ttt85 -143.98 88.71 1.98 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.043 1.337 . . . . 0.0 110.869 169.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 25.2 mt -75.78 127.63 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 170.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.1 p -138.62 170.39 16.08 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.664 1.986 . . . . 0.0 110.071 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.9 t -157.85 159.46 36.68 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.804 -1.185 . . . . 0.0 112.198 175.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -146.86 120.76 9.32 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.775 0.798 . . . . 0.0 111.843 159.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.43 -119.65 11.79 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 125.753 1.644 . . . . 0.0 110.139 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -95.55 13.49 25.97 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.6 1.56 . . . . 0.0 113.708 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.0 m -127.58 110.78 13.05 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.934 0.894 . . . . 0.0 111.063 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.85 159.46 19.07 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.405 0.682 . . . . 0.0 111.364 171.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -139.76 105.98 5.25 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.302 1.841 . . . . 0.0 109.252 -174.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.7 mp -82.61 97.55 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 168.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.4 mttp -94.31 139.29 31.27 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.38 0.672 . . . . 0.0 111.448 174.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.5 mp -112.34 135.51 52.94 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.445 1.898 . . . . 0.0 109.775 172.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -136.15 153.67 51.2 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.941 0.896 . . . . 0.0 113.018 -172.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -74.12 143.94 45.12 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.931 0.872 . . . . 0.0 111.969 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 pttt -84.87 -6.46 59.35 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.371 1.868 . . . . 0.0 115.124 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 92.0 t -122.4 -44.58 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 125.234 1.414 . . . . 0.0 111.396 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.7 m -91.72 -23.5 19.76 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -175.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.33 7.04 86.91 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 123.776 0.703 . . . . 0.0 113.586 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -82.81 155.55 24.13 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.327 1.451 . . . . 0.0 112.326 -175.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.7 tp -72.31 125.98 28.69 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.372 0.669 . . . . 0.0 110.684 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -84.51 -53.9 5.11 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.944 0.898 . . . . 0.0 110.915 169.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.34 161.3 37.6 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.067 1.347 . . . . 0.0 111.357 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -142.67 139.89 31.37 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.391 0.676 . . . . 0.0 112.382 171.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.98 110.54 41.57 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 124.854 1.261 . . . . 0.0 111.135 176.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -80.52 140.45 13.39 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.894 3.063 . . . . 0.0 111.565 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.1 t -134.83 131.26 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.805 1.642 . . . . 0.0 109.817 -172.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -97.47 -19.8 18.18 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -163.53 150.46 12.31 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.97 2.108 . . . . 0.0 110.085 175.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -125.57 130.67 24.01 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.558 1.143 . . . . 0.0 112.452 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -60.46 151.29 50.81 Favored 'Cis proline' 0 CA--C 1.54 0.781 0 CA-C-N 119.919 1.007 . . . . 0.0 113.313 -12.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.35 -171.35 29.49 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.909 1.242 . . . . 0.0 113.485 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.6 tp -59.29 -31.51 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.54 4.27 53.9 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -172.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.7 t -148.98 130.35 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.162 0.985 . . . . 0.0 111.233 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -140.39 162.4 35.41 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.325 1.85 . . . . 0.0 112.545 -176.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 38.8 p -117.33 158.03 25.09 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 127.1 2.16 . . . . 0.0 111.587 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.0 m -85.21 173.46 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.556 1.142 . . . . 0.0 111.385 168.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 72.5 p -94.49 -32.5 13.47 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.238 1.415 . . . . 0.0 113.17 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -94.59 -40.91 9.59 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -163.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.5 t -141.02 130.35 23.68 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -175.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.1 m -73.01 16.38 0.16 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -171.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.457 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.28 33.5 ptt180 -111.44 18.5 19.1 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 178.631 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -139.32 135.55 33.9 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.078 0.951 . . . . 0.0 110.842 -172.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -133.77 163.81 28.63 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.907 1.283 . . . . 0.0 111.016 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.7 t -120.6 142.59 35.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 124.583 1.153 . . . . 0.0 108.744 167.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.89 148.0 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 118.721 0.692 . . . . 0.0 112.425 173.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -89.88 81.77 6.28 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.675 0.79 . . . . 0.0 111.369 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -67.09 142.52 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 122.577 0.351 . . . . 0.0 111.372 177.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -138.3 148.32 44.53 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.733 1.613 . . . . 0.0 111.68 -171.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -94.04 2.75 55.99 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.393 1.077 . . . . 0.0 113.106 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.23 13.17 81.25 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.155 1.36 . . . . 0.0 114.68 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.9 t -139.04 15.37 2.64 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.579 1.552 . . . . 0.0 113.469 -171.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.32 -2.46 78.32 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.547 1.07 . . . . 0.0 114.953 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -74.76 135.17 41.76 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.318 1.447 . . . . 0.0 108.567 164.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.2 p -148.57 158.47 44.15 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 171.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.76 145.76 31.83 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.282 1.433 . . . . 0.0 110.869 169.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -90.66 118.36 30.04 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.131 0.573 . . . . 0.0 109.485 168.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.4 pt -117.27 141.54 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.306 1.042 . . . . 0.0 110.753 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.9 143.41 17.07 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 174.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.0 pt -128.87 140.86 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 125.341 1.456 . . . . 0.0 111.679 173.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -119.66 143.91 17.24 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.042 1.306 . . . . 0.0 113.338 175.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -106.88 167.86 9.59 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.352 1.861 . . . . 0.0 111.032 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.8 t -71.78 -36.09 70.23 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.738 -0.601 . . . . 0.0 112.304 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -153.07 153.32 32.61 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.204 -0.935 . . . . 0.0 112.299 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -58.07 -36.69 73.16 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.652 1.181 . . . . 0.0 112.096 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.95 -13.42 64.11 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 123.916 0.77 . . . . 0.0 114.408 177.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -102.44 -34.07 9.29 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 118.431 1.115 . . . . 0.0 112.376 170.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.457 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -64.07 -29.97 71.07 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.088 -1.008 . . . . 0.0 113.253 170.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -54.95 -33.35 62.21 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.603 -0.686 . . . . 0.0 112.289 168.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -69.25 -33.75 73.74 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.087 -1.008 . . . . 0.0 112.028 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -60.56 -50.32 74.03 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.143 0.977 . . . . 0.0 111.475 171.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.49 -26.27 45.91 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -177.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.5 t -77.39 -43.25 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 119.301 0.955 . . . . 0.0 111.246 175.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 96.7 p -64.85 -31.03 72.07 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.36 0.982 . . . . 0.0 113.103 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.7 mt -69.03 -54.89 12.75 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.063 0.945 . . . . 0.0 112.061 170.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -67.22 -29.71 69.44 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.055 -1.028 . . . . 0.0 112.978 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -82.84 -2.7 55.39 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.566 1.147 . . . . 0.0 112.672 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 63.9 t60 -88.39 -42.6 12.07 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.391 -0.818 . . . . 0.0 111.812 157.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -84.44 -7.24 59.35 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -172.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.25 -35.79 38.74 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 120.971 1.714 . . . . 0.0 115.366 -173.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 39.9 p-90 -75.78 -34.29 60.2 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.464 0.706 . . . . 0.0 112.897 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.7 t -67.2 -34.19 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.836 1.255 . . . . 0.0 110.5 171.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -80.51 5.3 15.62 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.091 2.156 . . . . 0.0 114.257 174.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 55.2 29.96 13.66 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 127.732 2.413 . . . . 0.0 115.587 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 . . . . . 0 C--O 1.253 1.241 0 C-N-CA 125.25 1.42 . . . . 0.0 113.911 177.471 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.651 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 43.8 m -66.63 145.83 98.99 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 124.302 1.041 . . . . 0.0 112.845 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -77.75 -9.16 17.05 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.623 2.882 . . . . 0.0 113.867 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -138.49 167.4 22.0 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.147 1.779 . . . . 0.0 111.959 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 18.5 m -91.0 5.09 50.2 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -171.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.2 mmm -82.2 57.92 3.79 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.907 -1.121 . . . . 0.0 112.418 -174.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.05 -11.41 18.15 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.682 1.593 . . . . 0.0 112.829 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.5 m 50.08 68.62 0.72 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 127.004 2.122 . . . . 0.0 112.843 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -101.73 19.54 17.96 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -163.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.79 50.33 0.69 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.416 1.886 . . . . 0.0 112.372 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -93.54 51.72 1.63 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.114 1.766 . . . . 0.0 110.946 -177.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -151.12 143.21 24.01 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.329 1.452 . . . . 0.0 110.351 -174.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -176.84 125.42 0.16 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.666 1.586 . . . . 0.0 109.099 171.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.8 m -92.86 109.2 20.64 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.817 0.847 . . . . 0.0 109.446 168.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.0 t -63.75 142.49 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 124.005 0.922 . . . . 0.0 111.761 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.7 mt -128.31 -43.56 1.45 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.309 1.443 . . . . 0.0 112.592 -176.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 34.2 t -148.39 135.16 19.91 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.379 1.072 . . . . 0.0 111.037 175.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.1 t -128.55 128.03 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.734 1.214 . . . . 0.0 109.539 172.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -124.9 135.28 26.53 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 125.577 1.551 . . . . 0.0 109.774 172.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -73.54 -29.57 10.8 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.918 2.412 . . . . 0.0 115.179 -168.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -138.16 114.92 10.64 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.263 1.03 . . . . 0.0 111.86 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.2 p -143.43 149.01 18.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 127.788 2.435 . . . . 0.0 109.004 176.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.2 m -123.3 132.02 53.86 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.257 0.623 . . . . 0.0 112.17 -167.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.7 t -96.24 138.21 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.837 1.655 . . . . 0.0 111.904 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -130.19 136.77 49.61 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.139 -1.392 . . . . 0.0 110.31 171.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -56.6 137.43 53.78 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.296 151.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.3 pt -109.09 151.0 41.72 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 125.182 1.393 . . . . 0.0 111.258 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -70.19 162.57 41.79 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.426 2.751 . . . . 0.0 111.919 172.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -61.46 130.6 32.46 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.971 2.447 . . . . 0.0 111.806 176.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.3 ttm-85 -73.54 148.82 42.67 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.313 1.045 . . . . 0.0 112.57 -174.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.1 156.16 39.32 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.169 153.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.4 m -65.77 -26.64 67.8 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.751 1.621 . . . . 0.0 113.832 -177.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -78.13 -1.84 34.56 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.453 1.101 . . . . 0.0 112.958 171.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -112.53 -60.62 1.84 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.483 1.913 . . . . 0.0 110.193 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.88 161.23 0.85 Allowed Glycine 0 CA--C 1.528 0.856 0 CA-C-O 122.133 0.852 . . . . 0.0 111.963 -163.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 18.8 m-30 -77.61 124.12 27.52 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 121.647 -0.914 . . . . 0.0 109.224 163.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.66 16.35 9.53 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -172.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.65 -46.5 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 128.152 2.581 . . . . 0.0 115.547 -171.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 94.5 p -68.41 -18.59 64.48 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.536 1.935 . . . . 0.0 115.082 -176.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -85.94 -1.95 57.81 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.22 1.008 . . . . 0.0 113.402 171.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.9 m0 -90.72 174.12 7.66 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.925 1.29 . . . . 0.0 110.952 174.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -76.67 47.98 0.53 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.855 1.662 . . . . 0.0 114.646 -176.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.2 mt -56.4 -33.55 65.87 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 -169.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -91.5 -2.51 57.18 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -145.74 71.99 13.86 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 125.868 1.667 . . . . 0.0 111.994 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -52.5 138.11 57.38 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.513 2.142 . . . . 0.0 112.088 174.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -73.09 -25.24 60.81 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.11 0.564 . . . . 0.0 111.194 172.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 50.4 t90 -155.84 154.08 30.74 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.69 1.596 . . . . 0.0 110.801 170.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.8 p -134.28 151.29 51.19 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.663 0.785 . . . . 0.0 112.001 165.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 173.04 -149.66 11.52 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 123.155 0.407 . . . . 0.0 113.484 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.0 mtt180 -94.35 141.15 28.91 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.227 1.811 . . . . 0.0 111.609 -174.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 24.9 tp -79.22 138.04 37.65 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 157.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.7 ttt-85 -144.82 87.47 1.85 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.234 1.016 . . . . 0.0 110.905 167.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.5 mt -72.44 127.07 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 172.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.5 p -134.19 165.02 26.07 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.697 1.999 . . . . 0.0 109.933 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.4 m -147.57 161.56 40.87 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.807 1.243 . . . . 0.0 112.212 175.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -150.6 118.09 6.09 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.307 0.643 . . . . 0.0 111.482 157.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 65.14 -132.23 36.22 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.034 1.302 . . . . 0.0 110.635 -175.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -85.92 22.65 1.64 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.902 1.681 . . . . 0.0 113.922 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.1 m -131.71 126.66 35.08 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.768 1.227 . . . . 0.0 110.282 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.63 160.04 14.59 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.659 1.184 . . . . 0.0 110.94 168.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -142.07 105.43 4.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.372 1.869 . . . . 0.0 108.986 -173.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.3 mp -81.03 95.99 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 169.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -92.04 137.95 31.94 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.274 0.63 . . . . 0.0 110.813 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.8 mp -112.43 128.88 56.44 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.814 1.646 . . . . 0.0 109.723 174.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -135.66 148.83 49.1 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.157 0.983 . . . . 0.0 111.639 -169.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -69.31 139.86 54.32 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 120.432 -1.417 . . . . 0.0 111.72 -176.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.5 pttt -79.74 -4.56 52.47 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -177.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.8 t -123.06 -43.59 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 125.297 1.439 . . . . 0.0 111.363 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.4 m -94.42 -21.97 18.59 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.41 15.37 77.2 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.143 0.878 . . . . 0.0 113.788 -176.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -88.5 148.44 24.15 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.212 1.405 . . . . 0.0 112.056 -176.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.6 tp -71.59 126.78 30.57 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.445 -0.784 . . . . 0.0 111.272 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -84.83 -58.9 2.52 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.055 0.942 . . . . 0.0 110.552 168.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.84 165.8 35.41 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.109 1.363 . . . . 0.0 111.369 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -142.46 143.0 32.41 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.333 0.653 . . . . 0.0 112.47 171.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.37 105.85 41.19 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 124.871 1.268 . . . . 0.0 110.99 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -77.22 145.06 23.92 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.792 2.995 . . . . 0.0 111.948 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.2 t -138.03 127.36 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 126.245 1.818 . . . . 0.0 109.58 -172.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -91.32 -22.77 20.37 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.66 147.83 13.93 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.412 1.885 . . . . 0.0 110.437 170.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -116.33 129.97 24.83 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.589 1.156 . . . . 0.0 110.956 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.83 149.09 79.9 Favored 'Cis proline' 0 CA--C 1.543 0.946 0 CA-C-N 119.824 0.973 . . . . 0.0 112.733 -6.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.68 -164.38 13.14 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.6 1.571 . . . . 0.0 112.548 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 19.3 tt -72.42 -35.58 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 121.654 -0.909 . . . . 0.0 112.979 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.67 6.26 21.55 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -167.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.0 t -151.37 129.18 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.508 1.523 . . . . 0.0 109.984 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -141.77 162.22 36.01 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.217 1.807 . . . . 0.0 112.86 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.5 p -109.75 160.35 16.4 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.792 2.037 . . . . 0.0 111.431 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.4 m -85.95 175.45 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 124.477 1.111 . . . . 0.0 111.398 168.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 71.8 p -91.18 -36.84 13.72 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.954 1.702 . . . . 0.0 112.098 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -89.33 -43.59 10.82 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -166.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.6 t -142.45 122.45 13.65 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -171.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.58 -9.06 23.38 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -169.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.438 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.305 49.0 ptt85 -84.73 19.33 2.07 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 178.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -139.13 139.94 37.78 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.479 1.512 . . . . 0.0 111.977 -176.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -140.66 162.21 35.94 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.437 1.495 . . . . 0.0 111.683 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 78.6 t -116.14 142.27 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.372 1.069 . . . . 0.0 109.294 166.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.67 147.3 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 118.98 0.809 . . . . 0.0 112.399 173.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -88.91 82.5 6.71 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.833 0.853 . . . . 0.0 111.187 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.5 pt -63.36 144.71 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 120.819 0.342 . . . . 0.0 111.696 174.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -137.04 140.39 42.02 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.661 1.584 . . . . 0.0 110.868 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -90.46 15.52 10.57 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.474 1.11 . . . . 0.0 113.573 -175.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.22 11.56 71.17 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 125.124 1.345 . . . . 0.0 115.669 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.9 t -134.25 -0.39 3.01 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.998 1.319 . . . . 0.0 114.462 -168.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 103.43 25.47 7.35 Favored Glycine 0 CA--C 1.536 1.376 0 O-C-N 120.836 -1.165 . . . . 0.0 114.288 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -132.49 144.28 50.34 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.103 2.161 . . . . 0.0 110.107 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.1 p -148.21 160.22 43.16 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -171.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.15 145.16 29.45 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.941 1.296 . . . . 0.0 111.389 171.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -90.66 114.53 26.85 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.794 0.837 . . . . 0.0 109.322 170.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.4 pt -115.01 148.73 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.875 1.27 . . . . 0.0 111.228 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.04 143.91 16.91 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 174.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.7 pt -128.24 144.01 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 125.386 1.474 . . . . 0.0 111.34 169.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.16 139.6 11.08 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.888 1.233 . . . . 0.0 112.967 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -101.17 157.18 16.96 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.814 1.646 . . . . 0.0 111.466 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.1 t -73.52 -20.27 60.7 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.911 0.884 . . . . 0.0 112.822 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -152.24 148.79 27.98 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.526 1.13 . . . . 0.0 111.935 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 47.4 ttt-85 -63.04 -31.53 72.68 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.642 1.177 . . . . 0.0 113.503 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.52 -31.76 79.67 Favored Glycine 0 CA--C 1.536 1.365 0 CA-C-N 119.039 0.836 . . . . 0.0 113.572 176.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -78.39 -35.44 47.19 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.771 -0.841 . . . . 0.0 111.407 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.438 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -65.97 -37.13 85.17 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.926 0.891 . . . . 0.0 113.209 168.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.21 -40.44 97.48 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.508 -0.745 . . . . 0.0 111.25 171.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -62.33 -36.76 83.2 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.592 1.087 . . . . 0.0 112.55 172.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -57.42 -56.33 23.3 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.392 0.996 . . . . 0.0 112.017 171.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -75.7 -24.68 56.26 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -176.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.5 -38.68 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 121.058 -1.027 . . . . 0.0 110.773 173.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 41.2 t -57.67 -38.55 75.3 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.406 0.683 . . . . 0.0 112.529 176.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.9 -52.32 20.81 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.456 0.702 . . . . 0.0 112.36 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -67.57 -28.48 67.81 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.045 -1.034 . . . . 0.0 113.064 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -83.91 0.1 49.15 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.581 1.152 . . . . 0.0 112.724 175.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -89.51 -39.97 12.97 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.253 -0.904 . . . . 0.0 112.284 161.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -91.99 -1.92 57.0 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -172.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.77 -30.02 55.56 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -177.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -83.47 -24.55 31.75 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.211 1.004 . . . . 0.0 113.374 176.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 19.6 t -80.93 -31.37 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.404 1.482 . . . . 0.0 111.097 176.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -92.46 26.99 2.41 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.718 2.007 . . . . 0.0 112.925 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -79.05 89.22 4.79 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.824 0.821 . . . . 0.0 109.954 172.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 . . . . . 0 C--O 1.252 1.226 0 C-N-CA 126.672 1.989 . . . . 0.0 112.737 -172.088 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.585 0 N-CA-C 111.64 -0.584 . . . . 0.0 111.64 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 56.3 m -133.5 147.93 66.69 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 125.389 1.476 . . . . 0.0 111.573 -177.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -76.12 -9.34 19.19 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.509 2.806 . . . . 0.0 114.295 -176.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -59.9 -28.58 67.7 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.505 1.122 . . . . 0.0 113.506 -173.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 77.6 p -63.38 -19.1 64.36 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.467 1.107 . . . . 0.0 113.969 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.9 mtp -76.24 -3.12 34.81 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.696 1.198 . . . . 0.0 113.254 174.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.19 -37.73 0.87 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.28 1.432 . . . . 0.0 112.706 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 51.2 m -137.79 108.32 6.55 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.058 1.343 . . . . 0.0 110.269 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -141.79 19.1 2.16 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.814 1.245 . . . . 0.0 113.67 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tt -77.77 96.37 4.9 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.913 1.285 . . . . 0.0 111.003 -178.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -136.87 48.84 2.08 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.512 1.525 . . . . 0.0 110.557 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -154.0 151.56 29.51 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.361 1.864 . . . . 0.0 110.308 -172.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -179.22 120.41 0.07 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.597 1.559 . . . . 0.0 108.304 165.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.7 m -94.71 107.97 19.97 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.799 -0.563 . . . . 0.0 110.122 170.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.0 t -65.43 145.83 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.473 1.109 . . . . 0.0 111.409 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.6 mt -129.86 -39.73 1.4 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.124 1.769 . . . . 0.0 112.309 -172.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 37.6 t -152.15 137.38 17.47 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.687 1.195 . . . . 0.0 110.646 174.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 88.5 t -129.77 126.87 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.764 1.226 . . . . 0.0 109.275 171.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -126.78 136.08 28.24 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 125.677 1.591 . . . . 0.0 110.233 174.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -78.9 -15.8 13.05 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.158 2.572 . . . . 0.0 115.037 -173.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -130.89 107.32 9.03 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.379 1.072 . . . . 0.0 110.904 -176.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -140.16 141.5 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 125.475 1.51 . . . . 0.0 109.988 170.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.5 m -124.35 125.84 44.99 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.301 1.04 . . . . 0.0 111.12 -171.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.7 t -92.4 136.72 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.064 1.346 . . . . 0.0 111.79 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -126.46 128.6 47.21 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.942 1.297 . . . . 0.0 109.284 169.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -65.33 133.68 51.93 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 160.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.6 pt -109.22 148.42 37.96 Favored Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 124.445 1.098 . . . . 0.0 112.483 -172.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -68.9 163.69 36.5 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.525 2.817 . . . . 0.0 112.453 173.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.76 114.85 2.75 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.934 2.423 . . . . 0.0 110.087 168.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -152.62 166.25 32.67 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.28 1.432 . . . . 0.0 112.93 -165.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.3 125.34 29.22 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 122.254 1.026 . . . . 0.0 111.555 172.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 64.3 p -77.75 -14.09 59.7 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 -157.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -139.37 17.22 2.57 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.943 1.297 . . . . 0.0 112.602 169.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -134.05 -28.45 1.35 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.595 1.558 . . . . 0.0 114.046 -175.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -118.49 -19.26 4.63 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.502 1.049 . . . . 0.0 115.431 -175.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 -67.48 107.01 2.31 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.547 1.173 . . . . 0.0 109.59 164.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.14 20.83 13.56 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.27 -48.94 0.05 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 127.175 2.19 . . . . 0.0 114.672 -163.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.2 m -64.46 -9.17 16.76 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.362 1.865 . . . . 0.0 114.739 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.5 -11.41 59.9 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.645 1.178 . . . . 0.0 112.876 172.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -104.18 175.92 5.33 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.248 1.819 . . . . 0.0 112.499 -171.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -76.92 47.33 0.51 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.715 2.006 . . . . 0.0 114.455 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.6 mt -55.0 -34.3 63.32 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -169.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -95.45 -0.36 52.45 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.134 0.973 . . . . 0.0 113.29 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.37 61.61 10.26 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 126.23 1.812 . . . . 0.0 111.719 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -55.44 136.67 74.84 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.593 2.195 . . . . 0.0 112.034 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -69.64 -26.04 64.22 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.561 1.144 . . . . 0.0 111.666 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.4 t90 -154.86 152.8 30.22 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.683 1.593 . . . . 0.0 110.747 170.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.7 p -134.42 148.79 50.7 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.874 0.87 . . . . 0.0 111.927 169.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.59 -145.34 6.5 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 113.931 0.333 . . . . 0.0 113.931 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -108.82 148.82 29.99 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.29 1.836 . . . . 0.0 111.721 -176.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 61.0 tp -92.92 142.22 27.55 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.099 1.76 . . . . 0.0 110.832 173.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -144.03 94.29 2.56 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.269 1.827 . . . . 0.0 109.494 173.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.9 mt -84.23 134.43 26.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 170.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.24 166.69 26.27 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.037 1.735 . . . . 0.0 110.338 -166.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 99.0 p -156.52 160.5 39.56 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 120.845 -1.159 . . . . 0.0 112.3 175.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -151.04 120.46 6.88 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.472 0.709 . . . . 0.0 112.23 156.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 65.22 -132.12 35.98 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 125.088 1.327 . . . . 0.0 110.502 -176.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -87.19 26.6 1.17 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.637 1.575 . . . . 0.0 113.328 178.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.0 m -132.97 129.65 38.51 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.85 1.26 . . . . 0.0 110.172 173.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.76 160.8 14.15 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.648 1.179 . . . . 0.0 110.577 167.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -140.64 109.61 6.08 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.811 1.644 . . . . 0.0 108.952 -173.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.0 mp -88.08 105.58 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 168.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -107.66 142.38 37.71 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.592 1.157 . . . . 0.0 111.179 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.4 mp -115.23 131.58 56.88 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.429 1.891 . . . . 0.0 109.656 177.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -133.58 148.35 51.59 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.828 0.851 . . . . 0.0 112.614 -174.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -67.47 135.64 53.38 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.065 0.946 . . . . 0.0 111.573 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -75.15 -6.96 52.38 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 -175.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 86.3 t -119.22 -43.72 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.158 1.383 . . . . 0.0 111.389 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.5 m -93.44 -20.15 20.58 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -175.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.8 15.7 76.0 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.279 0.942 . . . . 0.0 113.588 -177.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -90.53 149.92 21.98 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.144 1.378 . . . . 0.0 112.355 -174.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 31.3 tp -70.91 123.89 23.07 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.727 0.811 . . . . 0.0 111.566 -176.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -86.46 -55.24 3.98 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.47 1.108 . . . . 0.0 111.123 170.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.79 162.57 39.73 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.507 1.123 . . . . 0.0 112.146 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -142.71 135.21 27.75 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.052 1.341 . . . . 0.0 111.891 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.0 100.59 42.82 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.534 1.534 . . . . 0.0 111.136 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -68.45 142.07 53.01 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.995 3.13 . . . . 0.0 112.529 170.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.1 t -134.52 130.58 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.868 1.667 . . . . 0.0 109.894 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -86.1 -26.37 25.29 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -164.63 153.89 13.26 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.551 1.54 . . . . 0.0 111.239 169.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -118.02 133.0 23.44 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.883 1.273 . . . . 0.0 111.461 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.37 147.83 75.91 Favored 'Cis proline' 0 CA--C 1.541 0.875 0 CA-C-N 119.899 0.999 . . . . 0.0 112.22 -8.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.9 -175.82 36.69 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.491 1.043 . . . . 0.0 114.058 -177.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.2 tp -53.71 -34.65 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -169.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.04 4.92 52.03 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -172.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.6 t -148.6 127.31 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 CA-C-N 119.409 1.004 . . . . 0.0 111.739 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -140.61 168.93 18.64 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.648 1.979 . . . . 0.0 113.116 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 34.0 p -123.09 158.89 29.66 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.586 1.954 . . . . 0.0 111.59 -171.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.8 m -85.81 173.22 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 O-C-N 121.573 -0.704 . . . . 0.0 112.121 169.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 70.8 p -87.34 -35.93 18.12 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.851 1.26 . . . . 0.0 112.586 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -94.11 -42.4 9.01 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -162.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.4 t -143.33 130.24 20.52 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.3 m -69.3 4.53 1.66 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -172.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.438 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.281 30.2 ptt180 -96.59 17.05 17.15 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 176.1 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -140.15 132.12 27.76 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.181 0.992 . . . . 0.0 110.784 -174.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -137.05 162.53 33.08 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.325 1.45 . . . . 0.0 110.495 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.6 t -121.59 139.3 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.425 1.09 . . . . 0.0 108.717 171.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.29 147.44 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 118.81 0.732 . . . . 0.0 112.536 176.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -90.15 85.92 6.4 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.461 0.705 . . . . 0.0 111.099 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -69.38 139.95 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 122.635 0.374 . . . . 0.0 111.161 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -138.76 144.03 39.25 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.172 1.789 . . . . 0.0 111.429 -170.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -91.25 2.87 56.05 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.082 0.953 . . . . 0.0 113.154 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.24 13.79 80.1 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.17 1.367 . . . . 0.0 114.691 178.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.2 t -140.42 16.51 2.39 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.487 1.515 . . . . 0.0 113.509 -171.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.24 -2.03 80.62 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 124.58 1.086 . . . . 0.0 115.063 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -76.23 134.47 39.83 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.345 1.458 . . . . 0.0 108.482 164.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 80.7 p -151.2 159.87 44.17 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 171.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.73 147.58 32.08 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.604 1.561 . . . . 0.0 110.992 169.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -90.71 120.62 31.92 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.098 0.559 . . . . 0.0 109.584 167.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.9 pt -117.79 143.03 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.553 1.141 . . . . 0.0 110.871 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.38 143.15 17.14 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 174.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.9 pt -127.35 139.0 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 124.987 1.315 . . . . 0.0 111.644 171.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.37 143.7 16.72 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.83 1.681 . . . . 0.0 112.251 174.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -106.37 167.67 9.67 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.64 1.576 . . . . 0.0 111.534 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.3 t -68.91 -36.21 77.74 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.143 0.577 . . . . 0.0 112.172 175.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -156.66 154.3 29.89 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.086 -1.009 . . . . 0.0 112.048 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 72.2 mtm-85 -55.74 -39.34 71.0 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.554 1.142 . . . . 0.0 112.382 173.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.78 -6.53 30.68 Favored Glycine 0 CA--C 1.542 1.731 0 C-N-CA 124.407 1.004 . . . . 0.0 115.133 178.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -111.22 -33.86 6.33 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.243 1.417 . . . . 0.0 111.728 168.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.438 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -69.72 -24.96 63.63 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 175.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -61.21 -30.4 70.4 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.729 -1.232 . . . . 0.0 112.297 169.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -69.92 -27.93 65.18 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.495 1.043 . . . . 0.0 112.635 176.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -61.81 -44.87 95.99 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.408 -0.807 . . . . 0.0 111.26 169.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -76.95 -35.26 57.4 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.376 1.07 . . . . 0.0 113.147 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 66.6 t -78.73 -38.86 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.366 -0.834 . . . . 0.0 111.87 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 88.5 p -66.86 -31.65 72.4 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.984 -1.073 . . . . 0.0 113.312 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 73.2 mt -68.85 -51.6 38.73 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.943 0.897 . . . . 0.0 111.859 172.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -68.09 -27.8 66.8 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.111 -0.993 . . . . 0.0 112.756 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -82.44 -3.02 54.97 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.399 1.08 . . . . 0.0 112.795 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -89.63 -40.7 12.41 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 121.315 -0.866 . . . . 0.0 111.963 160.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -90.55 -0.29 57.62 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 -173.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.25 -29.72 58.63 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 120.909 1.686 . . . . 0.0 115.288 -177.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 41.7 p-90 -82.9 -19.5 37.22 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.815 1.042 . . . . 0.0 113.815 175.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 37.4 t -87.32 -30.04 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.741 1.616 . . . . 0.0 111.086 173.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 51.0 mmtt -88.65 40.77 0.98 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.131 2.172 . . . . 0.0 111.733 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -93.02 16.31 13.05 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.353 1.461 . . . . 0.0 113.427 173.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 . . . . . 0 C--O 1.251 1.139 0 C-N-CA 125.964 1.705 . . . . 0.0 114.893 177.874 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.622 0 N-CA-C 112.106 -0.398 . . . . 0.0 112.106 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 20.3 m -67.05 148.35 98.89 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.545 1.138 . . . . 0.0 112.872 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -77.17 -9.58 17.78 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 123.561 2.84 . . . . 0.0 114.084 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -136.96 166.39 23.77 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.93 1.692 . . . . 0.0 111.668 177.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 88.5 p -78.25 -10.88 59.85 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -175.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.6 mtt 53.62 28.43 7.91 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.695 1.598 . . . . 0.0 113.507 -167.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.87 -35.73 0.47 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.679 1.591 . . . . 0.0 112.763 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.6 m -93.79 75.62 4.26 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.801 1.241 . . . . 0.0 109.835 178.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -131.82 36.23 3.72 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.625 1.57 . . . . 0.0 112.721 -170.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.54 64.6 1.66 Allowed 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 126.301 1.84 . . . . 0.0 112.716 -175.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -126.81 58.05 1.43 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.445 1.898 . . . . 0.0 109.6 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -150.77 151.61 32.6 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 126.073 1.749 . . . . 0.0 110.478 -172.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -173.3 115.73 0.26 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.489 1.516 . . . . 0.0 109.414 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.9 m -93.99 110.79 22.45 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.199 1.0 . . . . 0.0 110.185 174.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.0 t -59.08 143.45 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 125.307 1.443 . . . . 0.0 112.877 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.1 mt -129.26 -39.37 1.53 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.544 1.938 . . . . 0.0 111.99 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 47.5 t -149.7 142.69 24.87 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.627 1.571 . . . . 0.0 109.611 174.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.6 t -137.97 126.9 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.702 1.201 . . . . 0.0 108.149 170.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -138.11 130.4 16.21 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 123.751 0.82 . . . . 0.0 111.912 -176.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -75.14 -17.08 19.53 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.188 2.592 . . . . 0.0 115.413 -167.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -130.61 109.72 10.87 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.249 1.019 . . . . 0.0 110.958 -176.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -142.26 145.95 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.589 1.556 . . . . 0.0 109.876 168.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.9 m -126.83 132.66 50.93 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.278 1.031 . . . . 0.0 110.85 -174.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.3 t -100.52 135.09 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.078 1.351 . . . . 0.0 111.527 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.4 119.71 22.03 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.884 1.274 . . . . 0.0 108.837 168.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -64.11 131.52 47.76 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.57 -0.706 . . . . 0.0 109.491 166.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.4 pt -93.52 152.58 41.04 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 124.696 1.199 . . . . 0.0 112.806 -167.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -64.19 161.19 34.94 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.627 2.885 . . . . 0.0 112.88 171.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -64.36 115.34 3.12 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.201 2.601 . . . . 0.0 110.412 170.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 60.8 mmt-85 -152.55 159.72 43.27 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.596 1.158 . . . . 0.0 113.723 -164.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.05 134.74 35.37 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.85 156.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 59.9 p -67.9 -64.97 0.75 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.552 1.541 . . . . 0.0 113.039 -174.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -77.38 -1.79 31.86 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.73 1.212 . . . . 0.0 113.289 -173.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 86.4 mtt-85 -116.77 -29.31 6.09 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.027 1.731 . . . . 0.0 113.655 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.87 -0.66 1.7 Allowed Glycine 0 CA--C 1.533 1.159 0 N-CA-C 117.887 1.915 . . . . 0.0 117.887 -166.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 -78.16 96.34 5.16 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 120.855 2.328 . . . . 0.0 108.641 161.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.8 19.36 19.21 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.74 -50.08 0.05 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 127.169 2.188 . . . . 0.0 114.206 -165.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.5 m -65.39 -11.31 41.13 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.174 1.79 . . . . 0.0 114.788 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.71 -14.86 59.49 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.339 1.056 . . . . 0.0 112.494 171.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 16.0 m0 -96.73 171.06 8.76 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.866 1.666 . . . . 0.0 111.693 -174.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -80.56 56.35 2.58 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.2 1.4 . . . . 0.0 113.081 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.0 mt -57.69 -24.88 59.05 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -169.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -106.96 0.58 23.85 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.347 1.059 . . . . 0.0 112.593 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -132.27 77.56 70.39 Favored Pre-proline 0 C--O 1.239 0.521 0 C-N-CA 125.809 1.644 . . . . 0.0 111.378 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -69.18 144.95 58.92 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 CA-C-N 118.94 0.657 . . . . 0.0 112.784 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -70.63 -28.92 65.19 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.705 0.802 . . . . 0.0 111.172 168.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 52.6 t90 -160.42 154.21 22.66 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.606 1.962 . . . . 0.0 110.579 175.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.4 p -133.13 149.16 52.12 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.286 1.035 . . . . 0.0 111.534 167.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.26 -143.43 5.97 Favored Glycine 0 CA--C 1.524 0.635 0 O-C-N 122.15 -0.343 . . . . 0.0 113.407 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -107.28 142.41 37.08 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.679 1.592 . . . . 0.0 111.657 -176.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.3 tp -81.79 137.92 35.23 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.131 1.372 . . . . 0.0 109.426 165.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.6 ttt-85 -145.74 89.28 1.89 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 122.217 1.008 . . . . 0.0 110.938 168.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.5 mt -74.91 127.03 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 172.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.0 p -131.73 173.92 10.66 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 127.083 2.153 . . . . 0.0 109.62 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -160.19 160.72 33.14 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.479 -1.388 . . . . 0.0 110.16 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -148.9 127.2 12.17 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 122.044 0.926 . . . . 0.0 111.769 153.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.02 -114.76 5.73 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 126.078 1.799 . . . . 0.0 110.061 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -104.24 15.38 28.46 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.615 1.566 . . . . 0.0 113.277 176.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.3 m -124.4 109.19 13.0 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.892 0.877 . . . . 0.0 110.649 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.26 159.52 20.06 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.371 0.668 . . . . 0.0 110.99 171.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -141.39 100.79 3.86 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.926 1.69 . . . . 0.0 109.533 -171.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mp -79.92 94.47 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 170.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -91.15 137.82 32.07 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.21 0.604 . . . . 0.0 111.088 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.2 mp -110.62 129.64 55.76 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 126.011 1.724 . . . . 0.0 109.329 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -133.04 145.82 51.15 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.958 0.903 . . . . 0.0 112.241 -169.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -68.43 135.7 52.13 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.12 -0.987 . . . . 0.0 111.655 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.9 pttt -75.11 -7.46 53.82 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -175.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.3 t -119.47 -43.17 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.188 1.395 . . . . 0.0 111.48 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.0 m -95.42 -19.84 19.57 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -174.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.86 14.42 75.74 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.461 1.029 . . . . 0.0 113.713 -176.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -88.07 151.53 22.68 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.224 1.41 . . . . 0.0 112.097 -175.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.3 tp -72.41 126.6 30.24 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.568 -0.707 . . . . 0.0 111.468 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -85.66 -56.69 3.38 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.377 1.071 . . . . 0.0 110.929 169.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.4 162.46 40.03 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.326 1.45 . . . . 0.0 110.918 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -143.36 139.06 29.87 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 172.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.53 106.77 53.89 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.845 1.258 . . . . 0.0 111.037 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.64 139.79 14.43 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.941 3.094 . . . . 0.0 111.325 175.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 t -134.45 121.95 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.611 1.565 . . . . 0.0 109.88 -171.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -89.04 -17.34 29.55 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.86 141.87 8.74 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.834 2.053 . . . . 0.0 110.167 174.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -126.51 127.48 24.54 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 124.352 1.061 . . . . 0.0 111.095 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -61.29 147.07 48.47 Favored 'Cis proline' 0 CA--C 1.539 0.767 0 CA-C-N 120.162 1.094 . . . . 0.0 114.104 -4.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.81 -163.76 29.59 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.99 1.281 . . . . 0.0 113.873 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.8 tp -64.67 -38.58 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 -167.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.77 6.21 48.38 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -168.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.8 t -151.09 124.52 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.75 1.22 . . . . 0.0 110.474 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -140.13 162.79 34.4 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.792 1.637 . . . . 0.0 113.459 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.2 p -109.18 162.46 14.26 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.87 1.668 . . . . 0.0 111.462 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.9 m -84.18 176.87 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.032 0.933 . . . . 0.0 111.299 169.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 57.8 p -90.82 -37.92 13.3 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.512 1.525 . . . . 0.0 111.798 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -96.0 -41.12 8.92 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 -165.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.5 t -139.74 116.54 10.89 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -171.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.69 -3.54 6.83 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -168.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.445 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.306 49.2 ptt85 -86.93 20.74 2.51 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 176.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -140.67 139.57 34.81 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.448 1.499 . . . . 0.0 111.36 -176.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -138.68 161.86 36.09 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.216 1.406 . . . . 0.0 111.615 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.6 t -117.93 137.46 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.04 0.936 . . . . 0.0 108.924 165.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.17 147.96 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 118.737 0.699 . . . . 0.0 112.157 174.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -91.33 84.39 5.6 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.623 0.769 . . . . 0.0 110.936 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -68.93 138.86 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.849 0.357 . . . . 0.0 110.965 176.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -139.31 149.54 44.35 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.445 1.498 . . . . 0.0 111.42 -169.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -95.12 3.1 55.12 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.472 1.109 . . . . 0.0 113.32 -177.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.54 11.24 84.33 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.078 1.323 . . . . 0.0 114.702 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.9 t -132.67 9.17 4.24 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.722 1.609 . . . . 0.0 113.478 -172.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.21 -1.67 64.95 Favored Glycine 0 CA--C 1.537 1.454 0 O-C-N 120.741 -1.225 . . . . 0.0 114.779 -177.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -72.4 135.23 45.76 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.273 1.429 . . . . 0.0 108.966 164.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 95.6 p -145.25 153.08 40.93 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 174.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.31 142.43 29.43 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.284 1.434 . . . . 0.0 110.963 168.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -91.74 118.85 31.05 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.44 0.696 . . . . 0.0 109.861 170.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.7 pt -118.0 141.77 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.732 1.213 . . . . 0.0 110.889 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -90.11 142.37 16.43 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 175.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.7 pt -129.42 145.98 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.907 1.283 . . . . 0.0 112.167 170.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.75 148.45 16.77 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.025 1.298 . . . . 0.0 113.698 176.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -114.57 156.65 24.27 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.15 1.78 . . . . 0.0 111.531 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.6 t -74.27 -23.77 59.17 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.054 0.941 . . . . 0.0 112.936 -178.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -151.91 147.66 26.85 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.414 1.086 . . . . 0.0 111.981 -176.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 -62.97 -33.59 75.71 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.241 1.016 . . . . 0.0 113.21 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.45 -28.46 73.63 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 119.086 0.857 . . . . 0.0 113.525 175.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -85.51 -30.11 23.71 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.116 0.966 . . . . 0.0 112.581 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.445 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -66.9 -35.96 81.19 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.588 -0.695 . . . . 0.0 112.625 163.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -62.29 -35.89 80.42 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.402 -0.811 . . . . 0.0 111.661 169.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -62.92 -36.65 84.1 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 119.846 1.203 . . . . 0.0 112.5 173.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -60.48 -51.51 69.15 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.035 0.934 . . . . 0.0 112.386 169.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.84 -26.18 40.51 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -175.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.3 t -77.27 -42.38 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 O-C-N 121.127 -0.983 . . . . 0.0 110.938 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 91.6 p -63.66 -31.36 72.51 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.895 0.77 . . . . 0.0 112.882 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.1 mt -68.51 -56.86 6.92 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.105 0.962 . . . . 0.0 111.993 169.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -68.16 -25.45 65.27 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.918 -1.113 . . . . 0.0 113.5 -173.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -79.46 -4.31 50.62 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.255 1.022 . . . . 0.0 112.518 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -90.17 -28.32 18.99 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.29 -0.881 . . . . 0.0 112.587 161.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -101.07 -1.16 34.86 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.875 1.805 . . . . 0.0 115.875 -175.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.68 -29.04 58.68 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 120.959 1.709 . . . . 0.0 115.164 -178.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 36.4 p-90 -82.25 -16.64 48.81 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 175.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.8 t -88.78 -33.83 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.62 1.568 . . . . 0.0 110.606 171.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -87.96 42.56 1.06 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 127.385 2.274 . . . . 0.0 111.978 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -85.68 97.13 9.95 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.404 1.082 . . . . 0.0 110.314 176.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 . . . . . 0 C--O 1.252 1.204 0 C-N-CA 126.043 1.737 . . . . 0.0 113.496 178.25 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 112.141 -0.383 . . . . 0.0 112.141 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 57.1 p -151.29 172.28 5.55 Favored Pre-proline 0 N--CA 1.475 0.799 0 C-N-CA 125.132 1.373 . . . . 0.0 111.217 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -54.6 -17.59 13.36 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.012 2.474 . . . . 0.0 115.054 171.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -75.73 -40.28 55.8 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.345 1.058 . . . . 0.0 112.437 175.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 78.8 p -86.84 -25.17 24.66 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.979 0.912 . . . . 0.0 112.839 176.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt -76.75 35.96 0.16 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 126.001 1.72 . . . . 0.0 112.739 173.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.16 -40.47 0.17 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.369 1.868 . . . . 0.0 112.068 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 44.5 m -132.29 107.27 8.44 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.292 1.437 . . . . 0.0 109.45 175.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -140.4 6.2 2.09 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -171.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -71.42 148.16 47.19 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -164.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -134.53 46.39 2.48 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.671 1.588 . . . . 0.0 110.438 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -145.41 146.47 31.55 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.55 1.54 . . . . 0.0 110.907 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -178.51 117.67 0.08 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.901 1.68 . . . . 0.0 108.311 165.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.7 m -91.86 110.11 21.46 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.431 -0.793 . . . . 0.0 110.065 172.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.2 t -70.13 147.36 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.898 1.279 . . . . 0.0 112.062 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.0 mt -132.33 -39.54 1.03 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.963 1.705 . . . . 0.0 110.995 -173.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.7 t -151.1 146.91 26.48 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.987 1.315 . . . . 0.0 110.86 175.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 72.4 t -139.99 123.34 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.239 1.416 . . . . 0.0 109.31 171.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -118.42 141.05 29.03 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 125.017 1.327 . . . . 0.0 111.141 175.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.72 -19.32 21.35 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 123.661 2.907 . . . . 0.0 114.515 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -133.29 110.83 10.35 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.191 0.905 . . . . 0.0 111.388 -172.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.2 p -142.55 143.03 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.917 1.287 . . . . 0.0 110.755 169.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.2 m -127.86 130.32 48.39 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.69 1.196 . . . . 0.0 110.993 -174.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.2 t -97.34 136.98 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.929 1.291 . . . . 0.0 111.948 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.17 126.75 36.44 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.823 1.249 . . . . 0.0 109.381 168.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -63.12 131.62 49.12 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 161.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.6 pt -98.25 149.7 35.99 Favored Pre-proline 0 N--CA 1.475 0.807 0 C-N-CA 123.904 0.882 . . . . 0.0 112.676 -168.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -67.32 166.86 22.05 Favored 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 123.374 2.716 . . . . 0.0 111.444 167.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -57.31 149.15 66.61 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.344 2.03 . . . . 0.0 111.715 168.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.3 ttm-85 -62.79 154.53 29.48 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.73 1.212 . . . . 0.0 112.64 -174.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.76 -179.59 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 122.253 1.025 . . . . 0.0 112.826 161.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.5 m -78.75 75.08 5.27 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.466 1.506 . . . . 0.0 111.652 -171.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.304 0.5 OUTLIER 54.93 23.71 5.26 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 127.298 2.239 . . . . 0.0 115.098 -165.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -95.06 -49.0 5.72 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.196 0.998 . . . . 0.0 112.339 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.63 -144.73 16.64 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-O 121.76 0.645 . . . . 0.0 111.78 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -120.48 158.41 27.3 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 127.066 2.146 . . . . 0.0 110.971 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.83 18.48 6.71 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -171.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.56 -51.11 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 128.149 2.58 . . . . 0.0 115.697 -174.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.5 m -65.07 -13.0 56.88 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.337 1.855 . . . . 0.0 114.367 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -89.41 -4.9 57.83 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.704 1.202 . . . . 0.0 112.552 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 22.4 m0 -92.75 172.11 8.56 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.867 1.667 . . . . 0.0 110.74 174.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -80.57 55.06 2.22 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.163 1.385 . . . . 0.0 114.074 -177.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.2 mt -60.34 -17.81 45.63 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -174.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -102.14 -8.13 21.64 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.82 1.248 . . . . 0.0 113.126 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -148.74 80.05 8.37 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.563 1.145 . . . . 0.0 112.102 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.72 146.8 53.13 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.498 2.798 . . . . 0.0 112.886 174.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -71.45 -29.64 65.09 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.497 0.719 . . . . 0.0 111.393 167.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 51.4 t90 -158.54 154.43 26.66 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.028 1.731 . . . . 0.0 110.937 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.3 p -134.88 148.01 50.0 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.57 1.148 . . . . 0.0 111.594 169.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.48 -141.16 4.88 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 113.916 0.326 . . . . 0.0 113.916 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -110.79 140.53 45.13 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.802 2.041 . . . . 0.0 110.318 -170.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.6 tp -93.55 137.66 32.6 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.328 1.051 . . . . 0.0 109.997 173.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 28.0 ttp-105 -127.98 136.1 50.83 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.236 1.014 . . . . 0.0 110.271 156.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.1 mt -111.35 135.28 51.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 125.227 1.411 . . . . 0.0 107.25 164.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.74 166.77 28.4 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.847 1.659 . . . . 0.0 110.23 -164.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.3 t -157.45 160.35 38.24 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.056 -1.028 . . . . 0.0 111.951 172.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -144.68 119.95 10.2 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.513 0.725 . . . . 0.0 111.609 157.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.61 -115.11 6.72 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 125.802 1.668 . . . . 0.0 110.494 -177.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -104.5 17.02 24.93 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.17 1.788 . . . . 0.0 113.225 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.4 m -124.84 108.5 12.0 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.065 0.946 . . . . 0.0 110.396 177.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.64 159.47 25.34 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.734 0.413 . . . . 0.0 110.98 169.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -139.23 117.25 11.72 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.795 1.638 . . . . 0.0 109.214 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.1 mp -92.21 109.22 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 165.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -112.65 130.79 55.92 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.216 1.006 . . . . 0.0 111.876 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.9 mp -104.2 127.06 51.78 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.763 1.625 . . . . 0.0 110.053 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -132.98 150.28 52.17 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -170.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -65.61 141.7 58.32 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 122.252 1.025 . . . . 0.0 112.744 -173.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.0 pttt -74.81 -10.36 59.43 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -175.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 64.0 t -121.12 -38.32 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.868 1.267 . . . . 0.0 111.963 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.3 m -118.93 -8.64 10.23 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -172.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.84 14.49 80.01 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 123.992 0.806 . . . . 0.0 114.44 177.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -63.29 136.83 57.93 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.91 1.684 . . . . 0.0 111.277 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 38.1 tp -71.12 112.75 7.51 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.767 -0.583 . . . . 0.0 111.011 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -78.27 -53.52 7.23 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.932 0.893 . . . . 0.0 110.674 172.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.81 161.54 38.39 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.487 1.115 . . . . 0.0 112.052 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -141.86 134.47 28.34 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.03 1.332 . . . . 0.0 111.357 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.78 96.67 50.28 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 124.997 1.319 . . . . 0.0 111.573 176.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -59.56 138.51 84.09 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 124.213 3.275 . . . . 0.0 112.824 164.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.0 t -135.55 131.8 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.082 1.753 . . . . 0.0 109.598 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -91.15 -24.14 20.04 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -165.47 155.5 13.02 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.772 1.629 . . . . 0.0 111.18 169.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -126.19 127.22 24.71 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.87 1.268 . . . . 0.0 111.171 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.18 147.93 78.61 Favored 'Cis proline' 0 CA--C 1.542 0.888 0 CA-C-N 119.98 1.028 . . . . 0.0 113.185 -2.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -161.54 -164.71 16.98 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.901 1.715 . . . . 0.0 112.556 -178.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.9 tt -73.36 -38.62 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -175.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.5 7.51 16.81 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -167.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.2 t -149.94 130.55 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.78 1.632 . . . . 0.0 109.703 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.16 164.08 33.36 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.081 1.752 . . . . 0.0 112.731 -171.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 73.1 p -121.49 161.67 21.86 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.861 1.664 . . . . 0.0 111.956 -174.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.8 m -91.39 169.91 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.102 1.361 . . . . 0.0 110.906 168.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 79.6 p -95.03 -31.09 13.76 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.894 1.277 . . . . 0.0 113.506 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -95.3 -39.55 9.99 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -163.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.0 t -138.95 123.24 18.16 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -174.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.1 m -79.34 31.12 0.22 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 -168.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.411 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.257 18.4 ptt180 -120.68 18.06 11.95 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.293 1.437 . . . . 0.0 114.693 174.341 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -138.34 137.84 37.75 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.219 1.008 . . . . 0.0 111.202 -170.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -136.66 160.35 39.08 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.967 1.307 . . . . 0.0 111.325 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 80.7 t -112.75 143.8 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.498 1.119 . . . . 0.0 108.88 165.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.8 148.49 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 118.981 0.81 . . . . 0.0 112.104 171.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -89.28 89.28 7.84 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.668 0.787 . . . . 0.0 110.426 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -71.27 142.0 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 O-C-N 122.161 -0.337 . . . . 0.0 110.802 175.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -135.35 144.21 46.53 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.594 1.558 . . . . 0.0 111.83 -172.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -96.56 14.42 24.8 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.779 1.232 . . . . 0.0 113.557 -175.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.14 8.26 85.07 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 125.228 1.394 . . . . 0.0 115.476 176.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.5 t -131.79 3.95 4.16 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.543 1.537 . . . . 0.0 113.722 -172.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.36 -5.42 67.74 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.353 1.454 . . . . 0.0 113.888 -175.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -76.04 130.15 37.94 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 127.276 2.23 . . . . 0.0 108.564 165.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 86.3 p -152.41 161.06 43.13 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.565 1.146 . . . . 0.0 114.023 -175.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.93 148.38 31.71 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.455 1.502 . . . . 0.0 111.348 172.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -93.08 116.74 29.33 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.53 0.732 . . . . 0.0 109.733 170.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.7 pt -116.94 146.01 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.715 1.206 . . . . 0.0 111.149 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.8 142.68 16.17 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 174.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.6 pt -127.54 139.81 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 125.319 1.448 . . . . 0.0 111.866 171.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -117.38 142.71 17.51 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 125.45 1.5 . . . . 0.0 112.474 174.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -100.37 162.74 12.75 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.209 1.404 . . . . 0.0 111.842 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.3 t -68.76 -28.02 66.42 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.643 0.777 . . . . 0.0 112.388 176.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -158.71 155.85 28.8 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.601 1.16 . . . . 0.0 111.406 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.3 ttp85 -54.28 -40.98 68.36 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.397 1.079 . . . . 0.0 112.513 173.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.69 -29.85 73.21 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 123.995 0.807 . . . . 0.0 114.304 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -82.2 -36.82 26.89 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.298 1.049 . . . . 0.0 111.748 176.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.411 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -63.61 -31.59 72.8 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.523 -0.735 . . . . 0.0 112.764 168.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -72.54 0.9 9.2 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.795 1.405 . . . . 0.0 114.795 170.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -96.87 -32.77 11.91 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.431 -0.793 . . . . 0.0 112.322 162.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -58.4 -53.03 62.93 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.638 1.175 . . . . 0.0 112.518 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -66.41 -34.47 78.02 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.669 1.187 . . . . 0.0 113.366 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 52.6 t -75.48 -40.04 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.44 1.096 . . . . 0.0 111.005 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.3 m -66.69 -28.55 68.54 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.34 0.656 . . . . 0.0 112.735 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.7 mt -75.74 -53.1 9.05 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.828 0.851 . . . . 0.0 111.981 171.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -66.62 -27.39 67.66 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.224 -0.922 . . . . 0.0 113.161 -175.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -84.29 -3.12 58.04 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.303 1.041 . . . . 0.0 112.752 175.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 52.5 t60 -88.85 -38.8 14.31 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 120.901 -1.125 . . . . 0.0 111.911 158.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -91.92 1.83 56.93 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 -171.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.24 -21.98 50.46 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -177.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 29.5 p-90 -93.79 -16.7 23.89 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.977 1.311 . . . . 0.0 114.177 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.5 t -97.15 -36.83 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.555 1.542 . . . . 0.0 111.766 -176.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.0 tptt -89.9 25.33 2.13 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.634 1.574 . . . . 0.0 112.917 -173.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -84.1 93.53 8.14 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.607 1.163 . . . . 0.0 110.452 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 . . . . . 0 C--O 1.253 1.251 0 C-N-CA 126.92 2.088 . . . . 0.0 112.807 -178.081 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.592 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 53.3 m 63.19 152.1 0.11 Allowed Pre-proline 0 N--CA 1.484 1.236 0 C-N-CA 127.293 2.237 . . . . 0.0 115.365 -172.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -80.0 -16.81 11.05 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.278 2.652 . . . . 0.0 113.842 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -76.83 151.44 35.89 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.569 1.148 . . . . 0.0 112.339 -178.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 62.1 p -83.09 -14.97 52.65 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.656 1.182 . . . . 0.0 113.751 178.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -149.2 148.19 29.31 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.743 1.617 . . . . 0.0 110.798 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.26 -52.07 0.23 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.913 1.285 . . . . 0.0 111.27 169.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.9 m -158.25 132.04 7.79 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.191 2.197 . . . . 0.0 108.083 168.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -155.02 150.73 27.62 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.035 1.734 . . . . 0.0 109.537 170.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.35 139.49 30.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.308 1.843 . . . . 0.0 110.667 174.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -89.1 30.34 0.97 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.733 1.213 . . . . 0.0 113.307 -170.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -156.92 151.75 25.86 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.519 1.528 . . . . 0.0 110.822 -175.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 176.44 118.46 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.414 1.886 . . . . 0.0 108.533 160.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.2 m -97.09 104.4 16.42 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.501 -0.749 . . . . 0.0 110.935 173.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.48 145.07 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.914 1.286 . . . . 0.0 112.221 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 71.8 mt -128.58 -41.38 1.52 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.077 1.751 . . . . 0.0 112.529 -175.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.6 t -151.37 135.71 16.86 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.86 1.264 . . . . 0.0 110.346 175.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 78.6 t -128.16 127.87 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.6 1.16 . . . . 0.0 109.624 171.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -126.95 131.66 23.97 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 124.797 1.239 . . . . 0.0 110.945 172.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -66.71 -24.91 46.99 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.098 2.532 . . . . 0.0 115.349 -176.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -133.81 120.95 21.12 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.108 0.963 . . . . 0.0 112.336 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -150.97 147.24 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.732 2.013 . . . . 0.0 109.369 174.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.8 m -125.95 130.94 52.24 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.852 0.861 . . . . 0.0 111.84 -171.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.3 t -96.65 137.38 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.773 1.629 . . . . 0.0 112.153 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -131.39 126.05 34.17 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.876 1.271 . . . . 0.0 109.472 168.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -67.11 118.08 10.04 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.595 0.758 . . . . 0.0 109.478 166.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.9 pt -85.04 153.7 60.12 Favored Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -166.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -65.94 160.97 41.62 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 123.035 2.49 . . . . 0.0 111.299 159.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -64.8 147.61 89.65 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.024 2.482 . . . . 0.0 113.453 -176.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.3 tpt85 -68.33 154.32 42.0 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.917 1.687 . . . . 0.0 111.844 175.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -143.72 160.99 39.73 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.216 162.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.6 p -82.76 -41.41 19.24 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.943 1.697 . . . . 0.0 113.194 -164.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -92.89 4.01 54.68 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.701 1.6 . . . . 0.0 112.242 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 -112.32 -64.25 1.32 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.553 1.541 . . . . 0.0 111.48 174.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.15 169.36 15.44 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-O 122.585 1.103 . . . . 0.0 111.915 -167.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -70.81 147.5 48.84 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 123.704 0.801 . . . . 0.0 110.288 171.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.4 16.35 3.18 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -171.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.75 -49.04 0.06 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 127.805 2.442 . . . . 0.0 115.673 -176.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.9 m -68.5 -15.58 63.59 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.028 1.731 . . . . 0.0 114.18 -177.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.45 -11.75 59.64 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.8 0.84 . . . . 0.0 112.995 171.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 18.0 m0 -88.61 171.17 10.23 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.136 1.374 . . . . 0.0 110.851 178.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -81.42 55.52 2.63 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.21 1.404 . . . . 0.0 114.095 -174.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.5 mt -61.14 -14.6 25.97 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -171.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -108.83 -3.46 17.66 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.609 1.163 . . . . 0.0 113.033 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -148.71 71.33 10.54 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 125.151 1.38 . . . . 0.0 112.105 177.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -56.46 144.39 84.03 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.131 2.554 . . . . 0.0 112.307 173.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -70.22 -29.85 66.79 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.378 1.071 . . . . 0.0 111.689 175.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 38.8 t90 -156.84 152.48 26.9 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.554 1.542 . . . . 0.0 110.559 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.2 p -134.03 150.77 51.23 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.691 0.796 . . . . 0.0 111.869 168.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.28 -143.62 6.31 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 123.129 0.395 . . . . 0.0 113.542 -176.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 36.7 mtm105 -105.74 149.37 26.49 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.597 1.959 . . . . 0.0 112.135 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.5 tp -90.37 138.68 31.35 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.707 1.203 . . . . 0.0 109.755 162.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.8 ttp85 -144.1 91.44 2.21 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.17 0.988 . . . . 0.0 110.731 162.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.2 mt -72.06 131.93 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 170.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.41 174.91 10.01 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 127.364 2.265 . . . . 0.0 110.564 -177.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.6 p -158.32 153.31 25.26 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 120.721 -1.237 . . . . 0.0 111.562 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -158.76 128.61 5.77 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.242 1.017 . . . . 0.0 112.085 159.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.59 53.65 37.08 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.452 1.025 . . . . 0.0 114.902 163.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt 61.99 24.25 14.41 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 126.292 1.837 . . . . 0.0 113.909 -175.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.5 m -123.7 132.26 53.79 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.659 1.584 . . . . 0.0 108.726 165.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.17 157.55 16.5 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.219 1.008 . . . . 0.0 110.162 166.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -136.54 107.62 6.75 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.501 1.521 . . . . 0.0 109.22 -175.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.5 mp -81.18 96.38 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 168.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -95.93 136.83 35.85 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.268 0.556 . . . . 0.0 111.516 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.6 mp -110.36 133.46 53.24 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 126.238 1.815 . . . . 0.0 109.4 174.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -139.6 154.05 47.5 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.854 0.862 . . . . 0.0 111.946 -169.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -74.88 148.77 39.87 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 120.974 -1.079 . . . . 0.0 112.311 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.1 pttt -89.08 -1.35 58.06 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.9 1.68 . . . . 0.0 114.986 -178.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 80.3 t -127.83 -41.8 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.152 1.381 . . . . 0.0 111.951 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.1 p -96.15 -27.42 15.05 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.53 1.059 . . . . 0.0 113.289 175.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.58 8.59 87.15 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-O 119.346 -0.697 . . . . 0.0 113.8 -170.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -68.75 151.34 46.78 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.622 1.211 . . . . 0.0 111.886 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.4 tp -72.66 125.96 28.74 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.638 -0.664 . . . . 0.0 110.683 176.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -86.37 -55.02 4.1 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.133 0.973 . . . . 0.0 111.063 171.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.8 159.56 36.87 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.66 1.184 . . . . 0.0 111.651 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -140.3 133.97 30.31 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.47 0.708 . . . . 0.0 112.576 175.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.74 103.24 53.91 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 125.108 1.363 . . . . 0.0 111.257 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -74.65 141.72 28.11 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.566 2.844 . . . . 0.0 111.728 173.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.5 t -134.94 125.38 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.68 1.992 . . . . 0.0 109.07 -174.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -90.04 -23.51 21.43 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -161.86 150.03 15.02 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.67 1.988 . . . . 0.0 110.151 171.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -122.85 127.56 25.69 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 124.537 1.135 . . . . 0.0 110.973 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -62.18 147.72 55.53 Favored 'Cis proline' 0 CA--C 1.541 0.869 0 CA-C-N 119.991 1.033 . . . . 0.0 114.392 -5.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.37 -166.68 18.81 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.919 1.723 . . . . 0.0 112.392 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.0 tt -69.52 -37.39 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 121.607 -0.937 . . . . 0.0 112.873 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.83 6.66 23.71 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -165.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.6 t -150.4 130.71 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.481 1.512 . . . . 0.0 110.063 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -140.32 161.34 37.92 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.282 1.833 . . . . 0.0 112.316 177.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.2 p -107.96 160.98 15.35 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.6 1.96 . . . . 0.0 111.735 177.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.1 m -87.01 173.33 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.212 1.005 . . . . 0.0 110.879 163.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 73.9 p -104.56 -23.3 13.14 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.485 1.514 . . . . 0.0 113.921 -176.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -99.87 -39.29 8.26 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -171.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.9 t -134.03 117.27 16.48 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -173.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.0 m -72.48 24.82 0.05 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 115.956 1.835 . . . . 0.0 115.956 -169.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.4 ptt85 -131.42 27.08 4.77 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.507 1.923 . . . . 0.0 113.995 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -140.09 141.28 36.18 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.671 1.589 . . . . 0.0 111.441 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -140.14 162.11 36.03 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.03 1.332 . . . . 0.0 111.54 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.9 t -116.96 142.85 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.596 1.158 . . . . 0.0 108.997 167.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.21 148.09 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 173.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -87.94 84.68 6.96 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.976 0.911 . . . . 0.0 110.717 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -68.3 141.03 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 120.816 0.341 . . . . 0.0 110.582 173.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -135.19 149.76 50.0 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.302 1.441 . . . . 0.0 111.78 -169.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -95.72 11.25 34.09 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.612 1.165 . . . . 0.0 113.108 -176.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.35 3.55 88.66 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.3 1.428 . . . . 0.0 115.412 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.1 t -125.28 2.57 7.81 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.726 1.611 . . . . 0.0 113.603 -176.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.01 -9.16 65.55 Favored Glycine 0 N--CA 1.478 1.439 0 C-N-CA 125.569 1.557 . . . . 0.0 113.979 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -68.35 131.86 46.06 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 127.364 2.266 . . . . 0.0 108.61 164.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 82.3 p -150.51 163.79 37.57 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -173.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.54 147.67 41.53 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.539 1.536 . . . . 0.0 110.612 164.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -92.83 116.75 29.32 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 167.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.1 pt -117.62 144.11 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.474 1.109 . . . . 0.0 110.937 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.73 142.08 15.92 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 175.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.4 pt -127.15 140.14 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 125.478 1.511 . . . . 0.0 111.661 172.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -119.94 141.35 15.35 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.798 1.189 . . . . 0.0 113.511 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -109.06 153.85 23.06 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.488 1.915 . . . . 0.0 110.792 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.3 t -73.0 -23.16 60.6 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.616 0.766 . . . . 0.0 112.784 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -155.54 151.06 27.17 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.446 1.098 . . . . 0.0 111.62 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.33 -33.05 70.65 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.904 0.882 . . . . 0.0 112.732 177.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.0 -19.25 63.32 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-N 118.979 0.808 . . . . 0.0 114.59 177.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -94.83 -37.31 11.28 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.689 1.244 . . . . 0.0 111.694 176.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.42 -29.14 68.8 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.135 0.974 . . . . 0.0 112.929 166.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . 0.262 19.8 m-85 -92.51 19.39 7.33 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.571 1.548 . . . . 0.0 114.112 170.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -99.71 -38.7 8.59 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.551 -0.718 . . . . 0.0 111.295 142.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -54.3 -57.72 10.14 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.58 1.082 . . . . 0.0 112.927 178.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -80.42 -22.74 40.91 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.256 -0.902 . . . . 0.0 113.345 -174.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 93.7 t -81.48 -39.2 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.412 0.685 . . . . 0.0 110.803 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 95.1 p -65.46 -31.42 72.49 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.566 -0.709 . . . . 0.0 112.848 173.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 72.0 mt -69.54 -52.65 24.4 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.189 0.995 . . . . 0.0 111.951 172.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -67.67 -29.03 68.22 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 120.971 -1.081 . . . . 0.0 112.823 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -82.77 -3.0 56.0 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.507 1.123 . . . . 0.0 112.916 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -90.15 -29.25 18.4 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.165 -0.96 . . . . 0.0 112.547 166.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -101.75 -4.15 26.91 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -176.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.2 -28.54 58.65 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -176.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 33.1 p-90 -84.69 -23.49 29.36 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.554 1.142 . . . . 0.0 113.44 176.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 22.0 t -82.26 -30.69 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.562 1.545 . . . . 0.0 111.062 175.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -96.21 30.01 2.63 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.888 2.075 . . . . 0.0 112.859 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -79.44 90.45 5.05 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.859 0.838 . . . . 0.0 109.945 171.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 C--O 1.252 1.188 0 C-N-CA 126.861 2.064 . . . . 0.0 112.7 -172.156 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.57 0 N-CA-C 111.656 -0.577 . . . . 0.0 111.656 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 44.1 m -70.95 138.59 85.14 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 123.886 0.875 . . . . 0.0 112.84 -174.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -69.15 -29.09 27.35 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.979 2.453 . . . . 0.0 112.688 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -66.86 -19.77 65.8 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.143 0.977 . . . . 0.0 112.957 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 28.5 m -99.48 -5.98 28.37 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.456 1.502 . . . . 0.0 113.718 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt 49.04 51.58 15.94 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.631 1.572 . . . . 0.0 112.353 -176.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.35 -6.62 14.94 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.157 1.383 . . . . 0.0 113.585 -165.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.1 m -134.9 72.64 1.46 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.888 1.675 . . . . 0.0 108.498 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -127.76 28.12 5.65 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.164 1.786 . . . . 0.0 112.628 -170.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 tt -60.98 115.35 3.66 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.32 1.848 . . . . 0.0 111.586 -174.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -146.07 56.09 1.18 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.141 1.376 . . . . 0.0 110.662 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.4 ' CD2' ' HG2' ' A' ' 52' ' ' LYS . 13.8 p90 -150.09 148.09 28.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.45 1.5 . . . . 0.0 110.738 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 173.5 105.66 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.786 2.434 . . . . 0.0 107.555 162.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.8 m -86.57 120.58 28.04 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.592 0.757 . . . . 0.0 111.684 -172.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -72.34 149.67 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.825 1.25 . . . . 0.0 113.855 -171.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.5 mt -134.07 -38.6 0.87 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.05 1.74 . . . . 0.0 112.425 -171.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 39.0 t -152.59 139.52 19.08 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.89 1.276 . . . . 0.0 110.588 172.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 79.1 t -131.71 127.55 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.697 1.199 . . . . 0.0 109.28 171.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -129.21 135.24 27.29 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 125.207 1.403 . . . . 0.0 110.524 173.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.66 -18.46 13.52 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.987 2.458 . . . . 0.0 114.975 -172.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -129.65 109.42 10.97 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.5 1.12 . . . . 0.0 111.146 -175.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.7 p -143.05 141.37 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.721 1.609 . . . . 0.0 110.028 171.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.3 m -123.33 125.36 44.87 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.265 1.026 . . . . 0.0 111.371 -171.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.6 t -92.16 137.82 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.142 1.377 . . . . 0.0 112.201 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -127.31 123.3 36.05 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.277 1.431 . . . . 0.0 108.621 168.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -68.96 109.3 3.88 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 164.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.4 pt -80.87 156.08 72.66 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 124.425 1.09 . . . . 0.0 113.819 -166.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -61.68 161.22 25.53 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 122.729 2.286 . . . . 0.0 111.405 158.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -60.39 150.09 82.58 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.788 2.325 . . . . 0.0 112.336 175.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 21.6 ttm105 -61.56 150.05 37.22 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.707 1.203 . . . . 0.0 111.837 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.511 ' HB1' ' H ' ' A' ' 30' ' ' GLY . . . -60.48 172.15 0.94 Allowed 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 122.307 1.051 . . . . 0.0 112.539 162.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 79.5 p -87.59 -31.31 19.92 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.006 1.322 . . . . 0.0 113.049 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -137.97 6.18 2.63 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.815 1.646 . . . . 0.0 113.794 -174.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 -115.06 -57.75 2.22 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.735 1.214 . . . . 0.0 113.646 -176.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.511 ' H ' ' HB1' ' A' ' 26' ' ' ALA . . . 117.34 -123.17 5.69 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -161.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -134.68 155.57 50.3 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 127.617 2.367 . . . . 0.0 109.966 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.31 131.09 53.54 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 163.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.18 -33.73 63.24 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.454 1.102 . . . . 0.0 113.215 -172.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.7 p -65.44 -13.26 58.35 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 175.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.29 -10.25 58.63 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.054 0.942 . . . . 0.0 112.704 170.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 22.8 m0 -94.68 171.71 8.62 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.629 1.572 . . . . 0.0 111.835 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -79.22 47.52 0.8 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.16 1.784 . . . . 0.0 114.177 -176.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.7 mt -54.72 -34.86 63.02 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -167.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -93.77 -2.41 53.72 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.95 0.9 . . . . 0.0 113.321 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -145.89 66.85 12.0 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 125.992 1.717 . . . . 0.0 111.747 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -55.91 144.02 79.69 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.282 2.654 . . . . 0.0 112.84 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -73.86 -27.81 61.26 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.45 1.1 . . . . 0.0 111.73 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 40.7 t90 -153.17 152.48 31.3 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.656 1.582 . . . . 0.0 110.663 170.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.5 p -134.56 143.17 47.24 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.964 0.906 . . . . 0.0 111.864 171.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.15 -144.63 5.4 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 114.556 0.582 . . . . 0.0 114.556 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -107.9 144.3 35.34 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.507 1.923 . . . . 0.0 111.035 -172.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 42.9 tp -91.56 138.44 31.57 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.652 1.581 . . . . 0.0 110.119 170.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -144.26 99.53 3.39 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.685 1.194 . . . . 0.0 110.57 170.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.4 mt -86.31 132.96 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.604 1.162 . . . . 0.0 108.624 174.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.12 171.28 14.3 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.167 1.787 . . . . 0.0 111.279 -170.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.8 t -156.21 149.06 24.03 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.796 -1.19 . . . . 0.0 112.555 173.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.4 ' HG2' ' CD2' ' A' ' 7' ' ' TYR . 13.0 tppt? -150.86 132.76 15.1 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.724 152.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.47 58.45 5.45 Favored Glycine 0 N--CA 1.474 1.192 0 C-N-CA 124.752 1.168 . . . . 0.0 114.466 166.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 56.52 27.3 12.07 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 126.203 1.801 . . . . 0.0 113.174 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.7 m -137.93 121.83 17.72 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.655 1.582 . . . . 0.0 108.536 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -90.33 158.57 17.08 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.842 0.857 . . . . 0.0 110.513 171.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -139.34 99.52 3.76 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.318 1.847 . . . . 0.0 108.628 -173.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.3 mp -79.65 103.66 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 168.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 50.6 mttt -105.12 141.18 37.13 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.939 0.876 . . . . 0.0 111.732 174.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.8 mp -108.9 133.01 53.49 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 126.301 1.84 . . . . 0.0 109.785 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -132.2 147.19 52.41 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.942 0.897 . . . . 0.0 112.499 -168.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -66.33 140.81 58.12 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.882 0.873 . . . . 0.0 112.717 -175.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.274 0.0 OUTLIER -77.59 -5.22 49.48 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 -174.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.6 t -112.46 -48.59 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.93 1.292 . . . . 0.0 111.107 170.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.8 m -99.54 -16.75 18.18 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -167.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.87 12.43 74.8 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.658 1.123 . . . . 0.0 113.994 -176.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -82.78 152.09 25.84 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.078 1.351 . . . . 0.0 112.322 -174.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.7 122.16 19.31 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.959 0.903 . . . . 0.0 112.074 -169.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -86.1 -54.91 4.19 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.217 1.007 . . . . 0.0 111.098 168.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.58 161.61 38.73 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.895 1.278 . . . . 0.0 111.771 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -141.22 134.88 30.1 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.722 1.209 . . . . 0.0 112.065 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.86 100.68 48.5 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.955 1.302 . . . . 0.0 111.405 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -65.1 139.07 59.36 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 124.292 3.328 . . . . 0.0 112.422 167.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.4 t -135.8 129.68 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.73 1.612 . . . . 0.0 109.659 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -89.71 -23.52 21.8 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.75 150.05 13.38 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.15 1.78 . . . . 0.0 110.391 172.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -126.12 132.19 24.23 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.526 1.13 . . . . 0.0 112.131 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -63.57 144.66 53.94 Favored 'Cis proline' 0 CA--C 1.54 0.814 0 CA-C-N 119.71 0.932 . . . . 0.0 113.772 -6.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -169.59 -173.26 36.97 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.606 1.098 . . . . 0.0 114.116 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.6 tp -54.86 -36.72 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -166.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.55 8.35 39.25 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -171.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.4 t -148.33 129.12 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.307 1.043 . . . . 0.0 111.221 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -138.11 162.52 33.97 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.282 1.833 . . . . 0.0 112.218 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 65.8 p -112.49 161.28 16.91 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.628 1.971 . . . . 0.0 111.388 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.4 m -89.57 173.1 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.841 0.857 . . . . 0.0 111.453 166.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 46.5 p -99.05 -24.9 14.73 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 174.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -81.21 -42.69 20.38 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -171.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.2 t -156.76 134.44 10.86 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.0 m -72.99 22.15 0.07 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -174.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.468 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.26 5.1 ptm180 -108.73 19.67 19.4 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.011 1.724 . . . . 0.0 114.043 173.268 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -142.53 135.5 28.38 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.029 1.331 . . . . 0.0 110.412 -174.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -135.95 164.49 27.85 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.975 1.31 . . . . 0.0 111.103 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.2 t -117.72 142.96 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.705 1.202 . . . . 0.0 108.418 166.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.89 147.13 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 118.664 0.665 . . . . 0.0 112.14 172.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -87.75 86.67 7.2 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.507 0.723 . . . . 0.0 110.449 176.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -69.04 140.32 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.575 0.226 . . . . 0.0 110.8 175.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -137.03 144.73 43.38 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.762 1.625 . . . . 0.0 111.792 -170.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -94.48 11.43 30.8 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.479 1.112 . . . . 0.0 113.265 -175.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.87 6.69 85.82 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 125.122 1.344 . . . . 0.0 115.358 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.3 t -128.56 0.42 5.56 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 125.728 1.611 . . . . 0.0 113.828 -173.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.94 -7.1 60.49 Favored Glycine 0 N--CA 1.478 1.453 0 C-N-CA 125.484 1.516 . . . . 0.0 113.974 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -72.96 129.37 37.96 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 127.162 2.185 . . . . 0.0 108.451 164.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 76.8 p -152.47 161.06 43.11 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -173.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.11 147.46 30.6 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.465 1.506 . . . . 0.0 111.234 171.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -90.92 117.99 29.96 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.396 0.678 . . . . 0.0 109.472 168.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.4 pt -116.93 143.19 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.567 1.147 . . . . 0.0 111.027 177.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.25 144.06 17.72 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 174.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.0 pt -128.9 139.61 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 C-N-CA 125.59 1.556 . . . . 0.0 111.641 171.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.68 142.14 15.53 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 125.663 1.601 . . . . 0.0 112.725 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -105.25 163.63 12.45 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.419 1.488 . . . . 0.0 111.298 -177.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.7 t -76.32 -24.65 54.31 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 177.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -156.19 151.14 26.25 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.402 1.081 . . . . 0.0 111.636 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -62.62 -32.69 73.75 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.087 0.955 . . . . 0.0 113.151 178.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.24 -30.09 76.92 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 118.942 0.792 . . . . 0.0 113.646 175.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -82.84 -36.49 25.42 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.119 0.96 . . . . 0.0 111.918 175.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.468 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -64.2 -31.77 73.09 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 169.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -61.25 -33.75 74.04 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.098 -1.001 . . . . 0.0 112.508 171.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -70.36 -32.72 70.54 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.835 1.198 . . . . 0.0 112.846 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -57.64 -43.85 85.18 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.029 0.831 . . . . 0.0 111.329 170.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -81.28 -35.59 30.91 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.532 1.133 . . . . 0.0 113.496 -175.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.5 t -76.78 -40.5 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 O-C-N 121.245 -0.909 . . . . 0.0 111.519 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 85.4 p -63.67 -27.41 69.2 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 83.8 mt -75.38 -55.51 5.62 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.018 0.927 . . . . 0.0 111.534 171.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -66.83 -30.71 70.97 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.09 -1.006 . . . . 0.0 113.484 -172.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -90.91 4.38 52.04 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.8 1.64 . . . . 0.0 112.716 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -97.67 -33.12 11.43 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.304 -0.872 . . . . 0.0 112.276 163.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -89.96 -2.37 58.14 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.61 -34.08 64.56 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 121.18 1.809 . . . . 0.0 115.09 -174.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 28.7 p-90 -75.43 -30.93 60.17 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.827 0.851 . . . . 0.0 112.799 175.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.6 t -71.61 -35.4 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.58 1.152 . . . . 0.0 110.587 172.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -78.39 -2.44 38.32 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.024 1.73 . . . . 0.0 114.909 171.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 51.05 28.8 4.12 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 128.061 2.544 . . . . 0.0 115.353 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 . . . . . 0 C--O 1.252 1.227 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -178.79 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.473 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 25.9 p -80.79 156.18 72.8 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 124.722 1.209 . . . . 0.0 112.957 177.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.08 99.88 1.15 Allowed 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.251 2.634 . . . . 0.0 111.098 178.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -101.94 -6.58 23.31 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.708 1.203 . . . . 0.0 113.847 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 53.7 p -64.42 -17.06 63.44 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -176.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -76.85 -2.2 32.19 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.416 1.486 . . . . 0.0 113.697 173.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.7 -46.11 0.54 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.755 1.622 . . . . 0.0 111.934 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.7 m -80.3 66.26 5.74 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.32 1.448 . . . . 0.0 108.597 164.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -91.01 84.06 5.7 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.998 0.919 . . . . 0.0 112.545 -158.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 pp -125.77 142.8 51.34 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.832 1.253 . . . . 0.0 111.255 165.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -138.34 50.85 1.87 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.515 1.526 . . . . 0.0 109.856 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -135.41 136.99 41.83 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.608 1.163 . . . . 0.0 109.622 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -174.47 131.53 0.36 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.077 1.751 . . . . 0.0 108.151 162.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.6 m -92.46 109.39 20.78 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.101 0.961 . . . . 0.0 108.526 167.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.6 t -69.99 143.05 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 O-C-N 121.305 -0.872 . . . . 0.0 111.673 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.5 mt -126.88 -41.75 1.8 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.572 1.549 . . . . 0.0 112.293 -174.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.4 t -153.92 135.39 14.24 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.229 1.012 . . . . 0.0 111.245 173.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.1 t -128.31 127.33 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.677 1.191 . . . . 0.0 109.014 171.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -131.07 137.43 30.7 Favored Pre-proline 0 N--CA 1.475 0.81 0 C-N-CA 125.408 1.483 . . . . 0.0 110.65 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.53 -18.57 22.59 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.217 2.611 . . . . 0.0 113.689 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -109.08 122.64 47.7 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.025 1.33 . . . . 0.0 112.152 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.0 p -154.72 143.25 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.803 1.241 . . . . 0.0 109.585 157.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.7 p -127.32 144.14 51.1 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.071 1.348 . . . . 0.0 110.586 177.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.4 t -113.41 130.22 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.931 1.292 . . . . 0.0 111.113 -177.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.67 118.17 14.81 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.418 1.487 . . . . 0.0 108.976 173.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 -69.45 132.45 46.35 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.893 0.877 . . . . 0.0 109.943 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.3 pt -86.87 151.46 52.28 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -160.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -65.08 167.91 15.11 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 123.996 3.131 . . . . 0.0 112.121 171.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -63.81 98.21 0.24 Allowed 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.392 2.728 . . . . 0.0 111.28 173.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.2 mmt-85 -149.07 161.74 41.33 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 127.503 2.321 . . . . 0.0 110.562 -177.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -135.27 161.51 35.2 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.926 1.69 . . . . 0.0 111.072 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.4 t -55.59 -39.34 70.59 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.356 1.462 . . . . 0.0 113.026 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -76.22 -8.42 57.01 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 177.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -108.44 -25.13 11.12 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.196 1.798 . . . . 0.0 112.524 175.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.64 106.56 0.8 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.857 1.218 . . . . 0.0 113.242 166.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -61.57 142.35 57.16 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.309 1.044 . . . . 0.0 109.944 164.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.77 15.96 8.07 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 -174.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 55.84 -48.15 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.825 2.85 . . . . 0.0 116.156 -173.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 90.7 p -64.53 -17.77 64.21 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.095 1.758 . . . . 0.0 114.466 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -85.84 -4.79 59.25 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.445 1.498 . . . . 0.0 112.633 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.8 m0 -93.44 168.52 11.0 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.085 1.754 . . . . 0.0 110.635 175.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -78.13 49.7 0.84 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.659 1.584 . . . . 0.0 114.041 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 45.7 mt -56.46 -36.07 68.64 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -172.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -92.8 -2.68 55.73 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.237 1.015 . . . . 0.0 113.232 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -141.6 70.32 25.7 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 125.521 1.528 . . . . 0.0 111.726 177.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.85 147.37 73.42 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.144 2.563 . . . . 0.0 113.16 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -74.03 -27.94 61.18 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.158 0.983 . . . . 0.0 111.535 169.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 57.7 t90 -158.15 155.01 28.35 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.399 1.88 . . . . 0.0 110.884 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.1 p -136.72 149.9 48.13 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.666 1.186 . . . . 0.0 112.024 169.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.69 -142.49 4.6 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 123.319 0.485 . . . . 0.0 113.825 -177.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -118.91 148.74 42.6 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.849 2.06 . . . . 0.0 111.558 -175.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.1 tp -89.15 140.42 29.48 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.54 1.536 . . . . 0.0 110.626 174.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -141.01 93.36 2.58 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.519 1.127 . . . . 0.0 110.567 162.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.1 mt -76.65 127.24 37.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 166.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.1 p -138.31 171.71 13.98 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 126.919 2.088 . . . . 0.0 110.153 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.8 p -152.81 166.09 33.34 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 125.014 1.326 . . . . 0.0 112.185 174.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -148.68 121.25 8.56 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.243 0.544 . . . . 0.0 111.326 154.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.33 -118.43 9.32 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 125.232 1.396 . . . . 0.0 110.211 -176.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -101.48 20.16 16.55 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.331 1.852 . . . . 0.0 113.714 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.4 m -127.47 128.15 45.25 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.704 1.202 . . . . 0.0 109.957 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.65 160.8 14.03 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.552 1.141 . . . . 0.0 111.157 170.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -141.21 107.13 5.15 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.733 2.013 . . . . 0.0 108.802 -174.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -83.99 94.56 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 168.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -88.58 136.67 32.88 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.86 0.864 . . . . 0.0 110.805 174.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.3 mp -111.98 131.2 55.55 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.143 1.777 . . . . 0.0 110.111 174.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -132.67 147.56 52.33 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.858 0.863 . . . . 0.0 113.177 -170.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -67.8 135.39 52.54 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.367 1.067 . . . . 0.0 111.329 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.7 pttt -76.05 -5.2 45.35 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -175.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 85.6 t -120.26 -43.17 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 125.03 1.332 . . . . 0.0 111.47 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.5 m -93.82 -19.71 20.76 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.32 13.5 76.97 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.487 1.041 . . . . 0.0 113.693 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -90.58 152.16 21.01 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.241 1.416 . . . . 0.0 112.295 -173.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.5 tp -72.47 128.34 35.29 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.491 -0.756 . . . . 0.0 111.666 -175.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -85.35 -58.25 2.75 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.55 1.14 . . . . 0.0 110.778 169.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.68 165.44 36.25 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.042 1.737 . . . . 0.0 110.12 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -146.35 146.22 30.59 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 169.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.34 107.2 49.74 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.333 1.453 . . . . 0.0 111.665 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -67.92 144.47 64.66 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.838 3.026 . . . . 0.0 111.988 169.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.2 t -139.23 126.52 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.46 1.504 . . . . 0.0 109.414 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -95.45 -19.96 19.45 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -160.56 145.49 14.43 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.733 2.013 . . . . 0.0 110.081 171.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -126.22 127.67 24.6 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 124.697 1.199 . . . . 0.0 110.488 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -64.47 146.96 67.06 Favored 'Cis proline' 0 CA--C 1.542 0.899 0 CA-C-N 120.073 1.062 . . . . 0.0 113.434 -2.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.65 -156.94 8.74 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.721 1.629 . . . . 0.0 112.642 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.6 tt -79.33 -41.89 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -176.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.59 8.0 15.57 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -165.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 23.5 t -153.02 130.45 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 126.363 1.865 . . . . 0.0 109.122 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.17 158.72 44.24 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.871 1.268 . . . . 0.0 113.067 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.0 p -104.73 161.6 14.02 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.506 1.522 . . . . 0.0 112.182 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.3 m -90.72 173.27 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.81 1.244 . . . . 0.0 110.806 167.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.6 p -96.79 -29.4 13.78 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.31 1.444 . . . . 0.0 113.384 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -91.32 -43.1 9.99 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -169.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.7 t -143.32 124.48 14.52 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -176.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -67.29 -7.89 27.87 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.297 1.592 . . . . 0.0 115.297 -169.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.429 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.32 44.9 ptt85 -84.91 21.3 1.62 Allowed 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -179.338 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -142.86 140.02 31.09 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.814 1.646 . . . . 0.0 111.868 -174.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -142.62 149.36 38.86 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.435 1.494 . . . . 0.0 112.512 -176.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.9 t -92.4 142.35 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 161.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.26 149.65 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 119.348 0.977 . . . . 0.0 111.949 164.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.486 ' HE ' ' NE2' ' A' ' 97' ' ' GLN . 41.1 ttp180 -93.04 95.72 9.63 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.706 0.803 . . . . 0.0 110.259 174.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -76.91 150.98 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.301 0.64 . . . . 0.0 111.705 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.486 ' NE2' ' HE ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -124.93 150.41 46.61 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.901 1.68 . . . . 0.0 110.395 174.367 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -94.55 3.66 54.84 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.403 1.081 . . . . 0.0 113.085 175.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.68 12.45 82.84 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.273 1.416 . . . . 0.0 114.822 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.5 t -137.79 15.97 2.89 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.476 1.51 . . . . 0.0 113.371 -172.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.7 -1.58 78.78 Favored Glycine 0 CA--C 1.537 1.442 0 O-C-N 120.609 -1.307 . . . . 0.0 114.904 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -77.06 138.8 39.78 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.481 1.513 . . . . 0.0 108.927 165.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 84.7 p -143.63 157.34 44.48 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 166.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.59 142.45 27.98 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.671 1.188 . . . . 0.0 111.276 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -87.66 117.54 26.55 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.378 0.671 . . . . 0.0 109.537 168.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.9 pt -118.56 147.61 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.888 1.275 . . . . 0.0 110.761 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.7 136.32 12.9 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.5 pt -127.66 159.77 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 125.008 1.323 . . . . 0.0 112.067 171.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -154.38 168.82 32.68 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-O 122.039 0.799 . . . . 0.0 114.513 173.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -121.77 157.41 31.08 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 126.08 1.752 . . . . 0.0 111.797 -171.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.7 t -70.01 -19.34 63.33 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.055 0.942 . . . . 0.0 112.592 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -154.79 150.76 27.88 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.197 0.999 . . . . 0.0 111.921 -176.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 35.6 ttt-85 -61.32 -31.62 71.48 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.694 1.198 . . . . 0.0 113.276 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.27 -29.33 75.02 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-N 119.102 0.865 . . . . 0.0 113.976 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -82.53 -34.67 27.8 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.455 -1.026 . . . . 0.0 111.642 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.429 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -67.67 -30.51 70.06 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.26 1.024 . . . . 0.0 113.388 167.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -61.5 -47.48 85.42 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.446 -0.784 . . . . 0.0 110.797 168.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -62.31 -36.92 83.64 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.386 0.993 . . . . 0.0 112.876 175.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -55.55 -55.76 28.13 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.224 0.92 . . . . 0.0 112.263 173.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -81.34 -27.3 35.01 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.114 1.154 . . . . 0.0 114.114 -174.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 73.0 t -76.3 -38.8 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 O-C-N 121.45 -0.781 . . . . 0.0 111.181 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 93.5 p -65.05 -30.98 71.98 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.152 0.887 . . . . 0.0 112.988 175.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.5 mt -68.43 -54.99 13.45 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.265 1.026 . . . . 0.0 111.761 171.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -67.27 -26.74 66.71 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 120.988 -1.07 . . . . 0.0 113.007 -176.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -81.78 -3.87 54.95 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.874 1.27 . . . . 0.0 112.713 174.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -91.53 -25.13 19.39 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.681 -1.262 . . . . 0.0 112.446 163.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -100.29 -6.76 25.42 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 116.007 1.855 . . . . 0.0 116.007 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.98 -24.99 41.95 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -174.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 38.1 p-90 -90.2 -17.48 27.47 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.494 1.517 . . . . 0.0 113.967 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.5 t -80.0 -26.68 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.635 1.174 . . . . 0.0 112.227 -171.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? -112.33 59.96 0.63 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.715 1.606 . . . . 0.0 109.864 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -125.33 113.92 18.22 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.156 1.382 . . . . 0.0 109.126 174.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 C--O 1.254 1.33 0 C-N-CA 126.257 1.823 . . . . 0.0 112.666 -171.464 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.688 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 15.9 m -48.48 -43.98 63.37 Favored Pre-proline 0 N--CA 1.477 0.92 0 N-CA-C 117.796 2.517 . . . . 0.0 117.796 -168.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -66.07 -11.8 32.68 Favored 'Trans proline' 0 C--N 1.356 0.948 0 CA-C-N 122.745 2.016 . . . . 0.0 114.826 -175.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -69.92 -22.42 63.2 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.238 -0.914 . . . . 0.0 112.904 173.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 68.3 m -66.8 -28.93 68.77 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.305 -0.872 . . . . 0.0 112.877 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -72.88 2.21 7.23 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.651 1.581 . . . . 0.0 113.933 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.36 -28.29 47.11 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.696 1.198 . . . . 0.0 113.059 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 41.6 p -135.63 -41.22 0.7 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.785 1.634 . . . . 0.0 111.927 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 61.27 21.87 12.3 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.661 1.984 . . . . 0.0 115.637 164.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.48 36.62 2.23 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -153.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -80.85 55.38 2.4 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.424 1.49 . . . . 0.0 112.192 -178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -153.7 157.38 39.44 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 126.48 1.912 . . . . 0.0 110.717 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -176.49 78.78 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 127.77 2.428 . . . . 0.0 109.491 -174.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.65 126.55 30.89 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.021 -1.05 . . . . 0.0 112.883 -160.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.3 t -70.96 141.1 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 O-C-N 121.138 -0.976 . . . . 0.0 112.971 -168.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.3 mt -122.7 -41.77 2.35 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.874 1.67 . . . . 0.0 112.495 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 33.6 t -152.42 132.31 13.32 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.545 1.138 . . . . 0.0 110.596 175.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 72.6 t -127.94 127.07 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.546 1.138 . . . . 0.0 109.744 172.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -133.17 143.03 46.64 Favored Pre-proline 0 N--CA 1.474 0.737 0 C-N-CA 124.853 1.261 . . . . 0.0 111.683 173.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.02 -17.42 22.25 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.51 2.807 . . . . 0.0 115.098 -174.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -134.25 110.81 9.77 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.118 0.967 . . . . 0.0 112.21 -169.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -149.36 146.37 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 126.324 1.85 . . . . 0.0 109.739 171.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.3 m -125.27 131.59 53.06 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.058 0.943 . . . . 0.0 111.573 -171.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.1 t -98.9 139.97 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 126.028 1.731 . . . . 0.0 112.054 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -127.59 132.38 49.83 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.71 1.604 . . . . 0.0 108.968 169.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 48.0 mtm180 -70.05 139.29 52.61 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 155.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.8 pt -125.99 156.53 71.58 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 125.16 1.384 . . . . 0.0 112.95 -163.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -64.25 161.62 33.41 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 123.343 2.696 . . . . 0.0 112.622 170.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -65.59 108.25 1.19 Allowed 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.439 2.759 . . . . 0.0 111.52 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.5 mmt-85 -148.59 175.79 10.88 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.985 1.714 . . . . 0.0 112.594 -177.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -148.62 162.83 38.92 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 128.482 2.713 . . . . 0.0 108.57 176.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.3 t -59.48 -38.04 79.8 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 120.564 -1.335 . . . . 0.0 112.349 174.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -76.32 1.79 15.18 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.838 1.255 . . . . 0.0 113.717 174.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 77.7 mmt-85 -124.03 -19.33 5.66 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.758 2.023 . . . . 0.0 113.327 176.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.05 92.76 1.12 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.717 1.627 . . . . 0.0 114.796 165.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -61.95 141.5 57.99 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 146.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.27 22.9 4.81 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.284 1.434 . . . . 0.0 113.021 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 56.64 -46.94 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 128.471 2.709 . . . . 0.0 115.304 -170.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.4 m -64.82 -13.43 55.82 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.552 1.941 . . . . 0.0 114.276 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -78.57 -4.6 49.56 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.405 1.482 . . . . 0.0 113.588 170.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 10.6 m0 -107.0 167.83 9.62 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.655 1.582 . . . . 0.0 111.425 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -78.01 53.67 1.21 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.02 1.728 . . . . 0.0 113.589 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.9 mt -55.56 -32.6 63.14 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -170.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -87.63 -6.82 58.1 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.068 0.947 . . . . 0.0 113.085 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -140.19 59.29 12.35 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 126.886 2.075 . . . . 0.0 111.183 -160.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -65.04 139.61 62.03 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 CA-C-N 119.593 0.89 . . . . 0.0 112.424 -171.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -74.46 -26.64 60.17 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.207 1.003 . . . . 0.0 111.717 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 39.4 t90 -153.6 153.57 32.59 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.887 1.675 . . . . 0.0 110.71 169.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 56.0 p -135.88 148.38 48.58 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.486 1.114 . . . . 0.0 112.091 171.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 173.09 -144.13 7.64 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 123.017 0.341 . . . . 0.0 113.852 177.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.4 mtm180 -98.14 145.48 26.53 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.94 1.696 . . . . 0.0 112.069 -174.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.4 tp -85.61 136.47 33.37 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.584 1.553 . . . . 0.0 109.778 163.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 39.3 ttt-85 -145.68 87.08 1.76 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.626 1.17 . . . . 0.0 110.862 167.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.1 mt -71.28 125.59 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 171.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.7 p -128.23 163.91 23.7 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.376 1.87 . . . . 0.0 110.131 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.3 t -163.78 148.73 10.67 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.678 -1.264 . . . . 0.0 110.754 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.515 ' HE3' ' CE1' ' A' ' 57' ' ' TYR . 57.9 mttt -125.21 -126.37 0.24 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.967 1.307 . . . . 0.0 110.037 -172.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.48 94.11 1.69 Allowed Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.293 1.425 . . . . 0.0 112.309 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 54.58 28.54 10.0 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 126.653 1.981 . . . . 0.0 113.635 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.0 m -148.16 118.21 7.23 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.634 1.573 . . . . 0.0 109.35 -174.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -96.0 163.89 12.94 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.057 1.343 . . . . 0.0 111.63 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.515 ' CE1' ' HE3' ' A' ' 52' ' ' LYS . 82.2 m-85 -147.67 107.38 3.96 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.205 1.802 . . . . 0.0 109.298 -174.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.3 mp -80.46 96.11 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 170.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -92.41 138.21 31.71 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.173 0.589 . . . . 0.0 111.475 173.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.1 mp -115.62 134.48 55.01 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.365 1.866 . . . . 0.0 109.911 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -136.09 148.47 48.29 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.962 0.905 . . . . 0.0 112.07 -168.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -71.01 141.05 50.98 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 122.766 1.269 . . . . 0.0 111.643 177.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.54 ' H ' ' CD ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -85.25 1.53 47.84 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 127.007 2.123 . . . . 0.0 116.139 -175.124 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.1 t -116.97 -45.67 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 125.336 1.454 . . . . 0.0 111.014 171.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.2 m -96.71 -20.12 18.47 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -173.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.79 9.69 83.14 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.431 1.015 . . . . 0.0 113.823 -176.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -83.34 149.07 26.96 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.999 1.319 . . . . 0.0 112.186 -174.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.4 tp -70.89 125.45 26.88 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.59 0.756 . . . . 0.0 111.24 -177.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -83.5 -57.82 3.08 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.725 0.81 . . . . 0.0 110.475 167.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.59 163.02 40.69 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.486 1.114 . . . . 0.0 112.071 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -136.39 137.69 40.79 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.469 1.507 . . . . 0.0 110.606 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.81 92.1 49.31 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.291 1.036 . . . . 0.0 111.535 176.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -56.6 139.56 88.16 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 124.649 3.566 . . . . 0.0 113.457 168.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.3 t -138.94 123.99 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 126.58 1.952 . . . . 0.0 109.618 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -88.59 -21.41 24.05 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 121.01 -1.056 . . . . 0.0 113.425 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -160.29 144.94 14.53 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.169 1.788 . . . . 0.0 110.252 170.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -118.34 129.08 25.6 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.493 1.117 . . . . 0.0 110.75 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -66.39 148.23 76.77 Favored 'Cis proline' 0 CA--C 1.542 0.887 0 CA-C-N 119.976 1.027 . . . . 0.0 113.094 -4.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.81 -163.4 15.39 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.529 1.537 . . . . 0.0 113.054 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.4 tt -69.9 -37.42 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 O-C-N 121.797 -0.826 . . . . 0.0 113.191 -175.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.54 7.14 27.35 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -165.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 23.8 t -150.55 125.13 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.478 1.511 . . . . 0.0 109.606 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -139.16 159.83 41.23 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.114 1.766 . . . . 0.0 112.17 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.0 p -114.35 156.06 25.13 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.085 1.754 . . . . 0.0 111.725 -176.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.5 m -85.91 172.09 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.089 0.956 . . . . 0.0 111.114 170.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 70.5 p -96.7 -28.09 14.47 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 178.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -88.62 -43.37 11.41 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.232 0.826 . . . . 0.0 113.232 -168.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.5 t -146.17 125.73 13.28 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.34 1.77 3.56 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -170.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.456 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.286 31.5 ptt180 -86.59 16.59 4.52 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 177.162 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -139.5 137.6 35.65 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.997 1.319 . . . . 0.0 111.102 -173.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -139.07 155.02 48.24 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.979 1.312 . . . . 0.0 111.567 -178.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.76 141.77 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.497 0.719 . . . . 0.0 109.38 164.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.44 146.85 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 118.811 0.732 . . . . 0.0 112.354 171.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -87.54 89.87 8.16 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.906 0.883 . . . . 0.0 110.071 176.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.1 pt -68.34 144.14 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 O-C-N 122.126 -0.359 . . . . 0.0 111.127 173.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -136.13 137.88 41.45 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.713 1.205 . . . . 0.0 111.613 -175.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -85.37 10.0 13.92 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.464 1.106 . . . . 0.0 113.831 -176.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.2 6.75 75.63 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.062 1.315 . . . . 0.0 115.473 177.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.4 t -123.91 3.34 8.75 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.618 1.567 . . . . 0.0 114.143 -173.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.94 21.63 15.37 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.784 1.183 . . . . 0.0 113.951 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.52 148.04 50.43 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.963 1.705 . . . . 0.0 111.011 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.0 p -151.72 166.01 32.63 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -164.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.73 146.39 33.12 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.271 1.429 . . . . 0.0 111.334 168.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -92.55 117.37 29.88 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.704 0.802 . . . . 0.0 109.672 171.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 32.9 pt -118.76 145.56 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.939 1.296 . . . . 0.0 111.419 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -90.95 141.83 15.88 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 176.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.3 pt -127.95 140.56 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 125.385 1.474 . . . . 0.0 111.646 171.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.08 143.78 15.84 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.835 1.207 . . . . 0.0 113.324 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -105.77 163.74 12.47 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.878 1.671 . . . . 0.0 111.061 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.1 t -74.08 -30.57 62.42 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.241 0.616 . . . . 0.0 112.407 176.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -151.1 150.21 30.41 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.133 0.973 . . . . 0.0 112.107 -174.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 54.7 ttt-85 -61.06 -33.68 73.7 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.43 1.092 . . . . 0.0 113.154 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.04 -27.17 73.77 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 123.901 0.763 . . . . 0.0 113.849 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -83.43 -36.27 24.35 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.088 0.944 . . . . 0.0 111.422 175.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -65.12 -33.08 75.17 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 169.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -61.0 -33.79 73.8 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.42 -0.8 . . . . 0.0 112.674 172.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -64.86 -37.87 89.08 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.808 1.185 . . . . 0.0 111.943 173.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -58.27 -50.38 73.79 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.738 0.815 . . . . 0.0 111.837 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.96 -24.27 38.2 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -176.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.7 t -80.67 -41.79 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 119.368 0.986 . . . . 0.0 111.427 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 93.2 p -63.47 -32.96 74.55 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.4 1.0 . . . . 0.0 112.87 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 61.6 mt -64.54 -58.46 6.33 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.22 1.008 . . . . 0.0 111.798 170.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -66.82 -29.8 69.83 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.247 -0.908 . . . . 0.0 113.121 -174.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -80.68 -3.55 51.08 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.42 1.088 . . . . 0.0 112.579 177.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -95.13 -19.39 20.14 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 163.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -101.41 -9.21 21.31 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.43 -31.6 55.7 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 -174.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 29.4 p-90 -79.52 -25.23 41.8 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.174 1.39 . . . . 0.0 113.283 176.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.7 t -79.26 -30.76 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.493 1.517 . . . . 0.0 110.816 172.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -94.27 29.26 2.25 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 127.235 2.214 . . . . 0.0 112.871 -177.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -79.53 90.38 5.1 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.89 0.853 . . . . 0.0 109.965 172.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 C--O 1.252 1.201 0 C-N-CA 126.813 2.045 . . . . 0.0 112.685 -172.098 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.612 0 N-CA-C 112.129 -0.388 . . . . 0.0 112.129 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 55.2 p -150.0 172.37 5.34 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 125.342 1.457 . . . . 0.0 111.783 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -65.49 -9.78 23.71 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.451 2.767 . . . . 0.0 115.322 174.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -72.66 139.83 47.56 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.263 1.025 . . . . 0.0 112.113 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 67.1 p -91.31 -13.49 32.5 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.715 1.206 . . . . 0.0 114.02 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -73.84 143.81 45.75 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.338 1.455 . . . . 0.0 112.245 -176.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.0 -49.39 0.11 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.027 1.331 . . . . 0.0 112.012 174.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.0 m -139.9 121.94 15.7 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.23 1.812 . . . . 0.0 108.258 171.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -136.57 15.84 3.15 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -173.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.78 59.45 3.11 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.435 1.494 . . . . 0.0 113.008 -172.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -121.27 56.02 1.05 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.614 1.966 . . . . 0.0 109.778 176.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -151.93 148.19 27.47 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 126.295 1.838 . . . . 0.0 109.576 -172.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -174.69 128.81 0.32 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.438 1.495 . . . . 0.0 108.587 167.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.4 m -91.1 110.78 22.06 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 165.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.6 t -65.06 142.05 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 123.766 0.826 . . . . 0.0 111.288 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.5 mt -128.18 -40.17 1.67 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.633 1.573 . . . . 0.0 112.338 -175.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 37.0 t -152.99 135.99 15.52 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.464 1.106 . . . . 0.0 111.036 173.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.4 t -129.0 126.89 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.492 1.117 . . . . 0.0 109.253 171.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -128.12 134.65 26.47 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 125.352 1.461 . . . . 0.0 110.287 175.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -78.64 -13.28 14.79 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.21 2.607 . . . . 0.0 115.268 -171.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -135.18 108.19 7.63 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.806 0.843 . . . . 0.0 111.339 -174.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.52 143.34 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.084 1.354 . . . . 0.0 110.568 173.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.5 m -123.65 131.93 53.73 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.426 1.09 . . . . 0.0 111.254 -173.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 76.6 t -97.44 134.32 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.509 1.524 . . . . 0.0 111.68 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.17 132.83 53.66 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.198 1.399 . . . . 0.0 108.685 168.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -71.4 131.72 43.78 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 162.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.1 pt -111.8 151.82 43.72 Favored Pre-proline 0 N--CA 1.476 0.849 0 C-N-CA 124.043 0.937 . . . . 0.0 113.327 -164.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -63.93 163.98 23.49 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.068 2.512 . . . . 0.0 111.571 165.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -59.49 149.87 79.15 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.92 2.413 . . . . 0.0 112.705 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.7 ttm105 -61.51 155.05 22.94 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.643 1.577 . . . . 0.0 112.384 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.12 174.93 0.46 Allowed 'General case' 0 CA--C 1.551 0.987 0 CA-C-O 122.005 0.907 . . . . 0.0 112.51 159.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 84.7 p -83.38 -41.71 17.86 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.22 -0.925 . . . . 0.0 113.288 -170.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -130.52 -1.89 4.35 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.603 1.561 . . . . 0.0 113.165 -175.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -107.65 -55.87 2.3 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -169.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.81 -129.89 7.22 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -160.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -131.68 169.91 15.51 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.428 2.291 . . . . 0.0 110.526 -175.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.43 18.89 7.5 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -175.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.92 -51.4 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.968 2.507 . . . . 0.0 115.481 -173.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.0 m -65.43 -13.26 58.31 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.253 1.821 . . . . 0.0 114.257 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -79.89 -12.01 59.77 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.323 1.049 . . . . 0.0 112.645 172.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -95.35 165.33 12.43 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.801 1.641 . . . . 0.0 111.12 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.1 mttt -78.07 57.68 1.84 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.622 1.569 . . . . 0.0 113.261 175.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.1 mt -55.47 -31.75 62.23 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -173.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -89.68 -5.67 56.85 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.838 0.855 . . . . 0.0 113.042 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -138.62 68.92 45.24 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 125.479 1.512 . . . . 0.0 111.685 -161.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -68.0 145.66 68.43 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 CA-C-N 119.535 0.869 . . . . 0.0 113.097 -170.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -71.33 -31.15 67.05 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.255 0.622 . . . . 0.0 111.001 166.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 54.9 t90 -157.36 154.8 29.51 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.757 1.623 . . . . 0.0 111.149 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.2 p -132.94 148.31 52.28 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.745 1.218 . . . . 0.0 111.522 170.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.484 ' HA2' ' HE3' ' A' ' 63' ' ' LYS . . . -178.54 -146.1 6.37 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 114.332 0.493 . . . . 0.0 114.332 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -110.84 145.08 38.85 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.426 1.89 . . . . 0.0 110.952 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.6 tp -85.49 138.73 32.03 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.594 1.558 . . . . 0.0 109.939 170.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.1 ttt85 -142.81 87.95 2.02 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.676 1.19 . . . . 0.0 110.649 170.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.1 mt -75.37 124.82 34.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 170.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.4 p -134.78 169.37 17.45 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 127.065 2.146 . . . . 0.0 109.712 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.3 t -157.17 160.14 38.45 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.732 -1.23 . . . . 0.0 112.176 176.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -147.85 118.66 7.58 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.658 0.742 . . . . 0.0 111.879 160.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.24 -119.96 11.23 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 125.899 1.714 . . . . 0.0 110.506 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -92.03 10.62 28.33 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.853 1.661 . . . . 0.0 113.824 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.1 m -129.31 112.75 14.19 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.592 0.757 . . . . 0.0 111.231 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.13 161.27 16.59 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.55 0.74 . . . . 0.0 111.493 172.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -141.45 106.01 4.87 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.443 1.897 . . . . 0.0 109.31 -173.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -82.77 95.68 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 168.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -91.1 138.28 31.72 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.74 0.816 . . . . 0.0 110.86 175.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mp -112.75 130.48 56.05 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.075 1.75 . . . . 0.0 109.927 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -133.99 148.78 51.16 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.005 0.922 . . . . 0.0 112.427 -172.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -66.53 147.56 53.11 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.05 -1.031 . . . . 0.0 111.824 177.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.484 ' HE3' ' HA2' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -83.93 -0.3 50.86 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -174.168 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.5 t -120.05 -45.26 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.856 1.262 . . . . 0.0 111.508 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.7 p -94.04 -23.54 17.97 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.55 11.85 80.29 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 123.814 0.721 . . . . 0.0 113.478 -169.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -70.57 142.8 51.71 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.888 1.344 . . . . 0.0 111.621 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.4 tp -71.03 125.21 26.25 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.154 0.582 . . . . 0.0 111.208 -176.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -85.23 -56.35 3.58 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.443 1.097 . . . . 0.0 110.923 170.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.0 164.41 36.8 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.563 1.545 . . . . 0.0 110.547 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -144.98 143.32 30.46 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 169.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -114.56 111.97 46.07 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 125.086 1.355 . . . . 0.0 111.177 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.57 144.07 13.91 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.406 2.737 . . . . 0.0 111.36 175.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.8 t -135.65 128.91 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.488 1.515 . . . . 0.0 109.496 -173.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -94.65 -21.5 18.75 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.74 147.59 11.88 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.636 1.974 . . . . 0.0 110.05 170.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -116.07 128.61 25.85 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 124.803 1.241 . . . . 0.0 110.859 176.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -67.56 149.72 82.88 Favored 'Cis proline' 0 CA--C 1.544 0.978 0 CA-C-N 119.788 0.96 . . . . 0.0 112.804 -5.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.54 -167.31 17.62 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.658 1.599 . . . . 0.0 112.728 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.6 tt -67.52 -36.7 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 O-C-N 121.56 -0.965 . . . . 0.0 112.907 -177.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.32 4.23 32.11 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 -167.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.2 t -151.49 127.61 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.145 1.378 . . . . 0.0 110.448 -177.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -142.63 158.25 43.85 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.983 1.713 . . . . 0.0 112.872 -177.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.5 p -101.72 163.27 12.34 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.237 1.815 . . . . 0.0 111.749 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.5 m -89.54 169.64 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.178 0.991 . . . . 0.0 110.084 162.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 81.3 p -95.09 -30.72 13.92 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.864 1.266 . . . . 0.0 113.53 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -94.73 -39.1 10.48 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -164.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.6 t -137.09 118.84 15.06 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -175.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.3 m -74.92 21.02 0.12 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -164.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.9 ptt-85 -120.44 20.94 11.79 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.532 1.933 . . . . 0.0 114.095 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -138.56 140.9 39.23 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.308 1.443 . . . . 0.0 110.883 -173.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -140.8 156.84 46.06 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.842 1.257 . . . . 0.0 111.42 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 83.2 t -107.97 142.42 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.991 0.917 . . . . 0.0 109.5 165.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.75 148.19 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 118.492 0.587 . . . . 0.0 111.889 169.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.0 ttp85 -92.19 91.81 7.93 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.337 0.655 . . . . 0.0 110.581 176.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.5 pp -75.26 152.96 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.64 0.776 . . . . 0.0 112.05 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.63 150.83 40.3 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.958 1.703 . . . . 0.0 110.9 173.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -93.37 2.4 56.54 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.55 1.14 . . . . 0.0 113.054 174.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.65 12.8 81.13 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.26 1.409 . . . . 0.0 114.871 177.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.2 t -138.93 16.43 2.66 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.491 1.516 . . . . 0.0 113.276 -171.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.2 -0.37 78.34 Favored Glycine 0 CA--C 1.537 1.453 0 O-C-N 120.7 -1.25 . . . . 0.0 115.167 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 83.1 mtt180 -80.7 137.47 36.3 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.693 1.597 . . . . 0.0 108.836 166.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.6 p -142.7 157.41 44.69 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 166.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.03 143.4 28.35 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.824 1.25 . . . . 0.0 111.646 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -84.36 118.07 24.0 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.681 0.792 . . . . 0.0 109.536 168.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 30.3 pt -118.34 144.73 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.828 1.251 . . . . 0.0 110.996 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -92.08 139.0 14.5 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.1 pt -124.23 142.21 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 125.039 1.336 . . . . 0.0 111.867 171.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -124.05 143.16 14.68 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 124.777 1.179 . . . . 0.0 113.69 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -106.0 159.79 15.78 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.976 1.711 . . . . 0.0 110.833 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.5 t -72.87 -23.83 60.78 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.699 0.799 . . . . 0.0 112.739 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -158.75 153.74 25.13 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.915 1.286 . . . . 0.0 110.82 -175.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -58.78 -34.44 71.45 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.575 0.75 . . . . 0.0 112.715 176.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.46 -31.65 78.28 Favored Glycine 0 CA--C 1.536 1.368 0 CA-C-N 119.491 1.041 . . . . 0.0 114.348 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -85.85 -36.02 20.26 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.237 1.018 . . . . 0.0 112.114 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.92 -31.96 71.46 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.681 -0.637 . . . . 0.0 112.472 167.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . 0.28 8.2 m-85 -78.88 11.19 2.78 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 173.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -105.24 -31.46 9.09 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.765 0.826 . . . . 0.0 112.813 157.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -55.38 -47.09 76.34 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.263 1.025 . . . . 0.0 112.227 175.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -78.23 -32.71 49.95 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.8 t -76.87 -41.62 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.316 1.046 . . . . 0.0 110.906 -177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 81.8 p -64.35 -30.32 71.37 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 81.5 mt -71.67 -54.91 8.82 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.115 0.966 . . . . 0.0 111.92 171.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -66.85 -28.64 68.5 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.048 -1.033 . . . . 0.0 113.194 -175.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -84.76 -3.63 58.69 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.282 1.033 . . . . 0.0 112.664 175.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 53.1 t60 -89.06 -39.49 13.62 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 120.838 -1.164 . . . . 0.0 111.765 158.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -89.84 -1.63 58.03 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -172.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.47 -30.06 59.87 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 120.705 1.593 . . . . 0.0 114.638 -175.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 39.7 p-90 -84.97 -20.92 29.84 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.455 1.102 . . . . 0.0 113.905 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.6 t -84.69 -37.72 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.986 1.315 . . . . 0.0 110.599 175.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.0 tptt -91.5 47.6 1.39 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.165 1.786 . . . . 0.0 111.45 -177.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -86.36 11.4 12.39 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.215 1.406 . . . . 0.0 114.555 177.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 . . . . . 0 C--O 1.252 1.22 0 C-N-CA 126.77 2.028 . . . . 0.0 112.781 -178.935 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.614 0 N-CA-C 111.714 -0.555 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 35.8 m 48.03 62.04 12.74 Favored Pre-proline 0 N--CA 1.481 1.085 0 C-N-CA 126.145 1.778 . . . . 0.0 114.932 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -75.43 0.95 8.48 Favored 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 124.168 3.245 . . . . 0.0 114.304 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -66.15 158.87 27.55 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.93 1.692 . . . . 0.0 113.364 -175.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 60.2 m -109.74 -24.26 10.99 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.685 1.594 . . . . 0.0 113.343 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.9 ttp 53.1 48.4 22.37 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.843 1.657 . . . . 0.0 112.58 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.66 34.15 1.62 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.795 1.638 . . . . 0.0 111.402 -172.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.1 m 58.18 80.3 0.18 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.511 1.925 . . . . 0.0 111.995 -168.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -100.78 17.53 21.81 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.7 1.6 . . . . 0.0 114.631 -170.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.5 tt -76.37 55.18 0.97 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 127.012 2.125 . . . . 0.0 111.819 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -88.32 50.44 1.98 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.714 1.606 . . . . 0.0 111.653 -176.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -149.15 146.09 27.5 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.396 1.478 . . . . 0.0 111.516 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -175.22 96.3 0.07 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.435 1.894 . . . . 0.0 108.076 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 m -80.87 112.01 17.86 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.908 -1.12 . . . . 0.0 109.631 172.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 p -66.85 145.45 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.386 0.674 . . . . 0.0 112.54 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 50.0 mt -126.82 -44.02 1.67 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.747 1.619 . . . . 0.0 112.209 -176.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.3 t -152.36 134.84 15.24 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.637 1.175 . . . . 0.0 110.482 175.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 86.3 t -127.21 127.06 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.333 1.053 . . . . 0.0 109.325 170.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -127.64 132.91 24.57 Favored Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 125.081 1.352 . . . . 0.0 110.228 174.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.13 -15.75 16.08 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.137 2.558 . . . . 0.0 114.874 -172.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -133.81 106.9 7.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.353 1.061 . . . . 0.0 110.987 -175.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.2 p -142.77 146.18 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 125.342 1.457 . . . . 0.0 110.224 173.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.5 m -127.83 132.13 49.47 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.057 0.943 . . . . 0.0 111.597 -171.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.2 t -98.8 130.24 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.399 1.479 . . . . 0.0 111.803 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -131.31 131.49 43.83 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.236 1.414 . . . . 0.0 109.637 170.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.8 mmt-85 -59.89 140.36 56.71 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.482 165.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.9 pt -107.74 154.45 40.91 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 125.499 1.519 . . . . 0.0 112.834 -174.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -69.73 161.91 44.09 Favored 'Trans proline' 0 CA--C 1.548 1.191 0 C-N-CA 123.065 2.51 . . . . 0.0 111.559 164.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -62.74 144.2 93.45 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.898 2.398 . . . . 0.0 112.204 175.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.19 160.23 28.1 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.691 1.196 . . . . 0.0 112.632 -177.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -144.03 165.81 26.73 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.589 154.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.0 m -82.52 -31.58 29.14 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.122 1.769 . . . . 0.0 112.439 -176.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 -93.25 20.24 7.23 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.343 1.457 . . . . 0.0 112.325 171.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 91.4 mmt-85 -133.3 -64.28 0.73 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.522 1.529 . . . . 0.0 111.778 175.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.0 161.84 6.47 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 122.651 1.14 . . . . 0.0 112.986 -172.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -74.84 138.28 42.42 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.915 0.886 . . . . 0.0 110.0 168.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.13 19.67 6.43 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -172.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.49 -50.07 0.05 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.789 2.435 . . . . 0.0 115.39 -174.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.9 m -68.54 -16.62 63.94 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.843 1.657 . . . . 0.0 114.75 -175.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.52 -7.35 59.55 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 172.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.0 m0 -85.58 168.02 14.85 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.857 1.263 . . . . 0.0 110.639 175.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.8 mttt -77.72 52.23 0.99 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.129 1.372 . . . . 0.0 113.964 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.8 mt -57.52 -28.46 63.49 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -175.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -90.28 -6.15 55.48 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -149.91 83.56 6.18 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.502 1.121 . . . . 0.0 112.332 177.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -56.52 147.08 71.55 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.248 2.632 . . . . 0.0 112.95 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -70.1 -33.96 72.51 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.399 0.68 . . . . 0.0 111.14 165.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.5 t90 -156.61 152.68 27.49 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.812 1.645 . . . . 0.0 110.801 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.3 p -132.55 149.88 52.25 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.122 0.969 . . . . 0.0 111.554 167.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.99 -141.44 5.13 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 123.07 0.367 . . . . 0.0 113.282 -178.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.2 mtm105 -109.8 144.92 37.55 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.065 1.746 . . . . 0.0 111.88 -175.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.8 tp -85.36 137.59 32.84 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.711 1.204 . . . . 0.0 109.129 163.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.8 ttt-85 -143.97 89.37 2.03 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.263 1.025 . . . . 0.0 110.56 164.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.1 mt -71.53 130.05 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 170.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 p -132.83 173.76 11.04 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.933 2.093 . . . . 0.0 110.282 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 92.9 p -161.89 166.73 25.82 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 120.687 -1.258 . . . . 0.0 111.712 178.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.2 mmtt -152.92 -117.74 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.658 1.583 . . . . 0.0 110.451 153.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.47 92.05 0.41 Allowed Glycine 0 N--CA 1.471 1.024 0 C-N-CA 125.636 1.588 . . . . 0.0 113.802 -160.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.7 mttt 50.99 27.91 3.52 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.429 1.891 . . . . 0.0 112.915 -175.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.1 m -143.42 127.82 17.85 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.24 1.416 . . . . 0.0 109.269 -173.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.76 161.57 13.51 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.637 1.175 . . . . 0.0 110.562 169.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -141.25 102.34 4.21 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.163 1.785 . . . . 0.0 108.905 -173.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.1 mp -78.57 98.09 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 170.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -97.61 138.02 35.65 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.395 0.617 . . . . 0.0 111.575 173.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mp -109.11 132.93 53.64 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.197 1.799 . . . . 0.0 109.568 174.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -137.88 151.92 48.52 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.891 0.876 . . . . 0.0 112.569 -168.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -74.12 143.99 45.1 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.123 -0.986 . . . . 0.0 112.092 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -84.07 -6.55 59.43 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.376 1.871 . . . . 0.0 115.128 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 92.5 t -123.37 -44.32 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 125.315 1.446 . . . . 0.0 111.423 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.8 m -93.64 -22.88 18.5 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -174.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.0 6.88 86.43 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 123.956 0.789 . . . . 0.0 113.805 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -82.37 155.68 24.6 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.364 1.466 . . . . 0.0 112.441 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.3 tp -74.5 129.01 36.97 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.492 0.717 . . . . 0.0 111.223 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -88.04 -55.19 3.86 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.234 1.014 . . . . 0.0 111.16 169.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.39 161.25 40.13 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.918 1.287 . . . . 0.0 111.323 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -144.22 140.74 29.46 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.759 0.824 . . . . 0.0 112.565 176.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.79 102.5 22.37 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 125.936 1.694 . . . . 0.0 111.157 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -69.33 147.15 64.98 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.927 3.085 . . . . 0.0 112.438 170.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.9 t -138.15 125.07 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.796 1.638 . . . . 0.0 109.152 -176.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -92.02 -22.48 19.94 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -159.88 147.45 16.73 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.562 1.945 . . . . 0.0 109.642 168.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -124.14 127.62 25.29 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 124.684 1.194 . . . . 0.0 110.964 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.43 147.4 50.06 Favored 'Cis proline' 0 CA--C 1.541 0.87 0 CA-C-N 120.079 1.064 . . . . 0.0 114.534 -4.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.33 -166.58 19.44 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.488 1.518 . . . . 0.0 113.429 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.4 tp -70.65 -31.24 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -174.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.85 3.54 50.84 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -171.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.9 t -150.34 133.54 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.902 1.281 . . . . 0.0 110.844 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -141.35 161.61 37.49 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.319 1.448 . . . . 0.0 112.83 175.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 73.0 p -107.21 161.23 14.96 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 127.055 2.142 . . . . 0.0 111.093 177.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.8 m -88.27 172.83 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 123.897 0.879 . . . . 0.0 111.232 166.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 60.0 p -96.22 -30.29 13.55 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.39 1.476 . . . . 0.0 113.368 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -96.28 -40.59 9.08 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -165.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.5 t -137.74 117.96 13.59 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -173.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.3 p -75.08 29.25 0.09 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -172.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.96 24.82 7.48 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 127.108 2.163 . . . . 0.0 113.937 174.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -140.96 139.88 34.31 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.902 1.281 . . . . 0.0 111.261 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -137.74 159.87 40.8 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.813 1.245 . . . . 0.0 110.738 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.8 t -112.18 144.66 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 124.288 1.035 . . . . 0.0 108.772 165.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.94 148.07 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 118.095 0.407 . . . . 0.0 111.755 168.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -89.86 99.98 12.88 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.31 0.644 . . . . 0.0 109.542 172.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -84.7 155.21 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.536 1.135 . . . . 0.0 111.335 176.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -129.97 145.79 51.65 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.969 1.308 . . . . 0.0 111.592 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -95.25 13.88 24.07 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.104 1.362 . . . . 0.0 113.388 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.72 5.26 86.23 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 125.291 1.424 . . . . 0.0 115.65 176.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.9 t -127.32 6.35 6.38 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.571 1.548 . . . . 0.0 113.77 -174.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.19 -5.39 71.55 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 125.388 1.47 . . . . 0.0 113.92 -175.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -74.53 132.94 42.26 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 127.567 2.347 . . . . 0.0 109.069 166.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 84.1 p -139.86 160.38 40.02 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.064 1.345 . . . . 0.0 113.772 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.48 144.77 28.82 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.89 1.276 . . . . 0.0 111.267 172.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -87.88 119.89 28.67 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 165.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 31.3 pt -120.69 142.81 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.628 1.171 . . . . 0.0 111.218 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.69 137.31 13.51 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 176.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.3 pt -124.6 139.05 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 125.226 1.41 . . . . 0.0 111.713 175.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.1 140.28 14.45 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.719 1.152 . . . . 0.0 113.082 177.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -101.84 159.47 15.31 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.025 1.73 . . . . 0.0 111.37 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.5 t -70.58 -27.38 64.07 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.32 0.648 . . . . 0.0 112.646 178.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -158.05 155.96 30.23 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.382 1.073 . . . . 0.0 111.997 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -56.58 -38.41 71.94 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.662 1.185 . . . . 0.0 112.482 174.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.05 -10.43 46.72 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.541 1.067 . . . . 0.0 115.022 176.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -104.75 -35.97 7.58 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.746 1.273 . . . . 0.0 111.754 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.7 -28.27 68.52 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.65 0.78 . . . . 0.0 112.835 164.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -70.74 -6.51 38.01 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 169.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -93.76 -35.25 12.87 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.939 1.245 . . . . 0.0 112.26 163.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -55.2 -55.76 27.64 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.304 0.957 . . . . 0.0 112.267 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -78.81 -27.66 44.42 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 -173.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.6 t -79.74 -39.58 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 121.749 -0.595 . . . . 0.0 111.043 -178.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 88.5 p -65.7 -33.31 75.59 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.544 -0.722 . . . . 0.0 112.524 174.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 40.6 mt -66.62 -55.73 13.96 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.035 0.934 . . . . 0.0 112.154 172.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -64.85 -27.26 68.75 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.136 0.88 . . . . 0.0 112.874 -176.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -79.0 -7.8 58.38 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.345 1.058 . . . . 0.0 112.873 176.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -84.89 -15.61 44.0 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.087 -1.008 . . . . 0.0 112.815 165.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -115.17 -7.92 12.41 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -173.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.17 -24.37 53.89 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 36.1 p-90 -94.65 -21.43 18.8 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.771 1.628 . . . . 0.0 113.579 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.2 t -78.09 -32.49 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.047 1.339 . . . . 0.0 111.739 -175.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -98.46 22.5 9.69 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.546 1.538 . . . . 0.0 113.138 -177.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -85.19 90.2 7.83 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.174 0.989 . . . . 0.0 109.605 171.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 C--O 1.252 1.199 0 C-N-CA 126.51 1.924 . . . . 0.0 112.801 -169.33 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 N-CA-C 111.965 -0.454 . . . . 0.0 111.965 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 39.3 m -67.05 149.09 98.7 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.423 1.089 . . . . 0.0 112.924 -179.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -66.32 -26.42 48.64 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.061 2.507 . . . . 0.0 114.117 173.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -81.64 163.54 22.47 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.396 1.478 . . . . 0.0 112.53 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 65.3 p -75.1 -3.31 31.99 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptp -61.06 148.44 40.32 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.578 1.551 . . . . 0.0 113.009 176.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.16 -57.68 0.13 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.845 1.258 . . . . 0.0 111.508 176.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 52.0 m -153.89 116.79 4.48 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.923 1.689 . . . . 0.0 109.092 169.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -150.31 17.03 0.83 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.968 1.307 . . . . 0.0 113.273 -174.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tt -81.27 50.19 1.4 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.791 2.036 . . . . 0.0 111.761 -177.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -84.76 44.94 1.1 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.774 1.63 . . . . 0.0 112.581 -170.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -147.01 149.91 34.06 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.322 1.449 . . . . 0.0 113.051 -177.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -177.37 77.53 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 129.613 3.165 . . . . 0.0 106.479 -173.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.05 113.57 7.38 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 120.668 -1.27 . . . . 0.0 111.299 -165.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.5 t -73.52 143.72 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.741 1.216 . . . . 0.0 111.583 -169.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.9 mt -128.86 -38.67 1.65 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.73 1.612 . . . . 0.0 112.625 -174.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 34.8 t -154.22 136.76 15.09 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.618 1.167 . . . . 0.0 110.726 173.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 88.7 t -130.14 127.27 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.639 1.176 . . . . 0.0 109.383 171.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -129.05 140.17 37.84 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 125.791 1.636 . . . . 0.0 110.794 176.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -77.35 -27.26 6.64 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.464 2.776 . . . . 0.0 115.84 -168.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -140.05 115.87 10.24 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.087 0.946 . . . . 0.0 111.843 -175.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.9 145.4 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 126.84 2.056 . . . . 0.0 109.726 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.2 m -124.71 130.05 51.68 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.767 0.827 . . . . 0.0 112.133 -167.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 77.8 t -94.6 137.44 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.212 1.405 . . . . 0.0 112.051 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.56 128.72 37.84 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.624 1.17 . . . . 0.0 110.133 169.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.41 135.95 57.34 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.306 1.042 . . . . 0.0 111.035 161.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.8 pt -120.71 152.39 55.75 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 126.248 1.819 . . . . 0.0 112.294 -177.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -68.81 158.25 58.58 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 122.247 1.964 . . . . 0.0 110.929 161.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -64.02 145.42 89.74 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.726 2.284 . . . . 0.0 111.688 174.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.8 ttm105 -67.45 158.55 31.54 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.096 0.958 . . . . 0.0 112.685 -177.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -123.74 136.68 54.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.955 145.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.2 m -71.61 -22.71 61.67 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.364 1.466 . . . . 0.0 113.77 -172.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 -84.92 10.24 12.26 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.768 1.227 . . . . 0.0 112.608 169.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 88.2 mmt-85 -130.2 -57.99 1.07 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.144 1.778 . . . . 0.0 111.989 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.73 156.16 6.91 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 122.343 0.968 . . . . 0.0 113.392 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -75.52 139.04 41.94 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.677 0.791 . . . . 0.0 109.975 169.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.62 18.45 6.83 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -170.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.73 -50.67 0.05 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.879 2.472 . . . . 0.0 115.464 -175.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.6 m -66.77 -14.6 62.79 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.069 1.748 . . . . 0.0 114.19 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -76.36 -21.51 56.01 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.723 1.209 . . . . 0.0 112.56 172.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 17.3 m0 -84.52 172.09 11.96 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.667 1.587 . . . . 0.0 111.524 -177.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -80.16 54.55 1.98 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.365 1.466 . . . . 0.0 113.978 -177.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.7 mt -60.71 -17.27 47.23 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -174.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -102.08 -8.04 21.77 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.813 1.245 . . . . 0.0 113.104 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -149.0 72.52 10.29 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.896 1.278 . . . . 0.0 111.867 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -57.47 145.58 87.77 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.043 2.495 . . . . 0.0 112.374 174.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -70.07 -29.14 66.07 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.513 1.125 . . . . 0.0 111.749 175.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 42.1 t90 -159.44 152.99 22.63 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.035 1.734 . . . . 0.0 110.476 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.2 p -133.7 152.31 51.85 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.575 -0.703 . . . . 0.0 112.381 166.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.08 -146.72 7.35 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 116.174 -0.466 . . . . 0.0 114.085 -176.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 42.7 mtm105 -104.84 148.27 26.83 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.047 2.139 . . . . 0.0 111.734 -175.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.3 tp -89.51 139.43 30.54 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.257 1.423 . . . . 0.0 110.247 167.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 -141.53 97.15 3.1 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.65 1.58 . . . . 0.0 109.682 167.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.3 mt -83.31 130.67 35.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 169.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.81 162.82 34.47 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.51 2.324 . . . . 0.0 109.508 -168.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.5 t -163.48 153.73 15.66 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.431 -1.418 . . . . 0.0 110.508 175.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -128.58 -41.79 1.5 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 116.786 2.143 . . . . 0.0 116.786 -176.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.92 82.53 0.1 OUTLIER Glycine 0 N--CA 1.472 1.072 0 CA-C-N 118.652 0.66 . . . . 0.0 112.075 -175.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt 54.71 25.24 6.29 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.006 1.722 . . . . 0.0 112.749 -171.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.7 m -141.43 118.27 11.11 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.197 1.399 . . . . 0.0 107.649 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.51 160.06 14.69 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.241 1.016 . . . . 0.0 110.799 174.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -138.44 113.81 9.55 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 126.346 1.858 . . . . 0.0 108.956 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.5 mp -86.12 102.17 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 166.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -100.67 140.01 35.55 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.349 1.059 . . . . 0.0 111.409 176.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.8 mp -113.32 130.6 56.22 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.444 1.898 . . . . 0.0 109.605 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -135.85 153.26 51.54 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.079 0.952 . . . . 0.0 112.259 -174.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -73.12 142.91 47.49 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.85 -1.156 . . . . 0.0 111.9 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.3 pttt -84.63 -4.64 59.1 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.973 1.709 . . . . 0.0 115.048 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 64.8 t -124.79 -43.81 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 125.468 1.507 . . . . 0.0 111.361 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.7 m -91.54 -24.2 19.69 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.5 5.77 87.99 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 123.992 0.806 . . . . 0.0 113.831 -177.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -82.78 151.17 26.24 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.343 1.457 . . . . 0.0 112.566 -173.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.1 tp -73.36 126.12 29.41 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.612 0.765 . . . . 0.0 110.886 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -87.65 -54.8 4.07 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.462 1.105 . . . . 0.0 111.226 171.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.29 163.64 38.51 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.575 1.15 . . . . 0.0 112.01 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -142.23 134.41 27.59 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.707 1.203 . . . . 0.0 111.653 177.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.15 97.08 50.5 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.11 1.364 . . . . 0.0 111.669 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -58.89 139.7 91.97 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 124.568 3.512 . . . . 0.0 113.315 166.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.3 t -139.13 128.87 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.571 1.949 . . . . 0.0 109.52 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -90.77 -24.12 20.44 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.34 149.97 15.94 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.034 1.734 . . . . 0.0 110.772 173.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -118.83 130.43 24.82 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.589 1.156 . . . . 0.0 111.469 175.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -63.34 148.33 64.16 Favored 'Cis proline' 0 CA--C 1.542 0.879 0 CA-C-N 119.761 0.951 . . . . 0.0 113.583 -7.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -152.39 -163.91 11.96 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.578 1.561 . . . . 0.0 112.461 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.9 tt -78.13 -36.47 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 O-C-N 121.82 -0.812 . . . . 0.0 112.938 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.94 8.71 9.76 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -169.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.0 t -149.8 133.69 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 126.33 1.852 . . . . 0.0 109.446 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -146.43 159.17 43.74 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.464 1.506 . . . . 0.0 112.489 -177.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.8 p -109.7 155.66 21.25 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 126.638 1.975 . . . . 0.0 111.696 176.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.1 m -80.51 173.46 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 124.01 0.924 . . . . 0.0 110.982 165.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.6 p -95.68 -30.21 13.88 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.409 1.484 . . . . 0.0 113.357 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -91.1 -50.24 5.96 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.927 0.891 . . . . 0.0 113.266 -167.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.7 m -133.78 117.39 16.84 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -167.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.0 m -73.23 28.36 0.06 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -171.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.418 ' HA ' ' CB ' ' A' ' 116' ' ' ALA . 6.1 ptm180 -125.23 23.62 7.61 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.859 2.064 . . . . 0.0 113.577 175.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -141.07 137.43 32.87 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.279 1.432 . . . . 0.0 110.99 -178.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -137.35 165.24 26.67 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.855 1.262 . . . . 0.0 111.128 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.3 t -120.28 143.29 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 124.658 1.183 . . . . 0.0 108.539 168.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.72 149.05 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 118.639 0.654 . . . . 0.0 111.744 172.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -92.49 90.23 7.08 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.051 0.54 . . . . 0.0 110.858 177.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -70.57 141.32 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 122.894 0.478 . . . . 0.0 110.995 177.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -137.87 146.4 43.36 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.09 1.756 . . . . 0.0 111.491 -172.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -90.23 -0.31 57.56 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.948 0.899 . . . . 0.0 113.074 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.6 12.8 77.24 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 125.227 1.394 . . . . 0.0 114.896 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.4 t -138.28 18.07 2.77 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.382 1.473 . . . . 0.0 113.465 -173.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.27 -6.14 82.57 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.756 1.17 . . . . 0.0 114.927 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -72.62 129.87 39.26 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.301 1.44 . . . . 0.0 108.469 164.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 93.6 p -152.82 161.31 42.71 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 172.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.14 146.46 30.87 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.527 1.531 . . . . 0.0 111.29 171.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -87.11 124.56 33.38 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.737 -0.602 . . . . 0.0 109.425 166.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.8 pt -122.5 143.57 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.522 1.129 . . . . 0.0 111.092 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -90.18 144.28 17.46 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 173.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.8 pt -129.67 140.43 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 125.53 1.532 . . . . 0.0 111.991 173.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.23 137.7 11.59 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 125.64 1.591 . . . . 0.0 113.151 178.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -102.09 162.92 12.54 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.252 1.821 . . . . 0.0 111.29 -178.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.4 t -74.14 -27.73 60.99 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.722 0.809 . . . . 0.0 113.006 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -157.11 153.27 27.52 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.276 1.03 . . . . 0.0 112.229 -177.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -60.01 -34.4 73.28 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.601 1.16 . . . . 0.0 113.151 176.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.1 -31.54 81.12 Favored Glycine 0 CA--C 1.536 1.39 0 CA-C-N 119.131 0.878 . . . . 0.0 113.382 176.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -83.69 -34.69 24.9 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.804 0.842 . . . . 0.0 112.093 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.418 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -65.46 -33.51 76.12 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 170.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -61.77 -32.19 72.45 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.043 -1.036 . . . . 0.0 112.582 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -66.34 -30.15 70.49 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.049 -1.032 . . . . 0.0 112.738 173.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -63.09 -49.35 74.83 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.372 0.987 . . . . 0.0 111.943 173.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.8 -25.11 33.03 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -177.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.8 t -78.37 -41.59 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 119.197 0.908 . . . . 0.0 111.39 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 93.7 p -64.58 -29.49 70.51 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.251 0.932 . . . . 0.0 113.302 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 78.0 mt -70.96 -54.28 11.9 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.004 0.922 . . . . 0.0 111.712 171.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -68.51 -32.74 72.91 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.01 -1.056 . . . . 0.0 113.225 -174.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -83.81 -1.34 54.12 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.088 0.955 . . . . 0.0 112.364 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -96.44 -33.24 11.95 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 120.931 -1.106 . . . . 0.0 112.545 164.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -93.05 -3.28 54.57 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -31.17 58.37 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 121.595 1.998 . . . . 0.0 114.936 -175.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 35.6 p-90 -81.03 -20.29 42.02 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.695 1.198 . . . . 0.0 113.716 177.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.8 t -84.24 -36.13 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.21 1.404 . . . . 0.0 110.364 170.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 48.3 tptt -93.12 45.52 1.18 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 127.519 2.327 . . . . 0.0 111.597 -177.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -84.07 95.28 8.54 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.656 1.183 . . . . 0.0 110.774 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 . . . . . 0 C--O 1.254 1.3 0 C-N-CA 127.002 2.121 . . . . 0.0 112.398 176.078 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.574 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 38.0 t -73.99 136.11 76.66 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 123.704 0.802 . . . . 0.0 112.36 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -78.73 -3.48 13.3 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.782 2.988 . . . . 0.0 113.338 173.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -83.79 28.36 0.59 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.483 1.513 . . . . 0.0 113.935 -171.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 60.4 p -58.46 -33.14 69.42 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.664 -1.272 . . . . 0.0 113.422 -178.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mmt -84.65 14.15 4.95 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.533 1.533 . . . . 0.0 113.844 176.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.63 -40.98 0.86 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.832 1.653 . . . . 0.0 112.323 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 58.5 m -66.18 -39.63 89.85 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.952 0.901 . . . . 0.0 110.746 165.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 46.3 72.08 0.25 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.887 2.475 . . . . 0.0 115.814 157.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.6 pp -70.17 140.21 52.52 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.494 -0.754 . . . . 0.0 111.172 165.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -135.78 51.06 2.07 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.471 1.508 . . . . 0.0 110.209 -178.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -136.02 139.81 43.4 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.954 1.302 . . . . 0.0 110.7 178.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -179.82 121.53 0.07 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.144 1.778 . . . . 0.0 108.516 163.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 82.6 p -97.98 109.25 22.04 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.083 0.468 . . . . 0.0 111.096 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 82.5 t -70.62 141.01 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.916 0.886 . . . . 0.0 111.053 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.6 mt -127.49 -40.54 1.77 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.697 1.599 . . . . 0.0 112.646 -171.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 51.1 t -146.87 137.28 23.65 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.505 1.522 . . . . 0.0 109.247 172.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 76.8 t -126.6 130.48 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.355 1.062 . . . . 0.0 108.936 168.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -133.57 127.84 19.79 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 124.562 1.145 . . . . 0.0 111.076 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.19 -13.24 12.65 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.986 2.457 . . . . 0.0 114.947 -171.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -134.11 104.52 6.25 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.223 1.009 . . . . 0.0 110.717 -176.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.5 p -143.18 144.42 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.508 1.123 . . . . 0.0 110.726 174.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.8 m -124.88 131.21 53.46 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.55 1.14 . . . . 0.0 110.629 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.0 t -96.61 134.33 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.946 1.298 . . . . 0.0 111.127 177.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.38 120.63 25.87 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.06 1.344 . . . . 0.0 108.932 169.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -63.24 130.79 46.06 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.425 -0.797 . . . . 0.0 109.145 163.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.2 pt -93.85 153.03 41.04 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 124.845 1.258 . . . . 0.0 112.834 -166.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -65.08 159.57 46.0 Favored 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 122.896 2.397 . . . . 0.0 111.454 165.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -63.02 140.79 80.88 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.013 2.475 . . . . 0.0 112.138 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.3 ttm-85 -74.28 156.57 37.04 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.691 1.197 . . . . 0.0 112.39 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -132.43 137.65 47.36 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.598 141.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.1 m -68.92 -29.77 68.09 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.493 1.517 . . . . 0.0 114.106 -169.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -75.93 -7.71 55.21 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.875 0.87 . . . . 0.0 113.009 171.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 27.0 mmt-85 -104.71 -52.16 2.93 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.845 1.658 . . . . 0.0 111.893 175.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.32 161.94 19.31 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 122.195 0.886 . . . . 0.0 112.653 -177.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -75.28 133.95 41.19 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.864 0.866 . . . . 0.0 109.84 169.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.92 18.64 7.86 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -171.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.16 -49.89 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 128.141 2.576 . . . . 0.0 115.607 -173.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.5 m -67.61 -15.2 63.53 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.012 1.725 . . . . 0.0 114.603 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.95 -10.8 58.62 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 171.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.0 m0 -85.55 170.45 12.59 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.813 1.245 . . . . 0.0 110.841 176.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.9 mtmm -80.24 52.94 1.66 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.408 1.483 . . . . 0.0 113.606 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.6 mt -57.89 -23.76 54.69 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -173.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -96.28 -6.51 37.71 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.547 1.139 . . . . 0.0 112.446 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -151.99 72.37 7.88 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 125.111 1.364 . . . . 0.0 111.817 -169.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -57.97 149.59 69.62 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.725 2.95 . . . . 0.0 113.605 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -73.32 -31.11 63.81 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.76 0.824 . . . . 0.0 111.401 167.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 33.5 t90 -158.13 153.02 25.15 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.48 1.912 . . . . 0.0 110.391 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.2 p -134.18 146.74 50.45 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.719 1.208 . . . . 0.0 111.486 171.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.41 -138.5 4.28 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 114.088 0.395 . . . . 0.0 114.088 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -115.89 144.72 43.64 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.816 1.646 . . . . 0.0 111.578 -172.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.2 tp -92.49 137.72 32.12 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.354 1.462 . . . . 0.0 109.821 172.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 53.9 ttp85 -138.68 102.21 4.53 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.96 0.904 . . . . 0.0 110.026 162.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 25.8 mt -79.16 132.67 31.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 169.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.74 171.69 14.13 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 126.229 1.812 . . . . 0.0 110.708 -175.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.0 t -161.41 159.53 28.31 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.369 1.068 . . . . 0.0 110.869 172.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -147.55 -85.03 0.1 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 158.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.56 68.39 3.36 Favored Glycine 0 N--CA 1.474 1.226 0 C-N-CA 124.629 1.109 . . . . 0.0 113.959 -166.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.7 mttt 51.67 30.13 6.39 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.815 1.646 . . . . 0.0 112.49 -172.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.8 m -146.92 120.8 9.3 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.383 1.873 . . . . 0.0 108.237 -173.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.84 156.7 19.77 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.318 1.047 . . . . 0.0 110.939 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -135.15 100.41 4.54 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.336 1.855 . . . . 0.0 108.713 -173.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.6 mp -79.74 104.84 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 171.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.4 mttt -105.4 135.26 47.11 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.526 0.73 . . . . 0.0 111.775 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -101.08 133.17 46.01 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 125.237 1.415 . . . . 0.0 110.189 169.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -138.32 148.34 44.5 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.038 0.935 . . . . 0.0 112.233 -171.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -68.51 149.67 48.97 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.217 1.008 . . . . 0.0 113.688 -171.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.89 -3.84 43.73 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.9 t -123.41 -48.25 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.636 1.174 . . . . 0.0 111.705 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.6 p -95.35 -24.6 16.66 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -176.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.05 13.98 76.16 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 123.609 0.623 . . . . 0.0 113.522 -167.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -69.13 149.28 48.82 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 118.727 1.263 . . . . 0.0 111.533 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.4 tp -71.2 124.11 23.75 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.444 0.698 . . . . 0.0 111.441 -175.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -84.26 -53.86 5.2 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.971 0.908 . . . . 0.0 110.924 168.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -159.39 157.67 30.74 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.925 1.29 . . . . 0.0 111.516 -177.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -138.99 138.77 37.56 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.59 0.756 . . . . 0.0 112.81 174.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.65 111.09 36.4 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.059 1.343 . . . . 0.0 111.685 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -82.81 123.73 3.76 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.981 3.121 . . . . 0.0 111.91 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.6 t -114.41 119.73 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 126.862 2.065 . . . . 0.0 109.324 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -81.97 -20.56 38.28 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 -176.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.08 162.54 15.44 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.245 1.818 . . . . 0.0 109.308 171.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -120.45 129.81 25.15 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -173.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -64.95 151.94 76.03 Favored 'Cis proline' 0 CA--C 1.542 0.912 0 CA-C-N 119.193 0.748 . . . . 0.0 112.895 -11.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -147.37 175.48 26.71 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.165 0.888 . . . . 0.0 114.15 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.5 tp -52.97 -30.11 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 124.695 1.198 . . . . 0.0 114.066 -176.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.68 9.82 28.28 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.6 p -155.45 138.36 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.197 0.999 . . . . 0.0 113.561 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -152.24 161.12 43.09 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.664 1.586 . . . . 0.0 113.069 -172.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 62.9 p -112.88 161.01 17.46 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 127.307 2.243 . . . . 0.0 111.202 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.0 m -88.5 175.8 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.319 1.047 . . . . 0.0 111.314 167.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.7 p -95.79 -31.59 13.11 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.673 1.589 . . . . 0.0 113.357 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -93.98 -42.37 9.08 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -165.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.4 t -142.49 121.39 12.77 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -177.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.15 0.73 5.69 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -169.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.472 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.303 28.4 ptt180 -87.12 16.21 5.34 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 176.509 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -137.24 136.8 38.43 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.168 1.387 . . . . 0.0 110.908 -174.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -137.54 160.3 39.54 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.138 1.375 . . . . 0.0 111.263 -177.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.1 t -116.2 143.05 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.258 1.023 . . . . 0.0 108.915 166.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.67 149.66 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 123.441 0.697 . . . . 0.0 111.395 170.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -93.25 87.44 5.65 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.776 0.831 . . . . 0.0 110.357 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -70.24 138.35 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 120.958 0.409 . . . . 0.0 110.695 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -139.97 149.85 43.77 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.484 1.514 . . . . 0.0 111.212 -167.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -96.67 3.21 52.6 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.146 0.978 . . . . 0.0 113.071 -178.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.32 12.76 81.72 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.129 1.347 . . . . 0.0 114.704 178.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.1 t -134.52 9.86 3.7 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.64 1.576 . . . . 0.0 113.575 -172.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.39 -5.44 67.67 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.959 1.266 . . . . 0.0 114.643 -177.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -67.87 131.47 45.57 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.207 1.403 . . . . 0.0 108.828 163.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 95.6 p -146.22 152.66 39.57 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 114.646 1.351 . . . . 0.0 114.646 174.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.14 140.72 28.18 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.208 1.403 . . . . 0.0 110.927 168.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -88.39 119.69 29.06 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.175 0.59 . . . . 0.0 109.896 170.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.8 pt -118.54 142.0 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.543 1.137 . . . . 0.0 110.756 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -90.99 144.27 17.12 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 173.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.2 pt -128.38 141.81 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 125.052 1.341 . . . . 0.0 111.631 169.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -121.4 142.67 15.52 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.142 1.353 . . . . 0.0 113.169 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -107.19 164.97 11.72 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.718 1.607 . . . . 0.0 111.551 -177.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.6 t -74.39 -31.91 62.52 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.486 0.714 . . . . 0.0 112.521 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -151.71 146.36 25.71 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.245 -0.909 . . . . 0.0 112.071 -172.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -61.71 -33.78 74.62 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.329 1.051 . . . . 0.0 113.195 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.7 -25.54 75.03 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-N 118.935 0.789 . . . . 0.0 113.838 176.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -92.96 -26.38 17.59 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.193 0.997 . . . . 0.0 112.821 176.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.472 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -66.11 -34.53 78.27 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.422 -0.799 . . . . 0.0 112.598 161.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -59.82 -31.32 69.62 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.049 -1.032 . . . . 0.0 112.197 168.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -67.28 -25.19 65.93 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 119.553 1.07 . . . . 0.0 112.968 174.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -69.74 -51.87 30.42 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.205 1.002 . . . . 0.0 111.878 168.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.08 -25.3 40.08 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -174.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 65.0 t -77.97 -42.41 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 121.134 -0.979 . . . . 0.0 111.05 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 88.7 p -66.37 -30.66 71.09 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.1 mt -69.93 -55.95 8.33 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.828 0.851 . . . . 0.0 111.536 171.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -63.68 -33.7 76.22 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.117 0.871 . . . . 0.0 113.256 -174.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -83.53 -0.89 52.26 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.468 1.107 . . . . 0.0 112.762 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -94.11 -13.41 26.81 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.263 -0.898 . . . . 0.0 113.31 164.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -108.17 -4.86 17.26 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.02 -23.59 54.83 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 121.079 1.763 . . . . 0.0 115.677 -176.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 34.5 p-90 -89.95 -13.42 36.23 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.512 1.525 . . . . 0.0 114.058 175.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.4 t -91.1 -47.23 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.228 1.411 . . . . 0.0 109.546 171.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -94.16 65.76 3.42 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.569 1.947 . . . . 0.0 110.554 173.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -66.47 96.8 0.39 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.626 1.571 . . . . 0.0 111.673 -179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 C--O 1.254 1.334 0 C-N-CA 127.538 2.335 . . . . 0.0 112.628 176.071 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.581 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 40.9 m -69.3 147.91 97.27 Favored Pre-proline 0 N--CA 1.476 0.838 0 C-N-CA 124.212 1.005 . . . . 0.0 112.902 -177.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -58.31 -28.2 83.77 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.229 2.619 . . . . 0.0 114.512 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -64.52 -17.0 63.5 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.55 1.14 . . . . 0.0 113.743 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 44.0 m -80.37 -7.29 59.03 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.602 1.161 . . . . 0.0 113.757 175.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt -111.55 152.8 27.12 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.546 1.538 . . . . 0.0 112.378 -177.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.02 -45.07 0.11 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.179 1.392 . . . . 0.0 112.007 175.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 31.6 m -138.38 113.28 9.14 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.94 1.696 . . . . 0.0 107.744 167.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.43 17.91 2.93 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -158.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.89 58.29 1.88 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.391 1.476 . . . . 0.0 112.346 178.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -122.45 62.56 0.97 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.493 1.917 . . . . 0.0 108.869 175.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -147.76 143.93 27.89 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.54 1.536 . . . . 0.0 109.669 -173.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -177.5 126.04 0.14 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.759 1.623 . . . . 0.0 108.853 169.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.0 m -90.87 108.72 20.03 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.753 0.821 . . . . 0.0 109.617 168.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.36 146.99 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.779 0.831 . . . . 0.0 113.015 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.6 mt -130.82 -42.56 1.12 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.65 1.58 . . . . 0.0 112.409 -173.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 27.1 t -151.64 134.67 15.8 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.336 1.054 . . . . 0.0 110.933 177.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 96.9 t -129.31 127.85 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.516 1.126 . . . . 0.0 109.474 172.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -127.36 130.55 23.7 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 125.176 1.391 . . . . 0.0 110.085 173.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.7 -13.96 15.99 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 122.959 2.439 . . . . 0.0 115.144 -171.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -134.37 108.59 8.26 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.029 0.932 . . . . 0.0 111.425 -176.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.69 146.16 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.975 1.71 . . . . 0.0 109.926 174.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.0 m -127.6 131.02 49.99 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.908 0.883 . . . . 0.0 111.695 -170.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 68.2 t -97.77 131.66 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.361 1.464 . . . . 0.0 111.749 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.17 120.89 25.26 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.071 1.348 . . . . 0.0 108.611 167.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.0 mtt-85 -71.69 130.08 40.27 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.094 0.557 . . . . 0.0 109.939 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.4 pt -92.49 153.38 42.62 Favored Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 124.095 0.958 . . . . 0.0 113.435 -163.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -65.48 158.94 50.25 Favored 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 122.586 2.191 . . . . 0.0 111.082 160.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -62.09 147.64 94.71 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.827 2.351 . . . . 0.0 111.987 176.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.7 ttm105 -65.69 147.88 52.67 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.823 0.849 . . . . 0.0 112.052 -176.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.412 ' HB3' ' H ' ' A' ' 30' ' ' GLY . . . -63.74 179.31 0.51 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.777 1.231 . . . . 0.0 112.854 161.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 81.2 p -102.65 -35.93 8.51 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.842 1.657 . . . . 0.0 112.437 177.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -132.96 25.68 4.28 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.361 1.864 . . . . 0.0 112.124 -175.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -129.35 -61.39 1.03 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.494 1.118 . . . . 0.0 113.087 177.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.412 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . 89.62 178.52 45.19 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 122.551 1.084 . . . . 0.0 111.603 -166.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -76.1 146.26 39.45 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 125.122 1.369 . . . . 0.0 110.757 177.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.21 18.58 4.92 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -173.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 59.98 -48.47 0.09 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 128.4 2.68 . . . . 0.0 115.253 -174.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.5 p -65.5 -18.32 65.23 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.838 2.055 . . . . 0.0 114.688 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.74 -15.32 59.21 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.963 0.905 . . . . 0.0 112.988 173.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -90.56 165.29 13.85 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.853 1.261 . . . . 0.0 110.341 176.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.3 mtmt -87.0 64.17 8.33 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.793 0.837 . . . . 0.0 112.435 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.0 mt -56.52 -27.63 57.89 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.752 1.621 . . . . 0.0 115.032 -172.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -86.04 -8.09 58.16 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.107 0.963 . . . . 0.0 113.137 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -135.04 58.82 29.96 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 125.27 1.428 . . . . 0.0 111.814 -161.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -65.82 139.45 57.3 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 CA-C-N 119.719 0.935 . . . . 0.0 112.421 -172.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -69.44 -27.88 65.64 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.747 0.819 . . . . 0.0 111.222 174.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 50.2 t90 -158.09 151.34 23.15 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.89 1.676 . . . . 0.0 110.713 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.3 p -132.97 150.68 52.14 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.791 0.836 . . . . 0.0 111.835 167.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.1 -142.91 5.53 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 116.259 -0.428 . . . . 0.0 113.524 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.5 mtm180 -109.64 146.4 34.84 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.528 1.931 . . . . 0.0 111.812 -176.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.2 tp -84.99 139.49 31.75 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.483 1.513 . . . . 0.0 109.746 163.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -143.93 92.41 2.33 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.091 1.356 . . . . 0.0 110.714 167.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.3 mt -76.95 126.27 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 171.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.2 p -138.22 165.53 26.46 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.771 2.028 . . . . 0.0 110.111 -178.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.0 m -148.15 160.12 43.24 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.562 1.145 . . . . 0.0 112.426 175.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -148.8 125.0 10.79 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.281 0.562 . . . . 0.0 112.35 155.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.55 -124.24 8.66 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 125.377 1.465 . . . . 0.0 110.025 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -99.86 17.86 19.77 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.714 1.605 . . . . 0.0 113.317 176.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.3 m -124.45 125.8 44.85 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.63 1.172 . . . . 0.0 110.172 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.68 160.11 14.5 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.549 1.14 . . . . 0.0 111.205 171.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -141.78 103.16 4.3 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.849 2.06 . . . . 0.0 109.071 -171.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.3 mp -81.45 94.16 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 169.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -90.15 141.7 28.43 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.613 0.765 . . . . 0.0 111.27 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.4 mp -113.2 133.04 55.26 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.618 1.967 . . . . 0.0 109.918 173.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -131.45 147.86 52.59 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.105 0.962 . . . . 0.0 113.003 -172.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -68.68 133.77 48.91 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.066 -1.021 . . . . 0.0 110.93 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.5 pttt -77.48 -4.24 44.49 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -176.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 64.1 t -120.62 -42.44 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 125.205 1.402 . . . . 0.0 111.537 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.9 m -93.44 -20.57 20.18 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.09 11.46 79.09 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.551 1.072 . . . . 0.0 113.831 -176.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -87.19 152.44 22.32 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.325 1.45 . . . . 0.0 112.254 -173.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.5 tp -71.9 127.19 31.79 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.601 -0.687 . . . . 0.0 111.389 -178.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -87.27 -55.87 3.62 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.361 1.065 . . . . 0.0 111.047 169.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.95 163.54 39.02 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.438 1.495 . . . . 0.0 110.603 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -145.99 141.43 27.68 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 172.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.08 104.16 52.56 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 125.323 1.449 . . . . 0.0 111.606 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -64.6 142.59 78.16 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.037 3.158 . . . . 0.0 112.54 169.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.6 t -138.37 132.29 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.972 1.709 . . . . 0.0 108.793 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -103.42 -18.22 14.91 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.98 147.24 14.8 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.909 2.083 . . . . 0.0 109.766 173.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -134.3 124.62 17.36 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.484 1.113 . . . . 0.0 111.551 -177.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -59.25 147.89 38.86 Favored 'Cis proline' 0 CA--C 1.54 0.81 0 CA-C-N 120.123 1.08 . . . . 0.0 114.533 -4.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -161.7 -160.0 10.57 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 126.166 1.841 . . . . 0.0 112.025 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.6 tt -76.12 -40.0 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 118.185 0.993 . . . . 0.0 113.158 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.77 7.24 18.42 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -166.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.3 t -150.73 130.08 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.575 1.55 . . . . 0.0 109.947 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -141.84 158.01 44.31 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.041 1.736 . . . . 0.0 112.487 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.4 p -108.28 160.81 15.55 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.745 2.018 . . . . 0.0 111.153 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.9 m -88.87 169.35 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 124.062 0.945 . . . . 0.0 110.862 165.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.5 p -94.1 -29.5 15.13 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.869 1.267 . . . . 0.0 113.556 178.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -92.71 -41.25 10.26 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -166.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.2 t -142.27 112.76 7.21 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -177.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.6 p -72.94 30.32 0.06 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -174.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.421 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.254 1.0 OUTLIER -115.86 23.12 12.51 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.854 2.061 . . . . 0.0 113.519 166.785 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -140.44 138.59 34.82 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.69 1.596 . . . . 0.0 110.622 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -137.34 163.59 30.64 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.902 1.281 . . . . 0.0 111.562 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 37.2 t -117.57 144.83 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.862 1.265 . . . . 0.0 109.13 166.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.69 148.76 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 123.07 0.548 . . . . 0.0 111.538 170.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.471 ' HE ' ' NE2' ' A' ' 97' ' ' GLN . 42.0 ttp180 -91.05 98.82 12.0 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.397 0.679 . . . . 0.0 109.858 173.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -79.61 150.17 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.793 0.837 . . . . 0.0 111.628 176.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.471 ' NE2' ' HE ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -126.53 145.48 50.5 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.848 1.659 . . . . 0.0 110.835 177.05 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -87.67 1.09 54.67 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.59 1.156 . . . . 0.0 113.17 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.72 12.61 79.72 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.21 1.386 . . . . 0.0 114.862 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.6 t -138.31 17.71 2.77 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.414 1.486 . . . . 0.0 113.353 -172.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.99 -1.36 83.08 Favored Glycine 0 CA--C 1.539 1.543 0 O-C-N 120.489 -1.382 . . . . 0.0 115.025 -178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -77.29 139.03 39.71 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.491 1.517 . . . . 0.0 108.929 165.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.4 p -144.19 157.73 44.13 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 168.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.25 144.23 29.72 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.999 1.319 . . . . 0.0 111.334 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -89.87 120.25 30.94 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.509 0.724 . . . . 0.0 109.607 169.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.5 pt -120.31 144.05 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.77 1.228 . . . . 0.0 111.053 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.44 142.71 16.17 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 124.151 0.881 . . . . 0.0 111.312 174.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.7 pt -129.33 143.09 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 125.506 1.522 . . . . 0.0 112.121 174.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.19 144.2 17.09 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.797 1.189 . . . . 0.0 113.491 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -107.08 158.7 16.86 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.084 1.754 . . . . 0.0 111.213 -178.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.8 t -72.21 -26.73 62.16 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.596 0.758 . . . . 0.0 112.796 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -157.23 151.64 25.17 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.441 1.096 . . . . 0.0 111.804 -176.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 43.2 ttm105 -61.32 -32.58 72.45 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.226 1.01 . . . . 0.0 113.197 177.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.94 -31.72 81.75 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 119.382 0.992 . . . . 0.0 113.464 176.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -85.89 -30.67 22.69 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 117.963 0.882 . . . . 0.0 112.395 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.421 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -65.92 -37.39 85.93 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 168.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -61.28 -36.46 80.12 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.105 -0.997 . . . . 0.0 110.91 170.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -71.17 -13.28 61.88 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 113.547 0.944 . . . . 0.0 113.547 175.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -77.97 -50.73 11.58 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.55 1.14 . . . . 0.0 111.568 165.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.11 -27.14 39.23 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -174.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 71.8 t -77.86 -43.02 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.129 -0.982 . . . . 0.0 111.159 177.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 92.1 p -65.58 -33.9 76.99 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.606 -0.684 . . . . 0.0 112.687 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 35.1 tp -72.58 -47.04 51.25 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.913 1.285 . . . . 0.0 111.591 176.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -69.75 -29.82 67.26 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.162 -0.961 . . . . 0.0 113.239 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -78.96 -4.02 47.85 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.215 1.006 . . . . 0.0 112.333 177.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -89.5 -21.89 22.72 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.299 -0.876 . . . . 0.0 113.143 162.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -99.28 -13.23 19.76 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -177.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.01 -28.95 41.4 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 -172.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 35.8 p-90 -82.92 -24.97 32.86 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.472 1.109 . . . . 0.0 113.256 176.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.4 t -76.47 -43.21 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.266 1.426 . . . . 0.0 110.61 177.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -92.24 8.24 39.04 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 42.42 82.73 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 129.134 2.974 . . . . 0.0 115.253 176.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 . . . . . 0 C--O 1.252 1.213 0 C-N-CA 126.933 2.093 . . . . 0.0 112.787 172.826 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.527 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 54.0 p -147.07 179.45 1.17 Allowed Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 125.788 1.635 . . . . 0.0 110.876 178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -57.78 -24.04 61.58 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.347 2.032 . . . . 0.0 113.733 171.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -70.12 -24.61 63.22 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.648 1.179 . . . . 0.0 112.515 174.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 5.6 m -72.73 -15.58 61.67 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.924 1.29 . . . . 0.0 112.433 170.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mmt -103.62 -120.67 0.2 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.651 1.98 . . . . 0.0 109.59 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.92 31.87 4.14 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.822 1.649 . . . . 0.0 111.817 174.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.2 m 59.17 61.22 2.14 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 123.84 1.781 . . . . 0.0 109.496 -157.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -127.58 123.29 35.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.349 2.26 . . . . 0.0 106.984 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.09 160.35 20.45 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.942 1.297 . . . . 0.0 113.43 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -133.92 40.29 3.09 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.263 1.825 . . . . 0.0 110.478 176.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -150.37 147.36 27.49 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.068 1.747 . . . . 0.0 109.972 -177.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 176.05 116.0 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.702 2.001 . . . . 0.0 108.552 157.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.3 m -87.99 113.05 23.25 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.653 -0.654 . . . . 0.0 110.65 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.9 p -69.24 148.82 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.492 1.117 . . . . 0.0 112.908 -177.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.2 mt -135.58 -38.84 0.73 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.916 1.686 . . . . 0.0 112.305 -171.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.0 t -147.02 140.52 25.58 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.415 1.486 . . . . 0.0 109.753 174.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.4 t -131.85 132.07 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.374 1.07 . . . . 0.0 108.637 167.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.61 131.72 18.39 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 124.694 1.197 . . . . 0.0 111.341 177.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -81.04 -15.63 10.32 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.843 2.362 . . . . 0.0 115.302 -170.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -130.5 106.79 8.76 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.38 1.072 . . . . 0.0 110.82 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.8 p -143.81 142.38 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.032 1.333 . . . . 0.0 110.359 173.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.8 m -125.72 132.04 52.43 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.721 1.208 . . . . 0.0 111.137 -173.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 79.4 t -97.43 130.68 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.497 1.119 . . . . 0.0 111.225 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -131.78 117.02 18.01 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.99 1.316 . . . . 0.0 108.295 168.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.3 mtt-85 -71.63 128.85 37.14 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.87 -0.519 . . . . 0.0 109.73 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 39.3 pt -86.78 150.24 50.08 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -163.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -67.53 162.98 36.7 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 122.948 2.432 . . . . 0.0 111.401 164.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -60.45 145.58 98.44 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.553 2.169 . . . . 0.0 111.315 170.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.4 ttm-85 -65.69 147.83 52.75 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.823 0.849 . . . . 0.0 112.53 -173.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.61 178.13 0.46 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.392 1.477 . . . . 0.0 113.236 161.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 80.4 p -95.23 -41.48 9.04 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.144 1.377 . . . . 0.0 112.993 -177.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -125.03 -6.79 7.22 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.481 1.512 . . . . 0.0 113.741 -174.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -93.18 -61.08 1.64 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.481 1.112 . . . . 0.0 112.274 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.26 -170.45 42.94 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 122.588 1.104 . . . . 0.0 111.148 -162.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -80.24 134.65 36.13 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 124.852 1.261 . . . . 0.0 110.606 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.67 21.36 7.73 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -173.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 56.9 -49.91 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.29 2.636 . . . . 0.0 115.399 -171.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.7 m -64.71 -14.64 59.36 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.26 1.824 . . . . 0.0 114.558 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -84.18 -7.84 59.24 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.774 1.23 . . . . 0.0 113.039 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.2 m0 -93.7 169.4 10.35 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.73 1.612 . . . . 0.0 111.151 176.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -76.56 51.89 0.76 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.194 1.798 . . . . 0.0 114.185 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.5 mt -55.58 -28.54 55.64 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.205 1.402 . . . . 0.0 114.487 -177.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -88.37 -7.42 56.68 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.428 0.691 . . . . 0.0 112.547 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -152.38 66.52 6.47 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.965 1.306 . . . . 0.0 111.887 -168.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -58.27 145.29 93.86 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.397 2.731 . . . . 0.0 112.856 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -72.56 -28.8 63.04 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.544 1.138 . . . . 0.0 111.657 174.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 42.1 t90 -158.11 152.14 24.08 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.431 1.892 . . . . 0.0 110.234 177.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.8 p -134.11 150.63 51.16 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.882 0.873 . . . . 0.0 111.862 169.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.38 -139.15 4.19 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 123.233 0.444 . . . . 0.0 113.325 -177.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.1 mtm105 -115.82 150.36 37.08 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.709 2.004 . . . . 0.0 112.001 -173.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.5 tp -94.61 138.33 32.61 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.227 1.811 . . . . 0.0 110.207 171.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.5 ttm-85 -135.74 111.1 9.08 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.825 1.25 . . . . 0.0 109.808 160.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 24.9 mt -91.32 131.3 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 168.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.25 170.36 16.1 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 127.396 2.279 . . . . 0.0 110.13 -173.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.6 t -158.54 149.47 20.47 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 120.409 -1.432 . . . . 0.0 111.792 176.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -151.42 129.14 11.55 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.631 0.772 . . . . 0.0 112.663 158.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.88 45.88 55.41 Favored Glycine 0 N--CA 1.473 1.162 0 C-N-CA 124.432 1.015 . . . . 0.0 114.956 164.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt 62.99 26.24 15.42 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.294 1.838 . . . . 0.0 113.269 -174.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.4 m -131.03 114.11 14.79 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.112 1.365 . . . . 0.0 108.72 168.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -83.99 159.23 21.27 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.507 0.723 . . . . 0.0 110.464 172.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -136.08 115.7 12.89 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 125.956 1.702 . . . . 0.0 108.693 -175.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.7 mp -92.29 99.48 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 168.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -99.83 139.7 35.12 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.876 0.846 . . . . 0.0 112.207 175.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.8 mp -110.68 132.94 53.76 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.091 1.756 . . . . 0.0 109.92 176.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -134.77 151.02 50.64 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.017 0.927 . . . . 0.0 113.04 -171.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -73.14 144.11 47.04 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.924 0.869 . . . . 0.0 112.112 -178.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.1 pttt -84.22 -6.56 59.41 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.209 1.804 . . . . 0.0 115.144 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 95.7 t -122.73 -44.17 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.206 1.402 . . . . 0.0 111.447 178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.0 m -94.08 -21.8 18.9 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -175.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.01 5.92 85.4 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.182 0.896 . . . . 0.0 113.861 -177.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -82.02 153.88 25.96 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.276 1.431 . . . . 0.0 112.752 -173.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.5 tp -73.52 126.08 29.41 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.993 0.917 . . . . 0.0 111.107 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -86.18 -55.78 3.76 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.437 1.095 . . . . 0.0 111.121 170.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.85 164.01 38.55 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.755 1.222 . . . . 0.0 111.838 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -140.83 136.4 32.36 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.831 1.252 . . . . 0.0 111.816 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.4 107.69 36.58 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 124.778 1.231 . . . . 0.0 111.633 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -76.42 136.55 17.72 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.563 2.842 . . . . 0.0 111.925 173.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.1 t -127.71 119.53 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 127.093 2.157 . . . . 0.0 108.761 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -88.27 -17.69 30.18 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.48 151.33 16.9 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.18 1.792 . . . . 0.0 109.939 172.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -116.28 130.91 24.1 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 123.597 0.759 . . . . 0.0 113.014 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.63 151.37 74.54 Favored 'Cis proline' 0 CA--C 1.542 0.886 0 CA-C-N 119.247 0.767 . . . . 0.0 112.694 -13.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -132.16 -163.1 10.61 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.099 1.333 . . . . 0.0 113.361 176.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.6 tt -79.77 -34.6 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.538 0.735 . . . . 0.0 112.263 171.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.04 11.72 3.88 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.484 1.114 . . . . 0.0 113.63 -172.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.7 p -156.4 141.85 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 126.369 1.868 . . . . 0.0 110.815 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -159.3 161.26 35.85 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.489 1.116 . . . . 0.0 113.552 -175.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.2 p -110.76 159.54 17.54 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 127.114 2.165 . . . . 0.0 111.719 174.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.9 m -85.02 176.52 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.659 1.183 . . . . 0.0 111.255 166.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 73.4 p -92.28 -33.71 14.53 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.761 1.224 . . . . 0.0 113.47 177.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -92.45 -41.31 10.37 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -162.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.2 t -141.41 132.92 26.9 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -176.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.8 m -64.45 -12.14 40.57 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -172.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.431 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.289 31.3 ptt180 -89.0 14.56 10.3 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -174.743 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -135.72 136.48 40.86 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.472 1.109 . . . . 0.0 111.87 -173.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -138.04 161.07 37.68 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.113 1.365 . . . . 0.0 111.655 -178.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.2 t -114.67 143.2 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.499 1.12 . . . . 0.0 108.951 166.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.29 150.37 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 118.468 0.576 . . . . 0.0 111.625 169.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -93.06 89.72 6.61 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.012 0.925 . . . . 0.0 110.398 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -71.09 137.78 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 120.712 0.291 . . . . 0.0 110.956 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -145.13 143.81 30.57 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.066 1.746 . . . . 0.0 110.924 -168.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -88.15 -4.31 58.76 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.85 3.83 90.46 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 125.023 1.297 . . . . 0.0 114.668 -177.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.7 t -108.29 1.81 22.2 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.275 1.83 . . . . 0.0 113.586 -176.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.91 -4.08 49.22 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.172 1.368 . . . . 0.0 114.415 -174.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -70.93 137.15 48.97 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.389 1.476 . . . . 0.0 109.603 164.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 89.6 p -147.78 151.86 36.73 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 169.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.11 140.97 25.83 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.338 1.455 . . . . 0.0 111.005 168.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -90.01 119.61 30.51 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.294 0.638 . . . . 0.0 109.837 171.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.4 pt -117.8 145.41 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.594 1.158 . . . . 0.0 110.955 177.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.68 140.02 14.82 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 173.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.6 pt -125.12 141.75 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 124.879 1.272 . . . . 0.0 111.665 173.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -125.13 141.88 13.4 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.265 1.412 . . . . 0.0 112.572 174.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -101.96 170.97 7.79 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.165 1.786 . . . . 0.0 111.417 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.7 t -70.04 -37.56 75.59 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.349 0.66 . . . . 0.0 112.277 175.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -152.99 154.35 34.78 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.073 -1.017 . . . . 0.0 112.765 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -58.14 -38.87 77.38 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.349 1.46 . . . . 0.0 112.131 176.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.05 -14.05 73.26 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.014 0.816 . . . . 0.0 114.06 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -97.26 -36.94 10.26 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 118.191 0.995 . . . . 0.0 111.69 172.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.431 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -64.91 -30.73 71.74 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.293 1.037 . . . . 0.0 113.668 170.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.13 -29.05 60.17 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.439 1.018 . . . . 0.0 112.974 175.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -69.66 -27.19 64.83 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.316 -0.865 . . . . 0.0 112.954 176.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -62.77 -52.59 62.59 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.429 1.092 . . . . 0.0 111.356 173.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -80.61 -24.33 39.15 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -175.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.7 t -78.87 -42.56 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 119.062 0.846 . . . . 0.0 111.542 174.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 93.8 p -65.62 -31.3 72.26 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.434 1.015 . . . . 0.0 113.337 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.5 mt -69.38 -54.13 15.99 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.77 0.828 . . . . 0.0 111.435 172.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -65.61 -31.37 72.36 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.408 -0.808 . . . . 0.0 112.763 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -81.11 -4.37 55.08 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.339 1.056 . . . . 0.0 112.727 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -95.84 -15.86 22.21 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 164.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -106.52 -6.18 18.28 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.35 -29.21 57.94 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 121.397 1.908 . . . . 0.0 115.577 -175.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 36.3 p-90 -79.81 -23.55 41.99 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.135 1.374 . . . . 0.0 113.54 175.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 18.7 t -83.53 -31.7 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.644 1.578 . . . . 0.0 110.844 172.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -91.31 31.26 1.16 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 127.562 2.345 . . . . 0.0 112.572 -177.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -79.56 91.7 5.22 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.887 0.875 . . . . 0.0 109.663 173.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 C--O 1.252 1.198 0 C-N-CA 126.8 2.04 . . . . 0.0 112.725 -171.784 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.612 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 53.6 p -148.94 160.48 35.17 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 125.154 1.382 . . . . 0.0 111.544 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.22 -4.85 15.75 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.109 2.539 . . . . 0.0 114.49 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -60.71 -22.01 63.51 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.287 1.035 . . . . 0.0 113.589 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 78.8 p -61.39 -18.98 61.33 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 173.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.0 mtm -86.37 1.08 52.49 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.122 1.369 . . . . 0.0 113.592 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.37 -34.84 0.93 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.303 1.441 . . . . 0.0 113.264 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 49.3 m -123.77 103.17 8.21 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.527 1.531 . . . . 0.0 109.361 178.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -140.28 17.98 2.41 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.342 1.457 . . . . 0.0 112.955 -176.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.42 49.62 1.33 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.929 2.092 . . . . 0.0 112.07 -174.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -84.76 40.35 0.8 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.842 1.657 . . . . 0.0 112.156 -174.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -156.92 151.18 25.15 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.452 1.901 . . . . 0.0 110.23 -169.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -169.45 127.37 0.95 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.047 1.739 . . . . 0.0 107.739 167.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -104.46 107.19 17.99 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 167.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.6 t -64.39 145.13 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 125.753 1.621 . . . . 0.0 112.386 -177.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.4 mt -130.79 -41.24 1.17 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.814 1.646 . . . . 0.0 112.223 -173.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 36.8 t -148.65 137.68 21.62 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.75 1.22 . . . . 0.0 110.717 174.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 81.8 t -130.21 127.79 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.912 1.285 . . . . 0.0 109.511 172.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -125.96 132.4 24.3 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 125.362 1.465 . . . . 0.0 110.096 173.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.52 -10.88 14.5 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.36 2.706 . . . . 0.0 115.495 -170.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -136.74 111.79 8.97 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.92 0.867 . . . . 0.0 112.192 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -143.9 144.02 23.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 125.437 1.495 . . . . 0.0 110.144 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.9 m -125.86 128.18 47.22 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.227 1.011 . . . . 0.0 111.492 -170.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.8 t -92.87 136.21 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.374 1.47 . . . . 0.0 112.006 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -129.85 128.36 42.11 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.962 1.305 . . . . 0.0 109.281 169.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 17.7 mmm-85 -76.02 112.55 12.57 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.003 0.921 . . . . 0.0 108.867 172.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.5 pt -82.16 153.04 68.97 Favored Pre-proline 0 N--CA 1.477 0.904 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -162.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.29 162.71 37.42 Favored 'Trans proline' 0 CA--C 1.548 1.216 0 C-N-CA 123.694 2.93 . . . . 0.0 112.367 169.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -63.62 150.85 87.48 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 123.484 2.789 . . . . 0.0 112.917 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.4 ttt85 -100.31 151.32 21.62 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.426 1.49 . . . . 0.0 113.242 -172.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -144.97 140.01 27.92 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.151 143.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.6 m -69.38 -18.72 63.8 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.727 1.381 . . . . 0.0 114.727 -171.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -70.83 -10.62 59.94 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 167.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -108.41 -57.96 2.06 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 127.017 2.127 . . . . 0.0 110.641 173.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.47 159.39 5.59 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 125.444 1.497 . . . . 0.0 112.708 -174.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -71.88 136.95 47.12 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.479 0.712 . . . . 0.0 109.813 168.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.78 19.39 6.11 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -172.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 56.68 -47.07 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 128.127 2.571 . . . . 0.0 115.893 -173.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.4 m -64.71 -18.41 64.98 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.062 1.745 . . . . 0.0 114.576 -177.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -85.3 -5.82 59.29 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 173.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.0 m0 -89.09 172.01 9.41 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.039 1.336 . . . . 0.0 110.743 174.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -79.72 52.86 1.51 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.187 1.395 . . . . 0.0 114.279 -176.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 mt -59.83 -18.56 44.85 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 -172.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -105.43 -6.08 19.8 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.771 1.229 . . . . 0.0 113.168 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -148.97 67.74 9.32 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.863 1.265 . . . . 0.0 112.055 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -54.66 145.52 59.26 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.554 2.836 . . . . 0.0 113.02 177.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -70.7 -29.34 65.61 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.424 1.089 . . . . 0.0 111.661 175.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 40.8 t90 -156.96 154.12 29.16 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.615 1.566 . . . . 0.0 110.946 173.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.3 p -135.69 150.42 49.57 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.238 1.015 . . . . 0.0 112.331 171.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.18 -142.1 5.14 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.239 0.447 . . . . 0.0 114.006 -176.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.5 mtm180 -111.23 152.0 27.63 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 127.066 2.146 . . . . 0.0 111.919 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.4 tp -90.31 139.6 30.5 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.075 1.75 . . . . 0.0 110.184 165.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -140.07 98.83 3.53 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.053 1.341 . . . . 0.0 110.249 163.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.2 mt -80.03 130.4 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 170.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.4 p -137.5 159.35 42.2 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.592 1.957 . . . . 0.0 110.06 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.2 t -156.26 133.89 10.95 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.474 -1.391 . . . . 0.0 113.411 173.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -146.15 128.58 15.94 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.159 1.784 . . . . 0.0 110.587 177.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.75 36.88 52.45 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.438 1.018 . . . . 0.0 114.963 169.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? 61.95 27.92 16.96 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.467 1.907 . . . . 0.0 113.477 -170.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.0 m -132.23 117.82 18.71 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.195 1.398 . . . . 0.0 109.132 172.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.32 157.5 19.89 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.746 0.818 . . . . 0.0 110.856 172.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -138.3 116.67 11.95 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.6 1.56 . . . . 0.0 108.928 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mp -86.1 93.45 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 168.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -88.02 139.43 30.52 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.502 0.721 . . . . 0.0 111.265 174.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.0 mp -113.69 132.87 55.64 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.442 1.897 . . . . 0.0 110.63 176.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -129.06 147.88 50.96 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -171.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.94 128.21 34.83 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 121.18 -0.95 . . . . 0.0 109.539 171.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -75.44 -9.01 58.19 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -172.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.5 t -112.28 -36.95 2.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 124.239 1.016 . . . . 0.0 110.807 -171.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.1 m -110.47 -15.44 13.91 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.66 19.77 79.77 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 118.882 0.764 . . . . 0.0 113.708 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -63.51 158.94 19.68 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.647 1.179 . . . . 0.0 111.442 173.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.8 tp -95.11 119.59 33.88 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.832 0.853 . . . . 0.0 109.279 167.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -84.31 -55.44 4.17 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.611 0.764 . . . . 0.0 111.28 175.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.4 165.91 35.16 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.724 1.21 . . . . 0.0 111.533 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -144.63 135.32 24.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.737 1.215 . . . . 0.0 111.036 175.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.71 97.17 48.34 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.169 0.988 . . . . 0.0 111.943 175.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.78 137.26 80.25 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 124.367 3.378 . . . . 0.0 113.121 165.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.8 t -139.14 129.03 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 126.414 1.886 . . . . 0.0 109.739 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -90.19 -23.07 21.39 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.44 152.19 16.09 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.82 1.648 . . . . 0.0 111.078 174.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -130.85 135.51 27.46 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 124.876 1.27 . . . . 0.0 112.003 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -61.7 145.0 45.39 Favored 'Cis proline' 0 CA--C 1.539 0.747 0 CA-C-N 119.889 0.996 . . . . 0.0 113.19 -9.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -157.29 -155.71 7.6 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.736 1.16 . . . . 0.0 114.0 -174.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.59 -38.94 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.464 1.106 . . . . 0.0 113.692 -174.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.37 9.29 15.91 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -173.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.6 t -149.33 133.18 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.819 1.648 . . . . 0.0 109.922 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.55 163.99 34.0 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.248 1.819 . . . . 0.0 112.555 -174.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 62.2 p -116.84 162.27 17.98 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.166 1.787 . . . . 0.0 111.822 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.7 m -89.75 175.46 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.296 1.038 . . . . 0.0 111.057 165.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 71.5 p -95.96 -30.9 13.35 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.218 1.407 . . . . 0.0 113.441 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -90.18 -43.78 10.2 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -167.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.3 t -143.37 127.67 17.73 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -176.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.43 -3.28 7.97 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -173.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.469 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.278 23.4 ptt180 -84.7 14.89 4.23 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 177.761 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -139.25 134.06 32.14 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.744 1.218 . . . . 0.0 111.119 -174.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -136.11 161.46 35.64 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.257 1.423 . . . . 0.0 111.168 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 75.9 t -116.21 143.89 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.577 1.151 . . . . 0.0 108.937 167.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.86 148.51 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 119.123 0.874 . . . . 0.0 112.261 173.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -87.65 88.76 7.76 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.414 0.686 . . . . 0.0 110.259 173.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.25 141.6 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 O-C-N 121.99 -0.444 . . . . 0.0 110.841 174.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -135.61 142.57 45.28 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.425 1.49 . . . . 0.0 111.597 -175.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -94.95 13.98 23.19 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.919 1.288 . . . . 0.0 113.529 -176.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.76 7.04 85.9 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.335 1.445 . . . . 0.0 115.463 176.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.4 t -130.06 4.58 4.87 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.521 1.528 . . . . 0.0 113.802 -172.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.74 -4.85 69.2 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.304 1.43 . . . . 0.0 113.843 -175.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -76.87 129.76 36.66 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 127.414 2.285 . . . . 0.0 108.455 166.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.0 p -153.55 161.55 42.11 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.497 1.119 . . . . 0.0 113.981 -175.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -148.08 150.51 34.02 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.32 1.448 . . . . 0.0 111.523 172.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -92.94 118.7 31.44 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.251 0.62 . . . . 0.0 109.787 168.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.8 pt -120.11 145.84 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.668 1.187 . . . . 0.0 111.063 178.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.44 144.32 17.11 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 173.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.1 pt -128.1 140.62 48.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.719 1.608 . . . . 0.0 111.452 172.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.83 143.06 14.69 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.857 1.694 . . . . 0.0 112.787 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -104.98 161.75 13.94 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.11 1.364 . . . . 0.0 112.466 -174.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.7 t -69.86 -28.1 65.39 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.245 1.018 . . . . 0.0 112.699 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -156.85 151.02 25.06 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.27 1.028 . . . . 0.0 111.828 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -62.43 -34.66 77.21 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.281 1.032 . . . . 0.0 113.118 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.35 -26.16 74.82 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 123.864 0.745 . . . . 0.0 113.733 175.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -84.91 -32.73 22.98 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.039 0.936 . . . . 0.0 111.632 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.469 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -67.61 -32.11 72.61 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 168.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.04 -31.54 67.13 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.377 -0.827 . . . . 0.0 112.569 173.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -68.3 -27.39 66.26 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.315 -0.865 . . . . 0.0 112.992 174.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -63.87 -55.17 24.78 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.816 1.189 . . . . 0.0 111.739 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -75.13 -24.87 58.08 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.5 t -75.94 -40.81 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 121.414 -0.804 . . . . 0.0 111.093 173.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.5 t -59.04 -39.67 82.72 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.061 0.846 . . . . 0.0 112.662 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.6 mt -67.94 -54.43 18.72 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.408 0.683 . . . . 0.0 111.92 175.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -67.15 -32.21 73.16 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.3 -0.875 . . . . 0.0 113.02 -174.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -84.82 -0.63 54.56 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.379 1.072 . . . . 0.0 112.708 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -92.81 -37.97 12.02 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.438 -0.789 . . . . 0.0 112.287 159.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -85.39 -7.15 59.1 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -175.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.63 -31.58 57.56 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -172.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 34.2 p-90 -81.66 -27.77 33.9 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.75 1.22 . . . . 0.0 113.136 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.1 t -74.63 -32.55 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.238 1.415 . . . . 0.0 110.764 174.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -102.43 41.61 1.22 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.752 2.021 . . . . 0.0 112.365 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -81.01 2.78 25.51 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 164.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 C--O 1.254 1.294 0 C-N-CA 128.914 2.886 . . . . 0.0 112.029 176.66 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.652 0 N-CA-C 112.098 -0.401 . . . . 0.0 112.098 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 9.5 p -76.02 162.76 70.45 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.118 0.967 . . . . 0.0 112.495 177.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.53 1.59 8.29 Favored 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 123.359 2.706 . . . . 0.0 114.265 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -72.29 163.42 27.99 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.43 1.092 . . . . 0.0 112.804 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 62.9 p -71.68 -14.43 62.03 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.834 1.254 . . . . 0.0 114.36 177.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 mmt -131.51 151.59 51.44 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.567 1.947 . . . . 0.0 111.42 175.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.33 -48.17 0.16 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.465 1.106 . . . . 0.0 112.964 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 93.4 m -81.06 -37.05 29.67 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.584 0.754 . . . . 0.0 111.08 172.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 47.98 75.7 0.13 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.8 2.44 . . . . 0.0 115.057 169.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.2 pp -128.76 145.61 51.13 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.719 0.808 . . . . 0.0 112.136 164.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -129.68 49.17 2.29 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.741 1.616 . . . . 0.0 110.406 176.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -143.18 153.56 42.98 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.028 1.331 . . . . 0.0 112.719 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -174.56 78.18 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 129.877 3.271 . . . . 0.0 105.146 -175.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.25 115.01 12.08 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 121.115 -0.991 . . . . 0.0 110.596 -163.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.4 t -75.31 145.67 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.031 0.932 . . . . 0.0 111.231 -169.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.8 mt -131.45 -39.79 1.13 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.624 1.569 . . . . 0.0 111.856 -171.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.5 t -148.57 141.72 24.99 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.058 1.343 . . . . 0.0 110.393 176.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.7 t -136.37 127.32 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.984 1.314 . . . . 0.0 108.882 169.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -131.8 138.53 32.74 Favored Pre-proline 0 N--CA 1.48 1.062 0 C-N-CA 125.135 1.374 . . . . 0.0 111.072 177.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -81.23 -17.1 9.31 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 123.242 2.628 . . . . 0.0 115.67 -170.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -132.81 107.55 8.42 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.988 0.915 . . . . 0.0 111.345 -173.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.4 p -143.75 142.95 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.488 1.515 . . . . 0.0 110.331 173.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.8 m -126.32 128.0 46.42 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.456 1.102 . . . . 0.0 111.518 -171.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.2 t -93.99 137.13 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.128 1.371 . . . . 0.0 112.091 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -129.88 125.22 35.09 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.037 1.335 . . . . 0.0 108.98 168.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.9 mmt85 -70.58 109.18 4.71 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.524 -0.735 . . . . 0.0 109.617 169.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.1 pt -77.87 155.74 80.29 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 125.019 1.328 . . . . 0.0 113.292 -171.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -67.03 159.41 52.13 Favored 'Trans proline' 0 CA--C 1.549 1.245 0 C-N-CA 122.411 2.074 . . . . 0.0 111.06 158.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -62.86 149.51 91.18 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.794 2.329 . . . . 0.0 111.897 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.9 ttm105 -65.88 147.62 53.09 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.829 0.852 . . . . 0.0 112.188 -176.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.4 178.08 1.01 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.419 1.088 . . . . 0.0 112.558 160.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 79.8 p -94.98 -39.03 10.39 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.18 1.392 . . . . 0.0 112.488 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -126.76 -3.11 6.59 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.777 1.631 . . . . 0.0 113.571 -175.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -100.68 -52.4 3.34 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.243 1.017 . . . . 0.0 113.253 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.33 173.15 49.65 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-O 122.5 1.055 . . . . 0.0 111.711 -176.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -72.87 141.58 47.93 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.637 1.175 . . . . 0.0 110.728 174.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.66 18.97 5.69 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -172.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.53 -50.01 0.05 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.968 2.507 . . . . 0.0 115.411 -174.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.2 m -65.97 -14.9 62.42 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.247 1.819 . . . . 0.0 114.359 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.25 -15.54 58.67 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.84 0.856 . . . . 0.0 112.813 172.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -89.66 172.51 8.89 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.442 1.497 . . . . 0.0 111.424 -178.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -81.11 54.86 2.34 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.438 1.495 . . . . 0.0 114.059 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.9 mt -60.3 -17.41 42.51 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -172.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -105.96 -3.89 21.21 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.558 1.143 . . . . 0.0 113.078 177.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -147.81 72.03 11.45 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.068 1.347 . . . . 0.0 111.949 176.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -56.77 143.92 88.86 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 123.147 2.564 . . . . 0.0 112.43 173.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -71.04 -29.09 64.9 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.682 1.193 . . . . 0.0 111.766 175.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 37.9 t90 -156.95 153.17 27.66 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.675 1.59 . . . . 0.0 110.52 174.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.7 p -134.57 150.14 50.69 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.673 0.789 . . . . 0.0 112.043 169.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.18 -141.07 4.92 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 123.336 0.493 . . . . 0.0 113.422 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.7 mtm105 -113.51 149.92 33.67 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.712 2.005 . . . . 0.0 112.168 -173.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.5 tp -90.28 141.57 28.59 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.751 1.62 . . . . 0.0 110.629 169.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.6 ttm-85 -132.66 130.94 40.79 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.214 1.406 . . . . 0.0 109.719 156.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.4 mt -107.9 132.56 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 164.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.14 156.06 44.71 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 127.523 2.329 . . . . 0.0 108.72 -166.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.6 t -163.9 152.24 13.23 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.107 -1.621 . . . . 0.0 110.819 178.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -127.39 -46.6 1.47 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 -174.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.1 86.04 0.1 OUTLIER Glycine 0 N--CA 1.472 1.065 0 C-N-CA 123.606 0.622 . . . . 0.0 111.722 -175.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 94.1 mttt 55.53 23.47 6.0 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.141 1.776 . . . . 0.0 112.826 -171.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.9 m -141.74 121.04 13.09 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.836 1.254 . . . . 0.0 108.237 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.87 160.13 14.54 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.628 1.171 . . . . 0.0 111.053 174.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -139.2 113.19 8.64 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 127.076 2.15 . . . . 0.0 108.839 -176.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.3 mp -88.62 109.04 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 167.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -108.44 134.75 50.8 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.748 1.219 . . . . 0.0 111.588 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.6 mp -105.31 132.4 51.56 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 125.435 1.494 . . . . 0.0 110.089 176.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -134.9 151.6 51.02 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.946 0.899 . . . . 0.0 112.98 -170.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -74.12 143.91 45.14 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.282 -0.886 . . . . 0.0 112.071 -178.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.4 pttt -84.41 -6.61 59.4 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.296 1.838 . . . . 0.0 115.067 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.1 t -122.7 -44.18 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.341 1.456 . . . . 0.0 111.543 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.6 m -93.93 -22.37 18.63 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -174.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.3 6.08 86.05 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.14 0.876 . . . . 0.0 113.803 -177.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -81.8 154.59 25.86 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.31 1.444 . . . . 0.0 112.623 -174.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.5 tp -75.05 125.46 28.96 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.94 0.896 . . . . 0.0 111.147 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -85.23 -54.19 4.76 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.286 1.035 . . . . 0.0 111.156 170.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.52 162.89 38.86 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.595 1.158 . . . . 0.0 112.098 -178.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -140.68 133.86 29.53 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.831 1.252 . . . . 0.0 111.905 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.17 104.29 43.78 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.362 1.465 . . . . 0.0 111.159 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.96 144.52 30.49 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.833 3.022 . . . . 0.0 112.141 173.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.8 t -139.78 125.41 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 126.327 1.851 . . . . 0.0 109.554 -172.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -91.01 -23.4 20.39 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.13 149.15 15.65 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.268 1.827 . . . . 0.0 110.344 172.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -118.0 129.69 25.2 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.639 1.176 . . . . 0.0 111.153 175.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.85 149.41 80.32 Favored 'Cis proline' 0 CA--C 1.542 0.891 0 CA-C-N 119.715 0.934 . . . . 0.0 112.737 -6.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -151.57 -162.42 10.75 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.827 1.679 . . . . 0.0 112.293 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 19.6 tt -76.43 -35.15 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 121.688 -0.889 . . . . 0.0 112.837 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.47 7.23 17.58 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -168.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.1 t -150.97 130.51 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.856 1.662 . . . . 0.0 109.736 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -141.09 158.95 43.22 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.641 1.977 . . . . 0.0 112.317 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 47.4 p -107.05 160.89 15.21 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.751 2.02 . . . . 0.0 111.356 175.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 m -86.81 172.28 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.149 0.98 . . . . 0.0 110.949 163.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 58.8 p -95.07 -30.0 14.3 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.011 1.325 . . . . 0.0 113.608 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -90.11 -50.25 6.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.889 0.876 . . . . 0.0 113.229 -167.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.9 m -136.35 116.91 13.84 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.352 0.661 . . . . 0.0 112.724 -169.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.26 -8.68 18.9 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -168.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.453 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.322 43.2 ptt85 -84.12 21.31 1.39 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 178.875 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -140.3 137.45 34.18 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.896 1.278 . . . . 0.0 111.496 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -138.88 163.35 32.53 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.176 1.39 . . . . 0.0 111.032 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 55.9 t -118.21 142.44 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 124.546 1.139 . . . . 0.0 108.914 167.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.73 148.62 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 118.527 0.603 . . . . 0.0 111.975 173.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -90.66 87.54 6.75 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.57 0.748 . . . . 0.0 111.007 178.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -70.83 139.48 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 122.574 0.35 . . . . 0.0 111.044 176.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -142.78 144.02 32.42 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.251 1.82 . . . . 0.0 111.044 -169.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -91.37 5.45 49.26 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.15 13.17 81.4 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 124.958 1.266 . . . . 0.0 114.751 175.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.0 t -133.06 14.06 4.26 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.683 1.593 . . . . 0.0 113.386 -173.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.32 -3.97 76.56 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.651 1.119 . . . . 0.0 114.362 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 72.7 mtp85 -70.04 139.38 52.66 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 125.441 1.496 . . . . 0.0 109.415 162.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 56.8 p -154.58 158.1 39.25 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 115.046 1.498 . . . . 0.0 115.046 171.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.46 145.05 31.67 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.668 1.587 . . . . 0.0 110.495 165.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -91.1 119.85 31.58 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 167.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.8 pt -118.28 144.56 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.447 1.099 . . . . 0.0 110.93 178.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.63 142.95 16.3 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 174.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.9 pt -128.46 139.29 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 125.456 1.502 . . . . 0.0 111.725 173.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -118.85 139.78 14.68 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.93 1.729 . . . . 0.0 112.518 176.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -102.47 155.79 18.03 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.524 1.53 . . . . 0.0 112.222 -176.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.1 t -71.3 -23.56 61.98 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.351 1.061 . . . . 0.0 112.839 177.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -154.18 147.04 24.38 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.157 0.983 . . . . 0.0 112.212 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -64.42 -35.11 79.84 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.428 1.091 . . . . 0.0 113.273 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.36 -30.42 76.6 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-N 118.851 0.75 . . . . 0.0 113.165 176.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -82.5 -31.76 29.11 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.877 -0.778 . . . . 0.0 112.248 177.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.453 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -64.93 -38.58 91.43 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 166.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -61.35 -38.27 86.34 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.132 -0.98 . . . . 0.0 111.279 168.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -67.43 -36.31 80.98 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 119.093 0.861 . . . . 0.0 112.856 177.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -54.65 -51.39 65.6 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.74 1.216 . . . . 0.0 111.735 167.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -68.52 -42.55 78.37 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.611 0.764 . . . . 0.0 112.496 -177.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.8 t -65.84 -37.76 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 O-C-N 121.615 -0.678 . . . . 0.0 110.884 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 55.7 m -65.9 -14.42 61.49 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 176.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.6 mt -91.75 -54.13 4.0 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.008 0.923 . . . . 0.0 111.342 168.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -69.33 -32.92 72.33 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.952 -1.093 . . . . 0.0 113.669 -172.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -87.27 7.0 30.51 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.397 1.079 . . . . 0.0 112.423 174.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -102.77 -34.0 9.18 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.049 0.94 . . . . 0.0 112.631 165.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -89.5 -4.11 58.07 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.31 -31.6 61.78 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -175.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 35.5 p-90 -81.64 -20.2 40.15 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.764 1.226 . . . . 0.0 113.28 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 19.4 t -81.84 -32.81 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.165 1.386 . . . . 0.0 110.691 173.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 42.0 tptt -94.8 49.2 1.23 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.579 1.952 . . . . 0.0 111.162 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -97.62 104.33 16.35 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.949 1.3 . . . . 0.0 109.968 176.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 . . . . . 0 C--O 1.255 1.356 0 C-N-CA 125.773 1.629 . . . . 0.0 113.504 175.879 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.721 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 39.4 t -70.01 137.75 87.35 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 123.897 0.879 . . . . 0.0 112.003 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -65.39 -20.42 61.4 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.743 2.295 . . . . 0.0 112.546 174.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -68.76 -24.0 64.38 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.609 1.163 . . . . 0.0 112.686 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 50.2 m -77.4 -15.55 59.3 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.698 1.199 . . . . 0.0 113.524 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 mmt -80.03 34.95 0.3 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.777 1.631 . . . . 0.0 113.926 -169.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.7 -47.38 0.1 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.472 1.509 . . . . 0.0 111.591 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 36.2 m -153.49 129.86 10.57 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.574 1.95 . . . . 0.0 108.599 170.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -137.07 14.81 3.05 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.749 1.219 . . . . 0.0 113.854 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.73 107.88 9.35 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.116 0.966 . . . . 0.0 111.213 -177.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -81.31 58.59 3.65 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.931 1.293 . . . . 0.0 110.66 170.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.78 129.4 20.29 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.088 1.755 . . . . 0.0 111.097 -158.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -174.91 82.15 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.277 1.831 . . . . 0.0 106.931 166.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.8 m -72.01 101.21 2.66 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.027 1.731 . . . . 0.0 111.295 -174.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.97 144.05 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.761 1.224 . . . . 0.0 111.964 -174.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 78.8 mt -126.05 -43.94 1.79 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.786 1.634 . . . . 0.0 112.308 -175.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 46.5 t -153.77 136.03 14.88 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.519 1.128 . . . . 0.0 110.939 175.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.9 t -127.28 125.83 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.588 1.155 . . . . 0.0 109.47 172.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -129.08 133.61 25.39 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 125.367 1.467 . . . . 0.0 110.579 176.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.83 -12.02 15.01 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.22 2.613 . . . . 0.0 115.331 -172.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -129.74 106.38 8.67 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.273 1.029 . . . . 0.0 110.854 -177.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.1 p -141.66 142.01 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.782 1.233 . . . . 0.0 110.52 170.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.4 m -124.37 130.32 52.28 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.443 1.097 . . . . 0.0 110.751 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 77.1 t -94.18 136.47 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.749 1.22 . . . . 0.0 111.355 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.09 125.75 33.97 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.48 1.112 . . . . 0.0 109.436 168.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.7 mtt85 -62.39 131.3 48.8 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.347 0.659 . . . . 0.0 109.371 163.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.6 pt -96.17 150.36 37.1 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 124.239 1.016 . . . . 0.0 112.533 -171.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -67.14 160.23 48.4 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 122.758 2.305 . . . . 0.0 111.217 165.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.34 140.45 82.73 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.846 2.364 . . . . 0.0 111.962 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.2 ttm-85 -72.05 159.53 34.03 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.578 1.151 . . . . 0.0 112.465 -177.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -134.45 156.25 48.9 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.63 148.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.0 p -79.34 -36.07 40.01 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.696 1.998 . . . . 0.0 113.572 -167.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -90.91 21.14 4.32 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.048 1.739 . . . . 0.0 110.976 174.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -134.34 -59.7 0.82 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.365 1.866 . . . . 0.0 111.812 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.11 165.52 23.79 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 122.504 1.058 . . . . 0.0 113.06 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.7 m-30 -75.3 132.54 41.07 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.507 1.123 . . . . 0.0 110.102 169.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.54 18.25 8.12 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -172.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.31 -49.35 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 128.094 2.557 . . . . 0.0 115.565 -173.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.5 m -66.65 -15.93 63.83 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.887 1.675 . . . . 0.0 114.646 -176.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.01 -7.91 59.28 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 171.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.7 m0 -88.1 171.61 10.13 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.006 1.322 . . . . 0.0 110.769 176.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -79.6 54.34 1.76 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.214 1.406 . . . . 0.0 114.068 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.5 mt -60.75 -16.59 41.75 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -173.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -105.3 -4.59 21.41 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.565 1.146 . . . . 0.0 112.958 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -148.42 81.34 8.01 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 124.539 1.136 . . . . 0.0 112.015 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.3 145.35 67.19 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.395 2.73 . . . . 0.0 112.89 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -71.86 -29.62 64.57 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.822 0.849 . . . . 0.0 111.267 168.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 41.1 t90 -159.6 155.05 25.57 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.996 1.718 . . . . 0.0 110.929 175.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.3 p -133.76 142.54 47.96 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.717 1.207 . . . . 0.0 111.961 171.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.31 -148.39 6.54 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 123.419 0.533 . . . . 0.0 114.195 -177.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -110.76 144.64 39.43 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.737 1.615 . . . . 0.0 110.849 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.1 tp -82.53 136.43 34.86 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.13 1.372 . . . . 0.0 109.369 168.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.6 ttt-85 -142.09 88.07 2.08 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.579 1.152 . . . . 0.0 109.952 166.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.7 mt -70.22 122.11 21.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 169.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.01 -179.88 4.29 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 127.82 2.448 . . . . 0.0 109.542 177.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.423 ' HB2' ' CE1' ' A' ' 126' ' ' HIS . 80.3 p -161.27 171.2 18.79 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.858 2.063 . . . . 0.0 108.491 177.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -140.0 -107.64 0.16 Allowed 'General case' 0 CA--C 1.54 0.59 0 O-C-N 122.004 -0.435 . . . . 0.0 109.929 166.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.62 106.13 3.21 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.051 1.31 . . . . 0.0 112.603 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 51.48 28.69 4.7 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 126.768 2.027 . . . . 0.0 113.917 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.8 m -148.1 131.07 16.21 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.17 1.788 . . . . 0.0 108.582 -172.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.69 159.5 15.12 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.084 1.353 . . . . 0.0 110.917 171.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -138.33 111.83 8.15 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.532 1.533 . . . . 0.0 109.785 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.2 mp -81.97 98.39 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 170.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -100.15 139.87 35.2 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.621 0.724 . . . . 0.0 111.831 175.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mp -113.82 127.96 56.22 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 126.487 1.915 . . . . 0.0 109.771 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -134.06 146.68 50.55 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.96 0.904 . . . . 0.0 112.114 -170.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -66.47 143.41 57.11 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 120.918 -1.114 . . . . 0.0 112.442 -177.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.545 ' H ' ' HD3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -81.81 -3.63 54.43 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 -173.753 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.0 t -115.91 -42.46 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.95 1.3 . . . . 0.0 111.403 173.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.3 m -116.13 -6.26 11.9 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -169.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.26 16.83 78.65 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 123.864 0.745 . . . . 0.0 114.171 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -66.73 126.75 29.98 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.531 1.533 . . . . 0.0 111.199 -175.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 57.4 tp -68.16 110.07 3.83 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.538 0.608 . . . . 0.0 110.424 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -79.29 -52.05 8.63 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.536 1.135 . . . . 0.0 111.042 176.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.27 162.06 37.77 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.437 1.095 . . . . 0.0 112.025 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -142.71 133.72 25.74 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.035 1.334 . . . . 0.0 111.551 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.24 101.93 48.99 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 124.742 1.217 . . . . 0.0 111.633 176.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -66.29 141.05 60.91 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 124.25 3.3 . . . . 0.0 112.788 171.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 t -137.14 123.79 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.763 1.625 . . . . 0.0 109.652 -177.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -89.05 -21.75 23.29 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -159.91 145.13 15.25 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.439 1.895 . . . . 0.0 110.291 169.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -116.97 130.12 24.83 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 124.664 1.186 . . . . 0.0 110.98 176.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.82 148.56 78.85 Favored 'Cis proline' 0 CA--C 1.542 0.915 0 CA-C-N 119.86 0.986 . . . . 0.0 112.968 -5.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.28 -168.2 24.88 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.95 1.262 . . . . 0.0 113.916 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.8 tp -63.69 -32.83 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -172.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.26 5.47 49.04 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -170.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.4 t -149.57 131.3 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.458 1.103 . . . . 0.0 110.892 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -140.64 158.85 43.37 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.711 1.604 . . . . 0.0 112.94 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 75.1 p -105.13 158.87 16.28 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.666 1.986 . . . . 0.0 110.941 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.4 m -84.12 176.03 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.762 0.825 . . . . 0.0 110.9 165.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 59.1 p -94.89 -31.98 13.44 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.598 1.559 . . . . 0.0 113.011 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -92.65 -43.77 8.92 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -167.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.7 t -142.81 120.16 11.61 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -173.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.25 -2.87 9.08 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -169.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . 0.265 0.9 OUTLIER -87.47 22.3 2.24 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.677 1.591 . . . . 0.0 114.217 174.242 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -140.92 135.33 31.15 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.052 1.341 . . . . 0.0 111.254 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -135.76 161.3 35.96 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.206 1.402 . . . . 0.0 111.376 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 89.8 t -115.89 141.8 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.628 1.171 . . . . 0.0 108.675 166.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.52 147.56 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 118.754 0.707 . . . . 0.0 112.392 173.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -89.79 84.74 6.28 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.627 0.771 . . . . 0.0 111.074 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -68.92 139.51 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 122.627 0.371 . . . . 0.0 111.062 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -139.46 144.33 37.96 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.947 1.699 . . . . 0.0 111.604 -170.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -91.1 2.4 56.36 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.275 1.03 . . . . 0.0 113.021 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.09 13.79 78.42 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.207 1.384 . . . . 0.0 114.778 178.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.6 t -139.79 16.76 2.5 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.427 1.491 . . . . 0.0 113.6 -171.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.12 -2.64 81.76 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.602 1.096 . . . . 0.0 115.0 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -74.39 133.65 42.46 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.424 1.489 . . . . 0.0 108.527 164.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.9 p -150.55 159.19 44.66 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 171.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.61 148.28 32.95 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.579 1.552 . . . . 0.0 111.106 169.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -93.41 118.54 31.43 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.466 0.707 . . . . 0.0 109.682 168.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 27.7 pt -118.06 144.2 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.493 1.117 . . . . 0.0 111.15 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -90.5 144.49 17.45 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.059 0.838 . . . . 0.0 111.013 174.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.8 pt -129.96 140.61 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 125.43 1.492 . . . . 0.0 111.667 172.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.26 142.95 16.37 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.66 1.6 . . . . 0.0 113.077 176.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -106.76 161.07 14.99 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.85 1.66 . . . . 0.0 111.855 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.9 t -73.09 -28.02 62.05 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.64 0.776 . . . . 0.0 112.857 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -155.88 151.86 27.61 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.312 1.045 . . . . 0.0 112.083 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 63.7 ttt-85 -62.8 -33.07 74.44 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.501 1.12 . . . . 0.0 113.397 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.64 -28.62 73.03 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-N 118.798 0.726 . . . . 0.0 113.525 175.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -83.71 -34.15 24.97 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.963 0.905 . . . . 0.0 111.812 175.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.51 -31.77 73.01 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 168.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.39 -35.64 74.32 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.349 -0.844 . . . . 0.0 112.611 173.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -67.0 -29.46 69.3 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.228 -0.92 . . . . 0.0 112.934 176.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -60.82 -50.24 74.24 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.304 0.956 . . . . 0.0 111.693 172.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -82.19 -25.1 34.56 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.8 t -77.38 -42.25 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.194 -0.941 . . . . 0.0 111.285 175.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 92.5 p -65.52 -31.57 72.7 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.354 0.979 . . . . 0.0 113.111 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 61.0 mt -68.51 -52.5 31.46 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.961 0.905 . . . . 0.0 112.006 172.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -67.47 -29.38 68.82 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.957 -1.089 . . . . 0.0 112.793 -177.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -81.31 -1.53 45.6 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.055 1.342 . . . . 0.0 112.571 174.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.423 ' CE1' ' HB2' ' A' ' 51' ' ' SER . 29.6 t-80 -91.29 -23.31 20.18 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 120.701 -1.249 . . . . 0.0 113.005 165.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -104.16 -4.37 23.22 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -176.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.41 -32.61 62.82 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 120.444 1.474 . . . . 0.0 114.52 -177.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 32.1 p-90 -81.25 -23.11 38.24 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.913 1.285 . . . . 0.0 113.406 178.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.7 t -82.05 -30.46 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 125.195 1.398 . . . . 0.0 110.803 173.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -95.89 35.29 1.42 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 127.106 2.162 . . . . 0.0 111.875 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -81.73 96.3 7.52 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 122.043 0.925 . . . . 0.0 109.335 170.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 . . . . . 0 C--O 1.252 1.229 0 C-N-CA 125.408 1.483 . . . . 0.0 113.269 -161.398 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.683 0 N-CA-C 111.866 -0.494 . . . . 0.0 111.866 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 46.2 p -74.41 149.65 86.71 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 124.492 1.117 . . . . 0.0 112.5 177.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.28 -32.28 42.06 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.136 2.557 . . . . 0.0 113.075 -174.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -63.67 -30.91 71.95 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.027 0.931 . . . . 0.0 112.749 173.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 66.1 m -70.4 -4.67 23.59 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.7 mtp -75.26 -6.7 51.18 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.68 1.192 . . . . 0.0 113.222 169.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.23 -37.01 0.17 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.078 1.351 . . . . 0.0 113.554 -177.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 35.6 m -129.32 96.92 4.42 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.986 1.714 . . . . 0.0 109.509 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -126.55 12.21 7.44 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.706 1.602 . . . . 0.0 113.589 -176.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.8 mp -78.28 104.4 8.84 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.349 1.059 . . . . 0.0 111.406 -177.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -82.44 59.57 4.67 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.67 1.188 . . . . 0.0 110.153 167.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.09 122.89 21.17 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.91 1.684 . . . . 0.0 111.414 -162.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -175.85 93.64 0.06 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.263 1.825 . . . . 0.0 106.526 162.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.8 m -76.04 89.52 3.0 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.107 1.763 . . . . 0.0 110.913 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.44 142.17 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 125.367 1.467 . . . . 0.0 111.273 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.3 mt -127.41 -44.21 1.57 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.183 1.393 . . . . 0.0 111.813 -172.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 27.6 t -151.9 137.12 17.48 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.599 1.16 . . . . 0.0 111.013 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.7 t -130.84 121.82 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.774 1.23 . . . . 0.0 109.962 174.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -117.57 137.92 24.66 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 125.27 1.428 . . . . 0.0 110.192 172.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.93 -20.51 25.64 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.478 2.786 . . . . 0.0 114.418 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -135.9 113.27 10.68 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.953 0.901 . . . . 0.0 111.668 -169.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.0 p -149.56 146.38 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.737 1.615 . . . . 0.0 110.248 175.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.6 m -125.18 128.37 48.25 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.024 0.93 . . . . 0.0 111.381 -172.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.1 t -94.84 139.12 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.457 1.503 . . . . 0.0 112.067 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -127.63 123.82 36.53 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.109 1.364 . . . . 0.0 109.772 171.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -69.54 101.9 1.71 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.39 0.676 . . . . 0.0 109.198 166.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.2 pt -72.51 156.18 90.48 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.109 0.963 . . . . 0.0 113.11 -172.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -59.94 160.85 20.51 Favored 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 122.984 2.456 . . . . 0.0 112.314 165.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -67.91 98.69 0.52 Allowed 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.612 2.875 . . . . 0.0 110.918 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -146.95 176.4 9.94 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.261 1.824 . . . . 0.0 112.867 -165.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -133.88 160.63 37.07 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.036 1.734 . . . . 0.0 110.501 165.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.8 p -60.89 -49.79 76.05 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.52 1.928 . . . . 0.0 113.641 -176.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -83.48 17.4 2.19 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.881 1.673 . . . . 0.0 111.892 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 86.9 mmt-85 -130.71 -36.76 1.38 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.59 1.956 . . . . 0.0 112.546 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 172.08 44.5 0.04 OUTLIER Glycine 0 C--N 1.339 0.722 0 N-CA-C 118.522 2.169 . . . . 0.0 118.522 177.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -84.54 96.34 9.12 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.028 1.414 . . . . 0.0 108.751 154.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.7 20.6 15.14 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.52 -1.362 . . . . 0.0 114.347 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.15 -47.99 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.761 2.424 . . . . 0.0 115.092 -168.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.4 m -64.92 -16.09 62.86 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.496 1.918 . . . . 0.0 115.016 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -81.08 -10.01 59.74 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.715 0.806 . . . . 0.0 112.846 173.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 14.2 m0 -92.96 173.23 7.85 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.488 1.515 . . . . 0.0 111.147 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -79.5 53.39 1.55 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.33 1.452 . . . . 0.0 114.182 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.5 mt -61.3 -16.49 46.2 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.389 1.625 . . . . 0.0 115.389 -172.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -108.22 -3.58 18.35 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.45 1.1 . . . . 0.0 112.714 177.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -149.39 67.29 8.83 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.362 1.465 . . . . 0.0 111.48 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -53.26 141.03 60.98 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.163 2.575 . . . . 0.0 111.926 176.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -72.83 -27.51 61.99 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.453 0.701 . . . . 0.0 111.717 -177.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -151.92 152.66 32.83 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.214 1.805 . . . . 0.0 110.152 169.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.5 p -135.14 148.52 49.77 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.925 0.89 . . . . 0.0 111.646 169.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.64 -141.32 5.17 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 114.097 0.399 . . . . 0.0 114.097 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -107.06 145.64 32.13 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.01 2.124 . . . . 0.0 111.106 -174.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.8 tp -93.13 136.48 33.35 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.993 1.317 . . . . 0.0 109.458 169.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.3 ttp85 -137.76 103.51 5.03 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.594 0.758 . . . . 0.0 110.223 160.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.0 mt -77.7 118.76 25.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 166.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.55 178.12 4.58 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 127.93 2.492 . . . . 0.0 110.272 176.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 t -160.12 172.45 17.45 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 126.804 2.042 . . . . 0.0 107.763 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -143.66 -107.29 0.12 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.336 1.055 . . . . 0.0 109.01 167.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.19 97.5 2.0 Allowed Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.135 1.35 . . . . 0.0 112.564 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 52.86 28.5 6.55 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 126.603 1.961 . . . . 0.0 113.811 178.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.1 m -147.2 116.36 6.93 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 126.177 1.791 . . . . 0.0 108.396 -173.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.94 159.22 18.43 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.098 0.959 . . . . 0.0 110.823 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -136.12 117.08 14.24 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.206 1.402 . . . . 0.0 109.911 177.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.4 mp -87.15 100.48 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 168.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -98.64 137.0 37.92 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.793 0.806 . . . . 0.0 111.813 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -102.38 131.95 48.69 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.499 1.519 . . . . 0.0 109.636 168.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -136.44 152.27 50.4 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.784 0.834 . . . . 0.0 111.781 -173.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -73.03 142.01 47.66 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.865 -1.147 . . . . 0.0 112.667 -170.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -78.36 -6.13 54.24 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.194 1.797 . . . . 0.0 115.703 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 99.4 t -121.85 -44.63 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.101 1.36 . . . . 0.0 111.257 177.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.7 m -98.67 -19.99 17.21 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -174.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.77 10.3 80.02 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.513 1.054 . . . . 0.0 114.033 -176.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -82.71 154.24 24.93 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.243 1.417 . . . . 0.0 112.466 -175.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.2 tp -72.53 125.12 26.66 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.68 0.792 . . . . 0.0 111.918 -174.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -87.37 -55.22 3.9 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.118 0.967 . . . . 0.0 111.035 168.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.63 160.87 39.81 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.622 1.169 . . . . 0.0 112.027 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -141.47 131.12 24.06 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.797 1.239 . . . . 0.0 111.93 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.2 102.88 53.6 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 124.464 1.106 . . . . 0.0 111.534 175.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.77 139.93 25.53 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.963 3.109 . . . . 0.0 111.958 175.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.5 t -134.42 123.49 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 126.193 1.797 . . . . 0.0 109.548 -174.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -87.53 -23.02 24.52 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 121.366 -0.834 . . . . 0.0 113.158 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.12 144.3 15.96 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.409 1.883 . . . . 0.0 110.199 169.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -115.11 130.13 24.49 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.547 1.139 . . . . 0.0 110.918 176.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.94 148.05 78.12 Favored 'Cis proline' 0 CA--C 1.541 0.873 0 CA-C-N 119.827 0.974 . . . . 0.0 113.032 -5.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.85 -170.72 30.19 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.937 1.256 . . . . 0.0 113.822 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.3 tp -60.44 -31.05 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -170.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.4 4.33 53.65 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -171.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.5 t -149.33 130.37 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 119.456 1.025 . . . . 0.0 111.631 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -142.42 165.87 26.23 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.563 1.945 . . . . 0.0 112.364 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 56.1 p -116.9 160.17 21.29 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 127.087 2.155 . . . . 0.0 111.63 -176.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.7 m -84.16 172.58 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.034 0.934 . . . . 0.0 111.565 168.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.6 p -91.61 -33.59 15.05 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.313 1.445 . . . . 0.0 112.768 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -97.51 -40.66 8.55 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -162.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.5 t -139.2 122.59 17.16 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -175.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 p -74.5 30.19 0.08 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 -172.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.426 ' HA ' ' CB ' ' A' ' 116' ' ' ALA . 53.9 ptt85 -123.65 23.58 8.76 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.14 1.776 . . . . 0.0 114.298 171.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -140.52 138.76 34.81 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.905 1.282 . . . . 0.0 111.227 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -137.0 164.54 28.11 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.597 1.559 . . . . 0.0 111.108 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.2 t -122.1 139.67 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.737 1.215 . . . . 0.0 108.589 167.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.87 148.05 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 118.731 0.696 . . . . 0.0 112.415 176.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -89.34 85.68 6.64 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.475 0.71 . . . . 0.0 110.805 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.08 137.22 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 122.105 -0.372 . . . . 0.0 110.773 175.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -138.36 145.48 41.15 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.474 1.51 . . . . 0.0 111.738 -169.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -96.05 14.65 23.05 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.273 1.029 . . . . 0.0 113.289 -175.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.0 8.69 83.33 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.327 1.441 . . . . 0.0 115.518 177.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.2 t -131.42 6.98 4.5 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.377 1.471 . . . . 0.0 114.008 -173.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.34 -7.31 72.02 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.224 1.393 . . . . 0.0 113.916 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -72.87 127.13 31.63 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 127.12 2.168 . . . . 0.0 108.709 166.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 86.2 p -146.97 157.39 43.61 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.865 1.266 . . . . 0.0 114.368 -171.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.57 146.63 29.48 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.664 1.586 . . . . 0.0 111.057 168.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -92.12 121.4 33.63 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.058 0.543 . . . . 0.0 109.853 168.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.1 pt -120.92 144.57 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.675 1.19 . . . . 0.0 110.929 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -88.32 145.88 19.27 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 173.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.6 pt -128.05 141.63 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 125.274 1.43 . . . . 0.0 111.634 167.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.15 143.28 15.53 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.601 1.572 . . . . 0.0 112.931 175.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -108.65 157.41 18.54 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.51 1.924 . . . . 0.0 110.903 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.6 t -69.26 -27.7 65.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.918 0.887 . . . . 0.0 112.644 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -155.52 153.09 29.68 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.204 1.001 . . . . 0.0 112.029 -178.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.54 -35.03 75.02 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.589 1.156 . . . . 0.0 112.122 175.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.95 -14.73 68.42 Favored Glycine 0 CA--C 1.54 1.604 0 CA-C-O 119.384 -0.676 . . . . 0.0 114.364 176.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -97.1 -30.9 12.77 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.819 1.248 . . . . 0.0 111.886 171.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.426 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -72.98 -30.84 64.13 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 173.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -59.44 -32.1 69.91 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.35 -0.844 . . . . 0.0 112.064 172.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -64.77 -32.43 74.11 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.531 -0.731 . . . . 0.0 112.384 174.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -63.11 -56.35 17.58 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.213 1.005 . . . . 0.0 111.691 178.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -73.97 -24.48 59.63 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -177.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 68.4 t -78.29 -42.3 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 121.254 -0.904 . . . . 0.0 111.306 174.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.9 m -66.36 -30.78 71.25 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.137 0.88 . . . . 0.0 112.539 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.0 mt -67.37 -57.3 6.86 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.457 0.703 . . . . 0.0 111.867 170.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -64.74 -31.94 73.39 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.457 -0.777 . . . . 0.0 112.973 -173.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -80.73 -0.28 37.75 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.368 1.067 . . . . 0.0 112.666 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -101.78 -3.99 27.14 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 164.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -111.45 -10.8 14.16 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 175.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.94 -32.87 61.7 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -176.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 32.9 p-90 -81.13 -24.05 37.91 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.359 1.464 . . . . 0.0 113.347 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.6 t -79.28 -34.42 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.062 1.345 . . . . 0.0 110.665 174.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -101.41 52.42 0.83 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.138 1.775 . . . . 0.0 111.54 -177.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -89.96 12.63 16.92 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.262 1.425 . . . . 0.0 113.582 169.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 . . . . . 0 C--O 1.254 1.313 0 C-N-CA 126.057 1.743 . . . . 0.0 114.74 179.353 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.528 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 58.2 m -135.04 149.73 71.12 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 125.308 1.443 . . . . 0.0 111.88 -176.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.04 -18.42 12.94 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.325 2.683 . . . . 0.0 113.898 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -77.69 143.17 38.32 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.586 1.154 . . . . 0.0 112.142 -177.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 70.1 m -79.48 -29.0 41.51 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.328 1.051 . . . . 0.0 113.218 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.6 mtp 54.65 34.97 22.68 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.618 1.967 . . . . 0.0 114.141 176.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.76 31.6 1.83 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.959 1.703 . . . . 0.0 111.99 -175.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.1 m 65.89 125.41 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 127.325 2.25 . . . . 0.0 112.134 -158.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -159.62 162.16 35.19 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.789 2.036 . . . . 0.0 108.599 -173.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.3 pp -135.66 155.27 50.69 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.698 1.199 . . . . 0.0 113.655 174.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -144.37 48.96 1.35 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.948 1.699 . . . . 0.0 109.463 172.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -144.54 158.97 43.52 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 125.536 1.534 . . . . 0.0 112.336 -174.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -173.88 73.76 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 129.459 3.104 . . . . 0.0 105.468 -174.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.4 t -73.06 116.09 13.17 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 126.386 1.875 . . . . 0.0 111.251 -164.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.8 t -70.54 144.42 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.705 0.802 . . . . 0.0 111.126 -171.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 44.9 mt -127.07 -42.83 1.7 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.715 1.606 . . . . 0.0 111.949 -174.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 32.7 t -149.26 139.22 22.02 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.59 1.156 . . . . 0.0 109.808 177.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.5 t -133.99 127.15 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.641 1.176 . . . . 0.0 109.116 170.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -131.0 134.37 25.88 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 125.004 1.322 . . . . 0.0 110.23 175.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.28 -18.51 16.02 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.878 2.385 . . . . 0.0 114.854 -172.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -132.69 111.79 11.46 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.452 1.101 . . . . 0.0 111.434 -173.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.0 p -146.61 144.63 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.847 1.659 . . . . 0.0 109.882 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.6 m -123.73 131.8 53.68 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.986 0.915 . . . . 0.0 111.549 -173.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 76.0 t -96.97 131.6 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.492 1.517 . . . . 0.0 111.594 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -128.82 126.9 40.85 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.936 1.295 . . . . 0.0 109.15 169.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -65.83 129.9 41.41 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.479 0.712 . . . . 0.0 109.546 170.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.6 pt -98.89 152.83 37.97 Favored Pre-proline 0 N--CA 1.476 0.875 0 C-N-CA 124.333 1.053 . . . . 0.0 112.851 -171.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -69.84 153.63 68.34 Favored 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 122.576 2.184 . . . . 0.0 111.162 163.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.41 151.0 80.9 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.972 2.448 . . . . 0.0 111.608 173.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -72.79 152.11 41.74 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.218 0.607 . . . . 0.0 112.55 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.15 -82.17 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.759 1.623 . . . . 0.0 111.585 163.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 86.0 p -162.01 -53.93 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.835 1.654 . . . . 0.0 111.402 166.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -125.07 1.37 7.94 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.899 1.679 . . . . 0.0 113.78 -173.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.5 mmt85 -77.55 -36.27 52.41 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.757 1.223 . . . . 0.0 112.95 -176.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.93 153.9 17.55 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 122.197 0.887 . . . . 0.0 113.131 175.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -73.24 145.15 46.39 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 124.177 0.991 . . . . 0.0 109.687 172.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.37 19.92 7.44 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -171.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.42 -48.29 0.05 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 127.76 2.424 . . . . 0.0 115.299 -172.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.6 m -66.44 -16.63 64.25 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.239 1.816 . . . . 0.0 114.813 -177.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -85.5 -2.53 58.23 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 172.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 24.7 m0 -92.3 169.16 10.8 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.059 1.344 . . . . 0.0 110.833 173.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.5 mttt -78.33 52.44 1.13 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.341 1.456 . . . . 0.0 114.136 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.9 mt -57.53 -28.43 63.49 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -175.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -91.36 -6.07 53.56 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -149.76 74.36 9.45 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 124.873 1.269 . . . . 0.0 111.917 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -56.69 143.39 89.79 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.913 2.408 . . . . 0.0 112.565 174.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -72.0 -28.43 63.4 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.739 1.216 . . . . 0.0 111.624 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 49.4 t90 -155.73 151.97 27.98 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.985 1.714 . . . . 0.0 110.523 174.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.6 p -134.9 149.63 50.31 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.006 0.922 . . . . 0.0 111.723 170.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.74 -142.24 6.01 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 114.135 0.414 . . . . 0.0 114.135 -178.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 47.0 mtt180 -105.16 144.46 31.91 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 127.233 2.213 . . . . 0.0 111.751 -173.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.5 tp -90.29 137.15 32.58 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.434 1.494 . . . . 0.0 110.324 166.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.0 ttm-85 -130.27 132.23 45.83 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.659 1.184 . . . . 0.0 109.56 156.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.7 mt -109.59 131.57 60.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 163.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.72 151.06 42.61 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 127.879 2.471 . . . . 0.0 108.23 -168.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 92.3 p -161.04 155.08 22.64 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 120.142 -1.598 . . . . 0.0 111.908 -169.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -132.56 -105.1 0.25 Allowed 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.066 -1.022 . . . . 0.0 112.378 -173.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.32 -125.53 0.28 Allowed Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.26 0.933 . . . . 0.0 111.252 168.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -77.13 34.11 0.15 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.962 1.305 . . . . 0.0 112.52 173.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.8 m -143.45 133.59 24.36 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.935 0.894 . . . . 0.0 110.671 -174.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -115.09 162.86 16.44 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.15 1.38 . . . . 0.0 111.052 169.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -144.13 107.95 4.69 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.612 1.965 . . . . 0.0 108.88 -170.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mp -86.34 108.29 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 169.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -109.01 128.96 55.41 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.732 1.213 . . . . 0.0 111.309 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.0 mp -101.62 131.11 48.02 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.871 1.268 . . . . 0.0 110.168 177.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -133.16 149.66 52.05 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.063 0.945 . . . . 0.0 112.602 -169.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -69.58 141.14 53.82 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.033 -1.042 . . . . 0.0 111.977 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.0 pttt -79.85 -4.7 53.32 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 -177.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 95.8 t -121.98 -43.84 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.171 1.389 . . . . 0.0 111.355 178.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.9 m -97.47 -20.27 17.87 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.19 11.32 79.31 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.443 1.021 . . . . 0.0 114.032 -176.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -83.59 151.19 25.48 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.192 1.397 . . . . 0.0 112.24 -175.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.3 tp -72.96 127.26 32.02 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.437 0.695 . . . . 0.0 111.66 -175.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -86.76 -55.41 3.87 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.704 1.202 . . . . 0.0 111.171 169.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.11 159.69 38.11 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.117 1.367 . . . . 0.0 111.307 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -139.35 137.57 35.86 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 174.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.32 106.5 48.82 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.601 1.56 . . . . 0.0 110.621 177.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.57 142.13 18.1 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.718 2.946 . . . . 0.0 111.107 173.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.9 t -135.58 129.91 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 126.352 1.861 . . . . 0.0 109.476 -170.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -97.68 -20.1 17.83 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.227 1.011 . . . . 0.0 113.061 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.91 147.39 11.49 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.449 2.3 . . . . 0.0 110.33 -177.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -135.12 125.11 16.83 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 124.064 0.946 . . . . 0.0 111.529 174.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -65.31 150.13 75.93 Favored 'Cis proline' 0 CA--C 1.541 0.849 0 CA-C-N 119.894 0.998 . . . . 0.0 113.122 -2.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -170.06 -158.86 14.62 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.037 1.304 . . . . 0.0 113.697 -175.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.4 tp -75.53 -39.79 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -172.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.54 5.6 41.94 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -168.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.4 t -150.8 130.91 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.684 1.593 . . . . 0.0 109.397 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.3 163.2 34.39 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.814 1.646 . . . . 0.0 112.735 -174.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 66.3 p -116.43 162.9 16.85 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.904 1.682 . . . . 0.0 111.659 -177.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.5 m -91.08 177.39 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 124.479 1.112 . . . . 0.0 110.726 166.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.8 p -98.81 -32.4 11.38 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.051 1.74 . . . . 0.0 113.045 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -88.68 -43.36 11.37 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -167.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.2 t -143.9 124.44 14.01 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -176.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.05 -1.4 7.48 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 -170.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.467 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.295 27.9 ptt180 -85.63 15.37 4.71 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 177.469 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -137.02 133.97 36.07 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.874 1.269 . . . . 0.0 110.855 -173.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -133.74 160.46 37.52 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.087 1.355 . . . . 0.0 111.512 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 78.8 t -112.25 143.92 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.328 1.051 . . . . 0.0 108.985 164.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.0 149.49 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 119.025 0.829 . . . . 0.0 112.049 169.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -91.72 82.88 5.24 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.783 0.833 . . . . 0.0 111.177 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -66.93 139.99 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 120.91 0.386 . . . . 0.0 111.065 176.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -140.22 152.5 46.03 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.778 1.631 . . . . 0.0 111.474 -169.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -96.14 1.75 52.61 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.254 1.021 . . . . 0.0 112.957 177.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.98 12.13 81.57 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 125.278 1.418 . . . . 0.0 114.909 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.3 t -135.54 13.18 3.47 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.485 1.514 . . . . 0.0 113.544 -172.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.2 -4.71 74.51 Favored Glycine 0 CA--C 1.537 1.432 0 O-C-N 120.655 -1.278 . . . . 0.0 114.807 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -70.87 131.63 44.05 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.252 1.421 . . . . 0.0 108.499 163.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.1 p -149.55 159.17 44.53 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 173.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.25 146.26 32.54 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.491 1.516 . . . . 0.0 110.832 167.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -90.95 120.31 31.85 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.074 0.55 . . . . 0.0 109.65 167.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.6 pt -117.9 143.22 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.404 1.082 . . . . 0.0 110.832 176.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -92.24 140.69 15.26 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 175.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.0 pt -126.64 141.35 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 125.285 1.434 . . . . 0.0 111.708 173.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.1 142.14 14.3 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.038 1.304 . . . . 0.0 113.144 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -104.37 162.42 13.24 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.626 1.57 . . . . 0.0 111.531 -177.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.1 t -72.64 -29.18 63.24 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.578 0.751 . . . . 0.0 112.486 176.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -153.04 147.63 26.11 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.184 0.994 . . . . 0.0 112.069 -174.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.6 ttt-85 -62.33 -32.82 73.64 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.348 1.059 . . . . 0.0 113.234 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.96 -28.32 73.45 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-N 119.025 0.829 . . . . 0.0 113.714 176.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -84.71 -32.51 23.49 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.015 0.907 . . . . 0.0 111.953 176.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.467 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -66.9 -34.37 77.62 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 166.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -60.57 -35.96 77.33 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.251 -0.906 . . . . 0.0 111.677 168.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -62.47 -37.59 86.53 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 119.247 0.93 . . . . 0.0 111.88 175.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -58.73 -56.54 20.87 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.448 1.099 . . . . 0.0 112.017 171.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.03 -26.13 53.35 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -174.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.2 t -77.24 -43.31 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 121.193 -0.942 . . . . 0.0 110.98 176.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.3 t -69.91 -29.77 67.03 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.137 0.88 . . . . 0.0 112.469 -178.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.6 mt -64.44 -55.06 23.35 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.445 -0.784 . . . . 0.0 112.124 167.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -68.27 -29.48 68.28 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.108 -0.995 . . . . 0.0 113.069 -173.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -82.62 -3.64 56.51 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.852 0.861 . . . . 0.0 112.799 176.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -93.45 -34.08 13.56 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.39 -0.819 . . . . 0.0 112.47 161.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -90.64 -6.39 54.63 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 -177.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.52 -27.5 38.65 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 121.259 1.845 . . . . 0.0 115.773 -173.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 27.3 p-90 -86.21 -21.57 27.39 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.622 1.169 . . . . 0.0 113.98 175.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 17.5 t -86.11 -41.0 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.085 1.354 . . . . 0.0 110.625 175.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -98.56 49.35 0.98 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.318 2.247 . . . . 0.0 111.38 -175.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -78.21 88.95 4.28 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.009 0.924 . . . . 0.0 111.22 175.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 C--O 1.253 1.268 0 C-N-CA 127.237 2.215 . . . . 0.0 112.325 176.641 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.574 0 N-CA-C 111.576 -0.609 . . . . 0.0 111.576 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 37.4 t -134.17 157.77 76.83 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 125.979 1.712 . . . . 0.0 110.937 -178.236 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.11 -24.71 34.22 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.585 2.19 . . . . 0.0 113.318 161.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -74.2 -14.86 61.0 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.966 1.307 . . . . 0.0 113.726 174.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 14.9 m -77.03 -7.75 56.21 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.032 1.333 . . . . 0.0 113.788 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt 52.99 -98.95 0.08 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.003 2.121 . . . . 0.0 113.861 177.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.44 -47.97 0.09 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.166 1.386 . . . . 0.0 111.523 177.168 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.2 m -130.22 120.4 24.41 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.083 1.753 . . . . 0.0 106.739 163.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -146.12 116.66 7.57 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.108 1.363 . . . . 0.0 108.531 -169.7 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.5 mt -137.23 40.25 2.47 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.4 1.48 . . . . 0.0 113.703 -168.413 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -76.29 34.4 0.13 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.821 1.248 . . . . 0.0 112.602 172.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -156.62 150.07 24.45 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 128.211 2.604 . . . . 0.0 109.524 -175.199 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -173.11 139.21 0.79 Allowed 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.095 1.358 . . . . 0.0 107.781 172.564 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.8 m -96.48 113.9 25.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.856 151.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.5 p -70.62 145.33 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 178.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.6 mt -129.86 -39.68 1.4 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.829 1.652 . . . . 0.0 111.957 -172.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.427 ' SG ' ' HE2' ' A' ' 14' ' ' LYS . 12.5 t -152.8 133.25 13.7 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.096 0.958 . . . . 0.0 111.26 175.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 92.9 t -130.5 127.14 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.538 1.135 . . . . 0.0 108.963 170.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.427 ' HE2' ' SG ' ' A' ' 12' ' ' CYS . 68.1 mttm -133.55 144.08 50.62 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 124.968 1.307 . . . . 0.0 112.3 -179.522 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -77.7 -11.44 16.91 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 124.098 3.199 . . . . 0.0 114.636 -178.289 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -117.99 110.15 17.34 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.148 1.379 . . . . 0.0 111.673 -174.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 p -156.82 142.05 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.527 1.131 . . . . 0.0 110.424 163.296 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.6 m -123.43 144.23 49.64 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.408 1.483 . . . . 0.0 110.238 178.517 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 76.7 t -113.7 129.36 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.821 1.248 . . . . 0.0 111.047 177.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.17 116.41 11.85 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.89 1.676 . . . . 0.0 109.196 173.796 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.9 mtt-85 -71.37 134.54 46.77 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.138 0.975 . . . . 0.0 110.509 -176.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.7 pt -90.1 150.21 42.97 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 124.266 1.026 . . . . 0.0 113.177 -165.003 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -73.2 162.34 40.84 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 123.421 2.747 . . . . 0.0 112.372 173.115 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.56 111.97 2.03 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.321 2.681 . . . . 0.0 111.024 174.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.1 tpp85 -157.81 157.96 34.3 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.338 1.855 . . . . 0.0 110.932 -172.39 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.55 134.23 54.1 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.268 1.427 . . . . 0.0 113.19 173.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.5 p -77.64 -51.39 10.7 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.655 1.982 . . . . 0.0 113.316 -170.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -83.02 -11.69 57.87 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -174.001 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.51 -6.55 0.71 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 117.063 2.246 . . . . 0.0 117.063 -171.762 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -113.58 -18.44 7.03 Favored Glycine 0 N--CA 1.469 0.867 0 N-CA-C 117.913 1.925 . . . . 0.0 117.913 -161.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -85.15 125.79 33.1 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 120.106 1.953 . . . . 0.0 110.632 178.151 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.401 ' HE ' ' CG ' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -118.61 26.13 9.78 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 178.113 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 60.46 -42.13 0.1 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.686 2.394 . . . . 0.0 115.272 -170.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 89.6 p -66.47 -15.92 63.72 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.384 1.874 . . . . 0.0 114.398 -179.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.401 ' CG ' ' HE ' ' A' ' 32' ' ' ARG . 31.9 m-20 -63.33 -26.21 68.66 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 167.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 9.6 m0 -94.13 164.89 12.88 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.964 1.306 . . . . 0.0 111.256 -168.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -76.92 55.21 1.08 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.643 1.577 . . . . 0.0 114.172 179.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.6 mt -59.49 -25.69 64.66 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.66 1.184 . . . . 0.0 113.745 -179.278 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -94.87 -7.63 39.58 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.608 0.763 . . . . 0.0 113.004 -179.053 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -149.88 78.97 7.96 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.644 1.178 . . . . 0.0 111.959 175.549 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.88 147.61 50.68 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.519 2.813 . . . . 0.0 113.114 176.229 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -71.22 -28.92 64.54 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.881 0.872 . . . . 0.0 111.302 169.003 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 66.9 t90 -156.56 153.53 28.81 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.243 1.817 . . . . 0.0 110.891 177.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.7 p -135.67 149.4 49.27 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.576 1.151 . . . . 0.0 111.331 169.374 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.62 -140.44 4.29 Favored Glycine 0 CA--C 1.525 0.717 0 O-C-N 122.135 -0.353 . . . . 0.0 113.462 -178.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.9 mtm105 -119.56 147.76 44.1 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.222 1.809 . . . . 0.0 111.715 -173.189 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 40.4 tp -85.13 142.04 29.79 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.674 1.59 . . . . 0.0 110.616 176.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.8 ttm-85 -142.2 95.55 2.82 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.376 1.07 . . . . 0.0 111.073 165.427 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.7 mt -83.06 128.53 38.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 169.271 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.8 p -140.57 171.97 13.37 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.71 2.004 . . . . 0.0 110.472 -176.011 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.7 t -155.34 153.43 30.48 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.681 1.192 . . . . 0.0 112.076 175.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -155.96 123.76 5.62 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.166 0.986 . . . . 0.0 111.012 163.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.52 46.31 48.71 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.151 0.882 . . . . 0.0 114.845 167.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt 63.32 28.2 15.58 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 126.408 1.883 . . . . 0.0 113.679 -176.061 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.1 m -135.42 120.55 18.84 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.658 1.583 . . . . 0.0 108.774 170.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.3 159.25 18.85 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.891 0.876 . . . . 0.0 111.034 174.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -137.63 114.05 10.23 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.592 1.557 . . . . 0.0 109.29 178.514 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.4 mp -85.93 92.88 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 167.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -84.98 146.1 27.38 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.208 1.003 . . . . 0.0 110.266 172.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -110.44 137.54 48.02 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.564 1.546 . . . . 0.0 111.2 172.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -123.71 147.7 47.22 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.34 1.056 . . . . 0.0 113.286 -178.103 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.73 144.15 52.86 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 122.148 0.975 . . . . 0.0 112.065 169.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.4 pttt -81.49 -6.38 58.9 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -177.021 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 90.7 t -122.62 -39.52 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.657 1.183 . . . . 0.0 111.983 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.4 m -116.0 -10.38 11.6 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -172.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.65 19.74 79.3 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 123.613 0.625 . . . . 0.0 114.331 177.399 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -65.79 139.13 58.31 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.385 1.474 . . . . 0.0 111.24 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.9 tp -72.23 112.31 8.2 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.103 0.561 . . . . 0.0 109.882 172.492 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -78.52 -56.58 4.32 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.241 0.616 . . . . 0.0 111.3 177.071 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.0 165.24 35.61 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.225 1.81 . . . . 0.0 109.795 179.266 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -146.25 142.87 28.78 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 170.488 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.22 105.71 50.31 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.355 1.462 . . . . 0.0 111.808 -178.544 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -67.54 142.89 60.71 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 124.129 3.22 . . . . 0.0 112.39 170.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.5 t -139.2 117.33 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.294 1.437 . . . . 0.0 109.688 -177.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -81.45 -25.96 35.68 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 121.45 -0.781 . . . . 0.0 112.96 -177.396 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.19 145.35 16.52 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.336 1.854 . . . . 0.0 110.077 169.435 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -118.75 127.94 26.25 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.569 1.148 . . . . 0.0 110.588 175.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.54 147.5 75.76 Favored 'Cis proline' 0 CA--C 1.542 0.905 0 CA-C-N 119.997 1.035 . . . . 0.0 113.434 -2.684 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.91 -158.2 9.05 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.686 1.612 . . . . 0.0 112.948 -179.169 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.2 tt -76.29 -40.41 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 O-C-N 121.853 -0.793 . . . . 0.0 113.093 -178.245 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.44 7.72 18.77 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -166.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.9 t -152.83 125.99 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 126.421 1.889 . . . . 0.0 108.571 177.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -145.95 154.06 41.5 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.607 1.163 . . . . 0.0 112.224 -173.834 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.7 p -103.2 154.78 18.96 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.524 1.53 . . . . 0.0 112.453 179.693 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.9 m -76.42 175.28 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.8 1.24 . . . . 0.0 111.065 165.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 68.7 p -92.21 -30.12 16.08 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.909 1.283 . . . . 0.0 113.152 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -100.94 -39.34 7.8 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -163.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.4 t -141.42 125.76 17.58 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -176.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.88 -12.73 26.93 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -172.318 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.444 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.272 27.7 ptt180 -82.61 11.78 5.4 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -176.892 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -136.98 140.82 42.45 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.082 1.353 . . . . 0.0 112.03 -174.078 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -140.95 158.82 43.41 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.231 1.412 . . . . 0.0 111.656 -178.262 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.3 t -108.39 140.26 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.379 1.072 . . . . 0.0 108.56 162.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.95 148.31 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 119.159 0.891 . . . . 0.0 112.229 170.184 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -93.25 91.65 7.35 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.743 0.817 . . . . 0.0 110.834 178.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -75.02 152.28 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.245 0.618 . . . . 0.0 111.894 176.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.1 141.85 47.58 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.591 1.556 . . . . 0.0 110.102 171.249 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -96.14 30.27 2.52 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.227 1.011 . . . . 0.0 113.694 -170.326 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.81 8.77 73.71 Favored Glycine 0 CA--C 1.538 1.53 0 N-CA-C 116.129 1.211 . . . . 0.0 116.129 173.418 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.6 t -134.36 -25.84 1.49 Allowed 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -174.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 135.74 -11.95 4.25 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.779 1.18 . . . . 0.0 114.342 177.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.94 157.12 16.04 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.948 1.699 . . . . 0.0 111.129 173.409 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 90.5 p -142.3 162.31 35.8 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.867 1.267 . . . . 0.0 114.119 -165.058 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.81 146.69 31.26 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.894 1.278 . . . . 0.0 111.443 174.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -90.38 117.12 28.85 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.552 0.741 . . . . 0.0 109.438 167.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.8 pt -116.77 144.63 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.804 1.242 . . . . 0.0 110.821 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -92.36 139.15 14.54 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 176.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 31.7 pt -130.67 160.61 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.175 1.39 . . . . 0.0 112.152 171.386 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -155.2 174.45 33.36 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-O 121.865 0.703 . . . . 0.0 114.794 167.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -124.2 149.26 46.57 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 126.721 2.008 . . . . 0.0 110.642 -173.255 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.0 t -74.68 -11.97 60.31 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 178.379 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -119.12 -24.16 6.57 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -155.282 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 61.09 -41.29 0.12 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 127.152 2.181 . . . . 0.0 115.036 -166.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.17 -27.89 72.14 Favored Glycine 0 CA--C 1.537 1.456 0 CA-C-N 119.675 1.125 . . . . 0.0 113.632 171.038 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -79.69 -34.72 39.96 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.122 0.961 . . . . 0.0 112.095 173.317 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.444 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -63.96 -36.77 85.05 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.563 -0.711 . . . . 0.0 112.636 167.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -70.27 9.91 0.52 Allowed 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 167.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -122.4 -32.57 3.6 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.219 1.408 . . . . 0.0 112.114 170.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -50.15 -48.89 53.58 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.223 1.409 . . . . 0.0 111.974 164.148 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -77.07 -29.83 55.22 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -178.672 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.2 t -77.96 -42.75 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 121.041 -1.037 . . . . 0.0 111.004 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 77.8 p -64.08 -26.66 68.65 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 176.309 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.9 mt -71.62 -59.51 2.72 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.22 1.008 . . . . 0.0 112.004 168.092 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -65.3 -30.34 71.18 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -172.412 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -79.04 -1.18 34.44 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.484 1.114 . . . . 0.0 112.608 177.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -100.06 -3.98 30.83 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 164.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -113.87 -10.24 12.98 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 176.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.08 -32.42 61.93 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 120.431 1.469 . . . . 0.0 114.855 -176.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 41.3 p-90 -78.54 -22.71 46.84 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.114 1.366 . . . . 0.0 113.35 178.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.4 t -78.78 -26.37 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.26 1.424 . . . . 0.0 111.074 175.137 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -95.48 27.4 3.4 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.937 2.095 . . . . 0.0 112.594 -179.171 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -83.58 94.63 8.11 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.209 1.003 . . . . 0.0 110.489 173.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 C--O 1.253 1.245 0 C-N-CA 126.808 2.043 . . . . 0.0 113.669 177.581 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.65 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 29.6 t -148.88 144.03 17.75 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 125.112 1.365 . . . . 0.0 111.368 178.822 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -69.69 -13.05 34.29 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.079 2.519 . . . . 0.0 113.421 172.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 51.95 35.66 16.48 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.609 1.563 . . . . 0.0 113.226 -177.504 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 59.6 p -84.43 -6.18 59.35 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 115.267 1.581 . . . . 0.0 115.267 -170.19 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.1 mtt -134.31 159.75 40.04 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.588 1.555 . . . . 0.0 112.276 -179.12 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.5 45.98 2.03 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.997 1.719 . . . . 0.0 110.286 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 30.3 m 58.75 71.24 0.6 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.534 1.534 . . . . 0.0 109.282 -159.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -95.67 90.73 5.8 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.23 1.412 . . . . 0.0 110.953 -168.065 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 29.3 mt -83.9 1.06 45.17 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.358 1.463 . . . . 0.0 114.4 -175.336 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 56.43 23.31 7.28 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.318 1.447 . . . . 0.0 112.819 -155.075 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -149.57 143.5 25.62 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 124.878 1.271 . . . . 0.0 112.896 168.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -161.41 87.27 0.69 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 129.894 3.278 . . . . 0.0 105.697 168.151 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.8 t -75.23 125.23 28.52 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 121.36 -0.838 . . . . 0.0 111.405 -165.236 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.0 p -72.3 146.26 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 123.481 0.712 . . . . 0.0 111.184 -178.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.7 mt -129.5 -37.47 1.6 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.361 1.465 . . . . 0.0 112.521 -170.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 36.8 t -149.31 139.42 22.14 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.954 1.301 . . . . 0.0 109.865 173.312 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.2 t -134.84 127.71 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.826 1.25 . . . . 0.0 108.864 168.636 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -130.96 136.98 29.75 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 125.048 1.339 . . . . 0.0 110.868 176.162 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.11 -14.32 16.82 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.349 2.699 . . . . 0.0 114.968 -174.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -134.58 108.69 8.21 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.135 0.974 . . . . 0.0 111.295 -173.149 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.37 144.35 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.189 1.396 . . . . 0.0 110.191 171.659 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.1 m -123.19 137.5 54.88 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.441 1.096 . . . . 0.0 111.267 -176.574 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.2 t -101.79 133.05 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.324 1.449 . . . . 0.0 111.444 178.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.22 121.51 22.6 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.973 1.309 . . . . 0.0 109.109 170.597 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -66.51 130.82 44.49 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.069 0.548 . . . . 0.0 109.98 174.123 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.0 pt -90.01 151.35 45.02 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.134 0.974 . . . . 0.0 113.205 -168.206 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -67.76 163.18 36.33 Favored 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 123.233 2.622 . . . . 0.0 111.508 165.345 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -61.32 142.66 96.69 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.946 2.431 . . . . 0.0 112.349 176.795 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.48 161.91 28.79 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.089 1.356 . . . . 0.0 112.582 -177.198 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -143.59 163.0 34.44 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.643 1.177 . . . . 0.0 111.182 160.401 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.3 p -85.73 -40.63 15.9 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.552 1.941 . . . . 0.0 113.796 -162.142 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -91.54 23.75 3.35 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.843 1.657 . . . . 0.0 110.944 173.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -133.01 -68.95 0.57 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 127.47 2.308 . . . . 0.0 111.273 -176.359 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.56 172.3 24.5 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-O 122.872 1.262 . . . . 0.0 112.269 -168.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -76.14 134.47 39.95 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.561 1.144 . . . . 0.0 110.375 170.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.54 18.53 7.46 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -172.412 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.3 -49.66 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 128.192 2.597 . . . . 0.0 115.597 -173.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.2 m -65.21 -17.8 64.79 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.99 1.716 . . . . 0.0 114.611 -176.295 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.89 -8.64 59.14 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 172.695 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -88.99 168.9 11.99 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.78 1.232 . . . . 0.0 110.732 174.639 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -81.26 55.36 2.53 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.686 1.195 . . . . 0.0 113.436 179.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.3 mt -54.84 -31.53 59.55 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -172.432 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -90.34 -8.78 49.9 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.32 1.048 . . . . 0.0 113.054 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -137.16 71.17 55.06 Favored Pre-proline 0 N--CA 1.471 0.62 0 C-N-CA 125.624 1.57 . . . . 0.0 111.358 -164.239 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -69.0 148.14 69.35 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 CA-C-N 119.315 0.791 . . . . 0.0 113.051 -171.753 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -72.35 -29.59 63.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.323 0.649 . . . . 0.0 111.239 167.486 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 56.0 t90 -159.56 154.21 24.32 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.533 1.933 . . . . 0.0 110.612 176.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.6 p -133.29 149.27 51.94 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.32 1.048 . . . . 0.0 111.749 167.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.84 -139.91 4.45 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 123.058 0.361 . . . . 0.0 113.261 -179.392 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.7 mtm105 -113.78 143.91 43.85 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.087 1.755 . . . . 0.0 111.736 -173.025 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.6 tp -83.37 140.34 32.47 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.62 1.168 . . . . 0.0 110.142 168.13 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -133.39 138.24 46.19 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.508 1.523 . . . . 0.0 108.816 156.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.1 mt -120.4 133.41 67.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 166.078 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.44 162.82 34.41 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 127.1 2.16 . . . . 0.0 109.309 -167.515 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 84.1 p -160.21 132.46 6.27 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 120.018 -1.676 . . . . 0.0 113.954 -169.452 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.64 137.18 7.64 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 125.51 1.524 . . . . 0.0 114.653 172.027 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 65.5 48.96 63.25 Favored Glycine 0 N--CA 1.475 1.259 0 C-N-CA 125.74 1.638 . . . . 0.0 114.123 171.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 56.1 30.57 16.58 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.99 1.716 . . . . 0.0 112.986 -174.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.5 m -134.05 132.92 40.6 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.775 2.03 . . . . 0.0 108.257 178.489 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.63 158.35 16.16 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.091 0.956 . . . . 0.0 110.434 171.418 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -142.12 91.89 2.38 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.666 1.586 . . . . 0.0 108.833 -164.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.8 mp -78.52 110.84 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 171.558 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -112.9 127.91 56.32 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.927 0.891 . . . . 0.0 110.868 177.201 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mp -96.94 130.29 44.28 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.583 1.153 . . . . 0.0 110.019 177.754 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -129.96 149.56 51.63 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.873 0.869 . . . . 0.0 112.845 -171.358 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -73.58 144.79 45.87 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.983 0.897 . . . . 0.0 112.186 -178.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.0 pttt -84.44 -6.73 59.41 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.238 1.815 . . . . 0.0 115.158 -178.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 96.0 t -122.7 -43.99 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.241 1.416 . . . . 0.0 111.586 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.2 m -95.34 -21.39 18.42 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -174.508 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.13 6.94 84.0 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.218 0.913 . . . . 0.0 113.902 -176.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.43 155.89 24.42 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.421 1.489 . . . . 0.0 112.626 -174.425 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.8 tp -74.57 128.06 34.62 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.632 0.773 . . . . 0.0 111.149 178.282 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -85.93 -56.41 3.49 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.327 1.051 . . . . 0.0 111.133 169.041 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.88 160.71 39.4 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.162 1.385 . . . . 0.0 111.204 -178.602 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? -140.18 136.02 33.02 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 176.17 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.73 100.56 51.02 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 126.136 1.774 . . . . 0.0 110.691 179.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -74.83 141.44 27.17 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.35 2.7 . . . . 0.0 111.33 169.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.5 t -134.65 125.93 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 126.921 2.088 . . . . 0.0 108.987 -172.108 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -90.97 -22.24 20.92 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.295 0.952 . . . . 0.0 113.53 -177.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -161.54 150.5 16.0 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.322 1.849 . . . . 0.0 110.438 173.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -130.16 131.77 23.65 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.347 1.059 . . . . 0.0 111.443 175.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.73 145.42 46.72 Favored 'Cis proline' 0 CA--C 1.539 0.736 0 CA-C-N 119.922 1.008 . . . . 0.0 113.739 -7.042 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -161.77 -156.26 8.29 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 125.669 1.605 . . . . 0.0 112.357 -177.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 19.9 tt -81.42 -39.94 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -176.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.68 6.35 15.53 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -167.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.1 t -152.22 128.51 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 126.364 1.866 . . . . 0.0 109.238 178.568 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -140.02 158.46 44.03 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.438 1.495 . . . . 0.0 113.11 176.155 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 67.5 p -100.56 159.04 15.48 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.294 1.838 . . . . 0.0 111.638 175.191 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.9 m -83.91 174.22 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.738 0.815 . . . . 0.0 110.862 164.575 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 59.9 p -96.02 -30.71 13.42 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.35 1.46 . . . . 0.0 113.224 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -96.04 -40.72 9.11 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -165.513 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.1 t -137.38 120.59 16.8 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -174.19 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.8 m -73.91 24.44 0.08 Allowed 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 -168.001 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -128.61 23.82 5.82 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 127.136 2.175 . . . . 0.0 113.529 -178.169 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -141.55 139.52 33.21 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.644 1.577 . . . . 0.0 111.391 -178.454 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -140.18 161.29 37.99 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.807 1.243 . . . . 0.0 111.89 -177.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 78.1 t -113.04 142.34 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.473 1.109 . . . . 0.0 108.725 166.021 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.43 149.46 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 118.509 0.595 . . . . 0.0 112.085 170.51 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -89.47 87.4 7.06 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.814 0.846 . . . . 0.0 110.508 177.019 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.8 141.05 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 O-C-N 122.102 -0.374 . . . . 0.0 110.469 172.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -134.43 148.01 50.54 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.377 1.471 . . . . 0.0 111.418 -170.262 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -97.84 13.55 30.18 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.523 1.129 . . . . 0.0 113.255 -175.475 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.5 8.71 86.03 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.308 1.432 . . . . 0.0 115.481 176.165 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.5 t -130.99 3.64 4.41 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.581 1.552 . . . . 0.0 113.665 -173.127 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.9 -6.31 66.91 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 125.416 1.484 . . . . 0.0 113.87 -175.471 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 47.5 ttt180 -74.84 131.7 40.96 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 127.393 2.277 . . . . 0.0 108.825 166.28 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 84.1 p -147.94 160.82 42.41 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -175.278 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.87 145.92 31.81 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.644 1.577 . . . . 0.0 110.952 170.048 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -93.57 116.56 29.08 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.63 0.772 . . . . 0.0 109.726 171.284 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.3 pt -115.69 144.04 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.539 1.136 . . . . 0.0 110.953 179.339 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.46 142.47 16.11 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 174.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.4 pt -128.85 147.78 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 125.331 1.452 . . . . 0.0 111.925 172.217 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.15 146.94 17.89 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.454 1.026 . . . . 0.0 114.022 177.178 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -109.72 161.1 15.73 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.536 1.934 . . . . 0.0 111.104 178.405 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.9 t -74.41 -24.13 59.06 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.721 0.808 . . . . 0.0 112.802 179.091 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -157.47 156.35 31.96 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.814 1.246 . . . . 0.0 111.504 -177.133 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -57.84 -33.25 68.44 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 118.642 -0.694 . . . . 0.0 112.465 175.228 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -59.65 -30.98 69.91 Favored Glycine 0 CA--C 1.536 1.401 0 CA-C-N 119.491 1.041 . . . . 0.0 114.237 -179.279 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -86.85 -36.89 18.21 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.381 1.09 . . . . 0.0 112.241 176.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.46 -30.26 70.48 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 168.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . 0.259 18.3 m-85 -91.0 17.92 7.35 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.006 1.722 . . . . 0.0 114.096 170.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -99.41 -40.66 7.77 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.635 -0.666 . . . . 0.0 111.099 143.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -53.78 -56.7 15.13 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.566 1.076 . . . . 0.0 113.047 178.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -80.45 -24.47 39.54 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -175.396 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 85.2 t -81.76 -39.2 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 123.144 0.577 . . . . 0.0 110.941 -177.136 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 89.4 p -64.41 -31.64 72.94 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 175.115 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 67.5 mt -68.14 -56.8 7.47 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.28 1.032 . . . . 0.0 111.704 171.143 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -67.23 -32.63 73.8 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.319 -0.863 . . . . 0.0 113.004 -173.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -84.69 -3.16 58.41 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.785 0.834 . . . . 0.0 112.762 177.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -93.97 -31.9 14.08 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.41 -0.806 . . . . 0.0 112.375 163.3 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -90.4 -9.81 46.2 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -178.539 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.74 -25.94 30.93 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -171.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 30.9 p-90 -88.1 -26.67 22.39 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.81 1.244 . . . . 0.0 113.849 175.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 32.0 t -77.68 -44.53 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.062 1.345 . . . . 0.0 110.173 175.318 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 52.3 tttt -115.84 77.28 1.07 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.981 1.712 . . . . 0.0 110.231 176.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -74.45 88.85 2.11 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.458 1.103 . . . . 0.0 110.499 173.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 . . . . . 0 C--O 1.253 1.238 0 C-N-CA 126.026 1.73 . . . . 0.0 113.429 -179.872 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.661 0 N-CA-C 111.833 -0.507 . . . . 0.0 111.833 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 65.3 m -65.85 136.19 95.65 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 124.268 1.027 . . . . 0.0 112.358 -178.678 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -84.47 40.51 0.87 Allowed 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 124.33 3.353 . . . . 0.0 113.457 -171.586 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -61.59 -31.49 71.55 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 120.557 -1.339 . . . . 0.0 113.042 -171.348 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 19.3 m -63.85 -15.17 58.25 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.128 1.371 . . . . 0.0 114.034 174.706 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.5 mtp -106.08 8.08 32.09 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.14 1.776 . . . . 0.0 112.66 173.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.81 -47.83 2.29 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.66 1.584 . . . . 0.0 112.433 -176.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.8 t -78.07 -33.04 51.03 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.299 0.571 . . . . 0.0 111.315 165.068 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 46.96 50.21 13.99 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 127.642 2.377 . . . . 0.0 115.265 168.282 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 pp -88.88 130.95 35.32 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.629 0.728 . . . . 0.0 111.257 170.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -138.5 59.61 1.63 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.659 1.583 . . . . 0.0 109.447 176.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -124.83 141.11 52.34 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.837 1.655 . . . . 0.0 110.792 -178.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -177.16 94.04 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.314 1.845 . . . . 0.0 108.156 -178.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.4 t -83.79 112.99 20.59 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.738 -1.226 . . . . 0.0 110.146 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.4 p -72.57 144.56 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.707 0.803 . . . . 0.0 112.579 -174.512 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.6 mt -128.26 -43.97 1.44 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.239 1.416 . . . . 0.0 112.248 -173.539 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 24.4 t -149.6 135.06 18.38 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.376 1.07 . . . . 0.0 110.604 175.494 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 96.5 t -127.91 127.96 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.551 1.14 . . . . 0.0 109.304 171.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -128.35 133.27 24.97 Favored Pre-proline 0 N--CA 1.476 0.87 0 C-N-CA 125.259 1.424 . . . . 0.0 110.122 174.207 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.22 -15.48 14.36 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.116 2.544 . . . . 0.0 115.037 -171.305 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -133.48 108.58 8.73 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.138 0.975 . . . . 0.0 110.879 -174.444 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.3 p -144.94 144.48 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.161 1.384 . . . . 0.0 110.289 174.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.0 m -125.9 130.64 51.71 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.188 0.995 . . . . 0.0 111.081 -172.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.5 t -96.39 134.82 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.286 1.435 . . . . 0.0 111.345 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.98 124.76 26.86 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.952 1.301 . . . . 0.0 108.918 170.959 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.4 mmm-85 -63.14 136.77 57.96 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.634 -0.666 . . . . 0.0 110.451 167.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.5 pt -100.23 151.21 37.46 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.981 1.312 . . . . 0.0 112.349 -174.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.76 162.47 41.95 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 123.145 2.564 . . . . 0.0 111.978 169.383 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -64.62 112.2 1.89 Allowed 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.919 2.413 . . . . 0.0 110.279 170.745 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.2 mmt180 -150.97 164.0 37.39 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.398 1.479 . . . . 0.0 113.046 -167.203 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.07 123.23 23.99 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 122.206 1.003 . . . . 0.0 112.321 175.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.6 m -61.75 -24.63 66.95 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 127.331 2.252 . . . . 0.0 117.02 -160.091 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -140.06 16.42 2.45 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.008 1.323 . . . . 0.0 112.939 174.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -131.8 -26.59 1.97 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.774 1.63 . . . . 0.0 113.694 -177.459 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -122.96 -9.76 6.04 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.872 1.225 . . . . 0.0 115.293 -176.405 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -74.19 106.1 5.69 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.999 1.399 . . . . 0.0 109.447 161.744 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.13 22.6 12.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.911 -1.118 . . . . 0.0 113.821 178.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.87 -48.78 0.06 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.369 2.268 . . . . 0.0 114.969 -167.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.6 m -66.86 -13.79 62.01 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.943 1.697 . . . . 0.0 114.903 -176.207 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.38 -12.98 60.37 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.129 0.972 . . . . 0.0 112.876 171.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 13.7 m0 -95.76 171.77 8.45 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.483 1.513 . . . . 0.0 111.958 -174.345 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -75.69 49.39 0.51 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.146 1.779 . . . . 0.0 113.844 177.19 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.5 mt -56.06 -33.61 65.15 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -171.025 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -94.44 -3.89 49.29 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.457 1.103 . . . . 0.0 113.209 177.492 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -128.04 59.91 43.05 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 127.054 2.141 . . . . 0.0 111.843 -173.715 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.0 133.34 33.07 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 CA-C-N 120.537 1.227 . . . . 0.0 112.423 -173.468 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -70.34 -24.49 62.99 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.853 1.261 . . . . 0.0 111.243 178.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 33.9 t90 -159.74 154.47 24.37 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.862 2.065 . . . . 0.0 110.451 170.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.9 p -133.76 150.17 51.46 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.075 0.95 . . . . 0.0 112.112 167.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.16 -140.15 4.74 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.099 0.38 . . . . 0.0 113.581 -178.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.0 mtm105 -111.5 147.7 34.78 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.538 1.935 . . . . 0.0 111.971 -175.355 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.9 tp -89.19 138.43 31.43 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.632 1.573 . . . . 0.0 109.672 166.441 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 36.8 ttt-85 -144.5 93.04 2.37 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.475 1.11 . . . . 0.0 110.697 165.44 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.1 mt -73.08 128.29 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 171.69 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.2 p -132.86 167.32 20.41 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.741 2.016 . . . . 0.0 110.552 -179.18 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.3 t -160.54 146.77 15.24 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.603 -1.311 . . . . 0.0 112.153 177.076 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.5 mmtt -153.3 131.76 12.13 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.358 1.463 . . . . 0.0 111.428 161.154 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.98 45.99 47.48 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.859 1.219 . . . . 0.0 115.026 163.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt 63.68 21.39 12.68 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.432 1.893 . . . . 0.0 113.696 -173.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.2 m -127.7 112.7 15.11 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.072 1.349 . . . . 0.0 109.143 170.411 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.97 161.49 18.98 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.63 0.772 . . . . 0.0 110.573 170.024 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -141.11 108.75 5.61 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.941 1.696 . . . . 0.0 108.695 -175.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.5 mp -81.39 95.14 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 168.36 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -95.04 137.29 34.29 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.445 0.641 . . . . 0.0 111.605 175.586 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.3 mp -110.94 134.36 52.64 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.447 1.899 . . . . 0.0 109.491 176.402 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -139.21 152.13 47.1 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.544 0.738 . . . . 0.0 112.734 -168.374 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -73.6 143.26 46.44 Favored 'General case' 0 C--O 1.238 0.492 0 O-C-N 121.304 -0.872 . . . . 0.0 111.907 -176.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.4 pttt -84.01 -6.18 59.36 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.377 1.871 . . . . 0.0 115.05 -178.761 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 91.8 t -123.5 -44.42 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.357 1.463 . . . . 0.0 111.416 178.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.9 m -92.77 -23.11 18.99 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -174.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.84 6.06 86.94 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 123.872 0.748 . . . . 0.0 113.778 -177.421 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -82.05 154.48 25.6 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.361 1.464 . . . . 0.0 112.616 -174.625 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.1 tp -73.37 125.54 28.1 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.818 0.847 . . . . 0.0 110.981 178.136 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -84.56 -56.94 3.35 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.131 0.972 . . . . 0.0 110.806 169.683 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.32 163.3 39.67 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.744 1.218 . . . . 0.0 111.774 -179.273 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -139.63 135.79 33.65 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.583 1.153 . . . . 0.0 111.5 177.405 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.53 102.81 49.67 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.547 1.139 . . . . 0.0 111.076 174.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -70.06 137.89 35.63 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.828 3.019 . . . . 0.0 112.09 173.213 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.8 t -131.98 131.93 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.212 1.805 . . . . 0.0 109.251 -179.193 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -101.11 -16.29 17.11 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.435 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -161.71 152.13 17.42 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.926 1.69 . . . . 0.0 110.411 175.151 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -124.7 134.88 25.99 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -173.095 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -66.9 149.31 80.4 Favored 'Cis proline' 0 CA--C 1.542 0.909 0 CA-C-N 119.41 0.825 . . . . 0.0 111.221 -13.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -148.09 -172.78 18.41 Favored Glycine 0 N--CA 1.474 1.217 0 N-CA-C 115.1 0.8 . . . . 0.0 115.1 -174.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.3 tp -58.79 -29.03 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -174.521 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.53 7.97 43.77 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.584 1.154 . . . . 0.0 113.763 -172.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.1 p -158.94 128.58 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.004 0.922 . . . . 0.0 113.266 179.008 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -148.57 165.51 31.04 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.185 1.794 . . . . 0.0 113.455 -168.147 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 50.0 p -121.77 155.91 34.28 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.625 1.97 . . . . 0.0 111.592 -172.692 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.0 m -84.45 172.89 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.761 0.824 . . . . 0.0 111.901 172.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 68.7 p -89.03 -34.17 16.9 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.028 1.331 . . . . 0.0 112.539 177.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -92.92 -43.41 8.97 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -164.307 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.4 t -145.81 121.56 10.54 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -174.2 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.37 -2.3 5.99 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -169.707 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.408 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.264 1.2 ptm180 -88.19 22.16 2.54 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.922 1.689 . . . . 0.0 114.528 174.2 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -140.47 134.71 31.11 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.893 1.277 . . . . 0.0 110.813 178.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -134.26 161.55 34.64 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.418 1.487 . . . . 0.0 111.763 -179.672 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.5 t -117.5 142.35 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.522 1.129 . . . . 0.0 109.116 166.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.38 150.77 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 123.381 0.673 . . . . 0.0 111.721 171.014 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -95.06 89.69 5.66 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.125 0.97 . . . . 0.0 109.988 177.78 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -71.05 137.0 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 120.724 0.297 . . . . 0.0 110.757 177.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -142.52 144.1 32.81 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.725 1.61 . . . . 0.0 111.521 -167.198 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -90.95 3.03 55.72 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.489 1.116 . . . . 0.0 113.121 -177.665 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.28 13.09 79.61 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 125.218 1.39 . . . . 0.0 114.794 178.286 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.5 t -137.22 15.88 3.0 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.44 1.496 . . . . 0.0 113.721 -172.647 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.38 -1.88 80.06 Favored Glycine 0 CA--C 1.537 1.453 0 O-C-N 121.036 -1.04 . . . . 0.0 114.957 -178.131 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -71.59 131.89 43.88 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.445 1.498 . . . . 0.0 108.678 163.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 92.7 p -146.7 152.27 38.56 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 176.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.75 141.02 26.3 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.303 1.441 . . . . 0.0 111.195 167.565 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -87.42 125.13 34.09 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 121.842 -0.536 . . . . 0.0 110.352 169.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 14.9 pt -122.27 142.92 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.117 1.367 . . . . 0.0 110.469 175.131 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.99 143.68 16.68 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 172.542 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.9 pt -129.17 141.59 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.971 1.308 . . . . 0.0 111.951 172.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -119.21 145.31 18.07 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.936 1.255 . . . . 0.0 113.157 175.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -108.21 161.51 14.92 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.016 1.726 . . . . 0.0 111.689 -176.334 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.9 t -72.57 -29.41 63.51 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.744 0.818 . . . . 0.0 112.91 -179.391 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -155.6 153.37 30.0 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.523 1.129 . . . . 0.0 111.753 -178.469 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 57.4 ttt-85 -61.29 -34.29 74.97 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.185 0.994 . . . . 0.0 113.176 178.065 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.43 -29.67 74.38 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 118.898 0.772 . . . . 0.0 113.515 175.481 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -82.43 -33.51 28.55 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 117.893 0.847 . . . . 0.0 111.825 175.349 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.408 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -67.09 -33.4 75.39 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.7 0.8 . . . . 0.0 112.962 170.146 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -60.84 -34.06 74.0 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.51 -0.744 . . . . 0.0 112.347 172.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -64.87 -32.63 74.43 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.543 1.065 . . . . 0.0 112.606 174.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -60.97 -55.66 30.24 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.241 0.928 . . . . 0.0 111.604 173.011 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.05 -26.73 56.85 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -175.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.9 t -74.62 -43.29 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 119.288 0.949 . . . . 0.0 110.953 175.271 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 41.9 m -66.41 -27.18 67.64 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.96 0.8 . . . . 0.0 112.843 -179.187 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 75.4 mt -73.71 -57.52 3.93 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.638 0.775 . . . . 0.0 111.483 169.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -64.27 -32.35 73.91 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -173.595 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -80.58 -5.42 56.78 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.039 0.936 . . . . 0.0 112.575 178.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -94.77 -15.05 24.14 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 165.403 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -108.81 -7.01 15.6 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.85 -23.34 43.43 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 121.218 1.826 . . . . 0.0 115.786 -175.653 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 31.0 p-90 -88.85 -18.64 27.21 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.278 1.431 . . . . 0.0 113.955 175.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.1 t -87.5 -44.79 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.559 1.543 . . . . 0.0 109.849 173.593 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.1 ttpp -107.73 77.71 1.15 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.523 1.929 . . . . 0.0 110.028 172.137 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -72.4 20.38 0.07 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.348 1.859 . . . . 0.0 115.269 177.481 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 C--O 1.252 1.195 0 C-N-CA 127.044 2.137 . . . . 0.0 113.169 -178.655 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.638 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 33.2 m 48.29 59.94 16.14 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 126.144 1.777 . . . . 0.0 114.9 177.162 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -71.65 -1.04 9.21 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 124.077 3.185 . . . . 0.0 114.362 -177.392 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -58.32 -22.95 55.03 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.718 1.607 . . . . 0.0 113.668 -177.013 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 73.7 p -62.88 -14.13 42.61 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.048 1.339 . . . . 0.0 114.306 172.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.9 mtp -88.53 6.42 37.99 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.47 1.508 . . . . 0.0 113.382 174.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.57 -46.8 0.41 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.787 1.635 . . . . 0.0 111.603 179.15 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 35.9 m -86.16 75.25 9.92 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.767 1.227 . . . . 0.0 107.975 161.723 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -106.51 22.2 16.2 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 114.703 1.372 . . . . 0.0 114.703 -159.084 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.5 mp -58.9 123.02 15.11 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.036 0.935 . . . . 0.0 111.341 179.118 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -111.84 54.15 0.7 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 122.933 1.349 . . . . 0.0 110.371 168.48 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.25 65.26 1.14 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 123.824 1.773 . . . . 0.0 111.337 -146.251 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -172.6 75.89 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 128.296 2.639 . . . . 0.0 108.029 167.455 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.2 m -70.98 109.25 4.98 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.33 -0.856 . . . . 0.0 110.212 173.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.9 t -73.55 147.25 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.103 1.361 . . . . 0.0 111.622 -174.54 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.84 -40.88 1.05 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.516 1.527 . . . . 0.0 111.843 -172.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 22.5 t -147.41 142.5 27.1 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.899 1.28 . . . . 0.0 110.669 173.58 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 76.1 t -136.05 129.03 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 125.076 1.35 . . . . 0.0 109.087 170.082 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -130.92 137.65 31.24 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 125.44 1.496 . . . . 0.0 110.381 173.27 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.59 -17.86 15.87 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.028 2.485 . . . . 0.0 114.797 -174.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -133.77 111.11 10.27 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.236 1.015 . . . . 0.0 111.794 -171.009 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.0 p -148.42 144.3 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.038 1.735 . . . . 0.0 110.017 172.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.4 m -123.09 136.63 54.88 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.45 1.1 . . . . 0.0 111.29 -174.053 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.2 t -101.29 133.42 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.063 1.345 . . . . 0.0 111.532 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -134.18 119.6 19.02 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.055 1.342 . . . . 0.0 108.864 171.044 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -66.36 129.86 41.26 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.975 0.51 . . . . 0.0 109.808 174.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.4 pt -88.89 151.04 46.75 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -166.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -66.86 169.27 15.08 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.313 2.676 . . . . 0.0 111.383 163.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -56.47 152.38 40.45 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.325 2.017 . . . . 0.0 111.948 166.605 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 40.0 ttm-85 -60.99 156.32 18.0 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.309 1.444 . . . . 0.0 112.772 -175.306 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.29 -175.9 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.511 1.124 . . . . 0.0 112.863 163.129 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.2 p -76.23 70.29 2.85 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.351 1.861 . . . . 0.0 113.26 -170.554 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 62.64 14.24 7.0 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 127.009 2.124 . . . . 0.0 113.798 -169.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -89.82 -54.9 3.85 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.6 1.16 . . . . 0.0 112.197 -175.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 141.12 -148.61 20.28 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-O 122.038 0.799 . . . . 0.0 112.431 -169.543 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -117.27 159.83 22.06 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 127.379 2.272 . . . . 0.0 111.041 -179.633 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.42 17.13 3.68 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -171.377 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.06 -52.23 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 128.16 2.584 . . . . 0.0 115.616 -175.487 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.6 m -66.66 -13.94 61.85 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.872 1.669 . . . . 0.0 114.187 -176.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -84.6 -8.44 58.89 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.943 1.297 . . . . 0.0 112.633 173.479 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.2 m0 -92.93 169.36 10.5 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.753 1.621 . . . . 0.0 111.234 177.214 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -79.62 51.33 1.25 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.197 1.799 . . . . 0.0 112.574 178.305 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.2 mt -54.62 -32.44 58.92 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.389 1.476 . . . . 0.0 114.36 -173.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -87.92 -9.5 53.44 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.796 0.838 . . . . 0.0 112.485 -177.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -139.13 68.66 41.23 Favored Pre-proline 0 N--CA 1.47 0.545 0 C-N-CA 125.396 1.478 . . . . 0.0 111.231 -160.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -68.7 147.23 69.17 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 CA-C-N 119.519 0.864 . . . . 0.0 113.215 -169.1 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -72.52 -30.12 64.19 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.493 0.717 . . . . 0.0 111.286 168.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.6 t90 -159.24 155.14 26.47 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.472 1.909 . . . . 0.0 110.517 176.789 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.8 p -134.7 146.99 49.98 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.81 1.244 . . . . 0.0 111.945 171.233 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.14 -140.8 5.45 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 114.574 0.59 . . . . 0.0 114.574 176.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -107.14 141.54 38.25 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 126.677 1.991 . . . . 0.0 111.249 -169.253 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.5 tp -84.67 139.39 32.06 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.037 1.335 . . . . 0.0 110.127 168.237 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.6 ttm-85 -131.82 132.05 43.4 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.408 1.083 . . . . 0.0 109.554 154.546 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.4 mt -109.34 132.8 56.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 163.282 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.84 164.19 31.24 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 126.379 1.871 . . . . 0.0 109.866 -168.322 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.2 t -156.96 155.99 32.24 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 120.772 -1.205 . . . . 0.0 111.805 177.241 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -159.97 133.3 6.92 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.388 1.475 . . . . 0.0 110.045 152.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.97 49.94 20.28 Favored Glycine 0 N--CA 1.475 1.258 0 C-N-CA 124.7 1.143 . . . . 0.0 114.82 166.666 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt 59.93 23.1 12.16 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 126.406 1.882 . . . . 0.0 113.697 -175.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.8 m -126.93 126.48 43.31 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.824 1.65 . . . . 0.0 108.308 172.285 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.68 161.11 13.81 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.125 0.97 . . . . 0.0 110.873 170.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -139.65 110.68 6.89 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 126.438 1.895 . . . . 0.0 108.356 -175.057 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.5 mp -86.33 106.92 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 166.098 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.7 mttt -107.43 131.3 54.43 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.64 1.176 . . . . 0.0 111.358 177.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.0 mp -103.32 130.01 50.49 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.053 1.341 . . . . 0.0 110.481 178.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -131.75 147.2 52.48 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.912 0.885 . . . . 0.0 113.289 -167.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -64.42 142.92 58.25 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.815 -1.178 . . . . 0.0 113.063 -177.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.26 -2.7 36.07 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 -178.299 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.5 t -116.78 -48.77 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.481 1.112 . . . . 0.0 111.269 170.836 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.7 m -114.22 -4.67 13.04 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.6 1.334 . . . . 0.0 114.6 -168.045 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.21 15.73 78.73 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 123.85 0.738 . . . . 0.0 114.143 177.257 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -63.97 133.35 53.03 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.839 1.656 . . . . 0.0 111.383 -177.032 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.1 tp -68.67 115.11 7.66 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 122.881 0.472 . . . . 0.0 111.056 -179.391 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -80.8 -53.3 6.61 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.714 1.206 . . . . 0.0 111.131 173.569 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.24 159.13 35.69 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.052 1.341 . . . . 0.0 111.287 -178.187 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -138.31 136.63 36.61 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.5 0.72 . . . . 0.0 112.502 173.182 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.96 107.93 47.23 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 125.339 1.456 . . . . 0.0 110.752 176.517 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -79.66 141.07 15.24 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.721 2.947 . . . . 0.0 111.314 175.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.8 t -134.14 129.52 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 126.145 1.778 . . . . 0.0 109.237 -172.3 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -96.52 -21.14 17.88 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 178.836 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.33 149.12 13.42 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.704 2.001 . . . . 0.0 110.301 175.981 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -129.24 129.76 23.33 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 124.334 1.054 . . . . 0.0 111.963 177.224 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -65.58 149.02 75.63 Favored 'Cis proline' 0 CA--C 1.541 0.854 0 CA-C-N 119.807 0.967 . . . . 0.0 113.191 -5.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -169.1 -162.28 21.03 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.639 1.59 . . . . 0.0 113.473 -177.282 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.9 tp -68.43 -35.42 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -170.249 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.04 4.1 53.81 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -168.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.4 t -151.35 129.64 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.806 1.242 . . . . 0.0 110.229 -179.38 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -138.84 158.4 44.3 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.535 1.534 . . . . 0.0 112.91 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 57.0 p -104.79 156.77 17.7 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.35 1.86 . . . . 0.0 111.225 175.785 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.7 m -82.89 178.37 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.82 0.848 . . . . 0.0 110.759 166.058 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 73.3 p -107.99 -22.27 12.48 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.775 1.63 . . . . 0.0 114.005 -177.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -90.68 -45.04 9.11 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -175.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t -145.32 125.7 13.96 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -179.416 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.8 m -69.57 11.83 0.23 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 -173.012 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.45 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.27 28.9 ptt180 -96.51 12.58 30.99 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.27 1.428 . . . . 0.0 114.43 174.016 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -136.75 139.66 42.02 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.428 1.491 . . . . 0.0 111.382 -173.338 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -140.13 162.89 34.15 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.062 1.345 . . . . 0.0 111.602 -177.26 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.4 t -117.17 141.77 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.526 1.131 . . . . 0.0 108.446 166.053 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.32 148.36 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 118.805 0.729 . . . . 0.0 112.281 171.246 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -91.04 81.76 5.61 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.906 0.883 . . . . 0.0 111.162 179.417 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -67.26 141.55 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.966 0.412 . . . . 0.0 111.148 176.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -139.63 152.13 46.53 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.646 1.578 . . . . 0.0 111.736 -169.058 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -95.58 1.9 53.97 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.174 0.99 . . . . 0.0 113.084 178.197 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.82 12.57 81.17 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.141 1.353 . . . . 0.0 114.796 178.381 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.9 t -136.3 12.45 3.28 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.516 1.526 . . . . 0.0 113.432 -172.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.82 -3.86 71.33 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 124.855 1.217 . . . . 0.0 114.793 -177.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -72.37 132.91 44.59 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.294 1.437 . . . . 0.0 108.588 163.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.9 p -149.27 159.48 44.23 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 173.08 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.35 146.22 32.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.436 1.494 . . . . 0.0 110.803 168.301 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -91.44 117.13 29.42 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.361 0.664 . . . . 0.0 109.535 168.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.6 pt -115.2 142.19 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.442 1.097 . . . . 0.0 110.795 177.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.7 141.27 16.01 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 175.293 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.5 pt -127.32 148.72 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 125.19 1.396 . . . . 0.0 111.602 170.432 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -134.61 147.24 19.05 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 124.093 0.854 . . . . 0.0 113.423 175.46 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -105.12 157.06 17.52 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.449 1.5 . . . . 0.0 111.279 176.1 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.4 t -73.8 -17.4 61.09 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.554 0.742 . . . . 0.0 112.78 178.211 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -154.28 145.92 23.27 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.675 1.19 . . . . 0.0 110.868 -178.188 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -64.27 -28.07 69.48 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.84 0.856 . . . . 0.0 113.193 -179.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.82 -30.75 78.07 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 124.164 0.888 . . . . 0.0 114.257 173.299 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -81.79 -34.89 30.08 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.603 1.201 . . . . 0.0 111.763 176.486 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.45 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -66.68 -30.18 70.37 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.162 0.985 . . . . 0.0 113.446 168.919 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.01 -49.54 76.51 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.363 0.665 . . . . 0.0 111.048 166.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -64.37 -28.96 70.05 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 118.837 0.744 . . . . 0.0 113.007 176.782 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -62.43 -61.25 2.57 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.651 1.114 . . . . 0.0 111.535 170.397 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -76.78 -27.29 55.22 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -171.589 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 65.5 t -71.76 -37.97 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 O-C-N 121.404 -0.81 . . . . 0.0 110.924 176.582 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 51.1 m -67.11 -16.29 64.24 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 176.466 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.5 mt -84.75 -56.73 3.43 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.164 0.985 . . . . 0.0 111.3 168.192 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -66.89 -34.33 77.54 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -172.184 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -85.77 -0.45 55.28 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.688 0.795 . . . . 0.0 112.44 177.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -99.4 -29.06 12.98 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.064 -1.023 . . . . 0.0 112.524 165.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -96.83 -5.95 37.12 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -179.601 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.82 -31.89 41.37 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 121.302 1.865 . . . . 0.0 114.887 -173.529 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -84.87 -25.79 27.78 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.745 1.218 . . . . 0.0 113.796 179.178 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.5 t -80.22 -39.46 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.939 1.296 . . . . 0.0 110.531 175.004 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -100.98 55.29 0.85 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.136 1.775 . . . . 0.0 111.259 -177.414 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -79.14 90.22 4.86 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.351 167.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 . . . . . 0 C--O 1.253 1.251 0 C-N-CA 126.937 2.095 . . . . 0.0 112.522 -175.817 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.566 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 35.5 m 47.98 61.54 13.63 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 126.245 1.818 . . . . 0.0 114.892 177.264 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.29 -19.11 26.01 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.43 2.753 . . . . 0.0 113.815 -178.739 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 75.6 m-80 -100.71 155.11 18.08 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.481 1.512 . . . . 0.0 111.877 177.563 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 21.9 m -72.82 -17.67 61.54 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -177.045 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -85.74 126.96 34.38 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.172 1.389 . . . . 0.0 111.282 -176.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.15 138.06 15.41 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.054 1.742 . . . . 0.0 107.962 172.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.9 m -86.95 73.74 9.87 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 122.693 1.235 . . . . 0.0 110.115 -175.524 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -97.22 12.71 31.92 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 115.105 1.521 . . . . 0.0 115.105 -156.615 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.83 43.56 0.6 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.383 1.873 . . . . 0.0 112.4 -179.712 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -92.38 51.86 1.83 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.174 1.789 . . . . 0.0 110.827 -177.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -148.47 142.44 25.84 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.905 1.282 . . . . 0.0 111.375 -175.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -178.11 123.83 0.11 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.88 1.672 . . . . 0.0 107.905 167.014 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.2 m -93.35 106.35 18.33 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 165.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.7 t -73.6 143.44 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.066 0.946 . . . . 0.0 110.764 177.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.2 mt -131.09 -36.8 1.3 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.089 1.355 . . . . 0.0 111.817 -169.576 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 47.9 t -153.17 142.67 21.76 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.3 1.44 . . . . 0.0 110.182 171.266 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 89.4 t -134.55 127.31 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.49 1.116 . . . . 0.0 109.315 169.223 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -121.54 133.35 24.21 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 124.932 1.293 . . . . 0.0 111.027 174.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -69.06 -29.96 26.34 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.47 2.113 . . . . 0.0 115.911 -171.508 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -137.14 122.48 19.4 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.792 0.805 . . . . 0.0 112.744 -175.218 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 p -149.24 149.07 15.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 127.571 2.348 . . . . 0.0 109.243 177.115 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.7 m -124.75 130.96 53.41 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.652 0.781 . . . . 0.0 112.358 -169.238 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 78.6 t -96.58 136.42 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.733 1.613 . . . . 0.0 112.473 -178.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -129.2 126.44 39.17 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.148 1.379 . . . . 0.0 109.357 169.892 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -66.88 131.29 45.6 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 167.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.7 pt -109.14 151.5 42.02 Favored Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 124.699 1.2 . . . . 0.0 112.36 -175.088 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -70.47 158.45 55.99 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 122.765 2.31 . . . . 0.0 111.38 166.459 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -63.53 144.53 90.39 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.76 2.307 . . . . 0.0 110.975 170.546 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -71.7 151.34 43.71 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 122.01 0.91 . . . . 0.0 113.445 -173.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.24 -137.86 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 127.969 2.507 . . . . 0.0 112.116 163.521 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 89.3 p -141.07 -36.13 0.46 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.868 1.667 . . . . 0.0 112.578 177.19 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -126.51 40.47 3.72 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.486 1.914 . . . . 0.0 111.23 -178.211 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 90.9 mmt-85 -131.47 -58.84 0.98 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.682 1.193 . . . . 0.0 113.313 177.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.35 152.54 5.19 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 123.413 0.446 . . . . 0.0 112.909 -177.732 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -68.15 133.02 48.24 Favored 'General case' 0 C--O 1.223 -0.318 0 O-C-N 121.968 -0.725 . . . . 0.0 109.721 171.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.67 18.27 10.34 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -174.5 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 60.35 -46.47 0.1 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.583 2.353 . . . . 0.0 115.064 -171.573 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 92.1 p -65.66 -16.91 64.19 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.56 1.944 . . . . 0.0 114.694 179.309 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -73.32 -18.79 61.16 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.766 1.226 . . . . 0.0 112.86 171.417 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 16.6 m0 -90.52 173.09 8.26 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.454 1.501 . . . . 0.0 111.881 -176.171 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -79.23 53.65 1.52 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.653 1.581 . . . . 0.0 114.36 -176.252 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.1 mt -60.01 -17.87 41.84 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -171.304 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -106.78 -3.16 20.74 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.497 1.119 . . . . 0.0 113.067 177.209 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -149.09 69.33 9.79 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 125.207 1.403 . . . . 0.0 112.122 177.798 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -55.31 145.69 65.46 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.134 2.556 . . . . 0.0 112.44 174.571 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.28 -30.68 68.83 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.711 0.804 . . . . 0.0 111.394 173.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 46.8 t90 -156.62 152.67 27.48 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.225 1.41 . . . . 0.0 111.056 176.076 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.9 p -133.57 152.2 51.86 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.495 -0.753 . . . . 0.0 112.13 166.274 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 176.55 -149.58 9.83 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.139 -0.482 . . . . 0.0 113.558 -175.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 17.5 mtm180 -97.05 148.27 23.18 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.432 1.893 . . . . 0.0 111.677 -175.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.0 tp -91.75 134.5 34.68 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.664 1.185 . . . . 0.0 109.596 163.332 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -127.83 119.53 25.87 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.891 1.276 . . . . 0.0 108.882 160.677 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.5 mt -101.93 130.86 50.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 166.471 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.92 166.48 26.62 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 126.254 1.822 . . . . 0.0 110.028 -166.906 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.9 t -157.21 160.12 38.38 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 121.273 -0.892 . . . . 0.0 112.168 173.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -144.42 122.04 11.82 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.652 0.739 . . . . 0.0 111.809 154.594 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.2 -117.98 9.68 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 125.863 1.697 . . . . 0.0 110.523 -177.551 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -100.2 14.01 32.28 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.917 1.687 . . . . 0.0 113.378 179.11 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.0 m -123.57 108.74 12.95 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.904 0.882 . . . . 0.0 110.285 177.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -83.16 158.94 22.16 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.158 0.504 . . . . 0.0 110.762 169.418 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -138.74 112.89 8.64 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.358 1.863 . . . . 0.0 108.729 -175.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.2 mp -91.98 105.54 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 165.458 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -104.09 135.06 46.28 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.115 1.366 . . . . 0.0 110.798 178.112 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.1 mp -107.06 128.79 54.69 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.616 1.566 . . . . 0.0 109.664 176.438 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -132.69 146.55 51.95 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.943 0.897 . . . . 0.0 112.004 -170.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -69.23 133.13 47.54 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.75 -1.219 . . . . 0.0 111.128 -179.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.5 pttt -77.19 -2.5 34.82 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -176.759 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.07 -42.41 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.42 1.488 . . . . 0.0 111.466 178.64 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.4 m -93.6 -21.07 19.63 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -178.764 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.66 10.07 82.83 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.645 1.117 . . . . 0.0 113.99 -177.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -86.75 149.11 25.1 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.287 1.435 . . . . 0.0 112.512 -172.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.3 tp -72.57 123.92 24.18 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.603 -0.686 . . . . 0.0 111.404 -178.029 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -87.49 -54.47 4.26 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.864 1.265 . . . . 0.0 111.245 171.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.9 163.2 40.64 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.684 1.194 . . . . 0.0 111.691 -177.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -145.84 131.46 18.86 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.505 1.122 . . . . 0.0 111.531 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.33 104.79 49.65 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 125.472 1.509 . . . . 0.0 110.855 178.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -77.22 144.32 23.26 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.053 2.502 . . . . 0.0 111.264 173.149 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.3 t -135.94 131.42 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.727 1.611 . . . . 0.0 109.014 -174.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -96.07 -22.68 17.19 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -179.54 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -163.29 150.67 12.89 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.786 2.034 . . . . 0.0 110.202 173.451 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -122.69 128.42 25.41 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.865 1.266 . . . . 0.0 111.204 177.635 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -63.14 149.49 65.88 Favored 'Cis proline' 0 CA--C 1.541 0.83 0 CA-C-N 119.849 0.982 . . . . 0.0 113.793 -6.344 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.01 -165.99 14.77 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.715 1.626 . . . . 0.0 112.532 178.347 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.7 tt -73.06 -36.86 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 O-C-N 121.698 -0.883 . . . . 0.0 112.867 -179.215 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.63 6.27 18.34 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -167.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.2 t -150.36 132.74 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.639 1.576 . . . . 0.0 110.26 -178.801 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -146.62 161.46 40.5 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.355 1.862 . . . . 0.0 112.331 -175.616 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 20.0 p -111.15 162.97 14.38 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 126.834 2.054 . . . . 0.0 111.719 177.447 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.0 m -87.7 174.8 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.64 1.176 . . . . 0.0 110.543 164.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 73.2 p -96.09 -36.38 11.01 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.147 1.379 . . . . 0.0 112.629 179.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -103.51 -28.33 11.83 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 -161.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.6 t -132.87 127.0 33.47 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.489 1.04 . . . . 0.0 113.51 -177.608 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.6 p -75.79 22.08 0.15 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.914 2.086 . . . . 0.0 116.164 -166.049 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -138.81 26.77 2.48 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 126.245 1.818 . . . . 0.0 114.632 -173.225 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -141.7 141.93 33.32 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.871 1.268 . . . . 0.0 111.735 -175.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -140.09 163.5 32.55 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.053 1.341 . . . . 0.0 111.085 -179.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.2 t -116.47 144.54 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.938 1.295 . . . . 0.0 108.843 166.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.8 149.42 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 118.565 0.621 . . . . 0.0 111.811 171.159 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.453 ' HE ' ' NE2' ' A' ' 97' ' ' GLN . 38.6 ttp180 -91.87 103.14 15.72 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.158 0.583 . . . . 0.0 109.954 173.285 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -84.96 148.29 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.441 1.096 . . . . 0.0 111.434 177.057 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.453 ' NE2' ' HE ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -130.75 139.66 50.27 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.863 1.665 . . . . 0.0 111.447 -179.756 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -84.18 3.99 32.59 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.233 1.013 . . . . 0.0 113.384 177.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.94 13.06 82.71 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 125.199 1.38 . . . . 0.0 114.789 177.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.2 t -139.66 17.66 2.52 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.413 1.485 . . . . 0.0 113.534 -171.645 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.97 0.46 77.82 Favored Glycine 0 CA--C 1.538 1.476 0 O-C-N 120.956 -1.09 . . . . 0.0 115.017 -179.094 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -80.53 143.25 33.41 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.39 1.476 . . . . 0.0 109.101 165.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 82.8 p -148.03 159.73 43.59 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 168.549 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.62 145.48 30.97 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.983 1.313 . . . . 0.0 110.999 170.38 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -90.13 121.72 32.44 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 166.056 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.8 pt -121.66 144.12 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.823 1.249 . . . . 0.0 110.965 178.698 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -90.7 142.81 16.41 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 173.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.1 pt -126.86 140.58 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 125.404 1.482 . . . . 0.0 111.651 172.104 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.48 138.95 11.83 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.185 1.374 . . . . 0.0 112.93 177.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -100.64 158.21 16.11 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.768 1.627 . . . . 0.0 111.488 -177.505 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.9 t -73.81 -21.56 60.11 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.732 0.813 . . . . 0.0 112.834 178.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -157.89 151.3 23.47 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.473 1.109 . . . . 0.0 111.577 -178.543 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -55.23 -41.64 72.36 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.716 1.207 . . . . 0.0 112.762 174.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.83 -29.08 71.29 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.163 0.887 . . . . 0.0 114.149 -179.275 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -83.72 -36.43 23.68 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.242 1.021 . . . . 0.0 112.103 176.225 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.0 -31.81 73.03 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.562 -0.711 . . . . 0.0 112.524 168.057 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -75.91 5.95 5.79 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 171.214 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -99.38 -32.51 11.12 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.419 -0.801 . . . . 0.0 112.715 157.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -55.88 -50.96 69.2 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.822 1.192 . . . . 0.0 112.458 178.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 48.0 p-10 -70.87 -34.28 71.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.262 1.025 . . . . 0.0 113.617 -179.44 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.1 t -73.91 -39.65 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.383 1.073 . . . . 0.0 110.742 178.825 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 27.6 t -57.28 -38.06 73.34 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.855 1.262 . . . . 0.0 112.63 176.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.7 mt -76.45 -52.53 9.66 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.875 0.87 . . . . 0.0 112.333 176.394 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -65.88 -30.79 71.45 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.409 -0.807 . . . . 0.0 112.999 -175.203 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -88.24 6.3 37.54 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.379 1.072 . . . . 0.0 112.942 176.684 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -94.14 -43.65 8.37 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.498 -0.751 . . . . 0.0 111.97 154.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -85.82 1.1 51.07 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -171.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.95 -17.94 20.24 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 -178.754 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 30.1 p-90 -99.48 -16.61 18.28 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.032 1.333 . . . . 0.0 114.147 172.261 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.2 t -94.31 -38.71 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.513 1.525 . . . . 0.0 111.606 -175.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -90.71 33.47 0.92 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.524 1.53 . . . . 0.0 111.88 -176.237 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -91.48 97.9 11.35 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.325 1.45 . . . . 0.0 109.921 178.094 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 . . . . . 0 C--O 1.253 1.284 0 C-N-CA 126.755 2.022 . . . . 0.0 112.665 -177.479 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.623 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 39.3 t -141.8 157.21 65.15 Favored Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 126.036 1.734 . . . . 0.0 110.834 -177.49 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.7 -19.42 18.51 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.797 2.331 . . . . 0.0 113.823 162.01 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -82.38 -9.55 59.41 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.473 1.509 . . . . 0.0 114.05 175.236 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 50.0 m -74.45 -9.53 58.68 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -175.232 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.58 154.78 41.9 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.975 1.71 . . . . 0.0 111.846 -179.629 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.02 23.88 2.19 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.591 1.156 . . . . 0.0 113.121 -179.377 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 61.5 m 62.34 104.56 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.466 1.907 . . . . 0.0 110.142 -155.646 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -148.89 117.05 6.4 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.223 1.009 . . . . 0.0 109.934 -159.624 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -147.27 146.24 29.68 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.191 1.396 . . . . 0.0 112.363 179.331 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -133.87 44.22 2.77 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.928 1.691 . . . . 0.0 110.273 177.62 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.413 ' CD2' ' HG3' ' A' ' 52' ' ' LYS . 2.9 p90 -152.98 156.65 39.25 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.963 2.105 . . . . 0.0 110.065 -171.142 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -174.66 105.22 0.1 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.677 1.591 . . . . 0.0 108.351 -178.7 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.63 108.8 19.88 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.381 -0.825 . . . . 0.0 109.742 171.245 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.74 147.23 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.343 1.057 . . . . 0.0 113.152 175.76 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.1 mt -123.57 -38.72 2.5 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.727 2.011 . . . . 0.0 110.32 179.804 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.1 t -155.36 147.28 23.39 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.344 1.458 . . . . 0.0 110.686 170.102 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.0 t -136.9 125.28 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.342 1.457 . . . . 0.0 108.906 174.121 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -127.82 143.12 46.49 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 124.63 1.172 . . . . 0.0 112.482 178.392 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.19 -19.34 15.53 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.836 3.024 . . . . 0.0 115.623 -172.834 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -132.25 112.07 11.93 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.9 0.88 . . . . 0.0 111.713 -172.008 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.8 p -145.07 143.58 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.785 1.634 . . . . 0.0 110.074 169.722 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.3 m -126.61 127.78 45.76 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.204 1.001 . . . . 0.0 111.172 -172.843 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 78.7 t -94.91 138.39 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.383 1.473 . . . . 0.0 112.194 -177.652 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -129.2 126.71 39.78 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.026 1.33 . . . . 0.0 109.356 168.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -69.55 119.25 13.51 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 165.454 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.5 pt -91.59 153.3 44.0 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 124.247 1.019 . . . . 0.0 113.304 -167.922 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -67.51 157.16 63.05 Favored 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 122.872 2.381 . . . . 0.0 111.664 165.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -65.76 143.44 73.97 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.136 2.557 . . . . 0.0 112.047 177.896 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -75.88 152.94 37.06 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.695 0.798 . . . . 0.0 112.937 -175.91 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -146.97 149.26 32.81 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.89 1.276 . . . . 0.0 109.575 154.728 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.5 m -65.42 -26.47 67.99 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.775 1.63 . . . . 0.0 114.036 -174.615 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -78.24 -3.98 45.5 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.422 1.089 . . . . 0.0 112.891 171.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -114.76 -58.31 2.16 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.463 1.905 . . . . 0.0 111.449 178.198 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.05 168.43 3.42 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 122.227 0.904 . . . . 0.0 111.793 -163.256 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -81.36 130.87 35.21 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 159.137 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.38 18.12 6.44 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -171.162 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.07 -47.05 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 127.842 2.457 . . . . 0.0 115.591 -171.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.5 m -66.29 -17.08 64.54 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.359 1.864 . . . . 0.0 114.739 -178.623 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -87.04 -2.01 58.31 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.075 0.95 . . . . 0.0 113.261 172.22 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 22.2 m0 -93.0 169.29 10.54 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.319 1.447 . . . . 0.0 110.615 172.866 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.6 mmtm -77.22 53.63 1.02 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.762 1.625 . . . . 0.0 114.445 -178.086 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.8 mt -58.52 -20.94 50.32 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 -175.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -100.79 -4.0 28.87 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 178.753 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -153.19 81.72 5.02 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.914 1.286 . . . . 0.0 111.784 175.041 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.37 145.8 34.85 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.308 2.672 . . . . 0.0 112.936 175.331 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -68.62 -31.54 70.78 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.092 0.557 . . . . 0.0 111.077 169.523 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 42.3 t90 -157.06 156.15 32.36 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.703 1.601 . . . . 0.0 111.057 174.297 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.8 p -135.08 149.46 50.07 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.277 1.031 . . . . 0.0 112.276 169.157 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.42 -143.94 6.17 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 123.289 0.471 . . . . 0.0 113.631 179.586 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.3 mtm105 -107.94 150.68 26.78 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.61 1.964 . . . . 0.0 112.093 -175.604 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.7 tp -94.71 138.18 32.86 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.485 1.914 . . . . 0.0 110.513 173.211 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -134.77 106.39 6.89 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.494 1.518 . . . . 0.0 109.684 165.26 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.3 mt -87.18 130.64 36.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 166.16 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.88 164.93 29.13 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.817 1.647 . . . . 0.0 110.739 -169.366 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.4 t -159.0 157.02 30.45 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.572 1.149 . . . . 0.0 111.009 171.54 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.413 ' HG3' ' CD2' ' A' ' 7' ' ' TYR . 38.4 mmtt -147.62 128.6 14.5 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.027 0.931 . . . . 0.0 110.782 152.728 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.43 -125.49 7.36 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 125.841 1.686 . . . . 0.0 110.054 -177.332 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -104.44 22.62 14.59 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.638 1.575 . . . . 0.0 112.78 177.389 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.6 m -127.47 123.17 35.37 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.995 1.318 . . . . 0.0 109.678 178.633 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.29 162.1 13.82 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.164 0.986 . . . . 0.0 110.791 169.487 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -140.93 112.74 7.65 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.041 1.736 . . . . 0.0 108.758 -176.326 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -89.88 105.41 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 167.28 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -108.84 141.93 40.16 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.893 1.277 . . . . 0.0 111.286 179.138 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.3 mp -111.69 131.1 55.52 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 126.047 1.739 . . . . 0.0 110.347 178.877 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -126.04 154.16 43.4 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.347 1.059 . . . . 0.0 113.441 -171.685 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -72.7 141.98 48.21 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 122.093 0.949 . . . . 0.0 111.611 174.254 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -83.99 -2.83 57.35 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 -176.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.7 t -126.43 -39.77 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.572 1.149 . . . . 0.0 111.871 -179.212 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.6 m -110.8 -15.57 13.78 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -172.14 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.97 21.83 79.56 Favored Glycine 0 CA--C 1.535 1.307 0 O-C-N 121.823 -0.548 . . . . 0.0 113.966 -179.702 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -63.63 160.75 16.17 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.683 1.193 . . . . 0.0 111.43 171.556 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.3 tp -93.92 120.54 34.31 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.048 0.939 . . . . 0.0 109.653 169.049 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -83.46 -54.3 5.07 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.479 0.712 . . . . 0.0 111.255 173.257 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.13 163.86 37.19 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.565 1.146 . . . . 0.0 111.973 -178.463 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -144.72 134.8 24.0 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.882 1.273 . . . . 0.0 111.841 179.477 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.74 100.88 43.32 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.482 1.513 . . . . 0.0 111.189 178.834 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -68.96 142.1 50.49 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 124.123 3.216 . . . . 0.0 112.559 172.203 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.0 t -136.31 130.89 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 126.003 1.721 . . . . 0.0 109.697 -176.528 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -92.65 -23.24 19.05 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.76 149.69 13.07 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.438 1.895 . . . . 0.0 110.234 172.118 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -115.37 131.01 23.82 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 124.526 1.13 . . . . 0.0 111.346 175.374 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.26 149.19 81.33 Favored 'Cis proline' 0 CA--C 1.542 0.92 0 CA-C-N 119.929 1.01 . . . . 0.0 112.574 -6.567 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.15 -176.88 36.41 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.561 1.077 . . . . 0.0 114.155 -179.022 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.9 tp -56.89 -32.38 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 125.184 1.394 . . . . 0.0 114.55 -171.459 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.85 4.82 52.03 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -171.485 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.6 t -148.2 128.83 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.334 1.054 . . . . 0.0 110.898 179.829 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.75 164.33 30.4 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.682 1.993 . . . . 0.0 112.43 -171.574 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 72.8 p -123.26 160.81 25.83 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.957 1.703 . . . . 0.0 111.697 -173.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.5 m -90.21 175.3 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 124.512 1.125 . . . . 0.0 111.202 169.374 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.6 p -94.99 -34.94 12.17 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.464 1.506 . . . . 0.0 112.867 178.567 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -89.5 -42.25 11.57 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -165.349 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.2 t -142.27 125.19 16.12 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -177.217 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.9 m -70.51 9.19 0.67 Allowed 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -173.261 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.45 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.315 44.8 ptt85 -97.14 19.71 12.53 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.179 1.392 . . . . 0.0 114.75 173.795 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -140.14 136.33 33.41 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.774 1.23 . . . . 0.0 110.993 -175.585 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -135.55 162.45 32.66 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.971 1.308 . . . . 0.0 111.01 -179.752 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.1 t -117.15 142.02 32.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 124.504 1.122 . . . . 0.0 108.71 166.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.15 147.56 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 118.962 0.801 . . . . 0.0 111.875 173.344 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -88.61 88.01 7.46 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.187 0.595 . . . . 0.0 110.661 177.33 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -71.55 137.74 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 120.797 0.332 . . . . 0.0 110.789 176.897 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -139.34 143.33 37.74 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.047 1.739 . . . . 0.0 111.233 -169.185 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -91.74 7.07 43.44 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.368 1.067 . . . . 0.0 113.33 -174.588 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.96 13.59 83.51 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.088 1.328 . . . . 0.0 114.516 178.371 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.0 t -137.6 10.71 2.93 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.588 1.555 . . . . 0.0 113.438 -171.154 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.67 0.57 66.67 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.749 1.166 . . . . 0.0 114.996 -178.409 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -76.42 142.88 40.92 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.104 1.362 . . . . 0.0 109.045 165.433 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 94.2 p -150.32 155.93 40.57 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 172.425 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.03 146.18 30.86 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.8 1.64 . . . . 0.0 110.848 167.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -94.04 119.39 32.84 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.278 0.631 . . . . 0.0 109.926 170.28 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.6 pt -117.63 143.14 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.449 1.099 . . . . 0.0 111.062 176.606 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.04 144.22 17.9 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 174.013 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.8 pt -129.42 140.86 48.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 125.563 1.545 . . . . 0.0 111.674 171.348 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -116.47 144.62 18.49 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.258 1.408 . . . . 0.0 112.884 174.256 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -106.46 153.61 22.03 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 126.013 1.725 . . . . 0.0 111.215 178.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.1 t -74.36 -18.07 60.73 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.017 0.927 . . . . 0.0 113.115 -178.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -154.56 145.32 22.44 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.61 1.164 . . . . 0.0 111.116 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -66.29 -30.91 71.43 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 179.787 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.76 -33.02 86.13 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-N 119.083 0.856 . . . . 0.0 113.328 173.381 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -80.69 -30.78 36.37 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.619 -0.93 . . . . 0.0 112.381 175.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.45 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -67.43 -37.26 82.75 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 167.697 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -61.23 -41.34 96.71 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.637 -0.664 . . . . 0.0 110.964 168.195 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.66 -34.18 77.28 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 121.452 -0.78 . . . . 0.0 112.709 175.652 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -59.78 -55.53 33.09 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.298 1.039 . . . . 0.0 112.194 168.496 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.65 -24.98 62.8 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -177.921 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.1 t -73.15 -41.65 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 121.422 -0.799 . . . . 0.0 110.942 172.059 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.0 m -64.71 -16.25 62.63 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 177.369 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.4 mt -88.51 -55.42 3.73 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.604 1.162 . . . . 0.0 112.427 167.793 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -69.05 -33.71 74.01 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.829 -1.17 . . . . 0.0 113.595 -173.032 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -86.9 5.62 36.03 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.665 1.186 . . . . 0.0 112.189 176.147 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -97.22 -42.59 7.74 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.664 0.786 . . . . 0.0 112.048 160.22 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -84.9 -2.98 58.5 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -174.897 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.26 -33.35 27.97 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 -177.569 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 35.8 p-90 -83.99 -20.92 31.99 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.612 1.165 . . . . 0.0 113.746 178.319 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.3 t -85.44 -40.07 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.153 1.381 . . . . 0.0 110.766 177.751 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.0 ttpp -90.7 41.35 1.05 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.659 1.583 . . . . 0.0 112.074 -177.268 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -79.51 94.92 5.69 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.43 1.092 . . . . 0.0 110.101 176.856 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 C--O 1.252 1.229 0 C-N-CA 126.681 1.992 . . . . 0.0 113.097 -179.389 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.594 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 56.1 m -120.66 102.3 44.95 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 124.903 1.281 . . . . 0.0 111.098 -175.759 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -83.45 5.74 6.21 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 124.17 3.247 . . . . 0.0 114.018 -176.559 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -63.43 145.46 55.56 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.67 1.588 . . . . 0.0 113.144 -171.386 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 64.6 p -81.2 -16.26 53.32 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.816 1.247 . . . . 0.0 114.342 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.8 mtm -136.11 156.81 48.16 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.112 1.765 . . . . 0.0 111.377 178.217 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.34 -38.34 0.1 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.773 1.229 . . . . 0.0 112.921 179.81 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 53.7 m -133.07 106.83 7.86 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.465 1.506 . . . . 0.0 108.708 172.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.28 23.65 1.99 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.145 1.378 . . . . 0.0 113.399 -165.711 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.1 tt -76.37 69.56 2.87 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.939 1.695 . . . . 0.0 112.425 -175.883 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -126.32 63.19 1.26 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.207 1.803 . . . . 0.0 109.773 176.726 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.402 ' CD2' ' HG2' ' A' ' 52' ' ' LYS . 10.1 p90 -152.45 151.51 30.86 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.992 1.717 . . . . 0.0 110.78 -173.456 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 178.66 121.48 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.386 1.874 . . . . 0.0 108.304 166.829 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.0 m -92.05 107.87 19.52 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.925 -0.485 . . . . 0.0 110.054 169.215 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.8 p -66.33 147.81 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.193 0.997 . . . . 0.0 112.077 175.843 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.6 mt -132.9 -37.9 1.0 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.673 1.589 . . . . 0.0 112.493 -171.853 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 35.0 t -153.34 137.52 16.5 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.691 1.196 . . . . 0.0 110.585 173.706 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 87.9 t -130.97 126.49 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.654 1.181 . . . . 0.0 109.226 171.708 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -129.2 136.41 29.11 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 125.443 1.497 . . . . 0.0 110.76 176.652 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -81.42 -13.69 10.85 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.267 2.645 . . . . 0.0 115.405 -171.819 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -131.08 105.52 7.77 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.249 1.02 . . . . 0.0 110.945 -175.781 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.0 p -141.77 140.14 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.972 1.309 . . . . 0.0 110.367 172.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.6 m -125.73 126.91 45.37 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.587 1.155 . . . . 0.0 110.979 -171.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 79.1 t -92.85 137.74 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.356 1.462 . . . . 0.0 111.92 -178.848 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -130.83 132.64 45.33 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.945 1.298 . . . . 0.0 109.885 169.5 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -60.22 131.96 52.44 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.256 0.622 . . . . 0.0 109.732 157.398 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.9 pt -104.91 150.41 38.66 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 124.666 1.187 . . . . 0.0 112.431 -173.833 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -69.41 158.81 56.05 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.038 2.492 . . . . 0.0 111.49 168.096 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.43 143.98 71.73 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.027 2.485 . . . . 0.0 112.615 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -74.2 154.18 39.16 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.307 1.443 . . . . 0.0 111.602 175.292 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.73 -97.76 0.06 Allowed 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.04 -1.436 . . . . 0.0 109.784 161.866 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.9 m -150.85 -69.93 0.18 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.42 1.488 . . . . 0.0 110.534 159.355 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -87.44 -9.71 53.89 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -173.284 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -65.18 -53.5 43.81 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.451 1.1 . . . . 0.0 111.769 178.265 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.35 156.02 29.11 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 124.579 1.085 . . . . 0.0 113.58 -179.517 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -71.02 146.31 49.45 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.031 0.932 . . . . 0.0 109.204 168.307 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.88 19.42 5.55 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -170.372 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.95 -46.15 0.06 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 128.453 2.701 . . . . 0.0 115.655 -174.632 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 90.9 p -64.04 -18.49 64.38 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.854 2.062 . . . . 0.0 114.61 179.626 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.52 -9.12 59.77 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.077 0.951 . . . . 0.0 113.144 174.054 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 16.7 m0 -92.88 170.58 9.57 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.22 1.408 . . . . 0.0 110.881 177.226 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.1 mtmm -80.28 54.53 2.01 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.041 1.337 . . . . 0.0 113.749 -177.844 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.0 mt -54.66 -29.3 52.11 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 -171.208 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -90.62 -10.67 42.41 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.033 0.933 . . . . 0.0 112.714 179.178 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -139.52 60.42 16.49 Favored Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 126.303 1.841 . . . . 0.0 110.842 -161.487 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -64.66 140.11 66.67 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 120.648 0.899 . . . . 0.0 111.966 -173.225 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -70.52 -26.91 63.79 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.79 0.836 . . . . 0.0 111.445 176.774 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 42.6 t90 -156.96 154.21 29.31 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.552 1.541 . . . . 0.0 111.023 170.08 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.4 p -134.15 144.95 48.84 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.312 1.045 . . . . 0.0 112.083 171.478 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.89 -143.69 5.17 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 123.497 0.57 . . . . 0.0 113.812 -178.087 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 34.8 mtm105 -117.92 148.59 42.01 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.818 2.047 . . . . 0.0 111.193 -172.576 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.7 tp -92.68 141.84 28.03 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.175 1.79 . . . . 0.0 111.029 176.208 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -142.47 99.08 3.42 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.926 1.69 . . . . 0.0 109.716 169.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.1 mt -85.98 133.8 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 169.693 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.04 168.15 22.28 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.093 1.757 . . . . 0.0 110.495 -168.286 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.2 t -157.17 150.75 24.23 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.741 -1.225 . . . . 0.0 112.087 173.658 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.402 ' HG2' ' CD2' ' A' ' 7' ' ' TYR . 12.0 tppt? -149.86 134.19 17.33 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.53 151.976 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.34 50.28 33.69 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.513 1.054 . . . . 0.0 114.814 164.6 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt 60.06 26.88 16.26 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.075 1.75 . . . . 0.0 113.347 -175.765 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.5 m -130.67 124.06 30.76 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 126.028 1.731 . . . . 0.0 108.035 170.142 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -92.94 159.83 15.16 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.647 0.779 . . . . 0.0 110.585 170.183 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -139.04 106.39 5.53 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.149 1.78 . . . . 0.0 108.518 -172.669 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.3 mp -87.37 104.29 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 168.646 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -104.9 138.79 40.6 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.937 1.295 . . . . 0.0 111.121 177.508 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.9 mp -110.23 131.24 55.23 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.814 1.646 . . . . 0.0 109.933 176.596 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -130.38 149.85 51.87 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.558 1.143 . . . . 0.0 112.1 -173.713 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -75.28 152.46 38.24 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.007 -1.058 . . . . 0.0 112.455 177.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.499 ' H ' ' HD3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -93.79 -0.61 55.78 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.131 1.773 . . . . 0.0 115.486 -176.829 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.8 t -118.73 -45.8 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.207 1.403 . . . . 0.0 111.378 173.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.3 m -97.24 -21.22 17.4 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -173.714 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.72 6.81 85.51 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.085 0.85 . . . . 0.0 113.886 -177.466 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -79.3 151.25 31.19 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.045 1.338 . . . . 0.0 112.462 -174.513 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.6 tp -72.52 126.82 30.78 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.769 0.828 . . . . 0.0 110.924 178.361 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -86.66 -55.32 3.92 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.425 1.09 . . . . 0.0 111.265 170.688 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.39 160.67 39.85 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.852 1.261 . . . . 0.0 111.58 -178.349 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -141.65 136.22 30.73 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.75 0.82 . . . . 0.0 112.721 177.091 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.99 98.08 47.7 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 125.96 1.704 . . . . 0.0 111.482 -179.068 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -62.52 140.29 80.91 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 124.33 3.353 . . . . 0.0 113.042 166.002 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.1 t -136.43 126.47 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 126.453 1.901 . . . . 0.0 109.223 -178.493 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -86.69 -25.82 24.6 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 121.27 -0.894 . . . . 0.0 113.289 -178.054 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.31 151.15 15.14 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.102 1.761 . . . . 0.0 110.808 173.594 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -122.57 129.82 24.9 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.653 1.181 . . . . 0.0 111.174 176.486 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -62.65 148.2 59.79 Favored 'Cis proline' 0 CA--C 1.539 0.746 0 CA-C-N 119.982 1.029 . . . . 0.0 113.754 -6.14 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.29 -164.38 15.26 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.48 1.514 . . . . 0.0 112.702 179.772 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.0 tt -75.21 -38.32 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -177.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.06 6.51 16.04 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -167.424 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 25.1 t -149.03 132.09 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 125.992 1.717 . . . . 0.0 109.522 178.13 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.24 161.43 38.92 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.006 1.722 . . . . 0.0 111.94 -177.199 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.9 p -110.16 165.67 11.57 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.427 1.491 . . . . 0.0 111.373 177.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.7 m -87.05 179.51 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.469 0.707 . . . . 0.0 110.473 160.116 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 71.0 p -101.23 -30.01 11.77 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.614 1.566 . . . . 0.0 113.543 177.884 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -90.24 -42.77 10.81 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -167.604 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.2 t -143.31 125.12 15.08 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -176.26 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.04 -3.85 14.71 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -170.471 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.414 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.286 0.9 OUTLIER -86.68 22.86 1.81 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.56 1.544 . . . . 0.0 114.615 174.434 . . . . . . . . 4 4 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -142.24 133.25 25.91 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.633 1.173 . . . . 0.0 111.703 -179.575 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -136.07 162.94 31.51 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.373 1.469 . . . . 0.0 111.587 179.347 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 55.2 t -117.14 142.91 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.877 1.271 . . . . 0.0 109.044 168.597 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.62 148.72 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 118.835 0.743 . . . . 0.0 112.47 173.48 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -86.11 85.33 7.36 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.096 0.959 . . . . 0.0 110.406 175.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -68.82 140.31 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 121.945 -0.472 . . . . 0.0 110.428 172.311 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -131.43 151.92 51.12 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.704 1.602 . . . . 0.0 111.087 -171.038 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -94.87 8.73 41.77 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.968 0.907 . . . . 0.0 113.213 -176.386 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.17 -18.77 4.99 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.698 1.618 . . . . 0.0 115.163 -178.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.3 t -86.49 -25.01 25.36 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.784 1.234 . . . . 0.0 112.995 176.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 136.07 -17.94 3.81 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.553 1.549 . . . . 0.0 114.268 176.27 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.9 156.0 22.6 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 125.428 1.491 . . . . 0.0 111.47 176.701 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 38.3 p -153.24 166.59 32.08 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -165.075 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -137.3 150.03 47.49 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.646 1.578 . . . . 0.0 110.635 162.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -95.32 113.06 24.69 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.497 0.719 . . . . 0.0 109.346 170.177 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 32.2 pt -112.41 146.36 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.62 1.168 . . . . 0.0 111.109 -179.617 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -92.33 142.99 16.26 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 174.271 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 34.3 pt -128.45 139.76 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 125.171 1.388 . . . . 0.0 111.56 172.552 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -118.45 143.96 17.8 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.69 1.614 . . . . 0.0 112.567 174.197 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -105.31 161.39 14.33 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.806 1.642 . . . . 0.0 111.812 -176.373 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.3 t -72.7 -27.63 62.19 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.62 0.768 . . . . 0.0 113.055 178.132 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -156.05 150.75 26.03 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.165 0.986 . . . . 0.0 112.152 -178.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 47.3 ttt-85 -62.27 -34.84 77.31 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.555 1.142 . . . . 0.0 113.107 178.446 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.16 -26.72 73.99 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 118.814 0.734 . . . . 0.0 113.698 176.084 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -85.56 -32.84 21.91 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.048 0.939 . . . . 0.0 111.821 173.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.414 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -67.76 -32.18 72.59 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 170.914 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -57.68 -36.57 72.1 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.547 -0.721 . . . . 0.0 112.074 172.356 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -66.18 -29.27 69.51 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.207 -0.933 . . . . 0.0 112.999 176.431 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -62.38 -47.99 81.72 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.473 1.033 . . . . 0.0 112.032 174.029 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -83.33 -25.22 31.68 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.345 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.0 t -78.45 -42.09 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 121.36 -0.838 . . . . 0.0 111.486 177.07 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 92.4 p -65.07 -28.56 69.55 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 179.666 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.3 mt -72.23 -54.41 9.68 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.98 0.912 . . . . 0.0 111.658 170.742 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -68.42 -33.96 75.14 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.028 -1.045 . . . . 0.0 113.102 -173.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -86.44 7.33 26.31 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.309 1.044 . . . . 0.0 112.538 175.986 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -102.72 -35.73 8.56 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.056 0.943 . . . . 0.0 112.42 161.885 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -88.6 -3.35 58.82 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -179.508 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.79 -25.08 39.56 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -175.278 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 31.1 p-90 -87.7 -22.67 24.51 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.013 1.325 . . . . 0.0 113.52 174.424 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.8 t -83.31 -27.53 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.88 1.672 . . . . 0.0 111.329 176.265 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -86.06 18.93 2.81 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.6 1.96 . . . . 0.0 113.308 177.796 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -85.59 91.52 8.28 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.092 0.957 . . . . 0.0 109.427 173.576 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 . . . . . 0 C--O 1.253 1.27 0 C-N-CA 126.468 1.907 . . . . 0.0 112.862 -168.598 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 112.067 -0.413 . . . . 0.0 112.067 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 37.2 t -68.76 141.26 92.43 Favored Pre-proline 0 N--CA 1.476 0.838 0 C-N-CA 123.935 0.894 . . . . 0.0 112.224 178.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.9 -10.34 19.75 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.412 2.742 . . . . 0.0 113.152 172.372 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -80.95 156.36 26.01 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.755 1.222 . . . . 0.0 111.965 -178.545 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 92.9 p -79.47 -5.73 55.39 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 177.67 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 mtt 58.46 18.27 5.52 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.204 1.802 . . . . 0.0 114.095 -166.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.45 -29.86 1.53 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.105 1.762 . . . . 0.0 112.521 174.489 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 58.8 m -129.58 108.42 10.21 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.162 1.785 . . . . 0.0 108.886 174.622 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -146.76 25.38 1.17 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.85 1.26 . . . . 0.0 113.302 -172.954 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.7 tt -64.91 104.99 0.93 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.737 1.615 . . . . 0.0 111.477 -179.638 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -147.11 71.7 1.23 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.685 1.594 . . . . 0.0 109.177 175.765 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.426 ' CD2' ' HG2' ' A' ' 52' ' ' LYS . 8.0 p90 -133.52 139.84 46.86 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.617 1.167 . . . . 0.0 110.704 175.98 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 173.92 110.39 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 127.149 2.18 . . . . 0.0 107.725 165.663 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.9 m -87.56 109.49 19.67 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.246 -0.909 . . . . 0.0 110.612 177.578 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 86.4 t -68.79 143.06 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.651 1.18 . . . . 0.0 111.854 -176.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.6 mt -125.19 -40.98 2.09 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.908 1.683 . . . . 0.0 112.168 -176.278 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 49.9 t -153.2 135.01 14.58 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.563 1.145 . . . . 0.0 110.664 172.091 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 74.1 t -127.88 127.59 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.677 1.191 . . . . 0.0 109.261 170.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -127.87 134.8 26.6 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 124.861 1.264 . . . . 0.0 111.035 174.602 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -63.17 -26.14 72.69 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.084 2.522 . . . . 0.0 114.328 178.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -111.82 129.18 56.23 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.349 1.46 . . . . 0.0 113.228 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.4 p -157.64 142.3 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 126.327 1.851 . . . . 0.0 108.886 158.789 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.7 m -124.4 134.83 52.99 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.361 1.065 . . . . 0.0 110.493 -178.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 86.2 t -103.18 134.87 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.819 1.248 . . . . 0.0 111.751 -177.773 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.75 118.92 11.99 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.997 1.319 . . . . 0.0 109.096 172.859 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -63.4 130.46 44.56 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.983 0.913 . . . . 0.0 110.618 176.46 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.6 pt -96.8 154.78 38.23 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 124.645 1.178 . . . . 0.0 112.669 -173.758 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.66 146.54 43.69 Favored 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 122.515 2.143 . . . . 0.0 110.85 159.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.11 135.5 29.78 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.944 2.429 . . . . 0.0 111.615 177.644 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -153.16 -170.89 3.75 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.074 1.35 . . . . 0.0 112.036 179.373 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.64 -1.31 13.25 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.286 1.834 . . . . 0.0 114.633 176.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.8 m 60.63 -76.79 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 127.412 2.285 . . . . 0.0 114.092 -171.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -62.71 -30.62 71.55 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.352 1.461 . . . . 0.0 114.424 -164.093 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.0 ptt-85 -103.72 -12.31 17.07 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 178.658 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.83 -16.38 0.88 Allowed Glycine 0 N--CA 1.47 0.93 0 N-CA-C 117.831 1.892 . . . . 0.0 117.831 -162.398 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -78.12 114.43 16.99 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.807 2.303 . . . . 0.0 108.328 161.653 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.18 21.19 11.85 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -176.104 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.18 -50.26 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.856 2.462 . . . . 0.0 114.879 -168.421 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.3 m -63.63 -13.89 46.64 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.61 1.964 . . . . 0.0 114.692 -178.474 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.53 -24.0 58.9 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.697 1.199 . . . . 0.0 112.506 172.77 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 12.5 m0 -88.25 168.47 12.69 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.068 1.747 . . . . 0.0 111.499 -174.753 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.3 mtpp -77.45 53.82 1.09 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.836 1.654 . . . . 0.0 113.402 176.861 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.5 mt -55.76 -38.23 69.56 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.84 1.256 . . . . 0.0 114.017 -173.375 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -87.12 -3.84 59.1 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.518 1.127 . . . . 0.0 113.029 179.444 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -136.74 63.64 47.07 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 126.339 1.856 . . . . 0.0 111.561 -166.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -68.9 148.15 69.97 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 CA-C-N 119.916 1.006 . . . . 0.0 113.103 -169.689 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -69.49 -31.12 69.19 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.901 0.88 . . . . 0.0 111.355 168.626 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 39.6 t90 -161.25 155.68 23.04 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.667 1.987 . . . . 0.0 110.414 177.432 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 55.5 p -135.28 147.81 49.33 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.835 1.254 . . . . 0.0 112.002 171.361 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.11 -142.36 5.27 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.177 0.418 . . . . 0.0 114.064 179.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.3 mtm180 -106.91 145.27 32.4 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.434 1.894 . . . . 0.0 111.619 -174.596 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.7 tp -82.46 138.49 34.36 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.714 0.806 . . . . 0.0 109.544 163.428 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.6 ttt-85 -145.75 90.76 2.02 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 122.159 0.981 . . . . 0.0 111.333 163.307 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.0 mt -73.6 128.3 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 170.444 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.2 p -134.79 175.96 9.09 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.958 2.103 . . . . 0.0 110.642 -177.248 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.7 t -156.53 148.94 23.42 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.687 -1.258 . . . . 0.0 111.118 173.78 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.426 ' HG2' ' CD2' ' A' ' 7' ' ' TYR . 11.4 tppt? -150.77 132.11 14.6 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.358 0.663 . . . . 0.0 112.76 154.168 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.12 51.13 19.48 Favored Glycine 0 N--CA 1.474 1.213 0 C-N-CA 124.561 1.076 . . . . 0.0 114.298 169.092 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 59.3 23.47 11.9 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 126.412 1.885 . . . . 0.0 113.326 -175.619 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.5 m -130.79 111.65 12.33 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 125.2 1.4 . . . . 0.0 108.733 176.494 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.93 159.36 24.96 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.073 0.463 . . . . 0.0 110.371 172.389 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -137.98 107.24 6.08 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.787 1.635 . . . . 0.0 108.577 -176.187 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.5 mp -78.36 96.63 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 106.463 -1.681 . . . . 0.0 106.463 167.177 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -95.67 137.99 33.96 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.168 0.587 . . . . 0.0 111.479 174.601 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.6 mp -110.43 129.77 55.7 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.066 1.746 . . . . 0.0 110.183 177.024 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -132.9 149.77 52.22 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -166.384 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -65.98 142.5 57.82 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.986 -1.071 . . . . 0.0 112.788 179.02 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.34 -3.78 35.48 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 116.955 2.206 . . . . 0.0 116.955 -177.959 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.1 t -117.59 -45.04 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.506 1.122 . . . . 0.0 111.822 174.289 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.7 m -117.2 -4.82 11.38 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -169.759 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.5 15.15 79.19 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 123.871 0.748 . . . . 0.0 114.245 176.638 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -61.33 131.72 51.23 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.906 1.683 . . . . 0.0 111.308 -177.267 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 39.0 tp -69.78 115.92 9.57 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 122.782 0.433 . . . . 0.0 111.146 -178.104 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -81.36 -53.87 5.95 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.439 1.095 . . . . 0.0 111.085 173.088 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.55 160.93 38.68 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.064 1.346 . . . . 0.0 111.206 -178.971 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -141.87 137.14 31.19 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.758 0.823 . . . . 0.0 112.572 174.776 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.65 103.72 50.35 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.136 1.374 . . . . 0.0 111.182 177.6 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -67.9 140.97 52.08 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 124.17 3.247 . . . . 0.0 112.65 172.015 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.2 t -135.3 126.63 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.788 1.635 . . . . 0.0 109.464 -177.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -90.24 -24.32 20.99 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 179.704 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -161.59 150.0 15.5 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.696 1.999 . . . . 0.0 110.401 172.44 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -121.63 132.38 24.24 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.74 1.216 . . . . 0.0 111.57 176.403 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -62.15 147.21 54.06 Favored 'Cis proline' 0 CA--C 1.541 0.854 0 CA-C-N 119.874 0.991 . . . . 0.0 113.583 -7.153 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.63 -172.49 32.17 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.632 1.11 . . . . 0.0 113.954 -178.722 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.2 tp -61.87 -34.92 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -171.619 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.05 4.62 49.68 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -169.062 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.8 t -149.04 126.48 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.414 1.086 . . . . 0.0 110.539 -178.645 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -139.43 158.57 43.91 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.799 2.04 . . . . 0.0 111.775 -172.698 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.1 p -113.52 163.52 14.82 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.579 1.952 . . . . 0.0 111.381 -179.051 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.2 m -88.8 178.67 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.255 1.422 . . . . 0.0 109.769 165.496 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.2 t -105.16 -23.81 12.85 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.707 1.203 . . . . 0.0 113.604 179.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -88.65 -51.17 5.82 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -174.673 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.3 t -139.37 129.79 25.61 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -174.56 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.66 -2.86 12.89 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -171.562 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.474 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.299 31.4 ptt180 -84.78 15.65 3.77 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 178.061 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -140.36 136.77 33.49 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.203 1.401 . . . . 0.0 110.768 -172.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -138.48 165.43 26.86 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.271 1.429 . . . . 0.0 111.281 -178.634 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.5 t -118.49 141.53 37.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 124.7 1.2 . . . . 0.0 108.745 165.547 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.8 148.11 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 119.036 0.835 . . . . 0.0 112.516 171.711 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -89.17 82.41 6.59 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.794 0.838 . . . . 0.0 111.1 177.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -67.72 141.96 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 121.01 0.433 . . . . 0.0 111.04 176.04 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -138.17 151.64 47.92 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.831 1.653 . . . . 0.0 111.307 -170.296 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -96.55 2.98 52.89 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.257 1.023 . . . . 0.0 113.199 179.222 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.45 12.59 82.86 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 125.138 1.352 . . . . 0.0 114.751 178.487 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.3 t -137.37 12.5 3.01 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.576 1.551 . . . . 0.0 113.521 -171.655 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.21 -1.89 70.66 Favored Glycine 0 CA--C 1.538 1.498 0 O-C-N 120.736 -1.227 . . . . 0.0 114.975 -178.266 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -75.59 135.99 40.52 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.283 1.433 . . . . 0.0 108.595 164.653 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 65.0 p -151.28 160.32 43.87 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 171.642 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.95 147.54 32.81 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.367 1.467 . . . . 0.0 110.873 168.249 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -92.15 115.4 28.05 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.421 0.689 . . . . 0.0 109.316 169.355 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 28.8 pt -112.7 141.73 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.379 1.072 . . . . 0.0 110.747 179.419 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.15 139.73 15.38 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 175.954 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.2 pt -129.49 155.37 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 125.259 1.424 . . . . 0.0 111.952 172.351 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -148.48 166.29 29.13 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 114.421 0.528 . . . . 0.0 114.421 168.57 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -116.73 162.76 17.18 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.995 1.718 . . . . 0.0 111.388 -175.378 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.3 t -70.54 -22.9 62.56 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.462 0.705 . . . . 0.0 112.455 175.635 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -152.76 147.24 25.84 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.798 0.839 . . . . 0.0 112.537 -174.267 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 47.1 ttt-85 -62.61 -32.61 73.65 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.694 1.198 . . . . 0.0 113.152 179.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.26 -27.21 73.84 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-N 118.908 0.776 . . . . 0.0 113.851 176.649 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -84.33 -36.2 22.71 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 118.074 0.937 . . . . 0.0 111.658 175.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.474 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -65.17 -32.34 73.98 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 168.564 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -59.32 -37.48 77.89 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.264 -0.898 . . . . 0.0 111.98 173.279 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -67.19 -31.42 71.81 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.194 -0.941 . . . . 0.0 112.847 176.013 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -58.6 -50.91 72.09 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.295 0.952 . . . . 0.0 111.545 171.667 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.2 -24.28 30.15 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -176.302 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.3 t -78.46 -40.37 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 O-C-N 121.068 -1.02 . . . . 0.0 110.954 176.641 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 95.0 p -63.75 -28.86 70.17 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 177.411 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 78.5 mt -72.14 -52.97 14.18 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.182 0.993 . . . . 0.0 111.923 172.307 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -68.58 -31.17 70.18 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.993 -1.067 . . . . 0.0 113.22 -176.112 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -87.88 2.14 52.24 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.641 1.176 . . . . 0.0 112.492 174.383 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -92.03 -40.02 11.32 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 120.74 -1.225 . . . . 0.0 111.992 163.975 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -89.31 -1.73 58.18 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 -174.518 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.56 -32.44 63.0 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 120.25 1.386 . . . . 0.0 114.524 -175.07 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 30.6 p-90 -81.36 -28.6 34.37 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.624 1.17 . . . . 0.0 113.301 178.034 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 37.6 t -74.42 -30.23 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.024 1.329 . . . . 0.0 110.967 175.707 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -105.3 40.99 1.42 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.348 1.859 . . . . 0.0 112.632 -178.524 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -82.5 4.77 23.04 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 162.889 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 C--O 1.252 1.22 0 C-N-CA 128.699 2.8 . . . . 0.0 112.172 177.905 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.608 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 56.2 m -135.04 145.63 55.19 Favored Pre-proline 0 N--CA 1.477 0.921 0 C-N-CA 125.252 1.421 . . . . 0.0 111.756 -176.175 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -70.49 -34.87 11.43 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.044 2.496 . . . . 0.0 112.23 175.11 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -78.34 138.43 38.55 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.699 1.999 . . . . 0.0 111.302 171.584 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 64.4 p -85.25 -11.63 54.4 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.057 1.343 . . . . 0.0 114.297 -179.009 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.04 171.73 13.67 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.369 1.868 . . . . 0.0 111.534 -179.495 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.23 -39.61 0.53 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.545 1.138 . . . . 0.0 112.693 173.568 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 88.2 m -140.78 123.93 16.55 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.286 1.834 . . . . 0.0 108.424 170.784 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -138.56 34.1 2.25 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.967 1.307 . . . . 0.0 113.2 -177.506 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.78 58.1 1.8 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.182 1.393 . . . . 0.0 112.379 179.301 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -111.68 40.51 2.11 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.13 2.172 . . . . 0.0 111.759 -179.284 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -142.55 148.15 37.1 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 126.802 2.041 . . . . 0.0 109.142 -172.874 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -177.84 125.14 0.12 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.572 1.549 . . . . 0.0 108.797 171.118 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.4 m -90.52 110.7 21.82 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.797 -0.565 . . . . 0.0 109.836 166.215 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.9 t -63.57 141.68 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 124.496 1.118 . . . . 0.0 111.717 178.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.4 mt -126.94 -39.9 1.92 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.992 1.717 . . . . 0.0 112.54 -177.369 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.0 t -152.27 133.06 14.06 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.412 1.085 . . . . 0.0 110.821 174.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 81.1 t -128.67 128.13 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.394 1.078 . . . . 0.0 109.319 171.822 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -130.49 134.79 26.46 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 125.293 1.437 . . . . 0.0 110.337 176.429 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -77.35 -13.96 16.58 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.285 2.657 . . . . 0.0 114.76 -174.347 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -134.37 106.57 7.15 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.404 1.082 . . . . 0.0 111.236 -174.125 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -143.69 144.64 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.144 1.378 . . . . 0.0 110.205 171.078 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.0 m -118.0 140.66 49.42 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.354 1.062 . . . . 0.0 111.388 -176.485 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 66.1 t -105.76 138.28 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.726 1.61 . . . . 0.0 111.792 175.741 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -125.1 127.99 47.76 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.47 1.508 . . . . 0.0 108.995 170.67 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -76.58 111.62 12.25 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 165.111 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.7 pt -87.57 153.15 52.84 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 124.492 1.117 . . . . 0.0 113.286 -164.185 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -64.94 167.84 15.0 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.646 2.898 . . . . 0.0 112.402 171.502 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.32 91.65 0.33 Allowed 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.649 2.9 . . . . 0.0 112.294 178.038 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.75 161.83 35.51 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 128.337 2.655 . . . . 0.0 109.895 177.02 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -143.25 160.46 40.43 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.302 1.441 . . . . 0.0 111.386 -179.331 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 76.9 p -57.38 -32.79 67.16 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.782 2.033 . . . . 0.0 114.93 -179.521 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -77.02 -4.42 44.07 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.96 1.304 . . . . 0.0 112.726 178.453 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -110.98 -43.92 3.69 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 127.634 2.374 . . . . 0.0 110.185 172.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.7 118.14 3.53 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 127.178 2.323 . . . . 0.0 113.037 174.278 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -66.14 143.75 57.09 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.332 1.053 . . . . 0.0 109.455 163.512 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.405 ' HE ' ' CG ' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -122.66 25.03 8.93 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.046 0.938 . . . . 0.0 113.385 178.796 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 60.42 -44.81 0.1 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.569 2.347 . . . . 0.0 114.936 -172.269 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.6 m -63.92 -13.14 43.27 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.738 2.015 . . . . 0.0 114.26 177.122 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.405 ' CG ' ' HE ' ' A' ' 32' ' ' ARG . 43.5 m-20 -59.03 -30.6 68.15 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.834 0.853 . . . . 0.0 112.839 164.95 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 9.2 m0 -99.24 171.23 8.13 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.035 1.334 . . . . 0.0 112.592 -164.447 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -78.86 49.34 0.9 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.377 1.871 . . . . 0.0 113.87 -178.531 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.8 mt -54.86 -35.07 63.63 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -166.635 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -94.79 -1.87 52.02 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.203 1.001 . . . . 0.0 113.644 179.552 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -145.46 73.76 14.04 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 125.573 1.549 . . . . 0.0 112.019 179.658 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.85 148.16 38.63 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.515 2.81 . . . . 0.0 113.736 178.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -71.93 -31.54 66.45 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.247 0.619 . . . . 0.0 111.295 168.269 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 48.7 t90 -154.3 154.37 33.26 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.846 1.659 . . . . 0.0 110.869 174.793 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.4 p -133.36 148.37 51.85 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.109 0.964 . . . . 0.0 111.674 169.004 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.51 -141.76 4.69 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 116.366 -0.379 . . . . 0.0 113.433 -178.804 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.7 mtm105 -114.32 144.97 42.4 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.152 1.781 . . . . 0.0 111.92 -172.901 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.1 tp -85.34 139.98 31.14 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.26 1.424 . . . . 0.0 109.822 168.386 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.1 ttt85 -145.5 86.64 1.75 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.699 1.199 . . . . 0.0 110.866 168.245 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.0 mt -74.33 127.74 36.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 170.649 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 p -136.51 171.68 14.14 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.854 2.062 . . . . 0.0 110.188 -178.663 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.7 t -156.7 148.89 23.12 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 120.632 -1.292 . . . . 0.0 111.674 177.866 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -153.59 128.26 9.39 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.723 0.809 . . . . 0.0 112.193 161.418 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.35 54.12 18.0 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.316 0.96 . . . . 0.0 114.231 166.344 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 93.8 mttt 60.02 25.75 15.01 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 126.249 1.82 . . . . 0.0 113.31 -176.059 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.8 m -136.22 114.45 11.57 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.25 1.42 . . . . 0.0 109.429 177.875 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.7 159.78 19.06 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.559 0.743 . . . . 0.0 110.775 173.872 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -139.89 105.31 5.07 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.099 1.76 . . . . 0.0 108.725 -175.727 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.4 mp -79.99 91.99 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 167.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -86.01 138.18 32.16 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.221 0.608 . . . . 0.0 110.421 173.167 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.4 mp -112.17 133.33 54.37 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.125 1.77 . . . . 0.0 109.645 173.103 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -135.14 153.47 51.98 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -172.269 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -73.92 144.61 45.26 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.946 0.879 . . . . 0.0 111.94 179.614 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.4 pttt -85.36 -6.18 59.25 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.368 1.867 . . . . 0.0 115.125 -178.635 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 92.6 t -122.47 -44.61 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.234 1.414 . . . . 0.0 111.437 178.648 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.2 m -92.32 -23.06 19.38 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -175.296 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.96 7.16 86.48 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 123.973 0.797 . . . . 0.0 113.702 -177.452 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -82.7 154.51 24.8 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.288 1.435 . . . . 0.0 112.473 -175.082 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.5 tp -73.45 127.18 31.99 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.371 0.668 . . . . 0.0 110.827 177.337 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -84.47 -54.99 4.38 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.427 1.091 . . . . 0.0 110.922 170.098 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -159.5 165.85 32.12 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.689 1.596 . . . . 0.0 110.562 179.755 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -144.99 142.49 29.84 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 168.706 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.78 111.53 48.5 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.071 1.348 . . . . 0.0 111.378 177.729 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -82.85 140.29 10.18 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.57 2.847 . . . . 0.0 111.502 176.961 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.26 128.61 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.396 1.478 . . . . 0.0 109.857 -174.449 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -90.64 -24.26 20.55 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 178.274 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -164.31 149.37 10.15 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.144 1.778 . . . . 0.0 110.411 171.569 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.408 ' CD2' ' HA ' ' A' ' 78' ' ' PRO . 82.5 t80 -125.75 130.28 24.09 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.819 1.248 . . . . 0.0 111.53 -177.554 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.408 ' HA ' ' CD2' ' A' ' 77' ' ' TYR . 73.5 Cg_endo -66.51 143.89 65.54 Favored 'Cis proline' 0 CA--C 1.54 0.801 0 CA-C-N 120.267 1.131 . . . . 0.0 113.353 -2.077 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.02 -168.34 29.06 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.12 1.343 . . . . 0.0 113.637 -176.607 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.3 tp -59.08 -39.64 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -169.659 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -89.31 3.84 50.78 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -167.395 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.6 t -151.54 124.18 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.392 1.077 . . . . 0.0 110.82 -176.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -141.39 167.07 23.04 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.626 1.97 . . . . 0.0 112.863 -176.264 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 73.1 p -121.25 158.62 27.72 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.503 1.521 . . . . 0.0 112.061 -169.807 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.3 m -84.62 168.12 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.839 0.856 . . . . 0.0 110.676 166.584 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 72.3 p -96.74 -24.94 15.71 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.956 1.302 . . . . 0.0 113.642 179.532 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -98.69 -38.97 8.89 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -166.21 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.6 t -138.87 124.12 19.17 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -173.905 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.2 m -74.54 26.1 0.08 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 -168.226 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.456 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.265 34.3 ptt180 -125.29 18.69 8.26 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.631 1.572 . . . . 0.0 114.923 179.851 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -140.28 142.6 35.7 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.404 1.082 . . . . 0.0 112.167 -171.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -141.7 158.2 44.11 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.189 1.396 . . . . 0.0 111.933 -176.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.2 t -110.68 137.93 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.939 0.895 . . . . 0.0 108.812 163.555 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.88 146.73 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 119.263 0.938 . . . . 0.0 112.018 172.472 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -91.16 92.54 8.72 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.379 0.672 . . . . 0.0 110.124 175.737 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -74.49 152.72 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.07 0.548 . . . . 0.0 111.229 176.09 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.03 150.35 45.03 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.488 1.515 . . . . 0.0 111.171 173.865 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -99.52 17.23 20.89 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.08 1.352 . . . . 0.0 113.257 -178.944 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.86 6.55 87.24 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.385 1.469 . . . . 0.0 115.603 175.669 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.1 t -131.06 5.27 4.5 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.473 1.509 . . . . 0.0 113.757 -174.289 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.14 -7.56 72.73 Favored Glycine 0 N--CA 1.478 1.439 0 C-N-CA 125.381 1.467 . . . . 0.0 113.86 -176.049 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 49.3 ttt180 -70.07 132.19 45.48 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 127.301 2.241 . . . . 0.0 108.927 165.184 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 95.3 p -139.12 159.19 42.74 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.125 1.37 . . . . 0.0 113.952 -178.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.96 146.1 28.84 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.989 1.315 . . . . 0.0 111.226 172.124 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -87.9 121.11 29.92 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 166.147 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.8 pt -119.32 144.93 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.82 1.248 . . . . 0.0 110.58 176.295 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.04 141.33 16.24 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 174.355 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.6 pt -126.33 144.49 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 124.548 1.139 . . . . 0.0 112.503 168.961 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -125.67 138.27 10.77 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 124.857 1.218 . . . . 0.0 113.244 177.923 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -102.91 163.6 12.12 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.849 1.66 . . . . 0.0 109.998 166.541 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.9 t -92.91 -20.65 20.43 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 175.559 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -109.15 -18.75 13.56 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -149.47 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 60.49 -48.72 0.1 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.914 2.086 . . . . 0.0 114.134 -161.236 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.44 -31.2 66.12 Favored Glycine 0 CA--C 1.539 1.564 0 CA-C-N 119.578 1.081 . . . . 0.0 114.176 174.575 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -81.0 -32.01 34.41 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.35 -1.088 . . . . 0.0 112.466 175.648 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -68.57 -32.69 72.78 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 168.112 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -60.67 -47.49 86.04 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.588 0.755 . . . . 0.0 110.204 166.767 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -60.3 -42.2 95.01 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 118.703 0.683 . . . . 0.0 112.356 177.19 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -53.09 -54.81 30.1 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.811 1.244 . . . . 0.0 112.566 174.125 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -82.4 -26.04 33.17 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -174.71 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.3 t -75.92 -40.97 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 121.6 -0.687 . . . . 0.0 110.898 177.823 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 91.4 p -64.05 -29.81 70.92 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 175.217 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.5 mt -68.81 -59.09 3.33 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.087 0.955 . . . . 0.0 111.779 170.168 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -64.94 -30.98 72.0 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -172.791 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -83.25 -4.15 58.14 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.648 1.179 . . . . 0.0 112.721 178.218 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -95.32 -11.71 27.36 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.94 -1.1 . . . . 0.0 113.39 165.639 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -110.42 -6.02 15.05 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 179.376 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -35.91 64.14 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 121.182 1.81 . . . . 0.0 113.896 -176.521 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 25.2 p-90 -75.89 -33.06 59.92 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.826 1.251 . . . . 0.0 112.887 178.242 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.0 t -68.72 -37.92 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.675 1.19 . . . . 0.0 110.55 174.137 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -83.92 -1.1 53.88 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.478 1.511 . . . . 0.0 114.888 175.429 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 47.81 42.52 16.0 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 127.586 2.354 . . . . 0.0 114.538 -176.743 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 . . . . . 0 C--O 1.254 1.302 0 C-N-CA 126.213 1.805 . . . . 0.0 113.471 175.986 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.629 0 N-CA-C 112.11 -0.396 . . . . 0.0 112.11 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 46.6 m -67.02 146.61 99.11 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 124.296 1.038 . . . . 0.0 112.852 -178.621 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.7 104.62 0.99 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.508 2.805 . . . . 0.0 112.22 -173.471 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -131.45 150.12 52.27 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.281 1.833 . . . . 0.0 111.172 176.178 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 46.1 m -102.78 -20.67 14.25 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.427 1.091 . . . . 0.0 113.154 178.118 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.2 ttm -152.28 107.02 3.21 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.55 1.54 . . . . 0.0 109.962 175.02 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.32 17.46 1.53 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.601 1.56 . . . . 0.0 112.719 -178.236 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.5 m 54.78 72.46 0.47 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.412 1.885 . . . . 0.0 111.949 -173.231 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.11 17.82 12.4 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.568 1.947 . . . . 0.0 113.979 -164.934 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.2 mp -60.18 131.46 50.89 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.714 1.205 . . . . 0.0 112.611 -173.21 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -88.37 56.56 3.86 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.95 1.3 . . . . 0.0 110.305 168.232 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -141.06 172.83 12.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.257 2.223 . . . . 0.0 109.819 -175.663 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . 0.253 1.8 tt0 70.83 63.6 0.18 Allowed 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 124.075 1.893 . . . . 0.0 107.676 -179.221 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 t -74.35 104.72 5.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 112.327 -2.215 . . . . 0.0 109.301 -170.222 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.9 t -57.83 139.41 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 125.401 1.48 . . . . 0.0 112.088 -174.062 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.3 mt -125.5 -40.36 2.1 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.682 1.593 . . . . 0.0 112.14 -176.353 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 33.0 t -154.41 136.06 14.36 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.495 1.118 . . . . 0.0 110.678 176.926 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.3 t -130.68 125.79 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.421 1.088 . . . . 0.0 109.239 172.42 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -131.61 142.98 47.28 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 124.68 1.192 . . . . 0.0 112.021 176.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.01 -19.08 20.82 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.535 2.824 . . . . 0.0 115.048 -174.951 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -135.15 112.52 10.56 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.777 0.831 . . . . 0.0 112.279 -167.509 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.3 p -149.64 143.27 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.209 1.803 . . . . 0.0 109.902 171.191 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.9 m -120.71 129.23 53.57 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.351 1.06 . . . . 0.0 111.19 -174.272 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.1 t -93.0 140.47 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.331 1.452 . . . . 0.0 111.929 178.57 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -121.62 129.09 52.58 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.659 1.184 . . . . 0.0 109.628 168.655 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 -78.8 73.9 5.33 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.46 1.504 . . . . 0.0 109.841 172.143 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.7 pt -59.88 150.96 66.47 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 125.629 1.572 . . . . 0.0 114.468 -164.516 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.58 160.03 45.15 Favored 'Trans proline' 0 CA--C 1.545 1.025 0 C-N-CA 123.235 2.623 . . . . 0.0 112.168 171.636 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -63.68 142.94 85.53 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.078 2.519 . . . . 0.0 112.159 176.758 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.53 ' CG ' ' H ' ' A' ' 26' ' ' ALA . 1.6 ttp180 -134.39 -147.09 0.27 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.36 1.864 . . . . 0.0 110.232 -177.855 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.53 ' H ' ' CG ' ' A' ' 25' ' ' ARG . . . -125.82 -131.71 0.25 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.65 1.98 . . . . 0.0 110.57 -175.535 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 88.1 p -136.65 -31.4 0.86 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.841 1.657 . . . . 0.0 113.456 -175.319 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -133.35 -2.06 3.14 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.083 1.753 . . . . 0.0 113.702 -174.105 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.8 mmt-85 -87.68 -25.7 23.36 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.023 1.329 . . . . 0.0 113.173 -175.447 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.46 134.23 5.69 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 122.442 1.023 . . . . 0.0 114.003 170.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -74.73 156.34 36.72 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.18 0.992 . . . . 0.0 108.891 164.066 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.24 17.88 5.46 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -171.77 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.89 -45.84 0.06 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 127.75 2.42 . . . . 0.0 115.679 -175.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.2 m -69.41 -14.46 62.91 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.689 1.596 . . . . 0.0 113.908 -177.318 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.88 -13.31 60.54 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 169.786 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -95.88 171.65 8.51 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.462 1.505 . . . . 0.0 111.613 -174.59 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -79.57 53.81 1.65 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.383 1.473 . . . . 0.0 113.941 -178.463 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 69.3 mt -61.35 -14.85 30.57 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -172.842 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -107.02 -4.51 18.9 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.455 1.102 . . . . 0.0 112.782 177.03 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -150.26 77.18 8.31 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 125.083 1.353 . . . . 0.0 111.653 176.258 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -50.11 141.99 28.95 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.171 2.581 . . . . 0.0 112.462 175.245 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -72.09 -27.72 62.83 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.071 0.548 . . . . 0.0 111.577 175.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 33.4 t90 -154.26 156.54 37.21 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.937 1.695 . . . . 0.0 110.738 168.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.9 p -133.97 146.18 50.21 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.623 1.169 . . . . 0.0 111.978 170.327 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 176.77 -142.65 5.97 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 114.536 0.574 . . . . 0.0 114.536 177.213 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -106.22 143.83 33.79 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 126.603 1.961 . . . . 0.0 111.547 -169.822 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.0 tp -88.4 138.18 31.66 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.468 1.507 . . . . 0.0 110.154 170.21 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -143.93 96.77 2.95 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.396 1.078 . . . . 0.0 110.788 168.461 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.0 mt -82.06 129.03 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 172.364 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.46 160.57 38.05 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 127.38 2.272 . . . . 0.0 109.738 -177.703 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.618 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 8.7 t -161.37 160.8 29.99 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 120.811 -1.181 . . . . 0.0 111.079 177.517 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -129.22 -106.01 0.29 Allowed 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.142 -0.974 . . . . 0.0 111.499 -174.526 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.59 -116.68 0.21 Allowed Glycine 0 N--CA 1.472 1.072 0 C-N-CA 124.489 1.042 . . . . 0.0 111.134 169.42 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -86.12 25.16 1.2 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.693 1.197 . . . . 0.0 113.118 174.366 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.5 m -137.55 123.0 19.58 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.8 0.84 . . . . 0.0 110.589 -178.312 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.26 164.16 12.25 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.232 1.413 . . . . 0.0 111.706 172.5 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -145.89 103.59 3.77 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.744 1.618 . . . . 0.0 110.054 -172.574 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.7 mp -82.06 101.52 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 169.071 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -102.78 140.8 36.58 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.863 0.84 . . . . 0.0 111.519 176.413 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.3 mp -112.12 132.93 54.58 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.434 1.894 . . . . 0.0 110.045 179.508 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -133.79 151.2 51.5 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.897 0.879 . . . . 0.0 112.518 -168.31 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -69.82 144.0 52.74 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 120.812 -1.18 . . . . 0.0 113.175 -175.409 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.67 -3.79 36.6 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 116.666 2.099 . . . . 0.0 116.666 -179.365 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.1 t -118.8 -50.44 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.749 1.22 . . . . 0.0 110.892 172.622 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.0 m -96.9 -18.15 19.68 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -170.245 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.22 12.6 76.29 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.317 0.96 . . . . 0.0 113.759 -175.672 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -79.97 150.83 30.34 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.079 1.352 . . . . 0.0 112.005 -176.603 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 32.5 tp -71.34 122.16 19.81 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.85 0.86 . . . . 0.0 111.797 -171.663 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -84.64 -56.25 3.7 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.272 1.029 . . . . 0.0 110.877 169.547 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.81 163.24 40.08 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.973 1.309 . . . . 0.0 111.537 -179.042 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -143.85 132.82 22.78 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.603 1.161 . . . . 0.0 111.561 -179.351 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.56 97.78 49.41 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 124.721 1.208 . . . . 0.0 111.236 176.009 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -58.03 136.29 74.04 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 124.085 3.19 . . . . 0.0 112.288 163.065 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.7 t -132.24 123.54 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 126.528 1.931 . . . . 0.0 108.885 -178.42 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -91.56 -19.32 22.88 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 121.413 -0.804 . . . . 0.0 112.781 -177.405 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -163.64 143.21 8.3 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.831 2.452 . . . . 0.0 109.425 -178.584 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -135.92 121.93 13.9 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-O 118.375 -0.822 . . . . 0.0 111.301 175.291 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -61.92 149.45 57.75 Favored 'Cis proline' 0 CA--C 1.539 0.758 0 CA-C-N 119.956 1.02 . . . . 0.0 114.504 -1.648 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -170.96 -158.29 14.58 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 126.016 1.769 . . . . 0.0 112.442 -177.109 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.3 tt -79.17 -39.03 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -176.556 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.35 4.49 17.72 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -168.145 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.9 t -152.02 129.01 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 126.028 1.731 . . . . 0.0 109.744 179.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -141.05 160.26 40.47 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.05 1.74 . . . . 0.0 112.24 176.656 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.6 p -101.23 159.39 15.29 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.988 1.715 . . . . 0.0 111.589 175.324 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.4 m -81.28 169.34 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 O-C-N 121.587 -0.696 . . . . 0.0 110.523 162.418 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.5 p -98.31 -24.69 15.12 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.168 1.387 . . . . 0.0 113.587 -178.278 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -100.84 -40.41 7.32 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -167.136 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.5 t -134.41 116.15 14.84 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -175.038 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.6 m -73.59 24.93 0.07 Allowed 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 116.159 1.911 . . . . 0.0 116.159 -165.386 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.4 ' HA ' ' CB ' ' A' ' 116' ' ' ALA . 4.9 ptm180 -127.3 23.43 6.42 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 127.309 2.244 . . . . 0.0 113.875 -178.915 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -140.82 143.94 35.09 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.756 1.623 . . . . 0.0 111.955 -177.124 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -142.04 161.24 38.49 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.251 1.42 . . . . 0.0 111.496 -178.299 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 89.0 t -114.73 139.67 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.403 1.081 . . . . 0.0 109.112 166.455 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.64 147.83 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 118.667 0.667 . . . . 0.0 112.085 173.808 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -89.51 89.33 7.8 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.838 0.855 . . . . 0.0 110.745 178.322 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.1 pp -71.32 140.38 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 122.542 0.337 . . . . 0.0 111.172 175.616 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -137.42 145.38 43.12 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.999 1.72 . . . . 0.0 111.718 -172.769 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -89.76 1.15 56.46 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.895 0.878 . . . . 0.0 113.161 179.071 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.96 12.55 80.99 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 125.248 1.404 . . . . 0.0 114.758 178.617 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.2 t -138.33 16.72 2.77 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.47 1.508 . . . . 0.0 113.44 -172.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.82 -3.14 80.9 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.704 1.145 . . . . 0.0 114.975 -178.418 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -76.04 133.97 40.22 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.242 1.417 . . . . 0.0 108.509 164.38 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.9 p -151.67 161.18 43.1 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 171.62 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.91 149.1 34.7 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.661 1.584 . . . . 0.0 110.964 170.021 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -94.05 117.36 30.0 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.465 0.706 . . . . 0.0 109.308 169.122 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 17.8 pt -116.61 147.41 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.595 1.158 . . . . 0.0 111.046 177.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -87.73 146.15 19.8 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 172.394 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.2 pt -129.02 145.51 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 125.388 1.475 . . . . 0.0 111.488 167.167 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.61 146.53 16.96 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 125.097 1.332 . . . . 0.0 113.518 177.163 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -108.47 164.48 12.3 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.286 1.834 . . . . 0.0 111.77 178.605 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.6 t -73.88 -25.49 60.06 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.056 0.942 . . . . 0.0 112.906 177.049 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -156.41 154.68 30.86 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.759 1.224 . . . . 0.0 111.924 -176.229 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -57.45 -35.62 70.37 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.253 1.021 . . . . 0.0 112.82 175.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.25 -35.97 92.36 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 119.48 1.036 . . . . 0.0 113.406 -179.802 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -80.19 -35.48 36.28 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 117.988 0.894 . . . . 0.0 112.265 177.256 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.4 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -62.88 -39.45 94.51 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 169.237 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -68.67 -33.54 74.15 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.065 -1.022 . . . . 0.0 111.877 174.403 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -68.2 -36.87 80.24 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 119.365 0.984 . . . . 0.0 112.417 173.731 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -57.91 -45.59 86.26 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.134 1.374 . . . . 0.0 111.65 168.649 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -74.95 -38.16 61.79 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.713 1.205 . . . . 0.0 113.252 -176.399 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.9 t -77.73 -39.75 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 O-C-N 121.213 -0.93 . . . . 0.0 111.599 -179.088 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 78.7 p -64.79 -30.78 71.8 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.236 -0.915 . . . . 0.0 113.125 177.248 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 44.4 tp -73.12 -49.17 29.85 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.805 1.242 . . . . 0.0 111.689 175.331 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -70.52 -23.53 62.66 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.248 -0.907 . . . . 0.0 113.434 -178.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -79.42 -1.04 35.41 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.378 1.071 . . . . 0.0 112.418 175.572 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.618 ' CD2' ' HG ' ' A' ' 51' ' ' SER . 45.2 t60 -87.94 -35.3 17.74 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.325 -0.859 . . . . 0.0 112.708 157.504 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -89.29 -5.55 57.48 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 -172.819 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.87 -27.3 41.52 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 115.81 1.782 . . . . 0.0 115.81 -175.397 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 29.6 p-90 -84.99 -22.04 29.25 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.546 1.139 . . . . 0.0 113.822 174.794 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 19.1 t -86.66 -34.19 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.929 1.692 . . . . 0.0 111.295 177.354 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.8 mmtt -89.21 30.98 0.91 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.873 2.069 . . . . 0.0 112.893 -177.737 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -80.84 92.55 6.11 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.975 0.91 . . . . 0.0 109.728 173.215 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 . . . . . 0 C--O 1.252 1.198 0 C-N-CA 126.955 2.102 . . . . 0.0 112.558 -176.448 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.3 m . . . . . 0 CA--C 1.529 0.156 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.2 p -68.45 144.81 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 121.557 -0.714 . . . . 0.0 112.544 178.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.5 mt -129.5 -39.81 1.46 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.685 1.594 . . . . 0.0 112.508 -172.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 45.2 t -152.7 134.74 14.85 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.693 1.197 . . . . 0.0 110.384 173.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 94.6 t -130.28 127.24 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.363 1.065 . . . . 0.0 109.68 171.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -131.62 142.07 43.98 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 124.496 1.118 . . . . 0.0 112.206 173.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.6 -15.46 19.45 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.851 3.034 . . . . 0.0 114.972 -175.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -135.48 108.28 7.54 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.072 0.949 . . . . 0.0 111.653 -170.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 p -145.49 144.62 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 125.522 1.529 . . . . 0.0 110.213 171.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.1 m -126.04 129.15 48.58 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.12 0.968 . . . . 0.0 111.371 -171.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.5 t -96.05 136.82 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.738 1.615 . . . . 0.0 112.294 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -129.86 127.92 41.21 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.39 1.476 . . . . 0.0 109.407 170.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -70.1 123.76 22.4 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.359 0.664 . . . . 0.0 109.491 165.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.412 HD12 ' CZ ' ' A' ' 31' ' ' TYR . 30.6 pt . . . . . 0 N--CA 1.477 0.88 0 C-N-CA 124.785 1.234 . . . . 0.0 113.57 -168.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.412 ' CZ ' HD12 ' A' ' 22' ' ' ILE . 17.7 m-30 . . . . . 0 CA--C 1.534 0.34 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.86 19.84 10.92 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -174.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 56.81 -48.33 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.932 2.493 . . . . 0.0 115.455 -170.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.9 m -67.58 -15.07 63.46 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.294 1.838 . . . . 0.0 114.85 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.82 -15.99 56.35 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.701 0.8 . . . . 0.0 112.502 172.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 17.9 m0 -86.22 169.52 12.96 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.382 1.473 . . . . 0.0 111.178 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -78.88 57.25 2.09 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.189 1.796 . . . . 0.0 114.211 -177.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.7 mt -61.75 -20.35 63.44 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -95.49 -12.97 24.96 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.509 1.124 . . . . 0.0 112.592 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -152.09 69.72 7.62 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 125.61 1.564 . . . . 0.0 112.265 -165.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -54.37 147.22 47.59 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.471 2.781 . . . . 0.0 113.358 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -72.51 -29.3 63.49 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.195 0.598 . . . . 0.0 111.427 168.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.2 t90 -156.95 154.58 29.92 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.37 1.468 . . . . 0.0 111.058 173.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.2 p -133.93 148.82 51.25 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.239 1.015 . . . . 0.0 111.81 168.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.37 -142.88 5.69 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 123.067 0.365 . . . . 0.0 113.48 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.7 mtm105 -110.51 148.19 32.61 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.305 1.842 . . . . 0.0 112.103 -173.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.0 tp -92.91 137.85 32.0 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.22 1.808 . . . . 0.0 110.277 172.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.6 ttt85 -143.98 88.71 1.98 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.043 1.337 . . . . 0.0 110.869 169.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.503 HD11 ' CD1' ' A' ' 119' ' ' PHE . 25.2 mt -75.78 127.63 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 170.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.1 p -138.62 170.39 16.08 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.664 1.986 . . . . 0.0 110.071 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.9 t -157.85 159.46 36.68 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.804 -1.185 . . . . 0.0 112.198 175.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -146.86 120.76 9.32 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.775 0.798 . . . . 0.0 111.843 159.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.43 -119.65 11.79 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 125.753 1.644 . . . . 0.0 110.139 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -95.55 13.49 25.97 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.6 1.56 . . . . 0.0 113.708 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.0 m -127.58 110.78 13.05 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.934 0.894 . . . . 0.0 111.063 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.85 159.46 19.07 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.405 0.682 . . . . 0.0 111.364 171.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -139.76 105.98 5.25 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.302 1.841 . . . . 0.0 109.252 -174.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.7 mp -82.61 97.55 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 168.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.4 mttp -94.31 139.29 31.27 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.38 0.672 . . . . 0.0 111.448 174.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.5 mp -112.34 135.51 52.94 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.445 1.898 . . . . 0.0 109.775 172.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -136.15 153.67 51.2 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.941 0.896 . . . . 0.0 113.018 -172.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -74.12 143.94 45.12 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.931 0.872 . . . . 0.0 111.969 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 pttt -84.87 -6.46 59.35 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.371 1.868 . . . . 0.0 115.124 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 92.0 t -122.4 -44.58 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 125.234 1.414 . . . . 0.0 111.396 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.7 m -91.72 -23.5 19.76 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -175.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.33 7.04 86.91 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 123.776 0.703 . . . . 0.0 113.586 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -82.81 155.55 24.13 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.327 1.451 . . . . 0.0 112.326 -175.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.7 tp -72.31 125.98 28.69 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.372 0.669 . . . . 0.0 110.684 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -84.51 -53.9 5.11 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.944 0.898 . . . . 0.0 110.915 169.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.34 161.3 37.6 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.067 1.347 . . . . 0.0 111.357 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -142.67 139.89 31.37 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.391 0.676 . . . . 0.0 112.382 171.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.98 110.54 41.57 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 124.854 1.261 . . . . 0.0 111.135 176.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -80.52 140.45 13.39 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.894 3.063 . . . . 0.0 111.565 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.1 t -134.83 131.26 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.805 1.642 . . . . 0.0 109.817 -172.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -97.47 -19.8 18.18 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -163.53 150.46 12.31 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.97 2.108 . . . . 0.0 110.085 175.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -125.57 130.67 24.01 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.558 1.143 . . . . 0.0 112.452 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -60.46 151.29 50.81 Favored 'Cis proline' 0 CA--C 1.54 0.781 0 CA-C-N 119.919 1.007 . . . . 0.0 113.313 -12.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.35 -171.35 29.49 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.909 1.242 . . . . 0.0 113.485 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.6 tp -59.29 -31.51 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.54 4.27 53.9 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -172.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.7 t -148.98 130.35 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.162 0.985 . . . . 0.0 111.233 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -140.39 162.4 35.41 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.325 1.85 . . . . 0.0 112.545 -176.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 38.8 p -117.33 158.03 25.09 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 127.1 2.16 . . . . 0.0 111.587 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.0 m -85.21 173.46 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.556 1.142 . . . . 0.0 111.385 168.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 72.5 p -94.49 -32.5 13.47 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.238 1.415 . . . . 0.0 113.17 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -94.59 -40.91 9.59 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -163.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.5 t -141.02 130.35 23.68 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -175.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.1 m -73.01 16.38 0.16 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -171.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.47 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.28 33.5 ptt180 -111.44 18.5 19.1 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 178.631 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -139.32 135.55 33.9 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.078 0.951 . . . . 0.0 110.842 -172.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -133.77 163.81 28.63 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.907 1.283 . . . . 0.0 111.016 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.7 t -120.6 142.59 35.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 124.583 1.153 . . . . 0.0 108.744 167.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.89 148.0 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 118.721 0.692 . . . . 0.0 112.425 173.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -89.88 81.77 6.28 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.675 0.79 . . . . 0.0 111.369 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -67.09 142.52 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 122.577 0.351 . . . . 0.0 111.372 177.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 . . . . . 0 N--CA 1.469 0.487 0 C-N-CA 125.733 1.613 . . . . 0.0 111.68 -171.382 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.2 p . . . . . 0 C--O 1.234 0.288 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.76 145.76 31.83 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.282 1.433 . . . . 0.0 110.869 169.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -90.66 118.36 30.04 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.131 0.573 . . . . 0.0 109.485 168.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.4 pt -117.27 141.54 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.306 1.042 . . . . 0.0 110.753 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.9 143.41 17.07 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 174.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.0 pt -128.87 140.86 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 125.341 1.456 . . . . 0.0 111.679 173.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -119.66 143.91 17.24 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.042 1.306 . . . . 0.0 113.338 175.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -106.88 167.86 9.59 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.352 1.861 . . . . 0.0 111.032 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.8 t -71.78 -36.09 70.23 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.738 -0.601 . . . . 0.0 112.304 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -153.07 153.32 32.61 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.204 -0.935 . . . . 0.0 112.299 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -58.07 -36.69 73.16 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.652 1.181 . . . . 0.0 112.096 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.95 -13.42 64.11 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 123.916 0.77 . . . . 0.0 114.408 177.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -102.44 -34.07 9.29 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 118.431 1.115 . . . . 0.0 112.376 170.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.47 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -64.07 -29.97 71.07 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.088 -1.008 . . . . 0.0 113.253 170.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -54.95 -33.35 62.21 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.603 -0.686 . . . . 0.0 112.289 168.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -69.25 -33.75 73.74 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.087 -1.008 . . . . 0.0 112.028 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.503 ' CD1' HD11 ' A' ' 49' ' ' ILE . 18.6 t80 -60.56 -50.32 74.03 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.143 0.977 . . . . 0.0 111.475 171.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.49 -26.27 45.91 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -177.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.5 t -77.39 -43.25 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 119.301 0.955 . . . . 0.0 111.246 175.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 96.7 p -64.85 -31.03 72.07 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.36 0.982 . . . . 0.0 113.103 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.7 mt -69.03 -54.89 12.75 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.063 0.945 . . . . 0.0 112.061 170.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -67.22 -29.71 69.44 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.055 -1.028 . . . . 0.0 112.978 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -82.84 -2.7 55.39 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.566 1.147 . . . . 0.0 112.672 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 63.9 t60 -88.39 -42.6 12.07 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.391 -0.818 . . . . 0.0 111.812 157.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -84.44 -7.24 59.35 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -172.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.481 1.092 0 CA-C-N 120.971 1.714 . . . . 0.0 115.366 -173.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.8 m . . . . . 0 N--CA 1.467 0.387 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.402 ' HA ' HG22 ' A' ' 50' ' ' THR . 45.0 t -63.75 142.49 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 124.005 0.922 . . . . 0.0 111.761 177.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.7 mt -128.31 -43.56 1.45 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.309 1.443 . . . . 0.0 112.592 -176.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 34.2 t -148.39 135.16 19.91 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.379 1.072 . . . . 0.0 111.037 175.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.1 t -128.55 128.03 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.734 1.214 . . . . 0.0 109.539 172.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -124.9 135.28 26.53 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 125.577 1.551 . . . . 0.0 109.774 172.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -73.54 -29.57 10.8 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.918 2.412 . . . . 0.0 115.179 -168.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -138.16 114.92 10.64 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.263 1.03 . . . . 0.0 111.86 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.2 p -143.43 149.01 18.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 127.788 2.435 . . . . 0.0 109.004 176.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.2 m -123.3 132.02 53.86 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.257 0.623 . . . . 0.0 112.17 -167.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.7 t -96.24 138.21 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.837 1.655 . . . . 0.0 111.904 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -130.19 136.77 49.61 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.139 -1.392 . . . . 0.0 110.31 171.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -56.6 137.43 53.78 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.296 151.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.3 pt . . . . . 0 N--CA 1.473 0.71 0 C-N-CA 125.182 1.393 . . . . 0.0 111.258 178.099 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 18.8 m-30 . . . . . 0 C--O 1.22 -0.463 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.66 16.35 9.53 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -172.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.65 -46.5 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 128.152 2.581 . . . . 0.0 115.547 -171.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 94.5 p -68.41 -18.59 64.48 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.536 1.935 . . . . 0.0 115.082 -176.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -85.94 -1.95 57.81 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.22 1.008 . . . . 0.0 113.402 171.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.9 m0 -90.72 174.12 7.66 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.925 1.29 . . . . 0.0 110.952 174.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -76.67 47.98 0.53 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.855 1.662 . . . . 0.0 114.646 -176.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.2 mt -56.4 -33.55 65.87 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 -169.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -91.5 -2.51 57.18 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -145.74 71.99 13.86 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 125.868 1.667 . . . . 0.0 111.994 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -52.5 138.11 57.38 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.513 2.142 . . . . 0.0 112.088 174.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -73.09 -25.24 60.81 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.11 0.564 . . . . 0.0 111.194 172.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 50.4 t90 -155.84 154.08 30.74 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.69 1.596 . . . . 0.0 110.801 170.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.8 p -134.28 151.29 51.19 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.663 0.785 . . . . 0.0 112.001 165.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 173.04 -149.66 11.52 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 123.155 0.407 . . . . 0.0 113.484 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.0 mtt180 -94.35 141.15 28.91 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.227 1.811 . . . . 0.0 111.609 -174.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 24.9 tp -79.22 138.04 37.65 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 157.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.7 ttt-85 -144.82 87.47 1.85 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.234 1.016 . . . . 0.0 110.905 167.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.5 mt -72.44 127.07 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 172.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.402 HG22 ' HA ' ' A' ' 10' ' ' VAL . 7.5 p -134.19 165.02 26.07 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.697 1.999 . . . . 0.0 109.933 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.4 m -147.57 161.56 40.87 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.807 1.243 . . . . 0.0 112.212 175.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -150.6 118.09 6.09 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.307 0.643 . . . . 0.0 111.482 157.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 65.14 -132.23 36.22 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.034 1.302 . . . . 0.0 110.635 -175.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -85.92 22.65 1.64 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.902 1.681 . . . . 0.0 113.922 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.1 m -131.71 126.66 35.08 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.768 1.227 . . . . 0.0 110.282 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.63 160.04 14.59 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.659 1.184 . . . . 0.0 110.94 168.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -142.07 105.43 4.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.372 1.869 . . . . 0.0 108.986 -173.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.3 mp -81.03 95.99 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 169.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -92.04 137.95 31.94 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.274 0.63 . . . . 0.0 110.813 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.8 mp -112.43 128.88 56.44 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.814 1.646 . . . . 0.0 109.723 174.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -135.66 148.83 49.1 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.157 0.983 . . . . 0.0 111.639 -169.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -69.31 139.86 54.32 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 120.432 -1.417 . . . . 0.0 111.72 -176.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.5 pttt -79.74 -4.56 52.47 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -177.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.8 t -123.06 -43.59 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 125.297 1.439 . . . . 0.0 111.363 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.4 m -94.42 -21.97 18.59 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.41 15.37 77.2 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.143 0.878 . . . . 0.0 113.788 -176.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -88.5 148.44 24.15 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.212 1.405 . . . . 0.0 112.056 -176.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.6 tp -71.59 126.78 30.57 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.445 -0.784 . . . . 0.0 111.272 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -84.83 -58.9 2.52 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.055 0.942 . . . . 0.0 110.552 168.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.84 165.8 35.41 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.109 1.363 . . . . 0.0 111.369 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -142.46 143.0 32.41 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.333 0.653 . . . . 0.0 112.47 171.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.37 105.85 41.19 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 124.871 1.268 . . . . 0.0 110.99 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -77.22 145.06 23.92 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.792 2.995 . . . . 0.0 111.948 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.2 t -138.03 127.36 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 126.245 1.818 . . . . 0.0 109.58 -172.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -91.32 -22.77 20.37 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.66 147.83 13.93 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.412 1.885 . . . . 0.0 110.437 170.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -116.33 129.97 24.83 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.589 1.156 . . . . 0.0 110.956 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.83 149.09 79.9 Favored 'Cis proline' 0 CA--C 1.543 0.946 0 CA-C-N 119.824 0.973 . . . . 0.0 112.733 -6.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.68 -164.38 13.14 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.6 1.571 . . . . 0.0 112.548 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 19.3 tt -72.42 -35.58 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 121.654 -0.909 . . . . 0.0 112.979 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.67 6.26 21.55 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -167.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.0 t -151.37 129.18 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.508 1.523 . . . . 0.0 109.984 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -141.77 162.22 36.01 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.217 1.807 . . . . 0.0 112.86 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.5 p -109.75 160.35 16.4 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.792 2.037 . . . . 0.0 111.431 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.4 m -85.95 175.45 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 124.477 1.111 . . . . 0.0 111.398 168.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 71.8 p -91.18 -36.84 13.72 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.954 1.702 . . . . 0.0 112.098 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -89.33 -43.59 10.82 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -166.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.6 t -142.45 122.45 13.65 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -171.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.58 -9.06 23.38 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -169.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.451 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.305 49.0 ptt85 -84.73 19.33 2.07 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 178.787 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -139.13 139.94 37.78 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.479 1.512 . . . . 0.0 111.977 -176.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -140.66 162.21 35.94 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.437 1.495 . . . . 0.0 111.683 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 78.6 t -116.14 142.27 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.372 1.069 . . . . 0.0 109.294 166.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.67 147.3 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 118.98 0.809 . . . . 0.0 112.399 173.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -88.91 82.5 6.71 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.833 0.853 . . . . 0.0 111.187 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.5 pt -63.36 144.71 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 120.819 0.342 . . . . 0.0 111.696 174.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 . . . . . 0 N--CA 1.466 0.338 0 C-N-CA 125.661 1.584 . . . . 0.0 110.868 -178.606 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.1 p . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.15 145.16 29.45 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.941 1.296 . . . . 0.0 111.389 171.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -90.66 114.53 26.85 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.794 0.837 . . . . 0.0 109.322 170.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.4 pt -115.01 148.73 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.875 1.27 . . . . 0.0 111.228 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.04 143.91 16.91 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 174.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.7 pt -128.24 144.01 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 125.386 1.474 . . . . 0.0 111.34 169.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.16 139.6 11.08 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.888 1.233 . . . . 0.0 112.967 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -101.17 157.18 16.96 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.814 1.646 . . . . 0.0 111.466 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.1 t -73.52 -20.27 60.7 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.911 0.884 . . . . 0.0 112.822 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -152.24 148.79 27.98 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.526 1.13 . . . . 0.0 111.935 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 47.4 ttt-85 -63.04 -31.53 72.68 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.642 1.177 . . . . 0.0 113.503 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.52 -31.76 79.67 Favored Glycine 0 CA--C 1.536 1.365 0 CA-C-N 119.039 0.836 . . . . 0.0 113.572 176.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -78.39 -35.44 47.19 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.771 -0.841 . . . . 0.0 111.407 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.451 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -65.97 -37.13 85.17 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.926 0.891 . . . . 0.0 113.209 168.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.21 -40.44 97.48 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.508 -0.745 . . . . 0.0 111.25 171.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -62.33 -36.76 83.2 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.592 1.087 . . . . 0.0 112.55 172.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -57.42 -56.33 23.3 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.392 0.996 . . . . 0.0 112.017 171.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -75.7 -24.68 56.26 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -176.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.5 -38.68 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 121.058 -1.027 . . . . 0.0 110.773 173.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 41.2 t -57.67 -38.55 75.3 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.406 0.683 . . . . 0.0 112.529 176.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.9 -52.32 20.81 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.456 0.702 . . . . 0.0 112.36 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -67.57 -28.48 67.81 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.045 -1.034 . . . . 0.0 113.064 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -83.91 0.1 49.15 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.581 1.152 . . . . 0.0 112.724 175.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -89.51 -39.97 12.97 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.253 -0.904 . . . . 0.0 112.284 161.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -91.99 -1.92 57.0 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -172.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.481 1.125 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.7 m . . . . . 0 N--CA 1.468 0.454 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.0 t -65.43 145.83 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.473 1.109 . . . . 0.0 111.409 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.6 mt -129.86 -39.73 1.4 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.124 1.769 . . . . 0.0 112.309 -172.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 37.6 t -152.15 137.38 17.47 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.687 1.195 . . . . 0.0 110.646 174.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 88.5 t -129.77 126.87 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.764 1.226 . . . . 0.0 109.275 171.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -126.78 136.08 28.24 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 125.677 1.591 . . . . 0.0 110.233 174.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -78.9 -15.8 13.05 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.158 2.572 . . . . 0.0 115.037 -173.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -130.89 107.32 9.03 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.379 1.072 . . . . 0.0 110.904 -176.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -140.16 141.5 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 125.475 1.51 . . . . 0.0 109.988 170.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.5 m -124.35 125.84 44.99 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.301 1.04 . . . . 0.0 111.12 -171.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.7 t -92.4 136.72 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.064 1.346 . . . . 0.0 111.79 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -126.46 128.6 47.21 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.942 1.297 . . . . 0.0 109.284 169.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -65.33 133.68 51.93 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 160.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.6 pt . . . . . 0 N--CA 1.474 0.752 0 C-N-CA 124.445 1.098 . . . . 0.0 112.483 -172.501 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 . . . . . 0 CA--C 1.54 0.588 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.14 20.83 13.56 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.27 -48.94 0.05 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 127.175 2.19 . . . . 0.0 114.672 -163.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.2 m -64.46 -9.17 16.76 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.362 1.865 . . . . 0.0 114.739 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.5 -11.41 59.9 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.645 1.178 . . . . 0.0 112.876 172.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -104.18 175.92 5.33 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.248 1.819 . . . . 0.0 112.499 -171.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -76.92 47.33 0.51 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.715 2.006 . . . . 0.0 114.455 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.6 mt -55.0 -34.3 63.32 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -169.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -95.45 -0.36 52.45 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.134 0.973 . . . . 0.0 113.29 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.37 61.61 10.26 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 126.23 1.812 . . . . 0.0 111.719 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -55.44 136.67 74.84 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.593 2.195 . . . . 0.0 112.034 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -69.64 -26.04 64.22 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.561 1.144 . . . . 0.0 111.666 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.4 t90 -154.86 152.8 30.22 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.683 1.593 . . . . 0.0 110.747 170.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.7 p -134.42 148.79 50.7 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.874 0.87 . . . . 0.0 111.927 169.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.59 -145.34 6.5 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 113.931 0.333 . . . . 0.0 113.931 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -108.82 148.82 29.99 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.29 1.836 . . . . 0.0 111.721 -176.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 61.0 tp -92.92 142.22 27.55 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.099 1.76 . . . . 0.0 110.832 173.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -144.03 94.29 2.56 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.269 1.827 . . . . 0.0 109.494 173.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.482 HD11 ' CD2' ' A' ' 119' ' ' PHE . 27.9 mt -84.23 134.43 26.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 170.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.24 166.69 26.27 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.037 1.735 . . . . 0.0 110.338 -166.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 99.0 p -156.52 160.5 39.56 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 120.845 -1.159 . . . . 0.0 112.3 175.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -151.04 120.46 6.88 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.472 0.709 . . . . 0.0 112.23 156.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 65.22 -132.12 35.98 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 125.088 1.327 . . . . 0.0 110.502 -176.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -87.19 26.6 1.17 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.637 1.575 . . . . 0.0 113.328 178.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.0 m -132.97 129.65 38.51 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.85 1.26 . . . . 0.0 110.172 173.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.76 160.8 14.15 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.648 1.179 . . . . 0.0 110.577 167.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -140.64 109.61 6.08 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.811 1.644 . . . . 0.0 108.952 -173.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.0 mp -88.08 105.58 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 168.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -107.66 142.38 37.71 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.592 1.157 . . . . 0.0 111.179 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.4 mp -115.23 131.58 56.88 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.429 1.891 . . . . 0.0 109.656 177.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -133.58 148.35 51.59 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.828 0.851 . . . . 0.0 112.614 -174.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -67.47 135.64 53.38 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.065 0.946 . . . . 0.0 111.573 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -75.15 -6.96 52.38 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 -175.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 86.3 t -119.22 -43.72 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.158 1.383 . . . . 0.0 111.389 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.5 m -93.44 -20.15 20.58 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -175.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.8 15.7 76.0 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.279 0.942 . . . . 0.0 113.588 -177.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -90.53 149.92 21.98 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.144 1.378 . . . . 0.0 112.355 -174.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 31.3 tp -70.91 123.89 23.07 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.727 0.811 . . . . 0.0 111.566 -176.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -86.46 -55.24 3.98 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.47 1.108 . . . . 0.0 111.123 170.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.79 162.57 39.73 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.507 1.123 . . . . 0.0 112.146 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -142.71 135.21 27.75 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.052 1.341 . . . . 0.0 111.891 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.0 100.59 42.82 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.534 1.534 . . . . 0.0 111.136 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -68.45 142.07 53.01 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.995 3.13 . . . . 0.0 112.529 170.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.1 t -134.52 130.58 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.868 1.667 . . . . 0.0 109.894 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -86.1 -26.37 25.29 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -164.63 153.89 13.26 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.551 1.54 . . . . 0.0 111.239 169.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -118.02 133.0 23.44 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.883 1.273 . . . . 0.0 111.461 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.37 147.83 75.91 Favored 'Cis proline' 0 CA--C 1.541 0.875 0 CA-C-N 119.899 0.999 . . . . 0.0 112.22 -8.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.9 -175.82 36.69 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.491 1.043 . . . . 0.0 114.058 -177.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.2 tp -53.71 -34.65 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -169.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.04 4.92 52.03 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -172.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.6 t -148.6 127.31 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 CA-C-N 119.409 1.004 . . . . 0.0 111.739 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -140.61 168.93 18.64 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.648 1.979 . . . . 0.0 113.116 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 34.0 p -123.09 158.89 29.66 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.586 1.954 . . . . 0.0 111.59 -171.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.8 m -85.81 173.22 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 O-C-N 121.573 -0.704 . . . . 0.0 112.121 169.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 70.8 p -87.34 -35.93 18.12 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.851 1.26 . . . . 0.0 112.586 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -94.11 -42.4 9.01 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -162.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.4 t -143.33 130.24 20.52 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.3 m -69.3 4.53 1.66 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -172.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.446 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.281 30.2 ptt180 -96.59 17.05 17.15 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 176.1 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -140.15 132.12 27.76 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.181 0.992 . . . . 0.0 110.784 -174.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -137.05 162.53 33.08 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.325 1.45 . . . . 0.0 110.495 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.6 t -121.59 139.3 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.425 1.09 . . . . 0.0 108.717 171.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.29 147.44 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 118.81 0.732 . . . . 0.0 112.536 176.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -90.15 85.92 6.4 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.461 0.705 . . . . 0.0 111.099 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -69.38 139.95 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 122.635 0.374 . . . . 0.0 111.161 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 . . . . . 0 N--CA 1.469 0.521 0 C-N-CA 126.172 1.789 . . . . 0.0 111.429 -170.403 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 80.7 p . . . . . 0 C--O 1.235 0.303 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.73 147.58 32.08 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.604 1.561 . . . . 0.0 110.992 169.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -90.71 120.62 31.92 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.098 0.559 . . . . 0.0 109.584 167.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.9 pt -117.79 143.03 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.553 1.141 . . . . 0.0 110.871 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.38 143.15 17.14 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 174.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.9 pt -127.35 139.0 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 124.987 1.315 . . . . 0.0 111.644 171.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.37 143.7 16.72 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.83 1.681 . . . . 0.0 112.251 174.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -106.37 167.67 9.67 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.64 1.576 . . . . 0.0 111.534 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.3 t -68.91 -36.21 77.74 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.143 0.577 . . . . 0.0 112.172 175.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -156.66 154.3 29.89 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.086 -1.009 . . . . 0.0 112.048 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 72.2 mtm-85 -55.74 -39.34 71.0 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.554 1.142 . . . . 0.0 112.382 173.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.78 -6.53 30.68 Favored Glycine 0 CA--C 1.542 1.731 0 C-N-CA 124.407 1.004 . . . . 0.0 115.133 178.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -111.22 -33.86 6.33 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.243 1.417 . . . . 0.0 111.728 168.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.446 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -69.72 -24.96 63.63 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 175.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -61.21 -30.4 70.4 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.729 -1.232 . . . . 0.0 112.297 169.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -69.92 -27.93 65.18 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.495 1.043 . . . . 0.0 112.635 176.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.482 ' CD2' HD11 ' A' ' 49' ' ' ILE . 10.6 t80 -61.81 -44.87 95.99 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.408 -0.807 . . . . 0.0 111.26 169.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -76.95 -35.26 57.4 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.376 1.07 . . . . 0.0 113.147 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 66.6 t -78.73 -38.86 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.366 -0.834 . . . . 0.0 111.87 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 88.5 p -66.86 -31.65 72.4 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.984 -1.073 . . . . 0.0 113.312 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 73.2 mt -68.85 -51.6 38.73 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.943 0.897 . . . . 0.0 111.859 172.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -68.09 -27.8 66.8 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.111 -0.993 . . . . 0.0 112.756 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -82.44 -3.02 54.97 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.399 1.08 . . . . 0.0 112.795 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -89.63 -40.7 12.41 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 121.315 -0.866 . . . . 0.0 111.963 160.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -90.55 -0.29 57.62 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 -173.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.483 1.213 0 CA-C-N 120.909 1.686 . . . . 0.0 115.288 -177.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.9 m . . . . . 0 N--CA 1.469 0.495 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.0 t -59.08 143.45 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 125.307 1.443 . . . . 0.0 112.877 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.1 mt -129.26 -39.37 1.53 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.544 1.938 . . . . 0.0 111.99 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 47.5 t -149.7 142.69 24.87 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.627 1.571 . . . . 0.0 109.611 174.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.6 t -137.97 126.9 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.702 1.201 . . . . 0.0 108.149 170.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -138.11 130.4 16.21 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 123.751 0.82 . . . . 0.0 111.912 -176.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -75.14 -17.08 19.53 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.188 2.592 . . . . 0.0 115.413 -167.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -130.61 109.72 10.87 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.249 1.019 . . . . 0.0 110.958 -176.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -142.26 145.95 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.589 1.556 . . . . 0.0 109.876 168.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.9 m -126.83 132.66 50.93 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.278 1.031 . . . . 0.0 110.85 -174.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.3 t -100.52 135.09 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.078 1.351 . . . . 0.0 111.527 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.4 119.71 22.03 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.884 1.274 . . . . 0.0 108.837 168.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -64.11 131.52 47.76 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.57 -0.706 . . . . 0.0 109.491 166.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.4 pt . . . . . 0 CA--C 1.545 0.776 0 C-N-CA 124.696 1.199 . . . . 0.0 112.806 -167.509 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 . . . . . 0 CA--C 1.536 0.43 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.8 19.36 19.21 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.74 -50.08 0.05 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 127.169 2.188 . . . . 0.0 114.206 -165.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.5 m -65.39 -11.31 41.13 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.174 1.79 . . . . 0.0 114.788 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.71 -14.86 59.49 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.339 1.056 . . . . 0.0 112.494 171.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 16.0 m0 -96.73 171.06 8.76 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.866 1.666 . . . . 0.0 111.693 -174.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -80.56 56.35 2.58 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.2 1.4 . . . . 0.0 113.081 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.0 mt -57.69 -24.88 59.05 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -169.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -106.96 0.58 23.85 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.347 1.059 . . . . 0.0 112.593 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -132.27 77.56 70.39 Favored Pre-proline 0 C--O 1.239 0.521 0 C-N-CA 125.809 1.644 . . . . 0.0 111.378 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -69.18 144.95 58.92 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 CA-C-N 118.94 0.657 . . . . 0.0 112.784 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -70.63 -28.92 65.19 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.705 0.802 . . . . 0.0 111.172 168.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 52.6 t90 -160.42 154.21 22.66 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.606 1.962 . . . . 0.0 110.579 175.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.4 p -133.13 149.16 52.12 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.286 1.035 . . . . 0.0 111.534 167.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.26 -143.43 5.97 Favored Glycine 0 CA--C 1.524 0.635 0 O-C-N 122.15 -0.343 . . . . 0.0 113.407 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -107.28 142.41 37.08 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.679 1.592 . . . . 0.0 111.657 -176.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.3 tp -81.79 137.92 35.23 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.131 1.372 . . . . 0.0 109.426 165.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.6 ttt-85 -145.74 89.28 1.89 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 122.217 1.008 . . . . 0.0 110.938 168.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.515 HD11 ' CD1' ' A' ' 119' ' ' PHE . 17.5 mt -74.91 127.03 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 172.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.0 p -131.73 173.92 10.66 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 127.083 2.153 . . . . 0.0 109.62 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -160.19 160.72 33.14 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.479 -1.388 . . . . 0.0 110.16 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -148.9 127.2 12.17 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 122.044 0.926 . . . . 0.0 111.769 153.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.02 -114.76 5.73 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 126.078 1.799 . . . . 0.0 110.061 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -104.24 15.38 28.46 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.615 1.566 . . . . 0.0 113.277 176.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.3 m -124.4 109.19 13.0 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.892 0.877 . . . . 0.0 110.649 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.26 159.52 20.06 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.371 0.668 . . . . 0.0 110.99 171.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -141.39 100.79 3.86 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.926 1.69 . . . . 0.0 109.533 -171.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mp -79.92 94.47 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 170.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -91.15 137.82 32.07 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.21 0.604 . . . . 0.0 111.088 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.2 mp -110.62 129.64 55.76 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 126.011 1.724 . . . . 0.0 109.329 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -133.04 145.82 51.15 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.958 0.903 . . . . 0.0 112.241 -169.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -68.43 135.7 52.13 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.12 -0.987 . . . . 0.0 111.655 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.9 pttt -75.11 -7.46 53.82 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -175.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.3 t -119.47 -43.17 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.188 1.395 . . . . 0.0 111.48 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.0 m -95.42 -19.84 19.57 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -174.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.86 14.42 75.74 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.461 1.029 . . . . 0.0 113.713 -176.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -88.07 151.53 22.68 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.224 1.41 . . . . 0.0 112.097 -175.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.3 tp -72.41 126.6 30.24 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.568 -0.707 . . . . 0.0 111.468 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -85.66 -56.69 3.38 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.377 1.071 . . . . 0.0 110.929 169.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.4 162.46 40.03 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.326 1.45 . . . . 0.0 110.918 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -143.36 139.06 29.87 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 172.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.53 106.77 53.89 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.845 1.258 . . . . 0.0 111.037 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.64 139.79 14.43 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.941 3.094 . . . . 0.0 111.325 175.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 t -134.45 121.95 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.611 1.565 . . . . 0.0 109.88 -171.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -89.04 -17.34 29.55 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.86 141.87 8.74 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.834 2.053 . . . . 0.0 110.167 174.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -126.51 127.48 24.54 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 124.352 1.061 . . . . 0.0 111.095 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -61.29 147.07 48.47 Favored 'Cis proline' 0 CA--C 1.539 0.767 0 CA-C-N 120.162 1.094 . . . . 0.0 114.104 -4.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.81 -163.76 29.59 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.99 1.281 . . . . 0.0 113.873 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.8 tp -64.67 -38.58 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 -167.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.77 6.21 48.38 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -168.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.8 t -151.09 124.52 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.75 1.22 . . . . 0.0 110.474 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -140.13 162.79 34.4 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.792 1.637 . . . . 0.0 113.459 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.2 p -109.18 162.46 14.26 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.87 1.668 . . . . 0.0 111.462 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.9 m -84.18 176.87 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.032 0.933 . . . . 0.0 111.299 169.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 57.8 p -90.82 -37.92 13.3 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.512 1.525 . . . . 0.0 111.798 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -96.0 -41.12 8.92 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 -165.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.5 t -139.74 116.54 10.89 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -171.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.69 -3.54 6.83 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -168.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.455 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.306 49.2 ptt85 -86.93 20.74 2.51 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 176.814 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -140.67 139.57 34.81 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.448 1.499 . . . . 0.0 111.36 -176.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -138.68 161.86 36.09 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.216 1.406 . . . . 0.0 111.615 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.6 t -117.93 137.46 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.04 0.936 . . . . 0.0 108.924 165.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.17 147.96 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 118.737 0.699 . . . . 0.0 112.157 174.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -91.33 84.39 5.6 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.623 0.769 . . . . 0.0 110.936 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -68.93 138.86 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.849 0.357 . . . . 0.0 110.965 176.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 . . . . . 0 N--CA 1.469 0.503 0 C-N-CA 125.445 1.498 . . . . 0.0 111.42 -169.896 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 95.6 p . . . . . 0 C--O 1.236 0.383 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.31 142.43 29.43 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.284 1.434 . . . . 0.0 110.963 168.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -91.74 118.85 31.05 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.44 0.696 . . . . 0.0 109.861 170.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.7 pt -118.0 141.77 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.732 1.213 . . . . 0.0 110.889 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -90.11 142.37 16.43 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 175.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.7 pt -129.42 145.98 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.907 1.283 . . . . 0.0 112.167 170.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.75 148.45 16.77 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.025 1.298 . . . . 0.0 113.698 176.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -114.57 156.65 24.27 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.15 1.78 . . . . 0.0 111.531 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.6 t -74.27 -23.77 59.17 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.054 0.941 . . . . 0.0 112.936 -178.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -151.91 147.66 26.85 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.414 1.086 . . . . 0.0 111.981 -176.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 -62.97 -33.59 75.71 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.241 1.016 . . . . 0.0 113.21 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.45 -28.46 73.63 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 119.086 0.857 . . . . 0.0 113.525 175.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -85.51 -30.11 23.71 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.116 0.966 . . . . 0.0 112.581 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.455 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -66.9 -35.96 81.19 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.588 -0.695 . . . . 0.0 112.625 163.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -62.29 -35.89 80.42 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.402 -0.811 . . . . 0.0 111.661 169.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -62.92 -36.65 84.1 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 119.846 1.203 . . . . 0.0 112.5 173.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.515 ' CD1' HD11 ' A' ' 49' ' ' ILE . 18.0 t80 -60.48 -51.51 69.15 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.035 0.934 . . . . 0.0 112.386 169.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.84 -26.18 40.51 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -175.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.3 t -77.27 -42.38 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 O-C-N 121.127 -0.983 . . . . 0.0 110.938 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 91.6 p -63.66 -31.36 72.51 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.895 0.77 . . . . 0.0 112.882 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.1 mt -68.51 -56.86 6.92 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.105 0.962 . . . . 0.0 111.993 169.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -68.16 -25.45 65.27 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.918 -1.113 . . . . 0.0 113.5 -173.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -79.46 -4.31 50.62 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.255 1.022 . . . . 0.0 112.518 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -90.17 -28.32 18.99 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.29 -0.881 . . . . 0.0 112.587 161.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -101.07 -1.16 34.86 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.875 1.805 . . . . 0.0 115.875 -175.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.482 1.163 0 CA-C-N 120.959 1.709 . . . . 0.0 115.164 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.7 m . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.2 t -70.13 147.36 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.898 1.279 . . . . 0.0 112.062 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.0 mt -132.33 -39.54 1.03 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.963 1.705 . . . . 0.0 110.995 -173.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.7 t -151.1 146.91 26.48 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.987 1.315 . . . . 0.0 110.86 175.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 72.4 t -139.99 123.34 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.239 1.416 . . . . 0.0 109.31 171.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -118.42 141.05 29.03 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 125.017 1.327 . . . . 0.0 111.141 175.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.72 -19.32 21.35 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 123.661 2.907 . . . . 0.0 114.515 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -133.29 110.83 10.35 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.191 0.905 . . . . 0.0 111.388 -172.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.2 p -142.55 143.03 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.917 1.287 . . . . 0.0 110.755 169.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.2 m -127.86 130.32 48.39 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.69 1.196 . . . . 0.0 110.993 -174.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.2 t -97.34 136.98 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.929 1.291 . . . . 0.0 111.948 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.17 126.75 36.44 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.823 1.249 . . . . 0.0 109.381 168.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -63.12 131.62 49.12 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 161.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.6 pt . . . . . 0 N--CA 1.475 0.807 0 C-N-CA 123.904 0.882 . . . . 0.0 112.676 -168.352 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 . . . . . 0 CA--C 1.533 0.322 0 CA-C-O 119.991 -0.052 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.83 18.48 6.71 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -171.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.56 -51.11 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 128.149 2.58 . . . . 0.0 115.697 -174.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.5 m -65.07 -13.0 56.88 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.337 1.855 . . . . 0.0 114.367 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -89.41 -4.9 57.83 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.704 1.202 . . . . 0.0 112.552 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 22.4 m0 -92.75 172.11 8.56 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.867 1.667 . . . . 0.0 110.74 174.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -80.57 55.06 2.22 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.163 1.385 . . . . 0.0 114.074 -177.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.2 mt -60.34 -17.81 45.63 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -174.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -102.14 -8.13 21.64 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.82 1.248 . . . . 0.0 113.126 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -148.74 80.05 8.37 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.563 1.145 . . . . 0.0 112.102 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.72 146.8 53.13 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.498 2.798 . . . . 0.0 112.886 174.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -71.45 -29.64 65.09 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.497 0.719 . . . . 0.0 111.393 167.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 51.4 t90 -158.54 154.43 26.66 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.028 1.731 . . . . 0.0 110.937 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.3 p -134.88 148.01 50.0 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.57 1.148 . . . . 0.0 111.594 169.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.48 -141.16 4.88 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 113.916 0.326 . . . . 0.0 113.916 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -110.79 140.53 45.13 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.802 2.041 . . . . 0.0 110.318 -170.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.6 tp -93.55 137.66 32.6 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.328 1.051 . . . . 0.0 109.997 173.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 28.0 ttp-105 -127.98 136.1 50.83 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.236 1.014 . . . . 0.0 110.271 156.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.432 HD11 ' CD2' ' A' ' 119' ' ' PHE . 36.1 mt -111.35 135.28 51.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 125.227 1.411 . . . . 0.0 107.25 164.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.74 166.77 28.4 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.847 1.659 . . . . 0.0 110.23 -164.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.3 t -157.45 160.35 38.24 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.056 -1.028 . . . . 0.0 111.951 172.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -144.68 119.95 10.2 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.513 0.725 . . . . 0.0 111.609 157.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.61 -115.11 6.72 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 125.802 1.668 . . . . 0.0 110.494 -177.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -104.5 17.02 24.93 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.17 1.788 . . . . 0.0 113.225 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.4 m -124.84 108.5 12.0 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.065 0.946 . . . . 0.0 110.396 177.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.64 159.47 25.34 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.734 0.413 . . . . 0.0 110.98 169.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -139.23 117.25 11.72 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.795 1.638 . . . . 0.0 109.214 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.1 mp -92.21 109.22 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 165.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -112.65 130.79 55.92 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.216 1.006 . . . . 0.0 111.876 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.9 mp -104.2 127.06 51.78 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.763 1.625 . . . . 0.0 110.053 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -132.98 150.28 52.17 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -170.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -65.61 141.7 58.32 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 122.252 1.025 . . . . 0.0 112.744 -173.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.0 pttt -74.81 -10.36 59.43 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -175.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 64.0 t -121.12 -38.32 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.868 1.267 . . . . 0.0 111.963 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.3 m -118.93 -8.64 10.23 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -172.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.84 14.49 80.01 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 123.992 0.806 . . . . 0.0 114.44 177.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -63.29 136.83 57.93 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.91 1.684 . . . . 0.0 111.277 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 38.1 tp -71.12 112.75 7.51 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.767 -0.583 . . . . 0.0 111.011 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -78.27 -53.52 7.23 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.932 0.893 . . . . 0.0 110.674 172.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.81 161.54 38.39 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.487 1.115 . . . . 0.0 112.052 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -141.86 134.47 28.34 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.03 1.332 . . . . 0.0 111.357 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.78 96.67 50.28 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 124.997 1.319 . . . . 0.0 111.573 176.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -59.56 138.51 84.09 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 124.213 3.275 . . . . 0.0 112.824 164.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.0 t -135.55 131.8 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.082 1.753 . . . . 0.0 109.598 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -91.15 -24.14 20.04 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -165.47 155.5 13.02 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.772 1.629 . . . . 0.0 111.18 169.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -126.19 127.22 24.71 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.87 1.268 . . . . 0.0 111.171 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.18 147.93 78.61 Favored 'Cis proline' 0 CA--C 1.542 0.888 0 CA-C-N 119.98 1.028 . . . . 0.0 113.185 -2.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -161.54 -164.71 16.98 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.901 1.715 . . . . 0.0 112.556 -178.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.9 tt -73.36 -38.62 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -175.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.5 7.51 16.81 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -167.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.2 t -149.94 130.55 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.78 1.632 . . . . 0.0 109.703 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.16 164.08 33.36 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.081 1.752 . . . . 0.0 112.731 -171.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 73.1 p -121.49 161.67 21.86 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.861 1.664 . . . . 0.0 111.956 -174.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.8 m -91.39 169.91 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.102 1.361 . . . . 0.0 110.906 168.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 79.6 p -95.03 -31.09 13.76 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.894 1.277 . . . . 0.0 113.506 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -95.3 -39.55 9.99 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -163.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.0 t -138.95 123.24 18.16 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -174.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.1 m -79.34 31.12 0.22 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 -168.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.418 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.257 18.4 ptt180 -120.68 18.06 11.95 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.293 1.437 . . . . 0.0 114.693 174.341 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -138.34 137.84 37.75 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.219 1.008 . . . . 0.0 111.202 -170.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -136.66 160.35 39.08 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.967 1.307 . . . . 0.0 111.325 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 80.7 t -112.75 143.8 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.498 1.119 . . . . 0.0 108.88 165.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.8 148.49 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 118.981 0.81 . . . . 0.0 112.104 171.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -89.28 89.28 7.84 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.668 0.787 . . . . 0.0 110.426 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -71.27 142.0 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 O-C-N 122.161 -0.337 . . . . 0.0 110.802 175.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 . . . . . 0 N--CA 1.47 0.557 0 C-N-CA 125.594 1.558 . . . . 0.0 111.83 -172.478 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 86.3 p . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.93 148.38 31.71 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.455 1.502 . . . . 0.0 111.348 172.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -93.08 116.74 29.33 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.53 0.732 . . . . 0.0 109.733 170.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.7 pt -116.94 146.01 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.715 1.206 . . . . 0.0 111.149 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.8 142.68 16.17 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 174.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.6 pt -127.54 139.81 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 125.319 1.448 . . . . 0.0 111.866 171.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -117.38 142.71 17.51 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 125.45 1.5 . . . . 0.0 112.474 174.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -100.37 162.74 12.75 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.209 1.404 . . . . 0.0 111.842 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.3 t -68.76 -28.02 66.42 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.643 0.777 . . . . 0.0 112.388 176.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -158.71 155.85 28.8 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.601 1.16 . . . . 0.0 111.406 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.3 ttp85 -54.28 -40.98 68.36 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.397 1.079 . . . . 0.0 112.513 173.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.69 -29.85 73.21 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 123.995 0.807 . . . . 0.0 114.304 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -82.2 -36.82 26.89 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.298 1.049 . . . . 0.0 111.748 176.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.418 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -63.61 -31.59 72.8 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.523 -0.735 . . . . 0.0 112.764 168.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -72.54 0.9 9.2 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.795 1.405 . . . . 0.0 114.795 170.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -96.87 -32.77 11.91 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.431 -0.793 . . . . 0.0 112.322 162.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.432 ' CD2' HD11 ' A' ' 49' ' ' ILE . 47.0 t80 -58.4 -53.03 62.93 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.638 1.175 . . . . 0.0 112.518 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -66.41 -34.47 78.02 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.669 1.187 . . . . 0.0 113.366 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 52.6 t -75.48 -40.04 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.44 1.096 . . . . 0.0 111.005 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.3 m -66.69 -28.55 68.54 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.34 0.656 . . . . 0.0 112.735 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.7 mt -75.74 -53.1 9.05 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.828 0.851 . . . . 0.0 111.981 171.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -66.62 -27.39 67.66 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.224 -0.922 . . . . 0.0 113.161 -175.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -84.29 -3.12 58.04 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.303 1.041 . . . . 0.0 112.752 175.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 52.5 t60 -88.85 -38.8 14.31 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 120.901 -1.125 . . . . 0.0 111.911 158.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -91.92 1.83 56.93 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 -171.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -177.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.2 m . . . . . 0 N--CA 1.473 0.7 0 CA-C-O 120.607 0.241 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.48 145.07 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.914 1.286 . . . . 0.0 112.221 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 71.8 mt -128.58 -41.38 1.52 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.077 1.751 . . . . 0.0 112.529 -175.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.6 t -151.37 135.71 16.86 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.86 1.264 . . . . 0.0 110.346 175.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 78.6 t -128.16 127.87 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.6 1.16 . . . . 0.0 109.624 171.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -126.95 131.66 23.97 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 124.797 1.239 . . . . 0.0 110.945 172.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -66.71 -24.91 46.99 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.098 2.532 . . . . 0.0 115.349 -176.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -133.81 120.95 21.12 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.108 0.963 . . . . 0.0 112.336 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -150.97 147.24 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.732 2.013 . . . . 0.0 109.369 174.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.8 m -125.95 130.94 52.24 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.852 0.861 . . . . 0.0 111.84 -171.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.3 t -96.65 137.38 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.773 1.629 . . . . 0.0 112.153 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -131.39 126.05 34.17 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.876 1.271 . . . . 0.0 109.472 168.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -67.11 118.08 10.04 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.595 0.758 . . . . 0.0 109.478 166.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.9 pt . . . . . 0 CA--C 1.545 0.788 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -166.854 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 . . . . . 0 CA--C 1.535 0.38 0 CA-C-O 120.845 0.355 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.4 16.35 3.18 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -171.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.75 -49.04 0.06 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 127.805 2.442 . . . . 0.0 115.673 -176.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.9 m -68.5 -15.58 63.59 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.028 1.731 . . . . 0.0 114.18 -177.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.45 -11.75 59.64 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.8 0.84 . . . . 0.0 112.995 171.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 18.0 m0 -88.61 171.17 10.23 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.136 1.374 . . . . 0.0 110.851 178.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -81.42 55.52 2.63 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.21 1.404 . . . . 0.0 114.095 -174.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.5 mt -61.14 -14.6 25.97 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -171.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -108.83 -3.46 17.66 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.609 1.163 . . . . 0.0 113.033 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -148.71 71.33 10.54 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 125.151 1.38 . . . . 0.0 112.105 177.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -56.46 144.39 84.03 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.131 2.554 . . . . 0.0 112.307 173.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -70.22 -29.85 66.79 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.378 1.071 . . . . 0.0 111.689 175.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 38.8 t90 -156.84 152.48 26.9 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.554 1.542 . . . . 0.0 110.559 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.2 p -134.03 150.77 51.23 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.691 0.796 . . . . 0.0 111.869 168.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.28 -143.62 6.31 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 123.129 0.395 . . . . 0.0 113.542 -176.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 36.7 mtm105 -105.74 149.37 26.49 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.597 1.959 . . . . 0.0 112.135 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.5 tp -90.37 138.68 31.35 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.707 1.203 . . . . 0.0 109.755 162.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.8 ttp85 -144.1 91.44 2.21 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.17 0.988 . . . . 0.0 110.731 162.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.469 HD11 ' CD2' ' A' ' 119' ' ' PHE . 15.2 mt -72.06 131.93 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 170.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.41 174.91 10.01 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 127.364 2.265 . . . . 0.0 110.564 -177.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.6 p -158.32 153.31 25.26 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 120.721 -1.237 . . . . 0.0 111.562 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -158.76 128.61 5.77 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.242 1.017 . . . . 0.0 112.085 159.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.59 53.65 37.08 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.452 1.025 . . . . 0.0 114.902 163.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt 61.99 24.25 14.41 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 126.292 1.837 . . . . 0.0 113.909 -175.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.5 m -123.7 132.26 53.79 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.659 1.584 . . . . 0.0 108.726 165.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.17 157.55 16.5 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.219 1.008 . . . . 0.0 110.162 166.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -136.54 107.62 6.75 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.501 1.521 . . . . 0.0 109.22 -175.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.5 mp -81.18 96.38 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 168.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -95.93 136.83 35.85 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.268 0.556 . . . . 0.0 111.516 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.6 mp -110.36 133.46 53.24 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 126.238 1.815 . . . . 0.0 109.4 174.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -139.6 154.05 47.5 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.854 0.862 . . . . 0.0 111.946 -169.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -74.88 148.77 39.87 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 120.974 -1.079 . . . . 0.0 112.311 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.1 pttt -89.08 -1.35 58.06 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.9 1.68 . . . . 0.0 114.986 -178.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 80.3 t -127.83 -41.8 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.152 1.381 . . . . 0.0 111.951 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.1 p -96.15 -27.42 15.05 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.53 1.059 . . . . 0.0 113.289 175.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.58 8.59 87.15 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-O 119.346 -0.697 . . . . 0.0 113.8 -170.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -68.75 151.34 46.78 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.622 1.211 . . . . 0.0 111.886 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.4 tp -72.66 125.96 28.74 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.638 -0.664 . . . . 0.0 110.683 176.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -86.37 -55.02 4.1 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.133 0.973 . . . . 0.0 111.063 171.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.8 159.56 36.87 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.66 1.184 . . . . 0.0 111.651 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -140.3 133.97 30.31 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.47 0.708 . . . . 0.0 112.576 175.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.74 103.24 53.91 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 125.108 1.363 . . . . 0.0 111.257 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -74.65 141.72 28.11 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.566 2.844 . . . . 0.0 111.728 173.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.5 t -134.94 125.38 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.68 1.992 . . . . 0.0 109.07 -174.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -90.04 -23.51 21.43 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -161.86 150.03 15.02 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.67 1.988 . . . . 0.0 110.151 171.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -122.85 127.56 25.69 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 124.537 1.135 . . . . 0.0 110.973 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -62.18 147.72 55.53 Favored 'Cis proline' 0 CA--C 1.541 0.869 0 CA-C-N 119.991 1.033 . . . . 0.0 114.392 -5.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.37 -166.68 18.81 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.919 1.723 . . . . 0.0 112.392 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.0 tt -69.52 -37.39 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 121.607 -0.937 . . . . 0.0 112.873 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.83 6.66 23.71 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -165.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.6 t -150.4 130.71 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.481 1.512 . . . . 0.0 110.063 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -140.32 161.34 37.92 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.282 1.833 . . . . 0.0 112.316 177.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.2 p -107.96 160.98 15.35 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.6 1.96 . . . . 0.0 111.735 177.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.1 m -87.01 173.33 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.212 1.005 . . . . 0.0 110.879 163.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 73.9 p -104.56 -23.3 13.14 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.485 1.514 . . . . 0.0 113.921 -176.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -99.87 -39.29 8.26 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -171.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.9 t -134.03 117.27 16.48 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -173.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.0 m -72.48 24.82 0.05 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 115.956 1.835 . . . . 0.0 115.956 -169.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.4 ptt85 -131.42 27.08 4.77 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.507 1.923 . . . . 0.0 113.995 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -140.09 141.28 36.18 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.671 1.589 . . . . 0.0 111.441 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -140.14 162.11 36.03 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.03 1.332 . . . . 0.0 111.54 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.9 t -116.96 142.85 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.596 1.158 . . . . 0.0 108.997 167.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.21 148.09 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 173.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -87.94 84.68 6.96 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.976 0.911 . . . . 0.0 110.717 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -68.3 141.03 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 120.816 0.341 . . . . 0.0 110.582 173.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 . . . . . 0 N--CA 1.467 0.413 0 C-N-CA 125.302 1.441 . . . . 0.0 111.78 -169.744 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 82.3 p . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.54 147.67 41.53 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.539 1.536 . . . . 0.0 110.612 164.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -92.83 116.75 29.32 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 167.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.1 pt -117.62 144.11 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.474 1.109 . . . . 0.0 110.937 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.73 142.08 15.92 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 175.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.4 pt -127.15 140.14 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 125.478 1.511 . . . . 0.0 111.661 172.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -119.94 141.35 15.35 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.798 1.189 . . . . 0.0 113.511 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -109.06 153.85 23.06 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.488 1.915 . . . . 0.0 110.792 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.3 t -73.0 -23.16 60.6 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.616 0.766 . . . . 0.0 112.784 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -155.54 151.06 27.17 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.446 1.098 . . . . 0.0 111.62 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.33 -33.05 70.65 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.904 0.882 . . . . 0.0 112.732 177.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.0 -19.25 63.32 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-N 118.979 0.808 . . . . 0.0 114.59 177.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -94.83 -37.31 11.28 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.689 1.244 . . . . 0.0 111.694 176.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.42 -29.14 68.8 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.135 0.974 . . . . 0.0 112.929 166.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . 0.262 19.8 m-85 -92.51 19.39 7.33 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.571 1.548 . . . . 0.0 114.112 170.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -99.71 -38.7 8.59 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.551 -0.718 . . . . 0.0 111.295 142.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.469 ' CD2' HD11 ' A' ' 49' ' ' ILE . 36.9 t80 -54.3 -57.72 10.14 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.58 1.082 . . . . 0.0 112.927 178.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -80.42 -22.74 40.91 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.256 -0.902 . . . . 0.0 113.345 -174.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 93.7 t -81.48 -39.2 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.412 0.685 . . . . 0.0 110.803 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 95.1 p -65.46 -31.42 72.49 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.566 -0.709 . . . . 0.0 112.848 173.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 72.0 mt -69.54 -52.65 24.4 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.189 0.995 . . . . 0.0 111.951 172.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -67.67 -29.03 68.22 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 120.971 -1.081 . . . . 0.0 112.823 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -82.77 -3.0 56.0 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.507 1.123 . . . . 0.0 112.916 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -90.15 -29.25 18.4 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.165 -0.96 . . . . 0.0 112.547 166.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -101.75 -4.15 26.91 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -176.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -176.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -72.34 149.67 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.825 1.25 . . . . 0.0 113.855 -171.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.5 mt -134.07 -38.6 0.87 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.05 1.74 . . . . 0.0 112.425 -171.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 39.0 t -152.59 139.52 19.08 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.89 1.276 . . . . 0.0 110.588 172.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 79.1 t -131.71 127.55 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.697 1.199 . . . . 0.0 109.28 171.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -129.21 135.24 27.29 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 125.207 1.403 . . . . 0.0 110.524 173.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.66 -18.46 13.52 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.987 2.458 . . . . 0.0 114.975 -172.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -129.65 109.42 10.97 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.5 1.12 . . . . 0.0 111.146 -175.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.7 p -143.05 141.37 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.721 1.609 . . . . 0.0 110.028 171.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.3 m -123.33 125.36 44.87 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.265 1.026 . . . . 0.0 111.371 -171.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.6 t -92.16 137.82 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.142 1.377 . . . . 0.0 112.201 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -127.31 123.3 36.05 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.277 1.431 . . . . 0.0 108.621 168.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -68.96 109.3 3.88 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 164.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.415 HD12 ' CE2' ' A' ' 31' ' ' TYR . 35.4 pt . . . . . 0 N--CA 1.473 0.716 0 C-N-CA 124.425 1.09 . . . . 0.0 113.819 -166.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.415 ' CE2' HD12 ' A' ' 22' ' ' ILE . 28.6 m-85 . . . . . 0 N--CA 1.451 -0.398 0 CA-C-O 120.997 0.427 . . . . 0.0 109.966 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.528 ' H ' ' HD3' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -123.31 131.09 53.54 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 163.139 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.18 -33.73 63.24 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.454 1.102 . . . . 0.0 113.215 -172.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.7 p -65.44 -13.26 58.35 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 175.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.29 -10.25 58.63 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.054 0.942 . . . . 0.0 112.704 170.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 22.8 m0 -94.68 171.71 8.62 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.629 1.572 . . . . 0.0 111.835 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -79.22 47.52 0.8 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.16 1.784 . . . . 0.0 114.177 -176.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.7 mt -54.72 -34.86 63.02 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -167.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -93.77 -2.41 53.72 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.95 0.9 . . . . 0.0 113.321 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -145.89 66.85 12.0 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 125.992 1.717 . . . . 0.0 111.747 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -55.91 144.02 79.69 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.282 2.654 . . . . 0.0 112.84 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -73.86 -27.81 61.26 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.45 1.1 . . . . 0.0 111.73 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 40.7 t90 -153.17 152.48 31.3 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.656 1.582 . . . . 0.0 110.663 170.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.5 p -134.56 143.17 47.24 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.964 0.906 . . . . 0.0 111.864 171.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.15 -144.63 5.4 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 114.556 0.582 . . . . 0.0 114.556 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -107.9 144.3 35.34 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.507 1.923 . . . . 0.0 111.035 -172.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 42.9 tp -91.56 138.44 31.57 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.652 1.581 . . . . 0.0 110.119 170.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -144.26 99.53 3.39 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.685 1.194 . . . . 0.0 110.57 170.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.48 HD11 ' CD2' ' A' ' 119' ' ' PHE . 18.4 mt -86.31 132.96 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.604 1.162 . . . . 0.0 108.624 174.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.12 171.28 14.3 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.167 1.787 . . . . 0.0 111.279 -170.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.8 t -156.21 149.06 24.03 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.796 -1.19 . . . . 0.0 112.555 173.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -150.86 132.76 15.1 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.724 152.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.47 58.45 5.45 Favored Glycine 0 N--CA 1.474 1.192 0 C-N-CA 124.752 1.168 . . . . 0.0 114.466 166.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 56.52 27.3 12.07 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 126.203 1.801 . . . . 0.0 113.174 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.7 m -137.93 121.83 17.72 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.655 1.582 . . . . 0.0 108.536 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -90.33 158.57 17.08 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.842 0.857 . . . . 0.0 110.513 171.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -139.34 99.52 3.76 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.318 1.847 . . . . 0.0 108.628 -173.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.3 mp -79.65 103.66 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 168.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 50.6 mttt -105.12 141.18 37.13 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.939 0.876 . . . . 0.0 111.732 174.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.8 mp -108.9 133.01 53.49 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 126.301 1.84 . . . . 0.0 109.785 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -132.2 147.19 52.41 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.942 0.897 . . . . 0.0 112.499 -168.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -66.33 140.81 58.12 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.882 0.873 . . . . 0.0 112.717 -175.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.274 0.0 OUTLIER -77.59 -5.22 49.48 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 -174.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.6 t -112.46 -48.59 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.93 1.292 . . . . 0.0 111.107 170.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.8 m -99.54 -16.75 18.18 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -167.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.87 12.43 74.8 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.658 1.123 . . . . 0.0 113.994 -176.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -82.78 152.09 25.84 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.078 1.351 . . . . 0.0 112.322 -174.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.7 122.16 19.31 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.959 0.903 . . . . 0.0 112.074 -169.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -86.1 -54.91 4.19 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.217 1.007 . . . . 0.0 111.098 168.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.58 161.61 38.73 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.895 1.278 . . . . 0.0 111.771 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -141.22 134.88 30.1 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.722 1.209 . . . . 0.0 112.065 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.86 100.68 48.5 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.955 1.302 . . . . 0.0 111.405 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -65.1 139.07 59.36 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 124.292 3.328 . . . . 0.0 112.422 167.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.4 t -135.8 129.68 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.73 1.612 . . . . 0.0 109.659 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -89.71 -23.52 21.8 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.75 150.05 13.38 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.15 1.78 . . . . 0.0 110.391 172.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -126.12 132.19 24.23 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.526 1.13 . . . . 0.0 112.131 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -63.57 144.66 53.94 Favored 'Cis proline' 0 CA--C 1.54 0.814 0 CA-C-N 119.71 0.932 . . . . 0.0 113.772 -6.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -169.59 -173.26 36.97 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.606 1.098 . . . . 0.0 114.116 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.6 tp -54.86 -36.72 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -166.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.55 8.35 39.25 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -171.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.4 t -148.33 129.12 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.307 1.043 . . . . 0.0 111.221 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -138.11 162.52 33.97 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.282 1.833 . . . . 0.0 112.218 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 65.8 p -112.49 161.28 16.91 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.628 1.971 . . . . 0.0 111.388 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.4 m -89.57 173.1 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.841 0.857 . . . . 0.0 111.453 166.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 46.5 p -99.05 -24.9 14.73 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 174.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -81.21 -42.69 20.38 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -171.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.2 t -156.76 134.44 10.86 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.0 m -72.99 22.15 0.07 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -174.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.482 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.26 5.1 ptm180 -108.73 19.67 19.4 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.011 1.724 . . . . 0.0 114.043 173.268 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -142.53 135.5 28.38 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.029 1.331 . . . . 0.0 110.412 -174.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -135.95 164.49 27.85 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.975 1.31 . . . . 0.0 111.103 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.2 t -117.72 142.96 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.705 1.202 . . . . 0.0 108.418 166.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.89 147.13 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 118.664 0.665 . . . . 0.0 112.14 172.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -87.75 86.67 7.2 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.507 0.723 . . . . 0.0 110.449 176.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -69.04 140.32 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.575 0.226 . . . . 0.0 110.8 175.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 . . . . . 0 N--CA 1.47 0.534 0 C-N-CA 125.762 1.625 . . . . 0.0 111.792 -170.247 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 76.8 p . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.11 147.46 30.6 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.465 1.506 . . . . 0.0 111.234 171.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -90.92 117.99 29.96 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.396 0.678 . . . . 0.0 109.472 168.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.4 pt -116.93 143.19 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.567 1.147 . . . . 0.0 111.027 177.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.25 144.06 17.72 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 174.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.0 pt -128.9 139.61 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 C-N-CA 125.59 1.556 . . . . 0.0 111.641 171.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.68 142.14 15.53 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 125.663 1.601 . . . . 0.0 112.725 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -105.25 163.63 12.45 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.419 1.488 . . . . 0.0 111.298 -177.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.7 t -76.32 -24.65 54.31 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 177.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -156.19 151.14 26.25 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.402 1.081 . . . . 0.0 111.636 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -62.62 -32.69 73.75 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.087 0.955 . . . . 0.0 113.151 178.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.24 -30.09 76.92 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 118.942 0.792 . . . . 0.0 113.646 175.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -82.84 -36.49 25.42 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.119 0.96 . . . . 0.0 111.918 175.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.482 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -64.2 -31.77 73.09 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 169.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -61.25 -33.75 74.04 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.098 -1.001 . . . . 0.0 112.508 171.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -70.36 -32.72 70.54 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.835 1.198 . . . . 0.0 112.846 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.48 ' CD2' HD11 ' A' ' 49' ' ' ILE . 9.6 t80 -57.64 -43.85 85.18 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.029 0.831 . . . . 0.0 111.329 170.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -81.28 -35.59 30.91 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.532 1.133 . . . . 0.0 113.496 -175.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.5 t -76.78 -40.5 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 O-C-N 121.245 -0.909 . . . . 0.0 111.519 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 85.4 p -63.67 -27.41 69.2 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 83.8 mt -75.38 -55.51 5.62 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.018 0.927 . . . . 0.0 111.534 171.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -66.83 -30.71 70.97 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.09 -1.006 . . . . 0.0 113.484 -172.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -90.91 4.38 52.04 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.8 1.64 . . . . 0.0 112.716 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -97.67 -33.12 11.43 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.304 -0.872 . . . . 0.0 112.276 163.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -89.96 -2.37 58.14 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.321 0 CA-C-N 121.18 1.809 . . . . 0.0 115.09 -174.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.6 m . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.6 t -69.99 143.05 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 O-C-N 121.305 -0.872 . . . . 0.0 111.673 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.5 mt -126.88 -41.75 1.8 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.572 1.549 . . . . 0.0 112.293 -174.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.4 t -153.92 135.39 14.24 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.229 1.012 . . . . 0.0 111.245 173.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.1 t -128.31 127.33 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.677 1.191 . . . . 0.0 109.014 171.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -131.07 137.43 30.7 Favored Pre-proline 0 N--CA 1.475 0.81 0 C-N-CA 125.408 1.483 . . . . 0.0 110.65 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.53 -18.57 22.59 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.217 2.611 . . . . 0.0 113.689 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -109.08 122.64 47.7 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.025 1.33 . . . . 0.0 112.152 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.0 p -154.72 143.25 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.803 1.241 . . . . 0.0 109.585 157.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.7 p -127.32 144.14 51.1 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.071 1.348 . . . . 0.0 110.586 177.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.4 t -113.41 130.22 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.931 1.292 . . . . 0.0 111.113 -177.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.67 118.17 14.81 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.418 1.487 . . . . 0.0 108.976 173.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 -69.45 132.45 46.35 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.893 0.877 . . . . 0.0 109.943 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.3 pt . . . . . 0 CA--C 1.545 0.78 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -160.152 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 . . . . . 0 CA--C 1.532 0.284 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.77 15.96 8.07 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 -174.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 55.84 -48.15 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.825 2.85 . . . . 0.0 116.156 -173.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 90.7 p -64.53 -17.77 64.21 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.095 1.758 . . . . 0.0 114.466 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -85.84 -4.79 59.25 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.445 1.498 . . . . 0.0 112.633 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.8 m0 -93.44 168.52 11.0 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.085 1.754 . . . . 0.0 110.635 175.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -78.13 49.7 0.84 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.659 1.584 . . . . 0.0 114.041 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 45.7 mt -56.46 -36.07 68.64 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -172.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -92.8 -2.68 55.73 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.237 1.015 . . . . 0.0 113.232 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -141.6 70.32 25.7 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 125.521 1.528 . . . . 0.0 111.726 177.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.85 147.37 73.42 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.144 2.563 . . . . 0.0 113.16 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -74.03 -27.94 61.18 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.158 0.983 . . . . 0.0 111.535 169.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 57.7 t90 -158.15 155.01 28.35 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.399 1.88 . . . . 0.0 110.884 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.1 p -136.72 149.9 48.13 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.666 1.186 . . . . 0.0 112.024 169.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.69 -142.49 4.6 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 123.319 0.485 . . . . 0.0 113.825 -177.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -118.91 148.74 42.6 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.849 2.06 . . . . 0.0 111.558 -175.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.1 tp -89.15 140.42 29.48 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.54 1.536 . . . . 0.0 110.626 174.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -141.01 93.36 2.58 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.519 1.127 . . . . 0.0 110.567 162.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.471 HD11 ' CD2' ' A' ' 119' ' ' PHE . 23.1 mt -76.65 127.24 37.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 166.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.1 p -138.31 171.71 13.98 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 126.919 2.088 . . . . 0.0 110.153 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.8 p -152.81 166.09 33.34 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 125.014 1.326 . . . . 0.0 112.185 174.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -148.68 121.25 8.56 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.243 0.544 . . . . 0.0 111.326 154.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.33 -118.43 9.32 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 125.232 1.396 . . . . 0.0 110.211 -176.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -101.48 20.16 16.55 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.331 1.852 . . . . 0.0 113.714 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.4 m -127.47 128.15 45.25 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.704 1.202 . . . . 0.0 109.957 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.65 160.8 14.03 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.552 1.141 . . . . 0.0 111.157 170.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -141.21 107.13 5.15 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.733 2.013 . . . . 0.0 108.802 -174.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -83.99 94.56 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 168.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -88.58 136.67 32.88 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.86 0.864 . . . . 0.0 110.805 174.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.3 mp -111.98 131.2 55.55 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.143 1.777 . . . . 0.0 110.111 174.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -132.67 147.56 52.33 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.858 0.863 . . . . 0.0 113.177 -170.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -67.8 135.39 52.54 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.367 1.067 . . . . 0.0 111.329 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.7 pttt -76.05 -5.2 45.35 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -175.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 85.6 t -120.26 -43.17 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 125.03 1.332 . . . . 0.0 111.47 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.5 m -93.82 -19.71 20.76 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.32 13.5 76.97 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.487 1.041 . . . . 0.0 113.693 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -90.58 152.16 21.01 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.241 1.416 . . . . 0.0 112.295 -173.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.5 tp -72.47 128.34 35.29 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.491 -0.756 . . . . 0.0 111.666 -175.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -85.35 -58.25 2.75 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.55 1.14 . . . . 0.0 110.778 169.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.68 165.44 36.25 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.042 1.737 . . . . 0.0 110.12 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -146.35 146.22 30.59 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 169.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.34 107.2 49.74 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.333 1.453 . . . . 0.0 111.665 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -67.92 144.47 64.66 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.838 3.026 . . . . 0.0 111.988 169.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.2 t -139.23 126.52 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.46 1.504 . . . . 0.0 109.414 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -95.45 -19.96 19.45 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -160.56 145.49 14.43 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.733 2.013 . . . . 0.0 110.081 171.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -126.22 127.67 24.6 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 124.697 1.199 . . . . 0.0 110.488 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -64.47 146.96 67.06 Favored 'Cis proline' 0 CA--C 1.542 0.899 0 CA-C-N 120.073 1.062 . . . . 0.0 113.434 -2.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.65 -156.94 8.74 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.721 1.629 . . . . 0.0 112.642 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.6 tt -79.33 -41.89 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -176.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.59 8.0 15.57 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -165.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 23.5 t -153.02 130.45 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 126.363 1.865 . . . . 0.0 109.122 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.17 158.72 44.24 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.871 1.268 . . . . 0.0 113.067 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.0 p -104.73 161.6 14.02 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.506 1.522 . . . . 0.0 112.182 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.3 m -90.72 173.27 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.81 1.244 . . . . 0.0 110.806 167.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.6 p -96.79 -29.4 13.78 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.31 1.444 . . . . 0.0 113.384 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -91.32 -43.1 9.99 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -169.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.7 t -143.32 124.48 14.52 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -176.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -67.29 -7.89 27.87 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.297 1.592 . . . . 0.0 115.297 -169.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.443 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.32 44.9 ptt85 -84.91 21.3 1.62 Allowed 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -179.338 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -142.86 140.02 31.09 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.814 1.646 . . . . 0.0 111.868 -174.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -142.62 149.36 38.86 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.435 1.494 . . . . 0.0 112.512 -176.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.9 t -92.4 142.35 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 161.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.26 149.65 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 119.348 0.977 . . . . 0.0 111.949 164.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.478 ' HE ' ' NE2' ' A' ' 97' ' ' GLN . 41.1 ttp180 -93.04 95.72 9.63 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.706 0.803 . . . . 0.0 110.259 174.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -76.91 150.98 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.301 0.64 . . . . 0.0 111.705 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.478 ' NE2' ' HE ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.594 0 C-N-CA 125.901 1.68 . . . . 0.0 110.395 174.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 84.7 p . . . . . 0 N--CA 1.465 0.32 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.59 142.45 27.98 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.671 1.188 . . . . 0.0 111.276 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -87.66 117.54 26.55 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.378 0.671 . . . . 0.0 109.537 168.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.9 pt -118.56 147.61 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.888 1.275 . . . . 0.0 110.761 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.7 136.32 12.9 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.5 pt -127.66 159.77 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 125.008 1.323 . . . . 0.0 112.067 171.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -154.38 168.82 32.68 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-O 122.039 0.799 . . . . 0.0 114.513 173.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -121.77 157.41 31.08 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 126.08 1.752 . . . . 0.0 111.797 -171.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.7 t -70.01 -19.34 63.33 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.055 0.942 . . . . 0.0 112.592 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -154.79 150.76 27.88 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.197 0.999 . . . . 0.0 111.921 -176.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 35.6 ttt-85 -61.32 -31.62 71.48 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.694 1.198 . . . . 0.0 113.276 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.27 -29.33 75.02 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-N 119.102 0.865 . . . . 0.0 113.976 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -82.53 -34.67 27.8 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.455 -1.026 . . . . 0.0 111.642 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.443 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -67.67 -30.51 70.06 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.26 1.024 . . . . 0.0 113.388 167.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -61.5 -47.48 85.42 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.446 -0.784 . . . . 0.0 110.797 168.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -62.31 -36.92 83.64 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.386 0.993 . . . . 0.0 112.876 175.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.471 ' CD2' HD11 ' A' ' 49' ' ' ILE . 35.2 t80 -55.55 -55.76 28.13 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.224 0.92 . . . . 0.0 112.263 173.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -81.34 -27.3 35.01 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.114 1.154 . . . . 0.0 114.114 -174.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 73.0 t -76.3 -38.8 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 O-C-N 121.45 -0.781 . . . . 0.0 111.181 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 93.5 p -65.05 -30.98 71.98 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.152 0.887 . . . . 0.0 112.988 175.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.5 mt -68.43 -54.99 13.45 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.265 1.026 . . . . 0.0 111.761 171.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -67.27 -26.74 66.71 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 120.988 -1.07 . . . . 0.0 113.007 -176.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -81.78 -3.87 54.95 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.874 1.27 . . . . 0.0 112.713 174.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -91.53 -25.13 19.39 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.681 -1.262 . . . . 0.0 112.446 163.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -100.29 -6.76 25.42 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 116.007 1.855 . . . . 0.0 116.007 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -174.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.535 0.383 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.3 t -70.96 141.1 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 O-C-N 121.138 -0.976 . . . . 0.0 112.971 -168.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.3 mt -122.7 -41.77 2.35 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.874 1.67 . . . . 0.0 112.495 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 33.6 t -152.42 132.31 13.32 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.545 1.138 . . . . 0.0 110.596 175.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 72.6 t -127.94 127.07 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.546 1.138 . . . . 0.0 109.744 172.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -133.17 143.03 46.64 Favored Pre-proline 0 N--CA 1.474 0.737 0 C-N-CA 124.853 1.261 . . . . 0.0 111.683 173.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.02 -17.42 22.25 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.51 2.807 . . . . 0.0 115.098 -174.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -134.25 110.81 9.77 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.118 0.967 . . . . 0.0 112.21 -169.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -149.36 146.37 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 126.324 1.85 . . . . 0.0 109.739 171.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.3 m -125.27 131.59 53.06 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.058 0.943 . . . . 0.0 111.573 -171.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.1 t -98.9 139.97 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 126.028 1.731 . . . . 0.0 112.054 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -127.59 132.38 49.83 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.71 1.604 . . . . 0.0 108.968 169.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 48.0 mtm180 -70.05 139.29 52.61 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 155.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.8 pt . . . . . 0 N--CA 1.479 1.006 0 C-N-CA 125.16 1.384 . . . . 0.0 112.95 -163.59 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.27 22.9 4.81 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.284 1.434 . . . . 0.0 113.021 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 56.64 -46.94 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 128.471 2.709 . . . . 0.0 115.304 -170.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.4 m -64.82 -13.43 55.82 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.552 1.941 . . . . 0.0 114.276 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -78.57 -4.6 49.56 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.405 1.482 . . . . 0.0 113.588 170.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 10.6 m0 -107.0 167.83 9.62 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.655 1.582 . . . . 0.0 111.425 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -78.01 53.67 1.21 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.02 1.728 . . . . 0.0 113.589 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.9 mt -55.56 -32.6 63.14 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -170.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -87.63 -6.82 58.1 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.068 0.947 . . . . 0.0 113.085 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -140.19 59.29 12.35 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 126.886 2.075 . . . . 0.0 111.183 -160.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -65.04 139.61 62.03 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 CA-C-N 119.593 0.89 . . . . 0.0 112.424 -171.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -74.46 -26.64 60.17 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.207 1.003 . . . . 0.0 111.717 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 39.4 t90 -153.6 153.57 32.59 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.887 1.675 . . . . 0.0 110.71 169.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 56.0 p -135.88 148.38 48.58 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.486 1.114 . . . . 0.0 112.091 171.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 173.09 -144.13 7.64 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 123.017 0.341 . . . . 0.0 113.852 177.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.4 mtm180 -98.14 145.48 26.53 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.94 1.696 . . . . 0.0 112.069 -174.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.4 tp -85.61 136.47 33.37 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.584 1.553 . . . . 0.0 109.778 163.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 39.3 ttt-85 -145.68 87.08 1.76 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.626 1.17 . . . . 0.0 110.862 167.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.478 HD11 ' CD1' ' A' ' 119' ' ' PHE . 21.1 mt -71.28 125.59 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 171.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.7 p -128.23 163.91 23.7 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.376 1.87 . . . . 0.0 110.131 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.3 t -163.78 148.73 10.67 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.678 -1.264 . . . . 0.0 110.754 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.511 ' HE3' ' CE1' ' A' ' 57' ' ' TYR . 57.9 mttt -125.21 -126.37 0.24 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.967 1.307 . . . . 0.0 110.037 -172.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.48 94.11 1.69 Allowed Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.293 1.425 . . . . 0.0 112.309 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 54.58 28.54 10.0 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 126.653 1.981 . . . . 0.0 113.635 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.0 m -148.16 118.21 7.23 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.634 1.573 . . . . 0.0 109.35 -174.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -96.0 163.89 12.94 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.057 1.343 . . . . 0.0 111.63 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.511 ' CE1' ' HE3' ' A' ' 52' ' ' LYS . 82.2 m-85 -147.67 107.38 3.96 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.205 1.802 . . . . 0.0 109.298 -174.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.3 mp -80.46 96.11 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 170.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -92.41 138.21 31.71 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.173 0.589 . . . . 0.0 111.475 173.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.1 mp -115.62 134.48 55.01 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.365 1.866 . . . . 0.0 109.911 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -136.09 148.47 48.29 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.962 0.905 . . . . 0.0 112.07 -168.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -71.01 141.05 50.98 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 122.766 1.269 . . . . 0.0 111.643 177.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.623 ' H ' ' CD ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -85.25 1.53 47.84 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 127.007 2.123 . . . . 0.0 116.139 -175.124 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.1 t -116.97 -45.67 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 125.336 1.454 . . . . 0.0 111.014 171.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.2 m -96.71 -20.12 18.47 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -173.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.79 9.69 83.14 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.431 1.015 . . . . 0.0 113.823 -176.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -83.34 149.07 26.96 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.999 1.319 . . . . 0.0 112.186 -174.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.4 tp -70.89 125.45 26.88 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.59 0.756 . . . . 0.0 111.24 -177.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -83.5 -57.82 3.08 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.725 0.81 . . . . 0.0 110.475 167.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.59 163.02 40.69 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.486 1.114 . . . . 0.0 112.071 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -136.39 137.69 40.79 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.469 1.507 . . . . 0.0 110.606 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.81 92.1 49.31 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.291 1.036 . . . . 0.0 111.535 176.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -56.6 139.56 88.16 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 124.649 3.566 . . . . 0.0 113.457 168.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.3 t -138.94 123.99 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 126.58 1.952 . . . . 0.0 109.618 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -88.59 -21.41 24.05 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 121.01 -1.056 . . . . 0.0 113.425 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -160.29 144.94 14.53 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.169 1.788 . . . . 0.0 110.252 170.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -118.34 129.08 25.6 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.493 1.117 . . . . 0.0 110.75 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -66.39 148.23 76.77 Favored 'Cis proline' 0 CA--C 1.542 0.887 0 CA-C-N 119.976 1.027 . . . . 0.0 113.094 -4.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.81 -163.4 15.39 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.529 1.537 . . . . 0.0 113.054 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.4 tt -69.9 -37.42 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 O-C-N 121.797 -0.826 . . . . 0.0 113.191 -175.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.54 7.14 27.35 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -165.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 23.8 t -150.55 125.13 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.478 1.511 . . . . 0.0 109.606 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -139.16 159.83 41.23 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.114 1.766 . . . . 0.0 112.17 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.0 p -114.35 156.06 25.13 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.085 1.754 . . . . 0.0 111.725 -176.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.5 m -85.91 172.09 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.089 0.956 . . . . 0.0 111.114 170.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 70.5 p -96.7 -28.09 14.47 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 178.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -88.62 -43.37 11.41 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.232 0.826 . . . . 0.0 113.232 -168.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.5 t -146.17 125.73 13.28 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.34 1.77 3.56 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -170.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.471 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.286 31.5 ptt180 -86.59 16.59 4.52 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 177.162 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -139.5 137.6 35.65 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.997 1.319 . . . . 0.0 111.102 -173.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -139.07 155.02 48.24 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.979 1.312 . . . . 0.0 111.567 -178.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.76 141.77 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.497 0.719 . . . . 0.0 109.38 164.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.44 146.85 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 118.811 0.732 . . . . 0.0 112.354 171.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -87.54 89.87 8.16 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.906 0.883 . . . . 0.0 110.071 176.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.1 pt -68.34 144.14 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 O-C-N 122.126 -0.359 . . . . 0.0 111.127 173.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 . . . . . 0 N--CA 1.471 0.577 0 C-N-CA 124.713 1.205 . . . . 0.0 111.613 -175.884 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.0 p . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.73 146.39 33.12 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.271 1.429 . . . . 0.0 111.334 168.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -92.55 117.37 29.88 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.704 0.802 . . . . 0.0 109.672 171.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 32.9 pt -118.76 145.56 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.939 1.296 . . . . 0.0 111.419 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -90.95 141.83 15.88 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 176.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.3 pt -127.95 140.56 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 125.385 1.474 . . . . 0.0 111.646 171.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.08 143.78 15.84 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.835 1.207 . . . . 0.0 113.324 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -105.77 163.74 12.47 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.878 1.671 . . . . 0.0 111.061 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.1 t -74.08 -30.57 62.42 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.241 0.616 . . . . 0.0 112.407 176.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -151.1 150.21 30.41 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.133 0.973 . . . . 0.0 112.107 -174.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 54.7 ttt-85 -61.06 -33.68 73.7 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.43 1.092 . . . . 0.0 113.154 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.04 -27.17 73.77 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 123.901 0.763 . . . . 0.0 113.849 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -83.43 -36.27 24.35 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.088 0.944 . . . . 0.0 111.422 175.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.471 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -65.12 -33.08 75.17 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 169.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -61.0 -33.79 73.8 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.42 -0.8 . . . . 0.0 112.674 172.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -64.86 -37.87 89.08 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.808 1.185 . . . . 0.0 111.943 173.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.478 ' CD1' HD11 ' A' ' 49' ' ' ILE . 19.2 t80 -58.27 -50.38 73.79 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.738 0.815 . . . . 0.0 111.837 174.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.96 -24.27 38.2 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -176.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.7 t -80.67 -41.79 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 119.368 0.986 . . . . 0.0 111.427 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 93.2 p -63.47 -32.96 74.55 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.4 1.0 . . . . 0.0 112.87 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 61.6 mt -64.54 -58.46 6.33 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.22 1.008 . . . . 0.0 111.798 170.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -66.82 -29.8 69.83 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.247 -0.908 . . . . 0.0 113.121 -174.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -80.68 -3.55 51.08 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.42 1.088 . . . . 0.0 112.579 177.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -95.13 -19.39 20.14 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 163.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -101.41 -9.21 21.31 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.315 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 -174.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.4 m . . . . . 0 N--CA 1.464 0.248 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.6 t -65.06 142.05 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 123.766 0.826 . . . . 0.0 111.288 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.5 mt -128.18 -40.17 1.67 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.633 1.573 . . . . 0.0 112.338 -175.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 37.0 t -152.99 135.99 15.52 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.464 1.106 . . . . 0.0 111.036 173.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.4 t -129.0 126.89 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.492 1.117 . . . . 0.0 109.253 171.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -128.12 134.65 26.47 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 125.352 1.461 . . . . 0.0 110.287 175.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -78.64 -13.28 14.79 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.21 2.607 . . . . 0.0 115.268 -171.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -135.18 108.19 7.63 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.806 0.843 . . . . 0.0 111.339 -174.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.52 143.34 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.084 1.354 . . . . 0.0 110.568 173.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.5 m -123.65 131.93 53.73 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.426 1.09 . . . . 0.0 111.254 -173.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 76.6 t -97.44 134.32 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.509 1.524 . . . . 0.0 111.68 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.17 132.83 53.66 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.198 1.399 . . . . 0.0 108.685 168.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -71.4 131.72 43.78 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 162.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.1 pt . . . . . 0 N--CA 1.476 0.849 0 C-N-CA 124.043 0.937 . . . . 0.0 113.327 -164.955 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 . . . . . 0 CA--C 1.54 0.566 0 CA-C-O 119.661 -0.209 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.43 18.89 7.5 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -175.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.92 -51.4 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.968 2.507 . . . . 0.0 115.481 -173.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.0 m -65.43 -13.26 58.31 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.253 1.821 . . . . 0.0 114.257 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -79.89 -12.01 59.77 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.323 1.049 . . . . 0.0 112.645 172.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -95.35 165.33 12.43 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.801 1.641 . . . . 0.0 111.12 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.1 mttt -78.07 57.68 1.84 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.622 1.569 . . . . 0.0 113.261 175.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.1 mt -55.47 -31.75 62.23 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -173.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -89.68 -5.67 56.85 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.838 0.855 . . . . 0.0 113.042 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -138.62 68.92 45.24 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 125.479 1.512 . . . . 0.0 111.685 -161.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -68.0 145.66 68.43 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 CA-C-N 119.535 0.869 . . . . 0.0 113.097 -170.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -71.33 -31.15 67.05 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.255 0.622 . . . . 0.0 111.001 166.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 54.9 t90 -157.36 154.8 29.51 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.757 1.623 . . . . 0.0 111.149 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.2 p -132.94 148.31 52.28 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.745 1.218 . . . . 0.0 111.522 170.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.526 ' HA2' ' HE3' ' A' ' 63' ' ' LYS . . . -178.54 -146.1 6.37 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 114.332 0.493 . . . . 0.0 114.332 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -110.84 145.08 38.85 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.426 1.89 . . . . 0.0 110.952 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.6 tp -85.49 138.73 32.03 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.594 1.558 . . . . 0.0 109.939 170.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.1 ttt85 -142.81 87.95 2.02 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.676 1.19 . . . . 0.0 110.649 170.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.444 HD11 ' CD2' ' A' ' 119' ' ' PHE . 27.1 mt -75.37 124.82 34.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 170.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.4 p -134.78 169.37 17.45 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 127.065 2.146 . . . . 0.0 109.712 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.3 t -157.17 160.14 38.45 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.732 -1.23 . . . . 0.0 112.176 176.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -147.85 118.66 7.58 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.658 0.742 . . . . 0.0 111.879 160.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.24 -119.96 11.23 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 125.899 1.714 . . . . 0.0 110.506 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -92.03 10.62 28.33 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.853 1.661 . . . . 0.0 113.824 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.1 m -129.31 112.75 14.19 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.592 0.757 . . . . 0.0 111.231 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.13 161.27 16.59 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.55 0.74 . . . . 0.0 111.493 172.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -141.45 106.01 4.87 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.443 1.897 . . . . 0.0 109.31 -173.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -82.77 95.68 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 168.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -91.1 138.28 31.72 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.74 0.816 . . . . 0.0 110.86 175.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mp -112.75 130.48 56.05 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.075 1.75 . . . . 0.0 109.927 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -133.99 148.78 51.16 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.005 0.922 . . . . 0.0 112.427 -172.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -66.53 147.56 53.11 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.05 -1.031 . . . . 0.0 111.824 177.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.526 ' HE3' ' HA2' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -83.93 -0.3 50.86 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -174.168 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.5 t -120.05 -45.26 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.856 1.262 . . . . 0.0 111.508 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.7 p -94.04 -23.54 17.97 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -178.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.55 11.85 80.29 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 123.814 0.721 . . . . 0.0 113.478 -169.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -70.57 142.8 51.71 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.888 1.344 . . . . 0.0 111.621 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.4 tp -71.03 125.21 26.25 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.154 0.582 . . . . 0.0 111.208 -176.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -85.23 -56.35 3.58 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.443 1.097 . . . . 0.0 110.923 170.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.0 164.41 36.8 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.563 1.545 . . . . 0.0 110.547 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -144.98 143.32 30.46 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 169.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -114.56 111.97 46.07 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 125.086 1.355 . . . . 0.0 111.177 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.57 144.07 13.91 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.406 2.737 . . . . 0.0 111.36 175.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.8 t -135.65 128.91 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.488 1.515 . . . . 0.0 109.496 -173.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -94.65 -21.5 18.75 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.74 147.59 11.88 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.636 1.974 . . . . 0.0 110.05 170.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -116.07 128.61 25.85 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 124.803 1.241 . . . . 0.0 110.859 176.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -67.56 149.72 82.88 Favored 'Cis proline' 0 CA--C 1.544 0.978 0 CA-C-N 119.788 0.96 . . . . 0.0 112.804 -5.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.54 -167.31 17.62 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.658 1.599 . . . . 0.0 112.728 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.6 tt -67.52 -36.7 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 O-C-N 121.56 -0.965 . . . . 0.0 112.907 -177.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.32 4.23 32.11 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 -167.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.2 t -151.49 127.61 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.145 1.378 . . . . 0.0 110.448 -177.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -142.63 158.25 43.85 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.983 1.713 . . . . 0.0 112.872 -177.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.5 p -101.72 163.27 12.34 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.237 1.815 . . . . 0.0 111.749 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.5 m -89.54 169.64 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.178 0.991 . . . . 0.0 110.084 162.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 81.3 p -95.09 -30.72 13.92 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.864 1.266 . . . . 0.0 113.53 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -94.73 -39.1 10.48 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -164.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.6 t -137.09 118.84 15.06 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -175.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.3 m -74.92 21.02 0.12 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -164.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.405 ' HA ' ' CB ' ' A' ' 116' ' ' ALA . 15.9 ptt-85 -120.44 20.94 11.79 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.532 1.933 . . . . 0.0 114.095 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -138.56 140.9 39.23 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.308 1.443 . . . . 0.0 110.883 -173.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -140.8 156.84 46.06 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.842 1.257 . . . . 0.0 111.42 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 83.2 t -107.97 142.42 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.991 0.917 . . . . 0.0 109.5 165.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.75 148.19 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 118.492 0.587 . . . . 0.0 111.889 169.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.0 ttp85 -92.19 91.81 7.93 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.337 0.655 . . . . 0.0 110.581 176.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.5 pp -75.26 152.96 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.64 0.776 . . . . 0.0 112.05 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.469 0.507 0 C-N-CA 125.958 1.703 . . . . 0.0 110.9 173.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.6 p . . . . . 0 N--CA 1.466 0.36 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.03 143.4 28.35 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.824 1.25 . . . . 0.0 111.646 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -84.36 118.07 24.0 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.681 0.792 . . . . 0.0 109.536 168.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 30.3 pt -118.34 144.73 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.828 1.251 . . . . 0.0 110.996 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -92.08 139.0 14.5 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.1 pt -124.23 142.21 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 125.039 1.336 . . . . 0.0 111.867 171.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -124.05 143.16 14.68 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 124.777 1.179 . . . . 0.0 113.69 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -106.0 159.79 15.78 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.976 1.711 . . . . 0.0 110.833 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.5 t -72.87 -23.83 60.78 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.699 0.799 . . . . 0.0 112.739 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -158.75 153.74 25.13 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.915 1.286 . . . . 0.0 110.82 -175.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -58.78 -34.44 71.45 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.575 0.75 . . . . 0.0 112.715 176.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.46 -31.65 78.28 Favored Glycine 0 CA--C 1.536 1.368 0 CA-C-N 119.491 1.041 . . . . 0.0 114.348 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -85.85 -36.02 20.26 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.237 1.018 . . . . 0.0 112.114 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.405 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -60.92 -31.96 71.46 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.681 -0.637 . . . . 0.0 112.472 167.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . 0.28 8.2 m-85 -78.88 11.19 2.78 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 173.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -105.24 -31.46 9.09 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.765 0.826 . . . . 0.0 112.813 157.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.444 ' CD2' HD11 ' A' ' 49' ' ' ILE . 26.0 t80 -55.38 -47.09 76.34 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.263 1.025 . . . . 0.0 112.227 175.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -78.23 -32.71 49.95 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.8 t -76.87 -41.62 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.316 1.046 . . . . 0.0 110.906 -177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 81.8 p -64.35 -30.32 71.37 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 81.5 mt -71.67 -54.91 8.82 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.115 0.966 . . . . 0.0 111.92 171.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -66.85 -28.64 68.5 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.048 -1.033 . . . . 0.0 113.194 -175.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -84.76 -3.63 58.69 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.282 1.033 . . . . 0.0 112.664 175.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 53.1 t60 -89.06 -39.49 13.62 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 120.838 -1.164 . . . . 0.0 111.765 158.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -89.84 -1.63 58.03 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -172.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.031 0 CA-C-N 120.705 1.593 . . . . 0.0 114.638 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 p -66.85 145.45 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.386 0.674 . . . . 0.0 112.54 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 50.0 mt -126.82 -44.02 1.67 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.747 1.619 . . . . 0.0 112.209 -176.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.3 t -152.36 134.84 15.24 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.637 1.175 . . . . 0.0 110.482 175.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 86.3 t -127.21 127.06 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.333 1.053 . . . . 0.0 109.325 170.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -127.64 132.91 24.57 Favored Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 125.081 1.352 . . . . 0.0 110.228 174.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.13 -15.75 16.08 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.137 2.558 . . . . 0.0 114.874 -172.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -133.81 106.9 7.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.353 1.061 . . . . 0.0 110.987 -175.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.2 p -142.77 146.18 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 125.342 1.457 . . . . 0.0 110.224 173.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.5 m -127.83 132.13 49.47 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.057 0.943 . . . . 0.0 111.597 -171.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.2 t -98.8 130.24 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.399 1.479 . . . . 0.0 111.803 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -131.31 131.49 43.83 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.236 1.414 . . . . 0.0 109.637 170.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.8 mmt-85 -59.89 140.36 56.71 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.482 165.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.9 pt . . . . . 0 N--CA 1.475 0.817 0 C-N-CA 125.499 1.519 . . . . 0.0 112.834 -174.749 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 . . . . . 0 CA--C 1.532 0.274 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.13 19.67 6.43 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -172.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.49 -50.07 0.05 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.789 2.435 . . . . 0.0 115.39 -174.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.9 m -68.54 -16.62 63.94 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.843 1.657 . . . . 0.0 114.75 -175.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.52 -7.35 59.55 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 172.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.0 m0 -85.58 168.02 14.85 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.857 1.263 . . . . 0.0 110.639 175.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.8 mttt -77.72 52.23 0.99 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.129 1.372 . . . . 0.0 113.964 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.8 mt -57.52 -28.46 63.49 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -175.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -90.28 -6.15 55.48 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -149.91 83.56 6.18 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.502 1.121 . . . . 0.0 112.332 177.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -56.52 147.08 71.55 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.248 2.632 . . . . 0.0 112.95 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -70.1 -33.96 72.51 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.399 0.68 . . . . 0.0 111.14 165.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.5 t90 -156.61 152.68 27.49 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.812 1.645 . . . . 0.0 110.801 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.3 p -132.55 149.88 52.25 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.122 0.969 . . . . 0.0 111.554 167.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.99 -141.44 5.13 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 123.07 0.367 . . . . 0.0 113.282 -178.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.2 mtm105 -109.8 144.92 37.55 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.065 1.746 . . . . 0.0 111.88 -175.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.8 tp -85.36 137.59 32.84 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.711 1.204 . . . . 0.0 109.129 163.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.8 ttt-85 -143.97 89.37 2.03 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.263 1.025 . . . . 0.0 110.56 164.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.503 HD11 ' CD2' ' A' ' 119' ' ' PHE . 15.1 mt -71.53 130.05 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 170.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 p -132.83 173.76 11.04 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.933 2.093 . . . . 0.0 110.282 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 92.9 p -161.89 166.73 25.82 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 120.687 -1.258 . . . . 0.0 111.712 178.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.2 mmtt -152.92 -117.74 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.658 1.583 . . . . 0.0 110.451 153.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.47 92.05 0.41 Allowed Glycine 0 N--CA 1.471 1.024 0 C-N-CA 125.636 1.588 . . . . 0.0 113.802 -160.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.7 mttt 50.99 27.91 3.52 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.429 1.891 . . . . 0.0 112.915 -175.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.1 m -143.42 127.82 17.85 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.24 1.416 . . . . 0.0 109.269 -173.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.76 161.57 13.51 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.637 1.175 . . . . 0.0 110.562 169.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -141.25 102.34 4.21 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.163 1.785 . . . . 0.0 108.905 -173.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.1 mp -78.57 98.09 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 170.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -97.61 138.02 35.65 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.395 0.617 . . . . 0.0 111.575 173.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mp -109.11 132.93 53.64 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.197 1.799 . . . . 0.0 109.568 174.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -137.88 151.92 48.52 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.891 0.876 . . . . 0.0 112.569 -168.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -74.12 143.99 45.1 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.123 -0.986 . . . . 0.0 112.092 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -84.07 -6.55 59.43 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.376 1.871 . . . . 0.0 115.128 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 92.5 t -123.37 -44.32 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 125.315 1.446 . . . . 0.0 111.423 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.8 m -93.64 -22.88 18.5 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -174.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.0 6.88 86.43 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 123.956 0.789 . . . . 0.0 113.805 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -82.37 155.68 24.6 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.364 1.466 . . . . 0.0 112.441 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.3 tp -74.5 129.01 36.97 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.492 0.717 . . . . 0.0 111.223 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -88.04 -55.19 3.86 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.234 1.014 . . . . 0.0 111.16 169.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.39 161.25 40.13 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.918 1.287 . . . . 0.0 111.323 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -144.22 140.74 29.46 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.759 0.824 . . . . 0.0 112.565 176.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.79 102.5 22.37 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 125.936 1.694 . . . . 0.0 111.157 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -69.33 147.15 64.98 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.927 3.085 . . . . 0.0 112.438 170.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.9 t -138.15 125.07 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.796 1.638 . . . . 0.0 109.152 -176.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -92.02 -22.48 19.94 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -159.88 147.45 16.73 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.562 1.945 . . . . 0.0 109.642 168.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -124.14 127.62 25.29 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 124.684 1.194 . . . . 0.0 110.964 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.43 147.4 50.06 Favored 'Cis proline' 0 CA--C 1.541 0.87 0 CA-C-N 120.079 1.064 . . . . 0.0 114.534 -4.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.33 -166.58 19.44 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.488 1.518 . . . . 0.0 113.429 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.4 tp -70.65 -31.24 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -174.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.85 3.54 50.84 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -171.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.9 t -150.34 133.54 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.902 1.281 . . . . 0.0 110.844 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -141.35 161.61 37.49 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.319 1.448 . . . . 0.0 112.83 175.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 73.0 p -107.21 161.23 14.96 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 127.055 2.142 . . . . 0.0 111.093 177.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.8 m -88.27 172.83 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 123.897 0.879 . . . . 0.0 111.232 166.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 60.0 p -96.22 -30.29 13.55 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.39 1.476 . . . . 0.0 113.368 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -96.28 -40.59 9.08 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -165.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.5 t -137.74 117.96 13.59 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -173.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.3 p -75.08 29.25 0.09 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -172.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.96 24.82 7.48 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 127.108 2.163 . . . . 0.0 113.937 174.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -140.96 139.88 34.31 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.902 1.281 . . . . 0.0 111.261 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -137.74 159.87 40.8 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.813 1.245 . . . . 0.0 110.738 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.8 t -112.18 144.66 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 124.288 1.035 . . . . 0.0 108.772 165.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.94 148.07 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 118.095 0.407 . . . . 0.0 111.755 168.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -89.86 99.98 12.88 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.31 0.644 . . . . 0.0 109.542 172.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -84.7 155.21 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.536 1.135 . . . . 0.0 111.335 176.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 . . . . . 0 N--CA 1.469 0.507 0 C-N-CA 124.969 1.308 . . . . 0.0 111.592 178.244 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 84.1 p . . . . . 0 N--CA 1.473 0.719 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.48 144.77 28.82 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.89 1.276 . . . . 0.0 111.267 172.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -87.88 119.89 28.67 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 165.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 31.3 pt -120.69 142.81 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.628 1.171 . . . . 0.0 111.218 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.69 137.31 13.51 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 176.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.3 pt -124.6 139.05 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 125.226 1.41 . . . . 0.0 111.713 175.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.1 140.28 14.45 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.719 1.152 . . . . 0.0 113.082 177.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -101.84 159.47 15.31 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.025 1.73 . . . . 0.0 111.37 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.5 t -70.58 -27.38 64.07 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.32 0.648 . . . . 0.0 112.646 178.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -158.05 155.96 30.23 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.382 1.073 . . . . 0.0 111.997 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -56.58 -38.41 71.94 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.662 1.185 . . . . 0.0 112.482 174.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.05 -10.43 46.72 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.541 1.067 . . . . 0.0 115.022 176.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -104.75 -35.97 7.58 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.746 1.273 . . . . 0.0 111.754 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.7 -28.27 68.52 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.65 0.78 . . . . 0.0 112.835 164.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -70.74 -6.51 38.01 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 169.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -93.76 -35.25 12.87 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.939 1.245 . . . . 0.0 112.26 163.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.503 ' CD2' HD11 ' A' ' 49' ' ' ILE . 43.5 t80 -55.2 -55.76 27.64 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.304 0.957 . . . . 0.0 112.267 177.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -78.81 -27.66 44.42 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 -173.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.6 t -79.74 -39.58 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 121.749 -0.595 . . . . 0.0 111.043 -178.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 88.5 p -65.7 -33.31 75.59 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.544 -0.722 . . . . 0.0 112.524 174.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 40.6 mt -66.62 -55.73 13.96 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.035 0.934 . . . . 0.0 112.154 172.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -64.85 -27.26 68.75 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.136 0.88 . . . . 0.0 112.874 -176.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -79.0 -7.8 58.38 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.345 1.058 . . . . 0.0 112.873 176.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -84.89 -15.61 44.0 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.087 -1.008 . . . . 0.0 112.815 165.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -115.17 -7.92 12.41 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -173.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.466 0.352 0 CA-C-O 120.53 0.205 . . . . 0.0 111.299 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.5 t -73.52 143.72 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.741 1.216 . . . . 0.0 111.583 -169.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.9 mt -128.86 -38.67 1.65 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.73 1.612 . . . . 0.0 112.625 -174.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 34.8 t -154.22 136.76 15.09 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.618 1.167 . . . . 0.0 110.726 173.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 88.7 t -130.14 127.27 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.639 1.176 . . . . 0.0 109.383 171.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -129.05 140.17 37.84 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 125.791 1.636 . . . . 0.0 110.794 176.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -77.35 -27.26 6.64 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.464 2.776 . . . . 0.0 115.84 -168.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -140.05 115.87 10.24 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.087 0.946 . . . . 0.0 111.843 -175.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.9 145.4 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 126.84 2.056 . . . . 0.0 109.726 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.2 m -124.71 130.05 51.68 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.767 0.827 . . . . 0.0 112.133 -167.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 77.8 t -94.6 137.44 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.212 1.405 . . . . 0.0 112.051 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.56 128.72 37.84 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.624 1.17 . . . . 0.0 110.133 169.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.41 135.95 57.34 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.306 1.042 . . . . 0.0 111.035 161.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.8 pt . . . . . 0 N--CA 1.475 0.8 0 C-N-CA 126.248 1.819 . . . . 0.0 112.294 -177.623 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.62 18.45 6.83 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -170.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.73 -50.67 0.05 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.879 2.472 . . . . 0.0 115.464 -175.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.6 m -66.77 -14.6 62.79 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.069 1.748 . . . . 0.0 114.19 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -76.36 -21.51 56.01 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.723 1.209 . . . . 0.0 112.56 172.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 17.3 m0 -84.52 172.09 11.96 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.667 1.587 . . . . 0.0 111.524 -177.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -80.16 54.55 1.98 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.365 1.466 . . . . 0.0 113.978 -177.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.7 mt -60.71 -17.27 47.23 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -174.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -102.08 -8.04 21.77 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.813 1.245 . . . . 0.0 113.104 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -149.0 72.52 10.29 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.896 1.278 . . . . 0.0 111.867 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -57.47 145.58 87.77 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.043 2.495 . . . . 0.0 112.374 174.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -70.07 -29.14 66.07 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.513 1.125 . . . . 0.0 111.749 175.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 42.1 t90 -159.44 152.99 22.63 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.035 1.734 . . . . 0.0 110.476 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.2 p -133.7 152.31 51.85 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.575 -0.703 . . . . 0.0 112.381 166.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.08 -146.72 7.35 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 116.174 -0.466 . . . . 0.0 114.085 -176.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 42.7 mtm105 -104.84 148.27 26.83 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.047 2.139 . . . . 0.0 111.734 -175.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.3 tp -89.51 139.43 30.54 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.257 1.423 . . . . 0.0 110.247 167.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 -141.53 97.15 3.1 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.65 1.58 . . . . 0.0 109.682 167.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.472 HD11 ' CD2' ' A' ' 119' ' ' PHE . 17.3 mt -83.31 130.67 35.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 169.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.81 162.82 34.47 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.51 2.324 . . . . 0.0 109.508 -168.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.5 t -163.48 153.73 15.66 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.431 -1.418 . . . . 0.0 110.508 175.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -128.58 -41.79 1.5 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 116.786 2.143 . . . . 0.0 116.786 -176.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.92 82.53 0.1 OUTLIER Glycine 0 N--CA 1.472 1.072 0 CA-C-N 118.652 0.66 . . . . 0.0 112.075 -175.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt 54.71 25.24 6.29 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.006 1.722 . . . . 0.0 112.749 -171.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.7 m -141.43 118.27 11.11 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.197 1.399 . . . . 0.0 107.649 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.51 160.06 14.69 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.241 1.016 . . . . 0.0 110.799 174.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -138.44 113.81 9.55 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 126.346 1.858 . . . . 0.0 108.956 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.5 mp -86.12 102.17 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 166.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -100.67 140.01 35.55 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.349 1.059 . . . . 0.0 111.409 176.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.8 mp -113.32 130.6 56.22 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.444 1.898 . . . . 0.0 109.605 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -135.85 153.26 51.54 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.079 0.952 . . . . 0.0 112.259 -174.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -73.12 142.91 47.49 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.85 -1.156 . . . . 0.0 111.9 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.3 pttt -84.63 -4.64 59.1 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.973 1.709 . . . . 0.0 115.048 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 64.8 t -124.79 -43.81 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 125.468 1.507 . . . . 0.0 111.361 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.7 m -91.54 -24.2 19.69 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.5 5.77 87.99 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 123.992 0.806 . . . . 0.0 113.831 -177.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -82.78 151.17 26.24 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.343 1.457 . . . . 0.0 112.566 -173.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.1 tp -73.36 126.12 29.41 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.612 0.765 . . . . 0.0 110.886 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -87.65 -54.8 4.07 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.462 1.105 . . . . 0.0 111.226 171.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.29 163.64 38.51 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.575 1.15 . . . . 0.0 112.01 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -142.23 134.41 27.59 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.707 1.203 . . . . 0.0 111.653 177.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.15 97.08 50.5 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.11 1.364 . . . . 0.0 111.669 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -58.89 139.7 91.97 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 124.568 3.512 . . . . 0.0 113.315 166.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.3 t -139.13 128.87 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.571 1.949 . . . . 0.0 109.52 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -90.77 -24.12 20.44 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.34 149.97 15.94 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.034 1.734 . . . . 0.0 110.772 173.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -118.83 130.43 24.82 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.589 1.156 . . . . 0.0 111.469 175.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -63.34 148.33 64.16 Favored 'Cis proline' 0 CA--C 1.542 0.879 0 CA-C-N 119.761 0.951 . . . . 0.0 113.583 -7.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -152.39 -163.91 11.96 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.578 1.561 . . . . 0.0 112.461 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.9 tt -78.13 -36.47 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 O-C-N 121.82 -0.812 . . . . 0.0 112.938 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.94 8.71 9.76 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -169.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.0 t -149.8 133.69 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 126.33 1.852 . . . . 0.0 109.446 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -146.43 159.17 43.74 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.464 1.506 . . . . 0.0 112.489 -177.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.8 p -109.7 155.66 21.25 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 126.638 1.975 . . . . 0.0 111.696 176.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.1 m -80.51 173.46 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 124.01 0.924 . . . . 0.0 110.982 165.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.6 p -95.68 -30.21 13.88 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.409 1.484 . . . . 0.0 113.357 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -91.1 -50.24 5.96 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.927 0.891 . . . . 0.0 113.266 -167.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.7 m -133.78 117.39 16.84 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -167.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.0 m -73.23 28.36 0.06 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -171.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.428 ' HA ' ' CB ' ' A' ' 116' ' ' ALA . 6.1 ptm180 -125.23 23.62 7.61 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.859 2.064 . . . . 0.0 113.577 175.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -141.07 137.43 32.87 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.279 1.432 . . . . 0.0 110.99 -178.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -137.35 165.24 26.67 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.855 1.262 . . . . 0.0 111.128 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.3 t -120.28 143.29 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 124.658 1.183 . . . . 0.0 108.539 168.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.72 149.05 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 118.639 0.654 . . . . 0.0 111.744 172.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -92.49 90.23 7.08 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.051 0.54 . . . . 0.0 110.858 177.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -70.57 141.32 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 122.894 0.478 . . . . 0.0 110.995 177.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 . . . . . 0 N--CA 1.47 0.564 0 C-N-CA 126.09 1.756 . . . . 0.0 111.491 -172.83 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 93.6 p . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.14 146.46 30.87 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.527 1.531 . . . . 0.0 111.29 171.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -87.11 124.56 33.38 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.737 -0.602 . . . . 0.0 109.425 166.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.8 pt -122.5 143.57 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.522 1.129 . . . . 0.0 111.092 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -90.18 144.28 17.46 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 173.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.8 pt -129.67 140.43 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 125.53 1.532 . . . . 0.0 111.991 173.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.23 137.7 11.59 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 125.64 1.591 . . . . 0.0 113.151 178.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -102.09 162.92 12.54 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.252 1.821 . . . . 0.0 111.29 -178.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.4 t -74.14 -27.73 60.99 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.722 0.809 . . . . 0.0 113.006 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -157.11 153.27 27.52 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.276 1.03 . . . . 0.0 112.229 -177.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -60.01 -34.4 73.28 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.601 1.16 . . . . 0.0 113.151 176.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.1 -31.54 81.12 Favored Glycine 0 CA--C 1.536 1.39 0 CA-C-N 119.131 0.878 . . . . 0.0 113.382 176.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -83.69 -34.69 24.9 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.804 0.842 . . . . 0.0 112.093 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.428 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -65.46 -33.51 76.12 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 170.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -61.77 -32.19 72.45 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.043 -1.036 . . . . 0.0 112.582 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -66.34 -30.15 70.49 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.049 -1.032 . . . . 0.0 112.738 173.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.472 ' CD2' HD11 ' A' ' 49' ' ' ILE . 24.4 t80 -63.09 -49.35 74.83 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.372 0.987 . . . . 0.0 111.943 173.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.8 -25.11 33.03 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -177.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.8 t -78.37 -41.59 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 119.197 0.908 . . . . 0.0 111.39 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 93.7 p -64.58 -29.49 70.51 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.251 0.932 . . . . 0.0 113.302 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 78.0 mt -70.96 -54.28 11.9 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.004 0.922 . . . . 0.0 111.712 171.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -68.51 -32.74 72.91 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.01 -1.056 . . . . 0.0 113.225 -174.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -83.81 -1.34 54.12 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.088 0.955 . . . . 0.0 112.364 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -96.44 -33.24 11.95 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 120.931 -1.106 . . . . 0.0 112.545 164.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -93.05 -3.28 54.57 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.301 0 CA-C-N 121.595 1.998 . . . . 0.0 114.936 -175.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 82.6 p . . . . . 0 N--CA 1.469 0.509 0 CA-C-O 121.083 0.468 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 82.5 t -70.62 141.01 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.916 0.886 . . . . 0.0 111.053 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.6 mt -127.49 -40.54 1.77 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.697 1.599 . . . . 0.0 112.646 -171.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 51.1 t -146.87 137.28 23.65 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.505 1.522 . . . . 0.0 109.247 172.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 76.8 t -126.6 130.48 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.355 1.062 . . . . 0.0 108.936 168.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -133.57 127.84 19.79 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 124.562 1.145 . . . . 0.0 111.076 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.19 -13.24 12.65 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.986 2.457 . . . . 0.0 114.947 -171.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -134.11 104.52 6.25 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.223 1.009 . . . . 0.0 110.717 -176.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.5 p -143.18 144.42 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.508 1.123 . . . . 0.0 110.726 174.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.8 m -124.88 131.21 53.46 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.55 1.14 . . . . 0.0 110.629 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.0 t -96.61 134.33 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.946 1.298 . . . . 0.0 111.127 177.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.38 120.63 25.87 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.06 1.344 . . . . 0.0 108.932 169.105 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -63.24 130.79 46.06 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.425 -0.797 . . . . 0.0 109.145 163.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.2 pt . . . . . 0 CA--C 1.544 0.745 0 C-N-CA 124.845 1.258 . . . . 0.0 112.834 -166.703 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 . . . . . 0 C--O 1.223 -0.329 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.92 18.64 7.86 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -171.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.16 -49.89 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 128.141 2.576 . . . . 0.0 115.607 -173.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.5 m -67.61 -15.2 63.53 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.012 1.725 . . . . 0.0 114.603 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.95 -10.8 58.62 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 171.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.0 m0 -85.55 170.45 12.59 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.813 1.245 . . . . 0.0 110.841 176.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.9 mtmm -80.24 52.94 1.66 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.408 1.483 . . . . 0.0 113.606 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.6 mt -57.89 -23.76 54.69 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -173.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -96.28 -6.51 37.71 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.547 1.139 . . . . 0.0 112.446 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -151.99 72.37 7.88 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 125.111 1.364 . . . . 0.0 111.817 -169.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -57.97 149.59 69.62 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.725 2.95 . . . . 0.0 113.605 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -73.32 -31.11 63.81 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.76 0.824 . . . . 0.0 111.401 167.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 33.5 t90 -158.13 153.02 25.15 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.48 1.912 . . . . 0.0 110.391 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.2 p -134.18 146.74 50.45 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.719 1.208 . . . . 0.0 111.486 171.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.41 -138.5 4.28 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 114.088 0.395 . . . . 0.0 114.088 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -115.89 144.72 43.64 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.816 1.646 . . . . 0.0 111.578 -172.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.2 tp -92.49 137.72 32.12 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.354 1.462 . . . . 0.0 109.821 172.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 53.9 ttp85 -138.68 102.21 4.53 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.96 0.904 . . . . 0.0 110.026 162.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.54 HD11 ' CD1' ' A' ' 119' ' ' PHE . 25.8 mt -79.16 132.67 31.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 169.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.74 171.69 14.13 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 126.229 1.812 . . . . 0.0 110.708 -175.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.0 t -161.41 159.53 28.31 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.369 1.068 . . . . 0.0 110.869 172.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -147.55 -85.03 0.1 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 158.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.56 68.39 3.36 Favored Glycine 0 N--CA 1.474 1.226 0 C-N-CA 124.629 1.109 . . . . 0.0 113.959 -166.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.7 mttt 51.67 30.13 6.39 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.815 1.646 . . . . 0.0 112.49 -172.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.8 m -146.92 120.8 9.3 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.383 1.873 . . . . 0.0 108.237 -173.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.84 156.7 19.77 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.318 1.047 . . . . 0.0 110.939 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -135.15 100.41 4.54 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.336 1.855 . . . . 0.0 108.713 -173.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.6 mp -79.74 104.84 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 171.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.4 mttt -105.4 135.26 47.11 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.526 0.73 . . . . 0.0 111.775 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -101.08 133.17 46.01 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 125.237 1.415 . . . . 0.0 110.189 169.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -138.32 148.34 44.5 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.038 0.935 . . . . 0.0 112.233 -171.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -68.51 149.67 48.97 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.217 1.008 . . . . 0.0 113.688 -171.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.89 -3.84 43.73 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.9 t -123.41 -48.25 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.636 1.174 . . . . 0.0 111.705 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.6 p -95.35 -24.6 16.66 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -176.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.05 13.98 76.16 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 123.609 0.623 . . . . 0.0 113.522 -167.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -69.13 149.28 48.82 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 118.727 1.263 . . . . 0.0 111.533 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.4 tp -71.2 124.11 23.75 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.444 0.698 . . . . 0.0 111.441 -175.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -84.26 -53.86 5.2 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.971 0.908 . . . . 0.0 110.924 168.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -159.39 157.67 30.74 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.925 1.29 . . . . 0.0 111.516 -177.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -138.99 138.77 37.56 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.59 0.756 . . . . 0.0 112.81 174.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.65 111.09 36.4 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.059 1.343 . . . . 0.0 111.685 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -82.81 123.73 3.76 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.981 3.121 . . . . 0.0 111.91 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.6 t -114.41 119.73 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 126.862 2.065 . . . . 0.0 109.324 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -81.97 -20.56 38.28 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 -176.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.08 162.54 15.44 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.245 1.818 . . . . 0.0 109.308 171.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -120.45 129.81 25.15 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -173.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -64.95 151.94 76.03 Favored 'Cis proline' 0 CA--C 1.542 0.912 0 CA-C-N 119.193 0.748 . . . . 0.0 112.895 -11.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -147.37 175.48 26.71 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.165 0.888 . . . . 0.0 114.15 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.5 tp -52.97 -30.11 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 124.695 1.198 . . . . 0.0 114.066 -176.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.68 9.82 28.28 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.6 p -155.45 138.36 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.197 0.999 . . . . 0.0 113.561 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -152.24 161.12 43.09 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.664 1.586 . . . . 0.0 113.069 -172.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 62.9 p -112.88 161.01 17.46 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 127.307 2.243 . . . . 0.0 111.202 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.0 m -88.5 175.8 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.319 1.047 . . . . 0.0 111.314 167.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.7 p -95.79 -31.59 13.11 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.673 1.589 . . . . 0.0 113.357 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -93.98 -42.37 9.08 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -165.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.4 t -142.49 121.39 12.77 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -177.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.15 0.73 5.69 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -169.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.486 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.303 28.4 ptt180 -87.12 16.21 5.34 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 176.509 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -137.24 136.8 38.43 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.168 1.387 . . . . 0.0 110.908 -174.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -137.54 160.3 39.54 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.138 1.375 . . . . 0.0 111.263 -177.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.1 t -116.2 143.05 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.258 1.023 . . . . 0.0 108.915 166.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.67 149.66 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 123.441 0.697 . . . . 0.0 111.395 170.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -93.25 87.44 5.65 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.776 0.831 . . . . 0.0 110.357 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -70.24 138.35 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 120.958 0.409 . . . . 0.0 110.695 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 . . . . . 0 N--CA 1.468 0.442 0 C-N-CA 125.484 1.514 . . . . 0.0 111.212 -167.77 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 95.6 p . . . . . 0 CA--C 1.534 0.362 0 N-CA-C 114.646 1.351 . . . . 0.0 114.646 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.14 140.72 28.18 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.208 1.403 . . . . 0.0 110.927 168.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -88.39 119.69 29.06 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.175 0.59 . . . . 0.0 109.896 170.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.8 pt -118.54 142.0 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.543 1.137 . . . . 0.0 110.756 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -90.99 144.27 17.12 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 173.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.2 pt -128.38 141.81 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 125.052 1.341 . . . . 0.0 111.631 169.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -121.4 142.67 15.52 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.142 1.353 . . . . 0.0 113.169 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -107.19 164.97 11.72 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.718 1.607 . . . . 0.0 111.551 -177.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.6 t -74.39 -31.91 62.52 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.486 0.714 . . . . 0.0 112.521 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -151.71 146.36 25.71 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.245 -0.909 . . . . 0.0 112.071 -172.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -61.71 -33.78 74.62 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.329 1.051 . . . . 0.0 113.195 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.7 -25.54 75.03 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-N 118.935 0.789 . . . . 0.0 113.838 176.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -92.96 -26.38 17.59 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.193 0.997 . . . . 0.0 112.821 176.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.486 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -66.11 -34.53 78.27 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.422 -0.799 . . . . 0.0 112.598 161.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -59.82 -31.32 69.62 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.049 -1.032 . . . . 0.0 112.197 168.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -67.28 -25.19 65.93 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 119.553 1.07 . . . . 0.0 112.968 174.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.54 ' CD1' HD11 ' A' ' 49' ' ' ILE . 13.4 t80 -69.74 -51.87 30.42 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.205 1.002 . . . . 0.0 111.878 168.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.08 -25.3 40.08 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -174.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 65.0 t -77.97 -42.41 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 121.134 -0.979 . . . . 0.0 111.05 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 88.7 p -66.37 -30.66 71.09 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.1 mt -69.93 -55.95 8.33 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.828 0.851 . . . . 0.0 111.536 171.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -63.68 -33.7 76.22 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.117 0.871 . . . . 0.0 113.256 -174.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -83.53 -0.89 52.26 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.468 1.107 . . . . 0.0 112.762 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -94.11 -13.41 26.81 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.263 -0.898 . . . . 0.0 113.31 164.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -108.17 -4.86 17.26 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.331 0 CA-C-N 121.079 1.763 . . . . 0.0 115.677 -176.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.0 m . . . . . 0 N--CA 1.468 0.451 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.36 146.99 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.779 0.831 . . . . 0.0 113.015 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.6 mt -130.82 -42.56 1.12 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.65 1.58 . . . . 0.0 112.409 -173.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 27.1 t -151.64 134.67 15.8 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.336 1.054 . . . . 0.0 110.933 177.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 96.9 t -129.31 127.85 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.516 1.126 . . . . 0.0 109.474 172.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -127.36 130.55 23.7 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 125.176 1.391 . . . . 0.0 110.085 173.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.7 -13.96 15.99 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 122.959 2.439 . . . . 0.0 115.144 -171.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -134.37 108.59 8.26 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.029 0.932 . . . . 0.0 111.425 -176.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.69 146.16 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.975 1.71 . . . . 0.0 109.926 174.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.0 m -127.6 131.02 49.99 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.908 0.883 . . . . 0.0 111.695 -170.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 68.2 t -97.77 131.66 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.361 1.464 . . . . 0.0 111.749 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.17 120.89 25.26 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.071 1.348 . . . . 0.0 108.611 167.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.0 mtt-85 -71.69 130.08 40.27 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.094 0.557 . . . . 0.0 109.939 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.4 pt . . . . . 0 N--CA 1.474 0.726 0 C-N-CA 124.095 0.958 . . . . 0.0 113.435 -163.482 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 . . . . . 0 CA--C 1.534 0.327 0 CA-C-O 120.444 0.164 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.21 18.58 4.92 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -173.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 59.98 -48.47 0.09 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 128.4 2.68 . . . . 0.0 115.253 -174.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.5 p -65.5 -18.32 65.23 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.838 2.055 . . . . 0.0 114.688 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.74 -15.32 59.21 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.963 0.905 . . . . 0.0 112.988 173.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -90.56 165.29 13.85 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.853 1.261 . . . . 0.0 110.341 176.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.3 mtmt -87.0 64.17 8.33 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.793 0.837 . . . . 0.0 112.435 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.0 mt -56.52 -27.63 57.89 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.752 1.621 . . . . 0.0 115.032 -172.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -86.04 -8.09 58.16 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.107 0.963 . . . . 0.0 113.137 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -135.04 58.82 29.96 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 125.27 1.428 . . . . 0.0 111.814 -161.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -65.82 139.45 57.3 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 CA-C-N 119.719 0.935 . . . . 0.0 112.421 -172.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -69.44 -27.88 65.64 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.747 0.819 . . . . 0.0 111.222 174.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 50.2 t90 -158.09 151.34 23.15 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.89 1.676 . . . . 0.0 110.713 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.3 p -132.97 150.68 52.14 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.791 0.836 . . . . 0.0 111.835 167.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.1 -142.91 5.53 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 116.259 -0.428 . . . . 0.0 113.524 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.5 mtm180 -109.64 146.4 34.84 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.528 1.931 . . . . 0.0 111.812 -176.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.2 tp -84.99 139.49 31.75 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.483 1.513 . . . . 0.0 109.746 163.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -143.93 92.41 2.33 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.091 1.356 . . . . 0.0 110.714 167.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.42 HD11 ' CD2' ' A' ' 119' ' ' PHE . 20.3 mt -76.95 126.27 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 171.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.2 p -138.22 165.53 26.46 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.771 2.028 . . . . 0.0 110.111 -178.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.0 m -148.15 160.12 43.24 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.562 1.145 . . . . 0.0 112.426 175.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -148.8 125.0 10.79 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.281 0.562 . . . . 0.0 112.35 155.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.55 -124.24 8.66 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 125.377 1.465 . . . . 0.0 110.025 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -99.86 17.86 19.77 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.714 1.605 . . . . 0.0 113.317 176.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.3 m -124.45 125.8 44.85 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.63 1.172 . . . . 0.0 110.172 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.68 160.11 14.5 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.549 1.14 . . . . 0.0 111.205 171.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -141.78 103.16 4.3 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.849 2.06 . . . . 0.0 109.071 -171.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.3 mp -81.45 94.16 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 169.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -90.15 141.7 28.43 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.613 0.765 . . . . 0.0 111.27 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.4 mp -113.2 133.04 55.26 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.618 1.967 . . . . 0.0 109.918 173.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -131.45 147.86 52.59 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.105 0.962 . . . . 0.0 113.003 -172.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -68.68 133.77 48.91 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.066 -1.021 . . . . 0.0 110.93 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.416 ' HG2' ' H ' ' A' ' 63' ' ' LYS . 36.5 pttt -77.48 -4.24 44.49 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -176.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 64.1 t -120.62 -42.44 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 125.205 1.402 . . . . 0.0 111.537 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.9 m -93.44 -20.57 20.18 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.09 11.46 79.09 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.551 1.072 . . . . 0.0 113.831 -176.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -87.19 152.44 22.32 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.325 1.45 . . . . 0.0 112.254 -173.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.5 tp -71.9 127.19 31.79 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.601 -0.687 . . . . 0.0 111.389 -178.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -87.27 -55.87 3.62 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.361 1.065 . . . . 0.0 111.047 169.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.95 163.54 39.02 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.438 1.495 . . . . 0.0 110.603 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -145.99 141.43 27.68 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 172.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.08 104.16 52.56 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 125.323 1.449 . . . . 0.0 111.606 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -64.6 142.59 78.16 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.037 3.158 . . . . 0.0 112.54 169.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.6 t -138.37 132.29 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.972 1.709 . . . . 0.0 108.793 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -103.42 -18.22 14.91 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.98 147.24 14.8 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.909 2.083 . . . . 0.0 109.766 173.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -134.3 124.62 17.36 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.484 1.113 . . . . 0.0 111.551 -177.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -59.25 147.89 38.86 Favored 'Cis proline' 0 CA--C 1.54 0.81 0 CA-C-N 120.123 1.08 . . . . 0.0 114.533 -4.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -161.7 -160.0 10.57 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 126.166 1.841 . . . . 0.0 112.025 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.6 tt -76.12 -40.0 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 118.185 0.993 . . . . 0.0 113.158 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.77 7.24 18.42 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -166.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.3 t -150.73 130.08 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.575 1.55 . . . . 0.0 109.947 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -141.84 158.01 44.31 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.041 1.736 . . . . 0.0 112.487 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.4 p -108.28 160.81 15.55 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.745 2.018 . . . . 0.0 111.153 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.9 m -88.87 169.35 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 124.062 0.945 . . . . 0.0 110.862 165.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.5 p -94.1 -29.5 15.13 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.869 1.267 . . . . 0.0 113.556 178.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -92.71 -41.25 10.26 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -166.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.2 t -142.27 112.76 7.21 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -177.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.6 p -72.94 30.32 0.06 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -174.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.43 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.254 1.0 OUTLIER -115.86 23.12 12.51 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.854 2.061 . . . . 0.0 113.519 166.785 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -140.44 138.59 34.82 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.69 1.596 . . . . 0.0 110.622 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -137.34 163.59 30.64 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.902 1.281 . . . . 0.0 111.562 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 37.2 t -117.57 144.83 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.862 1.265 . . . . 0.0 109.13 166.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.69 148.76 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 123.07 0.548 . . . . 0.0 111.538 170.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.459 ' HE ' ' NE2' ' A' ' 97' ' ' GLN . 42.0 ttp180 -91.05 98.82 12.0 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.397 0.679 . . . . 0.0 109.858 173.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -79.61 150.17 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.793 0.837 . . . . 0.0 111.628 176.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.459 ' NE2' ' HE ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.638 0 C-N-CA 125.848 1.659 . . . . 0.0 110.835 177.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 CA--C 1.534 0.354 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.25 144.23 29.72 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.999 1.319 . . . . 0.0 111.334 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -89.87 120.25 30.94 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.509 0.724 . . . . 0.0 109.607 169.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.5 pt -120.31 144.05 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.77 1.228 . . . . 0.0 111.053 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.44 142.71 16.17 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 124.151 0.881 . . . . 0.0 111.312 174.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.7 pt -129.33 143.09 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 125.506 1.522 . . . . 0.0 112.121 174.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.19 144.2 17.09 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.797 1.189 . . . . 0.0 113.491 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -107.08 158.7 16.86 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.084 1.754 . . . . 0.0 111.213 -178.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.8 t -72.21 -26.73 62.16 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.596 0.758 . . . . 0.0 112.796 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -157.23 151.64 25.17 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.441 1.096 . . . . 0.0 111.804 -176.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 43.2 ttm105 -61.32 -32.58 72.45 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.226 1.01 . . . . 0.0 113.197 177.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.94 -31.72 81.75 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 119.382 0.992 . . . . 0.0 113.464 176.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -85.89 -30.67 22.69 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 117.963 0.882 . . . . 0.0 112.395 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.43 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -65.92 -37.39 85.93 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 168.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -61.28 -36.46 80.12 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.105 -0.997 . . . . 0.0 110.91 170.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -71.17 -13.28 61.88 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 113.547 0.944 . . . . 0.0 113.547 175.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.42 ' CD2' HD11 ' A' ' 49' ' ' ILE . 15.5 t80 -77.97 -50.73 11.58 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.55 1.14 . . . . 0.0 111.568 165.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.11 -27.14 39.23 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -174.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 71.8 t -77.86 -43.02 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.129 -0.982 . . . . 0.0 111.159 177.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 92.1 p -65.58 -33.9 76.99 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.606 -0.684 . . . . 0.0 112.687 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 35.1 tp -72.58 -47.04 51.25 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.913 1.285 . . . . 0.0 111.591 176.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -69.75 -29.82 67.26 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.162 -0.961 . . . . 0.0 113.239 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -78.96 -4.02 47.85 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.215 1.006 . . . . 0.0 112.333 177.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -89.5 -21.89 22.72 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.299 -0.876 . . . . 0.0 113.143 162.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -99.28 -13.23 19.76 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -177.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 -172.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.3 m . . . . . 0 N--CA 1.473 0.695 0 N-CA-C 110.65 -0.13 . . . . 0.0 110.65 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.9 p -69.24 148.82 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.492 1.117 . . . . 0.0 112.908 -177.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.2 mt -135.58 -38.84 0.73 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.916 1.686 . . . . 0.0 112.305 -171.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.0 t -147.02 140.52 25.58 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.415 1.486 . . . . 0.0 109.753 174.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.4 t -131.85 132.07 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.374 1.07 . . . . 0.0 108.637 167.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.61 131.72 18.39 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 124.694 1.197 . . . . 0.0 111.341 177.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -81.04 -15.63 10.32 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.843 2.362 . . . . 0.0 115.302 -170.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -130.5 106.79 8.76 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.38 1.072 . . . . 0.0 110.82 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.8 p -143.81 142.38 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.032 1.333 . . . . 0.0 110.359 173.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.8 m -125.72 132.04 52.43 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.721 1.208 . . . . 0.0 111.137 -173.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 79.4 t -97.43 130.68 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.497 1.119 . . . . 0.0 111.225 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -131.78 117.02 18.01 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.99 1.316 . . . . 0.0 108.295 168.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.3 mtt-85 -71.63 128.85 37.14 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.87 -0.519 . . . . 0.0 109.73 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 39.3 pt . . . . . 0 CA--C 1.543 0.674 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -163.161 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 . . . . . 0 CA--C 1.533 0.324 0 N-CA-C 110.606 -0.146 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.67 21.36 7.73 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -173.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 56.9 -49.91 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.29 2.636 . . . . 0.0 115.399 -171.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.7 m -64.71 -14.64 59.36 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.26 1.824 . . . . 0.0 114.558 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -84.18 -7.84 59.24 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.774 1.23 . . . . 0.0 113.039 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.2 m0 -93.7 169.4 10.35 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.73 1.612 . . . . 0.0 111.151 176.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -76.56 51.89 0.76 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.194 1.798 . . . . 0.0 114.185 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.5 mt -55.58 -28.54 55.64 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.205 1.402 . . . . 0.0 114.487 -177.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -88.37 -7.42 56.68 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.428 0.691 . . . . 0.0 112.547 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -152.38 66.52 6.47 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.965 1.306 . . . . 0.0 111.887 -168.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -58.27 145.29 93.86 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.397 2.731 . . . . 0.0 112.856 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -72.56 -28.8 63.04 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.544 1.138 . . . . 0.0 111.657 174.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 42.1 t90 -158.11 152.14 24.08 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.431 1.892 . . . . 0.0 110.234 177.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.8 p -134.11 150.63 51.16 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.882 0.873 . . . . 0.0 111.862 169.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.38 -139.15 4.19 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 123.233 0.444 . . . . 0.0 113.325 -177.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.1 mtm105 -115.82 150.36 37.08 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.709 2.004 . . . . 0.0 112.001 -173.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.5 tp -94.61 138.33 32.61 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.227 1.811 . . . . 0.0 110.207 171.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.5 ttm-85 -135.74 111.1 9.08 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.825 1.25 . . . . 0.0 109.808 160.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.516 HD11 ' CD2' ' A' ' 119' ' ' PHE . 24.9 mt -91.32 131.3 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 168.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.25 170.36 16.1 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 127.396 2.279 . . . . 0.0 110.13 -173.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.6 t -158.54 149.47 20.47 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 120.409 -1.432 . . . . 0.0 111.792 176.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -151.42 129.14 11.55 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.631 0.772 . . . . 0.0 112.663 158.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.88 45.88 55.41 Favored Glycine 0 N--CA 1.473 1.162 0 C-N-CA 124.432 1.015 . . . . 0.0 114.956 164.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt 62.99 26.24 15.42 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.294 1.838 . . . . 0.0 113.269 -174.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.4 m -131.03 114.11 14.79 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.112 1.365 . . . . 0.0 108.72 168.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -83.99 159.23 21.27 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.507 0.723 . . . . 0.0 110.464 172.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -136.08 115.7 12.89 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 125.956 1.702 . . . . 0.0 108.693 -175.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.7 mp -92.29 99.48 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 168.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -99.83 139.7 35.12 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.876 0.846 . . . . 0.0 112.207 175.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.8 mp -110.68 132.94 53.76 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.091 1.756 . . . . 0.0 109.92 176.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -134.77 151.02 50.64 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.017 0.927 . . . . 0.0 113.04 -171.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -73.14 144.11 47.04 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.924 0.869 . . . . 0.0 112.112 -178.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.1 pttt -84.22 -6.56 59.41 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.209 1.804 . . . . 0.0 115.144 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 95.7 t -122.73 -44.17 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.206 1.402 . . . . 0.0 111.447 178.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.0 m -94.08 -21.8 18.9 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -175.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.01 5.92 85.4 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.182 0.896 . . . . 0.0 113.861 -177.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -82.02 153.88 25.96 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.276 1.431 . . . . 0.0 112.752 -173.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.5 tp -73.52 126.08 29.41 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.993 0.917 . . . . 0.0 111.107 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -86.18 -55.78 3.76 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.437 1.095 . . . . 0.0 111.121 170.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.85 164.01 38.55 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.755 1.222 . . . . 0.0 111.838 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -140.83 136.4 32.36 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.831 1.252 . . . . 0.0 111.816 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.4 107.69 36.58 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 124.778 1.231 . . . . 0.0 111.633 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -76.42 136.55 17.72 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.563 2.842 . . . . 0.0 111.925 173.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.1 t -127.71 119.53 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 127.093 2.157 . . . . 0.0 108.761 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -88.27 -17.69 30.18 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.48 151.33 16.9 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.18 1.792 . . . . 0.0 109.939 172.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -116.28 130.91 24.1 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 123.597 0.759 . . . . 0.0 113.014 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.63 151.37 74.54 Favored 'Cis proline' 0 CA--C 1.542 0.886 0 CA-C-N 119.247 0.767 . . . . 0.0 112.694 -13.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -132.16 -163.1 10.61 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.099 1.333 . . . . 0.0 113.361 176.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.6 tt -79.77 -34.6 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.538 0.735 . . . . 0.0 112.263 171.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.04 11.72 3.88 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.484 1.114 . . . . 0.0 113.63 -172.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.7 p -156.4 141.85 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 126.369 1.868 . . . . 0.0 110.815 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -159.3 161.26 35.85 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.489 1.116 . . . . 0.0 113.552 -175.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.2 p -110.76 159.54 17.54 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 127.114 2.165 . . . . 0.0 111.719 174.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.9 m -85.02 176.52 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.659 1.183 . . . . 0.0 111.255 166.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 73.4 p -92.28 -33.71 14.53 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.761 1.224 . . . . 0.0 113.47 177.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -92.45 -41.31 10.37 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -162.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.2 t -141.41 132.92 26.9 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -176.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.8 m -64.45 -12.14 40.57 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -172.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.439 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.289 31.3 ptt180 -89.0 14.56 10.3 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -174.743 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -135.72 136.48 40.86 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.472 1.109 . . . . 0.0 111.87 -173.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -138.04 161.07 37.68 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.113 1.365 . . . . 0.0 111.655 -178.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.2 t -114.67 143.2 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.499 1.12 . . . . 0.0 108.951 166.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.29 150.37 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 118.468 0.576 . . . . 0.0 111.625 169.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -93.06 89.72 6.61 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.012 0.925 . . . . 0.0 110.398 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -71.09 137.78 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 120.712 0.291 . . . . 0.0 110.956 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 . . . . . 0 N--CA 1.47 0.528 0 C-N-CA 126.066 1.746 . . . . 0.0 110.924 -168.283 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 89.6 p . . . . . 0 CA--C 1.535 0.379 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.11 140.97 25.83 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.338 1.455 . . . . 0.0 111.005 168.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -90.01 119.61 30.51 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.294 0.638 . . . . 0.0 109.837 171.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.4 pt -117.8 145.41 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.594 1.158 . . . . 0.0 110.955 177.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.68 140.02 14.82 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 173.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.6 pt -125.12 141.75 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 124.879 1.272 . . . . 0.0 111.665 173.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -125.13 141.88 13.4 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.265 1.412 . . . . 0.0 112.572 174.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -101.96 170.97 7.79 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.165 1.786 . . . . 0.0 111.417 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.7 t -70.04 -37.56 75.59 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.349 0.66 . . . . 0.0 112.277 175.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -152.99 154.35 34.78 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.073 -1.017 . . . . 0.0 112.765 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -58.14 -38.87 77.38 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.349 1.46 . . . . 0.0 112.131 176.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.05 -14.05 73.26 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.014 0.816 . . . . 0.0 114.06 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -97.26 -36.94 10.26 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 118.191 0.995 . . . . 0.0 111.69 172.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.439 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -64.91 -30.73 71.74 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.293 1.037 . . . . 0.0 113.668 170.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.13 -29.05 60.17 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.439 1.018 . . . . 0.0 112.974 175.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -69.66 -27.19 64.83 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.316 -0.865 . . . . 0.0 112.954 176.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.516 ' CD2' HD11 ' A' ' 49' ' ' ILE . 32.7 t80 -62.77 -52.59 62.59 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.429 1.092 . . . . 0.0 111.356 173.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -80.61 -24.33 39.15 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -175.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.7 t -78.87 -42.56 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 119.062 0.846 . . . . 0.0 111.542 174.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 93.8 p -65.62 -31.3 72.26 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.434 1.015 . . . . 0.0 113.337 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.5 mt -69.38 -54.13 15.99 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.77 0.828 . . . . 0.0 111.435 172.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -65.61 -31.37 72.36 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.408 -0.808 . . . . 0.0 112.763 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -81.11 -4.37 55.08 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.339 1.056 . . . . 0.0 112.727 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -95.84 -15.86 22.21 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 164.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -106.52 -6.18 18.28 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.301 0 CA-C-N 121.397 1.908 . . . . 0.0 115.577 -175.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.471 0.596 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.445 ' HA ' HG22 ' A' ' 50' ' ' THR . 41.6 t -64.39 145.13 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 125.753 1.621 . . . . 0.0 112.386 -177.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.4 mt -130.79 -41.24 1.17 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.814 1.646 . . . . 0.0 112.223 -173.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 36.8 t -148.65 137.68 21.62 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.75 1.22 . . . . 0.0 110.717 174.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 81.8 t -130.21 127.79 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.912 1.285 . . . . 0.0 109.511 172.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -125.96 132.4 24.3 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 125.362 1.465 . . . . 0.0 110.096 173.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.52 -10.88 14.5 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.36 2.706 . . . . 0.0 115.495 -170.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -136.74 111.79 8.97 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.92 0.867 . . . . 0.0 112.192 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -143.9 144.02 23.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 125.437 1.495 . . . . 0.0 110.144 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.9 m -125.86 128.18 47.22 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.227 1.011 . . . . 0.0 111.492 -170.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.8 t -92.87 136.21 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.374 1.47 . . . . 0.0 112.006 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -129.85 128.36 42.11 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.962 1.305 . . . . 0.0 109.281 169.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 17.7 mmm-85 -76.02 112.55 12.57 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.003 0.921 . . . . 0.0 108.867 172.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.5 pt . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -162.541 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 . . . . . 0 CA--C 1.532 0.285 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.78 19.39 6.11 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -172.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 56.68 -47.07 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 128.127 2.571 . . . . 0.0 115.893 -173.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.4 m -64.71 -18.41 64.98 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.062 1.745 . . . . 0.0 114.576 -177.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -85.3 -5.82 59.29 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 173.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.0 m0 -89.09 172.01 9.41 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.039 1.336 . . . . 0.0 110.743 174.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -79.72 52.86 1.51 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.187 1.395 . . . . 0.0 114.279 -176.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 mt -59.83 -18.56 44.85 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 -172.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -105.43 -6.08 19.8 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.771 1.229 . . . . 0.0 113.168 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -148.97 67.74 9.32 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.863 1.265 . . . . 0.0 112.055 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -54.66 145.52 59.26 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.554 2.836 . . . . 0.0 113.02 177.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -70.7 -29.34 65.61 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.424 1.089 . . . . 0.0 111.661 175.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 40.8 t90 -156.96 154.12 29.16 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.615 1.566 . . . . 0.0 110.946 173.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.3 p -135.69 150.42 49.57 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.238 1.015 . . . . 0.0 112.331 171.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.18 -142.1 5.14 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.239 0.447 . . . . 0.0 114.006 -176.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.5 mtm180 -111.23 152.0 27.63 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 127.066 2.146 . . . . 0.0 111.919 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.4 tp -90.31 139.6 30.5 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.075 1.75 . . . . 0.0 110.184 165.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -140.07 98.83 3.53 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.053 1.341 . . . . 0.0 110.249 163.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.2 mt -80.03 130.4 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 170.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.445 HG22 ' HA ' ' A' ' 10' ' ' VAL . 5.4 p -137.5 159.35 42.2 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.592 1.957 . . . . 0.0 110.06 -177.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.2 t -156.26 133.89 10.95 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.474 -1.391 . . . . 0.0 113.411 173.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -146.15 128.58 15.94 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.159 1.784 . . . . 0.0 110.587 177.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.75 36.88 52.45 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.438 1.018 . . . . 0.0 114.963 169.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? 61.95 27.92 16.96 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.467 1.907 . . . . 0.0 113.477 -170.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.0 m -132.23 117.82 18.71 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.195 1.398 . . . . 0.0 109.132 172.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.32 157.5 19.89 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.746 0.818 . . . . 0.0 110.856 172.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -138.3 116.67 11.95 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.6 1.56 . . . . 0.0 108.928 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mp -86.1 93.45 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 168.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -88.02 139.43 30.52 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.502 0.721 . . . . 0.0 111.265 174.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.0 mp -113.69 132.87 55.64 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.442 1.897 . . . . 0.0 110.63 176.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -129.06 147.88 50.96 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -171.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.94 128.21 34.83 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 121.18 -0.95 . . . . 0.0 109.539 171.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -75.44 -9.01 58.19 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -172.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.5 t -112.28 -36.95 2.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 124.239 1.016 . . . . 0.0 110.807 -171.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.1 m -110.47 -15.44 13.91 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.66 19.77 79.77 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 118.882 0.764 . . . . 0.0 113.708 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -63.51 158.94 19.68 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.647 1.179 . . . . 0.0 111.442 173.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.8 tp -95.11 119.59 33.88 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.832 0.853 . . . . 0.0 109.279 167.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -84.31 -55.44 4.17 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.611 0.764 . . . . 0.0 111.28 175.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.4 165.91 35.16 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.724 1.21 . . . . 0.0 111.533 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -144.63 135.32 24.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.737 1.215 . . . . 0.0 111.036 175.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.71 97.17 48.34 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.169 0.988 . . . . 0.0 111.943 175.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.78 137.26 80.25 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 124.367 3.378 . . . . 0.0 113.121 165.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.8 t -139.14 129.03 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 126.414 1.886 . . . . 0.0 109.739 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -90.19 -23.07 21.39 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.44 152.19 16.09 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.82 1.648 . . . . 0.0 111.078 174.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -130.85 135.51 27.46 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 124.876 1.27 . . . . 0.0 112.003 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -61.7 145.0 45.39 Favored 'Cis proline' 0 CA--C 1.539 0.747 0 CA-C-N 119.889 0.996 . . . . 0.0 113.19 -9.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -157.29 -155.71 7.6 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.736 1.16 . . . . 0.0 114.0 -174.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.59 -38.94 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.464 1.106 . . . . 0.0 113.692 -174.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.37 9.29 15.91 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -173.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.6 t -149.33 133.18 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.819 1.648 . . . . 0.0 109.922 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.55 163.99 34.0 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.248 1.819 . . . . 0.0 112.555 -174.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 62.2 p -116.84 162.27 17.98 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.166 1.787 . . . . 0.0 111.822 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.7 m -89.75 175.46 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.296 1.038 . . . . 0.0 111.057 165.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 71.5 p -95.96 -30.9 13.35 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.218 1.407 . . . . 0.0 113.441 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -90.18 -43.78 10.2 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -167.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.3 t -143.37 127.67 17.73 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -176.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.43 -3.28 7.97 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -173.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.478 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.278 23.4 ptt180 -84.7 14.89 4.23 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 177.761 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -139.25 134.06 32.14 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.744 1.218 . . . . 0.0 111.119 -174.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -136.11 161.46 35.64 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.257 1.423 . . . . 0.0 111.168 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 75.9 t -116.21 143.89 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.577 1.151 . . . . 0.0 108.937 167.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.86 148.51 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 119.123 0.874 . . . . 0.0 112.261 173.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -87.65 88.76 7.76 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.414 0.686 . . . . 0.0 110.259 173.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.25 141.6 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 O-C-N 121.99 -0.444 . . . . 0.0 110.841 174.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 . . . . . 0 N--CA 1.47 0.569 0 C-N-CA 125.425 1.49 . . . . 0.0 111.597 -175.58 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.0 p . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -148.08 150.51 34.02 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.32 1.448 . . . . 0.0 111.523 172.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -92.94 118.7 31.44 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.251 0.62 . . . . 0.0 109.787 168.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.8 pt -120.11 145.84 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.668 1.187 . . . . 0.0 111.063 178.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.44 144.32 17.11 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 173.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.1 pt -128.1 140.62 48.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.719 1.608 . . . . 0.0 111.452 172.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.83 143.06 14.69 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.857 1.694 . . . . 0.0 112.787 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -104.98 161.75 13.94 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.11 1.364 . . . . 0.0 112.466 -174.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.7 t -69.86 -28.1 65.39 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.245 1.018 . . . . 0.0 112.699 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -156.85 151.02 25.06 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.27 1.028 . . . . 0.0 111.828 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -62.43 -34.66 77.21 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.281 1.032 . . . . 0.0 113.118 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.35 -26.16 74.82 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 123.864 0.745 . . . . 0.0 113.733 175.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -84.91 -32.73 22.98 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.039 0.936 . . . . 0.0 111.632 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.478 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -67.61 -32.11 72.61 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 168.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.04 -31.54 67.13 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.377 -0.827 . . . . 0.0 112.569 173.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -68.3 -27.39 66.26 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.315 -0.865 . . . . 0.0 112.992 174.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -63.87 -55.17 24.78 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.816 1.189 . . . . 0.0 111.739 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -75.13 -24.87 58.08 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.5 t -75.94 -40.81 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 121.414 -0.804 . . . . 0.0 111.093 173.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.5 t -59.04 -39.67 82.72 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.061 0.846 . . . . 0.0 112.662 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.6 mt -67.94 -54.43 18.72 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.408 0.683 . . . . 0.0 111.92 175.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -67.15 -32.21 73.16 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.3 -0.875 . . . . 0.0 113.02 -174.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -84.82 -0.63 54.56 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.379 1.072 . . . . 0.0 112.708 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -92.81 -37.97 12.02 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.438 -0.789 . . . . 0.0 112.287 159.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -85.39 -7.15 59.1 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -175.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -172.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.245 0 N-CA-C 110.596 -0.15 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.4 t -75.31 145.67 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.031 0.932 . . . . 0.0 111.231 -169.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.8 mt -131.45 -39.79 1.13 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.624 1.569 . . . . 0.0 111.856 -171.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.5 t -148.57 141.72 24.99 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.058 1.343 . . . . 0.0 110.393 176.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.7 t -136.37 127.32 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.984 1.314 . . . . 0.0 108.882 169.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -131.8 138.53 32.74 Favored Pre-proline 0 N--CA 1.48 1.062 0 C-N-CA 125.135 1.374 . . . . 0.0 111.072 177.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -81.23 -17.1 9.31 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 123.242 2.628 . . . . 0.0 115.67 -170.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -132.81 107.55 8.42 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.988 0.915 . . . . 0.0 111.345 -173.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.4 p -143.75 142.95 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.488 1.515 . . . . 0.0 110.331 173.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.8 m -126.32 128.0 46.42 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.456 1.102 . . . . 0.0 111.518 -171.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.2 t -93.99 137.13 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.128 1.371 . . . . 0.0 112.091 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -129.88 125.22 35.09 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.037 1.335 . . . . 0.0 108.98 168.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.9 mmt85 -70.58 109.18 4.71 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.524 -0.735 . . . . 0.0 109.617 169.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.1 pt . . . . . 0 CA--C 1.544 0.738 0 C-N-CA 125.019 1.328 . . . . 0.0 113.292 -171.383 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 . . . . . 0 CA--C 1.533 0.289 0 CA-C-O 120.366 0.126 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.66 18.97 5.69 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -172.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.53 -50.01 0.05 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.968 2.507 . . . . 0.0 115.411 -174.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.2 m -65.97 -14.9 62.42 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.247 1.819 . . . . 0.0 114.359 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.25 -15.54 58.67 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.84 0.856 . . . . 0.0 112.813 172.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -89.66 172.51 8.89 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.442 1.497 . . . . 0.0 111.424 -178.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -81.11 54.86 2.34 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.438 1.495 . . . . 0.0 114.059 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.9 mt -60.3 -17.41 42.51 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -172.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -105.96 -3.89 21.21 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.558 1.143 . . . . 0.0 113.078 177.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -147.81 72.03 11.45 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.068 1.347 . . . . 0.0 111.949 176.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -56.77 143.92 88.86 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 123.147 2.564 . . . . 0.0 112.43 173.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -71.04 -29.09 64.9 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.682 1.193 . . . . 0.0 111.766 175.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 37.9 t90 -156.95 153.17 27.66 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.675 1.59 . . . . 0.0 110.52 174.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.7 p -134.57 150.14 50.69 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.673 0.789 . . . . 0.0 112.043 169.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.18 -141.07 4.92 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 123.336 0.493 . . . . 0.0 113.422 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.7 mtm105 -113.51 149.92 33.67 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.712 2.005 . . . . 0.0 112.168 -173.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.5 tp -90.28 141.57 28.59 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.751 1.62 . . . . 0.0 110.629 169.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.6 ttm-85 -132.66 130.94 40.79 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.214 1.406 . . . . 0.0 109.719 156.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.5 HD11 ' CD1' ' A' ' 119' ' ' PHE . 26.4 mt -107.9 132.56 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 164.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.14 156.06 44.71 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 127.523 2.329 . . . . 0.0 108.72 -166.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.6 t -163.9 152.24 13.23 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.107 -1.621 . . . . 0.0 110.819 178.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -127.39 -46.6 1.47 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 -174.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.1 86.04 0.1 OUTLIER Glycine 0 N--CA 1.472 1.065 0 C-N-CA 123.606 0.622 . . . . 0.0 111.722 -175.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 94.1 mttt 55.53 23.47 6.0 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.141 1.776 . . . . 0.0 112.826 -171.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.9 m -141.74 121.04 13.09 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.836 1.254 . . . . 0.0 108.237 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.87 160.13 14.54 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.628 1.171 . . . . 0.0 111.053 174.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -139.2 113.19 8.64 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 127.076 2.15 . . . . 0.0 108.839 -176.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.3 mp -88.62 109.04 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 167.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -108.44 134.75 50.8 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.748 1.219 . . . . 0.0 111.588 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.6 mp -105.31 132.4 51.56 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 125.435 1.494 . . . . 0.0 110.089 176.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -134.9 151.6 51.02 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.946 0.899 . . . . 0.0 112.98 -170.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -74.12 143.91 45.14 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.282 -0.886 . . . . 0.0 112.071 -178.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.4 pttt -84.41 -6.61 59.4 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.296 1.838 . . . . 0.0 115.067 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.1 t -122.7 -44.18 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.341 1.456 . . . . 0.0 111.543 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.6 m -93.93 -22.37 18.63 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -174.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.3 6.08 86.05 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.14 0.876 . . . . 0.0 113.803 -177.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -81.8 154.59 25.86 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.31 1.444 . . . . 0.0 112.623 -174.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.5 tp -75.05 125.46 28.96 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.94 0.896 . . . . 0.0 111.147 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -85.23 -54.19 4.76 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.286 1.035 . . . . 0.0 111.156 170.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.52 162.89 38.86 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.595 1.158 . . . . 0.0 112.098 -178.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -140.68 133.86 29.53 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.831 1.252 . . . . 0.0 111.905 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.17 104.29 43.78 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.362 1.465 . . . . 0.0 111.159 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.96 144.52 30.49 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.833 3.022 . . . . 0.0 112.141 173.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.8 t -139.78 125.41 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 126.327 1.851 . . . . 0.0 109.554 -172.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -91.01 -23.4 20.39 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.13 149.15 15.65 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.268 1.827 . . . . 0.0 110.344 172.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -118.0 129.69 25.2 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.639 1.176 . . . . 0.0 111.153 175.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.85 149.41 80.32 Favored 'Cis proline' 0 CA--C 1.542 0.891 0 CA-C-N 119.715 0.934 . . . . 0.0 112.737 -6.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -151.57 -162.42 10.75 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.827 1.679 . . . . 0.0 112.293 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 19.6 tt -76.43 -35.15 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 121.688 -0.889 . . . . 0.0 112.837 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.47 7.23 17.58 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -168.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.1 t -150.97 130.51 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.856 1.662 . . . . 0.0 109.736 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -141.09 158.95 43.22 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.641 1.977 . . . . 0.0 112.317 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 47.4 p -107.05 160.89 15.21 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.751 2.02 . . . . 0.0 111.356 175.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 m -86.81 172.28 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.149 0.98 . . . . 0.0 110.949 163.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 58.8 p -95.07 -30.0 14.3 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.011 1.325 . . . . 0.0 113.608 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -90.11 -50.25 6.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.889 0.876 . . . . 0.0 113.229 -167.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.9 m -136.35 116.91 13.84 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.352 0.661 . . . . 0.0 112.724 -169.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.26 -8.68 18.9 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -168.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.462 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.322 43.2 ptt85 -84.12 21.31 1.39 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 178.875 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -140.3 137.45 34.18 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.896 1.278 . . . . 0.0 111.496 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -138.88 163.35 32.53 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.176 1.39 . . . . 0.0 111.032 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 55.9 t -118.21 142.44 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 124.546 1.139 . . . . 0.0 108.914 167.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.73 148.62 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 118.527 0.603 . . . . 0.0 111.975 173.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -90.66 87.54 6.75 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.57 0.748 . . . . 0.0 111.007 178.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -70.83 139.48 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 122.574 0.35 . . . . 0.0 111.044 176.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 . . . . . 0 N--CA 1.471 0.612 0 C-N-CA 126.251 1.82 . . . . 0.0 111.044 -169.192 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 56.8 p . . . . . 0 N--CA 1.466 0.362 0 N-CA-C 115.046 1.498 . . . . 0.0 115.046 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.46 145.05 31.67 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.668 1.587 . . . . 0.0 110.495 165.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -91.1 119.85 31.58 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 167.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.8 pt -118.28 144.56 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.447 1.099 . . . . 0.0 110.93 178.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.63 142.95 16.3 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 174.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.9 pt -128.46 139.29 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 125.456 1.502 . . . . 0.0 111.725 173.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -118.85 139.78 14.68 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.93 1.729 . . . . 0.0 112.518 176.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -102.47 155.79 18.03 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.524 1.53 . . . . 0.0 112.222 -176.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.1 t -71.3 -23.56 61.98 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.351 1.061 . . . . 0.0 112.839 177.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -154.18 147.04 24.38 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.157 0.983 . . . . 0.0 112.212 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -64.42 -35.11 79.84 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.428 1.091 . . . . 0.0 113.273 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.36 -30.42 76.6 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-N 118.851 0.75 . . . . 0.0 113.165 176.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -82.5 -31.76 29.11 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.877 -0.778 . . . . 0.0 112.248 177.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.462 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -64.93 -38.58 91.43 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 166.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -61.35 -38.27 86.34 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.132 -0.98 . . . . 0.0 111.279 168.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -67.43 -36.31 80.98 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 119.093 0.861 . . . . 0.0 112.856 177.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.5 ' CD1' HD11 ' A' ' 49' ' ' ILE . 13.2 t80 -54.65 -51.39 65.6 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.74 1.216 . . . . 0.0 111.735 167.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -68.52 -42.55 78.37 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.611 0.764 . . . . 0.0 112.496 -177.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.8 t -65.84 -37.76 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 O-C-N 121.615 -0.678 . . . . 0.0 110.884 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 55.7 m -65.9 -14.42 61.49 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 176.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.6 mt -91.75 -54.13 4.0 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.008 0.923 . . . . 0.0 111.342 168.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -69.33 -32.92 72.33 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.952 -1.093 . . . . 0.0 113.669 -172.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -87.27 7.0 30.51 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.397 1.079 . . . . 0.0 112.423 174.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -102.77 -34.0 9.18 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.049 0.94 . . . . 0.0 112.631 165.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -89.5 -4.11 58.07 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.282 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -175.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.8 m . . . . . 0 CA--C 1.539 0.558 0 CA-C-O 120.944 0.402 . . . . 0.0 111.295 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.97 144.05 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.761 1.224 . . . . 0.0 111.964 -174.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 78.8 mt -126.05 -43.94 1.79 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.786 1.634 . . . . 0.0 112.308 -175.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 46.5 t -153.77 136.03 14.88 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.519 1.128 . . . . 0.0 110.939 175.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.9 t -127.28 125.83 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.588 1.155 . . . . 0.0 109.47 172.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -129.08 133.61 25.39 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 125.367 1.467 . . . . 0.0 110.579 176.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.83 -12.02 15.01 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.22 2.613 . . . . 0.0 115.331 -172.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -129.74 106.38 8.67 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.273 1.029 . . . . 0.0 110.854 -177.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.1 p -141.66 142.01 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.782 1.233 . . . . 0.0 110.52 170.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.4 m -124.37 130.32 52.28 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.443 1.097 . . . . 0.0 110.751 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 77.1 t -94.18 136.47 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.749 1.22 . . . . 0.0 111.355 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.09 125.75 33.97 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.48 1.112 . . . . 0.0 109.436 168.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.7 mtt85 -62.39 131.3 48.8 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.347 0.659 . . . . 0.0 109.371 163.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.6 pt . . . . . 0 N--CA 1.474 0.761 0 C-N-CA 124.239 1.016 . . . . 0.0 112.533 -171.131 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.7 m-30 . . . . . 0 C--O 1.224 -0.285 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.54 18.25 8.12 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -172.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.31 -49.35 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 128.094 2.557 . . . . 0.0 115.565 -173.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.5 m -66.65 -15.93 63.83 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.887 1.675 . . . . 0.0 114.646 -176.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.01 -7.91 59.28 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 171.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.7 m0 -88.1 171.61 10.13 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.006 1.322 . . . . 0.0 110.769 176.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -79.6 54.34 1.76 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.214 1.406 . . . . 0.0 114.068 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.5 mt -60.75 -16.59 41.75 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -173.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -105.3 -4.59 21.41 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.565 1.146 . . . . 0.0 112.958 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -148.42 81.34 8.01 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 124.539 1.136 . . . . 0.0 112.015 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.3 145.35 67.19 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.395 2.73 . . . . 0.0 112.89 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -71.86 -29.62 64.57 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.822 0.849 . . . . 0.0 111.267 168.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 41.1 t90 -159.6 155.05 25.57 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.996 1.718 . . . . 0.0 110.929 175.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.3 p -133.76 142.54 47.96 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.717 1.207 . . . . 0.0 111.961 171.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.31 -148.39 6.54 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 123.419 0.533 . . . . 0.0 114.195 -177.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -110.76 144.64 39.43 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.737 1.615 . . . . 0.0 110.849 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.1 tp -82.53 136.43 34.86 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.13 1.372 . . . . 0.0 109.369 168.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.6 ttt-85 -142.09 88.07 2.08 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.579 1.152 . . . . 0.0 109.952 166.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.493 HD11 ' CD2' ' A' ' 119' ' ' PHE . 12.7 mt -70.22 122.11 21.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 169.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.01 -179.88 4.29 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 127.82 2.448 . . . . 0.0 109.542 177.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 80.3 p -161.27 171.2 18.79 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.858 2.063 . . . . 0.0 108.491 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -140.0 -107.64 0.16 Allowed 'General case' 0 CA--C 1.54 0.59 0 O-C-N 122.004 -0.435 . . . . 0.0 109.929 166.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.62 106.13 3.21 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.051 1.31 . . . . 0.0 112.603 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 51.48 28.69 4.7 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 126.768 2.027 . . . . 0.0 113.917 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.8 m -148.1 131.07 16.21 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.17 1.788 . . . . 0.0 108.582 -172.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.69 159.5 15.12 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.084 1.353 . . . . 0.0 110.917 171.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -138.33 111.83 8.15 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.532 1.533 . . . . 0.0 109.785 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.2 mp -81.97 98.39 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 170.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -100.15 139.87 35.2 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.621 0.724 . . . . 0.0 111.831 175.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mp -113.82 127.96 56.22 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 126.487 1.915 . . . . 0.0 109.771 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -134.06 146.68 50.55 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.96 0.904 . . . . 0.0 112.114 -170.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -66.47 143.41 57.11 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 120.918 -1.114 . . . . 0.0 112.442 -177.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.596 ' H ' ' HD3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -81.81 -3.63 54.43 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 -173.753 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.0 t -115.91 -42.46 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.95 1.3 . . . . 0.0 111.403 173.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.3 m -116.13 -6.26 11.9 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -169.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.26 16.83 78.65 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 123.864 0.745 . . . . 0.0 114.171 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -66.73 126.75 29.98 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.531 1.533 . . . . 0.0 111.199 -175.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 57.4 tp -68.16 110.07 3.83 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.538 0.608 . . . . 0.0 110.424 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -79.29 -52.05 8.63 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.536 1.135 . . . . 0.0 111.042 176.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.27 162.06 37.77 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.437 1.095 . . . . 0.0 112.025 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -142.71 133.72 25.74 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.035 1.334 . . . . 0.0 111.551 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.24 101.93 48.99 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 124.742 1.217 . . . . 0.0 111.633 176.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -66.29 141.05 60.91 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 124.25 3.3 . . . . 0.0 112.788 171.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 t -137.14 123.79 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.763 1.625 . . . . 0.0 109.652 -177.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -89.05 -21.75 23.29 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -159.91 145.13 15.25 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.439 1.895 . . . . 0.0 110.291 169.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -116.97 130.12 24.83 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 124.664 1.186 . . . . 0.0 110.98 176.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.82 148.56 78.85 Favored 'Cis proline' 0 CA--C 1.542 0.915 0 CA-C-N 119.86 0.986 . . . . 0.0 112.968 -5.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.28 -168.2 24.88 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.95 1.262 . . . . 0.0 113.916 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.8 tp -63.69 -32.83 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -172.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.26 5.47 49.04 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -170.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.4 t -149.57 131.3 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.458 1.103 . . . . 0.0 110.892 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -140.64 158.85 43.37 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.711 1.604 . . . . 0.0 112.94 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 75.1 p -105.13 158.87 16.28 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.666 1.986 . . . . 0.0 110.941 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.4 m -84.12 176.03 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.762 0.825 . . . . 0.0 110.9 165.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 59.1 p -94.89 -31.98 13.44 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.598 1.559 . . . . 0.0 113.011 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -92.65 -43.77 8.92 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -167.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.7 t -142.81 120.16 11.61 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -173.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.25 -2.87 9.08 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -169.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.402 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.265 0.9 OUTLIER -87.47 22.3 2.24 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.677 1.591 . . . . 0.0 114.217 174.242 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -140.92 135.33 31.15 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.052 1.341 . . . . 0.0 111.254 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -135.76 161.3 35.96 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.206 1.402 . . . . 0.0 111.376 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 89.8 t -115.89 141.8 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.628 1.171 . . . . 0.0 108.675 166.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.52 147.56 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 118.754 0.707 . . . . 0.0 112.392 173.31 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -89.79 84.74 6.28 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.627 0.771 . . . . 0.0 111.074 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -68.92 139.51 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 122.627 0.371 . . . . 0.0 111.062 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 . . . . . 0 N--CA 1.468 0.441 0 C-N-CA 125.947 1.699 . . . . 0.0 111.604 -170.396 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.9 p . . . . . 0 CA--C 1.533 0.301 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.61 148.28 32.95 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.579 1.552 . . . . 0.0 111.106 169.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -93.41 118.54 31.43 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.466 0.707 . . . . 0.0 109.682 168.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 27.7 pt -118.06 144.2 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.493 1.117 . . . . 0.0 111.15 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -90.5 144.49 17.45 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.059 0.838 . . . . 0.0 111.013 174.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.8 pt -129.96 140.61 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 125.43 1.492 . . . . 0.0 111.667 172.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.26 142.95 16.37 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.66 1.6 . . . . 0.0 113.077 176.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -106.76 161.07 14.99 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.85 1.66 . . . . 0.0 111.855 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.9 t -73.09 -28.02 62.05 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.64 0.776 . . . . 0.0 112.857 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -155.88 151.86 27.61 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.312 1.045 . . . . 0.0 112.083 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 63.7 ttt-85 -62.8 -33.07 74.44 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.501 1.12 . . . . 0.0 113.397 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.64 -28.62 73.03 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-N 118.798 0.726 . . . . 0.0 113.525 175.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -83.71 -34.15 24.97 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.963 0.905 . . . . 0.0 111.812 175.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.402 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -65.51 -31.77 73.01 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 168.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.39 -35.64 74.32 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.349 -0.844 . . . . 0.0 112.611 173.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -67.0 -29.46 69.3 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.228 -0.92 . . . . 0.0 112.934 176.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.493 ' CD2' HD11 ' A' ' 49' ' ' ILE . 27.2 t80 -60.82 -50.24 74.24 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.304 0.956 . . . . 0.0 111.693 172.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -82.19 -25.1 34.56 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.8 t -77.38 -42.25 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.194 -0.941 . . . . 0.0 111.285 175.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 92.5 p -65.52 -31.57 72.7 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.354 0.979 . . . . 0.0 113.111 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 61.0 mt -68.51 -52.5 31.46 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.961 0.905 . . . . 0.0 112.006 172.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -67.47 -29.38 68.82 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.957 -1.089 . . . . 0.0 112.793 -177.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -81.31 -1.53 45.6 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.055 1.342 . . . . 0.0 112.571 174.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -91.29 -23.31 20.18 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 120.701 -1.249 . . . . 0.0 113.005 165.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -104.16 -4.37 23.22 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -176.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.203 0 CA-C-N 120.444 1.474 . . . . 0.0 114.52 -177.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.8 m . . . . . 0 CA--C 1.536 0.438 0 CA-C-O 120.995 0.426 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.44 142.17 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 125.367 1.467 . . . . 0.0 111.273 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.3 mt -127.41 -44.21 1.57 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.183 1.393 . . . . 0.0 111.813 -172.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 27.6 t -151.9 137.12 17.48 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.599 1.16 . . . . 0.0 111.013 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.7 t -130.84 121.82 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.774 1.23 . . . . 0.0 109.962 174.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -117.57 137.92 24.66 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 125.27 1.428 . . . . 0.0 110.192 172.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.93 -20.51 25.64 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.478 2.786 . . . . 0.0 114.418 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -135.9 113.27 10.68 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.953 0.901 . . . . 0.0 111.668 -169.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.0 p -149.56 146.38 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.737 1.615 . . . . 0.0 110.248 175.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.6 m -125.18 128.37 48.25 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.024 0.93 . . . . 0.0 111.381 -172.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.1 t -94.84 139.12 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.457 1.503 . . . . 0.0 112.067 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -127.63 123.82 36.53 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.109 1.364 . . . . 0.0 109.772 171.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -69.54 101.9 1.71 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.39 0.676 . . . . 0.0 109.198 166.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.2 pt . . . . . 0 CA--C 1.546 0.813 0 C-N-CA 124.109 0.963 . . . . 0.0 113.11 -172.164 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.7 20.6 15.14 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.52 -1.362 . . . . 0.0 114.347 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.15 -47.99 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.761 2.424 . . . . 0.0 115.092 -168.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.4 m -64.92 -16.09 62.86 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.496 1.918 . . . . 0.0 115.016 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -81.08 -10.01 59.74 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.715 0.806 . . . . 0.0 112.846 173.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 14.2 m0 -92.96 173.23 7.85 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.488 1.515 . . . . 0.0 111.147 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -79.5 53.39 1.55 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.33 1.452 . . . . 0.0 114.182 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.5 mt -61.3 -16.49 46.2 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.389 1.625 . . . . 0.0 115.389 -172.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -108.22 -3.58 18.35 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.45 1.1 . . . . 0.0 112.714 177.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -149.39 67.29 8.83 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.362 1.465 . . . . 0.0 111.48 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -53.26 141.03 60.98 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.163 2.575 . . . . 0.0 111.926 176.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -72.83 -27.51 61.99 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.453 0.701 . . . . 0.0 111.717 -177.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -151.92 152.66 32.83 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.214 1.805 . . . . 0.0 110.152 169.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.5 p -135.14 148.52 49.77 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.925 0.89 . . . . 0.0 111.646 169.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.64 -141.32 5.17 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 114.097 0.399 . . . . 0.0 114.097 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -107.06 145.64 32.13 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.01 2.124 . . . . 0.0 111.106 -174.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.8 tp -93.13 136.48 33.35 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.993 1.317 . . . . 0.0 109.458 169.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.3 ttp85 -137.76 103.51 5.03 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.594 0.758 . . . . 0.0 110.223 160.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.441 HD11 ' CD2' ' A' ' 119' ' ' PHE . 14.0 mt -77.7 118.76 25.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 166.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.55 178.12 4.58 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 127.93 2.492 . . . . 0.0 110.272 176.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 t -160.12 172.45 17.45 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 126.804 2.042 . . . . 0.0 107.763 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -143.66 -107.29 0.12 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.336 1.055 . . . . 0.0 109.01 167.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.19 97.5 2.0 Allowed Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.135 1.35 . . . . 0.0 112.564 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 52.86 28.5 6.55 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 126.603 1.961 . . . . 0.0 113.811 178.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.1 m -147.2 116.36 6.93 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 126.177 1.791 . . . . 0.0 108.396 -173.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.94 159.22 18.43 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.098 0.959 . . . . 0.0 110.823 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -136.12 117.08 14.24 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.206 1.402 . . . . 0.0 109.911 177.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.4 mp -87.15 100.48 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 168.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -98.64 137.0 37.92 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.793 0.806 . . . . 0.0 111.813 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -102.38 131.95 48.69 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.499 1.519 . . . . 0.0 109.636 168.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -136.44 152.27 50.4 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.784 0.834 . . . . 0.0 111.781 -173.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -73.03 142.01 47.66 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.865 -1.147 . . . . 0.0 112.667 -170.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -78.36 -6.13 54.24 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.194 1.797 . . . . 0.0 115.703 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 99.4 t -121.85 -44.63 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.101 1.36 . . . . 0.0 111.257 177.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.7 m -98.67 -19.99 17.21 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -174.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.77 10.3 80.02 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.513 1.054 . . . . 0.0 114.033 -176.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -82.71 154.24 24.93 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.243 1.417 . . . . 0.0 112.466 -175.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.2 tp -72.53 125.12 26.66 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.68 0.792 . . . . 0.0 111.918 -174.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -87.37 -55.22 3.9 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.118 0.967 . . . . 0.0 111.035 168.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.63 160.87 39.81 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.622 1.169 . . . . 0.0 112.027 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -141.47 131.12 24.06 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.797 1.239 . . . . 0.0 111.93 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.2 102.88 53.6 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 124.464 1.106 . . . . 0.0 111.534 175.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.77 139.93 25.53 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.963 3.109 . . . . 0.0 111.958 175.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.5 t -134.42 123.49 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 126.193 1.797 . . . . 0.0 109.548 -174.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -87.53 -23.02 24.52 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 121.366 -0.834 . . . . 0.0 113.158 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.12 144.3 15.96 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.409 1.883 . . . . 0.0 110.199 169.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -115.11 130.13 24.49 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.547 1.139 . . . . 0.0 110.918 176.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.94 148.05 78.12 Favored 'Cis proline' 0 CA--C 1.541 0.873 0 CA-C-N 119.827 0.974 . . . . 0.0 113.032 -5.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.85 -170.72 30.19 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.937 1.256 . . . . 0.0 113.822 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.3 tp -60.44 -31.05 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -170.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.4 4.33 53.65 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -171.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.5 t -149.33 130.37 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 119.456 1.025 . . . . 0.0 111.631 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -142.42 165.87 26.23 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.563 1.945 . . . . 0.0 112.364 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 56.1 p -116.9 160.17 21.29 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 127.087 2.155 . . . . 0.0 111.63 -176.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.7 m -84.16 172.58 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.034 0.934 . . . . 0.0 111.565 168.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.6 p -91.61 -33.59 15.05 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.313 1.445 . . . . 0.0 112.768 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -97.51 -40.66 8.55 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -162.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.5 t -139.2 122.59 17.16 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -175.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 p -74.5 30.19 0.08 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 -172.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.433 ' HA ' ' CB ' ' A' ' 116' ' ' ALA . 53.9 ptt85 -123.65 23.58 8.76 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.14 1.776 . . . . 0.0 114.298 171.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -140.52 138.76 34.81 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.905 1.282 . . . . 0.0 111.227 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -137.0 164.54 28.11 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.597 1.559 . . . . 0.0 111.108 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.2 t -122.1 139.67 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.737 1.215 . . . . 0.0 108.589 167.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.87 148.05 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 118.731 0.696 . . . . 0.0 112.415 176.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -89.34 85.68 6.64 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.475 0.71 . . . . 0.0 110.805 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.08 137.22 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 122.105 -0.372 . . . . 0.0 110.773 175.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 . . . . . 0 N--CA 1.468 0.473 0 C-N-CA 125.474 1.51 . . . . 0.0 111.738 -169.123 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 86.2 p . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.57 146.63 29.48 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.664 1.586 . . . . 0.0 111.057 168.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -92.12 121.4 33.63 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.058 0.543 . . . . 0.0 109.853 168.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.1 pt -120.92 144.57 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.675 1.19 . . . . 0.0 110.929 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -88.32 145.88 19.27 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 173.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.6 pt -128.05 141.63 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 125.274 1.43 . . . . 0.0 111.634 167.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.15 143.28 15.53 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.601 1.572 . . . . 0.0 112.931 175.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -108.65 157.41 18.54 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.51 1.924 . . . . 0.0 110.903 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.6 t -69.26 -27.7 65.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.918 0.887 . . . . 0.0 112.644 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -155.52 153.09 29.68 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.204 1.001 . . . . 0.0 112.029 -178.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.54 -35.03 75.02 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.589 1.156 . . . . 0.0 112.122 175.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.95 -14.73 68.42 Favored Glycine 0 CA--C 1.54 1.604 0 CA-C-O 119.384 -0.676 . . . . 0.0 114.364 176.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -97.1 -30.9 12.77 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.819 1.248 . . . . 0.0 111.886 171.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.433 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -72.98 -30.84 64.13 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 173.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -59.44 -32.1 69.91 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.35 -0.844 . . . . 0.0 112.064 172.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -64.77 -32.43 74.11 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.531 -0.731 . . . . 0.0 112.384 174.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.441 ' CD2' HD11 ' A' ' 49' ' ' ILE . 47.7 t80 -63.11 -56.35 17.58 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.213 1.005 . . . . 0.0 111.691 178.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -73.97 -24.48 59.63 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -177.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 68.4 t -78.29 -42.3 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 121.254 -0.904 . . . . 0.0 111.306 174.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.9 m -66.36 -30.78 71.25 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.137 0.88 . . . . 0.0 112.539 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.0 mt -67.37 -57.3 6.86 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.457 0.703 . . . . 0.0 111.867 170.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -64.74 -31.94 73.39 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.457 -0.777 . . . . 0.0 112.973 -173.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -80.73 -0.28 37.75 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.368 1.067 . . . . 0.0 112.666 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -101.78 -3.99 27.14 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 164.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -111.45 -10.8 14.16 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 175.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -176.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.824 0.345 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.8 t -70.54 144.42 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.705 0.802 . . . . 0.0 111.126 -171.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 44.9 mt -127.07 -42.83 1.7 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.715 1.606 . . . . 0.0 111.949 -174.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 32.7 t -149.26 139.22 22.02 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.59 1.156 . . . . 0.0 109.808 177.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.5 t -133.99 127.15 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.641 1.176 . . . . 0.0 109.116 170.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -131.0 134.37 25.88 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 125.004 1.322 . . . . 0.0 110.23 175.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.28 -18.51 16.02 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.878 2.385 . . . . 0.0 114.854 -172.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -132.69 111.79 11.46 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.452 1.101 . . . . 0.0 111.434 -173.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.0 p -146.61 144.63 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.847 1.659 . . . . 0.0 109.882 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.6 m -123.73 131.8 53.68 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.986 0.915 . . . . 0.0 111.549 -173.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 76.0 t -96.97 131.6 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.492 1.517 . . . . 0.0 111.594 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -128.82 126.9 40.85 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.936 1.295 . . . . 0.0 109.15 169.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -65.83 129.9 41.41 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.479 0.712 . . . . 0.0 109.546 170.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.6 pt . . . . . 0 N--CA 1.476 0.875 0 C-N-CA 124.333 1.053 . . . . 0.0 112.851 -171.095 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 . . . . . 0 C--O 1.221 -0.413 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.37 19.92 7.44 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -171.168 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.42 -48.29 0.05 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 127.76 2.424 . . . . 0.0 115.299 -172.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.6 m -66.44 -16.63 64.25 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.239 1.816 . . . . 0.0 114.813 -177.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -85.5 -2.53 58.23 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 172.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 24.7 m0 -92.3 169.16 10.8 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.059 1.344 . . . . 0.0 110.833 173.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.5 mttt -78.33 52.44 1.13 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.341 1.456 . . . . 0.0 114.136 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.9 mt -57.53 -28.43 63.49 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -175.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -91.36 -6.07 53.56 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -149.76 74.36 9.45 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 124.873 1.269 . . . . 0.0 111.917 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -56.69 143.39 89.79 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.913 2.408 . . . . 0.0 112.565 174.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -72.0 -28.43 63.4 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.739 1.216 . . . . 0.0 111.624 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 49.4 t90 -155.73 151.97 27.98 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.985 1.714 . . . . 0.0 110.523 174.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.6 p -134.9 149.63 50.31 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.006 0.922 . . . . 0.0 111.723 170.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.74 -142.24 6.01 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 114.135 0.414 . . . . 0.0 114.135 -178.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 47.0 mtt180 -105.16 144.46 31.91 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 127.233 2.213 . . . . 0.0 111.751 -173.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.5 tp -90.29 137.15 32.58 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.434 1.494 . . . . 0.0 110.324 166.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.0 ttm-85 -130.27 132.23 45.83 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.659 1.184 . . . . 0.0 109.56 156.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.565 HD11 ' CD1' ' A' ' 119' ' ' PHE . 17.7 mt -109.59 131.57 60.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 163.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.72 151.06 42.61 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 127.879 2.471 . . . . 0.0 108.23 -168.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 92.3 p -161.04 155.08 22.64 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 120.142 -1.598 . . . . 0.0 111.908 -169.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -132.56 -105.1 0.25 Allowed 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.066 -1.022 . . . . 0.0 112.378 -173.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.32 -125.53 0.28 Allowed Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.26 0.933 . . . . 0.0 111.252 168.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -77.13 34.11 0.15 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.962 1.305 . . . . 0.0 112.52 173.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.8 m -143.45 133.59 24.36 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.935 0.894 . . . . 0.0 110.671 -174.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -115.09 162.86 16.44 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.15 1.38 . . . . 0.0 111.052 169.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -144.13 107.95 4.69 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.612 1.965 . . . . 0.0 108.88 -170.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mp -86.34 108.29 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 169.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -109.01 128.96 55.41 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.732 1.213 . . . . 0.0 111.309 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.0 mp -101.62 131.11 48.02 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.871 1.268 . . . . 0.0 110.168 177.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -133.16 149.66 52.05 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.063 0.945 . . . . 0.0 112.602 -169.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -69.58 141.14 53.82 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.033 -1.042 . . . . 0.0 111.977 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.0 pttt -79.85 -4.7 53.32 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 -177.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 95.8 t -121.98 -43.84 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.171 1.389 . . . . 0.0 111.355 178.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.9 m -97.47 -20.27 17.87 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.19 11.32 79.31 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.443 1.021 . . . . 0.0 114.032 -176.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -83.59 151.19 25.48 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.192 1.397 . . . . 0.0 112.24 -175.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.3 tp -72.96 127.26 32.02 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.437 0.695 . . . . 0.0 111.66 -175.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -86.76 -55.41 3.87 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.704 1.202 . . . . 0.0 111.171 169.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.11 159.69 38.11 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.117 1.367 . . . . 0.0 111.307 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -139.35 137.57 35.86 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 174.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.32 106.5 48.82 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.601 1.56 . . . . 0.0 110.621 177.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.57 142.13 18.1 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.718 2.946 . . . . 0.0 111.107 173.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.9 t -135.58 129.91 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 126.352 1.861 . . . . 0.0 109.476 -170.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -97.68 -20.1 17.83 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.227 1.011 . . . . 0.0 113.061 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.91 147.39 11.49 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.449 2.3 . . . . 0.0 110.33 -177.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -135.12 125.11 16.83 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 124.064 0.946 . . . . 0.0 111.529 174.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -65.31 150.13 75.93 Favored 'Cis proline' 0 CA--C 1.541 0.849 0 CA-C-N 119.894 0.998 . . . . 0.0 113.122 -2.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -170.06 -158.86 14.62 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.037 1.304 . . . . 0.0 113.697 -175.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.4 tp -75.53 -39.79 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -172.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.54 5.6 41.94 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -168.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.4 t -150.8 130.91 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.684 1.593 . . . . 0.0 109.397 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.3 163.2 34.39 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.814 1.646 . . . . 0.0 112.735 -174.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 66.3 p -116.43 162.9 16.85 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.904 1.682 . . . . 0.0 111.659 -177.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.5 m -91.08 177.39 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 124.479 1.112 . . . . 0.0 110.726 166.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.8 p -98.81 -32.4 11.38 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.051 1.74 . . . . 0.0 113.045 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -88.68 -43.36 11.37 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -167.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.2 t -143.9 124.44 14.01 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -176.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.05 -1.4 7.48 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 -170.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.484 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.295 27.9 ptt180 -85.63 15.37 4.71 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 177.469 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -137.02 133.97 36.07 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.874 1.269 . . . . 0.0 110.855 -173.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -133.74 160.46 37.52 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.087 1.355 . . . . 0.0 111.512 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 78.8 t -112.25 143.92 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.328 1.051 . . . . 0.0 108.985 164.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.0 149.49 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 119.025 0.829 . . . . 0.0 112.049 169.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -91.72 82.88 5.24 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.783 0.833 . . . . 0.0 111.177 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -66.93 139.99 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 120.91 0.386 . . . . 0.0 111.065 176.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 . . . . . 0 N--CA 1.469 0.487 0 C-N-CA 125.778 1.631 . . . . 0.0 111.474 -169.314 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.1 p . . . . . 0 C--O 1.234 0.288 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.25 146.26 32.54 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.491 1.516 . . . . 0.0 110.832 167.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -90.95 120.31 31.85 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.074 0.55 . . . . 0.0 109.65 167.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.6 pt -117.9 143.22 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.404 1.082 . . . . 0.0 110.832 176.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -92.24 140.69 15.26 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 175.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.0 pt -126.64 141.35 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 125.285 1.434 . . . . 0.0 111.708 173.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.1 142.14 14.3 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.038 1.304 . . . . 0.0 113.144 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -104.37 162.42 13.24 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.626 1.57 . . . . 0.0 111.531 -177.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.1 t -72.64 -29.18 63.24 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.578 0.751 . . . . 0.0 112.486 176.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -153.04 147.63 26.11 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.184 0.994 . . . . 0.0 112.069 -174.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.6 ttt-85 -62.33 -32.82 73.64 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.348 1.059 . . . . 0.0 113.234 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.96 -28.32 73.45 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-N 119.025 0.829 . . . . 0.0 113.714 176.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -84.71 -32.51 23.49 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.015 0.907 . . . . 0.0 111.953 176.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.484 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -66.9 -34.37 77.62 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 166.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -60.57 -35.96 77.33 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.251 -0.906 . . . . 0.0 111.677 168.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -62.47 -37.59 86.53 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 119.247 0.93 . . . . 0.0 111.88 175.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.565 ' CD1' HD11 ' A' ' 49' ' ' ILE . 17.6 t80 -58.73 -56.54 20.87 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.448 1.099 . . . . 0.0 112.017 171.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.03 -26.13 53.35 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -174.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.2 t -77.24 -43.31 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 121.193 -0.942 . . . . 0.0 110.98 176.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.3 t -69.91 -29.77 67.03 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.137 0.88 . . . . 0.0 112.469 -178.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.6 mt -64.44 -55.06 23.35 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.445 -0.784 . . . . 0.0 112.124 167.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -68.27 -29.48 68.28 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.108 -0.995 . . . . 0.0 113.069 -173.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -82.62 -3.64 56.51 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.852 0.861 . . . . 0.0 112.799 176.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -93.45 -34.08 13.56 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.39 -0.819 . . . . 0.0 112.47 161.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -90.64 -6.39 54.63 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 -177.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.484 1.228 0 CA-C-N 121.259 1.845 . . . . 0.0 115.773 -173.933 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.8 m . . . . . 0 CA--C 1.53 0.206 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.517 ' HA ' HG22 ' A' ' 50' ' ' THR . 8.5 p -70.62 145.33 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 178.363 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.6 mt -129.86 -39.68 1.4 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.829 1.652 . . . . 0.0 111.957 -172.712 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.426 ' SG ' ' HE2' ' A' ' 14' ' ' LYS . 12.5 t -152.8 133.25 13.7 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.096 0.958 . . . . 0.0 111.26 175.938 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 92.9 t -130.5 127.14 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.538 1.135 . . . . 0.0 108.963 170.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.426 ' HE2' ' SG ' ' A' ' 12' ' ' CYS . 68.1 mttm -133.55 144.08 50.62 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 124.968 1.307 . . . . 0.0 112.3 -179.522 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -77.7 -11.44 16.91 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 124.098 3.199 . . . . 0.0 114.636 -178.289 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -117.99 110.15 17.34 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.148 1.379 . . . . 0.0 111.673 -174.914 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 p -156.82 142.05 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.527 1.131 . . . . 0.0 110.424 163.296 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.6 m -123.43 144.23 49.64 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.408 1.483 . . . . 0.0 110.238 178.517 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.41 HG22 HG22 ' A' ' 108' ' ' ILE . 76.7 t -113.7 129.36 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.821 1.248 . . . . 0.0 111.047 177.866 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.17 116.41 11.85 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.89 1.676 . . . . 0.0 109.196 173.796 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.9 mtt-85 -71.37 134.54 46.77 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.138 0.975 . . . . 0.0 110.509 -176.755 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.7 pt . . . . . 0 CA--C 1.546 0.801 0 C-N-CA 124.266 1.026 . . . . 0.0 113.177 -165.003 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 . . . . . 0 N--CA 1.466 0.361 0 CA-C-O 119.446 -0.311 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.61 26.13 9.78 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 178.113 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 60.46 -42.13 0.1 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.686 2.394 . . . . 0.0 115.272 -170.925 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 89.6 p -66.47 -15.92 63.72 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.384 1.874 . . . . 0.0 114.398 -179.855 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -63.33 -26.21 68.66 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 167.804 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 9.6 m0 -94.13 164.89 12.88 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.964 1.306 . . . . 0.0 111.256 -168.645 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -76.92 55.21 1.08 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.643 1.577 . . . . 0.0 114.172 179.469 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.6 mt -59.49 -25.69 64.66 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.66 1.184 . . . . 0.0 113.745 -179.278 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -94.87 -7.63 39.58 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.608 0.763 . . . . 0.0 113.004 -179.053 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -149.88 78.97 7.96 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.644 1.178 . . . . 0.0 111.959 175.549 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.88 147.61 50.68 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.519 2.813 . . . . 0.0 113.114 176.229 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -71.22 -28.92 64.54 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.881 0.872 . . . . 0.0 111.302 169.003 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 66.9 t90 -156.56 153.53 28.81 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.243 1.817 . . . . 0.0 110.891 177.223 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.7 p -135.67 149.4 49.27 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.576 1.151 . . . . 0.0 111.331 169.374 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.62 -140.44 4.29 Favored Glycine 0 CA--C 1.525 0.717 0 O-C-N 122.135 -0.353 . . . . 0.0 113.462 -178.692 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.9 mtm105 -119.56 147.76 44.1 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.222 1.809 . . . . 0.0 111.715 -173.189 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 40.4 tp -85.13 142.04 29.79 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.674 1.59 . . . . 0.0 110.616 176.827 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.8 ttm-85 -142.2 95.55 2.82 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.376 1.07 . . . . 0.0 111.073 165.427 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.7 mt -83.06 128.53 38.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 169.271 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.517 HG22 ' HA ' ' A' ' 10' ' ' VAL . 11.8 p -140.57 171.97 13.37 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.71 2.004 . . . . 0.0 110.472 -176.011 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.7 t -155.34 153.43 30.48 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.681 1.192 . . . . 0.0 112.076 175.935 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -155.96 123.76 5.62 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.166 0.986 . . . . 0.0 111.012 163.626 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.52 46.31 48.71 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.151 0.882 . . . . 0.0 114.845 167.547 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt 63.32 28.2 15.58 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 126.408 1.883 . . . . 0.0 113.679 -176.061 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.1 m -135.42 120.55 18.84 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.658 1.583 . . . . 0.0 108.774 170.83 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.3 159.25 18.85 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.891 0.876 . . . . 0.0 111.034 174.897 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -137.63 114.05 10.23 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.592 1.557 . . . . 0.0 109.29 178.514 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.4 mp -85.93 92.88 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 167.188 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -84.98 146.1 27.38 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.208 1.003 . . . . 0.0 110.266 172.187 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -110.44 137.54 48.02 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.564 1.546 . . . . 0.0 111.2 172.78 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -123.71 147.7 47.22 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.34 1.056 . . . . 0.0 113.286 -178.103 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.73 144.15 52.86 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 122.148 0.975 . . . . 0.0 112.065 169.933 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.4 pttt -81.49 -6.38 58.9 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -177.021 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 90.7 t -122.62 -39.52 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.657 1.183 . . . . 0.0 111.983 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.4 m -116.0 -10.38 11.6 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -172.769 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.65 19.74 79.3 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 123.613 0.625 . . . . 0.0 114.331 177.399 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -65.79 139.13 58.31 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.385 1.474 . . . . 0.0 111.24 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.9 tp -72.23 112.31 8.2 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.103 0.561 . . . . 0.0 109.882 172.492 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -78.52 -56.58 4.32 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.241 0.616 . . . . 0.0 111.3 177.071 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.0 165.24 35.61 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.225 1.81 . . . . 0.0 109.795 179.266 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -146.25 142.87 28.78 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 170.488 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.22 105.71 50.31 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.355 1.462 . . . . 0.0 111.808 -178.544 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -67.54 142.89 60.71 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 124.129 3.22 . . . . 0.0 112.39 170.823 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.5 t -139.2 117.33 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.294 1.437 . . . . 0.0 109.688 -177.792 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -81.45 -25.96 35.68 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 121.45 -0.781 . . . . 0.0 112.96 -177.396 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.19 145.35 16.52 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.336 1.854 . . . . 0.0 110.077 169.435 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -118.75 127.94 26.25 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.569 1.148 . . . . 0.0 110.588 175.865 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.54 147.5 75.76 Favored 'Cis proline' 0 CA--C 1.542 0.905 0 CA-C-N 119.997 1.035 . . . . 0.0 113.434 -2.684 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.91 -158.2 9.05 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.686 1.612 . . . . 0.0 112.948 -179.169 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.2 tt -76.29 -40.41 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 O-C-N 121.853 -0.793 . . . . 0.0 113.093 -178.245 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.44 7.72 18.77 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -166.534 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.9 t -152.83 125.99 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 126.421 1.889 . . . . 0.0 108.571 177.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -145.95 154.06 41.5 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.607 1.163 . . . . 0.0 112.224 -173.834 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.7 p -103.2 154.78 18.96 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.524 1.53 . . . . 0.0 112.453 179.693 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.9 m -76.42 175.28 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.8 1.24 . . . . 0.0 111.065 165.875 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 68.7 p -92.21 -30.12 16.08 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.909 1.283 . . . . 0.0 113.152 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -100.94 -39.34 7.8 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -163.697 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.4 t -141.42 125.76 17.58 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -176.489 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.88 -12.73 26.93 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -172.318 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.455 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.272 27.7 ptt180 -82.61 11.78 5.4 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -176.892 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -136.98 140.82 42.45 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.082 1.353 . . . . 0.0 112.03 -174.078 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -140.95 158.82 43.41 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.231 1.412 . . . . 0.0 111.656 -178.262 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.3 t -108.39 140.26 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.379 1.072 . . . . 0.0 108.56 162.85 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.95 148.31 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 119.159 0.891 . . . . 0.0 112.229 170.184 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -93.25 91.65 7.35 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.743 0.817 . . . . 0.0 110.834 178.081 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -75.02 152.28 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.245 0.618 . . . . 0.0 111.894 176.701 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.46 0 C-N-CA 125.591 1.556 . . . . 0.0 110.102 171.249 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 90.5 p . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.81 146.69 31.26 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.894 1.278 . . . . 0.0 111.443 174.51 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -90.38 117.12 28.85 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.552 0.741 . . . . 0.0 109.438 167.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.8 pt -116.77 144.63 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.804 1.242 . . . . 0.0 110.821 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -92.36 139.15 14.54 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 176.797 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.41 HG22 HG22 ' A' ' 19' ' ' VAL . 31.7 pt -130.67 160.61 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.175 1.39 . . . . 0.0 112.152 171.386 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -155.2 174.45 33.36 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-O 121.865 0.703 . . . . 0.0 114.794 167.341 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -124.2 149.26 46.57 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 126.721 2.008 . . . . 0.0 110.642 -173.255 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.0 t -74.68 -11.97 60.31 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 178.379 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -119.12 -24.16 6.57 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -155.282 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 61.09 -41.29 0.12 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 127.152 2.181 . . . . 0.0 115.036 -166.442 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.17 -27.89 72.14 Favored Glycine 0 CA--C 1.537 1.456 0 CA-C-N 119.675 1.125 . . . . 0.0 113.632 171.038 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -79.69 -34.72 39.96 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.122 0.961 . . . . 0.0 112.095 173.317 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.455 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -63.96 -36.77 85.05 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.563 -0.711 . . . . 0.0 112.636 167.88 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -70.27 9.91 0.52 Allowed 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 167.933 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -122.4 -32.57 3.6 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.219 1.408 . . . . 0.0 112.114 170.577 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -50.15 -48.89 53.58 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.223 1.409 . . . . 0.0 111.974 164.148 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -77.07 -29.83 55.22 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -178.672 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.2 t -77.96 -42.75 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 121.041 -1.037 . . . . 0.0 111.004 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 77.8 p -64.08 -26.66 68.65 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 176.309 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.9 mt -71.62 -59.51 2.72 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.22 1.008 . . . . 0.0 112.004 168.092 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -65.3 -30.34 71.18 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -172.412 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -79.04 -1.18 34.44 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.484 1.114 . . . . 0.0 112.608 177.341 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -100.06 -3.98 30.83 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 164.73 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -113.87 -10.24 12.98 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 176.574 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.28 0 CA-C-N 120.431 1.469 . . . . 0.0 114.855 -176.799 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.234 0.274 0 N-CA-C 111.405 0.15 . . . . 0.0 111.405 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.0 p -72.3 146.26 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 123.481 0.712 . . . . 0.0 111.184 -178.76 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.7 mt -129.5 -37.47 1.6 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.361 1.465 . . . . 0.0 112.521 -170.817 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 36.8 t -149.31 139.42 22.14 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.954 1.301 . . . . 0.0 109.865 173.312 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.2 t -134.84 127.71 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.826 1.25 . . . . 0.0 108.864 168.636 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -130.96 136.98 29.75 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 125.048 1.339 . . . . 0.0 110.868 176.162 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.11 -14.32 16.82 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.349 2.699 . . . . 0.0 114.968 -174.919 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -134.58 108.69 8.21 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.135 0.974 . . . . 0.0 111.295 -173.149 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.37 144.35 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.189 1.396 . . . . 0.0 110.191 171.659 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.1 m -123.19 137.5 54.88 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.441 1.096 . . . . 0.0 111.267 -176.574 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.2 t -101.79 133.05 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.324 1.449 . . . . 0.0 111.444 178.391 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.22 121.51 22.6 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.973 1.309 . . . . 0.0 109.109 170.597 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -66.51 130.82 44.49 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.069 0.548 . . . . 0.0 109.98 174.123 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.0 pt . . . . . 0 CA--C 1.545 0.765 0 C-N-CA 124.134 0.974 . . . . 0.0 113.205 -168.206 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 . . . . . 0 C--O 1.224 -0.258 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.54 18.53 7.46 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -172.412 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.3 -49.66 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 128.192 2.597 . . . . 0.0 115.597 -173.726 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.2 m -65.21 -17.8 64.79 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.99 1.716 . . . . 0.0 114.611 -176.295 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.89 -8.64 59.14 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 172.695 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -88.99 168.9 11.99 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.78 1.232 . . . . 0.0 110.732 174.639 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -81.26 55.36 2.53 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.686 1.195 . . . . 0.0 113.436 179.805 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.3 mt -54.84 -31.53 59.55 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -172.432 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -90.34 -8.78 49.9 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.32 1.048 . . . . 0.0 113.054 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -137.16 71.17 55.06 Favored Pre-proline 0 N--CA 1.471 0.62 0 C-N-CA 125.624 1.57 . . . . 0.0 111.358 -164.239 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -69.0 148.14 69.35 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 CA-C-N 119.315 0.791 . . . . 0.0 113.051 -171.753 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -72.35 -29.59 63.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.323 0.649 . . . . 0.0 111.239 167.486 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 56.0 t90 -159.56 154.21 24.32 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.533 1.933 . . . . 0.0 110.612 176.266 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.6 p -133.29 149.27 51.94 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.32 1.048 . . . . 0.0 111.749 167.952 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.84 -139.91 4.45 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 123.058 0.361 . . . . 0.0 113.261 -179.392 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.7 mtm105 -113.78 143.91 43.85 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.087 1.755 . . . . 0.0 111.736 -173.025 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.6 tp -83.37 140.34 32.47 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.62 1.168 . . . . 0.0 110.142 168.13 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -133.39 138.24 46.19 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.508 1.523 . . . . 0.0 108.816 156.69 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.407 HD11 ' CD2' ' A' ' 119' ' ' PHE . 21.1 mt -120.4 133.41 67.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 166.078 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.44 162.82 34.41 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 127.1 2.16 . . . . 0.0 109.309 -167.515 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 84.1 p -160.21 132.46 6.27 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 120.018 -1.676 . . . . 0.0 113.954 -169.452 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.64 137.18 7.64 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 125.51 1.524 . . . . 0.0 114.653 172.027 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 65.5 48.96 63.25 Favored Glycine 0 N--CA 1.475 1.259 0 C-N-CA 125.74 1.638 . . . . 0.0 114.123 171.835 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 56.1 30.57 16.58 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.99 1.716 . . . . 0.0 112.986 -174.498 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.5 m -134.05 132.92 40.6 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.775 2.03 . . . . 0.0 108.257 178.489 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.63 158.35 16.16 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.091 0.956 . . . . 0.0 110.434 171.418 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -142.12 91.89 2.38 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.666 1.586 . . . . 0.0 108.833 -164.967 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.8 mp -78.52 110.84 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 171.558 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -112.9 127.91 56.32 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.927 0.891 . . . . 0.0 110.868 177.201 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mp -96.94 130.29 44.28 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.583 1.153 . . . . 0.0 110.019 177.754 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -129.96 149.56 51.63 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.873 0.869 . . . . 0.0 112.845 -171.358 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -73.58 144.79 45.87 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.983 0.897 . . . . 0.0 112.186 -178.9 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.0 pttt -84.44 -6.73 59.41 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.238 1.815 . . . . 0.0 115.158 -178.666 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 96.0 t -122.7 -43.99 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.241 1.416 . . . . 0.0 111.586 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.2 m -95.34 -21.39 18.42 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -174.508 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.13 6.94 84.0 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.218 0.913 . . . . 0.0 113.902 -176.989 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.43 155.89 24.42 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.421 1.489 . . . . 0.0 112.626 -174.425 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.8 tp -74.57 128.06 34.62 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.632 0.773 . . . . 0.0 111.149 178.282 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -85.93 -56.41 3.49 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.327 1.051 . . . . 0.0 111.133 169.041 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.88 160.71 39.4 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.162 1.385 . . . . 0.0 111.204 -178.602 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? -140.18 136.02 33.02 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 176.17 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.73 100.56 51.02 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 126.136 1.774 . . . . 0.0 110.691 179.685 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -74.83 141.44 27.17 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.35 2.7 . . . . 0.0 111.33 169.775 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.5 t -134.65 125.93 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 126.921 2.088 . . . . 0.0 108.987 -172.108 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -90.97 -22.24 20.92 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.295 0.952 . . . . 0.0 113.53 -177.734 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -161.54 150.5 16.0 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.322 1.849 . . . . 0.0 110.438 173.988 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -130.16 131.77 23.65 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.347 1.059 . . . . 0.0 111.443 175.971 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.73 145.42 46.72 Favored 'Cis proline' 0 CA--C 1.539 0.736 0 CA-C-N 119.922 1.008 . . . . 0.0 113.739 -7.042 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -161.77 -156.26 8.29 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 125.669 1.605 . . . . 0.0 112.357 -177.925 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 19.9 tt -81.42 -39.94 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -176.723 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.68 6.35 15.53 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -167.936 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.1 t -152.22 128.51 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 126.364 1.866 . . . . 0.0 109.238 178.568 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -140.02 158.46 44.03 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.438 1.495 . . . . 0.0 113.11 176.155 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 67.5 p -100.56 159.04 15.48 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.294 1.838 . . . . 0.0 111.638 175.191 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.9 m -83.91 174.22 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.738 0.815 . . . . 0.0 110.862 164.575 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 59.9 p -96.02 -30.71 13.42 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.35 1.46 . . . . 0.0 113.224 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -96.04 -40.72 9.11 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -165.513 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.1 t -137.38 120.59 16.8 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -174.19 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.8 m -73.91 24.44 0.08 Allowed 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 -168.001 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -128.61 23.82 5.82 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 127.136 2.175 . . . . 0.0 113.529 -178.169 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -141.55 139.52 33.21 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.644 1.577 . . . . 0.0 111.391 -178.454 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -140.18 161.29 37.99 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.807 1.243 . . . . 0.0 111.89 -177.923 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 78.1 t -113.04 142.34 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.473 1.109 . . . . 0.0 108.725 166.021 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.43 149.46 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 118.509 0.595 . . . . 0.0 112.085 170.51 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -89.47 87.4 7.06 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.814 0.846 . . . . 0.0 110.508 177.019 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.8 141.05 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 O-C-N 122.102 -0.374 . . . . 0.0 110.469 172.947 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 . . . . . 0 N--CA 1.467 0.402 0 C-N-CA 125.377 1.471 . . . . 0.0 111.418 -170.262 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 84.1 p . . . . . 0 N--CA 1.47 0.547 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.87 145.92 31.81 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.644 1.577 . . . . 0.0 110.952 170.048 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -93.57 116.56 29.08 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.63 0.772 . . . . 0.0 109.726 171.284 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.3 pt -115.69 144.04 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.539 1.136 . . . . 0.0 110.953 179.339 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.46 142.47 16.11 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 174.858 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.4 pt -128.85 147.78 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 125.331 1.452 . . . . 0.0 111.925 172.217 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.15 146.94 17.89 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.454 1.026 . . . . 0.0 114.022 177.178 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -109.72 161.1 15.73 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.536 1.934 . . . . 0.0 111.104 178.405 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.9 t -74.41 -24.13 59.06 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.721 0.808 . . . . 0.0 112.802 179.091 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -157.47 156.35 31.96 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.814 1.246 . . . . 0.0 111.504 -177.133 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -57.84 -33.25 68.44 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 118.642 -0.694 . . . . 0.0 112.465 175.228 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -59.65 -30.98 69.91 Favored Glycine 0 CA--C 1.536 1.401 0 CA-C-N 119.491 1.041 . . . . 0.0 114.237 -179.279 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -86.85 -36.89 18.21 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.381 1.09 . . . . 0.0 112.241 176.667 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.46 -30.26 70.48 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 168.971 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . 0.259 18.3 m-85 -91.0 17.92 7.35 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.006 1.722 . . . . 0.0 114.096 170.867 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -99.41 -40.66 7.77 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.635 -0.666 . . . . 0.0 111.099 143.706 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.407 ' CD2' HD11 ' A' ' 49' ' ' ILE . 40.4 t80 -53.78 -56.7 15.13 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.566 1.076 . . . . 0.0 113.047 178.889 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -80.45 -24.47 39.54 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -175.396 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 85.2 t -81.76 -39.2 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 123.144 0.577 . . . . 0.0 110.941 -177.136 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 89.4 p -64.41 -31.64 72.94 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 175.115 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 67.5 mt -68.14 -56.8 7.47 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.28 1.032 . . . . 0.0 111.704 171.143 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -67.23 -32.63 73.8 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.319 -0.863 . . . . 0.0 113.004 -173.478 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -84.69 -3.16 58.41 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.785 0.834 . . . . 0.0 112.762 177.748 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -93.97 -31.9 14.08 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.41 -0.806 . . . . 0.0 112.375 163.3 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -90.4 -9.81 46.2 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -178.539 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -171.832 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.4 p -72.57 144.56 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.707 0.803 . . . . 0.0 112.579 -174.512 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.6 mt -128.26 -43.97 1.44 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.239 1.416 . . . . 0.0 112.248 -173.539 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 24.4 t -149.6 135.06 18.38 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.376 1.07 . . . . 0.0 110.604 175.494 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 96.5 t -127.91 127.96 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.551 1.14 . . . . 0.0 109.304 171.809 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -128.35 133.27 24.97 Favored Pre-proline 0 N--CA 1.476 0.87 0 C-N-CA 125.259 1.424 . . . . 0.0 110.122 174.207 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.22 -15.48 14.36 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.116 2.544 . . . . 0.0 115.037 -171.305 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -133.48 108.58 8.73 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.138 0.975 . . . . 0.0 110.879 -174.444 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.3 p -144.94 144.48 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.161 1.384 . . . . 0.0 110.289 174.697 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.0 m -125.9 130.64 51.71 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.188 0.995 . . . . 0.0 111.081 -172.752 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.5 t -96.39 134.82 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.286 1.435 . . . . 0.0 111.345 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.98 124.76 26.86 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.952 1.301 . . . . 0.0 108.918 170.959 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.4 mmm-85 -63.14 136.77 57.96 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.634 -0.666 . . . . 0.0 110.451 167.843 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.5 pt . . . . . 0 CA--C 1.544 0.727 0 C-N-CA 124.981 1.312 . . . . 0.0 112.349 -174.841 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 . . . . . 0 CA--C 1.538 0.51 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.13 22.6 12.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.911 -1.118 . . . . 0.0 113.821 178.943 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.87 -48.78 0.06 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.369 2.268 . . . . 0.0 114.969 -167.859 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.6 m -66.86 -13.79 62.01 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.943 1.697 . . . . 0.0 114.903 -176.207 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.38 -12.98 60.37 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.129 0.972 . . . . 0.0 112.876 171.898 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 13.7 m0 -95.76 171.77 8.45 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.483 1.513 . . . . 0.0 111.958 -174.345 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -75.69 49.39 0.51 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.146 1.779 . . . . 0.0 113.844 177.19 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.5 mt -56.06 -33.61 65.15 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -171.025 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -94.44 -3.89 49.29 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.457 1.103 . . . . 0.0 113.209 177.492 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -128.04 59.91 43.05 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 127.054 2.141 . . . . 0.0 111.843 -173.715 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.0 133.34 33.07 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 CA-C-N 120.537 1.227 . . . . 0.0 112.423 -173.468 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -70.34 -24.49 62.99 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.853 1.261 . . . . 0.0 111.243 178.604 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 33.9 t90 -159.74 154.47 24.37 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.862 2.065 . . . . 0.0 110.451 170.946 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.9 p -133.76 150.17 51.46 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.075 0.95 . . . . 0.0 112.112 167.757 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.16 -140.15 4.74 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.099 0.38 . . . . 0.0 113.581 -178.858 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.0 mtm105 -111.5 147.7 34.78 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.538 1.935 . . . . 0.0 111.971 -175.355 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.9 tp -89.19 138.43 31.43 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.632 1.573 . . . . 0.0 109.672 166.441 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 36.8 ttt-85 -144.5 93.04 2.37 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.475 1.11 . . . . 0.0 110.697 165.44 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.471 HD11 ' CD1' ' A' ' 119' ' ' PHE . 16.1 mt -73.08 128.29 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 171.69 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.2 p -132.86 167.32 20.41 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.741 2.016 . . . . 0.0 110.552 -179.18 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.3 t -160.54 146.77 15.24 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.603 -1.311 . . . . 0.0 112.153 177.076 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.5 mmtt -153.3 131.76 12.13 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.358 1.463 . . . . 0.0 111.428 161.154 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.98 45.99 47.48 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.859 1.219 . . . . 0.0 115.026 163.812 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt 63.68 21.39 12.68 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.432 1.893 . . . . 0.0 113.696 -173.905 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.2 m -127.7 112.7 15.11 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.072 1.349 . . . . 0.0 109.143 170.411 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.97 161.49 18.98 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.63 0.772 . . . . 0.0 110.573 170.024 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -141.11 108.75 5.61 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.941 1.696 . . . . 0.0 108.695 -175.637 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.5 mp -81.39 95.14 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 168.36 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -95.04 137.29 34.29 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.445 0.641 . . . . 0.0 111.605 175.586 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.3 mp -110.94 134.36 52.64 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.447 1.899 . . . . 0.0 109.491 176.402 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -139.21 152.13 47.1 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.544 0.738 . . . . 0.0 112.734 -168.374 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -73.6 143.26 46.44 Favored 'General case' 0 C--O 1.238 0.492 0 O-C-N 121.304 -0.872 . . . . 0.0 111.907 -176.809 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.4 pttt -84.01 -6.18 59.36 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.377 1.871 . . . . 0.0 115.05 -178.761 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 91.8 t -123.5 -44.42 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.357 1.463 . . . . 0.0 111.416 178.671 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.9 m -92.77 -23.11 18.99 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -174.906 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.84 6.06 86.94 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 123.872 0.748 . . . . 0.0 113.778 -177.421 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -82.05 154.48 25.6 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.361 1.464 . . . . 0.0 112.616 -174.625 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.1 tp -73.37 125.54 28.1 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.818 0.847 . . . . 0.0 110.981 178.136 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -84.56 -56.94 3.35 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.131 0.972 . . . . 0.0 110.806 169.683 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.32 163.3 39.67 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.744 1.218 . . . . 0.0 111.774 -179.273 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -139.63 135.79 33.65 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.583 1.153 . . . . 0.0 111.5 177.405 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.53 102.81 49.67 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.547 1.139 . . . . 0.0 111.076 174.695 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -70.06 137.89 35.63 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.828 3.019 . . . . 0.0 112.09 173.213 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.8 t -131.98 131.93 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.212 1.805 . . . . 0.0 109.251 -179.193 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -101.11 -16.29 17.11 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.435 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -161.71 152.13 17.42 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.926 1.69 . . . . 0.0 110.411 175.151 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -124.7 134.88 25.99 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -173.095 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -66.9 149.31 80.4 Favored 'Cis proline' 0 CA--C 1.542 0.909 0 CA-C-N 119.41 0.825 . . . . 0.0 111.221 -13.993 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -148.09 -172.78 18.41 Favored Glycine 0 N--CA 1.474 1.217 0 N-CA-C 115.1 0.8 . . . . 0.0 115.1 -174.183 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.3 tp -58.79 -29.03 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -174.521 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.53 7.97 43.77 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.584 1.154 . . . . 0.0 113.763 -172.977 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.1 p -158.94 128.58 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.004 0.922 . . . . 0.0 113.266 179.008 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -148.57 165.51 31.04 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.185 1.794 . . . . 0.0 113.455 -168.147 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 50.0 p -121.77 155.91 34.28 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.625 1.97 . . . . 0.0 111.592 -172.692 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.0 m -84.45 172.89 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.761 0.824 . . . . 0.0 111.901 172.941 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 68.7 p -89.03 -34.17 16.9 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.028 1.331 . . . . 0.0 112.539 177.868 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -92.92 -43.41 8.97 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -164.307 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.4 t -145.81 121.56 10.54 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -174.2 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.37 -2.3 5.99 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -169.707 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.416 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.264 1.2 ptm180 -88.19 22.16 2.54 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.922 1.689 . . . . 0.0 114.528 174.2 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -140.47 134.71 31.11 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.893 1.277 . . . . 0.0 110.813 178.695 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -134.26 161.55 34.64 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.418 1.487 . . . . 0.0 111.763 -179.672 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.5 t -117.5 142.35 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.522 1.129 . . . . 0.0 109.116 166.762 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.38 150.77 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 123.381 0.673 . . . . 0.0 111.721 171.014 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -95.06 89.69 5.66 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.125 0.97 . . . . 0.0 109.988 177.78 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -71.05 137.0 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 120.724 0.297 . . . . 0.0 110.757 177.842 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 . . . . . 0 N--CA 1.467 0.406 0 C-N-CA 125.725 1.61 . . . . 0.0 111.521 -167.198 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 CA--C 1.535 0.383 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.75 141.02 26.3 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.303 1.441 . . . . 0.0 111.195 167.565 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -87.42 125.13 34.09 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 121.842 -0.536 . . . . 0.0 110.352 169.682 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 14.9 pt -122.27 142.92 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.117 1.367 . . . . 0.0 110.469 175.131 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.99 143.68 16.68 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 172.542 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.9 pt -129.17 141.59 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.971 1.308 . . . . 0.0 111.951 172.335 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -119.21 145.31 18.07 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.936 1.255 . . . . 0.0 113.157 175.267 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -108.21 161.51 14.92 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.016 1.726 . . . . 0.0 111.689 -176.334 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.9 t -72.57 -29.41 63.51 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.744 0.818 . . . . 0.0 112.91 -179.391 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -155.6 153.37 30.0 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.523 1.129 . . . . 0.0 111.753 -178.469 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 57.4 ttt-85 -61.29 -34.29 74.97 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.185 0.994 . . . . 0.0 113.176 178.065 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.43 -29.67 74.38 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 118.898 0.772 . . . . 0.0 113.515 175.481 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -82.43 -33.51 28.55 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 117.893 0.847 . . . . 0.0 111.825 175.349 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.416 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -67.09 -33.4 75.39 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.7 0.8 . . . . 0.0 112.962 170.146 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -60.84 -34.06 74.0 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.51 -0.744 . . . . 0.0 112.347 172.671 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -64.87 -32.63 74.43 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.543 1.065 . . . . 0.0 112.606 174.726 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.471 ' CD1' HD11 ' A' ' 49' ' ' ILE . 27.3 t80 -60.97 -55.66 30.24 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.241 0.928 . . . . 0.0 111.604 173.011 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.05 -26.73 56.85 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -175.884 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.9 t -74.62 -43.29 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 119.288 0.949 . . . . 0.0 110.953 175.271 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 41.9 m -66.41 -27.18 67.64 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.96 0.8 . . . . 0.0 112.843 -179.187 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 75.4 mt -73.71 -57.52 3.93 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.638 0.775 . . . . 0.0 111.483 169.877 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -64.27 -32.35 73.91 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -173.595 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -80.58 -5.42 56.78 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.039 0.936 . . . . 0.0 112.575 178.785 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -94.77 -15.05 24.14 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 165.403 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -108.81 -7.01 15.6 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-N 121.218 1.826 . . . . 0.0 115.786 -175.653 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.9 t -73.55 147.25 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.103 1.361 . . . . 0.0 111.622 -174.54 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.84 -40.88 1.05 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.516 1.527 . . . . 0.0 111.843 -172.99 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 22.5 t -147.41 142.5 27.1 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.899 1.28 . . . . 0.0 110.669 173.58 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 76.1 t -136.05 129.03 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 125.076 1.35 . . . . 0.0 109.087 170.082 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -130.92 137.65 31.24 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 125.44 1.496 . . . . 0.0 110.381 173.27 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.59 -17.86 15.87 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.028 2.485 . . . . 0.0 114.797 -174.744 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -133.77 111.11 10.27 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.236 1.015 . . . . 0.0 111.794 -171.009 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.0 p -148.42 144.3 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.038 1.735 . . . . 0.0 110.017 172.939 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.4 m -123.09 136.63 54.88 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.45 1.1 . . . . 0.0 111.29 -174.053 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.2 t -101.29 133.42 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.063 1.345 . . . . 0.0 111.532 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -134.18 119.6 19.02 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.055 1.342 . . . . 0.0 108.864 171.044 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -66.36 129.86 41.26 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.975 0.51 . . . . 0.0 109.808 174.577 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.4 pt . . . . . 0 CA--C 1.544 0.746 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -166.575 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 . . . . . 0 CA--C 1.534 0.355 0 CA-C-O 120.505 0.193 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.42 17.13 3.68 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -171.377 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.06 -52.23 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 128.16 2.584 . . . . 0.0 115.616 -175.487 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.6 m -66.66 -13.94 61.85 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.872 1.669 . . . . 0.0 114.187 -176.819 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -84.6 -8.44 58.89 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.943 1.297 . . . . 0.0 112.633 173.479 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.2 m0 -92.93 169.36 10.5 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.753 1.621 . . . . 0.0 111.234 177.214 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -79.62 51.33 1.25 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.197 1.799 . . . . 0.0 112.574 178.305 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.2 mt -54.62 -32.44 58.92 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.389 1.476 . . . . 0.0 114.36 -173.852 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -87.92 -9.5 53.44 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.796 0.838 . . . . 0.0 112.485 -177.757 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -139.13 68.66 41.23 Favored Pre-proline 0 N--CA 1.47 0.545 0 C-N-CA 125.396 1.478 . . . . 0.0 111.231 -160.511 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -68.7 147.23 69.17 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 CA-C-N 119.519 0.864 . . . . 0.0 113.215 -169.1 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -72.52 -30.12 64.19 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.493 0.717 . . . . 0.0 111.286 168.674 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.6 t90 -159.24 155.14 26.47 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.472 1.909 . . . . 0.0 110.517 176.789 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.8 p -134.7 146.99 49.98 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.81 1.244 . . . . 0.0 111.945 171.233 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.14 -140.8 5.45 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 114.574 0.59 . . . . 0.0 114.574 176.707 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -107.14 141.54 38.25 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 126.677 1.991 . . . . 0.0 111.249 -169.253 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.5 tp -84.67 139.39 32.06 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.037 1.335 . . . . 0.0 110.127 168.237 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.6 ttm-85 -131.82 132.05 43.4 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.408 1.083 . . . . 0.0 109.554 154.546 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.402 HD11 ' CD2' ' A' ' 119' ' ' PHE . 22.4 mt -109.34 132.8 56.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 163.282 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.84 164.19 31.24 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 126.379 1.871 . . . . 0.0 109.866 -168.322 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.2 t -156.96 155.99 32.24 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 120.772 -1.205 . . . . 0.0 111.805 177.241 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -159.97 133.3 6.92 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.388 1.475 . . . . 0.0 110.045 152.641 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.97 49.94 20.28 Favored Glycine 0 N--CA 1.475 1.258 0 C-N-CA 124.7 1.143 . . . . 0.0 114.82 166.666 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt 59.93 23.1 12.16 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 126.406 1.882 . . . . 0.0 113.697 -175.834 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.8 m -126.93 126.48 43.31 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.824 1.65 . . . . 0.0 108.308 172.285 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.68 161.11 13.81 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.125 0.97 . . . . 0.0 110.873 170.577 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -139.65 110.68 6.89 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 126.438 1.895 . . . . 0.0 108.356 -175.057 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.5 mp -86.33 106.92 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 166.098 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.7 mttt -107.43 131.3 54.43 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.64 1.176 . . . . 0.0 111.358 177.965 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.0 mp -103.32 130.01 50.49 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.053 1.341 . . . . 0.0 110.481 178.754 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -131.75 147.2 52.48 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.912 0.885 . . . . 0.0 113.289 -167.765 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -64.42 142.92 58.25 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.815 -1.178 . . . . 0.0 113.063 -177.858 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.26 -2.7 36.07 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 -178.299 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.5 t -116.78 -48.77 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.481 1.112 . . . . 0.0 111.269 170.836 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.7 m -114.22 -4.67 13.04 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.6 1.334 . . . . 0.0 114.6 -168.045 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.21 15.73 78.73 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 123.85 0.738 . . . . 0.0 114.143 177.257 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -63.97 133.35 53.03 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.839 1.656 . . . . 0.0 111.383 -177.032 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.1 tp -68.67 115.11 7.66 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 122.881 0.472 . . . . 0.0 111.056 -179.391 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -80.8 -53.3 6.61 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.714 1.206 . . . . 0.0 111.131 173.569 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.24 159.13 35.69 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.052 1.341 . . . . 0.0 111.287 -178.187 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -138.31 136.63 36.61 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.5 0.72 . . . . 0.0 112.502 173.182 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.96 107.93 47.23 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 125.339 1.456 . . . . 0.0 110.752 176.517 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -79.66 141.07 15.24 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.721 2.947 . . . . 0.0 111.314 175.101 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.8 t -134.14 129.52 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 126.145 1.778 . . . . 0.0 109.237 -172.3 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -96.52 -21.14 17.88 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 178.836 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.33 149.12 13.42 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.704 2.001 . . . . 0.0 110.301 175.981 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -129.24 129.76 23.33 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 124.334 1.054 . . . . 0.0 111.963 177.224 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -65.58 149.02 75.63 Favored 'Cis proline' 0 CA--C 1.541 0.854 0 CA-C-N 119.807 0.967 . . . . 0.0 113.191 -5.966 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -169.1 -162.28 21.03 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.639 1.59 . . . . 0.0 113.473 -177.282 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.9 tp -68.43 -35.42 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -170.249 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.04 4.1 53.81 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -168.511 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.4 t -151.35 129.64 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.806 1.242 . . . . 0.0 110.229 -179.38 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -138.84 158.4 44.3 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.535 1.534 . . . . 0.0 112.91 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 57.0 p -104.79 156.77 17.7 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.35 1.86 . . . . 0.0 111.225 175.785 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.7 m -82.89 178.37 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.82 0.848 . . . . 0.0 110.759 166.058 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 73.3 p -107.99 -22.27 12.48 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.775 1.63 . . . . 0.0 114.005 -177.941 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -90.68 -45.04 9.11 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -175.967 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t -145.32 125.7 13.96 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -179.416 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.8 m -69.57 11.83 0.23 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 -173.012 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.466 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.27 28.9 ptt180 -96.51 12.58 30.99 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.27 1.428 . . . . 0.0 114.43 174.016 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -136.75 139.66 42.02 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.428 1.491 . . . . 0.0 111.382 -173.338 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -140.13 162.89 34.15 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.062 1.345 . . . . 0.0 111.602 -177.26 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.4 t -117.17 141.77 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.526 1.131 . . . . 0.0 108.446 166.053 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.32 148.36 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 118.805 0.729 . . . . 0.0 112.281 171.246 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -91.04 81.76 5.61 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.906 0.883 . . . . 0.0 111.162 179.417 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -67.26 141.55 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.966 0.412 . . . . 0.0 111.148 176.812 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 . . . . . 0 N--CA 1.468 0.465 0 C-N-CA 125.646 1.578 . . . . 0.0 111.736 -169.058 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.9 p . . . . . 0 CA--C 1.534 0.33 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.35 146.22 32.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.436 1.494 . . . . 0.0 110.803 168.301 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -91.44 117.13 29.42 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.361 0.664 . . . . 0.0 109.535 168.586 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.6 pt -115.2 142.19 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.442 1.097 . . . . 0.0 110.795 177.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.7 141.27 16.01 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 175.293 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.5 pt -127.32 148.72 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 125.19 1.396 . . . . 0.0 111.602 170.432 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -134.61 147.24 19.05 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 124.093 0.854 . . . . 0.0 113.423 175.46 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -105.12 157.06 17.52 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.449 1.5 . . . . 0.0 111.279 176.1 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.4 t -73.8 -17.4 61.09 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.554 0.742 . . . . 0.0 112.78 178.211 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -154.28 145.92 23.27 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.675 1.19 . . . . 0.0 110.868 -178.188 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -64.27 -28.07 69.48 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.84 0.856 . . . . 0.0 113.193 -179.801 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.82 -30.75 78.07 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 124.164 0.888 . . . . 0.0 114.257 173.299 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -81.79 -34.89 30.08 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.603 1.201 . . . . 0.0 111.763 176.486 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.466 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -66.68 -30.18 70.37 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.162 0.985 . . . . 0.0 113.446 168.919 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.01 -49.54 76.51 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.363 0.665 . . . . 0.0 111.048 166.995 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -64.37 -28.96 70.05 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 118.837 0.744 . . . . 0.0 113.007 176.782 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.402 ' CD2' HD11 ' A' ' 49' ' ' ILE . 48.4 t80 -62.43 -61.25 2.57 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.651 1.114 . . . . 0.0 111.535 170.397 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -76.78 -27.29 55.22 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -171.589 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 65.5 t -71.76 -37.97 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 O-C-N 121.404 -0.81 . . . . 0.0 110.924 176.582 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 51.1 m -67.11 -16.29 64.24 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 176.466 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.5 mt -84.75 -56.73 3.43 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.164 0.985 . . . . 0.0 111.3 168.192 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -66.89 -34.33 77.54 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -172.184 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -85.77 -0.45 55.28 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.688 0.795 . . . . 0.0 112.44 177.522 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -99.4 -29.06 12.98 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.064 -1.023 . . . . 0.0 112.524 165.951 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -96.83 -5.95 37.12 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -179.601 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.248 0 CA-C-N 121.302 1.865 . . . . 0.0 114.887 -173.529 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.2 m . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.7 t -73.6 143.44 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.066 0.946 . . . . 0.0 110.764 177.612 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.2 mt -131.09 -36.8 1.3 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.089 1.355 . . . . 0.0 111.817 -169.576 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 47.9 t -153.17 142.67 21.76 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.3 1.44 . . . . 0.0 110.182 171.266 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 89.4 t -134.55 127.31 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.49 1.116 . . . . 0.0 109.315 169.223 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 75.1 mmtt -121.54 133.35 24.21 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 124.932 1.293 . . . . 0.0 111.027 174.701 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 14' ' ' LYS . 42.2 Cg_exo -69.06 -29.96 26.34 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.47 2.113 . . . . 0.0 115.911 -171.508 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -137.14 122.48 19.4 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.792 0.805 . . . . 0.0 112.744 -175.218 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 p -149.24 149.07 15.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 127.571 2.348 . . . . 0.0 109.243 177.115 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.7 m -124.75 130.96 53.41 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.652 0.781 . . . . 0.0 112.358 -169.238 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 78.6 t -96.58 136.42 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.733 1.613 . . . . 0.0 112.473 -178.772 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -129.2 126.44 39.17 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.148 1.379 . . . . 0.0 109.357 169.892 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -66.88 131.29 45.6 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 167.552 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.7 pt . . . . . 0 N--CA 1.476 0.829 0 C-N-CA 124.699 1.2 . . . . 0.0 112.36 -175.088 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 . . . . . 0 C--O 1.223 -0.318 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.67 18.27 10.34 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -174.5 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 60.35 -46.47 0.1 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.583 2.353 . . . . 0.0 115.064 -171.573 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 92.1 p -65.66 -16.91 64.19 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.56 1.944 . . . . 0.0 114.694 179.309 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -73.32 -18.79 61.16 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.766 1.226 . . . . 0.0 112.86 171.417 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 16.6 m0 -90.52 173.09 8.26 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.454 1.501 . . . . 0.0 111.881 -176.171 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -79.23 53.65 1.52 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.653 1.581 . . . . 0.0 114.36 -176.252 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.1 mt -60.01 -17.87 41.84 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -171.304 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -106.78 -3.16 20.74 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.497 1.119 . . . . 0.0 113.067 177.209 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -149.09 69.33 9.79 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 125.207 1.403 . . . . 0.0 112.122 177.798 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -55.31 145.69 65.46 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.134 2.556 . . . . 0.0 112.44 174.571 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.28 -30.68 68.83 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.711 0.804 . . . . 0.0 111.394 173.958 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 46.8 t90 -156.62 152.67 27.48 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.225 1.41 . . . . 0.0 111.056 176.076 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.9 p -133.57 152.2 51.86 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.495 -0.753 . . . . 0.0 112.13 166.274 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 176.55 -149.58 9.83 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.139 -0.482 . . . . 0.0 113.558 -175.944 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 17.5 mtm180 -97.05 148.27 23.18 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.432 1.893 . . . . 0.0 111.677 -175.959 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.0 tp -91.75 134.5 34.68 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.664 1.185 . . . . 0.0 109.596 163.332 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -127.83 119.53 25.87 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.891 1.276 . . . . 0.0 108.882 160.677 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.5 mt -101.93 130.86 50.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 166.471 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.92 166.48 26.62 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 126.254 1.822 . . . . 0.0 110.028 -166.906 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.9 t -157.21 160.12 38.38 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 121.273 -0.892 . . . . 0.0 112.168 173.67 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -144.42 122.04 11.82 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.652 0.739 . . . . 0.0 111.809 154.594 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.2 -117.98 9.68 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 125.863 1.697 . . . . 0.0 110.523 -177.551 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -100.2 14.01 32.28 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.917 1.687 . . . . 0.0 113.378 179.11 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.0 m -123.57 108.74 12.95 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.904 0.882 . . . . 0.0 110.285 177.948 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -83.16 158.94 22.16 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.158 0.504 . . . . 0.0 110.762 169.418 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -138.74 112.89 8.64 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.358 1.863 . . . . 0.0 108.729 -175.78 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.2 mp -91.98 105.54 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 165.458 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -104.09 135.06 46.28 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.115 1.366 . . . . 0.0 110.798 178.112 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.1 mp -107.06 128.79 54.69 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.616 1.566 . . . . 0.0 109.664 176.438 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -132.69 146.55 51.95 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.943 0.897 . . . . 0.0 112.004 -170.646 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -69.23 133.13 47.54 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.75 -1.219 . . . . 0.0 111.128 -179.689 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.5 pttt -77.19 -2.5 34.82 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -176.759 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.07 -42.41 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.42 1.488 . . . . 0.0 111.466 178.64 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.4 m -93.6 -21.07 19.63 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -178.764 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.66 10.07 82.83 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.645 1.117 . . . . 0.0 113.99 -177.308 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -86.75 149.11 25.1 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.287 1.435 . . . . 0.0 112.512 -172.762 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.3 tp -72.57 123.92 24.18 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.603 -0.686 . . . . 0.0 111.404 -178.029 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -87.49 -54.47 4.26 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.864 1.265 . . . . 0.0 111.245 171.826 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.9 163.2 40.64 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.684 1.194 . . . . 0.0 111.691 -177.892 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -145.84 131.46 18.86 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.505 1.122 . . . . 0.0 111.531 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.33 104.79 49.65 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 125.472 1.509 . . . . 0.0 110.855 178.895 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -77.22 144.32 23.26 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.053 2.502 . . . . 0.0 111.264 173.149 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.3 t -135.94 131.42 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.727 1.611 . . . . 0.0 109.014 -174.982 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -96.07 -22.68 17.19 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -179.54 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -163.29 150.67 12.89 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.786 2.034 . . . . 0.0 110.202 173.451 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -122.69 128.42 25.41 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.865 1.266 . . . . 0.0 111.204 177.635 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -63.14 149.49 65.88 Favored 'Cis proline' 0 CA--C 1.541 0.83 0 CA-C-N 119.849 0.982 . . . . 0.0 113.793 -6.344 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.01 -165.99 14.77 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.715 1.626 . . . . 0.0 112.532 178.347 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.7 tt -73.06 -36.86 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 O-C-N 121.698 -0.883 . . . . 0.0 112.867 -179.215 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.63 6.27 18.34 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -167.735 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.2 t -150.36 132.74 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.639 1.576 . . . . 0.0 110.26 -178.801 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -146.62 161.46 40.5 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.355 1.862 . . . . 0.0 112.331 -175.616 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 20.0 p -111.15 162.97 14.38 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 126.834 2.054 . . . . 0.0 111.719 177.447 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.0 m -87.7 174.8 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.64 1.176 . . . . 0.0 110.543 164.603 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 73.2 p -96.09 -36.38 11.01 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.147 1.379 . . . . 0.0 112.629 179.476 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -103.51 -28.33 11.83 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 -161.709 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.6 t -132.87 127.0 33.47 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.489 1.04 . . . . 0.0 113.51 -177.608 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.6 p -75.79 22.08 0.15 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.914 2.086 . . . . 0.0 116.164 -166.049 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -138.81 26.77 2.48 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 126.245 1.818 . . . . 0.0 114.632 -173.225 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -141.7 141.93 33.32 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.871 1.268 . . . . 0.0 111.735 -175.966 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -140.09 163.5 32.55 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.053 1.341 . . . . 0.0 111.085 -179.701 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.2 t -116.47 144.54 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.938 1.295 . . . . 0.0 108.843 166.959 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.8 149.42 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 118.565 0.621 . . . . 0.0 111.811 171.159 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.443 ' HE ' ' NE2' ' A' ' 97' ' ' GLN . 38.6 ttp180 -91.87 103.14 15.72 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.158 0.583 . . . . 0.0 109.954 173.285 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -84.96 148.29 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.441 1.096 . . . . 0.0 111.434 177.057 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.443 ' NE2' ' HE ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.804 0 C-N-CA 125.863 1.665 . . . . 0.0 111.447 -179.756 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 82.8 p . . . . . 0 N--CA 1.465 0.316 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.62 145.48 30.97 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.983 1.313 . . . . 0.0 110.999 170.38 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -90.13 121.72 32.44 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 166.056 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.8 pt -121.66 144.12 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.823 1.249 . . . . 0.0 110.965 178.698 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -90.7 142.81 16.41 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 173.588 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.1 pt -126.86 140.58 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 125.404 1.482 . . . . 0.0 111.651 172.104 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.48 138.95 11.83 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.185 1.374 . . . . 0.0 112.93 177.646 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -100.64 158.21 16.11 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.768 1.627 . . . . 0.0 111.488 -177.505 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.9 t -73.81 -21.56 60.11 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.732 0.813 . . . . 0.0 112.834 178.889 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -157.89 151.3 23.47 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.473 1.109 . . . . 0.0 111.577 -178.543 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -55.23 -41.64 72.36 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.716 1.207 . . . . 0.0 112.762 174.938 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.83 -29.08 71.29 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.163 0.887 . . . . 0.0 114.149 -179.275 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -83.72 -36.43 23.68 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.242 1.021 . . . . 0.0 112.103 176.225 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.0 -31.81 73.03 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.562 -0.711 . . . . 0.0 112.524 168.057 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -75.91 5.95 5.79 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 171.214 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -99.38 -32.51 11.12 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.419 -0.801 . . . . 0.0 112.715 157.963 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -55.88 -50.96 69.2 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.822 1.192 . . . . 0.0 112.458 178.603 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 48.0 p-10 -70.87 -34.28 71.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.262 1.025 . . . . 0.0 113.617 -179.44 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.1 t -73.91 -39.65 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.383 1.073 . . . . 0.0 110.742 178.825 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 27.6 t -57.28 -38.06 73.34 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.855 1.262 . . . . 0.0 112.63 176.772 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.7 mt -76.45 -52.53 9.66 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.875 0.87 . . . . 0.0 112.333 176.394 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -65.88 -30.79 71.45 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.409 -0.807 . . . . 0.0 112.999 -175.203 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -88.24 6.3 37.54 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.379 1.072 . . . . 0.0 112.942 176.684 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -94.14 -43.65 8.37 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.498 -0.751 . . . . 0.0 111.97 154.776 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -85.82 1.1 51.07 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -171.922 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 -178.754 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.74 147.23 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.343 1.057 . . . . 0.0 113.152 175.76 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.1 mt -123.57 -38.72 2.5 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.727 2.011 . . . . 0.0 110.32 179.804 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.1 t -155.36 147.28 23.39 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.344 1.458 . . . . 0.0 110.686 170.102 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.0 t -136.9 125.28 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.342 1.457 . . . . 0.0 108.906 174.121 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -127.82 143.12 46.49 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 124.63 1.172 . . . . 0.0 112.482 178.392 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.19 -19.34 15.53 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.836 3.024 . . . . 0.0 115.623 -172.834 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -132.25 112.07 11.93 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.9 0.88 . . . . 0.0 111.713 -172.008 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.8 p -145.07 143.58 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.785 1.634 . . . . 0.0 110.074 169.722 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.3 m -126.61 127.78 45.76 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.204 1.001 . . . . 0.0 111.172 -172.843 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 78.7 t -94.91 138.39 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.383 1.473 . . . . 0.0 112.194 -177.652 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -129.2 126.71 39.78 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.026 1.33 . . . . 0.0 109.356 168.918 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -69.55 119.25 13.51 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 165.454 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.5 pt . . . . . 0 N--CA 1.477 0.894 0 C-N-CA 124.247 1.019 . . . . 0.0 113.304 -167.922 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 . . . . . 0 C--O 1.223 -0.321 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.38 18.12 6.44 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -171.162 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.07 -47.05 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 127.842 2.457 . . . . 0.0 115.591 -171.878 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.5 m -66.29 -17.08 64.54 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.359 1.864 . . . . 0.0 114.739 -178.623 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -87.04 -2.01 58.31 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.075 0.95 . . . . 0.0 113.261 172.22 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 22.2 m0 -93.0 169.29 10.54 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.319 1.447 . . . . 0.0 110.615 172.866 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.6 mmtm -77.22 53.63 1.02 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.762 1.625 . . . . 0.0 114.445 -178.086 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.8 mt -58.52 -20.94 50.32 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 -175.376 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -100.79 -4.0 28.87 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 178.753 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -153.19 81.72 5.02 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.914 1.286 . . . . 0.0 111.784 175.041 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.37 145.8 34.85 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.308 2.672 . . . . 0.0 112.936 175.331 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -68.62 -31.54 70.78 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.092 0.557 . . . . 0.0 111.077 169.523 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 42.3 t90 -157.06 156.15 32.36 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.703 1.601 . . . . 0.0 111.057 174.297 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.8 p -135.08 149.46 50.07 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.277 1.031 . . . . 0.0 112.276 169.157 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.42 -143.94 6.17 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 123.289 0.471 . . . . 0.0 113.631 179.586 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.3 mtm105 -107.94 150.68 26.78 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.61 1.964 . . . . 0.0 112.093 -175.604 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.7 tp -94.71 138.18 32.86 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.485 1.914 . . . . 0.0 110.513 173.211 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -134.77 106.39 6.89 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.494 1.518 . . . . 0.0 109.684 165.26 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.3 mt -87.18 130.64 36.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 166.16 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.88 164.93 29.13 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.817 1.647 . . . . 0.0 110.739 -169.366 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.4 t -159.0 157.02 30.45 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.572 1.149 . . . . 0.0 111.009 171.54 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.4 mmtt -147.62 128.6 14.5 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.027 0.931 . . . . 0.0 110.782 152.728 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.43 -125.49 7.36 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 125.841 1.686 . . . . 0.0 110.054 -177.332 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -104.44 22.62 14.59 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.638 1.575 . . . . 0.0 112.78 177.389 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.6 m -127.47 123.17 35.37 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.995 1.318 . . . . 0.0 109.678 178.633 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.29 162.1 13.82 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.164 0.986 . . . . 0.0 110.791 169.487 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -140.93 112.74 7.65 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.041 1.736 . . . . 0.0 108.758 -176.326 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -89.88 105.41 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 167.28 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -108.84 141.93 40.16 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.893 1.277 . . . . 0.0 111.286 179.138 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.3 mp -111.69 131.1 55.52 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 126.047 1.739 . . . . 0.0 110.347 178.877 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -126.04 154.16 43.4 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.347 1.059 . . . . 0.0 113.441 -171.685 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -72.7 141.98 48.21 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 122.093 0.949 . . . . 0.0 111.611 174.254 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -83.99 -2.83 57.35 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 -176.983 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.7 t -126.43 -39.77 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.572 1.149 . . . . 0.0 111.871 -179.212 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.6 m -110.8 -15.57 13.78 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -172.14 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.97 21.83 79.56 Favored Glycine 0 CA--C 1.535 1.307 0 O-C-N 121.823 -0.548 . . . . 0.0 113.966 -179.702 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -63.63 160.75 16.17 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.683 1.193 . . . . 0.0 111.43 171.556 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.3 tp -93.92 120.54 34.31 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.048 0.939 . . . . 0.0 109.653 169.049 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -83.46 -54.3 5.07 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.479 0.712 . . . . 0.0 111.255 173.257 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.13 163.86 37.19 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.565 1.146 . . . . 0.0 111.973 -178.463 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -144.72 134.8 24.0 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.882 1.273 . . . . 0.0 111.841 179.477 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.74 100.88 43.32 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.482 1.513 . . . . 0.0 111.189 178.834 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -68.96 142.1 50.49 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 124.123 3.216 . . . . 0.0 112.559 172.203 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.0 t -136.31 130.89 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 126.003 1.721 . . . . 0.0 109.697 -176.528 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -92.65 -23.24 19.05 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.76 149.69 13.07 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.438 1.895 . . . . 0.0 110.234 172.118 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -115.37 131.01 23.82 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 124.526 1.13 . . . . 0.0 111.346 175.374 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.26 149.19 81.33 Favored 'Cis proline' 0 CA--C 1.542 0.92 0 CA-C-N 119.929 1.01 . . . . 0.0 112.574 -6.567 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.15 -176.88 36.41 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.561 1.077 . . . . 0.0 114.155 -179.022 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.9 tp -56.89 -32.38 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 125.184 1.394 . . . . 0.0 114.55 -171.459 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.85 4.82 52.03 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -171.485 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.6 t -148.2 128.83 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.334 1.054 . . . . 0.0 110.898 179.829 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.75 164.33 30.4 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.682 1.993 . . . . 0.0 112.43 -171.574 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 72.8 p -123.26 160.81 25.83 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.957 1.703 . . . . 0.0 111.697 -173.723 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.5 m -90.21 175.3 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 124.512 1.125 . . . . 0.0 111.202 169.374 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.6 p -94.99 -34.94 12.17 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.464 1.506 . . . . 0.0 112.867 178.567 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -89.5 -42.25 11.57 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -165.349 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.2 t -142.27 125.19 16.12 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -177.217 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.9 m -70.51 9.19 0.67 Allowed 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -173.261 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.458 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.315 44.8 ptt85 -97.14 19.71 12.53 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.179 1.392 . . . . 0.0 114.75 173.795 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -140.14 136.33 33.41 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.774 1.23 . . . . 0.0 110.993 -175.585 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -135.55 162.45 32.66 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.971 1.308 . . . . 0.0 111.01 -179.752 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.1 t -117.15 142.02 32.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 124.504 1.122 . . . . 0.0 108.71 166.832 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.15 147.56 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 118.962 0.801 . . . . 0.0 111.875 173.344 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -88.61 88.01 7.46 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.187 0.595 . . . . 0.0 110.661 177.33 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -71.55 137.74 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 120.797 0.332 . . . . 0.0 110.789 176.897 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 . . . . . 0 N--CA 1.468 0.449 0 C-N-CA 126.047 1.739 . . . . 0.0 111.233 -169.185 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 94.2 p . . . . . 0 CA--C 1.535 0.37 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.03 146.18 30.86 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.8 1.64 . . . . 0.0 110.848 167.878 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -94.04 119.39 32.84 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.278 0.631 . . . . 0.0 109.926 170.28 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.6 pt -117.63 143.14 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.449 1.099 . . . . 0.0 111.062 176.606 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.04 144.22 17.9 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 174.013 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.8 pt -129.42 140.86 48.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 125.563 1.545 . . . . 0.0 111.674 171.348 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -116.47 144.62 18.49 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.258 1.408 . . . . 0.0 112.884 174.256 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -106.46 153.61 22.03 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 126.013 1.725 . . . . 0.0 111.215 178.949 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.1 t -74.36 -18.07 60.73 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.017 0.927 . . . . 0.0 113.115 -178.977 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -154.56 145.32 22.44 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.61 1.164 . . . . 0.0 111.116 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -66.29 -30.91 71.43 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 179.787 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.76 -33.02 86.13 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-N 119.083 0.856 . . . . 0.0 113.328 173.381 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -80.69 -30.78 36.37 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.619 -0.93 . . . . 0.0 112.381 175.992 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.458 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -67.43 -37.26 82.75 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 167.697 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -61.23 -41.34 96.71 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.637 -0.664 . . . . 0.0 110.964 168.195 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.66 -34.18 77.28 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 121.452 -0.78 . . . . 0.0 112.709 175.652 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -59.78 -55.53 33.09 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.298 1.039 . . . . 0.0 112.194 168.496 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.65 -24.98 62.8 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -177.921 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.1 t -73.15 -41.65 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 121.422 -0.799 . . . . 0.0 110.942 172.059 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.0 m -64.71 -16.25 62.63 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 177.369 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.4 mt -88.51 -55.42 3.73 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.604 1.162 . . . . 0.0 112.427 167.793 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -69.05 -33.71 74.01 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.829 -1.17 . . . . 0.0 113.595 -173.032 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -86.9 5.62 36.03 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.665 1.186 . . . . 0.0 112.189 176.147 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -97.22 -42.59 7.74 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.664 0.786 . . . . 0.0 112.048 160.22 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -84.9 -2.98 58.5 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -174.897 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 -177.569 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.0 m . . . . . 0 N--CA 1.468 0.457 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.8 p -66.33 147.81 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.193 0.997 . . . . 0.0 112.077 175.843 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.6 mt -132.9 -37.9 1.0 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.673 1.589 . . . . 0.0 112.493 -171.853 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 35.0 t -153.34 137.52 16.5 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.691 1.196 . . . . 0.0 110.585 173.706 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 87.9 t -130.97 126.49 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.654 1.181 . . . . 0.0 109.226 171.708 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -129.2 136.41 29.11 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 125.443 1.497 . . . . 0.0 110.76 176.652 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -81.42 -13.69 10.85 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.267 2.645 . . . . 0.0 115.405 -171.819 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -131.08 105.52 7.77 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.249 1.02 . . . . 0.0 110.945 -175.781 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.0 p -141.77 140.14 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.972 1.309 . . . . 0.0 110.367 172.389 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.6 m -125.73 126.91 45.37 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.587 1.155 . . . . 0.0 110.979 -171.966 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 79.1 t -92.85 137.74 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.356 1.462 . . . . 0.0 111.92 -178.848 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -130.83 132.64 45.33 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.945 1.298 . . . . 0.0 109.885 169.5 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -60.22 131.96 52.44 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.256 0.622 . . . . 0.0 109.732 157.398 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.9 pt . . . . . 0 N--CA 1.477 0.892 0 C-N-CA 124.666 1.187 . . . . 0.0 112.431 -173.833 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 . . . . . 0 CA--C 1.532 0.286 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.88 19.42 5.55 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -170.372 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.95 -46.15 0.06 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 128.453 2.701 . . . . 0.0 115.655 -174.632 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 90.9 p -64.04 -18.49 64.38 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.854 2.062 . . . . 0.0 114.61 179.626 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.52 -9.12 59.77 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.077 0.951 . . . . 0.0 113.144 174.054 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 16.7 m0 -92.88 170.58 9.57 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.22 1.408 . . . . 0.0 110.881 177.226 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.1 mtmm -80.28 54.53 2.01 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.041 1.337 . . . . 0.0 113.749 -177.844 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.0 mt -54.66 -29.3 52.11 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 -171.208 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -90.62 -10.67 42.41 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.033 0.933 . . . . 0.0 112.714 179.178 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -139.52 60.42 16.49 Favored Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 126.303 1.841 . . . . 0.0 110.842 -161.487 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -64.66 140.11 66.67 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 120.648 0.899 . . . . 0.0 111.966 -173.225 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -70.52 -26.91 63.79 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.79 0.836 . . . . 0.0 111.445 176.774 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 42.6 t90 -156.96 154.21 29.31 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.552 1.541 . . . . 0.0 111.023 170.08 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.4 p -134.15 144.95 48.84 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.312 1.045 . . . . 0.0 112.083 171.478 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.89 -143.69 5.17 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 123.497 0.57 . . . . 0.0 113.812 -178.087 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 34.8 mtm105 -117.92 148.59 42.01 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.818 2.047 . . . . 0.0 111.193 -172.576 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.7 tp -92.68 141.84 28.03 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.175 1.79 . . . . 0.0 111.029 176.208 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -142.47 99.08 3.42 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.926 1.69 . . . . 0.0 109.716 169.893 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.451 HD11 ' CD2' ' A' ' 119' ' ' PHE . 23.1 mt -85.98 133.8 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 169.693 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.04 168.15 22.28 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.093 1.757 . . . . 0.0 110.495 -168.286 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.2 t -157.17 150.75 24.23 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.741 -1.225 . . . . 0.0 112.087 173.658 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -149.86 134.19 17.33 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.53 151.976 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.34 50.28 33.69 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.513 1.054 . . . . 0.0 114.814 164.6 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt 60.06 26.88 16.26 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.075 1.75 . . . . 0.0 113.347 -175.765 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.5 m -130.67 124.06 30.76 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 126.028 1.731 . . . . 0.0 108.035 170.142 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -92.94 159.83 15.16 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.647 0.779 . . . . 0.0 110.585 170.183 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -139.04 106.39 5.53 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.149 1.78 . . . . 0.0 108.518 -172.669 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.3 mp -87.37 104.29 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 168.646 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -104.9 138.79 40.6 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.937 1.295 . . . . 0.0 111.121 177.508 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.9 mp -110.23 131.24 55.23 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.814 1.646 . . . . 0.0 109.933 176.596 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -130.38 149.85 51.87 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.558 1.143 . . . . 0.0 112.1 -173.713 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -75.28 152.46 38.24 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.007 -1.058 . . . . 0.0 112.455 177.814 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.564 ' H ' ' HD3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -93.79 -0.61 55.78 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.131 1.773 . . . . 0.0 115.486 -176.829 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.8 t -118.73 -45.8 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.207 1.403 . . . . 0.0 111.378 173.855 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.3 m -97.24 -21.22 17.4 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -173.714 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.72 6.81 85.51 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.085 0.85 . . . . 0.0 113.886 -177.466 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -79.3 151.25 31.19 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.045 1.338 . . . . 0.0 112.462 -174.513 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.6 tp -72.52 126.82 30.78 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.769 0.828 . . . . 0.0 110.924 178.361 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -86.66 -55.32 3.92 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.425 1.09 . . . . 0.0 111.265 170.688 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.39 160.67 39.85 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.852 1.261 . . . . 0.0 111.58 -178.349 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -141.65 136.22 30.73 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.75 0.82 . . . . 0.0 112.721 177.091 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.99 98.08 47.7 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 125.96 1.704 . . . . 0.0 111.482 -179.068 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -62.52 140.29 80.91 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 124.33 3.353 . . . . 0.0 113.042 166.002 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.1 t -136.43 126.47 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 126.453 1.901 . . . . 0.0 109.223 -178.493 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -86.69 -25.82 24.6 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 121.27 -0.894 . . . . 0.0 113.289 -178.054 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.31 151.15 15.14 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.102 1.761 . . . . 0.0 110.808 173.594 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -122.57 129.82 24.9 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.653 1.181 . . . . 0.0 111.174 176.486 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -62.65 148.2 59.79 Favored 'Cis proline' 0 CA--C 1.539 0.746 0 CA-C-N 119.982 1.029 . . . . 0.0 113.754 -6.14 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.29 -164.38 15.26 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.48 1.514 . . . . 0.0 112.702 179.772 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.0 tt -75.21 -38.32 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -177.918 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.06 6.51 16.04 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -167.424 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 25.1 t -149.03 132.09 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 125.992 1.717 . . . . 0.0 109.522 178.13 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.24 161.43 38.92 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.006 1.722 . . . . 0.0 111.94 -177.199 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.9 p -110.16 165.67 11.57 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.427 1.491 . . . . 0.0 111.373 177.912 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.7 m -87.05 179.51 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.469 0.707 . . . . 0.0 110.473 160.116 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 71.0 p -101.23 -30.01 11.77 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.614 1.566 . . . . 0.0 113.543 177.884 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -90.24 -42.77 10.81 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -167.604 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.2 t -143.31 125.12 15.08 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -176.26 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.04 -3.85 14.71 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -170.471 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.42 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.286 0.9 OUTLIER -86.68 22.86 1.81 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.56 1.544 . . . . 0.0 114.615 174.434 . . . . . . . . 4 4 . 1 . 027 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -142.24 133.25 25.91 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.633 1.173 . . . . 0.0 111.703 -179.575 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -136.07 162.94 31.51 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.373 1.469 . . . . 0.0 111.587 179.347 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 55.2 t -117.14 142.91 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.877 1.271 . . . . 0.0 109.044 168.597 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.62 148.72 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 118.835 0.743 . . . . 0.0 112.47 173.48 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -86.11 85.33 7.36 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.096 0.959 . . . . 0.0 110.406 175.855 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -68.82 140.31 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 121.945 -0.472 . . . . 0.0 110.428 172.311 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 . . . . . 0 N--CA 1.468 0.435 0 C-N-CA 125.704 1.602 . . . . 0.0 111.087 -171.038 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 38.3 p . . . . . 0 N--CA 1.467 0.416 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -137.3 150.03 47.49 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.646 1.578 . . . . 0.0 110.635 162.873 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -95.32 113.06 24.69 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.497 0.719 . . . . 0.0 109.346 170.177 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 32.2 pt -112.41 146.36 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.62 1.168 . . . . 0.0 111.109 -179.617 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -92.33 142.99 16.26 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 174.271 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 34.3 pt -128.45 139.76 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 125.171 1.388 . . . . 0.0 111.56 172.552 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -118.45 143.96 17.8 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.69 1.614 . . . . 0.0 112.567 174.197 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -105.31 161.39 14.33 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.806 1.642 . . . . 0.0 111.812 -176.373 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.3 t -72.7 -27.63 62.19 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.62 0.768 . . . . 0.0 113.055 178.132 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -156.05 150.75 26.03 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.165 0.986 . . . . 0.0 112.152 -178.918 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 47.3 ttt-85 -62.27 -34.84 77.31 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.555 1.142 . . . . 0.0 113.107 178.446 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.16 -26.72 73.99 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 118.814 0.734 . . . . 0.0 113.698 176.084 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -85.56 -32.84 21.91 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.048 0.939 . . . . 0.0 111.821 173.991 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.42 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -67.76 -32.18 72.59 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 170.914 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -57.68 -36.57 72.1 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.547 -0.721 . . . . 0.0 112.074 172.356 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -66.18 -29.27 69.51 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.207 -0.933 . . . . 0.0 112.999 176.431 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.451 ' CD2' HD11 ' A' ' 49' ' ' ILE . 26.1 t80 -62.38 -47.99 81.72 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.473 1.033 . . . . 0.0 112.032 174.029 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -83.33 -25.22 31.68 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.345 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.0 t -78.45 -42.09 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 121.36 -0.838 . . . . 0.0 111.486 177.07 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 92.4 p -65.07 -28.56 69.55 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 179.666 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.3 mt -72.23 -54.41 9.68 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.98 0.912 . . . . 0.0 111.658 170.742 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -68.42 -33.96 75.14 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.028 -1.045 . . . . 0.0 113.102 -173.895 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -86.44 7.33 26.31 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.309 1.044 . . . . 0.0 112.538 175.986 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -102.72 -35.73 8.56 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.056 0.943 . . . . 0.0 112.42 161.885 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -88.6 -3.35 58.82 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -179.508 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.263 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -175.278 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 86.4 t -68.79 143.06 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.651 1.18 . . . . 0.0 111.854 -176.937 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.6 mt -125.19 -40.98 2.09 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.908 1.683 . . . . 0.0 112.168 -176.278 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 49.9 t -153.2 135.01 14.58 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.563 1.145 . . . . 0.0 110.664 172.091 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 74.1 t -127.88 127.59 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.677 1.191 . . . . 0.0 109.261 170.944 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -127.87 134.8 26.6 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 124.861 1.264 . . . . 0.0 111.035 174.602 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -63.17 -26.14 72.69 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.084 2.522 . . . . 0.0 114.328 178.97 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -111.82 129.18 56.23 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.349 1.46 . . . . 0.0 113.228 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.4 p -157.64 142.3 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 126.327 1.851 . . . . 0.0 108.886 158.789 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.7 m -124.4 134.83 52.99 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.361 1.065 . . . . 0.0 110.493 -178.785 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 86.2 t -103.18 134.87 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.819 1.248 . . . . 0.0 111.751 -177.773 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.75 118.92 11.99 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.997 1.319 . . . . 0.0 109.096 172.859 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -63.4 130.46 44.56 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.983 0.913 . . . . 0.0 110.618 176.46 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.6 pt . . . . . 0 N--CA 1.474 0.748 0 C-N-CA 124.645 1.178 . . . . 0.0 112.669 -173.758 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.18 21.19 11.85 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -176.104 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.18 -50.26 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.856 2.462 . . . . 0.0 114.879 -168.421 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.3 m -63.63 -13.89 46.64 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.61 1.964 . . . . 0.0 114.692 -178.474 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.53 -24.0 58.9 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.697 1.199 . . . . 0.0 112.506 172.77 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 12.5 m0 -88.25 168.47 12.69 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.068 1.747 . . . . 0.0 111.499 -174.753 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.3 mtpp -77.45 53.82 1.09 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.836 1.654 . . . . 0.0 113.402 176.861 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.5 mt -55.76 -38.23 69.56 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.84 1.256 . . . . 0.0 114.017 -173.375 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -87.12 -3.84 59.1 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.518 1.127 . . . . 0.0 113.029 179.444 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -136.74 63.64 47.07 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 126.339 1.856 . . . . 0.0 111.561 -166.963 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -68.9 148.15 69.97 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 CA-C-N 119.916 1.006 . . . . 0.0 113.103 -169.689 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -69.49 -31.12 69.19 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.901 0.88 . . . . 0.0 111.355 168.626 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 39.6 t90 -161.25 155.68 23.04 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.667 1.987 . . . . 0.0 110.414 177.432 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 55.5 p -135.28 147.81 49.33 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.835 1.254 . . . . 0.0 112.002 171.361 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.11 -142.36 5.27 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.177 0.418 . . . . 0.0 114.064 179.994 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.3 mtm180 -106.91 145.27 32.4 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.434 1.894 . . . . 0.0 111.619 -174.596 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.7 tp -82.46 138.49 34.36 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.714 0.806 . . . . 0.0 109.544 163.428 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.6 ttt-85 -145.75 90.76 2.02 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 122.159 0.981 . . . . 0.0 111.333 163.307 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.45 HD11 ' CD1' ' A' ' 119' ' ' PHE . 13.0 mt -73.6 128.3 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 170.444 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.2 p -134.79 175.96 9.09 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.958 2.103 . . . . 0.0 110.642 -177.248 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.7 t -156.53 148.94 23.42 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.687 -1.258 . . . . 0.0 111.118 173.78 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -150.77 132.11 14.6 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.358 0.663 . . . . 0.0 112.76 154.168 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.12 51.13 19.48 Favored Glycine 0 N--CA 1.474 1.213 0 C-N-CA 124.561 1.076 . . . . 0.0 114.298 169.092 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 59.3 23.47 11.9 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 126.412 1.885 . . . . 0.0 113.326 -175.619 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.5 m -130.79 111.65 12.33 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 125.2 1.4 . . . . 0.0 108.733 176.494 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.93 159.36 24.96 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.073 0.463 . . . . 0.0 110.371 172.389 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -137.98 107.24 6.08 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.787 1.635 . . . . 0.0 108.577 -176.187 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.5 mp -78.36 96.63 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 106.463 -1.681 . . . . 0.0 106.463 167.177 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -95.67 137.99 33.96 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.168 0.587 . . . . 0.0 111.479 174.601 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.6 mp -110.43 129.77 55.7 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.066 1.746 . . . . 0.0 110.183 177.024 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -132.9 149.77 52.22 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -166.384 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -65.98 142.5 57.82 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.986 -1.071 . . . . 0.0 112.788 179.02 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.34 -3.78 35.48 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 116.955 2.206 . . . . 0.0 116.955 -177.959 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.1 t -117.59 -45.04 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.506 1.122 . . . . 0.0 111.822 174.289 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.7 m -117.2 -4.82 11.38 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -169.759 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.5 15.15 79.19 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 123.871 0.748 . . . . 0.0 114.245 176.638 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -61.33 131.72 51.23 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.906 1.683 . . . . 0.0 111.308 -177.267 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 39.0 tp -69.78 115.92 9.57 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 122.782 0.433 . . . . 0.0 111.146 -178.104 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -81.36 -53.87 5.95 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.439 1.095 . . . . 0.0 111.085 173.088 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.55 160.93 38.68 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.064 1.346 . . . . 0.0 111.206 -178.971 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -141.87 137.14 31.19 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.758 0.823 . . . . 0.0 112.572 174.776 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.65 103.72 50.35 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.136 1.374 . . . . 0.0 111.182 177.6 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -67.9 140.97 52.08 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 124.17 3.247 . . . . 0.0 112.65 172.015 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.2 t -135.3 126.63 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.788 1.635 . . . . 0.0 109.464 -177.994 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -90.24 -24.32 20.99 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 179.704 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -161.59 150.0 15.5 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.696 1.999 . . . . 0.0 110.401 172.44 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -121.63 132.38 24.24 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.74 1.216 . . . . 0.0 111.57 176.403 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -62.15 147.21 54.06 Favored 'Cis proline' 0 CA--C 1.541 0.854 0 CA-C-N 119.874 0.991 . . . . 0.0 113.583 -7.153 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.63 -172.49 32.17 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.632 1.11 . . . . 0.0 113.954 -178.722 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.2 tp -61.87 -34.92 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -171.619 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.05 4.62 49.68 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -169.062 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.8 t -149.04 126.48 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.414 1.086 . . . . 0.0 110.539 -178.645 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -139.43 158.57 43.91 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.799 2.04 . . . . 0.0 111.775 -172.698 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.1 p -113.52 163.52 14.82 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.579 1.952 . . . . 0.0 111.381 -179.051 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.2 m -88.8 178.67 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.255 1.422 . . . . 0.0 109.769 165.496 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.2 t -105.16 -23.81 12.85 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.707 1.203 . . . . 0.0 113.604 179.456 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -88.65 -51.17 5.82 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -174.673 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.3 t -139.37 129.79 25.61 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -174.56 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.66 -2.86 12.89 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -171.562 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.485 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.299 31.4 ptt180 -84.78 15.65 3.77 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 178.061 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -140.36 136.77 33.49 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.203 1.401 . . . . 0.0 110.768 -172.942 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -138.48 165.43 26.86 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.271 1.429 . . . . 0.0 111.281 -178.634 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.5 t -118.49 141.53 37.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 124.7 1.2 . . . . 0.0 108.745 165.547 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.8 148.11 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 119.036 0.835 . . . . 0.0 112.516 171.711 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -89.17 82.41 6.59 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.794 0.838 . . . . 0.0 111.1 177.903 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -67.72 141.96 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 121.01 0.433 . . . . 0.0 111.04 176.04 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 . . . . . 0 N--CA 1.468 0.454 0 C-N-CA 125.831 1.653 . . . . 0.0 111.307 -170.296 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 65.0 p . . . . . 0 CA--C 1.533 0.314 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.95 147.54 32.81 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.367 1.467 . . . . 0.0 110.873 168.249 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -92.15 115.4 28.05 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.421 0.689 . . . . 0.0 109.316 169.355 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 28.8 pt -112.7 141.73 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.379 1.072 . . . . 0.0 110.747 179.419 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.15 139.73 15.38 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 175.954 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.2 pt -129.49 155.37 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 125.259 1.424 . . . . 0.0 111.952 172.351 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -148.48 166.29 29.13 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 114.421 0.528 . . . . 0.0 114.421 168.57 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -116.73 162.76 17.18 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.995 1.718 . . . . 0.0 111.388 -175.378 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.3 t -70.54 -22.9 62.56 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.462 0.705 . . . . 0.0 112.455 175.635 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -152.76 147.24 25.84 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.798 0.839 . . . . 0.0 112.537 -174.267 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 47.1 ttt-85 -62.61 -32.61 73.65 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.694 1.198 . . . . 0.0 113.152 179.951 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.26 -27.21 73.84 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-N 118.908 0.776 . . . . 0.0 113.851 176.649 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -84.33 -36.2 22.71 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 118.074 0.937 . . . . 0.0 111.658 175.814 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.485 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -65.17 -32.34 73.98 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 168.564 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -59.32 -37.48 77.89 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.264 -0.898 . . . . 0.0 111.98 173.279 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -67.19 -31.42 71.81 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.194 -0.941 . . . . 0.0 112.847 176.013 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.45 ' CD1' HD11 ' A' ' 49' ' ' ILE . 22.0 t80 -58.6 -50.91 72.09 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.295 0.952 . . . . 0.0 111.545 171.667 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.2 -24.28 30.15 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -176.302 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.3 t -78.46 -40.37 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 O-C-N 121.068 -1.02 . . . . 0.0 110.954 176.641 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 95.0 p -63.75 -28.86 70.17 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 177.411 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 78.5 mt -72.14 -52.97 14.18 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.182 0.993 . . . . 0.0 111.923 172.307 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -68.58 -31.17 70.18 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.993 -1.067 . . . . 0.0 113.22 -176.112 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -87.88 2.14 52.24 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.641 1.176 . . . . 0.0 112.492 174.383 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -92.03 -40.02 11.32 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 120.74 -1.225 . . . . 0.0 111.992 163.975 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -89.31 -1.73 58.18 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 -174.518 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.104 0 CA-C-N 120.25 1.386 . . . . 0.0 114.524 -175.07 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.4 m . . . . . 0 N--CA 1.468 0.432 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.9 t -63.57 141.68 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 124.496 1.118 . . . . 0.0 111.717 178.415 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.4 mt -126.94 -39.9 1.92 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.992 1.717 . . . . 0.0 112.54 -177.369 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.0 t -152.27 133.06 14.06 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.412 1.085 . . . . 0.0 110.821 174.967 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 81.1 t -128.67 128.13 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.394 1.078 . . . . 0.0 109.319 171.822 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -130.49 134.79 26.46 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 125.293 1.437 . . . . 0.0 110.337 176.429 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -77.35 -13.96 16.58 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.285 2.657 . . . . 0.0 114.76 -174.347 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -134.37 106.57 7.15 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.404 1.082 . . . . 0.0 111.236 -174.125 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -143.69 144.64 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.144 1.378 . . . . 0.0 110.205 171.078 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.0 m -118.0 140.66 49.42 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.354 1.062 . . . . 0.0 111.388 -176.485 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 66.1 t -105.76 138.28 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.726 1.61 . . . . 0.0 111.792 175.741 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -125.1 127.99 47.76 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.47 1.508 . . . . 0.0 108.995 170.67 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -76.58 111.62 12.25 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 165.111 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.7 pt . . . . . 0 N--CA 1.475 0.808 0 C-N-CA 124.492 1.117 . . . . 0.0 113.286 -164.185 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 . . . . . 0 CA--C 1.533 0.32 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.66 25.03 8.93 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.046 0.938 . . . . 0.0 113.385 178.796 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 60.42 -44.81 0.1 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.569 2.347 . . . . 0.0 114.936 -172.269 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.6 m -63.92 -13.14 43.27 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.738 2.015 . . . . 0.0 114.26 177.122 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -59.03 -30.6 68.15 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.834 0.853 . . . . 0.0 112.839 164.95 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 9.2 m0 -99.24 171.23 8.13 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.035 1.334 . . . . 0.0 112.592 -164.447 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -78.86 49.34 0.9 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.377 1.871 . . . . 0.0 113.87 -178.531 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.8 mt -54.86 -35.07 63.63 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -166.635 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -94.79 -1.87 52.02 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.203 1.001 . . . . 0.0 113.644 179.552 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -145.46 73.76 14.04 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 125.573 1.549 . . . . 0.0 112.019 179.658 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.85 148.16 38.63 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.515 2.81 . . . . 0.0 113.736 178.958 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -71.93 -31.54 66.45 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.247 0.619 . . . . 0.0 111.295 168.269 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 48.7 t90 -154.3 154.37 33.26 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.846 1.659 . . . . 0.0 110.869 174.793 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.4 p -133.36 148.37 51.85 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.109 0.964 . . . . 0.0 111.674 169.004 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.51 -141.76 4.69 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 116.366 -0.379 . . . . 0.0 113.433 -178.804 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.7 mtm105 -114.32 144.97 42.4 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.152 1.781 . . . . 0.0 111.92 -172.901 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.1 tp -85.34 139.98 31.14 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.26 1.424 . . . . 0.0 109.822 168.386 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.1 ttt85 -145.5 86.64 1.75 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.699 1.199 . . . . 0.0 110.866 168.245 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.44 HD11 ' CD2' ' A' ' 119' ' ' PHE . 21.0 mt -74.33 127.74 36.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 170.649 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 p -136.51 171.68 14.14 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.854 2.062 . . . . 0.0 110.188 -178.663 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.7 t -156.7 148.89 23.12 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 120.632 -1.292 . . . . 0.0 111.674 177.866 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -153.59 128.26 9.39 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.723 0.809 . . . . 0.0 112.193 161.418 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.35 54.12 18.0 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.316 0.96 . . . . 0.0 114.231 166.344 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 93.8 mttt 60.02 25.75 15.01 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 126.249 1.82 . . . . 0.0 113.31 -176.059 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.8 m -136.22 114.45 11.57 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.25 1.42 . . . . 0.0 109.429 177.875 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.7 159.78 19.06 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.559 0.743 . . . . 0.0 110.775 173.872 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -139.89 105.31 5.07 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.099 1.76 . . . . 0.0 108.725 -175.727 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.4 mp -79.99 91.99 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 167.974 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -86.01 138.18 32.16 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.221 0.608 . . . . 0.0 110.421 173.167 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.4 mp -112.17 133.33 54.37 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.125 1.77 . . . . 0.0 109.645 173.103 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -135.14 153.47 51.98 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -172.269 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -73.92 144.61 45.26 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.946 0.879 . . . . 0.0 111.94 179.614 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.4 pttt -85.36 -6.18 59.25 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.368 1.867 . . . . 0.0 115.125 -178.635 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 92.6 t -122.47 -44.61 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.234 1.414 . . . . 0.0 111.437 178.648 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.2 m -92.32 -23.06 19.38 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -175.296 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.96 7.16 86.48 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 123.973 0.797 . . . . 0.0 113.702 -177.452 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -82.7 154.51 24.8 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.288 1.435 . . . . 0.0 112.473 -175.082 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.5 tp -73.45 127.18 31.99 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.371 0.668 . . . . 0.0 110.827 177.337 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -84.47 -54.99 4.38 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.427 1.091 . . . . 0.0 110.922 170.098 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -159.5 165.85 32.12 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.689 1.596 . . . . 0.0 110.562 179.755 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -144.99 142.49 29.84 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 168.706 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.78 111.53 48.5 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.071 1.348 . . . . 0.0 111.378 177.729 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -82.85 140.29 10.18 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.57 2.847 . . . . 0.0 111.502 176.961 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.26 128.61 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.396 1.478 . . . . 0.0 109.857 -174.449 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -90.64 -24.26 20.55 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 178.274 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -164.31 149.37 10.15 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.144 1.778 . . . . 0.0 110.411 171.569 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.419 ' CD2' ' HA ' ' A' ' 78' ' ' PRO . 82.5 t80 -125.75 130.28 24.09 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.819 1.248 . . . . 0.0 111.53 -177.554 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.419 ' HA ' ' CD2' ' A' ' 77' ' ' TYR . 73.5 Cg_endo -66.51 143.89 65.54 Favored 'Cis proline' 0 CA--C 1.54 0.801 0 CA-C-N 120.267 1.131 . . . . 0.0 113.353 -2.077 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.02 -168.34 29.06 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.12 1.343 . . . . 0.0 113.637 -176.607 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.3 tp -59.08 -39.64 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -169.659 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -89.31 3.84 50.78 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -167.395 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.6 t -151.54 124.18 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.392 1.077 . . . . 0.0 110.82 -176.88 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -141.39 167.07 23.04 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.626 1.97 . . . . 0.0 112.863 -176.264 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 73.1 p -121.25 158.62 27.72 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.503 1.521 . . . . 0.0 112.061 -169.807 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.3 m -84.62 168.12 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.839 0.856 . . . . 0.0 110.676 166.584 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 72.3 p -96.74 -24.94 15.71 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.956 1.302 . . . . 0.0 113.642 179.532 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -98.69 -38.97 8.89 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -166.21 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.6 t -138.87 124.12 19.17 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -173.905 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.2 m -74.54 26.1 0.08 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 -168.226 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.467 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.265 34.3 ptt180 -125.29 18.69 8.26 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.631 1.572 . . . . 0.0 114.923 179.851 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -140.28 142.6 35.7 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.404 1.082 . . . . 0.0 112.167 -171.795 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -141.7 158.2 44.11 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.189 1.396 . . . . 0.0 111.933 -176.94 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.2 t -110.68 137.93 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.939 0.895 . . . . 0.0 108.812 163.555 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.88 146.73 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 119.263 0.938 . . . . 0.0 112.018 172.472 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -91.16 92.54 8.72 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.379 0.672 . . . . 0.0 110.124 175.737 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -74.49 152.72 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.07 0.548 . . . . 0.0 111.229 176.09 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.459 0 C-N-CA 125.488 1.515 . . . . 0.0 111.171 173.865 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 95.3 p . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.96 146.1 28.84 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.989 1.315 . . . . 0.0 111.226 172.124 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -87.9 121.11 29.92 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 166.147 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.8 pt -119.32 144.93 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.82 1.248 . . . . 0.0 110.58 176.295 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.04 141.33 16.24 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 174.355 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.6 pt -126.33 144.49 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 124.548 1.139 . . . . 0.0 112.503 168.961 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -125.67 138.27 10.77 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 124.857 1.218 . . . . 0.0 113.244 177.923 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -102.91 163.6 12.12 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.849 1.66 . . . . 0.0 109.998 166.541 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.9 t -92.91 -20.65 20.43 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 175.559 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -109.15 -18.75 13.56 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -149.47 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 60.49 -48.72 0.1 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.914 2.086 . . . . 0.0 114.134 -161.236 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.44 -31.2 66.12 Favored Glycine 0 CA--C 1.539 1.564 0 CA-C-N 119.578 1.081 . . . . 0.0 114.176 174.575 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -81.0 -32.01 34.41 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.35 -1.088 . . . . 0.0 112.466 175.648 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.467 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -68.57 -32.69 72.78 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 168.112 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -60.67 -47.49 86.04 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.588 0.755 . . . . 0.0 110.204 166.767 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -60.3 -42.2 95.01 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 118.703 0.683 . . . . 0.0 112.356 177.19 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.44 ' CD2' HD11 ' A' ' 49' ' ' ILE . 36.9 t80 -53.09 -54.81 30.1 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.811 1.244 . . . . 0.0 112.566 174.125 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -82.4 -26.04 33.17 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -174.71 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.3 t -75.92 -40.97 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 121.6 -0.687 . . . . 0.0 110.898 177.823 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 91.4 p -64.05 -29.81 70.92 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 175.217 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.5 mt -68.81 -59.09 3.33 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.087 0.955 . . . . 0.0 111.779 170.168 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -64.94 -30.98 72.0 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -172.791 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -83.25 -4.15 58.14 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.648 1.179 . . . . 0.0 112.721 178.218 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -95.32 -11.71 27.36 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.94 -1.1 . . . . 0.0 113.39 165.639 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -110.42 -6.02 15.05 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 179.376 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.176 0 CA-C-N 121.182 1.81 . . . . 0.0 113.896 -176.521 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.449 -0.498 0 CA-C-O 121.909 0.862 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.9 t -57.83 139.41 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 125.401 1.48 . . . . 0.0 112.088 -174.062 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.3 mt -125.5 -40.36 2.1 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.682 1.593 . . . . 0.0 112.14 -176.353 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 33.0 t -154.41 136.06 14.36 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.495 1.118 . . . . 0.0 110.678 176.926 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.3 t -130.68 125.79 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.421 1.088 . . . . 0.0 109.239 172.42 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -131.61 142.98 47.28 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 124.68 1.192 . . . . 0.0 112.021 176.909 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.01 -19.08 20.82 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.535 2.824 . . . . 0.0 115.048 -174.951 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -135.15 112.52 10.56 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.777 0.831 . . . . 0.0 112.279 -167.509 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.3 p -149.64 143.27 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.209 1.803 . . . . 0.0 109.902 171.191 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.9 m -120.71 129.23 53.57 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.351 1.06 . . . . 0.0 111.19 -174.272 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.1 t -93.0 140.47 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.331 1.452 . . . . 0.0 111.929 178.57 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -121.62 129.09 52.58 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.659 1.184 . . . . 0.0 109.628 168.655 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 -78.8 73.9 5.33 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.46 1.504 . . . . 0.0 109.841 172.143 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.7 pt . . . . . 0 CA--C 1.545 0.77 0 C-N-CA 125.629 1.572 . . . . 0.0 114.468 -164.516 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 . . . . . 0 CA--C 1.535 0.372 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.24 17.88 5.46 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -171.77 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.89 -45.84 0.06 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 127.75 2.42 . . . . 0.0 115.679 -175.779 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.2 m -69.41 -14.46 62.91 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.689 1.596 . . . . 0.0 113.908 -177.318 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.88 -13.31 60.54 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 169.786 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -95.88 171.65 8.51 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.462 1.505 . . . . 0.0 111.613 -174.59 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -79.57 53.81 1.65 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.383 1.473 . . . . 0.0 113.941 -178.463 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 69.3 mt -61.35 -14.85 30.57 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -172.842 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -107.02 -4.51 18.9 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.455 1.102 . . . . 0.0 112.782 177.03 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -150.26 77.18 8.31 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 125.083 1.353 . . . . 0.0 111.653 176.258 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -50.11 141.99 28.95 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.171 2.581 . . . . 0.0 112.462 175.245 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -72.09 -27.72 62.83 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.071 0.548 . . . . 0.0 111.577 175.78 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 33.4 t90 -154.26 156.54 37.21 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.937 1.695 . . . . 0.0 110.738 168.946 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.9 p -133.97 146.18 50.21 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.623 1.169 . . . . 0.0 111.978 170.327 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 176.77 -142.65 5.97 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 114.536 0.574 . . . . 0.0 114.536 177.213 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -106.22 143.83 33.79 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 126.603 1.961 . . . . 0.0 111.547 -169.822 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.0 tp -88.4 138.18 31.66 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.468 1.507 . . . . 0.0 110.154 170.21 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -143.93 96.77 2.95 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.396 1.078 . . . . 0.0 110.788 168.461 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.427 HD11 ' CD2' ' A' ' 119' ' ' PHE . 16.0 mt -82.06 129.03 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 172.364 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.46 160.57 38.05 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 127.38 2.272 . . . . 0.0 109.738 -177.703 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.7 t -161.37 160.8 29.99 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 120.811 -1.181 . . . . 0.0 111.079 177.517 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -129.22 -106.01 0.29 Allowed 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.142 -0.974 . . . . 0.0 111.499 -174.526 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.59 -116.68 0.21 Allowed Glycine 0 N--CA 1.472 1.072 0 C-N-CA 124.489 1.042 . . . . 0.0 111.134 169.42 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -86.12 25.16 1.2 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.693 1.197 . . . . 0.0 113.118 174.366 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.5 m -137.55 123.0 19.58 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.8 0.84 . . . . 0.0 110.589 -178.312 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.26 164.16 12.25 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.232 1.413 . . . . 0.0 111.706 172.5 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -145.89 103.59 3.77 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.744 1.618 . . . . 0.0 110.054 -172.574 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.7 mp -82.06 101.52 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 169.071 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -102.78 140.8 36.58 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.863 0.84 . . . . 0.0 111.519 176.413 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.3 mp -112.12 132.93 54.58 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.434 1.894 . . . . 0.0 110.045 179.508 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -133.79 151.2 51.5 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.897 0.879 . . . . 0.0 112.518 -168.31 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -69.82 144.0 52.74 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 120.812 -1.18 . . . . 0.0 113.175 -175.409 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.67 -3.79 36.6 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 116.666 2.099 . . . . 0.0 116.666 -179.365 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.1 t -118.8 -50.44 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.749 1.22 . . . . 0.0 110.892 172.622 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.0 m -96.9 -18.15 19.68 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -170.245 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.22 12.6 76.29 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.317 0.96 . . . . 0.0 113.759 -175.672 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -79.97 150.83 30.34 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.079 1.352 . . . . 0.0 112.005 -176.603 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 32.5 tp -71.34 122.16 19.81 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.85 0.86 . . . . 0.0 111.797 -171.663 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -84.64 -56.25 3.7 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.272 1.029 . . . . 0.0 110.877 169.547 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.81 163.24 40.08 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.973 1.309 . . . . 0.0 111.537 -179.042 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -143.85 132.82 22.78 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.603 1.161 . . . . 0.0 111.561 -179.351 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.56 97.78 49.41 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 124.721 1.208 . . . . 0.0 111.236 176.009 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -58.03 136.29 74.04 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 124.085 3.19 . . . . 0.0 112.288 163.065 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.7 t -132.24 123.54 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 126.528 1.931 . . . . 0.0 108.885 -178.42 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -91.56 -19.32 22.88 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 121.413 -0.804 . . . . 0.0 112.781 -177.405 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -163.64 143.21 8.3 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.831 2.452 . . . . 0.0 109.425 -178.584 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -135.92 121.93 13.9 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-O 118.375 -0.822 . . . . 0.0 111.301 175.291 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -61.92 149.45 57.75 Favored 'Cis proline' 0 CA--C 1.539 0.758 0 CA-C-N 119.956 1.02 . . . . 0.0 114.504 -1.648 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -170.96 -158.29 14.58 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 126.016 1.769 . . . . 0.0 112.442 -177.109 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.3 tt -79.17 -39.03 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -176.556 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.35 4.49 17.72 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -168.145 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.9 t -152.02 129.01 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 126.028 1.731 . . . . 0.0 109.744 179.86 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -141.05 160.26 40.47 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.05 1.74 . . . . 0.0 112.24 176.656 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.6 p -101.23 159.39 15.29 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.988 1.715 . . . . 0.0 111.589 175.324 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.4 m -81.28 169.34 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 O-C-N 121.587 -0.696 . . . . 0.0 110.523 162.418 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.5 p -98.31 -24.69 15.12 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.168 1.387 . . . . 0.0 113.587 -178.278 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -100.84 -40.41 7.32 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -167.136 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.5 t -134.41 116.15 14.84 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -175.038 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.6 m -73.59 24.93 0.07 Allowed 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 116.159 1.911 . . . . 0.0 116.159 -165.386 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.413 ' HA ' ' CB ' ' A' ' 116' ' ' ALA . 4.9 ptm180 -127.3 23.43 6.42 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 127.309 2.244 . . . . 0.0 113.875 -178.915 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -140.82 143.94 35.09 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.756 1.623 . . . . 0.0 111.955 -177.124 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -142.04 161.24 38.49 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.251 1.42 . . . . 0.0 111.496 -178.299 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 89.0 t -114.73 139.67 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.403 1.081 . . . . 0.0 109.112 166.455 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.64 147.83 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 118.667 0.667 . . . . 0.0 112.085 173.808 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -89.51 89.33 7.8 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.838 0.855 . . . . 0.0 110.745 178.322 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.1 pp -71.32 140.38 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 122.542 0.337 . . . . 0.0 111.172 175.616 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 . . . . . 0 N--CA 1.472 0.629 0 C-N-CA 125.999 1.72 . . . . 0.0 111.718 -172.769 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.9 p . . . . . 0 CA--C 1.534 0.342 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.91 149.1 34.7 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.661 1.584 . . . . 0.0 110.964 170.021 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -94.05 117.36 30.0 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.465 0.706 . . . . 0.0 109.308 169.122 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 17.8 pt -116.61 147.41 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.595 1.158 . . . . 0.0 111.046 177.928 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -87.73 146.15 19.8 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 172.394 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.2 pt -129.02 145.51 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 125.388 1.475 . . . . 0.0 111.488 167.167 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.61 146.53 16.96 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 125.097 1.332 . . . . 0.0 113.518 177.163 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -108.47 164.48 12.3 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.286 1.834 . . . . 0.0 111.77 178.605 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.6 t -73.88 -25.49 60.06 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.056 0.942 . . . . 0.0 112.906 177.049 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -156.41 154.68 30.86 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.759 1.224 . . . . 0.0 111.924 -176.229 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -57.45 -35.62 70.37 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.253 1.021 . . . . 0.0 112.82 175.977 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.25 -35.97 92.36 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 119.48 1.036 . . . . 0.0 113.406 -179.802 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -80.19 -35.48 36.28 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 117.988 0.894 . . . . 0.0 112.265 177.256 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.413 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -62.88 -39.45 94.51 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 169.237 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -68.67 -33.54 74.15 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.065 -1.022 . . . . 0.0 111.877 174.403 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -68.2 -36.87 80.24 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 119.365 0.984 . . . . 0.0 112.417 173.731 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.427 ' CD2' HD11 ' A' ' 49' ' ' ILE . 3.5 t80 -57.91 -45.59 86.26 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.134 1.374 . . . . 0.0 111.65 168.649 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -74.95 -38.16 61.79 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.713 1.205 . . . . 0.0 113.252 -176.399 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.9 t -77.73 -39.75 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 O-C-N 121.213 -0.93 . . . . 0.0 111.599 -179.088 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 78.7 p -64.79 -30.78 71.8 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.236 -0.915 . . . . 0.0 113.125 177.248 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 44.4 tp -73.12 -49.17 29.85 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.805 1.242 . . . . 0.0 111.689 175.331 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -70.52 -23.53 62.66 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.248 -0.907 . . . . 0.0 113.434 -178.92 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -79.42 -1.04 35.41 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.378 1.071 . . . . 0.0 112.418 175.572 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 45.2 t60 -87.94 -35.3 17.74 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.325 -0.859 . . . . 0.0 112.708 157.504 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -89.29 -5.55 57.48 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 -172.819 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 115.81 1.782 . . . . 0.0 115.81 -175.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.612 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 56.9 m -129.51 112.46 17.89 Favored Pre-proline 0 N--CA 1.477 0.882 0 C-N-CA 124.857 1.263 . . . . 0.0 111.099 -174.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -81.1 2.16 8.78 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 123.946 3.097 . . . . 0.0 113.796 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -68.32 -4.12 13.29 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.337 1.855 . . . . 0.0 114.893 -168.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 61.8 p -68.34 -15.74 63.67 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.203 1.401 . . . . 0.0 113.836 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.3 mtm -129.88 151.29 50.6 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.599 1.56 . . . . 0.0 111.746 174.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.44 -42.99 0.1 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.846 1.258 . . . . 0.0 112.532 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 63.4 m -107.83 101.18 10.48 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.269 1.428 . . . . 0.0 108.351 171.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -129.42 19.53 5.77 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.051 1.341 . . . . 0.0 114.109 -168.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.95 48.1 0.69 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.961 1.704 . . . . 0.0 112.548 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -97.29 52.91 1.14 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.221 1.808 . . . . 0.0 110.334 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -150.03 142.03 23.92 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.566 1.546 . . . . 0.0 109.543 -174.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -176.41 128.55 0.2 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.69 1.596 . . . . 0.0 108.606 167.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.3 m -89.62 110.9 21.73 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 165.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.2 p -68.45 144.81 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 121.557 -0.714 . . . . 0.0 112.544 178.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.5 mt -129.5 -39.81 1.46 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.685 1.594 . . . . 0.0 112.508 -172.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 45.2 t -152.7 134.74 14.85 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.693 1.197 . . . . 0.0 110.384 173.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 94.6 t -130.28 127.24 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.363 1.065 . . . . 0.0 109.68 171.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -131.62 142.07 43.98 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 124.496 1.118 . . . . 0.0 112.206 173.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.6 -15.46 19.45 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.851 3.034 . . . . 0.0 114.972 -175.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -135.48 108.28 7.54 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.072 0.949 . . . . 0.0 111.653 -170.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 p -145.49 144.62 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 125.522 1.529 . . . . 0.0 110.213 171.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.1 m -126.04 129.15 48.58 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.12 0.968 . . . . 0.0 111.371 -171.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.5 t -96.05 136.82 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.738 1.615 . . . . 0.0 112.294 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -129.86 127.92 41.21 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.39 1.476 . . . . 0.0 109.407 170.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -70.1 123.76 22.4 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.359 0.664 . . . . 0.0 109.491 165.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.412 HD12 ' CZ ' ' A' ' 31' ' ' TYR . 30.6 pt -99.12 157.3 34.31 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 124.785 1.234 . . . . 0.0 113.57 -168.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -66.6 156.74 64.2 Favored 'Trans proline' 0 CA--C 1.548 1.215 0 C-N-CA 122.795 2.33 . . . . 0.0 111.425 160.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.58 147.4 70.26 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.221 2.614 . . . . 0.0 112.61 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -68.46 139.52 55.72 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.698 1.199 . . . . 0.0 112.067 -176.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -159.84 137.75 10.05 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.67 1.188 . . . . 0.0 110.196 162.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.9 m -63.83 -17.45 63.14 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.519 1.527 . . . . 0.0 114.614 -175.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -73.78 -10.61 59.85 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.414 1.086 . . . . 0.0 113.287 171.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.3 ptt-85 -128.36 -45.78 1.35 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.789 1.635 . . . . 0.0 113.653 174.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.68 159.59 2.33 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.656 1.122 . . . . 0.0 112.262 -169.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.412 ' CZ ' HD12 ' A' ' 22' ' ' ILE . 17.7 m-30 -72.06 119.14 15.82 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 156.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.86 19.84 10.92 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -174.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 56.81 -48.33 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.932 2.493 . . . . 0.0 115.455 -170.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.9 m -67.58 -15.07 63.46 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.294 1.838 . . . . 0.0 114.85 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.82 -15.99 56.35 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.701 0.8 . . . . 0.0 112.502 172.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 17.9 m0 -86.22 169.52 12.96 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.382 1.473 . . . . 0.0 111.178 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -78.88 57.25 2.09 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.189 1.796 . . . . 0.0 114.211 -177.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.7 mt -61.75 -20.35 63.44 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -95.49 -12.97 24.96 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.509 1.124 . . . . 0.0 112.592 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -152.09 69.72 7.62 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 125.61 1.564 . . . . 0.0 112.265 -165.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -54.37 147.22 47.59 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.471 2.781 . . . . 0.0 113.358 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -72.51 -29.3 63.49 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.195 0.598 . . . . 0.0 111.427 168.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.2 t90 -156.95 154.58 29.92 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.37 1.468 . . . . 0.0 111.058 173.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.2 p -133.93 148.82 51.25 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.239 1.015 . . . . 0.0 111.81 168.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.37 -142.88 5.69 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 123.067 0.365 . . . . 0.0 113.48 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.7 mtm105 -110.51 148.19 32.61 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.305 1.842 . . . . 0.0 112.103 -173.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.0 tp -92.91 137.85 32.0 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.22 1.808 . . . . 0.0 110.277 172.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.6 ttt85 -143.98 88.71 1.98 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.043 1.337 . . . . 0.0 110.869 169.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.503 HD11 ' CD1' ' A' ' 119' ' ' PHE . 25.2 mt -75.78 127.63 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 170.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.1 p -138.62 170.39 16.08 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.664 1.986 . . . . 0.0 110.071 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.9 t -157.85 159.46 36.68 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.804 -1.185 . . . . 0.0 112.198 175.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -146.86 120.76 9.32 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.775 0.798 . . . . 0.0 111.843 159.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.43 -119.65 11.79 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 125.753 1.644 . . . . 0.0 110.139 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -95.55 13.49 25.97 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.6 1.56 . . . . 0.0 113.708 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.0 m -127.58 110.78 13.05 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.934 0.894 . . . . 0.0 111.063 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.85 159.46 19.07 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.405 0.682 . . . . 0.0 111.364 171.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -139.76 105.98 5.25 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.302 1.841 . . . . 0.0 109.252 -174.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.7 mp -82.61 97.55 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 168.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.4 mttp -94.31 139.29 31.27 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.38 0.672 . . . . 0.0 111.448 174.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.5 mp -112.34 135.51 52.94 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.445 1.898 . . . . 0.0 109.775 172.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -136.15 153.67 51.2 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.941 0.896 . . . . 0.0 113.018 -172.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -74.12 143.94 45.12 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.931 0.872 . . . . 0.0 111.969 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 pttt -84.87 -6.46 59.35 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.371 1.868 . . . . 0.0 115.124 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 92.0 t -122.4 -44.58 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 125.234 1.414 . . . . 0.0 111.396 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.7 m -91.72 -23.5 19.76 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -175.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.33 7.04 86.91 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 123.776 0.703 . . . . 0.0 113.586 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -82.81 155.55 24.13 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.327 1.451 . . . . 0.0 112.326 -175.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.7 tp -72.31 125.98 28.69 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.372 0.669 . . . . 0.0 110.684 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -84.51 -53.9 5.11 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.944 0.898 . . . . 0.0 110.915 169.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.34 161.3 37.6 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.067 1.347 . . . . 0.0 111.357 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -142.67 139.89 31.37 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.391 0.676 . . . . 0.0 112.382 171.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.98 110.54 41.57 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 124.854 1.261 . . . . 0.0 111.135 176.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -80.52 140.45 13.39 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.894 3.063 . . . . 0.0 111.565 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.1 t -134.83 131.26 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.805 1.642 . . . . 0.0 109.817 -172.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -97.47 -19.8 18.18 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -163.53 150.46 12.31 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.97 2.108 . . . . 0.0 110.085 175.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -125.57 130.67 24.01 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.558 1.143 . . . . 0.0 112.452 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -60.46 151.29 50.81 Favored 'Cis proline' 0 CA--C 1.54 0.781 0 CA-C-N 119.919 1.007 . . . . 0.0 113.313 -12.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.35 -171.35 29.49 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.909 1.242 . . . . 0.0 113.485 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.6 tp -59.29 -31.51 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.54 4.27 53.9 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -172.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.7 t -148.98 130.35 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.162 0.985 . . . . 0.0 111.233 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -140.39 162.4 35.41 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.325 1.85 . . . . 0.0 112.545 -176.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 38.8 p -117.33 158.03 25.09 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 127.1 2.16 . . . . 0.0 111.587 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.0 m -85.21 173.46 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.556 1.142 . . . . 0.0 111.385 168.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 72.5 p -94.49 -32.5 13.47 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.238 1.415 . . . . 0.0 113.17 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -94.59 -40.91 9.59 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -163.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.5 t -141.02 130.35 23.68 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -175.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.1 m -73.01 16.38 0.16 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -171.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.47 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.28 33.5 ptt180 -111.44 18.5 19.1 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 178.631 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -139.32 135.55 33.9 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.078 0.951 . . . . 0.0 110.842 -172.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -133.77 163.81 28.63 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.907 1.283 . . . . 0.0 111.016 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.7 t -120.6 142.59 35.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 124.583 1.153 . . . . 0.0 108.744 167.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.89 148.0 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 118.721 0.692 . . . . 0.0 112.425 173.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -89.88 81.77 6.28 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.675 0.79 . . . . 0.0 111.369 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -67.09 142.52 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 122.577 0.351 . . . . 0.0 111.372 177.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -138.3 148.32 44.53 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.733 1.613 . . . . 0.0 111.68 -171.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -94.04 2.75 55.99 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.393 1.077 . . . . 0.0 113.106 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.23 13.17 81.25 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.155 1.36 . . . . 0.0 114.68 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.9 t -139.04 15.37 2.64 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.579 1.552 . . . . 0.0 113.469 -171.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.32 -2.46 78.32 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.547 1.07 . . . . 0.0 114.953 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -74.76 135.17 41.76 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.318 1.447 . . . . 0.0 108.567 164.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.2 p -148.57 158.47 44.15 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 171.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.76 145.76 31.83 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.282 1.433 . . . . 0.0 110.869 169.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -90.66 118.36 30.04 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.131 0.573 . . . . 0.0 109.485 168.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.4 pt -117.27 141.54 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.306 1.042 . . . . 0.0 110.753 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.9 143.41 17.07 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 174.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.0 pt -128.87 140.86 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 125.341 1.456 . . . . 0.0 111.679 173.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -119.66 143.91 17.24 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.042 1.306 . . . . 0.0 113.338 175.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -106.88 167.86 9.59 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.352 1.861 . . . . 0.0 111.032 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.8 t -71.78 -36.09 70.23 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.738 -0.601 . . . . 0.0 112.304 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -153.07 153.32 32.61 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.204 -0.935 . . . . 0.0 112.299 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -58.07 -36.69 73.16 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.652 1.181 . . . . 0.0 112.096 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.95 -13.42 64.11 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 123.916 0.77 . . . . 0.0 114.408 177.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -102.44 -34.07 9.29 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 118.431 1.115 . . . . 0.0 112.376 170.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.47 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -64.07 -29.97 71.07 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.088 -1.008 . . . . 0.0 113.253 170.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -54.95 -33.35 62.21 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.603 -0.686 . . . . 0.0 112.289 168.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -69.25 -33.75 73.74 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.087 -1.008 . . . . 0.0 112.028 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.503 ' CD1' HD11 ' A' ' 49' ' ' ILE . 18.6 t80 -60.56 -50.32 74.03 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.143 0.977 . . . . 0.0 111.475 171.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.49 -26.27 45.91 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -177.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.5 t -77.39 -43.25 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 119.301 0.955 . . . . 0.0 111.246 175.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 96.7 p -64.85 -31.03 72.07 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.36 0.982 . . . . 0.0 113.103 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.7 mt -69.03 -54.89 12.75 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.063 0.945 . . . . 0.0 112.061 170.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -67.22 -29.71 69.44 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.055 -1.028 . . . . 0.0 112.978 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -82.84 -2.7 55.39 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.566 1.147 . . . . 0.0 112.672 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 63.9 t60 -88.39 -42.6 12.07 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.391 -0.818 . . . . 0.0 111.812 157.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -84.44 -7.24 59.35 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -172.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.25 -35.79 38.74 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 120.971 1.714 . . . . 0.0 115.366 -173.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 39.9 p-90 -75.78 -34.29 60.2 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.464 0.706 . . . . 0.0 112.897 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.7 t -67.2 -34.19 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.836 1.255 . . . . 0.0 110.5 171.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -80.51 5.3 15.62 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.091 2.156 . . . . 0.0 114.257 174.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 55.2 29.96 13.66 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 127.732 2.413 . . . . 0.0 115.587 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 . . . . . 0 C--O 1.253 1.241 0 C-N-CA 125.25 1.42 . . . . 0.0 113.911 177.471 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.651 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 43.8 m -66.63 145.83 98.99 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 124.302 1.041 . . . . 0.0 112.845 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -77.75 -9.16 17.05 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.623 2.882 . . . . 0.0 113.867 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -138.49 167.4 22.0 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.147 1.779 . . . . 0.0 111.959 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 18.5 m -91.0 5.09 50.2 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -171.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.2 mmm -82.2 57.92 3.79 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.907 -1.121 . . . . 0.0 112.418 -174.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.05 -11.41 18.15 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.682 1.593 . . . . 0.0 112.829 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.5 m 50.08 68.62 0.72 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 127.004 2.122 . . . . 0.0 112.843 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -101.73 19.54 17.96 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -163.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.79 50.33 0.69 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.416 1.886 . . . . 0.0 112.372 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -93.54 51.72 1.63 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.114 1.766 . . . . 0.0 110.946 -177.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -151.12 143.21 24.01 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.329 1.452 . . . . 0.0 110.351 -174.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -176.84 125.42 0.16 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.666 1.586 . . . . 0.0 109.099 171.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.8 m -92.86 109.2 20.64 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.817 0.847 . . . . 0.0 109.446 168.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.402 ' HA ' HG22 ' A' ' 50' ' ' THR . 45.0 t -63.75 142.49 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 124.005 0.922 . . . . 0.0 111.761 177.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.7 mt -128.31 -43.56 1.45 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.309 1.443 . . . . 0.0 112.592 -176.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 34.2 t -148.39 135.16 19.91 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.379 1.072 . . . . 0.0 111.037 175.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.1 t -128.55 128.03 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.734 1.214 . . . . 0.0 109.539 172.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -124.9 135.28 26.53 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 125.577 1.551 . . . . 0.0 109.774 172.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -73.54 -29.57 10.8 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.918 2.412 . . . . 0.0 115.179 -168.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -138.16 114.92 10.64 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.263 1.03 . . . . 0.0 111.86 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.2 p -143.43 149.01 18.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 127.788 2.435 . . . . 0.0 109.004 176.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.2 m -123.3 132.02 53.86 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.257 0.623 . . . . 0.0 112.17 -167.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.7 t -96.24 138.21 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.837 1.655 . . . . 0.0 111.904 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -130.19 136.77 49.61 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.139 -1.392 . . . . 0.0 110.31 171.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -56.6 137.43 53.78 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.296 151.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.3 pt -109.09 151.0 41.72 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 125.182 1.393 . . . . 0.0 111.258 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -70.19 162.57 41.79 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.426 2.751 . . . . 0.0 111.919 172.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -61.46 130.6 32.46 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.971 2.447 . . . . 0.0 111.806 176.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.3 ttm-85 -73.54 148.82 42.67 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.313 1.045 . . . . 0.0 112.57 -174.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.1 156.16 39.32 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.169 153.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.4 m -65.77 -26.64 67.8 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.751 1.621 . . . . 0.0 113.832 -177.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -78.13 -1.84 34.56 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.453 1.101 . . . . 0.0 112.958 171.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -112.53 -60.62 1.84 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.483 1.913 . . . . 0.0 110.193 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.88 161.23 0.85 Allowed Glycine 0 CA--C 1.528 0.856 0 CA-C-O 122.133 0.852 . . . . 0.0 111.963 -163.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 18.8 m-30 -77.61 124.12 27.52 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 121.647 -0.914 . . . . 0.0 109.224 163.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.66 16.35 9.53 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -172.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.65 -46.5 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 128.152 2.581 . . . . 0.0 115.547 -171.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 94.5 p -68.41 -18.59 64.48 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.536 1.935 . . . . 0.0 115.082 -176.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -85.94 -1.95 57.81 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.22 1.008 . . . . 0.0 113.402 171.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.9 m0 -90.72 174.12 7.66 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.925 1.29 . . . . 0.0 110.952 174.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -76.67 47.98 0.53 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.855 1.662 . . . . 0.0 114.646 -176.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.2 mt -56.4 -33.55 65.87 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 -169.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -91.5 -2.51 57.18 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -145.74 71.99 13.86 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 125.868 1.667 . . . . 0.0 111.994 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -52.5 138.11 57.38 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.513 2.142 . . . . 0.0 112.088 174.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -73.09 -25.24 60.81 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.11 0.564 . . . . 0.0 111.194 172.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 50.4 t90 -155.84 154.08 30.74 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.69 1.596 . . . . 0.0 110.801 170.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.8 p -134.28 151.29 51.19 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.663 0.785 . . . . 0.0 112.001 165.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 173.04 -149.66 11.52 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 123.155 0.407 . . . . 0.0 113.484 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.0 mtt180 -94.35 141.15 28.91 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.227 1.811 . . . . 0.0 111.609 -174.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 24.9 tp -79.22 138.04 37.65 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 157.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.7 ttt-85 -144.82 87.47 1.85 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.234 1.016 . . . . 0.0 110.905 167.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.5 mt -72.44 127.07 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 172.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.402 HG22 ' HA ' ' A' ' 10' ' ' VAL . 7.5 p -134.19 165.02 26.07 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.697 1.999 . . . . 0.0 109.933 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.4 m -147.57 161.56 40.87 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.807 1.243 . . . . 0.0 112.212 175.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -150.6 118.09 6.09 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.307 0.643 . . . . 0.0 111.482 157.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 65.14 -132.23 36.22 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.034 1.302 . . . . 0.0 110.635 -175.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -85.92 22.65 1.64 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.902 1.681 . . . . 0.0 113.922 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.1 m -131.71 126.66 35.08 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.768 1.227 . . . . 0.0 110.282 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.63 160.04 14.59 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.659 1.184 . . . . 0.0 110.94 168.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -142.07 105.43 4.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.372 1.869 . . . . 0.0 108.986 -173.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.3 mp -81.03 95.99 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 169.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -92.04 137.95 31.94 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.274 0.63 . . . . 0.0 110.813 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.8 mp -112.43 128.88 56.44 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.814 1.646 . . . . 0.0 109.723 174.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -135.66 148.83 49.1 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.157 0.983 . . . . 0.0 111.639 -169.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -69.31 139.86 54.32 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 120.432 -1.417 . . . . 0.0 111.72 -176.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.5 pttt -79.74 -4.56 52.47 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -177.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.8 t -123.06 -43.59 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 125.297 1.439 . . . . 0.0 111.363 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.4 m -94.42 -21.97 18.59 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.41 15.37 77.2 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.143 0.878 . . . . 0.0 113.788 -176.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -88.5 148.44 24.15 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.212 1.405 . . . . 0.0 112.056 -176.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.6 tp -71.59 126.78 30.57 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.445 -0.784 . . . . 0.0 111.272 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -84.83 -58.9 2.52 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.055 0.942 . . . . 0.0 110.552 168.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.84 165.8 35.41 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.109 1.363 . . . . 0.0 111.369 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -142.46 143.0 32.41 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.333 0.653 . . . . 0.0 112.47 171.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.37 105.85 41.19 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 124.871 1.268 . . . . 0.0 110.99 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -77.22 145.06 23.92 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.792 2.995 . . . . 0.0 111.948 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.2 t -138.03 127.36 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 126.245 1.818 . . . . 0.0 109.58 -172.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -91.32 -22.77 20.37 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.66 147.83 13.93 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.412 1.885 . . . . 0.0 110.437 170.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -116.33 129.97 24.83 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.589 1.156 . . . . 0.0 110.956 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.83 149.09 79.9 Favored 'Cis proline' 0 CA--C 1.543 0.946 0 CA-C-N 119.824 0.973 . . . . 0.0 112.733 -6.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.68 -164.38 13.14 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.6 1.571 . . . . 0.0 112.548 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 19.3 tt -72.42 -35.58 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 121.654 -0.909 . . . . 0.0 112.979 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.67 6.26 21.55 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -167.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.0 t -151.37 129.18 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.508 1.523 . . . . 0.0 109.984 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -141.77 162.22 36.01 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.217 1.807 . . . . 0.0 112.86 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.5 p -109.75 160.35 16.4 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.792 2.037 . . . . 0.0 111.431 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.4 m -85.95 175.45 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 124.477 1.111 . . . . 0.0 111.398 168.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 71.8 p -91.18 -36.84 13.72 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.954 1.702 . . . . 0.0 112.098 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -89.33 -43.59 10.82 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -166.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.6 t -142.45 122.45 13.65 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -171.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.58 -9.06 23.38 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -169.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.451 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.305 49.0 ptt85 -84.73 19.33 2.07 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 178.787 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -139.13 139.94 37.78 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.479 1.512 . . . . 0.0 111.977 -176.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -140.66 162.21 35.94 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.437 1.495 . . . . 0.0 111.683 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 78.6 t -116.14 142.27 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.372 1.069 . . . . 0.0 109.294 166.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.67 147.3 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 118.98 0.809 . . . . 0.0 112.399 173.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -88.91 82.5 6.71 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.833 0.853 . . . . 0.0 111.187 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.5 pt -63.36 144.71 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 120.819 0.342 . . . . 0.0 111.696 174.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -137.04 140.39 42.02 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.661 1.584 . . . . 0.0 110.868 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -90.46 15.52 10.57 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.474 1.11 . . . . 0.0 113.573 -175.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.22 11.56 71.17 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 125.124 1.345 . . . . 0.0 115.669 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.9 t -134.25 -0.39 3.01 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.998 1.319 . . . . 0.0 114.462 -168.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 103.43 25.47 7.35 Favored Glycine 0 CA--C 1.536 1.376 0 O-C-N 120.836 -1.165 . . . . 0.0 114.288 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -132.49 144.28 50.34 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.103 2.161 . . . . 0.0 110.107 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.1 p -148.21 160.22 43.16 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -171.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.15 145.16 29.45 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.941 1.296 . . . . 0.0 111.389 171.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -90.66 114.53 26.85 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.794 0.837 . . . . 0.0 109.322 170.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.4 pt -115.01 148.73 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.875 1.27 . . . . 0.0 111.228 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.04 143.91 16.91 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 174.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.7 pt -128.24 144.01 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 125.386 1.474 . . . . 0.0 111.34 169.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.16 139.6 11.08 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.888 1.233 . . . . 0.0 112.967 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -101.17 157.18 16.96 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.814 1.646 . . . . 0.0 111.466 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.1 t -73.52 -20.27 60.7 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.911 0.884 . . . . 0.0 112.822 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -152.24 148.79 27.98 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.526 1.13 . . . . 0.0 111.935 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 47.4 ttt-85 -63.04 -31.53 72.68 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.642 1.177 . . . . 0.0 113.503 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.52 -31.76 79.67 Favored Glycine 0 CA--C 1.536 1.365 0 CA-C-N 119.039 0.836 . . . . 0.0 113.572 176.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -78.39 -35.44 47.19 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.771 -0.841 . . . . 0.0 111.407 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.451 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -65.97 -37.13 85.17 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.926 0.891 . . . . 0.0 113.209 168.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.21 -40.44 97.48 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.508 -0.745 . . . . 0.0 111.25 171.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -62.33 -36.76 83.2 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.592 1.087 . . . . 0.0 112.55 172.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -57.42 -56.33 23.3 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.392 0.996 . . . . 0.0 112.017 171.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -75.7 -24.68 56.26 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -176.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.5 -38.68 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 121.058 -1.027 . . . . 0.0 110.773 173.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 41.2 t -57.67 -38.55 75.3 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.406 0.683 . . . . 0.0 112.529 176.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.9 -52.32 20.81 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.456 0.702 . . . . 0.0 112.36 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -67.57 -28.48 67.81 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.045 -1.034 . . . . 0.0 113.064 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -83.91 0.1 49.15 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.581 1.152 . . . . 0.0 112.724 175.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -89.51 -39.97 12.97 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.253 -0.904 . . . . 0.0 112.284 161.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -91.99 -1.92 57.0 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -172.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.77 -30.02 55.56 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -177.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -83.47 -24.55 31.75 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.211 1.004 . . . . 0.0 113.374 176.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 19.6 t -80.93 -31.37 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.404 1.482 . . . . 0.0 111.097 176.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -92.46 26.99 2.41 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.718 2.007 . . . . 0.0 112.925 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -79.05 89.22 4.79 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.824 0.821 . . . . 0.0 109.954 172.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 . . . . . 0 C--O 1.252 1.226 0 C-N-CA 126.672 1.989 . . . . 0.0 112.737 -172.088 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.585 0 N-CA-C 111.64 -0.584 . . . . 0.0 111.64 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 56.3 m -133.5 147.93 66.69 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 125.389 1.476 . . . . 0.0 111.573 -177.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -76.12 -9.34 19.19 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.509 2.806 . . . . 0.0 114.295 -176.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -59.9 -28.58 67.7 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.505 1.122 . . . . 0.0 113.506 -173.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 77.6 p -63.38 -19.1 64.36 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.467 1.107 . . . . 0.0 113.969 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.9 mtp -76.24 -3.12 34.81 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.696 1.198 . . . . 0.0 113.254 174.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.19 -37.73 0.87 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.28 1.432 . . . . 0.0 112.706 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 51.2 m -137.79 108.32 6.55 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.058 1.343 . . . . 0.0 110.269 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -141.79 19.1 2.16 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.814 1.245 . . . . 0.0 113.67 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tt -77.77 96.37 4.9 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.913 1.285 . . . . 0.0 111.003 -178.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -136.87 48.84 2.08 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.512 1.525 . . . . 0.0 110.557 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -154.0 151.56 29.51 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.361 1.864 . . . . 0.0 110.308 -172.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -179.22 120.41 0.07 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.597 1.559 . . . . 0.0 108.304 165.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.7 m -94.71 107.97 19.97 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.799 -0.563 . . . . 0.0 110.122 170.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.0 t -65.43 145.83 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.473 1.109 . . . . 0.0 111.409 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.6 mt -129.86 -39.73 1.4 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.124 1.769 . . . . 0.0 112.309 -172.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 37.6 t -152.15 137.38 17.47 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.687 1.195 . . . . 0.0 110.646 174.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 88.5 t -129.77 126.87 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.764 1.226 . . . . 0.0 109.275 171.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -126.78 136.08 28.24 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 125.677 1.591 . . . . 0.0 110.233 174.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -78.9 -15.8 13.05 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.158 2.572 . . . . 0.0 115.037 -173.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -130.89 107.32 9.03 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.379 1.072 . . . . 0.0 110.904 -176.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -140.16 141.5 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 125.475 1.51 . . . . 0.0 109.988 170.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.5 m -124.35 125.84 44.99 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.301 1.04 . . . . 0.0 111.12 -171.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.7 t -92.4 136.72 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.064 1.346 . . . . 0.0 111.79 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -126.46 128.6 47.21 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.942 1.297 . . . . 0.0 109.284 169.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -65.33 133.68 51.93 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 160.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.6 pt -109.22 148.42 37.96 Favored Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 124.445 1.098 . . . . 0.0 112.483 -172.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -68.9 163.69 36.5 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.525 2.817 . . . . 0.0 112.453 173.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.76 114.85 2.75 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.934 2.423 . . . . 0.0 110.087 168.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -152.62 166.25 32.67 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.28 1.432 . . . . 0.0 112.93 -165.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.3 125.34 29.22 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 122.254 1.026 . . . . 0.0 111.555 172.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 64.3 p -77.75 -14.09 59.7 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 -157.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -139.37 17.22 2.57 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.943 1.297 . . . . 0.0 112.602 169.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -134.05 -28.45 1.35 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.595 1.558 . . . . 0.0 114.046 -175.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -118.49 -19.26 4.63 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.502 1.049 . . . . 0.0 115.431 -175.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 -67.48 107.01 2.31 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.547 1.173 . . . . 0.0 109.59 164.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.14 20.83 13.56 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.27 -48.94 0.05 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 127.175 2.19 . . . . 0.0 114.672 -163.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.2 m -64.46 -9.17 16.76 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.362 1.865 . . . . 0.0 114.739 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.5 -11.41 59.9 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.645 1.178 . . . . 0.0 112.876 172.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -104.18 175.92 5.33 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.248 1.819 . . . . 0.0 112.499 -171.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -76.92 47.33 0.51 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.715 2.006 . . . . 0.0 114.455 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.6 mt -55.0 -34.3 63.32 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -169.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -95.45 -0.36 52.45 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.134 0.973 . . . . 0.0 113.29 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.37 61.61 10.26 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 126.23 1.812 . . . . 0.0 111.719 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -55.44 136.67 74.84 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.593 2.195 . . . . 0.0 112.034 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -69.64 -26.04 64.22 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.561 1.144 . . . . 0.0 111.666 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.4 t90 -154.86 152.8 30.22 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.683 1.593 . . . . 0.0 110.747 170.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.7 p -134.42 148.79 50.7 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.874 0.87 . . . . 0.0 111.927 169.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.59 -145.34 6.5 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 113.931 0.333 . . . . 0.0 113.931 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -108.82 148.82 29.99 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.29 1.836 . . . . 0.0 111.721 -176.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 61.0 tp -92.92 142.22 27.55 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.099 1.76 . . . . 0.0 110.832 173.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -144.03 94.29 2.56 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.269 1.827 . . . . 0.0 109.494 173.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.482 HD11 ' CD2' ' A' ' 119' ' ' PHE . 27.9 mt -84.23 134.43 26.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 170.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.24 166.69 26.27 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.037 1.735 . . . . 0.0 110.338 -166.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 99.0 p -156.52 160.5 39.56 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 120.845 -1.159 . . . . 0.0 112.3 175.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -151.04 120.46 6.88 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.472 0.709 . . . . 0.0 112.23 156.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 65.22 -132.12 35.98 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 125.088 1.327 . . . . 0.0 110.502 -176.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -87.19 26.6 1.17 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.637 1.575 . . . . 0.0 113.328 178.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.0 m -132.97 129.65 38.51 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.85 1.26 . . . . 0.0 110.172 173.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.76 160.8 14.15 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.648 1.179 . . . . 0.0 110.577 167.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -140.64 109.61 6.08 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.811 1.644 . . . . 0.0 108.952 -173.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.0 mp -88.08 105.58 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 168.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -107.66 142.38 37.71 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.592 1.157 . . . . 0.0 111.179 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.4 mp -115.23 131.58 56.88 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.429 1.891 . . . . 0.0 109.656 177.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -133.58 148.35 51.59 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.828 0.851 . . . . 0.0 112.614 -174.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -67.47 135.64 53.38 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.065 0.946 . . . . 0.0 111.573 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -75.15 -6.96 52.38 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 -175.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 86.3 t -119.22 -43.72 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.158 1.383 . . . . 0.0 111.389 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.5 m -93.44 -20.15 20.58 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -175.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.8 15.7 76.0 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.279 0.942 . . . . 0.0 113.588 -177.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -90.53 149.92 21.98 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.144 1.378 . . . . 0.0 112.355 -174.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 31.3 tp -70.91 123.89 23.07 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.727 0.811 . . . . 0.0 111.566 -176.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -86.46 -55.24 3.98 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.47 1.108 . . . . 0.0 111.123 170.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.79 162.57 39.73 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.507 1.123 . . . . 0.0 112.146 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -142.71 135.21 27.75 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.052 1.341 . . . . 0.0 111.891 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.0 100.59 42.82 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.534 1.534 . . . . 0.0 111.136 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -68.45 142.07 53.01 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.995 3.13 . . . . 0.0 112.529 170.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.1 t -134.52 130.58 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.868 1.667 . . . . 0.0 109.894 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -86.1 -26.37 25.29 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -164.63 153.89 13.26 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.551 1.54 . . . . 0.0 111.239 169.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -118.02 133.0 23.44 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.883 1.273 . . . . 0.0 111.461 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.37 147.83 75.91 Favored 'Cis proline' 0 CA--C 1.541 0.875 0 CA-C-N 119.899 0.999 . . . . 0.0 112.22 -8.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.9 -175.82 36.69 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.491 1.043 . . . . 0.0 114.058 -177.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.2 tp -53.71 -34.65 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -169.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.04 4.92 52.03 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -172.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.6 t -148.6 127.31 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 CA-C-N 119.409 1.004 . . . . 0.0 111.739 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -140.61 168.93 18.64 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.648 1.979 . . . . 0.0 113.116 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 34.0 p -123.09 158.89 29.66 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.586 1.954 . . . . 0.0 111.59 -171.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.8 m -85.81 173.22 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 O-C-N 121.573 -0.704 . . . . 0.0 112.121 169.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 70.8 p -87.34 -35.93 18.12 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.851 1.26 . . . . 0.0 112.586 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -94.11 -42.4 9.01 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -162.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.4 t -143.33 130.24 20.52 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.3 m -69.3 4.53 1.66 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -172.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.446 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.281 30.2 ptt180 -96.59 17.05 17.15 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 176.1 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -140.15 132.12 27.76 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.181 0.992 . . . . 0.0 110.784 -174.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -137.05 162.53 33.08 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.325 1.45 . . . . 0.0 110.495 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.6 t -121.59 139.3 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.425 1.09 . . . . 0.0 108.717 171.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.29 147.44 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 118.81 0.732 . . . . 0.0 112.536 176.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -90.15 85.92 6.4 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.461 0.705 . . . . 0.0 111.099 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -69.38 139.95 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 122.635 0.374 . . . . 0.0 111.161 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -138.76 144.03 39.25 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.172 1.789 . . . . 0.0 111.429 -170.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -91.25 2.87 56.05 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.082 0.953 . . . . 0.0 113.154 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.24 13.79 80.1 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.17 1.367 . . . . 0.0 114.691 178.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.2 t -140.42 16.51 2.39 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.487 1.515 . . . . 0.0 113.509 -171.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.24 -2.03 80.62 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 124.58 1.086 . . . . 0.0 115.063 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -76.23 134.47 39.83 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.345 1.458 . . . . 0.0 108.482 164.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 80.7 p -151.2 159.87 44.17 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 171.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.73 147.58 32.08 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.604 1.561 . . . . 0.0 110.992 169.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -90.71 120.62 31.92 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.098 0.559 . . . . 0.0 109.584 167.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.9 pt -117.79 143.03 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.553 1.141 . . . . 0.0 110.871 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.38 143.15 17.14 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 174.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.9 pt -127.35 139.0 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 124.987 1.315 . . . . 0.0 111.644 171.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.37 143.7 16.72 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.83 1.681 . . . . 0.0 112.251 174.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -106.37 167.67 9.67 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.64 1.576 . . . . 0.0 111.534 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.3 t -68.91 -36.21 77.74 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.143 0.577 . . . . 0.0 112.172 175.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -156.66 154.3 29.89 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.086 -1.009 . . . . 0.0 112.048 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 72.2 mtm-85 -55.74 -39.34 71.0 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.554 1.142 . . . . 0.0 112.382 173.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.78 -6.53 30.68 Favored Glycine 0 CA--C 1.542 1.731 0 C-N-CA 124.407 1.004 . . . . 0.0 115.133 178.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -111.22 -33.86 6.33 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.243 1.417 . . . . 0.0 111.728 168.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.446 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -69.72 -24.96 63.63 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 175.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -61.21 -30.4 70.4 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.729 -1.232 . . . . 0.0 112.297 169.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -69.92 -27.93 65.18 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.495 1.043 . . . . 0.0 112.635 176.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.482 ' CD2' HD11 ' A' ' 49' ' ' ILE . 10.6 t80 -61.81 -44.87 95.99 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.408 -0.807 . . . . 0.0 111.26 169.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -76.95 -35.26 57.4 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.376 1.07 . . . . 0.0 113.147 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 66.6 t -78.73 -38.86 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.366 -0.834 . . . . 0.0 111.87 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 88.5 p -66.86 -31.65 72.4 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.984 -1.073 . . . . 0.0 113.312 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 73.2 mt -68.85 -51.6 38.73 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.943 0.897 . . . . 0.0 111.859 172.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -68.09 -27.8 66.8 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.111 -0.993 . . . . 0.0 112.756 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -82.44 -3.02 54.97 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.399 1.08 . . . . 0.0 112.795 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -89.63 -40.7 12.41 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 121.315 -0.866 . . . . 0.0 111.963 160.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -90.55 -0.29 57.62 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 -173.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.25 -29.72 58.63 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 120.909 1.686 . . . . 0.0 115.288 -177.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 41.7 p-90 -82.9 -19.5 37.22 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.815 1.042 . . . . 0.0 113.815 175.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 37.4 t -87.32 -30.04 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.741 1.616 . . . . 0.0 111.086 173.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 51.0 mmtt -88.65 40.77 0.98 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.131 2.172 . . . . 0.0 111.733 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -93.02 16.31 13.05 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.353 1.461 . . . . 0.0 113.427 173.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 . . . . . 0 C--O 1.251 1.139 0 C-N-CA 125.964 1.705 . . . . 0.0 114.893 177.874 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.622 0 N-CA-C 112.106 -0.398 . . . . 0.0 112.106 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 20.3 m -67.05 148.35 98.89 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.545 1.138 . . . . 0.0 112.872 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -77.17 -9.58 17.78 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 123.561 2.84 . . . . 0.0 114.084 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -136.96 166.39 23.77 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.93 1.692 . . . . 0.0 111.668 177.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 88.5 p -78.25 -10.88 59.85 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -175.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.6 mtt 53.62 28.43 7.91 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.695 1.598 . . . . 0.0 113.507 -167.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.87 -35.73 0.47 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.679 1.591 . . . . 0.0 112.763 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.6 m -93.79 75.62 4.26 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.801 1.241 . . . . 0.0 109.835 178.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -131.82 36.23 3.72 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.625 1.57 . . . . 0.0 112.721 -170.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.54 64.6 1.66 Allowed 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 126.301 1.84 . . . . 0.0 112.716 -175.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -126.81 58.05 1.43 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.445 1.898 . . . . 0.0 109.6 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -150.77 151.61 32.6 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 126.073 1.749 . . . . 0.0 110.478 -172.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -173.3 115.73 0.26 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.489 1.516 . . . . 0.0 109.414 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.9 m -93.99 110.79 22.45 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.199 1.0 . . . . 0.0 110.185 174.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.0 t -59.08 143.45 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 125.307 1.443 . . . . 0.0 112.877 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.1 mt -129.26 -39.37 1.53 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.544 1.938 . . . . 0.0 111.99 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 47.5 t -149.7 142.69 24.87 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.627 1.571 . . . . 0.0 109.611 174.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.6 t -137.97 126.9 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.702 1.201 . . . . 0.0 108.149 170.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -138.11 130.4 16.21 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 123.751 0.82 . . . . 0.0 111.912 -176.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -75.14 -17.08 19.53 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.188 2.592 . . . . 0.0 115.413 -167.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -130.61 109.72 10.87 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.249 1.019 . . . . 0.0 110.958 -176.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -142.26 145.95 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.589 1.556 . . . . 0.0 109.876 168.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.9 m -126.83 132.66 50.93 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.278 1.031 . . . . 0.0 110.85 -174.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.3 t -100.52 135.09 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.078 1.351 . . . . 0.0 111.527 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.4 119.71 22.03 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.884 1.274 . . . . 0.0 108.837 168.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -64.11 131.52 47.76 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.57 -0.706 . . . . 0.0 109.491 166.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.4 pt -93.52 152.58 41.04 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 124.696 1.199 . . . . 0.0 112.806 -167.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -64.19 161.19 34.94 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.627 2.885 . . . . 0.0 112.88 171.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -64.36 115.34 3.12 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.201 2.601 . . . . 0.0 110.412 170.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 60.8 mmt-85 -152.55 159.72 43.27 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.596 1.158 . . . . 0.0 113.723 -164.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.05 134.74 35.37 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.85 156.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 59.9 p -67.9 -64.97 0.75 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.552 1.541 . . . . 0.0 113.039 -174.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -77.38 -1.79 31.86 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.73 1.212 . . . . 0.0 113.289 -173.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 86.4 mtt-85 -116.77 -29.31 6.09 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.027 1.731 . . . . 0.0 113.655 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.87 -0.66 1.7 Allowed Glycine 0 CA--C 1.533 1.159 0 N-CA-C 117.887 1.915 . . . . 0.0 117.887 -166.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 -78.16 96.34 5.16 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 120.855 2.328 . . . . 0.0 108.641 161.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.8 19.36 19.21 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.74 -50.08 0.05 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 127.169 2.188 . . . . 0.0 114.206 -165.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.5 m -65.39 -11.31 41.13 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.174 1.79 . . . . 0.0 114.788 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.71 -14.86 59.49 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.339 1.056 . . . . 0.0 112.494 171.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 16.0 m0 -96.73 171.06 8.76 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.866 1.666 . . . . 0.0 111.693 -174.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -80.56 56.35 2.58 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.2 1.4 . . . . 0.0 113.081 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.0 mt -57.69 -24.88 59.05 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -169.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -106.96 0.58 23.85 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.347 1.059 . . . . 0.0 112.593 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -132.27 77.56 70.39 Favored Pre-proline 0 C--O 1.239 0.521 0 C-N-CA 125.809 1.644 . . . . 0.0 111.378 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -69.18 144.95 58.92 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 CA-C-N 118.94 0.657 . . . . 0.0 112.784 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -70.63 -28.92 65.19 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.705 0.802 . . . . 0.0 111.172 168.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 52.6 t90 -160.42 154.21 22.66 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.606 1.962 . . . . 0.0 110.579 175.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.4 p -133.13 149.16 52.12 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.286 1.035 . . . . 0.0 111.534 167.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.26 -143.43 5.97 Favored Glycine 0 CA--C 1.524 0.635 0 O-C-N 122.15 -0.343 . . . . 0.0 113.407 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -107.28 142.41 37.08 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.679 1.592 . . . . 0.0 111.657 -176.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.3 tp -81.79 137.92 35.23 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.131 1.372 . . . . 0.0 109.426 165.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.6 ttt-85 -145.74 89.28 1.89 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 122.217 1.008 . . . . 0.0 110.938 168.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.515 HD11 ' CD1' ' A' ' 119' ' ' PHE . 17.5 mt -74.91 127.03 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 172.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.0 p -131.73 173.92 10.66 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 127.083 2.153 . . . . 0.0 109.62 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -160.19 160.72 33.14 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.479 -1.388 . . . . 0.0 110.16 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -148.9 127.2 12.17 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 122.044 0.926 . . . . 0.0 111.769 153.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.02 -114.76 5.73 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 126.078 1.799 . . . . 0.0 110.061 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -104.24 15.38 28.46 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.615 1.566 . . . . 0.0 113.277 176.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.3 m -124.4 109.19 13.0 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.892 0.877 . . . . 0.0 110.649 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.26 159.52 20.06 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.371 0.668 . . . . 0.0 110.99 171.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -141.39 100.79 3.86 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.926 1.69 . . . . 0.0 109.533 -171.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mp -79.92 94.47 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 170.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -91.15 137.82 32.07 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.21 0.604 . . . . 0.0 111.088 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.2 mp -110.62 129.64 55.76 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 126.011 1.724 . . . . 0.0 109.329 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -133.04 145.82 51.15 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.958 0.903 . . . . 0.0 112.241 -169.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -68.43 135.7 52.13 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.12 -0.987 . . . . 0.0 111.655 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.9 pttt -75.11 -7.46 53.82 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -175.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.3 t -119.47 -43.17 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.188 1.395 . . . . 0.0 111.48 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.0 m -95.42 -19.84 19.57 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -174.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.86 14.42 75.74 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.461 1.029 . . . . 0.0 113.713 -176.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -88.07 151.53 22.68 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.224 1.41 . . . . 0.0 112.097 -175.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.3 tp -72.41 126.6 30.24 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.568 -0.707 . . . . 0.0 111.468 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -85.66 -56.69 3.38 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.377 1.071 . . . . 0.0 110.929 169.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.4 162.46 40.03 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.326 1.45 . . . . 0.0 110.918 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -143.36 139.06 29.87 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 172.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.53 106.77 53.89 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.845 1.258 . . . . 0.0 111.037 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.64 139.79 14.43 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.941 3.094 . . . . 0.0 111.325 175.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 t -134.45 121.95 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.611 1.565 . . . . 0.0 109.88 -171.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -89.04 -17.34 29.55 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.86 141.87 8.74 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.834 2.053 . . . . 0.0 110.167 174.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -126.51 127.48 24.54 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 124.352 1.061 . . . . 0.0 111.095 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -61.29 147.07 48.47 Favored 'Cis proline' 0 CA--C 1.539 0.767 0 CA-C-N 120.162 1.094 . . . . 0.0 114.104 -4.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.81 -163.76 29.59 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.99 1.281 . . . . 0.0 113.873 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.8 tp -64.67 -38.58 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 -167.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.77 6.21 48.38 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -168.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.8 t -151.09 124.52 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.75 1.22 . . . . 0.0 110.474 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -140.13 162.79 34.4 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.792 1.637 . . . . 0.0 113.459 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.2 p -109.18 162.46 14.26 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.87 1.668 . . . . 0.0 111.462 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.9 m -84.18 176.87 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.032 0.933 . . . . 0.0 111.299 169.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 57.8 p -90.82 -37.92 13.3 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.512 1.525 . . . . 0.0 111.798 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -96.0 -41.12 8.92 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 -165.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.5 t -139.74 116.54 10.89 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -171.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.69 -3.54 6.83 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -168.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.455 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.306 49.2 ptt85 -86.93 20.74 2.51 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 176.814 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -140.67 139.57 34.81 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.448 1.499 . . . . 0.0 111.36 -176.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -138.68 161.86 36.09 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.216 1.406 . . . . 0.0 111.615 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.6 t -117.93 137.46 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.04 0.936 . . . . 0.0 108.924 165.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.17 147.96 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 118.737 0.699 . . . . 0.0 112.157 174.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -91.33 84.39 5.6 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.623 0.769 . . . . 0.0 110.936 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -68.93 138.86 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.849 0.357 . . . . 0.0 110.965 176.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -139.31 149.54 44.35 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.445 1.498 . . . . 0.0 111.42 -169.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -95.12 3.1 55.12 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.472 1.109 . . . . 0.0 113.32 -177.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.54 11.24 84.33 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.078 1.323 . . . . 0.0 114.702 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.9 t -132.67 9.17 4.24 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.722 1.609 . . . . 0.0 113.478 -172.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.21 -1.67 64.95 Favored Glycine 0 CA--C 1.537 1.454 0 O-C-N 120.741 -1.225 . . . . 0.0 114.779 -177.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -72.4 135.23 45.76 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.273 1.429 . . . . 0.0 108.966 164.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 95.6 p -145.25 153.08 40.93 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 174.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.31 142.43 29.43 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.284 1.434 . . . . 0.0 110.963 168.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -91.74 118.85 31.05 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.44 0.696 . . . . 0.0 109.861 170.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.7 pt -118.0 141.77 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.732 1.213 . . . . 0.0 110.889 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -90.11 142.37 16.43 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 175.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.7 pt -129.42 145.98 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.907 1.283 . . . . 0.0 112.167 170.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.75 148.45 16.77 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.025 1.298 . . . . 0.0 113.698 176.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -114.57 156.65 24.27 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.15 1.78 . . . . 0.0 111.531 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.6 t -74.27 -23.77 59.17 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.054 0.941 . . . . 0.0 112.936 -178.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -151.91 147.66 26.85 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.414 1.086 . . . . 0.0 111.981 -176.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 -62.97 -33.59 75.71 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.241 1.016 . . . . 0.0 113.21 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.45 -28.46 73.63 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 119.086 0.857 . . . . 0.0 113.525 175.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -85.51 -30.11 23.71 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.116 0.966 . . . . 0.0 112.581 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.455 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -66.9 -35.96 81.19 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.588 -0.695 . . . . 0.0 112.625 163.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -62.29 -35.89 80.42 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.402 -0.811 . . . . 0.0 111.661 169.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -62.92 -36.65 84.1 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 119.846 1.203 . . . . 0.0 112.5 173.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.515 ' CD1' HD11 ' A' ' 49' ' ' ILE . 18.0 t80 -60.48 -51.51 69.15 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.035 0.934 . . . . 0.0 112.386 169.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.84 -26.18 40.51 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -175.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.3 t -77.27 -42.38 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 O-C-N 121.127 -0.983 . . . . 0.0 110.938 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 91.6 p -63.66 -31.36 72.51 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.895 0.77 . . . . 0.0 112.882 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.1 mt -68.51 -56.86 6.92 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.105 0.962 . . . . 0.0 111.993 169.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -68.16 -25.45 65.27 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.918 -1.113 . . . . 0.0 113.5 -173.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -79.46 -4.31 50.62 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.255 1.022 . . . . 0.0 112.518 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -90.17 -28.32 18.99 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.29 -0.881 . . . . 0.0 112.587 161.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -101.07 -1.16 34.86 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.875 1.805 . . . . 0.0 115.875 -175.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.68 -29.04 58.68 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 120.959 1.709 . . . . 0.0 115.164 -178.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 36.4 p-90 -82.25 -16.64 48.81 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 175.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.8 t -88.78 -33.83 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.62 1.568 . . . . 0.0 110.606 171.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -87.96 42.56 1.06 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 127.385 2.274 . . . . 0.0 111.978 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -85.68 97.13 9.95 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.404 1.082 . . . . 0.0 110.314 176.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 . . . . . 0 C--O 1.252 1.204 0 C-N-CA 126.043 1.737 . . . . 0.0 113.496 178.25 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 112.141 -0.383 . . . . 0.0 112.141 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 57.1 p -151.29 172.28 5.55 Favored Pre-proline 0 N--CA 1.475 0.799 0 C-N-CA 125.132 1.373 . . . . 0.0 111.217 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -54.6 -17.59 13.36 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.012 2.474 . . . . 0.0 115.054 171.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -75.73 -40.28 55.8 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.345 1.058 . . . . 0.0 112.437 175.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 78.8 p -86.84 -25.17 24.66 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.979 0.912 . . . . 0.0 112.839 176.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt -76.75 35.96 0.16 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 126.001 1.72 . . . . 0.0 112.739 173.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.16 -40.47 0.17 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.369 1.868 . . . . 0.0 112.068 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 44.5 m -132.29 107.27 8.44 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.292 1.437 . . . . 0.0 109.45 175.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -140.4 6.2 2.09 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -171.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -71.42 148.16 47.19 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -164.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -134.53 46.39 2.48 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.671 1.588 . . . . 0.0 110.438 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -145.41 146.47 31.55 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.55 1.54 . . . . 0.0 110.907 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -178.51 117.67 0.08 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.901 1.68 . . . . 0.0 108.311 165.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.7 m -91.86 110.11 21.46 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.431 -0.793 . . . . 0.0 110.065 172.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.2 t -70.13 147.36 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.898 1.279 . . . . 0.0 112.062 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.0 mt -132.33 -39.54 1.03 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.963 1.705 . . . . 0.0 110.995 -173.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.7 t -151.1 146.91 26.48 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.987 1.315 . . . . 0.0 110.86 175.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 72.4 t -139.99 123.34 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.239 1.416 . . . . 0.0 109.31 171.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -118.42 141.05 29.03 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 125.017 1.327 . . . . 0.0 111.141 175.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.72 -19.32 21.35 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 123.661 2.907 . . . . 0.0 114.515 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -133.29 110.83 10.35 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.191 0.905 . . . . 0.0 111.388 -172.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.2 p -142.55 143.03 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.917 1.287 . . . . 0.0 110.755 169.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.2 m -127.86 130.32 48.39 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.69 1.196 . . . . 0.0 110.993 -174.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.2 t -97.34 136.98 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.929 1.291 . . . . 0.0 111.948 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.17 126.75 36.44 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.823 1.249 . . . . 0.0 109.381 168.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -63.12 131.62 49.12 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 161.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.6 pt -98.25 149.7 35.99 Favored Pre-proline 0 N--CA 1.475 0.807 0 C-N-CA 123.904 0.882 . . . . 0.0 112.676 -168.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -67.32 166.86 22.05 Favored 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 123.374 2.716 . . . . 0.0 111.444 167.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -57.31 149.15 66.61 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.344 2.03 . . . . 0.0 111.715 168.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.3 ttm-85 -62.79 154.53 29.48 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.73 1.212 . . . . 0.0 112.64 -174.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.76 -179.59 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 122.253 1.025 . . . . 0.0 112.826 161.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.5 m -78.75 75.08 5.27 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.466 1.506 . . . . 0.0 111.652 -171.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.304 0.5 OUTLIER 54.93 23.71 5.26 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 127.298 2.239 . . . . 0.0 115.098 -165.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -95.06 -49.0 5.72 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.196 0.998 . . . . 0.0 112.339 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.63 -144.73 16.64 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-O 121.76 0.645 . . . . 0.0 111.78 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -120.48 158.41 27.3 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 127.066 2.146 . . . . 0.0 110.971 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.83 18.48 6.71 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -171.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.56 -51.11 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 128.149 2.58 . . . . 0.0 115.697 -174.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.5 m -65.07 -13.0 56.88 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.337 1.855 . . . . 0.0 114.367 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -89.41 -4.9 57.83 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.704 1.202 . . . . 0.0 112.552 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 22.4 m0 -92.75 172.11 8.56 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.867 1.667 . . . . 0.0 110.74 174.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -80.57 55.06 2.22 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.163 1.385 . . . . 0.0 114.074 -177.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.2 mt -60.34 -17.81 45.63 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -174.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -102.14 -8.13 21.64 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.82 1.248 . . . . 0.0 113.126 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -148.74 80.05 8.37 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.563 1.145 . . . . 0.0 112.102 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.72 146.8 53.13 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.498 2.798 . . . . 0.0 112.886 174.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -71.45 -29.64 65.09 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.497 0.719 . . . . 0.0 111.393 167.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 51.4 t90 -158.54 154.43 26.66 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.028 1.731 . . . . 0.0 110.937 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.3 p -134.88 148.01 50.0 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.57 1.148 . . . . 0.0 111.594 169.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.48 -141.16 4.88 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 113.916 0.326 . . . . 0.0 113.916 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -110.79 140.53 45.13 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.802 2.041 . . . . 0.0 110.318 -170.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.6 tp -93.55 137.66 32.6 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.328 1.051 . . . . 0.0 109.997 173.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 28.0 ttp-105 -127.98 136.1 50.83 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.236 1.014 . . . . 0.0 110.271 156.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.432 HD11 ' CD2' ' A' ' 119' ' ' PHE . 36.1 mt -111.35 135.28 51.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 125.227 1.411 . . . . 0.0 107.25 164.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.74 166.77 28.4 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.847 1.659 . . . . 0.0 110.23 -164.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.3 t -157.45 160.35 38.24 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.056 -1.028 . . . . 0.0 111.951 172.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -144.68 119.95 10.2 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.513 0.725 . . . . 0.0 111.609 157.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.61 -115.11 6.72 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 125.802 1.668 . . . . 0.0 110.494 -177.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -104.5 17.02 24.93 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.17 1.788 . . . . 0.0 113.225 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.4 m -124.84 108.5 12.0 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.065 0.946 . . . . 0.0 110.396 177.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.64 159.47 25.34 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.734 0.413 . . . . 0.0 110.98 169.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -139.23 117.25 11.72 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.795 1.638 . . . . 0.0 109.214 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.1 mp -92.21 109.22 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 165.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -112.65 130.79 55.92 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.216 1.006 . . . . 0.0 111.876 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.9 mp -104.2 127.06 51.78 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.763 1.625 . . . . 0.0 110.053 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -132.98 150.28 52.17 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -170.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -65.61 141.7 58.32 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 122.252 1.025 . . . . 0.0 112.744 -173.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.0 pttt -74.81 -10.36 59.43 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -175.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 64.0 t -121.12 -38.32 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.868 1.267 . . . . 0.0 111.963 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.3 m -118.93 -8.64 10.23 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -172.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.84 14.49 80.01 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 123.992 0.806 . . . . 0.0 114.44 177.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -63.29 136.83 57.93 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.91 1.684 . . . . 0.0 111.277 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 38.1 tp -71.12 112.75 7.51 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.767 -0.583 . . . . 0.0 111.011 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -78.27 -53.52 7.23 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.932 0.893 . . . . 0.0 110.674 172.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.81 161.54 38.39 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.487 1.115 . . . . 0.0 112.052 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -141.86 134.47 28.34 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.03 1.332 . . . . 0.0 111.357 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.78 96.67 50.28 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 124.997 1.319 . . . . 0.0 111.573 176.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -59.56 138.51 84.09 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 124.213 3.275 . . . . 0.0 112.824 164.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.0 t -135.55 131.8 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.082 1.753 . . . . 0.0 109.598 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -91.15 -24.14 20.04 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -165.47 155.5 13.02 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.772 1.629 . . . . 0.0 111.18 169.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -126.19 127.22 24.71 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.87 1.268 . . . . 0.0 111.171 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.18 147.93 78.61 Favored 'Cis proline' 0 CA--C 1.542 0.888 0 CA-C-N 119.98 1.028 . . . . 0.0 113.185 -2.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -161.54 -164.71 16.98 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.901 1.715 . . . . 0.0 112.556 -178.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.9 tt -73.36 -38.62 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -175.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.5 7.51 16.81 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -167.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.2 t -149.94 130.55 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.78 1.632 . . . . 0.0 109.703 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.16 164.08 33.36 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.081 1.752 . . . . 0.0 112.731 -171.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 73.1 p -121.49 161.67 21.86 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.861 1.664 . . . . 0.0 111.956 -174.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.8 m -91.39 169.91 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.102 1.361 . . . . 0.0 110.906 168.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 79.6 p -95.03 -31.09 13.76 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.894 1.277 . . . . 0.0 113.506 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -95.3 -39.55 9.99 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -163.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.0 t -138.95 123.24 18.16 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -174.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.1 m -79.34 31.12 0.22 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 -168.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.418 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.257 18.4 ptt180 -120.68 18.06 11.95 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.293 1.437 . . . . 0.0 114.693 174.341 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -138.34 137.84 37.75 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.219 1.008 . . . . 0.0 111.202 -170.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -136.66 160.35 39.08 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.967 1.307 . . . . 0.0 111.325 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 80.7 t -112.75 143.8 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.498 1.119 . . . . 0.0 108.88 165.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.8 148.49 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 118.981 0.81 . . . . 0.0 112.104 171.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -89.28 89.28 7.84 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.668 0.787 . . . . 0.0 110.426 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -71.27 142.0 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 O-C-N 122.161 -0.337 . . . . 0.0 110.802 175.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -135.35 144.21 46.53 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.594 1.558 . . . . 0.0 111.83 -172.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -96.56 14.42 24.8 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.779 1.232 . . . . 0.0 113.557 -175.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.14 8.26 85.07 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 125.228 1.394 . . . . 0.0 115.476 176.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.5 t -131.79 3.95 4.16 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.543 1.537 . . . . 0.0 113.722 -172.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.36 -5.42 67.74 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.353 1.454 . . . . 0.0 113.888 -175.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -76.04 130.15 37.94 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 127.276 2.23 . . . . 0.0 108.564 165.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 86.3 p -152.41 161.06 43.13 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.565 1.146 . . . . 0.0 114.023 -175.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.93 148.38 31.71 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.455 1.502 . . . . 0.0 111.348 172.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -93.08 116.74 29.33 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.53 0.732 . . . . 0.0 109.733 170.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.7 pt -116.94 146.01 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.715 1.206 . . . . 0.0 111.149 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.8 142.68 16.17 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 174.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.6 pt -127.54 139.81 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 125.319 1.448 . . . . 0.0 111.866 171.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -117.38 142.71 17.51 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 125.45 1.5 . . . . 0.0 112.474 174.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -100.37 162.74 12.75 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.209 1.404 . . . . 0.0 111.842 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.3 t -68.76 -28.02 66.42 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.643 0.777 . . . . 0.0 112.388 176.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -158.71 155.85 28.8 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.601 1.16 . . . . 0.0 111.406 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.3 ttp85 -54.28 -40.98 68.36 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.397 1.079 . . . . 0.0 112.513 173.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.69 -29.85 73.21 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 123.995 0.807 . . . . 0.0 114.304 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -82.2 -36.82 26.89 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.298 1.049 . . . . 0.0 111.748 176.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.418 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -63.61 -31.59 72.8 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.523 -0.735 . . . . 0.0 112.764 168.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -72.54 0.9 9.2 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.795 1.405 . . . . 0.0 114.795 170.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -96.87 -32.77 11.91 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.431 -0.793 . . . . 0.0 112.322 162.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.432 ' CD2' HD11 ' A' ' 49' ' ' ILE . 47.0 t80 -58.4 -53.03 62.93 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.638 1.175 . . . . 0.0 112.518 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -66.41 -34.47 78.02 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.669 1.187 . . . . 0.0 113.366 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 52.6 t -75.48 -40.04 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.44 1.096 . . . . 0.0 111.005 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.3 m -66.69 -28.55 68.54 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.34 0.656 . . . . 0.0 112.735 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.7 mt -75.74 -53.1 9.05 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.828 0.851 . . . . 0.0 111.981 171.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -66.62 -27.39 67.66 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.224 -0.922 . . . . 0.0 113.161 -175.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -84.29 -3.12 58.04 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.303 1.041 . . . . 0.0 112.752 175.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 52.5 t60 -88.85 -38.8 14.31 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 120.901 -1.125 . . . . 0.0 111.911 158.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -91.92 1.83 56.93 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 -171.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.24 -21.98 50.46 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -177.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 29.5 p-90 -93.79 -16.7 23.89 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.977 1.311 . . . . 0.0 114.177 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.5 t -97.15 -36.83 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.555 1.542 . . . . 0.0 111.766 -176.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.0 tptt -89.9 25.33 2.13 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.634 1.574 . . . . 0.0 112.917 -173.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -84.1 93.53 8.14 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.607 1.163 . . . . 0.0 110.452 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 . . . . . 0 C--O 1.253 1.251 0 C-N-CA 126.92 2.088 . . . . 0.0 112.807 -178.081 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.592 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 53.3 m 63.19 152.1 0.11 Allowed Pre-proline 0 N--CA 1.484 1.236 0 C-N-CA 127.293 2.237 . . . . 0.0 115.365 -172.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -80.0 -16.81 11.05 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.278 2.652 . . . . 0.0 113.842 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -76.83 151.44 35.89 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.569 1.148 . . . . 0.0 112.339 -178.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 62.1 p -83.09 -14.97 52.65 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.656 1.182 . . . . 0.0 113.751 178.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -149.2 148.19 29.31 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.743 1.617 . . . . 0.0 110.798 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.26 -52.07 0.23 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.913 1.285 . . . . 0.0 111.27 169.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.9 m -158.25 132.04 7.79 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.191 2.197 . . . . 0.0 108.083 168.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -155.02 150.73 27.62 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.035 1.734 . . . . 0.0 109.537 170.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.35 139.49 30.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.308 1.843 . . . . 0.0 110.667 174.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -89.1 30.34 0.97 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.733 1.213 . . . . 0.0 113.307 -170.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -156.92 151.75 25.86 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.519 1.528 . . . . 0.0 110.822 -175.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 176.44 118.46 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.414 1.886 . . . . 0.0 108.533 160.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.2 m -97.09 104.4 16.42 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.501 -0.749 . . . . 0.0 110.935 173.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.48 145.07 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.914 1.286 . . . . 0.0 112.221 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 71.8 mt -128.58 -41.38 1.52 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.077 1.751 . . . . 0.0 112.529 -175.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.6 t -151.37 135.71 16.86 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.86 1.264 . . . . 0.0 110.346 175.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 78.6 t -128.16 127.87 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.6 1.16 . . . . 0.0 109.624 171.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -126.95 131.66 23.97 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 124.797 1.239 . . . . 0.0 110.945 172.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -66.71 -24.91 46.99 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.098 2.532 . . . . 0.0 115.349 -176.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -133.81 120.95 21.12 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.108 0.963 . . . . 0.0 112.336 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -150.97 147.24 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.732 2.013 . . . . 0.0 109.369 174.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.8 m -125.95 130.94 52.24 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.852 0.861 . . . . 0.0 111.84 -171.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.3 t -96.65 137.38 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.773 1.629 . . . . 0.0 112.153 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -131.39 126.05 34.17 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.876 1.271 . . . . 0.0 109.472 168.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -67.11 118.08 10.04 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.595 0.758 . . . . 0.0 109.478 166.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.9 pt -85.04 153.7 60.12 Favored Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -166.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -65.94 160.97 41.62 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 123.035 2.49 . . . . 0.0 111.299 159.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -64.8 147.61 89.65 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.024 2.482 . . . . 0.0 113.453 -176.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.3 tpt85 -68.33 154.32 42.0 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.917 1.687 . . . . 0.0 111.844 175.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -143.72 160.99 39.73 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.216 162.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.6 p -82.76 -41.41 19.24 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.943 1.697 . . . . 0.0 113.194 -164.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -92.89 4.01 54.68 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.701 1.6 . . . . 0.0 112.242 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 -112.32 -64.25 1.32 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.553 1.541 . . . . 0.0 111.48 174.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.15 169.36 15.44 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-O 122.585 1.103 . . . . 0.0 111.915 -167.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -70.81 147.5 48.84 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 123.704 0.801 . . . . 0.0 110.288 171.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.4 16.35 3.18 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -171.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.75 -49.04 0.06 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 127.805 2.442 . . . . 0.0 115.673 -176.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.9 m -68.5 -15.58 63.59 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.028 1.731 . . . . 0.0 114.18 -177.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.45 -11.75 59.64 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.8 0.84 . . . . 0.0 112.995 171.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 18.0 m0 -88.61 171.17 10.23 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.136 1.374 . . . . 0.0 110.851 178.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -81.42 55.52 2.63 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.21 1.404 . . . . 0.0 114.095 -174.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.5 mt -61.14 -14.6 25.97 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -171.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -108.83 -3.46 17.66 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.609 1.163 . . . . 0.0 113.033 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -148.71 71.33 10.54 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 125.151 1.38 . . . . 0.0 112.105 177.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -56.46 144.39 84.03 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.131 2.554 . . . . 0.0 112.307 173.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -70.22 -29.85 66.79 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.378 1.071 . . . . 0.0 111.689 175.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 38.8 t90 -156.84 152.48 26.9 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.554 1.542 . . . . 0.0 110.559 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.2 p -134.03 150.77 51.23 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.691 0.796 . . . . 0.0 111.869 168.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.28 -143.62 6.31 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 123.129 0.395 . . . . 0.0 113.542 -176.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 36.7 mtm105 -105.74 149.37 26.49 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.597 1.959 . . . . 0.0 112.135 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.5 tp -90.37 138.68 31.35 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.707 1.203 . . . . 0.0 109.755 162.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.8 ttp85 -144.1 91.44 2.21 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.17 0.988 . . . . 0.0 110.731 162.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.469 HD11 ' CD2' ' A' ' 119' ' ' PHE . 15.2 mt -72.06 131.93 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 170.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.41 174.91 10.01 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 127.364 2.265 . . . . 0.0 110.564 -177.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.6 p -158.32 153.31 25.26 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 120.721 -1.237 . . . . 0.0 111.562 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -158.76 128.61 5.77 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.242 1.017 . . . . 0.0 112.085 159.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.59 53.65 37.08 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.452 1.025 . . . . 0.0 114.902 163.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt 61.99 24.25 14.41 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 126.292 1.837 . . . . 0.0 113.909 -175.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.5 m -123.7 132.26 53.79 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.659 1.584 . . . . 0.0 108.726 165.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.17 157.55 16.5 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.219 1.008 . . . . 0.0 110.162 166.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -136.54 107.62 6.75 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.501 1.521 . . . . 0.0 109.22 -175.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.5 mp -81.18 96.38 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 168.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -95.93 136.83 35.85 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.268 0.556 . . . . 0.0 111.516 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.6 mp -110.36 133.46 53.24 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 126.238 1.815 . . . . 0.0 109.4 174.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -139.6 154.05 47.5 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.854 0.862 . . . . 0.0 111.946 -169.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -74.88 148.77 39.87 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 120.974 -1.079 . . . . 0.0 112.311 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.1 pttt -89.08 -1.35 58.06 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.9 1.68 . . . . 0.0 114.986 -178.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 80.3 t -127.83 -41.8 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.152 1.381 . . . . 0.0 111.951 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.1 p -96.15 -27.42 15.05 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.53 1.059 . . . . 0.0 113.289 175.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.58 8.59 87.15 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-O 119.346 -0.697 . . . . 0.0 113.8 -170.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -68.75 151.34 46.78 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.622 1.211 . . . . 0.0 111.886 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.4 tp -72.66 125.96 28.74 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.638 -0.664 . . . . 0.0 110.683 176.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -86.37 -55.02 4.1 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.133 0.973 . . . . 0.0 111.063 171.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.8 159.56 36.87 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.66 1.184 . . . . 0.0 111.651 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -140.3 133.97 30.31 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.47 0.708 . . . . 0.0 112.576 175.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.74 103.24 53.91 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 125.108 1.363 . . . . 0.0 111.257 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -74.65 141.72 28.11 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.566 2.844 . . . . 0.0 111.728 173.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.5 t -134.94 125.38 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.68 1.992 . . . . 0.0 109.07 -174.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -90.04 -23.51 21.43 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -161.86 150.03 15.02 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.67 1.988 . . . . 0.0 110.151 171.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -122.85 127.56 25.69 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 124.537 1.135 . . . . 0.0 110.973 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -62.18 147.72 55.53 Favored 'Cis proline' 0 CA--C 1.541 0.869 0 CA-C-N 119.991 1.033 . . . . 0.0 114.392 -5.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.37 -166.68 18.81 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.919 1.723 . . . . 0.0 112.392 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.0 tt -69.52 -37.39 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 121.607 -0.937 . . . . 0.0 112.873 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.83 6.66 23.71 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -165.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.6 t -150.4 130.71 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.481 1.512 . . . . 0.0 110.063 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -140.32 161.34 37.92 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.282 1.833 . . . . 0.0 112.316 177.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.2 p -107.96 160.98 15.35 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.6 1.96 . . . . 0.0 111.735 177.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.1 m -87.01 173.33 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.212 1.005 . . . . 0.0 110.879 163.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 73.9 p -104.56 -23.3 13.14 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.485 1.514 . . . . 0.0 113.921 -176.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -99.87 -39.29 8.26 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -171.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.9 t -134.03 117.27 16.48 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -173.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.0 m -72.48 24.82 0.05 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 115.956 1.835 . . . . 0.0 115.956 -169.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.4 ptt85 -131.42 27.08 4.77 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.507 1.923 . . . . 0.0 113.995 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -140.09 141.28 36.18 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.671 1.589 . . . . 0.0 111.441 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -140.14 162.11 36.03 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.03 1.332 . . . . 0.0 111.54 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.9 t -116.96 142.85 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.596 1.158 . . . . 0.0 108.997 167.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.21 148.09 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 173.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -87.94 84.68 6.96 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.976 0.911 . . . . 0.0 110.717 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -68.3 141.03 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 120.816 0.341 . . . . 0.0 110.582 173.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -135.19 149.76 50.0 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.302 1.441 . . . . 0.0 111.78 -169.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -95.72 11.25 34.09 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.612 1.165 . . . . 0.0 113.108 -176.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.35 3.55 88.66 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.3 1.428 . . . . 0.0 115.412 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.1 t -125.28 2.57 7.81 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.726 1.611 . . . . 0.0 113.603 -176.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.01 -9.16 65.55 Favored Glycine 0 N--CA 1.478 1.439 0 C-N-CA 125.569 1.557 . . . . 0.0 113.979 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -68.35 131.86 46.06 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 127.364 2.266 . . . . 0.0 108.61 164.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 82.3 p -150.51 163.79 37.57 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -173.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.54 147.67 41.53 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.539 1.536 . . . . 0.0 110.612 164.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -92.83 116.75 29.32 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 167.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.1 pt -117.62 144.11 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.474 1.109 . . . . 0.0 110.937 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.73 142.08 15.92 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 175.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.4 pt -127.15 140.14 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 125.478 1.511 . . . . 0.0 111.661 172.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -119.94 141.35 15.35 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.798 1.189 . . . . 0.0 113.511 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -109.06 153.85 23.06 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.488 1.915 . . . . 0.0 110.792 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.3 t -73.0 -23.16 60.6 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.616 0.766 . . . . 0.0 112.784 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -155.54 151.06 27.17 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.446 1.098 . . . . 0.0 111.62 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.33 -33.05 70.65 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.904 0.882 . . . . 0.0 112.732 177.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.0 -19.25 63.32 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-N 118.979 0.808 . . . . 0.0 114.59 177.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -94.83 -37.31 11.28 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.689 1.244 . . . . 0.0 111.694 176.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.42 -29.14 68.8 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.135 0.974 . . . . 0.0 112.929 166.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . 0.262 19.8 m-85 -92.51 19.39 7.33 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.571 1.548 . . . . 0.0 114.112 170.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -99.71 -38.7 8.59 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.551 -0.718 . . . . 0.0 111.295 142.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.469 ' CD2' HD11 ' A' ' 49' ' ' ILE . 36.9 t80 -54.3 -57.72 10.14 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.58 1.082 . . . . 0.0 112.927 178.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -80.42 -22.74 40.91 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.256 -0.902 . . . . 0.0 113.345 -174.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 93.7 t -81.48 -39.2 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.412 0.685 . . . . 0.0 110.803 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 95.1 p -65.46 -31.42 72.49 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.566 -0.709 . . . . 0.0 112.848 173.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 72.0 mt -69.54 -52.65 24.4 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.189 0.995 . . . . 0.0 111.951 172.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -67.67 -29.03 68.22 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 120.971 -1.081 . . . . 0.0 112.823 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -82.77 -3.0 56.0 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.507 1.123 . . . . 0.0 112.916 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -90.15 -29.25 18.4 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.165 -0.96 . . . . 0.0 112.547 166.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -101.75 -4.15 26.91 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -176.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.2 -28.54 58.65 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -176.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 33.1 p-90 -84.69 -23.49 29.36 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.554 1.142 . . . . 0.0 113.44 176.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 22.0 t -82.26 -30.69 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.562 1.545 . . . . 0.0 111.062 175.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -96.21 30.01 2.63 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.888 2.075 . . . . 0.0 112.859 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -79.44 90.45 5.05 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.859 0.838 . . . . 0.0 109.945 171.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 C--O 1.252 1.188 0 C-N-CA 126.861 2.064 . . . . 0.0 112.7 -172.156 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.57 0 N-CA-C 111.656 -0.577 . . . . 0.0 111.656 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 44.1 m -70.95 138.59 85.14 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 123.886 0.875 . . . . 0.0 112.84 -174.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -69.15 -29.09 27.35 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.979 2.453 . . . . 0.0 112.688 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -66.86 -19.77 65.8 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.143 0.977 . . . . 0.0 112.957 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 28.5 m -99.48 -5.98 28.37 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.456 1.502 . . . . 0.0 113.718 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt 49.04 51.58 15.94 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.631 1.572 . . . . 0.0 112.353 -176.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.35 -6.62 14.94 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.157 1.383 . . . . 0.0 113.585 -165.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.1 m -134.9 72.64 1.46 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.888 1.675 . . . . 0.0 108.498 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -127.76 28.12 5.65 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.164 1.786 . . . . 0.0 112.628 -170.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 tt -60.98 115.35 3.66 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.32 1.848 . . . . 0.0 111.586 -174.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -146.07 56.09 1.18 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.141 1.376 . . . . 0.0 110.662 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -150.09 148.09 28.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.45 1.5 . . . . 0.0 110.738 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 173.5 105.66 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.786 2.434 . . . . 0.0 107.555 162.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.8 m -86.57 120.58 28.04 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.592 0.757 . . . . 0.0 111.684 -172.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -72.34 149.67 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.825 1.25 . . . . 0.0 113.855 -171.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.5 mt -134.07 -38.6 0.87 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.05 1.74 . . . . 0.0 112.425 -171.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 39.0 t -152.59 139.52 19.08 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.89 1.276 . . . . 0.0 110.588 172.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 79.1 t -131.71 127.55 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.697 1.199 . . . . 0.0 109.28 171.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -129.21 135.24 27.29 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 125.207 1.403 . . . . 0.0 110.524 173.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.66 -18.46 13.52 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.987 2.458 . . . . 0.0 114.975 -172.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -129.65 109.42 10.97 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.5 1.12 . . . . 0.0 111.146 -175.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.7 p -143.05 141.37 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.721 1.609 . . . . 0.0 110.028 171.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.3 m -123.33 125.36 44.87 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.265 1.026 . . . . 0.0 111.371 -171.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.6 t -92.16 137.82 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.142 1.377 . . . . 0.0 112.201 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -127.31 123.3 36.05 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.277 1.431 . . . . 0.0 108.621 168.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -68.96 109.3 3.88 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 164.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.415 HD12 ' CE2' ' A' ' 31' ' ' TYR . 35.4 pt -80.87 156.08 72.66 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 124.425 1.09 . . . . 0.0 113.819 -166.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -61.68 161.22 25.53 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 122.729 2.286 . . . . 0.0 111.405 158.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -60.39 150.09 82.58 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.788 2.325 . . . . 0.0 112.336 175.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 21.6 ttm105 -61.56 150.05 37.22 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.707 1.203 . . . . 0.0 111.837 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.48 172.15 0.94 Allowed 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 122.307 1.051 . . . . 0.0 112.539 162.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 79.5 p -87.59 -31.31 19.92 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.006 1.322 . . . . 0.0 113.049 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -137.97 6.18 2.63 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.815 1.646 . . . . 0.0 113.794 -174.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 -115.06 -57.75 2.22 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.735 1.214 . . . . 0.0 113.646 -176.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.34 -123.17 5.69 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -161.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.415 ' CE2' HD12 ' A' ' 22' ' ' ILE . 28.6 m-85 -134.68 155.57 50.3 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 127.617 2.367 . . . . 0.0 109.966 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.528 ' H ' ' HD3' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -123.31 131.09 53.54 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 163.139 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.18 -33.73 63.24 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.454 1.102 . . . . 0.0 113.215 -172.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.7 p -65.44 -13.26 58.35 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 175.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.29 -10.25 58.63 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.054 0.942 . . . . 0.0 112.704 170.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 22.8 m0 -94.68 171.71 8.62 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.629 1.572 . . . . 0.0 111.835 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -79.22 47.52 0.8 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.16 1.784 . . . . 0.0 114.177 -176.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.7 mt -54.72 -34.86 63.02 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -167.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -93.77 -2.41 53.72 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.95 0.9 . . . . 0.0 113.321 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -145.89 66.85 12.0 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 125.992 1.717 . . . . 0.0 111.747 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -55.91 144.02 79.69 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.282 2.654 . . . . 0.0 112.84 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -73.86 -27.81 61.26 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.45 1.1 . . . . 0.0 111.73 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 40.7 t90 -153.17 152.48 31.3 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.656 1.582 . . . . 0.0 110.663 170.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.5 p -134.56 143.17 47.24 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.964 0.906 . . . . 0.0 111.864 171.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.15 -144.63 5.4 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 114.556 0.582 . . . . 0.0 114.556 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -107.9 144.3 35.34 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.507 1.923 . . . . 0.0 111.035 -172.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 42.9 tp -91.56 138.44 31.57 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.652 1.581 . . . . 0.0 110.119 170.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -144.26 99.53 3.39 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.685 1.194 . . . . 0.0 110.57 170.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.48 HD11 ' CD2' ' A' ' 119' ' ' PHE . 18.4 mt -86.31 132.96 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.604 1.162 . . . . 0.0 108.624 174.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.12 171.28 14.3 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.167 1.787 . . . . 0.0 111.279 -170.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.8 t -156.21 149.06 24.03 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.796 -1.19 . . . . 0.0 112.555 173.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -150.86 132.76 15.1 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.724 152.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.47 58.45 5.45 Favored Glycine 0 N--CA 1.474 1.192 0 C-N-CA 124.752 1.168 . . . . 0.0 114.466 166.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 56.52 27.3 12.07 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 126.203 1.801 . . . . 0.0 113.174 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.7 m -137.93 121.83 17.72 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.655 1.582 . . . . 0.0 108.536 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -90.33 158.57 17.08 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.842 0.857 . . . . 0.0 110.513 171.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -139.34 99.52 3.76 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.318 1.847 . . . . 0.0 108.628 -173.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.3 mp -79.65 103.66 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 168.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 50.6 mttt -105.12 141.18 37.13 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.939 0.876 . . . . 0.0 111.732 174.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.8 mp -108.9 133.01 53.49 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 126.301 1.84 . . . . 0.0 109.785 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -132.2 147.19 52.41 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.942 0.897 . . . . 0.0 112.499 -168.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -66.33 140.81 58.12 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.882 0.873 . . . . 0.0 112.717 -175.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.274 0.0 OUTLIER -77.59 -5.22 49.48 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 -174.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.6 t -112.46 -48.59 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.93 1.292 . . . . 0.0 111.107 170.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.8 m -99.54 -16.75 18.18 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -167.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.87 12.43 74.8 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.658 1.123 . . . . 0.0 113.994 -176.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -82.78 152.09 25.84 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.078 1.351 . . . . 0.0 112.322 -174.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.7 122.16 19.31 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.959 0.903 . . . . 0.0 112.074 -169.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -86.1 -54.91 4.19 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.217 1.007 . . . . 0.0 111.098 168.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.58 161.61 38.73 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.895 1.278 . . . . 0.0 111.771 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -141.22 134.88 30.1 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.722 1.209 . . . . 0.0 112.065 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.86 100.68 48.5 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.955 1.302 . . . . 0.0 111.405 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -65.1 139.07 59.36 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 124.292 3.328 . . . . 0.0 112.422 167.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.4 t -135.8 129.68 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.73 1.612 . . . . 0.0 109.659 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -89.71 -23.52 21.8 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.75 150.05 13.38 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.15 1.78 . . . . 0.0 110.391 172.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -126.12 132.19 24.23 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.526 1.13 . . . . 0.0 112.131 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -63.57 144.66 53.94 Favored 'Cis proline' 0 CA--C 1.54 0.814 0 CA-C-N 119.71 0.932 . . . . 0.0 113.772 -6.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -169.59 -173.26 36.97 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.606 1.098 . . . . 0.0 114.116 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.6 tp -54.86 -36.72 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -166.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.55 8.35 39.25 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -171.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.4 t -148.33 129.12 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.307 1.043 . . . . 0.0 111.221 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -138.11 162.52 33.97 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.282 1.833 . . . . 0.0 112.218 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 65.8 p -112.49 161.28 16.91 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.628 1.971 . . . . 0.0 111.388 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.4 m -89.57 173.1 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.841 0.857 . . . . 0.0 111.453 166.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 46.5 p -99.05 -24.9 14.73 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 174.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -81.21 -42.69 20.38 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -171.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.2 t -156.76 134.44 10.86 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.0 m -72.99 22.15 0.07 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -174.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.482 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.26 5.1 ptm180 -108.73 19.67 19.4 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.011 1.724 . . . . 0.0 114.043 173.268 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -142.53 135.5 28.38 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.029 1.331 . . . . 0.0 110.412 -174.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -135.95 164.49 27.85 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.975 1.31 . . . . 0.0 111.103 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.2 t -117.72 142.96 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.705 1.202 . . . . 0.0 108.418 166.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.89 147.13 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 118.664 0.665 . . . . 0.0 112.14 172.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -87.75 86.67 7.2 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.507 0.723 . . . . 0.0 110.449 176.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -69.04 140.32 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.575 0.226 . . . . 0.0 110.8 175.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -137.03 144.73 43.38 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.762 1.625 . . . . 0.0 111.792 -170.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -94.48 11.43 30.8 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.479 1.112 . . . . 0.0 113.265 -175.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.87 6.69 85.82 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 125.122 1.344 . . . . 0.0 115.358 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.3 t -128.56 0.42 5.56 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 125.728 1.611 . . . . 0.0 113.828 -173.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.94 -7.1 60.49 Favored Glycine 0 N--CA 1.478 1.453 0 C-N-CA 125.484 1.516 . . . . 0.0 113.974 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -72.96 129.37 37.96 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 127.162 2.185 . . . . 0.0 108.451 164.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 76.8 p -152.47 161.06 43.11 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -173.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.11 147.46 30.6 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.465 1.506 . . . . 0.0 111.234 171.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -90.92 117.99 29.96 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.396 0.678 . . . . 0.0 109.472 168.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.4 pt -116.93 143.19 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.567 1.147 . . . . 0.0 111.027 177.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.25 144.06 17.72 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 174.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.0 pt -128.9 139.61 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 C-N-CA 125.59 1.556 . . . . 0.0 111.641 171.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.68 142.14 15.53 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 125.663 1.601 . . . . 0.0 112.725 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -105.25 163.63 12.45 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.419 1.488 . . . . 0.0 111.298 -177.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.7 t -76.32 -24.65 54.31 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 177.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -156.19 151.14 26.25 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.402 1.081 . . . . 0.0 111.636 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -62.62 -32.69 73.75 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.087 0.955 . . . . 0.0 113.151 178.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.24 -30.09 76.92 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 118.942 0.792 . . . . 0.0 113.646 175.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -82.84 -36.49 25.42 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.119 0.96 . . . . 0.0 111.918 175.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.482 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -64.2 -31.77 73.09 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 169.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -61.25 -33.75 74.04 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.098 -1.001 . . . . 0.0 112.508 171.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -70.36 -32.72 70.54 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.835 1.198 . . . . 0.0 112.846 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.48 ' CD2' HD11 ' A' ' 49' ' ' ILE . 9.6 t80 -57.64 -43.85 85.18 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.029 0.831 . . . . 0.0 111.329 170.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -81.28 -35.59 30.91 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.532 1.133 . . . . 0.0 113.496 -175.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.5 t -76.78 -40.5 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 O-C-N 121.245 -0.909 . . . . 0.0 111.519 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 85.4 p -63.67 -27.41 69.2 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 83.8 mt -75.38 -55.51 5.62 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.018 0.927 . . . . 0.0 111.534 171.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -66.83 -30.71 70.97 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.09 -1.006 . . . . 0.0 113.484 -172.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -90.91 4.38 52.04 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.8 1.64 . . . . 0.0 112.716 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -97.67 -33.12 11.43 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.304 -0.872 . . . . 0.0 112.276 163.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -89.96 -2.37 58.14 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.61 -34.08 64.56 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 121.18 1.809 . . . . 0.0 115.09 -174.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 28.7 p-90 -75.43 -30.93 60.17 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.827 0.851 . . . . 0.0 112.799 175.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.6 t -71.61 -35.4 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.58 1.152 . . . . 0.0 110.587 172.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -78.39 -2.44 38.32 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.024 1.73 . . . . 0.0 114.909 171.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 51.05 28.8 4.12 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 128.061 2.544 . . . . 0.0 115.353 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 . . . . . 0 C--O 1.252 1.227 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -178.79 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.473 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 25.9 p -80.79 156.18 72.8 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 124.722 1.209 . . . . 0.0 112.957 177.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.08 99.88 1.15 Allowed 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.251 2.634 . . . . 0.0 111.098 178.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -101.94 -6.58 23.31 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.708 1.203 . . . . 0.0 113.847 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 53.7 p -64.42 -17.06 63.44 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -176.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -76.85 -2.2 32.19 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.416 1.486 . . . . 0.0 113.697 173.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.7 -46.11 0.54 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.755 1.622 . . . . 0.0 111.934 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.7 m -80.3 66.26 5.74 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.32 1.448 . . . . 0.0 108.597 164.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -91.01 84.06 5.7 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.998 0.919 . . . . 0.0 112.545 -158.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 pp -125.77 142.8 51.34 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.832 1.253 . . . . 0.0 111.255 165.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -138.34 50.85 1.87 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.515 1.526 . . . . 0.0 109.856 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -135.41 136.99 41.83 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.608 1.163 . . . . 0.0 109.622 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -174.47 131.53 0.36 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.077 1.751 . . . . 0.0 108.151 162.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.6 m -92.46 109.39 20.78 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.101 0.961 . . . . 0.0 108.526 167.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.6 t -69.99 143.05 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 O-C-N 121.305 -0.872 . . . . 0.0 111.673 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.5 mt -126.88 -41.75 1.8 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.572 1.549 . . . . 0.0 112.293 -174.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.4 t -153.92 135.39 14.24 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.229 1.012 . . . . 0.0 111.245 173.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.1 t -128.31 127.33 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.677 1.191 . . . . 0.0 109.014 171.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -131.07 137.43 30.7 Favored Pre-proline 0 N--CA 1.475 0.81 0 C-N-CA 125.408 1.483 . . . . 0.0 110.65 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.53 -18.57 22.59 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.217 2.611 . . . . 0.0 113.689 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -109.08 122.64 47.7 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.025 1.33 . . . . 0.0 112.152 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.0 p -154.72 143.25 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.803 1.241 . . . . 0.0 109.585 157.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.7 p -127.32 144.14 51.1 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.071 1.348 . . . . 0.0 110.586 177.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.4 t -113.41 130.22 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.931 1.292 . . . . 0.0 111.113 -177.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.67 118.17 14.81 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.418 1.487 . . . . 0.0 108.976 173.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 -69.45 132.45 46.35 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.893 0.877 . . . . 0.0 109.943 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.3 pt -86.87 151.46 52.28 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -160.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -65.08 167.91 15.11 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 123.996 3.131 . . . . 0.0 112.121 171.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -63.81 98.21 0.24 Allowed 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.392 2.728 . . . . 0.0 111.28 173.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.2 mmt-85 -149.07 161.74 41.33 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 127.503 2.321 . . . . 0.0 110.562 -177.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -135.27 161.51 35.2 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.926 1.69 . . . . 0.0 111.072 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.4 t -55.59 -39.34 70.59 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.356 1.462 . . . . 0.0 113.026 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -76.22 -8.42 57.01 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 177.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -108.44 -25.13 11.12 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.196 1.798 . . . . 0.0 112.524 175.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.64 106.56 0.8 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.857 1.218 . . . . 0.0 113.242 166.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -61.57 142.35 57.16 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.309 1.044 . . . . 0.0 109.944 164.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.77 15.96 8.07 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 -174.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 55.84 -48.15 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.825 2.85 . . . . 0.0 116.156 -173.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 90.7 p -64.53 -17.77 64.21 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.095 1.758 . . . . 0.0 114.466 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -85.84 -4.79 59.25 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.445 1.498 . . . . 0.0 112.633 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.8 m0 -93.44 168.52 11.0 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.085 1.754 . . . . 0.0 110.635 175.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -78.13 49.7 0.84 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.659 1.584 . . . . 0.0 114.041 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 45.7 mt -56.46 -36.07 68.64 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -172.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -92.8 -2.68 55.73 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.237 1.015 . . . . 0.0 113.232 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -141.6 70.32 25.7 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 125.521 1.528 . . . . 0.0 111.726 177.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.85 147.37 73.42 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.144 2.563 . . . . 0.0 113.16 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -74.03 -27.94 61.18 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.158 0.983 . . . . 0.0 111.535 169.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 57.7 t90 -158.15 155.01 28.35 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.399 1.88 . . . . 0.0 110.884 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.1 p -136.72 149.9 48.13 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.666 1.186 . . . . 0.0 112.024 169.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.69 -142.49 4.6 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 123.319 0.485 . . . . 0.0 113.825 -177.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -118.91 148.74 42.6 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.849 2.06 . . . . 0.0 111.558 -175.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.1 tp -89.15 140.42 29.48 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.54 1.536 . . . . 0.0 110.626 174.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -141.01 93.36 2.58 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.519 1.127 . . . . 0.0 110.567 162.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.471 HD11 ' CD2' ' A' ' 119' ' ' PHE . 23.1 mt -76.65 127.24 37.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 166.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.1 p -138.31 171.71 13.98 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 126.919 2.088 . . . . 0.0 110.153 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.8 p -152.81 166.09 33.34 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 125.014 1.326 . . . . 0.0 112.185 174.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -148.68 121.25 8.56 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.243 0.544 . . . . 0.0 111.326 154.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.33 -118.43 9.32 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 125.232 1.396 . . . . 0.0 110.211 -176.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -101.48 20.16 16.55 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.331 1.852 . . . . 0.0 113.714 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.4 m -127.47 128.15 45.25 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.704 1.202 . . . . 0.0 109.957 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.65 160.8 14.03 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.552 1.141 . . . . 0.0 111.157 170.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -141.21 107.13 5.15 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.733 2.013 . . . . 0.0 108.802 -174.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -83.99 94.56 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 168.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -88.58 136.67 32.88 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.86 0.864 . . . . 0.0 110.805 174.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.3 mp -111.98 131.2 55.55 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.143 1.777 . . . . 0.0 110.111 174.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -132.67 147.56 52.33 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.858 0.863 . . . . 0.0 113.177 -170.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -67.8 135.39 52.54 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.367 1.067 . . . . 0.0 111.329 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.7 pttt -76.05 -5.2 45.35 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -175.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 85.6 t -120.26 -43.17 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 125.03 1.332 . . . . 0.0 111.47 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.5 m -93.82 -19.71 20.76 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.32 13.5 76.97 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.487 1.041 . . . . 0.0 113.693 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -90.58 152.16 21.01 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.241 1.416 . . . . 0.0 112.295 -173.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.5 tp -72.47 128.34 35.29 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.491 -0.756 . . . . 0.0 111.666 -175.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -85.35 -58.25 2.75 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.55 1.14 . . . . 0.0 110.778 169.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.68 165.44 36.25 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.042 1.737 . . . . 0.0 110.12 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -146.35 146.22 30.59 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 169.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.34 107.2 49.74 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.333 1.453 . . . . 0.0 111.665 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -67.92 144.47 64.66 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.838 3.026 . . . . 0.0 111.988 169.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.2 t -139.23 126.52 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.46 1.504 . . . . 0.0 109.414 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -95.45 -19.96 19.45 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -160.56 145.49 14.43 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.733 2.013 . . . . 0.0 110.081 171.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -126.22 127.67 24.6 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 124.697 1.199 . . . . 0.0 110.488 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -64.47 146.96 67.06 Favored 'Cis proline' 0 CA--C 1.542 0.899 0 CA-C-N 120.073 1.062 . . . . 0.0 113.434 -2.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.65 -156.94 8.74 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.721 1.629 . . . . 0.0 112.642 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.6 tt -79.33 -41.89 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -176.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.59 8.0 15.57 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -165.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 23.5 t -153.02 130.45 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 126.363 1.865 . . . . 0.0 109.122 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.17 158.72 44.24 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.871 1.268 . . . . 0.0 113.067 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.0 p -104.73 161.6 14.02 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.506 1.522 . . . . 0.0 112.182 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.3 m -90.72 173.27 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.81 1.244 . . . . 0.0 110.806 167.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.6 p -96.79 -29.4 13.78 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.31 1.444 . . . . 0.0 113.384 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -91.32 -43.1 9.99 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -169.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.7 t -143.32 124.48 14.52 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -176.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -67.29 -7.89 27.87 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.297 1.592 . . . . 0.0 115.297 -169.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.443 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.32 44.9 ptt85 -84.91 21.3 1.62 Allowed 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -179.338 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -142.86 140.02 31.09 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.814 1.646 . . . . 0.0 111.868 -174.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -142.62 149.36 38.86 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.435 1.494 . . . . 0.0 112.512 -176.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.9 t -92.4 142.35 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 161.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.26 149.65 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 119.348 0.977 . . . . 0.0 111.949 164.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.478 ' HE ' ' NE2' ' A' ' 97' ' ' GLN . 41.1 ttp180 -93.04 95.72 9.63 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.706 0.803 . . . . 0.0 110.259 174.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -76.91 150.98 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.301 0.64 . . . . 0.0 111.705 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.478 ' NE2' ' HE ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -124.93 150.41 46.61 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.901 1.68 . . . . 0.0 110.395 174.367 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -94.55 3.66 54.84 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.403 1.081 . . . . 0.0 113.085 175.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.68 12.45 82.84 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.273 1.416 . . . . 0.0 114.822 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.5 t -137.79 15.97 2.89 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.476 1.51 . . . . 0.0 113.371 -172.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.7 -1.58 78.78 Favored Glycine 0 CA--C 1.537 1.442 0 O-C-N 120.609 -1.307 . . . . 0.0 114.904 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -77.06 138.8 39.78 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.481 1.513 . . . . 0.0 108.927 165.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 84.7 p -143.63 157.34 44.48 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 166.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.59 142.45 27.98 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.671 1.188 . . . . 0.0 111.276 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -87.66 117.54 26.55 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.378 0.671 . . . . 0.0 109.537 168.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.9 pt -118.56 147.61 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.888 1.275 . . . . 0.0 110.761 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.7 136.32 12.9 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.5 pt -127.66 159.77 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 125.008 1.323 . . . . 0.0 112.067 171.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -154.38 168.82 32.68 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-O 122.039 0.799 . . . . 0.0 114.513 173.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -121.77 157.41 31.08 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 126.08 1.752 . . . . 0.0 111.797 -171.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.7 t -70.01 -19.34 63.33 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.055 0.942 . . . . 0.0 112.592 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -154.79 150.76 27.88 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.197 0.999 . . . . 0.0 111.921 -176.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 35.6 ttt-85 -61.32 -31.62 71.48 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.694 1.198 . . . . 0.0 113.276 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.27 -29.33 75.02 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-N 119.102 0.865 . . . . 0.0 113.976 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -82.53 -34.67 27.8 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.455 -1.026 . . . . 0.0 111.642 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.443 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -67.67 -30.51 70.06 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.26 1.024 . . . . 0.0 113.388 167.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -61.5 -47.48 85.42 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.446 -0.784 . . . . 0.0 110.797 168.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -62.31 -36.92 83.64 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.386 0.993 . . . . 0.0 112.876 175.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.471 ' CD2' HD11 ' A' ' 49' ' ' ILE . 35.2 t80 -55.55 -55.76 28.13 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.224 0.92 . . . . 0.0 112.263 173.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -81.34 -27.3 35.01 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.114 1.154 . . . . 0.0 114.114 -174.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 73.0 t -76.3 -38.8 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 O-C-N 121.45 -0.781 . . . . 0.0 111.181 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 93.5 p -65.05 -30.98 71.98 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.152 0.887 . . . . 0.0 112.988 175.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.5 mt -68.43 -54.99 13.45 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.265 1.026 . . . . 0.0 111.761 171.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -67.27 -26.74 66.71 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 120.988 -1.07 . . . . 0.0 113.007 -176.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -81.78 -3.87 54.95 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.874 1.27 . . . . 0.0 112.713 174.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -91.53 -25.13 19.39 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.681 -1.262 . . . . 0.0 112.446 163.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -100.29 -6.76 25.42 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 116.007 1.855 . . . . 0.0 116.007 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.98 -24.99 41.95 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -174.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 38.1 p-90 -90.2 -17.48 27.47 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.494 1.517 . . . . 0.0 113.967 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.5 t -80.0 -26.68 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.635 1.174 . . . . 0.0 112.227 -171.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? -112.33 59.96 0.63 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.715 1.606 . . . . 0.0 109.864 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -125.33 113.92 18.22 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.156 1.382 . . . . 0.0 109.126 174.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 C--O 1.254 1.33 0 C-N-CA 126.257 1.823 . . . . 0.0 112.666 -171.464 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.688 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 15.9 m -48.48 -43.98 63.37 Favored Pre-proline 0 N--CA 1.477 0.92 0 N-CA-C 117.796 2.517 . . . . 0.0 117.796 -168.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -66.07 -11.8 32.68 Favored 'Trans proline' 0 C--N 1.356 0.948 0 CA-C-N 122.745 2.016 . . . . 0.0 114.826 -175.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -69.92 -22.42 63.2 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.238 -0.914 . . . . 0.0 112.904 173.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 68.3 m -66.8 -28.93 68.77 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.305 -0.872 . . . . 0.0 112.877 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -72.88 2.21 7.23 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.651 1.581 . . . . 0.0 113.933 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.36 -28.29 47.11 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.696 1.198 . . . . 0.0 113.059 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 41.6 p -135.63 -41.22 0.7 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.785 1.634 . . . . 0.0 111.927 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 61.27 21.87 12.3 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.661 1.984 . . . . 0.0 115.637 164.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.48 36.62 2.23 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -153.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -80.85 55.38 2.4 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.424 1.49 . . . . 0.0 112.192 -178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -153.7 157.38 39.44 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 126.48 1.912 . . . . 0.0 110.717 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -176.49 78.78 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 127.77 2.428 . . . . 0.0 109.491 -174.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.65 126.55 30.89 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.021 -1.05 . . . . 0.0 112.883 -160.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.3 t -70.96 141.1 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 O-C-N 121.138 -0.976 . . . . 0.0 112.971 -168.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.3 mt -122.7 -41.77 2.35 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.874 1.67 . . . . 0.0 112.495 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 33.6 t -152.42 132.31 13.32 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.545 1.138 . . . . 0.0 110.596 175.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 72.6 t -127.94 127.07 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.546 1.138 . . . . 0.0 109.744 172.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -133.17 143.03 46.64 Favored Pre-proline 0 N--CA 1.474 0.737 0 C-N-CA 124.853 1.261 . . . . 0.0 111.683 173.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.02 -17.42 22.25 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.51 2.807 . . . . 0.0 115.098 -174.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -134.25 110.81 9.77 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.118 0.967 . . . . 0.0 112.21 -169.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -149.36 146.37 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 126.324 1.85 . . . . 0.0 109.739 171.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.3 m -125.27 131.59 53.06 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.058 0.943 . . . . 0.0 111.573 -171.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.1 t -98.9 139.97 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 126.028 1.731 . . . . 0.0 112.054 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -127.59 132.38 49.83 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.71 1.604 . . . . 0.0 108.968 169.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 48.0 mtm180 -70.05 139.29 52.61 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 155.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.8 pt -125.99 156.53 71.58 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 125.16 1.384 . . . . 0.0 112.95 -163.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -64.25 161.62 33.41 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 123.343 2.696 . . . . 0.0 112.622 170.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -65.59 108.25 1.19 Allowed 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.439 2.759 . . . . 0.0 111.52 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.5 mmt-85 -148.59 175.79 10.88 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.985 1.714 . . . . 0.0 112.594 -177.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -148.62 162.83 38.92 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 128.482 2.713 . . . . 0.0 108.57 176.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.3 t -59.48 -38.04 79.8 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 120.564 -1.335 . . . . 0.0 112.349 174.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -76.32 1.79 15.18 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.838 1.255 . . . . 0.0 113.717 174.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 77.7 mmt-85 -124.03 -19.33 5.66 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.758 2.023 . . . . 0.0 113.327 176.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.05 92.76 1.12 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.717 1.627 . . . . 0.0 114.796 165.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -61.95 141.5 57.99 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 146.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.27 22.9 4.81 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.284 1.434 . . . . 0.0 113.021 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 56.64 -46.94 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 128.471 2.709 . . . . 0.0 115.304 -170.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.4 m -64.82 -13.43 55.82 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.552 1.941 . . . . 0.0 114.276 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -78.57 -4.6 49.56 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.405 1.482 . . . . 0.0 113.588 170.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 10.6 m0 -107.0 167.83 9.62 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.655 1.582 . . . . 0.0 111.425 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -78.01 53.67 1.21 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.02 1.728 . . . . 0.0 113.589 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.9 mt -55.56 -32.6 63.14 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -170.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -87.63 -6.82 58.1 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.068 0.947 . . . . 0.0 113.085 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -140.19 59.29 12.35 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 126.886 2.075 . . . . 0.0 111.183 -160.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -65.04 139.61 62.03 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 CA-C-N 119.593 0.89 . . . . 0.0 112.424 -171.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -74.46 -26.64 60.17 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.207 1.003 . . . . 0.0 111.717 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 39.4 t90 -153.6 153.57 32.59 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.887 1.675 . . . . 0.0 110.71 169.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 56.0 p -135.88 148.38 48.58 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.486 1.114 . . . . 0.0 112.091 171.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 173.09 -144.13 7.64 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 123.017 0.341 . . . . 0.0 113.852 177.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.4 mtm180 -98.14 145.48 26.53 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.94 1.696 . . . . 0.0 112.069 -174.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.4 tp -85.61 136.47 33.37 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.584 1.553 . . . . 0.0 109.778 163.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 39.3 ttt-85 -145.68 87.08 1.76 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.626 1.17 . . . . 0.0 110.862 167.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.478 HD11 ' CD1' ' A' ' 119' ' ' PHE . 21.1 mt -71.28 125.59 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 171.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.7 p -128.23 163.91 23.7 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.376 1.87 . . . . 0.0 110.131 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.3 t -163.78 148.73 10.67 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.678 -1.264 . . . . 0.0 110.754 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.511 ' HE3' ' CE1' ' A' ' 57' ' ' TYR . 57.9 mttt -125.21 -126.37 0.24 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.967 1.307 . . . . 0.0 110.037 -172.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.48 94.11 1.69 Allowed Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.293 1.425 . . . . 0.0 112.309 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 54.58 28.54 10.0 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 126.653 1.981 . . . . 0.0 113.635 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.0 m -148.16 118.21 7.23 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.634 1.573 . . . . 0.0 109.35 -174.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -96.0 163.89 12.94 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.057 1.343 . . . . 0.0 111.63 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.511 ' CE1' ' HE3' ' A' ' 52' ' ' LYS . 82.2 m-85 -147.67 107.38 3.96 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.205 1.802 . . . . 0.0 109.298 -174.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.3 mp -80.46 96.11 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 170.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -92.41 138.21 31.71 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.173 0.589 . . . . 0.0 111.475 173.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.1 mp -115.62 134.48 55.01 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.365 1.866 . . . . 0.0 109.911 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -136.09 148.47 48.29 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.962 0.905 . . . . 0.0 112.07 -168.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -71.01 141.05 50.98 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 122.766 1.269 . . . . 0.0 111.643 177.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.623 ' H ' ' CD ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -85.25 1.53 47.84 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 127.007 2.123 . . . . 0.0 116.139 -175.124 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.1 t -116.97 -45.67 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 125.336 1.454 . . . . 0.0 111.014 171.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.2 m -96.71 -20.12 18.47 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -173.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.79 9.69 83.14 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.431 1.015 . . . . 0.0 113.823 -176.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -83.34 149.07 26.96 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.999 1.319 . . . . 0.0 112.186 -174.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.4 tp -70.89 125.45 26.88 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.59 0.756 . . . . 0.0 111.24 -177.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -83.5 -57.82 3.08 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.725 0.81 . . . . 0.0 110.475 167.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.59 163.02 40.69 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.486 1.114 . . . . 0.0 112.071 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -136.39 137.69 40.79 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.469 1.507 . . . . 0.0 110.606 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.81 92.1 49.31 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.291 1.036 . . . . 0.0 111.535 176.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -56.6 139.56 88.16 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 124.649 3.566 . . . . 0.0 113.457 168.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.3 t -138.94 123.99 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 126.58 1.952 . . . . 0.0 109.618 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -88.59 -21.41 24.05 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 121.01 -1.056 . . . . 0.0 113.425 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -160.29 144.94 14.53 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.169 1.788 . . . . 0.0 110.252 170.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -118.34 129.08 25.6 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.493 1.117 . . . . 0.0 110.75 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -66.39 148.23 76.77 Favored 'Cis proline' 0 CA--C 1.542 0.887 0 CA-C-N 119.976 1.027 . . . . 0.0 113.094 -4.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.81 -163.4 15.39 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.529 1.537 . . . . 0.0 113.054 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.4 tt -69.9 -37.42 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 O-C-N 121.797 -0.826 . . . . 0.0 113.191 -175.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.54 7.14 27.35 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -165.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 23.8 t -150.55 125.13 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.478 1.511 . . . . 0.0 109.606 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -139.16 159.83 41.23 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.114 1.766 . . . . 0.0 112.17 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.0 p -114.35 156.06 25.13 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.085 1.754 . . . . 0.0 111.725 -176.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.5 m -85.91 172.09 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.089 0.956 . . . . 0.0 111.114 170.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 70.5 p -96.7 -28.09 14.47 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 178.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -88.62 -43.37 11.41 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.232 0.826 . . . . 0.0 113.232 -168.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.5 t -146.17 125.73 13.28 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.34 1.77 3.56 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -170.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.471 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.286 31.5 ptt180 -86.59 16.59 4.52 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 177.162 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -139.5 137.6 35.65 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.997 1.319 . . . . 0.0 111.102 -173.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -139.07 155.02 48.24 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.979 1.312 . . . . 0.0 111.567 -178.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.76 141.77 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.497 0.719 . . . . 0.0 109.38 164.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.44 146.85 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 118.811 0.732 . . . . 0.0 112.354 171.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -87.54 89.87 8.16 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.906 0.883 . . . . 0.0 110.071 176.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.1 pt -68.34 144.14 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 O-C-N 122.126 -0.359 . . . . 0.0 111.127 173.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -136.13 137.88 41.45 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.713 1.205 . . . . 0.0 111.613 -175.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -85.37 10.0 13.92 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.464 1.106 . . . . 0.0 113.831 -176.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.2 6.75 75.63 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.062 1.315 . . . . 0.0 115.473 177.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.4 t -123.91 3.34 8.75 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.618 1.567 . . . . 0.0 114.143 -173.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.94 21.63 15.37 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.784 1.183 . . . . 0.0 113.951 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.52 148.04 50.43 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.963 1.705 . . . . 0.0 111.011 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.0 p -151.72 166.01 32.63 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -164.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.73 146.39 33.12 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.271 1.429 . . . . 0.0 111.334 168.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -92.55 117.37 29.88 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.704 0.802 . . . . 0.0 109.672 171.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 32.9 pt -118.76 145.56 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.939 1.296 . . . . 0.0 111.419 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -90.95 141.83 15.88 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 176.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.3 pt -127.95 140.56 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 125.385 1.474 . . . . 0.0 111.646 171.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.08 143.78 15.84 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.835 1.207 . . . . 0.0 113.324 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -105.77 163.74 12.47 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.878 1.671 . . . . 0.0 111.061 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.1 t -74.08 -30.57 62.42 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.241 0.616 . . . . 0.0 112.407 176.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -151.1 150.21 30.41 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.133 0.973 . . . . 0.0 112.107 -174.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 54.7 ttt-85 -61.06 -33.68 73.7 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.43 1.092 . . . . 0.0 113.154 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.04 -27.17 73.77 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 123.901 0.763 . . . . 0.0 113.849 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -83.43 -36.27 24.35 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.088 0.944 . . . . 0.0 111.422 175.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.471 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -65.12 -33.08 75.17 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 169.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -61.0 -33.79 73.8 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.42 -0.8 . . . . 0.0 112.674 172.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -64.86 -37.87 89.08 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.808 1.185 . . . . 0.0 111.943 173.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.478 ' CD1' HD11 ' A' ' 49' ' ' ILE . 19.2 t80 -58.27 -50.38 73.79 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.738 0.815 . . . . 0.0 111.837 174.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.96 -24.27 38.2 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -176.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.7 t -80.67 -41.79 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 119.368 0.986 . . . . 0.0 111.427 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 93.2 p -63.47 -32.96 74.55 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.4 1.0 . . . . 0.0 112.87 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 61.6 mt -64.54 -58.46 6.33 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.22 1.008 . . . . 0.0 111.798 170.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -66.82 -29.8 69.83 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.247 -0.908 . . . . 0.0 113.121 -174.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -80.68 -3.55 51.08 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.42 1.088 . . . . 0.0 112.579 177.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -95.13 -19.39 20.14 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 163.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -101.41 -9.21 21.31 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.43 -31.6 55.7 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 -174.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 29.4 p-90 -79.52 -25.23 41.8 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.174 1.39 . . . . 0.0 113.283 176.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.7 t -79.26 -30.76 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.493 1.517 . . . . 0.0 110.816 172.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -94.27 29.26 2.25 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 127.235 2.214 . . . . 0.0 112.871 -177.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -79.53 90.38 5.1 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.89 0.853 . . . . 0.0 109.965 172.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 C--O 1.252 1.201 0 C-N-CA 126.813 2.045 . . . . 0.0 112.685 -172.098 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.612 0 N-CA-C 112.129 -0.388 . . . . 0.0 112.129 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 55.2 p -150.0 172.37 5.34 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 125.342 1.457 . . . . 0.0 111.783 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -65.49 -9.78 23.71 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.451 2.767 . . . . 0.0 115.322 174.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -72.66 139.83 47.56 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.263 1.025 . . . . 0.0 112.113 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 67.1 p -91.31 -13.49 32.5 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.715 1.206 . . . . 0.0 114.02 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -73.84 143.81 45.75 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.338 1.455 . . . . 0.0 112.245 -176.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.0 -49.39 0.11 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.027 1.331 . . . . 0.0 112.012 174.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.0 m -139.9 121.94 15.7 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.23 1.812 . . . . 0.0 108.258 171.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -136.57 15.84 3.15 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -173.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.78 59.45 3.11 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.435 1.494 . . . . 0.0 113.008 -172.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -121.27 56.02 1.05 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.614 1.966 . . . . 0.0 109.778 176.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -151.93 148.19 27.47 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 126.295 1.838 . . . . 0.0 109.576 -172.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -174.69 128.81 0.32 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.438 1.495 . . . . 0.0 108.587 167.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.4 m -91.1 110.78 22.06 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 165.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.6 t -65.06 142.05 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 123.766 0.826 . . . . 0.0 111.288 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.5 mt -128.18 -40.17 1.67 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.633 1.573 . . . . 0.0 112.338 -175.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 37.0 t -152.99 135.99 15.52 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.464 1.106 . . . . 0.0 111.036 173.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.4 t -129.0 126.89 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.492 1.117 . . . . 0.0 109.253 171.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -128.12 134.65 26.47 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 125.352 1.461 . . . . 0.0 110.287 175.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -78.64 -13.28 14.79 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.21 2.607 . . . . 0.0 115.268 -171.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -135.18 108.19 7.63 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.806 0.843 . . . . 0.0 111.339 -174.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.52 143.34 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.084 1.354 . . . . 0.0 110.568 173.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.5 m -123.65 131.93 53.73 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.426 1.09 . . . . 0.0 111.254 -173.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 76.6 t -97.44 134.32 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.509 1.524 . . . . 0.0 111.68 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.17 132.83 53.66 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.198 1.399 . . . . 0.0 108.685 168.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -71.4 131.72 43.78 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 162.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.1 pt -111.8 151.82 43.72 Favored Pre-proline 0 N--CA 1.476 0.849 0 C-N-CA 124.043 0.937 . . . . 0.0 113.327 -164.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -63.93 163.98 23.49 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.068 2.512 . . . . 0.0 111.571 165.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -59.49 149.87 79.15 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.92 2.413 . . . . 0.0 112.705 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.7 ttm105 -61.51 155.05 22.94 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.643 1.577 . . . . 0.0 112.384 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.12 174.93 0.46 Allowed 'General case' 0 CA--C 1.551 0.987 0 CA-C-O 122.005 0.907 . . . . 0.0 112.51 159.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 84.7 p -83.38 -41.71 17.86 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.22 -0.925 . . . . 0.0 113.288 -170.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -130.52 -1.89 4.35 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.603 1.561 . . . . 0.0 113.165 -175.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -107.65 -55.87 2.3 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -169.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.81 -129.89 7.22 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -160.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -131.68 169.91 15.51 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.428 2.291 . . . . 0.0 110.526 -175.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.43 18.89 7.5 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -175.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.92 -51.4 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.968 2.507 . . . . 0.0 115.481 -173.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.0 m -65.43 -13.26 58.31 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.253 1.821 . . . . 0.0 114.257 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -79.89 -12.01 59.77 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.323 1.049 . . . . 0.0 112.645 172.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -95.35 165.33 12.43 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.801 1.641 . . . . 0.0 111.12 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.1 mttt -78.07 57.68 1.84 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.622 1.569 . . . . 0.0 113.261 175.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.1 mt -55.47 -31.75 62.23 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -173.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -89.68 -5.67 56.85 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.838 0.855 . . . . 0.0 113.042 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -138.62 68.92 45.24 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 125.479 1.512 . . . . 0.0 111.685 -161.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -68.0 145.66 68.43 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 CA-C-N 119.535 0.869 . . . . 0.0 113.097 -170.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -71.33 -31.15 67.05 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.255 0.622 . . . . 0.0 111.001 166.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 54.9 t90 -157.36 154.8 29.51 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.757 1.623 . . . . 0.0 111.149 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.2 p -132.94 148.31 52.28 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.745 1.218 . . . . 0.0 111.522 170.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.526 ' HA2' ' HE3' ' A' ' 63' ' ' LYS . . . -178.54 -146.1 6.37 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 114.332 0.493 . . . . 0.0 114.332 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -110.84 145.08 38.85 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.426 1.89 . . . . 0.0 110.952 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.6 tp -85.49 138.73 32.03 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.594 1.558 . . . . 0.0 109.939 170.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.1 ttt85 -142.81 87.95 2.02 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.676 1.19 . . . . 0.0 110.649 170.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.444 HD11 ' CD2' ' A' ' 119' ' ' PHE . 27.1 mt -75.37 124.82 34.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 170.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.4 p -134.78 169.37 17.45 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 127.065 2.146 . . . . 0.0 109.712 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.3 t -157.17 160.14 38.45 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.732 -1.23 . . . . 0.0 112.176 176.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -147.85 118.66 7.58 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.658 0.742 . . . . 0.0 111.879 160.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.24 -119.96 11.23 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 125.899 1.714 . . . . 0.0 110.506 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -92.03 10.62 28.33 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.853 1.661 . . . . 0.0 113.824 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.1 m -129.31 112.75 14.19 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.592 0.757 . . . . 0.0 111.231 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.13 161.27 16.59 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.55 0.74 . . . . 0.0 111.493 172.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -141.45 106.01 4.87 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.443 1.897 . . . . 0.0 109.31 -173.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -82.77 95.68 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 168.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -91.1 138.28 31.72 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.74 0.816 . . . . 0.0 110.86 175.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mp -112.75 130.48 56.05 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.075 1.75 . . . . 0.0 109.927 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -133.99 148.78 51.16 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.005 0.922 . . . . 0.0 112.427 -172.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -66.53 147.56 53.11 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.05 -1.031 . . . . 0.0 111.824 177.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.526 ' HE3' ' HA2' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -83.93 -0.3 50.86 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -174.168 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.5 t -120.05 -45.26 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.856 1.262 . . . . 0.0 111.508 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.7 p -94.04 -23.54 17.97 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -178.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.55 11.85 80.29 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 123.814 0.721 . . . . 0.0 113.478 -169.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -70.57 142.8 51.71 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.888 1.344 . . . . 0.0 111.621 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.4 tp -71.03 125.21 26.25 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.154 0.582 . . . . 0.0 111.208 -176.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -85.23 -56.35 3.58 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.443 1.097 . . . . 0.0 110.923 170.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.0 164.41 36.8 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.563 1.545 . . . . 0.0 110.547 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -144.98 143.32 30.46 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 169.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -114.56 111.97 46.07 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 125.086 1.355 . . . . 0.0 111.177 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.57 144.07 13.91 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.406 2.737 . . . . 0.0 111.36 175.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.8 t -135.65 128.91 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.488 1.515 . . . . 0.0 109.496 -173.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -94.65 -21.5 18.75 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.74 147.59 11.88 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.636 1.974 . . . . 0.0 110.05 170.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -116.07 128.61 25.85 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 124.803 1.241 . . . . 0.0 110.859 176.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -67.56 149.72 82.88 Favored 'Cis proline' 0 CA--C 1.544 0.978 0 CA-C-N 119.788 0.96 . . . . 0.0 112.804 -5.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.54 -167.31 17.62 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.658 1.599 . . . . 0.0 112.728 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.6 tt -67.52 -36.7 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 O-C-N 121.56 -0.965 . . . . 0.0 112.907 -177.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.32 4.23 32.11 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 -167.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.2 t -151.49 127.61 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.145 1.378 . . . . 0.0 110.448 -177.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -142.63 158.25 43.85 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.983 1.713 . . . . 0.0 112.872 -177.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.5 p -101.72 163.27 12.34 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.237 1.815 . . . . 0.0 111.749 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.5 m -89.54 169.64 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.178 0.991 . . . . 0.0 110.084 162.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 81.3 p -95.09 -30.72 13.92 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.864 1.266 . . . . 0.0 113.53 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -94.73 -39.1 10.48 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -164.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.6 t -137.09 118.84 15.06 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -175.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.3 m -74.92 21.02 0.12 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -164.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.405 ' HA ' ' CB ' ' A' ' 116' ' ' ALA . 15.9 ptt-85 -120.44 20.94 11.79 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.532 1.933 . . . . 0.0 114.095 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -138.56 140.9 39.23 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.308 1.443 . . . . 0.0 110.883 -173.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -140.8 156.84 46.06 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.842 1.257 . . . . 0.0 111.42 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 83.2 t -107.97 142.42 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.991 0.917 . . . . 0.0 109.5 165.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.75 148.19 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 118.492 0.587 . . . . 0.0 111.889 169.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.0 ttp85 -92.19 91.81 7.93 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.337 0.655 . . . . 0.0 110.581 176.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.5 pp -75.26 152.96 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.64 0.776 . . . . 0.0 112.05 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -120.63 150.83 40.3 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.958 1.703 . . . . 0.0 110.9 173.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -93.37 2.4 56.54 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.55 1.14 . . . . 0.0 113.054 174.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.65 12.8 81.13 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.26 1.409 . . . . 0.0 114.871 177.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.2 t -138.93 16.43 2.66 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.491 1.516 . . . . 0.0 113.276 -171.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.2 -0.37 78.34 Favored Glycine 0 CA--C 1.537 1.453 0 O-C-N 120.7 -1.25 . . . . 0.0 115.167 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 83.1 mtt180 -80.7 137.47 36.3 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.693 1.597 . . . . 0.0 108.836 166.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.6 p -142.7 157.41 44.69 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 166.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.03 143.4 28.35 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.824 1.25 . . . . 0.0 111.646 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -84.36 118.07 24.0 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.681 0.792 . . . . 0.0 109.536 168.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 30.3 pt -118.34 144.73 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.828 1.251 . . . . 0.0 110.996 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -92.08 139.0 14.5 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.1 pt -124.23 142.21 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 125.039 1.336 . . . . 0.0 111.867 171.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -124.05 143.16 14.68 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 124.777 1.179 . . . . 0.0 113.69 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -106.0 159.79 15.78 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.976 1.711 . . . . 0.0 110.833 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.5 t -72.87 -23.83 60.78 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.699 0.799 . . . . 0.0 112.739 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -158.75 153.74 25.13 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.915 1.286 . . . . 0.0 110.82 -175.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -58.78 -34.44 71.45 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.575 0.75 . . . . 0.0 112.715 176.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.46 -31.65 78.28 Favored Glycine 0 CA--C 1.536 1.368 0 CA-C-N 119.491 1.041 . . . . 0.0 114.348 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -85.85 -36.02 20.26 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.237 1.018 . . . . 0.0 112.114 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.405 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -60.92 -31.96 71.46 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.681 -0.637 . . . . 0.0 112.472 167.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . 0.28 8.2 m-85 -78.88 11.19 2.78 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 173.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -105.24 -31.46 9.09 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.765 0.826 . . . . 0.0 112.813 157.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.444 ' CD2' HD11 ' A' ' 49' ' ' ILE . 26.0 t80 -55.38 -47.09 76.34 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.263 1.025 . . . . 0.0 112.227 175.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -78.23 -32.71 49.95 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.8 t -76.87 -41.62 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.316 1.046 . . . . 0.0 110.906 -177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 81.8 p -64.35 -30.32 71.37 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 81.5 mt -71.67 -54.91 8.82 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.115 0.966 . . . . 0.0 111.92 171.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -66.85 -28.64 68.5 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.048 -1.033 . . . . 0.0 113.194 -175.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -84.76 -3.63 58.69 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.282 1.033 . . . . 0.0 112.664 175.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 53.1 t60 -89.06 -39.49 13.62 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 120.838 -1.164 . . . . 0.0 111.765 158.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -89.84 -1.63 58.03 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -172.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.47 -30.06 59.87 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 120.705 1.593 . . . . 0.0 114.638 -175.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 39.7 p-90 -84.97 -20.92 29.84 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.455 1.102 . . . . 0.0 113.905 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.6 t -84.69 -37.72 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.986 1.315 . . . . 0.0 110.599 175.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.0 tptt -91.5 47.6 1.39 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.165 1.786 . . . . 0.0 111.45 -177.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -86.36 11.4 12.39 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.215 1.406 . . . . 0.0 114.555 177.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 . . . . . 0 C--O 1.252 1.22 0 C-N-CA 126.77 2.028 . . . . 0.0 112.781 -178.935 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.614 0 N-CA-C 111.714 -0.555 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 35.8 m 48.03 62.04 12.74 Favored Pre-proline 0 N--CA 1.481 1.085 0 C-N-CA 126.145 1.778 . . . . 0.0 114.932 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -75.43 0.95 8.48 Favored 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 124.168 3.245 . . . . 0.0 114.304 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -66.15 158.87 27.55 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.93 1.692 . . . . 0.0 113.364 -175.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 60.2 m -109.74 -24.26 10.99 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.685 1.594 . . . . 0.0 113.343 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.9 ttp 53.1 48.4 22.37 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.843 1.657 . . . . 0.0 112.58 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.66 34.15 1.62 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.795 1.638 . . . . 0.0 111.402 -172.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.1 m 58.18 80.3 0.18 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.511 1.925 . . . . 0.0 111.995 -168.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -100.78 17.53 21.81 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.7 1.6 . . . . 0.0 114.631 -170.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.5 tt -76.37 55.18 0.97 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 127.012 2.125 . . . . 0.0 111.819 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -88.32 50.44 1.98 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.714 1.606 . . . . 0.0 111.653 -176.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -149.15 146.09 27.5 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.396 1.478 . . . . 0.0 111.516 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -175.22 96.3 0.07 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.435 1.894 . . . . 0.0 108.076 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 m -80.87 112.01 17.86 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.908 -1.12 . . . . 0.0 109.631 172.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 p -66.85 145.45 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.386 0.674 . . . . 0.0 112.54 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 50.0 mt -126.82 -44.02 1.67 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.747 1.619 . . . . 0.0 112.209 -176.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.3 t -152.36 134.84 15.24 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.637 1.175 . . . . 0.0 110.482 175.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 86.3 t -127.21 127.06 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.333 1.053 . . . . 0.0 109.325 170.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -127.64 132.91 24.57 Favored Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 125.081 1.352 . . . . 0.0 110.228 174.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.13 -15.75 16.08 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.137 2.558 . . . . 0.0 114.874 -172.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -133.81 106.9 7.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.353 1.061 . . . . 0.0 110.987 -175.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.2 p -142.77 146.18 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 125.342 1.457 . . . . 0.0 110.224 173.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.5 m -127.83 132.13 49.47 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.057 0.943 . . . . 0.0 111.597 -171.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.2 t -98.8 130.24 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.399 1.479 . . . . 0.0 111.803 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -131.31 131.49 43.83 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.236 1.414 . . . . 0.0 109.637 170.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.8 mmt-85 -59.89 140.36 56.71 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.482 165.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.9 pt -107.74 154.45 40.91 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 125.499 1.519 . . . . 0.0 112.834 -174.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -69.73 161.91 44.09 Favored 'Trans proline' 0 CA--C 1.548 1.191 0 C-N-CA 123.065 2.51 . . . . 0.0 111.559 164.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -62.74 144.2 93.45 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.898 2.398 . . . . 0.0 112.204 175.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.19 160.23 28.1 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.691 1.196 . . . . 0.0 112.632 -177.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -144.03 165.81 26.73 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.589 154.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.0 m -82.52 -31.58 29.14 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.122 1.769 . . . . 0.0 112.439 -176.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 -93.25 20.24 7.23 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.343 1.457 . . . . 0.0 112.325 171.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 91.4 mmt-85 -133.3 -64.28 0.73 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.522 1.529 . . . . 0.0 111.778 175.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.0 161.84 6.47 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 122.651 1.14 . . . . 0.0 112.986 -172.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -74.84 138.28 42.42 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.915 0.886 . . . . 0.0 110.0 168.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.13 19.67 6.43 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -172.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.49 -50.07 0.05 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.789 2.435 . . . . 0.0 115.39 -174.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.9 m -68.54 -16.62 63.94 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.843 1.657 . . . . 0.0 114.75 -175.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.52 -7.35 59.55 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 172.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.0 m0 -85.58 168.02 14.85 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.857 1.263 . . . . 0.0 110.639 175.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.8 mttt -77.72 52.23 0.99 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.129 1.372 . . . . 0.0 113.964 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.8 mt -57.52 -28.46 63.49 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -175.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -90.28 -6.15 55.48 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -149.91 83.56 6.18 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.502 1.121 . . . . 0.0 112.332 177.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -56.52 147.08 71.55 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.248 2.632 . . . . 0.0 112.95 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -70.1 -33.96 72.51 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.399 0.68 . . . . 0.0 111.14 165.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.5 t90 -156.61 152.68 27.49 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.812 1.645 . . . . 0.0 110.801 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.3 p -132.55 149.88 52.25 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.122 0.969 . . . . 0.0 111.554 167.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.99 -141.44 5.13 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 123.07 0.367 . . . . 0.0 113.282 -178.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.2 mtm105 -109.8 144.92 37.55 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.065 1.746 . . . . 0.0 111.88 -175.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.8 tp -85.36 137.59 32.84 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.711 1.204 . . . . 0.0 109.129 163.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.8 ttt-85 -143.97 89.37 2.03 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.263 1.025 . . . . 0.0 110.56 164.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.503 HD11 ' CD2' ' A' ' 119' ' ' PHE . 15.1 mt -71.53 130.05 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 170.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 p -132.83 173.76 11.04 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.933 2.093 . . . . 0.0 110.282 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 92.9 p -161.89 166.73 25.82 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 120.687 -1.258 . . . . 0.0 111.712 178.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.2 mmtt -152.92 -117.74 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.658 1.583 . . . . 0.0 110.451 153.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.47 92.05 0.41 Allowed Glycine 0 N--CA 1.471 1.024 0 C-N-CA 125.636 1.588 . . . . 0.0 113.802 -160.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.7 mttt 50.99 27.91 3.52 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.429 1.891 . . . . 0.0 112.915 -175.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.1 m -143.42 127.82 17.85 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.24 1.416 . . . . 0.0 109.269 -173.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.76 161.57 13.51 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.637 1.175 . . . . 0.0 110.562 169.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -141.25 102.34 4.21 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.163 1.785 . . . . 0.0 108.905 -173.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.1 mp -78.57 98.09 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 170.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -97.61 138.02 35.65 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.395 0.617 . . . . 0.0 111.575 173.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mp -109.11 132.93 53.64 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.197 1.799 . . . . 0.0 109.568 174.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -137.88 151.92 48.52 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.891 0.876 . . . . 0.0 112.569 -168.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -74.12 143.99 45.1 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.123 -0.986 . . . . 0.0 112.092 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -84.07 -6.55 59.43 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.376 1.871 . . . . 0.0 115.128 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 92.5 t -123.37 -44.32 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 125.315 1.446 . . . . 0.0 111.423 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.8 m -93.64 -22.88 18.5 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -174.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.0 6.88 86.43 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 123.956 0.789 . . . . 0.0 113.805 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -82.37 155.68 24.6 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.364 1.466 . . . . 0.0 112.441 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.3 tp -74.5 129.01 36.97 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.492 0.717 . . . . 0.0 111.223 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -88.04 -55.19 3.86 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.234 1.014 . . . . 0.0 111.16 169.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.39 161.25 40.13 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.918 1.287 . . . . 0.0 111.323 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -144.22 140.74 29.46 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.759 0.824 . . . . 0.0 112.565 176.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.79 102.5 22.37 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 125.936 1.694 . . . . 0.0 111.157 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -69.33 147.15 64.98 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.927 3.085 . . . . 0.0 112.438 170.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.9 t -138.15 125.07 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.796 1.638 . . . . 0.0 109.152 -176.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -92.02 -22.48 19.94 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -159.88 147.45 16.73 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.562 1.945 . . . . 0.0 109.642 168.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -124.14 127.62 25.29 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 124.684 1.194 . . . . 0.0 110.964 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.43 147.4 50.06 Favored 'Cis proline' 0 CA--C 1.541 0.87 0 CA-C-N 120.079 1.064 . . . . 0.0 114.534 -4.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.33 -166.58 19.44 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.488 1.518 . . . . 0.0 113.429 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.4 tp -70.65 -31.24 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -174.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.85 3.54 50.84 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -171.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.9 t -150.34 133.54 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.902 1.281 . . . . 0.0 110.844 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -141.35 161.61 37.49 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.319 1.448 . . . . 0.0 112.83 175.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 73.0 p -107.21 161.23 14.96 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 127.055 2.142 . . . . 0.0 111.093 177.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.8 m -88.27 172.83 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 123.897 0.879 . . . . 0.0 111.232 166.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 60.0 p -96.22 -30.29 13.55 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.39 1.476 . . . . 0.0 113.368 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -96.28 -40.59 9.08 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -165.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.5 t -137.74 117.96 13.59 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -173.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.3 p -75.08 29.25 0.09 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -172.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.96 24.82 7.48 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 127.108 2.163 . . . . 0.0 113.937 174.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -140.96 139.88 34.31 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.902 1.281 . . . . 0.0 111.261 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -137.74 159.87 40.8 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.813 1.245 . . . . 0.0 110.738 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.8 t -112.18 144.66 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 124.288 1.035 . . . . 0.0 108.772 165.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.94 148.07 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 118.095 0.407 . . . . 0.0 111.755 168.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -89.86 99.98 12.88 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.31 0.644 . . . . 0.0 109.542 172.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -84.7 155.21 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.536 1.135 . . . . 0.0 111.335 176.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -129.97 145.79 51.65 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.969 1.308 . . . . 0.0 111.592 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -95.25 13.88 24.07 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.104 1.362 . . . . 0.0 113.388 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.72 5.26 86.23 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 125.291 1.424 . . . . 0.0 115.65 176.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.9 t -127.32 6.35 6.38 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.571 1.548 . . . . 0.0 113.77 -174.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.19 -5.39 71.55 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 125.388 1.47 . . . . 0.0 113.92 -175.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -74.53 132.94 42.26 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 127.567 2.347 . . . . 0.0 109.069 166.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 84.1 p -139.86 160.38 40.02 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.064 1.345 . . . . 0.0 113.772 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.48 144.77 28.82 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.89 1.276 . . . . 0.0 111.267 172.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -87.88 119.89 28.67 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 165.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 31.3 pt -120.69 142.81 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.628 1.171 . . . . 0.0 111.218 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.69 137.31 13.51 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 176.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.3 pt -124.6 139.05 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 125.226 1.41 . . . . 0.0 111.713 175.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.1 140.28 14.45 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.719 1.152 . . . . 0.0 113.082 177.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -101.84 159.47 15.31 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.025 1.73 . . . . 0.0 111.37 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.5 t -70.58 -27.38 64.07 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.32 0.648 . . . . 0.0 112.646 178.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -158.05 155.96 30.23 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.382 1.073 . . . . 0.0 111.997 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -56.58 -38.41 71.94 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.662 1.185 . . . . 0.0 112.482 174.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.05 -10.43 46.72 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.541 1.067 . . . . 0.0 115.022 176.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -104.75 -35.97 7.58 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.746 1.273 . . . . 0.0 111.754 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.7 -28.27 68.52 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.65 0.78 . . . . 0.0 112.835 164.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -70.74 -6.51 38.01 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 169.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -93.76 -35.25 12.87 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.939 1.245 . . . . 0.0 112.26 163.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.503 ' CD2' HD11 ' A' ' 49' ' ' ILE . 43.5 t80 -55.2 -55.76 27.64 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.304 0.957 . . . . 0.0 112.267 177.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -78.81 -27.66 44.42 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 -173.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.6 t -79.74 -39.58 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 121.749 -0.595 . . . . 0.0 111.043 -178.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 88.5 p -65.7 -33.31 75.59 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.544 -0.722 . . . . 0.0 112.524 174.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 40.6 mt -66.62 -55.73 13.96 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.035 0.934 . . . . 0.0 112.154 172.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -64.85 -27.26 68.75 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.136 0.88 . . . . 0.0 112.874 -176.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -79.0 -7.8 58.38 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.345 1.058 . . . . 0.0 112.873 176.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -84.89 -15.61 44.0 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.087 -1.008 . . . . 0.0 112.815 165.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -115.17 -7.92 12.41 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -173.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.17 -24.37 53.89 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 36.1 p-90 -94.65 -21.43 18.8 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.771 1.628 . . . . 0.0 113.579 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.2 t -78.09 -32.49 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.047 1.339 . . . . 0.0 111.739 -175.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -98.46 22.5 9.69 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.546 1.538 . . . . 0.0 113.138 -177.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -85.19 90.2 7.83 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.174 0.989 . . . . 0.0 109.605 171.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 C--O 1.252 1.199 0 C-N-CA 126.51 1.924 . . . . 0.0 112.801 -169.33 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 N-CA-C 111.965 -0.454 . . . . 0.0 111.965 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 39.3 m -67.05 149.09 98.7 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.423 1.089 . . . . 0.0 112.924 -179.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -66.32 -26.42 48.64 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.061 2.507 . . . . 0.0 114.117 173.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -81.64 163.54 22.47 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.396 1.478 . . . . 0.0 112.53 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 65.3 p -75.1 -3.31 31.99 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptp -61.06 148.44 40.32 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.578 1.551 . . . . 0.0 113.009 176.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.16 -57.68 0.13 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.845 1.258 . . . . 0.0 111.508 176.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 52.0 m -153.89 116.79 4.48 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.923 1.689 . . . . 0.0 109.092 169.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -150.31 17.03 0.83 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.968 1.307 . . . . 0.0 113.273 -174.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tt -81.27 50.19 1.4 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.791 2.036 . . . . 0.0 111.761 -177.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -84.76 44.94 1.1 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.774 1.63 . . . . 0.0 112.581 -170.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -147.01 149.91 34.06 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.322 1.449 . . . . 0.0 113.051 -177.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.434 ' HG3' ' HE2' ' A' ' 52' ' ' LYS . 16.3 tt0 -177.37 77.53 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 129.613 3.165 . . . . 0.0 106.479 -173.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.05 113.57 7.38 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 120.668 -1.27 . . . . 0.0 111.299 -165.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.5 t -73.52 143.72 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.741 1.216 . . . . 0.0 111.583 -169.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.9 mt -128.86 -38.67 1.65 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.73 1.612 . . . . 0.0 112.625 -174.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 34.8 t -154.22 136.76 15.09 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.618 1.167 . . . . 0.0 110.726 173.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 88.7 t -130.14 127.27 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.639 1.176 . . . . 0.0 109.383 171.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -129.05 140.17 37.84 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 125.791 1.636 . . . . 0.0 110.794 176.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -77.35 -27.26 6.64 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.464 2.776 . . . . 0.0 115.84 -168.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -140.05 115.87 10.24 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.087 0.946 . . . . 0.0 111.843 -175.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.9 145.4 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 126.84 2.056 . . . . 0.0 109.726 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.2 m -124.71 130.05 51.68 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.767 0.827 . . . . 0.0 112.133 -167.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 77.8 t -94.6 137.44 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.212 1.405 . . . . 0.0 112.051 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.56 128.72 37.84 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.624 1.17 . . . . 0.0 110.133 169.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.41 135.95 57.34 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.306 1.042 . . . . 0.0 111.035 161.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.8 pt -120.71 152.39 55.75 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 126.248 1.819 . . . . 0.0 112.294 -177.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -68.81 158.25 58.58 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 122.247 1.964 . . . . 0.0 110.929 161.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -64.02 145.42 89.74 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.726 2.284 . . . . 0.0 111.688 174.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.8 ttm105 -67.45 158.55 31.54 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.096 0.958 . . . . 0.0 112.685 -177.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -123.74 136.68 54.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.955 145.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.2 m -71.61 -22.71 61.67 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.364 1.466 . . . . 0.0 113.77 -172.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 -84.92 10.24 12.26 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.768 1.227 . . . . 0.0 112.608 169.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 88.2 mmt-85 -130.2 -57.99 1.07 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.144 1.778 . . . . 0.0 111.989 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.73 156.16 6.91 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 122.343 0.968 . . . . 0.0 113.392 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -75.52 139.04 41.94 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.677 0.791 . . . . 0.0 109.975 169.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.62 18.45 6.83 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -170.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.73 -50.67 0.05 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.879 2.472 . . . . 0.0 115.464 -175.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.6 m -66.77 -14.6 62.79 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.069 1.748 . . . . 0.0 114.19 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -76.36 -21.51 56.01 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.723 1.209 . . . . 0.0 112.56 172.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 17.3 m0 -84.52 172.09 11.96 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.667 1.587 . . . . 0.0 111.524 -177.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -80.16 54.55 1.98 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.365 1.466 . . . . 0.0 113.978 -177.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.7 mt -60.71 -17.27 47.23 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -174.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -102.08 -8.04 21.77 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.813 1.245 . . . . 0.0 113.104 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -149.0 72.52 10.29 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.896 1.278 . . . . 0.0 111.867 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -57.47 145.58 87.77 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.043 2.495 . . . . 0.0 112.374 174.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -70.07 -29.14 66.07 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.513 1.125 . . . . 0.0 111.749 175.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 42.1 t90 -159.44 152.99 22.63 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.035 1.734 . . . . 0.0 110.476 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.2 p -133.7 152.31 51.85 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.575 -0.703 . . . . 0.0 112.381 166.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.08 -146.72 7.35 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 116.174 -0.466 . . . . 0.0 114.085 -176.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 42.7 mtm105 -104.84 148.27 26.83 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.047 2.139 . . . . 0.0 111.734 -175.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.3 tp -89.51 139.43 30.54 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.257 1.423 . . . . 0.0 110.247 167.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 -141.53 97.15 3.1 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.65 1.58 . . . . 0.0 109.682 167.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.472 HD11 ' CD2' ' A' ' 119' ' ' PHE . 17.3 mt -83.31 130.67 35.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 169.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.81 162.82 34.47 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.51 2.324 . . . . 0.0 109.508 -168.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.5 t -163.48 153.73 15.66 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.431 -1.418 . . . . 0.0 110.508 175.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.434 ' HE2' ' HG3' ' A' ' 8' ' ' GLU . 67.5 mttt -128.58 -41.79 1.5 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 116.786 2.143 . . . . 0.0 116.786 -176.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.92 82.53 0.1 OUTLIER Glycine 0 N--CA 1.472 1.072 0 CA-C-N 118.652 0.66 . . . . 0.0 112.075 -175.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt 54.71 25.24 6.29 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.006 1.722 . . . . 0.0 112.749 -171.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.7 m -141.43 118.27 11.11 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.197 1.399 . . . . 0.0 107.649 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.51 160.06 14.69 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.241 1.016 . . . . 0.0 110.799 174.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -138.44 113.81 9.55 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 126.346 1.858 . . . . 0.0 108.956 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.5 mp -86.12 102.17 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 166.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -100.67 140.01 35.55 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.349 1.059 . . . . 0.0 111.409 176.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.8 mp -113.32 130.6 56.22 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.444 1.898 . . . . 0.0 109.605 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -135.85 153.26 51.54 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.079 0.952 . . . . 0.0 112.259 -174.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -73.12 142.91 47.49 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.85 -1.156 . . . . 0.0 111.9 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.3 pttt -84.63 -4.64 59.1 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.973 1.709 . . . . 0.0 115.048 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 64.8 t -124.79 -43.81 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 125.468 1.507 . . . . 0.0 111.361 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.7 m -91.54 -24.2 19.69 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.5 5.77 87.99 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 123.992 0.806 . . . . 0.0 113.831 -177.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -82.78 151.17 26.24 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.343 1.457 . . . . 0.0 112.566 -173.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.1 tp -73.36 126.12 29.41 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.612 0.765 . . . . 0.0 110.886 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -87.65 -54.8 4.07 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.462 1.105 . . . . 0.0 111.226 171.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.29 163.64 38.51 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.575 1.15 . . . . 0.0 112.01 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -142.23 134.41 27.59 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.707 1.203 . . . . 0.0 111.653 177.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.15 97.08 50.5 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.11 1.364 . . . . 0.0 111.669 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -58.89 139.7 91.97 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 124.568 3.512 . . . . 0.0 113.315 166.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.3 t -139.13 128.87 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.571 1.949 . . . . 0.0 109.52 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -90.77 -24.12 20.44 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.34 149.97 15.94 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.034 1.734 . . . . 0.0 110.772 173.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -118.83 130.43 24.82 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.589 1.156 . . . . 0.0 111.469 175.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -63.34 148.33 64.16 Favored 'Cis proline' 0 CA--C 1.542 0.879 0 CA-C-N 119.761 0.951 . . . . 0.0 113.583 -7.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -152.39 -163.91 11.96 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.578 1.561 . . . . 0.0 112.461 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.9 tt -78.13 -36.47 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 O-C-N 121.82 -0.812 . . . . 0.0 112.938 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.94 8.71 9.76 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -169.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.0 t -149.8 133.69 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 126.33 1.852 . . . . 0.0 109.446 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -146.43 159.17 43.74 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.464 1.506 . . . . 0.0 112.489 -177.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.8 p -109.7 155.66 21.25 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 126.638 1.975 . . . . 0.0 111.696 176.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.1 m -80.51 173.46 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 124.01 0.924 . . . . 0.0 110.982 165.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.6 p -95.68 -30.21 13.88 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.409 1.484 . . . . 0.0 113.357 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -91.1 -50.24 5.96 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.927 0.891 . . . . 0.0 113.266 -167.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.7 m -133.78 117.39 16.84 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -167.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.0 m -73.23 28.36 0.06 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -171.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.428 ' HA ' ' CB ' ' A' ' 116' ' ' ALA . 6.1 ptm180 -125.23 23.62 7.61 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.859 2.064 . . . . 0.0 113.577 175.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -141.07 137.43 32.87 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.279 1.432 . . . . 0.0 110.99 -178.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -137.35 165.24 26.67 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.855 1.262 . . . . 0.0 111.128 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.3 t -120.28 143.29 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 124.658 1.183 . . . . 0.0 108.539 168.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.72 149.05 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 118.639 0.654 . . . . 0.0 111.744 172.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -92.49 90.23 7.08 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.051 0.54 . . . . 0.0 110.858 177.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -70.57 141.32 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 122.894 0.478 . . . . 0.0 110.995 177.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -137.87 146.4 43.36 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.09 1.756 . . . . 0.0 111.491 -172.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -90.23 -0.31 57.56 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.948 0.899 . . . . 0.0 113.074 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.6 12.8 77.24 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 125.227 1.394 . . . . 0.0 114.896 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.4 t -138.28 18.07 2.77 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.382 1.473 . . . . 0.0 113.465 -173.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.27 -6.14 82.57 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.756 1.17 . . . . 0.0 114.927 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -72.62 129.87 39.26 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.301 1.44 . . . . 0.0 108.469 164.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 93.6 p -152.82 161.31 42.71 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 172.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.14 146.46 30.87 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.527 1.531 . . . . 0.0 111.29 171.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -87.11 124.56 33.38 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.737 -0.602 . . . . 0.0 109.425 166.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.8 pt -122.5 143.57 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.522 1.129 . . . . 0.0 111.092 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -90.18 144.28 17.46 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 173.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.8 pt -129.67 140.43 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 125.53 1.532 . . . . 0.0 111.991 173.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.23 137.7 11.59 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 125.64 1.591 . . . . 0.0 113.151 178.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -102.09 162.92 12.54 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.252 1.821 . . . . 0.0 111.29 -178.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.4 t -74.14 -27.73 60.99 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.722 0.809 . . . . 0.0 113.006 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -157.11 153.27 27.52 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.276 1.03 . . . . 0.0 112.229 -177.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -60.01 -34.4 73.28 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.601 1.16 . . . . 0.0 113.151 176.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.1 -31.54 81.12 Favored Glycine 0 CA--C 1.536 1.39 0 CA-C-N 119.131 0.878 . . . . 0.0 113.382 176.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -83.69 -34.69 24.9 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.804 0.842 . . . . 0.0 112.093 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.428 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -65.46 -33.51 76.12 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 170.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -61.77 -32.19 72.45 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.043 -1.036 . . . . 0.0 112.582 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -66.34 -30.15 70.49 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.049 -1.032 . . . . 0.0 112.738 173.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.472 ' CD2' HD11 ' A' ' 49' ' ' ILE . 24.4 t80 -63.09 -49.35 74.83 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.372 0.987 . . . . 0.0 111.943 173.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.8 -25.11 33.03 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -177.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.8 t -78.37 -41.59 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 119.197 0.908 . . . . 0.0 111.39 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 93.7 p -64.58 -29.49 70.51 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.251 0.932 . . . . 0.0 113.302 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 78.0 mt -70.96 -54.28 11.9 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.004 0.922 . . . . 0.0 111.712 171.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -68.51 -32.74 72.91 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.01 -1.056 . . . . 0.0 113.225 -174.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -83.81 -1.34 54.12 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.088 0.955 . . . . 0.0 112.364 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -96.44 -33.24 11.95 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 120.931 -1.106 . . . . 0.0 112.545 164.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -93.05 -3.28 54.57 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -31.17 58.37 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 121.595 1.998 . . . . 0.0 114.936 -175.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 35.6 p-90 -81.03 -20.29 42.02 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.695 1.198 . . . . 0.0 113.716 177.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.8 t -84.24 -36.13 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.21 1.404 . . . . 0.0 110.364 170.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 48.3 tptt -93.12 45.52 1.18 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 127.519 2.327 . . . . 0.0 111.597 -177.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -84.07 95.28 8.54 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.656 1.183 . . . . 0.0 110.774 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 . . . . . 0 C--O 1.254 1.3 0 C-N-CA 127.002 2.121 . . . . 0.0 112.398 176.078 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.574 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 38.0 t -73.99 136.11 76.66 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 123.704 0.802 . . . . 0.0 112.36 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -78.73 -3.48 13.3 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.782 2.988 . . . . 0.0 113.338 173.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -83.79 28.36 0.59 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.483 1.513 . . . . 0.0 113.935 -171.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 60.4 p -58.46 -33.14 69.42 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.664 -1.272 . . . . 0.0 113.422 -178.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mmt -84.65 14.15 4.95 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.533 1.533 . . . . 0.0 113.844 176.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.63 -40.98 0.86 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.832 1.653 . . . . 0.0 112.323 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 58.5 m -66.18 -39.63 89.85 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.952 0.901 . . . . 0.0 110.746 165.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 46.3 72.08 0.25 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.887 2.475 . . . . 0.0 115.814 157.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.6 pp -70.17 140.21 52.52 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.494 -0.754 . . . . 0.0 111.172 165.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -135.78 51.06 2.07 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.471 1.508 . . . . 0.0 110.209 -178.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -136.02 139.81 43.4 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.954 1.302 . . . . 0.0 110.7 178.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -179.82 121.53 0.07 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.144 1.778 . . . . 0.0 108.516 163.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 82.6 p -97.98 109.25 22.04 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.083 0.468 . . . . 0.0 111.096 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 82.5 t -70.62 141.01 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.916 0.886 . . . . 0.0 111.053 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.6 mt -127.49 -40.54 1.77 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.697 1.599 . . . . 0.0 112.646 -171.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 51.1 t -146.87 137.28 23.65 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.505 1.522 . . . . 0.0 109.247 172.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 76.8 t -126.6 130.48 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.355 1.062 . . . . 0.0 108.936 168.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -133.57 127.84 19.79 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 124.562 1.145 . . . . 0.0 111.076 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.19 -13.24 12.65 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.986 2.457 . . . . 0.0 114.947 -171.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -134.11 104.52 6.25 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.223 1.009 . . . . 0.0 110.717 -176.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.5 p -143.18 144.42 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.508 1.123 . . . . 0.0 110.726 174.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.8 m -124.88 131.21 53.46 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.55 1.14 . . . . 0.0 110.629 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.0 t -96.61 134.33 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.946 1.298 . . . . 0.0 111.127 177.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.38 120.63 25.87 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.06 1.344 . . . . 0.0 108.932 169.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -63.24 130.79 46.06 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.425 -0.797 . . . . 0.0 109.145 163.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.2 pt -93.85 153.03 41.04 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 124.845 1.258 . . . . 0.0 112.834 -166.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -65.08 159.57 46.0 Favored 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 122.896 2.397 . . . . 0.0 111.454 165.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -63.02 140.79 80.88 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.013 2.475 . . . . 0.0 112.138 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.3 ttm-85 -74.28 156.57 37.04 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.691 1.197 . . . . 0.0 112.39 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -132.43 137.65 47.36 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.598 141.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.1 m -68.92 -29.77 68.09 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.493 1.517 . . . . 0.0 114.106 -169.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -75.93 -7.71 55.21 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.875 0.87 . . . . 0.0 113.009 171.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 27.0 mmt-85 -104.71 -52.16 2.93 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.845 1.658 . . . . 0.0 111.893 175.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.32 161.94 19.31 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 122.195 0.886 . . . . 0.0 112.653 -177.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -75.28 133.95 41.19 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.864 0.866 . . . . 0.0 109.84 169.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.92 18.64 7.86 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -171.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.16 -49.89 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 128.141 2.576 . . . . 0.0 115.607 -173.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.5 m -67.61 -15.2 63.53 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.012 1.725 . . . . 0.0 114.603 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.95 -10.8 58.62 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 171.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.0 m0 -85.55 170.45 12.59 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.813 1.245 . . . . 0.0 110.841 176.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.9 mtmm -80.24 52.94 1.66 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.408 1.483 . . . . 0.0 113.606 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.6 mt -57.89 -23.76 54.69 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -173.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -96.28 -6.51 37.71 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.547 1.139 . . . . 0.0 112.446 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -151.99 72.37 7.88 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 125.111 1.364 . . . . 0.0 111.817 -169.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -57.97 149.59 69.62 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.725 2.95 . . . . 0.0 113.605 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -73.32 -31.11 63.81 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.76 0.824 . . . . 0.0 111.401 167.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 33.5 t90 -158.13 153.02 25.15 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.48 1.912 . . . . 0.0 110.391 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.2 p -134.18 146.74 50.45 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.719 1.208 . . . . 0.0 111.486 171.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.41 -138.5 4.28 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 114.088 0.395 . . . . 0.0 114.088 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -115.89 144.72 43.64 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.816 1.646 . . . . 0.0 111.578 -172.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.2 tp -92.49 137.72 32.12 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.354 1.462 . . . . 0.0 109.821 172.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 53.9 ttp85 -138.68 102.21 4.53 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.96 0.904 . . . . 0.0 110.026 162.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.54 HD11 ' CD1' ' A' ' 119' ' ' PHE . 25.8 mt -79.16 132.67 31.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 169.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.74 171.69 14.13 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 126.229 1.812 . . . . 0.0 110.708 -175.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.0 t -161.41 159.53 28.31 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.369 1.068 . . . . 0.0 110.869 172.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -147.55 -85.03 0.1 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 158.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.56 68.39 3.36 Favored Glycine 0 N--CA 1.474 1.226 0 C-N-CA 124.629 1.109 . . . . 0.0 113.959 -166.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.7 mttt 51.67 30.13 6.39 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.815 1.646 . . . . 0.0 112.49 -172.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.8 m -146.92 120.8 9.3 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.383 1.873 . . . . 0.0 108.237 -173.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.84 156.7 19.77 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.318 1.047 . . . . 0.0 110.939 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -135.15 100.41 4.54 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.336 1.855 . . . . 0.0 108.713 -173.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.6 mp -79.74 104.84 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 171.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.4 mttt -105.4 135.26 47.11 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.526 0.73 . . . . 0.0 111.775 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -101.08 133.17 46.01 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 125.237 1.415 . . . . 0.0 110.189 169.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -138.32 148.34 44.5 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.038 0.935 . . . . 0.0 112.233 -171.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -68.51 149.67 48.97 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.217 1.008 . . . . 0.0 113.688 -171.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.89 -3.84 43.73 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.9 t -123.41 -48.25 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.636 1.174 . . . . 0.0 111.705 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.6 p -95.35 -24.6 16.66 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -176.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.05 13.98 76.16 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 123.609 0.623 . . . . 0.0 113.522 -167.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -69.13 149.28 48.82 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 118.727 1.263 . . . . 0.0 111.533 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.4 tp -71.2 124.11 23.75 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.444 0.698 . . . . 0.0 111.441 -175.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -84.26 -53.86 5.2 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.971 0.908 . . . . 0.0 110.924 168.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -159.39 157.67 30.74 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.925 1.29 . . . . 0.0 111.516 -177.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -138.99 138.77 37.56 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.59 0.756 . . . . 0.0 112.81 174.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.65 111.09 36.4 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.059 1.343 . . . . 0.0 111.685 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -82.81 123.73 3.76 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.981 3.121 . . . . 0.0 111.91 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.6 t -114.41 119.73 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 126.862 2.065 . . . . 0.0 109.324 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -81.97 -20.56 38.28 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 -176.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.08 162.54 15.44 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.245 1.818 . . . . 0.0 109.308 171.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -120.45 129.81 25.15 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -173.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -64.95 151.94 76.03 Favored 'Cis proline' 0 CA--C 1.542 0.912 0 CA-C-N 119.193 0.748 . . . . 0.0 112.895 -11.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -147.37 175.48 26.71 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.165 0.888 . . . . 0.0 114.15 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.5 tp -52.97 -30.11 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 124.695 1.198 . . . . 0.0 114.066 -176.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.68 9.82 28.28 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.6 p -155.45 138.36 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.197 0.999 . . . . 0.0 113.561 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -152.24 161.12 43.09 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.664 1.586 . . . . 0.0 113.069 -172.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 62.9 p -112.88 161.01 17.46 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 127.307 2.243 . . . . 0.0 111.202 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.0 m -88.5 175.8 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.319 1.047 . . . . 0.0 111.314 167.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.7 p -95.79 -31.59 13.11 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.673 1.589 . . . . 0.0 113.357 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -93.98 -42.37 9.08 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -165.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.4 t -142.49 121.39 12.77 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -177.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.15 0.73 5.69 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -169.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.486 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.303 28.4 ptt180 -87.12 16.21 5.34 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 176.509 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -137.24 136.8 38.43 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.168 1.387 . . . . 0.0 110.908 -174.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -137.54 160.3 39.54 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.138 1.375 . . . . 0.0 111.263 -177.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.1 t -116.2 143.05 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.258 1.023 . . . . 0.0 108.915 166.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.67 149.66 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 123.441 0.697 . . . . 0.0 111.395 170.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -93.25 87.44 5.65 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.776 0.831 . . . . 0.0 110.357 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -70.24 138.35 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 120.958 0.409 . . . . 0.0 110.695 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -139.97 149.85 43.77 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.484 1.514 . . . . 0.0 111.212 -167.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -96.67 3.21 52.6 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.146 0.978 . . . . 0.0 113.071 -178.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.32 12.76 81.72 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.129 1.347 . . . . 0.0 114.704 178.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.1 t -134.52 9.86 3.7 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.64 1.576 . . . . 0.0 113.575 -172.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.39 -5.44 67.67 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.959 1.266 . . . . 0.0 114.643 -177.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -67.87 131.47 45.57 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.207 1.403 . . . . 0.0 108.828 163.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 95.6 p -146.22 152.66 39.57 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 114.646 1.351 . . . . 0.0 114.646 174.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.14 140.72 28.18 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.208 1.403 . . . . 0.0 110.927 168.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -88.39 119.69 29.06 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.175 0.59 . . . . 0.0 109.896 170.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.8 pt -118.54 142.0 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.543 1.137 . . . . 0.0 110.756 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -90.99 144.27 17.12 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 173.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.2 pt -128.38 141.81 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 125.052 1.341 . . . . 0.0 111.631 169.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -121.4 142.67 15.52 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.142 1.353 . . . . 0.0 113.169 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -107.19 164.97 11.72 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.718 1.607 . . . . 0.0 111.551 -177.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.6 t -74.39 -31.91 62.52 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.486 0.714 . . . . 0.0 112.521 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -151.71 146.36 25.71 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.245 -0.909 . . . . 0.0 112.071 -172.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -61.71 -33.78 74.62 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.329 1.051 . . . . 0.0 113.195 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.7 -25.54 75.03 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-N 118.935 0.789 . . . . 0.0 113.838 176.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -92.96 -26.38 17.59 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.193 0.997 . . . . 0.0 112.821 176.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.486 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -66.11 -34.53 78.27 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.422 -0.799 . . . . 0.0 112.598 161.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -59.82 -31.32 69.62 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.049 -1.032 . . . . 0.0 112.197 168.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -67.28 -25.19 65.93 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 119.553 1.07 . . . . 0.0 112.968 174.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.54 ' CD1' HD11 ' A' ' 49' ' ' ILE . 13.4 t80 -69.74 -51.87 30.42 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.205 1.002 . . . . 0.0 111.878 168.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.08 -25.3 40.08 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -174.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 65.0 t -77.97 -42.41 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 121.134 -0.979 . . . . 0.0 111.05 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 88.7 p -66.37 -30.66 71.09 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.1 mt -69.93 -55.95 8.33 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.828 0.851 . . . . 0.0 111.536 171.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -63.68 -33.7 76.22 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.117 0.871 . . . . 0.0 113.256 -174.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -83.53 -0.89 52.26 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.468 1.107 . . . . 0.0 112.762 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -94.11 -13.41 26.81 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.263 -0.898 . . . . 0.0 113.31 164.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -108.17 -4.86 17.26 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.02 -23.59 54.83 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 121.079 1.763 . . . . 0.0 115.677 -176.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 34.5 p-90 -89.95 -13.42 36.23 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.512 1.525 . . . . 0.0 114.058 175.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.4 t -91.1 -47.23 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.228 1.411 . . . . 0.0 109.546 171.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -94.16 65.76 3.42 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.569 1.947 . . . . 0.0 110.554 173.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -66.47 96.8 0.39 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.626 1.571 . . . . 0.0 111.673 -179.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 C--O 1.254 1.334 0 C-N-CA 127.538 2.335 . . . . 0.0 112.628 176.071 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.581 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 40.9 m -69.3 147.91 97.27 Favored Pre-proline 0 N--CA 1.476 0.838 0 C-N-CA 124.212 1.005 . . . . 0.0 112.902 -177.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -58.31 -28.2 83.77 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.229 2.619 . . . . 0.0 114.512 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -64.52 -17.0 63.5 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.55 1.14 . . . . 0.0 113.743 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 44.0 m -80.37 -7.29 59.03 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.602 1.161 . . . . 0.0 113.757 175.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt -111.55 152.8 27.12 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.546 1.538 . . . . 0.0 112.378 -177.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.02 -45.07 0.11 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.179 1.392 . . . . 0.0 112.007 175.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 31.6 m -138.38 113.28 9.14 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.94 1.696 . . . . 0.0 107.744 167.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.43 17.91 2.93 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -158.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.89 58.29 1.88 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.391 1.476 . . . . 0.0 112.346 178.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -122.45 62.56 0.97 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.493 1.917 . . . . 0.0 108.869 175.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -147.76 143.93 27.89 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.54 1.536 . . . . 0.0 109.669 -173.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -177.5 126.04 0.14 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.759 1.623 . . . . 0.0 108.853 169.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.0 m -90.87 108.72 20.03 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.753 0.821 . . . . 0.0 109.617 168.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.36 146.99 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.779 0.831 . . . . 0.0 113.015 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.6 mt -130.82 -42.56 1.12 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.65 1.58 . . . . 0.0 112.409 -173.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 27.1 t -151.64 134.67 15.8 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.336 1.054 . . . . 0.0 110.933 177.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 96.9 t -129.31 127.85 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.516 1.126 . . . . 0.0 109.474 172.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -127.36 130.55 23.7 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 125.176 1.391 . . . . 0.0 110.085 173.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.7 -13.96 15.99 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 122.959 2.439 . . . . 0.0 115.144 -171.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -134.37 108.59 8.26 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.029 0.932 . . . . 0.0 111.425 -176.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.69 146.16 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.975 1.71 . . . . 0.0 109.926 174.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.0 m -127.6 131.02 49.99 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.908 0.883 . . . . 0.0 111.695 -170.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 68.2 t -97.77 131.66 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.361 1.464 . . . . 0.0 111.749 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.17 120.89 25.26 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.071 1.348 . . . . 0.0 108.611 167.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.0 mtt-85 -71.69 130.08 40.27 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.094 0.557 . . . . 0.0 109.939 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.4 pt -92.49 153.38 42.62 Favored Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 124.095 0.958 . . . . 0.0 113.435 -163.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -65.48 158.94 50.25 Favored 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 122.586 2.191 . . . . 0.0 111.082 160.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -62.09 147.64 94.71 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.827 2.351 . . . . 0.0 111.987 176.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.7 ttm105 -65.69 147.88 52.67 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.823 0.849 . . . . 0.0 112.052 -176.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.74 179.31 0.51 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.777 1.231 . . . . 0.0 112.854 161.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 81.2 p -102.65 -35.93 8.51 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.842 1.657 . . . . 0.0 112.437 177.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -132.96 25.68 4.28 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.361 1.864 . . . . 0.0 112.124 -175.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -129.35 -61.39 1.03 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.494 1.118 . . . . 0.0 113.087 177.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.62 178.52 45.19 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 122.551 1.084 . . . . 0.0 111.603 -166.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -76.1 146.26 39.45 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 125.122 1.369 . . . . 0.0 110.757 177.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.21 18.58 4.92 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -173.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 59.98 -48.47 0.09 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 128.4 2.68 . . . . 0.0 115.253 -174.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.5 p -65.5 -18.32 65.23 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.838 2.055 . . . . 0.0 114.688 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.74 -15.32 59.21 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.963 0.905 . . . . 0.0 112.988 173.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -90.56 165.29 13.85 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.853 1.261 . . . . 0.0 110.341 176.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.3 mtmt -87.0 64.17 8.33 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.793 0.837 . . . . 0.0 112.435 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.0 mt -56.52 -27.63 57.89 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.752 1.621 . . . . 0.0 115.032 -172.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -86.04 -8.09 58.16 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.107 0.963 . . . . 0.0 113.137 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -135.04 58.82 29.96 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 125.27 1.428 . . . . 0.0 111.814 -161.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -65.82 139.45 57.3 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 CA-C-N 119.719 0.935 . . . . 0.0 112.421 -172.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -69.44 -27.88 65.64 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.747 0.819 . . . . 0.0 111.222 174.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 50.2 t90 -158.09 151.34 23.15 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.89 1.676 . . . . 0.0 110.713 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.3 p -132.97 150.68 52.14 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.791 0.836 . . . . 0.0 111.835 167.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.1 -142.91 5.53 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 116.259 -0.428 . . . . 0.0 113.524 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.5 mtm180 -109.64 146.4 34.84 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.528 1.931 . . . . 0.0 111.812 -176.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.2 tp -84.99 139.49 31.75 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.483 1.513 . . . . 0.0 109.746 163.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -143.93 92.41 2.33 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.091 1.356 . . . . 0.0 110.714 167.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.42 HD11 ' CD2' ' A' ' 119' ' ' PHE . 20.3 mt -76.95 126.27 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 171.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.2 p -138.22 165.53 26.46 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.771 2.028 . . . . 0.0 110.111 -178.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.0 m -148.15 160.12 43.24 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.562 1.145 . . . . 0.0 112.426 175.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -148.8 125.0 10.79 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.281 0.562 . . . . 0.0 112.35 155.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.55 -124.24 8.66 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 125.377 1.465 . . . . 0.0 110.025 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -99.86 17.86 19.77 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.714 1.605 . . . . 0.0 113.317 176.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.3 m -124.45 125.8 44.85 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.63 1.172 . . . . 0.0 110.172 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.68 160.11 14.5 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.549 1.14 . . . . 0.0 111.205 171.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -141.78 103.16 4.3 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.849 2.06 . . . . 0.0 109.071 -171.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.3 mp -81.45 94.16 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 169.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -90.15 141.7 28.43 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.613 0.765 . . . . 0.0 111.27 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.4 mp -113.2 133.04 55.26 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.618 1.967 . . . . 0.0 109.918 173.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -131.45 147.86 52.59 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.105 0.962 . . . . 0.0 113.003 -172.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -68.68 133.77 48.91 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.066 -1.021 . . . . 0.0 110.93 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.416 ' HG2' ' H ' ' A' ' 63' ' ' LYS . 36.5 pttt -77.48 -4.24 44.49 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -176.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 64.1 t -120.62 -42.44 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 125.205 1.402 . . . . 0.0 111.537 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.9 m -93.44 -20.57 20.18 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.09 11.46 79.09 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.551 1.072 . . . . 0.0 113.831 -176.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -87.19 152.44 22.32 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.325 1.45 . . . . 0.0 112.254 -173.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.5 tp -71.9 127.19 31.79 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.601 -0.687 . . . . 0.0 111.389 -178.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -87.27 -55.87 3.62 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.361 1.065 . . . . 0.0 111.047 169.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.95 163.54 39.02 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.438 1.495 . . . . 0.0 110.603 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -145.99 141.43 27.68 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 172.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.08 104.16 52.56 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 125.323 1.449 . . . . 0.0 111.606 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -64.6 142.59 78.16 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.037 3.158 . . . . 0.0 112.54 169.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.6 t -138.37 132.29 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.972 1.709 . . . . 0.0 108.793 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -103.42 -18.22 14.91 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.98 147.24 14.8 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.909 2.083 . . . . 0.0 109.766 173.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -134.3 124.62 17.36 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.484 1.113 . . . . 0.0 111.551 -177.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -59.25 147.89 38.86 Favored 'Cis proline' 0 CA--C 1.54 0.81 0 CA-C-N 120.123 1.08 . . . . 0.0 114.533 -4.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -161.7 -160.0 10.57 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 126.166 1.841 . . . . 0.0 112.025 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.6 tt -76.12 -40.0 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 118.185 0.993 . . . . 0.0 113.158 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.77 7.24 18.42 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -166.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.3 t -150.73 130.08 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.575 1.55 . . . . 0.0 109.947 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -141.84 158.01 44.31 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.041 1.736 . . . . 0.0 112.487 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.4 p -108.28 160.81 15.55 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.745 2.018 . . . . 0.0 111.153 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.9 m -88.87 169.35 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 124.062 0.945 . . . . 0.0 110.862 165.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.5 p -94.1 -29.5 15.13 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.869 1.267 . . . . 0.0 113.556 178.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -92.71 -41.25 10.26 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -166.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.2 t -142.27 112.76 7.21 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -177.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.6 p -72.94 30.32 0.06 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -174.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.43 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.254 1.0 OUTLIER -115.86 23.12 12.51 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.854 2.061 . . . . 0.0 113.519 166.785 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -140.44 138.59 34.82 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.69 1.596 . . . . 0.0 110.622 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -137.34 163.59 30.64 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.902 1.281 . . . . 0.0 111.562 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 37.2 t -117.57 144.83 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.862 1.265 . . . . 0.0 109.13 166.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.69 148.76 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 123.07 0.548 . . . . 0.0 111.538 170.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.459 ' HE ' ' NE2' ' A' ' 97' ' ' GLN . 42.0 ttp180 -91.05 98.82 12.0 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.397 0.679 . . . . 0.0 109.858 173.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -79.61 150.17 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.793 0.837 . . . . 0.0 111.628 176.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.459 ' NE2' ' HE ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -126.53 145.48 50.5 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.848 1.659 . . . . 0.0 110.835 177.05 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -87.67 1.09 54.67 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.59 1.156 . . . . 0.0 113.17 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.72 12.61 79.72 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.21 1.386 . . . . 0.0 114.862 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.6 t -138.31 17.71 2.77 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.414 1.486 . . . . 0.0 113.353 -172.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.99 -1.36 83.08 Favored Glycine 0 CA--C 1.539 1.543 0 O-C-N 120.489 -1.382 . . . . 0.0 115.025 -178.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -77.29 139.03 39.71 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.491 1.517 . . . . 0.0 108.929 165.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.4 p -144.19 157.73 44.13 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 168.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.25 144.23 29.72 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.999 1.319 . . . . 0.0 111.334 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -89.87 120.25 30.94 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.509 0.724 . . . . 0.0 109.607 169.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.5 pt -120.31 144.05 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.77 1.228 . . . . 0.0 111.053 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.44 142.71 16.17 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 124.151 0.881 . . . . 0.0 111.312 174.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.7 pt -129.33 143.09 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 125.506 1.522 . . . . 0.0 112.121 174.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.19 144.2 17.09 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.797 1.189 . . . . 0.0 113.491 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -107.08 158.7 16.86 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.084 1.754 . . . . 0.0 111.213 -178.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.8 t -72.21 -26.73 62.16 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.596 0.758 . . . . 0.0 112.796 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -157.23 151.64 25.17 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.441 1.096 . . . . 0.0 111.804 -176.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 43.2 ttm105 -61.32 -32.58 72.45 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.226 1.01 . . . . 0.0 113.197 177.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.94 -31.72 81.75 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 119.382 0.992 . . . . 0.0 113.464 176.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -85.89 -30.67 22.69 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 117.963 0.882 . . . . 0.0 112.395 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.43 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -65.92 -37.39 85.93 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 168.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -61.28 -36.46 80.12 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.105 -0.997 . . . . 0.0 110.91 170.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -71.17 -13.28 61.88 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 113.547 0.944 . . . . 0.0 113.547 175.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.42 ' CD2' HD11 ' A' ' 49' ' ' ILE . 15.5 t80 -77.97 -50.73 11.58 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.55 1.14 . . . . 0.0 111.568 165.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.11 -27.14 39.23 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -174.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 71.8 t -77.86 -43.02 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.129 -0.982 . . . . 0.0 111.159 177.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 92.1 p -65.58 -33.9 76.99 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.606 -0.684 . . . . 0.0 112.687 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 35.1 tp -72.58 -47.04 51.25 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.913 1.285 . . . . 0.0 111.591 176.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -69.75 -29.82 67.26 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.162 -0.961 . . . . 0.0 113.239 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -78.96 -4.02 47.85 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.215 1.006 . . . . 0.0 112.333 177.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -89.5 -21.89 22.72 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.299 -0.876 . . . . 0.0 113.143 162.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -99.28 -13.23 19.76 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -177.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.01 -28.95 41.4 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 -172.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 35.8 p-90 -82.92 -24.97 32.86 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.472 1.109 . . . . 0.0 113.256 176.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.4 t -76.47 -43.21 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.266 1.426 . . . . 0.0 110.61 177.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -92.24 8.24 39.04 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 42.42 82.73 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 129.134 2.974 . . . . 0.0 115.253 176.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 . . . . . 0 C--O 1.252 1.213 0 C-N-CA 126.933 2.093 . . . . 0.0 112.787 172.826 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.527 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 54.0 p -147.07 179.45 1.17 Allowed Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 125.788 1.635 . . . . 0.0 110.876 178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -57.78 -24.04 61.58 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.347 2.032 . . . . 0.0 113.733 171.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -70.12 -24.61 63.22 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.648 1.179 . . . . 0.0 112.515 174.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 5.6 m -72.73 -15.58 61.67 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.924 1.29 . . . . 0.0 112.433 170.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mmt -103.62 -120.67 0.2 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.651 1.98 . . . . 0.0 109.59 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.92 31.87 4.14 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.822 1.649 . . . . 0.0 111.817 174.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.2 m 59.17 61.22 2.14 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 123.84 1.781 . . . . 0.0 109.496 -157.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -127.58 123.29 35.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.349 2.26 . . . . 0.0 106.984 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.09 160.35 20.45 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.942 1.297 . . . . 0.0 113.43 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -133.92 40.29 3.09 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.263 1.825 . . . . 0.0 110.478 176.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -150.37 147.36 27.49 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.068 1.747 . . . . 0.0 109.972 -177.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 176.05 116.0 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.702 2.001 . . . . 0.0 108.552 157.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.3 m -87.99 113.05 23.25 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.653 -0.654 . . . . 0.0 110.65 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.9 p -69.24 148.82 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.492 1.117 . . . . 0.0 112.908 -177.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.2 mt -135.58 -38.84 0.73 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.916 1.686 . . . . 0.0 112.305 -171.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.0 t -147.02 140.52 25.58 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.415 1.486 . . . . 0.0 109.753 174.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.4 t -131.85 132.07 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.374 1.07 . . . . 0.0 108.637 167.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.61 131.72 18.39 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 124.694 1.197 . . . . 0.0 111.341 177.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -81.04 -15.63 10.32 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.843 2.362 . . . . 0.0 115.302 -170.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -130.5 106.79 8.76 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.38 1.072 . . . . 0.0 110.82 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.8 p -143.81 142.38 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.032 1.333 . . . . 0.0 110.359 173.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.8 m -125.72 132.04 52.43 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.721 1.208 . . . . 0.0 111.137 -173.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 79.4 t -97.43 130.68 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.497 1.119 . . . . 0.0 111.225 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -131.78 117.02 18.01 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.99 1.316 . . . . 0.0 108.295 168.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.3 mtt-85 -71.63 128.85 37.14 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.87 -0.519 . . . . 0.0 109.73 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 39.3 pt -86.78 150.24 50.08 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -163.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -67.53 162.98 36.7 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 122.948 2.432 . . . . 0.0 111.401 164.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -60.45 145.58 98.44 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.553 2.169 . . . . 0.0 111.315 170.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.4 ttm-85 -65.69 147.83 52.75 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.823 0.849 . . . . 0.0 112.53 -173.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.61 178.13 0.46 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.392 1.477 . . . . 0.0 113.236 161.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 80.4 p -95.23 -41.48 9.04 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.144 1.377 . . . . 0.0 112.993 -177.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -125.03 -6.79 7.22 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.481 1.512 . . . . 0.0 113.741 -174.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -93.18 -61.08 1.64 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.481 1.112 . . . . 0.0 112.274 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.26 -170.45 42.94 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 122.588 1.104 . . . . 0.0 111.148 -162.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -80.24 134.65 36.13 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 124.852 1.261 . . . . 0.0 110.606 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.67 21.36 7.73 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -173.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 56.9 -49.91 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.29 2.636 . . . . 0.0 115.399 -171.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.7 m -64.71 -14.64 59.36 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.26 1.824 . . . . 0.0 114.558 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -84.18 -7.84 59.24 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.774 1.23 . . . . 0.0 113.039 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.2 m0 -93.7 169.4 10.35 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.73 1.612 . . . . 0.0 111.151 176.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -76.56 51.89 0.76 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.194 1.798 . . . . 0.0 114.185 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.5 mt -55.58 -28.54 55.64 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.205 1.402 . . . . 0.0 114.487 -177.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -88.37 -7.42 56.68 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.428 0.691 . . . . 0.0 112.547 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -152.38 66.52 6.47 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.965 1.306 . . . . 0.0 111.887 -168.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -58.27 145.29 93.86 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.397 2.731 . . . . 0.0 112.856 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -72.56 -28.8 63.04 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.544 1.138 . . . . 0.0 111.657 174.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 42.1 t90 -158.11 152.14 24.08 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.431 1.892 . . . . 0.0 110.234 177.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.8 p -134.11 150.63 51.16 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.882 0.873 . . . . 0.0 111.862 169.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.38 -139.15 4.19 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 123.233 0.444 . . . . 0.0 113.325 -177.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.1 mtm105 -115.82 150.36 37.08 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.709 2.004 . . . . 0.0 112.001 -173.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.5 tp -94.61 138.33 32.61 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.227 1.811 . . . . 0.0 110.207 171.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.5 ttm-85 -135.74 111.1 9.08 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.825 1.25 . . . . 0.0 109.808 160.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.516 HD11 ' CD2' ' A' ' 119' ' ' PHE . 24.9 mt -91.32 131.3 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 168.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.25 170.36 16.1 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 127.396 2.279 . . . . 0.0 110.13 -173.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.6 t -158.54 149.47 20.47 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 120.409 -1.432 . . . . 0.0 111.792 176.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -151.42 129.14 11.55 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.631 0.772 . . . . 0.0 112.663 158.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.88 45.88 55.41 Favored Glycine 0 N--CA 1.473 1.162 0 C-N-CA 124.432 1.015 . . . . 0.0 114.956 164.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt 62.99 26.24 15.42 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.294 1.838 . . . . 0.0 113.269 -174.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.4 m -131.03 114.11 14.79 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.112 1.365 . . . . 0.0 108.72 168.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -83.99 159.23 21.27 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.507 0.723 . . . . 0.0 110.464 172.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -136.08 115.7 12.89 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 125.956 1.702 . . . . 0.0 108.693 -175.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.7 mp -92.29 99.48 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 168.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -99.83 139.7 35.12 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.876 0.846 . . . . 0.0 112.207 175.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.8 mp -110.68 132.94 53.76 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.091 1.756 . . . . 0.0 109.92 176.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -134.77 151.02 50.64 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.017 0.927 . . . . 0.0 113.04 -171.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -73.14 144.11 47.04 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.924 0.869 . . . . 0.0 112.112 -178.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.1 pttt -84.22 -6.56 59.41 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.209 1.804 . . . . 0.0 115.144 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 95.7 t -122.73 -44.17 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.206 1.402 . . . . 0.0 111.447 178.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.0 m -94.08 -21.8 18.9 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -175.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.01 5.92 85.4 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.182 0.896 . . . . 0.0 113.861 -177.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -82.02 153.88 25.96 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.276 1.431 . . . . 0.0 112.752 -173.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.5 tp -73.52 126.08 29.41 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.993 0.917 . . . . 0.0 111.107 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -86.18 -55.78 3.76 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.437 1.095 . . . . 0.0 111.121 170.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.85 164.01 38.55 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.755 1.222 . . . . 0.0 111.838 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -140.83 136.4 32.36 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.831 1.252 . . . . 0.0 111.816 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.4 107.69 36.58 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 124.778 1.231 . . . . 0.0 111.633 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -76.42 136.55 17.72 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.563 2.842 . . . . 0.0 111.925 173.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.1 t -127.71 119.53 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 127.093 2.157 . . . . 0.0 108.761 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -88.27 -17.69 30.18 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.48 151.33 16.9 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.18 1.792 . . . . 0.0 109.939 172.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -116.28 130.91 24.1 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 123.597 0.759 . . . . 0.0 113.014 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.63 151.37 74.54 Favored 'Cis proline' 0 CA--C 1.542 0.886 0 CA-C-N 119.247 0.767 . . . . 0.0 112.694 -13.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -132.16 -163.1 10.61 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.099 1.333 . . . . 0.0 113.361 176.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.6 tt -79.77 -34.6 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.538 0.735 . . . . 0.0 112.263 171.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.04 11.72 3.88 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.484 1.114 . . . . 0.0 113.63 -172.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.7 p -156.4 141.85 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 126.369 1.868 . . . . 0.0 110.815 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -159.3 161.26 35.85 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.489 1.116 . . . . 0.0 113.552 -175.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.2 p -110.76 159.54 17.54 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 127.114 2.165 . . . . 0.0 111.719 174.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.9 m -85.02 176.52 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.659 1.183 . . . . 0.0 111.255 166.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 73.4 p -92.28 -33.71 14.53 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.761 1.224 . . . . 0.0 113.47 177.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -92.45 -41.31 10.37 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -162.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.2 t -141.41 132.92 26.9 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -176.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.8 m -64.45 -12.14 40.57 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -172.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.439 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.289 31.3 ptt180 -89.0 14.56 10.3 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -174.743 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -135.72 136.48 40.86 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.472 1.109 . . . . 0.0 111.87 -173.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -138.04 161.07 37.68 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.113 1.365 . . . . 0.0 111.655 -178.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.2 t -114.67 143.2 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.499 1.12 . . . . 0.0 108.951 166.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.29 150.37 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 118.468 0.576 . . . . 0.0 111.625 169.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -93.06 89.72 6.61 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.012 0.925 . . . . 0.0 110.398 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -71.09 137.78 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 120.712 0.291 . . . . 0.0 110.956 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -145.13 143.81 30.57 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.066 1.746 . . . . 0.0 110.924 -168.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -88.15 -4.31 58.76 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.85 3.83 90.46 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 125.023 1.297 . . . . 0.0 114.668 -177.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.7 t -108.29 1.81 22.2 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.275 1.83 . . . . 0.0 113.586 -176.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.91 -4.08 49.22 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.172 1.368 . . . . 0.0 114.415 -174.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -70.93 137.15 48.97 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.389 1.476 . . . . 0.0 109.603 164.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 89.6 p -147.78 151.86 36.73 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 169.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.11 140.97 25.83 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.338 1.455 . . . . 0.0 111.005 168.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -90.01 119.61 30.51 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.294 0.638 . . . . 0.0 109.837 171.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.4 pt -117.8 145.41 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.594 1.158 . . . . 0.0 110.955 177.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.68 140.02 14.82 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 173.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.6 pt -125.12 141.75 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 124.879 1.272 . . . . 0.0 111.665 173.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -125.13 141.88 13.4 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.265 1.412 . . . . 0.0 112.572 174.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -101.96 170.97 7.79 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.165 1.786 . . . . 0.0 111.417 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.7 t -70.04 -37.56 75.59 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.349 0.66 . . . . 0.0 112.277 175.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -152.99 154.35 34.78 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.073 -1.017 . . . . 0.0 112.765 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -58.14 -38.87 77.38 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.349 1.46 . . . . 0.0 112.131 176.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.05 -14.05 73.26 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.014 0.816 . . . . 0.0 114.06 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -97.26 -36.94 10.26 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 118.191 0.995 . . . . 0.0 111.69 172.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.439 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -64.91 -30.73 71.74 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.293 1.037 . . . . 0.0 113.668 170.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.13 -29.05 60.17 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.439 1.018 . . . . 0.0 112.974 175.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -69.66 -27.19 64.83 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.316 -0.865 . . . . 0.0 112.954 176.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.516 ' CD2' HD11 ' A' ' 49' ' ' ILE . 32.7 t80 -62.77 -52.59 62.59 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.429 1.092 . . . . 0.0 111.356 173.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -80.61 -24.33 39.15 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -175.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.7 t -78.87 -42.56 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 119.062 0.846 . . . . 0.0 111.542 174.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 93.8 p -65.62 -31.3 72.26 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.434 1.015 . . . . 0.0 113.337 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.5 mt -69.38 -54.13 15.99 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.77 0.828 . . . . 0.0 111.435 172.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -65.61 -31.37 72.36 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.408 -0.808 . . . . 0.0 112.763 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -81.11 -4.37 55.08 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.339 1.056 . . . . 0.0 112.727 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -95.84 -15.86 22.21 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 164.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -106.52 -6.18 18.28 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.35 -29.21 57.94 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 121.397 1.908 . . . . 0.0 115.577 -175.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 36.3 p-90 -79.81 -23.55 41.99 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.135 1.374 . . . . 0.0 113.54 175.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 18.7 t -83.53 -31.7 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.644 1.578 . . . . 0.0 110.844 172.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -91.31 31.26 1.16 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 127.562 2.345 . . . . 0.0 112.572 -177.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -79.56 91.7 5.22 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.887 0.875 . . . . 0.0 109.663 173.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 C--O 1.252 1.198 0 C-N-CA 126.8 2.04 . . . . 0.0 112.725 -171.784 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.612 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 53.6 p -148.94 160.48 35.17 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 125.154 1.382 . . . . 0.0 111.544 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.22 -4.85 15.75 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.109 2.539 . . . . 0.0 114.49 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -60.71 -22.01 63.51 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.287 1.035 . . . . 0.0 113.589 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 78.8 p -61.39 -18.98 61.33 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 173.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.0 mtm -86.37 1.08 52.49 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.122 1.369 . . . . 0.0 113.592 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.37 -34.84 0.93 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.303 1.441 . . . . 0.0 113.264 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 49.3 m -123.77 103.17 8.21 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.527 1.531 . . . . 0.0 109.361 178.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -140.28 17.98 2.41 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.342 1.457 . . . . 0.0 112.955 -176.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.42 49.62 1.33 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.929 2.092 . . . . 0.0 112.07 -174.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -84.76 40.35 0.8 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.842 1.657 . . . . 0.0 112.156 -174.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -156.92 151.18 25.15 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.452 1.901 . . . . 0.0 110.23 -169.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -169.45 127.37 0.95 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.047 1.739 . . . . 0.0 107.739 167.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -104.46 107.19 17.99 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 167.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.445 ' HA ' HG22 ' A' ' 50' ' ' THR . 41.6 t -64.39 145.13 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 125.753 1.621 . . . . 0.0 112.386 -177.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.4 mt -130.79 -41.24 1.17 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.814 1.646 . . . . 0.0 112.223 -173.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 36.8 t -148.65 137.68 21.62 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.75 1.22 . . . . 0.0 110.717 174.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 81.8 t -130.21 127.79 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.912 1.285 . . . . 0.0 109.511 172.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -125.96 132.4 24.3 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 125.362 1.465 . . . . 0.0 110.096 173.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.52 -10.88 14.5 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.36 2.706 . . . . 0.0 115.495 -170.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -136.74 111.79 8.97 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.92 0.867 . . . . 0.0 112.192 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -143.9 144.02 23.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 125.437 1.495 . . . . 0.0 110.144 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.9 m -125.86 128.18 47.22 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.227 1.011 . . . . 0.0 111.492 -170.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.8 t -92.87 136.21 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.374 1.47 . . . . 0.0 112.006 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -129.85 128.36 42.11 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.962 1.305 . . . . 0.0 109.281 169.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 17.7 mmm-85 -76.02 112.55 12.57 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.003 0.921 . . . . 0.0 108.867 172.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.5 pt -82.16 153.04 68.97 Favored Pre-proline 0 N--CA 1.477 0.904 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -162.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.29 162.71 37.42 Favored 'Trans proline' 0 CA--C 1.548 1.216 0 C-N-CA 123.694 2.93 . . . . 0.0 112.367 169.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -63.62 150.85 87.48 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 123.484 2.789 . . . . 0.0 112.917 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.4 ttt85 -100.31 151.32 21.62 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.426 1.49 . . . . 0.0 113.242 -172.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -144.97 140.01 27.92 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.151 143.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.6 m -69.38 -18.72 63.8 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.727 1.381 . . . . 0.0 114.727 -171.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -70.83 -10.62 59.94 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 167.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -108.41 -57.96 2.06 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 127.017 2.127 . . . . 0.0 110.641 173.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.47 159.39 5.59 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 125.444 1.497 . . . . 0.0 112.708 -174.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -71.88 136.95 47.12 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.479 0.712 . . . . 0.0 109.813 168.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.78 19.39 6.11 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -172.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 56.68 -47.07 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 128.127 2.571 . . . . 0.0 115.893 -173.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.4 m -64.71 -18.41 64.98 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.062 1.745 . . . . 0.0 114.576 -177.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -85.3 -5.82 59.29 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 173.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.0 m0 -89.09 172.01 9.41 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.039 1.336 . . . . 0.0 110.743 174.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -79.72 52.86 1.51 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.187 1.395 . . . . 0.0 114.279 -176.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 mt -59.83 -18.56 44.85 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 -172.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -105.43 -6.08 19.8 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.771 1.229 . . . . 0.0 113.168 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -148.97 67.74 9.32 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.863 1.265 . . . . 0.0 112.055 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -54.66 145.52 59.26 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.554 2.836 . . . . 0.0 113.02 177.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -70.7 -29.34 65.61 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.424 1.089 . . . . 0.0 111.661 175.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 40.8 t90 -156.96 154.12 29.16 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.615 1.566 . . . . 0.0 110.946 173.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.3 p -135.69 150.42 49.57 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.238 1.015 . . . . 0.0 112.331 171.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.18 -142.1 5.14 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.239 0.447 . . . . 0.0 114.006 -176.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.5 mtm180 -111.23 152.0 27.63 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 127.066 2.146 . . . . 0.0 111.919 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.4 tp -90.31 139.6 30.5 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.075 1.75 . . . . 0.0 110.184 165.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -140.07 98.83 3.53 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.053 1.341 . . . . 0.0 110.249 163.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.2 mt -80.03 130.4 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 170.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.445 HG22 ' HA ' ' A' ' 10' ' ' VAL . 5.4 p -137.5 159.35 42.2 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.592 1.957 . . . . 0.0 110.06 -177.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.2 t -156.26 133.89 10.95 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.474 -1.391 . . . . 0.0 113.411 173.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -146.15 128.58 15.94 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.159 1.784 . . . . 0.0 110.587 177.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.75 36.88 52.45 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.438 1.018 . . . . 0.0 114.963 169.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? 61.95 27.92 16.96 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.467 1.907 . . . . 0.0 113.477 -170.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.0 m -132.23 117.82 18.71 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.195 1.398 . . . . 0.0 109.132 172.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.32 157.5 19.89 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.746 0.818 . . . . 0.0 110.856 172.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -138.3 116.67 11.95 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.6 1.56 . . . . 0.0 108.928 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mp -86.1 93.45 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 168.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -88.02 139.43 30.52 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.502 0.721 . . . . 0.0 111.265 174.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.0 mp -113.69 132.87 55.64 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.442 1.897 . . . . 0.0 110.63 176.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -129.06 147.88 50.96 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -171.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.94 128.21 34.83 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 121.18 -0.95 . . . . 0.0 109.539 171.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -75.44 -9.01 58.19 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -172.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.5 t -112.28 -36.95 2.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 124.239 1.016 . . . . 0.0 110.807 -171.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.1 m -110.47 -15.44 13.91 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.66 19.77 79.77 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 118.882 0.764 . . . . 0.0 113.708 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -63.51 158.94 19.68 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.647 1.179 . . . . 0.0 111.442 173.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.8 tp -95.11 119.59 33.88 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.832 0.853 . . . . 0.0 109.279 167.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -84.31 -55.44 4.17 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.611 0.764 . . . . 0.0 111.28 175.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.4 165.91 35.16 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.724 1.21 . . . . 0.0 111.533 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -144.63 135.32 24.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.737 1.215 . . . . 0.0 111.036 175.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.71 97.17 48.34 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.169 0.988 . . . . 0.0 111.943 175.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.78 137.26 80.25 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 124.367 3.378 . . . . 0.0 113.121 165.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.8 t -139.14 129.03 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 126.414 1.886 . . . . 0.0 109.739 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -90.19 -23.07 21.39 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.44 152.19 16.09 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.82 1.648 . . . . 0.0 111.078 174.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -130.85 135.51 27.46 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 124.876 1.27 . . . . 0.0 112.003 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -61.7 145.0 45.39 Favored 'Cis proline' 0 CA--C 1.539 0.747 0 CA-C-N 119.889 0.996 . . . . 0.0 113.19 -9.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -157.29 -155.71 7.6 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.736 1.16 . . . . 0.0 114.0 -174.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.59 -38.94 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.464 1.106 . . . . 0.0 113.692 -174.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.37 9.29 15.91 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -173.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.6 t -149.33 133.18 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.819 1.648 . . . . 0.0 109.922 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.55 163.99 34.0 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.248 1.819 . . . . 0.0 112.555 -174.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 62.2 p -116.84 162.27 17.98 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.166 1.787 . . . . 0.0 111.822 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.7 m -89.75 175.46 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.296 1.038 . . . . 0.0 111.057 165.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 71.5 p -95.96 -30.9 13.35 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.218 1.407 . . . . 0.0 113.441 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -90.18 -43.78 10.2 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -167.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.3 t -143.37 127.67 17.73 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -176.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.43 -3.28 7.97 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -173.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.478 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.278 23.4 ptt180 -84.7 14.89 4.23 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 177.761 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -139.25 134.06 32.14 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.744 1.218 . . . . 0.0 111.119 -174.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -136.11 161.46 35.64 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.257 1.423 . . . . 0.0 111.168 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 75.9 t -116.21 143.89 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.577 1.151 . . . . 0.0 108.937 167.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.86 148.51 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 119.123 0.874 . . . . 0.0 112.261 173.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -87.65 88.76 7.76 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.414 0.686 . . . . 0.0 110.259 173.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.25 141.6 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 O-C-N 121.99 -0.444 . . . . 0.0 110.841 174.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -135.61 142.57 45.28 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.425 1.49 . . . . 0.0 111.597 -175.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -94.95 13.98 23.19 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.919 1.288 . . . . 0.0 113.529 -176.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.76 7.04 85.9 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.335 1.445 . . . . 0.0 115.463 176.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.4 t -130.06 4.58 4.87 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.521 1.528 . . . . 0.0 113.802 -172.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.74 -4.85 69.2 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.304 1.43 . . . . 0.0 113.843 -175.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -76.87 129.76 36.66 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 127.414 2.285 . . . . 0.0 108.455 166.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.0 p -153.55 161.55 42.11 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.497 1.119 . . . . 0.0 113.981 -175.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -148.08 150.51 34.02 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.32 1.448 . . . . 0.0 111.523 172.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -92.94 118.7 31.44 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.251 0.62 . . . . 0.0 109.787 168.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.8 pt -120.11 145.84 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.668 1.187 . . . . 0.0 111.063 178.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.44 144.32 17.11 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 173.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.1 pt -128.1 140.62 48.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.719 1.608 . . . . 0.0 111.452 172.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.83 143.06 14.69 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.857 1.694 . . . . 0.0 112.787 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -104.98 161.75 13.94 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.11 1.364 . . . . 0.0 112.466 -174.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.7 t -69.86 -28.1 65.39 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.245 1.018 . . . . 0.0 112.699 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -156.85 151.02 25.06 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.27 1.028 . . . . 0.0 111.828 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -62.43 -34.66 77.21 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.281 1.032 . . . . 0.0 113.118 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.35 -26.16 74.82 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 123.864 0.745 . . . . 0.0 113.733 175.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -84.91 -32.73 22.98 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.039 0.936 . . . . 0.0 111.632 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.478 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -67.61 -32.11 72.61 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 168.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.04 -31.54 67.13 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.377 -0.827 . . . . 0.0 112.569 173.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -68.3 -27.39 66.26 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.315 -0.865 . . . . 0.0 112.992 174.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -63.87 -55.17 24.78 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.816 1.189 . . . . 0.0 111.739 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -75.13 -24.87 58.08 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.5 t -75.94 -40.81 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 121.414 -0.804 . . . . 0.0 111.093 173.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.5 t -59.04 -39.67 82.72 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.061 0.846 . . . . 0.0 112.662 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.6 mt -67.94 -54.43 18.72 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.408 0.683 . . . . 0.0 111.92 175.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -67.15 -32.21 73.16 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.3 -0.875 . . . . 0.0 113.02 -174.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -84.82 -0.63 54.56 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.379 1.072 . . . . 0.0 112.708 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -92.81 -37.97 12.02 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.438 -0.789 . . . . 0.0 112.287 159.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -85.39 -7.15 59.1 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -175.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.63 -31.58 57.56 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -172.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 34.2 p-90 -81.66 -27.77 33.9 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.75 1.22 . . . . 0.0 113.136 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.1 t -74.63 -32.55 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.238 1.415 . . . . 0.0 110.764 174.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -102.43 41.61 1.22 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.752 2.021 . . . . 0.0 112.365 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -81.01 2.78 25.51 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 164.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 C--O 1.254 1.294 0 C-N-CA 128.914 2.886 . . . . 0.0 112.029 176.66 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.652 0 N-CA-C 112.098 -0.401 . . . . 0.0 112.098 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 9.5 p -76.02 162.76 70.45 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.118 0.967 . . . . 0.0 112.495 177.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.53 1.59 8.29 Favored 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 123.359 2.706 . . . . 0.0 114.265 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -72.29 163.42 27.99 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.43 1.092 . . . . 0.0 112.804 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 62.9 p -71.68 -14.43 62.03 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.834 1.254 . . . . 0.0 114.36 177.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 mmt -131.51 151.59 51.44 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.567 1.947 . . . . 0.0 111.42 175.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.33 -48.17 0.16 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.465 1.106 . . . . 0.0 112.964 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 93.4 m -81.06 -37.05 29.67 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.584 0.754 . . . . 0.0 111.08 172.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 47.98 75.7 0.13 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.8 2.44 . . . . 0.0 115.057 169.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.2 pp -128.76 145.61 51.13 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.719 0.808 . . . . 0.0 112.136 164.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -129.68 49.17 2.29 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.741 1.616 . . . . 0.0 110.406 176.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -143.18 153.56 42.98 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.028 1.331 . . . . 0.0 112.719 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -174.56 78.18 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 129.877 3.271 . . . . 0.0 105.146 -175.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.25 115.01 12.08 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 121.115 -0.991 . . . . 0.0 110.596 -163.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.4 t -75.31 145.67 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.031 0.932 . . . . 0.0 111.231 -169.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.8 mt -131.45 -39.79 1.13 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.624 1.569 . . . . 0.0 111.856 -171.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.5 t -148.57 141.72 24.99 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.058 1.343 . . . . 0.0 110.393 176.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.7 t -136.37 127.32 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.984 1.314 . . . . 0.0 108.882 169.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -131.8 138.53 32.74 Favored Pre-proline 0 N--CA 1.48 1.062 0 C-N-CA 125.135 1.374 . . . . 0.0 111.072 177.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -81.23 -17.1 9.31 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 123.242 2.628 . . . . 0.0 115.67 -170.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -132.81 107.55 8.42 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.988 0.915 . . . . 0.0 111.345 -173.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.4 p -143.75 142.95 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.488 1.515 . . . . 0.0 110.331 173.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.8 m -126.32 128.0 46.42 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.456 1.102 . . . . 0.0 111.518 -171.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.2 t -93.99 137.13 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.128 1.371 . . . . 0.0 112.091 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -129.88 125.22 35.09 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.037 1.335 . . . . 0.0 108.98 168.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.9 mmt85 -70.58 109.18 4.71 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.524 -0.735 . . . . 0.0 109.617 169.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.1 pt -77.87 155.74 80.29 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 125.019 1.328 . . . . 0.0 113.292 -171.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -67.03 159.41 52.13 Favored 'Trans proline' 0 CA--C 1.549 1.245 0 C-N-CA 122.411 2.074 . . . . 0.0 111.06 158.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -62.86 149.51 91.18 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.794 2.329 . . . . 0.0 111.897 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.9 ttm105 -65.88 147.62 53.09 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.829 0.852 . . . . 0.0 112.188 -176.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.4 178.08 1.01 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.419 1.088 . . . . 0.0 112.558 160.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 79.8 p -94.98 -39.03 10.39 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.18 1.392 . . . . 0.0 112.488 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -126.76 -3.11 6.59 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.777 1.631 . . . . 0.0 113.571 -175.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -100.68 -52.4 3.34 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.243 1.017 . . . . 0.0 113.253 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.33 173.15 49.65 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-O 122.5 1.055 . . . . 0.0 111.711 -176.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -72.87 141.58 47.93 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.637 1.175 . . . . 0.0 110.728 174.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.66 18.97 5.69 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -172.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.53 -50.01 0.05 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.968 2.507 . . . . 0.0 115.411 -174.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.2 m -65.97 -14.9 62.42 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.247 1.819 . . . . 0.0 114.359 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.25 -15.54 58.67 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.84 0.856 . . . . 0.0 112.813 172.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -89.66 172.51 8.89 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.442 1.497 . . . . 0.0 111.424 -178.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -81.11 54.86 2.34 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.438 1.495 . . . . 0.0 114.059 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.9 mt -60.3 -17.41 42.51 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -172.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -105.96 -3.89 21.21 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.558 1.143 . . . . 0.0 113.078 177.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -147.81 72.03 11.45 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.068 1.347 . . . . 0.0 111.949 176.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -56.77 143.92 88.86 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 123.147 2.564 . . . . 0.0 112.43 173.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -71.04 -29.09 64.9 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.682 1.193 . . . . 0.0 111.766 175.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 37.9 t90 -156.95 153.17 27.66 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.675 1.59 . . . . 0.0 110.52 174.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.7 p -134.57 150.14 50.69 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.673 0.789 . . . . 0.0 112.043 169.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.18 -141.07 4.92 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 123.336 0.493 . . . . 0.0 113.422 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.7 mtm105 -113.51 149.92 33.67 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.712 2.005 . . . . 0.0 112.168 -173.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.5 tp -90.28 141.57 28.59 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.751 1.62 . . . . 0.0 110.629 169.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.6 ttm-85 -132.66 130.94 40.79 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.214 1.406 . . . . 0.0 109.719 156.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.5 HD11 ' CD1' ' A' ' 119' ' ' PHE . 26.4 mt -107.9 132.56 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 164.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.14 156.06 44.71 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 127.523 2.329 . . . . 0.0 108.72 -166.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.6 t -163.9 152.24 13.23 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.107 -1.621 . . . . 0.0 110.819 178.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -127.39 -46.6 1.47 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 -174.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.1 86.04 0.1 OUTLIER Glycine 0 N--CA 1.472 1.065 0 C-N-CA 123.606 0.622 . . . . 0.0 111.722 -175.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 94.1 mttt 55.53 23.47 6.0 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.141 1.776 . . . . 0.0 112.826 -171.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.9 m -141.74 121.04 13.09 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.836 1.254 . . . . 0.0 108.237 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.87 160.13 14.54 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.628 1.171 . . . . 0.0 111.053 174.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -139.2 113.19 8.64 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 127.076 2.15 . . . . 0.0 108.839 -176.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.3 mp -88.62 109.04 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 167.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -108.44 134.75 50.8 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.748 1.219 . . . . 0.0 111.588 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.6 mp -105.31 132.4 51.56 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 125.435 1.494 . . . . 0.0 110.089 176.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -134.9 151.6 51.02 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.946 0.899 . . . . 0.0 112.98 -170.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -74.12 143.91 45.14 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.282 -0.886 . . . . 0.0 112.071 -178.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.4 pttt -84.41 -6.61 59.4 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.296 1.838 . . . . 0.0 115.067 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.1 t -122.7 -44.18 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.341 1.456 . . . . 0.0 111.543 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.6 m -93.93 -22.37 18.63 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -174.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.3 6.08 86.05 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.14 0.876 . . . . 0.0 113.803 -177.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -81.8 154.59 25.86 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.31 1.444 . . . . 0.0 112.623 -174.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.5 tp -75.05 125.46 28.96 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.94 0.896 . . . . 0.0 111.147 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -85.23 -54.19 4.76 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.286 1.035 . . . . 0.0 111.156 170.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.52 162.89 38.86 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.595 1.158 . . . . 0.0 112.098 -178.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -140.68 133.86 29.53 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.831 1.252 . . . . 0.0 111.905 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.17 104.29 43.78 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.362 1.465 . . . . 0.0 111.159 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.96 144.52 30.49 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.833 3.022 . . . . 0.0 112.141 173.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.8 t -139.78 125.41 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 126.327 1.851 . . . . 0.0 109.554 -172.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -91.01 -23.4 20.39 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.13 149.15 15.65 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.268 1.827 . . . . 0.0 110.344 172.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -118.0 129.69 25.2 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.639 1.176 . . . . 0.0 111.153 175.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.85 149.41 80.32 Favored 'Cis proline' 0 CA--C 1.542 0.891 0 CA-C-N 119.715 0.934 . . . . 0.0 112.737 -6.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -151.57 -162.42 10.75 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.827 1.679 . . . . 0.0 112.293 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 19.6 tt -76.43 -35.15 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 121.688 -0.889 . . . . 0.0 112.837 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.47 7.23 17.58 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -168.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.1 t -150.97 130.51 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.856 1.662 . . . . 0.0 109.736 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -141.09 158.95 43.22 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.641 1.977 . . . . 0.0 112.317 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 47.4 p -107.05 160.89 15.21 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.751 2.02 . . . . 0.0 111.356 175.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 m -86.81 172.28 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.149 0.98 . . . . 0.0 110.949 163.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 58.8 p -95.07 -30.0 14.3 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.011 1.325 . . . . 0.0 113.608 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -90.11 -50.25 6.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.889 0.876 . . . . 0.0 113.229 -167.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.9 m -136.35 116.91 13.84 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.352 0.661 . . . . 0.0 112.724 -169.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.26 -8.68 18.9 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -168.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.462 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.322 43.2 ptt85 -84.12 21.31 1.39 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 178.875 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -140.3 137.45 34.18 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.896 1.278 . . . . 0.0 111.496 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -138.88 163.35 32.53 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.176 1.39 . . . . 0.0 111.032 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 55.9 t -118.21 142.44 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 124.546 1.139 . . . . 0.0 108.914 167.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.73 148.62 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 118.527 0.603 . . . . 0.0 111.975 173.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -90.66 87.54 6.75 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.57 0.748 . . . . 0.0 111.007 178.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -70.83 139.48 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 122.574 0.35 . . . . 0.0 111.044 176.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -142.78 144.02 32.42 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.251 1.82 . . . . 0.0 111.044 -169.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -91.37 5.45 49.26 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.15 13.17 81.4 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 124.958 1.266 . . . . 0.0 114.751 175.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.0 t -133.06 14.06 4.26 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.683 1.593 . . . . 0.0 113.386 -173.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.32 -3.97 76.56 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.651 1.119 . . . . 0.0 114.362 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 72.7 mtp85 -70.04 139.38 52.66 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 125.441 1.496 . . . . 0.0 109.415 162.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 56.8 p -154.58 158.1 39.25 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 115.046 1.498 . . . . 0.0 115.046 171.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.46 145.05 31.67 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.668 1.587 . . . . 0.0 110.495 165.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -91.1 119.85 31.58 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 167.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.8 pt -118.28 144.56 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.447 1.099 . . . . 0.0 110.93 178.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.63 142.95 16.3 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 174.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.9 pt -128.46 139.29 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 125.456 1.502 . . . . 0.0 111.725 173.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -118.85 139.78 14.68 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.93 1.729 . . . . 0.0 112.518 176.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -102.47 155.79 18.03 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.524 1.53 . . . . 0.0 112.222 -176.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.1 t -71.3 -23.56 61.98 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.351 1.061 . . . . 0.0 112.839 177.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -154.18 147.04 24.38 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.157 0.983 . . . . 0.0 112.212 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -64.42 -35.11 79.84 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.428 1.091 . . . . 0.0 113.273 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.36 -30.42 76.6 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-N 118.851 0.75 . . . . 0.0 113.165 176.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -82.5 -31.76 29.11 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.877 -0.778 . . . . 0.0 112.248 177.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.462 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -64.93 -38.58 91.43 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 166.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -61.35 -38.27 86.34 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.132 -0.98 . . . . 0.0 111.279 168.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -67.43 -36.31 80.98 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 119.093 0.861 . . . . 0.0 112.856 177.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.5 ' CD1' HD11 ' A' ' 49' ' ' ILE . 13.2 t80 -54.65 -51.39 65.6 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.74 1.216 . . . . 0.0 111.735 167.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -68.52 -42.55 78.37 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.611 0.764 . . . . 0.0 112.496 -177.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.8 t -65.84 -37.76 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 O-C-N 121.615 -0.678 . . . . 0.0 110.884 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 55.7 m -65.9 -14.42 61.49 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 176.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.6 mt -91.75 -54.13 4.0 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.008 0.923 . . . . 0.0 111.342 168.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -69.33 -32.92 72.33 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.952 -1.093 . . . . 0.0 113.669 -172.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -87.27 7.0 30.51 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.397 1.079 . . . . 0.0 112.423 174.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -102.77 -34.0 9.18 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.049 0.94 . . . . 0.0 112.631 165.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -89.5 -4.11 58.07 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.31 -31.6 61.78 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -175.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 35.5 p-90 -81.64 -20.2 40.15 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.764 1.226 . . . . 0.0 113.28 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 19.4 t -81.84 -32.81 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.165 1.386 . . . . 0.0 110.691 173.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 42.0 tptt -94.8 49.2 1.23 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.579 1.952 . . . . 0.0 111.162 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -97.62 104.33 16.35 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.949 1.3 . . . . 0.0 109.968 176.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 . . . . . 0 C--O 1.255 1.356 0 C-N-CA 125.773 1.629 . . . . 0.0 113.504 175.879 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.721 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 39.4 t -70.01 137.75 87.35 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 123.897 0.879 . . . . 0.0 112.003 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -65.39 -20.42 61.4 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.743 2.295 . . . . 0.0 112.546 174.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -68.76 -24.0 64.38 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.609 1.163 . . . . 0.0 112.686 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 50.2 m -77.4 -15.55 59.3 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.698 1.199 . . . . 0.0 113.524 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 mmt -80.03 34.95 0.3 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.777 1.631 . . . . 0.0 113.926 -169.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.7 -47.38 0.1 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.472 1.509 . . . . 0.0 111.591 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 36.2 m -153.49 129.86 10.57 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.574 1.95 . . . . 0.0 108.599 170.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -137.07 14.81 3.05 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.749 1.219 . . . . 0.0 113.854 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.73 107.88 9.35 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.116 0.966 . . . . 0.0 111.213 -177.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -81.31 58.59 3.65 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.931 1.293 . . . . 0.0 110.66 170.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.78 129.4 20.29 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.088 1.755 . . . . 0.0 111.097 -158.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -174.91 82.15 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.277 1.831 . . . . 0.0 106.931 166.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.8 m -72.01 101.21 2.66 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.027 1.731 . . . . 0.0 111.295 -174.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.97 144.05 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.761 1.224 . . . . 0.0 111.964 -174.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 78.8 mt -126.05 -43.94 1.79 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.786 1.634 . . . . 0.0 112.308 -175.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 46.5 t -153.77 136.03 14.88 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.519 1.128 . . . . 0.0 110.939 175.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.9 t -127.28 125.83 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.588 1.155 . . . . 0.0 109.47 172.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -129.08 133.61 25.39 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 125.367 1.467 . . . . 0.0 110.579 176.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.83 -12.02 15.01 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.22 2.613 . . . . 0.0 115.331 -172.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -129.74 106.38 8.67 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.273 1.029 . . . . 0.0 110.854 -177.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.1 p -141.66 142.01 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.782 1.233 . . . . 0.0 110.52 170.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.4 m -124.37 130.32 52.28 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.443 1.097 . . . . 0.0 110.751 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 77.1 t -94.18 136.47 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.749 1.22 . . . . 0.0 111.355 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.09 125.75 33.97 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.48 1.112 . . . . 0.0 109.436 168.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.7 mtt85 -62.39 131.3 48.8 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.347 0.659 . . . . 0.0 109.371 163.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.6 pt -96.17 150.36 37.1 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 124.239 1.016 . . . . 0.0 112.533 -171.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -67.14 160.23 48.4 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 122.758 2.305 . . . . 0.0 111.217 165.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.34 140.45 82.73 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.846 2.364 . . . . 0.0 111.962 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.2 ttm-85 -72.05 159.53 34.03 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.578 1.151 . . . . 0.0 112.465 -177.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -134.45 156.25 48.9 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.63 148.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.0 p -79.34 -36.07 40.01 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.696 1.998 . . . . 0.0 113.572 -167.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -90.91 21.14 4.32 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.048 1.739 . . . . 0.0 110.976 174.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -134.34 -59.7 0.82 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.365 1.866 . . . . 0.0 111.812 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.11 165.52 23.79 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 122.504 1.058 . . . . 0.0 113.06 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.7 m-30 -75.3 132.54 41.07 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.507 1.123 . . . . 0.0 110.102 169.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.54 18.25 8.12 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -172.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.31 -49.35 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 128.094 2.557 . . . . 0.0 115.565 -173.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.5 m -66.65 -15.93 63.83 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.887 1.675 . . . . 0.0 114.646 -176.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.01 -7.91 59.28 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 171.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.7 m0 -88.1 171.61 10.13 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.006 1.322 . . . . 0.0 110.769 176.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -79.6 54.34 1.76 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.214 1.406 . . . . 0.0 114.068 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.5 mt -60.75 -16.59 41.75 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -173.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -105.3 -4.59 21.41 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.565 1.146 . . . . 0.0 112.958 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -148.42 81.34 8.01 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 124.539 1.136 . . . . 0.0 112.015 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.3 145.35 67.19 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.395 2.73 . . . . 0.0 112.89 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -71.86 -29.62 64.57 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.822 0.849 . . . . 0.0 111.267 168.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 41.1 t90 -159.6 155.05 25.57 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.996 1.718 . . . . 0.0 110.929 175.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.3 p -133.76 142.54 47.96 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.717 1.207 . . . . 0.0 111.961 171.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.31 -148.39 6.54 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 123.419 0.533 . . . . 0.0 114.195 -177.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -110.76 144.64 39.43 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.737 1.615 . . . . 0.0 110.849 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.1 tp -82.53 136.43 34.86 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.13 1.372 . . . . 0.0 109.369 168.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.6 ttt-85 -142.09 88.07 2.08 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.579 1.152 . . . . 0.0 109.952 166.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.493 HD11 ' CD2' ' A' ' 119' ' ' PHE . 12.7 mt -70.22 122.11 21.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 169.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.01 -179.88 4.29 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 127.82 2.448 . . . . 0.0 109.542 177.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 80.3 p -161.27 171.2 18.79 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.858 2.063 . . . . 0.0 108.491 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -140.0 -107.64 0.16 Allowed 'General case' 0 CA--C 1.54 0.59 0 O-C-N 122.004 -0.435 . . . . 0.0 109.929 166.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.62 106.13 3.21 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.051 1.31 . . . . 0.0 112.603 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 51.48 28.69 4.7 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 126.768 2.027 . . . . 0.0 113.917 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.8 m -148.1 131.07 16.21 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.17 1.788 . . . . 0.0 108.582 -172.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.69 159.5 15.12 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.084 1.353 . . . . 0.0 110.917 171.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -138.33 111.83 8.15 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.532 1.533 . . . . 0.0 109.785 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.2 mp -81.97 98.39 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 170.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -100.15 139.87 35.2 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.621 0.724 . . . . 0.0 111.831 175.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mp -113.82 127.96 56.22 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 126.487 1.915 . . . . 0.0 109.771 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -134.06 146.68 50.55 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.96 0.904 . . . . 0.0 112.114 -170.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -66.47 143.41 57.11 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 120.918 -1.114 . . . . 0.0 112.442 -177.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.596 ' H ' ' HD3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -81.81 -3.63 54.43 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 -173.753 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.0 t -115.91 -42.46 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.95 1.3 . . . . 0.0 111.403 173.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.3 m -116.13 -6.26 11.9 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -169.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.26 16.83 78.65 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 123.864 0.745 . . . . 0.0 114.171 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -66.73 126.75 29.98 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.531 1.533 . . . . 0.0 111.199 -175.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 57.4 tp -68.16 110.07 3.83 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.538 0.608 . . . . 0.0 110.424 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -79.29 -52.05 8.63 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.536 1.135 . . . . 0.0 111.042 176.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.27 162.06 37.77 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.437 1.095 . . . . 0.0 112.025 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -142.71 133.72 25.74 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.035 1.334 . . . . 0.0 111.551 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.24 101.93 48.99 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 124.742 1.217 . . . . 0.0 111.633 176.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -66.29 141.05 60.91 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 124.25 3.3 . . . . 0.0 112.788 171.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 t -137.14 123.79 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.763 1.625 . . . . 0.0 109.652 -177.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -89.05 -21.75 23.29 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -159.91 145.13 15.25 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.439 1.895 . . . . 0.0 110.291 169.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -116.97 130.12 24.83 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 124.664 1.186 . . . . 0.0 110.98 176.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.82 148.56 78.85 Favored 'Cis proline' 0 CA--C 1.542 0.915 0 CA-C-N 119.86 0.986 . . . . 0.0 112.968 -5.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.28 -168.2 24.88 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.95 1.262 . . . . 0.0 113.916 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.8 tp -63.69 -32.83 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -172.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.26 5.47 49.04 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -170.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.4 t -149.57 131.3 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.458 1.103 . . . . 0.0 110.892 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -140.64 158.85 43.37 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.711 1.604 . . . . 0.0 112.94 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 75.1 p -105.13 158.87 16.28 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.666 1.986 . . . . 0.0 110.941 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.4 m -84.12 176.03 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.762 0.825 . . . . 0.0 110.9 165.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 59.1 p -94.89 -31.98 13.44 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.598 1.559 . . . . 0.0 113.011 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -92.65 -43.77 8.92 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -167.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.7 t -142.81 120.16 11.61 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -173.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.25 -2.87 9.08 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -169.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.402 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.265 0.9 OUTLIER -87.47 22.3 2.24 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.677 1.591 . . . . 0.0 114.217 174.242 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -140.92 135.33 31.15 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.052 1.341 . . . . 0.0 111.254 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -135.76 161.3 35.96 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.206 1.402 . . . . 0.0 111.376 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 89.8 t -115.89 141.8 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.628 1.171 . . . . 0.0 108.675 166.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.52 147.56 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 118.754 0.707 . . . . 0.0 112.392 173.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -89.79 84.74 6.28 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.627 0.771 . . . . 0.0 111.074 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -68.92 139.51 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 122.627 0.371 . . . . 0.0 111.062 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -139.46 144.33 37.96 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.947 1.699 . . . . 0.0 111.604 -170.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -91.1 2.4 56.36 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.275 1.03 . . . . 0.0 113.021 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.09 13.79 78.42 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.207 1.384 . . . . 0.0 114.778 178.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.6 t -139.79 16.76 2.5 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.427 1.491 . . . . 0.0 113.6 -171.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.12 -2.64 81.76 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.602 1.096 . . . . 0.0 115.0 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -74.39 133.65 42.46 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.424 1.489 . . . . 0.0 108.527 164.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.9 p -150.55 159.19 44.66 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 171.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.61 148.28 32.95 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.579 1.552 . . . . 0.0 111.106 169.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -93.41 118.54 31.43 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.466 0.707 . . . . 0.0 109.682 168.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 27.7 pt -118.06 144.2 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.493 1.117 . . . . 0.0 111.15 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -90.5 144.49 17.45 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.059 0.838 . . . . 0.0 111.013 174.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.8 pt -129.96 140.61 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 125.43 1.492 . . . . 0.0 111.667 172.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.26 142.95 16.37 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.66 1.6 . . . . 0.0 113.077 176.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -106.76 161.07 14.99 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.85 1.66 . . . . 0.0 111.855 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.9 t -73.09 -28.02 62.05 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.64 0.776 . . . . 0.0 112.857 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -155.88 151.86 27.61 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.312 1.045 . . . . 0.0 112.083 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 63.7 ttt-85 -62.8 -33.07 74.44 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.501 1.12 . . . . 0.0 113.397 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.64 -28.62 73.03 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-N 118.798 0.726 . . . . 0.0 113.525 175.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -83.71 -34.15 24.97 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.963 0.905 . . . . 0.0 111.812 175.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.402 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -65.51 -31.77 73.01 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 168.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.39 -35.64 74.32 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.349 -0.844 . . . . 0.0 112.611 173.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -67.0 -29.46 69.3 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.228 -0.92 . . . . 0.0 112.934 176.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.493 ' CD2' HD11 ' A' ' 49' ' ' ILE . 27.2 t80 -60.82 -50.24 74.24 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.304 0.956 . . . . 0.0 111.693 172.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -82.19 -25.1 34.56 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.8 t -77.38 -42.25 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.194 -0.941 . . . . 0.0 111.285 175.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 92.5 p -65.52 -31.57 72.7 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.354 0.979 . . . . 0.0 113.111 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 61.0 mt -68.51 -52.5 31.46 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.961 0.905 . . . . 0.0 112.006 172.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -67.47 -29.38 68.82 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.957 -1.089 . . . . 0.0 112.793 -177.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -81.31 -1.53 45.6 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.055 1.342 . . . . 0.0 112.571 174.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -91.29 -23.31 20.18 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 120.701 -1.249 . . . . 0.0 113.005 165.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -104.16 -4.37 23.22 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -176.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.41 -32.61 62.82 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 120.444 1.474 . . . . 0.0 114.52 -177.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 32.1 p-90 -81.25 -23.11 38.24 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.913 1.285 . . . . 0.0 113.406 178.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.7 t -82.05 -30.46 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 125.195 1.398 . . . . 0.0 110.803 173.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -95.89 35.29 1.42 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 127.106 2.162 . . . . 0.0 111.875 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -81.73 96.3 7.52 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 122.043 0.925 . . . . 0.0 109.335 170.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 . . . . . 0 C--O 1.252 1.229 0 C-N-CA 125.408 1.483 . . . . 0.0 113.269 -161.398 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.683 0 N-CA-C 111.866 -0.494 . . . . 0.0 111.866 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 46.2 p -74.41 149.65 86.71 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 124.492 1.117 . . . . 0.0 112.5 177.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.28 -32.28 42.06 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.136 2.557 . . . . 0.0 113.075 -174.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -63.67 -30.91 71.95 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.027 0.931 . . . . 0.0 112.749 173.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 66.1 m -70.4 -4.67 23.59 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.7 mtp -75.26 -6.7 51.18 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.68 1.192 . . . . 0.0 113.222 169.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.23 -37.01 0.17 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.078 1.351 . . . . 0.0 113.554 -177.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 35.6 m -129.32 96.92 4.42 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.986 1.714 . . . . 0.0 109.509 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -126.55 12.21 7.44 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.706 1.602 . . . . 0.0 113.589 -176.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.8 mp -78.28 104.4 8.84 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.349 1.059 . . . . 0.0 111.406 -177.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -82.44 59.57 4.67 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.67 1.188 . . . . 0.0 110.153 167.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.09 122.89 21.17 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.91 1.684 . . . . 0.0 111.414 -162.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -175.85 93.64 0.06 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.263 1.825 . . . . 0.0 106.526 162.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.8 m -76.04 89.52 3.0 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.107 1.763 . . . . 0.0 110.913 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.44 142.17 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 125.367 1.467 . . . . 0.0 111.273 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.3 mt -127.41 -44.21 1.57 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.183 1.393 . . . . 0.0 111.813 -172.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 27.6 t -151.9 137.12 17.48 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.599 1.16 . . . . 0.0 111.013 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.7 t -130.84 121.82 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.774 1.23 . . . . 0.0 109.962 174.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -117.57 137.92 24.66 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 125.27 1.428 . . . . 0.0 110.192 172.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.93 -20.51 25.64 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.478 2.786 . . . . 0.0 114.418 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -135.9 113.27 10.68 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.953 0.901 . . . . 0.0 111.668 -169.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.0 p -149.56 146.38 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.737 1.615 . . . . 0.0 110.248 175.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.6 m -125.18 128.37 48.25 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.024 0.93 . . . . 0.0 111.381 -172.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.1 t -94.84 139.12 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.457 1.503 . . . . 0.0 112.067 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -127.63 123.82 36.53 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.109 1.364 . . . . 0.0 109.772 171.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -69.54 101.9 1.71 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.39 0.676 . . . . 0.0 109.198 166.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.2 pt -72.51 156.18 90.48 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.109 0.963 . . . . 0.0 113.11 -172.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -59.94 160.85 20.51 Favored 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 122.984 2.456 . . . . 0.0 112.314 165.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -67.91 98.69 0.52 Allowed 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.612 2.875 . . . . 0.0 110.918 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -146.95 176.4 9.94 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.261 1.824 . . . . 0.0 112.867 -165.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -133.88 160.63 37.07 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.036 1.734 . . . . 0.0 110.501 165.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.8 p -60.89 -49.79 76.05 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.52 1.928 . . . . 0.0 113.641 -176.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -83.48 17.4 2.19 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.881 1.673 . . . . 0.0 111.892 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 86.9 mmt-85 -130.71 -36.76 1.38 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.59 1.956 . . . . 0.0 112.546 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 172.08 44.5 0.04 OUTLIER Glycine 0 C--N 1.339 0.722 0 N-CA-C 118.522 2.169 . . . . 0.0 118.522 177.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -84.54 96.34 9.12 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.028 1.414 . . . . 0.0 108.751 154.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.7 20.6 15.14 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.52 -1.362 . . . . 0.0 114.347 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.15 -47.99 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.761 2.424 . . . . 0.0 115.092 -168.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.4 m -64.92 -16.09 62.86 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.496 1.918 . . . . 0.0 115.016 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -81.08 -10.01 59.74 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.715 0.806 . . . . 0.0 112.846 173.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 14.2 m0 -92.96 173.23 7.85 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.488 1.515 . . . . 0.0 111.147 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -79.5 53.39 1.55 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.33 1.452 . . . . 0.0 114.182 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.5 mt -61.3 -16.49 46.2 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.389 1.625 . . . . 0.0 115.389 -172.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -108.22 -3.58 18.35 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.45 1.1 . . . . 0.0 112.714 177.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -149.39 67.29 8.83 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.362 1.465 . . . . 0.0 111.48 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -53.26 141.03 60.98 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.163 2.575 . . . . 0.0 111.926 176.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -72.83 -27.51 61.99 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.453 0.701 . . . . 0.0 111.717 -177.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -151.92 152.66 32.83 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.214 1.805 . . . . 0.0 110.152 169.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.5 p -135.14 148.52 49.77 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.925 0.89 . . . . 0.0 111.646 169.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.64 -141.32 5.17 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 114.097 0.399 . . . . 0.0 114.097 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -107.06 145.64 32.13 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.01 2.124 . . . . 0.0 111.106 -174.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.8 tp -93.13 136.48 33.35 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.993 1.317 . . . . 0.0 109.458 169.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.3 ttp85 -137.76 103.51 5.03 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.594 0.758 . . . . 0.0 110.223 160.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.441 HD11 ' CD2' ' A' ' 119' ' ' PHE . 14.0 mt -77.7 118.76 25.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 166.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.55 178.12 4.58 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 127.93 2.492 . . . . 0.0 110.272 176.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 t -160.12 172.45 17.45 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 126.804 2.042 . . . . 0.0 107.763 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -143.66 -107.29 0.12 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.336 1.055 . . . . 0.0 109.01 167.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.19 97.5 2.0 Allowed Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.135 1.35 . . . . 0.0 112.564 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 52.86 28.5 6.55 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 126.603 1.961 . . . . 0.0 113.811 178.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.1 m -147.2 116.36 6.93 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 126.177 1.791 . . . . 0.0 108.396 -173.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.94 159.22 18.43 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.098 0.959 . . . . 0.0 110.823 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -136.12 117.08 14.24 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.206 1.402 . . . . 0.0 109.911 177.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.4 mp -87.15 100.48 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 168.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -98.64 137.0 37.92 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.793 0.806 . . . . 0.0 111.813 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -102.38 131.95 48.69 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.499 1.519 . . . . 0.0 109.636 168.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -136.44 152.27 50.4 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.784 0.834 . . . . 0.0 111.781 -173.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -73.03 142.01 47.66 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.865 -1.147 . . . . 0.0 112.667 -170.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -78.36 -6.13 54.24 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.194 1.797 . . . . 0.0 115.703 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 99.4 t -121.85 -44.63 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.101 1.36 . . . . 0.0 111.257 177.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.7 m -98.67 -19.99 17.21 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -174.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.77 10.3 80.02 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.513 1.054 . . . . 0.0 114.033 -176.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -82.71 154.24 24.93 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.243 1.417 . . . . 0.0 112.466 -175.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.2 tp -72.53 125.12 26.66 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.68 0.792 . . . . 0.0 111.918 -174.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -87.37 -55.22 3.9 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.118 0.967 . . . . 0.0 111.035 168.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.63 160.87 39.81 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.622 1.169 . . . . 0.0 112.027 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -141.47 131.12 24.06 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.797 1.239 . . . . 0.0 111.93 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.2 102.88 53.6 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 124.464 1.106 . . . . 0.0 111.534 175.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.77 139.93 25.53 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.963 3.109 . . . . 0.0 111.958 175.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.5 t -134.42 123.49 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 126.193 1.797 . . . . 0.0 109.548 -174.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -87.53 -23.02 24.52 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 121.366 -0.834 . . . . 0.0 113.158 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.12 144.3 15.96 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.409 1.883 . . . . 0.0 110.199 169.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -115.11 130.13 24.49 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.547 1.139 . . . . 0.0 110.918 176.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.94 148.05 78.12 Favored 'Cis proline' 0 CA--C 1.541 0.873 0 CA-C-N 119.827 0.974 . . . . 0.0 113.032 -5.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.85 -170.72 30.19 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.937 1.256 . . . . 0.0 113.822 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.3 tp -60.44 -31.05 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -170.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.4 4.33 53.65 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -171.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.5 t -149.33 130.37 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 119.456 1.025 . . . . 0.0 111.631 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -142.42 165.87 26.23 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.563 1.945 . . . . 0.0 112.364 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 56.1 p -116.9 160.17 21.29 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 127.087 2.155 . . . . 0.0 111.63 -176.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.7 m -84.16 172.58 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.034 0.934 . . . . 0.0 111.565 168.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.6 p -91.61 -33.59 15.05 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.313 1.445 . . . . 0.0 112.768 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -97.51 -40.66 8.55 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -162.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.5 t -139.2 122.59 17.16 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -175.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 p -74.5 30.19 0.08 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 -172.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.433 ' HA ' ' CB ' ' A' ' 116' ' ' ALA . 53.9 ptt85 -123.65 23.58 8.76 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.14 1.776 . . . . 0.0 114.298 171.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -140.52 138.76 34.81 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.905 1.282 . . . . 0.0 111.227 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -137.0 164.54 28.11 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.597 1.559 . . . . 0.0 111.108 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.2 t -122.1 139.67 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.737 1.215 . . . . 0.0 108.589 167.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.87 148.05 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 118.731 0.696 . . . . 0.0 112.415 176.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -89.34 85.68 6.64 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.475 0.71 . . . . 0.0 110.805 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.08 137.22 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 122.105 -0.372 . . . . 0.0 110.773 175.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -138.36 145.48 41.15 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.474 1.51 . . . . 0.0 111.738 -169.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -96.05 14.65 23.05 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.273 1.029 . . . . 0.0 113.289 -175.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.0 8.69 83.33 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.327 1.441 . . . . 0.0 115.518 177.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.2 t -131.42 6.98 4.5 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.377 1.471 . . . . 0.0 114.008 -173.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.34 -7.31 72.02 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.224 1.393 . . . . 0.0 113.916 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -72.87 127.13 31.63 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 127.12 2.168 . . . . 0.0 108.709 166.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 86.2 p -146.97 157.39 43.61 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.865 1.266 . . . . 0.0 114.368 -171.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.57 146.63 29.48 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.664 1.586 . . . . 0.0 111.057 168.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -92.12 121.4 33.63 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.058 0.543 . . . . 0.0 109.853 168.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.1 pt -120.92 144.57 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.675 1.19 . . . . 0.0 110.929 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -88.32 145.88 19.27 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 173.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.6 pt -128.05 141.63 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 125.274 1.43 . . . . 0.0 111.634 167.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.15 143.28 15.53 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.601 1.572 . . . . 0.0 112.931 175.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -108.65 157.41 18.54 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.51 1.924 . . . . 0.0 110.903 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.6 t -69.26 -27.7 65.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.918 0.887 . . . . 0.0 112.644 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -155.52 153.09 29.68 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.204 1.001 . . . . 0.0 112.029 -178.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.54 -35.03 75.02 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.589 1.156 . . . . 0.0 112.122 175.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.95 -14.73 68.42 Favored Glycine 0 CA--C 1.54 1.604 0 CA-C-O 119.384 -0.676 . . . . 0.0 114.364 176.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -97.1 -30.9 12.77 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.819 1.248 . . . . 0.0 111.886 171.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.433 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -72.98 -30.84 64.13 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 173.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -59.44 -32.1 69.91 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.35 -0.844 . . . . 0.0 112.064 172.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -64.77 -32.43 74.11 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.531 -0.731 . . . . 0.0 112.384 174.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.441 ' CD2' HD11 ' A' ' 49' ' ' ILE . 47.7 t80 -63.11 -56.35 17.58 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.213 1.005 . . . . 0.0 111.691 178.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -73.97 -24.48 59.63 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -177.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 68.4 t -78.29 -42.3 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 121.254 -0.904 . . . . 0.0 111.306 174.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.9 m -66.36 -30.78 71.25 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.137 0.88 . . . . 0.0 112.539 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.0 mt -67.37 -57.3 6.86 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.457 0.703 . . . . 0.0 111.867 170.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -64.74 -31.94 73.39 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.457 -0.777 . . . . 0.0 112.973 -173.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -80.73 -0.28 37.75 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.368 1.067 . . . . 0.0 112.666 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -101.78 -3.99 27.14 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 164.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -111.45 -10.8 14.16 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 175.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.94 -32.87 61.7 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -176.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 32.9 p-90 -81.13 -24.05 37.91 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.359 1.464 . . . . 0.0 113.347 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.6 t -79.28 -34.42 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.062 1.345 . . . . 0.0 110.665 174.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -101.41 52.42 0.83 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.138 1.775 . . . . 0.0 111.54 -177.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -89.96 12.63 16.92 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.262 1.425 . . . . 0.0 113.582 169.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 . . . . . 0 C--O 1.254 1.313 0 C-N-CA 126.057 1.743 . . . . 0.0 114.74 179.353 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.528 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 58.2 m -135.04 149.73 71.12 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 125.308 1.443 . . . . 0.0 111.88 -176.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.04 -18.42 12.94 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.325 2.683 . . . . 0.0 113.898 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -77.69 143.17 38.32 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.586 1.154 . . . . 0.0 112.142 -177.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 70.1 m -79.48 -29.0 41.51 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.328 1.051 . . . . 0.0 113.218 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.6 mtp 54.65 34.97 22.68 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.618 1.967 . . . . 0.0 114.141 176.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.76 31.6 1.83 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.959 1.703 . . . . 0.0 111.99 -175.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.1 m 65.89 125.41 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 127.325 2.25 . . . . 0.0 112.134 -158.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -159.62 162.16 35.19 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.789 2.036 . . . . 0.0 108.599 -173.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.3 pp -135.66 155.27 50.69 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.698 1.199 . . . . 0.0 113.655 174.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -144.37 48.96 1.35 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.948 1.699 . . . . 0.0 109.463 172.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -144.54 158.97 43.52 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 125.536 1.534 . . . . 0.0 112.336 -174.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -173.88 73.76 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 129.459 3.104 . . . . 0.0 105.468 -174.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.4 t -73.06 116.09 13.17 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 126.386 1.875 . . . . 0.0 111.251 -164.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.8 t -70.54 144.42 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.705 0.802 . . . . 0.0 111.126 -171.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 44.9 mt -127.07 -42.83 1.7 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.715 1.606 . . . . 0.0 111.949 -174.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 32.7 t -149.26 139.22 22.02 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.59 1.156 . . . . 0.0 109.808 177.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.5 t -133.99 127.15 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.641 1.176 . . . . 0.0 109.116 170.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -131.0 134.37 25.88 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 125.004 1.322 . . . . 0.0 110.23 175.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.28 -18.51 16.02 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.878 2.385 . . . . 0.0 114.854 -172.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -132.69 111.79 11.46 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.452 1.101 . . . . 0.0 111.434 -173.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.0 p -146.61 144.63 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.847 1.659 . . . . 0.0 109.882 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.6 m -123.73 131.8 53.68 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.986 0.915 . . . . 0.0 111.549 -173.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 76.0 t -96.97 131.6 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.492 1.517 . . . . 0.0 111.594 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -128.82 126.9 40.85 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.936 1.295 . . . . 0.0 109.15 169.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -65.83 129.9 41.41 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.479 0.712 . . . . 0.0 109.546 170.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.6 pt -98.89 152.83 37.97 Favored Pre-proline 0 N--CA 1.476 0.875 0 C-N-CA 124.333 1.053 . . . . 0.0 112.851 -171.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -69.84 153.63 68.34 Favored 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 122.576 2.184 . . . . 0.0 111.162 163.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.41 151.0 80.9 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.972 2.448 . . . . 0.0 111.608 173.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -72.79 152.11 41.74 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.218 0.607 . . . . 0.0 112.55 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.15 -82.17 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.759 1.623 . . . . 0.0 111.585 163.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 86.0 p -162.01 -53.93 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.835 1.654 . . . . 0.0 111.402 166.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -125.07 1.37 7.94 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.899 1.679 . . . . 0.0 113.78 -173.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.5 mmt85 -77.55 -36.27 52.41 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.757 1.223 . . . . 0.0 112.95 -176.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.93 153.9 17.55 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 122.197 0.887 . . . . 0.0 113.131 175.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -73.24 145.15 46.39 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 124.177 0.991 . . . . 0.0 109.687 172.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.37 19.92 7.44 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -171.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.42 -48.29 0.05 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 127.76 2.424 . . . . 0.0 115.299 -172.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.6 m -66.44 -16.63 64.25 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.239 1.816 . . . . 0.0 114.813 -177.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -85.5 -2.53 58.23 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 172.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 24.7 m0 -92.3 169.16 10.8 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.059 1.344 . . . . 0.0 110.833 173.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.5 mttt -78.33 52.44 1.13 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.341 1.456 . . . . 0.0 114.136 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.9 mt -57.53 -28.43 63.49 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -175.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -91.36 -6.07 53.56 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -149.76 74.36 9.45 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 124.873 1.269 . . . . 0.0 111.917 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -56.69 143.39 89.79 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.913 2.408 . . . . 0.0 112.565 174.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -72.0 -28.43 63.4 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.739 1.216 . . . . 0.0 111.624 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 49.4 t90 -155.73 151.97 27.98 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.985 1.714 . . . . 0.0 110.523 174.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.6 p -134.9 149.63 50.31 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.006 0.922 . . . . 0.0 111.723 170.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.74 -142.24 6.01 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 114.135 0.414 . . . . 0.0 114.135 -178.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 47.0 mtt180 -105.16 144.46 31.91 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 127.233 2.213 . . . . 0.0 111.751 -173.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.5 tp -90.29 137.15 32.58 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.434 1.494 . . . . 0.0 110.324 166.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.0 ttm-85 -130.27 132.23 45.83 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.659 1.184 . . . . 0.0 109.56 156.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.565 HD11 ' CD1' ' A' ' 119' ' ' PHE . 17.7 mt -109.59 131.57 60.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 163.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.72 151.06 42.61 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 127.879 2.471 . . . . 0.0 108.23 -168.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 92.3 p -161.04 155.08 22.64 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 120.142 -1.598 . . . . 0.0 111.908 -169.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -132.56 -105.1 0.25 Allowed 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.066 -1.022 . . . . 0.0 112.378 -173.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.32 -125.53 0.28 Allowed Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.26 0.933 . . . . 0.0 111.252 168.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -77.13 34.11 0.15 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.962 1.305 . . . . 0.0 112.52 173.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.8 m -143.45 133.59 24.36 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.935 0.894 . . . . 0.0 110.671 -174.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -115.09 162.86 16.44 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.15 1.38 . . . . 0.0 111.052 169.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -144.13 107.95 4.69 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.612 1.965 . . . . 0.0 108.88 -170.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mp -86.34 108.29 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 169.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -109.01 128.96 55.41 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.732 1.213 . . . . 0.0 111.309 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.0 mp -101.62 131.11 48.02 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.871 1.268 . . . . 0.0 110.168 177.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -133.16 149.66 52.05 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.063 0.945 . . . . 0.0 112.602 -169.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -69.58 141.14 53.82 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.033 -1.042 . . . . 0.0 111.977 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.0 pttt -79.85 -4.7 53.32 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 -177.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 95.8 t -121.98 -43.84 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.171 1.389 . . . . 0.0 111.355 178.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.9 m -97.47 -20.27 17.87 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.19 11.32 79.31 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.443 1.021 . . . . 0.0 114.032 -176.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -83.59 151.19 25.48 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.192 1.397 . . . . 0.0 112.24 -175.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.3 tp -72.96 127.26 32.02 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.437 0.695 . . . . 0.0 111.66 -175.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -86.76 -55.41 3.87 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.704 1.202 . . . . 0.0 111.171 169.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.11 159.69 38.11 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.117 1.367 . . . . 0.0 111.307 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -139.35 137.57 35.86 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 174.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.32 106.5 48.82 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.601 1.56 . . . . 0.0 110.621 177.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.57 142.13 18.1 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.718 2.946 . . . . 0.0 111.107 173.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.9 t -135.58 129.91 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 126.352 1.861 . . . . 0.0 109.476 -170.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -97.68 -20.1 17.83 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.227 1.011 . . . . 0.0 113.061 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.91 147.39 11.49 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.449 2.3 . . . . 0.0 110.33 -177.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -135.12 125.11 16.83 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 124.064 0.946 . . . . 0.0 111.529 174.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -65.31 150.13 75.93 Favored 'Cis proline' 0 CA--C 1.541 0.849 0 CA-C-N 119.894 0.998 . . . . 0.0 113.122 -2.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -170.06 -158.86 14.62 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.037 1.304 . . . . 0.0 113.697 -175.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.4 tp -75.53 -39.79 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -172.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.54 5.6 41.94 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -168.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.4 t -150.8 130.91 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.684 1.593 . . . . 0.0 109.397 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.3 163.2 34.39 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.814 1.646 . . . . 0.0 112.735 -174.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 66.3 p -116.43 162.9 16.85 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.904 1.682 . . . . 0.0 111.659 -177.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.5 m -91.08 177.39 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 124.479 1.112 . . . . 0.0 110.726 166.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.8 p -98.81 -32.4 11.38 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.051 1.74 . . . . 0.0 113.045 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -88.68 -43.36 11.37 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -167.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.2 t -143.9 124.44 14.01 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -176.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.05 -1.4 7.48 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 -170.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.484 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.295 27.9 ptt180 -85.63 15.37 4.71 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 177.469 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -137.02 133.97 36.07 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.874 1.269 . . . . 0.0 110.855 -173.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -133.74 160.46 37.52 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.087 1.355 . . . . 0.0 111.512 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 78.8 t -112.25 143.92 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.328 1.051 . . . . 0.0 108.985 164.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.0 149.49 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 119.025 0.829 . . . . 0.0 112.049 169.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -91.72 82.88 5.24 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.783 0.833 . . . . 0.0 111.177 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -66.93 139.99 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 120.91 0.386 . . . . 0.0 111.065 176.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -140.22 152.5 46.03 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.778 1.631 . . . . 0.0 111.474 -169.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -96.14 1.75 52.61 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.254 1.021 . . . . 0.0 112.957 177.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.98 12.13 81.57 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 125.278 1.418 . . . . 0.0 114.909 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.3 t -135.54 13.18 3.47 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.485 1.514 . . . . 0.0 113.544 -172.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.2 -4.71 74.51 Favored Glycine 0 CA--C 1.537 1.432 0 O-C-N 120.655 -1.278 . . . . 0.0 114.807 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -70.87 131.63 44.05 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.252 1.421 . . . . 0.0 108.499 163.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.1 p -149.55 159.17 44.53 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 173.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.25 146.26 32.54 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.491 1.516 . . . . 0.0 110.832 167.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -90.95 120.31 31.85 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.074 0.55 . . . . 0.0 109.65 167.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.6 pt -117.9 143.22 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.404 1.082 . . . . 0.0 110.832 176.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -92.24 140.69 15.26 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 175.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.0 pt -126.64 141.35 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 125.285 1.434 . . . . 0.0 111.708 173.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.1 142.14 14.3 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.038 1.304 . . . . 0.0 113.144 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -104.37 162.42 13.24 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.626 1.57 . . . . 0.0 111.531 -177.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.1 t -72.64 -29.18 63.24 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.578 0.751 . . . . 0.0 112.486 176.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -153.04 147.63 26.11 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.184 0.994 . . . . 0.0 112.069 -174.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.6 ttt-85 -62.33 -32.82 73.64 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.348 1.059 . . . . 0.0 113.234 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.96 -28.32 73.45 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-N 119.025 0.829 . . . . 0.0 113.714 176.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -84.71 -32.51 23.49 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.015 0.907 . . . . 0.0 111.953 176.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.484 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -66.9 -34.37 77.62 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 166.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -60.57 -35.96 77.33 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.251 -0.906 . . . . 0.0 111.677 168.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -62.47 -37.59 86.53 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 119.247 0.93 . . . . 0.0 111.88 175.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.565 ' CD1' HD11 ' A' ' 49' ' ' ILE . 17.6 t80 -58.73 -56.54 20.87 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.448 1.099 . . . . 0.0 112.017 171.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.03 -26.13 53.35 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -174.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.2 t -77.24 -43.31 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 121.193 -0.942 . . . . 0.0 110.98 176.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.3 t -69.91 -29.77 67.03 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.137 0.88 . . . . 0.0 112.469 -178.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.6 mt -64.44 -55.06 23.35 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.445 -0.784 . . . . 0.0 112.124 167.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -68.27 -29.48 68.28 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.108 -0.995 . . . . 0.0 113.069 -173.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -82.62 -3.64 56.51 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.852 0.861 . . . . 0.0 112.799 176.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -93.45 -34.08 13.56 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.39 -0.819 . . . . 0.0 112.47 161.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -90.64 -6.39 54.63 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 -177.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.52 -27.5 38.65 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 121.259 1.845 . . . . 0.0 115.773 -173.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 27.3 p-90 -86.21 -21.57 27.39 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.622 1.169 . . . . 0.0 113.98 175.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 17.5 t -86.11 -41.0 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.085 1.354 . . . . 0.0 110.625 175.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -98.56 49.35 0.98 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.318 2.247 . . . . 0.0 111.38 -175.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -78.21 88.95 4.28 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.009 0.924 . . . . 0.0 111.22 175.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 C--O 1.253 1.268 0 C-N-CA 127.237 2.215 . . . . 0.0 112.325 176.641 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.574 0 N-CA-C 111.576 -0.609 . . . . 0.0 111.576 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 37.4 t -134.17 157.77 76.83 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 125.979 1.712 . . . . 0.0 110.937 -178.236 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.11 -24.71 34.22 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.585 2.19 . . . . 0.0 113.318 161.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -74.2 -14.86 61.0 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.966 1.307 . . . . 0.0 113.726 174.596 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 14.9 m -77.03 -7.75 56.21 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.032 1.333 . . . . 0.0 113.788 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt 52.99 -98.95 0.08 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.003 2.121 . . . . 0.0 113.861 177.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.44 -47.97 0.09 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.166 1.386 . . . . 0.0 111.523 177.168 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.2 m -130.22 120.4 24.41 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.083 1.753 . . . . 0.0 106.739 163.409 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -146.12 116.66 7.57 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.108 1.363 . . . . 0.0 108.531 -169.7 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.5 mt -137.23 40.25 2.47 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.4 1.48 . . . . 0.0 113.703 -168.413 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -76.29 34.4 0.13 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.821 1.248 . . . . 0.0 112.602 172.639 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -156.62 150.07 24.45 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 128.211 2.604 . . . . 0.0 109.524 -175.199 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -173.11 139.21 0.79 Allowed 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.095 1.358 . . . . 0.0 107.781 172.564 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.8 m -96.48 113.9 25.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.856 151.528 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.517 ' HA ' HG22 ' A' ' 50' ' ' THR . 8.5 p -70.62 145.33 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 178.363 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.6 mt -129.86 -39.68 1.4 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.829 1.652 . . . . 0.0 111.957 -172.712 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.426 ' SG ' ' HE2' ' A' ' 14' ' ' LYS . 12.5 t -152.8 133.25 13.7 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.096 0.958 . . . . 0.0 111.26 175.938 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 92.9 t -130.5 127.14 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.538 1.135 . . . . 0.0 108.963 170.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.426 ' HE2' ' SG ' ' A' ' 12' ' ' CYS . 68.1 mttm -133.55 144.08 50.62 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 124.968 1.307 . . . . 0.0 112.3 -179.522 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -77.7 -11.44 16.91 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 124.098 3.199 . . . . 0.0 114.636 -178.289 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -117.99 110.15 17.34 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.148 1.379 . . . . 0.0 111.673 -174.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 p -156.82 142.05 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.527 1.131 . . . . 0.0 110.424 163.296 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.6 m -123.43 144.23 49.64 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.408 1.483 . . . . 0.0 110.238 178.517 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.41 HG22 HG22 ' A' ' 108' ' ' ILE . 76.7 t -113.7 129.36 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.821 1.248 . . . . 0.0 111.047 177.866 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.17 116.41 11.85 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.89 1.676 . . . . 0.0 109.196 173.796 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.9 mtt-85 -71.37 134.54 46.77 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.138 0.975 . . . . 0.0 110.509 -176.755 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.7 pt -90.1 150.21 42.97 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 124.266 1.026 . . . . 0.0 113.177 -165.003 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -73.2 162.34 40.84 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 123.421 2.747 . . . . 0.0 112.372 173.115 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.56 111.97 2.03 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.321 2.681 . . . . 0.0 111.024 174.402 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.1 tpp85 -157.81 157.96 34.3 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.338 1.855 . . . . 0.0 110.932 -172.39 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.55 134.23 54.1 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.268 1.427 . . . . 0.0 113.19 173.877 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.5 p -77.64 -51.39 10.7 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.655 1.982 . . . . 0.0 113.316 -170.504 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -83.02 -11.69 57.87 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -174.001 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.51 -6.55 0.71 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 117.063 2.246 . . . . 0.0 117.063 -171.762 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -113.58 -18.44 7.03 Favored Glycine 0 N--CA 1.469 0.867 0 N-CA-C 117.913 1.925 . . . . 0.0 117.913 -161.504 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -85.15 125.79 33.1 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 120.106 1.953 . . . . 0.0 110.632 178.151 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.61 26.13 9.78 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 178.113 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 60.46 -42.13 0.1 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.686 2.394 . . . . 0.0 115.272 -170.925 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 89.6 p -66.47 -15.92 63.72 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.384 1.874 . . . . 0.0 114.398 -179.855 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -63.33 -26.21 68.66 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 167.804 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 9.6 m0 -94.13 164.89 12.88 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.964 1.306 . . . . 0.0 111.256 -168.645 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -76.92 55.21 1.08 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.643 1.577 . . . . 0.0 114.172 179.469 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.6 mt -59.49 -25.69 64.66 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.66 1.184 . . . . 0.0 113.745 -179.278 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -94.87 -7.63 39.58 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.608 0.763 . . . . 0.0 113.004 -179.053 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -149.88 78.97 7.96 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.644 1.178 . . . . 0.0 111.959 175.549 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.88 147.61 50.68 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.519 2.813 . . . . 0.0 113.114 176.229 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -71.22 -28.92 64.54 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.881 0.872 . . . . 0.0 111.302 169.003 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 66.9 t90 -156.56 153.53 28.81 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.243 1.817 . . . . 0.0 110.891 177.223 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.7 p -135.67 149.4 49.27 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.576 1.151 . . . . 0.0 111.331 169.374 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.62 -140.44 4.29 Favored Glycine 0 CA--C 1.525 0.717 0 O-C-N 122.135 -0.353 . . . . 0.0 113.462 -178.692 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.9 mtm105 -119.56 147.76 44.1 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.222 1.809 . . . . 0.0 111.715 -173.189 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 40.4 tp -85.13 142.04 29.79 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.674 1.59 . . . . 0.0 110.616 176.827 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.8 ttm-85 -142.2 95.55 2.82 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.376 1.07 . . . . 0.0 111.073 165.427 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.7 mt -83.06 128.53 38.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 169.271 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.517 HG22 ' HA ' ' A' ' 10' ' ' VAL . 11.8 p -140.57 171.97 13.37 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.71 2.004 . . . . 0.0 110.472 -176.011 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.7 t -155.34 153.43 30.48 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.681 1.192 . . . . 0.0 112.076 175.935 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -155.96 123.76 5.62 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.166 0.986 . . . . 0.0 111.012 163.626 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.52 46.31 48.71 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.151 0.882 . . . . 0.0 114.845 167.547 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt 63.32 28.2 15.58 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 126.408 1.883 . . . . 0.0 113.679 -176.061 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.1 m -135.42 120.55 18.84 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.658 1.583 . . . . 0.0 108.774 170.83 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.3 159.25 18.85 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.891 0.876 . . . . 0.0 111.034 174.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -137.63 114.05 10.23 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.592 1.557 . . . . 0.0 109.29 178.514 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.4 mp -85.93 92.88 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 167.188 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -84.98 146.1 27.38 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.208 1.003 . . . . 0.0 110.266 172.187 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -110.44 137.54 48.02 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.564 1.546 . . . . 0.0 111.2 172.78 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -123.71 147.7 47.22 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.34 1.056 . . . . 0.0 113.286 -178.103 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.73 144.15 52.86 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 122.148 0.975 . . . . 0.0 112.065 169.933 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.4 pttt -81.49 -6.38 58.9 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -177.021 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 90.7 t -122.62 -39.52 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.657 1.183 . . . . 0.0 111.983 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.4 m -116.0 -10.38 11.6 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -172.769 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.65 19.74 79.3 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 123.613 0.625 . . . . 0.0 114.331 177.399 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -65.79 139.13 58.31 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.385 1.474 . . . . 0.0 111.24 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.9 tp -72.23 112.31 8.2 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.103 0.561 . . . . 0.0 109.882 172.492 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -78.52 -56.58 4.32 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.241 0.616 . . . . 0.0 111.3 177.071 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.0 165.24 35.61 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.225 1.81 . . . . 0.0 109.795 179.266 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -146.25 142.87 28.78 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 170.488 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.22 105.71 50.31 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.355 1.462 . . . . 0.0 111.808 -178.544 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -67.54 142.89 60.71 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 124.129 3.22 . . . . 0.0 112.39 170.823 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.5 t -139.2 117.33 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.294 1.437 . . . . 0.0 109.688 -177.792 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -81.45 -25.96 35.68 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 121.45 -0.781 . . . . 0.0 112.96 -177.396 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.19 145.35 16.52 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.336 1.854 . . . . 0.0 110.077 169.435 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -118.75 127.94 26.25 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.569 1.148 . . . . 0.0 110.588 175.865 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.54 147.5 75.76 Favored 'Cis proline' 0 CA--C 1.542 0.905 0 CA-C-N 119.997 1.035 . . . . 0.0 113.434 -2.684 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.91 -158.2 9.05 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.686 1.612 . . . . 0.0 112.948 -179.169 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.2 tt -76.29 -40.41 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 O-C-N 121.853 -0.793 . . . . 0.0 113.093 -178.245 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.44 7.72 18.77 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -166.534 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.9 t -152.83 125.99 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 126.421 1.889 . . . . 0.0 108.571 177.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -145.95 154.06 41.5 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.607 1.163 . . . . 0.0 112.224 -173.834 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.7 p -103.2 154.78 18.96 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.524 1.53 . . . . 0.0 112.453 179.693 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.9 m -76.42 175.28 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.8 1.24 . . . . 0.0 111.065 165.875 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 68.7 p -92.21 -30.12 16.08 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.909 1.283 . . . . 0.0 113.152 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -100.94 -39.34 7.8 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -163.697 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.4 t -141.42 125.76 17.58 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -176.489 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.88 -12.73 26.93 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -172.318 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.455 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.272 27.7 ptt180 -82.61 11.78 5.4 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -176.892 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -136.98 140.82 42.45 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.082 1.353 . . . . 0.0 112.03 -174.078 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -140.95 158.82 43.41 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.231 1.412 . . . . 0.0 111.656 -178.262 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.3 t -108.39 140.26 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.379 1.072 . . . . 0.0 108.56 162.85 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.95 148.31 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 119.159 0.891 . . . . 0.0 112.229 170.184 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -93.25 91.65 7.35 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.743 0.817 . . . . 0.0 110.834 178.081 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -75.02 152.28 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.245 0.618 . . . . 0.0 111.894 176.701 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.1 141.85 47.58 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.591 1.556 . . . . 0.0 110.102 171.249 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -96.14 30.27 2.52 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.227 1.011 . . . . 0.0 113.694 -170.326 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.81 8.77 73.71 Favored Glycine 0 CA--C 1.538 1.53 0 N-CA-C 116.129 1.211 . . . . 0.0 116.129 173.418 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.6 t -134.36 -25.84 1.49 Allowed 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -174.899 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 135.74 -11.95 4.25 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.779 1.18 . . . . 0.0 114.342 177.82 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.94 157.12 16.04 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.948 1.699 . . . . 0.0 111.129 173.409 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 90.5 p -142.3 162.31 35.8 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.867 1.267 . . . . 0.0 114.119 -165.058 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.81 146.69 31.26 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.894 1.278 . . . . 0.0 111.443 174.51 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -90.38 117.12 28.85 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.552 0.741 . . . . 0.0 109.438 167.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.8 pt -116.77 144.63 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.804 1.242 . . . . 0.0 110.821 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -92.36 139.15 14.54 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 176.797 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.41 HG22 HG22 ' A' ' 19' ' ' VAL . 31.7 pt -130.67 160.61 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.175 1.39 . . . . 0.0 112.152 171.386 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -155.2 174.45 33.36 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-O 121.865 0.703 . . . . 0.0 114.794 167.341 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -124.2 149.26 46.57 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 126.721 2.008 . . . . 0.0 110.642 -173.255 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.0 t -74.68 -11.97 60.31 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 178.379 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -119.12 -24.16 6.57 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -155.282 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 61.09 -41.29 0.12 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 127.152 2.181 . . . . 0.0 115.036 -166.442 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.17 -27.89 72.14 Favored Glycine 0 CA--C 1.537 1.456 0 CA-C-N 119.675 1.125 . . . . 0.0 113.632 171.038 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -79.69 -34.72 39.96 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.122 0.961 . . . . 0.0 112.095 173.317 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.455 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -63.96 -36.77 85.05 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.563 -0.711 . . . . 0.0 112.636 167.88 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -70.27 9.91 0.52 Allowed 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 167.933 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -122.4 -32.57 3.6 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.219 1.408 . . . . 0.0 112.114 170.577 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -50.15 -48.89 53.58 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.223 1.409 . . . . 0.0 111.974 164.148 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -77.07 -29.83 55.22 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -178.672 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.2 t -77.96 -42.75 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 121.041 -1.037 . . . . 0.0 111.004 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 77.8 p -64.08 -26.66 68.65 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 176.309 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.9 mt -71.62 -59.51 2.72 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.22 1.008 . . . . 0.0 112.004 168.092 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -65.3 -30.34 71.18 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -172.412 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -79.04 -1.18 34.44 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.484 1.114 . . . . 0.0 112.608 177.341 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -100.06 -3.98 30.83 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 164.73 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -113.87 -10.24 12.98 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 176.574 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.08 -32.42 61.93 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 120.431 1.469 . . . . 0.0 114.855 -176.799 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 41.3 p-90 -78.54 -22.71 46.84 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.114 1.366 . . . . 0.0 113.35 178.615 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.4 t -78.78 -26.37 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.26 1.424 . . . . 0.0 111.074 175.137 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -95.48 27.4 3.4 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.937 2.095 . . . . 0.0 112.594 -179.171 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -83.58 94.63 8.11 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.209 1.003 . . . . 0.0 110.489 173.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 C--O 1.253 1.245 0 C-N-CA 126.808 2.043 . . . . 0.0 113.669 177.581 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.65 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 29.6 t -148.88 144.03 17.75 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 125.112 1.365 . . . . 0.0 111.368 178.822 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -69.69 -13.05 34.29 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.079 2.519 . . . . 0.0 113.421 172.491 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 51.95 35.66 16.48 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.609 1.563 . . . . 0.0 113.226 -177.504 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 59.6 p -84.43 -6.18 59.35 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 115.267 1.581 . . . . 0.0 115.267 -170.19 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.1 mtt -134.31 159.75 40.04 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.588 1.555 . . . . 0.0 112.276 -179.12 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.5 45.98 2.03 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.997 1.719 . . . . 0.0 110.286 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 30.3 m 58.75 71.24 0.6 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.534 1.534 . . . . 0.0 109.282 -159.794 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -95.67 90.73 5.8 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.23 1.412 . . . . 0.0 110.953 -168.065 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 29.3 mt -83.9 1.06 45.17 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.358 1.463 . . . . 0.0 114.4 -175.336 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 56.43 23.31 7.28 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.318 1.447 . . . . 0.0 112.819 -155.075 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -149.57 143.5 25.62 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 124.878 1.271 . . . . 0.0 112.896 168.569 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -161.41 87.27 0.69 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 129.894 3.278 . . . . 0.0 105.697 168.151 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.8 t -75.23 125.23 28.52 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 121.36 -0.838 . . . . 0.0 111.405 -165.236 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.0 p -72.3 146.26 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 123.481 0.712 . . . . 0.0 111.184 -178.76 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.7 mt -129.5 -37.47 1.6 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.361 1.465 . . . . 0.0 112.521 -170.817 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 36.8 t -149.31 139.42 22.14 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.954 1.301 . . . . 0.0 109.865 173.312 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.2 t -134.84 127.71 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.826 1.25 . . . . 0.0 108.864 168.636 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -130.96 136.98 29.75 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 125.048 1.339 . . . . 0.0 110.868 176.162 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.11 -14.32 16.82 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.349 2.699 . . . . 0.0 114.968 -174.919 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -134.58 108.69 8.21 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.135 0.974 . . . . 0.0 111.295 -173.149 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.37 144.35 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.189 1.396 . . . . 0.0 110.191 171.659 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.1 m -123.19 137.5 54.88 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.441 1.096 . . . . 0.0 111.267 -176.574 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.2 t -101.79 133.05 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.324 1.449 . . . . 0.0 111.444 178.391 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.22 121.51 22.6 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.973 1.309 . . . . 0.0 109.109 170.597 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -66.51 130.82 44.49 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.069 0.548 . . . . 0.0 109.98 174.123 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.0 pt -90.01 151.35 45.02 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.134 0.974 . . . . 0.0 113.205 -168.206 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -67.76 163.18 36.33 Favored 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 123.233 2.622 . . . . 0.0 111.508 165.345 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -61.32 142.66 96.69 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.946 2.431 . . . . 0.0 112.349 176.795 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.48 161.91 28.79 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.089 1.356 . . . . 0.0 112.582 -177.198 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -143.59 163.0 34.44 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.643 1.177 . . . . 0.0 111.182 160.401 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.3 p -85.73 -40.63 15.9 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.552 1.941 . . . . 0.0 113.796 -162.142 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -91.54 23.75 3.35 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.843 1.657 . . . . 0.0 110.944 173.768 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -133.01 -68.95 0.57 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 127.47 2.308 . . . . 0.0 111.273 -176.359 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.56 172.3 24.5 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-O 122.872 1.262 . . . . 0.0 112.269 -168.824 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -76.14 134.47 39.95 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.561 1.144 . . . . 0.0 110.375 170.951 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.54 18.53 7.46 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -172.412 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.3 -49.66 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 128.192 2.597 . . . . 0.0 115.597 -173.726 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.2 m -65.21 -17.8 64.79 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.99 1.716 . . . . 0.0 114.611 -176.295 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.89 -8.64 59.14 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 172.695 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -88.99 168.9 11.99 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.78 1.232 . . . . 0.0 110.732 174.639 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -81.26 55.36 2.53 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.686 1.195 . . . . 0.0 113.436 179.805 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.3 mt -54.84 -31.53 59.55 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -172.432 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -90.34 -8.78 49.9 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.32 1.048 . . . . 0.0 113.054 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -137.16 71.17 55.06 Favored Pre-proline 0 N--CA 1.471 0.62 0 C-N-CA 125.624 1.57 . . . . 0.0 111.358 -164.239 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -69.0 148.14 69.35 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 CA-C-N 119.315 0.791 . . . . 0.0 113.051 -171.753 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -72.35 -29.59 63.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.323 0.649 . . . . 0.0 111.239 167.486 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 56.0 t90 -159.56 154.21 24.32 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.533 1.933 . . . . 0.0 110.612 176.266 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.6 p -133.29 149.27 51.94 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.32 1.048 . . . . 0.0 111.749 167.952 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.84 -139.91 4.45 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 123.058 0.361 . . . . 0.0 113.261 -179.392 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.7 mtm105 -113.78 143.91 43.85 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.087 1.755 . . . . 0.0 111.736 -173.025 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.6 tp -83.37 140.34 32.47 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.62 1.168 . . . . 0.0 110.142 168.13 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -133.39 138.24 46.19 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.508 1.523 . . . . 0.0 108.816 156.69 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.407 HD11 ' CD2' ' A' ' 119' ' ' PHE . 21.1 mt -120.4 133.41 67.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 166.078 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.44 162.82 34.41 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 127.1 2.16 . . . . 0.0 109.309 -167.515 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 84.1 p -160.21 132.46 6.27 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 120.018 -1.676 . . . . 0.0 113.954 -169.452 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.64 137.18 7.64 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 125.51 1.524 . . . . 0.0 114.653 172.027 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 65.5 48.96 63.25 Favored Glycine 0 N--CA 1.475 1.259 0 C-N-CA 125.74 1.638 . . . . 0.0 114.123 171.835 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 56.1 30.57 16.58 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.99 1.716 . . . . 0.0 112.986 -174.498 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.5 m -134.05 132.92 40.6 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.775 2.03 . . . . 0.0 108.257 178.489 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.63 158.35 16.16 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.091 0.956 . . . . 0.0 110.434 171.418 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -142.12 91.89 2.38 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.666 1.586 . . . . 0.0 108.833 -164.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.8 mp -78.52 110.84 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 171.558 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -112.9 127.91 56.32 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.927 0.891 . . . . 0.0 110.868 177.201 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mp -96.94 130.29 44.28 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.583 1.153 . . . . 0.0 110.019 177.754 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -129.96 149.56 51.63 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.873 0.869 . . . . 0.0 112.845 -171.358 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -73.58 144.79 45.87 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.983 0.897 . . . . 0.0 112.186 -178.9 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.0 pttt -84.44 -6.73 59.41 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.238 1.815 . . . . 0.0 115.158 -178.666 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 96.0 t -122.7 -43.99 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.241 1.416 . . . . 0.0 111.586 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.2 m -95.34 -21.39 18.42 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -174.508 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.13 6.94 84.0 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.218 0.913 . . . . 0.0 113.902 -176.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.43 155.89 24.42 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.421 1.489 . . . . 0.0 112.626 -174.425 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.8 tp -74.57 128.06 34.62 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.632 0.773 . . . . 0.0 111.149 178.282 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -85.93 -56.41 3.49 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.327 1.051 . . . . 0.0 111.133 169.041 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.88 160.71 39.4 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.162 1.385 . . . . 0.0 111.204 -178.602 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? -140.18 136.02 33.02 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 176.17 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.73 100.56 51.02 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 126.136 1.774 . . . . 0.0 110.691 179.685 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -74.83 141.44 27.17 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.35 2.7 . . . . 0.0 111.33 169.775 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.5 t -134.65 125.93 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 126.921 2.088 . . . . 0.0 108.987 -172.108 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -90.97 -22.24 20.92 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.295 0.952 . . . . 0.0 113.53 -177.734 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -161.54 150.5 16.0 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.322 1.849 . . . . 0.0 110.438 173.988 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -130.16 131.77 23.65 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.347 1.059 . . . . 0.0 111.443 175.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.73 145.42 46.72 Favored 'Cis proline' 0 CA--C 1.539 0.736 0 CA-C-N 119.922 1.008 . . . . 0.0 113.739 -7.042 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -161.77 -156.26 8.29 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 125.669 1.605 . . . . 0.0 112.357 -177.925 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 19.9 tt -81.42 -39.94 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -176.723 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.68 6.35 15.53 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -167.936 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.1 t -152.22 128.51 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 126.364 1.866 . . . . 0.0 109.238 178.568 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -140.02 158.46 44.03 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.438 1.495 . . . . 0.0 113.11 176.155 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 67.5 p -100.56 159.04 15.48 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.294 1.838 . . . . 0.0 111.638 175.191 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.9 m -83.91 174.22 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.738 0.815 . . . . 0.0 110.862 164.575 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 59.9 p -96.02 -30.71 13.42 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.35 1.46 . . . . 0.0 113.224 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -96.04 -40.72 9.11 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -165.513 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.1 t -137.38 120.59 16.8 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -174.19 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.8 m -73.91 24.44 0.08 Allowed 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 -168.001 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -128.61 23.82 5.82 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 127.136 2.175 . . . . 0.0 113.529 -178.169 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -141.55 139.52 33.21 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.644 1.577 . . . . 0.0 111.391 -178.454 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -140.18 161.29 37.99 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.807 1.243 . . . . 0.0 111.89 -177.923 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 78.1 t -113.04 142.34 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.473 1.109 . . . . 0.0 108.725 166.021 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.43 149.46 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 118.509 0.595 . . . . 0.0 112.085 170.51 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -89.47 87.4 7.06 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.814 0.846 . . . . 0.0 110.508 177.019 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.8 141.05 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 O-C-N 122.102 -0.374 . . . . 0.0 110.469 172.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -134.43 148.01 50.54 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.377 1.471 . . . . 0.0 111.418 -170.262 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -97.84 13.55 30.18 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.523 1.129 . . . . 0.0 113.255 -175.475 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.5 8.71 86.03 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.308 1.432 . . . . 0.0 115.481 176.165 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.5 t -130.99 3.64 4.41 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.581 1.552 . . . . 0.0 113.665 -173.127 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.9 -6.31 66.91 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 125.416 1.484 . . . . 0.0 113.87 -175.471 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 47.5 ttt180 -74.84 131.7 40.96 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 127.393 2.277 . . . . 0.0 108.825 166.28 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 84.1 p -147.94 160.82 42.41 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -175.278 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.87 145.92 31.81 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.644 1.577 . . . . 0.0 110.952 170.048 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -93.57 116.56 29.08 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.63 0.772 . . . . 0.0 109.726 171.284 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.3 pt -115.69 144.04 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.539 1.136 . . . . 0.0 110.953 179.339 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.46 142.47 16.11 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 174.858 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.4 pt -128.85 147.78 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 125.331 1.452 . . . . 0.0 111.925 172.217 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.15 146.94 17.89 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.454 1.026 . . . . 0.0 114.022 177.178 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -109.72 161.1 15.73 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.536 1.934 . . . . 0.0 111.104 178.405 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.9 t -74.41 -24.13 59.06 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.721 0.808 . . . . 0.0 112.802 179.091 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -157.47 156.35 31.96 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.814 1.246 . . . . 0.0 111.504 -177.133 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -57.84 -33.25 68.44 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 118.642 -0.694 . . . . 0.0 112.465 175.228 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -59.65 -30.98 69.91 Favored Glycine 0 CA--C 1.536 1.401 0 CA-C-N 119.491 1.041 . . . . 0.0 114.237 -179.279 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -86.85 -36.89 18.21 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.381 1.09 . . . . 0.0 112.241 176.667 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.46 -30.26 70.48 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 168.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . 0.259 18.3 m-85 -91.0 17.92 7.35 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.006 1.722 . . . . 0.0 114.096 170.867 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -99.41 -40.66 7.77 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.635 -0.666 . . . . 0.0 111.099 143.706 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.407 ' CD2' HD11 ' A' ' 49' ' ' ILE . 40.4 t80 -53.78 -56.7 15.13 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.566 1.076 . . . . 0.0 113.047 178.889 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -80.45 -24.47 39.54 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -175.396 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 85.2 t -81.76 -39.2 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 123.144 0.577 . . . . 0.0 110.941 -177.136 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 89.4 p -64.41 -31.64 72.94 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 175.115 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 67.5 mt -68.14 -56.8 7.47 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.28 1.032 . . . . 0.0 111.704 171.143 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -67.23 -32.63 73.8 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.319 -0.863 . . . . 0.0 113.004 -173.478 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -84.69 -3.16 58.41 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.785 0.834 . . . . 0.0 112.762 177.748 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -93.97 -31.9 14.08 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.41 -0.806 . . . . 0.0 112.375 163.3 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -90.4 -9.81 46.2 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -178.539 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.74 -25.94 30.93 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -171.832 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 30.9 p-90 -88.1 -26.67 22.39 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.81 1.244 . . . . 0.0 113.849 175.729 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 32.0 t -77.68 -44.53 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.062 1.345 . . . . 0.0 110.173 175.318 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 52.3 tttt -115.84 77.28 1.07 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.981 1.712 . . . . 0.0 110.231 176.898 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -74.45 88.85 2.11 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.458 1.103 . . . . 0.0 110.499 173.85 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 . . . . . 0 C--O 1.253 1.238 0 C-N-CA 126.026 1.73 . . . . 0.0 113.429 -179.872 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.661 0 N-CA-C 111.833 -0.507 . . . . 0.0 111.833 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 65.3 m -65.85 136.19 95.65 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 124.268 1.027 . . . . 0.0 112.358 -178.678 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -84.47 40.51 0.87 Allowed 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 124.33 3.353 . . . . 0.0 113.457 -171.586 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -61.59 -31.49 71.55 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 120.557 -1.339 . . . . 0.0 113.042 -171.348 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 19.3 m -63.85 -15.17 58.25 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.128 1.371 . . . . 0.0 114.034 174.706 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.5 mtp -106.08 8.08 32.09 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.14 1.776 . . . . 0.0 112.66 173.668 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.81 -47.83 2.29 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.66 1.584 . . . . 0.0 112.433 -176.937 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.8 t -78.07 -33.04 51.03 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.299 0.571 . . . . 0.0 111.315 165.068 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 46.96 50.21 13.99 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 127.642 2.377 . . . . 0.0 115.265 168.282 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 pp -88.88 130.95 35.32 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.629 0.728 . . . . 0.0 111.257 170.476 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -138.5 59.61 1.63 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.659 1.583 . . . . 0.0 109.447 176.939 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -124.83 141.11 52.34 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.837 1.655 . . . . 0.0 110.792 -178.812 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -177.16 94.04 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.314 1.845 . . . . 0.0 108.156 -178.782 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.4 t -83.79 112.99 20.59 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.738 -1.226 . . . . 0.0 110.146 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.4 p -72.57 144.56 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.707 0.803 . . . . 0.0 112.579 -174.512 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.6 mt -128.26 -43.97 1.44 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.239 1.416 . . . . 0.0 112.248 -173.539 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 24.4 t -149.6 135.06 18.38 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.376 1.07 . . . . 0.0 110.604 175.494 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 96.5 t -127.91 127.96 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.551 1.14 . . . . 0.0 109.304 171.809 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -128.35 133.27 24.97 Favored Pre-proline 0 N--CA 1.476 0.87 0 C-N-CA 125.259 1.424 . . . . 0.0 110.122 174.207 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.22 -15.48 14.36 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.116 2.544 . . . . 0.0 115.037 -171.305 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -133.48 108.58 8.73 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.138 0.975 . . . . 0.0 110.879 -174.444 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.3 p -144.94 144.48 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.161 1.384 . . . . 0.0 110.289 174.697 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.0 m -125.9 130.64 51.71 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.188 0.995 . . . . 0.0 111.081 -172.752 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.5 t -96.39 134.82 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.286 1.435 . . . . 0.0 111.345 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.98 124.76 26.86 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.952 1.301 . . . . 0.0 108.918 170.959 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.4 mmm-85 -63.14 136.77 57.96 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.634 -0.666 . . . . 0.0 110.451 167.843 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.5 pt -100.23 151.21 37.46 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.981 1.312 . . . . 0.0 112.349 -174.841 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.76 162.47 41.95 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 123.145 2.564 . . . . 0.0 111.978 169.383 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -64.62 112.2 1.89 Allowed 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.919 2.413 . . . . 0.0 110.279 170.745 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.2 mmt180 -150.97 164.0 37.39 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.398 1.479 . . . . 0.0 113.046 -167.203 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.07 123.23 23.99 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 122.206 1.003 . . . . 0.0 112.321 175.765 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.6 m -61.75 -24.63 66.95 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 127.331 2.252 . . . . 0.0 117.02 -160.091 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -140.06 16.42 2.45 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.008 1.323 . . . . 0.0 112.939 174.976 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -131.8 -26.59 1.97 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.774 1.63 . . . . 0.0 113.694 -177.459 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -122.96 -9.76 6.04 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.872 1.225 . . . . 0.0 115.293 -176.405 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -74.19 106.1 5.69 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.999 1.399 . . . . 0.0 109.447 161.744 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.13 22.6 12.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.911 -1.118 . . . . 0.0 113.821 178.943 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.87 -48.78 0.06 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.369 2.268 . . . . 0.0 114.969 -167.859 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.6 m -66.86 -13.79 62.01 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.943 1.697 . . . . 0.0 114.903 -176.207 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.38 -12.98 60.37 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.129 0.972 . . . . 0.0 112.876 171.898 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 13.7 m0 -95.76 171.77 8.45 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.483 1.513 . . . . 0.0 111.958 -174.345 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -75.69 49.39 0.51 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.146 1.779 . . . . 0.0 113.844 177.19 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.5 mt -56.06 -33.61 65.15 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -171.025 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -94.44 -3.89 49.29 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.457 1.103 . . . . 0.0 113.209 177.492 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -128.04 59.91 43.05 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 127.054 2.141 . . . . 0.0 111.843 -173.715 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.0 133.34 33.07 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 CA-C-N 120.537 1.227 . . . . 0.0 112.423 -173.468 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -70.34 -24.49 62.99 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.853 1.261 . . . . 0.0 111.243 178.604 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 33.9 t90 -159.74 154.47 24.37 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.862 2.065 . . . . 0.0 110.451 170.946 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.9 p -133.76 150.17 51.46 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.075 0.95 . . . . 0.0 112.112 167.757 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.16 -140.15 4.74 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.099 0.38 . . . . 0.0 113.581 -178.858 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.0 mtm105 -111.5 147.7 34.78 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.538 1.935 . . . . 0.0 111.971 -175.355 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.9 tp -89.19 138.43 31.43 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.632 1.573 . . . . 0.0 109.672 166.441 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 36.8 ttt-85 -144.5 93.04 2.37 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.475 1.11 . . . . 0.0 110.697 165.44 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.471 HD11 ' CD1' ' A' ' 119' ' ' PHE . 16.1 mt -73.08 128.29 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 171.69 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.2 p -132.86 167.32 20.41 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.741 2.016 . . . . 0.0 110.552 -179.18 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.3 t -160.54 146.77 15.24 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.603 -1.311 . . . . 0.0 112.153 177.076 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.5 mmtt -153.3 131.76 12.13 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.358 1.463 . . . . 0.0 111.428 161.154 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.98 45.99 47.48 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.859 1.219 . . . . 0.0 115.026 163.812 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt 63.68 21.39 12.68 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.432 1.893 . . . . 0.0 113.696 -173.905 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.2 m -127.7 112.7 15.11 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.072 1.349 . . . . 0.0 109.143 170.411 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.97 161.49 18.98 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.63 0.772 . . . . 0.0 110.573 170.024 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -141.11 108.75 5.61 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.941 1.696 . . . . 0.0 108.695 -175.637 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.5 mp -81.39 95.14 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 168.36 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -95.04 137.29 34.29 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.445 0.641 . . . . 0.0 111.605 175.586 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.3 mp -110.94 134.36 52.64 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.447 1.899 . . . . 0.0 109.491 176.402 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -139.21 152.13 47.1 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.544 0.738 . . . . 0.0 112.734 -168.374 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -73.6 143.26 46.44 Favored 'General case' 0 C--O 1.238 0.492 0 O-C-N 121.304 -0.872 . . . . 0.0 111.907 -176.809 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.4 pttt -84.01 -6.18 59.36 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.377 1.871 . . . . 0.0 115.05 -178.761 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 91.8 t -123.5 -44.42 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.357 1.463 . . . . 0.0 111.416 178.671 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.9 m -92.77 -23.11 18.99 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -174.906 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.84 6.06 86.94 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 123.872 0.748 . . . . 0.0 113.778 -177.421 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -82.05 154.48 25.6 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.361 1.464 . . . . 0.0 112.616 -174.625 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.1 tp -73.37 125.54 28.1 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.818 0.847 . . . . 0.0 110.981 178.136 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -84.56 -56.94 3.35 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.131 0.972 . . . . 0.0 110.806 169.683 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.32 163.3 39.67 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.744 1.218 . . . . 0.0 111.774 -179.273 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -139.63 135.79 33.65 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.583 1.153 . . . . 0.0 111.5 177.405 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.53 102.81 49.67 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.547 1.139 . . . . 0.0 111.076 174.695 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -70.06 137.89 35.63 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.828 3.019 . . . . 0.0 112.09 173.213 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.8 t -131.98 131.93 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.212 1.805 . . . . 0.0 109.251 -179.193 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -101.11 -16.29 17.11 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.435 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -161.71 152.13 17.42 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.926 1.69 . . . . 0.0 110.411 175.151 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -124.7 134.88 25.99 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -173.095 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -66.9 149.31 80.4 Favored 'Cis proline' 0 CA--C 1.542 0.909 0 CA-C-N 119.41 0.825 . . . . 0.0 111.221 -13.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -148.09 -172.78 18.41 Favored Glycine 0 N--CA 1.474 1.217 0 N-CA-C 115.1 0.8 . . . . 0.0 115.1 -174.183 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.3 tp -58.79 -29.03 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -174.521 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.53 7.97 43.77 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.584 1.154 . . . . 0.0 113.763 -172.977 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.1 p -158.94 128.58 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.004 0.922 . . . . 0.0 113.266 179.008 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -148.57 165.51 31.04 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.185 1.794 . . . . 0.0 113.455 -168.147 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 50.0 p -121.77 155.91 34.28 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.625 1.97 . . . . 0.0 111.592 -172.692 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.0 m -84.45 172.89 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.761 0.824 . . . . 0.0 111.901 172.941 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 68.7 p -89.03 -34.17 16.9 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.028 1.331 . . . . 0.0 112.539 177.868 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -92.92 -43.41 8.97 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -164.307 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.4 t -145.81 121.56 10.54 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -174.2 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.37 -2.3 5.99 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -169.707 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.416 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.264 1.2 ptm180 -88.19 22.16 2.54 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.922 1.689 . . . . 0.0 114.528 174.2 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -140.47 134.71 31.11 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.893 1.277 . . . . 0.0 110.813 178.695 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -134.26 161.55 34.64 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.418 1.487 . . . . 0.0 111.763 -179.672 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.5 t -117.5 142.35 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.522 1.129 . . . . 0.0 109.116 166.762 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.38 150.77 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 123.381 0.673 . . . . 0.0 111.721 171.014 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -95.06 89.69 5.66 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.125 0.97 . . . . 0.0 109.988 177.78 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -71.05 137.0 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 120.724 0.297 . . . . 0.0 110.757 177.842 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -142.52 144.1 32.81 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.725 1.61 . . . . 0.0 111.521 -167.198 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -90.95 3.03 55.72 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.489 1.116 . . . . 0.0 113.121 -177.665 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.28 13.09 79.61 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 125.218 1.39 . . . . 0.0 114.794 178.286 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.5 t -137.22 15.88 3.0 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.44 1.496 . . . . 0.0 113.721 -172.647 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.38 -1.88 80.06 Favored Glycine 0 CA--C 1.537 1.453 0 O-C-N 121.036 -1.04 . . . . 0.0 114.957 -178.131 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -71.59 131.89 43.88 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.445 1.498 . . . . 0.0 108.678 163.626 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 92.7 p -146.7 152.27 38.56 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 176.941 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.75 141.02 26.3 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.303 1.441 . . . . 0.0 111.195 167.565 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -87.42 125.13 34.09 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 121.842 -0.536 . . . . 0.0 110.352 169.682 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 14.9 pt -122.27 142.92 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.117 1.367 . . . . 0.0 110.469 175.131 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.99 143.68 16.68 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 172.542 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.9 pt -129.17 141.59 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.971 1.308 . . . . 0.0 111.951 172.335 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -119.21 145.31 18.07 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.936 1.255 . . . . 0.0 113.157 175.267 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -108.21 161.51 14.92 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.016 1.726 . . . . 0.0 111.689 -176.334 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.9 t -72.57 -29.41 63.51 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.744 0.818 . . . . 0.0 112.91 -179.391 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -155.6 153.37 30.0 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.523 1.129 . . . . 0.0 111.753 -178.469 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 57.4 ttt-85 -61.29 -34.29 74.97 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.185 0.994 . . . . 0.0 113.176 178.065 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.43 -29.67 74.38 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 118.898 0.772 . . . . 0.0 113.515 175.481 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -82.43 -33.51 28.55 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 117.893 0.847 . . . . 0.0 111.825 175.349 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.416 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -67.09 -33.4 75.39 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.7 0.8 . . . . 0.0 112.962 170.146 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -60.84 -34.06 74.0 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.51 -0.744 . . . . 0.0 112.347 172.671 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -64.87 -32.63 74.43 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.543 1.065 . . . . 0.0 112.606 174.726 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.471 ' CD1' HD11 ' A' ' 49' ' ' ILE . 27.3 t80 -60.97 -55.66 30.24 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.241 0.928 . . . . 0.0 111.604 173.011 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.05 -26.73 56.85 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -175.884 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.9 t -74.62 -43.29 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 119.288 0.949 . . . . 0.0 110.953 175.271 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 41.9 m -66.41 -27.18 67.64 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.96 0.8 . . . . 0.0 112.843 -179.187 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 75.4 mt -73.71 -57.52 3.93 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.638 0.775 . . . . 0.0 111.483 169.877 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -64.27 -32.35 73.91 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -173.595 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -80.58 -5.42 56.78 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.039 0.936 . . . . 0.0 112.575 178.785 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -94.77 -15.05 24.14 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 165.403 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -108.81 -7.01 15.6 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.85 -23.34 43.43 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 121.218 1.826 . . . . 0.0 115.786 -175.653 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 31.0 p-90 -88.85 -18.64 27.21 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.278 1.431 . . . . 0.0 113.955 175.559 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.1 t -87.5 -44.79 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.559 1.543 . . . . 0.0 109.849 173.593 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.1 ttpp -107.73 77.71 1.15 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.523 1.929 . . . . 0.0 110.028 172.137 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -72.4 20.38 0.07 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.348 1.859 . . . . 0.0 115.269 177.481 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 C--O 1.252 1.195 0 C-N-CA 127.044 2.137 . . . . 0.0 113.169 -178.655 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.638 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 33.2 m 48.29 59.94 16.14 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 126.144 1.777 . . . . 0.0 114.9 177.162 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -71.65 -1.04 9.21 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 124.077 3.185 . . . . 0.0 114.362 -177.392 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -58.32 -22.95 55.03 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.718 1.607 . . . . 0.0 113.668 -177.013 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 73.7 p -62.88 -14.13 42.61 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.048 1.339 . . . . 0.0 114.306 172.928 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.9 mtp -88.53 6.42 37.99 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.47 1.508 . . . . 0.0 113.382 174.754 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.57 -46.8 0.41 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.787 1.635 . . . . 0.0 111.603 179.15 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 35.9 m -86.16 75.25 9.92 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.767 1.227 . . . . 0.0 107.975 161.723 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -106.51 22.2 16.2 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 114.703 1.372 . . . . 0.0 114.703 -159.084 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.5 mp -58.9 123.02 15.11 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.036 0.935 . . . . 0.0 111.341 179.118 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -111.84 54.15 0.7 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 122.933 1.349 . . . . 0.0 110.371 168.48 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.25 65.26 1.14 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 123.824 1.773 . . . . 0.0 111.337 -146.251 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -172.6 75.89 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 128.296 2.639 . . . . 0.0 108.029 167.455 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.2 m -70.98 109.25 4.98 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.33 -0.856 . . . . 0.0 110.212 173.577 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.9 t -73.55 147.25 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.103 1.361 . . . . 0.0 111.622 -174.54 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.84 -40.88 1.05 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.516 1.527 . . . . 0.0 111.843 -172.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 22.5 t -147.41 142.5 27.1 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.899 1.28 . . . . 0.0 110.669 173.58 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 76.1 t -136.05 129.03 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 125.076 1.35 . . . . 0.0 109.087 170.082 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -130.92 137.65 31.24 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 125.44 1.496 . . . . 0.0 110.381 173.27 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.59 -17.86 15.87 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.028 2.485 . . . . 0.0 114.797 -174.744 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -133.77 111.11 10.27 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.236 1.015 . . . . 0.0 111.794 -171.009 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.0 p -148.42 144.3 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.038 1.735 . . . . 0.0 110.017 172.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.4 m -123.09 136.63 54.88 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.45 1.1 . . . . 0.0 111.29 -174.053 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.2 t -101.29 133.42 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.063 1.345 . . . . 0.0 111.532 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -134.18 119.6 19.02 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.055 1.342 . . . . 0.0 108.864 171.044 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -66.36 129.86 41.26 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.975 0.51 . . . . 0.0 109.808 174.577 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.4 pt -88.89 151.04 46.75 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -166.575 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -66.86 169.27 15.08 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.313 2.676 . . . . 0.0 111.383 163.807 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -56.47 152.38 40.45 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.325 2.017 . . . . 0.0 111.948 166.605 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 40.0 ttm-85 -60.99 156.32 18.0 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.309 1.444 . . . . 0.0 112.772 -175.306 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.29 -175.9 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.511 1.124 . . . . 0.0 112.863 163.129 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.2 p -76.23 70.29 2.85 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.351 1.861 . . . . 0.0 113.26 -170.554 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 62.64 14.24 7.0 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 127.009 2.124 . . . . 0.0 113.798 -169.974 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -89.82 -54.9 3.85 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.6 1.16 . . . . 0.0 112.197 -175.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 141.12 -148.61 20.28 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-O 122.038 0.799 . . . . 0.0 112.431 -169.543 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -117.27 159.83 22.06 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 127.379 2.272 . . . . 0.0 111.041 -179.633 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.42 17.13 3.68 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -171.377 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.06 -52.23 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 128.16 2.584 . . . . 0.0 115.616 -175.487 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.6 m -66.66 -13.94 61.85 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.872 1.669 . . . . 0.0 114.187 -176.819 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -84.6 -8.44 58.89 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.943 1.297 . . . . 0.0 112.633 173.479 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.2 m0 -92.93 169.36 10.5 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.753 1.621 . . . . 0.0 111.234 177.214 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -79.62 51.33 1.25 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.197 1.799 . . . . 0.0 112.574 178.305 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.2 mt -54.62 -32.44 58.92 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.389 1.476 . . . . 0.0 114.36 -173.852 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -87.92 -9.5 53.44 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.796 0.838 . . . . 0.0 112.485 -177.757 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -139.13 68.66 41.23 Favored Pre-proline 0 N--CA 1.47 0.545 0 C-N-CA 125.396 1.478 . . . . 0.0 111.231 -160.511 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -68.7 147.23 69.17 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 CA-C-N 119.519 0.864 . . . . 0.0 113.215 -169.1 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -72.52 -30.12 64.19 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.493 0.717 . . . . 0.0 111.286 168.674 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.6 t90 -159.24 155.14 26.47 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.472 1.909 . . . . 0.0 110.517 176.789 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.8 p -134.7 146.99 49.98 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.81 1.244 . . . . 0.0 111.945 171.233 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.14 -140.8 5.45 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 114.574 0.59 . . . . 0.0 114.574 176.707 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -107.14 141.54 38.25 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 126.677 1.991 . . . . 0.0 111.249 -169.253 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.5 tp -84.67 139.39 32.06 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.037 1.335 . . . . 0.0 110.127 168.237 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.6 ttm-85 -131.82 132.05 43.4 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.408 1.083 . . . . 0.0 109.554 154.546 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.402 HD11 ' CD2' ' A' ' 119' ' ' PHE . 22.4 mt -109.34 132.8 56.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 163.282 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.84 164.19 31.24 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 126.379 1.871 . . . . 0.0 109.866 -168.322 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.2 t -156.96 155.99 32.24 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 120.772 -1.205 . . . . 0.0 111.805 177.241 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -159.97 133.3 6.92 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.388 1.475 . . . . 0.0 110.045 152.641 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.97 49.94 20.28 Favored Glycine 0 N--CA 1.475 1.258 0 C-N-CA 124.7 1.143 . . . . 0.0 114.82 166.666 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt 59.93 23.1 12.16 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 126.406 1.882 . . . . 0.0 113.697 -175.834 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.8 m -126.93 126.48 43.31 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.824 1.65 . . . . 0.0 108.308 172.285 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.68 161.11 13.81 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.125 0.97 . . . . 0.0 110.873 170.577 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -139.65 110.68 6.89 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 126.438 1.895 . . . . 0.0 108.356 -175.057 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.5 mp -86.33 106.92 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 166.098 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.7 mttt -107.43 131.3 54.43 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.64 1.176 . . . . 0.0 111.358 177.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.0 mp -103.32 130.01 50.49 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.053 1.341 . . . . 0.0 110.481 178.754 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -131.75 147.2 52.48 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.912 0.885 . . . . 0.0 113.289 -167.765 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -64.42 142.92 58.25 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.815 -1.178 . . . . 0.0 113.063 -177.858 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.26 -2.7 36.07 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 -178.299 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.5 t -116.78 -48.77 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.481 1.112 . . . . 0.0 111.269 170.836 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.7 m -114.22 -4.67 13.04 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.6 1.334 . . . . 0.0 114.6 -168.045 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.21 15.73 78.73 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 123.85 0.738 . . . . 0.0 114.143 177.257 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -63.97 133.35 53.03 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.839 1.656 . . . . 0.0 111.383 -177.032 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.1 tp -68.67 115.11 7.66 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 122.881 0.472 . . . . 0.0 111.056 -179.391 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -80.8 -53.3 6.61 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.714 1.206 . . . . 0.0 111.131 173.569 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.24 159.13 35.69 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.052 1.341 . . . . 0.0 111.287 -178.187 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -138.31 136.63 36.61 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.5 0.72 . . . . 0.0 112.502 173.182 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.96 107.93 47.23 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 125.339 1.456 . . . . 0.0 110.752 176.517 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -79.66 141.07 15.24 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.721 2.947 . . . . 0.0 111.314 175.101 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.8 t -134.14 129.52 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 126.145 1.778 . . . . 0.0 109.237 -172.3 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -96.52 -21.14 17.88 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 178.836 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.33 149.12 13.42 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.704 2.001 . . . . 0.0 110.301 175.981 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -129.24 129.76 23.33 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 124.334 1.054 . . . . 0.0 111.963 177.224 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -65.58 149.02 75.63 Favored 'Cis proline' 0 CA--C 1.541 0.854 0 CA-C-N 119.807 0.967 . . . . 0.0 113.191 -5.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -169.1 -162.28 21.03 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.639 1.59 . . . . 0.0 113.473 -177.282 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.9 tp -68.43 -35.42 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -170.249 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.04 4.1 53.81 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -168.511 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.4 t -151.35 129.64 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.806 1.242 . . . . 0.0 110.229 -179.38 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -138.84 158.4 44.3 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.535 1.534 . . . . 0.0 112.91 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 57.0 p -104.79 156.77 17.7 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.35 1.86 . . . . 0.0 111.225 175.785 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.7 m -82.89 178.37 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.82 0.848 . . . . 0.0 110.759 166.058 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 73.3 p -107.99 -22.27 12.48 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.775 1.63 . . . . 0.0 114.005 -177.941 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -90.68 -45.04 9.11 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -175.967 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t -145.32 125.7 13.96 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -179.416 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.8 m -69.57 11.83 0.23 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 -173.012 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.466 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.27 28.9 ptt180 -96.51 12.58 30.99 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.27 1.428 . . . . 0.0 114.43 174.016 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -136.75 139.66 42.02 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.428 1.491 . . . . 0.0 111.382 -173.338 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -140.13 162.89 34.15 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.062 1.345 . . . . 0.0 111.602 -177.26 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.4 t -117.17 141.77 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.526 1.131 . . . . 0.0 108.446 166.053 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.32 148.36 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 118.805 0.729 . . . . 0.0 112.281 171.246 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -91.04 81.76 5.61 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.906 0.883 . . . . 0.0 111.162 179.417 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -67.26 141.55 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.966 0.412 . . . . 0.0 111.148 176.812 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -139.63 152.13 46.53 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.646 1.578 . . . . 0.0 111.736 -169.058 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -95.58 1.9 53.97 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.174 0.99 . . . . 0.0 113.084 178.197 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.82 12.57 81.17 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.141 1.353 . . . . 0.0 114.796 178.381 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.9 t -136.3 12.45 3.28 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.516 1.526 . . . . 0.0 113.432 -172.586 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.82 -3.86 71.33 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 124.855 1.217 . . . . 0.0 114.793 -177.964 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -72.37 132.91 44.59 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.294 1.437 . . . . 0.0 108.588 163.889 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.9 p -149.27 159.48 44.23 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 173.08 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.35 146.22 32.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.436 1.494 . . . . 0.0 110.803 168.301 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -91.44 117.13 29.42 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.361 0.664 . . . . 0.0 109.535 168.586 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.6 pt -115.2 142.19 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.442 1.097 . . . . 0.0 110.795 177.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.7 141.27 16.01 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 175.293 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.5 pt -127.32 148.72 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 125.19 1.396 . . . . 0.0 111.602 170.432 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -134.61 147.24 19.05 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 124.093 0.854 . . . . 0.0 113.423 175.46 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -105.12 157.06 17.52 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.449 1.5 . . . . 0.0 111.279 176.1 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.4 t -73.8 -17.4 61.09 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.554 0.742 . . . . 0.0 112.78 178.211 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -154.28 145.92 23.27 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.675 1.19 . . . . 0.0 110.868 -178.188 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -64.27 -28.07 69.48 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.84 0.856 . . . . 0.0 113.193 -179.801 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.82 -30.75 78.07 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 124.164 0.888 . . . . 0.0 114.257 173.299 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -81.79 -34.89 30.08 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.603 1.201 . . . . 0.0 111.763 176.486 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.466 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -66.68 -30.18 70.37 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.162 0.985 . . . . 0.0 113.446 168.919 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.01 -49.54 76.51 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.363 0.665 . . . . 0.0 111.048 166.995 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -64.37 -28.96 70.05 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 118.837 0.744 . . . . 0.0 113.007 176.782 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.402 ' CD2' HD11 ' A' ' 49' ' ' ILE . 48.4 t80 -62.43 -61.25 2.57 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.651 1.114 . . . . 0.0 111.535 170.397 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -76.78 -27.29 55.22 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -171.589 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 65.5 t -71.76 -37.97 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 O-C-N 121.404 -0.81 . . . . 0.0 110.924 176.582 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 51.1 m -67.11 -16.29 64.24 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 176.466 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.5 mt -84.75 -56.73 3.43 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.164 0.985 . . . . 0.0 111.3 168.192 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -66.89 -34.33 77.54 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -172.184 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -85.77 -0.45 55.28 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.688 0.795 . . . . 0.0 112.44 177.522 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -99.4 -29.06 12.98 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.064 -1.023 . . . . 0.0 112.524 165.951 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -96.83 -5.95 37.12 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -179.601 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.82 -31.89 41.37 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 121.302 1.865 . . . . 0.0 114.887 -173.529 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -84.87 -25.79 27.78 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.745 1.218 . . . . 0.0 113.796 179.178 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.5 t -80.22 -39.46 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.939 1.296 . . . . 0.0 110.531 175.004 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -100.98 55.29 0.85 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.136 1.775 . . . . 0.0 111.259 -177.414 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -79.14 90.22 4.86 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.351 167.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 . . . . . 0 C--O 1.253 1.251 0 C-N-CA 126.937 2.095 . . . . 0.0 112.522 -175.817 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.566 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 35.5 m 47.98 61.54 13.63 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 126.245 1.818 . . . . 0.0 114.892 177.264 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.29 -19.11 26.01 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.43 2.753 . . . . 0.0 113.815 -178.739 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 75.6 m-80 -100.71 155.11 18.08 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.481 1.512 . . . . 0.0 111.877 177.563 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 21.9 m -72.82 -17.67 61.54 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -177.045 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -85.74 126.96 34.38 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.172 1.389 . . . . 0.0 111.282 -176.843 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.15 138.06 15.41 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.054 1.742 . . . . 0.0 107.962 172.907 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.9 m -86.95 73.74 9.87 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 122.693 1.235 . . . . 0.0 110.115 -175.524 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -97.22 12.71 31.92 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 115.105 1.521 . . . . 0.0 115.105 -156.615 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.83 43.56 0.6 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.383 1.873 . . . . 0.0 112.4 -179.712 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -92.38 51.86 1.83 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.174 1.789 . . . . 0.0 110.827 -177.409 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -148.47 142.44 25.84 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.905 1.282 . . . . 0.0 111.375 -175.95 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -178.11 123.83 0.11 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.88 1.672 . . . . 0.0 107.905 167.014 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.2 m -93.35 106.35 18.33 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 165.912 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.7 t -73.6 143.44 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.066 0.946 . . . . 0.0 110.764 177.612 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.2 mt -131.09 -36.8 1.3 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.089 1.355 . . . . 0.0 111.817 -169.576 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 47.9 t -153.17 142.67 21.76 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.3 1.44 . . . . 0.0 110.182 171.266 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 89.4 t -134.55 127.31 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.49 1.116 . . . . 0.0 109.315 169.223 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 75.1 mmtt -121.54 133.35 24.21 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 124.932 1.293 . . . . 0.0 111.027 174.701 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 14' ' ' LYS . 42.2 Cg_exo -69.06 -29.96 26.34 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.47 2.113 . . . . 0.0 115.911 -171.508 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -137.14 122.48 19.4 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.792 0.805 . . . . 0.0 112.744 -175.218 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 p -149.24 149.07 15.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 127.571 2.348 . . . . 0.0 109.243 177.115 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.7 m -124.75 130.96 53.41 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.652 0.781 . . . . 0.0 112.358 -169.238 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 78.6 t -96.58 136.42 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.733 1.613 . . . . 0.0 112.473 -178.772 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -129.2 126.44 39.17 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.148 1.379 . . . . 0.0 109.357 169.892 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -66.88 131.29 45.6 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 167.552 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.7 pt -109.14 151.5 42.02 Favored Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 124.699 1.2 . . . . 0.0 112.36 -175.088 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -70.47 158.45 55.99 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 122.765 2.31 . . . . 0.0 111.38 166.459 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -63.53 144.53 90.39 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.76 2.307 . . . . 0.0 110.975 170.546 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -71.7 151.34 43.71 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 122.01 0.91 . . . . 0.0 113.445 -173.786 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.24 -137.86 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 127.969 2.507 . . . . 0.0 112.116 163.521 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 89.3 p -141.07 -36.13 0.46 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.868 1.667 . . . . 0.0 112.578 177.19 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -126.51 40.47 3.72 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.486 1.914 . . . . 0.0 111.23 -178.211 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 90.9 mmt-85 -131.47 -58.84 0.98 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.682 1.193 . . . . 0.0 113.313 177.945 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.35 152.54 5.19 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 123.413 0.446 . . . . 0.0 112.909 -177.732 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -68.15 133.02 48.24 Favored 'General case' 0 C--O 1.223 -0.318 0 O-C-N 121.968 -0.725 . . . . 0.0 109.721 171.972 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.67 18.27 10.34 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -174.5 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 60.35 -46.47 0.1 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.583 2.353 . . . . 0.0 115.064 -171.573 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 92.1 p -65.66 -16.91 64.19 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.56 1.944 . . . . 0.0 114.694 179.309 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -73.32 -18.79 61.16 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.766 1.226 . . . . 0.0 112.86 171.417 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 16.6 m0 -90.52 173.09 8.26 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.454 1.501 . . . . 0.0 111.881 -176.171 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -79.23 53.65 1.52 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.653 1.581 . . . . 0.0 114.36 -176.252 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.1 mt -60.01 -17.87 41.84 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -171.304 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -106.78 -3.16 20.74 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.497 1.119 . . . . 0.0 113.067 177.209 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -149.09 69.33 9.79 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 125.207 1.403 . . . . 0.0 112.122 177.798 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -55.31 145.69 65.46 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.134 2.556 . . . . 0.0 112.44 174.571 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.28 -30.68 68.83 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.711 0.804 . . . . 0.0 111.394 173.958 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 46.8 t90 -156.62 152.67 27.48 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.225 1.41 . . . . 0.0 111.056 176.076 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.9 p -133.57 152.2 51.86 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.495 -0.753 . . . . 0.0 112.13 166.274 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 176.55 -149.58 9.83 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.139 -0.482 . . . . 0.0 113.558 -175.944 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 17.5 mtm180 -97.05 148.27 23.18 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.432 1.893 . . . . 0.0 111.677 -175.959 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.0 tp -91.75 134.5 34.68 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.664 1.185 . . . . 0.0 109.596 163.332 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -127.83 119.53 25.87 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.891 1.276 . . . . 0.0 108.882 160.677 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.5 mt -101.93 130.86 50.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 166.471 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.92 166.48 26.62 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 126.254 1.822 . . . . 0.0 110.028 -166.906 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.9 t -157.21 160.12 38.38 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 121.273 -0.892 . . . . 0.0 112.168 173.67 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -144.42 122.04 11.82 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.652 0.739 . . . . 0.0 111.809 154.594 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.2 -117.98 9.68 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 125.863 1.697 . . . . 0.0 110.523 -177.551 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -100.2 14.01 32.28 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.917 1.687 . . . . 0.0 113.378 179.11 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.0 m -123.57 108.74 12.95 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.904 0.882 . . . . 0.0 110.285 177.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -83.16 158.94 22.16 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.158 0.504 . . . . 0.0 110.762 169.418 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -138.74 112.89 8.64 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.358 1.863 . . . . 0.0 108.729 -175.78 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.2 mp -91.98 105.54 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 165.458 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -104.09 135.06 46.28 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.115 1.366 . . . . 0.0 110.798 178.112 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.1 mp -107.06 128.79 54.69 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.616 1.566 . . . . 0.0 109.664 176.438 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -132.69 146.55 51.95 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.943 0.897 . . . . 0.0 112.004 -170.646 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -69.23 133.13 47.54 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.75 -1.219 . . . . 0.0 111.128 -179.689 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.5 pttt -77.19 -2.5 34.82 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -176.759 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.07 -42.41 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.42 1.488 . . . . 0.0 111.466 178.64 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.4 m -93.6 -21.07 19.63 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -178.764 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.66 10.07 82.83 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.645 1.117 . . . . 0.0 113.99 -177.308 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -86.75 149.11 25.1 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.287 1.435 . . . . 0.0 112.512 -172.762 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.3 tp -72.57 123.92 24.18 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.603 -0.686 . . . . 0.0 111.404 -178.029 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -87.49 -54.47 4.26 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.864 1.265 . . . . 0.0 111.245 171.826 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.9 163.2 40.64 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.684 1.194 . . . . 0.0 111.691 -177.892 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -145.84 131.46 18.86 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.505 1.122 . . . . 0.0 111.531 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.33 104.79 49.65 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 125.472 1.509 . . . . 0.0 110.855 178.895 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -77.22 144.32 23.26 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.053 2.502 . . . . 0.0 111.264 173.149 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.3 t -135.94 131.42 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.727 1.611 . . . . 0.0 109.014 -174.982 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -96.07 -22.68 17.19 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -179.54 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -163.29 150.67 12.89 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.786 2.034 . . . . 0.0 110.202 173.451 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -122.69 128.42 25.41 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.865 1.266 . . . . 0.0 111.204 177.635 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -63.14 149.49 65.88 Favored 'Cis proline' 0 CA--C 1.541 0.83 0 CA-C-N 119.849 0.982 . . . . 0.0 113.793 -6.344 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.01 -165.99 14.77 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.715 1.626 . . . . 0.0 112.532 178.347 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.7 tt -73.06 -36.86 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 O-C-N 121.698 -0.883 . . . . 0.0 112.867 -179.215 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.63 6.27 18.34 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -167.735 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.2 t -150.36 132.74 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.639 1.576 . . . . 0.0 110.26 -178.801 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -146.62 161.46 40.5 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.355 1.862 . . . . 0.0 112.331 -175.616 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 20.0 p -111.15 162.97 14.38 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 126.834 2.054 . . . . 0.0 111.719 177.447 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.0 m -87.7 174.8 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.64 1.176 . . . . 0.0 110.543 164.603 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 73.2 p -96.09 -36.38 11.01 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.147 1.379 . . . . 0.0 112.629 179.476 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -103.51 -28.33 11.83 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 -161.709 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.6 t -132.87 127.0 33.47 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.489 1.04 . . . . 0.0 113.51 -177.608 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.6 p -75.79 22.08 0.15 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.914 2.086 . . . . 0.0 116.164 -166.049 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -138.81 26.77 2.48 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 126.245 1.818 . . . . 0.0 114.632 -173.225 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -141.7 141.93 33.32 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.871 1.268 . . . . 0.0 111.735 -175.966 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -140.09 163.5 32.55 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.053 1.341 . . . . 0.0 111.085 -179.701 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.2 t -116.47 144.54 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.938 1.295 . . . . 0.0 108.843 166.959 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.8 149.42 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 118.565 0.621 . . . . 0.0 111.811 171.159 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.443 ' HE ' ' NE2' ' A' ' 97' ' ' GLN . 38.6 ttp180 -91.87 103.14 15.72 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.158 0.583 . . . . 0.0 109.954 173.285 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -84.96 148.29 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.441 1.096 . . . . 0.0 111.434 177.057 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.443 ' NE2' ' HE ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -130.75 139.66 50.27 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.863 1.665 . . . . 0.0 111.447 -179.756 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -84.18 3.99 32.59 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.233 1.013 . . . . 0.0 113.384 177.656 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.94 13.06 82.71 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 125.199 1.38 . . . . 0.0 114.789 177.924 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.2 t -139.66 17.66 2.52 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.413 1.485 . . . . 0.0 113.534 -171.645 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.97 0.46 77.82 Favored Glycine 0 CA--C 1.538 1.476 0 O-C-N 120.956 -1.09 . . . . 0.0 115.017 -179.094 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -80.53 143.25 33.41 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.39 1.476 . . . . 0.0 109.101 165.9 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 82.8 p -148.03 159.73 43.59 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 168.549 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.62 145.48 30.97 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.983 1.313 . . . . 0.0 110.999 170.38 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -90.13 121.72 32.44 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 166.056 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.8 pt -121.66 144.12 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.823 1.249 . . . . 0.0 110.965 178.698 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -90.7 142.81 16.41 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 173.588 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.1 pt -126.86 140.58 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 125.404 1.482 . . . . 0.0 111.651 172.104 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.48 138.95 11.83 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.185 1.374 . . . . 0.0 112.93 177.646 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -100.64 158.21 16.11 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.768 1.627 . . . . 0.0 111.488 -177.505 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.9 t -73.81 -21.56 60.11 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.732 0.813 . . . . 0.0 112.834 178.889 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -157.89 151.3 23.47 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.473 1.109 . . . . 0.0 111.577 -178.543 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -55.23 -41.64 72.36 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.716 1.207 . . . . 0.0 112.762 174.938 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.83 -29.08 71.29 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.163 0.887 . . . . 0.0 114.149 -179.275 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -83.72 -36.43 23.68 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.242 1.021 . . . . 0.0 112.103 176.225 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.0 -31.81 73.03 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.562 -0.711 . . . . 0.0 112.524 168.057 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -75.91 5.95 5.79 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 171.214 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -99.38 -32.51 11.12 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.419 -0.801 . . . . 0.0 112.715 157.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -55.88 -50.96 69.2 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.822 1.192 . . . . 0.0 112.458 178.603 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 48.0 p-10 -70.87 -34.28 71.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.262 1.025 . . . . 0.0 113.617 -179.44 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.1 t -73.91 -39.65 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.383 1.073 . . . . 0.0 110.742 178.825 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 27.6 t -57.28 -38.06 73.34 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.855 1.262 . . . . 0.0 112.63 176.772 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.7 mt -76.45 -52.53 9.66 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.875 0.87 . . . . 0.0 112.333 176.394 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -65.88 -30.79 71.45 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.409 -0.807 . . . . 0.0 112.999 -175.203 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -88.24 6.3 37.54 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.379 1.072 . . . . 0.0 112.942 176.684 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -94.14 -43.65 8.37 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.498 -0.751 . . . . 0.0 111.97 154.776 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -85.82 1.1 51.07 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -171.922 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.95 -17.94 20.24 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 -178.754 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 30.1 p-90 -99.48 -16.61 18.28 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.032 1.333 . . . . 0.0 114.147 172.261 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.2 t -94.31 -38.71 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.513 1.525 . . . . 0.0 111.606 -175.899 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -90.71 33.47 0.92 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.524 1.53 . . . . 0.0 111.88 -176.237 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -91.48 97.9 11.35 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.325 1.45 . . . . 0.0 109.921 178.094 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 . . . . . 0 C--O 1.253 1.284 0 C-N-CA 126.755 2.022 . . . . 0.0 112.665 -177.479 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.623 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 39.3 t -141.8 157.21 65.15 Favored Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 126.036 1.734 . . . . 0.0 110.834 -177.49 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.7 -19.42 18.51 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.797 2.331 . . . . 0.0 113.823 162.01 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -82.38 -9.55 59.41 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.473 1.509 . . . . 0.0 114.05 175.236 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 50.0 m -74.45 -9.53 58.68 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -175.232 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.58 154.78 41.9 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.975 1.71 . . . . 0.0 111.846 -179.629 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.02 23.88 2.19 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.591 1.156 . . . . 0.0 113.121 -179.377 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 61.5 m 62.34 104.56 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.466 1.907 . . . . 0.0 110.142 -155.646 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -148.89 117.05 6.4 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.223 1.009 . . . . 0.0 109.934 -159.624 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -147.27 146.24 29.68 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.191 1.396 . . . . 0.0 112.363 179.331 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -133.87 44.22 2.77 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.928 1.691 . . . . 0.0 110.273 177.62 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.443 ' CD2' ' HG3' ' A' ' 52' ' ' LYS . 2.9 p90 -152.98 156.65 39.25 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.963 2.105 . . . . 0.0 110.065 -171.142 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -174.66 105.22 0.1 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.677 1.591 . . . . 0.0 108.351 -178.7 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.63 108.8 19.88 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.381 -0.825 . . . . 0.0 109.742 171.245 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.74 147.23 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.343 1.057 . . . . 0.0 113.152 175.76 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.1 mt -123.57 -38.72 2.5 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.727 2.011 . . . . 0.0 110.32 179.804 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.1 t -155.36 147.28 23.39 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.344 1.458 . . . . 0.0 110.686 170.102 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.0 t -136.9 125.28 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.342 1.457 . . . . 0.0 108.906 174.121 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -127.82 143.12 46.49 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 124.63 1.172 . . . . 0.0 112.482 178.392 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.19 -19.34 15.53 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.836 3.024 . . . . 0.0 115.623 -172.834 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -132.25 112.07 11.93 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.9 0.88 . . . . 0.0 111.713 -172.008 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.8 p -145.07 143.58 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.785 1.634 . . . . 0.0 110.074 169.722 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.3 m -126.61 127.78 45.76 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.204 1.001 . . . . 0.0 111.172 -172.843 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 78.7 t -94.91 138.39 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.383 1.473 . . . . 0.0 112.194 -177.652 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -129.2 126.71 39.78 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.026 1.33 . . . . 0.0 109.356 168.918 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -69.55 119.25 13.51 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 165.454 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.5 pt -91.59 153.3 44.0 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 124.247 1.019 . . . . 0.0 113.304 -167.922 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -67.51 157.16 63.05 Favored 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 122.872 2.381 . . . . 0.0 111.664 165.908 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -65.76 143.44 73.97 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.136 2.557 . . . . 0.0 112.047 177.896 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -75.88 152.94 37.06 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.695 0.798 . . . . 0.0 112.937 -175.91 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -146.97 149.26 32.81 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.89 1.276 . . . . 0.0 109.575 154.728 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.5 m -65.42 -26.47 67.99 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.775 1.63 . . . . 0.0 114.036 -174.615 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -78.24 -3.98 45.5 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.422 1.089 . . . . 0.0 112.891 171.973 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -114.76 -58.31 2.16 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.463 1.905 . . . . 0.0 111.449 178.198 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.05 168.43 3.42 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 122.227 0.904 . . . . 0.0 111.793 -163.256 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -81.36 130.87 35.21 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 159.137 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.38 18.12 6.44 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -171.162 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.07 -47.05 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 127.842 2.457 . . . . 0.0 115.591 -171.878 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.5 m -66.29 -17.08 64.54 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.359 1.864 . . . . 0.0 114.739 -178.623 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -87.04 -2.01 58.31 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.075 0.95 . . . . 0.0 113.261 172.22 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 22.2 m0 -93.0 169.29 10.54 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.319 1.447 . . . . 0.0 110.615 172.866 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.6 mmtm -77.22 53.63 1.02 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.762 1.625 . . . . 0.0 114.445 -178.086 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.8 mt -58.52 -20.94 50.32 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 -175.376 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -100.79 -4.0 28.87 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 178.753 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -153.19 81.72 5.02 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.914 1.286 . . . . 0.0 111.784 175.041 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.37 145.8 34.85 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.308 2.672 . . . . 0.0 112.936 175.331 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -68.62 -31.54 70.78 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.092 0.557 . . . . 0.0 111.077 169.523 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 42.3 t90 -157.06 156.15 32.36 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.703 1.601 . . . . 0.0 111.057 174.297 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.8 p -135.08 149.46 50.07 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.277 1.031 . . . . 0.0 112.276 169.157 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.42 -143.94 6.17 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 123.289 0.471 . . . . 0.0 113.631 179.586 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.3 mtm105 -107.94 150.68 26.78 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.61 1.964 . . . . 0.0 112.093 -175.604 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.7 tp -94.71 138.18 32.86 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.485 1.914 . . . . 0.0 110.513 173.211 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -134.77 106.39 6.89 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.494 1.518 . . . . 0.0 109.684 165.26 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.3 mt -87.18 130.64 36.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 166.16 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.88 164.93 29.13 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.817 1.647 . . . . 0.0 110.739 -169.366 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.4 t -159.0 157.02 30.45 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.572 1.149 . . . . 0.0 111.009 171.54 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.443 ' HG3' ' CD2' ' A' ' 7' ' ' TYR . 38.4 mmtt -147.62 128.6 14.5 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.027 0.931 . . . . 0.0 110.782 152.728 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.43 -125.49 7.36 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 125.841 1.686 . . . . 0.0 110.054 -177.332 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -104.44 22.62 14.59 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.638 1.575 . . . . 0.0 112.78 177.389 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.6 m -127.47 123.17 35.37 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.995 1.318 . . . . 0.0 109.678 178.633 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.29 162.1 13.82 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.164 0.986 . . . . 0.0 110.791 169.487 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -140.93 112.74 7.65 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.041 1.736 . . . . 0.0 108.758 -176.326 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -89.88 105.41 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 167.28 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -108.84 141.93 40.16 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.893 1.277 . . . . 0.0 111.286 179.138 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.3 mp -111.69 131.1 55.52 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 126.047 1.739 . . . . 0.0 110.347 178.877 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -126.04 154.16 43.4 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.347 1.059 . . . . 0.0 113.441 -171.685 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -72.7 141.98 48.21 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 122.093 0.949 . . . . 0.0 111.611 174.254 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -83.99 -2.83 57.35 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 -176.983 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.7 t -126.43 -39.77 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.572 1.149 . . . . 0.0 111.871 -179.212 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.6 m -110.8 -15.57 13.78 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -172.14 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.97 21.83 79.56 Favored Glycine 0 CA--C 1.535 1.307 0 O-C-N 121.823 -0.548 . . . . 0.0 113.966 -179.702 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -63.63 160.75 16.17 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.683 1.193 . . . . 0.0 111.43 171.556 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.3 tp -93.92 120.54 34.31 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.048 0.939 . . . . 0.0 109.653 169.049 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -83.46 -54.3 5.07 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.479 0.712 . . . . 0.0 111.255 173.257 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.13 163.86 37.19 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.565 1.146 . . . . 0.0 111.973 -178.463 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -144.72 134.8 24.0 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.882 1.273 . . . . 0.0 111.841 179.477 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.74 100.88 43.32 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.482 1.513 . . . . 0.0 111.189 178.834 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -68.96 142.1 50.49 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 124.123 3.216 . . . . 0.0 112.559 172.203 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.0 t -136.31 130.89 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 126.003 1.721 . . . . 0.0 109.697 -176.528 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -92.65 -23.24 19.05 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.76 149.69 13.07 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.438 1.895 . . . . 0.0 110.234 172.118 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -115.37 131.01 23.82 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 124.526 1.13 . . . . 0.0 111.346 175.374 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.26 149.19 81.33 Favored 'Cis proline' 0 CA--C 1.542 0.92 0 CA-C-N 119.929 1.01 . . . . 0.0 112.574 -6.567 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.15 -176.88 36.41 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.561 1.077 . . . . 0.0 114.155 -179.022 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.9 tp -56.89 -32.38 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 125.184 1.394 . . . . 0.0 114.55 -171.459 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.85 4.82 52.03 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -171.485 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.6 t -148.2 128.83 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.334 1.054 . . . . 0.0 110.898 179.829 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.75 164.33 30.4 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.682 1.993 . . . . 0.0 112.43 -171.574 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 72.8 p -123.26 160.81 25.83 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.957 1.703 . . . . 0.0 111.697 -173.723 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.5 m -90.21 175.3 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 124.512 1.125 . . . . 0.0 111.202 169.374 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.6 p -94.99 -34.94 12.17 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.464 1.506 . . . . 0.0 112.867 178.567 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -89.5 -42.25 11.57 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -165.349 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.2 t -142.27 125.19 16.12 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -177.217 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.9 m -70.51 9.19 0.67 Allowed 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -173.261 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.458 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.315 44.8 ptt85 -97.14 19.71 12.53 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.179 1.392 . . . . 0.0 114.75 173.795 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -140.14 136.33 33.41 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.774 1.23 . . . . 0.0 110.993 -175.585 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -135.55 162.45 32.66 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.971 1.308 . . . . 0.0 111.01 -179.752 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.1 t -117.15 142.02 32.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 124.504 1.122 . . . . 0.0 108.71 166.832 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.15 147.56 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 118.962 0.801 . . . . 0.0 111.875 173.344 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -88.61 88.01 7.46 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.187 0.595 . . . . 0.0 110.661 177.33 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -71.55 137.74 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 120.797 0.332 . . . . 0.0 110.789 176.897 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -139.34 143.33 37.74 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.047 1.739 . . . . 0.0 111.233 -169.185 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -91.74 7.07 43.44 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.368 1.067 . . . . 0.0 113.33 -174.588 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.96 13.59 83.51 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.088 1.328 . . . . 0.0 114.516 178.371 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.0 t -137.6 10.71 2.93 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.588 1.555 . . . . 0.0 113.438 -171.154 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.67 0.57 66.67 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.749 1.166 . . . . 0.0 114.996 -178.409 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -76.42 142.88 40.92 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.104 1.362 . . . . 0.0 109.045 165.433 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 94.2 p -150.32 155.93 40.57 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 172.425 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.03 146.18 30.86 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.8 1.64 . . . . 0.0 110.848 167.878 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -94.04 119.39 32.84 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.278 0.631 . . . . 0.0 109.926 170.28 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.6 pt -117.63 143.14 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.449 1.099 . . . . 0.0 111.062 176.606 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.04 144.22 17.9 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 174.013 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.8 pt -129.42 140.86 48.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 125.563 1.545 . . . . 0.0 111.674 171.348 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -116.47 144.62 18.49 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.258 1.408 . . . . 0.0 112.884 174.256 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -106.46 153.61 22.03 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 126.013 1.725 . . . . 0.0 111.215 178.949 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.1 t -74.36 -18.07 60.73 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.017 0.927 . . . . 0.0 113.115 -178.977 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -154.56 145.32 22.44 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.61 1.164 . . . . 0.0 111.116 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -66.29 -30.91 71.43 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 179.787 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.76 -33.02 86.13 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-N 119.083 0.856 . . . . 0.0 113.328 173.381 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -80.69 -30.78 36.37 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.619 -0.93 . . . . 0.0 112.381 175.992 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.458 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -67.43 -37.26 82.75 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 167.697 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -61.23 -41.34 96.71 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.637 -0.664 . . . . 0.0 110.964 168.195 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.66 -34.18 77.28 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 121.452 -0.78 . . . . 0.0 112.709 175.652 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -59.78 -55.53 33.09 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.298 1.039 . . . . 0.0 112.194 168.496 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.65 -24.98 62.8 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -177.921 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.1 t -73.15 -41.65 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 121.422 -0.799 . . . . 0.0 110.942 172.059 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.0 m -64.71 -16.25 62.63 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 177.369 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.4 mt -88.51 -55.42 3.73 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.604 1.162 . . . . 0.0 112.427 167.793 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -69.05 -33.71 74.01 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.829 -1.17 . . . . 0.0 113.595 -173.032 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -86.9 5.62 36.03 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.665 1.186 . . . . 0.0 112.189 176.147 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -97.22 -42.59 7.74 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.664 0.786 . . . . 0.0 112.048 160.22 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -84.9 -2.98 58.5 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -174.897 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.26 -33.35 27.97 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 -177.569 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 35.8 p-90 -83.99 -20.92 31.99 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.612 1.165 . . . . 0.0 113.746 178.319 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.3 t -85.44 -40.07 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.153 1.381 . . . . 0.0 110.766 177.751 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.0 ttpp -90.7 41.35 1.05 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.659 1.583 . . . . 0.0 112.074 -177.268 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -79.51 94.92 5.69 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.43 1.092 . . . . 0.0 110.101 176.856 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 C--O 1.252 1.229 0 C-N-CA 126.681 1.992 . . . . 0.0 113.097 -179.389 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.594 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 56.1 m -120.66 102.3 44.95 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 124.903 1.281 . . . . 0.0 111.098 -175.759 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -83.45 5.74 6.21 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 124.17 3.247 . . . . 0.0 114.018 -176.559 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -63.43 145.46 55.56 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.67 1.588 . . . . 0.0 113.144 -171.386 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 64.6 p -81.2 -16.26 53.32 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.816 1.247 . . . . 0.0 114.342 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.8 mtm -136.11 156.81 48.16 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.112 1.765 . . . . 0.0 111.377 178.217 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.34 -38.34 0.1 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.773 1.229 . . . . 0.0 112.921 179.81 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 53.7 m -133.07 106.83 7.86 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.465 1.506 . . . . 0.0 108.708 172.922 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.28 23.65 1.99 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.145 1.378 . . . . 0.0 113.399 -165.711 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.1 tt -76.37 69.56 2.87 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.939 1.695 . . . . 0.0 112.425 -175.883 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -126.32 63.19 1.26 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.207 1.803 . . . . 0.0 109.773 176.726 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -152.45 151.51 30.86 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.992 1.717 . . . . 0.0 110.78 -173.456 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 178.66 121.48 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.386 1.874 . . . . 0.0 108.304 166.829 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.0 m -92.05 107.87 19.52 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.925 -0.485 . . . . 0.0 110.054 169.215 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.8 p -66.33 147.81 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.193 0.997 . . . . 0.0 112.077 175.843 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.6 mt -132.9 -37.9 1.0 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.673 1.589 . . . . 0.0 112.493 -171.853 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 35.0 t -153.34 137.52 16.5 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.691 1.196 . . . . 0.0 110.585 173.706 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 87.9 t -130.97 126.49 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.654 1.181 . . . . 0.0 109.226 171.708 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -129.2 136.41 29.11 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 125.443 1.497 . . . . 0.0 110.76 176.652 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -81.42 -13.69 10.85 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.267 2.645 . . . . 0.0 115.405 -171.819 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -131.08 105.52 7.77 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.249 1.02 . . . . 0.0 110.945 -175.781 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.0 p -141.77 140.14 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.972 1.309 . . . . 0.0 110.367 172.389 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.6 m -125.73 126.91 45.37 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.587 1.155 . . . . 0.0 110.979 -171.966 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 79.1 t -92.85 137.74 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.356 1.462 . . . . 0.0 111.92 -178.848 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -130.83 132.64 45.33 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.945 1.298 . . . . 0.0 109.885 169.5 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -60.22 131.96 52.44 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.256 0.622 . . . . 0.0 109.732 157.398 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.9 pt -104.91 150.41 38.66 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 124.666 1.187 . . . . 0.0 112.431 -173.833 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -69.41 158.81 56.05 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.038 2.492 . . . . 0.0 111.49 168.096 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.43 143.98 71.73 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.027 2.485 . . . . 0.0 112.615 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -74.2 154.18 39.16 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.307 1.443 . . . . 0.0 111.602 175.292 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.73 -97.76 0.06 Allowed 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.04 -1.436 . . . . 0.0 109.784 161.866 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.9 m -150.85 -69.93 0.18 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.42 1.488 . . . . 0.0 110.534 159.355 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -87.44 -9.71 53.89 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -173.284 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -65.18 -53.5 43.81 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.451 1.1 . . . . 0.0 111.769 178.265 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.35 156.02 29.11 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 124.579 1.085 . . . . 0.0 113.58 -179.517 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -71.02 146.31 49.45 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.031 0.932 . . . . 0.0 109.204 168.307 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.88 19.42 5.55 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -170.372 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.95 -46.15 0.06 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 128.453 2.701 . . . . 0.0 115.655 -174.632 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 90.9 p -64.04 -18.49 64.38 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.854 2.062 . . . . 0.0 114.61 179.626 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.52 -9.12 59.77 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.077 0.951 . . . . 0.0 113.144 174.054 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 16.7 m0 -92.88 170.58 9.57 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.22 1.408 . . . . 0.0 110.881 177.226 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.1 mtmm -80.28 54.53 2.01 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.041 1.337 . . . . 0.0 113.749 -177.844 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.0 mt -54.66 -29.3 52.11 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 -171.208 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -90.62 -10.67 42.41 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.033 0.933 . . . . 0.0 112.714 179.178 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -139.52 60.42 16.49 Favored Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 126.303 1.841 . . . . 0.0 110.842 -161.487 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -64.66 140.11 66.67 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 120.648 0.899 . . . . 0.0 111.966 -173.225 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -70.52 -26.91 63.79 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.79 0.836 . . . . 0.0 111.445 176.774 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 42.6 t90 -156.96 154.21 29.31 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.552 1.541 . . . . 0.0 111.023 170.08 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.4 p -134.15 144.95 48.84 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.312 1.045 . . . . 0.0 112.083 171.478 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.89 -143.69 5.17 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 123.497 0.57 . . . . 0.0 113.812 -178.087 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 34.8 mtm105 -117.92 148.59 42.01 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.818 2.047 . . . . 0.0 111.193 -172.576 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.7 tp -92.68 141.84 28.03 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.175 1.79 . . . . 0.0 111.029 176.208 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -142.47 99.08 3.42 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.926 1.69 . . . . 0.0 109.716 169.893 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.451 HD11 ' CD2' ' A' ' 119' ' ' PHE . 23.1 mt -85.98 133.8 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 169.693 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.04 168.15 22.28 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.093 1.757 . . . . 0.0 110.495 -168.286 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.2 t -157.17 150.75 24.23 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.741 -1.225 . . . . 0.0 112.087 173.658 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -149.86 134.19 17.33 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.53 151.976 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.34 50.28 33.69 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.513 1.054 . . . . 0.0 114.814 164.6 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt 60.06 26.88 16.26 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.075 1.75 . . . . 0.0 113.347 -175.765 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.5 m -130.67 124.06 30.76 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 126.028 1.731 . . . . 0.0 108.035 170.142 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -92.94 159.83 15.16 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.647 0.779 . . . . 0.0 110.585 170.183 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -139.04 106.39 5.53 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.149 1.78 . . . . 0.0 108.518 -172.669 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.3 mp -87.37 104.29 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 168.646 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -104.9 138.79 40.6 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.937 1.295 . . . . 0.0 111.121 177.508 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.9 mp -110.23 131.24 55.23 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.814 1.646 . . . . 0.0 109.933 176.596 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -130.38 149.85 51.87 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.558 1.143 . . . . 0.0 112.1 -173.713 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -75.28 152.46 38.24 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.007 -1.058 . . . . 0.0 112.455 177.814 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.564 ' H ' ' HD3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -93.79 -0.61 55.78 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.131 1.773 . . . . 0.0 115.486 -176.829 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.8 t -118.73 -45.8 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.207 1.403 . . . . 0.0 111.378 173.855 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.3 m -97.24 -21.22 17.4 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -173.714 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.72 6.81 85.51 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.085 0.85 . . . . 0.0 113.886 -177.466 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -79.3 151.25 31.19 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.045 1.338 . . . . 0.0 112.462 -174.513 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.6 tp -72.52 126.82 30.78 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.769 0.828 . . . . 0.0 110.924 178.361 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -86.66 -55.32 3.92 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.425 1.09 . . . . 0.0 111.265 170.688 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.39 160.67 39.85 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.852 1.261 . . . . 0.0 111.58 -178.349 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -141.65 136.22 30.73 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.75 0.82 . . . . 0.0 112.721 177.091 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.99 98.08 47.7 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 125.96 1.704 . . . . 0.0 111.482 -179.068 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -62.52 140.29 80.91 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 124.33 3.353 . . . . 0.0 113.042 166.002 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.1 t -136.43 126.47 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 126.453 1.901 . . . . 0.0 109.223 -178.493 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -86.69 -25.82 24.6 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 121.27 -0.894 . . . . 0.0 113.289 -178.054 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.31 151.15 15.14 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.102 1.761 . . . . 0.0 110.808 173.594 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -122.57 129.82 24.9 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.653 1.181 . . . . 0.0 111.174 176.486 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -62.65 148.2 59.79 Favored 'Cis proline' 0 CA--C 1.539 0.746 0 CA-C-N 119.982 1.029 . . . . 0.0 113.754 -6.14 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.29 -164.38 15.26 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.48 1.514 . . . . 0.0 112.702 179.772 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.0 tt -75.21 -38.32 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -177.918 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.06 6.51 16.04 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -167.424 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 25.1 t -149.03 132.09 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 125.992 1.717 . . . . 0.0 109.522 178.13 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.24 161.43 38.92 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.006 1.722 . . . . 0.0 111.94 -177.199 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.9 p -110.16 165.67 11.57 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.427 1.491 . . . . 0.0 111.373 177.912 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.7 m -87.05 179.51 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.469 0.707 . . . . 0.0 110.473 160.116 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 71.0 p -101.23 -30.01 11.77 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.614 1.566 . . . . 0.0 113.543 177.884 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -90.24 -42.77 10.81 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -167.604 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.2 t -143.31 125.12 15.08 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -176.26 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.04 -3.85 14.71 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -170.471 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.42 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.286 0.9 OUTLIER -86.68 22.86 1.81 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.56 1.544 . . . . 0.0 114.615 174.434 . . . . . . . . 4 4 . 1 . 027 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -142.24 133.25 25.91 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.633 1.173 . . . . 0.0 111.703 -179.575 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -136.07 162.94 31.51 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.373 1.469 . . . . 0.0 111.587 179.347 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 55.2 t -117.14 142.91 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.877 1.271 . . . . 0.0 109.044 168.597 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.62 148.72 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 118.835 0.743 . . . . 0.0 112.47 173.48 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -86.11 85.33 7.36 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.096 0.959 . . . . 0.0 110.406 175.855 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -68.82 140.31 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 121.945 -0.472 . . . . 0.0 110.428 172.311 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -131.43 151.92 51.12 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.704 1.602 . . . . 0.0 111.087 -171.038 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -94.87 8.73 41.77 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.968 0.907 . . . . 0.0 113.213 -176.386 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.17 -18.77 4.99 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.698 1.618 . . . . 0.0 115.163 -178.976 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.3 t -86.49 -25.01 25.36 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.784 1.234 . . . . 0.0 112.995 176.964 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 136.07 -17.94 3.81 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.553 1.549 . . . . 0.0 114.268 176.27 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.9 156.0 22.6 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 125.428 1.491 . . . . 0.0 111.47 176.701 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 38.3 p -153.24 166.59 32.08 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -165.075 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -137.3 150.03 47.49 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.646 1.578 . . . . 0.0 110.635 162.873 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -95.32 113.06 24.69 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.497 0.719 . . . . 0.0 109.346 170.177 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 32.2 pt -112.41 146.36 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.62 1.168 . . . . 0.0 111.109 -179.617 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -92.33 142.99 16.26 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 174.271 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 34.3 pt -128.45 139.76 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 125.171 1.388 . . . . 0.0 111.56 172.552 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -118.45 143.96 17.8 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.69 1.614 . . . . 0.0 112.567 174.197 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -105.31 161.39 14.33 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.806 1.642 . . . . 0.0 111.812 -176.373 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.3 t -72.7 -27.63 62.19 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.62 0.768 . . . . 0.0 113.055 178.132 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -156.05 150.75 26.03 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.165 0.986 . . . . 0.0 112.152 -178.918 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 47.3 ttt-85 -62.27 -34.84 77.31 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.555 1.142 . . . . 0.0 113.107 178.446 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.16 -26.72 73.99 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 118.814 0.734 . . . . 0.0 113.698 176.084 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -85.56 -32.84 21.91 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.048 0.939 . . . . 0.0 111.821 173.991 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.42 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -67.76 -32.18 72.59 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 170.914 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -57.68 -36.57 72.1 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.547 -0.721 . . . . 0.0 112.074 172.356 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -66.18 -29.27 69.51 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.207 -0.933 . . . . 0.0 112.999 176.431 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.451 ' CD2' HD11 ' A' ' 49' ' ' ILE . 26.1 t80 -62.38 -47.99 81.72 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.473 1.033 . . . . 0.0 112.032 174.029 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -83.33 -25.22 31.68 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.345 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.0 t -78.45 -42.09 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 121.36 -0.838 . . . . 0.0 111.486 177.07 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 92.4 p -65.07 -28.56 69.55 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 179.666 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.3 mt -72.23 -54.41 9.68 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.98 0.912 . . . . 0.0 111.658 170.742 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -68.42 -33.96 75.14 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.028 -1.045 . . . . 0.0 113.102 -173.895 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -86.44 7.33 26.31 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.309 1.044 . . . . 0.0 112.538 175.986 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -102.72 -35.73 8.56 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.056 0.943 . . . . 0.0 112.42 161.885 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -88.6 -3.35 58.82 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -179.508 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.79 -25.08 39.56 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -175.278 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 31.1 p-90 -87.7 -22.67 24.51 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.013 1.325 . . . . 0.0 113.52 174.424 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.8 t -83.31 -27.53 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.88 1.672 . . . . 0.0 111.329 176.265 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -86.06 18.93 2.81 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.6 1.96 . . . . 0.0 113.308 177.796 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -85.59 91.52 8.28 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.092 0.957 . . . . 0.0 109.427 173.576 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 . . . . . 0 C--O 1.253 1.27 0 C-N-CA 126.468 1.907 . . . . 0.0 112.862 -168.598 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 112.067 -0.413 . . . . 0.0 112.067 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 37.2 t -68.76 141.26 92.43 Favored Pre-proline 0 N--CA 1.476 0.838 0 C-N-CA 123.935 0.894 . . . . 0.0 112.224 178.931 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.9 -10.34 19.75 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.412 2.742 . . . . 0.0 113.152 172.372 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -80.95 156.36 26.01 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.755 1.222 . . . . 0.0 111.965 -178.545 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 92.9 p -79.47 -5.73 55.39 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 177.67 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 mtt 58.46 18.27 5.52 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.204 1.802 . . . . 0.0 114.095 -166.993 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.45 -29.86 1.53 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.105 1.762 . . . . 0.0 112.521 174.489 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 58.8 m -129.58 108.42 10.21 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.162 1.785 . . . . 0.0 108.886 174.622 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -146.76 25.38 1.17 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.85 1.26 . . . . 0.0 113.302 -172.954 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.7 tt -64.91 104.99 0.93 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.737 1.615 . . . . 0.0 111.477 -179.638 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -147.11 71.7 1.23 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.685 1.594 . . . . 0.0 109.177 175.765 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.415 ' CD2' ' HG2' ' A' ' 52' ' ' LYS . 8.0 p90 -133.52 139.84 46.86 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.617 1.167 . . . . 0.0 110.704 175.98 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 173.92 110.39 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 127.149 2.18 . . . . 0.0 107.725 165.663 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.9 m -87.56 109.49 19.67 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.246 -0.909 . . . . 0.0 110.612 177.578 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 86.4 t -68.79 143.06 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.651 1.18 . . . . 0.0 111.854 -176.937 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.6 mt -125.19 -40.98 2.09 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.908 1.683 . . . . 0.0 112.168 -176.278 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 49.9 t -153.2 135.01 14.58 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.563 1.145 . . . . 0.0 110.664 172.091 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 74.1 t -127.88 127.59 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.677 1.191 . . . . 0.0 109.261 170.944 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -127.87 134.8 26.6 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 124.861 1.264 . . . . 0.0 111.035 174.602 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -63.17 -26.14 72.69 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.084 2.522 . . . . 0.0 114.328 178.97 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -111.82 129.18 56.23 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.349 1.46 . . . . 0.0 113.228 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.4 p -157.64 142.3 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 126.327 1.851 . . . . 0.0 108.886 158.789 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.7 m -124.4 134.83 52.99 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.361 1.065 . . . . 0.0 110.493 -178.785 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 86.2 t -103.18 134.87 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.819 1.248 . . . . 0.0 111.751 -177.773 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.75 118.92 11.99 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.997 1.319 . . . . 0.0 109.096 172.859 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -63.4 130.46 44.56 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.983 0.913 . . . . 0.0 110.618 176.46 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.6 pt -96.8 154.78 38.23 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 124.645 1.178 . . . . 0.0 112.669 -173.758 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.66 146.54 43.69 Favored 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 122.515 2.143 . . . . 0.0 110.85 159.96 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.11 135.5 29.78 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.944 2.429 . . . . 0.0 111.615 177.644 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -153.16 -170.89 3.75 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.074 1.35 . . . . 0.0 112.036 179.373 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.64 -1.31 13.25 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.286 1.834 . . . . 0.0 114.633 176.832 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.8 m 60.63 -76.79 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 127.412 2.285 . . . . 0.0 114.092 -171.851 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -62.71 -30.62 71.55 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.352 1.461 . . . . 0.0 114.424 -164.093 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.0 ptt-85 -103.72 -12.31 17.07 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 178.658 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.83 -16.38 0.88 Allowed Glycine 0 N--CA 1.47 0.93 0 N-CA-C 117.831 1.892 . . . . 0.0 117.831 -162.398 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -78.12 114.43 16.99 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.807 2.303 . . . . 0.0 108.328 161.653 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.18 21.19 11.85 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -176.104 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.18 -50.26 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.856 2.462 . . . . 0.0 114.879 -168.421 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.3 m -63.63 -13.89 46.64 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.61 1.964 . . . . 0.0 114.692 -178.474 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.53 -24.0 58.9 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.697 1.199 . . . . 0.0 112.506 172.77 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 12.5 m0 -88.25 168.47 12.69 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.068 1.747 . . . . 0.0 111.499 -174.753 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.3 mtpp -77.45 53.82 1.09 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.836 1.654 . . . . 0.0 113.402 176.861 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.5 mt -55.76 -38.23 69.56 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.84 1.256 . . . . 0.0 114.017 -173.375 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -87.12 -3.84 59.1 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.518 1.127 . . . . 0.0 113.029 179.444 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -136.74 63.64 47.07 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 126.339 1.856 . . . . 0.0 111.561 -166.963 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -68.9 148.15 69.97 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 CA-C-N 119.916 1.006 . . . . 0.0 113.103 -169.689 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -69.49 -31.12 69.19 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.901 0.88 . . . . 0.0 111.355 168.626 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 39.6 t90 -161.25 155.68 23.04 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.667 1.987 . . . . 0.0 110.414 177.432 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 55.5 p -135.28 147.81 49.33 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.835 1.254 . . . . 0.0 112.002 171.361 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.11 -142.36 5.27 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.177 0.418 . . . . 0.0 114.064 179.994 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.3 mtm180 -106.91 145.27 32.4 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.434 1.894 . . . . 0.0 111.619 -174.596 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.7 tp -82.46 138.49 34.36 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.714 0.806 . . . . 0.0 109.544 163.428 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.6 ttt-85 -145.75 90.76 2.02 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 122.159 0.981 . . . . 0.0 111.333 163.307 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.45 HD11 ' CD1' ' A' ' 119' ' ' PHE . 13.0 mt -73.6 128.3 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 170.444 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.2 p -134.79 175.96 9.09 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.958 2.103 . . . . 0.0 110.642 -177.248 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.7 t -156.53 148.94 23.42 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.687 -1.258 . . . . 0.0 111.118 173.78 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.415 ' HG2' ' CD2' ' A' ' 7' ' ' TYR . 11.4 tppt? -150.77 132.11 14.6 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.358 0.663 . . . . 0.0 112.76 154.168 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.12 51.13 19.48 Favored Glycine 0 N--CA 1.474 1.213 0 C-N-CA 124.561 1.076 . . . . 0.0 114.298 169.092 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 59.3 23.47 11.9 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 126.412 1.885 . . . . 0.0 113.326 -175.619 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.5 m -130.79 111.65 12.33 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 125.2 1.4 . . . . 0.0 108.733 176.494 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.93 159.36 24.96 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.073 0.463 . . . . 0.0 110.371 172.389 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -137.98 107.24 6.08 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.787 1.635 . . . . 0.0 108.577 -176.187 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.5 mp -78.36 96.63 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 106.463 -1.681 . . . . 0.0 106.463 167.177 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -95.67 137.99 33.96 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.168 0.587 . . . . 0.0 111.479 174.601 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.6 mp -110.43 129.77 55.7 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.066 1.746 . . . . 0.0 110.183 177.024 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -132.9 149.77 52.22 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -166.384 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -65.98 142.5 57.82 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.986 -1.071 . . . . 0.0 112.788 179.02 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.34 -3.78 35.48 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 116.955 2.206 . . . . 0.0 116.955 -177.959 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.1 t -117.59 -45.04 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.506 1.122 . . . . 0.0 111.822 174.289 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.7 m -117.2 -4.82 11.38 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -169.759 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.5 15.15 79.19 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 123.871 0.748 . . . . 0.0 114.245 176.638 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -61.33 131.72 51.23 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.906 1.683 . . . . 0.0 111.308 -177.267 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 39.0 tp -69.78 115.92 9.57 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 122.782 0.433 . . . . 0.0 111.146 -178.104 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -81.36 -53.87 5.95 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.439 1.095 . . . . 0.0 111.085 173.088 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.55 160.93 38.68 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.064 1.346 . . . . 0.0 111.206 -178.971 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -141.87 137.14 31.19 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.758 0.823 . . . . 0.0 112.572 174.776 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.65 103.72 50.35 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.136 1.374 . . . . 0.0 111.182 177.6 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -67.9 140.97 52.08 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 124.17 3.247 . . . . 0.0 112.65 172.015 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.2 t -135.3 126.63 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.788 1.635 . . . . 0.0 109.464 -177.994 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -90.24 -24.32 20.99 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 179.704 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -161.59 150.0 15.5 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.696 1.999 . . . . 0.0 110.401 172.44 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -121.63 132.38 24.24 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.74 1.216 . . . . 0.0 111.57 176.403 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -62.15 147.21 54.06 Favored 'Cis proline' 0 CA--C 1.541 0.854 0 CA-C-N 119.874 0.991 . . . . 0.0 113.583 -7.153 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.63 -172.49 32.17 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.632 1.11 . . . . 0.0 113.954 -178.722 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.2 tp -61.87 -34.92 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -171.619 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.05 4.62 49.68 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -169.062 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.8 t -149.04 126.48 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.414 1.086 . . . . 0.0 110.539 -178.645 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -139.43 158.57 43.91 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.799 2.04 . . . . 0.0 111.775 -172.698 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.1 p -113.52 163.52 14.82 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.579 1.952 . . . . 0.0 111.381 -179.051 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.2 m -88.8 178.67 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.255 1.422 . . . . 0.0 109.769 165.496 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.2 t -105.16 -23.81 12.85 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.707 1.203 . . . . 0.0 113.604 179.456 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -88.65 -51.17 5.82 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -174.673 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.3 t -139.37 129.79 25.61 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -174.56 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.66 -2.86 12.89 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -171.562 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.485 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.299 31.4 ptt180 -84.78 15.65 3.77 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 178.061 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -140.36 136.77 33.49 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.203 1.401 . . . . 0.0 110.768 -172.942 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -138.48 165.43 26.86 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.271 1.429 . . . . 0.0 111.281 -178.634 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.5 t -118.49 141.53 37.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 124.7 1.2 . . . . 0.0 108.745 165.547 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.8 148.11 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 119.036 0.835 . . . . 0.0 112.516 171.711 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -89.17 82.41 6.59 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.794 0.838 . . . . 0.0 111.1 177.903 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -67.72 141.96 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 121.01 0.433 . . . . 0.0 111.04 176.04 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -138.17 151.64 47.92 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.831 1.653 . . . . 0.0 111.307 -170.296 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -96.55 2.98 52.89 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.257 1.023 . . . . 0.0 113.199 179.222 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.45 12.59 82.86 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 125.138 1.352 . . . . 0.0 114.751 178.487 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.3 t -137.37 12.5 3.01 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.576 1.551 . . . . 0.0 113.521 -171.655 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.21 -1.89 70.66 Favored Glycine 0 CA--C 1.538 1.498 0 O-C-N 120.736 -1.227 . . . . 0.0 114.975 -178.266 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -75.59 135.99 40.52 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.283 1.433 . . . . 0.0 108.595 164.653 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 65.0 p -151.28 160.32 43.87 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 171.642 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.95 147.54 32.81 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.367 1.467 . . . . 0.0 110.873 168.249 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -92.15 115.4 28.05 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.421 0.689 . . . . 0.0 109.316 169.355 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 28.8 pt -112.7 141.73 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.379 1.072 . . . . 0.0 110.747 179.419 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.15 139.73 15.38 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 175.954 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.2 pt -129.49 155.37 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 125.259 1.424 . . . . 0.0 111.952 172.351 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -148.48 166.29 29.13 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 114.421 0.528 . . . . 0.0 114.421 168.57 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -116.73 162.76 17.18 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.995 1.718 . . . . 0.0 111.388 -175.378 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.3 t -70.54 -22.9 62.56 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.462 0.705 . . . . 0.0 112.455 175.635 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -152.76 147.24 25.84 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.798 0.839 . . . . 0.0 112.537 -174.267 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 47.1 ttt-85 -62.61 -32.61 73.65 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.694 1.198 . . . . 0.0 113.152 179.951 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.26 -27.21 73.84 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-N 118.908 0.776 . . . . 0.0 113.851 176.649 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -84.33 -36.2 22.71 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 118.074 0.937 . . . . 0.0 111.658 175.814 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.485 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -65.17 -32.34 73.98 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 168.564 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -59.32 -37.48 77.89 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.264 -0.898 . . . . 0.0 111.98 173.279 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -67.19 -31.42 71.81 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.194 -0.941 . . . . 0.0 112.847 176.013 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.45 ' CD1' HD11 ' A' ' 49' ' ' ILE . 22.0 t80 -58.6 -50.91 72.09 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.295 0.952 . . . . 0.0 111.545 171.667 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.2 -24.28 30.15 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -176.302 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.3 t -78.46 -40.37 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 O-C-N 121.068 -1.02 . . . . 0.0 110.954 176.641 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 95.0 p -63.75 -28.86 70.17 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 177.411 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 78.5 mt -72.14 -52.97 14.18 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.182 0.993 . . . . 0.0 111.923 172.307 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -68.58 -31.17 70.18 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.993 -1.067 . . . . 0.0 113.22 -176.112 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -87.88 2.14 52.24 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.641 1.176 . . . . 0.0 112.492 174.383 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -92.03 -40.02 11.32 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 120.74 -1.225 . . . . 0.0 111.992 163.975 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -89.31 -1.73 58.18 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 -174.518 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.56 -32.44 63.0 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 120.25 1.386 . . . . 0.0 114.524 -175.07 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 30.6 p-90 -81.36 -28.6 34.37 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.624 1.17 . . . . 0.0 113.301 178.034 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 37.6 t -74.42 -30.23 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.024 1.329 . . . . 0.0 110.967 175.707 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -105.3 40.99 1.42 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.348 1.859 . . . . 0.0 112.632 -178.524 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -82.5 4.77 23.04 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 162.889 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 C--O 1.252 1.22 0 C-N-CA 128.699 2.8 . . . . 0.0 112.172 177.905 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.608 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 56.2 m -135.04 145.63 55.19 Favored Pre-proline 0 N--CA 1.477 0.921 0 C-N-CA 125.252 1.421 . . . . 0.0 111.756 -176.175 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -70.49 -34.87 11.43 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.044 2.496 . . . . 0.0 112.23 175.11 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -78.34 138.43 38.55 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.699 1.999 . . . . 0.0 111.302 171.584 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 64.4 p -85.25 -11.63 54.4 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.057 1.343 . . . . 0.0 114.297 -179.009 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.04 171.73 13.67 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.369 1.868 . . . . 0.0 111.534 -179.495 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.23 -39.61 0.53 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.545 1.138 . . . . 0.0 112.693 173.568 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 88.2 m -140.78 123.93 16.55 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.286 1.834 . . . . 0.0 108.424 170.784 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -138.56 34.1 2.25 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.967 1.307 . . . . 0.0 113.2 -177.506 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.78 58.1 1.8 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.182 1.393 . . . . 0.0 112.379 179.301 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -111.68 40.51 2.11 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.13 2.172 . . . . 0.0 111.759 -179.284 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -142.55 148.15 37.1 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 126.802 2.041 . . . . 0.0 109.142 -172.874 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -177.84 125.14 0.12 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.572 1.549 . . . . 0.0 108.797 171.118 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.4 m -90.52 110.7 21.82 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.797 -0.565 . . . . 0.0 109.836 166.215 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.9 t -63.57 141.68 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 124.496 1.118 . . . . 0.0 111.717 178.415 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.4 mt -126.94 -39.9 1.92 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.992 1.717 . . . . 0.0 112.54 -177.369 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.0 t -152.27 133.06 14.06 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.412 1.085 . . . . 0.0 110.821 174.967 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 81.1 t -128.67 128.13 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.394 1.078 . . . . 0.0 109.319 171.822 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -130.49 134.79 26.46 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 125.293 1.437 . . . . 0.0 110.337 176.429 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -77.35 -13.96 16.58 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.285 2.657 . . . . 0.0 114.76 -174.347 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -134.37 106.57 7.15 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.404 1.082 . . . . 0.0 111.236 -174.125 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -143.69 144.64 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.144 1.378 . . . . 0.0 110.205 171.078 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.0 m -118.0 140.66 49.42 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.354 1.062 . . . . 0.0 111.388 -176.485 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 66.1 t -105.76 138.28 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.726 1.61 . . . . 0.0 111.792 175.741 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -125.1 127.99 47.76 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.47 1.508 . . . . 0.0 108.995 170.67 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -76.58 111.62 12.25 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 165.111 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.7 pt -87.57 153.15 52.84 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 124.492 1.117 . . . . 0.0 113.286 -164.185 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -64.94 167.84 15.0 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.646 2.898 . . . . 0.0 112.402 171.502 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.32 91.65 0.33 Allowed 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.649 2.9 . . . . 0.0 112.294 178.038 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.75 161.83 35.51 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 128.337 2.655 . . . . 0.0 109.895 177.02 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -143.25 160.46 40.43 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.302 1.441 . . . . 0.0 111.386 -179.331 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 76.9 p -57.38 -32.79 67.16 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.782 2.033 . . . . 0.0 114.93 -179.521 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -77.02 -4.42 44.07 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.96 1.304 . . . . 0.0 112.726 178.453 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -110.98 -43.92 3.69 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 127.634 2.374 . . . . 0.0 110.185 172.838 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.7 118.14 3.53 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 127.178 2.323 . . . . 0.0 113.037 174.278 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -66.14 143.75 57.09 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.332 1.053 . . . . 0.0 109.455 163.512 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.66 25.03 8.93 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.046 0.938 . . . . 0.0 113.385 178.796 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 60.42 -44.81 0.1 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.569 2.347 . . . . 0.0 114.936 -172.269 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.6 m -63.92 -13.14 43.27 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.738 2.015 . . . . 0.0 114.26 177.122 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -59.03 -30.6 68.15 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.834 0.853 . . . . 0.0 112.839 164.95 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 9.2 m0 -99.24 171.23 8.13 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.035 1.334 . . . . 0.0 112.592 -164.447 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -78.86 49.34 0.9 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.377 1.871 . . . . 0.0 113.87 -178.531 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.8 mt -54.86 -35.07 63.63 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -166.635 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -94.79 -1.87 52.02 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.203 1.001 . . . . 0.0 113.644 179.552 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -145.46 73.76 14.04 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 125.573 1.549 . . . . 0.0 112.019 179.658 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.85 148.16 38.63 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.515 2.81 . . . . 0.0 113.736 178.958 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -71.93 -31.54 66.45 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.247 0.619 . . . . 0.0 111.295 168.269 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 48.7 t90 -154.3 154.37 33.26 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.846 1.659 . . . . 0.0 110.869 174.793 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.4 p -133.36 148.37 51.85 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.109 0.964 . . . . 0.0 111.674 169.004 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.51 -141.76 4.69 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 116.366 -0.379 . . . . 0.0 113.433 -178.804 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.7 mtm105 -114.32 144.97 42.4 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.152 1.781 . . . . 0.0 111.92 -172.901 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.1 tp -85.34 139.98 31.14 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.26 1.424 . . . . 0.0 109.822 168.386 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.1 ttt85 -145.5 86.64 1.75 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.699 1.199 . . . . 0.0 110.866 168.245 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.44 HD11 ' CD2' ' A' ' 119' ' ' PHE . 21.0 mt -74.33 127.74 36.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 170.649 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 p -136.51 171.68 14.14 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.854 2.062 . . . . 0.0 110.188 -178.663 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.7 t -156.7 148.89 23.12 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 120.632 -1.292 . . . . 0.0 111.674 177.866 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -153.59 128.26 9.39 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.723 0.809 . . . . 0.0 112.193 161.418 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.35 54.12 18.0 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.316 0.96 . . . . 0.0 114.231 166.344 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 93.8 mttt 60.02 25.75 15.01 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 126.249 1.82 . . . . 0.0 113.31 -176.059 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.8 m -136.22 114.45 11.57 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.25 1.42 . . . . 0.0 109.429 177.875 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.7 159.78 19.06 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.559 0.743 . . . . 0.0 110.775 173.872 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -139.89 105.31 5.07 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.099 1.76 . . . . 0.0 108.725 -175.727 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.4 mp -79.99 91.99 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 167.974 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -86.01 138.18 32.16 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.221 0.608 . . . . 0.0 110.421 173.167 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.4 mp -112.17 133.33 54.37 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.125 1.77 . . . . 0.0 109.645 173.103 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -135.14 153.47 51.98 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -172.269 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -73.92 144.61 45.26 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.946 0.879 . . . . 0.0 111.94 179.614 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.4 pttt -85.36 -6.18 59.25 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.368 1.867 . . . . 0.0 115.125 -178.635 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 92.6 t -122.47 -44.61 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.234 1.414 . . . . 0.0 111.437 178.648 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.2 m -92.32 -23.06 19.38 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -175.296 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.96 7.16 86.48 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 123.973 0.797 . . . . 0.0 113.702 -177.452 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -82.7 154.51 24.8 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.288 1.435 . . . . 0.0 112.473 -175.082 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.5 tp -73.45 127.18 31.99 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.371 0.668 . . . . 0.0 110.827 177.337 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -84.47 -54.99 4.38 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.427 1.091 . . . . 0.0 110.922 170.098 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -159.5 165.85 32.12 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.689 1.596 . . . . 0.0 110.562 179.755 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -144.99 142.49 29.84 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 168.706 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.78 111.53 48.5 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.071 1.348 . . . . 0.0 111.378 177.729 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -82.85 140.29 10.18 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.57 2.847 . . . . 0.0 111.502 176.961 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.26 128.61 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.396 1.478 . . . . 0.0 109.857 -174.449 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -90.64 -24.26 20.55 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 178.274 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -164.31 149.37 10.15 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.144 1.778 . . . . 0.0 110.411 171.569 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.419 ' CD2' ' HA ' ' A' ' 78' ' ' PRO . 82.5 t80 -125.75 130.28 24.09 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.819 1.248 . . . . 0.0 111.53 -177.554 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.419 ' HA ' ' CD2' ' A' ' 77' ' ' TYR . 73.5 Cg_endo -66.51 143.89 65.54 Favored 'Cis proline' 0 CA--C 1.54 0.801 0 CA-C-N 120.267 1.131 . . . . 0.0 113.353 -2.077 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.02 -168.34 29.06 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.12 1.343 . . . . 0.0 113.637 -176.607 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.3 tp -59.08 -39.64 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -169.659 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -89.31 3.84 50.78 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -167.395 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.6 t -151.54 124.18 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.392 1.077 . . . . 0.0 110.82 -176.88 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -141.39 167.07 23.04 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.626 1.97 . . . . 0.0 112.863 -176.264 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 73.1 p -121.25 158.62 27.72 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.503 1.521 . . . . 0.0 112.061 -169.807 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.3 m -84.62 168.12 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.839 0.856 . . . . 0.0 110.676 166.584 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 72.3 p -96.74 -24.94 15.71 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.956 1.302 . . . . 0.0 113.642 179.532 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -98.69 -38.97 8.89 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -166.21 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.6 t -138.87 124.12 19.17 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -173.905 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.2 m -74.54 26.1 0.08 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 -168.226 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.467 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.265 34.3 ptt180 -125.29 18.69 8.26 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.631 1.572 . . . . 0.0 114.923 179.851 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -140.28 142.6 35.7 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.404 1.082 . . . . 0.0 112.167 -171.795 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -141.7 158.2 44.11 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.189 1.396 . . . . 0.0 111.933 -176.94 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.2 t -110.68 137.93 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.939 0.895 . . . . 0.0 108.812 163.555 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.88 146.73 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 119.263 0.938 . . . . 0.0 112.018 172.472 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -91.16 92.54 8.72 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.379 0.672 . . . . 0.0 110.124 175.737 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -74.49 152.72 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.07 0.548 . . . . 0.0 111.229 176.09 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.03 150.35 45.03 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.488 1.515 . . . . 0.0 111.171 173.865 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -99.52 17.23 20.89 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.08 1.352 . . . . 0.0 113.257 -178.944 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.86 6.55 87.24 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.385 1.469 . . . . 0.0 115.603 175.669 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.1 t -131.06 5.27 4.5 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.473 1.509 . . . . 0.0 113.757 -174.289 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.14 -7.56 72.73 Favored Glycine 0 N--CA 1.478 1.439 0 C-N-CA 125.381 1.467 . . . . 0.0 113.86 -176.049 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 49.3 ttt180 -70.07 132.19 45.48 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 127.301 2.241 . . . . 0.0 108.927 165.184 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 95.3 p -139.12 159.19 42.74 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.125 1.37 . . . . 0.0 113.952 -178.922 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.96 146.1 28.84 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.989 1.315 . . . . 0.0 111.226 172.124 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -87.9 121.11 29.92 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 166.147 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.8 pt -119.32 144.93 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.82 1.248 . . . . 0.0 110.58 176.295 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.04 141.33 16.24 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 174.355 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.6 pt -126.33 144.49 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 124.548 1.139 . . . . 0.0 112.503 168.961 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -125.67 138.27 10.77 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 124.857 1.218 . . . . 0.0 113.244 177.923 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -102.91 163.6 12.12 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.849 1.66 . . . . 0.0 109.998 166.541 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.9 t -92.91 -20.65 20.43 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 175.559 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -109.15 -18.75 13.56 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -149.47 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 60.49 -48.72 0.1 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.914 2.086 . . . . 0.0 114.134 -161.236 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.44 -31.2 66.12 Favored Glycine 0 CA--C 1.539 1.564 0 CA-C-N 119.578 1.081 . . . . 0.0 114.176 174.575 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -81.0 -32.01 34.41 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.35 -1.088 . . . . 0.0 112.466 175.648 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.467 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -68.57 -32.69 72.78 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 168.112 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -60.67 -47.49 86.04 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.588 0.755 . . . . 0.0 110.204 166.767 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -60.3 -42.2 95.01 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 118.703 0.683 . . . . 0.0 112.356 177.19 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.44 ' CD2' HD11 ' A' ' 49' ' ' ILE . 36.9 t80 -53.09 -54.81 30.1 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.811 1.244 . . . . 0.0 112.566 174.125 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -82.4 -26.04 33.17 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -174.71 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.3 t -75.92 -40.97 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 121.6 -0.687 . . . . 0.0 110.898 177.823 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 91.4 p -64.05 -29.81 70.92 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 175.217 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.5 mt -68.81 -59.09 3.33 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.087 0.955 . . . . 0.0 111.779 170.168 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -64.94 -30.98 72.0 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -172.791 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -83.25 -4.15 58.14 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.648 1.179 . . . . 0.0 112.721 178.218 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -95.32 -11.71 27.36 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.94 -1.1 . . . . 0.0 113.39 165.639 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -110.42 -6.02 15.05 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 179.376 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -35.91 64.14 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 121.182 1.81 . . . . 0.0 113.896 -176.521 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 25.2 p-90 -75.89 -33.06 59.92 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.826 1.251 . . . . 0.0 112.887 178.242 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.0 t -68.72 -37.92 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.675 1.19 . . . . 0.0 110.55 174.137 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -83.92 -1.1 53.88 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.478 1.511 . . . . 0.0 114.888 175.429 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 47.81 42.52 16.0 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 127.586 2.354 . . . . 0.0 114.538 -176.743 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 . . . . . 0 C--O 1.254 1.302 0 C-N-CA 126.213 1.805 . . . . 0.0 113.471 175.986 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.629 0 N-CA-C 112.11 -0.396 . . . . 0.0 112.11 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 46.6 m -67.02 146.61 99.11 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 124.296 1.038 . . . . 0.0 112.852 -178.621 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.7 104.62 0.99 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.508 2.805 . . . . 0.0 112.22 -173.471 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -131.45 150.12 52.27 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.281 1.833 . . . . 0.0 111.172 176.178 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 46.1 m -102.78 -20.67 14.25 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.427 1.091 . . . . 0.0 113.154 178.118 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.2 ttm -152.28 107.02 3.21 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.55 1.54 . . . . 0.0 109.962 175.02 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.32 17.46 1.53 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.601 1.56 . . . . 0.0 112.719 -178.236 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.5 m 54.78 72.46 0.47 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.412 1.885 . . . . 0.0 111.949 -173.231 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.11 17.82 12.4 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.568 1.947 . . . . 0.0 113.979 -164.934 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.2 mp -60.18 131.46 50.89 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.714 1.205 . . . . 0.0 112.611 -173.21 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -88.37 56.56 3.86 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.95 1.3 . . . . 0.0 110.305 168.232 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -141.06 172.83 12.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.257 2.223 . . . . 0.0 109.819 -175.663 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.486 ' H ' ' HG2' ' A' ' 52' ' ' LYS 0.253 1.8 tt0 70.83 63.6 0.18 Allowed 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 124.075 1.893 . . . . 0.0 107.676 -179.221 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 t -74.35 104.72 5.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 112.327 -2.215 . . . . 0.0 109.301 -170.222 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.9 t -57.83 139.41 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 125.401 1.48 . . . . 0.0 112.088 -174.062 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.3 mt -125.5 -40.36 2.1 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.682 1.593 . . . . 0.0 112.14 -176.353 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 33.0 t -154.41 136.06 14.36 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.495 1.118 . . . . 0.0 110.678 176.926 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.3 t -130.68 125.79 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.421 1.088 . . . . 0.0 109.239 172.42 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -131.61 142.98 47.28 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 124.68 1.192 . . . . 0.0 112.021 176.909 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.01 -19.08 20.82 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.535 2.824 . . . . 0.0 115.048 -174.951 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -135.15 112.52 10.56 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.777 0.831 . . . . 0.0 112.279 -167.509 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.3 p -149.64 143.27 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.209 1.803 . . . . 0.0 109.902 171.191 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.9 m -120.71 129.23 53.57 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.351 1.06 . . . . 0.0 111.19 -174.272 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.1 t -93.0 140.47 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.331 1.452 . . . . 0.0 111.929 178.57 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -121.62 129.09 52.58 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.659 1.184 . . . . 0.0 109.628 168.655 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 -78.8 73.9 5.33 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.46 1.504 . . . . 0.0 109.841 172.143 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.7 pt -59.88 150.96 66.47 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 125.629 1.572 . . . . 0.0 114.468 -164.516 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.58 160.03 45.15 Favored 'Trans proline' 0 CA--C 1.545 1.025 0 C-N-CA 123.235 2.623 . . . . 0.0 112.168 171.636 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -63.68 142.94 85.53 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.078 2.519 . . . . 0.0 112.159 176.758 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.472 ' CG ' ' H ' ' A' ' 26' ' ' ALA . 1.6 ttp180 -134.39 -147.09 0.27 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.36 1.864 . . . . 0.0 110.232 -177.855 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.472 ' H ' ' CG ' ' A' ' 25' ' ' ARG . . . -125.82 -131.71 0.25 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.65 1.98 . . . . 0.0 110.57 -175.535 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 88.1 p -136.65 -31.4 0.86 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.841 1.657 . . . . 0.0 113.456 -175.319 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -133.35 -2.06 3.14 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.083 1.753 . . . . 0.0 113.702 -174.105 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.8 mmt-85 -87.68 -25.7 23.36 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.023 1.329 . . . . 0.0 113.173 -175.447 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.46 134.23 5.69 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 122.442 1.023 . . . . 0.0 114.003 170.962 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -74.73 156.34 36.72 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.18 0.992 . . . . 0.0 108.891 164.066 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.24 17.88 5.46 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -171.77 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.89 -45.84 0.06 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 127.75 2.42 . . . . 0.0 115.679 -175.779 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.2 m -69.41 -14.46 62.91 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.689 1.596 . . . . 0.0 113.908 -177.318 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.88 -13.31 60.54 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 169.786 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -95.88 171.65 8.51 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.462 1.505 . . . . 0.0 111.613 -174.59 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -79.57 53.81 1.65 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.383 1.473 . . . . 0.0 113.941 -178.463 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 69.3 mt -61.35 -14.85 30.57 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -172.842 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -107.02 -4.51 18.9 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.455 1.102 . . . . 0.0 112.782 177.03 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -150.26 77.18 8.31 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 125.083 1.353 . . . . 0.0 111.653 176.258 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -50.11 141.99 28.95 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.171 2.581 . . . . 0.0 112.462 175.245 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -72.09 -27.72 62.83 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.071 0.548 . . . . 0.0 111.577 175.78 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 33.4 t90 -154.26 156.54 37.21 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.937 1.695 . . . . 0.0 110.738 168.946 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.9 p -133.97 146.18 50.21 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.623 1.169 . . . . 0.0 111.978 170.327 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 176.77 -142.65 5.97 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 114.536 0.574 . . . . 0.0 114.536 177.213 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -106.22 143.83 33.79 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 126.603 1.961 . . . . 0.0 111.547 -169.822 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.0 tp -88.4 138.18 31.66 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.468 1.507 . . . . 0.0 110.154 170.21 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -143.93 96.77 2.95 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.396 1.078 . . . . 0.0 110.788 168.461 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.427 HD11 ' CD2' ' A' ' 119' ' ' PHE . 16.0 mt -82.06 129.03 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 172.364 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.46 160.57 38.05 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 127.38 2.272 . . . . 0.0 109.738 -177.703 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.7 t -161.37 160.8 29.99 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 120.811 -1.181 . . . . 0.0 111.079 177.517 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.486 ' HG2' ' H ' ' A' ' 8' ' ' GLU . 91.1 mttt -129.22 -106.01 0.29 Allowed 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.142 -0.974 . . . . 0.0 111.499 -174.526 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.59 -116.68 0.21 Allowed Glycine 0 N--CA 1.472 1.072 0 C-N-CA 124.489 1.042 . . . . 0.0 111.134 169.42 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -86.12 25.16 1.2 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.693 1.197 . . . . 0.0 113.118 174.366 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.5 m -137.55 123.0 19.58 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.8 0.84 . . . . 0.0 110.589 -178.312 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.26 164.16 12.25 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.232 1.413 . . . . 0.0 111.706 172.5 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -145.89 103.59 3.77 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.744 1.618 . . . . 0.0 110.054 -172.574 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.7 mp -82.06 101.52 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 169.071 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -102.78 140.8 36.58 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.863 0.84 . . . . 0.0 111.519 176.413 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.3 mp -112.12 132.93 54.58 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.434 1.894 . . . . 0.0 110.045 179.508 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -133.79 151.2 51.5 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.897 0.879 . . . . 0.0 112.518 -168.31 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -69.82 144.0 52.74 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 120.812 -1.18 . . . . 0.0 113.175 -175.409 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.67 -3.79 36.6 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 116.666 2.099 . . . . 0.0 116.666 -179.365 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.1 t -118.8 -50.44 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.749 1.22 . . . . 0.0 110.892 172.622 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.0 m -96.9 -18.15 19.68 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -170.245 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.22 12.6 76.29 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.317 0.96 . . . . 0.0 113.759 -175.672 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -79.97 150.83 30.34 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.079 1.352 . . . . 0.0 112.005 -176.603 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 32.5 tp -71.34 122.16 19.81 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.85 0.86 . . . . 0.0 111.797 -171.663 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -84.64 -56.25 3.7 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.272 1.029 . . . . 0.0 110.877 169.547 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.81 163.24 40.08 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.973 1.309 . . . . 0.0 111.537 -179.042 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -143.85 132.82 22.78 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.603 1.161 . . . . 0.0 111.561 -179.351 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.56 97.78 49.41 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 124.721 1.208 . . . . 0.0 111.236 176.009 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -58.03 136.29 74.04 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 124.085 3.19 . . . . 0.0 112.288 163.065 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.7 t -132.24 123.54 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 126.528 1.931 . . . . 0.0 108.885 -178.42 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -91.56 -19.32 22.88 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 121.413 -0.804 . . . . 0.0 112.781 -177.405 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -163.64 143.21 8.3 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.831 2.452 . . . . 0.0 109.425 -178.584 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -135.92 121.93 13.9 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-O 118.375 -0.822 . . . . 0.0 111.301 175.291 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -61.92 149.45 57.75 Favored 'Cis proline' 0 CA--C 1.539 0.758 0 CA-C-N 119.956 1.02 . . . . 0.0 114.504 -1.648 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -170.96 -158.29 14.58 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 126.016 1.769 . . . . 0.0 112.442 -177.109 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.3 tt -79.17 -39.03 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -176.556 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.35 4.49 17.72 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -168.145 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.9 t -152.02 129.01 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 126.028 1.731 . . . . 0.0 109.744 179.86 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -141.05 160.26 40.47 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.05 1.74 . . . . 0.0 112.24 176.656 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.6 p -101.23 159.39 15.29 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.988 1.715 . . . . 0.0 111.589 175.324 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.4 m -81.28 169.34 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 O-C-N 121.587 -0.696 . . . . 0.0 110.523 162.418 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.5 p -98.31 -24.69 15.12 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.168 1.387 . . . . 0.0 113.587 -178.278 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -100.84 -40.41 7.32 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -167.136 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.5 t -134.41 116.15 14.84 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -175.038 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.6 m -73.59 24.93 0.07 Allowed 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 116.159 1.911 . . . . 0.0 116.159 -165.386 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.413 ' HA ' ' CB ' ' A' ' 116' ' ' ALA . 4.9 ptm180 -127.3 23.43 6.42 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 127.309 2.244 . . . . 0.0 113.875 -178.915 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -140.82 143.94 35.09 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.756 1.623 . . . . 0.0 111.955 -177.124 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -142.04 161.24 38.49 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.251 1.42 . . . . 0.0 111.496 -178.299 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 89.0 t -114.73 139.67 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.403 1.081 . . . . 0.0 109.112 166.455 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.64 147.83 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 118.667 0.667 . . . . 0.0 112.085 173.808 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -89.51 89.33 7.8 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.838 0.855 . . . . 0.0 110.745 178.322 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.1 pp -71.32 140.38 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 122.542 0.337 . . . . 0.0 111.172 175.616 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -137.42 145.38 43.12 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.999 1.72 . . . . 0.0 111.718 -172.769 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -89.76 1.15 56.46 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.895 0.878 . . . . 0.0 113.161 179.071 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.96 12.55 80.99 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 125.248 1.404 . . . . 0.0 114.758 178.617 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.2 t -138.33 16.72 2.77 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.47 1.508 . . . . 0.0 113.44 -172.836 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.82 -3.14 80.9 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.704 1.145 . . . . 0.0 114.975 -178.418 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -76.04 133.97 40.22 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.242 1.417 . . . . 0.0 108.509 164.38 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.9 p -151.67 161.18 43.1 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 171.62 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.91 149.1 34.7 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.661 1.584 . . . . 0.0 110.964 170.021 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -94.05 117.36 30.0 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.465 0.706 . . . . 0.0 109.308 169.122 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 17.8 pt -116.61 147.41 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.595 1.158 . . . . 0.0 111.046 177.928 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -87.73 146.15 19.8 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 172.394 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.2 pt -129.02 145.51 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 125.388 1.475 . . . . 0.0 111.488 167.167 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.61 146.53 16.96 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 125.097 1.332 . . . . 0.0 113.518 177.163 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -108.47 164.48 12.3 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.286 1.834 . . . . 0.0 111.77 178.605 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.6 t -73.88 -25.49 60.06 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.056 0.942 . . . . 0.0 112.906 177.049 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -156.41 154.68 30.86 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.759 1.224 . . . . 0.0 111.924 -176.229 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -57.45 -35.62 70.37 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.253 1.021 . . . . 0.0 112.82 175.977 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.25 -35.97 92.36 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 119.48 1.036 . . . . 0.0 113.406 -179.802 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -80.19 -35.48 36.28 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 117.988 0.894 . . . . 0.0 112.265 177.256 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.413 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -62.88 -39.45 94.51 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 169.237 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -68.67 -33.54 74.15 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.065 -1.022 . . . . 0.0 111.877 174.403 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -68.2 -36.87 80.24 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 119.365 0.984 . . . . 0.0 112.417 173.731 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.427 ' CD2' HD11 ' A' ' 49' ' ' ILE . 3.5 t80 -57.91 -45.59 86.26 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.134 1.374 . . . . 0.0 111.65 168.649 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -74.95 -38.16 61.79 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.713 1.205 . . . . 0.0 113.252 -176.399 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.9 t -77.73 -39.75 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 O-C-N 121.213 -0.93 . . . . 0.0 111.599 -179.088 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 78.7 p -64.79 -30.78 71.8 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.236 -0.915 . . . . 0.0 113.125 177.248 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 44.4 tp -73.12 -49.17 29.85 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.805 1.242 . . . . 0.0 111.689 175.331 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -70.52 -23.53 62.66 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.248 -0.907 . . . . 0.0 113.434 -178.92 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -79.42 -1.04 35.41 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.378 1.071 . . . . 0.0 112.418 175.572 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 45.2 t60 -87.94 -35.3 17.74 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.325 -0.859 . . . . 0.0 112.708 157.504 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -89.29 -5.55 57.48 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 -172.819 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.87 -27.3 41.52 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 115.81 1.782 . . . . 0.0 115.81 -175.397 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 29.6 p-90 -84.99 -22.04 29.25 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.546 1.139 . . . . 0.0 113.822 174.794 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 19.1 t -86.66 -34.19 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.929 1.692 . . . . 0.0 111.295 177.354 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.8 mmtt -89.21 30.98 0.91 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.873 2.069 . . . . 0.0 112.893 -177.737 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -80.84 92.55 6.11 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.975 0.91 . . . . 0.0 109.728 173.215 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 . . . . . 0 C--O 1.252 1.198 0 C-N-CA 126.955 2.102 . . . . 0.0 112.558 -176.448 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.3 m . . . . . 0 CA--C 1.529 0.156 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.2 p -68.45 144.81 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 121.557 -0.714 . . . . 0.0 112.544 178.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.5 mt -129.5 -39.81 1.46 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.685 1.594 . . . . 0.0 112.508 -172.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 45.2 t -152.7 134.74 14.85 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.693 1.197 . . . . 0.0 110.384 173.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 94.6 t -130.28 127.24 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.363 1.065 . . . . 0.0 109.68 171.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -131.62 142.07 43.98 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 124.496 1.118 . . . . 0.0 112.206 173.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.6 -15.46 19.45 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.851 3.034 . . . . 0.0 114.972 -175.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -135.48 108.28 7.54 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.072 0.949 . . . . 0.0 111.653 -170.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 p -145.49 144.62 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 125.522 1.529 . . . . 0.0 110.213 171.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.1 m -126.04 129.15 48.58 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.12 0.968 . . . . 0.0 111.371 -171.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.5 t -96.05 136.82 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.738 1.615 . . . . 0.0 112.294 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -129.86 127.92 41.21 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.39 1.476 . . . . 0.0 109.407 170.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -70.1 123.76 22.4 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.359 0.664 . . . . 0.0 109.491 165.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.412 HD12 ' CZ ' ' A' ' 31' ' ' TYR . 30.6 pt . . . . . 0 N--CA 1.477 0.88 0 C-N-CA 124.785 1.234 . . . . 0.0 113.57 -168.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.412 ' CZ ' HD12 ' A' ' 22' ' ' ILE . 17.7 m-30 . . . . . 0 CA--C 1.534 0.34 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.86 19.84 10.92 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -174.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 56.81 -48.33 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.932 2.493 . . . . 0.0 115.455 -170.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.9 m -67.58 -15.07 63.46 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.294 1.838 . . . . 0.0 114.85 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.82 -15.99 56.35 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.701 0.8 . . . . 0.0 112.502 172.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 17.9 m0 -86.22 169.52 12.96 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.382 1.473 . . . . 0.0 111.178 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -78.88 57.25 2.09 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.189 1.796 . . . . 0.0 114.211 -177.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.7 mt -61.75 -20.35 63.44 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -95.49 -12.97 24.96 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.509 1.124 . . . . 0.0 112.592 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -152.09 69.72 7.62 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 125.61 1.564 . . . . 0.0 112.265 -165.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -54.37 147.22 47.59 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.471 2.781 . . . . 0.0 113.358 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -72.51 -29.3 63.49 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.195 0.598 . . . . 0.0 111.427 168.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.2 t90 -156.95 154.58 29.92 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.37 1.468 . . . . 0.0 111.058 173.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.2 p -133.93 148.82 51.25 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.239 1.015 . . . . 0.0 111.81 168.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.37 -142.88 5.69 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 123.067 0.365 . . . . 0.0 113.48 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.7 mtm105 -110.51 148.19 32.61 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.305 1.842 . . . . 0.0 112.103 -173.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.0 tp -92.91 137.85 32.0 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.22 1.808 . . . . 0.0 110.277 172.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.6 ttt85 -143.98 88.71 1.98 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.043 1.337 . . . . 0.0 110.869 169.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.503 HD11 ' CD1' ' A' ' 119' ' ' PHE . 25.2 mt -75.78 127.63 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 170.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.1 p -138.62 170.39 16.08 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.664 1.986 . . . . 0.0 110.071 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.9 t -157.85 159.46 36.68 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.804 -1.185 . . . . 0.0 112.198 175.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -146.86 120.76 9.32 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.775 0.798 . . . . 0.0 111.843 159.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.43 -119.65 11.79 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 125.753 1.644 . . . . 0.0 110.139 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -95.55 13.49 25.97 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.6 1.56 . . . . 0.0 113.708 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.0 m -127.58 110.78 13.05 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.934 0.894 . . . . 0.0 111.063 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.85 159.46 19.07 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.405 0.682 . . . . 0.0 111.364 171.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -139.76 105.98 5.25 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.302 1.841 . . . . 0.0 109.252 -174.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.7 mp -82.61 97.55 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 168.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.4 mttp -94.31 139.29 31.27 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.38 0.672 . . . . 0.0 111.448 174.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.5 mp -112.34 135.51 52.94 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.445 1.898 . . . . 0.0 109.775 172.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -136.15 153.67 51.2 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.941 0.896 . . . . 0.0 113.018 -172.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -74.12 143.94 45.12 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.931 0.872 . . . . 0.0 111.969 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 pttt -84.87 -6.46 59.35 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.371 1.868 . . . . 0.0 115.124 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 92.0 t -122.4 -44.58 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 125.234 1.414 . . . . 0.0 111.396 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.7 m -91.72 -23.5 19.76 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -175.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.33 7.04 86.91 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 123.776 0.703 . . . . 0.0 113.586 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -82.81 155.55 24.13 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.327 1.451 . . . . 0.0 112.326 -175.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.7 tp -72.31 125.98 28.69 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.372 0.669 . . . . 0.0 110.684 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -84.51 -53.9 5.11 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.944 0.898 . . . . 0.0 110.915 169.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.34 161.3 37.6 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.067 1.347 . . . . 0.0 111.357 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -142.67 139.89 31.37 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.391 0.676 . . . . 0.0 112.382 171.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.98 110.54 41.57 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 124.854 1.261 . . . . 0.0 111.135 176.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -80.52 140.45 13.39 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.894 3.063 . . . . 0.0 111.565 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.1 t -134.83 131.26 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.805 1.642 . . . . 0.0 109.817 -172.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -97.47 -19.8 18.18 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -163.53 150.46 12.31 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.97 2.108 . . . . 0.0 110.085 175.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -125.57 130.67 24.01 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.558 1.143 . . . . 0.0 112.452 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -60.46 151.29 50.81 Favored 'Cis proline' 0 CA--C 1.54 0.781 0 CA-C-N 119.919 1.007 . . . . 0.0 113.313 -12.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.35 -171.35 29.49 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.909 1.242 . . . . 0.0 113.485 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.6 tp -59.29 -31.51 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.54 4.27 53.9 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -172.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.7 t -148.98 130.35 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.162 0.985 . . . . 0.0 111.233 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -140.39 162.4 35.41 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.325 1.85 . . . . 0.0 112.545 -176.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 38.8 p -117.33 158.03 25.09 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 127.1 2.16 . . . . 0.0 111.587 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.0 m -85.21 173.46 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.556 1.142 . . . . 0.0 111.385 168.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 72.5 p -94.49 -32.5 13.47 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.238 1.415 . . . . 0.0 113.17 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -94.59 -40.91 9.59 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -163.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.5 t -141.02 130.35 23.68 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -175.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.1 m -73.01 16.38 0.16 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -171.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.47 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.28 33.5 ptt180 -111.44 18.5 19.1 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 178.631 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -139.32 135.55 33.9 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.078 0.951 . . . . 0.0 110.842 -172.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -133.77 163.81 28.63 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.907 1.283 . . . . 0.0 111.016 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.7 t -120.6 142.59 35.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 124.583 1.153 . . . . 0.0 108.744 167.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.89 148.0 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 118.721 0.692 . . . . 0.0 112.425 173.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -89.88 81.77 6.28 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.675 0.79 . . . . 0.0 111.369 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -67.09 142.52 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 122.577 0.351 . . . . 0.0 111.372 177.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 . . . . . 0 N--CA 1.469 0.487 0 C-N-CA 125.733 1.613 . . . . 0.0 111.68 -171.382 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.2 p . . . . . 0 C--O 1.234 0.288 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.76 145.76 31.83 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.282 1.433 . . . . 0.0 110.869 169.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -90.66 118.36 30.04 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.131 0.573 . . . . 0.0 109.485 168.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.4 pt -117.27 141.54 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.306 1.042 . . . . 0.0 110.753 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.9 143.41 17.07 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 174.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.0 pt -128.87 140.86 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 125.341 1.456 . . . . 0.0 111.679 173.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -119.66 143.91 17.24 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.042 1.306 . . . . 0.0 113.338 175.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -106.88 167.86 9.59 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.352 1.861 . . . . 0.0 111.032 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.8 t -71.78 -36.09 70.23 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.738 -0.601 . . . . 0.0 112.304 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -153.07 153.32 32.61 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.204 -0.935 . . . . 0.0 112.299 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -58.07 -36.69 73.16 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.652 1.181 . . . . 0.0 112.096 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.95 -13.42 64.11 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 123.916 0.77 . . . . 0.0 114.408 177.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -102.44 -34.07 9.29 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 118.431 1.115 . . . . 0.0 112.376 170.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.47 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -64.07 -29.97 71.07 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.088 -1.008 . . . . 0.0 113.253 170.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -54.95 -33.35 62.21 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.603 -0.686 . . . . 0.0 112.289 168.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -69.25 -33.75 73.74 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.087 -1.008 . . . . 0.0 112.028 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.503 ' CD1' HD11 ' A' ' 49' ' ' ILE . 18.6 t80 -60.56 -50.32 74.03 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.143 0.977 . . . . 0.0 111.475 171.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.49 -26.27 45.91 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -177.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.5 t -77.39 -43.25 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 119.301 0.955 . . . . 0.0 111.246 175.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 96.7 p -64.85 -31.03 72.07 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.36 0.982 . . . . 0.0 113.103 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.7 mt -69.03 -54.89 12.75 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.063 0.945 . . . . 0.0 112.061 170.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -67.22 -29.71 69.44 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.055 -1.028 . . . . 0.0 112.978 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -82.84 -2.7 55.39 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.566 1.147 . . . . 0.0 112.672 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 63.9 t60 -88.39 -42.6 12.07 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.391 -0.818 . . . . 0.0 111.812 157.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -84.44 -7.24 59.35 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -172.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.481 1.092 0 CA-C-N 120.971 1.714 . . . . 0.0 115.366 -173.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.8 m . . . . . 0 N--CA 1.467 0.387 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.402 ' HA ' HG22 ' A' ' 50' ' ' THR . 45.0 t -63.75 142.49 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 124.005 0.922 . . . . 0.0 111.761 177.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.7 mt -128.31 -43.56 1.45 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.309 1.443 . . . . 0.0 112.592 -176.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 34.2 t -148.39 135.16 19.91 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.379 1.072 . . . . 0.0 111.037 175.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.1 t -128.55 128.03 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.734 1.214 . . . . 0.0 109.539 172.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -124.9 135.28 26.53 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 125.577 1.551 . . . . 0.0 109.774 172.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -73.54 -29.57 10.8 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.918 2.412 . . . . 0.0 115.179 -168.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -138.16 114.92 10.64 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.263 1.03 . . . . 0.0 111.86 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.2 p -143.43 149.01 18.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 127.788 2.435 . . . . 0.0 109.004 176.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.2 m -123.3 132.02 53.86 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.257 0.623 . . . . 0.0 112.17 -167.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.7 t -96.24 138.21 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.837 1.655 . . . . 0.0 111.904 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -130.19 136.77 49.61 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.139 -1.392 . . . . 0.0 110.31 171.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -56.6 137.43 53.78 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.296 151.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.3 pt . . . . . 0 N--CA 1.473 0.71 0 C-N-CA 125.182 1.393 . . . . 0.0 111.258 178.099 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 18.8 m-30 . . . . . 0 C--O 1.22 -0.463 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.66 16.35 9.53 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -172.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.65 -46.5 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 128.152 2.581 . . . . 0.0 115.547 -171.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 94.5 p -68.41 -18.59 64.48 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.536 1.935 . . . . 0.0 115.082 -176.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -85.94 -1.95 57.81 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.22 1.008 . . . . 0.0 113.402 171.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.9 m0 -90.72 174.12 7.66 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.925 1.29 . . . . 0.0 110.952 174.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -76.67 47.98 0.53 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.855 1.662 . . . . 0.0 114.646 -176.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.2 mt -56.4 -33.55 65.87 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 -169.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -91.5 -2.51 57.18 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -145.74 71.99 13.86 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 125.868 1.667 . . . . 0.0 111.994 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -52.5 138.11 57.38 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.513 2.142 . . . . 0.0 112.088 174.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -73.09 -25.24 60.81 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.11 0.564 . . . . 0.0 111.194 172.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 50.4 t90 -155.84 154.08 30.74 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.69 1.596 . . . . 0.0 110.801 170.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.8 p -134.28 151.29 51.19 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.663 0.785 . . . . 0.0 112.001 165.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 173.04 -149.66 11.52 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 123.155 0.407 . . . . 0.0 113.484 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.0 mtt180 -94.35 141.15 28.91 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.227 1.811 . . . . 0.0 111.609 -174.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 24.9 tp -79.22 138.04 37.65 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 157.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.7 ttt-85 -144.82 87.47 1.85 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.234 1.016 . . . . 0.0 110.905 167.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.5 mt -72.44 127.07 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 172.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.402 HG22 ' HA ' ' A' ' 10' ' ' VAL . 7.5 p -134.19 165.02 26.07 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.697 1.999 . . . . 0.0 109.933 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.4 m -147.57 161.56 40.87 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.807 1.243 . . . . 0.0 112.212 175.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -150.6 118.09 6.09 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.307 0.643 . . . . 0.0 111.482 157.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 65.14 -132.23 36.22 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.034 1.302 . . . . 0.0 110.635 -175.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -85.92 22.65 1.64 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.902 1.681 . . . . 0.0 113.922 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.1 m -131.71 126.66 35.08 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.768 1.227 . . . . 0.0 110.282 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.63 160.04 14.59 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.659 1.184 . . . . 0.0 110.94 168.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -142.07 105.43 4.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.372 1.869 . . . . 0.0 108.986 -173.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.3 mp -81.03 95.99 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 169.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -92.04 137.95 31.94 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.274 0.63 . . . . 0.0 110.813 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.8 mp -112.43 128.88 56.44 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.814 1.646 . . . . 0.0 109.723 174.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -135.66 148.83 49.1 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.157 0.983 . . . . 0.0 111.639 -169.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -69.31 139.86 54.32 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 120.432 -1.417 . . . . 0.0 111.72 -176.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.5 pttt -79.74 -4.56 52.47 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -177.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.8 t -123.06 -43.59 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 125.297 1.439 . . . . 0.0 111.363 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.4 m -94.42 -21.97 18.59 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.41 15.37 77.2 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.143 0.878 . . . . 0.0 113.788 -176.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -88.5 148.44 24.15 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.212 1.405 . . . . 0.0 112.056 -176.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.6 tp -71.59 126.78 30.57 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.445 -0.784 . . . . 0.0 111.272 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -84.83 -58.9 2.52 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.055 0.942 . . . . 0.0 110.552 168.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.84 165.8 35.41 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.109 1.363 . . . . 0.0 111.369 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -142.46 143.0 32.41 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.333 0.653 . . . . 0.0 112.47 171.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.37 105.85 41.19 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 124.871 1.268 . . . . 0.0 110.99 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -77.22 145.06 23.92 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.792 2.995 . . . . 0.0 111.948 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.2 t -138.03 127.36 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 126.245 1.818 . . . . 0.0 109.58 -172.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -91.32 -22.77 20.37 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.66 147.83 13.93 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.412 1.885 . . . . 0.0 110.437 170.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -116.33 129.97 24.83 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.589 1.156 . . . . 0.0 110.956 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.83 149.09 79.9 Favored 'Cis proline' 0 CA--C 1.543 0.946 0 CA-C-N 119.824 0.973 . . . . 0.0 112.733 -6.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.68 -164.38 13.14 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.6 1.571 . . . . 0.0 112.548 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 19.3 tt -72.42 -35.58 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 121.654 -0.909 . . . . 0.0 112.979 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.67 6.26 21.55 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -167.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.0 t -151.37 129.18 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.508 1.523 . . . . 0.0 109.984 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -141.77 162.22 36.01 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.217 1.807 . . . . 0.0 112.86 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.5 p -109.75 160.35 16.4 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.792 2.037 . . . . 0.0 111.431 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.4 m -85.95 175.45 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 124.477 1.111 . . . . 0.0 111.398 168.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 71.8 p -91.18 -36.84 13.72 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.954 1.702 . . . . 0.0 112.098 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -89.33 -43.59 10.82 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -166.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.6 t -142.45 122.45 13.65 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -171.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.58 -9.06 23.38 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -169.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.451 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.305 49.0 ptt85 -84.73 19.33 2.07 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 178.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -139.13 139.94 37.78 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.479 1.512 . . . . 0.0 111.977 -176.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -140.66 162.21 35.94 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.437 1.495 . . . . 0.0 111.683 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 78.6 t -116.14 142.27 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.372 1.069 . . . . 0.0 109.294 166.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.67 147.3 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 118.98 0.809 . . . . 0.0 112.399 173.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -88.91 82.5 6.71 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.833 0.853 . . . . 0.0 111.187 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.5 pt -63.36 144.71 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 120.819 0.342 . . . . 0.0 111.696 174.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 . . . . . 0 N--CA 1.466 0.338 0 C-N-CA 125.661 1.584 . . . . 0.0 110.868 -178.606 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.1 p . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.15 145.16 29.45 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.941 1.296 . . . . 0.0 111.389 171.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -90.66 114.53 26.85 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.794 0.837 . . . . 0.0 109.322 170.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.4 pt -115.01 148.73 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.875 1.27 . . . . 0.0 111.228 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.04 143.91 16.91 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 174.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.7 pt -128.24 144.01 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 125.386 1.474 . . . . 0.0 111.34 169.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.16 139.6 11.08 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.888 1.233 . . . . 0.0 112.967 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -101.17 157.18 16.96 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.814 1.646 . . . . 0.0 111.466 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.1 t -73.52 -20.27 60.7 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.911 0.884 . . . . 0.0 112.822 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -152.24 148.79 27.98 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.526 1.13 . . . . 0.0 111.935 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 47.4 ttt-85 -63.04 -31.53 72.68 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.642 1.177 . . . . 0.0 113.503 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.52 -31.76 79.67 Favored Glycine 0 CA--C 1.536 1.365 0 CA-C-N 119.039 0.836 . . . . 0.0 113.572 176.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -78.39 -35.44 47.19 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.771 -0.841 . . . . 0.0 111.407 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.451 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -65.97 -37.13 85.17 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.926 0.891 . . . . 0.0 113.209 168.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.21 -40.44 97.48 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.508 -0.745 . . . . 0.0 111.25 171.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -62.33 -36.76 83.2 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.592 1.087 . . . . 0.0 112.55 172.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -57.42 -56.33 23.3 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.392 0.996 . . . . 0.0 112.017 171.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -75.7 -24.68 56.26 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -176.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.5 -38.68 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 121.058 -1.027 . . . . 0.0 110.773 173.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 41.2 t -57.67 -38.55 75.3 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.406 0.683 . . . . 0.0 112.529 176.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.9 -52.32 20.81 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.456 0.702 . . . . 0.0 112.36 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -67.57 -28.48 67.81 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.045 -1.034 . . . . 0.0 113.064 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -83.91 0.1 49.15 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.581 1.152 . . . . 0.0 112.724 175.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -89.51 -39.97 12.97 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.253 -0.904 . . . . 0.0 112.284 161.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -91.99 -1.92 57.0 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -172.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.481 1.125 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.7 m . . . . . 0 N--CA 1.468 0.454 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.0 t -65.43 145.83 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.473 1.109 . . . . 0.0 111.409 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.6 mt -129.86 -39.73 1.4 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.124 1.769 . . . . 0.0 112.309 -172.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 37.6 t -152.15 137.38 17.47 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.687 1.195 . . . . 0.0 110.646 174.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 88.5 t -129.77 126.87 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.764 1.226 . . . . 0.0 109.275 171.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -126.78 136.08 28.24 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 125.677 1.591 . . . . 0.0 110.233 174.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -78.9 -15.8 13.05 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.158 2.572 . . . . 0.0 115.037 -173.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -130.89 107.32 9.03 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.379 1.072 . . . . 0.0 110.904 -176.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -140.16 141.5 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 125.475 1.51 . . . . 0.0 109.988 170.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.5 m -124.35 125.84 44.99 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.301 1.04 . . . . 0.0 111.12 -171.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.7 t -92.4 136.72 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.064 1.346 . . . . 0.0 111.79 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -126.46 128.6 47.21 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.942 1.297 . . . . 0.0 109.284 169.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -65.33 133.68 51.93 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 160.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.6 pt . . . . . 0 N--CA 1.474 0.752 0 C-N-CA 124.445 1.098 . . . . 0.0 112.483 -172.501 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 . . . . . 0 CA--C 1.54 0.588 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.14 20.83 13.56 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.27 -48.94 0.05 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 127.175 2.19 . . . . 0.0 114.672 -163.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.2 m -64.46 -9.17 16.76 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.362 1.865 . . . . 0.0 114.739 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.5 -11.41 59.9 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.645 1.178 . . . . 0.0 112.876 172.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -104.18 175.92 5.33 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.248 1.819 . . . . 0.0 112.499 -171.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -76.92 47.33 0.51 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.715 2.006 . . . . 0.0 114.455 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.6 mt -55.0 -34.3 63.32 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -169.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -95.45 -0.36 52.45 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.134 0.973 . . . . 0.0 113.29 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.37 61.61 10.26 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 126.23 1.812 . . . . 0.0 111.719 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -55.44 136.67 74.84 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.593 2.195 . . . . 0.0 112.034 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -69.64 -26.04 64.22 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.561 1.144 . . . . 0.0 111.666 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.4 t90 -154.86 152.8 30.22 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.683 1.593 . . . . 0.0 110.747 170.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.7 p -134.42 148.79 50.7 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.874 0.87 . . . . 0.0 111.927 169.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.59 -145.34 6.5 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 113.931 0.333 . . . . 0.0 113.931 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -108.82 148.82 29.99 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.29 1.836 . . . . 0.0 111.721 -176.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 61.0 tp -92.92 142.22 27.55 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.099 1.76 . . . . 0.0 110.832 173.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -144.03 94.29 2.56 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.269 1.827 . . . . 0.0 109.494 173.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.482 HD11 ' CD2' ' A' ' 119' ' ' PHE . 27.9 mt -84.23 134.43 26.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 170.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.24 166.69 26.27 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.037 1.735 . . . . 0.0 110.338 -166.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 99.0 p -156.52 160.5 39.56 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 120.845 -1.159 . . . . 0.0 112.3 175.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -151.04 120.46 6.88 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.472 0.709 . . . . 0.0 112.23 156.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 65.22 -132.12 35.98 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 125.088 1.327 . . . . 0.0 110.502 -176.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -87.19 26.6 1.17 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.637 1.575 . . . . 0.0 113.328 178.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.0 m -132.97 129.65 38.51 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.85 1.26 . . . . 0.0 110.172 173.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.76 160.8 14.15 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.648 1.179 . . . . 0.0 110.577 167.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -140.64 109.61 6.08 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.811 1.644 . . . . 0.0 108.952 -173.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.0 mp -88.08 105.58 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 168.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -107.66 142.38 37.71 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.592 1.157 . . . . 0.0 111.179 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.4 mp -115.23 131.58 56.88 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.429 1.891 . . . . 0.0 109.656 177.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -133.58 148.35 51.59 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.828 0.851 . . . . 0.0 112.614 -174.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -67.47 135.64 53.38 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.065 0.946 . . . . 0.0 111.573 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -75.15 -6.96 52.38 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 -175.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 86.3 t -119.22 -43.72 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.158 1.383 . . . . 0.0 111.389 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.5 m -93.44 -20.15 20.58 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -175.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.8 15.7 76.0 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.279 0.942 . . . . 0.0 113.588 -177.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -90.53 149.92 21.98 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.144 1.378 . . . . 0.0 112.355 -174.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 31.3 tp -70.91 123.89 23.07 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.727 0.811 . . . . 0.0 111.566 -176.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -86.46 -55.24 3.98 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.47 1.108 . . . . 0.0 111.123 170.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.79 162.57 39.73 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.507 1.123 . . . . 0.0 112.146 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -142.71 135.21 27.75 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.052 1.341 . . . . 0.0 111.891 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.0 100.59 42.82 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.534 1.534 . . . . 0.0 111.136 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -68.45 142.07 53.01 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.995 3.13 . . . . 0.0 112.529 170.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.1 t -134.52 130.58 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.868 1.667 . . . . 0.0 109.894 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -86.1 -26.37 25.29 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -164.63 153.89 13.26 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.551 1.54 . . . . 0.0 111.239 169.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -118.02 133.0 23.44 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.883 1.273 . . . . 0.0 111.461 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.37 147.83 75.91 Favored 'Cis proline' 0 CA--C 1.541 0.875 0 CA-C-N 119.899 0.999 . . . . 0.0 112.22 -8.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.9 -175.82 36.69 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.491 1.043 . . . . 0.0 114.058 -177.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.2 tp -53.71 -34.65 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -169.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.04 4.92 52.03 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -172.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.6 t -148.6 127.31 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 CA-C-N 119.409 1.004 . . . . 0.0 111.739 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -140.61 168.93 18.64 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.648 1.979 . . . . 0.0 113.116 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 34.0 p -123.09 158.89 29.66 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.586 1.954 . . . . 0.0 111.59 -171.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.8 m -85.81 173.22 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 O-C-N 121.573 -0.704 . . . . 0.0 112.121 169.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 70.8 p -87.34 -35.93 18.12 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.851 1.26 . . . . 0.0 112.586 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -94.11 -42.4 9.01 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -162.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.4 t -143.33 130.24 20.52 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.3 m -69.3 4.53 1.66 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -172.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.446 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.281 30.2 ptt180 -96.59 17.05 17.15 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 176.1 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -140.15 132.12 27.76 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.181 0.992 . . . . 0.0 110.784 -174.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -137.05 162.53 33.08 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.325 1.45 . . . . 0.0 110.495 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.6 t -121.59 139.3 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.425 1.09 . . . . 0.0 108.717 171.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.29 147.44 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 118.81 0.732 . . . . 0.0 112.536 176.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -90.15 85.92 6.4 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.461 0.705 . . . . 0.0 111.099 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -69.38 139.95 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 122.635 0.374 . . . . 0.0 111.161 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 . . . . . 0 N--CA 1.469 0.521 0 C-N-CA 126.172 1.789 . . . . 0.0 111.429 -170.403 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 80.7 p . . . . . 0 C--O 1.235 0.303 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.73 147.58 32.08 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.604 1.561 . . . . 0.0 110.992 169.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -90.71 120.62 31.92 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.098 0.559 . . . . 0.0 109.584 167.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.9 pt -117.79 143.03 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.553 1.141 . . . . 0.0 110.871 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.38 143.15 17.14 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 174.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.9 pt -127.35 139.0 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 124.987 1.315 . . . . 0.0 111.644 171.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.37 143.7 16.72 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.83 1.681 . . . . 0.0 112.251 174.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -106.37 167.67 9.67 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.64 1.576 . . . . 0.0 111.534 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.3 t -68.91 -36.21 77.74 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.143 0.577 . . . . 0.0 112.172 175.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -156.66 154.3 29.89 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.086 -1.009 . . . . 0.0 112.048 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 72.2 mtm-85 -55.74 -39.34 71.0 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.554 1.142 . . . . 0.0 112.382 173.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.78 -6.53 30.68 Favored Glycine 0 CA--C 1.542 1.731 0 C-N-CA 124.407 1.004 . . . . 0.0 115.133 178.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -111.22 -33.86 6.33 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.243 1.417 . . . . 0.0 111.728 168.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.446 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -69.72 -24.96 63.63 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 175.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -61.21 -30.4 70.4 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.729 -1.232 . . . . 0.0 112.297 169.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -69.92 -27.93 65.18 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.495 1.043 . . . . 0.0 112.635 176.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.482 ' CD2' HD11 ' A' ' 49' ' ' ILE . 10.6 t80 -61.81 -44.87 95.99 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.408 -0.807 . . . . 0.0 111.26 169.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -76.95 -35.26 57.4 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.376 1.07 . . . . 0.0 113.147 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 66.6 t -78.73 -38.86 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.366 -0.834 . . . . 0.0 111.87 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 88.5 p -66.86 -31.65 72.4 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.984 -1.073 . . . . 0.0 113.312 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 73.2 mt -68.85 -51.6 38.73 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.943 0.897 . . . . 0.0 111.859 172.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -68.09 -27.8 66.8 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.111 -0.993 . . . . 0.0 112.756 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -82.44 -3.02 54.97 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.399 1.08 . . . . 0.0 112.795 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -89.63 -40.7 12.41 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 121.315 -0.866 . . . . 0.0 111.963 160.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -90.55 -0.29 57.62 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 -173.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.483 1.213 0 CA-C-N 120.909 1.686 . . . . 0.0 115.288 -177.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.9 m . . . . . 0 N--CA 1.469 0.495 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.0 t -59.08 143.45 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 125.307 1.443 . . . . 0.0 112.877 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.1 mt -129.26 -39.37 1.53 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.544 1.938 . . . . 0.0 111.99 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 47.5 t -149.7 142.69 24.87 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.627 1.571 . . . . 0.0 109.611 174.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.6 t -137.97 126.9 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.702 1.201 . . . . 0.0 108.149 170.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -138.11 130.4 16.21 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 123.751 0.82 . . . . 0.0 111.912 -176.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -75.14 -17.08 19.53 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.188 2.592 . . . . 0.0 115.413 -167.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -130.61 109.72 10.87 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.249 1.019 . . . . 0.0 110.958 -176.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -142.26 145.95 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.589 1.556 . . . . 0.0 109.876 168.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.9 m -126.83 132.66 50.93 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.278 1.031 . . . . 0.0 110.85 -174.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.3 t -100.52 135.09 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.078 1.351 . . . . 0.0 111.527 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.4 119.71 22.03 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.884 1.274 . . . . 0.0 108.837 168.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -64.11 131.52 47.76 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.57 -0.706 . . . . 0.0 109.491 166.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.4 pt . . . . . 0 CA--C 1.545 0.776 0 C-N-CA 124.696 1.199 . . . . 0.0 112.806 -167.509 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 . . . . . 0 CA--C 1.536 0.43 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.8 19.36 19.21 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.74 -50.08 0.05 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 127.169 2.188 . . . . 0.0 114.206 -165.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.5 m -65.39 -11.31 41.13 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.174 1.79 . . . . 0.0 114.788 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.71 -14.86 59.49 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.339 1.056 . . . . 0.0 112.494 171.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 16.0 m0 -96.73 171.06 8.76 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.866 1.666 . . . . 0.0 111.693 -174.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -80.56 56.35 2.58 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.2 1.4 . . . . 0.0 113.081 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.0 mt -57.69 -24.88 59.05 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -169.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -106.96 0.58 23.85 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.347 1.059 . . . . 0.0 112.593 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -132.27 77.56 70.39 Favored Pre-proline 0 C--O 1.239 0.521 0 C-N-CA 125.809 1.644 . . . . 0.0 111.378 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -69.18 144.95 58.92 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 CA-C-N 118.94 0.657 . . . . 0.0 112.784 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -70.63 -28.92 65.19 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.705 0.802 . . . . 0.0 111.172 168.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 52.6 t90 -160.42 154.21 22.66 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.606 1.962 . . . . 0.0 110.579 175.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.4 p -133.13 149.16 52.12 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.286 1.035 . . . . 0.0 111.534 167.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.26 -143.43 5.97 Favored Glycine 0 CA--C 1.524 0.635 0 O-C-N 122.15 -0.343 . . . . 0.0 113.407 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -107.28 142.41 37.08 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.679 1.592 . . . . 0.0 111.657 -176.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.3 tp -81.79 137.92 35.23 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.131 1.372 . . . . 0.0 109.426 165.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.6 ttt-85 -145.74 89.28 1.89 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 122.217 1.008 . . . . 0.0 110.938 168.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.515 HD11 ' CD1' ' A' ' 119' ' ' PHE . 17.5 mt -74.91 127.03 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 172.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.0 p -131.73 173.92 10.66 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 127.083 2.153 . . . . 0.0 109.62 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -160.19 160.72 33.14 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.479 -1.388 . . . . 0.0 110.16 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -148.9 127.2 12.17 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 122.044 0.926 . . . . 0.0 111.769 153.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.02 -114.76 5.73 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 126.078 1.799 . . . . 0.0 110.061 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -104.24 15.38 28.46 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.615 1.566 . . . . 0.0 113.277 176.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.3 m -124.4 109.19 13.0 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.892 0.877 . . . . 0.0 110.649 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.26 159.52 20.06 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.371 0.668 . . . . 0.0 110.99 171.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -141.39 100.79 3.86 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.926 1.69 . . . . 0.0 109.533 -171.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mp -79.92 94.47 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 170.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -91.15 137.82 32.07 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.21 0.604 . . . . 0.0 111.088 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.2 mp -110.62 129.64 55.76 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 126.011 1.724 . . . . 0.0 109.329 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -133.04 145.82 51.15 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.958 0.903 . . . . 0.0 112.241 -169.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -68.43 135.7 52.13 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.12 -0.987 . . . . 0.0 111.655 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.9 pttt -75.11 -7.46 53.82 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -175.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.3 t -119.47 -43.17 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.188 1.395 . . . . 0.0 111.48 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.0 m -95.42 -19.84 19.57 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -174.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.86 14.42 75.74 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.461 1.029 . . . . 0.0 113.713 -176.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -88.07 151.53 22.68 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.224 1.41 . . . . 0.0 112.097 -175.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.3 tp -72.41 126.6 30.24 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.568 -0.707 . . . . 0.0 111.468 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -85.66 -56.69 3.38 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.377 1.071 . . . . 0.0 110.929 169.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.4 162.46 40.03 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.326 1.45 . . . . 0.0 110.918 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -143.36 139.06 29.87 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 172.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.53 106.77 53.89 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.845 1.258 . . . . 0.0 111.037 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.64 139.79 14.43 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.941 3.094 . . . . 0.0 111.325 175.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 t -134.45 121.95 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.611 1.565 . . . . 0.0 109.88 -171.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -89.04 -17.34 29.55 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.86 141.87 8.74 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.834 2.053 . . . . 0.0 110.167 174.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -126.51 127.48 24.54 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 124.352 1.061 . . . . 0.0 111.095 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -61.29 147.07 48.47 Favored 'Cis proline' 0 CA--C 1.539 0.767 0 CA-C-N 120.162 1.094 . . . . 0.0 114.104 -4.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.81 -163.76 29.59 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.99 1.281 . . . . 0.0 113.873 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.8 tp -64.67 -38.58 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 -167.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.77 6.21 48.38 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -168.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.8 t -151.09 124.52 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.75 1.22 . . . . 0.0 110.474 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -140.13 162.79 34.4 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.792 1.637 . . . . 0.0 113.459 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.2 p -109.18 162.46 14.26 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.87 1.668 . . . . 0.0 111.462 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.9 m -84.18 176.87 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.032 0.933 . . . . 0.0 111.299 169.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 57.8 p -90.82 -37.92 13.3 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.512 1.525 . . . . 0.0 111.798 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -96.0 -41.12 8.92 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 -165.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.5 t -139.74 116.54 10.89 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -171.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.69 -3.54 6.83 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -168.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.455 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.306 49.2 ptt85 -86.93 20.74 2.51 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 176.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -140.67 139.57 34.81 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.448 1.499 . . . . 0.0 111.36 -176.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -138.68 161.86 36.09 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.216 1.406 . . . . 0.0 111.615 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.6 t -117.93 137.46 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.04 0.936 . . . . 0.0 108.924 165.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.17 147.96 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 118.737 0.699 . . . . 0.0 112.157 174.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -91.33 84.39 5.6 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.623 0.769 . . . . 0.0 110.936 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -68.93 138.86 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.849 0.357 . . . . 0.0 110.965 176.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 . . . . . 0 N--CA 1.469 0.503 0 C-N-CA 125.445 1.498 . . . . 0.0 111.42 -169.896 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 95.6 p . . . . . 0 C--O 1.236 0.383 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.31 142.43 29.43 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.284 1.434 . . . . 0.0 110.963 168.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -91.74 118.85 31.05 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.44 0.696 . . . . 0.0 109.861 170.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.7 pt -118.0 141.77 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.732 1.213 . . . . 0.0 110.889 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -90.11 142.37 16.43 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 175.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.7 pt -129.42 145.98 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.907 1.283 . . . . 0.0 112.167 170.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.75 148.45 16.77 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.025 1.298 . . . . 0.0 113.698 176.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -114.57 156.65 24.27 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.15 1.78 . . . . 0.0 111.531 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.6 t -74.27 -23.77 59.17 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.054 0.941 . . . . 0.0 112.936 -178.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -151.91 147.66 26.85 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.414 1.086 . . . . 0.0 111.981 -176.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 -62.97 -33.59 75.71 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.241 1.016 . . . . 0.0 113.21 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.45 -28.46 73.63 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 119.086 0.857 . . . . 0.0 113.525 175.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -85.51 -30.11 23.71 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.116 0.966 . . . . 0.0 112.581 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.455 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -66.9 -35.96 81.19 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.588 -0.695 . . . . 0.0 112.625 163.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -62.29 -35.89 80.42 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.402 -0.811 . . . . 0.0 111.661 169.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -62.92 -36.65 84.1 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 119.846 1.203 . . . . 0.0 112.5 173.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.515 ' CD1' HD11 ' A' ' 49' ' ' ILE . 18.0 t80 -60.48 -51.51 69.15 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.035 0.934 . . . . 0.0 112.386 169.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.84 -26.18 40.51 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -175.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.3 t -77.27 -42.38 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 O-C-N 121.127 -0.983 . . . . 0.0 110.938 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 91.6 p -63.66 -31.36 72.51 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.895 0.77 . . . . 0.0 112.882 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.1 mt -68.51 -56.86 6.92 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.105 0.962 . . . . 0.0 111.993 169.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -68.16 -25.45 65.27 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.918 -1.113 . . . . 0.0 113.5 -173.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -79.46 -4.31 50.62 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.255 1.022 . . . . 0.0 112.518 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -90.17 -28.32 18.99 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.29 -0.881 . . . . 0.0 112.587 161.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -101.07 -1.16 34.86 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.875 1.805 . . . . 0.0 115.875 -175.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.482 1.163 0 CA-C-N 120.959 1.709 . . . . 0.0 115.164 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.7 m . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.2 t -70.13 147.36 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.898 1.279 . . . . 0.0 112.062 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.0 mt -132.33 -39.54 1.03 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.963 1.705 . . . . 0.0 110.995 -173.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.7 t -151.1 146.91 26.48 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.987 1.315 . . . . 0.0 110.86 175.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 72.4 t -139.99 123.34 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.239 1.416 . . . . 0.0 109.31 171.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -118.42 141.05 29.03 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 125.017 1.327 . . . . 0.0 111.141 175.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.72 -19.32 21.35 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 123.661 2.907 . . . . 0.0 114.515 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -133.29 110.83 10.35 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.191 0.905 . . . . 0.0 111.388 -172.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.2 p -142.55 143.03 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.917 1.287 . . . . 0.0 110.755 169.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.2 m -127.86 130.32 48.39 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.69 1.196 . . . . 0.0 110.993 -174.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.2 t -97.34 136.98 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.929 1.291 . . . . 0.0 111.948 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.17 126.75 36.44 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.823 1.249 . . . . 0.0 109.381 168.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -63.12 131.62 49.12 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 161.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.6 pt . . . . . 0 N--CA 1.475 0.807 0 C-N-CA 123.904 0.882 . . . . 0.0 112.676 -168.352 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 . . . . . 0 CA--C 1.533 0.322 0 CA-C-O 119.991 -0.052 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.83 18.48 6.71 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -171.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.56 -51.11 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 128.149 2.58 . . . . 0.0 115.697 -174.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.5 m -65.07 -13.0 56.88 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.337 1.855 . . . . 0.0 114.367 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -89.41 -4.9 57.83 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.704 1.202 . . . . 0.0 112.552 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 22.4 m0 -92.75 172.11 8.56 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.867 1.667 . . . . 0.0 110.74 174.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -80.57 55.06 2.22 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.163 1.385 . . . . 0.0 114.074 -177.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.2 mt -60.34 -17.81 45.63 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -174.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -102.14 -8.13 21.64 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.82 1.248 . . . . 0.0 113.126 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -148.74 80.05 8.37 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.563 1.145 . . . . 0.0 112.102 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.72 146.8 53.13 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.498 2.798 . . . . 0.0 112.886 174.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -71.45 -29.64 65.09 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.497 0.719 . . . . 0.0 111.393 167.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 51.4 t90 -158.54 154.43 26.66 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.028 1.731 . . . . 0.0 110.937 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.3 p -134.88 148.01 50.0 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.57 1.148 . . . . 0.0 111.594 169.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.48 -141.16 4.88 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 113.916 0.326 . . . . 0.0 113.916 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -110.79 140.53 45.13 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.802 2.041 . . . . 0.0 110.318 -170.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.6 tp -93.55 137.66 32.6 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.328 1.051 . . . . 0.0 109.997 173.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 28.0 ttp-105 -127.98 136.1 50.83 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.236 1.014 . . . . 0.0 110.271 156.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.432 HD11 ' CD2' ' A' ' 119' ' ' PHE . 36.1 mt -111.35 135.28 51.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 125.227 1.411 . . . . 0.0 107.25 164.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.74 166.77 28.4 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.847 1.659 . . . . 0.0 110.23 -164.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.3 t -157.45 160.35 38.24 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.056 -1.028 . . . . 0.0 111.951 172.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -144.68 119.95 10.2 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.513 0.725 . . . . 0.0 111.609 157.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.61 -115.11 6.72 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 125.802 1.668 . . . . 0.0 110.494 -177.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -104.5 17.02 24.93 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.17 1.788 . . . . 0.0 113.225 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.4 m -124.84 108.5 12.0 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.065 0.946 . . . . 0.0 110.396 177.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.64 159.47 25.34 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.734 0.413 . . . . 0.0 110.98 169.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -139.23 117.25 11.72 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.795 1.638 . . . . 0.0 109.214 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.1 mp -92.21 109.22 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 165.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -112.65 130.79 55.92 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.216 1.006 . . . . 0.0 111.876 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.9 mp -104.2 127.06 51.78 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.763 1.625 . . . . 0.0 110.053 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -132.98 150.28 52.17 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -170.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -65.61 141.7 58.32 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 122.252 1.025 . . . . 0.0 112.744 -173.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.0 pttt -74.81 -10.36 59.43 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -175.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 64.0 t -121.12 -38.32 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.868 1.267 . . . . 0.0 111.963 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.3 m -118.93 -8.64 10.23 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -172.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.84 14.49 80.01 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 123.992 0.806 . . . . 0.0 114.44 177.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -63.29 136.83 57.93 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.91 1.684 . . . . 0.0 111.277 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 38.1 tp -71.12 112.75 7.51 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.767 -0.583 . . . . 0.0 111.011 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -78.27 -53.52 7.23 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.932 0.893 . . . . 0.0 110.674 172.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.81 161.54 38.39 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.487 1.115 . . . . 0.0 112.052 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -141.86 134.47 28.34 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.03 1.332 . . . . 0.0 111.357 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.78 96.67 50.28 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 124.997 1.319 . . . . 0.0 111.573 176.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -59.56 138.51 84.09 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 124.213 3.275 . . . . 0.0 112.824 164.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.0 t -135.55 131.8 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.082 1.753 . . . . 0.0 109.598 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -91.15 -24.14 20.04 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -165.47 155.5 13.02 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.772 1.629 . . . . 0.0 111.18 169.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -126.19 127.22 24.71 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.87 1.268 . . . . 0.0 111.171 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.18 147.93 78.61 Favored 'Cis proline' 0 CA--C 1.542 0.888 0 CA-C-N 119.98 1.028 . . . . 0.0 113.185 -2.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -161.54 -164.71 16.98 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.901 1.715 . . . . 0.0 112.556 -178.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.9 tt -73.36 -38.62 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -175.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.5 7.51 16.81 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -167.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.2 t -149.94 130.55 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.78 1.632 . . . . 0.0 109.703 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.16 164.08 33.36 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.081 1.752 . . . . 0.0 112.731 -171.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 73.1 p -121.49 161.67 21.86 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.861 1.664 . . . . 0.0 111.956 -174.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.8 m -91.39 169.91 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.102 1.361 . . . . 0.0 110.906 168.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 79.6 p -95.03 -31.09 13.76 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.894 1.277 . . . . 0.0 113.506 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -95.3 -39.55 9.99 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -163.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.0 t -138.95 123.24 18.16 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -174.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.1 m -79.34 31.12 0.22 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 -168.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.418 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.257 18.4 ptt180 -120.68 18.06 11.95 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.293 1.437 . . . . 0.0 114.693 174.341 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -138.34 137.84 37.75 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.219 1.008 . . . . 0.0 111.202 -170.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -136.66 160.35 39.08 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.967 1.307 . . . . 0.0 111.325 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 80.7 t -112.75 143.8 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.498 1.119 . . . . 0.0 108.88 165.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.8 148.49 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 118.981 0.81 . . . . 0.0 112.104 171.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -89.28 89.28 7.84 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.668 0.787 . . . . 0.0 110.426 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -71.27 142.0 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 O-C-N 122.161 -0.337 . . . . 0.0 110.802 175.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 . . . . . 0 N--CA 1.47 0.557 0 C-N-CA 125.594 1.558 . . . . 0.0 111.83 -172.478 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 86.3 p . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.93 148.38 31.71 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.455 1.502 . . . . 0.0 111.348 172.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -93.08 116.74 29.33 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.53 0.732 . . . . 0.0 109.733 170.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.7 pt -116.94 146.01 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.715 1.206 . . . . 0.0 111.149 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.8 142.68 16.17 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 174.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.6 pt -127.54 139.81 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 125.319 1.448 . . . . 0.0 111.866 171.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -117.38 142.71 17.51 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 125.45 1.5 . . . . 0.0 112.474 174.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -100.37 162.74 12.75 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.209 1.404 . . . . 0.0 111.842 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.3 t -68.76 -28.02 66.42 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.643 0.777 . . . . 0.0 112.388 176.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -158.71 155.85 28.8 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.601 1.16 . . . . 0.0 111.406 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.3 ttp85 -54.28 -40.98 68.36 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.397 1.079 . . . . 0.0 112.513 173.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.69 -29.85 73.21 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 123.995 0.807 . . . . 0.0 114.304 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -82.2 -36.82 26.89 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.298 1.049 . . . . 0.0 111.748 176.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.418 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -63.61 -31.59 72.8 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.523 -0.735 . . . . 0.0 112.764 168.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -72.54 0.9 9.2 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.795 1.405 . . . . 0.0 114.795 170.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -96.87 -32.77 11.91 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.431 -0.793 . . . . 0.0 112.322 162.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.432 ' CD2' HD11 ' A' ' 49' ' ' ILE . 47.0 t80 -58.4 -53.03 62.93 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.638 1.175 . . . . 0.0 112.518 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -66.41 -34.47 78.02 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.669 1.187 . . . . 0.0 113.366 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 52.6 t -75.48 -40.04 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.44 1.096 . . . . 0.0 111.005 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.3 m -66.69 -28.55 68.54 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.34 0.656 . . . . 0.0 112.735 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.7 mt -75.74 -53.1 9.05 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.828 0.851 . . . . 0.0 111.981 171.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -66.62 -27.39 67.66 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.224 -0.922 . . . . 0.0 113.161 -175.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -84.29 -3.12 58.04 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.303 1.041 . . . . 0.0 112.752 175.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 52.5 t60 -88.85 -38.8 14.31 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 120.901 -1.125 . . . . 0.0 111.911 158.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -91.92 1.83 56.93 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 -171.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -177.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.2 m . . . . . 0 N--CA 1.473 0.7 0 CA-C-O 120.607 0.241 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.48 145.07 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.914 1.286 . . . . 0.0 112.221 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 71.8 mt -128.58 -41.38 1.52 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.077 1.751 . . . . 0.0 112.529 -175.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.6 t -151.37 135.71 16.86 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.86 1.264 . . . . 0.0 110.346 175.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 78.6 t -128.16 127.87 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.6 1.16 . . . . 0.0 109.624 171.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -126.95 131.66 23.97 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 124.797 1.239 . . . . 0.0 110.945 172.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -66.71 -24.91 46.99 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.098 2.532 . . . . 0.0 115.349 -176.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -133.81 120.95 21.12 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.108 0.963 . . . . 0.0 112.336 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -150.97 147.24 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.732 2.013 . . . . 0.0 109.369 174.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.8 m -125.95 130.94 52.24 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.852 0.861 . . . . 0.0 111.84 -171.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.3 t -96.65 137.38 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.773 1.629 . . . . 0.0 112.153 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -131.39 126.05 34.17 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.876 1.271 . . . . 0.0 109.472 168.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -67.11 118.08 10.04 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.595 0.758 . . . . 0.0 109.478 166.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.9 pt . . . . . 0 CA--C 1.545 0.788 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -166.854 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 . . . . . 0 CA--C 1.535 0.38 0 CA-C-O 120.845 0.355 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.4 16.35 3.18 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -171.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.75 -49.04 0.06 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 127.805 2.442 . . . . 0.0 115.673 -176.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.9 m -68.5 -15.58 63.59 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.028 1.731 . . . . 0.0 114.18 -177.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.45 -11.75 59.64 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.8 0.84 . . . . 0.0 112.995 171.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 18.0 m0 -88.61 171.17 10.23 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.136 1.374 . . . . 0.0 110.851 178.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -81.42 55.52 2.63 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.21 1.404 . . . . 0.0 114.095 -174.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.5 mt -61.14 -14.6 25.97 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -171.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -108.83 -3.46 17.66 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.609 1.163 . . . . 0.0 113.033 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -148.71 71.33 10.54 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 125.151 1.38 . . . . 0.0 112.105 177.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -56.46 144.39 84.03 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.131 2.554 . . . . 0.0 112.307 173.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -70.22 -29.85 66.79 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.378 1.071 . . . . 0.0 111.689 175.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 38.8 t90 -156.84 152.48 26.9 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.554 1.542 . . . . 0.0 110.559 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.2 p -134.03 150.77 51.23 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.691 0.796 . . . . 0.0 111.869 168.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.28 -143.62 6.31 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 123.129 0.395 . . . . 0.0 113.542 -176.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 36.7 mtm105 -105.74 149.37 26.49 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.597 1.959 . . . . 0.0 112.135 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.5 tp -90.37 138.68 31.35 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.707 1.203 . . . . 0.0 109.755 162.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.8 ttp85 -144.1 91.44 2.21 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.17 0.988 . . . . 0.0 110.731 162.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.469 HD11 ' CD2' ' A' ' 119' ' ' PHE . 15.2 mt -72.06 131.93 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 170.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.41 174.91 10.01 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 127.364 2.265 . . . . 0.0 110.564 -177.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.6 p -158.32 153.31 25.26 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 120.721 -1.237 . . . . 0.0 111.562 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -158.76 128.61 5.77 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.242 1.017 . . . . 0.0 112.085 159.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.59 53.65 37.08 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.452 1.025 . . . . 0.0 114.902 163.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt 61.99 24.25 14.41 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 126.292 1.837 . . . . 0.0 113.909 -175.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.5 m -123.7 132.26 53.79 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.659 1.584 . . . . 0.0 108.726 165.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.17 157.55 16.5 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.219 1.008 . . . . 0.0 110.162 166.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -136.54 107.62 6.75 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.501 1.521 . . . . 0.0 109.22 -175.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.5 mp -81.18 96.38 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 168.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -95.93 136.83 35.85 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.268 0.556 . . . . 0.0 111.516 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.6 mp -110.36 133.46 53.24 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 126.238 1.815 . . . . 0.0 109.4 174.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -139.6 154.05 47.5 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.854 0.862 . . . . 0.0 111.946 -169.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -74.88 148.77 39.87 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 120.974 -1.079 . . . . 0.0 112.311 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.1 pttt -89.08 -1.35 58.06 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.9 1.68 . . . . 0.0 114.986 -178.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 80.3 t -127.83 -41.8 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.152 1.381 . . . . 0.0 111.951 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.1 p -96.15 -27.42 15.05 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.53 1.059 . . . . 0.0 113.289 175.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.58 8.59 87.15 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-O 119.346 -0.697 . . . . 0.0 113.8 -170.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -68.75 151.34 46.78 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.622 1.211 . . . . 0.0 111.886 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.4 tp -72.66 125.96 28.74 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.638 -0.664 . . . . 0.0 110.683 176.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -86.37 -55.02 4.1 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.133 0.973 . . . . 0.0 111.063 171.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.8 159.56 36.87 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.66 1.184 . . . . 0.0 111.651 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -140.3 133.97 30.31 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.47 0.708 . . . . 0.0 112.576 175.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.74 103.24 53.91 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 125.108 1.363 . . . . 0.0 111.257 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -74.65 141.72 28.11 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.566 2.844 . . . . 0.0 111.728 173.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.5 t -134.94 125.38 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.68 1.992 . . . . 0.0 109.07 -174.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -90.04 -23.51 21.43 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -161.86 150.03 15.02 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.67 1.988 . . . . 0.0 110.151 171.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -122.85 127.56 25.69 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 124.537 1.135 . . . . 0.0 110.973 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -62.18 147.72 55.53 Favored 'Cis proline' 0 CA--C 1.541 0.869 0 CA-C-N 119.991 1.033 . . . . 0.0 114.392 -5.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.37 -166.68 18.81 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.919 1.723 . . . . 0.0 112.392 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.0 tt -69.52 -37.39 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 121.607 -0.937 . . . . 0.0 112.873 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.83 6.66 23.71 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -165.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.6 t -150.4 130.71 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.481 1.512 . . . . 0.0 110.063 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -140.32 161.34 37.92 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.282 1.833 . . . . 0.0 112.316 177.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.2 p -107.96 160.98 15.35 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.6 1.96 . . . . 0.0 111.735 177.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.1 m -87.01 173.33 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.212 1.005 . . . . 0.0 110.879 163.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 73.9 p -104.56 -23.3 13.14 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.485 1.514 . . . . 0.0 113.921 -176.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -99.87 -39.29 8.26 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -171.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.9 t -134.03 117.27 16.48 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -173.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.0 m -72.48 24.82 0.05 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 115.956 1.835 . . . . 0.0 115.956 -169.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.4 ptt85 -131.42 27.08 4.77 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.507 1.923 . . . . 0.0 113.995 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -140.09 141.28 36.18 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.671 1.589 . . . . 0.0 111.441 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -140.14 162.11 36.03 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.03 1.332 . . . . 0.0 111.54 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.9 t -116.96 142.85 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.596 1.158 . . . . 0.0 108.997 167.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.21 148.09 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 173.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -87.94 84.68 6.96 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.976 0.911 . . . . 0.0 110.717 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -68.3 141.03 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 120.816 0.341 . . . . 0.0 110.582 173.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 . . . . . 0 N--CA 1.467 0.413 0 C-N-CA 125.302 1.441 . . . . 0.0 111.78 -169.744 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 82.3 p . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.54 147.67 41.53 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.539 1.536 . . . . 0.0 110.612 164.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -92.83 116.75 29.32 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 167.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.1 pt -117.62 144.11 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.474 1.109 . . . . 0.0 110.937 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.73 142.08 15.92 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 175.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.4 pt -127.15 140.14 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 125.478 1.511 . . . . 0.0 111.661 172.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -119.94 141.35 15.35 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.798 1.189 . . . . 0.0 113.511 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -109.06 153.85 23.06 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.488 1.915 . . . . 0.0 110.792 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.3 t -73.0 -23.16 60.6 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.616 0.766 . . . . 0.0 112.784 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -155.54 151.06 27.17 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.446 1.098 . . . . 0.0 111.62 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.33 -33.05 70.65 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.904 0.882 . . . . 0.0 112.732 177.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.0 -19.25 63.32 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-N 118.979 0.808 . . . . 0.0 114.59 177.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -94.83 -37.31 11.28 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.689 1.244 . . . . 0.0 111.694 176.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.42 -29.14 68.8 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.135 0.974 . . . . 0.0 112.929 166.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . 0.262 19.8 m-85 -92.51 19.39 7.33 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.571 1.548 . . . . 0.0 114.112 170.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -99.71 -38.7 8.59 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.551 -0.718 . . . . 0.0 111.295 142.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.469 ' CD2' HD11 ' A' ' 49' ' ' ILE . 36.9 t80 -54.3 -57.72 10.14 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.58 1.082 . . . . 0.0 112.927 178.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -80.42 -22.74 40.91 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.256 -0.902 . . . . 0.0 113.345 -174.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 93.7 t -81.48 -39.2 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.412 0.685 . . . . 0.0 110.803 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 95.1 p -65.46 -31.42 72.49 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.566 -0.709 . . . . 0.0 112.848 173.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 72.0 mt -69.54 -52.65 24.4 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.189 0.995 . . . . 0.0 111.951 172.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -67.67 -29.03 68.22 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 120.971 -1.081 . . . . 0.0 112.823 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -82.77 -3.0 56.0 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.507 1.123 . . . . 0.0 112.916 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -90.15 -29.25 18.4 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.165 -0.96 . . . . 0.0 112.547 166.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -101.75 -4.15 26.91 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -176.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -176.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -72.34 149.67 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.825 1.25 . . . . 0.0 113.855 -171.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.5 mt -134.07 -38.6 0.87 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.05 1.74 . . . . 0.0 112.425 -171.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 39.0 t -152.59 139.52 19.08 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.89 1.276 . . . . 0.0 110.588 172.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 79.1 t -131.71 127.55 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.697 1.199 . . . . 0.0 109.28 171.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -129.21 135.24 27.29 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 125.207 1.403 . . . . 0.0 110.524 173.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.66 -18.46 13.52 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.987 2.458 . . . . 0.0 114.975 -172.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -129.65 109.42 10.97 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.5 1.12 . . . . 0.0 111.146 -175.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.7 p -143.05 141.37 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.721 1.609 . . . . 0.0 110.028 171.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.3 m -123.33 125.36 44.87 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.265 1.026 . . . . 0.0 111.371 -171.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.6 t -92.16 137.82 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.142 1.377 . . . . 0.0 112.201 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -127.31 123.3 36.05 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.277 1.431 . . . . 0.0 108.621 168.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -68.96 109.3 3.88 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 164.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.415 HD12 ' CE2' ' A' ' 31' ' ' TYR . 35.4 pt . . . . . 0 N--CA 1.473 0.716 0 C-N-CA 124.425 1.09 . . . . 0.0 113.819 -166.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.415 ' CE2' HD12 ' A' ' 22' ' ' ILE . 28.6 m-85 . . . . . 0 N--CA 1.451 -0.398 0 CA-C-O 120.997 0.427 . . . . 0.0 109.966 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.528 ' H ' ' HD3' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -123.31 131.09 53.54 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 163.139 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.18 -33.73 63.24 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.454 1.102 . . . . 0.0 113.215 -172.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.7 p -65.44 -13.26 58.35 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 175.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.29 -10.25 58.63 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.054 0.942 . . . . 0.0 112.704 170.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 22.8 m0 -94.68 171.71 8.62 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.629 1.572 . . . . 0.0 111.835 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -79.22 47.52 0.8 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.16 1.784 . . . . 0.0 114.177 -176.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.7 mt -54.72 -34.86 63.02 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -167.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -93.77 -2.41 53.72 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.95 0.9 . . . . 0.0 113.321 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -145.89 66.85 12.0 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 125.992 1.717 . . . . 0.0 111.747 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -55.91 144.02 79.69 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.282 2.654 . . . . 0.0 112.84 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -73.86 -27.81 61.26 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.45 1.1 . . . . 0.0 111.73 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 40.7 t90 -153.17 152.48 31.3 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.656 1.582 . . . . 0.0 110.663 170.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.5 p -134.56 143.17 47.24 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.964 0.906 . . . . 0.0 111.864 171.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.15 -144.63 5.4 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 114.556 0.582 . . . . 0.0 114.556 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -107.9 144.3 35.34 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.507 1.923 . . . . 0.0 111.035 -172.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 42.9 tp -91.56 138.44 31.57 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.652 1.581 . . . . 0.0 110.119 170.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -144.26 99.53 3.39 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.685 1.194 . . . . 0.0 110.57 170.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.48 HD11 ' CD2' ' A' ' 119' ' ' PHE . 18.4 mt -86.31 132.96 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.604 1.162 . . . . 0.0 108.624 174.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.12 171.28 14.3 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.167 1.787 . . . . 0.0 111.279 -170.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.8 t -156.21 149.06 24.03 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.796 -1.19 . . . . 0.0 112.555 173.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -150.86 132.76 15.1 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.724 152.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.47 58.45 5.45 Favored Glycine 0 N--CA 1.474 1.192 0 C-N-CA 124.752 1.168 . . . . 0.0 114.466 166.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 56.52 27.3 12.07 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 126.203 1.801 . . . . 0.0 113.174 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.7 m -137.93 121.83 17.72 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.655 1.582 . . . . 0.0 108.536 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -90.33 158.57 17.08 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.842 0.857 . . . . 0.0 110.513 171.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -139.34 99.52 3.76 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.318 1.847 . . . . 0.0 108.628 -173.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.3 mp -79.65 103.66 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 168.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 50.6 mttt -105.12 141.18 37.13 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.939 0.876 . . . . 0.0 111.732 174.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.8 mp -108.9 133.01 53.49 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 126.301 1.84 . . . . 0.0 109.785 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -132.2 147.19 52.41 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.942 0.897 . . . . 0.0 112.499 -168.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -66.33 140.81 58.12 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.882 0.873 . . . . 0.0 112.717 -175.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.274 0.0 OUTLIER -77.59 -5.22 49.48 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 -174.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.6 t -112.46 -48.59 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.93 1.292 . . . . 0.0 111.107 170.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.8 m -99.54 -16.75 18.18 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -167.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.87 12.43 74.8 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.658 1.123 . . . . 0.0 113.994 -176.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -82.78 152.09 25.84 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.078 1.351 . . . . 0.0 112.322 -174.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.7 122.16 19.31 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.959 0.903 . . . . 0.0 112.074 -169.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -86.1 -54.91 4.19 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.217 1.007 . . . . 0.0 111.098 168.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.58 161.61 38.73 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.895 1.278 . . . . 0.0 111.771 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -141.22 134.88 30.1 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.722 1.209 . . . . 0.0 112.065 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.86 100.68 48.5 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.955 1.302 . . . . 0.0 111.405 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -65.1 139.07 59.36 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 124.292 3.328 . . . . 0.0 112.422 167.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.4 t -135.8 129.68 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.73 1.612 . . . . 0.0 109.659 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -89.71 -23.52 21.8 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.75 150.05 13.38 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.15 1.78 . . . . 0.0 110.391 172.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -126.12 132.19 24.23 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.526 1.13 . . . . 0.0 112.131 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -63.57 144.66 53.94 Favored 'Cis proline' 0 CA--C 1.54 0.814 0 CA-C-N 119.71 0.932 . . . . 0.0 113.772 -6.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -169.59 -173.26 36.97 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.606 1.098 . . . . 0.0 114.116 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.6 tp -54.86 -36.72 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -166.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.55 8.35 39.25 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -171.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.4 t -148.33 129.12 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.307 1.043 . . . . 0.0 111.221 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -138.11 162.52 33.97 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.282 1.833 . . . . 0.0 112.218 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 65.8 p -112.49 161.28 16.91 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.628 1.971 . . . . 0.0 111.388 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.4 m -89.57 173.1 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.841 0.857 . . . . 0.0 111.453 166.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 46.5 p -99.05 -24.9 14.73 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 174.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -81.21 -42.69 20.38 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -171.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.2 t -156.76 134.44 10.86 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.0 m -72.99 22.15 0.07 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -174.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.482 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.26 5.1 ptm180 -108.73 19.67 19.4 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.011 1.724 . . . . 0.0 114.043 173.268 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -142.53 135.5 28.38 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.029 1.331 . . . . 0.0 110.412 -174.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -135.95 164.49 27.85 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.975 1.31 . . . . 0.0 111.103 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.2 t -117.72 142.96 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.705 1.202 . . . . 0.0 108.418 166.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.89 147.13 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 118.664 0.665 . . . . 0.0 112.14 172.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -87.75 86.67 7.2 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.507 0.723 . . . . 0.0 110.449 176.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -69.04 140.32 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.575 0.226 . . . . 0.0 110.8 175.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 . . . . . 0 N--CA 1.47 0.534 0 C-N-CA 125.762 1.625 . . . . 0.0 111.792 -170.247 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 76.8 p . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.11 147.46 30.6 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.465 1.506 . . . . 0.0 111.234 171.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -90.92 117.99 29.96 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.396 0.678 . . . . 0.0 109.472 168.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.4 pt -116.93 143.19 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.567 1.147 . . . . 0.0 111.027 177.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.25 144.06 17.72 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 174.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.0 pt -128.9 139.61 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 C-N-CA 125.59 1.556 . . . . 0.0 111.641 171.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.68 142.14 15.53 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 125.663 1.601 . . . . 0.0 112.725 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -105.25 163.63 12.45 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.419 1.488 . . . . 0.0 111.298 -177.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.7 t -76.32 -24.65 54.31 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 177.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -156.19 151.14 26.25 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.402 1.081 . . . . 0.0 111.636 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -62.62 -32.69 73.75 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.087 0.955 . . . . 0.0 113.151 178.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.24 -30.09 76.92 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 118.942 0.792 . . . . 0.0 113.646 175.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -82.84 -36.49 25.42 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.119 0.96 . . . . 0.0 111.918 175.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.482 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -64.2 -31.77 73.09 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 169.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -61.25 -33.75 74.04 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.098 -1.001 . . . . 0.0 112.508 171.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -70.36 -32.72 70.54 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.835 1.198 . . . . 0.0 112.846 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.48 ' CD2' HD11 ' A' ' 49' ' ' ILE . 9.6 t80 -57.64 -43.85 85.18 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.029 0.831 . . . . 0.0 111.329 170.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -81.28 -35.59 30.91 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.532 1.133 . . . . 0.0 113.496 -175.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.5 t -76.78 -40.5 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 O-C-N 121.245 -0.909 . . . . 0.0 111.519 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 85.4 p -63.67 -27.41 69.2 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 83.8 mt -75.38 -55.51 5.62 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.018 0.927 . . . . 0.0 111.534 171.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -66.83 -30.71 70.97 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.09 -1.006 . . . . 0.0 113.484 -172.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -90.91 4.38 52.04 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.8 1.64 . . . . 0.0 112.716 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -97.67 -33.12 11.43 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.304 -0.872 . . . . 0.0 112.276 163.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -89.96 -2.37 58.14 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.321 0 CA-C-N 121.18 1.809 . . . . 0.0 115.09 -174.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.6 m . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.6 t -69.99 143.05 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 O-C-N 121.305 -0.872 . . . . 0.0 111.673 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.5 mt -126.88 -41.75 1.8 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.572 1.549 . . . . 0.0 112.293 -174.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.4 t -153.92 135.39 14.24 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.229 1.012 . . . . 0.0 111.245 173.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.1 t -128.31 127.33 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.677 1.191 . . . . 0.0 109.014 171.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -131.07 137.43 30.7 Favored Pre-proline 0 N--CA 1.475 0.81 0 C-N-CA 125.408 1.483 . . . . 0.0 110.65 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.53 -18.57 22.59 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.217 2.611 . . . . 0.0 113.689 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -109.08 122.64 47.7 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.025 1.33 . . . . 0.0 112.152 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.0 p -154.72 143.25 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.803 1.241 . . . . 0.0 109.585 157.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.7 p -127.32 144.14 51.1 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.071 1.348 . . . . 0.0 110.586 177.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.4 t -113.41 130.22 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.931 1.292 . . . . 0.0 111.113 -177.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.67 118.17 14.81 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.418 1.487 . . . . 0.0 108.976 173.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 -69.45 132.45 46.35 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.893 0.877 . . . . 0.0 109.943 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.3 pt . . . . . 0 CA--C 1.545 0.78 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -160.152 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 . . . . . 0 CA--C 1.532 0.284 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.77 15.96 8.07 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 -174.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 55.84 -48.15 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.825 2.85 . . . . 0.0 116.156 -173.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 90.7 p -64.53 -17.77 64.21 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.095 1.758 . . . . 0.0 114.466 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -85.84 -4.79 59.25 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.445 1.498 . . . . 0.0 112.633 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.8 m0 -93.44 168.52 11.0 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.085 1.754 . . . . 0.0 110.635 175.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -78.13 49.7 0.84 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.659 1.584 . . . . 0.0 114.041 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 45.7 mt -56.46 -36.07 68.64 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -172.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -92.8 -2.68 55.73 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.237 1.015 . . . . 0.0 113.232 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -141.6 70.32 25.7 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 125.521 1.528 . . . . 0.0 111.726 177.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.85 147.37 73.42 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.144 2.563 . . . . 0.0 113.16 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -74.03 -27.94 61.18 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.158 0.983 . . . . 0.0 111.535 169.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 57.7 t90 -158.15 155.01 28.35 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.399 1.88 . . . . 0.0 110.884 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.1 p -136.72 149.9 48.13 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.666 1.186 . . . . 0.0 112.024 169.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.69 -142.49 4.6 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 123.319 0.485 . . . . 0.0 113.825 -177.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -118.91 148.74 42.6 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.849 2.06 . . . . 0.0 111.558 -175.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.1 tp -89.15 140.42 29.48 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.54 1.536 . . . . 0.0 110.626 174.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -141.01 93.36 2.58 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.519 1.127 . . . . 0.0 110.567 162.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.471 HD11 ' CD2' ' A' ' 119' ' ' PHE . 23.1 mt -76.65 127.24 37.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 166.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.1 p -138.31 171.71 13.98 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 126.919 2.088 . . . . 0.0 110.153 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.8 p -152.81 166.09 33.34 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 125.014 1.326 . . . . 0.0 112.185 174.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -148.68 121.25 8.56 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.243 0.544 . . . . 0.0 111.326 154.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.33 -118.43 9.32 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 125.232 1.396 . . . . 0.0 110.211 -176.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -101.48 20.16 16.55 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.331 1.852 . . . . 0.0 113.714 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.4 m -127.47 128.15 45.25 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.704 1.202 . . . . 0.0 109.957 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.65 160.8 14.03 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.552 1.141 . . . . 0.0 111.157 170.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -141.21 107.13 5.15 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.733 2.013 . . . . 0.0 108.802 -174.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -83.99 94.56 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 168.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -88.58 136.67 32.88 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.86 0.864 . . . . 0.0 110.805 174.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.3 mp -111.98 131.2 55.55 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.143 1.777 . . . . 0.0 110.111 174.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -132.67 147.56 52.33 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.858 0.863 . . . . 0.0 113.177 -170.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -67.8 135.39 52.54 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.367 1.067 . . . . 0.0 111.329 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.7 pttt -76.05 -5.2 45.35 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -175.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 85.6 t -120.26 -43.17 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 125.03 1.332 . . . . 0.0 111.47 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.5 m -93.82 -19.71 20.76 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.32 13.5 76.97 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.487 1.041 . . . . 0.0 113.693 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -90.58 152.16 21.01 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.241 1.416 . . . . 0.0 112.295 -173.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.5 tp -72.47 128.34 35.29 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.491 -0.756 . . . . 0.0 111.666 -175.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -85.35 -58.25 2.75 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.55 1.14 . . . . 0.0 110.778 169.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.68 165.44 36.25 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.042 1.737 . . . . 0.0 110.12 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -146.35 146.22 30.59 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 169.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.34 107.2 49.74 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.333 1.453 . . . . 0.0 111.665 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -67.92 144.47 64.66 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.838 3.026 . . . . 0.0 111.988 169.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.2 t -139.23 126.52 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.46 1.504 . . . . 0.0 109.414 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -95.45 -19.96 19.45 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -160.56 145.49 14.43 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.733 2.013 . . . . 0.0 110.081 171.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -126.22 127.67 24.6 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 124.697 1.199 . . . . 0.0 110.488 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -64.47 146.96 67.06 Favored 'Cis proline' 0 CA--C 1.542 0.899 0 CA-C-N 120.073 1.062 . . . . 0.0 113.434 -2.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.65 -156.94 8.74 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.721 1.629 . . . . 0.0 112.642 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.6 tt -79.33 -41.89 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -176.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.59 8.0 15.57 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -165.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 23.5 t -153.02 130.45 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 126.363 1.865 . . . . 0.0 109.122 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.17 158.72 44.24 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.871 1.268 . . . . 0.0 113.067 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.0 p -104.73 161.6 14.02 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.506 1.522 . . . . 0.0 112.182 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.3 m -90.72 173.27 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.81 1.244 . . . . 0.0 110.806 167.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.6 p -96.79 -29.4 13.78 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.31 1.444 . . . . 0.0 113.384 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -91.32 -43.1 9.99 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -169.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.7 t -143.32 124.48 14.52 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -176.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -67.29 -7.89 27.87 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.297 1.592 . . . . 0.0 115.297 -169.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.443 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.32 44.9 ptt85 -84.91 21.3 1.62 Allowed 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -179.338 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -142.86 140.02 31.09 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.814 1.646 . . . . 0.0 111.868 -174.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -142.62 149.36 38.86 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.435 1.494 . . . . 0.0 112.512 -176.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.9 t -92.4 142.35 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 161.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.26 149.65 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 119.348 0.977 . . . . 0.0 111.949 164.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.478 ' HE ' ' NE2' ' A' ' 97' ' ' GLN . 41.1 ttp180 -93.04 95.72 9.63 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.706 0.803 . . . . 0.0 110.259 174.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -76.91 150.98 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.301 0.64 . . . . 0.0 111.705 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.478 ' NE2' ' HE ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.594 0 C-N-CA 125.901 1.68 . . . . 0.0 110.395 174.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 84.7 p . . . . . 0 N--CA 1.465 0.32 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.59 142.45 27.98 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.671 1.188 . . . . 0.0 111.276 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -87.66 117.54 26.55 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.378 0.671 . . . . 0.0 109.537 168.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.9 pt -118.56 147.61 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.888 1.275 . . . . 0.0 110.761 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.7 136.32 12.9 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.5 pt -127.66 159.77 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 125.008 1.323 . . . . 0.0 112.067 171.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -154.38 168.82 32.68 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-O 122.039 0.799 . . . . 0.0 114.513 173.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -121.77 157.41 31.08 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 126.08 1.752 . . . . 0.0 111.797 -171.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.7 t -70.01 -19.34 63.33 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.055 0.942 . . . . 0.0 112.592 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -154.79 150.76 27.88 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.197 0.999 . . . . 0.0 111.921 -176.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 35.6 ttt-85 -61.32 -31.62 71.48 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.694 1.198 . . . . 0.0 113.276 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.27 -29.33 75.02 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-N 119.102 0.865 . . . . 0.0 113.976 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -82.53 -34.67 27.8 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.455 -1.026 . . . . 0.0 111.642 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.443 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -67.67 -30.51 70.06 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.26 1.024 . . . . 0.0 113.388 167.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -61.5 -47.48 85.42 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.446 -0.784 . . . . 0.0 110.797 168.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -62.31 -36.92 83.64 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.386 0.993 . . . . 0.0 112.876 175.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.471 ' CD2' HD11 ' A' ' 49' ' ' ILE . 35.2 t80 -55.55 -55.76 28.13 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.224 0.92 . . . . 0.0 112.263 173.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -81.34 -27.3 35.01 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.114 1.154 . . . . 0.0 114.114 -174.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 73.0 t -76.3 -38.8 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 O-C-N 121.45 -0.781 . . . . 0.0 111.181 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 93.5 p -65.05 -30.98 71.98 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.152 0.887 . . . . 0.0 112.988 175.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.5 mt -68.43 -54.99 13.45 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.265 1.026 . . . . 0.0 111.761 171.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -67.27 -26.74 66.71 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 120.988 -1.07 . . . . 0.0 113.007 -176.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -81.78 -3.87 54.95 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.874 1.27 . . . . 0.0 112.713 174.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -91.53 -25.13 19.39 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.681 -1.262 . . . . 0.0 112.446 163.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -100.29 -6.76 25.42 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 116.007 1.855 . . . . 0.0 116.007 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -174.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.535 0.383 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.3 t -70.96 141.1 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 O-C-N 121.138 -0.976 . . . . 0.0 112.971 -168.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.3 mt -122.7 -41.77 2.35 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.874 1.67 . . . . 0.0 112.495 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 33.6 t -152.42 132.31 13.32 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.545 1.138 . . . . 0.0 110.596 175.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 72.6 t -127.94 127.07 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.546 1.138 . . . . 0.0 109.744 172.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -133.17 143.03 46.64 Favored Pre-proline 0 N--CA 1.474 0.737 0 C-N-CA 124.853 1.261 . . . . 0.0 111.683 173.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.02 -17.42 22.25 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.51 2.807 . . . . 0.0 115.098 -174.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -134.25 110.81 9.77 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.118 0.967 . . . . 0.0 112.21 -169.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -149.36 146.37 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 126.324 1.85 . . . . 0.0 109.739 171.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.3 m -125.27 131.59 53.06 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.058 0.943 . . . . 0.0 111.573 -171.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.1 t -98.9 139.97 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 126.028 1.731 . . . . 0.0 112.054 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -127.59 132.38 49.83 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.71 1.604 . . . . 0.0 108.968 169.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 48.0 mtm180 -70.05 139.29 52.61 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 155.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.8 pt . . . . . 0 N--CA 1.479 1.006 0 C-N-CA 125.16 1.384 . . . . 0.0 112.95 -163.59 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.27 22.9 4.81 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.284 1.434 . . . . 0.0 113.021 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 56.64 -46.94 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 128.471 2.709 . . . . 0.0 115.304 -170.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.4 m -64.82 -13.43 55.82 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.552 1.941 . . . . 0.0 114.276 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -78.57 -4.6 49.56 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.405 1.482 . . . . 0.0 113.588 170.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 10.6 m0 -107.0 167.83 9.62 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.655 1.582 . . . . 0.0 111.425 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -78.01 53.67 1.21 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.02 1.728 . . . . 0.0 113.589 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.9 mt -55.56 -32.6 63.14 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -170.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -87.63 -6.82 58.1 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.068 0.947 . . . . 0.0 113.085 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -140.19 59.29 12.35 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 126.886 2.075 . . . . 0.0 111.183 -160.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -65.04 139.61 62.03 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 CA-C-N 119.593 0.89 . . . . 0.0 112.424 -171.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -74.46 -26.64 60.17 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.207 1.003 . . . . 0.0 111.717 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 39.4 t90 -153.6 153.57 32.59 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.887 1.675 . . . . 0.0 110.71 169.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 56.0 p -135.88 148.38 48.58 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.486 1.114 . . . . 0.0 112.091 171.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 173.09 -144.13 7.64 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 123.017 0.341 . . . . 0.0 113.852 177.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.4 mtm180 -98.14 145.48 26.53 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.94 1.696 . . . . 0.0 112.069 -174.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.4 tp -85.61 136.47 33.37 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.584 1.553 . . . . 0.0 109.778 163.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 39.3 ttt-85 -145.68 87.08 1.76 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.626 1.17 . . . . 0.0 110.862 167.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.478 HD11 ' CD1' ' A' ' 119' ' ' PHE . 21.1 mt -71.28 125.59 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 171.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.7 p -128.23 163.91 23.7 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.376 1.87 . . . . 0.0 110.131 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.3 t -163.78 148.73 10.67 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.678 -1.264 . . . . 0.0 110.754 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.511 ' HE3' ' CE1' ' A' ' 57' ' ' TYR . 57.9 mttt -125.21 -126.37 0.24 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.967 1.307 . . . . 0.0 110.037 -172.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.48 94.11 1.69 Allowed Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.293 1.425 . . . . 0.0 112.309 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 54.58 28.54 10.0 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 126.653 1.981 . . . . 0.0 113.635 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.0 m -148.16 118.21 7.23 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.634 1.573 . . . . 0.0 109.35 -174.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -96.0 163.89 12.94 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.057 1.343 . . . . 0.0 111.63 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.511 ' CE1' ' HE3' ' A' ' 52' ' ' LYS . 82.2 m-85 -147.67 107.38 3.96 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.205 1.802 . . . . 0.0 109.298 -174.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.3 mp -80.46 96.11 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 170.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -92.41 138.21 31.71 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.173 0.589 . . . . 0.0 111.475 173.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.1 mp -115.62 134.48 55.01 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.365 1.866 . . . . 0.0 109.911 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -136.09 148.47 48.29 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.962 0.905 . . . . 0.0 112.07 -168.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -71.01 141.05 50.98 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 122.766 1.269 . . . . 0.0 111.643 177.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.623 ' H ' ' CD ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -85.25 1.53 47.84 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 127.007 2.123 . . . . 0.0 116.139 -175.124 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.1 t -116.97 -45.67 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 125.336 1.454 . . . . 0.0 111.014 171.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.2 m -96.71 -20.12 18.47 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -173.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.79 9.69 83.14 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.431 1.015 . . . . 0.0 113.823 -176.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -83.34 149.07 26.96 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.999 1.319 . . . . 0.0 112.186 -174.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.4 tp -70.89 125.45 26.88 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.59 0.756 . . . . 0.0 111.24 -177.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -83.5 -57.82 3.08 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.725 0.81 . . . . 0.0 110.475 167.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.59 163.02 40.69 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.486 1.114 . . . . 0.0 112.071 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -136.39 137.69 40.79 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.469 1.507 . . . . 0.0 110.606 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.81 92.1 49.31 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.291 1.036 . . . . 0.0 111.535 176.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -56.6 139.56 88.16 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 124.649 3.566 . . . . 0.0 113.457 168.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.3 t -138.94 123.99 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 126.58 1.952 . . . . 0.0 109.618 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -88.59 -21.41 24.05 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 121.01 -1.056 . . . . 0.0 113.425 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -160.29 144.94 14.53 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.169 1.788 . . . . 0.0 110.252 170.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -118.34 129.08 25.6 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.493 1.117 . . . . 0.0 110.75 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -66.39 148.23 76.77 Favored 'Cis proline' 0 CA--C 1.542 0.887 0 CA-C-N 119.976 1.027 . . . . 0.0 113.094 -4.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.81 -163.4 15.39 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.529 1.537 . . . . 0.0 113.054 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.4 tt -69.9 -37.42 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 O-C-N 121.797 -0.826 . . . . 0.0 113.191 -175.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.54 7.14 27.35 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -165.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 23.8 t -150.55 125.13 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.478 1.511 . . . . 0.0 109.606 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -139.16 159.83 41.23 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.114 1.766 . . . . 0.0 112.17 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.0 p -114.35 156.06 25.13 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.085 1.754 . . . . 0.0 111.725 -176.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.5 m -85.91 172.09 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.089 0.956 . . . . 0.0 111.114 170.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 70.5 p -96.7 -28.09 14.47 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 178.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -88.62 -43.37 11.41 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.232 0.826 . . . . 0.0 113.232 -168.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.5 t -146.17 125.73 13.28 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.34 1.77 3.56 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -170.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.471 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.286 31.5 ptt180 -86.59 16.59 4.52 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 177.162 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -139.5 137.6 35.65 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.997 1.319 . . . . 0.0 111.102 -173.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -139.07 155.02 48.24 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.979 1.312 . . . . 0.0 111.567 -178.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.76 141.77 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.497 0.719 . . . . 0.0 109.38 164.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.44 146.85 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 118.811 0.732 . . . . 0.0 112.354 171.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -87.54 89.87 8.16 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.906 0.883 . . . . 0.0 110.071 176.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.1 pt -68.34 144.14 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 O-C-N 122.126 -0.359 . . . . 0.0 111.127 173.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 . . . . . 0 N--CA 1.471 0.577 0 C-N-CA 124.713 1.205 . . . . 0.0 111.613 -175.884 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.0 p . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.73 146.39 33.12 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.271 1.429 . . . . 0.0 111.334 168.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -92.55 117.37 29.88 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.704 0.802 . . . . 0.0 109.672 171.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 32.9 pt -118.76 145.56 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.939 1.296 . . . . 0.0 111.419 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -90.95 141.83 15.88 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 176.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.3 pt -127.95 140.56 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 125.385 1.474 . . . . 0.0 111.646 171.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.08 143.78 15.84 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.835 1.207 . . . . 0.0 113.324 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -105.77 163.74 12.47 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.878 1.671 . . . . 0.0 111.061 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.1 t -74.08 -30.57 62.42 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.241 0.616 . . . . 0.0 112.407 176.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -151.1 150.21 30.41 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.133 0.973 . . . . 0.0 112.107 -174.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 54.7 ttt-85 -61.06 -33.68 73.7 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.43 1.092 . . . . 0.0 113.154 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.04 -27.17 73.77 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 123.901 0.763 . . . . 0.0 113.849 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -83.43 -36.27 24.35 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.088 0.944 . . . . 0.0 111.422 175.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.471 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -65.12 -33.08 75.17 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 169.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -61.0 -33.79 73.8 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.42 -0.8 . . . . 0.0 112.674 172.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -64.86 -37.87 89.08 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.808 1.185 . . . . 0.0 111.943 173.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.478 ' CD1' HD11 ' A' ' 49' ' ' ILE . 19.2 t80 -58.27 -50.38 73.79 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.738 0.815 . . . . 0.0 111.837 174.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.96 -24.27 38.2 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -176.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.7 t -80.67 -41.79 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 119.368 0.986 . . . . 0.0 111.427 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 93.2 p -63.47 -32.96 74.55 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.4 1.0 . . . . 0.0 112.87 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 61.6 mt -64.54 -58.46 6.33 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.22 1.008 . . . . 0.0 111.798 170.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -66.82 -29.8 69.83 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.247 -0.908 . . . . 0.0 113.121 -174.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -80.68 -3.55 51.08 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.42 1.088 . . . . 0.0 112.579 177.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -95.13 -19.39 20.14 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 163.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -101.41 -9.21 21.31 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.315 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 -174.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.4 m . . . . . 0 N--CA 1.464 0.248 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.6 t -65.06 142.05 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 123.766 0.826 . . . . 0.0 111.288 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.5 mt -128.18 -40.17 1.67 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.633 1.573 . . . . 0.0 112.338 -175.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 37.0 t -152.99 135.99 15.52 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.464 1.106 . . . . 0.0 111.036 173.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.4 t -129.0 126.89 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.492 1.117 . . . . 0.0 109.253 171.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -128.12 134.65 26.47 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 125.352 1.461 . . . . 0.0 110.287 175.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -78.64 -13.28 14.79 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.21 2.607 . . . . 0.0 115.268 -171.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -135.18 108.19 7.63 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.806 0.843 . . . . 0.0 111.339 -174.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.52 143.34 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.084 1.354 . . . . 0.0 110.568 173.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.5 m -123.65 131.93 53.73 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.426 1.09 . . . . 0.0 111.254 -173.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 76.6 t -97.44 134.32 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.509 1.524 . . . . 0.0 111.68 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.17 132.83 53.66 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.198 1.399 . . . . 0.0 108.685 168.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -71.4 131.72 43.78 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 162.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.1 pt . . . . . 0 N--CA 1.476 0.849 0 C-N-CA 124.043 0.937 . . . . 0.0 113.327 -164.955 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 . . . . . 0 CA--C 1.54 0.566 0 CA-C-O 119.661 -0.209 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.43 18.89 7.5 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -175.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.92 -51.4 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.968 2.507 . . . . 0.0 115.481 -173.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.0 m -65.43 -13.26 58.31 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.253 1.821 . . . . 0.0 114.257 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -79.89 -12.01 59.77 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.323 1.049 . . . . 0.0 112.645 172.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -95.35 165.33 12.43 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.801 1.641 . . . . 0.0 111.12 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.1 mttt -78.07 57.68 1.84 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.622 1.569 . . . . 0.0 113.261 175.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.1 mt -55.47 -31.75 62.23 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -173.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -89.68 -5.67 56.85 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.838 0.855 . . . . 0.0 113.042 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -138.62 68.92 45.24 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 125.479 1.512 . . . . 0.0 111.685 -161.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -68.0 145.66 68.43 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 CA-C-N 119.535 0.869 . . . . 0.0 113.097 -170.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -71.33 -31.15 67.05 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.255 0.622 . . . . 0.0 111.001 166.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 54.9 t90 -157.36 154.8 29.51 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.757 1.623 . . . . 0.0 111.149 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.2 p -132.94 148.31 52.28 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.745 1.218 . . . . 0.0 111.522 170.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.526 ' HA2' ' HE3' ' A' ' 63' ' ' LYS . . . -178.54 -146.1 6.37 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 114.332 0.493 . . . . 0.0 114.332 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -110.84 145.08 38.85 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.426 1.89 . . . . 0.0 110.952 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.6 tp -85.49 138.73 32.03 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.594 1.558 . . . . 0.0 109.939 170.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.1 ttt85 -142.81 87.95 2.02 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.676 1.19 . . . . 0.0 110.649 170.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.444 HD11 ' CD2' ' A' ' 119' ' ' PHE . 27.1 mt -75.37 124.82 34.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 170.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.4 p -134.78 169.37 17.45 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 127.065 2.146 . . . . 0.0 109.712 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.3 t -157.17 160.14 38.45 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.732 -1.23 . . . . 0.0 112.176 176.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -147.85 118.66 7.58 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.658 0.742 . . . . 0.0 111.879 160.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.24 -119.96 11.23 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 125.899 1.714 . . . . 0.0 110.506 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -92.03 10.62 28.33 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.853 1.661 . . . . 0.0 113.824 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.1 m -129.31 112.75 14.19 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.592 0.757 . . . . 0.0 111.231 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.13 161.27 16.59 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.55 0.74 . . . . 0.0 111.493 172.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -141.45 106.01 4.87 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.443 1.897 . . . . 0.0 109.31 -173.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -82.77 95.68 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 168.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -91.1 138.28 31.72 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.74 0.816 . . . . 0.0 110.86 175.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mp -112.75 130.48 56.05 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.075 1.75 . . . . 0.0 109.927 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -133.99 148.78 51.16 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.005 0.922 . . . . 0.0 112.427 -172.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -66.53 147.56 53.11 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.05 -1.031 . . . . 0.0 111.824 177.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.526 ' HE3' ' HA2' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -83.93 -0.3 50.86 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -174.168 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.5 t -120.05 -45.26 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.856 1.262 . . . . 0.0 111.508 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.7 p -94.04 -23.54 17.97 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -178.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.55 11.85 80.29 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 123.814 0.721 . . . . 0.0 113.478 -169.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -70.57 142.8 51.71 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.888 1.344 . . . . 0.0 111.621 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.4 tp -71.03 125.21 26.25 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.154 0.582 . . . . 0.0 111.208 -176.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -85.23 -56.35 3.58 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.443 1.097 . . . . 0.0 110.923 170.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.0 164.41 36.8 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.563 1.545 . . . . 0.0 110.547 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -144.98 143.32 30.46 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 169.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -114.56 111.97 46.07 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 125.086 1.355 . . . . 0.0 111.177 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.57 144.07 13.91 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.406 2.737 . . . . 0.0 111.36 175.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.8 t -135.65 128.91 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.488 1.515 . . . . 0.0 109.496 -173.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -94.65 -21.5 18.75 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.74 147.59 11.88 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.636 1.974 . . . . 0.0 110.05 170.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -116.07 128.61 25.85 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 124.803 1.241 . . . . 0.0 110.859 176.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -67.56 149.72 82.88 Favored 'Cis proline' 0 CA--C 1.544 0.978 0 CA-C-N 119.788 0.96 . . . . 0.0 112.804 -5.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.54 -167.31 17.62 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.658 1.599 . . . . 0.0 112.728 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.6 tt -67.52 -36.7 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 O-C-N 121.56 -0.965 . . . . 0.0 112.907 -177.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.32 4.23 32.11 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 -167.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.2 t -151.49 127.61 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.145 1.378 . . . . 0.0 110.448 -177.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -142.63 158.25 43.85 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.983 1.713 . . . . 0.0 112.872 -177.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.5 p -101.72 163.27 12.34 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.237 1.815 . . . . 0.0 111.749 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.5 m -89.54 169.64 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.178 0.991 . . . . 0.0 110.084 162.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 81.3 p -95.09 -30.72 13.92 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.864 1.266 . . . . 0.0 113.53 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -94.73 -39.1 10.48 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -164.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.6 t -137.09 118.84 15.06 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -175.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.3 m -74.92 21.02 0.12 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -164.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.405 ' HA ' ' CB ' ' A' ' 116' ' ' ALA . 15.9 ptt-85 -120.44 20.94 11.79 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.532 1.933 . . . . 0.0 114.095 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -138.56 140.9 39.23 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.308 1.443 . . . . 0.0 110.883 -173.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -140.8 156.84 46.06 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.842 1.257 . . . . 0.0 111.42 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 83.2 t -107.97 142.42 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.991 0.917 . . . . 0.0 109.5 165.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.75 148.19 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 118.492 0.587 . . . . 0.0 111.889 169.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.0 ttp85 -92.19 91.81 7.93 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.337 0.655 . . . . 0.0 110.581 176.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.5 pp -75.26 152.96 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.64 0.776 . . . . 0.0 112.05 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.507 0 C-N-CA 125.958 1.703 . . . . 0.0 110.9 173.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.6 p . . . . . 0 N--CA 1.466 0.36 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.03 143.4 28.35 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.824 1.25 . . . . 0.0 111.646 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -84.36 118.07 24.0 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.681 0.792 . . . . 0.0 109.536 168.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 30.3 pt -118.34 144.73 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.828 1.251 . . . . 0.0 110.996 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -92.08 139.0 14.5 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.1 pt -124.23 142.21 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 125.039 1.336 . . . . 0.0 111.867 171.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -124.05 143.16 14.68 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 124.777 1.179 . . . . 0.0 113.69 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -106.0 159.79 15.78 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.976 1.711 . . . . 0.0 110.833 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.5 t -72.87 -23.83 60.78 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.699 0.799 . . . . 0.0 112.739 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -158.75 153.74 25.13 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.915 1.286 . . . . 0.0 110.82 -175.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -58.78 -34.44 71.45 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.575 0.75 . . . . 0.0 112.715 176.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.46 -31.65 78.28 Favored Glycine 0 CA--C 1.536 1.368 0 CA-C-N 119.491 1.041 . . . . 0.0 114.348 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -85.85 -36.02 20.26 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.237 1.018 . . . . 0.0 112.114 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.405 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -60.92 -31.96 71.46 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.681 -0.637 . . . . 0.0 112.472 167.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . 0.28 8.2 m-85 -78.88 11.19 2.78 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 173.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -105.24 -31.46 9.09 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.765 0.826 . . . . 0.0 112.813 157.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.444 ' CD2' HD11 ' A' ' 49' ' ' ILE . 26.0 t80 -55.38 -47.09 76.34 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.263 1.025 . . . . 0.0 112.227 175.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -78.23 -32.71 49.95 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.8 t -76.87 -41.62 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.316 1.046 . . . . 0.0 110.906 -177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 81.8 p -64.35 -30.32 71.37 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 81.5 mt -71.67 -54.91 8.82 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.115 0.966 . . . . 0.0 111.92 171.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -66.85 -28.64 68.5 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.048 -1.033 . . . . 0.0 113.194 -175.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -84.76 -3.63 58.69 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.282 1.033 . . . . 0.0 112.664 175.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 53.1 t60 -89.06 -39.49 13.62 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 120.838 -1.164 . . . . 0.0 111.765 158.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -89.84 -1.63 58.03 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -172.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.031 0 CA-C-N 120.705 1.593 . . . . 0.0 114.638 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 p -66.85 145.45 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.386 0.674 . . . . 0.0 112.54 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 50.0 mt -126.82 -44.02 1.67 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.747 1.619 . . . . 0.0 112.209 -176.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.3 t -152.36 134.84 15.24 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.637 1.175 . . . . 0.0 110.482 175.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 86.3 t -127.21 127.06 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.333 1.053 . . . . 0.0 109.325 170.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -127.64 132.91 24.57 Favored Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 125.081 1.352 . . . . 0.0 110.228 174.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.13 -15.75 16.08 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.137 2.558 . . . . 0.0 114.874 -172.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -133.81 106.9 7.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.353 1.061 . . . . 0.0 110.987 -175.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.2 p -142.77 146.18 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 125.342 1.457 . . . . 0.0 110.224 173.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.5 m -127.83 132.13 49.47 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.057 0.943 . . . . 0.0 111.597 -171.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.2 t -98.8 130.24 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.399 1.479 . . . . 0.0 111.803 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -131.31 131.49 43.83 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.236 1.414 . . . . 0.0 109.637 170.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.8 mmt-85 -59.89 140.36 56.71 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.482 165.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.9 pt . . . . . 0 N--CA 1.475 0.817 0 C-N-CA 125.499 1.519 . . . . 0.0 112.834 -174.749 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 . . . . . 0 CA--C 1.532 0.274 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.13 19.67 6.43 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -172.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.49 -50.07 0.05 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.789 2.435 . . . . 0.0 115.39 -174.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.9 m -68.54 -16.62 63.94 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.843 1.657 . . . . 0.0 114.75 -175.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.52 -7.35 59.55 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 172.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.0 m0 -85.58 168.02 14.85 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.857 1.263 . . . . 0.0 110.639 175.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.8 mttt -77.72 52.23 0.99 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.129 1.372 . . . . 0.0 113.964 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.8 mt -57.52 -28.46 63.49 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -175.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -90.28 -6.15 55.48 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -149.91 83.56 6.18 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.502 1.121 . . . . 0.0 112.332 177.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -56.52 147.08 71.55 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.248 2.632 . . . . 0.0 112.95 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -70.1 -33.96 72.51 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.399 0.68 . . . . 0.0 111.14 165.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.5 t90 -156.61 152.68 27.49 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.812 1.645 . . . . 0.0 110.801 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.3 p -132.55 149.88 52.25 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.122 0.969 . . . . 0.0 111.554 167.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.99 -141.44 5.13 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 123.07 0.367 . . . . 0.0 113.282 -178.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.2 mtm105 -109.8 144.92 37.55 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.065 1.746 . . . . 0.0 111.88 -175.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.8 tp -85.36 137.59 32.84 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.711 1.204 . . . . 0.0 109.129 163.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.8 ttt-85 -143.97 89.37 2.03 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.263 1.025 . . . . 0.0 110.56 164.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.503 HD11 ' CD2' ' A' ' 119' ' ' PHE . 15.1 mt -71.53 130.05 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 170.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 p -132.83 173.76 11.04 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.933 2.093 . . . . 0.0 110.282 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 92.9 p -161.89 166.73 25.82 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 120.687 -1.258 . . . . 0.0 111.712 178.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.2 mmtt -152.92 -117.74 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.658 1.583 . . . . 0.0 110.451 153.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.47 92.05 0.41 Allowed Glycine 0 N--CA 1.471 1.024 0 C-N-CA 125.636 1.588 . . . . 0.0 113.802 -160.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.7 mttt 50.99 27.91 3.52 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.429 1.891 . . . . 0.0 112.915 -175.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.1 m -143.42 127.82 17.85 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.24 1.416 . . . . 0.0 109.269 -173.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.76 161.57 13.51 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.637 1.175 . . . . 0.0 110.562 169.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -141.25 102.34 4.21 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.163 1.785 . . . . 0.0 108.905 -173.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.1 mp -78.57 98.09 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 170.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -97.61 138.02 35.65 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.395 0.617 . . . . 0.0 111.575 173.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mp -109.11 132.93 53.64 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.197 1.799 . . . . 0.0 109.568 174.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -137.88 151.92 48.52 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.891 0.876 . . . . 0.0 112.569 -168.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -74.12 143.99 45.1 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.123 -0.986 . . . . 0.0 112.092 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -84.07 -6.55 59.43 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.376 1.871 . . . . 0.0 115.128 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 92.5 t -123.37 -44.32 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 125.315 1.446 . . . . 0.0 111.423 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.8 m -93.64 -22.88 18.5 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -174.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.0 6.88 86.43 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 123.956 0.789 . . . . 0.0 113.805 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -82.37 155.68 24.6 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.364 1.466 . . . . 0.0 112.441 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.3 tp -74.5 129.01 36.97 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.492 0.717 . . . . 0.0 111.223 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -88.04 -55.19 3.86 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.234 1.014 . . . . 0.0 111.16 169.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.39 161.25 40.13 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.918 1.287 . . . . 0.0 111.323 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -144.22 140.74 29.46 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.759 0.824 . . . . 0.0 112.565 176.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.79 102.5 22.37 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 125.936 1.694 . . . . 0.0 111.157 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -69.33 147.15 64.98 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.927 3.085 . . . . 0.0 112.438 170.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.9 t -138.15 125.07 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.796 1.638 . . . . 0.0 109.152 -176.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -92.02 -22.48 19.94 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -159.88 147.45 16.73 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.562 1.945 . . . . 0.0 109.642 168.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -124.14 127.62 25.29 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 124.684 1.194 . . . . 0.0 110.964 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.43 147.4 50.06 Favored 'Cis proline' 0 CA--C 1.541 0.87 0 CA-C-N 120.079 1.064 . . . . 0.0 114.534 -4.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.33 -166.58 19.44 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.488 1.518 . . . . 0.0 113.429 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.4 tp -70.65 -31.24 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -174.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.85 3.54 50.84 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -171.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.9 t -150.34 133.54 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.902 1.281 . . . . 0.0 110.844 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -141.35 161.61 37.49 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.319 1.448 . . . . 0.0 112.83 175.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 73.0 p -107.21 161.23 14.96 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 127.055 2.142 . . . . 0.0 111.093 177.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.8 m -88.27 172.83 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 123.897 0.879 . . . . 0.0 111.232 166.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 60.0 p -96.22 -30.29 13.55 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.39 1.476 . . . . 0.0 113.368 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -96.28 -40.59 9.08 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -165.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.5 t -137.74 117.96 13.59 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -173.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.3 p -75.08 29.25 0.09 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -172.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.96 24.82 7.48 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 127.108 2.163 . . . . 0.0 113.937 174.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -140.96 139.88 34.31 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.902 1.281 . . . . 0.0 111.261 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -137.74 159.87 40.8 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.813 1.245 . . . . 0.0 110.738 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.8 t -112.18 144.66 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 124.288 1.035 . . . . 0.0 108.772 165.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.94 148.07 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 118.095 0.407 . . . . 0.0 111.755 168.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -89.86 99.98 12.88 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.31 0.644 . . . . 0.0 109.542 172.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -84.7 155.21 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.536 1.135 . . . . 0.0 111.335 176.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 . . . . . 0 N--CA 1.469 0.507 0 C-N-CA 124.969 1.308 . . . . 0.0 111.592 178.244 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 84.1 p . . . . . 0 N--CA 1.473 0.719 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.48 144.77 28.82 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.89 1.276 . . . . 0.0 111.267 172.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -87.88 119.89 28.67 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 165.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 31.3 pt -120.69 142.81 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.628 1.171 . . . . 0.0 111.218 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.69 137.31 13.51 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 176.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.3 pt -124.6 139.05 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 125.226 1.41 . . . . 0.0 111.713 175.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.1 140.28 14.45 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.719 1.152 . . . . 0.0 113.082 177.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -101.84 159.47 15.31 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.025 1.73 . . . . 0.0 111.37 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.5 t -70.58 -27.38 64.07 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.32 0.648 . . . . 0.0 112.646 178.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -158.05 155.96 30.23 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.382 1.073 . . . . 0.0 111.997 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -56.58 -38.41 71.94 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.662 1.185 . . . . 0.0 112.482 174.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.05 -10.43 46.72 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.541 1.067 . . . . 0.0 115.022 176.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -104.75 -35.97 7.58 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.746 1.273 . . . . 0.0 111.754 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.7 -28.27 68.52 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.65 0.78 . . . . 0.0 112.835 164.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -70.74 -6.51 38.01 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 169.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -93.76 -35.25 12.87 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.939 1.245 . . . . 0.0 112.26 163.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.503 ' CD2' HD11 ' A' ' 49' ' ' ILE . 43.5 t80 -55.2 -55.76 27.64 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.304 0.957 . . . . 0.0 112.267 177.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -78.81 -27.66 44.42 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 -173.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.6 t -79.74 -39.58 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 121.749 -0.595 . . . . 0.0 111.043 -178.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 88.5 p -65.7 -33.31 75.59 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.544 -0.722 . . . . 0.0 112.524 174.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 40.6 mt -66.62 -55.73 13.96 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.035 0.934 . . . . 0.0 112.154 172.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -64.85 -27.26 68.75 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.136 0.88 . . . . 0.0 112.874 -176.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -79.0 -7.8 58.38 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.345 1.058 . . . . 0.0 112.873 176.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -84.89 -15.61 44.0 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.087 -1.008 . . . . 0.0 112.815 165.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -115.17 -7.92 12.41 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -173.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.466 0.352 0 CA-C-O 120.53 0.205 . . . . 0.0 111.299 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.5 t -73.52 143.72 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.741 1.216 . . . . 0.0 111.583 -169.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.9 mt -128.86 -38.67 1.65 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.73 1.612 . . . . 0.0 112.625 -174.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 34.8 t -154.22 136.76 15.09 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.618 1.167 . . . . 0.0 110.726 173.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 88.7 t -130.14 127.27 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.639 1.176 . . . . 0.0 109.383 171.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -129.05 140.17 37.84 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 125.791 1.636 . . . . 0.0 110.794 176.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -77.35 -27.26 6.64 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.464 2.776 . . . . 0.0 115.84 -168.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -140.05 115.87 10.24 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.087 0.946 . . . . 0.0 111.843 -175.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.9 145.4 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 126.84 2.056 . . . . 0.0 109.726 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.2 m -124.71 130.05 51.68 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.767 0.827 . . . . 0.0 112.133 -167.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 77.8 t -94.6 137.44 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.212 1.405 . . . . 0.0 112.051 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.56 128.72 37.84 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.624 1.17 . . . . 0.0 110.133 169.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.41 135.95 57.34 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.306 1.042 . . . . 0.0 111.035 161.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.8 pt . . . . . 0 N--CA 1.475 0.8 0 C-N-CA 126.248 1.819 . . . . 0.0 112.294 -177.623 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.62 18.45 6.83 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -170.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.73 -50.67 0.05 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.879 2.472 . . . . 0.0 115.464 -175.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.6 m -66.77 -14.6 62.79 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.069 1.748 . . . . 0.0 114.19 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -76.36 -21.51 56.01 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.723 1.209 . . . . 0.0 112.56 172.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 17.3 m0 -84.52 172.09 11.96 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.667 1.587 . . . . 0.0 111.524 -177.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -80.16 54.55 1.98 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.365 1.466 . . . . 0.0 113.978 -177.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.7 mt -60.71 -17.27 47.23 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -174.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -102.08 -8.04 21.77 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.813 1.245 . . . . 0.0 113.104 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -149.0 72.52 10.29 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.896 1.278 . . . . 0.0 111.867 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -57.47 145.58 87.77 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.043 2.495 . . . . 0.0 112.374 174.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -70.07 -29.14 66.07 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.513 1.125 . . . . 0.0 111.749 175.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 42.1 t90 -159.44 152.99 22.63 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.035 1.734 . . . . 0.0 110.476 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.2 p -133.7 152.31 51.85 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.575 -0.703 . . . . 0.0 112.381 166.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.08 -146.72 7.35 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 116.174 -0.466 . . . . 0.0 114.085 -176.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 42.7 mtm105 -104.84 148.27 26.83 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.047 2.139 . . . . 0.0 111.734 -175.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.3 tp -89.51 139.43 30.54 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.257 1.423 . . . . 0.0 110.247 167.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 -141.53 97.15 3.1 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.65 1.58 . . . . 0.0 109.682 167.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.472 HD11 ' CD2' ' A' ' 119' ' ' PHE . 17.3 mt -83.31 130.67 35.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 169.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.81 162.82 34.47 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.51 2.324 . . . . 0.0 109.508 -168.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.5 t -163.48 153.73 15.66 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.431 -1.418 . . . . 0.0 110.508 175.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -128.58 -41.79 1.5 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 116.786 2.143 . . . . 0.0 116.786 -176.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.92 82.53 0.1 OUTLIER Glycine 0 N--CA 1.472 1.072 0 CA-C-N 118.652 0.66 . . . . 0.0 112.075 -175.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt 54.71 25.24 6.29 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.006 1.722 . . . . 0.0 112.749 -171.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.7 m -141.43 118.27 11.11 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.197 1.399 . . . . 0.0 107.649 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.51 160.06 14.69 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.241 1.016 . . . . 0.0 110.799 174.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -138.44 113.81 9.55 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 126.346 1.858 . . . . 0.0 108.956 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.5 mp -86.12 102.17 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 166.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -100.67 140.01 35.55 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.349 1.059 . . . . 0.0 111.409 176.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.8 mp -113.32 130.6 56.22 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.444 1.898 . . . . 0.0 109.605 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -135.85 153.26 51.54 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.079 0.952 . . . . 0.0 112.259 -174.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -73.12 142.91 47.49 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.85 -1.156 . . . . 0.0 111.9 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.3 pttt -84.63 -4.64 59.1 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.973 1.709 . . . . 0.0 115.048 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 64.8 t -124.79 -43.81 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 125.468 1.507 . . . . 0.0 111.361 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.7 m -91.54 -24.2 19.69 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.5 5.77 87.99 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 123.992 0.806 . . . . 0.0 113.831 -177.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -82.78 151.17 26.24 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.343 1.457 . . . . 0.0 112.566 -173.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.1 tp -73.36 126.12 29.41 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.612 0.765 . . . . 0.0 110.886 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -87.65 -54.8 4.07 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.462 1.105 . . . . 0.0 111.226 171.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.29 163.64 38.51 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.575 1.15 . . . . 0.0 112.01 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -142.23 134.41 27.59 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.707 1.203 . . . . 0.0 111.653 177.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.15 97.08 50.5 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.11 1.364 . . . . 0.0 111.669 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -58.89 139.7 91.97 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 124.568 3.512 . . . . 0.0 113.315 166.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.3 t -139.13 128.87 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.571 1.949 . . . . 0.0 109.52 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -90.77 -24.12 20.44 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.34 149.97 15.94 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.034 1.734 . . . . 0.0 110.772 173.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -118.83 130.43 24.82 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.589 1.156 . . . . 0.0 111.469 175.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -63.34 148.33 64.16 Favored 'Cis proline' 0 CA--C 1.542 0.879 0 CA-C-N 119.761 0.951 . . . . 0.0 113.583 -7.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -152.39 -163.91 11.96 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.578 1.561 . . . . 0.0 112.461 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.9 tt -78.13 -36.47 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 O-C-N 121.82 -0.812 . . . . 0.0 112.938 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.94 8.71 9.76 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -169.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.0 t -149.8 133.69 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 126.33 1.852 . . . . 0.0 109.446 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -146.43 159.17 43.74 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.464 1.506 . . . . 0.0 112.489 -177.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.8 p -109.7 155.66 21.25 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 126.638 1.975 . . . . 0.0 111.696 176.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.1 m -80.51 173.46 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 124.01 0.924 . . . . 0.0 110.982 165.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.6 p -95.68 -30.21 13.88 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.409 1.484 . . . . 0.0 113.357 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -91.1 -50.24 5.96 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.927 0.891 . . . . 0.0 113.266 -167.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.7 m -133.78 117.39 16.84 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -167.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.0 m -73.23 28.36 0.06 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -171.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.428 ' HA ' ' CB ' ' A' ' 116' ' ' ALA . 6.1 ptm180 -125.23 23.62 7.61 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.859 2.064 . . . . 0.0 113.577 175.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -141.07 137.43 32.87 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.279 1.432 . . . . 0.0 110.99 -178.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -137.35 165.24 26.67 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.855 1.262 . . . . 0.0 111.128 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.3 t -120.28 143.29 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 124.658 1.183 . . . . 0.0 108.539 168.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.72 149.05 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 118.639 0.654 . . . . 0.0 111.744 172.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -92.49 90.23 7.08 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.051 0.54 . . . . 0.0 110.858 177.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -70.57 141.32 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 122.894 0.478 . . . . 0.0 110.995 177.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 . . . . . 0 N--CA 1.47 0.564 0 C-N-CA 126.09 1.756 . . . . 0.0 111.491 -172.83 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 93.6 p . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.14 146.46 30.87 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.527 1.531 . . . . 0.0 111.29 171.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -87.11 124.56 33.38 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.737 -0.602 . . . . 0.0 109.425 166.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.8 pt -122.5 143.57 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.522 1.129 . . . . 0.0 111.092 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -90.18 144.28 17.46 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 173.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.8 pt -129.67 140.43 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 125.53 1.532 . . . . 0.0 111.991 173.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.23 137.7 11.59 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 125.64 1.591 . . . . 0.0 113.151 178.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -102.09 162.92 12.54 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.252 1.821 . . . . 0.0 111.29 -178.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.4 t -74.14 -27.73 60.99 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.722 0.809 . . . . 0.0 113.006 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -157.11 153.27 27.52 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.276 1.03 . . . . 0.0 112.229 -177.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -60.01 -34.4 73.28 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.601 1.16 . . . . 0.0 113.151 176.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.1 -31.54 81.12 Favored Glycine 0 CA--C 1.536 1.39 0 CA-C-N 119.131 0.878 . . . . 0.0 113.382 176.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -83.69 -34.69 24.9 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.804 0.842 . . . . 0.0 112.093 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.428 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -65.46 -33.51 76.12 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 170.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -61.77 -32.19 72.45 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.043 -1.036 . . . . 0.0 112.582 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -66.34 -30.15 70.49 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.049 -1.032 . . . . 0.0 112.738 173.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.472 ' CD2' HD11 ' A' ' 49' ' ' ILE . 24.4 t80 -63.09 -49.35 74.83 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.372 0.987 . . . . 0.0 111.943 173.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.8 -25.11 33.03 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -177.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.8 t -78.37 -41.59 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 119.197 0.908 . . . . 0.0 111.39 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 93.7 p -64.58 -29.49 70.51 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.251 0.932 . . . . 0.0 113.302 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 78.0 mt -70.96 -54.28 11.9 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.004 0.922 . . . . 0.0 111.712 171.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -68.51 -32.74 72.91 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.01 -1.056 . . . . 0.0 113.225 -174.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -83.81 -1.34 54.12 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.088 0.955 . . . . 0.0 112.364 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -96.44 -33.24 11.95 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 120.931 -1.106 . . . . 0.0 112.545 164.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -93.05 -3.28 54.57 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.301 0 CA-C-N 121.595 1.998 . . . . 0.0 114.936 -175.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 82.6 p . . . . . 0 N--CA 1.469 0.509 0 CA-C-O 121.083 0.468 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 82.5 t -70.62 141.01 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.916 0.886 . . . . 0.0 111.053 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.6 mt -127.49 -40.54 1.77 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.697 1.599 . . . . 0.0 112.646 -171.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 51.1 t -146.87 137.28 23.65 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.505 1.522 . . . . 0.0 109.247 172.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 76.8 t -126.6 130.48 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.355 1.062 . . . . 0.0 108.936 168.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -133.57 127.84 19.79 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 124.562 1.145 . . . . 0.0 111.076 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.19 -13.24 12.65 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.986 2.457 . . . . 0.0 114.947 -171.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -134.11 104.52 6.25 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.223 1.009 . . . . 0.0 110.717 -176.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.5 p -143.18 144.42 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.508 1.123 . . . . 0.0 110.726 174.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.8 m -124.88 131.21 53.46 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.55 1.14 . . . . 0.0 110.629 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.0 t -96.61 134.33 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.946 1.298 . . . . 0.0 111.127 177.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.38 120.63 25.87 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.06 1.344 . . . . 0.0 108.932 169.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -63.24 130.79 46.06 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.425 -0.797 . . . . 0.0 109.145 163.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.2 pt . . . . . 0 CA--C 1.544 0.745 0 C-N-CA 124.845 1.258 . . . . 0.0 112.834 -166.703 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 . . . . . 0 C--O 1.223 -0.329 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.92 18.64 7.86 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -171.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.16 -49.89 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 128.141 2.576 . . . . 0.0 115.607 -173.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.5 m -67.61 -15.2 63.53 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.012 1.725 . . . . 0.0 114.603 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.95 -10.8 58.62 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 171.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.0 m0 -85.55 170.45 12.59 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.813 1.245 . . . . 0.0 110.841 176.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.9 mtmm -80.24 52.94 1.66 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.408 1.483 . . . . 0.0 113.606 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.6 mt -57.89 -23.76 54.69 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -173.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -96.28 -6.51 37.71 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.547 1.139 . . . . 0.0 112.446 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -151.99 72.37 7.88 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 125.111 1.364 . . . . 0.0 111.817 -169.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -57.97 149.59 69.62 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.725 2.95 . . . . 0.0 113.605 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -73.32 -31.11 63.81 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.76 0.824 . . . . 0.0 111.401 167.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 33.5 t90 -158.13 153.02 25.15 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.48 1.912 . . . . 0.0 110.391 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.2 p -134.18 146.74 50.45 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.719 1.208 . . . . 0.0 111.486 171.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.41 -138.5 4.28 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 114.088 0.395 . . . . 0.0 114.088 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -115.89 144.72 43.64 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.816 1.646 . . . . 0.0 111.578 -172.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.2 tp -92.49 137.72 32.12 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.354 1.462 . . . . 0.0 109.821 172.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 53.9 ttp85 -138.68 102.21 4.53 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.96 0.904 . . . . 0.0 110.026 162.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.54 HD11 ' CD1' ' A' ' 119' ' ' PHE . 25.8 mt -79.16 132.67 31.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 169.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.74 171.69 14.13 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 126.229 1.812 . . . . 0.0 110.708 -175.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.0 t -161.41 159.53 28.31 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.369 1.068 . . . . 0.0 110.869 172.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -147.55 -85.03 0.1 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 158.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.56 68.39 3.36 Favored Glycine 0 N--CA 1.474 1.226 0 C-N-CA 124.629 1.109 . . . . 0.0 113.959 -166.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.7 mttt 51.67 30.13 6.39 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.815 1.646 . . . . 0.0 112.49 -172.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.8 m -146.92 120.8 9.3 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.383 1.873 . . . . 0.0 108.237 -173.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.84 156.7 19.77 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.318 1.047 . . . . 0.0 110.939 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -135.15 100.41 4.54 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.336 1.855 . . . . 0.0 108.713 -173.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.6 mp -79.74 104.84 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 171.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.4 mttt -105.4 135.26 47.11 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.526 0.73 . . . . 0.0 111.775 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -101.08 133.17 46.01 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 125.237 1.415 . . . . 0.0 110.189 169.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -138.32 148.34 44.5 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.038 0.935 . . . . 0.0 112.233 -171.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -68.51 149.67 48.97 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.217 1.008 . . . . 0.0 113.688 -171.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.89 -3.84 43.73 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.9 t -123.41 -48.25 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.636 1.174 . . . . 0.0 111.705 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.6 p -95.35 -24.6 16.66 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -176.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.05 13.98 76.16 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 123.609 0.623 . . . . 0.0 113.522 -167.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -69.13 149.28 48.82 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 118.727 1.263 . . . . 0.0 111.533 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.4 tp -71.2 124.11 23.75 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.444 0.698 . . . . 0.0 111.441 -175.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -84.26 -53.86 5.2 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.971 0.908 . . . . 0.0 110.924 168.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -159.39 157.67 30.74 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.925 1.29 . . . . 0.0 111.516 -177.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -138.99 138.77 37.56 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.59 0.756 . . . . 0.0 112.81 174.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.65 111.09 36.4 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.059 1.343 . . . . 0.0 111.685 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -82.81 123.73 3.76 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.981 3.121 . . . . 0.0 111.91 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.6 t -114.41 119.73 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 126.862 2.065 . . . . 0.0 109.324 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -81.97 -20.56 38.28 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 -176.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.08 162.54 15.44 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.245 1.818 . . . . 0.0 109.308 171.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -120.45 129.81 25.15 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -173.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -64.95 151.94 76.03 Favored 'Cis proline' 0 CA--C 1.542 0.912 0 CA-C-N 119.193 0.748 . . . . 0.0 112.895 -11.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -147.37 175.48 26.71 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.165 0.888 . . . . 0.0 114.15 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.5 tp -52.97 -30.11 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 124.695 1.198 . . . . 0.0 114.066 -176.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.68 9.82 28.28 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.6 p -155.45 138.36 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.197 0.999 . . . . 0.0 113.561 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -152.24 161.12 43.09 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.664 1.586 . . . . 0.0 113.069 -172.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 62.9 p -112.88 161.01 17.46 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 127.307 2.243 . . . . 0.0 111.202 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.0 m -88.5 175.8 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.319 1.047 . . . . 0.0 111.314 167.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.7 p -95.79 -31.59 13.11 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.673 1.589 . . . . 0.0 113.357 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -93.98 -42.37 9.08 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -165.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.4 t -142.49 121.39 12.77 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -177.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.15 0.73 5.69 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -169.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.486 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.303 28.4 ptt180 -87.12 16.21 5.34 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 176.509 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -137.24 136.8 38.43 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.168 1.387 . . . . 0.0 110.908 -174.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -137.54 160.3 39.54 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.138 1.375 . . . . 0.0 111.263 -177.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.1 t -116.2 143.05 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.258 1.023 . . . . 0.0 108.915 166.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.67 149.66 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 123.441 0.697 . . . . 0.0 111.395 170.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -93.25 87.44 5.65 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.776 0.831 . . . . 0.0 110.357 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -70.24 138.35 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 120.958 0.409 . . . . 0.0 110.695 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 . . . . . 0 N--CA 1.468 0.442 0 C-N-CA 125.484 1.514 . . . . 0.0 111.212 -167.77 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 95.6 p . . . . . 0 CA--C 1.534 0.362 0 N-CA-C 114.646 1.351 . . . . 0.0 114.646 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.14 140.72 28.18 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.208 1.403 . . . . 0.0 110.927 168.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -88.39 119.69 29.06 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.175 0.59 . . . . 0.0 109.896 170.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.8 pt -118.54 142.0 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.543 1.137 . . . . 0.0 110.756 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -90.99 144.27 17.12 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 173.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.2 pt -128.38 141.81 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 125.052 1.341 . . . . 0.0 111.631 169.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -121.4 142.67 15.52 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.142 1.353 . . . . 0.0 113.169 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -107.19 164.97 11.72 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.718 1.607 . . . . 0.0 111.551 -177.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.6 t -74.39 -31.91 62.52 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.486 0.714 . . . . 0.0 112.521 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -151.71 146.36 25.71 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.245 -0.909 . . . . 0.0 112.071 -172.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -61.71 -33.78 74.62 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.329 1.051 . . . . 0.0 113.195 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.7 -25.54 75.03 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-N 118.935 0.789 . . . . 0.0 113.838 176.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -92.96 -26.38 17.59 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.193 0.997 . . . . 0.0 112.821 176.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.486 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -66.11 -34.53 78.27 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.422 -0.799 . . . . 0.0 112.598 161.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -59.82 -31.32 69.62 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.049 -1.032 . . . . 0.0 112.197 168.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -67.28 -25.19 65.93 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 119.553 1.07 . . . . 0.0 112.968 174.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.54 ' CD1' HD11 ' A' ' 49' ' ' ILE . 13.4 t80 -69.74 -51.87 30.42 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.205 1.002 . . . . 0.0 111.878 168.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.08 -25.3 40.08 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -174.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 65.0 t -77.97 -42.41 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 121.134 -0.979 . . . . 0.0 111.05 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 88.7 p -66.37 -30.66 71.09 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.1 mt -69.93 -55.95 8.33 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.828 0.851 . . . . 0.0 111.536 171.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -63.68 -33.7 76.22 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.117 0.871 . . . . 0.0 113.256 -174.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -83.53 -0.89 52.26 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.468 1.107 . . . . 0.0 112.762 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -94.11 -13.41 26.81 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.263 -0.898 . . . . 0.0 113.31 164.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -108.17 -4.86 17.26 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.331 0 CA-C-N 121.079 1.763 . . . . 0.0 115.677 -176.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.0 m . . . . . 0 N--CA 1.468 0.451 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.36 146.99 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.779 0.831 . . . . 0.0 113.015 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.6 mt -130.82 -42.56 1.12 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.65 1.58 . . . . 0.0 112.409 -173.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 27.1 t -151.64 134.67 15.8 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.336 1.054 . . . . 0.0 110.933 177.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 96.9 t -129.31 127.85 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.516 1.126 . . . . 0.0 109.474 172.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -127.36 130.55 23.7 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 125.176 1.391 . . . . 0.0 110.085 173.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.7 -13.96 15.99 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 122.959 2.439 . . . . 0.0 115.144 -171.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -134.37 108.59 8.26 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.029 0.932 . . . . 0.0 111.425 -176.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.69 146.16 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.975 1.71 . . . . 0.0 109.926 174.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.0 m -127.6 131.02 49.99 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.908 0.883 . . . . 0.0 111.695 -170.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 68.2 t -97.77 131.66 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.361 1.464 . . . . 0.0 111.749 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.17 120.89 25.26 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.071 1.348 . . . . 0.0 108.611 167.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.0 mtt-85 -71.69 130.08 40.27 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.094 0.557 . . . . 0.0 109.939 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.4 pt . . . . . 0 N--CA 1.474 0.726 0 C-N-CA 124.095 0.958 . . . . 0.0 113.435 -163.482 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 . . . . . 0 CA--C 1.534 0.327 0 CA-C-O 120.444 0.164 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.21 18.58 4.92 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -173.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 59.98 -48.47 0.09 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 128.4 2.68 . . . . 0.0 115.253 -174.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.5 p -65.5 -18.32 65.23 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.838 2.055 . . . . 0.0 114.688 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.74 -15.32 59.21 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.963 0.905 . . . . 0.0 112.988 173.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -90.56 165.29 13.85 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.853 1.261 . . . . 0.0 110.341 176.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.3 mtmt -87.0 64.17 8.33 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.793 0.837 . . . . 0.0 112.435 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.0 mt -56.52 -27.63 57.89 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.752 1.621 . . . . 0.0 115.032 -172.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -86.04 -8.09 58.16 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.107 0.963 . . . . 0.0 113.137 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -135.04 58.82 29.96 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 125.27 1.428 . . . . 0.0 111.814 -161.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -65.82 139.45 57.3 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 CA-C-N 119.719 0.935 . . . . 0.0 112.421 -172.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -69.44 -27.88 65.64 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.747 0.819 . . . . 0.0 111.222 174.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 50.2 t90 -158.09 151.34 23.15 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.89 1.676 . . . . 0.0 110.713 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.3 p -132.97 150.68 52.14 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.791 0.836 . . . . 0.0 111.835 167.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.1 -142.91 5.53 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 116.259 -0.428 . . . . 0.0 113.524 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.5 mtm180 -109.64 146.4 34.84 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.528 1.931 . . . . 0.0 111.812 -176.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.2 tp -84.99 139.49 31.75 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.483 1.513 . . . . 0.0 109.746 163.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -143.93 92.41 2.33 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.091 1.356 . . . . 0.0 110.714 167.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.42 HD11 ' CD2' ' A' ' 119' ' ' PHE . 20.3 mt -76.95 126.27 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 171.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.2 p -138.22 165.53 26.46 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.771 2.028 . . . . 0.0 110.111 -178.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.0 m -148.15 160.12 43.24 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.562 1.145 . . . . 0.0 112.426 175.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -148.8 125.0 10.79 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.281 0.562 . . . . 0.0 112.35 155.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.55 -124.24 8.66 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 125.377 1.465 . . . . 0.0 110.025 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -99.86 17.86 19.77 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.714 1.605 . . . . 0.0 113.317 176.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.3 m -124.45 125.8 44.85 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.63 1.172 . . . . 0.0 110.172 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.68 160.11 14.5 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.549 1.14 . . . . 0.0 111.205 171.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -141.78 103.16 4.3 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.849 2.06 . . . . 0.0 109.071 -171.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.3 mp -81.45 94.16 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 169.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -90.15 141.7 28.43 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.613 0.765 . . . . 0.0 111.27 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.4 mp -113.2 133.04 55.26 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.618 1.967 . . . . 0.0 109.918 173.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -131.45 147.86 52.59 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.105 0.962 . . . . 0.0 113.003 -172.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -68.68 133.77 48.91 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.066 -1.021 . . . . 0.0 110.93 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.416 ' HG2' ' H ' ' A' ' 63' ' ' LYS . 36.5 pttt -77.48 -4.24 44.49 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -176.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 64.1 t -120.62 -42.44 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 125.205 1.402 . . . . 0.0 111.537 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.9 m -93.44 -20.57 20.18 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.09 11.46 79.09 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.551 1.072 . . . . 0.0 113.831 -176.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -87.19 152.44 22.32 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.325 1.45 . . . . 0.0 112.254 -173.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.5 tp -71.9 127.19 31.79 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.601 -0.687 . . . . 0.0 111.389 -178.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -87.27 -55.87 3.62 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.361 1.065 . . . . 0.0 111.047 169.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.95 163.54 39.02 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.438 1.495 . . . . 0.0 110.603 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -145.99 141.43 27.68 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 172.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.08 104.16 52.56 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 125.323 1.449 . . . . 0.0 111.606 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -64.6 142.59 78.16 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.037 3.158 . . . . 0.0 112.54 169.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.6 t -138.37 132.29 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.972 1.709 . . . . 0.0 108.793 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -103.42 -18.22 14.91 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.98 147.24 14.8 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.909 2.083 . . . . 0.0 109.766 173.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -134.3 124.62 17.36 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.484 1.113 . . . . 0.0 111.551 -177.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -59.25 147.89 38.86 Favored 'Cis proline' 0 CA--C 1.54 0.81 0 CA-C-N 120.123 1.08 . . . . 0.0 114.533 -4.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -161.7 -160.0 10.57 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 126.166 1.841 . . . . 0.0 112.025 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.6 tt -76.12 -40.0 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 118.185 0.993 . . . . 0.0 113.158 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.77 7.24 18.42 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -166.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.3 t -150.73 130.08 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.575 1.55 . . . . 0.0 109.947 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -141.84 158.01 44.31 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.041 1.736 . . . . 0.0 112.487 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.4 p -108.28 160.81 15.55 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.745 2.018 . . . . 0.0 111.153 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.9 m -88.87 169.35 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 124.062 0.945 . . . . 0.0 110.862 165.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.5 p -94.1 -29.5 15.13 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.869 1.267 . . . . 0.0 113.556 178.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -92.71 -41.25 10.26 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -166.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.2 t -142.27 112.76 7.21 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -177.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.6 p -72.94 30.32 0.06 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -174.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.43 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.254 1.0 OUTLIER -115.86 23.12 12.51 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.854 2.061 . . . . 0.0 113.519 166.785 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -140.44 138.59 34.82 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.69 1.596 . . . . 0.0 110.622 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -137.34 163.59 30.64 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.902 1.281 . . . . 0.0 111.562 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 37.2 t -117.57 144.83 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.862 1.265 . . . . 0.0 109.13 166.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.69 148.76 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 123.07 0.548 . . . . 0.0 111.538 170.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.459 ' HE ' ' NE2' ' A' ' 97' ' ' GLN . 42.0 ttp180 -91.05 98.82 12.0 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.397 0.679 . . . . 0.0 109.858 173.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -79.61 150.17 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.793 0.837 . . . . 0.0 111.628 176.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.459 ' NE2' ' HE ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.638 0 C-N-CA 125.848 1.659 . . . . 0.0 110.835 177.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 CA--C 1.534 0.354 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.25 144.23 29.72 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.999 1.319 . . . . 0.0 111.334 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -89.87 120.25 30.94 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.509 0.724 . . . . 0.0 109.607 169.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.5 pt -120.31 144.05 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.77 1.228 . . . . 0.0 111.053 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.44 142.71 16.17 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 124.151 0.881 . . . . 0.0 111.312 174.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.7 pt -129.33 143.09 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 125.506 1.522 . . . . 0.0 112.121 174.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.19 144.2 17.09 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.797 1.189 . . . . 0.0 113.491 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -107.08 158.7 16.86 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.084 1.754 . . . . 0.0 111.213 -178.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.8 t -72.21 -26.73 62.16 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.596 0.758 . . . . 0.0 112.796 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -157.23 151.64 25.17 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.441 1.096 . . . . 0.0 111.804 -176.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 43.2 ttm105 -61.32 -32.58 72.45 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.226 1.01 . . . . 0.0 113.197 177.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.94 -31.72 81.75 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 119.382 0.992 . . . . 0.0 113.464 176.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -85.89 -30.67 22.69 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 117.963 0.882 . . . . 0.0 112.395 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.43 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -65.92 -37.39 85.93 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 168.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -61.28 -36.46 80.12 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.105 -0.997 . . . . 0.0 110.91 170.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -71.17 -13.28 61.88 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 113.547 0.944 . . . . 0.0 113.547 175.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.42 ' CD2' HD11 ' A' ' 49' ' ' ILE . 15.5 t80 -77.97 -50.73 11.58 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.55 1.14 . . . . 0.0 111.568 165.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.11 -27.14 39.23 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -174.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 71.8 t -77.86 -43.02 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.129 -0.982 . . . . 0.0 111.159 177.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 92.1 p -65.58 -33.9 76.99 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.606 -0.684 . . . . 0.0 112.687 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 35.1 tp -72.58 -47.04 51.25 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.913 1.285 . . . . 0.0 111.591 176.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -69.75 -29.82 67.26 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.162 -0.961 . . . . 0.0 113.239 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -78.96 -4.02 47.85 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.215 1.006 . . . . 0.0 112.333 177.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -89.5 -21.89 22.72 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.299 -0.876 . . . . 0.0 113.143 162.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -99.28 -13.23 19.76 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -177.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 -172.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.3 m . . . . . 0 N--CA 1.473 0.695 0 N-CA-C 110.65 -0.13 . . . . 0.0 110.65 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.9 p -69.24 148.82 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.492 1.117 . . . . 0.0 112.908 -177.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.2 mt -135.58 -38.84 0.73 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.916 1.686 . . . . 0.0 112.305 -171.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.0 t -147.02 140.52 25.58 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.415 1.486 . . . . 0.0 109.753 174.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.4 t -131.85 132.07 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.374 1.07 . . . . 0.0 108.637 167.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.61 131.72 18.39 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 124.694 1.197 . . . . 0.0 111.341 177.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -81.04 -15.63 10.32 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.843 2.362 . . . . 0.0 115.302 -170.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -130.5 106.79 8.76 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.38 1.072 . . . . 0.0 110.82 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.8 p -143.81 142.38 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.032 1.333 . . . . 0.0 110.359 173.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.8 m -125.72 132.04 52.43 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.721 1.208 . . . . 0.0 111.137 -173.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 79.4 t -97.43 130.68 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.497 1.119 . . . . 0.0 111.225 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -131.78 117.02 18.01 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.99 1.316 . . . . 0.0 108.295 168.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.3 mtt-85 -71.63 128.85 37.14 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.87 -0.519 . . . . 0.0 109.73 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 39.3 pt . . . . . 0 CA--C 1.543 0.674 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -163.161 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 . . . . . 0 CA--C 1.533 0.324 0 N-CA-C 110.606 -0.146 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.67 21.36 7.73 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -173.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 56.9 -49.91 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.29 2.636 . . . . 0.0 115.399 -171.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.7 m -64.71 -14.64 59.36 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.26 1.824 . . . . 0.0 114.558 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -84.18 -7.84 59.24 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.774 1.23 . . . . 0.0 113.039 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.2 m0 -93.7 169.4 10.35 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.73 1.612 . . . . 0.0 111.151 176.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -76.56 51.89 0.76 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.194 1.798 . . . . 0.0 114.185 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.5 mt -55.58 -28.54 55.64 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.205 1.402 . . . . 0.0 114.487 -177.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -88.37 -7.42 56.68 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.428 0.691 . . . . 0.0 112.547 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -152.38 66.52 6.47 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.965 1.306 . . . . 0.0 111.887 -168.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -58.27 145.29 93.86 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.397 2.731 . . . . 0.0 112.856 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -72.56 -28.8 63.04 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.544 1.138 . . . . 0.0 111.657 174.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 42.1 t90 -158.11 152.14 24.08 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.431 1.892 . . . . 0.0 110.234 177.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.8 p -134.11 150.63 51.16 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.882 0.873 . . . . 0.0 111.862 169.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.38 -139.15 4.19 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 123.233 0.444 . . . . 0.0 113.325 -177.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.1 mtm105 -115.82 150.36 37.08 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.709 2.004 . . . . 0.0 112.001 -173.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.5 tp -94.61 138.33 32.61 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.227 1.811 . . . . 0.0 110.207 171.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.5 ttm-85 -135.74 111.1 9.08 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.825 1.25 . . . . 0.0 109.808 160.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.516 HD11 ' CD2' ' A' ' 119' ' ' PHE . 24.9 mt -91.32 131.3 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 168.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.25 170.36 16.1 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 127.396 2.279 . . . . 0.0 110.13 -173.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.6 t -158.54 149.47 20.47 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 120.409 -1.432 . . . . 0.0 111.792 176.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -151.42 129.14 11.55 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.631 0.772 . . . . 0.0 112.663 158.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.88 45.88 55.41 Favored Glycine 0 N--CA 1.473 1.162 0 C-N-CA 124.432 1.015 . . . . 0.0 114.956 164.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt 62.99 26.24 15.42 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.294 1.838 . . . . 0.0 113.269 -174.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.4 m -131.03 114.11 14.79 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.112 1.365 . . . . 0.0 108.72 168.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -83.99 159.23 21.27 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.507 0.723 . . . . 0.0 110.464 172.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -136.08 115.7 12.89 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 125.956 1.702 . . . . 0.0 108.693 -175.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.7 mp -92.29 99.48 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 168.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -99.83 139.7 35.12 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.876 0.846 . . . . 0.0 112.207 175.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.8 mp -110.68 132.94 53.76 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.091 1.756 . . . . 0.0 109.92 176.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -134.77 151.02 50.64 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.017 0.927 . . . . 0.0 113.04 -171.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -73.14 144.11 47.04 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.924 0.869 . . . . 0.0 112.112 -178.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.1 pttt -84.22 -6.56 59.41 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.209 1.804 . . . . 0.0 115.144 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 95.7 t -122.73 -44.17 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.206 1.402 . . . . 0.0 111.447 178.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.0 m -94.08 -21.8 18.9 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -175.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.01 5.92 85.4 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.182 0.896 . . . . 0.0 113.861 -177.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -82.02 153.88 25.96 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.276 1.431 . . . . 0.0 112.752 -173.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.5 tp -73.52 126.08 29.41 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.993 0.917 . . . . 0.0 111.107 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -86.18 -55.78 3.76 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.437 1.095 . . . . 0.0 111.121 170.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.85 164.01 38.55 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.755 1.222 . . . . 0.0 111.838 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -140.83 136.4 32.36 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.831 1.252 . . . . 0.0 111.816 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.4 107.69 36.58 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 124.778 1.231 . . . . 0.0 111.633 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -76.42 136.55 17.72 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.563 2.842 . . . . 0.0 111.925 173.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.1 t -127.71 119.53 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 127.093 2.157 . . . . 0.0 108.761 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -88.27 -17.69 30.18 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.48 151.33 16.9 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.18 1.792 . . . . 0.0 109.939 172.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -116.28 130.91 24.1 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 123.597 0.759 . . . . 0.0 113.014 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.63 151.37 74.54 Favored 'Cis proline' 0 CA--C 1.542 0.886 0 CA-C-N 119.247 0.767 . . . . 0.0 112.694 -13.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -132.16 -163.1 10.61 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.099 1.333 . . . . 0.0 113.361 176.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.6 tt -79.77 -34.6 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.538 0.735 . . . . 0.0 112.263 171.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.04 11.72 3.88 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.484 1.114 . . . . 0.0 113.63 -172.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.7 p -156.4 141.85 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 126.369 1.868 . . . . 0.0 110.815 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -159.3 161.26 35.85 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.489 1.116 . . . . 0.0 113.552 -175.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.2 p -110.76 159.54 17.54 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 127.114 2.165 . . . . 0.0 111.719 174.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.9 m -85.02 176.52 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.659 1.183 . . . . 0.0 111.255 166.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 73.4 p -92.28 -33.71 14.53 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.761 1.224 . . . . 0.0 113.47 177.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -92.45 -41.31 10.37 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -162.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.2 t -141.41 132.92 26.9 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -176.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.8 m -64.45 -12.14 40.57 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -172.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.439 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.289 31.3 ptt180 -89.0 14.56 10.3 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -174.743 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -135.72 136.48 40.86 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.472 1.109 . . . . 0.0 111.87 -173.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -138.04 161.07 37.68 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.113 1.365 . . . . 0.0 111.655 -178.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.2 t -114.67 143.2 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.499 1.12 . . . . 0.0 108.951 166.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.29 150.37 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 118.468 0.576 . . . . 0.0 111.625 169.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -93.06 89.72 6.61 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.012 0.925 . . . . 0.0 110.398 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -71.09 137.78 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 120.712 0.291 . . . . 0.0 110.956 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 . . . . . 0 N--CA 1.47 0.528 0 C-N-CA 126.066 1.746 . . . . 0.0 110.924 -168.283 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 89.6 p . . . . . 0 CA--C 1.535 0.379 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.11 140.97 25.83 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.338 1.455 . . . . 0.0 111.005 168.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -90.01 119.61 30.51 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.294 0.638 . . . . 0.0 109.837 171.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.4 pt -117.8 145.41 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.594 1.158 . . . . 0.0 110.955 177.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.68 140.02 14.82 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 173.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.6 pt -125.12 141.75 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 124.879 1.272 . . . . 0.0 111.665 173.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -125.13 141.88 13.4 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.265 1.412 . . . . 0.0 112.572 174.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -101.96 170.97 7.79 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.165 1.786 . . . . 0.0 111.417 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.7 t -70.04 -37.56 75.59 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.349 0.66 . . . . 0.0 112.277 175.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -152.99 154.35 34.78 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.073 -1.017 . . . . 0.0 112.765 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -58.14 -38.87 77.38 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.349 1.46 . . . . 0.0 112.131 176.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.05 -14.05 73.26 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.014 0.816 . . . . 0.0 114.06 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -97.26 -36.94 10.26 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 118.191 0.995 . . . . 0.0 111.69 172.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.439 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -64.91 -30.73 71.74 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.293 1.037 . . . . 0.0 113.668 170.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.13 -29.05 60.17 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.439 1.018 . . . . 0.0 112.974 175.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -69.66 -27.19 64.83 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.316 -0.865 . . . . 0.0 112.954 176.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.516 ' CD2' HD11 ' A' ' 49' ' ' ILE . 32.7 t80 -62.77 -52.59 62.59 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.429 1.092 . . . . 0.0 111.356 173.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -80.61 -24.33 39.15 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -175.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.7 t -78.87 -42.56 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 119.062 0.846 . . . . 0.0 111.542 174.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 93.8 p -65.62 -31.3 72.26 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.434 1.015 . . . . 0.0 113.337 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.5 mt -69.38 -54.13 15.99 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.77 0.828 . . . . 0.0 111.435 172.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -65.61 -31.37 72.36 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.408 -0.808 . . . . 0.0 112.763 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -81.11 -4.37 55.08 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.339 1.056 . . . . 0.0 112.727 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -95.84 -15.86 22.21 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 164.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -106.52 -6.18 18.28 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.301 0 CA-C-N 121.397 1.908 . . . . 0.0 115.577 -175.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.471 0.596 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.445 ' HA ' HG22 ' A' ' 50' ' ' THR . 41.6 t -64.39 145.13 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 125.753 1.621 . . . . 0.0 112.386 -177.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.4 mt -130.79 -41.24 1.17 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.814 1.646 . . . . 0.0 112.223 -173.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 36.8 t -148.65 137.68 21.62 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.75 1.22 . . . . 0.0 110.717 174.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 81.8 t -130.21 127.79 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.912 1.285 . . . . 0.0 109.511 172.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -125.96 132.4 24.3 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 125.362 1.465 . . . . 0.0 110.096 173.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.52 -10.88 14.5 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.36 2.706 . . . . 0.0 115.495 -170.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -136.74 111.79 8.97 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.92 0.867 . . . . 0.0 112.192 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -143.9 144.02 23.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 125.437 1.495 . . . . 0.0 110.144 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.9 m -125.86 128.18 47.22 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.227 1.011 . . . . 0.0 111.492 -170.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.8 t -92.87 136.21 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.374 1.47 . . . . 0.0 112.006 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -129.85 128.36 42.11 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.962 1.305 . . . . 0.0 109.281 169.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 17.7 mmm-85 -76.02 112.55 12.57 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.003 0.921 . . . . 0.0 108.867 172.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.5 pt . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -162.541 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 . . . . . 0 CA--C 1.532 0.285 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.78 19.39 6.11 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -172.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 56.68 -47.07 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 128.127 2.571 . . . . 0.0 115.893 -173.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.4 m -64.71 -18.41 64.98 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.062 1.745 . . . . 0.0 114.576 -177.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -85.3 -5.82 59.29 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 173.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.0 m0 -89.09 172.01 9.41 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.039 1.336 . . . . 0.0 110.743 174.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -79.72 52.86 1.51 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.187 1.395 . . . . 0.0 114.279 -176.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 mt -59.83 -18.56 44.85 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 -172.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -105.43 -6.08 19.8 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.771 1.229 . . . . 0.0 113.168 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -148.97 67.74 9.32 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.863 1.265 . . . . 0.0 112.055 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -54.66 145.52 59.26 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.554 2.836 . . . . 0.0 113.02 177.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -70.7 -29.34 65.61 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.424 1.089 . . . . 0.0 111.661 175.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 40.8 t90 -156.96 154.12 29.16 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.615 1.566 . . . . 0.0 110.946 173.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.3 p -135.69 150.42 49.57 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.238 1.015 . . . . 0.0 112.331 171.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.18 -142.1 5.14 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.239 0.447 . . . . 0.0 114.006 -176.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.5 mtm180 -111.23 152.0 27.63 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 127.066 2.146 . . . . 0.0 111.919 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.4 tp -90.31 139.6 30.5 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.075 1.75 . . . . 0.0 110.184 165.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -140.07 98.83 3.53 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.053 1.341 . . . . 0.0 110.249 163.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.2 mt -80.03 130.4 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 170.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.445 HG22 ' HA ' ' A' ' 10' ' ' VAL . 5.4 p -137.5 159.35 42.2 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.592 1.957 . . . . 0.0 110.06 -177.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.2 t -156.26 133.89 10.95 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.474 -1.391 . . . . 0.0 113.411 173.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -146.15 128.58 15.94 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.159 1.784 . . . . 0.0 110.587 177.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.75 36.88 52.45 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.438 1.018 . . . . 0.0 114.963 169.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? 61.95 27.92 16.96 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.467 1.907 . . . . 0.0 113.477 -170.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.0 m -132.23 117.82 18.71 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.195 1.398 . . . . 0.0 109.132 172.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.32 157.5 19.89 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.746 0.818 . . . . 0.0 110.856 172.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -138.3 116.67 11.95 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.6 1.56 . . . . 0.0 108.928 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mp -86.1 93.45 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 168.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -88.02 139.43 30.52 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.502 0.721 . . . . 0.0 111.265 174.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.0 mp -113.69 132.87 55.64 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.442 1.897 . . . . 0.0 110.63 176.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -129.06 147.88 50.96 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -171.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.94 128.21 34.83 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 121.18 -0.95 . . . . 0.0 109.539 171.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -75.44 -9.01 58.19 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -172.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.5 t -112.28 -36.95 2.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 124.239 1.016 . . . . 0.0 110.807 -171.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.1 m -110.47 -15.44 13.91 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.66 19.77 79.77 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 118.882 0.764 . . . . 0.0 113.708 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -63.51 158.94 19.68 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.647 1.179 . . . . 0.0 111.442 173.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.8 tp -95.11 119.59 33.88 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.832 0.853 . . . . 0.0 109.279 167.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -84.31 -55.44 4.17 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.611 0.764 . . . . 0.0 111.28 175.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.4 165.91 35.16 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.724 1.21 . . . . 0.0 111.533 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -144.63 135.32 24.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.737 1.215 . . . . 0.0 111.036 175.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.71 97.17 48.34 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.169 0.988 . . . . 0.0 111.943 175.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.78 137.26 80.25 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 124.367 3.378 . . . . 0.0 113.121 165.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.8 t -139.14 129.03 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 126.414 1.886 . . . . 0.0 109.739 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -90.19 -23.07 21.39 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.44 152.19 16.09 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.82 1.648 . . . . 0.0 111.078 174.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -130.85 135.51 27.46 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 124.876 1.27 . . . . 0.0 112.003 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -61.7 145.0 45.39 Favored 'Cis proline' 0 CA--C 1.539 0.747 0 CA-C-N 119.889 0.996 . . . . 0.0 113.19 -9.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -157.29 -155.71 7.6 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.736 1.16 . . . . 0.0 114.0 -174.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.59 -38.94 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.464 1.106 . . . . 0.0 113.692 -174.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.37 9.29 15.91 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -173.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.6 t -149.33 133.18 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.819 1.648 . . . . 0.0 109.922 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.55 163.99 34.0 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.248 1.819 . . . . 0.0 112.555 -174.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 62.2 p -116.84 162.27 17.98 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.166 1.787 . . . . 0.0 111.822 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.7 m -89.75 175.46 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.296 1.038 . . . . 0.0 111.057 165.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 71.5 p -95.96 -30.9 13.35 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.218 1.407 . . . . 0.0 113.441 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -90.18 -43.78 10.2 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -167.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.3 t -143.37 127.67 17.73 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -176.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.43 -3.28 7.97 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -173.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.478 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.278 23.4 ptt180 -84.7 14.89 4.23 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 177.761 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -139.25 134.06 32.14 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.744 1.218 . . . . 0.0 111.119 -174.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -136.11 161.46 35.64 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.257 1.423 . . . . 0.0 111.168 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 75.9 t -116.21 143.89 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.577 1.151 . . . . 0.0 108.937 167.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.86 148.51 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 119.123 0.874 . . . . 0.0 112.261 173.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -87.65 88.76 7.76 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.414 0.686 . . . . 0.0 110.259 173.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.25 141.6 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 O-C-N 121.99 -0.444 . . . . 0.0 110.841 174.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 . . . . . 0 N--CA 1.47 0.569 0 C-N-CA 125.425 1.49 . . . . 0.0 111.597 -175.58 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.0 p . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -148.08 150.51 34.02 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.32 1.448 . . . . 0.0 111.523 172.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -92.94 118.7 31.44 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.251 0.62 . . . . 0.0 109.787 168.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.8 pt -120.11 145.84 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.668 1.187 . . . . 0.0 111.063 178.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.44 144.32 17.11 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 173.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.1 pt -128.1 140.62 48.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.719 1.608 . . . . 0.0 111.452 172.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.83 143.06 14.69 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.857 1.694 . . . . 0.0 112.787 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -104.98 161.75 13.94 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.11 1.364 . . . . 0.0 112.466 -174.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.7 t -69.86 -28.1 65.39 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.245 1.018 . . . . 0.0 112.699 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -156.85 151.02 25.06 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.27 1.028 . . . . 0.0 111.828 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -62.43 -34.66 77.21 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.281 1.032 . . . . 0.0 113.118 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.35 -26.16 74.82 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 123.864 0.745 . . . . 0.0 113.733 175.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -84.91 -32.73 22.98 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.039 0.936 . . . . 0.0 111.632 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.478 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -67.61 -32.11 72.61 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 168.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.04 -31.54 67.13 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.377 -0.827 . . . . 0.0 112.569 173.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -68.3 -27.39 66.26 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.315 -0.865 . . . . 0.0 112.992 174.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -63.87 -55.17 24.78 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.816 1.189 . . . . 0.0 111.739 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -75.13 -24.87 58.08 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.5 t -75.94 -40.81 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 121.414 -0.804 . . . . 0.0 111.093 173.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.5 t -59.04 -39.67 82.72 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.061 0.846 . . . . 0.0 112.662 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.6 mt -67.94 -54.43 18.72 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.408 0.683 . . . . 0.0 111.92 175.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -67.15 -32.21 73.16 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.3 -0.875 . . . . 0.0 113.02 -174.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -84.82 -0.63 54.56 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.379 1.072 . . . . 0.0 112.708 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -92.81 -37.97 12.02 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.438 -0.789 . . . . 0.0 112.287 159.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -85.39 -7.15 59.1 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -175.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -172.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.245 0 N-CA-C 110.596 -0.15 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.4 t -75.31 145.67 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.031 0.932 . . . . 0.0 111.231 -169.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.8 mt -131.45 -39.79 1.13 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.624 1.569 . . . . 0.0 111.856 -171.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.5 t -148.57 141.72 24.99 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.058 1.343 . . . . 0.0 110.393 176.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.7 t -136.37 127.32 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.984 1.314 . . . . 0.0 108.882 169.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -131.8 138.53 32.74 Favored Pre-proline 0 N--CA 1.48 1.062 0 C-N-CA 125.135 1.374 . . . . 0.0 111.072 177.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -81.23 -17.1 9.31 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 123.242 2.628 . . . . 0.0 115.67 -170.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -132.81 107.55 8.42 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.988 0.915 . . . . 0.0 111.345 -173.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.4 p -143.75 142.95 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.488 1.515 . . . . 0.0 110.331 173.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.8 m -126.32 128.0 46.42 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.456 1.102 . . . . 0.0 111.518 -171.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.2 t -93.99 137.13 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.128 1.371 . . . . 0.0 112.091 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -129.88 125.22 35.09 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.037 1.335 . . . . 0.0 108.98 168.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.9 mmt85 -70.58 109.18 4.71 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.524 -0.735 . . . . 0.0 109.617 169.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.1 pt . . . . . 0 CA--C 1.544 0.738 0 C-N-CA 125.019 1.328 . . . . 0.0 113.292 -171.383 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 . . . . . 0 CA--C 1.533 0.289 0 CA-C-O 120.366 0.126 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.66 18.97 5.69 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -172.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.53 -50.01 0.05 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.968 2.507 . . . . 0.0 115.411 -174.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.2 m -65.97 -14.9 62.42 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.247 1.819 . . . . 0.0 114.359 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.25 -15.54 58.67 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.84 0.856 . . . . 0.0 112.813 172.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -89.66 172.51 8.89 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.442 1.497 . . . . 0.0 111.424 -178.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -81.11 54.86 2.34 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.438 1.495 . . . . 0.0 114.059 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.9 mt -60.3 -17.41 42.51 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -172.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -105.96 -3.89 21.21 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.558 1.143 . . . . 0.0 113.078 177.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -147.81 72.03 11.45 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.068 1.347 . . . . 0.0 111.949 176.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -56.77 143.92 88.86 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 123.147 2.564 . . . . 0.0 112.43 173.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -71.04 -29.09 64.9 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.682 1.193 . . . . 0.0 111.766 175.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 37.9 t90 -156.95 153.17 27.66 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.675 1.59 . . . . 0.0 110.52 174.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.7 p -134.57 150.14 50.69 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.673 0.789 . . . . 0.0 112.043 169.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.18 -141.07 4.92 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 123.336 0.493 . . . . 0.0 113.422 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.7 mtm105 -113.51 149.92 33.67 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.712 2.005 . . . . 0.0 112.168 -173.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.5 tp -90.28 141.57 28.59 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.751 1.62 . . . . 0.0 110.629 169.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.6 ttm-85 -132.66 130.94 40.79 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.214 1.406 . . . . 0.0 109.719 156.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.5 HD11 ' CD1' ' A' ' 119' ' ' PHE . 26.4 mt -107.9 132.56 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 164.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.14 156.06 44.71 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 127.523 2.329 . . . . 0.0 108.72 -166.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.6 t -163.9 152.24 13.23 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.107 -1.621 . . . . 0.0 110.819 178.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -127.39 -46.6 1.47 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 -174.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.1 86.04 0.1 OUTLIER Glycine 0 N--CA 1.472 1.065 0 C-N-CA 123.606 0.622 . . . . 0.0 111.722 -175.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 94.1 mttt 55.53 23.47 6.0 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.141 1.776 . . . . 0.0 112.826 -171.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.9 m -141.74 121.04 13.09 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.836 1.254 . . . . 0.0 108.237 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.87 160.13 14.54 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.628 1.171 . . . . 0.0 111.053 174.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -139.2 113.19 8.64 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 127.076 2.15 . . . . 0.0 108.839 -176.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.3 mp -88.62 109.04 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 167.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -108.44 134.75 50.8 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.748 1.219 . . . . 0.0 111.588 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.6 mp -105.31 132.4 51.56 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 125.435 1.494 . . . . 0.0 110.089 176.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -134.9 151.6 51.02 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.946 0.899 . . . . 0.0 112.98 -170.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -74.12 143.91 45.14 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.282 -0.886 . . . . 0.0 112.071 -178.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.4 pttt -84.41 -6.61 59.4 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.296 1.838 . . . . 0.0 115.067 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.1 t -122.7 -44.18 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.341 1.456 . . . . 0.0 111.543 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.6 m -93.93 -22.37 18.63 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -174.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.3 6.08 86.05 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.14 0.876 . . . . 0.0 113.803 -177.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -81.8 154.59 25.86 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.31 1.444 . . . . 0.0 112.623 -174.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.5 tp -75.05 125.46 28.96 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.94 0.896 . . . . 0.0 111.147 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -85.23 -54.19 4.76 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.286 1.035 . . . . 0.0 111.156 170.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.52 162.89 38.86 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.595 1.158 . . . . 0.0 112.098 -178.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -140.68 133.86 29.53 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.831 1.252 . . . . 0.0 111.905 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.17 104.29 43.78 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.362 1.465 . . . . 0.0 111.159 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.96 144.52 30.49 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.833 3.022 . . . . 0.0 112.141 173.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.8 t -139.78 125.41 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 126.327 1.851 . . . . 0.0 109.554 -172.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -91.01 -23.4 20.39 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.13 149.15 15.65 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.268 1.827 . . . . 0.0 110.344 172.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -118.0 129.69 25.2 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.639 1.176 . . . . 0.0 111.153 175.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.85 149.41 80.32 Favored 'Cis proline' 0 CA--C 1.542 0.891 0 CA-C-N 119.715 0.934 . . . . 0.0 112.737 -6.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -151.57 -162.42 10.75 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.827 1.679 . . . . 0.0 112.293 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 19.6 tt -76.43 -35.15 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 121.688 -0.889 . . . . 0.0 112.837 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.47 7.23 17.58 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -168.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.1 t -150.97 130.51 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.856 1.662 . . . . 0.0 109.736 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -141.09 158.95 43.22 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.641 1.977 . . . . 0.0 112.317 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 47.4 p -107.05 160.89 15.21 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.751 2.02 . . . . 0.0 111.356 175.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 m -86.81 172.28 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.149 0.98 . . . . 0.0 110.949 163.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 58.8 p -95.07 -30.0 14.3 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.011 1.325 . . . . 0.0 113.608 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -90.11 -50.25 6.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.889 0.876 . . . . 0.0 113.229 -167.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.9 m -136.35 116.91 13.84 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.352 0.661 . . . . 0.0 112.724 -169.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.26 -8.68 18.9 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -168.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.462 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.322 43.2 ptt85 -84.12 21.31 1.39 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 178.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -140.3 137.45 34.18 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.896 1.278 . . . . 0.0 111.496 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -138.88 163.35 32.53 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.176 1.39 . . . . 0.0 111.032 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 55.9 t -118.21 142.44 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 124.546 1.139 . . . . 0.0 108.914 167.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.73 148.62 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 118.527 0.603 . . . . 0.0 111.975 173.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -90.66 87.54 6.75 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.57 0.748 . . . . 0.0 111.007 178.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -70.83 139.48 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 122.574 0.35 . . . . 0.0 111.044 176.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 . . . . . 0 N--CA 1.471 0.612 0 C-N-CA 126.251 1.82 . . . . 0.0 111.044 -169.192 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 56.8 p . . . . . 0 N--CA 1.466 0.362 0 N-CA-C 115.046 1.498 . . . . 0.0 115.046 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.46 145.05 31.67 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.668 1.587 . . . . 0.0 110.495 165.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -91.1 119.85 31.58 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 167.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.8 pt -118.28 144.56 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.447 1.099 . . . . 0.0 110.93 178.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.63 142.95 16.3 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 174.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.9 pt -128.46 139.29 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 125.456 1.502 . . . . 0.0 111.725 173.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -118.85 139.78 14.68 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.93 1.729 . . . . 0.0 112.518 176.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -102.47 155.79 18.03 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.524 1.53 . . . . 0.0 112.222 -176.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.1 t -71.3 -23.56 61.98 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.351 1.061 . . . . 0.0 112.839 177.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -154.18 147.04 24.38 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.157 0.983 . . . . 0.0 112.212 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -64.42 -35.11 79.84 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.428 1.091 . . . . 0.0 113.273 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.36 -30.42 76.6 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-N 118.851 0.75 . . . . 0.0 113.165 176.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -82.5 -31.76 29.11 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.877 -0.778 . . . . 0.0 112.248 177.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.462 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -64.93 -38.58 91.43 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 166.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -61.35 -38.27 86.34 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.132 -0.98 . . . . 0.0 111.279 168.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -67.43 -36.31 80.98 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 119.093 0.861 . . . . 0.0 112.856 177.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.5 ' CD1' HD11 ' A' ' 49' ' ' ILE . 13.2 t80 -54.65 -51.39 65.6 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.74 1.216 . . . . 0.0 111.735 167.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -68.52 -42.55 78.37 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.611 0.764 . . . . 0.0 112.496 -177.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.8 t -65.84 -37.76 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 O-C-N 121.615 -0.678 . . . . 0.0 110.884 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 55.7 m -65.9 -14.42 61.49 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 176.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.6 mt -91.75 -54.13 4.0 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.008 0.923 . . . . 0.0 111.342 168.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -69.33 -32.92 72.33 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.952 -1.093 . . . . 0.0 113.669 -172.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -87.27 7.0 30.51 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.397 1.079 . . . . 0.0 112.423 174.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -102.77 -34.0 9.18 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.049 0.94 . . . . 0.0 112.631 165.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -89.5 -4.11 58.07 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.282 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -175.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.8 m . . . . . 0 CA--C 1.539 0.558 0 CA-C-O 120.944 0.402 . . . . 0.0 111.295 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.97 144.05 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.761 1.224 . . . . 0.0 111.964 -174.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 78.8 mt -126.05 -43.94 1.79 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.786 1.634 . . . . 0.0 112.308 -175.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 46.5 t -153.77 136.03 14.88 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.519 1.128 . . . . 0.0 110.939 175.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.9 t -127.28 125.83 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.588 1.155 . . . . 0.0 109.47 172.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -129.08 133.61 25.39 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 125.367 1.467 . . . . 0.0 110.579 176.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.83 -12.02 15.01 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.22 2.613 . . . . 0.0 115.331 -172.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -129.74 106.38 8.67 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.273 1.029 . . . . 0.0 110.854 -177.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.1 p -141.66 142.01 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.782 1.233 . . . . 0.0 110.52 170.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.4 m -124.37 130.32 52.28 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.443 1.097 . . . . 0.0 110.751 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 77.1 t -94.18 136.47 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.749 1.22 . . . . 0.0 111.355 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.09 125.75 33.97 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.48 1.112 . . . . 0.0 109.436 168.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.7 mtt85 -62.39 131.3 48.8 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.347 0.659 . . . . 0.0 109.371 163.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.6 pt . . . . . 0 N--CA 1.474 0.761 0 C-N-CA 124.239 1.016 . . . . 0.0 112.533 -171.131 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.7 m-30 . . . . . 0 C--O 1.224 -0.285 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.54 18.25 8.12 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -172.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.31 -49.35 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 128.094 2.557 . . . . 0.0 115.565 -173.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.5 m -66.65 -15.93 63.83 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.887 1.675 . . . . 0.0 114.646 -176.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.01 -7.91 59.28 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 171.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.7 m0 -88.1 171.61 10.13 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.006 1.322 . . . . 0.0 110.769 176.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -79.6 54.34 1.76 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.214 1.406 . . . . 0.0 114.068 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.5 mt -60.75 -16.59 41.75 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -173.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -105.3 -4.59 21.41 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.565 1.146 . . . . 0.0 112.958 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -148.42 81.34 8.01 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 124.539 1.136 . . . . 0.0 112.015 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.3 145.35 67.19 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.395 2.73 . . . . 0.0 112.89 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -71.86 -29.62 64.57 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.822 0.849 . . . . 0.0 111.267 168.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 41.1 t90 -159.6 155.05 25.57 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.996 1.718 . . . . 0.0 110.929 175.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.3 p -133.76 142.54 47.96 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.717 1.207 . . . . 0.0 111.961 171.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.31 -148.39 6.54 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 123.419 0.533 . . . . 0.0 114.195 -177.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -110.76 144.64 39.43 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.737 1.615 . . . . 0.0 110.849 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.1 tp -82.53 136.43 34.86 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.13 1.372 . . . . 0.0 109.369 168.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.6 ttt-85 -142.09 88.07 2.08 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.579 1.152 . . . . 0.0 109.952 166.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.493 HD11 ' CD2' ' A' ' 119' ' ' PHE . 12.7 mt -70.22 122.11 21.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 169.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.01 -179.88 4.29 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 127.82 2.448 . . . . 0.0 109.542 177.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.457 ' HB2' ' CE1' ' A' ' 126' ' ' HIS . 80.3 p -161.27 171.2 18.79 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.858 2.063 . . . . 0.0 108.491 177.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -140.0 -107.64 0.16 Allowed 'General case' 0 CA--C 1.54 0.59 0 O-C-N 122.004 -0.435 . . . . 0.0 109.929 166.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.62 106.13 3.21 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.051 1.31 . . . . 0.0 112.603 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 51.48 28.69 4.7 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 126.768 2.027 . . . . 0.0 113.917 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.8 m -148.1 131.07 16.21 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.17 1.788 . . . . 0.0 108.582 -172.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.69 159.5 15.12 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.084 1.353 . . . . 0.0 110.917 171.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -138.33 111.83 8.15 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.532 1.533 . . . . 0.0 109.785 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.2 mp -81.97 98.39 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 170.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -100.15 139.87 35.2 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.621 0.724 . . . . 0.0 111.831 175.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mp -113.82 127.96 56.22 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 126.487 1.915 . . . . 0.0 109.771 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -134.06 146.68 50.55 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.96 0.904 . . . . 0.0 112.114 -170.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -66.47 143.41 57.11 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 120.918 -1.114 . . . . 0.0 112.442 -177.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.596 ' H ' ' HD3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -81.81 -3.63 54.43 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 -173.753 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.0 t -115.91 -42.46 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.95 1.3 . . . . 0.0 111.403 173.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.3 m -116.13 -6.26 11.9 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -169.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.26 16.83 78.65 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 123.864 0.745 . . . . 0.0 114.171 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -66.73 126.75 29.98 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.531 1.533 . . . . 0.0 111.199 -175.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 57.4 tp -68.16 110.07 3.83 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.538 0.608 . . . . 0.0 110.424 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -79.29 -52.05 8.63 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.536 1.135 . . . . 0.0 111.042 176.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.27 162.06 37.77 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.437 1.095 . . . . 0.0 112.025 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -142.71 133.72 25.74 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.035 1.334 . . . . 0.0 111.551 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.24 101.93 48.99 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 124.742 1.217 . . . . 0.0 111.633 176.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -66.29 141.05 60.91 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 124.25 3.3 . . . . 0.0 112.788 171.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 t -137.14 123.79 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.763 1.625 . . . . 0.0 109.652 -177.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -89.05 -21.75 23.29 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -159.91 145.13 15.25 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.439 1.895 . . . . 0.0 110.291 169.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -116.97 130.12 24.83 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 124.664 1.186 . . . . 0.0 110.98 176.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.82 148.56 78.85 Favored 'Cis proline' 0 CA--C 1.542 0.915 0 CA-C-N 119.86 0.986 . . . . 0.0 112.968 -5.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.28 -168.2 24.88 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.95 1.262 . . . . 0.0 113.916 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.8 tp -63.69 -32.83 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -172.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.26 5.47 49.04 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -170.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.4 t -149.57 131.3 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.458 1.103 . . . . 0.0 110.892 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -140.64 158.85 43.37 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.711 1.604 . . . . 0.0 112.94 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 75.1 p -105.13 158.87 16.28 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.666 1.986 . . . . 0.0 110.941 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.4 m -84.12 176.03 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.762 0.825 . . . . 0.0 110.9 165.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 59.1 p -94.89 -31.98 13.44 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.598 1.559 . . . . 0.0 113.011 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -92.65 -43.77 8.92 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -167.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.7 t -142.81 120.16 11.61 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -173.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.25 -2.87 9.08 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -169.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.402 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.265 0.9 OUTLIER -87.47 22.3 2.24 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.677 1.591 . . . . 0.0 114.217 174.242 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -140.92 135.33 31.15 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.052 1.341 . . . . 0.0 111.254 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -135.76 161.3 35.96 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.206 1.402 . . . . 0.0 111.376 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 89.8 t -115.89 141.8 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.628 1.171 . . . . 0.0 108.675 166.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.52 147.56 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 118.754 0.707 . . . . 0.0 112.392 173.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -89.79 84.74 6.28 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.627 0.771 . . . . 0.0 111.074 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -68.92 139.51 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 122.627 0.371 . . . . 0.0 111.062 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 . . . . . 0 N--CA 1.468 0.441 0 C-N-CA 125.947 1.699 . . . . 0.0 111.604 -170.396 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.9 p . . . . . 0 CA--C 1.533 0.301 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.61 148.28 32.95 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.579 1.552 . . . . 0.0 111.106 169.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -93.41 118.54 31.43 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.466 0.707 . . . . 0.0 109.682 168.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 27.7 pt -118.06 144.2 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.493 1.117 . . . . 0.0 111.15 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -90.5 144.49 17.45 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.059 0.838 . . . . 0.0 111.013 174.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.8 pt -129.96 140.61 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 125.43 1.492 . . . . 0.0 111.667 172.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.26 142.95 16.37 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.66 1.6 . . . . 0.0 113.077 176.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -106.76 161.07 14.99 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.85 1.66 . . . . 0.0 111.855 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.9 t -73.09 -28.02 62.05 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.64 0.776 . . . . 0.0 112.857 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -155.88 151.86 27.61 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.312 1.045 . . . . 0.0 112.083 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 63.7 ttt-85 -62.8 -33.07 74.44 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.501 1.12 . . . . 0.0 113.397 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.64 -28.62 73.03 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-N 118.798 0.726 . . . . 0.0 113.525 175.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -83.71 -34.15 24.97 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.963 0.905 . . . . 0.0 111.812 175.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.402 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -65.51 -31.77 73.01 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 168.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.39 -35.64 74.32 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.349 -0.844 . . . . 0.0 112.611 173.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -67.0 -29.46 69.3 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.228 -0.92 . . . . 0.0 112.934 176.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.493 ' CD2' HD11 ' A' ' 49' ' ' ILE . 27.2 t80 -60.82 -50.24 74.24 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.304 0.956 . . . . 0.0 111.693 172.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -82.19 -25.1 34.56 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.8 t -77.38 -42.25 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.194 -0.941 . . . . 0.0 111.285 175.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 92.5 p -65.52 -31.57 72.7 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.354 0.979 . . . . 0.0 113.111 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 61.0 mt -68.51 -52.5 31.46 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.961 0.905 . . . . 0.0 112.006 172.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -67.47 -29.38 68.82 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.957 -1.089 . . . . 0.0 112.793 -177.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -81.31 -1.53 45.6 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.055 1.342 . . . . 0.0 112.571 174.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.457 ' CE1' ' HB2' ' A' ' 51' ' ' SER . 29.6 t-80 -91.29 -23.31 20.18 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 120.701 -1.249 . . . . 0.0 113.005 165.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -104.16 -4.37 23.22 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -176.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.203 0 CA-C-N 120.444 1.474 . . . . 0.0 114.52 -177.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.8 m . . . . . 0 CA--C 1.536 0.438 0 CA-C-O 120.995 0.426 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.44 142.17 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 125.367 1.467 . . . . 0.0 111.273 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.3 mt -127.41 -44.21 1.57 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.183 1.393 . . . . 0.0 111.813 -172.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 27.6 t -151.9 137.12 17.48 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.599 1.16 . . . . 0.0 111.013 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.7 t -130.84 121.82 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.774 1.23 . . . . 0.0 109.962 174.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -117.57 137.92 24.66 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 125.27 1.428 . . . . 0.0 110.192 172.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.93 -20.51 25.64 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.478 2.786 . . . . 0.0 114.418 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -135.9 113.27 10.68 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.953 0.901 . . . . 0.0 111.668 -169.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.0 p -149.56 146.38 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.737 1.615 . . . . 0.0 110.248 175.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.6 m -125.18 128.37 48.25 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.024 0.93 . . . . 0.0 111.381 -172.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.1 t -94.84 139.12 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.457 1.503 . . . . 0.0 112.067 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -127.63 123.82 36.53 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.109 1.364 . . . . 0.0 109.772 171.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -69.54 101.9 1.71 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.39 0.676 . . . . 0.0 109.198 166.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.2 pt . . . . . 0 CA--C 1.546 0.813 0 C-N-CA 124.109 0.963 . . . . 0.0 113.11 -172.164 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.7 20.6 15.14 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.52 -1.362 . . . . 0.0 114.347 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.15 -47.99 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.761 2.424 . . . . 0.0 115.092 -168.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.4 m -64.92 -16.09 62.86 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.496 1.918 . . . . 0.0 115.016 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -81.08 -10.01 59.74 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.715 0.806 . . . . 0.0 112.846 173.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 14.2 m0 -92.96 173.23 7.85 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.488 1.515 . . . . 0.0 111.147 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -79.5 53.39 1.55 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.33 1.452 . . . . 0.0 114.182 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.5 mt -61.3 -16.49 46.2 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.389 1.625 . . . . 0.0 115.389 -172.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -108.22 -3.58 18.35 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.45 1.1 . . . . 0.0 112.714 177.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -149.39 67.29 8.83 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.362 1.465 . . . . 0.0 111.48 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -53.26 141.03 60.98 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.163 2.575 . . . . 0.0 111.926 176.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -72.83 -27.51 61.99 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.453 0.701 . . . . 0.0 111.717 -177.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -151.92 152.66 32.83 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.214 1.805 . . . . 0.0 110.152 169.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.5 p -135.14 148.52 49.77 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.925 0.89 . . . . 0.0 111.646 169.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.64 -141.32 5.17 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 114.097 0.399 . . . . 0.0 114.097 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -107.06 145.64 32.13 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.01 2.124 . . . . 0.0 111.106 -174.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.8 tp -93.13 136.48 33.35 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.993 1.317 . . . . 0.0 109.458 169.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.3 ttp85 -137.76 103.51 5.03 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.594 0.758 . . . . 0.0 110.223 160.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.441 HD11 ' CD2' ' A' ' 119' ' ' PHE . 14.0 mt -77.7 118.76 25.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 166.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.55 178.12 4.58 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 127.93 2.492 . . . . 0.0 110.272 176.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 t -160.12 172.45 17.45 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 126.804 2.042 . . . . 0.0 107.763 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -143.66 -107.29 0.12 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.336 1.055 . . . . 0.0 109.01 167.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.19 97.5 2.0 Allowed Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.135 1.35 . . . . 0.0 112.564 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 52.86 28.5 6.55 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 126.603 1.961 . . . . 0.0 113.811 178.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.1 m -147.2 116.36 6.93 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 126.177 1.791 . . . . 0.0 108.396 -173.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.94 159.22 18.43 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.098 0.959 . . . . 0.0 110.823 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -136.12 117.08 14.24 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.206 1.402 . . . . 0.0 109.911 177.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.4 mp -87.15 100.48 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 168.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -98.64 137.0 37.92 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.793 0.806 . . . . 0.0 111.813 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -102.38 131.95 48.69 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.499 1.519 . . . . 0.0 109.636 168.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -136.44 152.27 50.4 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.784 0.834 . . . . 0.0 111.781 -173.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -73.03 142.01 47.66 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.865 -1.147 . . . . 0.0 112.667 -170.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -78.36 -6.13 54.24 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.194 1.797 . . . . 0.0 115.703 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 99.4 t -121.85 -44.63 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.101 1.36 . . . . 0.0 111.257 177.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.7 m -98.67 -19.99 17.21 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -174.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.77 10.3 80.02 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.513 1.054 . . . . 0.0 114.033 -176.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -82.71 154.24 24.93 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.243 1.417 . . . . 0.0 112.466 -175.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.2 tp -72.53 125.12 26.66 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.68 0.792 . . . . 0.0 111.918 -174.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -87.37 -55.22 3.9 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.118 0.967 . . . . 0.0 111.035 168.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.63 160.87 39.81 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.622 1.169 . . . . 0.0 112.027 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -141.47 131.12 24.06 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.797 1.239 . . . . 0.0 111.93 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.2 102.88 53.6 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 124.464 1.106 . . . . 0.0 111.534 175.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.77 139.93 25.53 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.963 3.109 . . . . 0.0 111.958 175.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.5 t -134.42 123.49 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 126.193 1.797 . . . . 0.0 109.548 -174.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -87.53 -23.02 24.52 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 121.366 -0.834 . . . . 0.0 113.158 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.12 144.3 15.96 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.409 1.883 . . . . 0.0 110.199 169.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -115.11 130.13 24.49 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.547 1.139 . . . . 0.0 110.918 176.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.94 148.05 78.12 Favored 'Cis proline' 0 CA--C 1.541 0.873 0 CA-C-N 119.827 0.974 . . . . 0.0 113.032 -5.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.85 -170.72 30.19 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.937 1.256 . . . . 0.0 113.822 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.3 tp -60.44 -31.05 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -170.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.4 4.33 53.65 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -171.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.5 t -149.33 130.37 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 119.456 1.025 . . . . 0.0 111.631 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -142.42 165.87 26.23 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.563 1.945 . . . . 0.0 112.364 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 56.1 p -116.9 160.17 21.29 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 127.087 2.155 . . . . 0.0 111.63 -176.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.7 m -84.16 172.58 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.034 0.934 . . . . 0.0 111.565 168.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.6 p -91.61 -33.59 15.05 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.313 1.445 . . . . 0.0 112.768 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -97.51 -40.66 8.55 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -162.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.5 t -139.2 122.59 17.16 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -175.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 p -74.5 30.19 0.08 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 -172.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.433 ' HA ' ' CB ' ' A' ' 116' ' ' ALA . 53.9 ptt85 -123.65 23.58 8.76 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.14 1.776 . . . . 0.0 114.298 171.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -140.52 138.76 34.81 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.905 1.282 . . . . 0.0 111.227 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -137.0 164.54 28.11 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.597 1.559 . . . . 0.0 111.108 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.2 t -122.1 139.67 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.737 1.215 . . . . 0.0 108.589 167.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.87 148.05 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 118.731 0.696 . . . . 0.0 112.415 176.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -89.34 85.68 6.64 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.475 0.71 . . . . 0.0 110.805 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.08 137.22 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 122.105 -0.372 . . . . 0.0 110.773 175.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 . . . . . 0 N--CA 1.468 0.473 0 C-N-CA 125.474 1.51 . . . . 0.0 111.738 -169.123 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 86.2 p . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.57 146.63 29.48 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.664 1.586 . . . . 0.0 111.057 168.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -92.12 121.4 33.63 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.058 0.543 . . . . 0.0 109.853 168.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.1 pt -120.92 144.57 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.675 1.19 . . . . 0.0 110.929 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -88.32 145.88 19.27 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 173.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.6 pt -128.05 141.63 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 125.274 1.43 . . . . 0.0 111.634 167.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.15 143.28 15.53 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.601 1.572 . . . . 0.0 112.931 175.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -108.65 157.41 18.54 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.51 1.924 . . . . 0.0 110.903 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.6 t -69.26 -27.7 65.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.918 0.887 . . . . 0.0 112.644 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -155.52 153.09 29.68 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.204 1.001 . . . . 0.0 112.029 -178.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.54 -35.03 75.02 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.589 1.156 . . . . 0.0 112.122 175.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.95 -14.73 68.42 Favored Glycine 0 CA--C 1.54 1.604 0 CA-C-O 119.384 -0.676 . . . . 0.0 114.364 176.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -97.1 -30.9 12.77 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.819 1.248 . . . . 0.0 111.886 171.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.433 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -72.98 -30.84 64.13 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 173.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -59.44 -32.1 69.91 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.35 -0.844 . . . . 0.0 112.064 172.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -64.77 -32.43 74.11 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.531 -0.731 . . . . 0.0 112.384 174.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.441 ' CD2' HD11 ' A' ' 49' ' ' ILE . 47.7 t80 -63.11 -56.35 17.58 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.213 1.005 . . . . 0.0 111.691 178.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -73.97 -24.48 59.63 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -177.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 68.4 t -78.29 -42.3 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 121.254 -0.904 . . . . 0.0 111.306 174.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.9 m -66.36 -30.78 71.25 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.137 0.88 . . . . 0.0 112.539 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.0 mt -67.37 -57.3 6.86 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.457 0.703 . . . . 0.0 111.867 170.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -64.74 -31.94 73.39 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.457 -0.777 . . . . 0.0 112.973 -173.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -80.73 -0.28 37.75 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.368 1.067 . . . . 0.0 112.666 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -101.78 -3.99 27.14 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 164.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -111.45 -10.8 14.16 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 175.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -176.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.824 0.345 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.8 t -70.54 144.42 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.705 0.802 . . . . 0.0 111.126 -171.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 44.9 mt -127.07 -42.83 1.7 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.715 1.606 . . . . 0.0 111.949 -174.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 32.7 t -149.26 139.22 22.02 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.59 1.156 . . . . 0.0 109.808 177.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.5 t -133.99 127.15 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.641 1.176 . . . . 0.0 109.116 170.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -131.0 134.37 25.88 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 125.004 1.322 . . . . 0.0 110.23 175.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.28 -18.51 16.02 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.878 2.385 . . . . 0.0 114.854 -172.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -132.69 111.79 11.46 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.452 1.101 . . . . 0.0 111.434 -173.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.0 p -146.61 144.63 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.847 1.659 . . . . 0.0 109.882 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.6 m -123.73 131.8 53.68 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.986 0.915 . . . . 0.0 111.549 -173.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 76.0 t -96.97 131.6 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.492 1.517 . . . . 0.0 111.594 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -128.82 126.9 40.85 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.936 1.295 . . . . 0.0 109.15 169.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -65.83 129.9 41.41 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.479 0.712 . . . . 0.0 109.546 170.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.6 pt . . . . . 0 N--CA 1.476 0.875 0 C-N-CA 124.333 1.053 . . . . 0.0 112.851 -171.095 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 . . . . . 0 C--O 1.221 -0.413 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.37 19.92 7.44 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -171.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.42 -48.29 0.05 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 127.76 2.424 . . . . 0.0 115.299 -172.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.6 m -66.44 -16.63 64.25 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.239 1.816 . . . . 0.0 114.813 -177.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -85.5 -2.53 58.23 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 172.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 24.7 m0 -92.3 169.16 10.8 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.059 1.344 . . . . 0.0 110.833 173.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.5 mttt -78.33 52.44 1.13 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.341 1.456 . . . . 0.0 114.136 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.9 mt -57.53 -28.43 63.49 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -175.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -91.36 -6.07 53.56 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -149.76 74.36 9.45 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 124.873 1.269 . . . . 0.0 111.917 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -56.69 143.39 89.79 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.913 2.408 . . . . 0.0 112.565 174.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -72.0 -28.43 63.4 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.739 1.216 . . . . 0.0 111.624 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 49.4 t90 -155.73 151.97 27.98 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.985 1.714 . . . . 0.0 110.523 174.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.6 p -134.9 149.63 50.31 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.006 0.922 . . . . 0.0 111.723 170.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.74 -142.24 6.01 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 114.135 0.414 . . . . 0.0 114.135 -178.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 47.0 mtt180 -105.16 144.46 31.91 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 127.233 2.213 . . . . 0.0 111.751 -173.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.5 tp -90.29 137.15 32.58 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.434 1.494 . . . . 0.0 110.324 166.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.0 ttm-85 -130.27 132.23 45.83 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.659 1.184 . . . . 0.0 109.56 156.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.565 HD11 ' CD1' ' A' ' 119' ' ' PHE . 17.7 mt -109.59 131.57 60.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 163.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.72 151.06 42.61 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 127.879 2.471 . . . . 0.0 108.23 -168.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.4 ' HB2' ' CE1' ' A' ' 126' ' ' HIS . 92.3 p -161.04 155.08 22.64 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 120.142 -1.598 . . . . 0.0 111.908 -169.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -132.56 -105.1 0.25 Allowed 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.066 -1.022 . . . . 0.0 112.378 -173.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.32 -125.53 0.28 Allowed Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.26 0.933 . . . . 0.0 111.252 168.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -77.13 34.11 0.15 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.962 1.305 . . . . 0.0 112.52 173.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.8 m -143.45 133.59 24.36 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.935 0.894 . . . . 0.0 110.671 -174.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -115.09 162.86 16.44 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.15 1.38 . . . . 0.0 111.052 169.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -144.13 107.95 4.69 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.612 1.965 . . . . 0.0 108.88 -170.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mp -86.34 108.29 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 169.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -109.01 128.96 55.41 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.732 1.213 . . . . 0.0 111.309 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.0 mp -101.62 131.11 48.02 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.871 1.268 . . . . 0.0 110.168 177.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -133.16 149.66 52.05 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.063 0.945 . . . . 0.0 112.602 -169.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -69.58 141.14 53.82 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.033 -1.042 . . . . 0.0 111.977 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.0 pttt -79.85 -4.7 53.32 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 -177.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 95.8 t -121.98 -43.84 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.171 1.389 . . . . 0.0 111.355 178.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.9 m -97.47 -20.27 17.87 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.19 11.32 79.31 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.443 1.021 . . . . 0.0 114.032 -176.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -83.59 151.19 25.48 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.192 1.397 . . . . 0.0 112.24 -175.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.3 tp -72.96 127.26 32.02 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.437 0.695 . . . . 0.0 111.66 -175.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -86.76 -55.41 3.87 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.704 1.202 . . . . 0.0 111.171 169.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.11 159.69 38.11 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.117 1.367 . . . . 0.0 111.307 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -139.35 137.57 35.86 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 174.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.32 106.5 48.82 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.601 1.56 . . . . 0.0 110.621 177.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.57 142.13 18.1 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.718 2.946 . . . . 0.0 111.107 173.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.9 t -135.58 129.91 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 126.352 1.861 . . . . 0.0 109.476 -170.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -97.68 -20.1 17.83 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.227 1.011 . . . . 0.0 113.061 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.91 147.39 11.49 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.449 2.3 . . . . 0.0 110.33 -177.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -135.12 125.11 16.83 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 124.064 0.946 . . . . 0.0 111.529 174.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -65.31 150.13 75.93 Favored 'Cis proline' 0 CA--C 1.541 0.849 0 CA-C-N 119.894 0.998 . . . . 0.0 113.122 -2.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -170.06 -158.86 14.62 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.037 1.304 . . . . 0.0 113.697 -175.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.4 tp -75.53 -39.79 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -172.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.54 5.6 41.94 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -168.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.4 t -150.8 130.91 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.684 1.593 . . . . 0.0 109.397 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.3 163.2 34.39 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.814 1.646 . . . . 0.0 112.735 -174.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 66.3 p -116.43 162.9 16.85 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.904 1.682 . . . . 0.0 111.659 -177.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.5 m -91.08 177.39 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 124.479 1.112 . . . . 0.0 110.726 166.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.8 p -98.81 -32.4 11.38 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.051 1.74 . . . . 0.0 113.045 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -88.68 -43.36 11.37 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -167.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.2 t -143.9 124.44 14.01 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -176.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.05 -1.4 7.48 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 -170.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.484 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.295 27.9 ptt180 -85.63 15.37 4.71 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 177.469 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -137.02 133.97 36.07 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.874 1.269 . . . . 0.0 110.855 -173.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -133.74 160.46 37.52 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.087 1.355 . . . . 0.0 111.512 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 78.8 t -112.25 143.92 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.328 1.051 . . . . 0.0 108.985 164.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.0 149.49 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 119.025 0.829 . . . . 0.0 112.049 169.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -91.72 82.88 5.24 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.783 0.833 . . . . 0.0 111.177 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -66.93 139.99 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 120.91 0.386 . . . . 0.0 111.065 176.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 . . . . . 0 N--CA 1.469 0.487 0 C-N-CA 125.778 1.631 . . . . 0.0 111.474 -169.314 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.1 p . . . . . 0 C--O 1.234 0.288 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.25 146.26 32.54 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.491 1.516 . . . . 0.0 110.832 167.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -90.95 120.31 31.85 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.074 0.55 . . . . 0.0 109.65 167.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.6 pt -117.9 143.22 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.404 1.082 . . . . 0.0 110.832 176.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -92.24 140.69 15.26 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 175.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.0 pt -126.64 141.35 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 125.285 1.434 . . . . 0.0 111.708 173.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.1 142.14 14.3 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.038 1.304 . . . . 0.0 113.144 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -104.37 162.42 13.24 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.626 1.57 . . . . 0.0 111.531 -177.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.1 t -72.64 -29.18 63.24 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.578 0.751 . . . . 0.0 112.486 176.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -153.04 147.63 26.11 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.184 0.994 . . . . 0.0 112.069 -174.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.6 ttt-85 -62.33 -32.82 73.64 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.348 1.059 . . . . 0.0 113.234 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.96 -28.32 73.45 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-N 119.025 0.829 . . . . 0.0 113.714 176.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -84.71 -32.51 23.49 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.015 0.907 . . . . 0.0 111.953 176.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.484 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -66.9 -34.37 77.62 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 166.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -60.57 -35.96 77.33 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.251 -0.906 . . . . 0.0 111.677 168.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -62.47 -37.59 86.53 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 119.247 0.93 . . . . 0.0 111.88 175.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.565 ' CD1' HD11 ' A' ' 49' ' ' ILE . 17.6 t80 -58.73 -56.54 20.87 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.448 1.099 . . . . 0.0 112.017 171.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.03 -26.13 53.35 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -174.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.2 t -77.24 -43.31 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 121.193 -0.942 . . . . 0.0 110.98 176.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.3 t -69.91 -29.77 67.03 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.137 0.88 . . . . 0.0 112.469 -178.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.6 mt -64.44 -55.06 23.35 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.445 -0.784 . . . . 0.0 112.124 167.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -68.27 -29.48 68.28 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.108 -0.995 . . . . 0.0 113.069 -173.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -82.62 -3.64 56.51 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.852 0.861 . . . . 0.0 112.799 176.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.4 ' CE1' ' HB2' ' A' ' 51' ' ' SER . 52.9 t-80 -93.45 -34.08 13.56 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.39 -0.819 . . . . 0.0 112.47 161.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -90.64 -6.39 54.63 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 -177.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.484 1.228 0 CA-C-N 121.259 1.845 . . . . 0.0 115.773 -173.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.8 m . . . . . 0 CA--C 1.53 0.206 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.517 ' HA ' HG22 ' A' ' 50' ' ' THR . 8.5 p -70.62 145.33 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 178.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.6 mt -129.86 -39.68 1.4 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.829 1.652 . . . . 0.0 111.957 -172.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.426 ' SG ' ' HE2' ' A' ' 14' ' ' LYS . 12.5 t -152.8 133.25 13.7 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.096 0.958 . . . . 0.0 111.26 175.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 92.9 t -130.5 127.14 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.538 1.135 . . . . 0.0 108.963 170.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.426 ' HE2' ' SG ' ' A' ' 12' ' ' CYS . 68.1 mttm -133.55 144.08 50.62 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 124.968 1.307 . . . . 0.0 112.3 -179.522 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -77.7 -11.44 16.91 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 124.098 3.199 . . . . 0.0 114.636 -178.289 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -117.99 110.15 17.34 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.148 1.379 . . . . 0.0 111.673 -174.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 p -156.82 142.05 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.527 1.131 . . . . 0.0 110.424 163.296 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.6 m -123.43 144.23 49.64 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.408 1.483 . . . . 0.0 110.238 178.517 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.41 HG22 HG22 ' A' ' 108' ' ' ILE . 76.7 t -113.7 129.36 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.821 1.248 . . . . 0.0 111.047 177.866 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.17 116.41 11.85 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.89 1.676 . . . . 0.0 109.196 173.796 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.9 mtt-85 -71.37 134.54 46.77 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.138 0.975 . . . . 0.0 110.509 -176.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.7 pt . . . . . 0 CA--C 1.546 0.801 0 C-N-CA 124.266 1.026 . . . . 0.0 113.177 -165.003 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 . . . . . 0 N--CA 1.466 0.361 0 CA-C-O 119.446 -0.311 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.61 26.13 9.78 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 178.113 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 60.46 -42.13 0.1 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.686 2.394 . . . . 0.0 115.272 -170.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 89.6 p -66.47 -15.92 63.72 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.384 1.874 . . . . 0.0 114.398 -179.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -63.33 -26.21 68.66 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 167.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 9.6 m0 -94.13 164.89 12.88 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.964 1.306 . . . . 0.0 111.256 -168.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -76.92 55.21 1.08 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.643 1.577 . . . . 0.0 114.172 179.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.6 mt -59.49 -25.69 64.66 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.66 1.184 . . . . 0.0 113.745 -179.278 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -94.87 -7.63 39.58 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.608 0.763 . . . . 0.0 113.004 -179.053 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -149.88 78.97 7.96 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.644 1.178 . . . . 0.0 111.959 175.549 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.88 147.61 50.68 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.519 2.813 . . . . 0.0 113.114 176.229 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -71.22 -28.92 64.54 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.881 0.872 . . . . 0.0 111.302 169.003 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 66.9 t90 -156.56 153.53 28.81 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.243 1.817 . . . . 0.0 110.891 177.223 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.7 p -135.67 149.4 49.27 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.576 1.151 . . . . 0.0 111.331 169.374 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.62 -140.44 4.29 Favored Glycine 0 CA--C 1.525 0.717 0 O-C-N 122.135 -0.353 . . . . 0.0 113.462 -178.692 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.9 mtm105 -119.56 147.76 44.1 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.222 1.809 . . . . 0.0 111.715 -173.189 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 40.4 tp -85.13 142.04 29.79 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.674 1.59 . . . . 0.0 110.616 176.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.8 ttm-85 -142.2 95.55 2.82 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.376 1.07 . . . . 0.0 111.073 165.427 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.7 mt -83.06 128.53 38.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 169.271 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.517 HG22 ' HA ' ' A' ' 10' ' ' VAL . 11.8 p -140.57 171.97 13.37 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.71 2.004 . . . . 0.0 110.472 -176.011 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.7 t -155.34 153.43 30.48 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.681 1.192 . . . . 0.0 112.076 175.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -155.96 123.76 5.62 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.166 0.986 . . . . 0.0 111.012 163.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.52 46.31 48.71 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.151 0.882 . . . . 0.0 114.845 167.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt 63.32 28.2 15.58 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 126.408 1.883 . . . . 0.0 113.679 -176.061 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.1 m -135.42 120.55 18.84 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.658 1.583 . . . . 0.0 108.774 170.83 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.3 159.25 18.85 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.891 0.876 . . . . 0.0 111.034 174.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -137.63 114.05 10.23 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.592 1.557 . . . . 0.0 109.29 178.514 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.4 mp -85.93 92.88 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 167.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -84.98 146.1 27.38 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.208 1.003 . . . . 0.0 110.266 172.187 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -110.44 137.54 48.02 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.564 1.546 . . . . 0.0 111.2 172.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -123.71 147.7 47.22 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.34 1.056 . . . . 0.0 113.286 -178.103 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.73 144.15 52.86 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 122.148 0.975 . . . . 0.0 112.065 169.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.4 pttt -81.49 -6.38 58.9 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -177.021 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 90.7 t -122.62 -39.52 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.657 1.183 . . . . 0.0 111.983 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.4 m -116.0 -10.38 11.6 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -172.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.65 19.74 79.3 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 123.613 0.625 . . . . 0.0 114.331 177.399 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -65.79 139.13 58.31 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.385 1.474 . . . . 0.0 111.24 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.9 tp -72.23 112.31 8.2 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.103 0.561 . . . . 0.0 109.882 172.492 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -78.52 -56.58 4.32 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.241 0.616 . . . . 0.0 111.3 177.071 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.0 165.24 35.61 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.225 1.81 . . . . 0.0 109.795 179.266 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -146.25 142.87 28.78 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 170.488 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.22 105.71 50.31 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.355 1.462 . . . . 0.0 111.808 -178.544 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -67.54 142.89 60.71 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 124.129 3.22 . . . . 0.0 112.39 170.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.5 t -139.2 117.33 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.294 1.437 . . . . 0.0 109.688 -177.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -81.45 -25.96 35.68 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 121.45 -0.781 . . . . 0.0 112.96 -177.396 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.19 145.35 16.52 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.336 1.854 . . . . 0.0 110.077 169.435 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -118.75 127.94 26.25 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.569 1.148 . . . . 0.0 110.588 175.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.54 147.5 75.76 Favored 'Cis proline' 0 CA--C 1.542 0.905 0 CA-C-N 119.997 1.035 . . . . 0.0 113.434 -2.684 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.91 -158.2 9.05 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.686 1.612 . . . . 0.0 112.948 -179.169 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.2 tt -76.29 -40.41 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 O-C-N 121.853 -0.793 . . . . 0.0 113.093 -178.245 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.44 7.72 18.77 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -166.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.9 t -152.83 125.99 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 126.421 1.889 . . . . 0.0 108.571 177.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -145.95 154.06 41.5 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.607 1.163 . . . . 0.0 112.224 -173.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.7 p -103.2 154.78 18.96 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.524 1.53 . . . . 0.0 112.453 179.693 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.9 m -76.42 175.28 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.8 1.24 . . . . 0.0 111.065 165.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 68.7 p -92.21 -30.12 16.08 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.909 1.283 . . . . 0.0 113.152 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -100.94 -39.34 7.8 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -163.697 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.4 t -141.42 125.76 17.58 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -176.489 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.88 -12.73 26.93 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -172.318 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.455 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.272 27.7 ptt180 -82.61 11.78 5.4 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -176.892 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -136.98 140.82 42.45 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.082 1.353 . . . . 0.0 112.03 -174.078 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -140.95 158.82 43.41 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.231 1.412 . . . . 0.0 111.656 -178.262 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.3 t -108.39 140.26 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.379 1.072 . . . . 0.0 108.56 162.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.95 148.31 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 119.159 0.891 . . . . 0.0 112.229 170.184 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -93.25 91.65 7.35 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.743 0.817 . . . . 0.0 110.834 178.081 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -75.02 152.28 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.245 0.618 . . . . 0.0 111.894 176.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.46 0 C-N-CA 125.591 1.556 . . . . 0.0 110.102 171.249 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 90.5 p . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.81 146.69 31.26 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.894 1.278 . . . . 0.0 111.443 174.51 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -90.38 117.12 28.85 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.552 0.741 . . . . 0.0 109.438 167.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.8 pt -116.77 144.63 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.804 1.242 . . . . 0.0 110.821 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -92.36 139.15 14.54 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 176.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.41 HG22 HG22 ' A' ' 19' ' ' VAL . 31.7 pt -130.67 160.61 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.175 1.39 . . . . 0.0 112.152 171.386 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -155.2 174.45 33.36 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-O 121.865 0.703 . . . . 0.0 114.794 167.341 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -124.2 149.26 46.57 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 126.721 2.008 . . . . 0.0 110.642 -173.255 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.0 t -74.68 -11.97 60.31 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 178.379 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -119.12 -24.16 6.57 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -155.282 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 61.09 -41.29 0.12 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 127.152 2.181 . . . . 0.0 115.036 -166.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.17 -27.89 72.14 Favored Glycine 0 CA--C 1.537 1.456 0 CA-C-N 119.675 1.125 . . . . 0.0 113.632 171.038 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -79.69 -34.72 39.96 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.122 0.961 . . . . 0.0 112.095 173.317 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.455 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -63.96 -36.77 85.05 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.563 -0.711 . . . . 0.0 112.636 167.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -70.27 9.91 0.52 Allowed 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 167.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -122.4 -32.57 3.6 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.219 1.408 . . . . 0.0 112.114 170.577 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -50.15 -48.89 53.58 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.223 1.409 . . . . 0.0 111.974 164.148 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -77.07 -29.83 55.22 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -178.672 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.2 t -77.96 -42.75 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 121.041 -1.037 . . . . 0.0 111.004 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 77.8 p -64.08 -26.66 68.65 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 176.309 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.9 mt -71.62 -59.51 2.72 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.22 1.008 . . . . 0.0 112.004 168.092 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -65.3 -30.34 71.18 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -172.412 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -79.04 -1.18 34.44 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.484 1.114 . . . . 0.0 112.608 177.341 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -100.06 -3.98 30.83 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 164.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -113.87 -10.24 12.98 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 176.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.28 0 CA-C-N 120.431 1.469 . . . . 0.0 114.855 -176.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.234 0.274 0 N-CA-C 111.405 0.15 . . . . 0.0 111.405 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.0 p -72.3 146.26 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 123.481 0.712 . . . . 0.0 111.184 -178.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.7 mt -129.5 -37.47 1.6 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.361 1.465 . . . . 0.0 112.521 -170.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 36.8 t -149.31 139.42 22.14 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.954 1.301 . . . . 0.0 109.865 173.312 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.2 t -134.84 127.71 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.826 1.25 . . . . 0.0 108.864 168.636 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -130.96 136.98 29.75 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 125.048 1.339 . . . . 0.0 110.868 176.162 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.11 -14.32 16.82 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.349 2.699 . . . . 0.0 114.968 -174.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -134.58 108.69 8.21 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.135 0.974 . . . . 0.0 111.295 -173.149 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.37 144.35 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.189 1.396 . . . . 0.0 110.191 171.659 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.1 m -123.19 137.5 54.88 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.441 1.096 . . . . 0.0 111.267 -176.574 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.2 t -101.79 133.05 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.324 1.449 . . . . 0.0 111.444 178.391 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.22 121.51 22.6 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.973 1.309 . . . . 0.0 109.109 170.597 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -66.51 130.82 44.49 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.069 0.548 . . . . 0.0 109.98 174.123 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.0 pt . . . . . 0 CA--C 1.545 0.765 0 C-N-CA 124.134 0.974 . . . . 0.0 113.205 -168.206 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 . . . . . 0 C--O 1.224 -0.258 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.54 18.53 7.46 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -172.412 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.3 -49.66 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 128.192 2.597 . . . . 0.0 115.597 -173.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.2 m -65.21 -17.8 64.79 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.99 1.716 . . . . 0.0 114.611 -176.295 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.89 -8.64 59.14 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 172.695 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -88.99 168.9 11.99 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.78 1.232 . . . . 0.0 110.732 174.639 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -81.26 55.36 2.53 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.686 1.195 . . . . 0.0 113.436 179.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.3 mt -54.84 -31.53 59.55 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -172.432 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -90.34 -8.78 49.9 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.32 1.048 . . . . 0.0 113.054 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -137.16 71.17 55.06 Favored Pre-proline 0 N--CA 1.471 0.62 0 C-N-CA 125.624 1.57 . . . . 0.0 111.358 -164.239 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -69.0 148.14 69.35 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 CA-C-N 119.315 0.791 . . . . 0.0 113.051 -171.753 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -72.35 -29.59 63.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.323 0.649 . . . . 0.0 111.239 167.486 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 56.0 t90 -159.56 154.21 24.32 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.533 1.933 . . . . 0.0 110.612 176.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.6 p -133.29 149.27 51.94 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.32 1.048 . . . . 0.0 111.749 167.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.84 -139.91 4.45 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 123.058 0.361 . . . . 0.0 113.261 -179.392 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.7 mtm105 -113.78 143.91 43.85 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.087 1.755 . . . . 0.0 111.736 -173.025 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.6 tp -83.37 140.34 32.47 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.62 1.168 . . . . 0.0 110.142 168.13 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -133.39 138.24 46.19 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.508 1.523 . . . . 0.0 108.816 156.69 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.407 HD11 ' CD2' ' A' ' 119' ' ' PHE . 21.1 mt -120.4 133.41 67.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 166.078 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.44 162.82 34.41 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 127.1 2.16 . . . . 0.0 109.309 -167.515 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 84.1 p -160.21 132.46 6.27 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 120.018 -1.676 . . . . 0.0 113.954 -169.452 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.64 137.18 7.64 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 125.51 1.524 . . . . 0.0 114.653 172.027 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 65.5 48.96 63.25 Favored Glycine 0 N--CA 1.475 1.259 0 C-N-CA 125.74 1.638 . . . . 0.0 114.123 171.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 56.1 30.57 16.58 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.99 1.716 . . . . 0.0 112.986 -174.498 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.5 m -134.05 132.92 40.6 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.775 2.03 . . . . 0.0 108.257 178.489 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.63 158.35 16.16 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.091 0.956 . . . . 0.0 110.434 171.418 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -142.12 91.89 2.38 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.666 1.586 . . . . 0.0 108.833 -164.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.8 mp -78.52 110.84 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 171.558 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -112.9 127.91 56.32 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.927 0.891 . . . . 0.0 110.868 177.201 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mp -96.94 130.29 44.28 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.583 1.153 . . . . 0.0 110.019 177.754 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -129.96 149.56 51.63 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.873 0.869 . . . . 0.0 112.845 -171.358 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -73.58 144.79 45.87 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.983 0.897 . . . . 0.0 112.186 -178.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.0 pttt -84.44 -6.73 59.41 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.238 1.815 . . . . 0.0 115.158 -178.666 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 96.0 t -122.7 -43.99 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.241 1.416 . . . . 0.0 111.586 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.2 m -95.34 -21.39 18.42 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -174.508 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.13 6.94 84.0 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.218 0.913 . . . . 0.0 113.902 -176.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.43 155.89 24.42 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.421 1.489 . . . . 0.0 112.626 -174.425 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.8 tp -74.57 128.06 34.62 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.632 0.773 . . . . 0.0 111.149 178.282 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -85.93 -56.41 3.49 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.327 1.051 . . . . 0.0 111.133 169.041 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.88 160.71 39.4 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.162 1.385 . . . . 0.0 111.204 -178.602 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? -140.18 136.02 33.02 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 176.17 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.73 100.56 51.02 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 126.136 1.774 . . . . 0.0 110.691 179.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -74.83 141.44 27.17 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.35 2.7 . . . . 0.0 111.33 169.775 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.5 t -134.65 125.93 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 126.921 2.088 . . . . 0.0 108.987 -172.108 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -90.97 -22.24 20.92 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.295 0.952 . . . . 0.0 113.53 -177.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -161.54 150.5 16.0 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.322 1.849 . . . . 0.0 110.438 173.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -130.16 131.77 23.65 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.347 1.059 . . . . 0.0 111.443 175.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.73 145.42 46.72 Favored 'Cis proline' 0 CA--C 1.539 0.736 0 CA-C-N 119.922 1.008 . . . . 0.0 113.739 -7.042 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -161.77 -156.26 8.29 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 125.669 1.605 . . . . 0.0 112.357 -177.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 19.9 tt -81.42 -39.94 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -176.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.68 6.35 15.53 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -167.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.1 t -152.22 128.51 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 126.364 1.866 . . . . 0.0 109.238 178.568 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -140.02 158.46 44.03 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.438 1.495 . . . . 0.0 113.11 176.155 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 67.5 p -100.56 159.04 15.48 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.294 1.838 . . . . 0.0 111.638 175.191 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.9 m -83.91 174.22 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.738 0.815 . . . . 0.0 110.862 164.575 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 59.9 p -96.02 -30.71 13.42 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.35 1.46 . . . . 0.0 113.224 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -96.04 -40.72 9.11 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -165.513 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.1 t -137.38 120.59 16.8 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -174.19 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.8 m -73.91 24.44 0.08 Allowed 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 -168.001 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -128.61 23.82 5.82 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 127.136 2.175 . . . . 0.0 113.529 -178.169 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -141.55 139.52 33.21 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.644 1.577 . . . . 0.0 111.391 -178.454 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -140.18 161.29 37.99 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.807 1.243 . . . . 0.0 111.89 -177.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 78.1 t -113.04 142.34 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.473 1.109 . . . . 0.0 108.725 166.021 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.43 149.46 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 118.509 0.595 . . . . 0.0 112.085 170.51 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -89.47 87.4 7.06 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.814 0.846 . . . . 0.0 110.508 177.019 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.8 141.05 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 O-C-N 122.102 -0.374 . . . . 0.0 110.469 172.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 . . . . . 0 N--CA 1.467 0.402 0 C-N-CA 125.377 1.471 . . . . 0.0 111.418 -170.262 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 84.1 p . . . . . 0 N--CA 1.47 0.547 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.87 145.92 31.81 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.644 1.577 . . . . 0.0 110.952 170.048 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -93.57 116.56 29.08 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.63 0.772 . . . . 0.0 109.726 171.284 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.3 pt -115.69 144.04 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.539 1.136 . . . . 0.0 110.953 179.339 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.46 142.47 16.11 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 174.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.4 pt -128.85 147.78 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 125.331 1.452 . . . . 0.0 111.925 172.217 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.15 146.94 17.89 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.454 1.026 . . . . 0.0 114.022 177.178 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -109.72 161.1 15.73 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.536 1.934 . . . . 0.0 111.104 178.405 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.9 t -74.41 -24.13 59.06 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.721 0.808 . . . . 0.0 112.802 179.091 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -157.47 156.35 31.96 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.814 1.246 . . . . 0.0 111.504 -177.133 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -57.84 -33.25 68.44 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 118.642 -0.694 . . . . 0.0 112.465 175.228 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -59.65 -30.98 69.91 Favored Glycine 0 CA--C 1.536 1.401 0 CA-C-N 119.491 1.041 . . . . 0.0 114.237 -179.279 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -86.85 -36.89 18.21 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.381 1.09 . . . . 0.0 112.241 176.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.46 -30.26 70.48 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 168.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . 0.259 18.3 m-85 -91.0 17.92 7.35 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.006 1.722 . . . . 0.0 114.096 170.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -99.41 -40.66 7.77 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.635 -0.666 . . . . 0.0 111.099 143.706 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.407 ' CD2' HD11 ' A' ' 49' ' ' ILE . 40.4 t80 -53.78 -56.7 15.13 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.566 1.076 . . . . 0.0 113.047 178.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -80.45 -24.47 39.54 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -175.396 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 85.2 t -81.76 -39.2 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 123.144 0.577 . . . . 0.0 110.941 -177.136 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 89.4 p -64.41 -31.64 72.94 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 175.115 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 67.5 mt -68.14 -56.8 7.47 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.28 1.032 . . . . 0.0 111.704 171.143 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -67.23 -32.63 73.8 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.319 -0.863 . . . . 0.0 113.004 -173.478 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -84.69 -3.16 58.41 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.785 0.834 . . . . 0.0 112.762 177.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -93.97 -31.9 14.08 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.41 -0.806 . . . . 0.0 112.375 163.3 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -90.4 -9.81 46.2 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -178.539 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -171.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.4 p -72.57 144.56 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.707 0.803 . . . . 0.0 112.579 -174.512 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.6 mt -128.26 -43.97 1.44 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.239 1.416 . . . . 0.0 112.248 -173.539 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 24.4 t -149.6 135.06 18.38 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.376 1.07 . . . . 0.0 110.604 175.494 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 96.5 t -127.91 127.96 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.551 1.14 . . . . 0.0 109.304 171.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -128.35 133.27 24.97 Favored Pre-proline 0 N--CA 1.476 0.87 0 C-N-CA 125.259 1.424 . . . . 0.0 110.122 174.207 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.22 -15.48 14.36 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.116 2.544 . . . . 0.0 115.037 -171.305 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -133.48 108.58 8.73 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.138 0.975 . . . . 0.0 110.879 -174.444 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.3 p -144.94 144.48 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.161 1.384 . . . . 0.0 110.289 174.697 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.0 m -125.9 130.64 51.71 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.188 0.995 . . . . 0.0 111.081 -172.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.5 t -96.39 134.82 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.286 1.435 . . . . 0.0 111.345 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.98 124.76 26.86 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.952 1.301 . . . . 0.0 108.918 170.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.4 mmm-85 -63.14 136.77 57.96 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.634 -0.666 . . . . 0.0 110.451 167.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.5 pt . . . . . 0 CA--C 1.544 0.727 0 C-N-CA 124.981 1.312 . . . . 0.0 112.349 -174.841 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 . . . . . 0 CA--C 1.538 0.51 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.13 22.6 12.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.911 -1.118 . . . . 0.0 113.821 178.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.87 -48.78 0.06 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.369 2.268 . . . . 0.0 114.969 -167.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.6 m -66.86 -13.79 62.01 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.943 1.697 . . . . 0.0 114.903 -176.207 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.38 -12.98 60.37 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.129 0.972 . . . . 0.0 112.876 171.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 13.7 m0 -95.76 171.77 8.45 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.483 1.513 . . . . 0.0 111.958 -174.345 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -75.69 49.39 0.51 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.146 1.779 . . . . 0.0 113.844 177.19 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.5 mt -56.06 -33.61 65.15 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -171.025 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -94.44 -3.89 49.29 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.457 1.103 . . . . 0.0 113.209 177.492 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -128.04 59.91 43.05 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 127.054 2.141 . . . . 0.0 111.843 -173.715 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.0 133.34 33.07 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 CA-C-N 120.537 1.227 . . . . 0.0 112.423 -173.468 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -70.34 -24.49 62.99 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.853 1.261 . . . . 0.0 111.243 178.604 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 33.9 t90 -159.74 154.47 24.37 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.862 2.065 . . . . 0.0 110.451 170.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.9 p -133.76 150.17 51.46 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.075 0.95 . . . . 0.0 112.112 167.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.16 -140.15 4.74 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.099 0.38 . . . . 0.0 113.581 -178.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.0 mtm105 -111.5 147.7 34.78 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.538 1.935 . . . . 0.0 111.971 -175.355 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.9 tp -89.19 138.43 31.43 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.632 1.573 . . . . 0.0 109.672 166.441 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 36.8 ttt-85 -144.5 93.04 2.37 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.475 1.11 . . . . 0.0 110.697 165.44 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.471 HD11 ' CD1' ' A' ' 119' ' ' PHE . 16.1 mt -73.08 128.29 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 171.69 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.2 p -132.86 167.32 20.41 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.741 2.016 . . . . 0.0 110.552 -179.18 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.3 t -160.54 146.77 15.24 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.603 -1.311 . . . . 0.0 112.153 177.076 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.5 mmtt -153.3 131.76 12.13 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.358 1.463 . . . . 0.0 111.428 161.154 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.98 45.99 47.48 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.859 1.219 . . . . 0.0 115.026 163.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt 63.68 21.39 12.68 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.432 1.893 . . . . 0.0 113.696 -173.905 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.2 m -127.7 112.7 15.11 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.072 1.349 . . . . 0.0 109.143 170.411 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.97 161.49 18.98 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.63 0.772 . . . . 0.0 110.573 170.024 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -141.11 108.75 5.61 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.941 1.696 . . . . 0.0 108.695 -175.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.5 mp -81.39 95.14 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 168.36 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -95.04 137.29 34.29 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.445 0.641 . . . . 0.0 111.605 175.586 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.3 mp -110.94 134.36 52.64 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.447 1.899 . . . . 0.0 109.491 176.402 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -139.21 152.13 47.1 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.544 0.738 . . . . 0.0 112.734 -168.374 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -73.6 143.26 46.44 Favored 'General case' 0 C--O 1.238 0.492 0 O-C-N 121.304 -0.872 . . . . 0.0 111.907 -176.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.4 pttt -84.01 -6.18 59.36 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.377 1.871 . . . . 0.0 115.05 -178.761 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 91.8 t -123.5 -44.42 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.357 1.463 . . . . 0.0 111.416 178.671 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.9 m -92.77 -23.11 18.99 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -174.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.84 6.06 86.94 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 123.872 0.748 . . . . 0.0 113.778 -177.421 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -82.05 154.48 25.6 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.361 1.464 . . . . 0.0 112.616 -174.625 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.1 tp -73.37 125.54 28.1 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.818 0.847 . . . . 0.0 110.981 178.136 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -84.56 -56.94 3.35 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.131 0.972 . . . . 0.0 110.806 169.683 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.32 163.3 39.67 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.744 1.218 . . . . 0.0 111.774 -179.273 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -139.63 135.79 33.65 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.583 1.153 . . . . 0.0 111.5 177.405 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.53 102.81 49.67 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.547 1.139 . . . . 0.0 111.076 174.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -70.06 137.89 35.63 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.828 3.019 . . . . 0.0 112.09 173.213 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.8 t -131.98 131.93 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.212 1.805 . . . . 0.0 109.251 -179.193 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -101.11 -16.29 17.11 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.435 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -161.71 152.13 17.42 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.926 1.69 . . . . 0.0 110.411 175.151 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -124.7 134.88 25.99 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -173.095 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -66.9 149.31 80.4 Favored 'Cis proline' 0 CA--C 1.542 0.909 0 CA-C-N 119.41 0.825 . . . . 0.0 111.221 -13.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -148.09 -172.78 18.41 Favored Glycine 0 N--CA 1.474 1.217 0 N-CA-C 115.1 0.8 . . . . 0.0 115.1 -174.183 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.3 tp -58.79 -29.03 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -174.521 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.53 7.97 43.77 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.584 1.154 . . . . 0.0 113.763 -172.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.1 p -158.94 128.58 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.004 0.922 . . . . 0.0 113.266 179.008 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -148.57 165.51 31.04 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.185 1.794 . . . . 0.0 113.455 -168.147 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 50.0 p -121.77 155.91 34.28 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.625 1.97 . . . . 0.0 111.592 -172.692 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.0 m -84.45 172.89 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.761 0.824 . . . . 0.0 111.901 172.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 68.7 p -89.03 -34.17 16.9 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.028 1.331 . . . . 0.0 112.539 177.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -92.92 -43.41 8.97 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -164.307 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.4 t -145.81 121.56 10.54 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -174.2 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.37 -2.3 5.99 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -169.707 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.416 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.264 1.2 ptm180 -88.19 22.16 2.54 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.922 1.689 . . . . 0.0 114.528 174.2 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -140.47 134.71 31.11 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.893 1.277 . . . . 0.0 110.813 178.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -134.26 161.55 34.64 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.418 1.487 . . . . 0.0 111.763 -179.672 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.5 t -117.5 142.35 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.522 1.129 . . . . 0.0 109.116 166.762 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.38 150.77 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 123.381 0.673 . . . . 0.0 111.721 171.014 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -95.06 89.69 5.66 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.125 0.97 . . . . 0.0 109.988 177.78 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -71.05 137.0 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 120.724 0.297 . . . . 0.0 110.757 177.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 . . . . . 0 N--CA 1.467 0.406 0 C-N-CA 125.725 1.61 . . . . 0.0 111.521 -167.198 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 CA--C 1.535 0.383 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.75 141.02 26.3 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.303 1.441 . . . . 0.0 111.195 167.565 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -87.42 125.13 34.09 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 121.842 -0.536 . . . . 0.0 110.352 169.682 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 14.9 pt -122.27 142.92 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.117 1.367 . . . . 0.0 110.469 175.131 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.99 143.68 16.68 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 172.542 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.9 pt -129.17 141.59 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.971 1.308 . . . . 0.0 111.951 172.335 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -119.21 145.31 18.07 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.936 1.255 . . . . 0.0 113.157 175.267 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -108.21 161.51 14.92 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.016 1.726 . . . . 0.0 111.689 -176.334 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.9 t -72.57 -29.41 63.51 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.744 0.818 . . . . 0.0 112.91 -179.391 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -155.6 153.37 30.0 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.523 1.129 . . . . 0.0 111.753 -178.469 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 57.4 ttt-85 -61.29 -34.29 74.97 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.185 0.994 . . . . 0.0 113.176 178.065 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.43 -29.67 74.38 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 118.898 0.772 . . . . 0.0 113.515 175.481 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -82.43 -33.51 28.55 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 117.893 0.847 . . . . 0.0 111.825 175.349 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.416 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -67.09 -33.4 75.39 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.7 0.8 . . . . 0.0 112.962 170.146 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -60.84 -34.06 74.0 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.51 -0.744 . . . . 0.0 112.347 172.671 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -64.87 -32.63 74.43 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.543 1.065 . . . . 0.0 112.606 174.726 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.471 ' CD1' HD11 ' A' ' 49' ' ' ILE . 27.3 t80 -60.97 -55.66 30.24 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.241 0.928 . . . . 0.0 111.604 173.011 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.05 -26.73 56.85 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -175.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.9 t -74.62 -43.29 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 119.288 0.949 . . . . 0.0 110.953 175.271 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 41.9 m -66.41 -27.18 67.64 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.96 0.8 . . . . 0.0 112.843 -179.187 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 75.4 mt -73.71 -57.52 3.93 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.638 0.775 . . . . 0.0 111.483 169.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -64.27 -32.35 73.91 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -173.595 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -80.58 -5.42 56.78 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.039 0.936 . . . . 0.0 112.575 178.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -94.77 -15.05 24.14 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 165.403 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -108.81 -7.01 15.6 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-N 121.218 1.826 . . . . 0.0 115.786 -175.653 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.9 t -73.55 147.25 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.103 1.361 . . . . 0.0 111.622 -174.54 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.84 -40.88 1.05 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.516 1.527 . . . . 0.0 111.843 -172.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 22.5 t -147.41 142.5 27.1 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.899 1.28 . . . . 0.0 110.669 173.58 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 76.1 t -136.05 129.03 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 125.076 1.35 . . . . 0.0 109.087 170.082 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -130.92 137.65 31.24 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 125.44 1.496 . . . . 0.0 110.381 173.27 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.59 -17.86 15.87 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.028 2.485 . . . . 0.0 114.797 -174.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -133.77 111.11 10.27 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.236 1.015 . . . . 0.0 111.794 -171.009 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.0 p -148.42 144.3 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.038 1.735 . . . . 0.0 110.017 172.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.4 m -123.09 136.63 54.88 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.45 1.1 . . . . 0.0 111.29 -174.053 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.2 t -101.29 133.42 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.063 1.345 . . . . 0.0 111.532 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -134.18 119.6 19.02 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.055 1.342 . . . . 0.0 108.864 171.044 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -66.36 129.86 41.26 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.975 0.51 . . . . 0.0 109.808 174.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.4 pt . . . . . 0 CA--C 1.544 0.746 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -166.575 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 . . . . . 0 CA--C 1.534 0.355 0 CA-C-O 120.505 0.193 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.42 17.13 3.68 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -171.377 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.06 -52.23 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 128.16 2.584 . . . . 0.0 115.616 -175.487 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.6 m -66.66 -13.94 61.85 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.872 1.669 . . . . 0.0 114.187 -176.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -84.6 -8.44 58.89 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.943 1.297 . . . . 0.0 112.633 173.479 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.2 m0 -92.93 169.36 10.5 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.753 1.621 . . . . 0.0 111.234 177.214 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -79.62 51.33 1.25 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.197 1.799 . . . . 0.0 112.574 178.305 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.2 mt -54.62 -32.44 58.92 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.389 1.476 . . . . 0.0 114.36 -173.852 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -87.92 -9.5 53.44 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.796 0.838 . . . . 0.0 112.485 -177.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -139.13 68.66 41.23 Favored Pre-proline 0 N--CA 1.47 0.545 0 C-N-CA 125.396 1.478 . . . . 0.0 111.231 -160.511 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -68.7 147.23 69.17 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 CA-C-N 119.519 0.864 . . . . 0.0 113.215 -169.1 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -72.52 -30.12 64.19 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.493 0.717 . . . . 0.0 111.286 168.674 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.6 t90 -159.24 155.14 26.47 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.472 1.909 . . . . 0.0 110.517 176.789 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.8 p -134.7 146.99 49.98 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.81 1.244 . . . . 0.0 111.945 171.233 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.14 -140.8 5.45 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 114.574 0.59 . . . . 0.0 114.574 176.707 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -107.14 141.54 38.25 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 126.677 1.991 . . . . 0.0 111.249 -169.253 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.5 tp -84.67 139.39 32.06 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.037 1.335 . . . . 0.0 110.127 168.237 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.6 ttm-85 -131.82 132.05 43.4 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.408 1.083 . . . . 0.0 109.554 154.546 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.402 HD11 ' CD2' ' A' ' 119' ' ' PHE . 22.4 mt -109.34 132.8 56.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 163.282 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.84 164.19 31.24 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 126.379 1.871 . . . . 0.0 109.866 -168.322 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.2 t -156.96 155.99 32.24 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 120.772 -1.205 . . . . 0.0 111.805 177.241 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -159.97 133.3 6.92 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.388 1.475 . . . . 0.0 110.045 152.641 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.97 49.94 20.28 Favored Glycine 0 N--CA 1.475 1.258 0 C-N-CA 124.7 1.143 . . . . 0.0 114.82 166.666 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt 59.93 23.1 12.16 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 126.406 1.882 . . . . 0.0 113.697 -175.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.8 m -126.93 126.48 43.31 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.824 1.65 . . . . 0.0 108.308 172.285 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.68 161.11 13.81 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.125 0.97 . . . . 0.0 110.873 170.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -139.65 110.68 6.89 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 126.438 1.895 . . . . 0.0 108.356 -175.057 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.5 mp -86.33 106.92 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 166.098 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.7 mttt -107.43 131.3 54.43 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.64 1.176 . . . . 0.0 111.358 177.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.0 mp -103.32 130.01 50.49 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.053 1.341 . . . . 0.0 110.481 178.754 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -131.75 147.2 52.48 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.912 0.885 . . . . 0.0 113.289 -167.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -64.42 142.92 58.25 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.815 -1.178 . . . . 0.0 113.063 -177.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.26 -2.7 36.07 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 -178.299 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.5 t -116.78 -48.77 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.481 1.112 . . . . 0.0 111.269 170.836 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.7 m -114.22 -4.67 13.04 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.6 1.334 . . . . 0.0 114.6 -168.045 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.21 15.73 78.73 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 123.85 0.738 . . . . 0.0 114.143 177.257 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -63.97 133.35 53.03 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.839 1.656 . . . . 0.0 111.383 -177.032 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.1 tp -68.67 115.11 7.66 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 122.881 0.472 . . . . 0.0 111.056 -179.391 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -80.8 -53.3 6.61 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.714 1.206 . . . . 0.0 111.131 173.569 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.24 159.13 35.69 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.052 1.341 . . . . 0.0 111.287 -178.187 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -138.31 136.63 36.61 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.5 0.72 . . . . 0.0 112.502 173.182 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.96 107.93 47.23 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 125.339 1.456 . . . . 0.0 110.752 176.517 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -79.66 141.07 15.24 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.721 2.947 . . . . 0.0 111.314 175.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.8 t -134.14 129.52 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 126.145 1.778 . . . . 0.0 109.237 -172.3 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -96.52 -21.14 17.88 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 178.836 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.33 149.12 13.42 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.704 2.001 . . . . 0.0 110.301 175.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -129.24 129.76 23.33 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 124.334 1.054 . . . . 0.0 111.963 177.224 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -65.58 149.02 75.63 Favored 'Cis proline' 0 CA--C 1.541 0.854 0 CA-C-N 119.807 0.967 . . . . 0.0 113.191 -5.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -169.1 -162.28 21.03 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.639 1.59 . . . . 0.0 113.473 -177.282 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.9 tp -68.43 -35.42 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -170.249 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.04 4.1 53.81 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -168.511 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.4 t -151.35 129.64 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.806 1.242 . . . . 0.0 110.229 -179.38 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -138.84 158.4 44.3 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.535 1.534 . . . . 0.0 112.91 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 57.0 p -104.79 156.77 17.7 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.35 1.86 . . . . 0.0 111.225 175.785 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.7 m -82.89 178.37 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.82 0.848 . . . . 0.0 110.759 166.058 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 73.3 p -107.99 -22.27 12.48 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.775 1.63 . . . . 0.0 114.005 -177.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -90.68 -45.04 9.11 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -175.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t -145.32 125.7 13.96 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -179.416 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.8 m -69.57 11.83 0.23 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 -173.012 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.466 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.27 28.9 ptt180 -96.51 12.58 30.99 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.27 1.428 . . . . 0.0 114.43 174.016 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -136.75 139.66 42.02 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.428 1.491 . . . . 0.0 111.382 -173.338 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -140.13 162.89 34.15 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.062 1.345 . . . . 0.0 111.602 -177.26 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.4 t -117.17 141.77 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.526 1.131 . . . . 0.0 108.446 166.053 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.32 148.36 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 118.805 0.729 . . . . 0.0 112.281 171.246 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -91.04 81.76 5.61 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.906 0.883 . . . . 0.0 111.162 179.417 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -67.26 141.55 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.966 0.412 . . . . 0.0 111.148 176.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 . . . . . 0 N--CA 1.468 0.465 0 C-N-CA 125.646 1.578 . . . . 0.0 111.736 -169.058 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.9 p . . . . . 0 CA--C 1.534 0.33 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.35 146.22 32.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.436 1.494 . . . . 0.0 110.803 168.301 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -91.44 117.13 29.42 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.361 0.664 . . . . 0.0 109.535 168.586 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.6 pt -115.2 142.19 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.442 1.097 . . . . 0.0 110.795 177.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.7 141.27 16.01 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 175.293 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.5 pt -127.32 148.72 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 125.19 1.396 . . . . 0.0 111.602 170.432 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -134.61 147.24 19.05 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 124.093 0.854 . . . . 0.0 113.423 175.46 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -105.12 157.06 17.52 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.449 1.5 . . . . 0.0 111.279 176.1 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.4 t -73.8 -17.4 61.09 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.554 0.742 . . . . 0.0 112.78 178.211 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -154.28 145.92 23.27 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.675 1.19 . . . . 0.0 110.868 -178.188 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -64.27 -28.07 69.48 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.84 0.856 . . . . 0.0 113.193 -179.801 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.82 -30.75 78.07 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 124.164 0.888 . . . . 0.0 114.257 173.299 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -81.79 -34.89 30.08 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.603 1.201 . . . . 0.0 111.763 176.486 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.466 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -66.68 -30.18 70.37 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.162 0.985 . . . . 0.0 113.446 168.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.01 -49.54 76.51 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.363 0.665 . . . . 0.0 111.048 166.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -64.37 -28.96 70.05 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 118.837 0.744 . . . . 0.0 113.007 176.782 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.402 ' CD2' HD11 ' A' ' 49' ' ' ILE . 48.4 t80 -62.43 -61.25 2.57 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.651 1.114 . . . . 0.0 111.535 170.397 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -76.78 -27.29 55.22 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -171.589 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 65.5 t -71.76 -37.97 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 O-C-N 121.404 -0.81 . . . . 0.0 110.924 176.582 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 51.1 m -67.11 -16.29 64.24 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 176.466 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.5 mt -84.75 -56.73 3.43 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.164 0.985 . . . . 0.0 111.3 168.192 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -66.89 -34.33 77.54 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -172.184 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -85.77 -0.45 55.28 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.688 0.795 . . . . 0.0 112.44 177.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -99.4 -29.06 12.98 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.064 -1.023 . . . . 0.0 112.524 165.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -96.83 -5.95 37.12 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -179.601 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.248 0 CA-C-N 121.302 1.865 . . . . 0.0 114.887 -173.529 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.2 m . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.7 t -73.6 143.44 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.066 0.946 . . . . 0.0 110.764 177.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.2 mt -131.09 -36.8 1.3 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.089 1.355 . . . . 0.0 111.817 -169.576 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 47.9 t -153.17 142.67 21.76 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.3 1.44 . . . . 0.0 110.182 171.266 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 89.4 t -134.55 127.31 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.49 1.116 . . . . 0.0 109.315 169.223 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 75.1 mmtt -121.54 133.35 24.21 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 124.932 1.293 . . . . 0.0 111.027 174.701 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 14' ' ' LYS . 42.2 Cg_exo -69.06 -29.96 26.34 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.47 2.113 . . . . 0.0 115.911 -171.508 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -137.14 122.48 19.4 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.792 0.805 . . . . 0.0 112.744 -175.218 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 p -149.24 149.07 15.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 127.571 2.348 . . . . 0.0 109.243 177.115 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.7 m -124.75 130.96 53.41 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.652 0.781 . . . . 0.0 112.358 -169.238 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 78.6 t -96.58 136.42 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.733 1.613 . . . . 0.0 112.473 -178.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -129.2 126.44 39.17 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.148 1.379 . . . . 0.0 109.357 169.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -66.88 131.29 45.6 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 167.552 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.7 pt . . . . . 0 N--CA 1.476 0.829 0 C-N-CA 124.699 1.2 . . . . 0.0 112.36 -175.088 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 . . . . . 0 C--O 1.223 -0.318 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.67 18.27 10.34 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -174.5 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 60.35 -46.47 0.1 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.583 2.353 . . . . 0.0 115.064 -171.573 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 92.1 p -65.66 -16.91 64.19 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.56 1.944 . . . . 0.0 114.694 179.309 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -73.32 -18.79 61.16 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.766 1.226 . . . . 0.0 112.86 171.417 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 16.6 m0 -90.52 173.09 8.26 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.454 1.501 . . . . 0.0 111.881 -176.171 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -79.23 53.65 1.52 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.653 1.581 . . . . 0.0 114.36 -176.252 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.1 mt -60.01 -17.87 41.84 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -171.304 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -106.78 -3.16 20.74 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.497 1.119 . . . . 0.0 113.067 177.209 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -149.09 69.33 9.79 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 125.207 1.403 . . . . 0.0 112.122 177.798 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -55.31 145.69 65.46 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.134 2.556 . . . . 0.0 112.44 174.571 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.28 -30.68 68.83 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.711 0.804 . . . . 0.0 111.394 173.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 46.8 t90 -156.62 152.67 27.48 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.225 1.41 . . . . 0.0 111.056 176.076 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.9 p -133.57 152.2 51.86 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.495 -0.753 . . . . 0.0 112.13 166.274 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 176.55 -149.58 9.83 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.139 -0.482 . . . . 0.0 113.558 -175.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 17.5 mtm180 -97.05 148.27 23.18 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.432 1.893 . . . . 0.0 111.677 -175.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.0 tp -91.75 134.5 34.68 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.664 1.185 . . . . 0.0 109.596 163.332 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -127.83 119.53 25.87 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.891 1.276 . . . . 0.0 108.882 160.677 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.5 mt -101.93 130.86 50.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 166.471 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.92 166.48 26.62 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 126.254 1.822 . . . . 0.0 110.028 -166.906 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.9 t -157.21 160.12 38.38 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 121.273 -0.892 . . . . 0.0 112.168 173.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -144.42 122.04 11.82 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.652 0.739 . . . . 0.0 111.809 154.594 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.2 -117.98 9.68 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 125.863 1.697 . . . . 0.0 110.523 -177.551 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -100.2 14.01 32.28 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.917 1.687 . . . . 0.0 113.378 179.11 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.0 m -123.57 108.74 12.95 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.904 0.882 . . . . 0.0 110.285 177.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -83.16 158.94 22.16 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.158 0.504 . . . . 0.0 110.762 169.418 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -138.74 112.89 8.64 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.358 1.863 . . . . 0.0 108.729 -175.78 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.2 mp -91.98 105.54 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 165.458 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -104.09 135.06 46.28 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.115 1.366 . . . . 0.0 110.798 178.112 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.1 mp -107.06 128.79 54.69 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.616 1.566 . . . . 0.0 109.664 176.438 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -132.69 146.55 51.95 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.943 0.897 . . . . 0.0 112.004 -170.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -69.23 133.13 47.54 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.75 -1.219 . . . . 0.0 111.128 -179.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.5 pttt -77.19 -2.5 34.82 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -176.759 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.07 -42.41 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.42 1.488 . . . . 0.0 111.466 178.64 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.4 m -93.6 -21.07 19.63 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -178.764 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.66 10.07 82.83 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.645 1.117 . . . . 0.0 113.99 -177.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -86.75 149.11 25.1 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.287 1.435 . . . . 0.0 112.512 -172.762 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.3 tp -72.57 123.92 24.18 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.603 -0.686 . . . . 0.0 111.404 -178.029 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -87.49 -54.47 4.26 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.864 1.265 . . . . 0.0 111.245 171.826 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.9 163.2 40.64 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.684 1.194 . . . . 0.0 111.691 -177.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -145.84 131.46 18.86 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.505 1.122 . . . . 0.0 111.531 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.33 104.79 49.65 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 125.472 1.509 . . . . 0.0 110.855 178.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -77.22 144.32 23.26 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.053 2.502 . . . . 0.0 111.264 173.149 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.3 t -135.94 131.42 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.727 1.611 . . . . 0.0 109.014 -174.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -96.07 -22.68 17.19 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -179.54 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -163.29 150.67 12.89 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.786 2.034 . . . . 0.0 110.202 173.451 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -122.69 128.42 25.41 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.865 1.266 . . . . 0.0 111.204 177.635 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -63.14 149.49 65.88 Favored 'Cis proline' 0 CA--C 1.541 0.83 0 CA-C-N 119.849 0.982 . . . . 0.0 113.793 -6.344 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.01 -165.99 14.77 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.715 1.626 . . . . 0.0 112.532 178.347 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.7 tt -73.06 -36.86 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 O-C-N 121.698 -0.883 . . . . 0.0 112.867 -179.215 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.63 6.27 18.34 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -167.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.2 t -150.36 132.74 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.639 1.576 . . . . 0.0 110.26 -178.801 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -146.62 161.46 40.5 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.355 1.862 . . . . 0.0 112.331 -175.616 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 20.0 p -111.15 162.97 14.38 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 126.834 2.054 . . . . 0.0 111.719 177.447 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.0 m -87.7 174.8 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.64 1.176 . . . . 0.0 110.543 164.603 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 73.2 p -96.09 -36.38 11.01 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.147 1.379 . . . . 0.0 112.629 179.476 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -103.51 -28.33 11.83 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 -161.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.6 t -132.87 127.0 33.47 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.489 1.04 . . . . 0.0 113.51 -177.608 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.6 p -75.79 22.08 0.15 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.914 2.086 . . . . 0.0 116.164 -166.049 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -138.81 26.77 2.48 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 126.245 1.818 . . . . 0.0 114.632 -173.225 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -141.7 141.93 33.32 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.871 1.268 . . . . 0.0 111.735 -175.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -140.09 163.5 32.55 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.053 1.341 . . . . 0.0 111.085 -179.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.2 t -116.47 144.54 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.938 1.295 . . . . 0.0 108.843 166.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.8 149.42 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 118.565 0.621 . . . . 0.0 111.811 171.159 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.443 ' HE ' ' NE2' ' A' ' 97' ' ' GLN . 38.6 ttp180 -91.87 103.14 15.72 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.158 0.583 . . . . 0.0 109.954 173.285 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -84.96 148.29 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.441 1.096 . . . . 0.0 111.434 177.057 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.443 ' NE2' ' HE ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.804 0 C-N-CA 125.863 1.665 . . . . 0.0 111.447 -179.756 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 82.8 p . . . . . 0 N--CA 1.465 0.316 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.62 145.48 30.97 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.983 1.313 . . . . 0.0 110.999 170.38 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -90.13 121.72 32.44 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 166.056 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.8 pt -121.66 144.12 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.823 1.249 . . . . 0.0 110.965 178.698 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -90.7 142.81 16.41 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 173.588 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.1 pt -126.86 140.58 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 125.404 1.482 . . . . 0.0 111.651 172.104 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.48 138.95 11.83 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.185 1.374 . . . . 0.0 112.93 177.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -100.64 158.21 16.11 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.768 1.627 . . . . 0.0 111.488 -177.505 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.9 t -73.81 -21.56 60.11 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.732 0.813 . . . . 0.0 112.834 178.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -157.89 151.3 23.47 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.473 1.109 . . . . 0.0 111.577 -178.543 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -55.23 -41.64 72.36 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.716 1.207 . . . . 0.0 112.762 174.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.83 -29.08 71.29 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.163 0.887 . . . . 0.0 114.149 -179.275 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -83.72 -36.43 23.68 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.242 1.021 . . . . 0.0 112.103 176.225 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.0 -31.81 73.03 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.562 -0.711 . . . . 0.0 112.524 168.057 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -75.91 5.95 5.79 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 171.214 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -99.38 -32.51 11.12 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.419 -0.801 . . . . 0.0 112.715 157.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -55.88 -50.96 69.2 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.822 1.192 . . . . 0.0 112.458 178.603 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 48.0 p-10 -70.87 -34.28 71.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.262 1.025 . . . . 0.0 113.617 -179.44 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.1 t -73.91 -39.65 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.383 1.073 . . . . 0.0 110.742 178.825 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 27.6 t -57.28 -38.06 73.34 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.855 1.262 . . . . 0.0 112.63 176.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.7 mt -76.45 -52.53 9.66 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.875 0.87 . . . . 0.0 112.333 176.394 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -65.88 -30.79 71.45 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.409 -0.807 . . . . 0.0 112.999 -175.203 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -88.24 6.3 37.54 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.379 1.072 . . . . 0.0 112.942 176.684 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -94.14 -43.65 8.37 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.498 -0.751 . . . . 0.0 111.97 154.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -85.82 1.1 51.07 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -171.922 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 -178.754 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.74 147.23 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.343 1.057 . . . . 0.0 113.152 175.76 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.1 mt -123.57 -38.72 2.5 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.727 2.011 . . . . 0.0 110.32 179.804 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.1 t -155.36 147.28 23.39 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.344 1.458 . . . . 0.0 110.686 170.102 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.0 t -136.9 125.28 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.342 1.457 . . . . 0.0 108.906 174.121 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -127.82 143.12 46.49 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 124.63 1.172 . . . . 0.0 112.482 178.392 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.19 -19.34 15.53 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.836 3.024 . . . . 0.0 115.623 -172.834 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -132.25 112.07 11.93 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.9 0.88 . . . . 0.0 111.713 -172.008 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.8 p -145.07 143.58 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.785 1.634 . . . . 0.0 110.074 169.722 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.3 m -126.61 127.78 45.76 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.204 1.001 . . . . 0.0 111.172 -172.843 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 78.7 t -94.91 138.39 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.383 1.473 . . . . 0.0 112.194 -177.652 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -129.2 126.71 39.78 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.026 1.33 . . . . 0.0 109.356 168.918 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -69.55 119.25 13.51 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 165.454 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.5 pt . . . . . 0 N--CA 1.477 0.894 0 C-N-CA 124.247 1.019 . . . . 0.0 113.304 -167.922 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 . . . . . 0 C--O 1.223 -0.321 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.38 18.12 6.44 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -171.162 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.07 -47.05 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 127.842 2.457 . . . . 0.0 115.591 -171.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.5 m -66.29 -17.08 64.54 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.359 1.864 . . . . 0.0 114.739 -178.623 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -87.04 -2.01 58.31 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.075 0.95 . . . . 0.0 113.261 172.22 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 22.2 m0 -93.0 169.29 10.54 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.319 1.447 . . . . 0.0 110.615 172.866 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.6 mmtm -77.22 53.63 1.02 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.762 1.625 . . . . 0.0 114.445 -178.086 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.8 mt -58.52 -20.94 50.32 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 -175.376 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -100.79 -4.0 28.87 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 178.753 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -153.19 81.72 5.02 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.914 1.286 . . . . 0.0 111.784 175.041 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.37 145.8 34.85 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.308 2.672 . . . . 0.0 112.936 175.331 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -68.62 -31.54 70.78 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.092 0.557 . . . . 0.0 111.077 169.523 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 42.3 t90 -157.06 156.15 32.36 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.703 1.601 . . . . 0.0 111.057 174.297 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.8 p -135.08 149.46 50.07 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.277 1.031 . . . . 0.0 112.276 169.157 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.42 -143.94 6.17 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 123.289 0.471 . . . . 0.0 113.631 179.586 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.3 mtm105 -107.94 150.68 26.78 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.61 1.964 . . . . 0.0 112.093 -175.604 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.7 tp -94.71 138.18 32.86 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.485 1.914 . . . . 0.0 110.513 173.211 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -134.77 106.39 6.89 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.494 1.518 . . . . 0.0 109.684 165.26 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.3 mt -87.18 130.64 36.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 166.16 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.88 164.93 29.13 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.817 1.647 . . . . 0.0 110.739 -169.366 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.4 t -159.0 157.02 30.45 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.572 1.149 . . . . 0.0 111.009 171.54 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.4 mmtt -147.62 128.6 14.5 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.027 0.931 . . . . 0.0 110.782 152.728 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.43 -125.49 7.36 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 125.841 1.686 . . . . 0.0 110.054 -177.332 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -104.44 22.62 14.59 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.638 1.575 . . . . 0.0 112.78 177.389 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.6 m -127.47 123.17 35.37 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.995 1.318 . . . . 0.0 109.678 178.633 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.29 162.1 13.82 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.164 0.986 . . . . 0.0 110.791 169.487 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -140.93 112.74 7.65 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.041 1.736 . . . . 0.0 108.758 -176.326 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -89.88 105.41 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 167.28 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -108.84 141.93 40.16 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.893 1.277 . . . . 0.0 111.286 179.138 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.3 mp -111.69 131.1 55.52 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 126.047 1.739 . . . . 0.0 110.347 178.877 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -126.04 154.16 43.4 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.347 1.059 . . . . 0.0 113.441 -171.685 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -72.7 141.98 48.21 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 122.093 0.949 . . . . 0.0 111.611 174.254 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -83.99 -2.83 57.35 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 -176.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.7 t -126.43 -39.77 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.572 1.149 . . . . 0.0 111.871 -179.212 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.6 m -110.8 -15.57 13.78 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -172.14 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.97 21.83 79.56 Favored Glycine 0 CA--C 1.535 1.307 0 O-C-N 121.823 -0.548 . . . . 0.0 113.966 -179.702 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -63.63 160.75 16.17 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.683 1.193 . . . . 0.0 111.43 171.556 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.3 tp -93.92 120.54 34.31 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.048 0.939 . . . . 0.0 109.653 169.049 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -83.46 -54.3 5.07 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.479 0.712 . . . . 0.0 111.255 173.257 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.13 163.86 37.19 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.565 1.146 . . . . 0.0 111.973 -178.463 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -144.72 134.8 24.0 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.882 1.273 . . . . 0.0 111.841 179.477 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.74 100.88 43.32 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.482 1.513 . . . . 0.0 111.189 178.834 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -68.96 142.1 50.49 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 124.123 3.216 . . . . 0.0 112.559 172.203 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.0 t -136.31 130.89 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 126.003 1.721 . . . . 0.0 109.697 -176.528 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -92.65 -23.24 19.05 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.76 149.69 13.07 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.438 1.895 . . . . 0.0 110.234 172.118 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -115.37 131.01 23.82 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 124.526 1.13 . . . . 0.0 111.346 175.374 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.26 149.19 81.33 Favored 'Cis proline' 0 CA--C 1.542 0.92 0 CA-C-N 119.929 1.01 . . . . 0.0 112.574 -6.567 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.15 -176.88 36.41 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.561 1.077 . . . . 0.0 114.155 -179.022 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.9 tp -56.89 -32.38 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 125.184 1.394 . . . . 0.0 114.55 -171.459 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.85 4.82 52.03 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -171.485 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.6 t -148.2 128.83 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.334 1.054 . . . . 0.0 110.898 179.829 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.75 164.33 30.4 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.682 1.993 . . . . 0.0 112.43 -171.574 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 72.8 p -123.26 160.81 25.83 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.957 1.703 . . . . 0.0 111.697 -173.723 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.5 m -90.21 175.3 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 124.512 1.125 . . . . 0.0 111.202 169.374 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.6 p -94.99 -34.94 12.17 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.464 1.506 . . . . 0.0 112.867 178.567 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -89.5 -42.25 11.57 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -165.349 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.2 t -142.27 125.19 16.12 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -177.217 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.9 m -70.51 9.19 0.67 Allowed 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -173.261 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.458 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.315 44.8 ptt85 -97.14 19.71 12.53 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.179 1.392 . . . . 0.0 114.75 173.795 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -140.14 136.33 33.41 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.774 1.23 . . . . 0.0 110.993 -175.585 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -135.55 162.45 32.66 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.971 1.308 . . . . 0.0 111.01 -179.752 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.1 t -117.15 142.02 32.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 124.504 1.122 . . . . 0.0 108.71 166.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.15 147.56 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 118.962 0.801 . . . . 0.0 111.875 173.344 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -88.61 88.01 7.46 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.187 0.595 . . . . 0.0 110.661 177.33 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -71.55 137.74 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 120.797 0.332 . . . . 0.0 110.789 176.897 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 . . . . . 0 N--CA 1.468 0.449 0 C-N-CA 126.047 1.739 . . . . 0.0 111.233 -169.185 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 94.2 p . . . . . 0 CA--C 1.535 0.37 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.03 146.18 30.86 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.8 1.64 . . . . 0.0 110.848 167.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -94.04 119.39 32.84 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.278 0.631 . . . . 0.0 109.926 170.28 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.6 pt -117.63 143.14 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.449 1.099 . . . . 0.0 111.062 176.606 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.04 144.22 17.9 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 174.013 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.8 pt -129.42 140.86 48.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 125.563 1.545 . . . . 0.0 111.674 171.348 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -116.47 144.62 18.49 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.258 1.408 . . . . 0.0 112.884 174.256 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -106.46 153.61 22.03 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 126.013 1.725 . . . . 0.0 111.215 178.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.1 t -74.36 -18.07 60.73 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.017 0.927 . . . . 0.0 113.115 -178.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -154.56 145.32 22.44 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.61 1.164 . . . . 0.0 111.116 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -66.29 -30.91 71.43 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 179.787 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.76 -33.02 86.13 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-N 119.083 0.856 . . . . 0.0 113.328 173.381 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -80.69 -30.78 36.37 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.619 -0.93 . . . . 0.0 112.381 175.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.458 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -67.43 -37.26 82.75 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 167.697 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -61.23 -41.34 96.71 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.637 -0.664 . . . . 0.0 110.964 168.195 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.66 -34.18 77.28 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 121.452 -0.78 . . . . 0.0 112.709 175.652 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -59.78 -55.53 33.09 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.298 1.039 . . . . 0.0 112.194 168.496 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.65 -24.98 62.8 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -177.921 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.1 t -73.15 -41.65 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 121.422 -0.799 . . . . 0.0 110.942 172.059 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.0 m -64.71 -16.25 62.63 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 177.369 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.4 mt -88.51 -55.42 3.73 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.604 1.162 . . . . 0.0 112.427 167.793 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -69.05 -33.71 74.01 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.829 -1.17 . . . . 0.0 113.595 -173.032 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -86.9 5.62 36.03 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.665 1.186 . . . . 0.0 112.189 176.147 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -97.22 -42.59 7.74 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.664 0.786 . . . . 0.0 112.048 160.22 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -84.9 -2.98 58.5 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -174.897 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 -177.569 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.0 m . . . . . 0 N--CA 1.468 0.457 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.8 p -66.33 147.81 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.193 0.997 . . . . 0.0 112.077 175.843 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.6 mt -132.9 -37.9 1.0 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.673 1.589 . . . . 0.0 112.493 -171.853 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 35.0 t -153.34 137.52 16.5 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.691 1.196 . . . . 0.0 110.585 173.706 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 87.9 t -130.97 126.49 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.654 1.181 . . . . 0.0 109.226 171.708 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -129.2 136.41 29.11 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 125.443 1.497 . . . . 0.0 110.76 176.652 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -81.42 -13.69 10.85 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.267 2.645 . . . . 0.0 115.405 -171.819 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -131.08 105.52 7.77 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.249 1.02 . . . . 0.0 110.945 -175.781 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.0 p -141.77 140.14 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.972 1.309 . . . . 0.0 110.367 172.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.6 m -125.73 126.91 45.37 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.587 1.155 . . . . 0.0 110.979 -171.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 79.1 t -92.85 137.74 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.356 1.462 . . . . 0.0 111.92 -178.848 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -130.83 132.64 45.33 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.945 1.298 . . . . 0.0 109.885 169.5 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -60.22 131.96 52.44 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.256 0.622 . . . . 0.0 109.732 157.398 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.9 pt . . . . . 0 N--CA 1.477 0.892 0 C-N-CA 124.666 1.187 . . . . 0.0 112.431 -173.833 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 . . . . . 0 CA--C 1.532 0.286 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.88 19.42 5.55 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -170.372 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.95 -46.15 0.06 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 128.453 2.701 . . . . 0.0 115.655 -174.632 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 90.9 p -64.04 -18.49 64.38 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.854 2.062 . . . . 0.0 114.61 179.626 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.52 -9.12 59.77 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.077 0.951 . . . . 0.0 113.144 174.054 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 16.7 m0 -92.88 170.58 9.57 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.22 1.408 . . . . 0.0 110.881 177.226 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.1 mtmm -80.28 54.53 2.01 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.041 1.337 . . . . 0.0 113.749 -177.844 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.0 mt -54.66 -29.3 52.11 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 -171.208 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -90.62 -10.67 42.41 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.033 0.933 . . . . 0.0 112.714 179.178 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -139.52 60.42 16.49 Favored Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 126.303 1.841 . . . . 0.0 110.842 -161.487 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -64.66 140.11 66.67 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 120.648 0.899 . . . . 0.0 111.966 -173.225 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -70.52 -26.91 63.79 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.79 0.836 . . . . 0.0 111.445 176.774 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 42.6 t90 -156.96 154.21 29.31 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.552 1.541 . . . . 0.0 111.023 170.08 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.4 p -134.15 144.95 48.84 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.312 1.045 . . . . 0.0 112.083 171.478 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.89 -143.69 5.17 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 123.497 0.57 . . . . 0.0 113.812 -178.087 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 34.8 mtm105 -117.92 148.59 42.01 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.818 2.047 . . . . 0.0 111.193 -172.576 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.7 tp -92.68 141.84 28.03 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.175 1.79 . . . . 0.0 111.029 176.208 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -142.47 99.08 3.42 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.926 1.69 . . . . 0.0 109.716 169.893 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.451 HD11 ' CD2' ' A' ' 119' ' ' PHE . 23.1 mt -85.98 133.8 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 169.693 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.04 168.15 22.28 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.093 1.757 . . . . 0.0 110.495 -168.286 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.2 t -157.17 150.75 24.23 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.741 -1.225 . . . . 0.0 112.087 173.658 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -149.86 134.19 17.33 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.53 151.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.34 50.28 33.69 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.513 1.054 . . . . 0.0 114.814 164.6 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt 60.06 26.88 16.26 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.075 1.75 . . . . 0.0 113.347 -175.765 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.5 m -130.67 124.06 30.76 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 126.028 1.731 . . . . 0.0 108.035 170.142 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -92.94 159.83 15.16 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.647 0.779 . . . . 0.0 110.585 170.183 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -139.04 106.39 5.53 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.149 1.78 . . . . 0.0 108.518 -172.669 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.3 mp -87.37 104.29 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 168.646 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -104.9 138.79 40.6 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.937 1.295 . . . . 0.0 111.121 177.508 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.9 mp -110.23 131.24 55.23 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.814 1.646 . . . . 0.0 109.933 176.596 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -130.38 149.85 51.87 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.558 1.143 . . . . 0.0 112.1 -173.713 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -75.28 152.46 38.24 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.007 -1.058 . . . . 0.0 112.455 177.814 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.564 ' H ' ' HD3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -93.79 -0.61 55.78 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.131 1.773 . . . . 0.0 115.486 -176.829 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.8 t -118.73 -45.8 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.207 1.403 . . . . 0.0 111.378 173.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.3 m -97.24 -21.22 17.4 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -173.714 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.72 6.81 85.51 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.085 0.85 . . . . 0.0 113.886 -177.466 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -79.3 151.25 31.19 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.045 1.338 . . . . 0.0 112.462 -174.513 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.6 tp -72.52 126.82 30.78 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.769 0.828 . . . . 0.0 110.924 178.361 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -86.66 -55.32 3.92 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.425 1.09 . . . . 0.0 111.265 170.688 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.39 160.67 39.85 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.852 1.261 . . . . 0.0 111.58 -178.349 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -141.65 136.22 30.73 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.75 0.82 . . . . 0.0 112.721 177.091 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.99 98.08 47.7 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 125.96 1.704 . . . . 0.0 111.482 -179.068 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -62.52 140.29 80.91 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 124.33 3.353 . . . . 0.0 113.042 166.002 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.1 t -136.43 126.47 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 126.453 1.901 . . . . 0.0 109.223 -178.493 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -86.69 -25.82 24.6 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 121.27 -0.894 . . . . 0.0 113.289 -178.054 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.31 151.15 15.14 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.102 1.761 . . . . 0.0 110.808 173.594 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -122.57 129.82 24.9 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.653 1.181 . . . . 0.0 111.174 176.486 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -62.65 148.2 59.79 Favored 'Cis proline' 0 CA--C 1.539 0.746 0 CA-C-N 119.982 1.029 . . . . 0.0 113.754 -6.14 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.29 -164.38 15.26 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.48 1.514 . . . . 0.0 112.702 179.772 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.0 tt -75.21 -38.32 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -177.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.06 6.51 16.04 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -167.424 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 25.1 t -149.03 132.09 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 125.992 1.717 . . . . 0.0 109.522 178.13 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.24 161.43 38.92 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.006 1.722 . . . . 0.0 111.94 -177.199 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.9 p -110.16 165.67 11.57 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.427 1.491 . . . . 0.0 111.373 177.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.7 m -87.05 179.51 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.469 0.707 . . . . 0.0 110.473 160.116 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 71.0 p -101.23 -30.01 11.77 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.614 1.566 . . . . 0.0 113.543 177.884 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -90.24 -42.77 10.81 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -167.604 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.2 t -143.31 125.12 15.08 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -176.26 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.04 -3.85 14.71 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -170.471 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.42 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.286 0.9 OUTLIER -86.68 22.86 1.81 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.56 1.544 . . . . 0.0 114.615 174.434 . . . . . . . . 4 4 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -142.24 133.25 25.91 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.633 1.173 . . . . 0.0 111.703 -179.575 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -136.07 162.94 31.51 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.373 1.469 . . . . 0.0 111.587 179.347 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 55.2 t -117.14 142.91 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.877 1.271 . . . . 0.0 109.044 168.597 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.62 148.72 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 118.835 0.743 . . . . 0.0 112.47 173.48 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -86.11 85.33 7.36 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.096 0.959 . . . . 0.0 110.406 175.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -68.82 140.31 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 121.945 -0.472 . . . . 0.0 110.428 172.311 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 . . . . . 0 N--CA 1.468 0.435 0 C-N-CA 125.704 1.602 . . . . 0.0 111.087 -171.038 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 38.3 p . . . . . 0 N--CA 1.467 0.416 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -137.3 150.03 47.49 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.646 1.578 . . . . 0.0 110.635 162.873 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -95.32 113.06 24.69 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.497 0.719 . . . . 0.0 109.346 170.177 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 32.2 pt -112.41 146.36 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.62 1.168 . . . . 0.0 111.109 -179.617 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -92.33 142.99 16.26 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 174.271 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 34.3 pt -128.45 139.76 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 125.171 1.388 . . . . 0.0 111.56 172.552 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -118.45 143.96 17.8 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.69 1.614 . . . . 0.0 112.567 174.197 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -105.31 161.39 14.33 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.806 1.642 . . . . 0.0 111.812 -176.373 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.3 t -72.7 -27.63 62.19 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.62 0.768 . . . . 0.0 113.055 178.132 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -156.05 150.75 26.03 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.165 0.986 . . . . 0.0 112.152 -178.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 47.3 ttt-85 -62.27 -34.84 77.31 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.555 1.142 . . . . 0.0 113.107 178.446 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.16 -26.72 73.99 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 118.814 0.734 . . . . 0.0 113.698 176.084 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -85.56 -32.84 21.91 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.048 0.939 . . . . 0.0 111.821 173.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.42 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -67.76 -32.18 72.59 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 170.914 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -57.68 -36.57 72.1 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.547 -0.721 . . . . 0.0 112.074 172.356 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -66.18 -29.27 69.51 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.207 -0.933 . . . . 0.0 112.999 176.431 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.451 ' CD2' HD11 ' A' ' 49' ' ' ILE . 26.1 t80 -62.38 -47.99 81.72 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.473 1.033 . . . . 0.0 112.032 174.029 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -83.33 -25.22 31.68 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.345 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.0 t -78.45 -42.09 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 121.36 -0.838 . . . . 0.0 111.486 177.07 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 92.4 p -65.07 -28.56 69.55 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 179.666 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.3 mt -72.23 -54.41 9.68 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.98 0.912 . . . . 0.0 111.658 170.742 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -68.42 -33.96 75.14 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.028 -1.045 . . . . 0.0 113.102 -173.895 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -86.44 7.33 26.31 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.309 1.044 . . . . 0.0 112.538 175.986 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -102.72 -35.73 8.56 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.056 0.943 . . . . 0.0 112.42 161.885 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -88.6 -3.35 58.82 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -179.508 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.263 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -175.278 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 86.4 t -68.79 143.06 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.651 1.18 . . . . 0.0 111.854 -176.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.6 mt -125.19 -40.98 2.09 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.908 1.683 . . . . 0.0 112.168 -176.278 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 49.9 t -153.2 135.01 14.58 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.563 1.145 . . . . 0.0 110.664 172.091 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 74.1 t -127.88 127.59 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.677 1.191 . . . . 0.0 109.261 170.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -127.87 134.8 26.6 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 124.861 1.264 . . . . 0.0 111.035 174.602 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -63.17 -26.14 72.69 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.084 2.522 . . . . 0.0 114.328 178.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -111.82 129.18 56.23 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.349 1.46 . . . . 0.0 113.228 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.4 p -157.64 142.3 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 126.327 1.851 . . . . 0.0 108.886 158.789 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.7 m -124.4 134.83 52.99 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.361 1.065 . . . . 0.0 110.493 -178.785 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 86.2 t -103.18 134.87 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.819 1.248 . . . . 0.0 111.751 -177.773 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.75 118.92 11.99 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.997 1.319 . . . . 0.0 109.096 172.859 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -63.4 130.46 44.56 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.983 0.913 . . . . 0.0 110.618 176.46 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.6 pt . . . . . 0 N--CA 1.474 0.748 0 C-N-CA 124.645 1.178 . . . . 0.0 112.669 -173.758 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.18 21.19 11.85 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -176.104 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.18 -50.26 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.856 2.462 . . . . 0.0 114.879 -168.421 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.3 m -63.63 -13.89 46.64 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.61 1.964 . . . . 0.0 114.692 -178.474 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.53 -24.0 58.9 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.697 1.199 . . . . 0.0 112.506 172.77 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 12.5 m0 -88.25 168.47 12.69 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.068 1.747 . . . . 0.0 111.499 -174.753 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.3 mtpp -77.45 53.82 1.09 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.836 1.654 . . . . 0.0 113.402 176.861 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.5 mt -55.76 -38.23 69.56 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.84 1.256 . . . . 0.0 114.017 -173.375 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -87.12 -3.84 59.1 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.518 1.127 . . . . 0.0 113.029 179.444 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -136.74 63.64 47.07 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 126.339 1.856 . . . . 0.0 111.561 -166.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -68.9 148.15 69.97 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 CA-C-N 119.916 1.006 . . . . 0.0 113.103 -169.689 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -69.49 -31.12 69.19 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.901 0.88 . . . . 0.0 111.355 168.626 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 39.6 t90 -161.25 155.68 23.04 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.667 1.987 . . . . 0.0 110.414 177.432 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 55.5 p -135.28 147.81 49.33 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.835 1.254 . . . . 0.0 112.002 171.361 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.11 -142.36 5.27 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.177 0.418 . . . . 0.0 114.064 179.994 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.3 mtm180 -106.91 145.27 32.4 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.434 1.894 . . . . 0.0 111.619 -174.596 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.7 tp -82.46 138.49 34.36 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.714 0.806 . . . . 0.0 109.544 163.428 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.6 ttt-85 -145.75 90.76 2.02 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 122.159 0.981 . . . . 0.0 111.333 163.307 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.45 HD11 ' CD1' ' A' ' 119' ' ' PHE . 13.0 mt -73.6 128.3 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 170.444 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.2 p -134.79 175.96 9.09 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.958 2.103 . . . . 0.0 110.642 -177.248 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.7 t -156.53 148.94 23.42 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.687 -1.258 . . . . 0.0 111.118 173.78 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -150.77 132.11 14.6 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.358 0.663 . . . . 0.0 112.76 154.168 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.12 51.13 19.48 Favored Glycine 0 N--CA 1.474 1.213 0 C-N-CA 124.561 1.076 . . . . 0.0 114.298 169.092 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 59.3 23.47 11.9 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 126.412 1.885 . . . . 0.0 113.326 -175.619 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.5 m -130.79 111.65 12.33 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 125.2 1.4 . . . . 0.0 108.733 176.494 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.93 159.36 24.96 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.073 0.463 . . . . 0.0 110.371 172.389 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -137.98 107.24 6.08 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.787 1.635 . . . . 0.0 108.577 -176.187 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.5 mp -78.36 96.63 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 106.463 -1.681 . . . . 0.0 106.463 167.177 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -95.67 137.99 33.96 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.168 0.587 . . . . 0.0 111.479 174.601 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.6 mp -110.43 129.77 55.7 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.066 1.746 . . . . 0.0 110.183 177.024 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -132.9 149.77 52.22 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -166.384 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -65.98 142.5 57.82 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.986 -1.071 . . . . 0.0 112.788 179.02 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.34 -3.78 35.48 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 116.955 2.206 . . . . 0.0 116.955 -177.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.1 t -117.59 -45.04 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.506 1.122 . . . . 0.0 111.822 174.289 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.7 m -117.2 -4.82 11.38 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -169.759 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.5 15.15 79.19 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 123.871 0.748 . . . . 0.0 114.245 176.638 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -61.33 131.72 51.23 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.906 1.683 . . . . 0.0 111.308 -177.267 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 39.0 tp -69.78 115.92 9.57 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 122.782 0.433 . . . . 0.0 111.146 -178.104 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -81.36 -53.87 5.95 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.439 1.095 . . . . 0.0 111.085 173.088 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.55 160.93 38.68 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.064 1.346 . . . . 0.0 111.206 -178.971 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -141.87 137.14 31.19 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.758 0.823 . . . . 0.0 112.572 174.776 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.65 103.72 50.35 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.136 1.374 . . . . 0.0 111.182 177.6 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -67.9 140.97 52.08 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 124.17 3.247 . . . . 0.0 112.65 172.015 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.2 t -135.3 126.63 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.788 1.635 . . . . 0.0 109.464 -177.994 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -90.24 -24.32 20.99 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 179.704 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -161.59 150.0 15.5 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.696 1.999 . . . . 0.0 110.401 172.44 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -121.63 132.38 24.24 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.74 1.216 . . . . 0.0 111.57 176.403 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -62.15 147.21 54.06 Favored 'Cis proline' 0 CA--C 1.541 0.854 0 CA-C-N 119.874 0.991 . . . . 0.0 113.583 -7.153 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.63 -172.49 32.17 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.632 1.11 . . . . 0.0 113.954 -178.722 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.2 tp -61.87 -34.92 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -171.619 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.05 4.62 49.68 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -169.062 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.8 t -149.04 126.48 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.414 1.086 . . . . 0.0 110.539 -178.645 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -139.43 158.57 43.91 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.799 2.04 . . . . 0.0 111.775 -172.698 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.1 p -113.52 163.52 14.82 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.579 1.952 . . . . 0.0 111.381 -179.051 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.2 m -88.8 178.67 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.255 1.422 . . . . 0.0 109.769 165.496 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.2 t -105.16 -23.81 12.85 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.707 1.203 . . . . 0.0 113.604 179.456 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -88.65 -51.17 5.82 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -174.673 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.3 t -139.37 129.79 25.61 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -174.56 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.66 -2.86 12.89 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -171.562 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.485 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.299 31.4 ptt180 -84.78 15.65 3.77 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 178.061 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -140.36 136.77 33.49 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.203 1.401 . . . . 0.0 110.768 -172.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -138.48 165.43 26.86 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.271 1.429 . . . . 0.0 111.281 -178.634 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.5 t -118.49 141.53 37.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 124.7 1.2 . . . . 0.0 108.745 165.547 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.8 148.11 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 119.036 0.835 . . . . 0.0 112.516 171.711 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -89.17 82.41 6.59 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.794 0.838 . . . . 0.0 111.1 177.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -67.72 141.96 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 121.01 0.433 . . . . 0.0 111.04 176.04 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 . . . . . 0 N--CA 1.468 0.454 0 C-N-CA 125.831 1.653 . . . . 0.0 111.307 -170.296 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 65.0 p . . . . . 0 CA--C 1.533 0.314 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.95 147.54 32.81 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.367 1.467 . . . . 0.0 110.873 168.249 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -92.15 115.4 28.05 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.421 0.689 . . . . 0.0 109.316 169.355 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 28.8 pt -112.7 141.73 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.379 1.072 . . . . 0.0 110.747 179.419 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.15 139.73 15.38 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 175.954 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.2 pt -129.49 155.37 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 125.259 1.424 . . . . 0.0 111.952 172.351 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -148.48 166.29 29.13 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 114.421 0.528 . . . . 0.0 114.421 168.57 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -116.73 162.76 17.18 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.995 1.718 . . . . 0.0 111.388 -175.378 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.3 t -70.54 -22.9 62.56 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.462 0.705 . . . . 0.0 112.455 175.635 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -152.76 147.24 25.84 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.798 0.839 . . . . 0.0 112.537 -174.267 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 47.1 ttt-85 -62.61 -32.61 73.65 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.694 1.198 . . . . 0.0 113.152 179.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.26 -27.21 73.84 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-N 118.908 0.776 . . . . 0.0 113.851 176.649 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -84.33 -36.2 22.71 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 118.074 0.937 . . . . 0.0 111.658 175.814 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.485 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -65.17 -32.34 73.98 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 168.564 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -59.32 -37.48 77.89 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.264 -0.898 . . . . 0.0 111.98 173.279 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -67.19 -31.42 71.81 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.194 -0.941 . . . . 0.0 112.847 176.013 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.45 ' CD1' HD11 ' A' ' 49' ' ' ILE . 22.0 t80 -58.6 -50.91 72.09 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.295 0.952 . . . . 0.0 111.545 171.667 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.2 -24.28 30.15 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -176.302 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.3 t -78.46 -40.37 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 O-C-N 121.068 -1.02 . . . . 0.0 110.954 176.641 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 95.0 p -63.75 -28.86 70.17 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 177.411 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 78.5 mt -72.14 -52.97 14.18 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.182 0.993 . . . . 0.0 111.923 172.307 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -68.58 -31.17 70.18 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.993 -1.067 . . . . 0.0 113.22 -176.112 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -87.88 2.14 52.24 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.641 1.176 . . . . 0.0 112.492 174.383 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -92.03 -40.02 11.32 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 120.74 -1.225 . . . . 0.0 111.992 163.975 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -89.31 -1.73 58.18 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 -174.518 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.104 0 CA-C-N 120.25 1.386 . . . . 0.0 114.524 -175.07 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.4 m . . . . . 0 N--CA 1.468 0.432 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.9 t -63.57 141.68 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 124.496 1.118 . . . . 0.0 111.717 178.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.4 mt -126.94 -39.9 1.92 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.992 1.717 . . . . 0.0 112.54 -177.369 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.0 t -152.27 133.06 14.06 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.412 1.085 . . . . 0.0 110.821 174.967 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 81.1 t -128.67 128.13 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.394 1.078 . . . . 0.0 109.319 171.822 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -130.49 134.79 26.46 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 125.293 1.437 . . . . 0.0 110.337 176.429 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -77.35 -13.96 16.58 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.285 2.657 . . . . 0.0 114.76 -174.347 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -134.37 106.57 7.15 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.404 1.082 . . . . 0.0 111.236 -174.125 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -143.69 144.64 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.144 1.378 . . . . 0.0 110.205 171.078 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.0 m -118.0 140.66 49.42 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.354 1.062 . . . . 0.0 111.388 -176.485 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 66.1 t -105.76 138.28 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.726 1.61 . . . . 0.0 111.792 175.741 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -125.1 127.99 47.76 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.47 1.508 . . . . 0.0 108.995 170.67 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -76.58 111.62 12.25 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 165.111 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.7 pt . . . . . 0 N--CA 1.475 0.808 0 C-N-CA 124.492 1.117 . . . . 0.0 113.286 -164.185 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 . . . . . 0 CA--C 1.533 0.32 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.66 25.03 8.93 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.046 0.938 . . . . 0.0 113.385 178.796 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 60.42 -44.81 0.1 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.569 2.347 . . . . 0.0 114.936 -172.269 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.6 m -63.92 -13.14 43.27 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.738 2.015 . . . . 0.0 114.26 177.122 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -59.03 -30.6 68.15 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.834 0.853 . . . . 0.0 112.839 164.95 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 9.2 m0 -99.24 171.23 8.13 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.035 1.334 . . . . 0.0 112.592 -164.447 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -78.86 49.34 0.9 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.377 1.871 . . . . 0.0 113.87 -178.531 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.8 mt -54.86 -35.07 63.63 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -166.635 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -94.79 -1.87 52.02 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.203 1.001 . . . . 0.0 113.644 179.552 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -145.46 73.76 14.04 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 125.573 1.549 . . . . 0.0 112.019 179.658 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.85 148.16 38.63 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.515 2.81 . . . . 0.0 113.736 178.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -71.93 -31.54 66.45 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.247 0.619 . . . . 0.0 111.295 168.269 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 48.7 t90 -154.3 154.37 33.26 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.846 1.659 . . . . 0.0 110.869 174.793 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.4 p -133.36 148.37 51.85 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.109 0.964 . . . . 0.0 111.674 169.004 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.51 -141.76 4.69 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 116.366 -0.379 . . . . 0.0 113.433 -178.804 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.7 mtm105 -114.32 144.97 42.4 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.152 1.781 . . . . 0.0 111.92 -172.901 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.1 tp -85.34 139.98 31.14 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.26 1.424 . . . . 0.0 109.822 168.386 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.1 ttt85 -145.5 86.64 1.75 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.699 1.199 . . . . 0.0 110.866 168.245 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.44 HD11 ' CD2' ' A' ' 119' ' ' PHE . 21.0 mt -74.33 127.74 36.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 170.649 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 p -136.51 171.68 14.14 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.854 2.062 . . . . 0.0 110.188 -178.663 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.7 t -156.7 148.89 23.12 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 120.632 -1.292 . . . . 0.0 111.674 177.866 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -153.59 128.26 9.39 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.723 0.809 . . . . 0.0 112.193 161.418 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.35 54.12 18.0 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.316 0.96 . . . . 0.0 114.231 166.344 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 93.8 mttt 60.02 25.75 15.01 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 126.249 1.82 . . . . 0.0 113.31 -176.059 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.8 m -136.22 114.45 11.57 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.25 1.42 . . . . 0.0 109.429 177.875 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.7 159.78 19.06 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.559 0.743 . . . . 0.0 110.775 173.872 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -139.89 105.31 5.07 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.099 1.76 . . . . 0.0 108.725 -175.727 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.4 mp -79.99 91.99 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 167.974 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -86.01 138.18 32.16 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.221 0.608 . . . . 0.0 110.421 173.167 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.4 mp -112.17 133.33 54.37 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.125 1.77 . . . . 0.0 109.645 173.103 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -135.14 153.47 51.98 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -172.269 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -73.92 144.61 45.26 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.946 0.879 . . . . 0.0 111.94 179.614 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.4 pttt -85.36 -6.18 59.25 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.368 1.867 . . . . 0.0 115.125 -178.635 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 92.6 t -122.47 -44.61 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.234 1.414 . . . . 0.0 111.437 178.648 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.2 m -92.32 -23.06 19.38 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -175.296 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.96 7.16 86.48 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 123.973 0.797 . . . . 0.0 113.702 -177.452 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -82.7 154.51 24.8 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.288 1.435 . . . . 0.0 112.473 -175.082 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.5 tp -73.45 127.18 31.99 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.371 0.668 . . . . 0.0 110.827 177.337 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -84.47 -54.99 4.38 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.427 1.091 . . . . 0.0 110.922 170.098 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -159.5 165.85 32.12 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.689 1.596 . . . . 0.0 110.562 179.755 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -144.99 142.49 29.84 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 168.706 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.78 111.53 48.5 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.071 1.348 . . . . 0.0 111.378 177.729 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -82.85 140.29 10.18 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.57 2.847 . . . . 0.0 111.502 176.961 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.26 128.61 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.396 1.478 . . . . 0.0 109.857 -174.449 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -90.64 -24.26 20.55 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 178.274 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -164.31 149.37 10.15 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.144 1.778 . . . . 0.0 110.411 171.569 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.419 ' CD2' ' HA ' ' A' ' 78' ' ' PRO . 82.5 t80 -125.75 130.28 24.09 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.819 1.248 . . . . 0.0 111.53 -177.554 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.419 ' HA ' ' CD2' ' A' ' 77' ' ' TYR . 73.5 Cg_endo -66.51 143.89 65.54 Favored 'Cis proline' 0 CA--C 1.54 0.801 0 CA-C-N 120.267 1.131 . . . . 0.0 113.353 -2.077 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.02 -168.34 29.06 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.12 1.343 . . . . 0.0 113.637 -176.607 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.3 tp -59.08 -39.64 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -169.659 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -89.31 3.84 50.78 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -167.395 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.6 t -151.54 124.18 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.392 1.077 . . . . 0.0 110.82 -176.88 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -141.39 167.07 23.04 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.626 1.97 . . . . 0.0 112.863 -176.264 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 73.1 p -121.25 158.62 27.72 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.503 1.521 . . . . 0.0 112.061 -169.807 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.3 m -84.62 168.12 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.839 0.856 . . . . 0.0 110.676 166.584 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 72.3 p -96.74 -24.94 15.71 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.956 1.302 . . . . 0.0 113.642 179.532 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -98.69 -38.97 8.89 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -166.21 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.6 t -138.87 124.12 19.17 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -173.905 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.2 m -74.54 26.1 0.08 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 -168.226 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.467 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.265 34.3 ptt180 -125.29 18.69 8.26 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.631 1.572 . . . . 0.0 114.923 179.851 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -140.28 142.6 35.7 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.404 1.082 . . . . 0.0 112.167 -171.795 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -141.7 158.2 44.11 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.189 1.396 . . . . 0.0 111.933 -176.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.2 t -110.68 137.93 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.939 0.895 . . . . 0.0 108.812 163.555 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.88 146.73 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 119.263 0.938 . . . . 0.0 112.018 172.472 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -91.16 92.54 8.72 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.379 0.672 . . . . 0.0 110.124 175.737 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -74.49 152.72 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.07 0.548 . . . . 0.0 111.229 176.09 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.459 0 C-N-CA 125.488 1.515 . . . . 0.0 111.171 173.865 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 95.3 p . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.96 146.1 28.84 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.989 1.315 . . . . 0.0 111.226 172.124 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -87.9 121.11 29.92 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 166.147 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.8 pt -119.32 144.93 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.82 1.248 . . . . 0.0 110.58 176.295 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.04 141.33 16.24 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 174.355 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.6 pt -126.33 144.49 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 124.548 1.139 . . . . 0.0 112.503 168.961 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -125.67 138.27 10.77 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 124.857 1.218 . . . . 0.0 113.244 177.923 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -102.91 163.6 12.12 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.849 1.66 . . . . 0.0 109.998 166.541 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.9 t -92.91 -20.65 20.43 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 175.559 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -109.15 -18.75 13.56 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -149.47 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 60.49 -48.72 0.1 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.914 2.086 . . . . 0.0 114.134 -161.236 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.44 -31.2 66.12 Favored Glycine 0 CA--C 1.539 1.564 0 CA-C-N 119.578 1.081 . . . . 0.0 114.176 174.575 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -81.0 -32.01 34.41 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.35 -1.088 . . . . 0.0 112.466 175.648 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.467 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -68.57 -32.69 72.78 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 168.112 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -60.67 -47.49 86.04 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.588 0.755 . . . . 0.0 110.204 166.767 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -60.3 -42.2 95.01 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 118.703 0.683 . . . . 0.0 112.356 177.19 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.44 ' CD2' HD11 ' A' ' 49' ' ' ILE . 36.9 t80 -53.09 -54.81 30.1 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.811 1.244 . . . . 0.0 112.566 174.125 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -82.4 -26.04 33.17 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -174.71 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.3 t -75.92 -40.97 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 121.6 -0.687 . . . . 0.0 110.898 177.823 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 91.4 p -64.05 -29.81 70.92 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 175.217 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.5 mt -68.81 -59.09 3.33 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.087 0.955 . . . . 0.0 111.779 170.168 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -64.94 -30.98 72.0 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -172.791 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -83.25 -4.15 58.14 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.648 1.179 . . . . 0.0 112.721 178.218 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -95.32 -11.71 27.36 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.94 -1.1 . . . . 0.0 113.39 165.639 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -110.42 -6.02 15.05 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 179.376 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.176 0 CA-C-N 121.182 1.81 . . . . 0.0 113.896 -176.521 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.449 -0.498 0 CA-C-O 121.909 0.862 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.9 t -57.83 139.41 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 125.401 1.48 . . . . 0.0 112.088 -174.062 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.3 mt -125.5 -40.36 2.1 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.682 1.593 . . . . 0.0 112.14 -176.353 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 33.0 t -154.41 136.06 14.36 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.495 1.118 . . . . 0.0 110.678 176.926 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.3 t -130.68 125.79 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.421 1.088 . . . . 0.0 109.239 172.42 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -131.61 142.98 47.28 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 124.68 1.192 . . . . 0.0 112.021 176.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.01 -19.08 20.82 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.535 2.824 . . . . 0.0 115.048 -174.951 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -135.15 112.52 10.56 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.777 0.831 . . . . 0.0 112.279 -167.509 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.3 p -149.64 143.27 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.209 1.803 . . . . 0.0 109.902 171.191 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.9 m -120.71 129.23 53.57 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.351 1.06 . . . . 0.0 111.19 -174.272 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.1 t -93.0 140.47 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.331 1.452 . . . . 0.0 111.929 178.57 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -121.62 129.09 52.58 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.659 1.184 . . . . 0.0 109.628 168.655 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 -78.8 73.9 5.33 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.46 1.504 . . . . 0.0 109.841 172.143 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.7 pt . . . . . 0 CA--C 1.545 0.77 0 C-N-CA 125.629 1.572 . . . . 0.0 114.468 -164.516 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 . . . . . 0 CA--C 1.535 0.372 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.24 17.88 5.46 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -171.77 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.89 -45.84 0.06 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 127.75 2.42 . . . . 0.0 115.679 -175.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.2 m -69.41 -14.46 62.91 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.689 1.596 . . . . 0.0 113.908 -177.318 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.88 -13.31 60.54 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 169.786 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -95.88 171.65 8.51 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.462 1.505 . . . . 0.0 111.613 -174.59 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -79.57 53.81 1.65 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.383 1.473 . . . . 0.0 113.941 -178.463 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 69.3 mt -61.35 -14.85 30.57 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -172.842 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -107.02 -4.51 18.9 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.455 1.102 . . . . 0.0 112.782 177.03 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -150.26 77.18 8.31 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 125.083 1.353 . . . . 0.0 111.653 176.258 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -50.11 141.99 28.95 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.171 2.581 . . . . 0.0 112.462 175.245 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -72.09 -27.72 62.83 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.071 0.548 . . . . 0.0 111.577 175.78 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 33.4 t90 -154.26 156.54 37.21 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.937 1.695 . . . . 0.0 110.738 168.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.9 p -133.97 146.18 50.21 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.623 1.169 . . . . 0.0 111.978 170.327 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 176.77 -142.65 5.97 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 114.536 0.574 . . . . 0.0 114.536 177.213 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -106.22 143.83 33.79 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 126.603 1.961 . . . . 0.0 111.547 -169.822 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.0 tp -88.4 138.18 31.66 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.468 1.507 . . . . 0.0 110.154 170.21 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -143.93 96.77 2.95 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.396 1.078 . . . . 0.0 110.788 168.461 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.427 HD11 ' CD2' ' A' ' 119' ' ' PHE . 16.0 mt -82.06 129.03 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 172.364 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.46 160.57 38.05 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 127.38 2.272 . . . . 0.0 109.738 -177.703 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.7 t -161.37 160.8 29.99 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 120.811 -1.181 . . . . 0.0 111.079 177.517 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -129.22 -106.01 0.29 Allowed 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.142 -0.974 . . . . 0.0 111.499 -174.526 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.59 -116.68 0.21 Allowed Glycine 0 N--CA 1.472 1.072 0 C-N-CA 124.489 1.042 . . . . 0.0 111.134 169.42 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -86.12 25.16 1.2 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.693 1.197 . . . . 0.0 113.118 174.366 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.5 m -137.55 123.0 19.58 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.8 0.84 . . . . 0.0 110.589 -178.312 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.26 164.16 12.25 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.232 1.413 . . . . 0.0 111.706 172.5 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -145.89 103.59 3.77 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.744 1.618 . . . . 0.0 110.054 -172.574 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.7 mp -82.06 101.52 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 169.071 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -102.78 140.8 36.58 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.863 0.84 . . . . 0.0 111.519 176.413 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.3 mp -112.12 132.93 54.58 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.434 1.894 . . . . 0.0 110.045 179.508 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -133.79 151.2 51.5 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.897 0.879 . . . . 0.0 112.518 -168.31 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -69.82 144.0 52.74 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 120.812 -1.18 . . . . 0.0 113.175 -175.409 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.67 -3.79 36.6 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 116.666 2.099 . . . . 0.0 116.666 -179.365 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.1 t -118.8 -50.44 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.749 1.22 . . . . 0.0 110.892 172.622 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.0 m -96.9 -18.15 19.68 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -170.245 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.22 12.6 76.29 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.317 0.96 . . . . 0.0 113.759 -175.672 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -79.97 150.83 30.34 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.079 1.352 . . . . 0.0 112.005 -176.603 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 32.5 tp -71.34 122.16 19.81 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.85 0.86 . . . . 0.0 111.797 -171.663 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -84.64 -56.25 3.7 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.272 1.029 . . . . 0.0 110.877 169.547 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.81 163.24 40.08 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.973 1.309 . . . . 0.0 111.537 -179.042 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -143.85 132.82 22.78 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.603 1.161 . . . . 0.0 111.561 -179.351 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.56 97.78 49.41 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 124.721 1.208 . . . . 0.0 111.236 176.009 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -58.03 136.29 74.04 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 124.085 3.19 . . . . 0.0 112.288 163.065 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.7 t -132.24 123.54 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 126.528 1.931 . . . . 0.0 108.885 -178.42 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -91.56 -19.32 22.88 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 121.413 -0.804 . . . . 0.0 112.781 -177.405 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -163.64 143.21 8.3 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.831 2.452 . . . . 0.0 109.425 -178.584 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -135.92 121.93 13.9 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-O 118.375 -0.822 . . . . 0.0 111.301 175.291 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -61.92 149.45 57.75 Favored 'Cis proline' 0 CA--C 1.539 0.758 0 CA-C-N 119.956 1.02 . . . . 0.0 114.504 -1.648 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -170.96 -158.29 14.58 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 126.016 1.769 . . . . 0.0 112.442 -177.109 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.3 tt -79.17 -39.03 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -176.556 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.35 4.49 17.72 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -168.145 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.9 t -152.02 129.01 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 126.028 1.731 . . . . 0.0 109.744 179.86 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -141.05 160.26 40.47 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.05 1.74 . . . . 0.0 112.24 176.656 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.6 p -101.23 159.39 15.29 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.988 1.715 . . . . 0.0 111.589 175.324 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.4 m -81.28 169.34 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 O-C-N 121.587 -0.696 . . . . 0.0 110.523 162.418 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.5 p -98.31 -24.69 15.12 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.168 1.387 . . . . 0.0 113.587 -178.278 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -100.84 -40.41 7.32 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -167.136 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.5 t -134.41 116.15 14.84 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -175.038 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.6 m -73.59 24.93 0.07 Allowed 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 116.159 1.911 . . . . 0.0 116.159 -165.386 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.413 ' HA ' ' CB ' ' A' ' 116' ' ' ALA . 4.9 ptm180 -127.3 23.43 6.42 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 127.309 2.244 . . . . 0.0 113.875 -178.915 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -140.82 143.94 35.09 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.756 1.623 . . . . 0.0 111.955 -177.124 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -142.04 161.24 38.49 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.251 1.42 . . . . 0.0 111.496 -178.299 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 89.0 t -114.73 139.67 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.403 1.081 . . . . 0.0 109.112 166.455 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.64 147.83 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 118.667 0.667 . . . . 0.0 112.085 173.808 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -89.51 89.33 7.8 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.838 0.855 . . . . 0.0 110.745 178.322 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.1 pp -71.32 140.38 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 122.542 0.337 . . . . 0.0 111.172 175.616 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 . . . . . 0 N--CA 1.472 0.629 0 C-N-CA 125.999 1.72 . . . . 0.0 111.718 -172.769 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.9 p . . . . . 0 CA--C 1.534 0.342 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.91 149.1 34.7 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.661 1.584 . . . . 0.0 110.964 170.021 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -94.05 117.36 30.0 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.465 0.706 . . . . 0.0 109.308 169.122 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 17.8 pt -116.61 147.41 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.595 1.158 . . . . 0.0 111.046 177.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -87.73 146.15 19.8 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 172.394 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.2 pt -129.02 145.51 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 125.388 1.475 . . . . 0.0 111.488 167.167 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.61 146.53 16.96 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 125.097 1.332 . . . . 0.0 113.518 177.163 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -108.47 164.48 12.3 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.286 1.834 . . . . 0.0 111.77 178.605 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.6 t -73.88 -25.49 60.06 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.056 0.942 . . . . 0.0 112.906 177.049 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -156.41 154.68 30.86 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.759 1.224 . . . . 0.0 111.924 -176.229 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -57.45 -35.62 70.37 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.253 1.021 . . . . 0.0 112.82 175.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.25 -35.97 92.36 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 119.48 1.036 . . . . 0.0 113.406 -179.802 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -80.19 -35.48 36.28 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 117.988 0.894 . . . . 0.0 112.265 177.256 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.413 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -62.88 -39.45 94.51 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 169.237 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -68.67 -33.54 74.15 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.065 -1.022 . . . . 0.0 111.877 174.403 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -68.2 -36.87 80.24 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 119.365 0.984 . . . . 0.0 112.417 173.731 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.427 ' CD2' HD11 ' A' ' 49' ' ' ILE . 3.5 t80 -57.91 -45.59 86.26 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.134 1.374 . . . . 0.0 111.65 168.649 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -74.95 -38.16 61.79 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.713 1.205 . . . . 0.0 113.252 -176.399 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.9 t -77.73 -39.75 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 O-C-N 121.213 -0.93 . . . . 0.0 111.599 -179.088 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 78.7 p -64.79 -30.78 71.8 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.236 -0.915 . . . . 0.0 113.125 177.248 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 44.4 tp -73.12 -49.17 29.85 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.805 1.242 . . . . 0.0 111.689 175.331 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -70.52 -23.53 62.66 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.248 -0.907 . . . . 0.0 113.434 -178.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -79.42 -1.04 35.41 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.378 1.071 . . . . 0.0 112.418 175.572 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 45.2 t60 -87.94 -35.3 17.74 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.325 -0.859 . . . . 0.0 112.708 157.504 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -89.29 -5.55 57.48 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 -172.819 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 115.81 1.782 . . . . 0.0 115.81 -175.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.612 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 56.9 m -129.51 112.46 17.89 Favored Pre-proline 0 N--CA 1.477 0.882 0 C-N-CA 124.857 1.263 . . . . 0.0 111.099 -174.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -81.1 2.16 8.78 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 123.946 3.097 . . . . 0.0 113.796 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -68.32 -4.12 13.29 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.337 1.855 . . . . 0.0 114.893 -168.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 61.8 p -68.34 -15.74 63.67 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.203 1.401 . . . . 0.0 113.836 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.3 mtm -129.88 151.29 50.6 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.599 1.56 . . . . 0.0 111.746 174.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.44 -42.99 0.1 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.846 1.258 . . . . 0.0 112.532 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 63.4 m -107.83 101.18 10.48 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.269 1.428 . . . . 0.0 108.351 171.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -129.42 19.53 5.77 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.051 1.341 . . . . 0.0 114.109 -168.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.95 48.1 0.69 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.961 1.704 . . . . 0.0 112.548 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -97.29 52.91 1.14 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.221 1.808 . . . . 0.0 110.334 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -150.03 142.03 23.92 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.566 1.546 . . . . 0.0 109.543 -174.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -176.41 128.55 0.2 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.69 1.596 . . . . 0.0 108.606 167.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.3 m -89.62 110.9 21.73 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 165.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.2 p -68.45 144.81 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 121.557 -0.714 . . . . 0.0 112.544 178.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.5 mt -129.5 -39.81 1.46 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.685 1.594 . . . . 0.0 112.508 -172.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 45.2 t -152.7 134.74 14.85 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.693 1.197 . . . . 0.0 110.384 173.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 94.6 t -130.28 127.24 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.363 1.065 . . . . 0.0 109.68 171.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -131.62 142.07 43.98 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 124.496 1.118 . . . . 0.0 112.206 173.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.6 -15.46 19.45 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.851 3.034 . . . . 0.0 114.972 -175.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -135.48 108.28 7.54 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.072 0.949 . . . . 0.0 111.653 -170.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 p -145.49 144.62 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 125.522 1.529 . . . . 0.0 110.213 171.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.1 m -126.04 129.15 48.58 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.12 0.968 . . . . 0.0 111.371 -171.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.5 t -96.05 136.82 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.738 1.615 . . . . 0.0 112.294 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -129.86 127.92 41.21 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.39 1.476 . . . . 0.0 109.407 170.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -70.1 123.76 22.4 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.359 0.664 . . . . 0.0 109.491 165.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.412 HD12 ' CZ ' ' A' ' 31' ' ' TYR . 30.6 pt -99.12 157.3 34.31 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 124.785 1.234 . . . . 0.0 113.57 -168.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -66.6 156.74 64.2 Favored 'Trans proline' 0 CA--C 1.548 1.215 0 C-N-CA 122.795 2.33 . . . . 0.0 111.425 160.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.58 147.4 70.26 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.221 2.614 . . . . 0.0 112.61 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -68.46 139.52 55.72 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.698 1.199 . . . . 0.0 112.067 -176.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -159.84 137.75 10.05 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.67 1.188 . . . . 0.0 110.196 162.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.9 m -63.83 -17.45 63.14 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.519 1.527 . . . . 0.0 114.614 -175.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -73.78 -10.61 59.85 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.414 1.086 . . . . 0.0 113.287 171.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.3 ptt-85 -128.36 -45.78 1.35 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.789 1.635 . . . . 0.0 113.653 174.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.68 159.59 2.33 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.656 1.122 . . . . 0.0 112.262 -169.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.412 ' CZ ' HD12 ' A' ' 22' ' ' ILE . 17.7 m-30 -72.06 119.14 15.82 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 156.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.86 19.84 10.92 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -174.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 56.81 -48.33 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.932 2.493 . . . . 0.0 115.455 -170.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.9 m -67.58 -15.07 63.46 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.294 1.838 . . . . 0.0 114.85 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.82 -15.99 56.35 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.701 0.8 . . . . 0.0 112.502 172.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 17.9 m0 -86.22 169.52 12.96 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.382 1.473 . . . . 0.0 111.178 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -78.88 57.25 2.09 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.189 1.796 . . . . 0.0 114.211 -177.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.7 mt -61.75 -20.35 63.44 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -95.49 -12.97 24.96 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.509 1.124 . . . . 0.0 112.592 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -152.09 69.72 7.62 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 125.61 1.564 . . . . 0.0 112.265 -165.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -54.37 147.22 47.59 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.471 2.781 . . . . 0.0 113.358 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -72.51 -29.3 63.49 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.195 0.598 . . . . 0.0 111.427 168.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.2 t90 -156.95 154.58 29.92 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.37 1.468 . . . . 0.0 111.058 173.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.2 p -133.93 148.82 51.25 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.239 1.015 . . . . 0.0 111.81 168.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.37 -142.88 5.69 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 123.067 0.365 . . . . 0.0 113.48 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.7 mtm105 -110.51 148.19 32.61 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.305 1.842 . . . . 0.0 112.103 -173.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.0 tp -92.91 137.85 32.0 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.22 1.808 . . . . 0.0 110.277 172.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.6 ttt85 -143.98 88.71 1.98 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.043 1.337 . . . . 0.0 110.869 169.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.503 HD11 ' CD1' ' A' ' 119' ' ' PHE . 25.2 mt -75.78 127.63 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 170.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.1 p -138.62 170.39 16.08 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.664 1.986 . . . . 0.0 110.071 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.9 t -157.85 159.46 36.68 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.804 -1.185 . . . . 0.0 112.198 175.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -146.86 120.76 9.32 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.775 0.798 . . . . 0.0 111.843 159.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.43 -119.65 11.79 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 125.753 1.644 . . . . 0.0 110.139 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -95.55 13.49 25.97 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.6 1.56 . . . . 0.0 113.708 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.0 m -127.58 110.78 13.05 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.934 0.894 . . . . 0.0 111.063 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.85 159.46 19.07 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.405 0.682 . . . . 0.0 111.364 171.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -139.76 105.98 5.25 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.302 1.841 . . . . 0.0 109.252 -174.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.7 mp -82.61 97.55 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 168.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.4 mttp -94.31 139.29 31.27 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.38 0.672 . . . . 0.0 111.448 174.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.5 mp -112.34 135.51 52.94 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.445 1.898 . . . . 0.0 109.775 172.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -136.15 153.67 51.2 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.941 0.896 . . . . 0.0 113.018 -172.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -74.12 143.94 45.12 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.931 0.872 . . . . 0.0 111.969 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 pttt -84.87 -6.46 59.35 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.371 1.868 . . . . 0.0 115.124 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 92.0 t -122.4 -44.58 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 125.234 1.414 . . . . 0.0 111.396 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.7 m -91.72 -23.5 19.76 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -175.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.33 7.04 86.91 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 123.776 0.703 . . . . 0.0 113.586 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -82.81 155.55 24.13 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.327 1.451 . . . . 0.0 112.326 -175.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.7 tp -72.31 125.98 28.69 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.372 0.669 . . . . 0.0 110.684 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -84.51 -53.9 5.11 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.944 0.898 . . . . 0.0 110.915 169.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.34 161.3 37.6 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.067 1.347 . . . . 0.0 111.357 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -142.67 139.89 31.37 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.391 0.676 . . . . 0.0 112.382 171.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.98 110.54 41.57 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 124.854 1.261 . . . . 0.0 111.135 176.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -80.52 140.45 13.39 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.894 3.063 . . . . 0.0 111.565 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.1 t -134.83 131.26 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.805 1.642 . . . . 0.0 109.817 -172.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -97.47 -19.8 18.18 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -163.53 150.46 12.31 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.97 2.108 . . . . 0.0 110.085 175.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -125.57 130.67 24.01 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.558 1.143 . . . . 0.0 112.452 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -60.46 151.29 50.81 Favored 'Cis proline' 0 CA--C 1.54 0.781 0 CA-C-N 119.919 1.007 . . . . 0.0 113.313 -12.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.35 -171.35 29.49 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.909 1.242 . . . . 0.0 113.485 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.6 tp -59.29 -31.51 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.54 4.27 53.9 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -172.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.7 t -148.98 130.35 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.162 0.985 . . . . 0.0 111.233 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -140.39 162.4 35.41 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.325 1.85 . . . . 0.0 112.545 -176.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 38.8 p -117.33 158.03 25.09 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 127.1 2.16 . . . . 0.0 111.587 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.0 m -85.21 173.46 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.556 1.142 . . . . 0.0 111.385 168.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 72.5 p -94.49 -32.5 13.47 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.238 1.415 . . . . 0.0 113.17 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -94.59 -40.91 9.59 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -163.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.5 t -141.02 130.35 23.68 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -175.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.1 m -73.01 16.38 0.16 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -171.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.47 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.28 33.5 ptt180 -111.44 18.5 19.1 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 178.631 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -139.32 135.55 33.9 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.078 0.951 . . . . 0.0 110.842 -172.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -133.77 163.81 28.63 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.907 1.283 . . . . 0.0 111.016 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.7 t -120.6 142.59 35.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 124.583 1.153 . . . . 0.0 108.744 167.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.89 148.0 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 118.721 0.692 . . . . 0.0 112.425 173.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -89.88 81.77 6.28 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.675 0.79 . . . . 0.0 111.369 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -67.09 142.52 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 122.577 0.351 . . . . 0.0 111.372 177.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -138.3 148.32 44.53 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.733 1.613 . . . . 0.0 111.68 -171.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -94.04 2.75 55.99 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.393 1.077 . . . . 0.0 113.106 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.23 13.17 81.25 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.155 1.36 . . . . 0.0 114.68 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.9 t -139.04 15.37 2.64 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.579 1.552 . . . . 0.0 113.469 -171.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.32 -2.46 78.32 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.547 1.07 . . . . 0.0 114.953 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -74.76 135.17 41.76 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.318 1.447 . . . . 0.0 108.567 164.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.2 p -148.57 158.47 44.15 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 171.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.76 145.76 31.83 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.282 1.433 . . . . 0.0 110.869 169.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -90.66 118.36 30.04 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.131 0.573 . . . . 0.0 109.485 168.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.4 pt -117.27 141.54 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.306 1.042 . . . . 0.0 110.753 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.9 143.41 17.07 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 174.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.0 pt -128.87 140.86 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 125.341 1.456 . . . . 0.0 111.679 173.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -119.66 143.91 17.24 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.042 1.306 . . . . 0.0 113.338 175.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -106.88 167.86 9.59 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.352 1.861 . . . . 0.0 111.032 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.8 t -71.78 -36.09 70.23 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.738 -0.601 . . . . 0.0 112.304 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -153.07 153.32 32.61 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.204 -0.935 . . . . 0.0 112.299 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -58.07 -36.69 73.16 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.652 1.181 . . . . 0.0 112.096 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.95 -13.42 64.11 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 123.916 0.77 . . . . 0.0 114.408 177.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -102.44 -34.07 9.29 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 118.431 1.115 . . . . 0.0 112.376 170.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.47 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -64.07 -29.97 71.07 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.088 -1.008 . . . . 0.0 113.253 170.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -54.95 -33.35 62.21 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.603 -0.686 . . . . 0.0 112.289 168.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -69.25 -33.75 73.74 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.087 -1.008 . . . . 0.0 112.028 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.503 ' CD1' HD11 ' A' ' 49' ' ' ILE . 18.6 t80 -60.56 -50.32 74.03 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.143 0.977 . . . . 0.0 111.475 171.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.49 -26.27 45.91 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -177.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.5 t -77.39 -43.25 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 119.301 0.955 . . . . 0.0 111.246 175.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 96.7 p -64.85 -31.03 72.07 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.36 0.982 . . . . 0.0 113.103 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.7 mt -69.03 -54.89 12.75 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.063 0.945 . . . . 0.0 112.061 170.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -67.22 -29.71 69.44 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.055 -1.028 . . . . 0.0 112.978 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -82.84 -2.7 55.39 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.566 1.147 . . . . 0.0 112.672 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 63.9 t60 -88.39 -42.6 12.07 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.391 -0.818 . . . . 0.0 111.812 157.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -84.44 -7.24 59.35 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -172.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.25 -35.79 38.74 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 120.971 1.714 . . . . 0.0 115.366 -173.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 39.9 p-90 -75.78 -34.29 60.2 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.464 0.706 . . . . 0.0 112.897 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.7 t -67.2 -34.19 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.836 1.255 . . . . 0.0 110.5 171.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -80.51 5.3 15.62 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.091 2.156 . . . . 0.0 114.257 174.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 55.2 29.96 13.66 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 127.732 2.413 . . . . 0.0 115.587 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 . . . . . 0 C--O 1.253 1.241 0 C-N-CA 125.25 1.42 . . . . 0.0 113.911 177.471 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.651 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 43.8 m -66.63 145.83 98.99 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 124.302 1.041 . . . . 0.0 112.845 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -77.75 -9.16 17.05 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.623 2.882 . . . . 0.0 113.867 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -138.49 167.4 22.0 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.147 1.779 . . . . 0.0 111.959 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 18.5 m -91.0 5.09 50.2 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -171.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.2 mmm -82.2 57.92 3.79 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.907 -1.121 . . . . 0.0 112.418 -174.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.05 -11.41 18.15 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.682 1.593 . . . . 0.0 112.829 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.5 m 50.08 68.62 0.72 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 127.004 2.122 . . . . 0.0 112.843 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -101.73 19.54 17.96 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -163.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.79 50.33 0.69 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.416 1.886 . . . . 0.0 112.372 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -93.54 51.72 1.63 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.114 1.766 . . . . 0.0 110.946 -177.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -151.12 143.21 24.01 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.329 1.452 . . . . 0.0 110.351 -174.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -176.84 125.42 0.16 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.666 1.586 . . . . 0.0 109.099 171.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.8 m -92.86 109.2 20.64 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.817 0.847 . . . . 0.0 109.446 168.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.402 ' HA ' HG22 ' A' ' 50' ' ' THR . 45.0 t -63.75 142.49 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 124.005 0.922 . . . . 0.0 111.761 177.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.7 mt -128.31 -43.56 1.45 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.309 1.443 . . . . 0.0 112.592 -176.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 34.2 t -148.39 135.16 19.91 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.379 1.072 . . . . 0.0 111.037 175.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.1 t -128.55 128.03 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.734 1.214 . . . . 0.0 109.539 172.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -124.9 135.28 26.53 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 125.577 1.551 . . . . 0.0 109.774 172.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -73.54 -29.57 10.8 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.918 2.412 . . . . 0.0 115.179 -168.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -138.16 114.92 10.64 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.263 1.03 . . . . 0.0 111.86 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.2 p -143.43 149.01 18.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 127.788 2.435 . . . . 0.0 109.004 176.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.2 m -123.3 132.02 53.86 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.257 0.623 . . . . 0.0 112.17 -167.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.7 t -96.24 138.21 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.837 1.655 . . . . 0.0 111.904 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -130.19 136.77 49.61 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.139 -1.392 . . . . 0.0 110.31 171.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -56.6 137.43 53.78 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.296 151.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.3 pt -109.09 151.0 41.72 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 125.182 1.393 . . . . 0.0 111.258 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -70.19 162.57 41.79 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.426 2.751 . . . . 0.0 111.919 172.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -61.46 130.6 32.46 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.971 2.447 . . . . 0.0 111.806 176.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.3 ttm-85 -73.54 148.82 42.67 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.313 1.045 . . . . 0.0 112.57 -174.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.1 156.16 39.32 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.169 153.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.4 m -65.77 -26.64 67.8 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.751 1.621 . . . . 0.0 113.832 -177.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -78.13 -1.84 34.56 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.453 1.101 . . . . 0.0 112.958 171.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -112.53 -60.62 1.84 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.483 1.913 . . . . 0.0 110.193 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.88 161.23 0.85 Allowed Glycine 0 CA--C 1.528 0.856 0 CA-C-O 122.133 0.852 . . . . 0.0 111.963 -163.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 18.8 m-30 -77.61 124.12 27.52 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 121.647 -0.914 . . . . 0.0 109.224 163.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.66 16.35 9.53 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -172.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.65 -46.5 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 128.152 2.581 . . . . 0.0 115.547 -171.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 94.5 p -68.41 -18.59 64.48 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.536 1.935 . . . . 0.0 115.082 -176.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -85.94 -1.95 57.81 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.22 1.008 . . . . 0.0 113.402 171.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.9 m0 -90.72 174.12 7.66 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.925 1.29 . . . . 0.0 110.952 174.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -76.67 47.98 0.53 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.855 1.662 . . . . 0.0 114.646 -176.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.2 mt -56.4 -33.55 65.87 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 -169.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -91.5 -2.51 57.18 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -145.74 71.99 13.86 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 125.868 1.667 . . . . 0.0 111.994 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -52.5 138.11 57.38 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.513 2.142 . . . . 0.0 112.088 174.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -73.09 -25.24 60.81 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.11 0.564 . . . . 0.0 111.194 172.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 50.4 t90 -155.84 154.08 30.74 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.69 1.596 . . . . 0.0 110.801 170.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.8 p -134.28 151.29 51.19 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.663 0.785 . . . . 0.0 112.001 165.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 173.04 -149.66 11.52 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 123.155 0.407 . . . . 0.0 113.484 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.0 mtt180 -94.35 141.15 28.91 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.227 1.811 . . . . 0.0 111.609 -174.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 24.9 tp -79.22 138.04 37.65 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 157.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.7 ttt-85 -144.82 87.47 1.85 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.234 1.016 . . . . 0.0 110.905 167.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.5 mt -72.44 127.07 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 172.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.402 HG22 ' HA ' ' A' ' 10' ' ' VAL . 7.5 p -134.19 165.02 26.07 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.697 1.999 . . . . 0.0 109.933 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.4 m -147.57 161.56 40.87 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.807 1.243 . . . . 0.0 112.212 175.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -150.6 118.09 6.09 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.307 0.643 . . . . 0.0 111.482 157.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 65.14 -132.23 36.22 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.034 1.302 . . . . 0.0 110.635 -175.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -85.92 22.65 1.64 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.902 1.681 . . . . 0.0 113.922 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.1 m -131.71 126.66 35.08 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.768 1.227 . . . . 0.0 110.282 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.63 160.04 14.59 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.659 1.184 . . . . 0.0 110.94 168.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -142.07 105.43 4.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.372 1.869 . . . . 0.0 108.986 -173.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.3 mp -81.03 95.99 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 169.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -92.04 137.95 31.94 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.274 0.63 . . . . 0.0 110.813 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.8 mp -112.43 128.88 56.44 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.814 1.646 . . . . 0.0 109.723 174.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -135.66 148.83 49.1 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.157 0.983 . . . . 0.0 111.639 -169.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -69.31 139.86 54.32 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 120.432 -1.417 . . . . 0.0 111.72 -176.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.5 pttt -79.74 -4.56 52.47 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -177.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.8 t -123.06 -43.59 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 125.297 1.439 . . . . 0.0 111.363 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.4 m -94.42 -21.97 18.59 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.41 15.37 77.2 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.143 0.878 . . . . 0.0 113.788 -176.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -88.5 148.44 24.15 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.212 1.405 . . . . 0.0 112.056 -176.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.6 tp -71.59 126.78 30.57 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.445 -0.784 . . . . 0.0 111.272 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -84.83 -58.9 2.52 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.055 0.942 . . . . 0.0 110.552 168.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.84 165.8 35.41 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.109 1.363 . . . . 0.0 111.369 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -142.46 143.0 32.41 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.333 0.653 . . . . 0.0 112.47 171.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.37 105.85 41.19 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 124.871 1.268 . . . . 0.0 110.99 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -77.22 145.06 23.92 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.792 2.995 . . . . 0.0 111.948 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.2 t -138.03 127.36 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 126.245 1.818 . . . . 0.0 109.58 -172.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -91.32 -22.77 20.37 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.66 147.83 13.93 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.412 1.885 . . . . 0.0 110.437 170.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -116.33 129.97 24.83 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.589 1.156 . . . . 0.0 110.956 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.83 149.09 79.9 Favored 'Cis proline' 0 CA--C 1.543 0.946 0 CA-C-N 119.824 0.973 . . . . 0.0 112.733 -6.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.68 -164.38 13.14 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.6 1.571 . . . . 0.0 112.548 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 19.3 tt -72.42 -35.58 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 121.654 -0.909 . . . . 0.0 112.979 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.67 6.26 21.55 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -167.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.0 t -151.37 129.18 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.508 1.523 . . . . 0.0 109.984 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -141.77 162.22 36.01 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.217 1.807 . . . . 0.0 112.86 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.5 p -109.75 160.35 16.4 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.792 2.037 . . . . 0.0 111.431 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.4 m -85.95 175.45 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 124.477 1.111 . . . . 0.0 111.398 168.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 71.8 p -91.18 -36.84 13.72 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.954 1.702 . . . . 0.0 112.098 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -89.33 -43.59 10.82 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -166.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.6 t -142.45 122.45 13.65 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -171.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.58 -9.06 23.38 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -169.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.451 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.305 49.0 ptt85 -84.73 19.33 2.07 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 178.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -139.13 139.94 37.78 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.479 1.512 . . . . 0.0 111.977 -176.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -140.66 162.21 35.94 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.437 1.495 . . . . 0.0 111.683 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 78.6 t -116.14 142.27 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.372 1.069 . . . . 0.0 109.294 166.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.67 147.3 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 118.98 0.809 . . . . 0.0 112.399 173.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -88.91 82.5 6.71 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.833 0.853 . . . . 0.0 111.187 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.5 pt -63.36 144.71 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 120.819 0.342 . . . . 0.0 111.696 174.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -137.04 140.39 42.02 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.661 1.584 . . . . 0.0 110.868 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -90.46 15.52 10.57 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.474 1.11 . . . . 0.0 113.573 -175.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.22 11.56 71.17 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 125.124 1.345 . . . . 0.0 115.669 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.9 t -134.25 -0.39 3.01 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.998 1.319 . . . . 0.0 114.462 -168.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 103.43 25.47 7.35 Favored Glycine 0 CA--C 1.536 1.376 0 O-C-N 120.836 -1.165 . . . . 0.0 114.288 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -132.49 144.28 50.34 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.103 2.161 . . . . 0.0 110.107 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.1 p -148.21 160.22 43.16 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -171.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.15 145.16 29.45 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.941 1.296 . . . . 0.0 111.389 171.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -90.66 114.53 26.85 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.794 0.837 . . . . 0.0 109.322 170.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.4 pt -115.01 148.73 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.875 1.27 . . . . 0.0 111.228 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.04 143.91 16.91 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 174.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.7 pt -128.24 144.01 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 125.386 1.474 . . . . 0.0 111.34 169.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.16 139.6 11.08 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.888 1.233 . . . . 0.0 112.967 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -101.17 157.18 16.96 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.814 1.646 . . . . 0.0 111.466 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.1 t -73.52 -20.27 60.7 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.911 0.884 . . . . 0.0 112.822 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -152.24 148.79 27.98 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.526 1.13 . . . . 0.0 111.935 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 47.4 ttt-85 -63.04 -31.53 72.68 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.642 1.177 . . . . 0.0 113.503 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.52 -31.76 79.67 Favored Glycine 0 CA--C 1.536 1.365 0 CA-C-N 119.039 0.836 . . . . 0.0 113.572 176.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -78.39 -35.44 47.19 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.771 -0.841 . . . . 0.0 111.407 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.451 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -65.97 -37.13 85.17 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.926 0.891 . . . . 0.0 113.209 168.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.21 -40.44 97.48 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.508 -0.745 . . . . 0.0 111.25 171.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -62.33 -36.76 83.2 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.592 1.087 . . . . 0.0 112.55 172.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -57.42 -56.33 23.3 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.392 0.996 . . . . 0.0 112.017 171.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -75.7 -24.68 56.26 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -176.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.5 -38.68 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 121.058 -1.027 . . . . 0.0 110.773 173.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 41.2 t -57.67 -38.55 75.3 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.406 0.683 . . . . 0.0 112.529 176.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.9 -52.32 20.81 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.456 0.702 . . . . 0.0 112.36 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -67.57 -28.48 67.81 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.045 -1.034 . . . . 0.0 113.064 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -83.91 0.1 49.15 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.581 1.152 . . . . 0.0 112.724 175.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -89.51 -39.97 12.97 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.253 -0.904 . . . . 0.0 112.284 161.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -91.99 -1.92 57.0 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -172.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.77 -30.02 55.56 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -177.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -83.47 -24.55 31.75 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.211 1.004 . . . . 0.0 113.374 176.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 19.6 t -80.93 -31.37 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.404 1.482 . . . . 0.0 111.097 176.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -92.46 26.99 2.41 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.718 2.007 . . . . 0.0 112.925 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -79.05 89.22 4.79 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.824 0.821 . . . . 0.0 109.954 172.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 . . . . . 0 C--O 1.252 1.226 0 C-N-CA 126.672 1.989 . . . . 0.0 112.737 -172.088 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.585 0 N-CA-C 111.64 -0.584 . . . . 0.0 111.64 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 56.3 m -133.5 147.93 66.69 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 125.389 1.476 . . . . 0.0 111.573 -177.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -76.12 -9.34 19.19 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.509 2.806 . . . . 0.0 114.295 -176.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -59.9 -28.58 67.7 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.505 1.122 . . . . 0.0 113.506 -173.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 77.6 p -63.38 -19.1 64.36 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.467 1.107 . . . . 0.0 113.969 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.9 mtp -76.24 -3.12 34.81 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.696 1.198 . . . . 0.0 113.254 174.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.19 -37.73 0.87 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.28 1.432 . . . . 0.0 112.706 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 51.2 m -137.79 108.32 6.55 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.058 1.343 . . . . 0.0 110.269 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -141.79 19.1 2.16 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.814 1.245 . . . . 0.0 113.67 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tt -77.77 96.37 4.9 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.913 1.285 . . . . 0.0 111.003 -178.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -136.87 48.84 2.08 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.512 1.525 . . . . 0.0 110.557 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -154.0 151.56 29.51 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.361 1.864 . . . . 0.0 110.308 -172.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -179.22 120.41 0.07 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.597 1.559 . . . . 0.0 108.304 165.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.7 m -94.71 107.97 19.97 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.799 -0.563 . . . . 0.0 110.122 170.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.0 t -65.43 145.83 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.473 1.109 . . . . 0.0 111.409 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.6 mt -129.86 -39.73 1.4 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.124 1.769 . . . . 0.0 112.309 -172.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 37.6 t -152.15 137.38 17.47 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.687 1.195 . . . . 0.0 110.646 174.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 88.5 t -129.77 126.87 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.764 1.226 . . . . 0.0 109.275 171.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -126.78 136.08 28.24 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 125.677 1.591 . . . . 0.0 110.233 174.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -78.9 -15.8 13.05 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.158 2.572 . . . . 0.0 115.037 -173.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -130.89 107.32 9.03 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.379 1.072 . . . . 0.0 110.904 -176.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -140.16 141.5 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 125.475 1.51 . . . . 0.0 109.988 170.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.5 m -124.35 125.84 44.99 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.301 1.04 . . . . 0.0 111.12 -171.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.7 t -92.4 136.72 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.064 1.346 . . . . 0.0 111.79 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -126.46 128.6 47.21 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.942 1.297 . . . . 0.0 109.284 169.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -65.33 133.68 51.93 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 160.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.6 pt -109.22 148.42 37.96 Favored Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 124.445 1.098 . . . . 0.0 112.483 -172.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -68.9 163.69 36.5 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.525 2.817 . . . . 0.0 112.453 173.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.76 114.85 2.75 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.934 2.423 . . . . 0.0 110.087 168.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -152.62 166.25 32.67 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.28 1.432 . . . . 0.0 112.93 -165.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.3 125.34 29.22 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 122.254 1.026 . . . . 0.0 111.555 172.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 64.3 p -77.75 -14.09 59.7 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 -157.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -139.37 17.22 2.57 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.943 1.297 . . . . 0.0 112.602 169.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -134.05 -28.45 1.35 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.595 1.558 . . . . 0.0 114.046 -175.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -118.49 -19.26 4.63 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.502 1.049 . . . . 0.0 115.431 -175.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 -67.48 107.01 2.31 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.547 1.173 . . . . 0.0 109.59 164.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.14 20.83 13.56 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.27 -48.94 0.05 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 127.175 2.19 . . . . 0.0 114.672 -163.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.2 m -64.46 -9.17 16.76 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.362 1.865 . . . . 0.0 114.739 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.5 -11.41 59.9 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.645 1.178 . . . . 0.0 112.876 172.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -104.18 175.92 5.33 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.248 1.819 . . . . 0.0 112.499 -171.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -76.92 47.33 0.51 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.715 2.006 . . . . 0.0 114.455 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.6 mt -55.0 -34.3 63.32 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -169.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -95.45 -0.36 52.45 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.134 0.973 . . . . 0.0 113.29 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.37 61.61 10.26 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 126.23 1.812 . . . . 0.0 111.719 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -55.44 136.67 74.84 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.593 2.195 . . . . 0.0 112.034 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -69.64 -26.04 64.22 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.561 1.144 . . . . 0.0 111.666 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.4 t90 -154.86 152.8 30.22 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.683 1.593 . . . . 0.0 110.747 170.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.7 p -134.42 148.79 50.7 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.874 0.87 . . . . 0.0 111.927 169.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.59 -145.34 6.5 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 113.931 0.333 . . . . 0.0 113.931 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -108.82 148.82 29.99 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.29 1.836 . . . . 0.0 111.721 -176.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 61.0 tp -92.92 142.22 27.55 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.099 1.76 . . . . 0.0 110.832 173.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -144.03 94.29 2.56 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.269 1.827 . . . . 0.0 109.494 173.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.482 HD11 ' CD2' ' A' ' 119' ' ' PHE . 27.9 mt -84.23 134.43 26.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 170.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.24 166.69 26.27 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.037 1.735 . . . . 0.0 110.338 -166.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 99.0 p -156.52 160.5 39.56 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 120.845 -1.159 . . . . 0.0 112.3 175.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -151.04 120.46 6.88 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.472 0.709 . . . . 0.0 112.23 156.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 65.22 -132.12 35.98 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 125.088 1.327 . . . . 0.0 110.502 -176.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -87.19 26.6 1.17 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.637 1.575 . . . . 0.0 113.328 178.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.0 m -132.97 129.65 38.51 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.85 1.26 . . . . 0.0 110.172 173.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.76 160.8 14.15 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.648 1.179 . . . . 0.0 110.577 167.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -140.64 109.61 6.08 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.811 1.644 . . . . 0.0 108.952 -173.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.0 mp -88.08 105.58 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 168.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -107.66 142.38 37.71 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.592 1.157 . . . . 0.0 111.179 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.4 mp -115.23 131.58 56.88 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.429 1.891 . . . . 0.0 109.656 177.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -133.58 148.35 51.59 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.828 0.851 . . . . 0.0 112.614 -174.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -67.47 135.64 53.38 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.065 0.946 . . . . 0.0 111.573 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -75.15 -6.96 52.38 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 -175.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 86.3 t -119.22 -43.72 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.158 1.383 . . . . 0.0 111.389 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.5 m -93.44 -20.15 20.58 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -175.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.8 15.7 76.0 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.279 0.942 . . . . 0.0 113.588 -177.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -90.53 149.92 21.98 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.144 1.378 . . . . 0.0 112.355 -174.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 31.3 tp -70.91 123.89 23.07 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.727 0.811 . . . . 0.0 111.566 -176.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -86.46 -55.24 3.98 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.47 1.108 . . . . 0.0 111.123 170.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.79 162.57 39.73 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.507 1.123 . . . . 0.0 112.146 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -142.71 135.21 27.75 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.052 1.341 . . . . 0.0 111.891 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.0 100.59 42.82 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.534 1.534 . . . . 0.0 111.136 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -68.45 142.07 53.01 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.995 3.13 . . . . 0.0 112.529 170.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.1 t -134.52 130.58 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.868 1.667 . . . . 0.0 109.894 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -86.1 -26.37 25.29 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -164.63 153.89 13.26 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.551 1.54 . . . . 0.0 111.239 169.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -118.02 133.0 23.44 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.883 1.273 . . . . 0.0 111.461 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.37 147.83 75.91 Favored 'Cis proline' 0 CA--C 1.541 0.875 0 CA-C-N 119.899 0.999 . . . . 0.0 112.22 -8.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.9 -175.82 36.69 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.491 1.043 . . . . 0.0 114.058 -177.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.2 tp -53.71 -34.65 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -169.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.04 4.92 52.03 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -172.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.6 t -148.6 127.31 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 CA-C-N 119.409 1.004 . . . . 0.0 111.739 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -140.61 168.93 18.64 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.648 1.979 . . . . 0.0 113.116 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 34.0 p -123.09 158.89 29.66 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.586 1.954 . . . . 0.0 111.59 -171.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.8 m -85.81 173.22 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 O-C-N 121.573 -0.704 . . . . 0.0 112.121 169.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 70.8 p -87.34 -35.93 18.12 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.851 1.26 . . . . 0.0 112.586 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -94.11 -42.4 9.01 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -162.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.4 t -143.33 130.24 20.52 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.3 m -69.3 4.53 1.66 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -172.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.446 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.281 30.2 ptt180 -96.59 17.05 17.15 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 176.1 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -140.15 132.12 27.76 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.181 0.992 . . . . 0.0 110.784 -174.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -137.05 162.53 33.08 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.325 1.45 . . . . 0.0 110.495 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.6 t -121.59 139.3 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.425 1.09 . . . . 0.0 108.717 171.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.29 147.44 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 118.81 0.732 . . . . 0.0 112.536 176.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -90.15 85.92 6.4 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.461 0.705 . . . . 0.0 111.099 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -69.38 139.95 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 122.635 0.374 . . . . 0.0 111.161 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -138.76 144.03 39.25 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.172 1.789 . . . . 0.0 111.429 -170.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -91.25 2.87 56.05 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.082 0.953 . . . . 0.0 113.154 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.24 13.79 80.1 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.17 1.367 . . . . 0.0 114.691 178.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.2 t -140.42 16.51 2.39 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.487 1.515 . . . . 0.0 113.509 -171.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.24 -2.03 80.62 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 124.58 1.086 . . . . 0.0 115.063 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -76.23 134.47 39.83 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.345 1.458 . . . . 0.0 108.482 164.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 80.7 p -151.2 159.87 44.17 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 171.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.73 147.58 32.08 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.604 1.561 . . . . 0.0 110.992 169.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -90.71 120.62 31.92 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.098 0.559 . . . . 0.0 109.584 167.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.9 pt -117.79 143.03 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.553 1.141 . . . . 0.0 110.871 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.38 143.15 17.14 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 174.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.9 pt -127.35 139.0 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 124.987 1.315 . . . . 0.0 111.644 171.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.37 143.7 16.72 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.83 1.681 . . . . 0.0 112.251 174.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -106.37 167.67 9.67 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.64 1.576 . . . . 0.0 111.534 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.3 t -68.91 -36.21 77.74 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.143 0.577 . . . . 0.0 112.172 175.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -156.66 154.3 29.89 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.086 -1.009 . . . . 0.0 112.048 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 72.2 mtm-85 -55.74 -39.34 71.0 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.554 1.142 . . . . 0.0 112.382 173.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.78 -6.53 30.68 Favored Glycine 0 CA--C 1.542 1.731 0 C-N-CA 124.407 1.004 . . . . 0.0 115.133 178.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -111.22 -33.86 6.33 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.243 1.417 . . . . 0.0 111.728 168.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.446 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -69.72 -24.96 63.63 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 175.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -61.21 -30.4 70.4 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.729 -1.232 . . . . 0.0 112.297 169.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -69.92 -27.93 65.18 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.495 1.043 . . . . 0.0 112.635 176.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.482 ' CD2' HD11 ' A' ' 49' ' ' ILE . 10.6 t80 -61.81 -44.87 95.99 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.408 -0.807 . . . . 0.0 111.26 169.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -76.95 -35.26 57.4 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.376 1.07 . . . . 0.0 113.147 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 66.6 t -78.73 -38.86 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.366 -0.834 . . . . 0.0 111.87 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 88.5 p -66.86 -31.65 72.4 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.984 -1.073 . . . . 0.0 113.312 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 73.2 mt -68.85 -51.6 38.73 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.943 0.897 . . . . 0.0 111.859 172.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -68.09 -27.8 66.8 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.111 -0.993 . . . . 0.0 112.756 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -82.44 -3.02 54.97 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.399 1.08 . . . . 0.0 112.795 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -89.63 -40.7 12.41 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 121.315 -0.866 . . . . 0.0 111.963 160.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -90.55 -0.29 57.62 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 -173.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.25 -29.72 58.63 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 120.909 1.686 . . . . 0.0 115.288 -177.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 41.7 p-90 -82.9 -19.5 37.22 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.815 1.042 . . . . 0.0 113.815 175.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 37.4 t -87.32 -30.04 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.741 1.616 . . . . 0.0 111.086 173.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 51.0 mmtt -88.65 40.77 0.98 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.131 2.172 . . . . 0.0 111.733 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -93.02 16.31 13.05 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.353 1.461 . . . . 0.0 113.427 173.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 . . . . . 0 C--O 1.251 1.139 0 C-N-CA 125.964 1.705 . . . . 0.0 114.893 177.874 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.622 0 N-CA-C 112.106 -0.398 . . . . 0.0 112.106 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 20.3 m -67.05 148.35 98.89 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.545 1.138 . . . . 0.0 112.872 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -77.17 -9.58 17.78 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 123.561 2.84 . . . . 0.0 114.084 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -136.96 166.39 23.77 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.93 1.692 . . . . 0.0 111.668 177.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 88.5 p -78.25 -10.88 59.85 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -175.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.6 mtt 53.62 28.43 7.91 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.695 1.598 . . . . 0.0 113.507 -167.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.87 -35.73 0.47 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.679 1.591 . . . . 0.0 112.763 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.6 m -93.79 75.62 4.26 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.801 1.241 . . . . 0.0 109.835 178.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -131.82 36.23 3.72 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.625 1.57 . . . . 0.0 112.721 -170.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.54 64.6 1.66 Allowed 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 126.301 1.84 . . . . 0.0 112.716 -175.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -126.81 58.05 1.43 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.445 1.898 . . . . 0.0 109.6 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -150.77 151.61 32.6 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 126.073 1.749 . . . . 0.0 110.478 -172.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -173.3 115.73 0.26 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.489 1.516 . . . . 0.0 109.414 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.9 m -93.99 110.79 22.45 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.199 1.0 . . . . 0.0 110.185 174.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.0 t -59.08 143.45 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 125.307 1.443 . . . . 0.0 112.877 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.1 mt -129.26 -39.37 1.53 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.544 1.938 . . . . 0.0 111.99 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 47.5 t -149.7 142.69 24.87 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.627 1.571 . . . . 0.0 109.611 174.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.6 t -137.97 126.9 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.702 1.201 . . . . 0.0 108.149 170.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -138.11 130.4 16.21 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 123.751 0.82 . . . . 0.0 111.912 -176.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -75.14 -17.08 19.53 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.188 2.592 . . . . 0.0 115.413 -167.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -130.61 109.72 10.87 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.249 1.019 . . . . 0.0 110.958 -176.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -142.26 145.95 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.589 1.556 . . . . 0.0 109.876 168.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.9 m -126.83 132.66 50.93 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.278 1.031 . . . . 0.0 110.85 -174.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.3 t -100.52 135.09 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.078 1.351 . . . . 0.0 111.527 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.4 119.71 22.03 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.884 1.274 . . . . 0.0 108.837 168.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -64.11 131.52 47.76 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.57 -0.706 . . . . 0.0 109.491 166.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.4 pt -93.52 152.58 41.04 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 124.696 1.199 . . . . 0.0 112.806 -167.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -64.19 161.19 34.94 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.627 2.885 . . . . 0.0 112.88 171.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -64.36 115.34 3.12 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.201 2.601 . . . . 0.0 110.412 170.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 60.8 mmt-85 -152.55 159.72 43.27 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.596 1.158 . . . . 0.0 113.723 -164.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.05 134.74 35.37 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.85 156.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 59.9 p -67.9 -64.97 0.75 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.552 1.541 . . . . 0.0 113.039 -174.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -77.38 -1.79 31.86 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.73 1.212 . . . . 0.0 113.289 -173.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 86.4 mtt-85 -116.77 -29.31 6.09 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.027 1.731 . . . . 0.0 113.655 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.87 -0.66 1.7 Allowed Glycine 0 CA--C 1.533 1.159 0 N-CA-C 117.887 1.915 . . . . 0.0 117.887 -166.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 -78.16 96.34 5.16 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 120.855 2.328 . . . . 0.0 108.641 161.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.8 19.36 19.21 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.74 -50.08 0.05 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 127.169 2.188 . . . . 0.0 114.206 -165.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.5 m -65.39 -11.31 41.13 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.174 1.79 . . . . 0.0 114.788 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.71 -14.86 59.49 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.339 1.056 . . . . 0.0 112.494 171.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 16.0 m0 -96.73 171.06 8.76 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.866 1.666 . . . . 0.0 111.693 -174.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -80.56 56.35 2.58 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.2 1.4 . . . . 0.0 113.081 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.0 mt -57.69 -24.88 59.05 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -169.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -106.96 0.58 23.85 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.347 1.059 . . . . 0.0 112.593 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -132.27 77.56 70.39 Favored Pre-proline 0 C--O 1.239 0.521 0 C-N-CA 125.809 1.644 . . . . 0.0 111.378 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -69.18 144.95 58.92 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 CA-C-N 118.94 0.657 . . . . 0.0 112.784 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -70.63 -28.92 65.19 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.705 0.802 . . . . 0.0 111.172 168.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 52.6 t90 -160.42 154.21 22.66 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.606 1.962 . . . . 0.0 110.579 175.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.4 p -133.13 149.16 52.12 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.286 1.035 . . . . 0.0 111.534 167.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.26 -143.43 5.97 Favored Glycine 0 CA--C 1.524 0.635 0 O-C-N 122.15 -0.343 . . . . 0.0 113.407 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -107.28 142.41 37.08 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.679 1.592 . . . . 0.0 111.657 -176.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.3 tp -81.79 137.92 35.23 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.131 1.372 . . . . 0.0 109.426 165.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.6 ttt-85 -145.74 89.28 1.89 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 122.217 1.008 . . . . 0.0 110.938 168.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.515 HD11 ' CD1' ' A' ' 119' ' ' PHE . 17.5 mt -74.91 127.03 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 172.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.0 p -131.73 173.92 10.66 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 127.083 2.153 . . . . 0.0 109.62 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -160.19 160.72 33.14 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.479 -1.388 . . . . 0.0 110.16 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -148.9 127.2 12.17 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 122.044 0.926 . . . . 0.0 111.769 153.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.02 -114.76 5.73 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 126.078 1.799 . . . . 0.0 110.061 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -104.24 15.38 28.46 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.615 1.566 . . . . 0.0 113.277 176.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.3 m -124.4 109.19 13.0 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.892 0.877 . . . . 0.0 110.649 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.26 159.52 20.06 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.371 0.668 . . . . 0.0 110.99 171.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -141.39 100.79 3.86 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.926 1.69 . . . . 0.0 109.533 -171.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mp -79.92 94.47 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 170.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -91.15 137.82 32.07 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.21 0.604 . . . . 0.0 111.088 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.2 mp -110.62 129.64 55.76 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 126.011 1.724 . . . . 0.0 109.329 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -133.04 145.82 51.15 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.958 0.903 . . . . 0.0 112.241 -169.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -68.43 135.7 52.13 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.12 -0.987 . . . . 0.0 111.655 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.9 pttt -75.11 -7.46 53.82 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -175.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.3 t -119.47 -43.17 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.188 1.395 . . . . 0.0 111.48 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.0 m -95.42 -19.84 19.57 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -174.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.86 14.42 75.74 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.461 1.029 . . . . 0.0 113.713 -176.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -88.07 151.53 22.68 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.224 1.41 . . . . 0.0 112.097 -175.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.3 tp -72.41 126.6 30.24 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.568 -0.707 . . . . 0.0 111.468 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -85.66 -56.69 3.38 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.377 1.071 . . . . 0.0 110.929 169.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.4 162.46 40.03 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.326 1.45 . . . . 0.0 110.918 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -143.36 139.06 29.87 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 172.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.53 106.77 53.89 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.845 1.258 . . . . 0.0 111.037 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.64 139.79 14.43 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.941 3.094 . . . . 0.0 111.325 175.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 t -134.45 121.95 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.611 1.565 . . . . 0.0 109.88 -171.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -89.04 -17.34 29.55 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.86 141.87 8.74 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.834 2.053 . . . . 0.0 110.167 174.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -126.51 127.48 24.54 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 124.352 1.061 . . . . 0.0 111.095 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -61.29 147.07 48.47 Favored 'Cis proline' 0 CA--C 1.539 0.767 0 CA-C-N 120.162 1.094 . . . . 0.0 114.104 -4.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.81 -163.76 29.59 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.99 1.281 . . . . 0.0 113.873 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.8 tp -64.67 -38.58 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 -167.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.77 6.21 48.38 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -168.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.8 t -151.09 124.52 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.75 1.22 . . . . 0.0 110.474 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -140.13 162.79 34.4 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.792 1.637 . . . . 0.0 113.459 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.2 p -109.18 162.46 14.26 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.87 1.668 . . . . 0.0 111.462 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.9 m -84.18 176.87 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.032 0.933 . . . . 0.0 111.299 169.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 57.8 p -90.82 -37.92 13.3 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.512 1.525 . . . . 0.0 111.798 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -96.0 -41.12 8.92 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 -165.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.5 t -139.74 116.54 10.89 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -171.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.69 -3.54 6.83 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -168.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.455 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.306 49.2 ptt85 -86.93 20.74 2.51 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 176.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -140.67 139.57 34.81 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.448 1.499 . . . . 0.0 111.36 -176.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -138.68 161.86 36.09 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.216 1.406 . . . . 0.0 111.615 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.6 t -117.93 137.46 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.04 0.936 . . . . 0.0 108.924 165.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.17 147.96 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 118.737 0.699 . . . . 0.0 112.157 174.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -91.33 84.39 5.6 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.623 0.769 . . . . 0.0 110.936 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -68.93 138.86 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.849 0.357 . . . . 0.0 110.965 176.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -139.31 149.54 44.35 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.445 1.498 . . . . 0.0 111.42 -169.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -95.12 3.1 55.12 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.472 1.109 . . . . 0.0 113.32 -177.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.54 11.24 84.33 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.078 1.323 . . . . 0.0 114.702 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.9 t -132.67 9.17 4.24 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.722 1.609 . . . . 0.0 113.478 -172.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.21 -1.67 64.95 Favored Glycine 0 CA--C 1.537 1.454 0 O-C-N 120.741 -1.225 . . . . 0.0 114.779 -177.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -72.4 135.23 45.76 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.273 1.429 . . . . 0.0 108.966 164.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 95.6 p -145.25 153.08 40.93 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 174.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.31 142.43 29.43 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.284 1.434 . . . . 0.0 110.963 168.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -91.74 118.85 31.05 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.44 0.696 . . . . 0.0 109.861 170.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.7 pt -118.0 141.77 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.732 1.213 . . . . 0.0 110.889 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -90.11 142.37 16.43 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 175.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.7 pt -129.42 145.98 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.907 1.283 . . . . 0.0 112.167 170.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.75 148.45 16.77 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.025 1.298 . . . . 0.0 113.698 176.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -114.57 156.65 24.27 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.15 1.78 . . . . 0.0 111.531 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.6 t -74.27 -23.77 59.17 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.054 0.941 . . . . 0.0 112.936 -178.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -151.91 147.66 26.85 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.414 1.086 . . . . 0.0 111.981 -176.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 -62.97 -33.59 75.71 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.241 1.016 . . . . 0.0 113.21 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.45 -28.46 73.63 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 119.086 0.857 . . . . 0.0 113.525 175.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -85.51 -30.11 23.71 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.116 0.966 . . . . 0.0 112.581 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.455 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -66.9 -35.96 81.19 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.588 -0.695 . . . . 0.0 112.625 163.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -62.29 -35.89 80.42 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.402 -0.811 . . . . 0.0 111.661 169.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -62.92 -36.65 84.1 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 119.846 1.203 . . . . 0.0 112.5 173.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.515 ' CD1' HD11 ' A' ' 49' ' ' ILE . 18.0 t80 -60.48 -51.51 69.15 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.035 0.934 . . . . 0.0 112.386 169.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.84 -26.18 40.51 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -175.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.3 t -77.27 -42.38 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 O-C-N 121.127 -0.983 . . . . 0.0 110.938 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 91.6 p -63.66 -31.36 72.51 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.895 0.77 . . . . 0.0 112.882 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.1 mt -68.51 -56.86 6.92 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.105 0.962 . . . . 0.0 111.993 169.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -68.16 -25.45 65.27 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.918 -1.113 . . . . 0.0 113.5 -173.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -79.46 -4.31 50.62 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.255 1.022 . . . . 0.0 112.518 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -90.17 -28.32 18.99 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.29 -0.881 . . . . 0.0 112.587 161.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -101.07 -1.16 34.86 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.875 1.805 . . . . 0.0 115.875 -175.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.68 -29.04 58.68 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 120.959 1.709 . . . . 0.0 115.164 -178.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 36.4 p-90 -82.25 -16.64 48.81 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 175.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.8 t -88.78 -33.83 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.62 1.568 . . . . 0.0 110.606 171.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -87.96 42.56 1.06 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 127.385 2.274 . . . . 0.0 111.978 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -85.68 97.13 9.95 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.404 1.082 . . . . 0.0 110.314 176.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 . . . . . 0 C--O 1.252 1.204 0 C-N-CA 126.043 1.737 . . . . 0.0 113.496 178.25 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 112.141 -0.383 . . . . 0.0 112.141 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 57.1 p -151.29 172.28 5.55 Favored Pre-proline 0 N--CA 1.475 0.799 0 C-N-CA 125.132 1.373 . . . . 0.0 111.217 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -54.6 -17.59 13.36 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.012 2.474 . . . . 0.0 115.054 171.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -75.73 -40.28 55.8 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.345 1.058 . . . . 0.0 112.437 175.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 78.8 p -86.84 -25.17 24.66 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.979 0.912 . . . . 0.0 112.839 176.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt -76.75 35.96 0.16 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 126.001 1.72 . . . . 0.0 112.739 173.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.16 -40.47 0.17 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.369 1.868 . . . . 0.0 112.068 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 44.5 m -132.29 107.27 8.44 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.292 1.437 . . . . 0.0 109.45 175.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -140.4 6.2 2.09 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -171.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -71.42 148.16 47.19 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -164.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -134.53 46.39 2.48 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.671 1.588 . . . . 0.0 110.438 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -145.41 146.47 31.55 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.55 1.54 . . . . 0.0 110.907 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -178.51 117.67 0.08 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.901 1.68 . . . . 0.0 108.311 165.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.7 m -91.86 110.11 21.46 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.431 -0.793 . . . . 0.0 110.065 172.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.2 t -70.13 147.36 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.898 1.279 . . . . 0.0 112.062 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.0 mt -132.33 -39.54 1.03 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.963 1.705 . . . . 0.0 110.995 -173.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.7 t -151.1 146.91 26.48 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.987 1.315 . . . . 0.0 110.86 175.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 72.4 t -139.99 123.34 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.239 1.416 . . . . 0.0 109.31 171.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -118.42 141.05 29.03 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 125.017 1.327 . . . . 0.0 111.141 175.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.72 -19.32 21.35 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 123.661 2.907 . . . . 0.0 114.515 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -133.29 110.83 10.35 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.191 0.905 . . . . 0.0 111.388 -172.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.2 p -142.55 143.03 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.917 1.287 . . . . 0.0 110.755 169.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.2 m -127.86 130.32 48.39 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.69 1.196 . . . . 0.0 110.993 -174.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.2 t -97.34 136.98 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.929 1.291 . . . . 0.0 111.948 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.17 126.75 36.44 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.823 1.249 . . . . 0.0 109.381 168.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -63.12 131.62 49.12 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 161.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.6 pt -98.25 149.7 35.99 Favored Pre-proline 0 N--CA 1.475 0.807 0 C-N-CA 123.904 0.882 . . . . 0.0 112.676 -168.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -67.32 166.86 22.05 Favored 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 123.374 2.716 . . . . 0.0 111.444 167.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -57.31 149.15 66.61 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.344 2.03 . . . . 0.0 111.715 168.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.3 ttm-85 -62.79 154.53 29.48 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.73 1.212 . . . . 0.0 112.64 -174.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.76 -179.59 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 122.253 1.025 . . . . 0.0 112.826 161.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.5 m -78.75 75.08 5.27 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.466 1.506 . . . . 0.0 111.652 -171.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.304 0.5 OUTLIER 54.93 23.71 5.26 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 127.298 2.239 . . . . 0.0 115.098 -165.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -95.06 -49.0 5.72 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.196 0.998 . . . . 0.0 112.339 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.63 -144.73 16.64 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-O 121.76 0.645 . . . . 0.0 111.78 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -120.48 158.41 27.3 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 127.066 2.146 . . . . 0.0 110.971 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.83 18.48 6.71 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -171.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.56 -51.11 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 128.149 2.58 . . . . 0.0 115.697 -174.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.5 m -65.07 -13.0 56.88 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.337 1.855 . . . . 0.0 114.367 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -89.41 -4.9 57.83 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.704 1.202 . . . . 0.0 112.552 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 22.4 m0 -92.75 172.11 8.56 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.867 1.667 . . . . 0.0 110.74 174.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -80.57 55.06 2.22 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.163 1.385 . . . . 0.0 114.074 -177.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.2 mt -60.34 -17.81 45.63 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -174.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -102.14 -8.13 21.64 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.82 1.248 . . . . 0.0 113.126 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -148.74 80.05 8.37 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.563 1.145 . . . . 0.0 112.102 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.72 146.8 53.13 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.498 2.798 . . . . 0.0 112.886 174.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -71.45 -29.64 65.09 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.497 0.719 . . . . 0.0 111.393 167.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 51.4 t90 -158.54 154.43 26.66 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.028 1.731 . . . . 0.0 110.937 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.3 p -134.88 148.01 50.0 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.57 1.148 . . . . 0.0 111.594 169.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.48 -141.16 4.88 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 113.916 0.326 . . . . 0.0 113.916 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -110.79 140.53 45.13 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.802 2.041 . . . . 0.0 110.318 -170.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.6 tp -93.55 137.66 32.6 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.328 1.051 . . . . 0.0 109.997 173.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 28.0 ttp-105 -127.98 136.1 50.83 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.236 1.014 . . . . 0.0 110.271 156.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.432 HD11 ' CD2' ' A' ' 119' ' ' PHE . 36.1 mt -111.35 135.28 51.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 125.227 1.411 . . . . 0.0 107.25 164.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.74 166.77 28.4 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.847 1.659 . . . . 0.0 110.23 -164.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.3 t -157.45 160.35 38.24 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.056 -1.028 . . . . 0.0 111.951 172.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -144.68 119.95 10.2 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.513 0.725 . . . . 0.0 111.609 157.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.61 -115.11 6.72 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 125.802 1.668 . . . . 0.0 110.494 -177.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -104.5 17.02 24.93 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.17 1.788 . . . . 0.0 113.225 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.4 m -124.84 108.5 12.0 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.065 0.946 . . . . 0.0 110.396 177.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.64 159.47 25.34 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.734 0.413 . . . . 0.0 110.98 169.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -139.23 117.25 11.72 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.795 1.638 . . . . 0.0 109.214 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.1 mp -92.21 109.22 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 165.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -112.65 130.79 55.92 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.216 1.006 . . . . 0.0 111.876 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.9 mp -104.2 127.06 51.78 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.763 1.625 . . . . 0.0 110.053 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -132.98 150.28 52.17 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -170.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -65.61 141.7 58.32 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 122.252 1.025 . . . . 0.0 112.744 -173.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.0 pttt -74.81 -10.36 59.43 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -175.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 64.0 t -121.12 -38.32 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.868 1.267 . . . . 0.0 111.963 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.3 m -118.93 -8.64 10.23 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -172.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.84 14.49 80.01 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 123.992 0.806 . . . . 0.0 114.44 177.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -63.29 136.83 57.93 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.91 1.684 . . . . 0.0 111.277 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 38.1 tp -71.12 112.75 7.51 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.767 -0.583 . . . . 0.0 111.011 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -78.27 -53.52 7.23 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.932 0.893 . . . . 0.0 110.674 172.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.81 161.54 38.39 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.487 1.115 . . . . 0.0 112.052 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -141.86 134.47 28.34 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.03 1.332 . . . . 0.0 111.357 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.78 96.67 50.28 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 124.997 1.319 . . . . 0.0 111.573 176.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -59.56 138.51 84.09 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 124.213 3.275 . . . . 0.0 112.824 164.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.0 t -135.55 131.8 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.082 1.753 . . . . 0.0 109.598 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -91.15 -24.14 20.04 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -165.47 155.5 13.02 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.772 1.629 . . . . 0.0 111.18 169.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -126.19 127.22 24.71 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.87 1.268 . . . . 0.0 111.171 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.18 147.93 78.61 Favored 'Cis proline' 0 CA--C 1.542 0.888 0 CA-C-N 119.98 1.028 . . . . 0.0 113.185 -2.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -161.54 -164.71 16.98 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.901 1.715 . . . . 0.0 112.556 -178.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.9 tt -73.36 -38.62 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -175.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.5 7.51 16.81 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -167.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.2 t -149.94 130.55 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.78 1.632 . . . . 0.0 109.703 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.16 164.08 33.36 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.081 1.752 . . . . 0.0 112.731 -171.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 73.1 p -121.49 161.67 21.86 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.861 1.664 . . . . 0.0 111.956 -174.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.8 m -91.39 169.91 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.102 1.361 . . . . 0.0 110.906 168.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 79.6 p -95.03 -31.09 13.76 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.894 1.277 . . . . 0.0 113.506 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -95.3 -39.55 9.99 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -163.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.0 t -138.95 123.24 18.16 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -174.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.1 m -79.34 31.12 0.22 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 -168.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.418 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.257 18.4 ptt180 -120.68 18.06 11.95 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.293 1.437 . . . . 0.0 114.693 174.341 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -138.34 137.84 37.75 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.219 1.008 . . . . 0.0 111.202 -170.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -136.66 160.35 39.08 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.967 1.307 . . . . 0.0 111.325 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 80.7 t -112.75 143.8 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.498 1.119 . . . . 0.0 108.88 165.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.8 148.49 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 118.981 0.81 . . . . 0.0 112.104 171.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -89.28 89.28 7.84 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.668 0.787 . . . . 0.0 110.426 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -71.27 142.0 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 O-C-N 122.161 -0.337 . . . . 0.0 110.802 175.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -135.35 144.21 46.53 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.594 1.558 . . . . 0.0 111.83 -172.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -96.56 14.42 24.8 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.779 1.232 . . . . 0.0 113.557 -175.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.14 8.26 85.07 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 125.228 1.394 . . . . 0.0 115.476 176.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.5 t -131.79 3.95 4.16 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.543 1.537 . . . . 0.0 113.722 -172.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.36 -5.42 67.74 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.353 1.454 . . . . 0.0 113.888 -175.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -76.04 130.15 37.94 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 127.276 2.23 . . . . 0.0 108.564 165.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 86.3 p -152.41 161.06 43.13 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.565 1.146 . . . . 0.0 114.023 -175.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.93 148.38 31.71 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.455 1.502 . . . . 0.0 111.348 172.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -93.08 116.74 29.33 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.53 0.732 . . . . 0.0 109.733 170.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.7 pt -116.94 146.01 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.715 1.206 . . . . 0.0 111.149 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.8 142.68 16.17 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 174.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.6 pt -127.54 139.81 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 125.319 1.448 . . . . 0.0 111.866 171.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -117.38 142.71 17.51 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 125.45 1.5 . . . . 0.0 112.474 174.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -100.37 162.74 12.75 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.209 1.404 . . . . 0.0 111.842 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.3 t -68.76 -28.02 66.42 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.643 0.777 . . . . 0.0 112.388 176.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -158.71 155.85 28.8 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.601 1.16 . . . . 0.0 111.406 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.3 ttp85 -54.28 -40.98 68.36 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.397 1.079 . . . . 0.0 112.513 173.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.69 -29.85 73.21 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 123.995 0.807 . . . . 0.0 114.304 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -82.2 -36.82 26.89 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.298 1.049 . . . . 0.0 111.748 176.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.418 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -63.61 -31.59 72.8 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.523 -0.735 . . . . 0.0 112.764 168.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -72.54 0.9 9.2 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.795 1.405 . . . . 0.0 114.795 170.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -96.87 -32.77 11.91 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.431 -0.793 . . . . 0.0 112.322 162.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.432 ' CD2' HD11 ' A' ' 49' ' ' ILE . 47.0 t80 -58.4 -53.03 62.93 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.638 1.175 . . . . 0.0 112.518 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -66.41 -34.47 78.02 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.669 1.187 . . . . 0.0 113.366 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 52.6 t -75.48 -40.04 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.44 1.096 . . . . 0.0 111.005 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.3 m -66.69 -28.55 68.54 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.34 0.656 . . . . 0.0 112.735 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.7 mt -75.74 -53.1 9.05 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.828 0.851 . . . . 0.0 111.981 171.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -66.62 -27.39 67.66 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.224 -0.922 . . . . 0.0 113.161 -175.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -84.29 -3.12 58.04 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.303 1.041 . . . . 0.0 112.752 175.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 52.5 t60 -88.85 -38.8 14.31 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 120.901 -1.125 . . . . 0.0 111.911 158.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -91.92 1.83 56.93 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 -171.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.24 -21.98 50.46 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -177.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 29.5 p-90 -93.79 -16.7 23.89 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.977 1.311 . . . . 0.0 114.177 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.5 t -97.15 -36.83 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.555 1.542 . . . . 0.0 111.766 -176.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.0 tptt -89.9 25.33 2.13 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.634 1.574 . . . . 0.0 112.917 -173.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -84.1 93.53 8.14 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.607 1.163 . . . . 0.0 110.452 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 . . . . . 0 C--O 1.253 1.251 0 C-N-CA 126.92 2.088 . . . . 0.0 112.807 -178.081 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.592 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 53.3 m 63.19 152.1 0.11 Allowed Pre-proline 0 N--CA 1.484 1.236 0 C-N-CA 127.293 2.237 . . . . 0.0 115.365 -172.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -80.0 -16.81 11.05 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.278 2.652 . . . . 0.0 113.842 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -76.83 151.44 35.89 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.569 1.148 . . . . 0.0 112.339 -178.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 62.1 p -83.09 -14.97 52.65 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.656 1.182 . . . . 0.0 113.751 178.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -149.2 148.19 29.31 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.743 1.617 . . . . 0.0 110.798 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.26 -52.07 0.23 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.913 1.285 . . . . 0.0 111.27 169.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.9 m -158.25 132.04 7.79 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.191 2.197 . . . . 0.0 108.083 168.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -155.02 150.73 27.62 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.035 1.734 . . . . 0.0 109.537 170.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.35 139.49 30.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.308 1.843 . . . . 0.0 110.667 174.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -89.1 30.34 0.97 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.733 1.213 . . . . 0.0 113.307 -170.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -156.92 151.75 25.86 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.519 1.528 . . . . 0.0 110.822 -175.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 176.44 118.46 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.414 1.886 . . . . 0.0 108.533 160.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.2 m -97.09 104.4 16.42 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.501 -0.749 . . . . 0.0 110.935 173.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.48 145.07 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.914 1.286 . . . . 0.0 112.221 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 71.8 mt -128.58 -41.38 1.52 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.077 1.751 . . . . 0.0 112.529 -175.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.6 t -151.37 135.71 16.86 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.86 1.264 . . . . 0.0 110.346 175.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 78.6 t -128.16 127.87 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.6 1.16 . . . . 0.0 109.624 171.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -126.95 131.66 23.97 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 124.797 1.239 . . . . 0.0 110.945 172.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -66.71 -24.91 46.99 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.098 2.532 . . . . 0.0 115.349 -176.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -133.81 120.95 21.12 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.108 0.963 . . . . 0.0 112.336 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -150.97 147.24 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.732 2.013 . . . . 0.0 109.369 174.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.8 m -125.95 130.94 52.24 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.852 0.861 . . . . 0.0 111.84 -171.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.3 t -96.65 137.38 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.773 1.629 . . . . 0.0 112.153 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -131.39 126.05 34.17 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.876 1.271 . . . . 0.0 109.472 168.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -67.11 118.08 10.04 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.595 0.758 . . . . 0.0 109.478 166.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.9 pt -85.04 153.7 60.12 Favored Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -166.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -65.94 160.97 41.62 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 123.035 2.49 . . . . 0.0 111.299 159.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -64.8 147.61 89.65 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.024 2.482 . . . . 0.0 113.453 -176.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.3 tpt85 -68.33 154.32 42.0 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.917 1.687 . . . . 0.0 111.844 175.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -143.72 160.99 39.73 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.216 162.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.6 p -82.76 -41.41 19.24 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.943 1.697 . . . . 0.0 113.194 -164.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -92.89 4.01 54.68 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.701 1.6 . . . . 0.0 112.242 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 -112.32 -64.25 1.32 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.553 1.541 . . . . 0.0 111.48 174.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.15 169.36 15.44 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-O 122.585 1.103 . . . . 0.0 111.915 -167.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -70.81 147.5 48.84 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 123.704 0.801 . . . . 0.0 110.288 171.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.4 16.35 3.18 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -171.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.75 -49.04 0.06 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 127.805 2.442 . . . . 0.0 115.673 -176.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.9 m -68.5 -15.58 63.59 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.028 1.731 . . . . 0.0 114.18 -177.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.45 -11.75 59.64 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.8 0.84 . . . . 0.0 112.995 171.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 18.0 m0 -88.61 171.17 10.23 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.136 1.374 . . . . 0.0 110.851 178.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -81.42 55.52 2.63 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.21 1.404 . . . . 0.0 114.095 -174.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.5 mt -61.14 -14.6 25.97 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -171.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -108.83 -3.46 17.66 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.609 1.163 . . . . 0.0 113.033 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -148.71 71.33 10.54 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 125.151 1.38 . . . . 0.0 112.105 177.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -56.46 144.39 84.03 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.131 2.554 . . . . 0.0 112.307 173.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -70.22 -29.85 66.79 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.378 1.071 . . . . 0.0 111.689 175.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 38.8 t90 -156.84 152.48 26.9 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.554 1.542 . . . . 0.0 110.559 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.2 p -134.03 150.77 51.23 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.691 0.796 . . . . 0.0 111.869 168.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.28 -143.62 6.31 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 123.129 0.395 . . . . 0.0 113.542 -176.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 36.7 mtm105 -105.74 149.37 26.49 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.597 1.959 . . . . 0.0 112.135 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.5 tp -90.37 138.68 31.35 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.707 1.203 . . . . 0.0 109.755 162.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.8 ttp85 -144.1 91.44 2.21 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.17 0.988 . . . . 0.0 110.731 162.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.469 HD11 ' CD2' ' A' ' 119' ' ' PHE . 15.2 mt -72.06 131.93 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 170.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.41 174.91 10.01 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 127.364 2.265 . . . . 0.0 110.564 -177.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.6 p -158.32 153.31 25.26 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 120.721 -1.237 . . . . 0.0 111.562 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -158.76 128.61 5.77 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.242 1.017 . . . . 0.0 112.085 159.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.59 53.65 37.08 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.452 1.025 . . . . 0.0 114.902 163.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt 61.99 24.25 14.41 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 126.292 1.837 . . . . 0.0 113.909 -175.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.5 m -123.7 132.26 53.79 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.659 1.584 . . . . 0.0 108.726 165.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.17 157.55 16.5 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.219 1.008 . . . . 0.0 110.162 166.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -136.54 107.62 6.75 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.501 1.521 . . . . 0.0 109.22 -175.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.5 mp -81.18 96.38 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 168.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -95.93 136.83 35.85 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.268 0.556 . . . . 0.0 111.516 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.6 mp -110.36 133.46 53.24 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 126.238 1.815 . . . . 0.0 109.4 174.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -139.6 154.05 47.5 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.854 0.862 . . . . 0.0 111.946 -169.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -74.88 148.77 39.87 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 120.974 -1.079 . . . . 0.0 112.311 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.1 pttt -89.08 -1.35 58.06 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.9 1.68 . . . . 0.0 114.986 -178.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 80.3 t -127.83 -41.8 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.152 1.381 . . . . 0.0 111.951 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.1 p -96.15 -27.42 15.05 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.53 1.059 . . . . 0.0 113.289 175.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.58 8.59 87.15 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-O 119.346 -0.697 . . . . 0.0 113.8 -170.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -68.75 151.34 46.78 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.622 1.211 . . . . 0.0 111.886 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.4 tp -72.66 125.96 28.74 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.638 -0.664 . . . . 0.0 110.683 176.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -86.37 -55.02 4.1 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.133 0.973 . . . . 0.0 111.063 171.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.8 159.56 36.87 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.66 1.184 . . . . 0.0 111.651 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -140.3 133.97 30.31 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.47 0.708 . . . . 0.0 112.576 175.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.74 103.24 53.91 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 125.108 1.363 . . . . 0.0 111.257 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -74.65 141.72 28.11 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.566 2.844 . . . . 0.0 111.728 173.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.5 t -134.94 125.38 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.68 1.992 . . . . 0.0 109.07 -174.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -90.04 -23.51 21.43 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -161.86 150.03 15.02 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.67 1.988 . . . . 0.0 110.151 171.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -122.85 127.56 25.69 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 124.537 1.135 . . . . 0.0 110.973 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -62.18 147.72 55.53 Favored 'Cis proline' 0 CA--C 1.541 0.869 0 CA-C-N 119.991 1.033 . . . . 0.0 114.392 -5.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.37 -166.68 18.81 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.919 1.723 . . . . 0.0 112.392 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.0 tt -69.52 -37.39 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 121.607 -0.937 . . . . 0.0 112.873 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.83 6.66 23.71 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -165.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.6 t -150.4 130.71 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.481 1.512 . . . . 0.0 110.063 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -140.32 161.34 37.92 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.282 1.833 . . . . 0.0 112.316 177.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.2 p -107.96 160.98 15.35 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.6 1.96 . . . . 0.0 111.735 177.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.1 m -87.01 173.33 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.212 1.005 . . . . 0.0 110.879 163.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 73.9 p -104.56 -23.3 13.14 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.485 1.514 . . . . 0.0 113.921 -176.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -99.87 -39.29 8.26 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -171.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.9 t -134.03 117.27 16.48 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -173.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.0 m -72.48 24.82 0.05 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 115.956 1.835 . . . . 0.0 115.956 -169.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.4 ptt85 -131.42 27.08 4.77 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.507 1.923 . . . . 0.0 113.995 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -140.09 141.28 36.18 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.671 1.589 . . . . 0.0 111.441 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -140.14 162.11 36.03 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.03 1.332 . . . . 0.0 111.54 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.9 t -116.96 142.85 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.596 1.158 . . . . 0.0 108.997 167.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.21 148.09 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 173.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -87.94 84.68 6.96 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.976 0.911 . . . . 0.0 110.717 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -68.3 141.03 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 120.816 0.341 . . . . 0.0 110.582 173.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -135.19 149.76 50.0 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.302 1.441 . . . . 0.0 111.78 -169.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -95.72 11.25 34.09 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.612 1.165 . . . . 0.0 113.108 -176.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.35 3.55 88.66 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.3 1.428 . . . . 0.0 115.412 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.1 t -125.28 2.57 7.81 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.726 1.611 . . . . 0.0 113.603 -176.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.01 -9.16 65.55 Favored Glycine 0 N--CA 1.478 1.439 0 C-N-CA 125.569 1.557 . . . . 0.0 113.979 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -68.35 131.86 46.06 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 127.364 2.266 . . . . 0.0 108.61 164.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 82.3 p -150.51 163.79 37.57 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -173.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.54 147.67 41.53 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.539 1.536 . . . . 0.0 110.612 164.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -92.83 116.75 29.32 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 167.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.1 pt -117.62 144.11 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.474 1.109 . . . . 0.0 110.937 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.73 142.08 15.92 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 175.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.4 pt -127.15 140.14 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 125.478 1.511 . . . . 0.0 111.661 172.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -119.94 141.35 15.35 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.798 1.189 . . . . 0.0 113.511 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -109.06 153.85 23.06 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.488 1.915 . . . . 0.0 110.792 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.3 t -73.0 -23.16 60.6 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.616 0.766 . . . . 0.0 112.784 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -155.54 151.06 27.17 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.446 1.098 . . . . 0.0 111.62 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.33 -33.05 70.65 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.904 0.882 . . . . 0.0 112.732 177.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.0 -19.25 63.32 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-N 118.979 0.808 . . . . 0.0 114.59 177.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -94.83 -37.31 11.28 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.689 1.244 . . . . 0.0 111.694 176.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.42 -29.14 68.8 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.135 0.974 . . . . 0.0 112.929 166.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . 0.262 19.8 m-85 -92.51 19.39 7.33 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.571 1.548 . . . . 0.0 114.112 170.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -99.71 -38.7 8.59 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.551 -0.718 . . . . 0.0 111.295 142.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.469 ' CD2' HD11 ' A' ' 49' ' ' ILE . 36.9 t80 -54.3 -57.72 10.14 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.58 1.082 . . . . 0.0 112.927 178.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -80.42 -22.74 40.91 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.256 -0.902 . . . . 0.0 113.345 -174.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 93.7 t -81.48 -39.2 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.412 0.685 . . . . 0.0 110.803 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 95.1 p -65.46 -31.42 72.49 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.566 -0.709 . . . . 0.0 112.848 173.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 72.0 mt -69.54 -52.65 24.4 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.189 0.995 . . . . 0.0 111.951 172.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -67.67 -29.03 68.22 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 120.971 -1.081 . . . . 0.0 112.823 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -82.77 -3.0 56.0 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.507 1.123 . . . . 0.0 112.916 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -90.15 -29.25 18.4 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.165 -0.96 . . . . 0.0 112.547 166.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -101.75 -4.15 26.91 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -176.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.2 -28.54 58.65 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -176.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 33.1 p-90 -84.69 -23.49 29.36 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.554 1.142 . . . . 0.0 113.44 176.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 22.0 t -82.26 -30.69 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.562 1.545 . . . . 0.0 111.062 175.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -96.21 30.01 2.63 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.888 2.075 . . . . 0.0 112.859 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -79.44 90.45 5.05 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.859 0.838 . . . . 0.0 109.945 171.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 C--O 1.252 1.188 0 C-N-CA 126.861 2.064 . . . . 0.0 112.7 -172.156 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.57 0 N-CA-C 111.656 -0.577 . . . . 0.0 111.656 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 44.1 m -70.95 138.59 85.14 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 123.886 0.875 . . . . 0.0 112.84 -174.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -69.15 -29.09 27.35 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.979 2.453 . . . . 0.0 112.688 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -66.86 -19.77 65.8 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.143 0.977 . . . . 0.0 112.957 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 28.5 m -99.48 -5.98 28.37 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.456 1.502 . . . . 0.0 113.718 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt 49.04 51.58 15.94 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.631 1.572 . . . . 0.0 112.353 -176.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.35 -6.62 14.94 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.157 1.383 . . . . 0.0 113.585 -165.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.1 m -134.9 72.64 1.46 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.888 1.675 . . . . 0.0 108.498 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -127.76 28.12 5.65 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.164 1.786 . . . . 0.0 112.628 -170.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 tt -60.98 115.35 3.66 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.32 1.848 . . . . 0.0 111.586 -174.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -146.07 56.09 1.18 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.141 1.376 . . . . 0.0 110.662 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -150.09 148.09 28.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.45 1.5 . . . . 0.0 110.738 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 173.5 105.66 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.786 2.434 . . . . 0.0 107.555 162.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.8 m -86.57 120.58 28.04 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.592 0.757 . . . . 0.0 111.684 -172.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -72.34 149.67 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.825 1.25 . . . . 0.0 113.855 -171.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.5 mt -134.07 -38.6 0.87 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.05 1.74 . . . . 0.0 112.425 -171.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 39.0 t -152.59 139.52 19.08 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.89 1.276 . . . . 0.0 110.588 172.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 79.1 t -131.71 127.55 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.697 1.199 . . . . 0.0 109.28 171.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -129.21 135.24 27.29 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 125.207 1.403 . . . . 0.0 110.524 173.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.66 -18.46 13.52 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.987 2.458 . . . . 0.0 114.975 -172.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -129.65 109.42 10.97 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.5 1.12 . . . . 0.0 111.146 -175.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.7 p -143.05 141.37 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.721 1.609 . . . . 0.0 110.028 171.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.3 m -123.33 125.36 44.87 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.265 1.026 . . . . 0.0 111.371 -171.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.6 t -92.16 137.82 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.142 1.377 . . . . 0.0 112.201 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -127.31 123.3 36.05 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.277 1.431 . . . . 0.0 108.621 168.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -68.96 109.3 3.88 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 164.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.415 HD12 ' CE2' ' A' ' 31' ' ' TYR . 35.4 pt -80.87 156.08 72.66 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 124.425 1.09 . . . . 0.0 113.819 -166.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -61.68 161.22 25.53 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 122.729 2.286 . . . . 0.0 111.405 158.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -60.39 150.09 82.58 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.788 2.325 . . . . 0.0 112.336 175.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 21.6 ttm105 -61.56 150.05 37.22 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.707 1.203 . . . . 0.0 111.837 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.48 172.15 0.94 Allowed 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 122.307 1.051 . . . . 0.0 112.539 162.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 79.5 p -87.59 -31.31 19.92 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.006 1.322 . . . . 0.0 113.049 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -137.97 6.18 2.63 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.815 1.646 . . . . 0.0 113.794 -174.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 -115.06 -57.75 2.22 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.735 1.214 . . . . 0.0 113.646 -176.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.34 -123.17 5.69 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -161.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.415 ' CE2' HD12 ' A' ' 22' ' ' ILE . 28.6 m-85 -134.68 155.57 50.3 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 127.617 2.367 . . . . 0.0 109.966 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.528 ' H ' ' HD3' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -123.31 131.09 53.54 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 163.139 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.18 -33.73 63.24 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.454 1.102 . . . . 0.0 113.215 -172.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.7 p -65.44 -13.26 58.35 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 175.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.29 -10.25 58.63 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.054 0.942 . . . . 0.0 112.704 170.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 22.8 m0 -94.68 171.71 8.62 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.629 1.572 . . . . 0.0 111.835 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -79.22 47.52 0.8 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.16 1.784 . . . . 0.0 114.177 -176.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.7 mt -54.72 -34.86 63.02 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -167.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -93.77 -2.41 53.72 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.95 0.9 . . . . 0.0 113.321 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -145.89 66.85 12.0 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 125.992 1.717 . . . . 0.0 111.747 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -55.91 144.02 79.69 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.282 2.654 . . . . 0.0 112.84 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -73.86 -27.81 61.26 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.45 1.1 . . . . 0.0 111.73 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 40.7 t90 -153.17 152.48 31.3 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.656 1.582 . . . . 0.0 110.663 170.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.5 p -134.56 143.17 47.24 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.964 0.906 . . . . 0.0 111.864 171.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.15 -144.63 5.4 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 114.556 0.582 . . . . 0.0 114.556 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -107.9 144.3 35.34 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.507 1.923 . . . . 0.0 111.035 -172.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 42.9 tp -91.56 138.44 31.57 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.652 1.581 . . . . 0.0 110.119 170.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -144.26 99.53 3.39 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.685 1.194 . . . . 0.0 110.57 170.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.48 HD11 ' CD2' ' A' ' 119' ' ' PHE . 18.4 mt -86.31 132.96 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.604 1.162 . . . . 0.0 108.624 174.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.12 171.28 14.3 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.167 1.787 . . . . 0.0 111.279 -170.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.8 t -156.21 149.06 24.03 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.796 -1.19 . . . . 0.0 112.555 173.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -150.86 132.76 15.1 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.724 152.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.47 58.45 5.45 Favored Glycine 0 N--CA 1.474 1.192 0 C-N-CA 124.752 1.168 . . . . 0.0 114.466 166.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 56.52 27.3 12.07 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 126.203 1.801 . . . . 0.0 113.174 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.7 m -137.93 121.83 17.72 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.655 1.582 . . . . 0.0 108.536 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -90.33 158.57 17.08 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.842 0.857 . . . . 0.0 110.513 171.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -139.34 99.52 3.76 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.318 1.847 . . . . 0.0 108.628 -173.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.3 mp -79.65 103.66 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 168.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 50.6 mttt -105.12 141.18 37.13 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.939 0.876 . . . . 0.0 111.732 174.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.8 mp -108.9 133.01 53.49 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 126.301 1.84 . . . . 0.0 109.785 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -132.2 147.19 52.41 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.942 0.897 . . . . 0.0 112.499 -168.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -66.33 140.81 58.12 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.882 0.873 . . . . 0.0 112.717 -175.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.274 0.0 OUTLIER -77.59 -5.22 49.48 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 -174.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.6 t -112.46 -48.59 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.93 1.292 . . . . 0.0 111.107 170.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.8 m -99.54 -16.75 18.18 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -167.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.87 12.43 74.8 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.658 1.123 . . . . 0.0 113.994 -176.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -82.78 152.09 25.84 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.078 1.351 . . . . 0.0 112.322 -174.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.7 122.16 19.31 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.959 0.903 . . . . 0.0 112.074 -169.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -86.1 -54.91 4.19 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.217 1.007 . . . . 0.0 111.098 168.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.58 161.61 38.73 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.895 1.278 . . . . 0.0 111.771 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -141.22 134.88 30.1 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.722 1.209 . . . . 0.0 112.065 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.86 100.68 48.5 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.955 1.302 . . . . 0.0 111.405 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -65.1 139.07 59.36 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 124.292 3.328 . . . . 0.0 112.422 167.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.4 t -135.8 129.68 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.73 1.612 . . . . 0.0 109.659 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -89.71 -23.52 21.8 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.75 150.05 13.38 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.15 1.78 . . . . 0.0 110.391 172.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -126.12 132.19 24.23 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.526 1.13 . . . . 0.0 112.131 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -63.57 144.66 53.94 Favored 'Cis proline' 0 CA--C 1.54 0.814 0 CA-C-N 119.71 0.932 . . . . 0.0 113.772 -6.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -169.59 -173.26 36.97 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.606 1.098 . . . . 0.0 114.116 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.6 tp -54.86 -36.72 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -166.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.55 8.35 39.25 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -171.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.4 t -148.33 129.12 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.307 1.043 . . . . 0.0 111.221 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -138.11 162.52 33.97 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.282 1.833 . . . . 0.0 112.218 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 65.8 p -112.49 161.28 16.91 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.628 1.971 . . . . 0.0 111.388 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.4 m -89.57 173.1 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.841 0.857 . . . . 0.0 111.453 166.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 46.5 p -99.05 -24.9 14.73 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 174.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -81.21 -42.69 20.38 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -171.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.2 t -156.76 134.44 10.86 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.0 m -72.99 22.15 0.07 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -174.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.482 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.26 5.1 ptm180 -108.73 19.67 19.4 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.011 1.724 . . . . 0.0 114.043 173.268 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -142.53 135.5 28.38 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.029 1.331 . . . . 0.0 110.412 -174.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -135.95 164.49 27.85 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.975 1.31 . . . . 0.0 111.103 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.2 t -117.72 142.96 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.705 1.202 . . . . 0.0 108.418 166.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.89 147.13 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 118.664 0.665 . . . . 0.0 112.14 172.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -87.75 86.67 7.2 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.507 0.723 . . . . 0.0 110.449 176.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -69.04 140.32 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.575 0.226 . . . . 0.0 110.8 175.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -137.03 144.73 43.38 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.762 1.625 . . . . 0.0 111.792 -170.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -94.48 11.43 30.8 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.479 1.112 . . . . 0.0 113.265 -175.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.87 6.69 85.82 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 125.122 1.344 . . . . 0.0 115.358 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.3 t -128.56 0.42 5.56 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 125.728 1.611 . . . . 0.0 113.828 -173.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.94 -7.1 60.49 Favored Glycine 0 N--CA 1.478 1.453 0 C-N-CA 125.484 1.516 . . . . 0.0 113.974 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -72.96 129.37 37.96 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 127.162 2.185 . . . . 0.0 108.451 164.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 76.8 p -152.47 161.06 43.11 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -173.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.11 147.46 30.6 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.465 1.506 . . . . 0.0 111.234 171.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -90.92 117.99 29.96 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.396 0.678 . . . . 0.0 109.472 168.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.4 pt -116.93 143.19 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.567 1.147 . . . . 0.0 111.027 177.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.25 144.06 17.72 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 174.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.0 pt -128.9 139.61 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 C-N-CA 125.59 1.556 . . . . 0.0 111.641 171.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.68 142.14 15.53 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 125.663 1.601 . . . . 0.0 112.725 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -105.25 163.63 12.45 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.419 1.488 . . . . 0.0 111.298 -177.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.7 t -76.32 -24.65 54.31 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 177.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -156.19 151.14 26.25 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.402 1.081 . . . . 0.0 111.636 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -62.62 -32.69 73.75 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.087 0.955 . . . . 0.0 113.151 178.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.24 -30.09 76.92 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 118.942 0.792 . . . . 0.0 113.646 175.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -82.84 -36.49 25.42 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.119 0.96 . . . . 0.0 111.918 175.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.482 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -64.2 -31.77 73.09 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 169.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -61.25 -33.75 74.04 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.098 -1.001 . . . . 0.0 112.508 171.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -70.36 -32.72 70.54 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.835 1.198 . . . . 0.0 112.846 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.48 ' CD2' HD11 ' A' ' 49' ' ' ILE . 9.6 t80 -57.64 -43.85 85.18 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.029 0.831 . . . . 0.0 111.329 170.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -81.28 -35.59 30.91 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.532 1.133 . . . . 0.0 113.496 -175.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.5 t -76.78 -40.5 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 O-C-N 121.245 -0.909 . . . . 0.0 111.519 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 85.4 p -63.67 -27.41 69.2 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 83.8 mt -75.38 -55.51 5.62 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.018 0.927 . . . . 0.0 111.534 171.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -66.83 -30.71 70.97 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.09 -1.006 . . . . 0.0 113.484 -172.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -90.91 4.38 52.04 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.8 1.64 . . . . 0.0 112.716 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -97.67 -33.12 11.43 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.304 -0.872 . . . . 0.0 112.276 163.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -89.96 -2.37 58.14 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.61 -34.08 64.56 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 121.18 1.809 . . . . 0.0 115.09 -174.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 28.7 p-90 -75.43 -30.93 60.17 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.827 0.851 . . . . 0.0 112.799 175.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.6 t -71.61 -35.4 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.58 1.152 . . . . 0.0 110.587 172.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -78.39 -2.44 38.32 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.024 1.73 . . . . 0.0 114.909 171.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 51.05 28.8 4.12 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 128.061 2.544 . . . . 0.0 115.353 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 . . . . . 0 C--O 1.252 1.227 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -178.79 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.473 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 25.9 p -80.79 156.18 72.8 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 124.722 1.209 . . . . 0.0 112.957 177.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.08 99.88 1.15 Allowed 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.251 2.634 . . . . 0.0 111.098 178.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -101.94 -6.58 23.31 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.708 1.203 . . . . 0.0 113.847 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 53.7 p -64.42 -17.06 63.44 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -176.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -76.85 -2.2 32.19 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.416 1.486 . . . . 0.0 113.697 173.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.7 -46.11 0.54 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.755 1.622 . . . . 0.0 111.934 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.7 m -80.3 66.26 5.74 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.32 1.448 . . . . 0.0 108.597 164.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -91.01 84.06 5.7 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.998 0.919 . . . . 0.0 112.545 -158.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 pp -125.77 142.8 51.34 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.832 1.253 . . . . 0.0 111.255 165.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -138.34 50.85 1.87 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.515 1.526 . . . . 0.0 109.856 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -135.41 136.99 41.83 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.608 1.163 . . . . 0.0 109.622 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -174.47 131.53 0.36 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.077 1.751 . . . . 0.0 108.151 162.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.6 m -92.46 109.39 20.78 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.101 0.961 . . . . 0.0 108.526 167.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.6 t -69.99 143.05 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 O-C-N 121.305 -0.872 . . . . 0.0 111.673 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.5 mt -126.88 -41.75 1.8 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.572 1.549 . . . . 0.0 112.293 -174.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.4 t -153.92 135.39 14.24 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.229 1.012 . . . . 0.0 111.245 173.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.1 t -128.31 127.33 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.677 1.191 . . . . 0.0 109.014 171.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -131.07 137.43 30.7 Favored Pre-proline 0 N--CA 1.475 0.81 0 C-N-CA 125.408 1.483 . . . . 0.0 110.65 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.53 -18.57 22.59 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.217 2.611 . . . . 0.0 113.689 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -109.08 122.64 47.7 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.025 1.33 . . . . 0.0 112.152 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.0 p -154.72 143.25 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.803 1.241 . . . . 0.0 109.585 157.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.7 p -127.32 144.14 51.1 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.071 1.348 . . . . 0.0 110.586 177.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.4 t -113.41 130.22 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.931 1.292 . . . . 0.0 111.113 -177.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.67 118.17 14.81 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.418 1.487 . . . . 0.0 108.976 173.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 -69.45 132.45 46.35 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.893 0.877 . . . . 0.0 109.943 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.3 pt -86.87 151.46 52.28 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -160.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -65.08 167.91 15.11 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 123.996 3.131 . . . . 0.0 112.121 171.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -63.81 98.21 0.24 Allowed 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.392 2.728 . . . . 0.0 111.28 173.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.2 mmt-85 -149.07 161.74 41.33 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 127.503 2.321 . . . . 0.0 110.562 -177.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -135.27 161.51 35.2 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.926 1.69 . . . . 0.0 111.072 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.4 t -55.59 -39.34 70.59 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.356 1.462 . . . . 0.0 113.026 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -76.22 -8.42 57.01 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 177.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -108.44 -25.13 11.12 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.196 1.798 . . . . 0.0 112.524 175.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.64 106.56 0.8 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.857 1.218 . . . . 0.0 113.242 166.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -61.57 142.35 57.16 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.309 1.044 . . . . 0.0 109.944 164.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.77 15.96 8.07 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 -174.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 55.84 -48.15 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.825 2.85 . . . . 0.0 116.156 -173.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 90.7 p -64.53 -17.77 64.21 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.095 1.758 . . . . 0.0 114.466 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -85.84 -4.79 59.25 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.445 1.498 . . . . 0.0 112.633 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.8 m0 -93.44 168.52 11.0 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.085 1.754 . . . . 0.0 110.635 175.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -78.13 49.7 0.84 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.659 1.584 . . . . 0.0 114.041 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 45.7 mt -56.46 -36.07 68.64 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -172.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -92.8 -2.68 55.73 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.237 1.015 . . . . 0.0 113.232 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -141.6 70.32 25.7 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 125.521 1.528 . . . . 0.0 111.726 177.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.85 147.37 73.42 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.144 2.563 . . . . 0.0 113.16 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -74.03 -27.94 61.18 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.158 0.983 . . . . 0.0 111.535 169.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 57.7 t90 -158.15 155.01 28.35 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.399 1.88 . . . . 0.0 110.884 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.1 p -136.72 149.9 48.13 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.666 1.186 . . . . 0.0 112.024 169.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.69 -142.49 4.6 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 123.319 0.485 . . . . 0.0 113.825 -177.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -118.91 148.74 42.6 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.849 2.06 . . . . 0.0 111.558 -175.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.1 tp -89.15 140.42 29.48 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.54 1.536 . . . . 0.0 110.626 174.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -141.01 93.36 2.58 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.519 1.127 . . . . 0.0 110.567 162.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.471 HD11 ' CD2' ' A' ' 119' ' ' PHE . 23.1 mt -76.65 127.24 37.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 166.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.1 p -138.31 171.71 13.98 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 126.919 2.088 . . . . 0.0 110.153 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.8 p -152.81 166.09 33.34 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 125.014 1.326 . . . . 0.0 112.185 174.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -148.68 121.25 8.56 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.243 0.544 . . . . 0.0 111.326 154.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.33 -118.43 9.32 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 125.232 1.396 . . . . 0.0 110.211 -176.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -101.48 20.16 16.55 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.331 1.852 . . . . 0.0 113.714 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.4 m -127.47 128.15 45.25 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.704 1.202 . . . . 0.0 109.957 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.65 160.8 14.03 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.552 1.141 . . . . 0.0 111.157 170.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -141.21 107.13 5.15 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.733 2.013 . . . . 0.0 108.802 -174.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -83.99 94.56 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 168.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -88.58 136.67 32.88 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.86 0.864 . . . . 0.0 110.805 174.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.3 mp -111.98 131.2 55.55 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.143 1.777 . . . . 0.0 110.111 174.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -132.67 147.56 52.33 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.858 0.863 . . . . 0.0 113.177 -170.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -67.8 135.39 52.54 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.367 1.067 . . . . 0.0 111.329 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.7 pttt -76.05 -5.2 45.35 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -175.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 85.6 t -120.26 -43.17 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 125.03 1.332 . . . . 0.0 111.47 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.5 m -93.82 -19.71 20.76 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.32 13.5 76.97 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.487 1.041 . . . . 0.0 113.693 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -90.58 152.16 21.01 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.241 1.416 . . . . 0.0 112.295 -173.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.5 tp -72.47 128.34 35.29 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.491 -0.756 . . . . 0.0 111.666 -175.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -85.35 -58.25 2.75 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.55 1.14 . . . . 0.0 110.778 169.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.68 165.44 36.25 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.042 1.737 . . . . 0.0 110.12 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -146.35 146.22 30.59 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 169.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.34 107.2 49.74 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.333 1.453 . . . . 0.0 111.665 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -67.92 144.47 64.66 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.838 3.026 . . . . 0.0 111.988 169.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.2 t -139.23 126.52 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.46 1.504 . . . . 0.0 109.414 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -95.45 -19.96 19.45 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -160.56 145.49 14.43 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.733 2.013 . . . . 0.0 110.081 171.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -126.22 127.67 24.6 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 124.697 1.199 . . . . 0.0 110.488 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -64.47 146.96 67.06 Favored 'Cis proline' 0 CA--C 1.542 0.899 0 CA-C-N 120.073 1.062 . . . . 0.0 113.434 -2.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.65 -156.94 8.74 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.721 1.629 . . . . 0.0 112.642 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.6 tt -79.33 -41.89 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -176.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.59 8.0 15.57 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -165.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 23.5 t -153.02 130.45 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 126.363 1.865 . . . . 0.0 109.122 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.17 158.72 44.24 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.871 1.268 . . . . 0.0 113.067 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.0 p -104.73 161.6 14.02 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.506 1.522 . . . . 0.0 112.182 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.3 m -90.72 173.27 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.81 1.244 . . . . 0.0 110.806 167.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.6 p -96.79 -29.4 13.78 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.31 1.444 . . . . 0.0 113.384 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -91.32 -43.1 9.99 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -169.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.7 t -143.32 124.48 14.52 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -176.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -67.29 -7.89 27.87 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.297 1.592 . . . . 0.0 115.297 -169.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.443 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.32 44.9 ptt85 -84.91 21.3 1.62 Allowed 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -179.338 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -142.86 140.02 31.09 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.814 1.646 . . . . 0.0 111.868 -174.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -142.62 149.36 38.86 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.435 1.494 . . . . 0.0 112.512 -176.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.9 t -92.4 142.35 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 161.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.26 149.65 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 119.348 0.977 . . . . 0.0 111.949 164.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.478 ' HE ' ' NE2' ' A' ' 97' ' ' GLN . 41.1 ttp180 -93.04 95.72 9.63 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.706 0.803 . . . . 0.0 110.259 174.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -76.91 150.98 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.301 0.64 . . . . 0.0 111.705 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.478 ' NE2' ' HE ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -124.93 150.41 46.61 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.901 1.68 . . . . 0.0 110.395 174.367 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -94.55 3.66 54.84 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.403 1.081 . . . . 0.0 113.085 175.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.68 12.45 82.84 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.273 1.416 . . . . 0.0 114.822 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.5 t -137.79 15.97 2.89 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.476 1.51 . . . . 0.0 113.371 -172.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.7 -1.58 78.78 Favored Glycine 0 CA--C 1.537 1.442 0 O-C-N 120.609 -1.307 . . . . 0.0 114.904 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -77.06 138.8 39.78 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.481 1.513 . . . . 0.0 108.927 165.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 84.7 p -143.63 157.34 44.48 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 166.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.59 142.45 27.98 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.671 1.188 . . . . 0.0 111.276 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -87.66 117.54 26.55 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.378 0.671 . . . . 0.0 109.537 168.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.9 pt -118.56 147.61 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.888 1.275 . . . . 0.0 110.761 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.7 136.32 12.9 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.5 pt -127.66 159.77 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 125.008 1.323 . . . . 0.0 112.067 171.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -154.38 168.82 32.68 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-O 122.039 0.799 . . . . 0.0 114.513 173.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -121.77 157.41 31.08 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 126.08 1.752 . . . . 0.0 111.797 -171.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.7 t -70.01 -19.34 63.33 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.055 0.942 . . . . 0.0 112.592 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -154.79 150.76 27.88 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.197 0.999 . . . . 0.0 111.921 -176.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 35.6 ttt-85 -61.32 -31.62 71.48 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.694 1.198 . . . . 0.0 113.276 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.27 -29.33 75.02 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-N 119.102 0.865 . . . . 0.0 113.976 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -82.53 -34.67 27.8 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.455 -1.026 . . . . 0.0 111.642 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.443 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -67.67 -30.51 70.06 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.26 1.024 . . . . 0.0 113.388 167.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -61.5 -47.48 85.42 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.446 -0.784 . . . . 0.0 110.797 168.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -62.31 -36.92 83.64 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.386 0.993 . . . . 0.0 112.876 175.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.471 ' CD2' HD11 ' A' ' 49' ' ' ILE . 35.2 t80 -55.55 -55.76 28.13 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.224 0.92 . . . . 0.0 112.263 173.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -81.34 -27.3 35.01 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.114 1.154 . . . . 0.0 114.114 -174.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 73.0 t -76.3 -38.8 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 O-C-N 121.45 -0.781 . . . . 0.0 111.181 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 93.5 p -65.05 -30.98 71.98 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.152 0.887 . . . . 0.0 112.988 175.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.5 mt -68.43 -54.99 13.45 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.265 1.026 . . . . 0.0 111.761 171.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -67.27 -26.74 66.71 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 120.988 -1.07 . . . . 0.0 113.007 -176.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -81.78 -3.87 54.95 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.874 1.27 . . . . 0.0 112.713 174.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -91.53 -25.13 19.39 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.681 -1.262 . . . . 0.0 112.446 163.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -100.29 -6.76 25.42 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 116.007 1.855 . . . . 0.0 116.007 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.98 -24.99 41.95 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -174.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 38.1 p-90 -90.2 -17.48 27.47 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.494 1.517 . . . . 0.0 113.967 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.5 t -80.0 -26.68 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.635 1.174 . . . . 0.0 112.227 -171.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? -112.33 59.96 0.63 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.715 1.606 . . . . 0.0 109.864 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -125.33 113.92 18.22 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.156 1.382 . . . . 0.0 109.126 174.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 C--O 1.254 1.33 0 C-N-CA 126.257 1.823 . . . . 0.0 112.666 -171.464 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.688 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 15.9 m -48.48 -43.98 63.37 Favored Pre-proline 0 N--CA 1.477 0.92 0 N-CA-C 117.796 2.517 . . . . 0.0 117.796 -168.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -66.07 -11.8 32.68 Favored 'Trans proline' 0 C--N 1.356 0.948 0 CA-C-N 122.745 2.016 . . . . 0.0 114.826 -175.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -69.92 -22.42 63.2 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.238 -0.914 . . . . 0.0 112.904 173.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 68.3 m -66.8 -28.93 68.77 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.305 -0.872 . . . . 0.0 112.877 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -72.88 2.21 7.23 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.651 1.581 . . . . 0.0 113.933 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.36 -28.29 47.11 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.696 1.198 . . . . 0.0 113.059 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 41.6 p -135.63 -41.22 0.7 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.785 1.634 . . . . 0.0 111.927 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 61.27 21.87 12.3 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.661 1.984 . . . . 0.0 115.637 164.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.48 36.62 2.23 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -153.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -80.85 55.38 2.4 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.424 1.49 . . . . 0.0 112.192 -178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -153.7 157.38 39.44 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 126.48 1.912 . . . . 0.0 110.717 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -176.49 78.78 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 127.77 2.428 . . . . 0.0 109.491 -174.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.65 126.55 30.89 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.021 -1.05 . . . . 0.0 112.883 -160.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.3 t -70.96 141.1 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 O-C-N 121.138 -0.976 . . . . 0.0 112.971 -168.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.3 mt -122.7 -41.77 2.35 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.874 1.67 . . . . 0.0 112.495 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 33.6 t -152.42 132.31 13.32 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.545 1.138 . . . . 0.0 110.596 175.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 72.6 t -127.94 127.07 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.546 1.138 . . . . 0.0 109.744 172.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -133.17 143.03 46.64 Favored Pre-proline 0 N--CA 1.474 0.737 0 C-N-CA 124.853 1.261 . . . . 0.0 111.683 173.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.02 -17.42 22.25 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.51 2.807 . . . . 0.0 115.098 -174.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -134.25 110.81 9.77 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.118 0.967 . . . . 0.0 112.21 -169.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -149.36 146.37 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 126.324 1.85 . . . . 0.0 109.739 171.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.3 m -125.27 131.59 53.06 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.058 0.943 . . . . 0.0 111.573 -171.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.1 t -98.9 139.97 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 126.028 1.731 . . . . 0.0 112.054 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -127.59 132.38 49.83 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.71 1.604 . . . . 0.0 108.968 169.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 48.0 mtm180 -70.05 139.29 52.61 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 155.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.8 pt -125.99 156.53 71.58 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 125.16 1.384 . . . . 0.0 112.95 -163.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -64.25 161.62 33.41 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 123.343 2.696 . . . . 0.0 112.622 170.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -65.59 108.25 1.19 Allowed 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.439 2.759 . . . . 0.0 111.52 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.5 mmt-85 -148.59 175.79 10.88 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.985 1.714 . . . . 0.0 112.594 -177.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -148.62 162.83 38.92 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 128.482 2.713 . . . . 0.0 108.57 176.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.3 t -59.48 -38.04 79.8 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 120.564 -1.335 . . . . 0.0 112.349 174.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -76.32 1.79 15.18 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.838 1.255 . . . . 0.0 113.717 174.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 77.7 mmt-85 -124.03 -19.33 5.66 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.758 2.023 . . . . 0.0 113.327 176.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.05 92.76 1.12 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.717 1.627 . . . . 0.0 114.796 165.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -61.95 141.5 57.99 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 146.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.27 22.9 4.81 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.284 1.434 . . . . 0.0 113.021 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 56.64 -46.94 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 128.471 2.709 . . . . 0.0 115.304 -170.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.4 m -64.82 -13.43 55.82 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.552 1.941 . . . . 0.0 114.276 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -78.57 -4.6 49.56 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.405 1.482 . . . . 0.0 113.588 170.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 10.6 m0 -107.0 167.83 9.62 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.655 1.582 . . . . 0.0 111.425 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -78.01 53.67 1.21 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.02 1.728 . . . . 0.0 113.589 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.9 mt -55.56 -32.6 63.14 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -170.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -87.63 -6.82 58.1 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.068 0.947 . . . . 0.0 113.085 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -140.19 59.29 12.35 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 126.886 2.075 . . . . 0.0 111.183 -160.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -65.04 139.61 62.03 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 CA-C-N 119.593 0.89 . . . . 0.0 112.424 -171.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -74.46 -26.64 60.17 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.207 1.003 . . . . 0.0 111.717 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 39.4 t90 -153.6 153.57 32.59 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.887 1.675 . . . . 0.0 110.71 169.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 56.0 p -135.88 148.38 48.58 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.486 1.114 . . . . 0.0 112.091 171.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 173.09 -144.13 7.64 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 123.017 0.341 . . . . 0.0 113.852 177.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.4 mtm180 -98.14 145.48 26.53 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.94 1.696 . . . . 0.0 112.069 -174.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.4 tp -85.61 136.47 33.37 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.584 1.553 . . . . 0.0 109.778 163.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 39.3 ttt-85 -145.68 87.08 1.76 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.626 1.17 . . . . 0.0 110.862 167.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.478 HD11 ' CD1' ' A' ' 119' ' ' PHE . 21.1 mt -71.28 125.59 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 171.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.7 p -128.23 163.91 23.7 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.376 1.87 . . . . 0.0 110.131 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.3 t -163.78 148.73 10.67 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.678 -1.264 . . . . 0.0 110.754 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.511 ' HE3' ' CE1' ' A' ' 57' ' ' TYR . 57.9 mttt -125.21 -126.37 0.24 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.967 1.307 . . . . 0.0 110.037 -172.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.48 94.11 1.69 Allowed Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.293 1.425 . . . . 0.0 112.309 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 54.58 28.54 10.0 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 126.653 1.981 . . . . 0.0 113.635 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.0 m -148.16 118.21 7.23 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.634 1.573 . . . . 0.0 109.35 -174.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -96.0 163.89 12.94 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.057 1.343 . . . . 0.0 111.63 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.511 ' CE1' ' HE3' ' A' ' 52' ' ' LYS . 82.2 m-85 -147.67 107.38 3.96 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.205 1.802 . . . . 0.0 109.298 -174.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.3 mp -80.46 96.11 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 170.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -92.41 138.21 31.71 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.173 0.589 . . . . 0.0 111.475 173.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.1 mp -115.62 134.48 55.01 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.365 1.866 . . . . 0.0 109.911 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -136.09 148.47 48.29 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.962 0.905 . . . . 0.0 112.07 -168.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -71.01 141.05 50.98 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 122.766 1.269 . . . . 0.0 111.643 177.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.623 ' H ' ' CD ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -85.25 1.53 47.84 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 127.007 2.123 . . . . 0.0 116.139 -175.124 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.1 t -116.97 -45.67 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 125.336 1.454 . . . . 0.0 111.014 171.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.2 m -96.71 -20.12 18.47 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -173.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.79 9.69 83.14 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.431 1.015 . . . . 0.0 113.823 -176.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -83.34 149.07 26.96 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.999 1.319 . . . . 0.0 112.186 -174.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.4 tp -70.89 125.45 26.88 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.59 0.756 . . . . 0.0 111.24 -177.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -83.5 -57.82 3.08 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.725 0.81 . . . . 0.0 110.475 167.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.59 163.02 40.69 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.486 1.114 . . . . 0.0 112.071 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -136.39 137.69 40.79 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.469 1.507 . . . . 0.0 110.606 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.81 92.1 49.31 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.291 1.036 . . . . 0.0 111.535 176.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -56.6 139.56 88.16 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 124.649 3.566 . . . . 0.0 113.457 168.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.3 t -138.94 123.99 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 126.58 1.952 . . . . 0.0 109.618 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -88.59 -21.41 24.05 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 121.01 -1.056 . . . . 0.0 113.425 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -160.29 144.94 14.53 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.169 1.788 . . . . 0.0 110.252 170.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -118.34 129.08 25.6 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.493 1.117 . . . . 0.0 110.75 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -66.39 148.23 76.77 Favored 'Cis proline' 0 CA--C 1.542 0.887 0 CA-C-N 119.976 1.027 . . . . 0.0 113.094 -4.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.81 -163.4 15.39 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.529 1.537 . . . . 0.0 113.054 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.4 tt -69.9 -37.42 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 O-C-N 121.797 -0.826 . . . . 0.0 113.191 -175.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.54 7.14 27.35 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -165.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 23.8 t -150.55 125.13 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.478 1.511 . . . . 0.0 109.606 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -139.16 159.83 41.23 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.114 1.766 . . . . 0.0 112.17 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.0 p -114.35 156.06 25.13 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.085 1.754 . . . . 0.0 111.725 -176.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.5 m -85.91 172.09 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.089 0.956 . . . . 0.0 111.114 170.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 70.5 p -96.7 -28.09 14.47 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 178.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -88.62 -43.37 11.41 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.232 0.826 . . . . 0.0 113.232 -168.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.5 t -146.17 125.73 13.28 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.34 1.77 3.56 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -170.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.471 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.286 31.5 ptt180 -86.59 16.59 4.52 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 177.162 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -139.5 137.6 35.65 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.997 1.319 . . . . 0.0 111.102 -173.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -139.07 155.02 48.24 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.979 1.312 . . . . 0.0 111.567 -178.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.76 141.77 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.497 0.719 . . . . 0.0 109.38 164.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.44 146.85 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 118.811 0.732 . . . . 0.0 112.354 171.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -87.54 89.87 8.16 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.906 0.883 . . . . 0.0 110.071 176.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.1 pt -68.34 144.14 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 O-C-N 122.126 -0.359 . . . . 0.0 111.127 173.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -136.13 137.88 41.45 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.713 1.205 . . . . 0.0 111.613 -175.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -85.37 10.0 13.92 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.464 1.106 . . . . 0.0 113.831 -176.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.2 6.75 75.63 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.062 1.315 . . . . 0.0 115.473 177.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.4 t -123.91 3.34 8.75 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.618 1.567 . . . . 0.0 114.143 -173.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.94 21.63 15.37 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.784 1.183 . . . . 0.0 113.951 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.52 148.04 50.43 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.963 1.705 . . . . 0.0 111.011 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.0 p -151.72 166.01 32.63 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -164.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.73 146.39 33.12 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.271 1.429 . . . . 0.0 111.334 168.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -92.55 117.37 29.88 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.704 0.802 . . . . 0.0 109.672 171.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 32.9 pt -118.76 145.56 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.939 1.296 . . . . 0.0 111.419 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -90.95 141.83 15.88 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 176.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.3 pt -127.95 140.56 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 125.385 1.474 . . . . 0.0 111.646 171.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.08 143.78 15.84 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.835 1.207 . . . . 0.0 113.324 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -105.77 163.74 12.47 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.878 1.671 . . . . 0.0 111.061 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.1 t -74.08 -30.57 62.42 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.241 0.616 . . . . 0.0 112.407 176.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -151.1 150.21 30.41 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.133 0.973 . . . . 0.0 112.107 -174.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 54.7 ttt-85 -61.06 -33.68 73.7 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.43 1.092 . . . . 0.0 113.154 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.04 -27.17 73.77 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 123.901 0.763 . . . . 0.0 113.849 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -83.43 -36.27 24.35 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.088 0.944 . . . . 0.0 111.422 175.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.471 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -65.12 -33.08 75.17 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 169.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -61.0 -33.79 73.8 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.42 -0.8 . . . . 0.0 112.674 172.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -64.86 -37.87 89.08 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.808 1.185 . . . . 0.0 111.943 173.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.478 ' CD1' HD11 ' A' ' 49' ' ' ILE . 19.2 t80 -58.27 -50.38 73.79 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.738 0.815 . . . . 0.0 111.837 174.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.96 -24.27 38.2 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -176.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.7 t -80.67 -41.79 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 119.368 0.986 . . . . 0.0 111.427 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 93.2 p -63.47 -32.96 74.55 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.4 1.0 . . . . 0.0 112.87 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 61.6 mt -64.54 -58.46 6.33 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.22 1.008 . . . . 0.0 111.798 170.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -66.82 -29.8 69.83 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.247 -0.908 . . . . 0.0 113.121 -174.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -80.68 -3.55 51.08 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.42 1.088 . . . . 0.0 112.579 177.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -95.13 -19.39 20.14 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 163.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -101.41 -9.21 21.31 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.43 -31.6 55.7 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 -174.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 29.4 p-90 -79.52 -25.23 41.8 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.174 1.39 . . . . 0.0 113.283 176.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.7 t -79.26 -30.76 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.493 1.517 . . . . 0.0 110.816 172.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -94.27 29.26 2.25 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 127.235 2.214 . . . . 0.0 112.871 -177.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -79.53 90.38 5.1 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.89 0.853 . . . . 0.0 109.965 172.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 C--O 1.252 1.201 0 C-N-CA 126.813 2.045 . . . . 0.0 112.685 -172.098 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.612 0 N-CA-C 112.129 -0.388 . . . . 0.0 112.129 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 55.2 p -150.0 172.37 5.34 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 125.342 1.457 . . . . 0.0 111.783 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -65.49 -9.78 23.71 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.451 2.767 . . . . 0.0 115.322 174.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -72.66 139.83 47.56 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.263 1.025 . . . . 0.0 112.113 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 67.1 p -91.31 -13.49 32.5 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.715 1.206 . . . . 0.0 114.02 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -73.84 143.81 45.75 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.338 1.455 . . . . 0.0 112.245 -176.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.0 -49.39 0.11 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.027 1.331 . . . . 0.0 112.012 174.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.0 m -139.9 121.94 15.7 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.23 1.812 . . . . 0.0 108.258 171.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -136.57 15.84 3.15 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -173.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.78 59.45 3.11 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.435 1.494 . . . . 0.0 113.008 -172.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -121.27 56.02 1.05 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.614 1.966 . . . . 0.0 109.778 176.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -151.93 148.19 27.47 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 126.295 1.838 . . . . 0.0 109.576 -172.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -174.69 128.81 0.32 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.438 1.495 . . . . 0.0 108.587 167.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.4 m -91.1 110.78 22.06 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 165.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.6 t -65.06 142.05 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 123.766 0.826 . . . . 0.0 111.288 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.5 mt -128.18 -40.17 1.67 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.633 1.573 . . . . 0.0 112.338 -175.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 37.0 t -152.99 135.99 15.52 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.464 1.106 . . . . 0.0 111.036 173.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.4 t -129.0 126.89 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.492 1.117 . . . . 0.0 109.253 171.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -128.12 134.65 26.47 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 125.352 1.461 . . . . 0.0 110.287 175.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -78.64 -13.28 14.79 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.21 2.607 . . . . 0.0 115.268 -171.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -135.18 108.19 7.63 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.806 0.843 . . . . 0.0 111.339 -174.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.52 143.34 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.084 1.354 . . . . 0.0 110.568 173.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.5 m -123.65 131.93 53.73 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.426 1.09 . . . . 0.0 111.254 -173.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 76.6 t -97.44 134.32 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.509 1.524 . . . . 0.0 111.68 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.17 132.83 53.66 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.198 1.399 . . . . 0.0 108.685 168.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -71.4 131.72 43.78 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 162.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.1 pt -111.8 151.82 43.72 Favored Pre-proline 0 N--CA 1.476 0.849 0 C-N-CA 124.043 0.937 . . . . 0.0 113.327 -164.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -63.93 163.98 23.49 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.068 2.512 . . . . 0.0 111.571 165.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -59.49 149.87 79.15 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.92 2.413 . . . . 0.0 112.705 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.7 ttm105 -61.51 155.05 22.94 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.643 1.577 . . . . 0.0 112.384 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.12 174.93 0.46 Allowed 'General case' 0 CA--C 1.551 0.987 0 CA-C-O 122.005 0.907 . . . . 0.0 112.51 159.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 84.7 p -83.38 -41.71 17.86 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.22 -0.925 . . . . 0.0 113.288 -170.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -130.52 -1.89 4.35 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.603 1.561 . . . . 0.0 113.165 -175.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -107.65 -55.87 2.3 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -169.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.81 -129.89 7.22 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -160.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -131.68 169.91 15.51 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.428 2.291 . . . . 0.0 110.526 -175.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.43 18.89 7.5 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -175.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.92 -51.4 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.968 2.507 . . . . 0.0 115.481 -173.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.0 m -65.43 -13.26 58.31 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.253 1.821 . . . . 0.0 114.257 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -79.89 -12.01 59.77 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.323 1.049 . . . . 0.0 112.645 172.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -95.35 165.33 12.43 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.801 1.641 . . . . 0.0 111.12 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.1 mttt -78.07 57.68 1.84 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.622 1.569 . . . . 0.0 113.261 175.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.1 mt -55.47 -31.75 62.23 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -173.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -89.68 -5.67 56.85 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.838 0.855 . . . . 0.0 113.042 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -138.62 68.92 45.24 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 125.479 1.512 . . . . 0.0 111.685 -161.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -68.0 145.66 68.43 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 CA-C-N 119.535 0.869 . . . . 0.0 113.097 -170.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -71.33 -31.15 67.05 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.255 0.622 . . . . 0.0 111.001 166.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 54.9 t90 -157.36 154.8 29.51 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.757 1.623 . . . . 0.0 111.149 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.2 p -132.94 148.31 52.28 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.745 1.218 . . . . 0.0 111.522 170.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.526 ' HA2' ' HE3' ' A' ' 63' ' ' LYS . . . -178.54 -146.1 6.37 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 114.332 0.493 . . . . 0.0 114.332 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -110.84 145.08 38.85 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.426 1.89 . . . . 0.0 110.952 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.6 tp -85.49 138.73 32.03 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.594 1.558 . . . . 0.0 109.939 170.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.1 ttt85 -142.81 87.95 2.02 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.676 1.19 . . . . 0.0 110.649 170.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.444 HD11 ' CD2' ' A' ' 119' ' ' PHE . 27.1 mt -75.37 124.82 34.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 170.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.4 p -134.78 169.37 17.45 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 127.065 2.146 . . . . 0.0 109.712 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.3 t -157.17 160.14 38.45 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.732 -1.23 . . . . 0.0 112.176 176.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -147.85 118.66 7.58 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.658 0.742 . . . . 0.0 111.879 160.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.24 -119.96 11.23 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 125.899 1.714 . . . . 0.0 110.506 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -92.03 10.62 28.33 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.853 1.661 . . . . 0.0 113.824 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.1 m -129.31 112.75 14.19 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.592 0.757 . . . . 0.0 111.231 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.13 161.27 16.59 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.55 0.74 . . . . 0.0 111.493 172.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -141.45 106.01 4.87 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.443 1.897 . . . . 0.0 109.31 -173.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -82.77 95.68 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 168.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -91.1 138.28 31.72 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.74 0.816 . . . . 0.0 110.86 175.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mp -112.75 130.48 56.05 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.075 1.75 . . . . 0.0 109.927 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -133.99 148.78 51.16 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.005 0.922 . . . . 0.0 112.427 -172.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -66.53 147.56 53.11 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.05 -1.031 . . . . 0.0 111.824 177.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.526 ' HE3' ' HA2' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -83.93 -0.3 50.86 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -174.168 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.5 t -120.05 -45.26 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.856 1.262 . . . . 0.0 111.508 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.7 p -94.04 -23.54 17.97 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -178.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.55 11.85 80.29 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 123.814 0.721 . . . . 0.0 113.478 -169.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -70.57 142.8 51.71 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.888 1.344 . . . . 0.0 111.621 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.4 tp -71.03 125.21 26.25 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.154 0.582 . . . . 0.0 111.208 -176.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -85.23 -56.35 3.58 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.443 1.097 . . . . 0.0 110.923 170.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.0 164.41 36.8 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.563 1.545 . . . . 0.0 110.547 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -144.98 143.32 30.46 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 169.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -114.56 111.97 46.07 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 125.086 1.355 . . . . 0.0 111.177 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.57 144.07 13.91 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.406 2.737 . . . . 0.0 111.36 175.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.8 t -135.65 128.91 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.488 1.515 . . . . 0.0 109.496 -173.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -94.65 -21.5 18.75 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.74 147.59 11.88 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.636 1.974 . . . . 0.0 110.05 170.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -116.07 128.61 25.85 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 124.803 1.241 . . . . 0.0 110.859 176.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -67.56 149.72 82.88 Favored 'Cis proline' 0 CA--C 1.544 0.978 0 CA-C-N 119.788 0.96 . . . . 0.0 112.804 -5.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.54 -167.31 17.62 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.658 1.599 . . . . 0.0 112.728 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.6 tt -67.52 -36.7 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 O-C-N 121.56 -0.965 . . . . 0.0 112.907 -177.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.32 4.23 32.11 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 -167.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.2 t -151.49 127.61 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.145 1.378 . . . . 0.0 110.448 -177.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -142.63 158.25 43.85 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.983 1.713 . . . . 0.0 112.872 -177.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.5 p -101.72 163.27 12.34 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.237 1.815 . . . . 0.0 111.749 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.5 m -89.54 169.64 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.178 0.991 . . . . 0.0 110.084 162.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 81.3 p -95.09 -30.72 13.92 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.864 1.266 . . . . 0.0 113.53 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -94.73 -39.1 10.48 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -164.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.6 t -137.09 118.84 15.06 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -175.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.3 m -74.92 21.02 0.12 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -164.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.405 ' HA ' ' CB ' ' A' ' 116' ' ' ALA . 15.9 ptt-85 -120.44 20.94 11.79 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.532 1.933 . . . . 0.0 114.095 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -138.56 140.9 39.23 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.308 1.443 . . . . 0.0 110.883 -173.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -140.8 156.84 46.06 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.842 1.257 . . . . 0.0 111.42 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 83.2 t -107.97 142.42 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.991 0.917 . . . . 0.0 109.5 165.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.75 148.19 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 118.492 0.587 . . . . 0.0 111.889 169.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.0 ttp85 -92.19 91.81 7.93 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.337 0.655 . . . . 0.0 110.581 176.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.5 pp -75.26 152.96 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.64 0.776 . . . . 0.0 112.05 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.63 150.83 40.3 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.958 1.703 . . . . 0.0 110.9 173.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -93.37 2.4 56.54 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.55 1.14 . . . . 0.0 113.054 174.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.65 12.8 81.13 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.26 1.409 . . . . 0.0 114.871 177.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.2 t -138.93 16.43 2.66 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.491 1.516 . . . . 0.0 113.276 -171.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.2 -0.37 78.34 Favored Glycine 0 CA--C 1.537 1.453 0 O-C-N 120.7 -1.25 . . . . 0.0 115.167 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 83.1 mtt180 -80.7 137.47 36.3 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.693 1.597 . . . . 0.0 108.836 166.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.6 p -142.7 157.41 44.69 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 166.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.03 143.4 28.35 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.824 1.25 . . . . 0.0 111.646 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -84.36 118.07 24.0 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.681 0.792 . . . . 0.0 109.536 168.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 30.3 pt -118.34 144.73 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.828 1.251 . . . . 0.0 110.996 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -92.08 139.0 14.5 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.1 pt -124.23 142.21 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 125.039 1.336 . . . . 0.0 111.867 171.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -124.05 143.16 14.68 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 124.777 1.179 . . . . 0.0 113.69 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -106.0 159.79 15.78 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.976 1.711 . . . . 0.0 110.833 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.5 t -72.87 -23.83 60.78 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.699 0.799 . . . . 0.0 112.739 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -158.75 153.74 25.13 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.915 1.286 . . . . 0.0 110.82 -175.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -58.78 -34.44 71.45 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.575 0.75 . . . . 0.0 112.715 176.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.46 -31.65 78.28 Favored Glycine 0 CA--C 1.536 1.368 0 CA-C-N 119.491 1.041 . . . . 0.0 114.348 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -85.85 -36.02 20.26 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.237 1.018 . . . . 0.0 112.114 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.405 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -60.92 -31.96 71.46 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.681 -0.637 . . . . 0.0 112.472 167.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . 0.28 8.2 m-85 -78.88 11.19 2.78 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 173.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -105.24 -31.46 9.09 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.765 0.826 . . . . 0.0 112.813 157.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.444 ' CD2' HD11 ' A' ' 49' ' ' ILE . 26.0 t80 -55.38 -47.09 76.34 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.263 1.025 . . . . 0.0 112.227 175.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -78.23 -32.71 49.95 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.8 t -76.87 -41.62 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.316 1.046 . . . . 0.0 110.906 -177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 81.8 p -64.35 -30.32 71.37 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 81.5 mt -71.67 -54.91 8.82 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.115 0.966 . . . . 0.0 111.92 171.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -66.85 -28.64 68.5 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.048 -1.033 . . . . 0.0 113.194 -175.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -84.76 -3.63 58.69 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.282 1.033 . . . . 0.0 112.664 175.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 53.1 t60 -89.06 -39.49 13.62 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 120.838 -1.164 . . . . 0.0 111.765 158.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -89.84 -1.63 58.03 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -172.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.47 -30.06 59.87 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 120.705 1.593 . . . . 0.0 114.638 -175.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 39.7 p-90 -84.97 -20.92 29.84 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.455 1.102 . . . . 0.0 113.905 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.6 t -84.69 -37.72 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.986 1.315 . . . . 0.0 110.599 175.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.0 tptt -91.5 47.6 1.39 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.165 1.786 . . . . 0.0 111.45 -177.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -86.36 11.4 12.39 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.215 1.406 . . . . 0.0 114.555 177.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 . . . . . 0 C--O 1.252 1.22 0 C-N-CA 126.77 2.028 . . . . 0.0 112.781 -178.935 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.614 0 N-CA-C 111.714 -0.555 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 35.8 m 48.03 62.04 12.74 Favored Pre-proline 0 N--CA 1.481 1.085 0 C-N-CA 126.145 1.778 . . . . 0.0 114.932 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -75.43 0.95 8.48 Favored 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 124.168 3.245 . . . . 0.0 114.304 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -66.15 158.87 27.55 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.93 1.692 . . . . 0.0 113.364 -175.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 60.2 m -109.74 -24.26 10.99 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.685 1.594 . . . . 0.0 113.343 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.9 ttp 53.1 48.4 22.37 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.843 1.657 . . . . 0.0 112.58 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.66 34.15 1.62 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.795 1.638 . . . . 0.0 111.402 -172.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.1 m 58.18 80.3 0.18 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.511 1.925 . . . . 0.0 111.995 -168.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -100.78 17.53 21.81 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.7 1.6 . . . . 0.0 114.631 -170.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.5 tt -76.37 55.18 0.97 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 127.012 2.125 . . . . 0.0 111.819 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -88.32 50.44 1.98 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.714 1.606 . . . . 0.0 111.653 -176.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -149.15 146.09 27.5 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.396 1.478 . . . . 0.0 111.516 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -175.22 96.3 0.07 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.435 1.894 . . . . 0.0 108.076 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 m -80.87 112.01 17.86 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.908 -1.12 . . . . 0.0 109.631 172.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 p -66.85 145.45 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.386 0.674 . . . . 0.0 112.54 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 50.0 mt -126.82 -44.02 1.67 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.747 1.619 . . . . 0.0 112.209 -176.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.3 t -152.36 134.84 15.24 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.637 1.175 . . . . 0.0 110.482 175.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 86.3 t -127.21 127.06 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.333 1.053 . . . . 0.0 109.325 170.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -127.64 132.91 24.57 Favored Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 125.081 1.352 . . . . 0.0 110.228 174.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.13 -15.75 16.08 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.137 2.558 . . . . 0.0 114.874 -172.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -133.81 106.9 7.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.353 1.061 . . . . 0.0 110.987 -175.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.2 p -142.77 146.18 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 125.342 1.457 . . . . 0.0 110.224 173.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.5 m -127.83 132.13 49.47 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.057 0.943 . . . . 0.0 111.597 -171.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.2 t -98.8 130.24 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.399 1.479 . . . . 0.0 111.803 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -131.31 131.49 43.83 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.236 1.414 . . . . 0.0 109.637 170.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.8 mmt-85 -59.89 140.36 56.71 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.482 165.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.9 pt -107.74 154.45 40.91 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 125.499 1.519 . . . . 0.0 112.834 -174.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -69.73 161.91 44.09 Favored 'Trans proline' 0 CA--C 1.548 1.191 0 C-N-CA 123.065 2.51 . . . . 0.0 111.559 164.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -62.74 144.2 93.45 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.898 2.398 . . . . 0.0 112.204 175.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.19 160.23 28.1 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.691 1.196 . . . . 0.0 112.632 -177.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -144.03 165.81 26.73 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.589 154.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.0 m -82.52 -31.58 29.14 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.122 1.769 . . . . 0.0 112.439 -176.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 -93.25 20.24 7.23 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.343 1.457 . . . . 0.0 112.325 171.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 91.4 mmt-85 -133.3 -64.28 0.73 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.522 1.529 . . . . 0.0 111.778 175.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.0 161.84 6.47 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 122.651 1.14 . . . . 0.0 112.986 -172.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -74.84 138.28 42.42 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.915 0.886 . . . . 0.0 110.0 168.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.13 19.67 6.43 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -172.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.49 -50.07 0.05 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.789 2.435 . . . . 0.0 115.39 -174.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.9 m -68.54 -16.62 63.94 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.843 1.657 . . . . 0.0 114.75 -175.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.52 -7.35 59.55 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 172.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.0 m0 -85.58 168.02 14.85 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.857 1.263 . . . . 0.0 110.639 175.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.8 mttt -77.72 52.23 0.99 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.129 1.372 . . . . 0.0 113.964 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.8 mt -57.52 -28.46 63.49 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -175.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -90.28 -6.15 55.48 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -149.91 83.56 6.18 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.502 1.121 . . . . 0.0 112.332 177.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -56.52 147.08 71.55 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.248 2.632 . . . . 0.0 112.95 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -70.1 -33.96 72.51 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.399 0.68 . . . . 0.0 111.14 165.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.5 t90 -156.61 152.68 27.49 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.812 1.645 . . . . 0.0 110.801 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.3 p -132.55 149.88 52.25 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.122 0.969 . . . . 0.0 111.554 167.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.99 -141.44 5.13 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 123.07 0.367 . . . . 0.0 113.282 -178.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.2 mtm105 -109.8 144.92 37.55 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.065 1.746 . . . . 0.0 111.88 -175.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.8 tp -85.36 137.59 32.84 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.711 1.204 . . . . 0.0 109.129 163.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.8 ttt-85 -143.97 89.37 2.03 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.263 1.025 . . . . 0.0 110.56 164.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.503 HD11 ' CD2' ' A' ' 119' ' ' PHE . 15.1 mt -71.53 130.05 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 170.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 p -132.83 173.76 11.04 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.933 2.093 . . . . 0.0 110.282 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 92.9 p -161.89 166.73 25.82 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 120.687 -1.258 . . . . 0.0 111.712 178.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.2 mmtt -152.92 -117.74 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.658 1.583 . . . . 0.0 110.451 153.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.47 92.05 0.41 Allowed Glycine 0 N--CA 1.471 1.024 0 C-N-CA 125.636 1.588 . . . . 0.0 113.802 -160.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.7 mttt 50.99 27.91 3.52 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.429 1.891 . . . . 0.0 112.915 -175.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.1 m -143.42 127.82 17.85 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.24 1.416 . . . . 0.0 109.269 -173.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.76 161.57 13.51 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.637 1.175 . . . . 0.0 110.562 169.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -141.25 102.34 4.21 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.163 1.785 . . . . 0.0 108.905 -173.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.1 mp -78.57 98.09 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 170.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -97.61 138.02 35.65 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.395 0.617 . . . . 0.0 111.575 173.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mp -109.11 132.93 53.64 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.197 1.799 . . . . 0.0 109.568 174.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -137.88 151.92 48.52 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.891 0.876 . . . . 0.0 112.569 -168.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -74.12 143.99 45.1 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.123 -0.986 . . . . 0.0 112.092 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -84.07 -6.55 59.43 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.376 1.871 . . . . 0.0 115.128 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 92.5 t -123.37 -44.32 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 125.315 1.446 . . . . 0.0 111.423 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.8 m -93.64 -22.88 18.5 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -174.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.0 6.88 86.43 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 123.956 0.789 . . . . 0.0 113.805 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -82.37 155.68 24.6 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.364 1.466 . . . . 0.0 112.441 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.3 tp -74.5 129.01 36.97 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.492 0.717 . . . . 0.0 111.223 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -88.04 -55.19 3.86 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.234 1.014 . . . . 0.0 111.16 169.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.39 161.25 40.13 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.918 1.287 . . . . 0.0 111.323 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -144.22 140.74 29.46 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.759 0.824 . . . . 0.0 112.565 176.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.79 102.5 22.37 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 125.936 1.694 . . . . 0.0 111.157 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -69.33 147.15 64.98 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.927 3.085 . . . . 0.0 112.438 170.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.9 t -138.15 125.07 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.796 1.638 . . . . 0.0 109.152 -176.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -92.02 -22.48 19.94 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -159.88 147.45 16.73 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.562 1.945 . . . . 0.0 109.642 168.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -124.14 127.62 25.29 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 124.684 1.194 . . . . 0.0 110.964 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.43 147.4 50.06 Favored 'Cis proline' 0 CA--C 1.541 0.87 0 CA-C-N 120.079 1.064 . . . . 0.0 114.534 -4.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.33 -166.58 19.44 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.488 1.518 . . . . 0.0 113.429 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.4 tp -70.65 -31.24 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -174.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.85 3.54 50.84 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -171.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.9 t -150.34 133.54 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.902 1.281 . . . . 0.0 110.844 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -141.35 161.61 37.49 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.319 1.448 . . . . 0.0 112.83 175.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 73.0 p -107.21 161.23 14.96 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 127.055 2.142 . . . . 0.0 111.093 177.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.8 m -88.27 172.83 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 123.897 0.879 . . . . 0.0 111.232 166.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 60.0 p -96.22 -30.29 13.55 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.39 1.476 . . . . 0.0 113.368 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -96.28 -40.59 9.08 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -165.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.5 t -137.74 117.96 13.59 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -173.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.3 p -75.08 29.25 0.09 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -172.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.96 24.82 7.48 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 127.108 2.163 . . . . 0.0 113.937 174.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -140.96 139.88 34.31 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.902 1.281 . . . . 0.0 111.261 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -137.74 159.87 40.8 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.813 1.245 . . . . 0.0 110.738 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.8 t -112.18 144.66 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 124.288 1.035 . . . . 0.0 108.772 165.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.94 148.07 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 118.095 0.407 . . . . 0.0 111.755 168.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -89.86 99.98 12.88 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.31 0.644 . . . . 0.0 109.542 172.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -84.7 155.21 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.536 1.135 . . . . 0.0 111.335 176.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -129.97 145.79 51.65 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.969 1.308 . . . . 0.0 111.592 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -95.25 13.88 24.07 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.104 1.362 . . . . 0.0 113.388 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.72 5.26 86.23 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 125.291 1.424 . . . . 0.0 115.65 176.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.9 t -127.32 6.35 6.38 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.571 1.548 . . . . 0.0 113.77 -174.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.19 -5.39 71.55 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 125.388 1.47 . . . . 0.0 113.92 -175.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -74.53 132.94 42.26 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 127.567 2.347 . . . . 0.0 109.069 166.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 84.1 p -139.86 160.38 40.02 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.064 1.345 . . . . 0.0 113.772 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.48 144.77 28.82 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.89 1.276 . . . . 0.0 111.267 172.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -87.88 119.89 28.67 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 165.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 31.3 pt -120.69 142.81 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.628 1.171 . . . . 0.0 111.218 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.69 137.31 13.51 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 176.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.3 pt -124.6 139.05 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 125.226 1.41 . . . . 0.0 111.713 175.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.1 140.28 14.45 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.719 1.152 . . . . 0.0 113.082 177.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -101.84 159.47 15.31 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.025 1.73 . . . . 0.0 111.37 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.5 t -70.58 -27.38 64.07 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.32 0.648 . . . . 0.0 112.646 178.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -158.05 155.96 30.23 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.382 1.073 . . . . 0.0 111.997 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -56.58 -38.41 71.94 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.662 1.185 . . . . 0.0 112.482 174.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.05 -10.43 46.72 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.541 1.067 . . . . 0.0 115.022 176.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -104.75 -35.97 7.58 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.746 1.273 . . . . 0.0 111.754 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.7 -28.27 68.52 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.65 0.78 . . . . 0.0 112.835 164.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -70.74 -6.51 38.01 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 169.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -93.76 -35.25 12.87 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.939 1.245 . . . . 0.0 112.26 163.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.503 ' CD2' HD11 ' A' ' 49' ' ' ILE . 43.5 t80 -55.2 -55.76 27.64 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.304 0.957 . . . . 0.0 112.267 177.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -78.81 -27.66 44.42 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 -173.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.6 t -79.74 -39.58 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 121.749 -0.595 . . . . 0.0 111.043 -178.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 88.5 p -65.7 -33.31 75.59 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.544 -0.722 . . . . 0.0 112.524 174.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 40.6 mt -66.62 -55.73 13.96 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.035 0.934 . . . . 0.0 112.154 172.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -64.85 -27.26 68.75 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.136 0.88 . . . . 0.0 112.874 -176.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -79.0 -7.8 58.38 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.345 1.058 . . . . 0.0 112.873 176.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -84.89 -15.61 44.0 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.087 -1.008 . . . . 0.0 112.815 165.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -115.17 -7.92 12.41 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -173.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.17 -24.37 53.89 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 36.1 p-90 -94.65 -21.43 18.8 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.771 1.628 . . . . 0.0 113.579 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.2 t -78.09 -32.49 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.047 1.339 . . . . 0.0 111.739 -175.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -98.46 22.5 9.69 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.546 1.538 . . . . 0.0 113.138 -177.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -85.19 90.2 7.83 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.174 0.989 . . . . 0.0 109.605 171.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 C--O 1.252 1.199 0 C-N-CA 126.51 1.924 . . . . 0.0 112.801 -169.33 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 N-CA-C 111.965 -0.454 . . . . 0.0 111.965 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 39.3 m -67.05 149.09 98.7 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.423 1.089 . . . . 0.0 112.924 -179.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -66.32 -26.42 48.64 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.061 2.507 . . . . 0.0 114.117 173.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -81.64 163.54 22.47 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.396 1.478 . . . . 0.0 112.53 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 65.3 p -75.1 -3.31 31.99 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptp -61.06 148.44 40.32 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.578 1.551 . . . . 0.0 113.009 176.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.16 -57.68 0.13 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.845 1.258 . . . . 0.0 111.508 176.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 52.0 m -153.89 116.79 4.48 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.923 1.689 . . . . 0.0 109.092 169.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -150.31 17.03 0.83 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.968 1.307 . . . . 0.0 113.273 -174.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tt -81.27 50.19 1.4 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.791 2.036 . . . . 0.0 111.761 -177.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -84.76 44.94 1.1 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.774 1.63 . . . . 0.0 112.581 -170.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -147.01 149.91 34.06 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.322 1.449 . . . . 0.0 113.051 -177.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.434 ' HG3' ' HE2' ' A' ' 52' ' ' LYS . 16.3 tt0 -177.37 77.53 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 129.613 3.165 . . . . 0.0 106.479 -173.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.05 113.57 7.38 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 120.668 -1.27 . . . . 0.0 111.299 -165.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.5 t -73.52 143.72 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.741 1.216 . . . . 0.0 111.583 -169.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.9 mt -128.86 -38.67 1.65 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.73 1.612 . . . . 0.0 112.625 -174.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 34.8 t -154.22 136.76 15.09 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.618 1.167 . . . . 0.0 110.726 173.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 88.7 t -130.14 127.27 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.639 1.176 . . . . 0.0 109.383 171.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -129.05 140.17 37.84 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 125.791 1.636 . . . . 0.0 110.794 176.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -77.35 -27.26 6.64 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.464 2.776 . . . . 0.0 115.84 -168.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -140.05 115.87 10.24 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.087 0.946 . . . . 0.0 111.843 -175.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.9 145.4 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 126.84 2.056 . . . . 0.0 109.726 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.2 m -124.71 130.05 51.68 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.767 0.827 . . . . 0.0 112.133 -167.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 77.8 t -94.6 137.44 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.212 1.405 . . . . 0.0 112.051 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.56 128.72 37.84 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.624 1.17 . . . . 0.0 110.133 169.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.41 135.95 57.34 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.306 1.042 . . . . 0.0 111.035 161.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.8 pt -120.71 152.39 55.75 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 126.248 1.819 . . . . 0.0 112.294 -177.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -68.81 158.25 58.58 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 122.247 1.964 . . . . 0.0 110.929 161.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -64.02 145.42 89.74 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.726 2.284 . . . . 0.0 111.688 174.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.8 ttm105 -67.45 158.55 31.54 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.096 0.958 . . . . 0.0 112.685 -177.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -123.74 136.68 54.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.955 145.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.2 m -71.61 -22.71 61.67 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.364 1.466 . . . . 0.0 113.77 -172.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 -84.92 10.24 12.26 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.768 1.227 . . . . 0.0 112.608 169.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 88.2 mmt-85 -130.2 -57.99 1.07 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.144 1.778 . . . . 0.0 111.989 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.73 156.16 6.91 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 122.343 0.968 . . . . 0.0 113.392 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -75.52 139.04 41.94 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.677 0.791 . . . . 0.0 109.975 169.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.62 18.45 6.83 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -170.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.73 -50.67 0.05 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.879 2.472 . . . . 0.0 115.464 -175.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.6 m -66.77 -14.6 62.79 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.069 1.748 . . . . 0.0 114.19 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -76.36 -21.51 56.01 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.723 1.209 . . . . 0.0 112.56 172.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 17.3 m0 -84.52 172.09 11.96 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.667 1.587 . . . . 0.0 111.524 -177.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -80.16 54.55 1.98 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.365 1.466 . . . . 0.0 113.978 -177.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.7 mt -60.71 -17.27 47.23 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -174.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -102.08 -8.04 21.77 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.813 1.245 . . . . 0.0 113.104 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -149.0 72.52 10.29 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.896 1.278 . . . . 0.0 111.867 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -57.47 145.58 87.77 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.043 2.495 . . . . 0.0 112.374 174.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -70.07 -29.14 66.07 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.513 1.125 . . . . 0.0 111.749 175.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 42.1 t90 -159.44 152.99 22.63 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.035 1.734 . . . . 0.0 110.476 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.2 p -133.7 152.31 51.85 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.575 -0.703 . . . . 0.0 112.381 166.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.08 -146.72 7.35 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 116.174 -0.466 . . . . 0.0 114.085 -176.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 42.7 mtm105 -104.84 148.27 26.83 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.047 2.139 . . . . 0.0 111.734 -175.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.3 tp -89.51 139.43 30.54 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.257 1.423 . . . . 0.0 110.247 167.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 -141.53 97.15 3.1 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.65 1.58 . . . . 0.0 109.682 167.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.472 HD11 ' CD2' ' A' ' 119' ' ' PHE . 17.3 mt -83.31 130.67 35.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 169.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.81 162.82 34.47 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.51 2.324 . . . . 0.0 109.508 -168.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.5 t -163.48 153.73 15.66 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.431 -1.418 . . . . 0.0 110.508 175.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.434 ' HE2' ' HG3' ' A' ' 8' ' ' GLU . 67.5 mttt -128.58 -41.79 1.5 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 116.786 2.143 . . . . 0.0 116.786 -176.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.92 82.53 0.1 OUTLIER Glycine 0 N--CA 1.472 1.072 0 CA-C-N 118.652 0.66 . . . . 0.0 112.075 -175.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt 54.71 25.24 6.29 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.006 1.722 . . . . 0.0 112.749 -171.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.7 m -141.43 118.27 11.11 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.197 1.399 . . . . 0.0 107.649 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.51 160.06 14.69 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.241 1.016 . . . . 0.0 110.799 174.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -138.44 113.81 9.55 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 126.346 1.858 . . . . 0.0 108.956 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.5 mp -86.12 102.17 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 166.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -100.67 140.01 35.55 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.349 1.059 . . . . 0.0 111.409 176.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.8 mp -113.32 130.6 56.22 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.444 1.898 . . . . 0.0 109.605 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -135.85 153.26 51.54 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.079 0.952 . . . . 0.0 112.259 -174.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -73.12 142.91 47.49 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.85 -1.156 . . . . 0.0 111.9 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.3 pttt -84.63 -4.64 59.1 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.973 1.709 . . . . 0.0 115.048 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 64.8 t -124.79 -43.81 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 125.468 1.507 . . . . 0.0 111.361 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.7 m -91.54 -24.2 19.69 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.5 5.77 87.99 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 123.992 0.806 . . . . 0.0 113.831 -177.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -82.78 151.17 26.24 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.343 1.457 . . . . 0.0 112.566 -173.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.1 tp -73.36 126.12 29.41 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.612 0.765 . . . . 0.0 110.886 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -87.65 -54.8 4.07 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.462 1.105 . . . . 0.0 111.226 171.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.29 163.64 38.51 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.575 1.15 . . . . 0.0 112.01 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -142.23 134.41 27.59 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.707 1.203 . . . . 0.0 111.653 177.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.15 97.08 50.5 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.11 1.364 . . . . 0.0 111.669 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -58.89 139.7 91.97 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 124.568 3.512 . . . . 0.0 113.315 166.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.3 t -139.13 128.87 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.571 1.949 . . . . 0.0 109.52 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -90.77 -24.12 20.44 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.34 149.97 15.94 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.034 1.734 . . . . 0.0 110.772 173.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -118.83 130.43 24.82 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.589 1.156 . . . . 0.0 111.469 175.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -63.34 148.33 64.16 Favored 'Cis proline' 0 CA--C 1.542 0.879 0 CA-C-N 119.761 0.951 . . . . 0.0 113.583 -7.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -152.39 -163.91 11.96 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.578 1.561 . . . . 0.0 112.461 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.9 tt -78.13 -36.47 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 O-C-N 121.82 -0.812 . . . . 0.0 112.938 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.94 8.71 9.76 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -169.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.0 t -149.8 133.69 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 126.33 1.852 . . . . 0.0 109.446 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -146.43 159.17 43.74 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.464 1.506 . . . . 0.0 112.489 -177.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.8 p -109.7 155.66 21.25 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 126.638 1.975 . . . . 0.0 111.696 176.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.1 m -80.51 173.46 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 124.01 0.924 . . . . 0.0 110.982 165.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.6 p -95.68 -30.21 13.88 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.409 1.484 . . . . 0.0 113.357 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -91.1 -50.24 5.96 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.927 0.891 . . . . 0.0 113.266 -167.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.7 m -133.78 117.39 16.84 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -167.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.0 m -73.23 28.36 0.06 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -171.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.428 ' HA ' ' CB ' ' A' ' 116' ' ' ALA . 6.1 ptm180 -125.23 23.62 7.61 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.859 2.064 . . . . 0.0 113.577 175.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -141.07 137.43 32.87 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.279 1.432 . . . . 0.0 110.99 -178.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -137.35 165.24 26.67 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.855 1.262 . . . . 0.0 111.128 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.3 t -120.28 143.29 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 124.658 1.183 . . . . 0.0 108.539 168.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.72 149.05 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 118.639 0.654 . . . . 0.0 111.744 172.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -92.49 90.23 7.08 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.051 0.54 . . . . 0.0 110.858 177.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -70.57 141.32 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 122.894 0.478 . . . . 0.0 110.995 177.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -137.87 146.4 43.36 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.09 1.756 . . . . 0.0 111.491 -172.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -90.23 -0.31 57.56 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.948 0.899 . . . . 0.0 113.074 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.6 12.8 77.24 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 125.227 1.394 . . . . 0.0 114.896 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.4 t -138.28 18.07 2.77 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.382 1.473 . . . . 0.0 113.465 -173.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.27 -6.14 82.57 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.756 1.17 . . . . 0.0 114.927 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -72.62 129.87 39.26 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.301 1.44 . . . . 0.0 108.469 164.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 93.6 p -152.82 161.31 42.71 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 172.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.14 146.46 30.87 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.527 1.531 . . . . 0.0 111.29 171.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -87.11 124.56 33.38 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.737 -0.602 . . . . 0.0 109.425 166.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.8 pt -122.5 143.57 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.522 1.129 . . . . 0.0 111.092 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -90.18 144.28 17.46 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 173.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.8 pt -129.67 140.43 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 125.53 1.532 . . . . 0.0 111.991 173.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.23 137.7 11.59 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 125.64 1.591 . . . . 0.0 113.151 178.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -102.09 162.92 12.54 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.252 1.821 . . . . 0.0 111.29 -178.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.4 t -74.14 -27.73 60.99 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.722 0.809 . . . . 0.0 113.006 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -157.11 153.27 27.52 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.276 1.03 . . . . 0.0 112.229 -177.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -60.01 -34.4 73.28 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.601 1.16 . . . . 0.0 113.151 176.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.1 -31.54 81.12 Favored Glycine 0 CA--C 1.536 1.39 0 CA-C-N 119.131 0.878 . . . . 0.0 113.382 176.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -83.69 -34.69 24.9 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.804 0.842 . . . . 0.0 112.093 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.428 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -65.46 -33.51 76.12 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 170.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -61.77 -32.19 72.45 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.043 -1.036 . . . . 0.0 112.582 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -66.34 -30.15 70.49 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.049 -1.032 . . . . 0.0 112.738 173.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.472 ' CD2' HD11 ' A' ' 49' ' ' ILE . 24.4 t80 -63.09 -49.35 74.83 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.372 0.987 . . . . 0.0 111.943 173.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.8 -25.11 33.03 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -177.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.8 t -78.37 -41.59 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 119.197 0.908 . . . . 0.0 111.39 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 93.7 p -64.58 -29.49 70.51 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.251 0.932 . . . . 0.0 113.302 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 78.0 mt -70.96 -54.28 11.9 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.004 0.922 . . . . 0.0 111.712 171.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -68.51 -32.74 72.91 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.01 -1.056 . . . . 0.0 113.225 -174.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -83.81 -1.34 54.12 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.088 0.955 . . . . 0.0 112.364 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -96.44 -33.24 11.95 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 120.931 -1.106 . . . . 0.0 112.545 164.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -93.05 -3.28 54.57 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -31.17 58.37 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 121.595 1.998 . . . . 0.0 114.936 -175.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 35.6 p-90 -81.03 -20.29 42.02 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.695 1.198 . . . . 0.0 113.716 177.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.8 t -84.24 -36.13 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.21 1.404 . . . . 0.0 110.364 170.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 48.3 tptt -93.12 45.52 1.18 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 127.519 2.327 . . . . 0.0 111.597 -177.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -84.07 95.28 8.54 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.656 1.183 . . . . 0.0 110.774 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 . . . . . 0 C--O 1.254 1.3 0 C-N-CA 127.002 2.121 . . . . 0.0 112.398 176.078 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.574 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 38.0 t -73.99 136.11 76.66 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 123.704 0.802 . . . . 0.0 112.36 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -78.73 -3.48 13.3 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.782 2.988 . . . . 0.0 113.338 173.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -83.79 28.36 0.59 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.483 1.513 . . . . 0.0 113.935 -171.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 60.4 p -58.46 -33.14 69.42 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.664 -1.272 . . . . 0.0 113.422 -178.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mmt -84.65 14.15 4.95 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.533 1.533 . . . . 0.0 113.844 176.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.63 -40.98 0.86 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.832 1.653 . . . . 0.0 112.323 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 58.5 m -66.18 -39.63 89.85 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.952 0.901 . . . . 0.0 110.746 165.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 46.3 72.08 0.25 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.887 2.475 . . . . 0.0 115.814 157.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.6 pp -70.17 140.21 52.52 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.494 -0.754 . . . . 0.0 111.172 165.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -135.78 51.06 2.07 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.471 1.508 . . . . 0.0 110.209 -178.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -136.02 139.81 43.4 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.954 1.302 . . . . 0.0 110.7 178.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -179.82 121.53 0.07 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.144 1.778 . . . . 0.0 108.516 163.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 82.6 p -97.98 109.25 22.04 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.083 0.468 . . . . 0.0 111.096 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 82.5 t -70.62 141.01 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.916 0.886 . . . . 0.0 111.053 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.6 mt -127.49 -40.54 1.77 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.697 1.599 . . . . 0.0 112.646 -171.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 51.1 t -146.87 137.28 23.65 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.505 1.522 . . . . 0.0 109.247 172.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 76.8 t -126.6 130.48 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.355 1.062 . . . . 0.0 108.936 168.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -133.57 127.84 19.79 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 124.562 1.145 . . . . 0.0 111.076 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.19 -13.24 12.65 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.986 2.457 . . . . 0.0 114.947 -171.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -134.11 104.52 6.25 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.223 1.009 . . . . 0.0 110.717 -176.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.5 p -143.18 144.42 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.508 1.123 . . . . 0.0 110.726 174.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.8 m -124.88 131.21 53.46 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.55 1.14 . . . . 0.0 110.629 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.0 t -96.61 134.33 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.946 1.298 . . . . 0.0 111.127 177.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.38 120.63 25.87 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.06 1.344 . . . . 0.0 108.932 169.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -63.24 130.79 46.06 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.425 -0.797 . . . . 0.0 109.145 163.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.2 pt -93.85 153.03 41.04 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 124.845 1.258 . . . . 0.0 112.834 -166.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -65.08 159.57 46.0 Favored 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 122.896 2.397 . . . . 0.0 111.454 165.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -63.02 140.79 80.88 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.013 2.475 . . . . 0.0 112.138 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.3 ttm-85 -74.28 156.57 37.04 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.691 1.197 . . . . 0.0 112.39 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -132.43 137.65 47.36 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.598 141.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.1 m -68.92 -29.77 68.09 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.493 1.517 . . . . 0.0 114.106 -169.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -75.93 -7.71 55.21 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.875 0.87 . . . . 0.0 113.009 171.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 27.0 mmt-85 -104.71 -52.16 2.93 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.845 1.658 . . . . 0.0 111.893 175.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.32 161.94 19.31 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 122.195 0.886 . . . . 0.0 112.653 -177.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -75.28 133.95 41.19 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.864 0.866 . . . . 0.0 109.84 169.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.92 18.64 7.86 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -171.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.16 -49.89 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 128.141 2.576 . . . . 0.0 115.607 -173.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.5 m -67.61 -15.2 63.53 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.012 1.725 . . . . 0.0 114.603 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.95 -10.8 58.62 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 171.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.0 m0 -85.55 170.45 12.59 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.813 1.245 . . . . 0.0 110.841 176.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.9 mtmm -80.24 52.94 1.66 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.408 1.483 . . . . 0.0 113.606 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.6 mt -57.89 -23.76 54.69 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -173.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -96.28 -6.51 37.71 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.547 1.139 . . . . 0.0 112.446 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -151.99 72.37 7.88 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 125.111 1.364 . . . . 0.0 111.817 -169.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -57.97 149.59 69.62 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.725 2.95 . . . . 0.0 113.605 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -73.32 -31.11 63.81 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.76 0.824 . . . . 0.0 111.401 167.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 33.5 t90 -158.13 153.02 25.15 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.48 1.912 . . . . 0.0 110.391 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.2 p -134.18 146.74 50.45 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.719 1.208 . . . . 0.0 111.486 171.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.41 -138.5 4.28 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 114.088 0.395 . . . . 0.0 114.088 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -115.89 144.72 43.64 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.816 1.646 . . . . 0.0 111.578 -172.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.2 tp -92.49 137.72 32.12 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.354 1.462 . . . . 0.0 109.821 172.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 53.9 ttp85 -138.68 102.21 4.53 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.96 0.904 . . . . 0.0 110.026 162.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.54 HD11 ' CD1' ' A' ' 119' ' ' PHE . 25.8 mt -79.16 132.67 31.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 169.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.74 171.69 14.13 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 126.229 1.812 . . . . 0.0 110.708 -175.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.0 t -161.41 159.53 28.31 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.369 1.068 . . . . 0.0 110.869 172.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -147.55 -85.03 0.1 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 158.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.56 68.39 3.36 Favored Glycine 0 N--CA 1.474 1.226 0 C-N-CA 124.629 1.109 . . . . 0.0 113.959 -166.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.7 mttt 51.67 30.13 6.39 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.815 1.646 . . . . 0.0 112.49 -172.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.8 m -146.92 120.8 9.3 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.383 1.873 . . . . 0.0 108.237 -173.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.84 156.7 19.77 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.318 1.047 . . . . 0.0 110.939 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -135.15 100.41 4.54 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.336 1.855 . . . . 0.0 108.713 -173.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.6 mp -79.74 104.84 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 171.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.4 mttt -105.4 135.26 47.11 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.526 0.73 . . . . 0.0 111.775 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -101.08 133.17 46.01 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 125.237 1.415 . . . . 0.0 110.189 169.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -138.32 148.34 44.5 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.038 0.935 . . . . 0.0 112.233 -171.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -68.51 149.67 48.97 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.217 1.008 . . . . 0.0 113.688 -171.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.89 -3.84 43.73 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.9 t -123.41 -48.25 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.636 1.174 . . . . 0.0 111.705 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.6 p -95.35 -24.6 16.66 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -176.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.05 13.98 76.16 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 123.609 0.623 . . . . 0.0 113.522 -167.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -69.13 149.28 48.82 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 118.727 1.263 . . . . 0.0 111.533 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.4 tp -71.2 124.11 23.75 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.444 0.698 . . . . 0.0 111.441 -175.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -84.26 -53.86 5.2 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.971 0.908 . . . . 0.0 110.924 168.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -159.39 157.67 30.74 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.925 1.29 . . . . 0.0 111.516 -177.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -138.99 138.77 37.56 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.59 0.756 . . . . 0.0 112.81 174.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.65 111.09 36.4 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.059 1.343 . . . . 0.0 111.685 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -82.81 123.73 3.76 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.981 3.121 . . . . 0.0 111.91 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.6 t -114.41 119.73 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 126.862 2.065 . . . . 0.0 109.324 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -81.97 -20.56 38.28 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 -176.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.08 162.54 15.44 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.245 1.818 . . . . 0.0 109.308 171.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -120.45 129.81 25.15 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -173.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -64.95 151.94 76.03 Favored 'Cis proline' 0 CA--C 1.542 0.912 0 CA-C-N 119.193 0.748 . . . . 0.0 112.895 -11.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -147.37 175.48 26.71 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.165 0.888 . . . . 0.0 114.15 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.5 tp -52.97 -30.11 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 124.695 1.198 . . . . 0.0 114.066 -176.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.68 9.82 28.28 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.6 p -155.45 138.36 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.197 0.999 . . . . 0.0 113.561 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -152.24 161.12 43.09 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.664 1.586 . . . . 0.0 113.069 -172.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 62.9 p -112.88 161.01 17.46 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 127.307 2.243 . . . . 0.0 111.202 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.0 m -88.5 175.8 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.319 1.047 . . . . 0.0 111.314 167.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.7 p -95.79 -31.59 13.11 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.673 1.589 . . . . 0.0 113.357 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -93.98 -42.37 9.08 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -165.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.4 t -142.49 121.39 12.77 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -177.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.15 0.73 5.69 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -169.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.486 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.303 28.4 ptt180 -87.12 16.21 5.34 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 176.509 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -137.24 136.8 38.43 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.168 1.387 . . . . 0.0 110.908 -174.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -137.54 160.3 39.54 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.138 1.375 . . . . 0.0 111.263 -177.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.1 t -116.2 143.05 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.258 1.023 . . . . 0.0 108.915 166.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.67 149.66 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 123.441 0.697 . . . . 0.0 111.395 170.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -93.25 87.44 5.65 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.776 0.831 . . . . 0.0 110.357 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -70.24 138.35 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 120.958 0.409 . . . . 0.0 110.695 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -139.97 149.85 43.77 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.484 1.514 . . . . 0.0 111.212 -167.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -96.67 3.21 52.6 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.146 0.978 . . . . 0.0 113.071 -178.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.32 12.76 81.72 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.129 1.347 . . . . 0.0 114.704 178.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.1 t -134.52 9.86 3.7 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.64 1.576 . . . . 0.0 113.575 -172.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.39 -5.44 67.67 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.959 1.266 . . . . 0.0 114.643 -177.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -67.87 131.47 45.57 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.207 1.403 . . . . 0.0 108.828 163.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 95.6 p -146.22 152.66 39.57 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 114.646 1.351 . . . . 0.0 114.646 174.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.14 140.72 28.18 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.208 1.403 . . . . 0.0 110.927 168.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -88.39 119.69 29.06 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.175 0.59 . . . . 0.0 109.896 170.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.8 pt -118.54 142.0 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.543 1.137 . . . . 0.0 110.756 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -90.99 144.27 17.12 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 173.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.2 pt -128.38 141.81 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 125.052 1.341 . . . . 0.0 111.631 169.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -121.4 142.67 15.52 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.142 1.353 . . . . 0.0 113.169 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -107.19 164.97 11.72 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.718 1.607 . . . . 0.0 111.551 -177.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.6 t -74.39 -31.91 62.52 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.486 0.714 . . . . 0.0 112.521 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -151.71 146.36 25.71 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.245 -0.909 . . . . 0.0 112.071 -172.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -61.71 -33.78 74.62 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.329 1.051 . . . . 0.0 113.195 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.7 -25.54 75.03 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-N 118.935 0.789 . . . . 0.0 113.838 176.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -92.96 -26.38 17.59 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.193 0.997 . . . . 0.0 112.821 176.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.486 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -66.11 -34.53 78.27 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.422 -0.799 . . . . 0.0 112.598 161.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -59.82 -31.32 69.62 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.049 -1.032 . . . . 0.0 112.197 168.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -67.28 -25.19 65.93 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 119.553 1.07 . . . . 0.0 112.968 174.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.54 ' CD1' HD11 ' A' ' 49' ' ' ILE . 13.4 t80 -69.74 -51.87 30.42 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.205 1.002 . . . . 0.0 111.878 168.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.08 -25.3 40.08 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -174.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 65.0 t -77.97 -42.41 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 121.134 -0.979 . . . . 0.0 111.05 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 88.7 p -66.37 -30.66 71.09 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.1 mt -69.93 -55.95 8.33 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.828 0.851 . . . . 0.0 111.536 171.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -63.68 -33.7 76.22 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.117 0.871 . . . . 0.0 113.256 -174.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -83.53 -0.89 52.26 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.468 1.107 . . . . 0.0 112.762 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -94.11 -13.41 26.81 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.263 -0.898 . . . . 0.0 113.31 164.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -108.17 -4.86 17.26 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.02 -23.59 54.83 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 121.079 1.763 . . . . 0.0 115.677 -176.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 34.5 p-90 -89.95 -13.42 36.23 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.512 1.525 . . . . 0.0 114.058 175.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.4 t -91.1 -47.23 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.228 1.411 . . . . 0.0 109.546 171.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -94.16 65.76 3.42 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.569 1.947 . . . . 0.0 110.554 173.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -66.47 96.8 0.39 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.626 1.571 . . . . 0.0 111.673 -179.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 C--O 1.254 1.334 0 C-N-CA 127.538 2.335 . . . . 0.0 112.628 176.071 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.581 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 40.9 m -69.3 147.91 97.27 Favored Pre-proline 0 N--CA 1.476 0.838 0 C-N-CA 124.212 1.005 . . . . 0.0 112.902 -177.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -58.31 -28.2 83.77 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.229 2.619 . . . . 0.0 114.512 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -64.52 -17.0 63.5 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.55 1.14 . . . . 0.0 113.743 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 44.0 m -80.37 -7.29 59.03 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.602 1.161 . . . . 0.0 113.757 175.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt -111.55 152.8 27.12 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.546 1.538 . . . . 0.0 112.378 -177.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.02 -45.07 0.11 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.179 1.392 . . . . 0.0 112.007 175.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 31.6 m -138.38 113.28 9.14 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.94 1.696 . . . . 0.0 107.744 167.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.43 17.91 2.93 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -158.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.89 58.29 1.88 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.391 1.476 . . . . 0.0 112.346 178.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -122.45 62.56 0.97 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.493 1.917 . . . . 0.0 108.869 175.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -147.76 143.93 27.89 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.54 1.536 . . . . 0.0 109.669 -173.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -177.5 126.04 0.14 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.759 1.623 . . . . 0.0 108.853 169.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.0 m -90.87 108.72 20.03 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.753 0.821 . . . . 0.0 109.617 168.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.36 146.99 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.779 0.831 . . . . 0.0 113.015 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.6 mt -130.82 -42.56 1.12 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.65 1.58 . . . . 0.0 112.409 -173.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 27.1 t -151.64 134.67 15.8 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.336 1.054 . . . . 0.0 110.933 177.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 96.9 t -129.31 127.85 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.516 1.126 . . . . 0.0 109.474 172.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -127.36 130.55 23.7 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 125.176 1.391 . . . . 0.0 110.085 173.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.7 -13.96 15.99 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 122.959 2.439 . . . . 0.0 115.144 -171.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -134.37 108.59 8.26 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.029 0.932 . . . . 0.0 111.425 -176.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.69 146.16 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.975 1.71 . . . . 0.0 109.926 174.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.0 m -127.6 131.02 49.99 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.908 0.883 . . . . 0.0 111.695 -170.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 68.2 t -97.77 131.66 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.361 1.464 . . . . 0.0 111.749 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.17 120.89 25.26 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.071 1.348 . . . . 0.0 108.611 167.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.0 mtt-85 -71.69 130.08 40.27 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.094 0.557 . . . . 0.0 109.939 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.4 pt -92.49 153.38 42.62 Favored Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 124.095 0.958 . . . . 0.0 113.435 -163.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -65.48 158.94 50.25 Favored 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 122.586 2.191 . . . . 0.0 111.082 160.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -62.09 147.64 94.71 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.827 2.351 . . . . 0.0 111.987 176.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.7 ttm105 -65.69 147.88 52.67 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.823 0.849 . . . . 0.0 112.052 -176.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.74 179.31 0.51 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.777 1.231 . . . . 0.0 112.854 161.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 81.2 p -102.65 -35.93 8.51 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.842 1.657 . . . . 0.0 112.437 177.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -132.96 25.68 4.28 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.361 1.864 . . . . 0.0 112.124 -175.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -129.35 -61.39 1.03 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.494 1.118 . . . . 0.0 113.087 177.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.62 178.52 45.19 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 122.551 1.084 . . . . 0.0 111.603 -166.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -76.1 146.26 39.45 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 125.122 1.369 . . . . 0.0 110.757 177.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.21 18.58 4.92 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -173.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 59.98 -48.47 0.09 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 128.4 2.68 . . . . 0.0 115.253 -174.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.5 p -65.5 -18.32 65.23 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.838 2.055 . . . . 0.0 114.688 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.74 -15.32 59.21 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.963 0.905 . . . . 0.0 112.988 173.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -90.56 165.29 13.85 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.853 1.261 . . . . 0.0 110.341 176.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.3 mtmt -87.0 64.17 8.33 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.793 0.837 . . . . 0.0 112.435 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.0 mt -56.52 -27.63 57.89 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.752 1.621 . . . . 0.0 115.032 -172.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -86.04 -8.09 58.16 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.107 0.963 . . . . 0.0 113.137 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -135.04 58.82 29.96 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 125.27 1.428 . . . . 0.0 111.814 -161.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -65.82 139.45 57.3 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 CA-C-N 119.719 0.935 . . . . 0.0 112.421 -172.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -69.44 -27.88 65.64 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.747 0.819 . . . . 0.0 111.222 174.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 50.2 t90 -158.09 151.34 23.15 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.89 1.676 . . . . 0.0 110.713 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.3 p -132.97 150.68 52.14 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.791 0.836 . . . . 0.0 111.835 167.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.1 -142.91 5.53 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 116.259 -0.428 . . . . 0.0 113.524 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.5 mtm180 -109.64 146.4 34.84 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.528 1.931 . . . . 0.0 111.812 -176.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.2 tp -84.99 139.49 31.75 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.483 1.513 . . . . 0.0 109.746 163.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -143.93 92.41 2.33 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.091 1.356 . . . . 0.0 110.714 167.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.42 HD11 ' CD2' ' A' ' 119' ' ' PHE . 20.3 mt -76.95 126.27 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 171.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.2 p -138.22 165.53 26.46 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.771 2.028 . . . . 0.0 110.111 -178.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.0 m -148.15 160.12 43.24 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.562 1.145 . . . . 0.0 112.426 175.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -148.8 125.0 10.79 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.281 0.562 . . . . 0.0 112.35 155.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.55 -124.24 8.66 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 125.377 1.465 . . . . 0.0 110.025 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -99.86 17.86 19.77 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.714 1.605 . . . . 0.0 113.317 176.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.3 m -124.45 125.8 44.85 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.63 1.172 . . . . 0.0 110.172 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.68 160.11 14.5 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.549 1.14 . . . . 0.0 111.205 171.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -141.78 103.16 4.3 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.849 2.06 . . . . 0.0 109.071 -171.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.3 mp -81.45 94.16 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 169.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -90.15 141.7 28.43 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.613 0.765 . . . . 0.0 111.27 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.4 mp -113.2 133.04 55.26 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.618 1.967 . . . . 0.0 109.918 173.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -131.45 147.86 52.59 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.105 0.962 . . . . 0.0 113.003 -172.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -68.68 133.77 48.91 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.066 -1.021 . . . . 0.0 110.93 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.416 ' HG2' ' H ' ' A' ' 63' ' ' LYS . 36.5 pttt -77.48 -4.24 44.49 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -176.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 64.1 t -120.62 -42.44 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 125.205 1.402 . . . . 0.0 111.537 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.9 m -93.44 -20.57 20.18 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.09 11.46 79.09 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.551 1.072 . . . . 0.0 113.831 -176.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -87.19 152.44 22.32 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.325 1.45 . . . . 0.0 112.254 -173.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.5 tp -71.9 127.19 31.79 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.601 -0.687 . . . . 0.0 111.389 -178.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -87.27 -55.87 3.62 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.361 1.065 . . . . 0.0 111.047 169.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.95 163.54 39.02 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.438 1.495 . . . . 0.0 110.603 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -145.99 141.43 27.68 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 172.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.08 104.16 52.56 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 125.323 1.449 . . . . 0.0 111.606 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -64.6 142.59 78.16 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.037 3.158 . . . . 0.0 112.54 169.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.6 t -138.37 132.29 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.972 1.709 . . . . 0.0 108.793 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -103.42 -18.22 14.91 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.98 147.24 14.8 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.909 2.083 . . . . 0.0 109.766 173.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -134.3 124.62 17.36 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.484 1.113 . . . . 0.0 111.551 -177.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -59.25 147.89 38.86 Favored 'Cis proline' 0 CA--C 1.54 0.81 0 CA-C-N 120.123 1.08 . . . . 0.0 114.533 -4.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -161.7 -160.0 10.57 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 126.166 1.841 . . . . 0.0 112.025 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.6 tt -76.12 -40.0 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 118.185 0.993 . . . . 0.0 113.158 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.77 7.24 18.42 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -166.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.3 t -150.73 130.08 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.575 1.55 . . . . 0.0 109.947 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -141.84 158.01 44.31 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.041 1.736 . . . . 0.0 112.487 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.4 p -108.28 160.81 15.55 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.745 2.018 . . . . 0.0 111.153 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.9 m -88.87 169.35 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 124.062 0.945 . . . . 0.0 110.862 165.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.5 p -94.1 -29.5 15.13 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.869 1.267 . . . . 0.0 113.556 178.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -92.71 -41.25 10.26 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -166.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.2 t -142.27 112.76 7.21 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -177.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.6 p -72.94 30.32 0.06 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -174.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.43 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.254 1.0 OUTLIER -115.86 23.12 12.51 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.854 2.061 . . . . 0.0 113.519 166.785 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -140.44 138.59 34.82 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.69 1.596 . . . . 0.0 110.622 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -137.34 163.59 30.64 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.902 1.281 . . . . 0.0 111.562 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 37.2 t -117.57 144.83 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.862 1.265 . . . . 0.0 109.13 166.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.69 148.76 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 123.07 0.548 . . . . 0.0 111.538 170.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.459 ' HE ' ' NE2' ' A' ' 97' ' ' GLN . 42.0 ttp180 -91.05 98.82 12.0 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.397 0.679 . . . . 0.0 109.858 173.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -79.61 150.17 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.793 0.837 . . . . 0.0 111.628 176.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.459 ' NE2' ' HE ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -126.53 145.48 50.5 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.848 1.659 . . . . 0.0 110.835 177.05 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -87.67 1.09 54.67 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.59 1.156 . . . . 0.0 113.17 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.72 12.61 79.72 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.21 1.386 . . . . 0.0 114.862 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.6 t -138.31 17.71 2.77 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.414 1.486 . . . . 0.0 113.353 -172.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.99 -1.36 83.08 Favored Glycine 0 CA--C 1.539 1.543 0 O-C-N 120.489 -1.382 . . . . 0.0 115.025 -178.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -77.29 139.03 39.71 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.491 1.517 . . . . 0.0 108.929 165.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.4 p -144.19 157.73 44.13 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 168.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.25 144.23 29.72 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.999 1.319 . . . . 0.0 111.334 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -89.87 120.25 30.94 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.509 0.724 . . . . 0.0 109.607 169.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.5 pt -120.31 144.05 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.77 1.228 . . . . 0.0 111.053 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.44 142.71 16.17 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 124.151 0.881 . . . . 0.0 111.312 174.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.7 pt -129.33 143.09 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 125.506 1.522 . . . . 0.0 112.121 174.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.19 144.2 17.09 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.797 1.189 . . . . 0.0 113.491 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -107.08 158.7 16.86 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.084 1.754 . . . . 0.0 111.213 -178.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.8 t -72.21 -26.73 62.16 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.596 0.758 . . . . 0.0 112.796 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -157.23 151.64 25.17 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.441 1.096 . . . . 0.0 111.804 -176.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 43.2 ttm105 -61.32 -32.58 72.45 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.226 1.01 . . . . 0.0 113.197 177.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.94 -31.72 81.75 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 119.382 0.992 . . . . 0.0 113.464 176.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -85.89 -30.67 22.69 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 117.963 0.882 . . . . 0.0 112.395 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.43 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -65.92 -37.39 85.93 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 168.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -61.28 -36.46 80.12 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.105 -0.997 . . . . 0.0 110.91 170.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -71.17 -13.28 61.88 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 113.547 0.944 . . . . 0.0 113.547 175.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.42 ' CD2' HD11 ' A' ' 49' ' ' ILE . 15.5 t80 -77.97 -50.73 11.58 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.55 1.14 . . . . 0.0 111.568 165.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.11 -27.14 39.23 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -174.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 71.8 t -77.86 -43.02 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.129 -0.982 . . . . 0.0 111.159 177.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 92.1 p -65.58 -33.9 76.99 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.606 -0.684 . . . . 0.0 112.687 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 35.1 tp -72.58 -47.04 51.25 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.913 1.285 . . . . 0.0 111.591 176.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -69.75 -29.82 67.26 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.162 -0.961 . . . . 0.0 113.239 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -78.96 -4.02 47.85 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.215 1.006 . . . . 0.0 112.333 177.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -89.5 -21.89 22.72 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.299 -0.876 . . . . 0.0 113.143 162.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -99.28 -13.23 19.76 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -177.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.01 -28.95 41.4 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 -172.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 35.8 p-90 -82.92 -24.97 32.86 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.472 1.109 . . . . 0.0 113.256 176.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.4 t -76.47 -43.21 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.266 1.426 . . . . 0.0 110.61 177.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -92.24 8.24 39.04 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 42.42 82.73 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 129.134 2.974 . . . . 0.0 115.253 176.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 . . . . . 0 C--O 1.252 1.213 0 C-N-CA 126.933 2.093 . . . . 0.0 112.787 172.826 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.527 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 54.0 p -147.07 179.45 1.17 Allowed Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 125.788 1.635 . . . . 0.0 110.876 178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -57.78 -24.04 61.58 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.347 2.032 . . . . 0.0 113.733 171.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -70.12 -24.61 63.22 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.648 1.179 . . . . 0.0 112.515 174.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 5.6 m -72.73 -15.58 61.67 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.924 1.29 . . . . 0.0 112.433 170.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mmt -103.62 -120.67 0.2 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.651 1.98 . . . . 0.0 109.59 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.92 31.87 4.14 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.822 1.649 . . . . 0.0 111.817 174.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.2 m 59.17 61.22 2.14 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 123.84 1.781 . . . . 0.0 109.496 -157.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -127.58 123.29 35.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.349 2.26 . . . . 0.0 106.984 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.09 160.35 20.45 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.942 1.297 . . . . 0.0 113.43 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -133.92 40.29 3.09 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.263 1.825 . . . . 0.0 110.478 176.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -150.37 147.36 27.49 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.068 1.747 . . . . 0.0 109.972 -177.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 176.05 116.0 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.702 2.001 . . . . 0.0 108.552 157.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.3 m -87.99 113.05 23.25 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.653 -0.654 . . . . 0.0 110.65 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.9 p -69.24 148.82 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.492 1.117 . . . . 0.0 112.908 -177.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.2 mt -135.58 -38.84 0.73 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.916 1.686 . . . . 0.0 112.305 -171.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.0 t -147.02 140.52 25.58 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.415 1.486 . . . . 0.0 109.753 174.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.4 t -131.85 132.07 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.374 1.07 . . . . 0.0 108.637 167.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.61 131.72 18.39 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 124.694 1.197 . . . . 0.0 111.341 177.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -81.04 -15.63 10.32 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.843 2.362 . . . . 0.0 115.302 -170.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -130.5 106.79 8.76 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.38 1.072 . . . . 0.0 110.82 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.8 p -143.81 142.38 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.032 1.333 . . . . 0.0 110.359 173.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.8 m -125.72 132.04 52.43 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.721 1.208 . . . . 0.0 111.137 -173.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 79.4 t -97.43 130.68 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.497 1.119 . . . . 0.0 111.225 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -131.78 117.02 18.01 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.99 1.316 . . . . 0.0 108.295 168.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.3 mtt-85 -71.63 128.85 37.14 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.87 -0.519 . . . . 0.0 109.73 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 39.3 pt -86.78 150.24 50.08 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -163.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -67.53 162.98 36.7 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 122.948 2.432 . . . . 0.0 111.401 164.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -60.45 145.58 98.44 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.553 2.169 . . . . 0.0 111.315 170.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.4 ttm-85 -65.69 147.83 52.75 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.823 0.849 . . . . 0.0 112.53 -173.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.61 178.13 0.46 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.392 1.477 . . . . 0.0 113.236 161.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 80.4 p -95.23 -41.48 9.04 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.144 1.377 . . . . 0.0 112.993 -177.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -125.03 -6.79 7.22 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.481 1.512 . . . . 0.0 113.741 -174.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -93.18 -61.08 1.64 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.481 1.112 . . . . 0.0 112.274 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.26 -170.45 42.94 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 122.588 1.104 . . . . 0.0 111.148 -162.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -80.24 134.65 36.13 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 124.852 1.261 . . . . 0.0 110.606 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.67 21.36 7.73 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -173.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 56.9 -49.91 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.29 2.636 . . . . 0.0 115.399 -171.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.7 m -64.71 -14.64 59.36 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.26 1.824 . . . . 0.0 114.558 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -84.18 -7.84 59.24 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.774 1.23 . . . . 0.0 113.039 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.2 m0 -93.7 169.4 10.35 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.73 1.612 . . . . 0.0 111.151 176.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -76.56 51.89 0.76 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.194 1.798 . . . . 0.0 114.185 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.5 mt -55.58 -28.54 55.64 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.205 1.402 . . . . 0.0 114.487 -177.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -88.37 -7.42 56.68 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.428 0.691 . . . . 0.0 112.547 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -152.38 66.52 6.47 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.965 1.306 . . . . 0.0 111.887 -168.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -58.27 145.29 93.86 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.397 2.731 . . . . 0.0 112.856 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -72.56 -28.8 63.04 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.544 1.138 . . . . 0.0 111.657 174.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 42.1 t90 -158.11 152.14 24.08 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.431 1.892 . . . . 0.0 110.234 177.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.8 p -134.11 150.63 51.16 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.882 0.873 . . . . 0.0 111.862 169.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.38 -139.15 4.19 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 123.233 0.444 . . . . 0.0 113.325 -177.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.1 mtm105 -115.82 150.36 37.08 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.709 2.004 . . . . 0.0 112.001 -173.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.5 tp -94.61 138.33 32.61 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.227 1.811 . . . . 0.0 110.207 171.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.5 ttm-85 -135.74 111.1 9.08 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.825 1.25 . . . . 0.0 109.808 160.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.516 HD11 ' CD2' ' A' ' 119' ' ' PHE . 24.9 mt -91.32 131.3 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 168.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.25 170.36 16.1 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 127.396 2.279 . . . . 0.0 110.13 -173.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.6 t -158.54 149.47 20.47 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 120.409 -1.432 . . . . 0.0 111.792 176.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -151.42 129.14 11.55 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.631 0.772 . . . . 0.0 112.663 158.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.88 45.88 55.41 Favored Glycine 0 N--CA 1.473 1.162 0 C-N-CA 124.432 1.015 . . . . 0.0 114.956 164.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt 62.99 26.24 15.42 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.294 1.838 . . . . 0.0 113.269 -174.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.4 m -131.03 114.11 14.79 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.112 1.365 . . . . 0.0 108.72 168.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -83.99 159.23 21.27 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.507 0.723 . . . . 0.0 110.464 172.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -136.08 115.7 12.89 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 125.956 1.702 . . . . 0.0 108.693 -175.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.7 mp -92.29 99.48 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 168.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -99.83 139.7 35.12 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.876 0.846 . . . . 0.0 112.207 175.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.8 mp -110.68 132.94 53.76 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.091 1.756 . . . . 0.0 109.92 176.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -134.77 151.02 50.64 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.017 0.927 . . . . 0.0 113.04 -171.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -73.14 144.11 47.04 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.924 0.869 . . . . 0.0 112.112 -178.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.1 pttt -84.22 -6.56 59.41 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.209 1.804 . . . . 0.0 115.144 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 95.7 t -122.73 -44.17 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.206 1.402 . . . . 0.0 111.447 178.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.0 m -94.08 -21.8 18.9 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -175.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.01 5.92 85.4 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.182 0.896 . . . . 0.0 113.861 -177.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -82.02 153.88 25.96 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.276 1.431 . . . . 0.0 112.752 -173.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.5 tp -73.52 126.08 29.41 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.993 0.917 . . . . 0.0 111.107 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -86.18 -55.78 3.76 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.437 1.095 . . . . 0.0 111.121 170.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.85 164.01 38.55 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.755 1.222 . . . . 0.0 111.838 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -140.83 136.4 32.36 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.831 1.252 . . . . 0.0 111.816 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.4 107.69 36.58 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 124.778 1.231 . . . . 0.0 111.633 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -76.42 136.55 17.72 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.563 2.842 . . . . 0.0 111.925 173.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.1 t -127.71 119.53 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 127.093 2.157 . . . . 0.0 108.761 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -88.27 -17.69 30.18 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.48 151.33 16.9 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.18 1.792 . . . . 0.0 109.939 172.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -116.28 130.91 24.1 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 123.597 0.759 . . . . 0.0 113.014 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.63 151.37 74.54 Favored 'Cis proline' 0 CA--C 1.542 0.886 0 CA-C-N 119.247 0.767 . . . . 0.0 112.694 -13.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -132.16 -163.1 10.61 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.099 1.333 . . . . 0.0 113.361 176.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.6 tt -79.77 -34.6 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.538 0.735 . . . . 0.0 112.263 171.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.04 11.72 3.88 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.484 1.114 . . . . 0.0 113.63 -172.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.7 p -156.4 141.85 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 126.369 1.868 . . . . 0.0 110.815 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -159.3 161.26 35.85 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.489 1.116 . . . . 0.0 113.552 -175.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.2 p -110.76 159.54 17.54 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 127.114 2.165 . . . . 0.0 111.719 174.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.9 m -85.02 176.52 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.659 1.183 . . . . 0.0 111.255 166.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 73.4 p -92.28 -33.71 14.53 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.761 1.224 . . . . 0.0 113.47 177.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -92.45 -41.31 10.37 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -162.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.2 t -141.41 132.92 26.9 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -176.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.8 m -64.45 -12.14 40.57 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -172.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.439 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.289 31.3 ptt180 -89.0 14.56 10.3 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -174.743 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -135.72 136.48 40.86 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.472 1.109 . . . . 0.0 111.87 -173.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -138.04 161.07 37.68 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.113 1.365 . . . . 0.0 111.655 -178.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.2 t -114.67 143.2 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.499 1.12 . . . . 0.0 108.951 166.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.29 150.37 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 118.468 0.576 . . . . 0.0 111.625 169.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -93.06 89.72 6.61 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.012 0.925 . . . . 0.0 110.398 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -71.09 137.78 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 120.712 0.291 . . . . 0.0 110.956 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -145.13 143.81 30.57 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.066 1.746 . . . . 0.0 110.924 -168.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -88.15 -4.31 58.76 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.85 3.83 90.46 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 125.023 1.297 . . . . 0.0 114.668 -177.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.7 t -108.29 1.81 22.2 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.275 1.83 . . . . 0.0 113.586 -176.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.91 -4.08 49.22 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.172 1.368 . . . . 0.0 114.415 -174.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -70.93 137.15 48.97 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.389 1.476 . . . . 0.0 109.603 164.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 89.6 p -147.78 151.86 36.73 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 169.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.11 140.97 25.83 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.338 1.455 . . . . 0.0 111.005 168.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -90.01 119.61 30.51 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.294 0.638 . . . . 0.0 109.837 171.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.4 pt -117.8 145.41 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.594 1.158 . . . . 0.0 110.955 177.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.68 140.02 14.82 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 173.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.6 pt -125.12 141.75 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 124.879 1.272 . . . . 0.0 111.665 173.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -125.13 141.88 13.4 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.265 1.412 . . . . 0.0 112.572 174.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -101.96 170.97 7.79 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.165 1.786 . . . . 0.0 111.417 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.7 t -70.04 -37.56 75.59 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.349 0.66 . . . . 0.0 112.277 175.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -152.99 154.35 34.78 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.073 -1.017 . . . . 0.0 112.765 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -58.14 -38.87 77.38 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.349 1.46 . . . . 0.0 112.131 176.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.05 -14.05 73.26 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.014 0.816 . . . . 0.0 114.06 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -97.26 -36.94 10.26 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 118.191 0.995 . . . . 0.0 111.69 172.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.439 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -64.91 -30.73 71.74 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.293 1.037 . . . . 0.0 113.668 170.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.13 -29.05 60.17 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.439 1.018 . . . . 0.0 112.974 175.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -69.66 -27.19 64.83 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.316 -0.865 . . . . 0.0 112.954 176.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.516 ' CD2' HD11 ' A' ' 49' ' ' ILE . 32.7 t80 -62.77 -52.59 62.59 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.429 1.092 . . . . 0.0 111.356 173.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -80.61 -24.33 39.15 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -175.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.7 t -78.87 -42.56 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 119.062 0.846 . . . . 0.0 111.542 174.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 93.8 p -65.62 -31.3 72.26 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.434 1.015 . . . . 0.0 113.337 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.5 mt -69.38 -54.13 15.99 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.77 0.828 . . . . 0.0 111.435 172.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -65.61 -31.37 72.36 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.408 -0.808 . . . . 0.0 112.763 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -81.11 -4.37 55.08 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.339 1.056 . . . . 0.0 112.727 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -95.84 -15.86 22.21 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 164.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -106.52 -6.18 18.28 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.35 -29.21 57.94 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 121.397 1.908 . . . . 0.0 115.577 -175.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 36.3 p-90 -79.81 -23.55 41.99 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.135 1.374 . . . . 0.0 113.54 175.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 18.7 t -83.53 -31.7 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.644 1.578 . . . . 0.0 110.844 172.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -91.31 31.26 1.16 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 127.562 2.345 . . . . 0.0 112.572 -177.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -79.56 91.7 5.22 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.887 0.875 . . . . 0.0 109.663 173.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 C--O 1.252 1.198 0 C-N-CA 126.8 2.04 . . . . 0.0 112.725 -171.784 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.612 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 53.6 p -148.94 160.48 35.17 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 125.154 1.382 . . . . 0.0 111.544 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.22 -4.85 15.75 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.109 2.539 . . . . 0.0 114.49 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -60.71 -22.01 63.51 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.287 1.035 . . . . 0.0 113.589 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 78.8 p -61.39 -18.98 61.33 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 173.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.0 mtm -86.37 1.08 52.49 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.122 1.369 . . . . 0.0 113.592 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.37 -34.84 0.93 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.303 1.441 . . . . 0.0 113.264 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 49.3 m -123.77 103.17 8.21 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.527 1.531 . . . . 0.0 109.361 178.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -140.28 17.98 2.41 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.342 1.457 . . . . 0.0 112.955 -176.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.42 49.62 1.33 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.929 2.092 . . . . 0.0 112.07 -174.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -84.76 40.35 0.8 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.842 1.657 . . . . 0.0 112.156 -174.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -156.92 151.18 25.15 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.452 1.901 . . . . 0.0 110.23 -169.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -169.45 127.37 0.95 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.047 1.739 . . . . 0.0 107.739 167.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -104.46 107.19 17.99 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 167.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.445 ' HA ' HG22 ' A' ' 50' ' ' THR . 41.6 t -64.39 145.13 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 125.753 1.621 . . . . 0.0 112.386 -177.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.4 mt -130.79 -41.24 1.17 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.814 1.646 . . . . 0.0 112.223 -173.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 36.8 t -148.65 137.68 21.62 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.75 1.22 . . . . 0.0 110.717 174.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 81.8 t -130.21 127.79 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.912 1.285 . . . . 0.0 109.511 172.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -125.96 132.4 24.3 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 125.362 1.465 . . . . 0.0 110.096 173.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.52 -10.88 14.5 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.36 2.706 . . . . 0.0 115.495 -170.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -136.74 111.79 8.97 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.92 0.867 . . . . 0.0 112.192 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -143.9 144.02 23.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 125.437 1.495 . . . . 0.0 110.144 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.9 m -125.86 128.18 47.22 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.227 1.011 . . . . 0.0 111.492 -170.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.8 t -92.87 136.21 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.374 1.47 . . . . 0.0 112.006 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -129.85 128.36 42.11 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.962 1.305 . . . . 0.0 109.281 169.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 17.7 mmm-85 -76.02 112.55 12.57 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.003 0.921 . . . . 0.0 108.867 172.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.5 pt -82.16 153.04 68.97 Favored Pre-proline 0 N--CA 1.477 0.904 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -162.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.29 162.71 37.42 Favored 'Trans proline' 0 CA--C 1.548 1.216 0 C-N-CA 123.694 2.93 . . . . 0.0 112.367 169.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -63.62 150.85 87.48 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 123.484 2.789 . . . . 0.0 112.917 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.4 ttt85 -100.31 151.32 21.62 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.426 1.49 . . . . 0.0 113.242 -172.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -144.97 140.01 27.92 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.151 143.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.6 m -69.38 -18.72 63.8 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.727 1.381 . . . . 0.0 114.727 -171.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -70.83 -10.62 59.94 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 167.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -108.41 -57.96 2.06 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 127.017 2.127 . . . . 0.0 110.641 173.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.47 159.39 5.59 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 125.444 1.497 . . . . 0.0 112.708 -174.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -71.88 136.95 47.12 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.479 0.712 . . . . 0.0 109.813 168.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.78 19.39 6.11 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -172.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 56.68 -47.07 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 128.127 2.571 . . . . 0.0 115.893 -173.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.4 m -64.71 -18.41 64.98 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.062 1.745 . . . . 0.0 114.576 -177.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -85.3 -5.82 59.29 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 173.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.0 m0 -89.09 172.01 9.41 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.039 1.336 . . . . 0.0 110.743 174.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -79.72 52.86 1.51 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.187 1.395 . . . . 0.0 114.279 -176.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 mt -59.83 -18.56 44.85 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 -172.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -105.43 -6.08 19.8 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.771 1.229 . . . . 0.0 113.168 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -148.97 67.74 9.32 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.863 1.265 . . . . 0.0 112.055 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -54.66 145.52 59.26 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.554 2.836 . . . . 0.0 113.02 177.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -70.7 -29.34 65.61 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.424 1.089 . . . . 0.0 111.661 175.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 40.8 t90 -156.96 154.12 29.16 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.615 1.566 . . . . 0.0 110.946 173.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.3 p -135.69 150.42 49.57 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.238 1.015 . . . . 0.0 112.331 171.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.18 -142.1 5.14 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.239 0.447 . . . . 0.0 114.006 -176.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.5 mtm180 -111.23 152.0 27.63 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 127.066 2.146 . . . . 0.0 111.919 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.4 tp -90.31 139.6 30.5 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.075 1.75 . . . . 0.0 110.184 165.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -140.07 98.83 3.53 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.053 1.341 . . . . 0.0 110.249 163.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.2 mt -80.03 130.4 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 170.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.445 HG22 ' HA ' ' A' ' 10' ' ' VAL . 5.4 p -137.5 159.35 42.2 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.592 1.957 . . . . 0.0 110.06 -177.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.2 t -156.26 133.89 10.95 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.474 -1.391 . . . . 0.0 113.411 173.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -146.15 128.58 15.94 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.159 1.784 . . . . 0.0 110.587 177.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.75 36.88 52.45 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.438 1.018 . . . . 0.0 114.963 169.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? 61.95 27.92 16.96 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.467 1.907 . . . . 0.0 113.477 -170.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.0 m -132.23 117.82 18.71 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.195 1.398 . . . . 0.0 109.132 172.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.32 157.5 19.89 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.746 0.818 . . . . 0.0 110.856 172.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -138.3 116.67 11.95 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.6 1.56 . . . . 0.0 108.928 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mp -86.1 93.45 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 168.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -88.02 139.43 30.52 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.502 0.721 . . . . 0.0 111.265 174.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.0 mp -113.69 132.87 55.64 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.442 1.897 . . . . 0.0 110.63 176.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -129.06 147.88 50.96 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -171.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.94 128.21 34.83 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 121.18 -0.95 . . . . 0.0 109.539 171.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -75.44 -9.01 58.19 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -172.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.5 t -112.28 -36.95 2.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 124.239 1.016 . . . . 0.0 110.807 -171.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.1 m -110.47 -15.44 13.91 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.66 19.77 79.77 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 118.882 0.764 . . . . 0.0 113.708 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -63.51 158.94 19.68 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.647 1.179 . . . . 0.0 111.442 173.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.8 tp -95.11 119.59 33.88 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.832 0.853 . . . . 0.0 109.279 167.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -84.31 -55.44 4.17 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.611 0.764 . . . . 0.0 111.28 175.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.4 165.91 35.16 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.724 1.21 . . . . 0.0 111.533 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -144.63 135.32 24.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.737 1.215 . . . . 0.0 111.036 175.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.71 97.17 48.34 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.169 0.988 . . . . 0.0 111.943 175.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.78 137.26 80.25 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 124.367 3.378 . . . . 0.0 113.121 165.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.8 t -139.14 129.03 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 126.414 1.886 . . . . 0.0 109.739 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -90.19 -23.07 21.39 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.44 152.19 16.09 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.82 1.648 . . . . 0.0 111.078 174.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -130.85 135.51 27.46 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 124.876 1.27 . . . . 0.0 112.003 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -61.7 145.0 45.39 Favored 'Cis proline' 0 CA--C 1.539 0.747 0 CA-C-N 119.889 0.996 . . . . 0.0 113.19 -9.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -157.29 -155.71 7.6 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.736 1.16 . . . . 0.0 114.0 -174.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.59 -38.94 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.464 1.106 . . . . 0.0 113.692 -174.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.37 9.29 15.91 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -173.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.6 t -149.33 133.18 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.819 1.648 . . . . 0.0 109.922 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.55 163.99 34.0 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.248 1.819 . . . . 0.0 112.555 -174.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 62.2 p -116.84 162.27 17.98 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.166 1.787 . . . . 0.0 111.822 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.7 m -89.75 175.46 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.296 1.038 . . . . 0.0 111.057 165.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 71.5 p -95.96 -30.9 13.35 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.218 1.407 . . . . 0.0 113.441 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -90.18 -43.78 10.2 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -167.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.3 t -143.37 127.67 17.73 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -176.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.43 -3.28 7.97 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -173.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.478 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.278 23.4 ptt180 -84.7 14.89 4.23 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 177.761 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -139.25 134.06 32.14 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.744 1.218 . . . . 0.0 111.119 -174.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -136.11 161.46 35.64 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.257 1.423 . . . . 0.0 111.168 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 75.9 t -116.21 143.89 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.577 1.151 . . . . 0.0 108.937 167.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.86 148.51 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 119.123 0.874 . . . . 0.0 112.261 173.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -87.65 88.76 7.76 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.414 0.686 . . . . 0.0 110.259 173.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.25 141.6 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 O-C-N 121.99 -0.444 . . . . 0.0 110.841 174.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -135.61 142.57 45.28 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.425 1.49 . . . . 0.0 111.597 -175.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -94.95 13.98 23.19 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.919 1.288 . . . . 0.0 113.529 -176.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.76 7.04 85.9 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.335 1.445 . . . . 0.0 115.463 176.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.4 t -130.06 4.58 4.87 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.521 1.528 . . . . 0.0 113.802 -172.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.74 -4.85 69.2 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.304 1.43 . . . . 0.0 113.843 -175.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -76.87 129.76 36.66 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 127.414 2.285 . . . . 0.0 108.455 166.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.0 p -153.55 161.55 42.11 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.497 1.119 . . . . 0.0 113.981 -175.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -148.08 150.51 34.02 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.32 1.448 . . . . 0.0 111.523 172.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -92.94 118.7 31.44 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.251 0.62 . . . . 0.0 109.787 168.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.8 pt -120.11 145.84 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.668 1.187 . . . . 0.0 111.063 178.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.44 144.32 17.11 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 173.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.1 pt -128.1 140.62 48.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.719 1.608 . . . . 0.0 111.452 172.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.83 143.06 14.69 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.857 1.694 . . . . 0.0 112.787 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -104.98 161.75 13.94 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.11 1.364 . . . . 0.0 112.466 -174.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.7 t -69.86 -28.1 65.39 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.245 1.018 . . . . 0.0 112.699 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -156.85 151.02 25.06 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.27 1.028 . . . . 0.0 111.828 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -62.43 -34.66 77.21 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.281 1.032 . . . . 0.0 113.118 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.35 -26.16 74.82 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 123.864 0.745 . . . . 0.0 113.733 175.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -84.91 -32.73 22.98 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.039 0.936 . . . . 0.0 111.632 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.478 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -67.61 -32.11 72.61 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 168.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.04 -31.54 67.13 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.377 -0.827 . . . . 0.0 112.569 173.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -68.3 -27.39 66.26 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.315 -0.865 . . . . 0.0 112.992 174.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -63.87 -55.17 24.78 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.816 1.189 . . . . 0.0 111.739 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -75.13 -24.87 58.08 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.5 t -75.94 -40.81 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 121.414 -0.804 . . . . 0.0 111.093 173.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.5 t -59.04 -39.67 82.72 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.061 0.846 . . . . 0.0 112.662 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.6 mt -67.94 -54.43 18.72 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.408 0.683 . . . . 0.0 111.92 175.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -67.15 -32.21 73.16 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.3 -0.875 . . . . 0.0 113.02 -174.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -84.82 -0.63 54.56 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.379 1.072 . . . . 0.0 112.708 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -92.81 -37.97 12.02 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.438 -0.789 . . . . 0.0 112.287 159.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -85.39 -7.15 59.1 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -175.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.63 -31.58 57.56 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -172.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 34.2 p-90 -81.66 -27.77 33.9 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.75 1.22 . . . . 0.0 113.136 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.1 t -74.63 -32.55 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.238 1.415 . . . . 0.0 110.764 174.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -102.43 41.61 1.22 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.752 2.021 . . . . 0.0 112.365 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -81.01 2.78 25.51 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 164.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 C--O 1.254 1.294 0 C-N-CA 128.914 2.886 . . . . 0.0 112.029 176.66 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.652 0 N-CA-C 112.098 -0.401 . . . . 0.0 112.098 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 9.5 p -76.02 162.76 70.45 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.118 0.967 . . . . 0.0 112.495 177.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.53 1.59 8.29 Favored 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 123.359 2.706 . . . . 0.0 114.265 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -72.29 163.42 27.99 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.43 1.092 . . . . 0.0 112.804 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 62.9 p -71.68 -14.43 62.03 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.834 1.254 . . . . 0.0 114.36 177.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 mmt -131.51 151.59 51.44 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.567 1.947 . . . . 0.0 111.42 175.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.33 -48.17 0.16 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.465 1.106 . . . . 0.0 112.964 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 93.4 m -81.06 -37.05 29.67 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.584 0.754 . . . . 0.0 111.08 172.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 47.98 75.7 0.13 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.8 2.44 . . . . 0.0 115.057 169.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.2 pp -128.76 145.61 51.13 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.719 0.808 . . . . 0.0 112.136 164.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -129.68 49.17 2.29 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.741 1.616 . . . . 0.0 110.406 176.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -143.18 153.56 42.98 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.028 1.331 . . . . 0.0 112.719 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -174.56 78.18 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 129.877 3.271 . . . . 0.0 105.146 -175.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.25 115.01 12.08 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 121.115 -0.991 . . . . 0.0 110.596 -163.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.4 t -75.31 145.67 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.031 0.932 . . . . 0.0 111.231 -169.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.8 mt -131.45 -39.79 1.13 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.624 1.569 . . . . 0.0 111.856 -171.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.5 t -148.57 141.72 24.99 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.058 1.343 . . . . 0.0 110.393 176.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.7 t -136.37 127.32 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.984 1.314 . . . . 0.0 108.882 169.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -131.8 138.53 32.74 Favored Pre-proline 0 N--CA 1.48 1.062 0 C-N-CA 125.135 1.374 . . . . 0.0 111.072 177.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -81.23 -17.1 9.31 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 123.242 2.628 . . . . 0.0 115.67 -170.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -132.81 107.55 8.42 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.988 0.915 . . . . 0.0 111.345 -173.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.4 p -143.75 142.95 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.488 1.515 . . . . 0.0 110.331 173.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.8 m -126.32 128.0 46.42 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.456 1.102 . . . . 0.0 111.518 -171.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.2 t -93.99 137.13 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.128 1.371 . . . . 0.0 112.091 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -129.88 125.22 35.09 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.037 1.335 . . . . 0.0 108.98 168.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.9 mmt85 -70.58 109.18 4.71 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.524 -0.735 . . . . 0.0 109.617 169.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.1 pt -77.87 155.74 80.29 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 125.019 1.328 . . . . 0.0 113.292 -171.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -67.03 159.41 52.13 Favored 'Trans proline' 0 CA--C 1.549 1.245 0 C-N-CA 122.411 2.074 . . . . 0.0 111.06 158.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -62.86 149.51 91.18 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.794 2.329 . . . . 0.0 111.897 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.9 ttm105 -65.88 147.62 53.09 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.829 0.852 . . . . 0.0 112.188 -176.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.4 178.08 1.01 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.419 1.088 . . . . 0.0 112.558 160.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 79.8 p -94.98 -39.03 10.39 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.18 1.392 . . . . 0.0 112.488 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -126.76 -3.11 6.59 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.777 1.631 . . . . 0.0 113.571 -175.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -100.68 -52.4 3.34 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.243 1.017 . . . . 0.0 113.253 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.33 173.15 49.65 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-O 122.5 1.055 . . . . 0.0 111.711 -176.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -72.87 141.58 47.93 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.637 1.175 . . . . 0.0 110.728 174.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.66 18.97 5.69 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -172.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.53 -50.01 0.05 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.968 2.507 . . . . 0.0 115.411 -174.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.2 m -65.97 -14.9 62.42 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.247 1.819 . . . . 0.0 114.359 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.25 -15.54 58.67 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.84 0.856 . . . . 0.0 112.813 172.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -89.66 172.51 8.89 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.442 1.497 . . . . 0.0 111.424 -178.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -81.11 54.86 2.34 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.438 1.495 . . . . 0.0 114.059 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.9 mt -60.3 -17.41 42.51 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -172.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -105.96 -3.89 21.21 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.558 1.143 . . . . 0.0 113.078 177.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -147.81 72.03 11.45 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.068 1.347 . . . . 0.0 111.949 176.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -56.77 143.92 88.86 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 123.147 2.564 . . . . 0.0 112.43 173.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -71.04 -29.09 64.9 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.682 1.193 . . . . 0.0 111.766 175.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 37.9 t90 -156.95 153.17 27.66 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.675 1.59 . . . . 0.0 110.52 174.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.7 p -134.57 150.14 50.69 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.673 0.789 . . . . 0.0 112.043 169.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.18 -141.07 4.92 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 123.336 0.493 . . . . 0.0 113.422 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.7 mtm105 -113.51 149.92 33.67 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.712 2.005 . . . . 0.0 112.168 -173.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.5 tp -90.28 141.57 28.59 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.751 1.62 . . . . 0.0 110.629 169.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.6 ttm-85 -132.66 130.94 40.79 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.214 1.406 . . . . 0.0 109.719 156.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.5 HD11 ' CD1' ' A' ' 119' ' ' PHE . 26.4 mt -107.9 132.56 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 164.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.14 156.06 44.71 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 127.523 2.329 . . . . 0.0 108.72 -166.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.6 t -163.9 152.24 13.23 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.107 -1.621 . . . . 0.0 110.819 178.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -127.39 -46.6 1.47 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 -174.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.1 86.04 0.1 OUTLIER Glycine 0 N--CA 1.472 1.065 0 C-N-CA 123.606 0.622 . . . . 0.0 111.722 -175.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 94.1 mttt 55.53 23.47 6.0 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.141 1.776 . . . . 0.0 112.826 -171.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.9 m -141.74 121.04 13.09 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.836 1.254 . . . . 0.0 108.237 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.87 160.13 14.54 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.628 1.171 . . . . 0.0 111.053 174.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -139.2 113.19 8.64 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 127.076 2.15 . . . . 0.0 108.839 -176.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.3 mp -88.62 109.04 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 167.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -108.44 134.75 50.8 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.748 1.219 . . . . 0.0 111.588 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.6 mp -105.31 132.4 51.56 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 125.435 1.494 . . . . 0.0 110.089 176.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -134.9 151.6 51.02 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.946 0.899 . . . . 0.0 112.98 -170.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -74.12 143.91 45.14 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.282 -0.886 . . . . 0.0 112.071 -178.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.4 pttt -84.41 -6.61 59.4 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.296 1.838 . . . . 0.0 115.067 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.1 t -122.7 -44.18 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.341 1.456 . . . . 0.0 111.543 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.6 m -93.93 -22.37 18.63 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -174.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.3 6.08 86.05 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.14 0.876 . . . . 0.0 113.803 -177.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -81.8 154.59 25.86 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.31 1.444 . . . . 0.0 112.623 -174.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.5 tp -75.05 125.46 28.96 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.94 0.896 . . . . 0.0 111.147 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -85.23 -54.19 4.76 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.286 1.035 . . . . 0.0 111.156 170.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.52 162.89 38.86 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.595 1.158 . . . . 0.0 112.098 -178.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -140.68 133.86 29.53 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.831 1.252 . . . . 0.0 111.905 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.17 104.29 43.78 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.362 1.465 . . . . 0.0 111.159 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.96 144.52 30.49 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.833 3.022 . . . . 0.0 112.141 173.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.8 t -139.78 125.41 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 126.327 1.851 . . . . 0.0 109.554 -172.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -91.01 -23.4 20.39 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.13 149.15 15.65 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.268 1.827 . . . . 0.0 110.344 172.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -118.0 129.69 25.2 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.639 1.176 . . . . 0.0 111.153 175.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.85 149.41 80.32 Favored 'Cis proline' 0 CA--C 1.542 0.891 0 CA-C-N 119.715 0.934 . . . . 0.0 112.737 -6.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -151.57 -162.42 10.75 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.827 1.679 . . . . 0.0 112.293 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 19.6 tt -76.43 -35.15 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 121.688 -0.889 . . . . 0.0 112.837 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.47 7.23 17.58 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -168.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.1 t -150.97 130.51 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.856 1.662 . . . . 0.0 109.736 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -141.09 158.95 43.22 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.641 1.977 . . . . 0.0 112.317 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 47.4 p -107.05 160.89 15.21 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.751 2.02 . . . . 0.0 111.356 175.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 m -86.81 172.28 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.149 0.98 . . . . 0.0 110.949 163.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 58.8 p -95.07 -30.0 14.3 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.011 1.325 . . . . 0.0 113.608 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -90.11 -50.25 6.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.889 0.876 . . . . 0.0 113.229 -167.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.9 m -136.35 116.91 13.84 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.352 0.661 . . . . 0.0 112.724 -169.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.26 -8.68 18.9 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -168.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.462 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.322 43.2 ptt85 -84.12 21.31 1.39 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 178.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -140.3 137.45 34.18 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.896 1.278 . . . . 0.0 111.496 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -138.88 163.35 32.53 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.176 1.39 . . . . 0.0 111.032 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 55.9 t -118.21 142.44 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 124.546 1.139 . . . . 0.0 108.914 167.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.73 148.62 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 118.527 0.603 . . . . 0.0 111.975 173.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -90.66 87.54 6.75 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.57 0.748 . . . . 0.0 111.007 178.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -70.83 139.48 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 122.574 0.35 . . . . 0.0 111.044 176.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -142.78 144.02 32.42 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.251 1.82 . . . . 0.0 111.044 -169.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -91.37 5.45 49.26 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.15 13.17 81.4 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 124.958 1.266 . . . . 0.0 114.751 175.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.0 t -133.06 14.06 4.26 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.683 1.593 . . . . 0.0 113.386 -173.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.32 -3.97 76.56 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.651 1.119 . . . . 0.0 114.362 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 72.7 mtp85 -70.04 139.38 52.66 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 125.441 1.496 . . . . 0.0 109.415 162.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 56.8 p -154.58 158.1 39.25 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 115.046 1.498 . . . . 0.0 115.046 171.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.46 145.05 31.67 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.668 1.587 . . . . 0.0 110.495 165.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -91.1 119.85 31.58 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 167.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.8 pt -118.28 144.56 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.447 1.099 . . . . 0.0 110.93 178.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.63 142.95 16.3 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 174.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.9 pt -128.46 139.29 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 125.456 1.502 . . . . 0.0 111.725 173.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -118.85 139.78 14.68 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.93 1.729 . . . . 0.0 112.518 176.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -102.47 155.79 18.03 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.524 1.53 . . . . 0.0 112.222 -176.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.1 t -71.3 -23.56 61.98 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.351 1.061 . . . . 0.0 112.839 177.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -154.18 147.04 24.38 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.157 0.983 . . . . 0.0 112.212 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -64.42 -35.11 79.84 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.428 1.091 . . . . 0.0 113.273 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.36 -30.42 76.6 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-N 118.851 0.75 . . . . 0.0 113.165 176.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -82.5 -31.76 29.11 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.877 -0.778 . . . . 0.0 112.248 177.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.462 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -64.93 -38.58 91.43 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 166.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -61.35 -38.27 86.34 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.132 -0.98 . . . . 0.0 111.279 168.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -67.43 -36.31 80.98 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 119.093 0.861 . . . . 0.0 112.856 177.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.5 ' CD1' HD11 ' A' ' 49' ' ' ILE . 13.2 t80 -54.65 -51.39 65.6 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.74 1.216 . . . . 0.0 111.735 167.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -68.52 -42.55 78.37 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.611 0.764 . . . . 0.0 112.496 -177.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.8 t -65.84 -37.76 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 O-C-N 121.615 -0.678 . . . . 0.0 110.884 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 55.7 m -65.9 -14.42 61.49 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 176.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.6 mt -91.75 -54.13 4.0 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.008 0.923 . . . . 0.0 111.342 168.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -69.33 -32.92 72.33 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.952 -1.093 . . . . 0.0 113.669 -172.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -87.27 7.0 30.51 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.397 1.079 . . . . 0.0 112.423 174.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -102.77 -34.0 9.18 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.049 0.94 . . . . 0.0 112.631 165.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -89.5 -4.11 58.07 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.31 -31.6 61.78 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -175.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 35.5 p-90 -81.64 -20.2 40.15 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.764 1.226 . . . . 0.0 113.28 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 19.4 t -81.84 -32.81 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.165 1.386 . . . . 0.0 110.691 173.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 42.0 tptt -94.8 49.2 1.23 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.579 1.952 . . . . 0.0 111.162 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -97.62 104.33 16.35 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.949 1.3 . . . . 0.0 109.968 176.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 . . . . . 0 C--O 1.255 1.356 0 C-N-CA 125.773 1.629 . . . . 0.0 113.504 175.879 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.721 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 39.4 t -70.01 137.75 87.35 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 123.897 0.879 . . . . 0.0 112.003 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -65.39 -20.42 61.4 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.743 2.295 . . . . 0.0 112.546 174.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -68.76 -24.0 64.38 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.609 1.163 . . . . 0.0 112.686 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 50.2 m -77.4 -15.55 59.3 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.698 1.199 . . . . 0.0 113.524 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 mmt -80.03 34.95 0.3 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.777 1.631 . . . . 0.0 113.926 -169.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.7 -47.38 0.1 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.472 1.509 . . . . 0.0 111.591 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 36.2 m -153.49 129.86 10.57 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.574 1.95 . . . . 0.0 108.599 170.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -137.07 14.81 3.05 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.749 1.219 . . . . 0.0 113.854 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.73 107.88 9.35 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.116 0.966 . . . . 0.0 111.213 -177.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -81.31 58.59 3.65 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.931 1.293 . . . . 0.0 110.66 170.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.78 129.4 20.29 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.088 1.755 . . . . 0.0 111.097 -158.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -174.91 82.15 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.277 1.831 . . . . 0.0 106.931 166.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.8 m -72.01 101.21 2.66 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.027 1.731 . . . . 0.0 111.295 -174.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.97 144.05 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.761 1.224 . . . . 0.0 111.964 -174.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 78.8 mt -126.05 -43.94 1.79 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.786 1.634 . . . . 0.0 112.308 -175.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 46.5 t -153.77 136.03 14.88 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.519 1.128 . . . . 0.0 110.939 175.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.9 t -127.28 125.83 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.588 1.155 . . . . 0.0 109.47 172.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -129.08 133.61 25.39 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 125.367 1.467 . . . . 0.0 110.579 176.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.83 -12.02 15.01 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.22 2.613 . . . . 0.0 115.331 -172.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -129.74 106.38 8.67 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.273 1.029 . . . . 0.0 110.854 -177.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.1 p -141.66 142.01 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.782 1.233 . . . . 0.0 110.52 170.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.4 m -124.37 130.32 52.28 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.443 1.097 . . . . 0.0 110.751 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 77.1 t -94.18 136.47 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.749 1.22 . . . . 0.0 111.355 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.09 125.75 33.97 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.48 1.112 . . . . 0.0 109.436 168.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.7 mtt85 -62.39 131.3 48.8 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.347 0.659 . . . . 0.0 109.371 163.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.6 pt -96.17 150.36 37.1 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 124.239 1.016 . . . . 0.0 112.533 -171.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -67.14 160.23 48.4 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 122.758 2.305 . . . . 0.0 111.217 165.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.34 140.45 82.73 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.846 2.364 . . . . 0.0 111.962 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.2 ttm-85 -72.05 159.53 34.03 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.578 1.151 . . . . 0.0 112.465 -177.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -134.45 156.25 48.9 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.63 148.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.0 p -79.34 -36.07 40.01 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.696 1.998 . . . . 0.0 113.572 -167.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -90.91 21.14 4.32 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.048 1.739 . . . . 0.0 110.976 174.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -134.34 -59.7 0.82 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.365 1.866 . . . . 0.0 111.812 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.11 165.52 23.79 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 122.504 1.058 . . . . 0.0 113.06 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.7 m-30 -75.3 132.54 41.07 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.507 1.123 . . . . 0.0 110.102 169.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.54 18.25 8.12 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -172.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.31 -49.35 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 128.094 2.557 . . . . 0.0 115.565 -173.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.5 m -66.65 -15.93 63.83 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.887 1.675 . . . . 0.0 114.646 -176.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.01 -7.91 59.28 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 171.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.7 m0 -88.1 171.61 10.13 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.006 1.322 . . . . 0.0 110.769 176.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -79.6 54.34 1.76 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.214 1.406 . . . . 0.0 114.068 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.5 mt -60.75 -16.59 41.75 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -173.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -105.3 -4.59 21.41 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.565 1.146 . . . . 0.0 112.958 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -148.42 81.34 8.01 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 124.539 1.136 . . . . 0.0 112.015 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.3 145.35 67.19 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.395 2.73 . . . . 0.0 112.89 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -71.86 -29.62 64.57 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.822 0.849 . . . . 0.0 111.267 168.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 41.1 t90 -159.6 155.05 25.57 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.996 1.718 . . . . 0.0 110.929 175.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.3 p -133.76 142.54 47.96 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.717 1.207 . . . . 0.0 111.961 171.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.31 -148.39 6.54 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 123.419 0.533 . . . . 0.0 114.195 -177.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -110.76 144.64 39.43 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.737 1.615 . . . . 0.0 110.849 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.1 tp -82.53 136.43 34.86 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.13 1.372 . . . . 0.0 109.369 168.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.6 ttt-85 -142.09 88.07 2.08 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.579 1.152 . . . . 0.0 109.952 166.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.493 HD11 ' CD2' ' A' ' 119' ' ' PHE . 12.7 mt -70.22 122.11 21.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 169.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.01 -179.88 4.29 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 127.82 2.448 . . . . 0.0 109.542 177.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.457 ' HB2' ' CE1' ' A' ' 126' ' ' HIS . 80.3 p -161.27 171.2 18.79 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.858 2.063 . . . . 0.0 108.491 177.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -140.0 -107.64 0.16 Allowed 'General case' 0 CA--C 1.54 0.59 0 O-C-N 122.004 -0.435 . . . . 0.0 109.929 166.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.62 106.13 3.21 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.051 1.31 . . . . 0.0 112.603 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 51.48 28.69 4.7 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 126.768 2.027 . . . . 0.0 113.917 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.8 m -148.1 131.07 16.21 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.17 1.788 . . . . 0.0 108.582 -172.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.69 159.5 15.12 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.084 1.353 . . . . 0.0 110.917 171.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -138.33 111.83 8.15 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.532 1.533 . . . . 0.0 109.785 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.2 mp -81.97 98.39 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 170.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -100.15 139.87 35.2 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.621 0.724 . . . . 0.0 111.831 175.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mp -113.82 127.96 56.22 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 126.487 1.915 . . . . 0.0 109.771 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -134.06 146.68 50.55 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.96 0.904 . . . . 0.0 112.114 -170.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -66.47 143.41 57.11 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 120.918 -1.114 . . . . 0.0 112.442 -177.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.596 ' H ' ' HD3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -81.81 -3.63 54.43 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 -173.753 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.0 t -115.91 -42.46 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.95 1.3 . . . . 0.0 111.403 173.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.3 m -116.13 -6.26 11.9 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -169.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.26 16.83 78.65 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 123.864 0.745 . . . . 0.0 114.171 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -66.73 126.75 29.98 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.531 1.533 . . . . 0.0 111.199 -175.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 57.4 tp -68.16 110.07 3.83 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.538 0.608 . . . . 0.0 110.424 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -79.29 -52.05 8.63 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.536 1.135 . . . . 0.0 111.042 176.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.27 162.06 37.77 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.437 1.095 . . . . 0.0 112.025 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -142.71 133.72 25.74 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.035 1.334 . . . . 0.0 111.551 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.24 101.93 48.99 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 124.742 1.217 . . . . 0.0 111.633 176.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -66.29 141.05 60.91 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 124.25 3.3 . . . . 0.0 112.788 171.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 t -137.14 123.79 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.763 1.625 . . . . 0.0 109.652 -177.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -89.05 -21.75 23.29 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -159.91 145.13 15.25 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.439 1.895 . . . . 0.0 110.291 169.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -116.97 130.12 24.83 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 124.664 1.186 . . . . 0.0 110.98 176.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.82 148.56 78.85 Favored 'Cis proline' 0 CA--C 1.542 0.915 0 CA-C-N 119.86 0.986 . . . . 0.0 112.968 -5.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.28 -168.2 24.88 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.95 1.262 . . . . 0.0 113.916 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.8 tp -63.69 -32.83 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -172.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.26 5.47 49.04 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -170.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.4 t -149.57 131.3 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.458 1.103 . . . . 0.0 110.892 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -140.64 158.85 43.37 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.711 1.604 . . . . 0.0 112.94 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 75.1 p -105.13 158.87 16.28 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.666 1.986 . . . . 0.0 110.941 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.4 m -84.12 176.03 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.762 0.825 . . . . 0.0 110.9 165.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 59.1 p -94.89 -31.98 13.44 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.598 1.559 . . . . 0.0 113.011 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -92.65 -43.77 8.92 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -167.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.7 t -142.81 120.16 11.61 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -173.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.25 -2.87 9.08 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -169.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.402 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.265 0.9 OUTLIER -87.47 22.3 2.24 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.677 1.591 . . . . 0.0 114.217 174.242 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -140.92 135.33 31.15 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.052 1.341 . . . . 0.0 111.254 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -135.76 161.3 35.96 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.206 1.402 . . . . 0.0 111.376 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 89.8 t -115.89 141.8 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.628 1.171 . . . . 0.0 108.675 166.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.52 147.56 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 118.754 0.707 . . . . 0.0 112.392 173.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -89.79 84.74 6.28 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.627 0.771 . . . . 0.0 111.074 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -68.92 139.51 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 122.627 0.371 . . . . 0.0 111.062 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -139.46 144.33 37.96 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.947 1.699 . . . . 0.0 111.604 -170.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -91.1 2.4 56.36 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.275 1.03 . . . . 0.0 113.021 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.09 13.79 78.42 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.207 1.384 . . . . 0.0 114.778 178.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.6 t -139.79 16.76 2.5 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.427 1.491 . . . . 0.0 113.6 -171.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.12 -2.64 81.76 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.602 1.096 . . . . 0.0 115.0 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -74.39 133.65 42.46 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.424 1.489 . . . . 0.0 108.527 164.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.9 p -150.55 159.19 44.66 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 171.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.61 148.28 32.95 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.579 1.552 . . . . 0.0 111.106 169.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -93.41 118.54 31.43 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.466 0.707 . . . . 0.0 109.682 168.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 27.7 pt -118.06 144.2 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.493 1.117 . . . . 0.0 111.15 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -90.5 144.49 17.45 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.059 0.838 . . . . 0.0 111.013 174.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.8 pt -129.96 140.61 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 125.43 1.492 . . . . 0.0 111.667 172.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.26 142.95 16.37 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.66 1.6 . . . . 0.0 113.077 176.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -106.76 161.07 14.99 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.85 1.66 . . . . 0.0 111.855 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.9 t -73.09 -28.02 62.05 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.64 0.776 . . . . 0.0 112.857 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -155.88 151.86 27.61 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.312 1.045 . . . . 0.0 112.083 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 63.7 ttt-85 -62.8 -33.07 74.44 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.501 1.12 . . . . 0.0 113.397 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.64 -28.62 73.03 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-N 118.798 0.726 . . . . 0.0 113.525 175.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -83.71 -34.15 24.97 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.963 0.905 . . . . 0.0 111.812 175.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.402 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -65.51 -31.77 73.01 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 168.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.39 -35.64 74.32 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.349 -0.844 . . . . 0.0 112.611 173.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -67.0 -29.46 69.3 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.228 -0.92 . . . . 0.0 112.934 176.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.493 ' CD2' HD11 ' A' ' 49' ' ' ILE . 27.2 t80 -60.82 -50.24 74.24 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.304 0.956 . . . . 0.0 111.693 172.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -82.19 -25.1 34.56 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.8 t -77.38 -42.25 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.194 -0.941 . . . . 0.0 111.285 175.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 92.5 p -65.52 -31.57 72.7 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.354 0.979 . . . . 0.0 113.111 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 61.0 mt -68.51 -52.5 31.46 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.961 0.905 . . . . 0.0 112.006 172.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -67.47 -29.38 68.82 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.957 -1.089 . . . . 0.0 112.793 -177.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -81.31 -1.53 45.6 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.055 1.342 . . . . 0.0 112.571 174.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.457 ' CE1' ' HB2' ' A' ' 51' ' ' SER . 29.6 t-80 -91.29 -23.31 20.18 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 120.701 -1.249 . . . . 0.0 113.005 165.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -104.16 -4.37 23.22 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -176.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.41 -32.61 62.82 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 120.444 1.474 . . . . 0.0 114.52 -177.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 32.1 p-90 -81.25 -23.11 38.24 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.913 1.285 . . . . 0.0 113.406 178.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.7 t -82.05 -30.46 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 125.195 1.398 . . . . 0.0 110.803 173.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -95.89 35.29 1.42 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 127.106 2.162 . . . . 0.0 111.875 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -81.73 96.3 7.52 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 122.043 0.925 . . . . 0.0 109.335 170.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 . . . . . 0 C--O 1.252 1.229 0 C-N-CA 125.408 1.483 . . . . 0.0 113.269 -161.398 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.683 0 N-CA-C 111.866 -0.494 . . . . 0.0 111.866 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 46.2 p -74.41 149.65 86.71 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 124.492 1.117 . . . . 0.0 112.5 177.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.28 -32.28 42.06 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.136 2.557 . . . . 0.0 113.075 -174.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -63.67 -30.91 71.95 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.027 0.931 . . . . 0.0 112.749 173.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 66.1 m -70.4 -4.67 23.59 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.7 mtp -75.26 -6.7 51.18 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.68 1.192 . . . . 0.0 113.222 169.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.23 -37.01 0.17 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.078 1.351 . . . . 0.0 113.554 -177.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 35.6 m -129.32 96.92 4.42 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.986 1.714 . . . . 0.0 109.509 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -126.55 12.21 7.44 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.706 1.602 . . . . 0.0 113.589 -176.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.8 mp -78.28 104.4 8.84 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.349 1.059 . . . . 0.0 111.406 -177.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -82.44 59.57 4.67 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.67 1.188 . . . . 0.0 110.153 167.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.09 122.89 21.17 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.91 1.684 . . . . 0.0 111.414 -162.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -175.85 93.64 0.06 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.263 1.825 . . . . 0.0 106.526 162.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.8 m -76.04 89.52 3.0 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.107 1.763 . . . . 0.0 110.913 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.44 142.17 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 125.367 1.467 . . . . 0.0 111.273 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.3 mt -127.41 -44.21 1.57 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.183 1.393 . . . . 0.0 111.813 -172.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 27.6 t -151.9 137.12 17.48 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.599 1.16 . . . . 0.0 111.013 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.7 t -130.84 121.82 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.774 1.23 . . . . 0.0 109.962 174.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -117.57 137.92 24.66 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 125.27 1.428 . . . . 0.0 110.192 172.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.93 -20.51 25.64 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.478 2.786 . . . . 0.0 114.418 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -135.9 113.27 10.68 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.953 0.901 . . . . 0.0 111.668 -169.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.0 p -149.56 146.38 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.737 1.615 . . . . 0.0 110.248 175.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.6 m -125.18 128.37 48.25 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.024 0.93 . . . . 0.0 111.381 -172.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.1 t -94.84 139.12 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.457 1.503 . . . . 0.0 112.067 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -127.63 123.82 36.53 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.109 1.364 . . . . 0.0 109.772 171.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -69.54 101.9 1.71 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.39 0.676 . . . . 0.0 109.198 166.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.2 pt -72.51 156.18 90.48 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.109 0.963 . . . . 0.0 113.11 -172.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -59.94 160.85 20.51 Favored 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 122.984 2.456 . . . . 0.0 112.314 165.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -67.91 98.69 0.52 Allowed 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.612 2.875 . . . . 0.0 110.918 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -146.95 176.4 9.94 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.261 1.824 . . . . 0.0 112.867 -165.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -133.88 160.63 37.07 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.036 1.734 . . . . 0.0 110.501 165.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.8 p -60.89 -49.79 76.05 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.52 1.928 . . . . 0.0 113.641 -176.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -83.48 17.4 2.19 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.881 1.673 . . . . 0.0 111.892 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 86.9 mmt-85 -130.71 -36.76 1.38 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.59 1.956 . . . . 0.0 112.546 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 172.08 44.5 0.04 OUTLIER Glycine 0 C--N 1.339 0.722 0 N-CA-C 118.522 2.169 . . . . 0.0 118.522 177.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -84.54 96.34 9.12 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.028 1.414 . . . . 0.0 108.751 154.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.7 20.6 15.14 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.52 -1.362 . . . . 0.0 114.347 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.15 -47.99 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.761 2.424 . . . . 0.0 115.092 -168.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.4 m -64.92 -16.09 62.86 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.496 1.918 . . . . 0.0 115.016 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -81.08 -10.01 59.74 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.715 0.806 . . . . 0.0 112.846 173.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 14.2 m0 -92.96 173.23 7.85 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.488 1.515 . . . . 0.0 111.147 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -79.5 53.39 1.55 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.33 1.452 . . . . 0.0 114.182 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.5 mt -61.3 -16.49 46.2 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.389 1.625 . . . . 0.0 115.389 -172.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -108.22 -3.58 18.35 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.45 1.1 . . . . 0.0 112.714 177.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -149.39 67.29 8.83 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.362 1.465 . . . . 0.0 111.48 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -53.26 141.03 60.98 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.163 2.575 . . . . 0.0 111.926 176.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -72.83 -27.51 61.99 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.453 0.701 . . . . 0.0 111.717 -177.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -151.92 152.66 32.83 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.214 1.805 . . . . 0.0 110.152 169.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.5 p -135.14 148.52 49.77 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.925 0.89 . . . . 0.0 111.646 169.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.64 -141.32 5.17 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 114.097 0.399 . . . . 0.0 114.097 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -107.06 145.64 32.13 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.01 2.124 . . . . 0.0 111.106 -174.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.8 tp -93.13 136.48 33.35 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.993 1.317 . . . . 0.0 109.458 169.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.3 ttp85 -137.76 103.51 5.03 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.594 0.758 . . . . 0.0 110.223 160.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.441 HD11 ' CD2' ' A' ' 119' ' ' PHE . 14.0 mt -77.7 118.76 25.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 166.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.55 178.12 4.58 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 127.93 2.492 . . . . 0.0 110.272 176.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 t -160.12 172.45 17.45 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 126.804 2.042 . . . . 0.0 107.763 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -143.66 -107.29 0.12 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.336 1.055 . . . . 0.0 109.01 167.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.19 97.5 2.0 Allowed Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.135 1.35 . . . . 0.0 112.564 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 52.86 28.5 6.55 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 126.603 1.961 . . . . 0.0 113.811 178.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.1 m -147.2 116.36 6.93 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 126.177 1.791 . . . . 0.0 108.396 -173.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.94 159.22 18.43 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.098 0.959 . . . . 0.0 110.823 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -136.12 117.08 14.24 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.206 1.402 . . . . 0.0 109.911 177.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.4 mp -87.15 100.48 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 168.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -98.64 137.0 37.92 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.793 0.806 . . . . 0.0 111.813 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -102.38 131.95 48.69 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.499 1.519 . . . . 0.0 109.636 168.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -136.44 152.27 50.4 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.784 0.834 . . . . 0.0 111.781 -173.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -73.03 142.01 47.66 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.865 -1.147 . . . . 0.0 112.667 -170.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -78.36 -6.13 54.24 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.194 1.797 . . . . 0.0 115.703 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 99.4 t -121.85 -44.63 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.101 1.36 . . . . 0.0 111.257 177.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.7 m -98.67 -19.99 17.21 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -174.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.77 10.3 80.02 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.513 1.054 . . . . 0.0 114.033 -176.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -82.71 154.24 24.93 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.243 1.417 . . . . 0.0 112.466 -175.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.2 tp -72.53 125.12 26.66 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.68 0.792 . . . . 0.0 111.918 -174.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -87.37 -55.22 3.9 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.118 0.967 . . . . 0.0 111.035 168.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.63 160.87 39.81 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.622 1.169 . . . . 0.0 112.027 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -141.47 131.12 24.06 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.797 1.239 . . . . 0.0 111.93 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.2 102.88 53.6 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 124.464 1.106 . . . . 0.0 111.534 175.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.77 139.93 25.53 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.963 3.109 . . . . 0.0 111.958 175.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.5 t -134.42 123.49 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 126.193 1.797 . . . . 0.0 109.548 -174.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -87.53 -23.02 24.52 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 121.366 -0.834 . . . . 0.0 113.158 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.12 144.3 15.96 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.409 1.883 . . . . 0.0 110.199 169.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -115.11 130.13 24.49 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.547 1.139 . . . . 0.0 110.918 176.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.94 148.05 78.12 Favored 'Cis proline' 0 CA--C 1.541 0.873 0 CA-C-N 119.827 0.974 . . . . 0.0 113.032 -5.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.85 -170.72 30.19 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.937 1.256 . . . . 0.0 113.822 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.3 tp -60.44 -31.05 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -170.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.4 4.33 53.65 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -171.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.5 t -149.33 130.37 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 119.456 1.025 . . . . 0.0 111.631 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -142.42 165.87 26.23 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.563 1.945 . . . . 0.0 112.364 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 56.1 p -116.9 160.17 21.29 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 127.087 2.155 . . . . 0.0 111.63 -176.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.7 m -84.16 172.58 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.034 0.934 . . . . 0.0 111.565 168.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.6 p -91.61 -33.59 15.05 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.313 1.445 . . . . 0.0 112.768 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -97.51 -40.66 8.55 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -162.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.5 t -139.2 122.59 17.16 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -175.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 p -74.5 30.19 0.08 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 -172.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.433 ' HA ' ' CB ' ' A' ' 116' ' ' ALA . 53.9 ptt85 -123.65 23.58 8.76 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.14 1.776 . . . . 0.0 114.298 171.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -140.52 138.76 34.81 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.905 1.282 . . . . 0.0 111.227 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -137.0 164.54 28.11 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.597 1.559 . . . . 0.0 111.108 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.2 t -122.1 139.67 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.737 1.215 . . . . 0.0 108.589 167.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.87 148.05 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 118.731 0.696 . . . . 0.0 112.415 176.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -89.34 85.68 6.64 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.475 0.71 . . . . 0.0 110.805 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.08 137.22 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 122.105 -0.372 . . . . 0.0 110.773 175.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -138.36 145.48 41.15 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.474 1.51 . . . . 0.0 111.738 -169.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -96.05 14.65 23.05 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.273 1.029 . . . . 0.0 113.289 -175.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.0 8.69 83.33 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.327 1.441 . . . . 0.0 115.518 177.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.2 t -131.42 6.98 4.5 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.377 1.471 . . . . 0.0 114.008 -173.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.34 -7.31 72.02 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.224 1.393 . . . . 0.0 113.916 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -72.87 127.13 31.63 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 127.12 2.168 . . . . 0.0 108.709 166.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 86.2 p -146.97 157.39 43.61 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.865 1.266 . . . . 0.0 114.368 -171.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.57 146.63 29.48 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.664 1.586 . . . . 0.0 111.057 168.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -92.12 121.4 33.63 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.058 0.543 . . . . 0.0 109.853 168.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.1 pt -120.92 144.57 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.675 1.19 . . . . 0.0 110.929 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -88.32 145.88 19.27 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 173.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.6 pt -128.05 141.63 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 125.274 1.43 . . . . 0.0 111.634 167.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.15 143.28 15.53 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.601 1.572 . . . . 0.0 112.931 175.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -108.65 157.41 18.54 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.51 1.924 . . . . 0.0 110.903 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.6 t -69.26 -27.7 65.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.918 0.887 . . . . 0.0 112.644 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -155.52 153.09 29.68 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.204 1.001 . . . . 0.0 112.029 -178.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.54 -35.03 75.02 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.589 1.156 . . . . 0.0 112.122 175.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.95 -14.73 68.42 Favored Glycine 0 CA--C 1.54 1.604 0 CA-C-O 119.384 -0.676 . . . . 0.0 114.364 176.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -97.1 -30.9 12.77 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.819 1.248 . . . . 0.0 111.886 171.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.433 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -72.98 -30.84 64.13 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 173.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -59.44 -32.1 69.91 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.35 -0.844 . . . . 0.0 112.064 172.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -64.77 -32.43 74.11 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.531 -0.731 . . . . 0.0 112.384 174.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.441 ' CD2' HD11 ' A' ' 49' ' ' ILE . 47.7 t80 -63.11 -56.35 17.58 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.213 1.005 . . . . 0.0 111.691 178.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -73.97 -24.48 59.63 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -177.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 68.4 t -78.29 -42.3 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 121.254 -0.904 . . . . 0.0 111.306 174.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.9 m -66.36 -30.78 71.25 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.137 0.88 . . . . 0.0 112.539 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.0 mt -67.37 -57.3 6.86 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.457 0.703 . . . . 0.0 111.867 170.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -64.74 -31.94 73.39 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.457 -0.777 . . . . 0.0 112.973 -173.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -80.73 -0.28 37.75 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.368 1.067 . . . . 0.0 112.666 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -101.78 -3.99 27.14 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 164.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -111.45 -10.8 14.16 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 175.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.94 -32.87 61.7 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -176.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 32.9 p-90 -81.13 -24.05 37.91 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.359 1.464 . . . . 0.0 113.347 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.6 t -79.28 -34.42 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.062 1.345 . . . . 0.0 110.665 174.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -101.41 52.42 0.83 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.138 1.775 . . . . 0.0 111.54 -177.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -89.96 12.63 16.92 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.262 1.425 . . . . 0.0 113.582 169.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 . . . . . 0 C--O 1.254 1.313 0 C-N-CA 126.057 1.743 . . . . 0.0 114.74 179.353 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.528 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 58.2 m -135.04 149.73 71.12 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 125.308 1.443 . . . . 0.0 111.88 -176.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.04 -18.42 12.94 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.325 2.683 . . . . 0.0 113.898 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -77.69 143.17 38.32 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.586 1.154 . . . . 0.0 112.142 -177.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 70.1 m -79.48 -29.0 41.51 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.328 1.051 . . . . 0.0 113.218 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.6 mtp 54.65 34.97 22.68 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.618 1.967 . . . . 0.0 114.141 176.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.76 31.6 1.83 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.959 1.703 . . . . 0.0 111.99 -175.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.1 m 65.89 125.41 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 127.325 2.25 . . . . 0.0 112.134 -158.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -159.62 162.16 35.19 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.789 2.036 . . . . 0.0 108.599 -173.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.3 pp -135.66 155.27 50.69 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.698 1.199 . . . . 0.0 113.655 174.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -144.37 48.96 1.35 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.948 1.699 . . . . 0.0 109.463 172.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -144.54 158.97 43.52 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 125.536 1.534 . . . . 0.0 112.336 -174.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -173.88 73.76 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 129.459 3.104 . . . . 0.0 105.468 -174.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.4 t -73.06 116.09 13.17 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 126.386 1.875 . . . . 0.0 111.251 -164.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.8 t -70.54 144.42 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.705 0.802 . . . . 0.0 111.126 -171.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 44.9 mt -127.07 -42.83 1.7 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.715 1.606 . . . . 0.0 111.949 -174.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 32.7 t -149.26 139.22 22.02 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.59 1.156 . . . . 0.0 109.808 177.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.5 t -133.99 127.15 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.641 1.176 . . . . 0.0 109.116 170.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -131.0 134.37 25.88 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 125.004 1.322 . . . . 0.0 110.23 175.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.28 -18.51 16.02 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.878 2.385 . . . . 0.0 114.854 -172.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -132.69 111.79 11.46 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.452 1.101 . . . . 0.0 111.434 -173.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.0 p -146.61 144.63 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.847 1.659 . . . . 0.0 109.882 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.6 m -123.73 131.8 53.68 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.986 0.915 . . . . 0.0 111.549 -173.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 76.0 t -96.97 131.6 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.492 1.517 . . . . 0.0 111.594 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -128.82 126.9 40.85 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.936 1.295 . . . . 0.0 109.15 169.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -65.83 129.9 41.41 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.479 0.712 . . . . 0.0 109.546 170.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.6 pt -98.89 152.83 37.97 Favored Pre-proline 0 N--CA 1.476 0.875 0 C-N-CA 124.333 1.053 . . . . 0.0 112.851 -171.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -69.84 153.63 68.34 Favored 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 122.576 2.184 . . . . 0.0 111.162 163.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.41 151.0 80.9 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.972 2.448 . . . . 0.0 111.608 173.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -72.79 152.11 41.74 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.218 0.607 . . . . 0.0 112.55 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.15 -82.17 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.759 1.623 . . . . 0.0 111.585 163.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 86.0 p -162.01 -53.93 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.835 1.654 . . . . 0.0 111.402 166.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -125.07 1.37 7.94 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.899 1.679 . . . . 0.0 113.78 -173.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.5 mmt85 -77.55 -36.27 52.41 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.757 1.223 . . . . 0.0 112.95 -176.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.93 153.9 17.55 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 122.197 0.887 . . . . 0.0 113.131 175.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -73.24 145.15 46.39 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 124.177 0.991 . . . . 0.0 109.687 172.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.37 19.92 7.44 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -171.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.42 -48.29 0.05 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 127.76 2.424 . . . . 0.0 115.299 -172.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.6 m -66.44 -16.63 64.25 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.239 1.816 . . . . 0.0 114.813 -177.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -85.5 -2.53 58.23 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 172.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 24.7 m0 -92.3 169.16 10.8 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.059 1.344 . . . . 0.0 110.833 173.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.5 mttt -78.33 52.44 1.13 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.341 1.456 . . . . 0.0 114.136 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.9 mt -57.53 -28.43 63.49 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -175.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -91.36 -6.07 53.56 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -149.76 74.36 9.45 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 124.873 1.269 . . . . 0.0 111.917 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -56.69 143.39 89.79 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.913 2.408 . . . . 0.0 112.565 174.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -72.0 -28.43 63.4 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.739 1.216 . . . . 0.0 111.624 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 49.4 t90 -155.73 151.97 27.98 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.985 1.714 . . . . 0.0 110.523 174.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.6 p -134.9 149.63 50.31 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.006 0.922 . . . . 0.0 111.723 170.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.74 -142.24 6.01 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 114.135 0.414 . . . . 0.0 114.135 -178.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 47.0 mtt180 -105.16 144.46 31.91 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 127.233 2.213 . . . . 0.0 111.751 -173.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.5 tp -90.29 137.15 32.58 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.434 1.494 . . . . 0.0 110.324 166.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.0 ttm-85 -130.27 132.23 45.83 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.659 1.184 . . . . 0.0 109.56 156.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.565 HD11 ' CD1' ' A' ' 119' ' ' PHE . 17.7 mt -109.59 131.57 60.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 163.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.72 151.06 42.61 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 127.879 2.471 . . . . 0.0 108.23 -168.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.4 ' HB2' ' CE1' ' A' ' 126' ' ' HIS . 92.3 p -161.04 155.08 22.64 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 120.142 -1.598 . . . . 0.0 111.908 -169.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -132.56 -105.1 0.25 Allowed 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.066 -1.022 . . . . 0.0 112.378 -173.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.32 -125.53 0.28 Allowed Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.26 0.933 . . . . 0.0 111.252 168.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -77.13 34.11 0.15 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.962 1.305 . . . . 0.0 112.52 173.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.8 m -143.45 133.59 24.36 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.935 0.894 . . . . 0.0 110.671 -174.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -115.09 162.86 16.44 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.15 1.38 . . . . 0.0 111.052 169.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -144.13 107.95 4.69 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.612 1.965 . . . . 0.0 108.88 -170.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mp -86.34 108.29 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 169.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -109.01 128.96 55.41 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.732 1.213 . . . . 0.0 111.309 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.0 mp -101.62 131.11 48.02 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.871 1.268 . . . . 0.0 110.168 177.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -133.16 149.66 52.05 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.063 0.945 . . . . 0.0 112.602 -169.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -69.58 141.14 53.82 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.033 -1.042 . . . . 0.0 111.977 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.0 pttt -79.85 -4.7 53.32 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 -177.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 95.8 t -121.98 -43.84 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.171 1.389 . . . . 0.0 111.355 178.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.9 m -97.47 -20.27 17.87 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.19 11.32 79.31 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.443 1.021 . . . . 0.0 114.032 -176.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -83.59 151.19 25.48 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.192 1.397 . . . . 0.0 112.24 -175.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.3 tp -72.96 127.26 32.02 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.437 0.695 . . . . 0.0 111.66 -175.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -86.76 -55.41 3.87 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.704 1.202 . . . . 0.0 111.171 169.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.11 159.69 38.11 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.117 1.367 . . . . 0.0 111.307 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -139.35 137.57 35.86 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 174.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.32 106.5 48.82 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.601 1.56 . . . . 0.0 110.621 177.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.57 142.13 18.1 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.718 2.946 . . . . 0.0 111.107 173.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.9 t -135.58 129.91 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 126.352 1.861 . . . . 0.0 109.476 -170.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -97.68 -20.1 17.83 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.227 1.011 . . . . 0.0 113.061 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.91 147.39 11.49 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.449 2.3 . . . . 0.0 110.33 -177.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -135.12 125.11 16.83 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 124.064 0.946 . . . . 0.0 111.529 174.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -65.31 150.13 75.93 Favored 'Cis proline' 0 CA--C 1.541 0.849 0 CA-C-N 119.894 0.998 . . . . 0.0 113.122 -2.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -170.06 -158.86 14.62 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.037 1.304 . . . . 0.0 113.697 -175.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.4 tp -75.53 -39.79 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -172.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.54 5.6 41.94 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -168.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.4 t -150.8 130.91 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.684 1.593 . . . . 0.0 109.397 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.3 163.2 34.39 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.814 1.646 . . . . 0.0 112.735 -174.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 66.3 p -116.43 162.9 16.85 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.904 1.682 . . . . 0.0 111.659 -177.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.5 m -91.08 177.39 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 124.479 1.112 . . . . 0.0 110.726 166.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.8 p -98.81 -32.4 11.38 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.051 1.74 . . . . 0.0 113.045 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -88.68 -43.36 11.37 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -167.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.2 t -143.9 124.44 14.01 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -176.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.05 -1.4 7.48 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 -170.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.484 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.295 27.9 ptt180 -85.63 15.37 4.71 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 177.469 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -137.02 133.97 36.07 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.874 1.269 . . . . 0.0 110.855 -173.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -133.74 160.46 37.52 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.087 1.355 . . . . 0.0 111.512 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 78.8 t -112.25 143.92 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.328 1.051 . . . . 0.0 108.985 164.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.0 149.49 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 119.025 0.829 . . . . 0.0 112.049 169.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -91.72 82.88 5.24 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.783 0.833 . . . . 0.0 111.177 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -66.93 139.99 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 120.91 0.386 . . . . 0.0 111.065 176.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -140.22 152.5 46.03 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.778 1.631 . . . . 0.0 111.474 -169.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -96.14 1.75 52.61 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.254 1.021 . . . . 0.0 112.957 177.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.98 12.13 81.57 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 125.278 1.418 . . . . 0.0 114.909 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.3 t -135.54 13.18 3.47 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.485 1.514 . . . . 0.0 113.544 -172.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.2 -4.71 74.51 Favored Glycine 0 CA--C 1.537 1.432 0 O-C-N 120.655 -1.278 . . . . 0.0 114.807 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -70.87 131.63 44.05 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.252 1.421 . . . . 0.0 108.499 163.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.1 p -149.55 159.17 44.53 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 173.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.25 146.26 32.54 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.491 1.516 . . . . 0.0 110.832 167.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -90.95 120.31 31.85 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.074 0.55 . . . . 0.0 109.65 167.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.6 pt -117.9 143.22 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.404 1.082 . . . . 0.0 110.832 176.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -92.24 140.69 15.26 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 175.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.0 pt -126.64 141.35 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 125.285 1.434 . . . . 0.0 111.708 173.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.1 142.14 14.3 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.038 1.304 . . . . 0.0 113.144 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -104.37 162.42 13.24 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.626 1.57 . . . . 0.0 111.531 -177.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.1 t -72.64 -29.18 63.24 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.578 0.751 . . . . 0.0 112.486 176.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -153.04 147.63 26.11 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.184 0.994 . . . . 0.0 112.069 -174.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.6 ttt-85 -62.33 -32.82 73.64 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.348 1.059 . . . . 0.0 113.234 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.96 -28.32 73.45 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-N 119.025 0.829 . . . . 0.0 113.714 176.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -84.71 -32.51 23.49 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.015 0.907 . . . . 0.0 111.953 176.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.484 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -66.9 -34.37 77.62 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 166.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -60.57 -35.96 77.33 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.251 -0.906 . . . . 0.0 111.677 168.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -62.47 -37.59 86.53 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 119.247 0.93 . . . . 0.0 111.88 175.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.565 ' CD1' HD11 ' A' ' 49' ' ' ILE . 17.6 t80 -58.73 -56.54 20.87 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.448 1.099 . . . . 0.0 112.017 171.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.03 -26.13 53.35 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -174.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.2 t -77.24 -43.31 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 121.193 -0.942 . . . . 0.0 110.98 176.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.3 t -69.91 -29.77 67.03 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.137 0.88 . . . . 0.0 112.469 -178.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.6 mt -64.44 -55.06 23.35 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.445 -0.784 . . . . 0.0 112.124 167.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -68.27 -29.48 68.28 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.108 -0.995 . . . . 0.0 113.069 -173.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -82.62 -3.64 56.51 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.852 0.861 . . . . 0.0 112.799 176.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.4 ' CE1' ' HB2' ' A' ' 51' ' ' SER . 52.9 t-80 -93.45 -34.08 13.56 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.39 -0.819 . . . . 0.0 112.47 161.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -90.64 -6.39 54.63 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 -177.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.52 -27.5 38.65 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 121.259 1.845 . . . . 0.0 115.773 -173.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 27.3 p-90 -86.21 -21.57 27.39 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.622 1.169 . . . . 0.0 113.98 175.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 17.5 t -86.11 -41.0 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.085 1.354 . . . . 0.0 110.625 175.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -98.56 49.35 0.98 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.318 2.247 . . . . 0.0 111.38 -175.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -78.21 88.95 4.28 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.009 0.924 . . . . 0.0 111.22 175.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 C--O 1.253 1.268 0 C-N-CA 127.237 2.215 . . . . 0.0 112.325 176.641 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.574 0 N-CA-C 111.576 -0.609 . . . . 0.0 111.576 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 37.4 t -134.17 157.77 76.83 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 125.979 1.712 . . . . 0.0 110.937 -178.236 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.11 -24.71 34.22 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.585 2.19 . . . . 0.0 113.318 161.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -74.2 -14.86 61.0 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.966 1.307 . . . . 0.0 113.726 174.596 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 14.9 m -77.03 -7.75 56.21 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.032 1.333 . . . . 0.0 113.788 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt 52.99 -98.95 0.08 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.003 2.121 . . . . 0.0 113.861 177.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.44 -47.97 0.09 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.166 1.386 . . . . 0.0 111.523 177.168 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.2 m -130.22 120.4 24.41 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.083 1.753 . . . . 0.0 106.739 163.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -146.12 116.66 7.57 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.108 1.363 . . . . 0.0 108.531 -169.7 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.5 mt -137.23 40.25 2.47 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.4 1.48 . . . . 0.0 113.703 -168.413 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -76.29 34.4 0.13 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.821 1.248 . . . . 0.0 112.602 172.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -156.62 150.07 24.45 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 128.211 2.604 . . . . 0.0 109.524 -175.199 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -173.11 139.21 0.79 Allowed 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.095 1.358 . . . . 0.0 107.781 172.564 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.8 m -96.48 113.9 25.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.856 151.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.517 ' HA ' HG22 ' A' ' 50' ' ' THR . 8.5 p -70.62 145.33 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 178.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.6 mt -129.86 -39.68 1.4 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.829 1.652 . . . . 0.0 111.957 -172.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.426 ' SG ' ' HE2' ' A' ' 14' ' ' LYS . 12.5 t -152.8 133.25 13.7 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.096 0.958 . . . . 0.0 111.26 175.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 92.9 t -130.5 127.14 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.538 1.135 . . . . 0.0 108.963 170.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.426 ' HE2' ' SG ' ' A' ' 12' ' ' CYS . 68.1 mttm -133.55 144.08 50.62 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 124.968 1.307 . . . . 0.0 112.3 -179.522 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -77.7 -11.44 16.91 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 124.098 3.199 . . . . 0.0 114.636 -178.289 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -117.99 110.15 17.34 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.148 1.379 . . . . 0.0 111.673 -174.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 p -156.82 142.05 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.527 1.131 . . . . 0.0 110.424 163.296 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.6 m -123.43 144.23 49.64 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.408 1.483 . . . . 0.0 110.238 178.517 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.41 HG22 HG22 ' A' ' 108' ' ' ILE . 76.7 t -113.7 129.36 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.821 1.248 . . . . 0.0 111.047 177.866 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.17 116.41 11.85 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.89 1.676 . . . . 0.0 109.196 173.796 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.9 mtt-85 -71.37 134.54 46.77 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.138 0.975 . . . . 0.0 110.509 -176.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.7 pt -90.1 150.21 42.97 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 124.266 1.026 . . . . 0.0 113.177 -165.003 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -73.2 162.34 40.84 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 123.421 2.747 . . . . 0.0 112.372 173.115 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.56 111.97 2.03 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.321 2.681 . . . . 0.0 111.024 174.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.1 tpp85 -157.81 157.96 34.3 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.338 1.855 . . . . 0.0 110.932 -172.39 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.55 134.23 54.1 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.268 1.427 . . . . 0.0 113.19 173.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.5 p -77.64 -51.39 10.7 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.655 1.982 . . . . 0.0 113.316 -170.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -83.02 -11.69 57.87 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -174.001 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.51 -6.55 0.71 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 117.063 2.246 . . . . 0.0 117.063 -171.762 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -113.58 -18.44 7.03 Favored Glycine 0 N--CA 1.469 0.867 0 N-CA-C 117.913 1.925 . . . . 0.0 117.913 -161.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -85.15 125.79 33.1 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 120.106 1.953 . . . . 0.0 110.632 178.151 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.61 26.13 9.78 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 178.113 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 60.46 -42.13 0.1 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.686 2.394 . . . . 0.0 115.272 -170.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 89.6 p -66.47 -15.92 63.72 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.384 1.874 . . . . 0.0 114.398 -179.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -63.33 -26.21 68.66 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 167.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 9.6 m0 -94.13 164.89 12.88 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.964 1.306 . . . . 0.0 111.256 -168.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -76.92 55.21 1.08 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.643 1.577 . . . . 0.0 114.172 179.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.6 mt -59.49 -25.69 64.66 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.66 1.184 . . . . 0.0 113.745 -179.278 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -94.87 -7.63 39.58 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.608 0.763 . . . . 0.0 113.004 -179.053 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -149.88 78.97 7.96 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.644 1.178 . . . . 0.0 111.959 175.549 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.88 147.61 50.68 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.519 2.813 . . . . 0.0 113.114 176.229 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -71.22 -28.92 64.54 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.881 0.872 . . . . 0.0 111.302 169.003 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 66.9 t90 -156.56 153.53 28.81 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.243 1.817 . . . . 0.0 110.891 177.223 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.7 p -135.67 149.4 49.27 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.576 1.151 . . . . 0.0 111.331 169.374 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.62 -140.44 4.29 Favored Glycine 0 CA--C 1.525 0.717 0 O-C-N 122.135 -0.353 . . . . 0.0 113.462 -178.692 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.9 mtm105 -119.56 147.76 44.1 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.222 1.809 . . . . 0.0 111.715 -173.189 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 40.4 tp -85.13 142.04 29.79 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.674 1.59 . . . . 0.0 110.616 176.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.8 ttm-85 -142.2 95.55 2.82 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.376 1.07 . . . . 0.0 111.073 165.427 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.7 mt -83.06 128.53 38.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 169.271 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.517 HG22 ' HA ' ' A' ' 10' ' ' VAL . 11.8 p -140.57 171.97 13.37 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.71 2.004 . . . . 0.0 110.472 -176.011 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.7 t -155.34 153.43 30.48 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.681 1.192 . . . . 0.0 112.076 175.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -155.96 123.76 5.62 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.166 0.986 . . . . 0.0 111.012 163.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.52 46.31 48.71 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.151 0.882 . . . . 0.0 114.845 167.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt 63.32 28.2 15.58 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 126.408 1.883 . . . . 0.0 113.679 -176.061 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.1 m -135.42 120.55 18.84 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.658 1.583 . . . . 0.0 108.774 170.83 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.3 159.25 18.85 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.891 0.876 . . . . 0.0 111.034 174.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -137.63 114.05 10.23 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.592 1.557 . . . . 0.0 109.29 178.514 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.4 mp -85.93 92.88 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 167.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -84.98 146.1 27.38 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.208 1.003 . . . . 0.0 110.266 172.187 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -110.44 137.54 48.02 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.564 1.546 . . . . 0.0 111.2 172.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -123.71 147.7 47.22 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.34 1.056 . . . . 0.0 113.286 -178.103 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.73 144.15 52.86 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 122.148 0.975 . . . . 0.0 112.065 169.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.4 pttt -81.49 -6.38 58.9 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -177.021 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 90.7 t -122.62 -39.52 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.657 1.183 . . . . 0.0 111.983 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.4 m -116.0 -10.38 11.6 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -172.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.65 19.74 79.3 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 123.613 0.625 . . . . 0.0 114.331 177.399 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -65.79 139.13 58.31 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.385 1.474 . . . . 0.0 111.24 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.9 tp -72.23 112.31 8.2 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.103 0.561 . . . . 0.0 109.882 172.492 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -78.52 -56.58 4.32 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.241 0.616 . . . . 0.0 111.3 177.071 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.0 165.24 35.61 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.225 1.81 . . . . 0.0 109.795 179.266 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -146.25 142.87 28.78 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 170.488 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.22 105.71 50.31 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.355 1.462 . . . . 0.0 111.808 -178.544 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -67.54 142.89 60.71 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 124.129 3.22 . . . . 0.0 112.39 170.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.5 t -139.2 117.33 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.294 1.437 . . . . 0.0 109.688 -177.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -81.45 -25.96 35.68 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 121.45 -0.781 . . . . 0.0 112.96 -177.396 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.19 145.35 16.52 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.336 1.854 . . . . 0.0 110.077 169.435 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -118.75 127.94 26.25 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.569 1.148 . . . . 0.0 110.588 175.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.54 147.5 75.76 Favored 'Cis proline' 0 CA--C 1.542 0.905 0 CA-C-N 119.997 1.035 . . . . 0.0 113.434 -2.684 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.91 -158.2 9.05 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.686 1.612 . . . . 0.0 112.948 -179.169 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.2 tt -76.29 -40.41 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 O-C-N 121.853 -0.793 . . . . 0.0 113.093 -178.245 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.44 7.72 18.77 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -166.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.9 t -152.83 125.99 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 126.421 1.889 . . . . 0.0 108.571 177.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -145.95 154.06 41.5 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.607 1.163 . . . . 0.0 112.224 -173.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.7 p -103.2 154.78 18.96 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.524 1.53 . . . . 0.0 112.453 179.693 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.9 m -76.42 175.28 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.8 1.24 . . . . 0.0 111.065 165.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 68.7 p -92.21 -30.12 16.08 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.909 1.283 . . . . 0.0 113.152 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -100.94 -39.34 7.8 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -163.697 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.4 t -141.42 125.76 17.58 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -176.489 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.88 -12.73 26.93 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -172.318 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.455 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.272 27.7 ptt180 -82.61 11.78 5.4 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -176.892 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -136.98 140.82 42.45 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.082 1.353 . . . . 0.0 112.03 -174.078 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -140.95 158.82 43.41 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.231 1.412 . . . . 0.0 111.656 -178.262 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.3 t -108.39 140.26 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.379 1.072 . . . . 0.0 108.56 162.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.95 148.31 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 119.159 0.891 . . . . 0.0 112.229 170.184 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -93.25 91.65 7.35 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.743 0.817 . . . . 0.0 110.834 178.081 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -75.02 152.28 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.245 0.618 . . . . 0.0 111.894 176.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.1 141.85 47.58 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.591 1.556 . . . . 0.0 110.102 171.249 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -96.14 30.27 2.52 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.227 1.011 . . . . 0.0 113.694 -170.326 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.81 8.77 73.71 Favored Glycine 0 CA--C 1.538 1.53 0 N-CA-C 116.129 1.211 . . . . 0.0 116.129 173.418 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.6 t -134.36 -25.84 1.49 Allowed 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -174.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 135.74 -11.95 4.25 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.779 1.18 . . . . 0.0 114.342 177.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.94 157.12 16.04 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.948 1.699 . . . . 0.0 111.129 173.409 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 90.5 p -142.3 162.31 35.8 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.867 1.267 . . . . 0.0 114.119 -165.058 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.81 146.69 31.26 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.894 1.278 . . . . 0.0 111.443 174.51 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -90.38 117.12 28.85 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.552 0.741 . . . . 0.0 109.438 167.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.8 pt -116.77 144.63 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.804 1.242 . . . . 0.0 110.821 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -92.36 139.15 14.54 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 176.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.41 HG22 HG22 ' A' ' 19' ' ' VAL . 31.7 pt -130.67 160.61 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.175 1.39 . . . . 0.0 112.152 171.386 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -155.2 174.45 33.36 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-O 121.865 0.703 . . . . 0.0 114.794 167.341 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -124.2 149.26 46.57 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 126.721 2.008 . . . . 0.0 110.642 -173.255 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.0 t -74.68 -11.97 60.31 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 178.379 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -119.12 -24.16 6.57 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -155.282 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 61.09 -41.29 0.12 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 127.152 2.181 . . . . 0.0 115.036 -166.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.17 -27.89 72.14 Favored Glycine 0 CA--C 1.537 1.456 0 CA-C-N 119.675 1.125 . . . . 0.0 113.632 171.038 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -79.69 -34.72 39.96 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.122 0.961 . . . . 0.0 112.095 173.317 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.455 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -63.96 -36.77 85.05 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.563 -0.711 . . . . 0.0 112.636 167.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -70.27 9.91 0.52 Allowed 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 167.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -122.4 -32.57 3.6 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.219 1.408 . . . . 0.0 112.114 170.577 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -50.15 -48.89 53.58 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.223 1.409 . . . . 0.0 111.974 164.148 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -77.07 -29.83 55.22 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -178.672 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.2 t -77.96 -42.75 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 121.041 -1.037 . . . . 0.0 111.004 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 77.8 p -64.08 -26.66 68.65 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 176.309 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.9 mt -71.62 -59.51 2.72 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.22 1.008 . . . . 0.0 112.004 168.092 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -65.3 -30.34 71.18 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -172.412 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -79.04 -1.18 34.44 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.484 1.114 . . . . 0.0 112.608 177.341 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -100.06 -3.98 30.83 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 164.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -113.87 -10.24 12.98 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 176.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.08 -32.42 61.93 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 120.431 1.469 . . . . 0.0 114.855 -176.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 41.3 p-90 -78.54 -22.71 46.84 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.114 1.366 . . . . 0.0 113.35 178.615 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.4 t -78.78 -26.37 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.26 1.424 . . . . 0.0 111.074 175.137 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -95.48 27.4 3.4 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.937 2.095 . . . . 0.0 112.594 -179.171 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -83.58 94.63 8.11 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.209 1.003 . . . . 0.0 110.489 173.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 C--O 1.253 1.245 0 C-N-CA 126.808 2.043 . . . . 0.0 113.669 177.581 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.65 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 29.6 t -148.88 144.03 17.75 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 125.112 1.365 . . . . 0.0 111.368 178.822 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -69.69 -13.05 34.29 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.079 2.519 . . . . 0.0 113.421 172.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 51.95 35.66 16.48 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.609 1.563 . . . . 0.0 113.226 -177.504 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 59.6 p -84.43 -6.18 59.35 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 115.267 1.581 . . . . 0.0 115.267 -170.19 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.1 mtt -134.31 159.75 40.04 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.588 1.555 . . . . 0.0 112.276 -179.12 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.5 45.98 2.03 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.997 1.719 . . . . 0.0 110.286 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 30.3 m 58.75 71.24 0.6 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.534 1.534 . . . . 0.0 109.282 -159.794 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -95.67 90.73 5.8 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.23 1.412 . . . . 0.0 110.953 -168.065 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 29.3 mt -83.9 1.06 45.17 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.358 1.463 . . . . 0.0 114.4 -175.336 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 56.43 23.31 7.28 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.318 1.447 . . . . 0.0 112.819 -155.075 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -149.57 143.5 25.62 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 124.878 1.271 . . . . 0.0 112.896 168.569 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -161.41 87.27 0.69 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 129.894 3.278 . . . . 0.0 105.697 168.151 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.8 t -75.23 125.23 28.52 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 121.36 -0.838 . . . . 0.0 111.405 -165.236 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.0 p -72.3 146.26 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 123.481 0.712 . . . . 0.0 111.184 -178.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.7 mt -129.5 -37.47 1.6 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.361 1.465 . . . . 0.0 112.521 -170.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 36.8 t -149.31 139.42 22.14 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.954 1.301 . . . . 0.0 109.865 173.312 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.2 t -134.84 127.71 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.826 1.25 . . . . 0.0 108.864 168.636 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -130.96 136.98 29.75 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 125.048 1.339 . . . . 0.0 110.868 176.162 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.11 -14.32 16.82 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.349 2.699 . . . . 0.0 114.968 -174.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -134.58 108.69 8.21 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.135 0.974 . . . . 0.0 111.295 -173.149 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.37 144.35 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.189 1.396 . . . . 0.0 110.191 171.659 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.1 m -123.19 137.5 54.88 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.441 1.096 . . . . 0.0 111.267 -176.574 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.2 t -101.79 133.05 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.324 1.449 . . . . 0.0 111.444 178.391 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.22 121.51 22.6 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.973 1.309 . . . . 0.0 109.109 170.597 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -66.51 130.82 44.49 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.069 0.548 . . . . 0.0 109.98 174.123 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.0 pt -90.01 151.35 45.02 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.134 0.974 . . . . 0.0 113.205 -168.206 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -67.76 163.18 36.33 Favored 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 123.233 2.622 . . . . 0.0 111.508 165.345 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -61.32 142.66 96.69 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.946 2.431 . . . . 0.0 112.349 176.795 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.48 161.91 28.79 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.089 1.356 . . . . 0.0 112.582 -177.198 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -143.59 163.0 34.44 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.643 1.177 . . . . 0.0 111.182 160.401 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.3 p -85.73 -40.63 15.9 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.552 1.941 . . . . 0.0 113.796 -162.142 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -91.54 23.75 3.35 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.843 1.657 . . . . 0.0 110.944 173.768 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -133.01 -68.95 0.57 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 127.47 2.308 . . . . 0.0 111.273 -176.359 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.56 172.3 24.5 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-O 122.872 1.262 . . . . 0.0 112.269 -168.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -76.14 134.47 39.95 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.561 1.144 . . . . 0.0 110.375 170.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.54 18.53 7.46 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -172.412 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.3 -49.66 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 128.192 2.597 . . . . 0.0 115.597 -173.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.2 m -65.21 -17.8 64.79 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.99 1.716 . . . . 0.0 114.611 -176.295 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.89 -8.64 59.14 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 172.695 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -88.99 168.9 11.99 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.78 1.232 . . . . 0.0 110.732 174.639 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -81.26 55.36 2.53 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.686 1.195 . . . . 0.0 113.436 179.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.3 mt -54.84 -31.53 59.55 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -172.432 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -90.34 -8.78 49.9 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.32 1.048 . . . . 0.0 113.054 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -137.16 71.17 55.06 Favored Pre-proline 0 N--CA 1.471 0.62 0 C-N-CA 125.624 1.57 . . . . 0.0 111.358 -164.239 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -69.0 148.14 69.35 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 CA-C-N 119.315 0.791 . . . . 0.0 113.051 -171.753 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -72.35 -29.59 63.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.323 0.649 . . . . 0.0 111.239 167.486 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 56.0 t90 -159.56 154.21 24.32 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.533 1.933 . . . . 0.0 110.612 176.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.6 p -133.29 149.27 51.94 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.32 1.048 . . . . 0.0 111.749 167.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.84 -139.91 4.45 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 123.058 0.361 . . . . 0.0 113.261 -179.392 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.7 mtm105 -113.78 143.91 43.85 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.087 1.755 . . . . 0.0 111.736 -173.025 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.6 tp -83.37 140.34 32.47 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.62 1.168 . . . . 0.0 110.142 168.13 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -133.39 138.24 46.19 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.508 1.523 . . . . 0.0 108.816 156.69 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.407 HD11 ' CD2' ' A' ' 119' ' ' PHE . 21.1 mt -120.4 133.41 67.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 166.078 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.44 162.82 34.41 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 127.1 2.16 . . . . 0.0 109.309 -167.515 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 84.1 p -160.21 132.46 6.27 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 120.018 -1.676 . . . . 0.0 113.954 -169.452 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.64 137.18 7.64 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 125.51 1.524 . . . . 0.0 114.653 172.027 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 65.5 48.96 63.25 Favored Glycine 0 N--CA 1.475 1.259 0 C-N-CA 125.74 1.638 . . . . 0.0 114.123 171.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 56.1 30.57 16.58 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.99 1.716 . . . . 0.0 112.986 -174.498 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.5 m -134.05 132.92 40.6 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.775 2.03 . . . . 0.0 108.257 178.489 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.63 158.35 16.16 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.091 0.956 . . . . 0.0 110.434 171.418 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -142.12 91.89 2.38 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.666 1.586 . . . . 0.0 108.833 -164.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.8 mp -78.52 110.84 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 171.558 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -112.9 127.91 56.32 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.927 0.891 . . . . 0.0 110.868 177.201 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mp -96.94 130.29 44.28 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.583 1.153 . . . . 0.0 110.019 177.754 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -129.96 149.56 51.63 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.873 0.869 . . . . 0.0 112.845 -171.358 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -73.58 144.79 45.87 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.983 0.897 . . . . 0.0 112.186 -178.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.0 pttt -84.44 -6.73 59.41 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.238 1.815 . . . . 0.0 115.158 -178.666 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 96.0 t -122.7 -43.99 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.241 1.416 . . . . 0.0 111.586 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.2 m -95.34 -21.39 18.42 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -174.508 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.13 6.94 84.0 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.218 0.913 . . . . 0.0 113.902 -176.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.43 155.89 24.42 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.421 1.489 . . . . 0.0 112.626 -174.425 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.8 tp -74.57 128.06 34.62 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.632 0.773 . . . . 0.0 111.149 178.282 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -85.93 -56.41 3.49 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.327 1.051 . . . . 0.0 111.133 169.041 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.88 160.71 39.4 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.162 1.385 . . . . 0.0 111.204 -178.602 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? -140.18 136.02 33.02 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 176.17 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.73 100.56 51.02 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 126.136 1.774 . . . . 0.0 110.691 179.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -74.83 141.44 27.17 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.35 2.7 . . . . 0.0 111.33 169.775 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.5 t -134.65 125.93 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 126.921 2.088 . . . . 0.0 108.987 -172.108 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -90.97 -22.24 20.92 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.295 0.952 . . . . 0.0 113.53 -177.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -161.54 150.5 16.0 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.322 1.849 . . . . 0.0 110.438 173.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -130.16 131.77 23.65 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.347 1.059 . . . . 0.0 111.443 175.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.73 145.42 46.72 Favored 'Cis proline' 0 CA--C 1.539 0.736 0 CA-C-N 119.922 1.008 . . . . 0.0 113.739 -7.042 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -161.77 -156.26 8.29 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 125.669 1.605 . . . . 0.0 112.357 -177.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 19.9 tt -81.42 -39.94 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -176.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.68 6.35 15.53 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -167.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.1 t -152.22 128.51 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 126.364 1.866 . . . . 0.0 109.238 178.568 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -140.02 158.46 44.03 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.438 1.495 . . . . 0.0 113.11 176.155 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 67.5 p -100.56 159.04 15.48 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.294 1.838 . . . . 0.0 111.638 175.191 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.9 m -83.91 174.22 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.738 0.815 . . . . 0.0 110.862 164.575 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 59.9 p -96.02 -30.71 13.42 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.35 1.46 . . . . 0.0 113.224 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -96.04 -40.72 9.11 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -165.513 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.1 t -137.38 120.59 16.8 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -174.19 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.8 m -73.91 24.44 0.08 Allowed 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 -168.001 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -128.61 23.82 5.82 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 127.136 2.175 . . . . 0.0 113.529 -178.169 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -141.55 139.52 33.21 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.644 1.577 . . . . 0.0 111.391 -178.454 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -140.18 161.29 37.99 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.807 1.243 . . . . 0.0 111.89 -177.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 78.1 t -113.04 142.34 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.473 1.109 . . . . 0.0 108.725 166.021 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.43 149.46 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 118.509 0.595 . . . . 0.0 112.085 170.51 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -89.47 87.4 7.06 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.814 0.846 . . . . 0.0 110.508 177.019 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.8 141.05 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 O-C-N 122.102 -0.374 . . . . 0.0 110.469 172.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -134.43 148.01 50.54 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.377 1.471 . . . . 0.0 111.418 -170.262 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -97.84 13.55 30.18 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.523 1.129 . . . . 0.0 113.255 -175.475 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.5 8.71 86.03 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.308 1.432 . . . . 0.0 115.481 176.165 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.5 t -130.99 3.64 4.41 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.581 1.552 . . . . 0.0 113.665 -173.127 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.9 -6.31 66.91 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 125.416 1.484 . . . . 0.0 113.87 -175.471 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 47.5 ttt180 -74.84 131.7 40.96 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 127.393 2.277 . . . . 0.0 108.825 166.28 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 84.1 p -147.94 160.82 42.41 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -175.278 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.87 145.92 31.81 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.644 1.577 . . . . 0.0 110.952 170.048 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -93.57 116.56 29.08 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.63 0.772 . . . . 0.0 109.726 171.284 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.3 pt -115.69 144.04 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.539 1.136 . . . . 0.0 110.953 179.339 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.46 142.47 16.11 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 174.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.4 pt -128.85 147.78 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 125.331 1.452 . . . . 0.0 111.925 172.217 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.15 146.94 17.89 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.454 1.026 . . . . 0.0 114.022 177.178 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -109.72 161.1 15.73 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.536 1.934 . . . . 0.0 111.104 178.405 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.9 t -74.41 -24.13 59.06 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.721 0.808 . . . . 0.0 112.802 179.091 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -157.47 156.35 31.96 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.814 1.246 . . . . 0.0 111.504 -177.133 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -57.84 -33.25 68.44 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 118.642 -0.694 . . . . 0.0 112.465 175.228 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -59.65 -30.98 69.91 Favored Glycine 0 CA--C 1.536 1.401 0 CA-C-N 119.491 1.041 . . . . 0.0 114.237 -179.279 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -86.85 -36.89 18.21 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.381 1.09 . . . . 0.0 112.241 176.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.46 -30.26 70.48 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 168.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . 0.259 18.3 m-85 -91.0 17.92 7.35 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.006 1.722 . . . . 0.0 114.096 170.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -99.41 -40.66 7.77 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.635 -0.666 . . . . 0.0 111.099 143.706 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.407 ' CD2' HD11 ' A' ' 49' ' ' ILE . 40.4 t80 -53.78 -56.7 15.13 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.566 1.076 . . . . 0.0 113.047 178.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -80.45 -24.47 39.54 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -175.396 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 85.2 t -81.76 -39.2 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 123.144 0.577 . . . . 0.0 110.941 -177.136 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 89.4 p -64.41 -31.64 72.94 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 175.115 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 67.5 mt -68.14 -56.8 7.47 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.28 1.032 . . . . 0.0 111.704 171.143 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -67.23 -32.63 73.8 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.319 -0.863 . . . . 0.0 113.004 -173.478 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -84.69 -3.16 58.41 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.785 0.834 . . . . 0.0 112.762 177.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -93.97 -31.9 14.08 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.41 -0.806 . . . . 0.0 112.375 163.3 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -90.4 -9.81 46.2 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -178.539 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.74 -25.94 30.93 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -171.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 30.9 p-90 -88.1 -26.67 22.39 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.81 1.244 . . . . 0.0 113.849 175.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 32.0 t -77.68 -44.53 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.062 1.345 . . . . 0.0 110.173 175.318 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 52.3 tttt -115.84 77.28 1.07 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.981 1.712 . . . . 0.0 110.231 176.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -74.45 88.85 2.11 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.458 1.103 . . . . 0.0 110.499 173.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 . . . . . 0 C--O 1.253 1.238 0 C-N-CA 126.026 1.73 . . . . 0.0 113.429 -179.872 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.661 0 N-CA-C 111.833 -0.507 . . . . 0.0 111.833 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 65.3 m -65.85 136.19 95.65 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 124.268 1.027 . . . . 0.0 112.358 -178.678 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -84.47 40.51 0.87 Allowed 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 124.33 3.353 . . . . 0.0 113.457 -171.586 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -61.59 -31.49 71.55 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 120.557 -1.339 . . . . 0.0 113.042 -171.348 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 19.3 m -63.85 -15.17 58.25 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.128 1.371 . . . . 0.0 114.034 174.706 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.5 mtp -106.08 8.08 32.09 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.14 1.776 . . . . 0.0 112.66 173.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.81 -47.83 2.29 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.66 1.584 . . . . 0.0 112.433 -176.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.8 t -78.07 -33.04 51.03 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.299 0.571 . . . . 0.0 111.315 165.068 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 46.96 50.21 13.99 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 127.642 2.377 . . . . 0.0 115.265 168.282 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 pp -88.88 130.95 35.32 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.629 0.728 . . . . 0.0 111.257 170.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -138.5 59.61 1.63 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.659 1.583 . . . . 0.0 109.447 176.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -124.83 141.11 52.34 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.837 1.655 . . . . 0.0 110.792 -178.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -177.16 94.04 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.314 1.845 . . . . 0.0 108.156 -178.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.4 t -83.79 112.99 20.59 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.738 -1.226 . . . . 0.0 110.146 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.4 p -72.57 144.56 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.707 0.803 . . . . 0.0 112.579 -174.512 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.6 mt -128.26 -43.97 1.44 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.239 1.416 . . . . 0.0 112.248 -173.539 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 24.4 t -149.6 135.06 18.38 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.376 1.07 . . . . 0.0 110.604 175.494 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 96.5 t -127.91 127.96 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.551 1.14 . . . . 0.0 109.304 171.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -128.35 133.27 24.97 Favored Pre-proline 0 N--CA 1.476 0.87 0 C-N-CA 125.259 1.424 . . . . 0.0 110.122 174.207 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.22 -15.48 14.36 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.116 2.544 . . . . 0.0 115.037 -171.305 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -133.48 108.58 8.73 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.138 0.975 . . . . 0.0 110.879 -174.444 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.3 p -144.94 144.48 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.161 1.384 . . . . 0.0 110.289 174.697 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.0 m -125.9 130.64 51.71 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.188 0.995 . . . . 0.0 111.081 -172.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.5 t -96.39 134.82 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.286 1.435 . . . . 0.0 111.345 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.98 124.76 26.86 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.952 1.301 . . . . 0.0 108.918 170.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.4 mmm-85 -63.14 136.77 57.96 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.634 -0.666 . . . . 0.0 110.451 167.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.5 pt -100.23 151.21 37.46 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.981 1.312 . . . . 0.0 112.349 -174.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.76 162.47 41.95 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 123.145 2.564 . . . . 0.0 111.978 169.383 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -64.62 112.2 1.89 Allowed 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.919 2.413 . . . . 0.0 110.279 170.745 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.2 mmt180 -150.97 164.0 37.39 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.398 1.479 . . . . 0.0 113.046 -167.203 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.07 123.23 23.99 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 122.206 1.003 . . . . 0.0 112.321 175.765 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.6 m -61.75 -24.63 66.95 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 127.331 2.252 . . . . 0.0 117.02 -160.091 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -140.06 16.42 2.45 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.008 1.323 . . . . 0.0 112.939 174.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -131.8 -26.59 1.97 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.774 1.63 . . . . 0.0 113.694 -177.459 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -122.96 -9.76 6.04 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.872 1.225 . . . . 0.0 115.293 -176.405 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -74.19 106.1 5.69 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.999 1.399 . . . . 0.0 109.447 161.744 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.13 22.6 12.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.911 -1.118 . . . . 0.0 113.821 178.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.87 -48.78 0.06 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.369 2.268 . . . . 0.0 114.969 -167.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.6 m -66.86 -13.79 62.01 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.943 1.697 . . . . 0.0 114.903 -176.207 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.38 -12.98 60.37 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.129 0.972 . . . . 0.0 112.876 171.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 13.7 m0 -95.76 171.77 8.45 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.483 1.513 . . . . 0.0 111.958 -174.345 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -75.69 49.39 0.51 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.146 1.779 . . . . 0.0 113.844 177.19 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.5 mt -56.06 -33.61 65.15 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -171.025 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -94.44 -3.89 49.29 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.457 1.103 . . . . 0.0 113.209 177.492 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -128.04 59.91 43.05 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 127.054 2.141 . . . . 0.0 111.843 -173.715 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.0 133.34 33.07 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 CA-C-N 120.537 1.227 . . . . 0.0 112.423 -173.468 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -70.34 -24.49 62.99 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.853 1.261 . . . . 0.0 111.243 178.604 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 33.9 t90 -159.74 154.47 24.37 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.862 2.065 . . . . 0.0 110.451 170.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.9 p -133.76 150.17 51.46 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.075 0.95 . . . . 0.0 112.112 167.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.16 -140.15 4.74 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.099 0.38 . . . . 0.0 113.581 -178.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.0 mtm105 -111.5 147.7 34.78 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.538 1.935 . . . . 0.0 111.971 -175.355 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.9 tp -89.19 138.43 31.43 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.632 1.573 . . . . 0.0 109.672 166.441 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 36.8 ttt-85 -144.5 93.04 2.37 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.475 1.11 . . . . 0.0 110.697 165.44 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.471 HD11 ' CD1' ' A' ' 119' ' ' PHE . 16.1 mt -73.08 128.29 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 171.69 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.2 p -132.86 167.32 20.41 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.741 2.016 . . . . 0.0 110.552 -179.18 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.3 t -160.54 146.77 15.24 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.603 -1.311 . . . . 0.0 112.153 177.076 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.5 mmtt -153.3 131.76 12.13 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.358 1.463 . . . . 0.0 111.428 161.154 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.98 45.99 47.48 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.859 1.219 . . . . 0.0 115.026 163.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt 63.68 21.39 12.68 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.432 1.893 . . . . 0.0 113.696 -173.905 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.2 m -127.7 112.7 15.11 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.072 1.349 . . . . 0.0 109.143 170.411 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.97 161.49 18.98 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.63 0.772 . . . . 0.0 110.573 170.024 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -141.11 108.75 5.61 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.941 1.696 . . . . 0.0 108.695 -175.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.5 mp -81.39 95.14 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 168.36 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -95.04 137.29 34.29 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.445 0.641 . . . . 0.0 111.605 175.586 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.3 mp -110.94 134.36 52.64 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.447 1.899 . . . . 0.0 109.491 176.402 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -139.21 152.13 47.1 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.544 0.738 . . . . 0.0 112.734 -168.374 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -73.6 143.26 46.44 Favored 'General case' 0 C--O 1.238 0.492 0 O-C-N 121.304 -0.872 . . . . 0.0 111.907 -176.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.4 pttt -84.01 -6.18 59.36 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.377 1.871 . . . . 0.0 115.05 -178.761 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 91.8 t -123.5 -44.42 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.357 1.463 . . . . 0.0 111.416 178.671 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.9 m -92.77 -23.11 18.99 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -174.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.84 6.06 86.94 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 123.872 0.748 . . . . 0.0 113.778 -177.421 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -82.05 154.48 25.6 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.361 1.464 . . . . 0.0 112.616 -174.625 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.1 tp -73.37 125.54 28.1 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.818 0.847 . . . . 0.0 110.981 178.136 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -84.56 -56.94 3.35 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.131 0.972 . . . . 0.0 110.806 169.683 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.32 163.3 39.67 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.744 1.218 . . . . 0.0 111.774 -179.273 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -139.63 135.79 33.65 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.583 1.153 . . . . 0.0 111.5 177.405 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.53 102.81 49.67 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.547 1.139 . . . . 0.0 111.076 174.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -70.06 137.89 35.63 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.828 3.019 . . . . 0.0 112.09 173.213 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.8 t -131.98 131.93 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.212 1.805 . . . . 0.0 109.251 -179.193 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -101.11 -16.29 17.11 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.435 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -161.71 152.13 17.42 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.926 1.69 . . . . 0.0 110.411 175.151 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -124.7 134.88 25.99 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -173.095 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -66.9 149.31 80.4 Favored 'Cis proline' 0 CA--C 1.542 0.909 0 CA-C-N 119.41 0.825 . . . . 0.0 111.221 -13.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -148.09 -172.78 18.41 Favored Glycine 0 N--CA 1.474 1.217 0 N-CA-C 115.1 0.8 . . . . 0.0 115.1 -174.183 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.3 tp -58.79 -29.03 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -174.521 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.53 7.97 43.77 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.584 1.154 . . . . 0.0 113.763 -172.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.1 p -158.94 128.58 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.004 0.922 . . . . 0.0 113.266 179.008 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -148.57 165.51 31.04 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.185 1.794 . . . . 0.0 113.455 -168.147 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 50.0 p -121.77 155.91 34.28 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.625 1.97 . . . . 0.0 111.592 -172.692 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.0 m -84.45 172.89 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.761 0.824 . . . . 0.0 111.901 172.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 68.7 p -89.03 -34.17 16.9 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.028 1.331 . . . . 0.0 112.539 177.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -92.92 -43.41 8.97 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -164.307 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.4 t -145.81 121.56 10.54 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -174.2 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.37 -2.3 5.99 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -169.707 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.416 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.264 1.2 ptm180 -88.19 22.16 2.54 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.922 1.689 . . . . 0.0 114.528 174.2 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -140.47 134.71 31.11 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.893 1.277 . . . . 0.0 110.813 178.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -134.26 161.55 34.64 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.418 1.487 . . . . 0.0 111.763 -179.672 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.5 t -117.5 142.35 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.522 1.129 . . . . 0.0 109.116 166.762 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.38 150.77 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 123.381 0.673 . . . . 0.0 111.721 171.014 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -95.06 89.69 5.66 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.125 0.97 . . . . 0.0 109.988 177.78 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -71.05 137.0 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 120.724 0.297 . . . . 0.0 110.757 177.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -142.52 144.1 32.81 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.725 1.61 . . . . 0.0 111.521 -167.198 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -90.95 3.03 55.72 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.489 1.116 . . . . 0.0 113.121 -177.665 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.28 13.09 79.61 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 125.218 1.39 . . . . 0.0 114.794 178.286 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.5 t -137.22 15.88 3.0 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.44 1.496 . . . . 0.0 113.721 -172.647 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.38 -1.88 80.06 Favored Glycine 0 CA--C 1.537 1.453 0 O-C-N 121.036 -1.04 . . . . 0.0 114.957 -178.131 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -71.59 131.89 43.88 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.445 1.498 . . . . 0.0 108.678 163.626 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 92.7 p -146.7 152.27 38.56 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 176.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.75 141.02 26.3 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.303 1.441 . . . . 0.0 111.195 167.565 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -87.42 125.13 34.09 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 121.842 -0.536 . . . . 0.0 110.352 169.682 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 14.9 pt -122.27 142.92 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.117 1.367 . . . . 0.0 110.469 175.131 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.99 143.68 16.68 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 172.542 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.9 pt -129.17 141.59 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.971 1.308 . . . . 0.0 111.951 172.335 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -119.21 145.31 18.07 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.936 1.255 . . . . 0.0 113.157 175.267 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -108.21 161.51 14.92 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.016 1.726 . . . . 0.0 111.689 -176.334 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.9 t -72.57 -29.41 63.51 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.744 0.818 . . . . 0.0 112.91 -179.391 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -155.6 153.37 30.0 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.523 1.129 . . . . 0.0 111.753 -178.469 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 57.4 ttt-85 -61.29 -34.29 74.97 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.185 0.994 . . . . 0.0 113.176 178.065 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.43 -29.67 74.38 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 118.898 0.772 . . . . 0.0 113.515 175.481 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -82.43 -33.51 28.55 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 117.893 0.847 . . . . 0.0 111.825 175.349 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.416 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -67.09 -33.4 75.39 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.7 0.8 . . . . 0.0 112.962 170.146 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -60.84 -34.06 74.0 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.51 -0.744 . . . . 0.0 112.347 172.671 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -64.87 -32.63 74.43 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.543 1.065 . . . . 0.0 112.606 174.726 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.471 ' CD1' HD11 ' A' ' 49' ' ' ILE . 27.3 t80 -60.97 -55.66 30.24 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.241 0.928 . . . . 0.0 111.604 173.011 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.05 -26.73 56.85 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -175.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.9 t -74.62 -43.29 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 119.288 0.949 . . . . 0.0 110.953 175.271 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 41.9 m -66.41 -27.18 67.64 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.96 0.8 . . . . 0.0 112.843 -179.187 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 75.4 mt -73.71 -57.52 3.93 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.638 0.775 . . . . 0.0 111.483 169.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -64.27 -32.35 73.91 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -173.595 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -80.58 -5.42 56.78 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.039 0.936 . . . . 0.0 112.575 178.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -94.77 -15.05 24.14 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 165.403 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -108.81 -7.01 15.6 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.85 -23.34 43.43 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 121.218 1.826 . . . . 0.0 115.786 -175.653 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 31.0 p-90 -88.85 -18.64 27.21 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.278 1.431 . . . . 0.0 113.955 175.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.1 t -87.5 -44.79 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.559 1.543 . . . . 0.0 109.849 173.593 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.1 ttpp -107.73 77.71 1.15 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.523 1.929 . . . . 0.0 110.028 172.137 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -72.4 20.38 0.07 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.348 1.859 . . . . 0.0 115.269 177.481 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 C--O 1.252 1.195 0 C-N-CA 127.044 2.137 . . . . 0.0 113.169 -178.655 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.638 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 33.2 m 48.29 59.94 16.14 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 126.144 1.777 . . . . 0.0 114.9 177.162 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -71.65 -1.04 9.21 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 124.077 3.185 . . . . 0.0 114.362 -177.392 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -58.32 -22.95 55.03 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.718 1.607 . . . . 0.0 113.668 -177.013 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 73.7 p -62.88 -14.13 42.61 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.048 1.339 . . . . 0.0 114.306 172.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.9 mtp -88.53 6.42 37.99 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.47 1.508 . . . . 0.0 113.382 174.754 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.57 -46.8 0.41 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.787 1.635 . . . . 0.0 111.603 179.15 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 35.9 m -86.16 75.25 9.92 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.767 1.227 . . . . 0.0 107.975 161.723 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -106.51 22.2 16.2 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 114.703 1.372 . . . . 0.0 114.703 -159.084 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.5 mp -58.9 123.02 15.11 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.036 0.935 . . . . 0.0 111.341 179.118 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -111.84 54.15 0.7 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 122.933 1.349 . . . . 0.0 110.371 168.48 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.25 65.26 1.14 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 123.824 1.773 . . . . 0.0 111.337 -146.251 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -172.6 75.89 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 128.296 2.639 . . . . 0.0 108.029 167.455 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.2 m -70.98 109.25 4.98 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.33 -0.856 . . . . 0.0 110.212 173.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.9 t -73.55 147.25 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.103 1.361 . . . . 0.0 111.622 -174.54 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.84 -40.88 1.05 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.516 1.527 . . . . 0.0 111.843 -172.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 22.5 t -147.41 142.5 27.1 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.899 1.28 . . . . 0.0 110.669 173.58 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 76.1 t -136.05 129.03 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 125.076 1.35 . . . . 0.0 109.087 170.082 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -130.92 137.65 31.24 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 125.44 1.496 . . . . 0.0 110.381 173.27 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.59 -17.86 15.87 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.028 2.485 . . . . 0.0 114.797 -174.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -133.77 111.11 10.27 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.236 1.015 . . . . 0.0 111.794 -171.009 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.0 p -148.42 144.3 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.038 1.735 . . . . 0.0 110.017 172.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.4 m -123.09 136.63 54.88 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.45 1.1 . . . . 0.0 111.29 -174.053 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.2 t -101.29 133.42 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.063 1.345 . . . . 0.0 111.532 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -134.18 119.6 19.02 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.055 1.342 . . . . 0.0 108.864 171.044 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -66.36 129.86 41.26 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.975 0.51 . . . . 0.0 109.808 174.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.4 pt -88.89 151.04 46.75 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -166.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -66.86 169.27 15.08 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.313 2.676 . . . . 0.0 111.383 163.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -56.47 152.38 40.45 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.325 2.017 . . . . 0.0 111.948 166.605 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 40.0 ttm-85 -60.99 156.32 18.0 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.309 1.444 . . . . 0.0 112.772 -175.306 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.29 -175.9 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.511 1.124 . . . . 0.0 112.863 163.129 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.2 p -76.23 70.29 2.85 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.351 1.861 . . . . 0.0 113.26 -170.554 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 62.64 14.24 7.0 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 127.009 2.124 . . . . 0.0 113.798 -169.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -89.82 -54.9 3.85 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.6 1.16 . . . . 0.0 112.197 -175.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 141.12 -148.61 20.28 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-O 122.038 0.799 . . . . 0.0 112.431 -169.543 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -117.27 159.83 22.06 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 127.379 2.272 . . . . 0.0 111.041 -179.633 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.42 17.13 3.68 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -171.377 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.06 -52.23 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 128.16 2.584 . . . . 0.0 115.616 -175.487 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.6 m -66.66 -13.94 61.85 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.872 1.669 . . . . 0.0 114.187 -176.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -84.6 -8.44 58.89 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.943 1.297 . . . . 0.0 112.633 173.479 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.2 m0 -92.93 169.36 10.5 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.753 1.621 . . . . 0.0 111.234 177.214 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -79.62 51.33 1.25 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.197 1.799 . . . . 0.0 112.574 178.305 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.2 mt -54.62 -32.44 58.92 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.389 1.476 . . . . 0.0 114.36 -173.852 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -87.92 -9.5 53.44 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.796 0.838 . . . . 0.0 112.485 -177.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -139.13 68.66 41.23 Favored Pre-proline 0 N--CA 1.47 0.545 0 C-N-CA 125.396 1.478 . . . . 0.0 111.231 -160.511 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -68.7 147.23 69.17 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 CA-C-N 119.519 0.864 . . . . 0.0 113.215 -169.1 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -72.52 -30.12 64.19 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.493 0.717 . . . . 0.0 111.286 168.674 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.6 t90 -159.24 155.14 26.47 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.472 1.909 . . . . 0.0 110.517 176.789 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.8 p -134.7 146.99 49.98 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.81 1.244 . . . . 0.0 111.945 171.233 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.14 -140.8 5.45 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 114.574 0.59 . . . . 0.0 114.574 176.707 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -107.14 141.54 38.25 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 126.677 1.991 . . . . 0.0 111.249 -169.253 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.5 tp -84.67 139.39 32.06 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.037 1.335 . . . . 0.0 110.127 168.237 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.6 ttm-85 -131.82 132.05 43.4 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.408 1.083 . . . . 0.0 109.554 154.546 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.402 HD11 ' CD2' ' A' ' 119' ' ' PHE . 22.4 mt -109.34 132.8 56.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 163.282 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.84 164.19 31.24 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 126.379 1.871 . . . . 0.0 109.866 -168.322 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.2 t -156.96 155.99 32.24 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 120.772 -1.205 . . . . 0.0 111.805 177.241 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -159.97 133.3 6.92 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.388 1.475 . . . . 0.0 110.045 152.641 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.97 49.94 20.28 Favored Glycine 0 N--CA 1.475 1.258 0 C-N-CA 124.7 1.143 . . . . 0.0 114.82 166.666 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt 59.93 23.1 12.16 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 126.406 1.882 . . . . 0.0 113.697 -175.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.8 m -126.93 126.48 43.31 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.824 1.65 . . . . 0.0 108.308 172.285 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.68 161.11 13.81 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.125 0.97 . . . . 0.0 110.873 170.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -139.65 110.68 6.89 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 126.438 1.895 . . . . 0.0 108.356 -175.057 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.5 mp -86.33 106.92 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 166.098 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.7 mttt -107.43 131.3 54.43 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.64 1.176 . . . . 0.0 111.358 177.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.0 mp -103.32 130.01 50.49 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.053 1.341 . . . . 0.0 110.481 178.754 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -131.75 147.2 52.48 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.912 0.885 . . . . 0.0 113.289 -167.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -64.42 142.92 58.25 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.815 -1.178 . . . . 0.0 113.063 -177.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.26 -2.7 36.07 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 -178.299 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.5 t -116.78 -48.77 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.481 1.112 . . . . 0.0 111.269 170.836 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.7 m -114.22 -4.67 13.04 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.6 1.334 . . . . 0.0 114.6 -168.045 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.21 15.73 78.73 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 123.85 0.738 . . . . 0.0 114.143 177.257 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -63.97 133.35 53.03 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.839 1.656 . . . . 0.0 111.383 -177.032 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.1 tp -68.67 115.11 7.66 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 122.881 0.472 . . . . 0.0 111.056 -179.391 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -80.8 -53.3 6.61 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.714 1.206 . . . . 0.0 111.131 173.569 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.24 159.13 35.69 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.052 1.341 . . . . 0.0 111.287 -178.187 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -138.31 136.63 36.61 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.5 0.72 . . . . 0.0 112.502 173.182 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.96 107.93 47.23 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 125.339 1.456 . . . . 0.0 110.752 176.517 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -79.66 141.07 15.24 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.721 2.947 . . . . 0.0 111.314 175.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.8 t -134.14 129.52 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 126.145 1.778 . . . . 0.0 109.237 -172.3 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -96.52 -21.14 17.88 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 178.836 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.33 149.12 13.42 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.704 2.001 . . . . 0.0 110.301 175.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -129.24 129.76 23.33 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 124.334 1.054 . . . . 0.0 111.963 177.224 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -65.58 149.02 75.63 Favored 'Cis proline' 0 CA--C 1.541 0.854 0 CA-C-N 119.807 0.967 . . . . 0.0 113.191 -5.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -169.1 -162.28 21.03 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.639 1.59 . . . . 0.0 113.473 -177.282 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.9 tp -68.43 -35.42 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -170.249 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.04 4.1 53.81 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -168.511 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.4 t -151.35 129.64 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.806 1.242 . . . . 0.0 110.229 -179.38 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -138.84 158.4 44.3 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.535 1.534 . . . . 0.0 112.91 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 57.0 p -104.79 156.77 17.7 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.35 1.86 . . . . 0.0 111.225 175.785 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.7 m -82.89 178.37 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.82 0.848 . . . . 0.0 110.759 166.058 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 73.3 p -107.99 -22.27 12.48 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.775 1.63 . . . . 0.0 114.005 -177.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -90.68 -45.04 9.11 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -175.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t -145.32 125.7 13.96 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -179.416 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.8 m -69.57 11.83 0.23 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 -173.012 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.466 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.27 28.9 ptt180 -96.51 12.58 30.99 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.27 1.428 . . . . 0.0 114.43 174.016 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -136.75 139.66 42.02 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.428 1.491 . . . . 0.0 111.382 -173.338 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -140.13 162.89 34.15 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.062 1.345 . . . . 0.0 111.602 -177.26 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.4 t -117.17 141.77 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.526 1.131 . . . . 0.0 108.446 166.053 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.32 148.36 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 118.805 0.729 . . . . 0.0 112.281 171.246 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -91.04 81.76 5.61 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.906 0.883 . . . . 0.0 111.162 179.417 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -67.26 141.55 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.966 0.412 . . . . 0.0 111.148 176.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -139.63 152.13 46.53 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.646 1.578 . . . . 0.0 111.736 -169.058 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -95.58 1.9 53.97 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.174 0.99 . . . . 0.0 113.084 178.197 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.82 12.57 81.17 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.141 1.353 . . . . 0.0 114.796 178.381 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.9 t -136.3 12.45 3.28 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.516 1.526 . . . . 0.0 113.432 -172.586 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.82 -3.86 71.33 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 124.855 1.217 . . . . 0.0 114.793 -177.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -72.37 132.91 44.59 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.294 1.437 . . . . 0.0 108.588 163.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.9 p -149.27 159.48 44.23 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 173.08 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.35 146.22 32.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.436 1.494 . . . . 0.0 110.803 168.301 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -91.44 117.13 29.42 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.361 0.664 . . . . 0.0 109.535 168.586 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.6 pt -115.2 142.19 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.442 1.097 . . . . 0.0 110.795 177.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.7 141.27 16.01 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 175.293 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.5 pt -127.32 148.72 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 125.19 1.396 . . . . 0.0 111.602 170.432 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -134.61 147.24 19.05 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 124.093 0.854 . . . . 0.0 113.423 175.46 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -105.12 157.06 17.52 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.449 1.5 . . . . 0.0 111.279 176.1 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.4 t -73.8 -17.4 61.09 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.554 0.742 . . . . 0.0 112.78 178.211 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -154.28 145.92 23.27 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.675 1.19 . . . . 0.0 110.868 -178.188 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -64.27 -28.07 69.48 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.84 0.856 . . . . 0.0 113.193 -179.801 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.82 -30.75 78.07 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 124.164 0.888 . . . . 0.0 114.257 173.299 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -81.79 -34.89 30.08 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.603 1.201 . . . . 0.0 111.763 176.486 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.466 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -66.68 -30.18 70.37 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.162 0.985 . . . . 0.0 113.446 168.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.01 -49.54 76.51 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.363 0.665 . . . . 0.0 111.048 166.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -64.37 -28.96 70.05 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 118.837 0.744 . . . . 0.0 113.007 176.782 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.402 ' CD2' HD11 ' A' ' 49' ' ' ILE . 48.4 t80 -62.43 -61.25 2.57 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.651 1.114 . . . . 0.0 111.535 170.397 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -76.78 -27.29 55.22 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -171.589 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 65.5 t -71.76 -37.97 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 O-C-N 121.404 -0.81 . . . . 0.0 110.924 176.582 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 51.1 m -67.11 -16.29 64.24 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 176.466 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.5 mt -84.75 -56.73 3.43 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.164 0.985 . . . . 0.0 111.3 168.192 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -66.89 -34.33 77.54 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -172.184 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -85.77 -0.45 55.28 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.688 0.795 . . . . 0.0 112.44 177.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -99.4 -29.06 12.98 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.064 -1.023 . . . . 0.0 112.524 165.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -96.83 -5.95 37.12 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -179.601 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.82 -31.89 41.37 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 121.302 1.865 . . . . 0.0 114.887 -173.529 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -84.87 -25.79 27.78 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.745 1.218 . . . . 0.0 113.796 179.178 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.5 t -80.22 -39.46 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.939 1.296 . . . . 0.0 110.531 175.004 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -100.98 55.29 0.85 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.136 1.775 . . . . 0.0 111.259 -177.414 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -79.14 90.22 4.86 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.351 167.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 . . . . . 0 C--O 1.253 1.251 0 C-N-CA 126.937 2.095 . . . . 0.0 112.522 -175.817 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.566 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 35.5 m 47.98 61.54 13.63 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 126.245 1.818 . . . . 0.0 114.892 177.264 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.29 -19.11 26.01 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.43 2.753 . . . . 0.0 113.815 -178.739 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 75.6 m-80 -100.71 155.11 18.08 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.481 1.512 . . . . 0.0 111.877 177.563 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 21.9 m -72.82 -17.67 61.54 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -177.045 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -85.74 126.96 34.38 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.172 1.389 . . . . 0.0 111.282 -176.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.15 138.06 15.41 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.054 1.742 . . . . 0.0 107.962 172.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.9 m -86.95 73.74 9.87 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 122.693 1.235 . . . . 0.0 110.115 -175.524 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -97.22 12.71 31.92 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 115.105 1.521 . . . . 0.0 115.105 -156.615 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.83 43.56 0.6 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.383 1.873 . . . . 0.0 112.4 -179.712 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -92.38 51.86 1.83 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.174 1.789 . . . . 0.0 110.827 -177.409 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -148.47 142.44 25.84 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.905 1.282 . . . . 0.0 111.375 -175.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -178.11 123.83 0.11 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.88 1.672 . . . . 0.0 107.905 167.014 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.2 m -93.35 106.35 18.33 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 165.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.7 t -73.6 143.44 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.066 0.946 . . . . 0.0 110.764 177.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.2 mt -131.09 -36.8 1.3 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.089 1.355 . . . . 0.0 111.817 -169.576 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 47.9 t -153.17 142.67 21.76 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.3 1.44 . . . . 0.0 110.182 171.266 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 89.4 t -134.55 127.31 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.49 1.116 . . . . 0.0 109.315 169.223 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 75.1 mmtt -121.54 133.35 24.21 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 124.932 1.293 . . . . 0.0 111.027 174.701 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 14' ' ' LYS . 42.2 Cg_exo -69.06 -29.96 26.34 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.47 2.113 . . . . 0.0 115.911 -171.508 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -137.14 122.48 19.4 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.792 0.805 . . . . 0.0 112.744 -175.218 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 p -149.24 149.07 15.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 127.571 2.348 . . . . 0.0 109.243 177.115 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.7 m -124.75 130.96 53.41 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.652 0.781 . . . . 0.0 112.358 -169.238 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 78.6 t -96.58 136.42 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.733 1.613 . . . . 0.0 112.473 -178.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -129.2 126.44 39.17 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.148 1.379 . . . . 0.0 109.357 169.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -66.88 131.29 45.6 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 167.552 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.7 pt -109.14 151.5 42.02 Favored Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 124.699 1.2 . . . . 0.0 112.36 -175.088 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -70.47 158.45 55.99 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 122.765 2.31 . . . . 0.0 111.38 166.459 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -63.53 144.53 90.39 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.76 2.307 . . . . 0.0 110.975 170.546 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -71.7 151.34 43.71 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 122.01 0.91 . . . . 0.0 113.445 -173.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.24 -137.86 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 127.969 2.507 . . . . 0.0 112.116 163.521 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 89.3 p -141.07 -36.13 0.46 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.868 1.667 . . . . 0.0 112.578 177.19 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -126.51 40.47 3.72 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.486 1.914 . . . . 0.0 111.23 -178.211 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 90.9 mmt-85 -131.47 -58.84 0.98 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.682 1.193 . . . . 0.0 113.313 177.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.35 152.54 5.19 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 123.413 0.446 . . . . 0.0 112.909 -177.732 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -68.15 133.02 48.24 Favored 'General case' 0 C--O 1.223 -0.318 0 O-C-N 121.968 -0.725 . . . . 0.0 109.721 171.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.67 18.27 10.34 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -174.5 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 60.35 -46.47 0.1 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.583 2.353 . . . . 0.0 115.064 -171.573 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 92.1 p -65.66 -16.91 64.19 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.56 1.944 . . . . 0.0 114.694 179.309 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -73.32 -18.79 61.16 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.766 1.226 . . . . 0.0 112.86 171.417 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 16.6 m0 -90.52 173.09 8.26 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.454 1.501 . . . . 0.0 111.881 -176.171 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -79.23 53.65 1.52 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.653 1.581 . . . . 0.0 114.36 -176.252 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.1 mt -60.01 -17.87 41.84 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -171.304 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -106.78 -3.16 20.74 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.497 1.119 . . . . 0.0 113.067 177.209 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -149.09 69.33 9.79 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 125.207 1.403 . . . . 0.0 112.122 177.798 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -55.31 145.69 65.46 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.134 2.556 . . . . 0.0 112.44 174.571 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.28 -30.68 68.83 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.711 0.804 . . . . 0.0 111.394 173.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 46.8 t90 -156.62 152.67 27.48 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.225 1.41 . . . . 0.0 111.056 176.076 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.9 p -133.57 152.2 51.86 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.495 -0.753 . . . . 0.0 112.13 166.274 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 176.55 -149.58 9.83 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.139 -0.482 . . . . 0.0 113.558 -175.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 17.5 mtm180 -97.05 148.27 23.18 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.432 1.893 . . . . 0.0 111.677 -175.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.0 tp -91.75 134.5 34.68 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.664 1.185 . . . . 0.0 109.596 163.332 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -127.83 119.53 25.87 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.891 1.276 . . . . 0.0 108.882 160.677 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.5 mt -101.93 130.86 50.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 166.471 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.92 166.48 26.62 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 126.254 1.822 . . . . 0.0 110.028 -166.906 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.9 t -157.21 160.12 38.38 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 121.273 -0.892 . . . . 0.0 112.168 173.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -144.42 122.04 11.82 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.652 0.739 . . . . 0.0 111.809 154.594 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.2 -117.98 9.68 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 125.863 1.697 . . . . 0.0 110.523 -177.551 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -100.2 14.01 32.28 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.917 1.687 . . . . 0.0 113.378 179.11 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.0 m -123.57 108.74 12.95 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.904 0.882 . . . . 0.0 110.285 177.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -83.16 158.94 22.16 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.158 0.504 . . . . 0.0 110.762 169.418 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -138.74 112.89 8.64 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.358 1.863 . . . . 0.0 108.729 -175.78 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.2 mp -91.98 105.54 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 165.458 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -104.09 135.06 46.28 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.115 1.366 . . . . 0.0 110.798 178.112 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.1 mp -107.06 128.79 54.69 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.616 1.566 . . . . 0.0 109.664 176.438 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -132.69 146.55 51.95 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.943 0.897 . . . . 0.0 112.004 -170.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -69.23 133.13 47.54 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.75 -1.219 . . . . 0.0 111.128 -179.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.5 pttt -77.19 -2.5 34.82 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -176.759 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.07 -42.41 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.42 1.488 . . . . 0.0 111.466 178.64 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.4 m -93.6 -21.07 19.63 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -178.764 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.66 10.07 82.83 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.645 1.117 . . . . 0.0 113.99 -177.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -86.75 149.11 25.1 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.287 1.435 . . . . 0.0 112.512 -172.762 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.3 tp -72.57 123.92 24.18 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.603 -0.686 . . . . 0.0 111.404 -178.029 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -87.49 -54.47 4.26 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.864 1.265 . . . . 0.0 111.245 171.826 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.9 163.2 40.64 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.684 1.194 . . . . 0.0 111.691 -177.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -145.84 131.46 18.86 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.505 1.122 . . . . 0.0 111.531 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.33 104.79 49.65 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 125.472 1.509 . . . . 0.0 110.855 178.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -77.22 144.32 23.26 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.053 2.502 . . . . 0.0 111.264 173.149 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.3 t -135.94 131.42 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.727 1.611 . . . . 0.0 109.014 -174.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -96.07 -22.68 17.19 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -179.54 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -163.29 150.67 12.89 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.786 2.034 . . . . 0.0 110.202 173.451 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -122.69 128.42 25.41 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.865 1.266 . . . . 0.0 111.204 177.635 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -63.14 149.49 65.88 Favored 'Cis proline' 0 CA--C 1.541 0.83 0 CA-C-N 119.849 0.982 . . . . 0.0 113.793 -6.344 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.01 -165.99 14.77 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.715 1.626 . . . . 0.0 112.532 178.347 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.7 tt -73.06 -36.86 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 O-C-N 121.698 -0.883 . . . . 0.0 112.867 -179.215 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.63 6.27 18.34 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -167.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.2 t -150.36 132.74 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.639 1.576 . . . . 0.0 110.26 -178.801 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -146.62 161.46 40.5 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.355 1.862 . . . . 0.0 112.331 -175.616 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 20.0 p -111.15 162.97 14.38 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 126.834 2.054 . . . . 0.0 111.719 177.447 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.0 m -87.7 174.8 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.64 1.176 . . . . 0.0 110.543 164.603 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 73.2 p -96.09 -36.38 11.01 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.147 1.379 . . . . 0.0 112.629 179.476 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -103.51 -28.33 11.83 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 -161.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.6 t -132.87 127.0 33.47 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.489 1.04 . . . . 0.0 113.51 -177.608 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.6 p -75.79 22.08 0.15 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.914 2.086 . . . . 0.0 116.164 -166.049 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -138.81 26.77 2.48 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 126.245 1.818 . . . . 0.0 114.632 -173.225 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -141.7 141.93 33.32 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.871 1.268 . . . . 0.0 111.735 -175.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -140.09 163.5 32.55 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.053 1.341 . . . . 0.0 111.085 -179.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.2 t -116.47 144.54 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.938 1.295 . . . . 0.0 108.843 166.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.8 149.42 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 118.565 0.621 . . . . 0.0 111.811 171.159 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.443 ' HE ' ' NE2' ' A' ' 97' ' ' GLN . 38.6 ttp180 -91.87 103.14 15.72 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.158 0.583 . . . . 0.0 109.954 173.285 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -84.96 148.29 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.441 1.096 . . . . 0.0 111.434 177.057 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.443 ' NE2' ' HE ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -130.75 139.66 50.27 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.863 1.665 . . . . 0.0 111.447 -179.756 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -84.18 3.99 32.59 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.233 1.013 . . . . 0.0 113.384 177.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.94 13.06 82.71 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 125.199 1.38 . . . . 0.0 114.789 177.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.2 t -139.66 17.66 2.52 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.413 1.485 . . . . 0.0 113.534 -171.645 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.97 0.46 77.82 Favored Glycine 0 CA--C 1.538 1.476 0 O-C-N 120.956 -1.09 . . . . 0.0 115.017 -179.094 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -80.53 143.25 33.41 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.39 1.476 . . . . 0.0 109.101 165.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 82.8 p -148.03 159.73 43.59 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 168.549 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.62 145.48 30.97 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.983 1.313 . . . . 0.0 110.999 170.38 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -90.13 121.72 32.44 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 166.056 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.8 pt -121.66 144.12 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.823 1.249 . . . . 0.0 110.965 178.698 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -90.7 142.81 16.41 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 173.588 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.1 pt -126.86 140.58 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 125.404 1.482 . . . . 0.0 111.651 172.104 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.48 138.95 11.83 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.185 1.374 . . . . 0.0 112.93 177.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -100.64 158.21 16.11 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.768 1.627 . . . . 0.0 111.488 -177.505 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.9 t -73.81 -21.56 60.11 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.732 0.813 . . . . 0.0 112.834 178.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -157.89 151.3 23.47 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.473 1.109 . . . . 0.0 111.577 -178.543 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -55.23 -41.64 72.36 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.716 1.207 . . . . 0.0 112.762 174.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.83 -29.08 71.29 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.163 0.887 . . . . 0.0 114.149 -179.275 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -83.72 -36.43 23.68 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.242 1.021 . . . . 0.0 112.103 176.225 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.0 -31.81 73.03 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.562 -0.711 . . . . 0.0 112.524 168.057 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -75.91 5.95 5.79 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 171.214 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -99.38 -32.51 11.12 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.419 -0.801 . . . . 0.0 112.715 157.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -55.88 -50.96 69.2 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.822 1.192 . . . . 0.0 112.458 178.603 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 48.0 p-10 -70.87 -34.28 71.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.262 1.025 . . . . 0.0 113.617 -179.44 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.1 t -73.91 -39.65 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.383 1.073 . . . . 0.0 110.742 178.825 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 27.6 t -57.28 -38.06 73.34 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.855 1.262 . . . . 0.0 112.63 176.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.7 mt -76.45 -52.53 9.66 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.875 0.87 . . . . 0.0 112.333 176.394 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -65.88 -30.79 71.45 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.409 -0.807 . . . . 0.0 112.999 -175.203 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -88.24 6.3 37.54 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.379 1.072 . . . . 0.0 112.942 176.684 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -94.14 -43.65 8.37 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.498 -0.751 . . . . 0.0 111.97 154.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -85.82 1.1 51.07 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -171.922 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.95 -17.94 20.24 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 -178.754 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 30.1 p-90 -99.48 -16.61 18.28 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.032 1.333 . . . . 0.0 114.147 172.261 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.2 t -94.31 -38.71 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.513 1.525 . . . . 0.0 111.606 -175.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -90.71 33.47 0.92 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.524 1.53 . . . . 0.0 111.88 -176.237 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -91.48 97.9 11.35 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.325 1.45 . . . . 0.0 109.921 178.094 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 . . . . . 0 C--O 1.253 1.284 0 C-N-CA 126.755 2.022 . . . . 0.0 112.665 -177.479 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.623 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 39.3 t -141.8 157.21 65.15 Favored Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 126.036 1.734 . . . . 0.0 110.834 -177.49 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.7 -19.42 18.51 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.797 2.331 . . . . 0.0 113.823 162.01 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -82.38 -9.55 59.41 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.473 1.509 . . . . 0.0 114.05 175.236 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 50.0 m -74.45 -9.53 58.68 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -175.232 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.58 154.78 41.9 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.975 1.71 . . . . 0.0 111.846 -179.629 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.02 23.88 2.19 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.591 1.156 . . . . 0.0 113.121 -179.377 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 61.5 m 62.34 104.56 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.466 1.907 . . . . 0.0 110.142 -155.646 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -148.89 117.05 6.4 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.223 1.009 . . . . 0.0 109.934 -159.624 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -147.27 146.24 29.68 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.191 1.396 . . . . 0.0 112.363 179.331 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -133.87 44.22 2.77 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.928 1.691 . . . . 0.0 110.273 177.62 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.443 ' CD2' ' HG3' ' A' ' 52' ' ' LYS . 2.9 p90 -152.98 156.65 39.25 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.963 2.105 . . . . 0.0 110.065 -171.142 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -174.66 105.22 0.1 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.677 1.591 . . . . 0.0 108.351 -178.7 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.63 108.8 19.88 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.381 -0.825 . . . . 0.0 109.742 171.245 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.74 147.23 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.343 1.057 . . . . 0.0 113.152 175.76 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.1 mt -123.57 -38.72 2.5 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.727 2.011 . . . . 0.0 110.32 179.804 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.1 t -155.36 147.28 23.39 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.344 1.458 . . . . 0.0 110.686 170.102 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.0 t -136.9 125.28 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.342 1.457 . . . . 0.0 108.906 174.121 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -127.82 143.12 46.49 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 124.63 1.172 . . . . 0.0 112.482 178.392 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.19 -19.34 15.53 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.836 3.024 . . . . 0.0 115.623 -172.834 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -132.25 112.07 11.93 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.9 0.88 . . . . 0.0 111.713 -172.008 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.8 p -145.07 143.58 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.785 1.634 . . . . 0.0 110.074 169.722 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.3 m -126.61 127.78 45.76 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.204 1.001 . . . . 0.0 111.172 -172.843 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 78.7 t -94.91 138.39 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.383 1.473 . . . . 0.0 112.194 -177.652 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -129.2 126.71 39.78 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.026 1.33 . . . . 0.0 109.356 168.918 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -69.55 119.25 13.51 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 165.454 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.5 pt -91.59 153.3 44.0 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 124.247 1.019 . . . . 0.0 113.304 -167.922 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -67.51 157.16 63.05 Favored 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 122.872 2.381 . . . . 0.0 111.664 165.908 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -65.76 143.44 73.97 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.136 2.557 . . . . 0.0 112.047 177.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -75.88 152.94 37.06 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.695 0.798 . . . . 0.0 112.937 -175.91 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -146.97 149.26 32.81 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.89 1.276 . . . . 0.0 109.575 154.728 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.5 m -65.42 -26.47 67.99 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.775 1.63 . . . . 0.0 114.036 -174.615 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -78.24 -3.98 45.5 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.422 1.089 . . . . 0.0 112.891 171.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -114.76 -58.31 2.16 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.463 1.905 . . . . 0.0 111.449 178.198 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.05 168.43 3.42 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 122.227 0.904 . . . . 0.0 111.793 -163.256 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -81.36 130.87 35.21 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 159.137 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.38 18.12 6.44 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -171.162 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.07 -47.05 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 127.842 2.457 . . . . 0.0 115.591 -171.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.5 m -66.29 -17.08 64.54 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.359 1.864 . . . . 0.0 114.739 -178.623 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -87.04 -2.01 58.31 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.075 0.95 . . . . 0.0 113.261 172.22 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 22.2 m0 -93.0 169.29 10.54 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.319 1.447 . . . . 0.0 110.615 172.866 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.6 mmtm -77.22 53.63 1.02 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.762 1.625 . . . . 0.0 114.445 -178.086 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.8 mt -58.52 -20.94 50.32 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 -175.376 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -100.79 -4.0 28.87 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 178.753 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -153.19 81.72 5.02 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.914 1.286 . . . . 0.0 111.784 175.041 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.37 145.8 34.85 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.308 2.672 . . . . 0.0 112.936 175.331 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -68.62 -31.54 70.78 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.092 0.557 . . . . 0.0 111.077 169.523 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 42.3 t90 -157.06 156.15 32.36 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.703 1.601 . . . . 0.0 111.057 174.297 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.8 p -135.08 149.46 50.07 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.277 1.031 . . . . 0.0 112.276 169.157 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.42 -143.94 6.17 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 123.289 0.471 . . . . 0.0 113.631 179.586 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.3 mtm105 -107.94 150.68 26.78 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.61 1.964 . . . . 0.0 112.093 -175.604 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.7 tp -94.71 138.18 32.86 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.485 1.914 . . . . 0.0 110.513 173.211 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -134.77 106.39 6.89 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.494 1.518 . . . . 0.0 109.684 165.26 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.3 mt -87.18 130.64 36.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 166.16 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.88 164.93 29.13 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.817 1.647 . . . . 0.0 110.739 -169.366 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.4 t -159.0 157.02 30.45 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.572 1.149 . . . . 0.0 111.009 171.54 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.443 ' HG3' ' CD2' ' A' ' 7' ' ' TYR . 38.4 mmtt -147.62 128.6 14.5 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.027 0.931 . . . . 0.0 110.782 152.728 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.43 -125.49 7.36 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 125.841 1.686 . . . . 0.0 110.054 -177.332 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -104.44 22.62 14.59 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.638 1.575 . . . . 0.0 112.78 177.389 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.6 m -127.47 123.17 35.37 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.995 1.318 . . . . 0.0 109.678 178.633 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.29 162.1 13.82 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.164 0.986 . . . . 0.0 110.791 169.487 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -140.93 112.74 7.65 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.041 1.736 . . . . 0.0 108.758 -176.326 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -89.88 105.41 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 167.28 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -108.84 141.93 40.16 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.893 1.277 . . . . 0.0 111.286 179.138 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.3 mp -111.69 131.1 55.52 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 126.047 1.739 . . . . 0.0 110.347 178.877 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -126.04 154.16 43.4 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.347 1.059 . . . . 0.0 113.441 -171.685 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -72.7 141.98 48.21 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 122.093 0.949 . . . . 0.0 111.611 174.254 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -83.99 -2.83 57.35 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 -176.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.7 t -126.43 -39.77 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.572 1.149 . . . . 0.0 111.871 -179.212 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.6 m -110.8 -15.57 13.78 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -172.14 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.97 21.83 79.56 Favored Glycine 0 CA--C 1.535 1.307 0 O-C-N 121.823 -0.548 . . . . 0.0 113.966 -179.702 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -63.63 160.75 16.17 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.683 1.193 . . . . 0.0 111.43 171.556 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.3 tp -93.92 120.54 34.31 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.048 0.939 . . . . 0.0 109.653 169.049 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -83.46 -54.3 5.07 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.479 0.712 . . . . 0.0 111.255 173.257 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.13 163.86 37.19 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.565 1.146 . . . . 0.0 111.973 -178.463 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -144.72 134.8 24.0 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.882 1.273 . . . . 0.0 111.841 179.477 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.74 100.88 43.32 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.482 1.513 . . . . 0.0 111.189 178.834 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -68.96 142.1 50.49 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 124.123 3.216 . . . . 0.0 112.559 172.203 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.0 t -136.31 130.89 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 126.003 1.721 . . . . 0.0 109.697 -176.528 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -92.65 -23.24 19.05 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.76 149.69 13.07 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.438 1.895 . . . . 0.0 110.234 172.118 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -115.37 131.01 23.82 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 124.526 1.13 . . . . 0.0 111.346 175.374 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.26 149.19 81.33 Favored 'Cis proline' 0 CA--C 1.542 0.92 0 CA-C-N 119.929 1.01 . . . . 0.0 112.574 -6.567 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.15 -176.88 36.41 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.561 1.077 . . . . 0.0 114.155 -179.022 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.9 tp -56.89 -32.38 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 125.184 1.394 . . . . 0.0 114.55 -171.459 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.85 4.82 52.03 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -171.485 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.6 t -148.2 128.83 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.334 1.054 . . . . 0.0 110.898 179.829 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.75 164.33 30.4 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.682 1.993 . . . . 0.0 112.43 -171.574 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 72.8 p -123.26 160.81 25.83 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.957 1.703 . . . . 0.0 111.697 -173.723 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.5 m -90.21 175.3 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 124.512 1.125 . . . . 0.0 111.202 169.374 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.6 p -94.99 -34.94 12.17 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.464 1.506 . . . . 0.0 112.867 178.567 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -89.5 -42.25 11.57 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -165.349 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.2 t -142.27 125.19 16.12 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -177.217 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.9 m -70.51 9.19 0.67 Allowed 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -173.261 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.458 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.315 44.8 ptt85 -97.14 19.71 12.53 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.179 1.392 . . . . 0.0 114.75 173.795 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -140.14 136.33 33.41 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.774 1.23 . . . . 0.0 110.993 -175.585 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -135.55 162.45 32.66 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.971 1.308 . . . . 0.0 111.01 -179.752 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.1 t -117.15 142.02 32.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 124.504 1.122 . . . . 0.0 108.71 166.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.15 147.56 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 118.962 0.801 . . . . 0.0 111.875 173.344 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -88.61 88.01 7.46 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.187 0.595 . . . . 0.0 110.661 177.33 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -71.55 137.74 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 120.797 0.332 . . . . 0.0 110.789 176.897 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -139.34 143.33 37.74 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.047 1.739 . . . . 0.0 111.233 -169.185 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -91.74 7.07 43.44 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.368 1.067 . . . . 0.0 113.33 -174.588 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.96 13.59 83.51 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.088 1.328 . . . . 0.0 114.516 178.371 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.0 t -137.6 10.71 2.93 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.588 1.555 . . . . 0.0 113.438 -171.154 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.67 0.57 66.67 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.749 1.166 . . . . 0.0 114.996 -178.409 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -76.42 142.88 40.92 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.104 1.362 . . . . 0.0 109.045 165.433 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 94.2 p -150.32 155.93 40.57 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 172.425 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.03 146.18 30.86 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.8 1.64 . . . . 0.0 110.848 167.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -94.04 119.39 32.84 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.278 0.631 . . . . 0.0 109.926 170.28 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.6 pt -117.63 143.14 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.449 1.099 . . . . 0.0 111.062 176.606 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.04 144.22 17.9 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 174.013 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.8 pt -129.42 140.86 48.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 125.563 1.545 . . . . 0.0 111.674 171.348 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -116.47 144.62 18.49 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.258 1.408 . . . . 0.0 112.884 174.256 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -106.46 153.61 22.03 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 126.013 1.725 . . . . 0.0 111.215 178.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.1 t -74.36 -18.07 60.73 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.017 0.927 . . . . 0.0 113.115 -178.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -154.56 145.32 22.44 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.61 1.164 . . . . 0.0 111.116 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -66.29 -30.91 71.43 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 179.787 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.76 -33.02 86.13 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-N 119.083 0.856 . . . . 0.0 113.328 173.381 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -80.69 -30.78 36.37 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.619 -0.93 . . . . 0.0 112.381 175.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.458 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -67.43 -37.26 82.75 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 167.697 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -61.23 -41.34 96.71 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.637 -0.664 . . . . 0.0 110.964 168.195 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.66 -34.18 77.28 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 121.452 -0.78 . . . . 0.0 112.709 175.652 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -59.78 -55.53 33.09 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.298 1.039 . . . . 0.0 112.194 168.496 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.65 -24.98 62.8 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -177.921 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.1 t -73.15 -41.65 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 121.422 -0.799 . . . . 0.0 110.942 172.059 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.0 m -64.71 -16.25 62.63 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 177.369 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.4 mt -88.51 -55.42 3.73 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.604 1.162 . . . . 0.0 112.427 167.793 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -69.05 -33.71 74.01 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.829 -1.17 . . . . 0.0 113.595 -173.032 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -86.9 5.62 36.03 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.665 1.186 . . . . 0.0 112.189 176.147 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -97.22 -42.59 7.74 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.664 0.786 . . . . 0.0 112.048 160.22 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -84.9 -2.98 58.5 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -174.897 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.26 -33.35 27.97 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 -177.569 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 35.8 p-90 -83.99 -20.92 31.99 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.612 1.165 . . . . 0.0 113.746 178.319 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.3 t -85.44 -40.07 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.153 1.381 . . . . 0.0 110.766 177.751 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.0 ttpp -90.7 41.35 1.05 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.659 1.583 . . . . 0.0 112.074 -177.268 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -79.51 94.92 5.69 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.43 1.092 . . . . 0.0 110.101 176.856 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 C--O 1.252 1.229 0 C-N-CA 126.681 1.992 . . . . 0.0 113.097 -179.389 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.594 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 56.1 m -120.66 102.3 44.95 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 124.903 1.281 . . . . 0.0 111.098 -175.759 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -83.45 5.74 6.21 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 124.17 3.247 . . . . 0.0 114.018 -176.559 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -63.43 145.46 55.56 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.67 1.588 . . . . 0.0 113.144 -171.386 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 64.6 p -81.2 -16.26 53.32 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.816 1.247 . . . . 0.0 114.342 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.8 mtm -136.11 156.81 48.16 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.112 1.765 . . . . 0.0 111.377 178.217 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.34 -38.34 0.1 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.773 1.229 . . . . 0.0 112.921 179.81 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 53.7 m -133.07 106.83 7.86 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.465 1.506 . . . . 0.0 108.708 172.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.28 23.65 1.99 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.145 1.378 . . . . 0.0 113.399 -165.711 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.1 tt -76.37 69.56 2.87 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.939 1.695 . . . . 0.0 112.425 -175.883 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -126.32 63.19 1.26 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.207 1.803 . . . . 0.0 109.773 176.726 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -152.45 151.51 30.86 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.992 1.717 . . . . 0.0 110.78 -173.456 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 178.66 121.48 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.386 1.874 . . . . 0.0 108.304 166.829 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.0 m -92.05 107.87 19.52 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.925 -0.485 . . . . 0.0 110.054 169.215 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.8 p -66.33 147.81 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.193 0.997 . . . . 0.0 112.077 175.843 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.6 mt -132.9 -37.9 1.0 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.673 1.589 . . . . 0.0 112.493 -171.853 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 35.0 t -153.34 137.52 16.5 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.691 1.196 . . . . 0.0 110.585 173.706 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 87.9 t -130.97 126.49 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.654 1.181 . . . . 0.0 109.226 171.708 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -129.2 136.41 29.11 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 125.443 1.497 . . . . 0.0 110.76 176.652 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -81.42 -13.69 10.85 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.267 2.645 . . . . 0.0 115.405 -171.819 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -131.08 105.52 7.77 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.249 1.02 . . . . 0.0 110.945 -175.781 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.0 p -141.77 140.14 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.972 1.309 . . . . 0.0 110.367 172.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.6 m -125.73 126.91 45.37 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.587 1.155 . . . . 0.0 110.979 -171.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 79.1 t -92.85 137.74 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.356 1.462 . . . . 0.0 111.92 -178.848 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -130.83 132.64 45.33 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.945 1.298 . . . . 0.0 109.885 169.5 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -60.22 131.96 52.44 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.256 0.622 . . . . 0.0 109.732 157.398 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.9 pt -104.91 150.41 38.66 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 124.666 1.187 . . . . 0.0 112.431 -173.833 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -69.41 158.81 56.05 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.038 2.492 . . . . 0.0 111.49 168.096 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.43 143.98 71.73 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.027 2.485 . . . . 0.0 112.615 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -74.2 154.18 39.16 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.307 1.443 . . . . 0.0 111.602 175.292 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.73 -97.76 0.06 Allowed 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.04 -1.436 . . . . 0.0 109.784 161.866 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.9 m -150.85 -69.93 0.18 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.42 1.488 . . . . 0.0 110.534 159.355 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -87.44 -9.71 53.89 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -173.284 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -65.18 -53.5 43.81 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.451 1.1 . . . . 0.0 111.769 178.265 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.35 156.02 29.11 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 124.579 1.085 . . . . 0.0 113.58 -179.517 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -71.02 146.31 49.45 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.031 0.932 . . . . 0.0 109.204 168.307 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.88 19.42 5.55 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -170.372 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.95 -46.15 0.06 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 128.453 2.701 . . . . 0.0 115.655 -174.632 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 90.9 p -64.04 -18.49 64.38 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.854 2.062 . . . . 0.0 114.61 179.626 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.52 -9.12 59.77 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.077 0.951 . . . . 0.0 113.144 174.054 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 16.7 m0 -92.88 170.58 9.57 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.22 1.408 . . . . 0.0 110.881 177.226 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.1 mtmm -80.28 54.53 2.01 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.041 1.337 . . . . 0.0 113.749 -177.844 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.0 mt -54.66 -29.3 52.11 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 -171.208 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -90.62 -10.67 42.41 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.033 0.933 . . . . 0.0 112.714 179.178 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -139.52 60.42 16.49 Favored Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 126.303 1.841 . . . . 0.0 110.842 -161.487 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -64.66 140.11 66.67 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 120.648 0.899 . . . . 0.0 111.966 -173.225 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -70.52 -26.91 63.79 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.79 0.836 . . . . 0.0 111.445 176.774 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 42.6 t90 -156.96 154.21 29.31 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.552 1.541 . . . . 0.0 111.023 170.08 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.4 p -134.15 144.95 48.84 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.312 1.045 . . . . 0.0 112.083 171.478 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.89 -143.69 5.17 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 123.497 0.57 . . . . 0.0 113.812 -178.087 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 34.8 mtm105 -117.92 148.59 42.01 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.818 2.047 . . . . 0.0 111.193 -172.576 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.7 tp -92.68 141.84 28.03 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.175 1.79 . . . . 0.0 111.029 176.208 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -142.47 99.08 3.42 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.926 1.69 . . . . 0.0 109.716 169.893 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.451 HD11 ' CD2' ' A' ' 119' ' ' PHE . 23.1 mt -85.98 133.8 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 169.693 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.04 168.15 22.28 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.093 1.757 . . . . 0.0 110.495 -168.286 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.2 t -157.17 150.75 24.23 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.741 -1.225 . . . . 0.0 112.087 173.658 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -149.86 134.19 17.33 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.53 151.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.34 50.28 33.69 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.513 1.054 . . . . 0.0 114.814 164.6 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt 60.06 26.88 16.26 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.075 1.75 . . . . 0.0 113.347 -175.765 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.5 m -130.67 124.06 30.76 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 126.028 1.731 . . . . 0.0 108.035 170.142 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -92.94 159.83 15.16 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.647 0.779 . . . . 0.0 110.585 170.183 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -139.04 106.39 5.53 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.149 1.78 . . . . 0.0 108.518 -172.669 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.3 mp -87.37 104.29 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 168.646 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -104.9 138.79 40.6 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.937 1.295 . . . . 0.0 111.121 177.508 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.9 mp -110.23 131.24 55.23 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.814 1.646 . . . . 0.0 109.933 176.596 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -130.38 149.85 51.87 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.558 1.143 . . . . 0.0 112.1 -173.713 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -75.28 152.46 38.24 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.007 -1.058 . . . . 0.0 112.455 177.814 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.564 ' H ' ' HD3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -93.79 -0.61 55.78 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.131 1.773 . . . . 0.0 115.486 -176.829 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.8 t -118.73 -45.8 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.207 1.403 . . . . 0.0 111.378 173.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.3 m -97.24 -21.22 17.4 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -173.714 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.72 6.81 85.51 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.085 0.85 . . . . 0.0 113.886 -177.466 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -79.3 151.25 31.19 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.045 1.338 . . . . 0.0 112.462 -174.513 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.6 tp -72.52 126.82 30.78 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.769 0.828 . . . . 0.0 110.924 178.361 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -86.66 -55.32 3.92 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.425 1.09 . . . . 0.0 111.265 170.688 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.39 160.67 39.85 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.852 1.261 . . . . 0.0 111.58 -178.349 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -141.65 136.22 30.73 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.75 0.82 . . . . 0.0 112.721 177.091 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.99 98.08 47.7 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 125.96 1.704 . . . . 0.0 111.482 -179.068 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -62.52 140.29 80.91 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 124.33 3.353 . . . . 0.0 113.042 166.002 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.1 t -136.43 126.47 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 126.453 1.901 . . . . 0.0 109.223 -178.493 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -86.69 -25.82 24.6 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 121.27 -0.894 . . . . 0.0 113.289 -178.054 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.31 151.15 15.14 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.102 1.761 . . . . 0.0 110.808 173.594 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -122.57 129.82 24.9 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.653 1.181 . . . . 0.0 111.174 176.486 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -62.65 148.2 59.79 Favored 'Cis proline' 0 CA--C 1.539 0.746 0 CA-C-N 119.982 1.029 . . . . 0.0 113.754 -6.14 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.29 -164.38 15.26 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.48 1.514 . . . . 0.0 112.702 179.772 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.0 tt -75.21 -38.32 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -177.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.06 6.51 16.04 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -167.424 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 25.1 t -149.03 132.09 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 125.992 1.717 . . . . 0.0 109.522 178.13 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.24 161.43 38.92 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.006 1.722 . . . . 0.0 111.94 -177.199 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.9 p -110.16 165.67 11.57 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.427 1.491 . . . . 0.0 111.373 177.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.7 m -87.05 179.51 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.469 0.707 . . . . 0.0 110.473 160.116 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 71.0 p -101.23 -30.01 11.77 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.614 1.566 . . . . 0.0 113.543 177.884 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -90.24 -42.77 10.81 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -167.604 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.2 t -143.31 125.12 15.08 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -176.26 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.04 -3.85 14.71 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -170.471 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.42 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.286 0.9 OUTLIER -86.68 22.86 1.81 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.56 1.544 . . . . 0.0 114.615 174.434 . . . . . . . . 4 4 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -142.24 133.25 25.91 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.633 1.173 . . . . 0.0 111.703 -179.575 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -136.07 162.94 31.51 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.373 1.469 . . . . 0.0 111.587 179.347 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 55.2 t -117.14 142.91 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.877 1.271 . . . . 0.0 109.044 168.597 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.62 148.72 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 118.835 0.743 . . . . 0.0 112.47 173.48 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -86.11 85.33 7.36 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.096 0.959 . . . . 0.0 110.406 175.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 pp -68.82 140.31 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 121.945 -0.472 . . . . 0.0 110.428 172.311 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -131.43 151.92 51.12 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.704 1.602 . . . . 0.0 111.087 -171.038 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -94.87 8.73 41.77 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.968 0.907 . . . . 0.0 113.213 -176.386 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.17 -18.77 4.99 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.698 1.618 . . . . 0.0 115.163 -178.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.3 t -86.49 -25.01 25.36 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.784 1.234 . . . . 0.0 112.995 176.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 136.07 -17.94 3.81 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.553 1.549 . . . . 0.0 114.268 176.27 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.9 156.0 22.6 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 125.428 1.491 . . . . 0.0 111.47 176.701 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 38.3 p -153.24 166.59 32.08 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -165.075 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -137.3 150.03 47.49 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.646 1.578 . . . . 0.0 110.635 162.873 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -95.32 113.06 24.69 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.497 0.719 . . . . 0.0 109.346 170.177 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 32.2 pt -112.41 146.36 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.62 1.168 . . . . 0.0 111.109 -179.617 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -92.33 142.99 16.26 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 174.271 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 34.3 pt -128.45 139.76 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 125.171 1.388 . . . . 0.0 111.56 172.552 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -118.45 143.96 17.8 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.69 1.614 . . . . 0.0 112.567 174.197 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -105.31 161.39 14.33 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.806 1.642 . . . . 0.0 111.812 -176.373 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.3 t -72.7 -27.63 62.19 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.62 0.768 . . . . 0.0 113.055 178.132 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -156.05 150.75 26.03 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.165 0.986 . . . . 0.0 112.152 -178.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 47.3 ttt-85 -62.27 -34.84 77.31 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.555 1.142 . . . . 0.0 113.107 178.446 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.16 -26.72 73.99 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 118.814 0.734 . . . . 0.0 113.698 176.084 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -85.56 -32.84 21.91 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.048 0.939 . . . . 0.0 111.821 173.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.42 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -67.76 -32.18 72.59 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 170.914 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -57.68 -36.57 72.1 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.547 -0.721 . . . . 0.0 112.074 172.356 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -66.18 -29.27 69.51 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.207 -0.933 . . . . 0.0 112.999 176.431 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.451 ' CD2' HD11 ' A' ' 49' ' ' ILE . 26.1 t80 -62.38 -47.99 81.72 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.473 1.033 . . . . 0.0 112.032 174.029 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -83.33 -25.22 31.68 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.345 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.0 t -78.45 -42.09 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 121.36 -0.838 . . . . 0.0 111.486 177.07 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 92.4 p -65.07 -28.56 69.55 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 179.666 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.3 mt -72.23 -54.41 9.68 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.98 0.912 . . . . 0.0 111.658 170.742 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -68.42 -33.96 75.14 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.028 -1.045 . . . . 0.0 113.102 -173.895 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -86.44 7.33 26.31 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.309 1.044 . . . . 0.0 112.538 175.986 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -102.72 -35.73 8.56 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.056 0.943 . . . . 0.0 112.42 161.885 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -88.6 -3.35 58.82 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -179.508 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.79 -25.08 39.56 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -175.278 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 31.1 p-90 -87.7 -22.67 24.51 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.013 1.325 . . . . 0.0 113.52 174.424 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.8 t -83.31 -27.53 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.88 1.672 . . . . 0.0 111.329 176.265 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -86.06 18.93 2.81 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.6 1.96 . . . . 0.0 113.308 177.796 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -85.59 91.52 8.28 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.092 0.957 . . . . 0.0 109.427 173.576 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 . . . . . 0 C--O 1.253 1.27 0 C-N-CA 126.468 1.907 . . . . 0.0 112.862 -168.598 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 112.067 -0.413 . . . . 0.0 112.067 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 37.2 t -68.76 141.26 92.43 Favored Pre-proline 0 N--CA 1.476 0.838 0 C-N-CA 123.935 0.894 . . . . 0.0 112.224 178.931 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.9 -10.34 19.75 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.412 2.742 . . . . 0.0 113.152 172.372 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -80.95 156.36 26.01 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.755 1.222 . . . . 0.0 111.965 -178.545 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 92.9 p -79.47 -5.73 55.39 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 177.67 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 mtt 58.46 18.27 5.52 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.204 1.802 . . . . 0.0 114.095 -166.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.45 -29.86 1.53 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.105 1.762 . . . . 0.0 112.521 174.489 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 58.8 m -129.58 108.42 10.21 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.162 1.785 . . . . 0.0 108.886 174.622 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -146.76 25.38 1.17 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.85 1.26 . . . . 0.0 113.302 -172.954 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.7 tt -64.91 104.99 0.93 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.737 1.615 . . . . 0.0 111.477 -179.638 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -147.11 71.7 1.23 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.685 1.594 . . . . 0.0 109.177 175.765 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.415 ' CD2' ' HG2' ' A' ' 52' ' ' LYS . 8.0 p90 -133.52 139.84 46.86 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.617 1.167 . . . . 0.0 110.704 175.98 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 173.92 110.39 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 127.149 2.18 . . . . 0.0 107.725 165.663 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.9 m -87.56 109.49 19.67 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.246 -0.909 . . . . 0.0 110.612 177.578 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 86.4 t -68.79 143.06 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.651 1.18 . . . . 0.0 111.854 -176.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.6 mt -125.19 -40.98 2.09 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.908 1.683 . . . . 0.0 112.168 -176.278 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 49.9 t -153.2 135.01 14.58 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.563 1.145 . . . . 0.0 110.664 172.091 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 74.1 t -127.88 127.59 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.677 1.191 . . . . 0.0 109.261 170.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -127.87 134.8 26.6 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 124.861 1.264 . . . . 0.0 111.035 174.602 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -63.17 -26.14 72.69 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.084 2.522 . . . . 0.0 114.328 178.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -111.82 129.18 56.23 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.349 1.46 . . . . 0.0 113.228 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.4 p -157.64 142.3 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 126.327 1.851 . . . . 0.0 108.886 158.789 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.7 m -124.4 134.83 52.99 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.361 1.065 . . . . 0.0 110.493 -178.785 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 86.2 t -103.18 134.87 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.819 1.248 . . . . 0.0 111.751 -177.773 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.75 118.92 11.99 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.997 1.319 . . . . 0.0 109.096 172.859 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -63.4 130.46 44.56 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.983 0.913 . . . . 0.0 110.618 176.46 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.6 pt -96.8 154.78 38.23 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 124.645 1.178 . . . . 0.0 112.669 -173.758 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.66 146.54 43.69 Favored 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 122.515 2.143 . . . . 0.0 110.85 159.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.11 135.5 29.78 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.944 2.429 . . . . 0.0 111.615 177.644 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -153.16 -170.89 3.75 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.074 1.35 . . . . 0.0 112.036 179.373 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.64 -1.31 13.25 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.286 1.834 . . . . 0.0 114.633 176.832 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.8 m 60.63 -76.79 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 127.412 2.285 . . . . 0.0 114.092 -171.851 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -62.71 -30.62 71.55 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.352 1.461 . . . . 0.0 114.424 -164.093 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.0 ptt-85 -103.72 -12.31 17.07 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 178.658 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.83 -16.38 0.88 Allowed Glycine 0 N--CA 1.47 0.93 0 N-CA-C 117.831 1.892 . . . . 0.0 117.831 -162.398 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -78.12 114.43 16.99 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.807 2.303 . . . . 0.0 108.328 161.653 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.18 21.19 11.85 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -176.104 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 57.18 -50.26 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.856 2.462 . . . . 0.0 114.879 -168.421 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.3 m -63.63 -13.89 46.64 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.61 1.964 . . . . 0.0 114.692 -178.474 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.53 -24.0 58.9 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.697 1.199 . . . . 0.0 112.506 172.77 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 12.5 m0 -88.25 168.47 12.69 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.068 1.747 . . . . 0.0 111.499 -174.753 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.3 mtpp -77.45 53.82 1.09 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.836 1.654 . . . . 0.0 113.402 176.861 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.5 mt -55.76 -38.23 69.56 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.84 1.256 . . . . 0.0 114.017 -173.375 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -87.12 -3.84 59.1 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.518 1.127 . . . . 0.0 113.029 179.444 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -136.74 63.64 47.07 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 126.339 1.856 . . . . 0.0 111.561 -166.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -68.9 148.15 69.97 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 CA-C-N 119.916 1.006 . . . . 0.0 113.103 -169.689 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -69.49 -31.12 69.19 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.901 0.88 . . . . 0.0 111.355 168.626 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 39.6 t90 -161.25 155.68 23.04 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.667 1.987 . . . . 0.0 110.414 177.432 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 55.5 p -135.28 147.81 49.33 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.835 1.254 . . . . 0.0 112.002 171.361 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.11 -142.36 5.27 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.177 0.418 . . . . 0.0 114.064 179.994 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.3 mtm180 -106.91 145.27 32.4 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.434 1.894 . . . . 0.0 111.619 -174.596 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.7 tp -82.46 138.49 34.36 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.714 0.806 . . . . 0.0 109.544 163.428 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.6 ttt-85 -145.75 90.76 2.02 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 122.159 0.981 . . . . 0.0 111.333 163.307 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.45 HD11 ' CD1' ' A' ' 119' ' ' PHE . 13.0 mt -73.6 128.3 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 170.444 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.2 p -134.79 175.96 9.09 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.958 2.103 . . . . 0.0 110.642 -177.248 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.7 t -156.53 148.94 23.42 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.687 -1.258 . . . . 0.0 111.118 173.78 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.415 ' HG2' ' CD2' ' A' ' 7' ' ' TYR . 11.4 tppt? -150.77 132.11 14.6 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.358 0.663 . . . . 0.0 112.76 154.168 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.12 51.13 19.48 Favored Glycine 0 N--CA 1.474 1.213 0 C-N-CA 124.561 1.076 . . . . 0.0 114.298 169.092 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 59.3 23.47 11.9 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 126.412 1.885 . . . . 0.0 113.326 -175.619 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.5 m -130.79 111.65 12.33 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 125.2 1.4 . . . . 0.0 108.733 176.494 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.93 159.36 24.96 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.073 0.463 . . . . 0.0 110.371 172.389 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -137.98 107.24 6.08 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.787 1.635 . . . . 0.0 108.577 -176.187 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.5 mp -78.36 96.63 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 106.463 -1.681 . . . . 0.0 106.463 167.177 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -95.67 137.99 33.96 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.168 0.587 . . . . 0.0 111.479 174.601 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.6 mp -110.43 129.77 55.7 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.066 1.746 . . . . 0.0 110.183 177.024 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -132.9 149.77 52.22 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -166.384 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -65.98 142.5 57.82 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.986 -1.071 . . . . 0.0 112.788 179.02 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.34 -3.78 35.48 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 116.955 2.206 . . . . 0.0 116.955 -177.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.1 t -117.59 -45.04 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.506 1.122 . . . . 0.0 111.822 174.289 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.7 m -117.2 -4.82 11.38 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -169.759 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.5 15.15 79.19 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 123.871 0.748 . . . . 0.0 114.245 176.638 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -61.33 131.72 51.23 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.906 1.683 . . . . 0.0 111.308 -177.267 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 39.0 tp -69.78 115.92 9.57 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 122.782 0.433 . . . . 0.0 111.146 -178.104 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -81.36 -53.87 5.95 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.439 1.095 . . . . 0.0 111.085 173.088 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.55 160.93 38.68 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.064 1.346 . . . . 0.0 111.206 -178.971 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -141.87 137.14 31.19 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.758 0.823 . . . . 0.0 112.572 174.776 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.65 103.72 50.35 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.136 1.374 . . . . 0.0 111.182 177.6 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -67.9 140.97 52.08 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 124.17 3.247 . . . . 0.0 112.65 172.015 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.2 t -135.3 126.63 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.788 1.635 . . . . 0.0 109.464 -177.994 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -90.24 -24.32 20.99 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 179.704 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -161.59 150.0 15.5 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.696 1.999 . . . . 0.0 110.401 172.44 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -121.63 132.38 24.24 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.74 1.216 . . . . 0.0 111.57 176.403 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -62.15 147.21 54.06 Favored 'Cis proline' 0 CA--C 1.541 0.854 0 CA-C-N 119.874 0.991 . . . . 0.0 113.583 -7.153 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.63 -172.49 32.17 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.632 1.11 . . . . 0.0 113.954 -178.722 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.2 tp -61.87 -34.92 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -171.619 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.05 4.62 49.68 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -169.062 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.8 t -149.04 126.48 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.414 1.086 . . . . 0.0 110.539 -178.645 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -139.43 158.57 43.91 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.799 2.04 . . . . 0.0 111.775 -172.698 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.1 p -113.52 163.52 14.82 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.579 1.952 . . . . 0.0 111.381 -179.051 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.2 m -88.8 178.67 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.255 1.422 . . . . 0.0 109.769 165.496 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.2 t -105.16 -23.81 12.85 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.707 1.203 . . . . 0.0 113.604 179.456 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -88.65 -51.17 5.82 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -174.673 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.3 t -139.37 129.79 25.61 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -174.56 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.66 -2.86 12.89 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -171.562 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.485 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.299 31.4 ptt180 -84.78 15.65 3.77 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 178.061 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -140.36 136.77 33.49 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.203 1.401 . . . . 0.0 110.768 -172.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -138.48 165.43 26.86 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.271 1.429 . . . . 0.0 111.281 -178.634 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.5 t -118.49 141.53 37.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 124.7 1.2 . . . . 0.0 108.745 165.547 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.8 148.11 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 119.036 0.835 . . . . 0.0 112.516 171.711 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -89.17 82.41 6.59 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.794 0.838 . . . . 0.0 111.1 177.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -67.72 141.96 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 121.01 0.433 . . . . 0.0 111.04 176.04 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -138.17 151.64 47.92 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.831 1.653 . . . . 0.0 111.307 -170.296 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -96.55 2.98 52.89 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.257 1.023 . . . . 0.0 113.199 179.222 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.45 12.59 82.86 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 125.138 1.352 . . . . 0.0 114.751 178.487 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.3 t -137.37 12.5 3.01 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.576 1.551 . . . . 0.0 113.521 -171.655 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.21 -1.89 70.66 Favored Glycine 0 CA--C 1.538 1.498 0 O-C-N 120.736 -1.227 . . . . 0.0 114.975 -178.266 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -75.59 135.99 40.52 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.283 1.433 . . . . 0.0 108.595 164.653 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 65.0 p -151.28 160.32 43.87 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 171.642 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.95 147.54 32.81 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.367 1.467 . . . . 0.0 110.873 168.249 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -92.15 115.4 28.05 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.421 0.689 . . . . 0.0 109.316 169.355 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 28.8 pt -112.7 141.73 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.379 1.072 . . . . 0.0 110.747 179.419 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.15 139.73 15.38 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 175.954 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.2 pt -129.49 155.37 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 125.259 1.424 . . . . 0.0 111.952 172.351 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -148.48 166.29 29.13 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 114.421 0.528 . . . . 0.0 114.421 168.57 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -116.73 162.76 17.18 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.995 1.718 . . . . 0.0 111.388 -175.378 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.3 t -70.54 -22.9 62.56 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.462 0.705 . . . . 0.0 112.455 175.635 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -152.76 147.24 25.84 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.798 0.839 . . . . 0.0 112.537 -174.267 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 47.1 ttt-85 -62.61 -32.61 73.65 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.694 1.198 . . . . 0.0 113.152 179.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.26 -27.21 73.84 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-N 118.908 0.776 . . . . 0.0 113.851 176.649 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -84.33 -36.2 22.71 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 118.074 0.937 . . . . 0.0 111.658 175.814 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.485 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -65.17 -32.34 73.98 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 168.564 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -59.32 -37.48 77.89 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.264 -0.898 . . . . 0.0 111.98 173.279 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -67.19 -31.42 71.81 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.194 -0.941 . . . . 0.0 112.847 176.013 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.45 ' CD1' HD11 ' A' ' 49' ' ' ILE . 22.0 t80 -58.6 -50.91 72.09 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.295 0.952 . . . . 0.0 111.545 171.667 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.2 -24.28 30.15 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -176.302 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.3 t -78.46 -40.37 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 O-C-N 121.068 -1.02 . . . . 0.0 110.954 176.641 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 95.0 p -63.75 -28.86 70.17 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 177.411 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 78.5 mt -72.14 -52.97 14.18 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.182 0.993 . . . . 0.0 111.923 172.307 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -68.58 -31.17 70.18 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.993 -1.067 . . . . 0.0 113.22 -176.112 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -87.88 2.14 52.24 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.641 1.176 . . . . 0.0 112.492 174.383 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -92.03 -40.02 11.32 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 120.74 -1.225 . . . . 0.0 111.992 163.975 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -89.31 -1.73 58.18 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 -174.518 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.56 -32.44 63.0 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 120.25 1.386 . . . . 0.0 114.524 -175.07 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 30.6 p-90 -81.36 -28.6 34.37 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.624 1.17 . . . . 0.0 113.301 178.034 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 37.6 t -74.42 -30.23 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.024 1.329 . . . . 0.0 110.967 175.707 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -105.3 40.99 1.42 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.348 1.859 . . . . 0.0 112.632 -178.524 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -82.5 4.77 23.04 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 162.889 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 C--O 1.252 1.22 0 C-N-CA 128.699 2.8 . . . . 0.0 112.172 177.905 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.608 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 56.2 m -135.04 145.63 55.19 Favored Pre-proline 0 N--CA 1.477 0.921 0 C-N-CA 125.252 1.421 . . . . 0.0 111.756 -176.175 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -70.49 -34.87 11.43 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.044 2.496 . . . . 0.0 112.23 175.11 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -78.34 138.43 38.55 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.699 1.999 . . . . 0.0 111.302 171.584 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 64.4 p -85.25 -11.63 54.4 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.057 1.343 . . . . 0.0 114.297 -179.009 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.04 171.73 13.67 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.369 1.868 . . . . 0.0 111.534 -179.495 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.23 -39.61 0.53 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.545 1.138 . . . . 0.0 112.693 173.568 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 88.2 m -140.78 123.93 16.55 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.286 1.834 . . . . 0.0 108.424 170.784 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -138.56 34.1 2.25 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.967 1.307 . . . . 0.0 113.2 -177.506 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.78 58.1 1.8 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.182 1.393 . . . . 0.0 112.379 179.301 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -111.68 40.51 2.11 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.13 2.172 . . . . 0.0 111.759 -179.284 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -142.55 148.15 37.1 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 126.802 2.041 . . . . 0.0 109.142 -172.874 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -177.84 125.14 0.12 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.572 1.549 . . . . 0.0 108.797 171.118 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.4 m -90.52 110.7 21.82 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.797 -0.565 . . . . 0.0 109.836 166.215 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.9 t -63.57 141.68 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 124.496 1.118 . . . . 0.0 111.717 178.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.4 mt -126.94 -39.9 1.92 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.992 1.717 . . . . 0.0 112.54 -177.369 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.0 t -152.27 133.06 14.06 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.412 1.085 . . . . 0.0 110.821 174.967 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 81.1 t -128.67 128.13 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.394 1.078 . . . . 0.0 109.319 171.822 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -130.49 134.79 26.46 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 125.293 1.437 . . . . 0.0 110.337 176.429 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -77.35 -13.96 16.58 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.285 2.657 . . . . 0.0 114.76 -174.347 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -134.37 106.57 7.15 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.404 1.082 . . . . 0.0 111.236 -174.125 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -143.69 144.64 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.144 1.378 . . . . 0.0 110.205 171.078 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.0 m -118.0 140.66 49.42 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.354 1.062 . . . . 0.0 111.388 -176.485 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 66.1 t -105.76 138.28 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.726 1.61 . . . . 0.0 111.792 175.741 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -125.1 127.99 47.76 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.47 1.508 . . . . 0.0 108.995 170.67 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -76.58 111.62 12.25 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 165.111 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.7 pt -87.57 153.15 52.84 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 124.492 1.117 . . . . 0.0 113.286 -164.185 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -64.94 167.84 15.0 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.646 2.898 . . . . 0.0 112.402 171.502 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.32 91.65 0.33 Allowed 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.649 2.9 . . . . 0.0 112.294 178.038 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.75 161.83 35.51 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 128.337 2.655 . . . . 0.0 109.895 177.02 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -143.25 160.46 40.43 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.302 1.441 . . . . 0.0 111.386 -179.331 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 76.9 p -57.38 -32.79 67.16 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.782 2.033 . . . . 0.0 114.93 -179.521 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -77.02 -4.42 44.07 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.96 1.304 . . . . 0.0 112.726 178.453 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -110.98 -43.92 3.69 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 127.634 2.374 . . . . 0.0 110.185 172.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.7 118.14 3.53 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 127.178 2.323 . . . . 0.0 113.037 174.278 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -66.14 143.75 57.09 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.332 1.053 . . . . 0.0 109.455 163.512 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.66 25.03 8.93 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.046 0.938 . . . . 0.0 113.385 178.796 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 60.42 -44.81 0.1 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.569 2.347 . . . . 0.0 114.936 -172.269 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.6 m -63.92 -13.14 43.27 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.738 2.015 . . . . 0.0 114.26 177.122 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -59.03 -30.6 68.15 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.834 0.853 . . . . 0.0 112.839 164.95 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 9.2 m0 -99.24 171.23 8.13 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.035 1.334 . . . . 0.0 112.592 -164.447 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -78.86 49.34 0.9 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.377 1.871 . . . . 0.0 113.87 -178.531 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.8 mt -54.86 -35.07 63.63 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -166.635 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -94.79 -1.87 52.02 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.203 1.001 . . . . 0.0 113.644 179.552 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -145.46 73.76 14.04 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 125.573 1.549 . . . . 0.0 112.019 179.658 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.85 148.16 38.63 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.515 2.81 . . . . 0.0 113.736 178.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -71.93 -31.54 66.45 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.247 0.619 . . . . 0.0 111.295 168.269 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 48.7 t90 -154.3 154.37 33.26 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.846 1.659 . . . . 0.0 110.869 174.793 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.4 p -133.36 148.37 51.85 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.109 0.964 . . . . 0.0 111.674 169.004 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.51 -141.76 4.69 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 116.366 -0.379 . . . . 0.0 113.433 -178.804 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.7 mtm105 -114.32 144.97 42.4 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.152 1.781 . . . . 0.0 111.92 -172.901 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.1 tp -85.34 139.98 31.14 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.26 1.424 . . . . 0.0 109.822 168.386 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.1 ttt85 -145.5 86.64 1.75 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.699 1.199 . . . . 0.0 110.866 168.245 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.44 HD11 ' CD2' ' A' ' 119' ' ' PHE . 21.0 mt -74.33 127.74 36.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 170.649 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 p -136.51 171.68 14.14 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.854 2.062 . . . . 0.0 110.188 -178.663 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.7 t -156.7 148.89 23.12 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 120.632 -1.292 . . . . 0.0 111.674 177.866 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -153.59 128.26 9.39 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.723 0.809 . . . . 0.0 112.193 161.418 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.35 54.12 18.0 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.316 0.96 . . . . 0.0 114.231 166.344 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 93.8 mttt 60.02 25.75 15.01 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 126.249 1.82 . . . . 0.0 113.31 -176.059 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.8 m -136.22 114.45 11.57 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.25 1.42 . . . . 0.0 109.429 177.875 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.7 159.78 19.06 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.559 0.743 . . . . 0.0 110.775 173.872 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -139.89 105.31 5.07 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.099 1.76 . . . . 0.0 108.725 -175.727 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.4 mp -79.99 91.99 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 167.974 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -86.01 138.18 32.16 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.221 0.608 . . . . 0.0 110.421 173.167 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.4 mp -112.17 133.33 54.37 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.125 1.77 . . . . 0.0 109.645 173.103 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -135.14 153.47 51.98 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -172.269 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -73.92 144.61 45.26 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.946 0.879 . . . . 0.0 111.94 179.614 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.4 pttt -85.36 -6.18 59.25 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.368 1.867 . . . . 0.0 115.125 -178.635 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 92.6 t -122.47 -44.61 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.234 1.414 . . . . 0.0 111.437 178.648 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.2 m -92.32 -23.06 19.38 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -175.296 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.96 7.16 86.48 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 123.973 0.797 . . . . 0.0 113.702 -177.452 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -82.7 154.51 24.8 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.288 1.435 . . . . 0.0 112.473 -175.082 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.5 tp -73.45 127.18 31.99 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.371 0.668 . . . . 0.0 110.827 177.337 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -84.47 -54.99 4.38 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.427 1.091 . . . . 0.0 110.922 170.098 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -159.5 165.85 32.12 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.689 1.596 . . . . 0.0 110.562 179.755 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -144.99 142.49 29.84 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 168.706 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.78 111.53 48.5 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.071 1.348 . . . . 0.0 111.378 177.729 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -82.85 140.29 10.18 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.57 2.847 . . . . 0.0 111.502 176.961 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.26 128.61 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.396 1.478 . . . . 0.0 109.857 -174.449 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -90.64 -24.26 20.55 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 178.274 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -164.31 149.37 10.15 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.144 1.778 . . . . 0.0 110.411 171.569 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.419 ' CD2' ' HA ' ' A' ' 78' ' ' PRO . 82.5 t80 -125.75 130.28 24.09 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.819 1.248 . . . . 0.0 111.53 -177.554 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.419 ' HA ' ' CD2' ' A' ' 77' ' ' TYR . 73.5 Cg_endo -66.51 143.89 65.54 Favored 'Cis proline' 0 CA--C 1.54 0.801 0 CA-C-N 120.267 1.131 . . . . 0.0 113.353 -2.077 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.02 -168.34 29.06 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.12 1.343 . . . . 0.0 113.637 -176.607 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.3 tp -59.08 -39.64 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -169.659 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -89.31 3.84 50.78 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -167.395 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.6 t -151.54 124.18 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.392 1.077 . . . . 0.0 110.82 -176.88 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -141.39 167.07 23.04 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.626 1.97 . . . . 0.0 112.863 -176.264 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 73.1 p -121.25 158.62 27.72 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.503 1.521 . . . . 0.0 112.061 -169.807 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.3 m -84.62 168.12 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.839 0.856 . . . . 0.0 110.676 166.584 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 72.3 p -96.74 -24.94 15.71 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.956 1.302 . . . . 0.0 113.642 179.532 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -98.69 -38.97 8.89 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -166.21 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.6 t -138.87 124.12 19.17 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -173.905 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.2 m -74.54 26.1 0.08 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 -168.226 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.467 ' HA ' ' CB ' ' A' ' 116' ' ' ALA 0.265 34.3 ptt180 -125.29 18.69 8.26 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.631 1.572 . . . . 0.0 114.923 179.851 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -140.28 142.6 35.7 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.404 1.082 . . . . 0.0 112.167 -171.795 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -141.7 158.2 44.11 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.189 1.396 . . . . 0.0 111.933 -176.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.2 t -110.68 137.93 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.939 0.895 . . . . 0.0 108.812 163.555 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.88 146.73 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 119.263 0.938 . . . . 0.0 112.018 172.472 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -91.16 92.54 8.72 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.379 0.672 . . . . 0.0 110.124 175.737 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 pp -74.49 152.72 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.07 0.548 . . . . 0.0 111.229 176.09 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.03 150.35 45.03 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.488 1.515 . . . . 0.0 111.171 173.865 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -99.52 17.23 20.89 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.08 1.352 . . . . 0.0 113.257 -178.944 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.86 6.55 87.24 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.385 1.469 . . . . 0.0 115.603 175.669 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.1 t -131.06 5.27 4.5 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.473 1.509 . . . . 0.0 113.757 -174.289 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.14 -7.56 72.73 Favored Glycine 0 N--CA 1.478 1.439 0 C-N-CA 125.381 1.467 . . . . 0.0 113.86 -176.049 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 49.3 ttt180 -70.07 132.19 45.48 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 127.301 2.241 . . . . 0.0 108.927 165.184 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 95.3 p -139.12 159.19 42.74 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.125 1.37 . . . . 0.0 113.952 -178.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -147.96 146.1 28.84 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.989 1.315 . . . . 0.0 111.226 172.124 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -87.9 121.11 29.92 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 166.147 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.8 pt -119.32 144.93 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.82 1.248 . . . . 0.0 110.58 176.295 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.04 141.33 16.24 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 174.355 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.6 pt -126.33 144.49 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 124.548 1.139 . . . . 0.0 112.503 168.961 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -125.67 138.27 10.77 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 124.857 1.218 . . . . 0.0 113.244 177.923 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -102.91 163.6 12.12 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.849 1.66 . . . . 0.0 109.998 166.541 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.9 t -92.91 -20.65 20.43 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 175.559 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -109.15 -18.75 13.56 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -149.47 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 60.49 -48.72 0.1 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.914 2.086 . . . . 0.0 114.134 -161.236 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.44 -31.2 66.12 Favored Glycine 0 CA--C 1.539 1.564 0 CA-C-N 119.578 1.081 . . . . 0.0 114.176 174.575 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -81.0 -32.01 34.41 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.35 -1.088 . . . . 0.0 112.466 175.648 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.467 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -68.57 -32.69 72.78 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 168.112 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -60.67 -47.49 86.04 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.588 0.755 . . . . 0.0 110.204 166.767 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -60.3 -42.2 95.01 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 118.703 0.683 . . . . 0.0 112.356 177.19 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.44 ' CD2' HD11 ' A' ' 49' ' ' ILE . 36.9 t80 -53.09 -54.81 30.1 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.811 1.244 . . . . 0.0 112.566 174.125 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -82.4 -26.04 33.17 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -174.71 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.3 t -75.92 -40.97 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 121.6 -0.687 . . . . 0.0 110.898 177.823 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 91.4 p -64.05 -29.81 70.92 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 175.217 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.5 mt -68.81 -59.09 3.33 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.087 0.955 . . . . 0.0 111.779 170.168 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -64.94 -30.98 72.0 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -172.791 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -83.25 -4.15 58.14 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.648 1.179 . . . . 0.0 112.721 178.218 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -95.32 -11.71 27.36 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.94 -1.1 . . . . 0.0 113.39 165.639 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -110.42 -6.02 15.05 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 179.376 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -35.91 64.14 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 121.182 1.81 . . . . 0.0 113.896 -176.521 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 25.2 p-90 -75.89 -33.06 59.92 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.826 1.251 . . . . 0.0 112.887 178.242 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.0 t -68.72 -37.92 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.675 1.19 . . . . 0.0 110.55 174.137 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -83.92 -1.1 53.88 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.478 1.511 . . . . 0.0 114.888 175.429 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 47.81 42.52 16.0 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 127.586 2.354 . . . . 0.0 114.538 -176.743 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 . . . . . 0 C--O 1.254 1.302 0 C-N-CA 126.213 1.805 . . . . 0.0 113.471 175.986 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.629 0 N-CA-C 112.11 -0.396 . . . . 0.0 112.11 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 46.6 m -67.02 146.61 99.11 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 124.296 1.038 . . . . 0.0 112.852 -178.621 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' -2' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.7 104.62 0.99 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.508 2.805 . . . . 0.0 112.22 -173.471 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' -1' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -131.45 150.12 52.27 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.281 1.833 . . . . 0.0 111.172 176.178 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 46.1 m -102.78 -20.67 14.25 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.427 1.091 . . . . 0.0 113.154 178.118 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.2 ttm -152.28 107.02 3.21 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.55 1.54 . . . . 0.0 109.962 175.02 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.32 17.46 1.53 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.601 1.56 . . . . 0.0 112.719 -178.236 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.5 m 54.78 72.46 0.47 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.412 1.885 . . . . 0.0 111.949 -173.231 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.11 17.82 12.4 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.568 1.947 . . . . 0.0 113.979 -164.934 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.2 mp -60.18 131.46 50.89 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.714 1.205 . . . . 0.0 112.611 -173.21 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -88.37 56.56 3.86 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.95 1.3 . . . . 0.0 110.305 168.232 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -141.06 172.83 12.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.257 2.223 . . . . 0.0 109.819 -175.663 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.486 ' H ' ' HG2' ' A' ' 52' ' ' LYS 0.253 1.8 tt0 70.83 63.6 0.18 Allowed 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 124.075 1.893 . . . . 0.0 107.676 -179.221 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 t -74.35 104.72 5.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 112.327 -2.215 . . . . 0.0 109.301 -170.222 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.9 t -57.83 139.41 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 125.401 1.48 . . . . 0.0 112.088 -174.062 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.3 mt -125.5 -40.36 2.1 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.682 1.593 . . . . 0.0 112.14 -176.353 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 33.0 t -154.41 136.06 14.36 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.495 1.118 . . . . 0.0 110.678 176.926 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.3 t -130.68 125.79 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.421 1.088 . . . . 0.0 109.239 172.42 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -131.61 142.98 47.28 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 124.68 1.192 . . . . 0.0 112.021 176.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.01 -19.08 20.82 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.535 2.824 . . . . 0.0 115.048 -174.951 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -135.15 112.52 10.56 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.777 0.831 . . . . 0.0 112.279 -167.509 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.3 p -149.64 143.27 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.209 1.803 . . . . 0.0 109.902 171.191 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.9 m -120.71 129.23 53.57 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.351 1.06 . . . . 0.0 111.19 -174.272 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.1 t -93.0 140.47 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.331 1.452 . . . . 0.0 111.929 178.57 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -121.62 129.09 52.58 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.659 1.184 . . . . 0.0 109.628 168.655 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 -78.8 73.9 5.33 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.46 1.504 . . . . 0.0 109.841 172.143 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.7 pt -59.88 150.96 66.47 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 125.629 1.572 . . . . 0.0 114.468 -164.516 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.58 160.03 45.15 Favored 'Trans proline' 0 CA--C 1.545 1.025 0 C-N-CA 123.235 2.623 . . . . 0.0 112.168 171.636 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -63.68 142.94 85.53 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.078 2.519 . . . . 0.0 112.159 176.758 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.472 ' CG ' ' H ' ' A' ' 26' ' ' ALA . 1.6 ttp180 -134.39 -147.09 0.27 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.36 1.864 . . . . 0.0 110.232 -177.855 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.472 ' H ' ' CG ' ' A' ' 25' ' ' ARG . . . -125.82 -131.71 0.25 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.65 1.98 . . . . 0.0 110.57 -175.535 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 88.1 p -136.65 -31.4 0.86 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.841 1.657 . . . . 0.0 113.456 -175.319 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -133.35 -2.06 3.14 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.083 1.753 . . . . 0.0 113.702 -174.105 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.8 mmt-85 -87.68 -25.7 23.36 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.023 1.329 . . . . 0.0 113.173 -175.447 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.46 134.23 5.69 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 122.442 1.023 . . . . 0.0 114.003 170.962 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -74.73 156.34 36.72 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.18 0.992 . . . . 0.0 108.891 164.066 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.24 17.88 5.46 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -171.77 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 58.89 -45.84 0.06 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 127.75 2.42 . . . . 0.0 115.679 -175.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.2 m -69.41 -14.46 62.91 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.689 1.596 . . . . 0.0 113.908 -177.318 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.88 -13.31 60.54 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 169.786 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -95.88 171.65 8.51 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.462 1.505 . . . . 0.0 111.613 -174.59 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -79.57 53.81 1.65 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.383 1.473 . . . . 0.0 113.941 -178.463 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 69.3 mt -61.35 -14.85 30.57 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -172.842 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -107.02 -4.51 18.9 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.455 1.102 . . . . 0.0 112.782 177.03 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -150.26 77.18 8.31 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 125.083 1.353 . . . . 0.0 111.653 176.258 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -50.11 141.99 28.95 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.171 2.581 . . . . 0.0 112.462 175.245 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -72.09 -27.72 62.83 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.071 0.548 . . . . 0.0 111.577 175.78 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 33.4 t90 -154.26 156.54 37.21 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.937 1.695 . . . . 0.0 110.738 168.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.9 p -133.97 146.18 50.21 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.623 1.169 . . . . 0.0 111.978 170.327 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 176.77 -142.65 5.97 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 114.536 0.574 . . . . 0.0 114.536 177.213 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -106.22 143.83 33.79 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 126.603 1.961 . . . . 0.0 111.547 -169.822 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.0 tp -88.4 138.18 31.66 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.468 1.507 . . . . 0.0 110.154 170.21 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -143.93 96.77 2.95 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.396 1.078 . . . . 0.0 110.788 168.461 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.427 HD11 ' CD2' ' A' ' 119' ' ' PHE . 16.0 mt -82.06 129.03 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 172.364 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.46 160.57 38.05 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 127.38 2.272 . . . . 0.0 109.738 -177.703 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.7 t -161.37 160.8 29.99 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 120.811 -1.181 . . . . 0.0 111.079 177.517 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.486 ' HG2' ' H ' ' A' ' 8' ' ' GLU . 91.1 mttt -129.22 -106.01 0.29 Allowed 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.142 -0.974 . . . . 0.0 111.499 -174.526 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.59 -116.68 0.21 Allowed Glycine 0 N--CA 1.472 1.072 0 C-N-CA 124.489 1.042 . . . . 0.0 111.134 169.42 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -86.12 25.16 1.2 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.693 1.197 . . . . 0.0 113.118 174.366 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.5 m -137.55 123.0 19.58 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.8 0.84 . . . . 0.0 110.589 -178.312 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.26 164.16 12.25 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.232 1.413 . . . . 0.0 111.706 172.5 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -145.89 103.59 3.77 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.744 1.618 . . . . 0.0 110.054 -172.574 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.7 mp -82.06 101.52 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 169.071 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -102.78 140.8 36.58 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.863 0.84 . . . . 0.0 111.519 176.413 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.3 mp -112.12 132.93 54.58 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.434 1.894 . . . . 0.0 110.045 179.508 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -133.79 151.2 51.5 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.897 0.879 . . . . 0.0 112.518 -168.31 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -69.82 144.0 52.74 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 120.812 -1.18 . . . . 0.0 113.175 -175.409 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.67 -3.79 36.6 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 116.666 2.099 . . . . 0.0 116.666 -179.365 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.1 t -118.8 -50.44 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.749 1.22 . . . . 0.0 110.892 172.622 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.0 m -96.9 -18.15 19.68 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -170.245 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.22 12.6 76.29 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.317 0.96 . . . . 0.0 113.759 -175.672 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -79.97 150.83 30.34 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.079 1.352 . . . . 0.0 112.005 -176.603 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 32.5 tp -71.34 122.16 19.81 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.85 0.86 . . . . 0.0 111.797 -171.663 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -84.64 -56.25 3.7 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.272 1.029 . . . . 0.0 110.877 169.547 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.81 163.24 40.08 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.973 1.309 . . . . 0.0 111.537 -179.042 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -143.85 132.82 22.78 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.603 1.161 . . . . 0.0 111.561 -179.351 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.56 97.78 49.41 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 124.721 1.208 . . . . 0.0 111.236 176.009 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -58.03 136.29 74.04 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 124.085 3.19 . . . . 0.0 112.288 163.065 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.7 t -132.24 123.54 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 126.528 1.931 . . . . 0.0 108.885 -178.42 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -91.56 -19.32 22.88 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 121.413 -0.804 . . . . 0.0 112.781 -177.405 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -163.64 143.21 8.3 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.831 2.452 . . . . 0.0 109.425 -178.584 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -135.92 121.93 13.9 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-O 118.375 -0.822 . . . . 0.0 111.301 175.291 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -61.92 149.45 57.75 Favored 'Cis proline' 0 CA--C 1.539 0.758 0 CA-C-N 119.956 1.02 . . . . 0.0 114.504 -1.648 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -170.96 -158.29 14.58 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 126.016 1.769 . . . . 0.0 112.442 -177.109 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.3 tt -79.17 -39.03 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -176.556 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.35 4.49 17.72 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -168.145 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.9 t -152.02 129.01 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 126.028 1.731 . . . . 0.0 109.744 179.86 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -141.05 160.26 40.47 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.05 1.74 . . . . 0.0 112.24 176.656 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.6 p -101.23 159.39 15.29 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.988 1.715 . . . . 0.0 111.589 175.324 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.4 m -81.28 169.34 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 O-C-N 121.587 -0.696 . . . . 0.0 110.523 162.418 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.5 p -98.31 -24.69 15.12 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.168 1.387 . . . . 0.0 113.587 -178.278 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -100.84 -40.41 7.32 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -167.136 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.5 t -134.41 116.15 14.84 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -175.038 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.6 m -73.59 24.93 0.07 Allowed 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 116.159 1.911 . . . . 0.0 116.159 -165.386 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.413 ' HA ' ' CB ' ' A' ' 116' ' ' ALA . 4.9 ptm180 -127.3 23.43 6.42 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 127.309 2.244 . . . . 0.0 113.875 -178.915 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -140.82 143.94 35.09 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.756 1.623 . . . . 0.0 111.955 -177.124 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -142.04 161.24 38.49 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.251 1.42 . . . . 0.0 111.496 -178.299 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 89.0 t -114.73 139.67 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.403 1.081 . . . . 0.0 109.112 166.455 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.64 147.83 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 118.667 0.667 . . . . 0.0 112.085 173.808 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -89.51 89.33 7.8 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.838 0.855 . . . . 0.0 110.745 178.322 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.1 pp -71.32 140.38 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 122.542 0.337 . . . . 0.0 111.172 175.616 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -137.42 145.38 43.12 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.999 1.72 . . . . 0.0 111.718 -172.769 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -89.76 1.15 56.46 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.895 0.878 . . . . 0.0 113.161 179.071 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.96 12.55 80.99 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 125.248 1.404 . . . . 0.0 114.758 178.617 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.2 t -138.33 16.72 2.77 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.47 1.508 . . . . 0.0 113.44 -172.836 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.82 -3.14 80.9 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.704 1.145 . . . . 0.0 114.975 -178.418 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -76.04 133.97 40.22 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.242 1.417 . . . . 0.0 108.509 164.38 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.9 p -151.67 161.18 43.1 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 171.62 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.91 149.1 34.7 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.661 1.584 . . . . 0.0 110.964 170.021 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -94.05 117.36 30.0 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.465 0.706 . . . . 0.0 109.308 169.122 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 17.8 pt -116.61 147.41 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.595 1.158 . . . . 0.0 111.046 177.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -87.73 146.15 19.8 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 172.394 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.2 pt -129.02 145.51 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 125.388 1.475 . . . . 0.0 111.488 167.167 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.61 146.53 16.96 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 125.097 1.332 . . . . 0.0 113.518 177.163 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -108.47 164.48 12.3 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.286 1.834 . . . . 0.0 111.77 178.605 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.6 t -73.88 -25.49 60.06 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.056 0.942 . . . . 0.0 112.906 177.049 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -156.41 154.68 30.86 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.759 1.224 . . . . 0.0 111.924 -176.229 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -57.45 -35.62 70.37 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.253 1.021 . . . . 0.0 112.82 175.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.25 -35.97 92.36 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 119.48 1.036 . . . . 0.0 113.406 -179.802 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -80.19 -35.48 36.28 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 117.988 0.894 . . . . 0.0 112.265 177.256 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.413 ' CB ' ' HA ' ' A' ' 90' ' ' ARG . . . -62.88 -39.45 94.51 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 169.237 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -68.67 -33.54 74.15 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.065 -1.022 . . . . 0.0 111.877 174.403 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -68.2 -36.87 80.24 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 119.365 0.984 . . . . 0.0 112.417 173.731 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.427 ' CD2' HD11 ' A' ' 49' ' ' ILE . 3.5 t80 -57.91 -45.59 86.26 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.134 1.374 . . . . 0.0 111.65 168.649 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -74.95 -38.16 61.79 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.713 1.205 . . . . 0.0 113.252 -176.399 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.9 t -77.73 -39.75 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 O-C-N 121.213 -0.93 . . . . 0.0 111.599 -179.088 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 78.7 p -64.79 -30.78 71.8 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.236 -0.915 . . . . 0.0 113.125 177.248 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 44.4 tp -73.12 -49.17 29.85 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.805 1.242 . . . . 0.0 111.689 175.331 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -70.52 -23.53 62.66 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.248 -0.907 . . . . 0.0 113.434 -178.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -79.42 -1.04 35.41 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.378 1.071 . . . . 0.0 112.418 175.572 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 45.2 t60 -87.94 -35.3 17.74 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.325 -0.859 . . . . 0.0 112.708 157.504 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -89.29 -5.55 57.48 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 -172.819 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.87 -27.3 41.52 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 115.81 1.782 . . . . 0.0 115.81 -175.397 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 29.6 p-90 -84.99 -22.04 29.25 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.546 1.139 . . . . 0.0 113.822 174.794 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 19.1 t -86.66 -34.19 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.929 1.692 . . . . 0.0 111.295 177.354 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.8 mmtt -89.21 30.98 0.91 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.873 2.069 . . . . 0.0 112.893 -177.737 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -80.84 92.55 6.11 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.975 0.91 . . . . 0.0 109.728 173.215 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 . . . . . 0 C--O 1.252 1.198 0 C-N-CA 126.955 2.102 . . . . 0.0 112.558 -176.448 . . . . . . . . 0 0 . 1 stop_ save_